Citrus Sinensis ID: 018071

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-
Protein Sequence
MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGESAS
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccEEcccccEEEEEEEEccccEEEEEEccccccccHHHHHHHHHHHcccccccccEEEEEcccccEEEEEEEcccccHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccHHHHHHHHHHHcccccccccccccccHHHccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEEEcccccEEEEEEEccccccHHHHHHHHHHHHHHHcccHEEEEEEEEccccEEEEEEEcccccHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHHccccEEEEcccHcHEEccccccccHccccHHHccccccccEEEEEEEEccccccHHHHHHccccHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHcccccccccccc
Coil and Loop (DISEMBL)
mscfgcceeddmhkaadngnaymvkssagtdgayhaseaapkgaqavkvqpievpaisVDELKEITENfgtnaligegsygRVYYGILKSGHAAAIKKldaskqpdeEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFasngslhdilhgrkgvkgaqpgpvlswQQRVKIAVGAAKGLEylhekadphiihrdikssnvlifdddvakiadfdlsnqapdMAARLHSTRVLgtfgyhapeyamtgqlnaksdVYSFGVVLLELltgrkpvdhtlprgqqslvtwatpklsedkvrqcvdarlggdyppKAVAKMAAVAALCVQYEADFRPNMSIVVKALQpllnarpgpagesas
Flexible Loop (DISEMBL)
MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFgtnaligegSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTgrkpvdhtlprgqqslvtwatpklsedkvRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPllnarpgpagesas
Low Complexity Region (SEG)
MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPkavakmaavaaLCVQYEADFRPNMSIVVKALQPLLNARPGPAGESAS
Disordered region (IsUnstruct)
**********************************************VKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL*********FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL*************
Disordered Region (DISOPRED)
MSC****************************************************AISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ***************
Disordered Region (DISEMBL)
MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHAS**********KVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA**********
Disordered Region (DISPRO)
**************************************************PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN***********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGESAS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	361	2.2.26 [Sep-21-2011]
Q41328	354	Pto-interacting protein 1	N/A	no	0.980	1.0	0.834	1e-171
O80719	365	Probable receptor-like pr	no	no	0.991	0.980	0.828	1e-167
Q8H1G6	361	PTI1-like tyrosine-protei	no	no	0.944	0.944	0.720	1e-137
B9DFG5	408	PTI1-like tyrosine-protei	no	no	0.952	0.843	0.695	1e-135
O49339	366	PTI1-like tyrosine-protei	no	no	0.828	0.816	0.784	1e-135
P93749	365	Probable protein kinase A	no	no	0.977	0.967	0.653	1e-132
Q8RWW0	744	Receptor-like serine/thre	no	no	0.797	0.387	0.481	2e-74
Q9FE20	456	Serine/threonine-protein	no	no	0.983	0.778	0.428	4e-72
Q9SGY7	718	Putative proline-rich rec	no	no	0.778	0.391	0.5	4e-72
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.872	0.462	0.431	5e-72

>sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2

 Score =  602 bits (1552), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 297/356 (83%), Positives = 325/356 (91%), Gaps = 2/356 (0%)

Query: 1   MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
           MSCF CC++DDMH+A DNG  +M  +SAG +G   A+E+A +  Q V +QPI VP+I+VD
Sbjct: 1   MSCFSCCDDDDMHRATDNG-PFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVD 59

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ELK+IT+NFG+ ALIGEGSYGRVY+G+LKSG AAAIKKLD+SKQPD EFLAQVSMVSRLK
Sbjct: 60  ELKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLK 119

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
            EN V+LLGYCVDG  RVLAYE+A NGSLHDILHGRKGVKGAQPGPVLSW QRVKIAVGA
Sbjct: 120 DENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGA 179

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKGLEYLHEKA PHIIHRDIKSSN+L+FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 180 AKGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 239

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           GYHAPEYAMTGQL++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+LSEDKV
Sbjct: 240 GYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPRLSEDKV 299

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPA 356
           +QCVDARL  DYPPKA+AKMAAVAALCVQYEADFRPNMSIVVKALQPLL  RP P+
Sbjct: 300 KQCVDARLNTDYPPKAIAKMAAVAALCVQYEADFRPNMSIVVKALQPLL-PRPVPS 354

A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade.
Solanum lycopersicum (taxid: 4081)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1

 Score =  589 bits (1519), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 300/362 (82%), Positives = 323/362 (89%), Gaps = 4/362 (1%)

Query: 1   MSCFGCC-EEDDMHKAADNGNAYMVKS--SAGTDGAYH-ASEAAPKGAQAVKVQPIEVPA 56
           MSCFGCC E+DDMHK AD G  +        G D  +H ASE A KG   VK+QPIEVP 
Sbjct: 1   MSCFGCCGEDDDMHKTADYGGRHNQAKHFPPGNDARHHQASETAQKGPPVVKLQPIEVPI 60

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
           I   ELKE T++FG+N+LIGEGSYGRVYYG+L +   +AIKKLD++KQPD EFLAQVSMV
Sbjct: 61  IPFSELKEATDDFGSNSLIGEGSYGRVYYGVLNNDLPSAIKKLDSNKQPDNEFLAQVSMV 120

Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           SRLKH+NFVQLLGYCVDG SR+L+YEFA+NGSLHDILHGRKGVKGAQPGPVLSW QRVKI
Sbjct: 121 SRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHGRKGVKGAQPGPVLSWYQRVKI 180

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           AVGAA+GLEYLHEKA+PHIIHRDIKSSNVL+F+DDVAKIADFDLSNQAPDMAARLHSTRV
Sbjct: 181 AVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKIADFDLSNQAPDMAARLHSTRV 240

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 296
           LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH LPRGQQSLVTWATPKLS
Sbjct: 241 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHRLPRGQQSLVTWATPKLS 300

Query: 297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPA 356
           EDKV+QCVDARLGGDYPPKAVAK+AAVAALCVQYEADFRPNMSIVVKALQPLLNAR    
Sbjct: 301 EDKVKQCVDARLGGDYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNARAVAP 360

Query: 357 GE 358
           GE
Sbjct: 361 GE 362

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1

 Score =  488 bits (1255), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 253/351 (72%), Positives = 284/351 (80%), Gaps = 10/351 (2%)

Query: 3   CFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQ--PIEVPAISVD 60
           C  C  ED       N    +  S   +D  +  S+ AP     VK +  PIEVP +S+D
Sbjct: 6   CCTCQIEDS------NEEQQLKSSQQQSDANHKNSKPAPVAKHEVKKEALPIEVPPLSLD 59

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQVSMVSR 118
           E+KE TENFG+ ALIGEGSYGRVYY  L  G A A+KKLD + +   D EFL+QVSMVSR
Sbjct: 60  EVKEKTENFGSKALIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTEFLSQVSMVSR 119

Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
           LKHEN +QLLG+CVDG  RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L W  RVKIAV
Sbjct: 120 LKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRVKIAV 179

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
            AA+GLEYLHEK+ P +IHRDI+SSNVL+F+D  AKIADF+LSNQAPD AARLHSTRVLG
Sbjct: 180 EAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLHSTRVLG 239

Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           TFGYHAPEYAMTGQL  KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+LSED
Sbjct: 240 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 299

Query: 299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
           KV+QC+D +L  DYPPKAVAK+AAVAALCVQYEA+FRPNMSIVVKALQPLL
Sbjct: 300 KVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 350

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1

 Score =  483 bits (1242), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 247/355 (69%), Positives = 289/355 (81%), Gaps = 11/355 (3%)

Query: 3   CFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGA---QAVKVQP-IEVPAIS 58
           C  C  E+  H +    N ++       D  +H  +  P+ A    A+K  P I+VPA+S
Sbjct: 48  CCACHVEEPYHSSE---NEHLRSPKHHNDFGHHTRK--PQAAVKPDALKEPPSIDVPALS 102

Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE--EFLAQVSMV 116
           +DELKE T+NFG+ +LIGEGSYGR YY  LK G A A+KKLD + +P+   EFL QVS V
Sbjct: 103 LDELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRV 162

Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           S+LKH+NFV+L GYCV+G  R+LAYEFA+ GSLHDILHGRKGV+GAQPGP L W QRV+I
Sbjct: 163 SKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRI 222

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           AV AA+GLEYLHEK  P +IHRDI+SSNVL+F+D  AKIADF+LSNQ+PDMAARLHSTRV
Sbjct: 223 AVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRV 282

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 296
           LGTFGYHAPEYAMTGQL  KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+LS
Sbjct: 283 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 342

Query: 297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
           EDKV+QCVD +L G+YPPKAVAK+AAVAALCVQYE++FRPNMSIVVKALQPLL +
Sbjct: 343 EDKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRS 397

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1

 Score =  480 bits (1236), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 236/301 (78%), Positives = 265/301 (88%), Gaps = 2/301 (0%)

Query: 51  PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEE 108
           PIEVP +SVDE+KE T+NFG+ +LIGEGSYGRVYY  L  G A A+KKLD + +   + E
Sbjct: 53  PIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTE 112

Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL QVSMVSRLKHEN +QL+GYCVD   RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L
Sbjct: 113 FLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 172

Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
            W  RVKIAV AA+GLEYLHEK  P +IHRDI+SSNVL+F+D  AK+ADF+LSNQAPD A
Sbjct: 173 DWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNA 232

Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
           ARLHSTRVLGTFGYHAPEYAMTGQL  KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLV
Sbjct: 233 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 292

Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 348
           TWATP+LSEDKV+QCVD +L G+YPPK+VAK+AAVAALCVQYE++FRPNMSIVVKALQPL
Sbjct: 293 TWATPRLSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPL 352

Query: 349 L 349
           L
Sbjct: 353 L 353

Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1

 Score =  473 bits (1217), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 238/364 (65%), Positives = 289/364 (79%), Gaps = 11/364 (3%)

Query: 6   CCEEDDMHKAADNGNAYMVKSS-------AGTDGAYHASEAAPKGAQAVKVQPIEVPAIS 58
           CC   D   A    N Y    +        G +     +  AP+     KV PIE+P+++
Sbjct: 3   CCGGADEEPAGPPANQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAKVLPIEIPSVA 62

Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS--KQPDEEFLAQVSMV 116
           +DEL  +  NFG  ALIGEGSYGRV+ G  K G A AIKKLDAS  ++PD +F +Q+S+V
Sbjct: 63  LDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQLSVV 121

Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           SRLKH++FV+LLGYC++  +R+L Y+FA+ GSLHD+LHGRKGV+GA+PGPVL+W QRVKI
Sbjct: 122 SRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRVKI 181

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A GAAKGLE+LHEK  P I+HRD++SSNVL+FDD VAK+ADF+L+N + D AARLHSTRV
Sbjct: 182 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHSTRV 241

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 296
           LGTFGYHAPEYAMTGQ+  KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTWATP+LS
Sbjct: 242 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS 301

Query: 297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP-GP 355
           EDKV+QC+D +L  D+PPKAVAK+AAVAALCVQYEADFRPNM+IVVKALQPLLN++P GP
Sbjct: 302 EDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP 361

Query: 356 AGES 359
              S
Sbjct: 362 ESTS 365

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  279 bits (714), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 145/301 (48%), Positives = 200/301 (66%), Gaps = 13/301 (4%)

Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-DEEFL 110
           + V   ++ EL++ T+ F    ++GEG +GRVY G ++ G   A+K L    Q  D EF+
Sbjct: 332 LSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFI 391

Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
           A+V M+SRL H N V+L+G C++G +R L YE   NGS+   LH     +G      L W
Sbjct: 392 AEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH-----EG-----TLDW 441

Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
             R+KIA+GAA+GL YLHE ++P +IHRD K+SNVL+ DD   K++DF L+ +A + +  
Sbjct: 442 DARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 501

Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
           + STRV+GTFGY APEYAMTG L  KSDVYS+GVVLLELLTGR+PVD + P G+++LVTW
Sbjct: 502 I-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTW 560

Query: 291 ATPKL-SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
           A P L + + + Q VD  L G Y    +AK+AA+A++CV  E   RP M  VV+AL+ + 
Sbjct: 561 ARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIY 620

Query: 350 N 350
           N
Sbjct: 621 N 621

Required during the differentiation of the protoderm into shoots epidermis and cuticle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1

 Score =  272 bits (695), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 163/380 (42%), Positives = 214/380 (56%), Gaps = 25/380 (6%)

Query: 1   MSCFGCCEEDDMHK--AADNGNAYMVKSSAGT---------DGAYHASEAAPKGAQAVKV 49
           M CF C +  D  K    D  N    K S  T          G    S     G++   +
Sbjct: 1   MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60

Query: 50  QP------IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDAS 102
            P      I     +  EL   T NF  +  +GEG +GRVY G L S G   A+K+LD +
Sbjct: 61  LPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRN 120

Query: 103 K-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG 161
             Q + EFL +V M+S L H N V L+GYC DG  R+L YEF   GSL D LH     K 
Sbjct: 121 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 180

Query: 162 AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
           A     L W  R+KIA GAAKGLE+LH+KA+P +I+RD KSSN+L+ +    K++DF L+
Sbjct: 181 A-----LDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLA 235

Query: 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281
              P       STRV+GT+GY APEYAMTGQL  KSDVYSFGVV LEL+TGRK +D  +P
Sbjct: 236 KLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMP 295

Query: 282 RGQQSLVTWATPKLSE-DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 340
            G+Q+LV WA P  ++  K  +  D RL G +P +A+ +  AVA++C+Q +A  RP ++ 
Sbjct: 296 HGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIAD 355

Query: 341 VVKALQPLLNARPGPAGESA 360
           VV AL  L N    P+ + +
Sbjct: 356 VVTALSYLANQAYDPSKDDS 375

Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2

 Score =  271 bits (694), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 147/294 (50%), Positives = 191/294 (64%), Gaps = 13/294 (4%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSM 115
            + +EL +ITE F  + ++GEG +G VY GIL  G   AIK+L + S +   EF A+V +
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417

Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           +SR+ H + V L+GYC+    R L YEF  N +L   LHG+         PVL W +RV+
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNL-------PVLEWSRRVR 470

Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
           IA+GAAKGL YLHE   P IIHRDIKSSN+L+ D+  A++ADF L+ +  D A    STR
Sbjct: 471 IAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLA-RLNDTAQSHISTR 529

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 295
           V+GTFGY APEYA +G+L  +SDV+SFGVVLLEL+TGRKPVD + P G++SLV WA P+L
Sbjct: 530 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRL 589

Query: 296 SE----DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 345
            E      + + VD RL  DY    V KM   AA CV++ A  RP M  VV+AL
Sbjct: 590 IEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  271 bits (693), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 149/345 (43%), Positives = 210/345 (60%), Gaps = 30/345 (8%)

Query: 24  VKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRV 83
           ++S +G+D  Y +S++     Q            S DEL ++T  F    L+GEG +G V
Sbjct: 302 MRSHSGSDYMYASSDSGMVSNQRS--------WFSYDELSQVTSGFSEKNLLGEGGFGCV 353

Query: 84  YYGILKSGHAAAIKKLD-ASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142
           Y G+L  G   A+K+L     Q + EF A+V ++SR+ H + V L+GYC+    R+L Y+
Sbjct: 354 YKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYD 413

Query: 143 FASNGSLHDILHGRKGVKGAQPG-PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
           +  N +LH  LH         PG PV++W+ RV++A GAA+G+ YLHE   P IIHRDIK
Sbjct: 414 YVPNNTLHYHLHA--------PGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIK 465

Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVY 260
           SSN+L+ +   A +ADF L+  A ++    H STRV+GTFGY APEYA +G+L+ K+DVY
Sbjct: 466 SSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVY 525

Query: 261 SFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE----DKVRQCVDARLGGDYPPKA 316
           S+GV+LLEL+TGRKPVD + P G +SLV WA P L +    ++  + VD RLG ++ P  
Sbjct: 526 SYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGE 585

Query: 317 VAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA-------RPG 354
           + +M   AA CV++ A  RP MS VV+AL  L  A       RPG
Sbjct: 586 MFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDITNGMRPG 630

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	361
255548287	362	Serine/threonine-protein kinase PBS1, pu	1.0	0.997	0.939	0.0
357442089	476	Pto kinase interactor [Medicago truncatu	1.0	0.758	0.894	0.0
224064746	362	predicted protein [Populus trichocarpa]	1.0	0.997	0.905	0.0
357442087	361	Pto kinase interactor [Medicago truncatu	1.0	1.0	0.894	0.0
224130874	362	predicted protein [Populus trichocarpa]	0.994	0.991	0.919	0.0
359811321	361	pto-interacting protein 1-like [Glycine	0.991	0.991	0.899	0.0
351725893	361	serine/threonine protein kinase [Glycine	0.994	0.994	0.885	0.0
225437716	362	PREDICTED: pto-interacting protein 1 [Vi	0.991	0.988	0.879	0.0
449436713	362	PREDICTED: LOW QUALITY PROTEIN: probable	1.0	0.997	0.828	0.0
356505673	361	PREDICTED: pto-interacting protein 1-lik	0.994	0.994	0.874	1e-179

>gi|255548287|ref|XP_002515200.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223545680|gb|EEF47184.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  683 bits (1763), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/361 (93%), Positives = 348/361 (96%)

Query: 1   MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
           MSCFGCCEEDDMHKAAD+G  Y VKSSAG  G YHASE AP+GAQAVK+QPIEVP+ISVD
Sbjct: 1   MSCFGCCEEDDMHKAADSGGPYPVKSSAGNVGGYHASETAPRGAQAVKIQPIEVPSISVD 60

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ELKE+T+NFG N+LIGEGSYGRVYYGILKSG AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61  ELKEVTDNFGINSLIGEGSYGRVYYGILKSGQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           HENFVQLLGYCVDG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGESA 360
           RQCVD RL GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGE+ 
Sbjct: 301 RQCVDTRLQGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGETP 360

Query: 361 S 361
           S
Sbjct: 361 S 361

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357442089|ref|XP_003591322.1| Pto kinase interactor [Medicago truncatula] gi|355480370|gb|AES61573.1| Pto kinase interactor [Medicago truncatula]

 Score =  660 bits (1703), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/361 (89%), Positives = 342/361 (94%)

Query: 1   MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
           MSCFGCCEED+ HKAA++G  Y+VK+ AG DG YHAS+ A +GAQ VKVQPIEVP I  D
Sbjct: 116 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 175

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ELKE+T+NFG ++LIGEGSYGRVYYG+LKSG AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 176 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 235

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H+NFVQLLGYCVDG SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 236 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 295

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 296 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 355

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 356 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 415

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGESA 360
           RQCVD RLGG+YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL AR GPAGE+A
Sbjct: 416 RQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARAGPAGETA 475

Query: 361 S 361
           +
Sbjct: 476 N 476

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224064746|ref|XP_002301545.1| predicted protein [Populus trichocarpa] gi|222843271|gb|EEE80818.1| predicted protein [Populus trichocarpa]

 Score =  659 bits (1700), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 327/361 (90%), Positives = 342/361 (94%)

Query: 1   MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
           MSCF CCEEDD+HKAAD G  Y VKSSAG  G YHASE APKGAQA K+QPIEVP IS D
Sbjct: 1   MSCFCCCEEDDIHKAADYGGQYTVKSSAGNLGNYHASETAPKGAQAFKIQPIEVPEISGD 60

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ELKE+T+NFGT++LIGEGSYGRVYYG+LKSG  A+IKKLDASKQPD+EFL+QVSMVSRLK
Sbjct: 61  ELKEVTDNFGTSSLIGEGSYGRVYYGVLKSGQDASIKKLDASKQPDDEFLSQVSMVSRLK 120

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           HENFVQLLGYCVDG SRVL YEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGGSRVLIYEFASNGSLHDILHGRKGVKGAQPGPVLTWPQRVKIAVGA 180

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKGLEYLHEKADPHI+HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPHIVHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGESA 360
           +QCVDARL G+YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGE+ 
Sbjct: 301 KQCVDARLQGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGEAP 360

Query: 361 S 361
           S
Sbjct: 361 S 361

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357442087|ref|XP_003591321.1| Pto kinase interactor [Medicago truncatula] gi|355480369|gb|AES61572.1| Pto kinase interactor [Medicago truncatula]

 Score =  658 bits (1698), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/361 (89%), Positives = 342/361 (94%)

Query: 1   MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
           MSCFGCCEED+ HKAA++G  Y+VK+ AG DG YHAS+ A +GAQ VKVQPIEVP I  D
Sbjct: 1   MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 60

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ELKE+T+NFG ++LIGEGSYGRVYYG+LKSG AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 61  ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H+NFVQLLGYCVDG SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGESA 360
           RQCVD RLGG+YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL AR GPAGE+A
Sbjct: 301 RQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARAGPAGETA 360

Query: 361 S 361
           +
Sbjct: 361 N 361

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224130874|ref|XP_002320946.1| predicted protein [Populus trichocarpa] gi|222861719|gb|EEE99261.1| predicted protein [Populus trichocarpa]

 Score =  658 bits (1697), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/359 (91%), Positives = 341/359 (94%)

Query: 1   MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
           MSCFGCCEEDD+ KAADNG  Y VKSSAG  G YHASE AP+G QAVK+QPIEVPAISVD
Sbjct: 1   MSCFGCCEEDDVQKAADNGGPYAVKSSAGHVGNYHASETAPRGPQAVKIQPIEVPAISVD 60

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ELKE+T NFGT++LIGEGSYGRVYYG+LKS  AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61  ELKEVTVNFGTDSLIGEGSYGRVYYGVLKSEQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           HENFVQLLGYCVDG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGGSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWPQRVKIAVGA 180

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKGLEYLHEKADP IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPRIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGES 359
           +QCVDARL G+ P KAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGES
Sbjct: 301 KQCVDARLQGECPLKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGES 359

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359811321|ref|NP_001241285.1| pto-interacting protein 1-like [Glycine max] gi|223452480|gb|ACM89567.1| serine/threonine protein kinase [Glycine max] gi|255639418|gb|ACU20004.1| unknown [Glycine max]

 Score =  652 bits (1681), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/358 (89%), Positives = 338/358 (94%)

Query: 1   MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
           MSCF CCEEDD+HKAA++G  Y+VK+ AG DG Y ASE A +G Q VK QPIEVP IS D
Sbjct: 1   MSCFSCCEEDDLHKAAESGGPYVVKNPAGNDGNYLASETAKQGTQPVKPQPIEVPNISAD 60

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ELKE+T+NFG +ALIGEGSYGRVYYG+LKS  AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 61  ELKEVTDNFGQDALIGEGSYGRVYYGVLKSELAAAIKKLDASKQPDEEFLAQVSMVSRLK 120

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           HENFVQLLGYC+DG+SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCIDGSSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGE 358
           RQCVD RLGG+YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL ARPGPAGE
Sbjct: 301 RQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARPGPAGE 358

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351725893|ref|NP_001237620.1| serine/threonine protein kinase [Glycine max] gi|223452365|gb|ACM89510.1| serine/threonine protein kinase [Glycine max]

 Score =  647 bits (1670), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/359 (88%), Positives = 338/359 (94%)

Query: 1   MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
           MSCFGCCEEDD  K A++G  ++VK+S G DG   ASE A +G QAVK+QPIEVP + VD
Sbjct: 1   MSCFGCCEEDDYQKTAESGGQHVVKNSTGNDGNSRASETAKQGTQAVKIQPIEVPELQVD 60

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ELKEIT+ FG ++LIGEGSYGRVYYG+LKSG AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61  ELKEITDGFGESSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H+NFVQLLGYC+DG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HDNFVQLLGYCIDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWTQRVKIAVGA 180

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKGLEYLHE+ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHERADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+LSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPRLSEDKV 300

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGES 359
           RQCVDARLGG+YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR GPAGE+
Sbjct: 301 RQCVDARLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARHGPAGET 359

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225437716|ref|XP_002280340.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297744052|emb|CBI37022.3| unnamed protein product [Vitis vinifera]

 Score =  644 bits (1660), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/358 (87%), Positives = 336/358 (93%)

Query: 1   MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
           MSCFGCCE+DD+H A ++GN +  K+ AG DG Y  ++ APKG QAVKVQPI VP I  D
Sbjct: 1   MSCFGCCEDDDIHTAPESGNPFAAKNPAGNDGGYRHTDPAPKGTQAVKVQPIAVPPIPFD 60

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ELKEIT+NFGT+ALIGEGSYGRVYYG+LK+G AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 61  ELKEITDNFGTSALIGEGSYGRVYYGLLKNGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H+NFV+L+GYCVDG SR+LAYEFASNGSLHDILHGRKGVKGAQPGP+LSW QRVKIAVGA
Sbjct: 121 HDNFVELIGYCVDGGSRILAYEFASNGSLHDILHGRKGVKGAQPGPILSWAQRVKIAVGA 180

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A+GL+YLHEKA PHIIHRDIKSSNVL+FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLDYLHEKASPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGE 358
           RQCVD RLG DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP+GE
Sbjct: 301 RQCVDTRLGQDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPSGE 358

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449436713|ref|XP_004136137.1| PREDICTED: LOW QUALITY PROTEIN: probable receptor-like protein kinase At2g47060-like [Cucumis sativus]

 Score =  640 bits (1651), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 299/361 (82%), Positives = 325/361 (90%)

Query: 1   MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
           M CFGCCEED + KAADN N Y VK+SAGTD +YH  + APK    VK+QPIEVPAIS +
Sbjct: 1   MGCFGCCEEDAIQKAADNSNTYQVKTSAGTDESYHKRQTAPKSPPIVKIQPIEVPAISFE 60

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ELKE+T+NF  + LIGEGSYGRVYYG+  SG    IKKLDASKQ D+EFL+QVSMVSRLK
Sbjct: 61  ELKEVTKNFDADCLIGEGSYGRVYYGVFTSGQTVGIKKLDASKQSDDEFLSQVSMVSRLK 120

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H+NF+ L+GYCV G SR+LAYE+ASNGSLHDILHGRKGVKG+QPGPVLSW QRVKIAVGA
Sbjct: 121 HDNFLNLIGYCVGGNSRILAYEYASNGSLHDILHGRKGVKGSQPGPVLSWAQRVKIAVGA 180

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKGLEYLHEK DPHI HRDIKSSNVLIFDDD+AKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKVDPHITHRDIKSSNVLIFDDDLAKIADFDLSNQAPDMAARLHSTRVLGTF 240

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           GYHAPEYAMTGQLN+KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL EDKV
Sbjct: 241 GYHAPEYAMTGQLNSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLCEDKV 300

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGESA 360
           +QCVDA+LG +YPPK+VAK AAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP GE+ 
Sbjct: 301 KQCVDAKLGNEYPPKSVAKFAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPXGETT 360

Query: 361 S 361
           +
Sbjct: 361 N 361

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356505673|ref|XP_003521614.1| PREDICTED: pto-interacting protein 1-like [Glycine max]

 Score =  634 bits (1636), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 314/359 (87%), Positives = 335/359 (93%)

Query: 1   MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
           MSCF CCEEDD  KA+++G  ++VK+S G  G   ASE A +G QAVK+QPIEVP + VD
Sbjct: 1   MSCFSCCEEDDYQKASESGGQHVVKNSTGNHGNGRASETAKQGTQAVKIQPIEVPELPVD 60

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ELKEIT+ FG ++LIGEGSYGRVYYG+LKS  AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61  ELKEITDGFGESSLIGEGSYGRVYYGVLKSRQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H+NFVQLLGYC+DG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HDNFVQLLGYCIDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWTQRVKIAVGA 180

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKGLEYLHE+ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHERADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+LSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPRLSEDKV 300

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGES 359
           RQCVDARLGG+Y PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR GPAGE+
Sbjct: 301 RQCVDARLGGEYLPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARHGPAGET 359

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	361
TAIR|locus:2098083	361	AT3G62220 [Arabidopsis thalian	0.997	0.997	0.811	1.8e-156
TAIR|locus:2088990	364	AT3G17410 [Arabidopsis thalian	0.980	0.972	0.759	2.2e-144
TAIR|locus:2023767	363	AT1G48210 [Arabidopsis thalian	0.980	0.975	0.724	8.3e-138
TAIR|locus:2009115	361	AT1G06700 [Arabidopsis thalian	0.950	0.950	0.704	2.6e-125
TAIR|locus:2081277	408	AT3G59350 [Arabidopsis thalian	0.969	0.857	0.665	8e-124
TAIR|locus:2023752	364	AT1G48220 [Arabidopsis thalian	0.980	0.972	0.649	2.4e-122
TAIR|locus:2064557	365	AT2G41970 [Arabidopsis thalian	0.977	0.967	0.634	6.5e-122
TAIR|locus:2054502	366	AT2G30740 [Arabidopsis thalian	0.880	0.868	0.722	1.7e-121
TAIR|locus:2054492	338	AT2G30730 [Arabidopsis thalian	0.853	0.911	0.690	1.6e-111
TAIR|locus:2132168	725	AT4G02010 [Arabidopsis thalian	0.806	0.401	0.5	2.4e-69

TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)]

 Score = 1525 (541.9 bits), Expect = 1.8e-156, P = 1.8e-156
 Identities = 292/360 (81%), Positives = 315/360 (87%)

Query:     1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
             MSCFGCC EDD+  A D G   M K S G DG  + SE A KGAQ+VKVQPIEV AI  D
Sbjct:     1 MSCFGCCREDDLPGANDYGGHNMTKQSGGNDGRRNGSETAQKGAQSVKVQPIEVAAILAD 60

Query:    61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
             EL E T +FGTN+LIGEGSY RVY+G+LK+G  AAIKKLD++KQP+EEFLAQVSMVSRLK
Sbjct:    61 ELIEATNDFGTNSLIGEGSYARVYHGVLKNGQRAAIKKLDSNKQPNEEFLAQVSMVSRLK 120

Query:   121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
             H NFV+LLGY VDG SR+L +EFA NGSLHDILHGRKGVKGA+PGP+LSW QRVKIAVGA
Sbjct:   121 HVNFVELLGYSVDGNSRILVFEFAQNGSLHDILHGRKGVKGAKPGPLLSWHQRVKIAVGA 180

Query:   181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
             A+GLEYLHEKA+PH+IHRDIKSSNVLIFD+DVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct:   181 ARGLEYLHEKANPHVIHRDIKSSNVLIFDNDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240

Query:   241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
             GYHAPEYAMTGQL+AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct:   241 GYHAPEYAMTGQLSAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300

Query:   301 RQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARPGPAGESA 360
             +QCVD+RLGGDYPP           LCVQYEADFRPNMSIVVKALQPLLNAR GPAGE A
Sbjct:   301 KQCVDSRLGGDYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNARTGPAGEGA 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)]

 Score = 1411 (501.8 bits), Expect = 2.2e-144, P = 2.2e-144
 Identities = 271/357 (75%), Positives = 301/357 (84%)

Query:     1 MSCFGCCEE-DDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISV 59
             M CFGCC   +D  + ++ G    V ++ G +G +H     PK    +++QPI V AI  
Sbjct:     1 MGCFGCCGGGEDFRRVSETGPK-PVHNTGGYNGGHHQRADPPKNLPVIQMQPISVAAIPA 59

Query:    60 DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
             DEL++IT+N+G+ +LIGEGSYGRV+YGILKSG AAAIKKLD+SKQPD+EFLAQVSMVSRL
Sbjct:    60 DELRDITDNYGSKSLIGEGSYGRVFYGILKSGKAAAIKKLDSSKQPDQEFLAQVSMVSRL 119

Query:   120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
             + EN V LLGYCVDG  RVLAYE+A NGSLHDILHGRKGVKGAQPGPVLSW QRVKIAVG
Sbjct:   120 RQENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWHQRVKIAVG 179

Query:   180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
             AA+GLEYLHEKA+PH+IHRDIKSSNVL+FDDDVAKIADFDLSNQAPDMAARLHSTRVLGT
Sbjct:   180 AARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239

Query:   240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 299
             FGYHAPEYAMTG L+ KSDVYSFGVVLLELLTGRKPVDHTLPRGQQS+VTWATPKLSEDK
Sbjct:   240 FGYHAPEYAMTGTLSTKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSVVTWATPKLSEDK 299

Query:   300 VRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNA-RPGP 355
             V+QCVDARL G+YPP           LCVQYEADFRPNMSIVVKALQPLLN  R  P
Sbjct:   300 VKQCVDARLNGEYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNPPRSAP 356

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)]

 Score = 1349 (479.9 bits), Expect = 8.3e-138, P = 8.3e-138
 Identities = 258/356 (72%), Positives = 291/356 (81%)

Query:     1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
             MSCFG C  +D   A D G      + AG +G ++     P     + +QPI VPAI VD
Sbjct:     1 MSCFGWCGSEDFRNATDTGPR-PAHNPAGYNGGHYQRADPPMNQPVIPMQPISVPAIPVD 59

Query:    61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
             EL++IT+N+G+  LIGEGSYGRV+YG+LKSG AAAIKKLD+SKQPD+EFL+Q+SMVSRL+
Sbjct:    60 ELRDITDNYGSKTLIGEGSYGRVFYGVLKSGGAAAIKKLDSSKQPDQEFLSQISMVSRLR 119

Query:   121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
             H+N   L+GYCVDG  RVLAYEFA  GSLHD LHG+KG KGA  GPV++WQQRVKIAVGA
Sbjct:   120 HDNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHGKKGAKGALRGPVMTWQQRVKIAVGA 179

Query:   181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
             A+GLEYLHEK  P +IHRDIKSSNVL+FDDDVAKI DFDLS+QAPDMAARLHSTRVLGTF
Sbjct:   180 ARGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKIGDFDLSDQAPDMAARLHSTRVLGTF 239

Query:   241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
             GYHAPEYAMTG L++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct:   240 GYHAPEYAMTGTLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299

Query:   301 RQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNA-RPGP 355
             +QCVDARL G+YPP           LCVQYEA+FRPNMSIVVKALQPLLN  R  P
Sbjct:   300 KQCVDARLLGEYPPKAVGKLAAVAALCVQYEANFRPNMSIVVKALQPLLNPPRSAP 355

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)]

 Score = 1231 (438.4 bits), Expect = 2.6e-125, P = 2.6e-125
 Identities = 246/349 (70%), Positives = 275/349 (78%)

Query:    17 DNGNAYMVKSSAGTDGAYHA-SEAAPKGAQAVKVQ--PIEVPAISVDELKEITENFGTNA 73
             D+     +KSS     A H  S+ AP     VK +  PIEVP +S+DE+KE TENFG+ A
Sbjct:    13 DSNEEQQLKSSQQQSDANHKNSKPAPVAKHEVKKEALPIEVPPLSLDEVKEKTENFGSKA 72

Query:    74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYC 131
             LIGEGSYGRVYY  L  G A A+KKLD + +   D EFL+QVSMVSRLKHEN +QLLG+C
Sbjct:    73 LIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTEFLSQVSMVSRLKHENLIQLLGFC 132

Query:   132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
             VDG  RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L W  RVKIAV AA+GLEYLHEK+
Sbjct:   133 VDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRVKIAVEAARGLEYLHEKS 192

Query:   192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              P +IHRDI+SSNVL+F+D  AKIADF+LSNQAPD AARLHSTRVLGTFGYHAPEYAMTG
Sbjct:   193 QPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLHSTRVLGTFGYHAPEYAMTG 252

Query:   252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD 311
             QL  KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+LSEDKV+QC+D +L  D
Sbjct:   253 QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCIDPKLKAD 312

Query:   312 YPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNA-RPGPAGES 359
             YPP           LCVQYEA+FRPNMSIVVKALQPLL      PA ES
Sbjct:   313 YPPKAVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKPPAAAPAPES 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)]

 Score = 1217 (433.5 bits), Expect = 8.0e-124, P = 8.0e-124
 Identities = 239/359 (66%), Positives = 279/359 (77%)

Query:     3 CFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHAS--EAAPKGAQAVKVQP-IEVPAISV 59
             C  C  E+  H +    N ++       D  +H    +AA K   A+K  P I+VPA+S+
Sbjct:    48 CCACHVEEPYHSSE---NEHLRSPKHHNDFGHHTRKPQAAVK-PDALKEPPSIDVPALSL 103

Query:    60 DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE--EFLAQVSMVS 117
             DELKE T+NFG+ +LIGEGSYGR YY  LK G A A+KKLD + +P+   EFL QVS VS
Sbjct:   104 DELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRVS 163

Query:   118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
             +LKH+NFV+L GYCV+G  R+LAYEFA+ GSLHDILHGRKGV+GAQPGP L W QRV+IA
Sbjct:   164 KLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRIA 223

Query:   178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
             V AA+GLEYLHEK  P +IHRDI+SSNVL+F+D  AKIADF+LSNQ+PDMAARLHSTRVL
Sbjct:   224 VDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRVL 283

Query:   238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 297
             GTFGYHAPEYAMTGQL  KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+LSE
Sbjct:   284 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSE 343

Query:   298 DKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARPGPA 356
             DKV+QCVD +L G+YPP           LCVQYE++FRPNMSIVVKALQPLL +    A
Sbjct:   344 DKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRSSTAAA 402

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)]

 Score = 1203 (428.5 bits), Expect = 2.4e-122, P = 2.4e-122
 Identities = 232/357 (64%), Positives = 277/357 (77%)

Query:     1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
             MSCFG C  +D+   AD G +    +S G +G +H     P     V +QPI VPAI VD
Sbjct:     1 MSCFGWCGSEDVRNPADTGPS-QAHNSIGYNGRHHQRADPPMNQPVVNMQPIAVPAIPVD 59

Query:    61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
             EL++ITENF +  L+G+GSYGRV+YG+LKSG  AAIKKL  +KQPD+EFL+QVSMVSRL 
Sbjct:    60 ELEDITENFSSEVLVGKGSYGRVFYGVLKSGKEAAIKKLYPTKQPDQEFLSQVSMVSRLH 119

Query:   121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
             HEN V L+ YCVDG  RVLAYEFA+ G+LHD+LHG+ GV GA  GPV++WQ+RVKIA+GA
Sbjct:   120 HENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVIGALQGPVMTWQRRVKIALGA 179

Query:   181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV-LGT 239
             A+GLEYLH+K +P +IHRDIK+SN+L+FDDD+AKI DFDL +QAP+MA RLHS R+ LG 
Sbjct:   180 ARGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDLYDQAPNMAGRLHSCRMALGA 239

Query:   240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 299
                H PE+AMTG L  KSDVYSFGVVLLELLTGRKPVD TLPRGQQ+LVTWATPKLS+DK
Sbjct:   240 SRSHCPEHAMTGILTTKSDVYSFGVVLLELLTGRKPVDRTLPRGQQNLVTWATPKLSKDK 299

Query:   300 VRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNA-RPGP 355
             V+QCVDARL G+YPP            CV Y+ DFRP+MSIVVKALQPLLN+ R  P
Sbjct:   300 VKQCVDARLLGEYPPKAVAKLAAVSARCVHYDPDFRPDMSIVVKALQPLLNSSRSSP 356

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)]

 Score = 1199 (427.1 bits), Expect = 6.5e-122, P = 6.5e-122
 Identities = 231/364 (63%), Positives = 280/364 (76%)

Query:     6 CCEEDDMHKAADNGNAYMVK-SSAGTD--GAYHASEA----APKGAQAVKVQPIEVPAIS 58
             CC   D   A    N Y    + AG    G  +  E     AP+     KV PIE+P+++
Sbjct:     3 CCGGADEEPAGPPANQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAKVLPIEIPSVA 62

Query:    59 VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS--KQPDEEFLAQVSMV 116
             +DEL  +  NFG  ALIGEGSYGRV+ G  K G A AIKKLDAS  ++PD +F +Q+S+V
Sbjct:    63 LDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQLSVV 121

Query:   117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
             SRLKH++FV+LLGYC++  +R+L Y+FA+ GSLHD+LHGRKGV+GA+PGPVL+W QRVKI
Sbjct:   122 SRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRVKI 181

Query:   177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
             A GAAKGLE+LHEK  P I+HRD++SSNVL+FDD VAK+ADF+L+N + D AARLHSTRV
Sbjct:   182 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHSTRV 241

Query:   237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 296
             LGTFGYHAPEYAMTGQ+  KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTWATP+LS
Sbjct:   242 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS 301

Query:   297 EDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP-GP 355
             EDKV+QC+D +L  D+PP           LCVQYEADFRPNM+IVVKALQPLLN++P GP
Sbjct:   302 EDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP 361

Query:   356 AGES 359
                S
Sbjct:   362 ESTS 365

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)]

 Score = 1195 (425.7 bits), Expect = 1.7e-121, P = 1.7e-121
 Identities = 232/321 (72%), Positives = 261/321 (81%)

Query:    38 EAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIK 97
             +A  K     +  PIEVP +SVDE+KE T+NFG+ +LIGEGSYGRVYY  L  G A A+K
Sbjct:    40 QAVVKPEAQKEALPIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALK 99

Query:    98 KLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155
             KLD + + +   EFL QVSMVSRLKHEN +QL+GYCVD   RVLAYEFA+ GSLHDILHG
Sbjct:   100 KLDVAPEAETNTEFLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHG 159

Query:   156 RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215
             RKGV+GAQPGP L W  RVKIAV AA+GLEYLHEK  P +IHRDI+SSNVL+F+D  AK+
Sbjct:   160 RKGVQGAQPGPTLDWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKV 219

Query:   216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             ADF+LSNQAPD AARLHSTRVLGTFGYHAPEYAMTGQL  KSDVYSFGVVLLELLTGRKP
Sbjct:   220 ADFNLSNQAPDNAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 279

Query:   276 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFR 335
             VDHT+PRGQQSLVTWATP+LSEDKV+QCVD +L G+YPP           LCVQYE++FR
Sbjct:   280 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFR 339

Query:   336 PNMSIVVKALQPLLNARPGPA 356
             PNMSIVVKALQPLL   P PA
Sbjct:   340 PNMSIVVKALQPLLKP-PAPA 359

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)]

 Score = 1101 (392.6 bits), Expect = 1.6e-111, P = 1.6e-111
 Identities = 214/310 (69%), Positives = 248/310 (80%)

Query:    44 AQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK 103
             A+  ++ PI VP++SVDE+ E T+NFG N+LIGEGSYGRVYY  L  G A A+KKLD + 
Sbjct:    22 AKPKEILPIIVPSLSVDEVNEQTDNFGPNSLIGEGSYGRVYYATLNDGKAVALKKLDLAP 81

Query:   104 QPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG 161
             + +   EFL+QVSMVSRLKHEN +QL+GYCVD   RVLAYEFA+ GSLHDILHGRKGV+ 
Sbjct:    82 EDETNTEFLSQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQD 141

Query:   162 AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
             A PGP L W  RVKIAV AA+GLEYLHEK  P +IHRDI+SSN+L+FDD  AKIADF+LS
Sbjct:   142 ALPGPTLDWITRVKIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKIADFNLS 201

Query:   222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281
             NQ+PD AARL STRVLG+FGY++PEYAMTG+L  KSDVY FGVVLLELLTGRKPVDHT+P
Sbjct:   202 NQSPDNAARLQSTRVLGSFGYYSPEYAMTGELTHKSDVYGFGVVLLELLTGRKPVDHTMP 261

Query:   282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIV 341
             RGQQSLVTWATPKLSED V +CVD +L G+Y P           LCVQYE++ RP MS V
Sbjct:   262 RGQQSLVTWATPKLSEDTVEECVDPKLKGEYSPKSVAKLAAVAALCVQYESNCRPKMSTV 321

Query:   342 VKALQPLLNA 351
             VKALQ LL A
Sbjct:   322 VKALQQLLIA 331

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)]

 Score = 703 (252.5 bits), Expect = 2.4e-69, P = 2.4e-69
 Identities = 150/300 (50%), Positives = 194/300 (64%)

Query:    51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS-KQPDEEF 109
             P     +S +ELKE T NF + +++GEG +G+VY GIL  G A AIKKL +   Q D+EF
Sbjct:   362 PASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEF 421

Query:   110 LAQVSMVSRLKHENFVQLLGYCV--DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
               ++ M+SRL H N V+L+GY    D +  +L YE   NGSL   LHG  G+    P   
Sbjct:   422 QVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNC--P--- 476

Query:   168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
             L W  R+KIA+ AA+GL YLHE + P +IHRD K+SN+L+ ++  AK+ADF L+ QAP+ 
Sbjct:   477 LDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEG 536

Query:   228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287
                  STRV+GTFGY APEYAMTG L  KSDVYS+GVVLLELLTGRKPVD + P GQ++L
Sbjct:   537 RGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 596

Query:   288 VTWATPKLSE-DKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
             VTW  P L + D++ + VD+RL G YP             CV  EA  RP M  VV++L+
Sbjct:   597 VTWTRPVLRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLK 656

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O80719	Y2706_ARATH	2, ., 7, ., 1, 1, ., 1	0.8287	0.9916	0.9808	no	no
O49339	PTI12_ARATH	2, ., 7, ., 1, 0, ., 2	0.7840	0.8282	0.8169	no	no
Q41328	PTI1_SOLLC	2, ., 7, ., 1, 1, ., 1	0.8342	0.9806	1.0	N/A	no
Q8H1G6	PTI11_ARATH	2, ., 7, ., 1, 0, ., 2	0.7207	0.9445	0.9445	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.10.2	0.979
3rd Layer	2.7.10	0.983
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	361
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-53
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-51
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-45
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-41
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-40
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-33
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-30
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-29
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-27
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-27
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-25
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-25
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-25
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-25
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-24
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-23
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-23
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-22
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-21
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-20
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-20
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-20
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-20
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-20
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-20
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-18
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-18
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-18
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-18
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-17
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	9e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.001
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.002
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.002
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.002
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	0.003
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  176 bits (448), Expect = 3e-53
 Identities = 86/291 (29%), Positives = 130/291 (44%), Gaps = 60/291 (20%)

Query: 75  IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G VY G LK          A+K L  DAS+Q  EEFL +  ++ +L H N V+L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           LG C +     +  E+   G L   L   +        P LS    +  A+  A+G+EYL
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNR--------PKLSLSDLLSFALQIARGMEYL 118

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---- 243
             K   + IHRD+ + N L+ ++ V KI+DF LS             R L    Y+    
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLS-------------RDLYDDDYYRKRG 162

Query: 244 --------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 294
                   APE    G+  +KSDV+SFGV+L E+ T G +P                 P 
Sbjct: 163 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PG 206

Query: 295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 345
           +S ++V + +        PP    ++  +   C   + + RP  S +V+ L
Sbjct: 207 MSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  173 bits (441), Expect = 3e-52
 Identities = 84/280 (30%), Positives = 132/280 (47%), Gaps = 37/280 (13%)

Query: 75  IGEGSYGRVYYGILKSGHA-----AAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G VY G LK          A+K L  DAS+Q  EEFL +  ++ +L H N V+L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           LG C +    ++  E+   G L D L   +          LS    +  A+  A+G+EYL
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-------KELSLSDLLSFALQIARGMEYL 119

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPE 246
             K   + IHRD+ + N L+ ++ V KI+DF LS    D    ++   ++     + APE
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPE 174

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD 305
               G+  +KSDV+SFGV+L E+ T G +P                 P +S  +V + + 
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP----------------YPGMSNAEVLEYLK 218

Query: 306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 345
                  PP    ++  +   C   + + RP  S +V+ L
Sbjct: 219 KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  171 bits (436), Expect = 2e-51
 Identities = 89/282 (31%), Positives = 135/282 (47%), Gaps = 32/282 (11%)

Query: 75  IGEGSYGRVYYGILKSG----HAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           +GEG++G VY G LK         A+K L  DAS++  ++FL +  ++ +L H N V+LL
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +     L  E+   G L D L   + V  +     LS +  +  A+  AKG+EYL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARLHSTRVLGTFGYHAPEY 247
            K     +HRD+ + N L+ +D V KI+DF LS +   D   R  +   L    + APE 
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPES 178

Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA 306
              G   +KSDV+SFGV+L E+ T G  P                 P LS ++V + +  
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPY----------------PGLSNEEVLEYLRK 222

Query: 307 --RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
             RL    P     ++  +   C Q + + RP  S +V+ L+
Sbjct: 223 GYRL--PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  169 bits (431), Expect = 2e-51
 Identities = 70/200 (35%), Positives = 99/200 (49%), Gaps = 18/200 (9%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
           +GEG +G VY     K+G   AIK +         EE L ++ ++ +L H N V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            D     L  E+   GSL D+L   +G         LS  + ++I +   +GLEYLH   
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLHSN- 111

Query: 192 DPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE-YAM 249
              IIHRD+K  N+L+  D+   K+ADF LS       + L +    GT  Y APE    
Sbjct: 112 --GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLG 167

Query: 250 TGQLNAKSDVYSFGVVLLEL 269
            G  + KSD++S GV+L EL
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  168 bits (428), Expect = 3e-50
 Identities = 88/282 (31%), Positives = 136/282 (48%), Gaps = 41/282 (14%)

Query: 75  IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G VY G LK          A+K L   AS++  EEFL + S++ +L H N V+L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           LG C  G    +  E+   G L D L         + G  L+ +  +++A+  AKG+EYL
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLR--------KHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPE 246
             K   + +HRD+ + N L+ ++ V KI+DF LS     D   R      L      APE
Sbjct: 119 ESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD 305
               G+  +KSDV+SFGV+L E+ T G +P                 P +S ++V + ++
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLELLE 218

Query: 306 A--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 345
              RL    P     ++  +   C  Y+ + RP  S +V+ L
Sbjct: 219 DGYRL--PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  155 bits (395), Expect = 2e-45
 Identities = 70/205 (34%), Positives = 97/205 (47%), Gaps = 18/205 (8%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGY 130
            +GEGS+G+VY     K+G   AIK +   K     E  L ++ ++ +LKH N V+L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
             D     L  E+   G L D+L  R           LS  +           LEYLH K
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFYLRQILSALEYLHSK 116

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
               I+HRD+K  N+L+ +D   K+ADF L+ Q         +T V GT  Y APE  + 
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV-GTPEYMAPEVLLG 170

Query: 251 GQLNAKSDVYSFGVVLLELLTGRKP 275
                  D++S GV+L ELLTG+ P
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (393), Expect = 4e-45
 Identities = 75/219 (34%), Positives = 105/219 (47%), Gaps = 19/219 (8%)

Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
           +G GS+G VY    K  G   A+K L       + D+    ++ ++ RL H N V+L+  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
             D     L  E+   G L D L              LS  +  KIA+   +GLEYLH  
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGG---------PLSEDEAKKIALQILRGLEYLHSN 117

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
               IIHRD+K  N+L+ ++ V KIADF L+ +    ++   +T V GT  Y APE  + 
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLG 172

Query: 251 GQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
           G     K DV+S GV+L ELLTG+ P        Q  L+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (364), Expect = 8e-41
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 20/209 (9%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
           L+G GS+G VY  + K +G   A+K ++ S   +EE      ++ ++S L+H N V+  G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 130 YCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEY 186
              D     L    E+ S GSL  +L     +    P PV+  ++  + I     +GL Y
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL----PEPVI--RKYTRQI----LEGLAY 116

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           LH      I+HRDIK +N+L+  D V K+ADF  + +  D+     +  V GT  + APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                +    +D++S G  ++E+ TG+ P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  141 bits (359), Expect = 4e-40
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 16/203 (7%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
           IG+G +G VY     ++G   AIK +    +  +E +   + ++ + KH N V+  G  +
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
                 +  EF S GSL D+L              L+  Q   +     KGLEYLH    
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVCKELLKGLEYLHSN-- 117

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
             IIHRDIK++N+L+  D   K+ DF LS Q   ++       ++GT  + APE      
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQ---LSDTKARNTMVGTPYWMAPEVINGKP 173

Query: 253 LNAKSDVYSFGVVLLELLTGRKP 275
            + K+D++S G+  +EL  G+ P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  131 bits (332), Expect = 3e-36
 Identities = 71/206 (34%), Positives = 111/206 (53%), Gaps = 21/206 (10%)

Query: 73  ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
           A IG+G +G V  G  + G   A+K L       + FLA+ S+++ L+H N VQLLG  +
Sbjct: 12  ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  E+ + GSL D L  R    G     V++  Q++  A+   +G+EYL EK  
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSR----GRA---VITLAQQLGFALDVCEGMEYLEEK-- 121

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMT 250
            + +HRD+ + NVL+ +D VAK++DF L+ +A          +  G     + APE    
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA-------SQGQDSGKLPVKWTAPEALRE 173

Query: 251 GQLNAKSDVYSFGVVLLELLT-GRKP 275
            + + KSDV+SFG++L E+ + GR P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 4e-35
 Identities = 72/213 (33%), Positives = 109/213 (51%), Gaps = 32/213 (15%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE---EFLAQVSMVSRLKHENFVQLLG 129
           LIG G++G VY G+ L++G   AIK++   K  +E     + ++ ++  LKH N V+ +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 130 YCVDGTSRVLAYEFASNGSLHDIL--HGRKG-----VKGAQPGPVLSWQQRVKIAVGAAK 182
                 S  +  E+A NGSL  I+   G        V   Q   VL             +
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ---VL-------------Q 110

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL YLHE+    +IHRDIK++N+L   D V K+ADF ++ +  D++    S  V+GT  +
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYW 165

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            APE       +  SD++S G  ++ELLTG  P
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  128 bits (321), Expect = 1e-33
 Identities = 71/217 (32%), Positives = 100/217 (46%), Gaps = 24/217 (11%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHE-NFVQLL 128
            +GEGS+G VY    +     A+K L    +      E FL ++ +++ L H  N V+L 
Sbjct: 7   KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
            +  D  S  L  E+   GSL D+L              LS  + + I       LEYLH
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKI------GRKGPLSESEALFILAQILSALEYLH 118

Query: 189 EKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTR----VLGTFGYH 243
            K    IIHRDIK  N+L+  D  V K+ DF L+   PD  +           +GT GY 
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 244 APEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           APE  +       ++ SD++S G+ L ELLTG  P +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212

Length = 384

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  122 bits (309), Expect = 1e-32
 Identities = 68/222 (30%), Positives = 109/222 (49%), Gaps = 31/222 (13%)

Query: 75  IGEGSYGRVYYGILKSG------HAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
           +GEG++G+V+ G              A+K L  +   D  ++F  +  +++  +HEN V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV---LSWQQRVKIAVGAA 181
             G C +G   ++ +E+  +G L+  L  HG        P      L+  Q ++IAV  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST---RVLG 238
            G+ YL   A  H +HRD+ + N L+  D V KI DF +S         +++T   RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD-------VYTTDYYRVGG 182

Query: 239 T----FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                  +  PE  M  +   +SDV+SFGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  119 bits (300), Expect = 2e-31
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 36/217 (16%)

Query: 74  LIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
            IG+GS+G+VY       G    +K++D S   ++E    L +V ++ +L H N ++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              +     +  E+A  G L   +  +K     + G     +Q +   V     L+YLH 
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQK-----KEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-----VLGTFGYHA 244
           +    I+HRDIK  N+ +  + + K+ DF +S         L ST      V+GT  Y +
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-------LSSTVDLAKTVVGTPYYLS 171

Query: 245 PE------YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           PE      Y      N KSD++S G VL EL T + P
Sbjct: 172 PELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 1e-30
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G+  +    A+K L       ++FLA+  ++ +L+H   +QL   C   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E    GSL + L G  G         L   Q + +A   A G+ YL  +   +
Sbjct: 74  EPIYIVTELMKYGSLLEYLQGGAGRA-------LKLPQLIDMAAQVASGMAYLEAQ---N 123

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTF--GYHAPEY 247
            IHRD+ + NVL+ ++++ K+ADF L        AR+     +  R    F   + APE 
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGL--------ARVIKEDIYEAREGAKFPIKWTAPEA 175

Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           A+  + + KSDV+SFG++L E++T GR P
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  113 bits (285), Expect = 2e-29
 Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 38/270 (14%)

Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
           IG+GS+G V+  + K+     A+K++D    +++  EE + +  ++++L     ++    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
            +D     +  E+A NG LH +L         Q G  L   Q  +  +    GL +LH K
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLK-------MQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
               I+HRDIKS N+ +   D  KI D  ++    D      +  ++GT  Y +PE    
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCED 175

Query: 251 GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG 310
              N KSDV++ GVVL E  TG+ P D      Q +L+          K+       + G
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALIL---------KI-------IRG 216

Query: 311 DYPP---KAVAKMAAVAALCVQYEADFRPN 337
            +PP       ++A +   C+  +   RP+
Sbjct: 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPD 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 3e-29
 Identities = 70/209 (33%), Positives = 104/209 (49%), Gaps = 26/209 (12%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G        A+K L       E FL +  ++ +L+H+  VQL   C + 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ S GSL D L   +G K       L   Q V +A   A+G+ YL  +   +
Sbjct: 74  EPIYIVTEYMSKGSLLDFLKSGEGKK-------LRLPQLVDMAAQIAEGMAYLESR---N 123

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTF--GYHAPEY 247
            IHRD+ + N+L+ ++ V KIADF L        ARL     ++ R    F   + APE 
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGL--------ARLIEDDEYTAREGAKFPIKWTAPEA 175

Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           A  G+   KSDV+SFG++L E++T GR P
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  112 bits (281), Expect = 9e-29
 Identities = 69/208 (33%), Positives = 95/208 (45%), Gaps = 21/208 (10%)

Query: 75  IGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEEFLAQVSM----VSRLKHENFVQLLG 129
           +G G+ G V       +G   A+K +      +E    Q+      + +      V   G
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              +     +  E+   GSL  IL   K V+G  P  +L      KIAV   KGL YLHE
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILG-----KIAVAVLKGLTYLHE 118

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
           K    IIHRD+K SN+L+      K+ DF +S Q  +  A+   T V GT  Y APE   
Sbjct: 119 KH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFV-GTSSYMAPERIQ 172

Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPVD 277
               + KSD++S G+ L+EL TGR P  
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYP 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 9e-29
 Identities = 73/278 (26%), Positives = 132/278 (47%), Gaps = 34/278 (12%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
            IG+G++G VY G+LK     A+K   ++  PD   +FL +  ++ +  H N V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
           V      +  E    GSL   L  +K          L+ ++ +++++ AA G+EYL  K 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR--------LTVKKLLQMSLDAAAGMEYLESK- 112

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
             + IHRD+ + N L+ +++V KI+DF +S +       +          + APE    G
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 252 QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG 310
           +  ++SDV+S+G++L E  + G  P                 P +S  + R+ +++  G 
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPY----------------PGMSNQQTRERIES--GY 212

Query: 311 DYPPKAV--AKMAAVAALCVQYEADFRPNMSIVVKALQ 346
             P   +   ++  +   C  Y+ + RP+ S +   LQ
Sbjct: 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  111 bits (280), Expect = 1e-28
 Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 23/219 (10%)

Query: 75  IGEGSYGRVYYGIL------KSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
           +GEG++G+VY G L       S  + AIK L  + +P   +EF  +  ++S L+H N V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPVLSWQQRVKIAVG 179
           LLG C       + +E+ ++G LH+ L                     L     + IA+ 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVL 237
            A G+EYL   +  H +HRD+ + N L+ +    KI+DF LS    + D   R+ S  +L
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY-YRVQSKSLL 188

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
               +  PE  + G+   +SD++SFGVVL E+ + G +P
Sbjct: 189 -PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  110 bits (277), Expect = 3e-28
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 18/213 (8%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHEN 123
            +     ++G+GS G VY    K +G   A+KK+      +  ++ L ++  +   +   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 124 FVQLLG-YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
            V+  G +  +G    +  E+   GSL D+L     +    P PVL+      IA    K
Sbjct: 61  VVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKI----PEPVLA-----YIARQILK 110

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL+YLH K   HIIHRDIK SN+LI      KIADF +S    +   +  +T V GT  Y
Sbjct: 111 GLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-GTVTY 166

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            +PE       +  +D++S G+ LLE   G+ P
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  110 bits (276), Expect = 4e-28
 Identities = 73/248 (29%), Positives = 117/248 (47%), Gaps = 25/248 (10%)

Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
           E F     +GEGSYG VY  I  ++G   AIK +   ++  +E + ++S++ +      V
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIV 61

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +  G     T   +  E+   GS+ DI+              L+ ++   I     KGLE
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT--------NKTLTEEEIAAILYQTLKGLE 113

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YLH       IHRDIK+ N+L+ ++  AK+ADF +S Q  D  A+ ++  V+GT  + AP
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAP 168

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSE------- 297
           E       N K+D++S G+  +E+  G+ P     P R    +     P LS+       
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPE 228

Query: 298 --DKVRQC 303
             D V++C
Sbjct: 229 FNDFVKKC 236

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  108 bits (271), Expect = 2e-27
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 23/210 (10%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIK--KLDASKQPDEEFLAQ----VSMVSRLKHENFVQ 126
           L+G GS+G VY G+ L  G   A+K   L    Q  +E + Q    ++++S+L+H N VQ
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
            LG   +  +  +  E    GSL  +L       G+ P PV+    R  +      GLEY
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQIL-----LGLEY 117

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           LH++   + +HRDIK +N+L+  + V K+ADF ++ Q  + +    +    G+  + APE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPE 171

Query: 247 YAM-TGQLNAKSDVYSFGVVLLELLTGRKP 275
                G     +D++S G  +LE+ TG+ P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  108 bits (271), Expect = 2e-27
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 30/218 (13%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKL---------DASKQPD--EEFLAQVSMVSRLKH 121
           LIG+G+YGRVY  + + +G   A+K++           S+Q D  +   +++  +  L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVG 179
            N VQ LG+        +  E+   GS+   L  +GR      +   V  + ++V     
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQV----- 117

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
             +GL YLH K    I+HRD+K+ N+L+  D + KI+DF +S ++ D+     +  + G+
Sbjct: 118 -LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 240 FGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKP 275
             + APE   +     +AK D++S G V+LE+  GR+P
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  107 bits (269), Expect = 5e-27
 Identities = 87/293 (29%), Positives = 127/293 (43%), Gaps = 46/293 (15%)

Query: 74  LIGEGSYGRVYYG----ILKSGHA---AAIKKLD--ASKQPDEEFLAQVSMVSRLKHENF 124
            +G G++G VY G    IL  G      A+K L   A+ Q  +EFL +  ++S   H N 
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
           V+LLG C+    + +  E    G L   L  R         P+L+ ++ + I +  AKG 
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFDLSNQAPDMAA----RLHSTR 235
            YL      H IHRD+ + N L+ +       V KI DF L   A D+      R     
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL---ARDIYKSDYYRKEGEG 173

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 295
           +L    + APE  + G+   +SDV+SFGV++ E+LT           GQQ       P L
Sbjct: 174 LL-PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT----------LGQQPY-----PAL 217

Query: 296 SEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
           +  +V Q V A  GG    P     K+  +   C   +   RP    + + LQ
Sbjct: 218 NNQEVLQHVTA--GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 6e-27
 Identities = 68/274 (24%), Positives = 118/274 (43%), Gaps = 33/274 (12%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G  +     AIK +      +++F+ +  ++ +L H N VQL G C   
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ +NG L + L  RKG  G         +  + +     + +EYL       
Sbjct: 72  RPIFIVTEYMANGCLLNYLRERKGKLGT--------EWLLDMCSDVCEAMEYLESNG--- 120

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT---FGYHAPEYAMTG 251
            IHRD+ + N L+ +D+V K++DF L+    D       T   GT     +  PE     
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----QYTSSQGTKFPVKWAPPEVFDYS 176

Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD 311
           + ++KSDV+SFGV++ E+ +  K     +P            + S  +V + V A     
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGK-----MP----------YERFSNSEVVESVSAGYRLY 221

Query: 312 YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 345
            P  A  ++  +   C   + + RP    ++  L
Sbjct: 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  106 bits (265), Expect = 1e-26
 Identities = 75/277 (27%), Positives = 137/277 (49%), Gaps = 39/277 (14%)

Query: 73  ALIGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
            +IGEG +G V  G   +G   A+K  K D + Q    FL + +++++L H+N V+LLG 
Sbjct: 12  EIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGV 67

Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
            +     ++  E  S G+L + L  R   +           Q ++ ++  A+G+EYL  K
Sbjct: 68  ILHNGLYIVM-ELMSKGNLVNFLRTRG--RALVSVI-----QLLQFSLDVAEGMEYLESK 119

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
               ++HRD+ + N+L+ +D VAK++DF L+         + ++++     + APE    
Sbjct: 120 ---KLVHRDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKL--PVKWTAPEALKH 171

Query: 251 GQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG 309
            + ++KSDV+S+GV+L E+ + GR P                 PK+S  +V++CV+    
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPY----------------PKMSLKEVKECVEKGYR 215

Query: 310 GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
            + P    A +  +   C + E   RP+   + + L+
Sbjct: 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 40/281 (14%)

Query: 75  IGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQL 127
           +GEG +G+V           +G   A+K L+ S +     +F  ++ ++  L HEN V+ 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 128 LGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G C    G S  L  E+  +GSL D L   +          ++ ++ +  +    KG++
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--------DQINLKRLLLFSSQICKGMD 123

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP--DMAARLHSTRVLGTFGYH 243
           YL  +     IHRD+ + N+L+  +D+ KI+DF L+   P       +        F Y 
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT-GRK-------PVDHTLPRGQQSLVTWATPKL 295
           APE   T + ++ SDV+SFGV L EL T G          +        Q +VT     L
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239

Query: 296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP 336
            E +       RL    PP    ++  +  LC + E   RP
Sbjct: 240 KEGE-------RL--PRPPSCPDEVYDLMKLCWEAEPQDRP 271

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  105 bits (264), Expect = 3e-26
 Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 53/294 (18%)

Query: 75  IGEGSYGRVYYGILK------SGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
           +G G++G VY G+ +           A+K L    S+Q + +FL +  ++S+  H+N V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           L+G   +   R +  E  + G L   L   R   +  +P   L+ +  +  A   AKG +
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRP--RPERPSS-LTMKDLLFCARDVAKGCK 130

Query: 186 YLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAARLHST-------R 235
           YL E    H IHRDI + N L+       VAKIADF        MA  ++         R
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADF-------GMARDIYRASYYRKGGR 180

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 294
            +    +  PE  + G   +K+DV+SFGV+L E+ + G  P                 P 
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY----------------PG 224

Query: 295 LSEDKVRQCV--DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
            +  +V + V    RL  D P      +  +   C Q+  + RPN + +++ +Q
Sbjct: 225 RTNQEVMEFVTGGGRL--DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  104 bits (262), Expect = 4e-26
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G +G V+ G+ K+    AIK L +      ++F  +V  + RL+H++ + L   C  
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
           G    +  E    GSL   L        +  G VL     + +A   A+G+ YL E+   
Sbjct: 74  GEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL 253
           + IHRD+ + N+L+ +D V K+ADF L+    +        ++   + + APE A  G  
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 254 NAKSDVYSFGVVLLELLT 271
           + KSDV+SFG++L E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  104 bits (261), Expect = 6e-26
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)

Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 74  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 123

Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 180

Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 8e-26
 Identities = 77/290 (26%), Positives = 119/290 (41%), Gaps = 43/290 (14%)

Query: 75  IGEGSYGRVYYGILK---SGHA---AAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQ 126
           +G+GS+G VY G+ K    G      AIK ++ +    E  EFL + S++      + V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHG-RKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           LLG    G   ++  E  + G L   L   R   +        + Q+ +++A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQ---APDMAARLHSTRVLG 238
           YL  K     +HRD+ + N ++ +D   KI DF    D+             L   R   
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR--- 186

Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 297
              + APE    G    KSDV+SFGVVL E+ T   +P                   LS 
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY----------------QGLSN 227

Query: 298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 347
           ++V + V      D P     K+  +  +C QY    RP    +V +L+ 
Sbjct: 228 EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (259), Expect = 9e-26
 Identities = 78/266 (29%), Positives = 122/266 (45%), Gaps = 35/266 (13%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQL  Y V  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 71

Query: 135 TSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
              + +  E+ S GSL D L G       + G  L   Q V +A   A G+ Y+      
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERM--- 121

Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + +HRD++++N+L+ ++ V K+ADF L+    D     ++ R    F   + APE A+ G
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYG 178

Query: 252 QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG 310
           +   KSDV+SFG++L EL T GR P                 P +   +V   V+     
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVPY----------------PGMVNREVLDQVERGYRM 222

Query: 311 DYPPKAVAKMAAVAALCVQYEADFRP 336
             PP+    +  +   C + E + RP
Sbjct: 223 PCPPECPESLHDLMCQCWRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  103 bits (259), Expect = 1e-25
 Identities = 85/276 (30%), Positives = 118/276 (42%), Gaps = 36/276 (13%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
           IG G+   VY  I L +    AIK++D  K     +E   +V  +S+  H N V+     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
           V G    L   + S GSL DI      +K + P   L       +     KGLEYLH   
Sbjct: 69  VVGDELWLVMPYLSGGSLLDI------MKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR--VLGTFGYHAPEYAM 249
               IHRDIK+ N+L+ +D   KIADF +S    D   R    R   +GT  + APE  M
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VM 178

Query: 250 TGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--ATPKLSEDKVRQCVD 305
                 + K+D++SFG+  +EL TG  P     P  +  ++T     P L          
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY-SKYPPMKVLMLTLQNDPPSLETGA------ 231

Query: 306 ARLGGDYPP--KAVAKMAAVAALCVQYEADFRPNMS 339
                DY    K+  KM    +LC+Q +   RP   
Sbjct: 232 -----DYKKYSKSFRKM---ISLCLQKDPSKRPTAE 259

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  103 bits (257), Expect = 1e-25
 Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 37/277 (13%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V YG  +  +  AIK +      ++EF+ +  ++ +L HE  VQL G C   
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ SNG L + L  R+  K  QP       Q +++     +G+ YL  K    
Sbjct: 72  RPIYIVTEYMSNGCLLNYL--REHGKRFQP------SQLLEMCKDVCEGMAYLESK---Q 120

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT---FGYHAPEYAMTG 251
            IHRD+ + N L+ D    K++DF LS    D       T  +G+     +  PE  +  
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD----EYTSSVGSKFPVRWSPPEVLLYS 176

Query: 252 QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG 310
           + ++KSDV++FGV++ E+ + G+ P +    R   S           +KV Q    RL  
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYE----RFNNSETV--------EKVSQ--GLRL-- 220

Query: 311 DYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
            Y P  A  K+ A+   C   +A+ RP    ++ +++
Sbjct: 221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (260), Expect = 1e-25
 Identities = 68/208 (32%), Positives = 97/208 (46%), Gaps = 26/208 (12%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLG-YCV 132
           IGEG+ G VY      +G   AIKK+   KQ  E  + ++ ++   KH N V     Y V
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
                V   E+   GSL DI+         Q    ++  Q   +     +GLEYLH +  
Sbjct: 87  GDELWV-VMEYMDGGSLTDII--------TQNFVRMNEPQIAYVCREVLQGLEYLHSQ-- 135

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL---HSTR--VLGTFGYHAPEY 247
            ++IHRDIKS N+L+  D   K+ADF         AA+L    S R  V+GT  + APE 
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFGF-------AAQLTKEKSKRNSVVGTPYWMAPEV 187

Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                   K D++S G++ +E+  G  P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  103 bits (258), Expect = 2e-25
 Identities = 80/291 (27%), Positives = 133/291 (45%), Gaps = 31/291 (10%)

Query: 75  IGEGSYGRVY----YGILKSGHA--AAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G+V+    Y +         A+K L DAS    ++F  +  +++ L+HE+ V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV--LSWQQRVKIAVGAAKG 183
            G CV+G   ++ +E+  +G L+  L  HG   V  A+      L+  Q + IA   A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           + YL   A  H +HRD+ + N L+ ++ + KI DF +S               +    + 
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ 302
            PE  M  +   +SDV+S GVVL E+ T G++P              W   +LS ++V +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------------WY--QLSNNEVIE 233

Query: 303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 353
           C+        P     ++  +   C Q E   R N+  +   LQ L  A P
Sbjct: 234 CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-25
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 31/214 (14%)

Query: 75  IGEGSYGRVYYGI--LKSGH--AAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V  G+  +KSG     A+K L  +      +EFL + S++++L H   V+L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C  G   +L  E A  G L   L  R+ +  +    +     +V      A G+ YL 
Sbjct: 63  GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQV------AMGMAYLE 112

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG------Y 242
            K   H +HRD+ + NVL+ +   AKI+DF +S      A    S     T        +
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSR-----ALGAGSDYYRATTAGRWPLKW 164

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           +APE    G+ ++KSDV+S+GV L E  + G KP
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  102 bits (256), Expect = 2e-25
 Identities = 71/215 (33%), Positives = 100/215 (46%), Gaps = 29/215 (13%)

Query: 74  LIGEGSYGRVYYGILKS--GH--AAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQL 127
            +G+GS+G V  G   +  G     A+K L + K  D  ++FL + +++  L HEN ++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G  +     ++  E A  GSL D L  RK   G      L     V+IA     G+ YL
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRL--RKDALGHFLISTL-CDYAVQIA----NGMRYL 113

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD------MAARLHSTRVLGTFG 241
             K     IHRD+ + N+L+  DD  KI DF L    P       M   L   +V   F 
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL---KV--PFA 165

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           + APE   T   +  SDV+ FGV L E+ T G +P
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  102 bits (255), Expect = 3e-25
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 22/224 (9%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
           I   EL  + E       IG G +G V+ G        AIK +      +E+F+ +  ++
Sbjct: 1   IHPSELTLVQE-------IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVM 53

Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
            +L H   VQL G C + +   L +EF  +G L D L  ++G          S +  + +
Sbjct: 54  MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--------KFSQETLLGM 105

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTR 235
            +   +G+ YL       +IHRD+ + N L+ ++ V K++DF ++     D       T+
Sbjct: 106 CLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK 162

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDH 278
                 + +PE     + ++KSDV+SFGV++ E+ + G+ P ++
Sbjct: 163 F--PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  101 bits (253), Expect = 5e-25
 Identities = 70/205 (34%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G        A+K L       E FL +  ++ +L+H+  VQL  Y V  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVS 71

Query: 135 TSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
              + +  E+ S GSL D L  + G      G  L     V +A   A G+ Y+      
Sbjct: 72  EEPIYIVTEYMSKGSLLDFL--KDG-----EGRALKLPNLVDMAAQVAAGMAYIERM--- 121

Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD++S+N+L+ D  V KIADF L+    D     ++ R    F   + APE A+ G
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYG 178

Query: 252 QLNAKSDVYSFGVVLLELLT-GRKP 275
           +   KSDV+SFG++L EL+T GR P
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 6e-25
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 26/209 (12%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
           IGEG+YG+VY     K+G   A+KK+   +   E F    + ++ ++ +L+H N V+L  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 130 YCVD--GTSRVLAYEFASNGSLHDI--LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
                   S  + +E+      HD+  L     VK        +  Q         +GL+
Sbjct: 66  IVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVK-------FTESQIKCYMKQLLEGLQ 114

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YLH      I+HRDIK SN+LI +D V K+ADF L+       +  ++ RV+ T  Y  P
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170

Query: 246 EYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
           E  +   +   + D++S G +L EL  G+
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 7e-25
 Identities = 68/206 (33%), Positives = 96/206 (46%), Gaps = 18/206 (8%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
           IG G+YG VY    + +G   AIK +      D E + Q +SM+   +H N V   G  +
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
                 +  E+   GSL DI            GP LS  Q   +     KGL YLHE   
Sbjct: 71  RRDKLWIVMEYCGGGSLQDIYQ-------VTRGP-LSELQIAYVCRETLKGLAYLHET-- 120

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA---M 249
              IHRDIK +N+L+ +D   K+ADF +S Q     A+  S   +GT  + APE A    
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVER 177

Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKP 275
            G  + K D+++ G+  +EL   + P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 8e-25
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE-EFLAQ-VSMVSRLKHENFVQLLGY 130
            IG+GS+G VY  I  ++    AIK +D  +  DE E + Q +  +S+ +     +  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
            + G+   +  E+   GS  D+L         +PG  L       I      GLEYLHE+
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLL---------KPGK-LDETYIAFILREVLLGLEYLHEE 117

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
                IHRDIK++N+L+ ++   K+ADF +S Q     ++ ++   +GT  + APE    
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEVIKQ 172

Query: 251 GQLNAKSDVYSFGVVLLELLTGRKP 275
              + K+D++S G+  +EL  G  P
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  100 bits (251), Expect = 9e-25
 Identities = 77/276 (27%), Positives = 128/276 (46%), Gaps = 33/276 (11%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           L+G+G++G V+ G LK     A+K  K D  ++   +FL++  ++ +  H N V+L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                  +  E    G     L  +K          L  +Q VK A+ AA G+ YL  K 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLVKFALDAAAGMAYLESK- 112

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYHAPEYAM 249
             + IHRD+ + N L+ +++V KI+DF +S Q  D    ++S+  L      + APE   
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD---GIYSSSGLKQIPIKWTAPEALN 167

Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG 309
            G+ +++SDV+S+G++L E                 SL     P ++  + R+ V+    
Sbjct: 168 YGRYSSESDVWSYGILLWETF---------------SLGVCPYPGMTNQQAREQVEKGYR 212

Query: 310 GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 345
              P K    +  V   C  Y+ + RP  S + K L
Sbjct: 213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 98.5 bits (245), Expect = 6e-24
 Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 29/275 (10%)

Query: 75  IGEGSYGRVYYGILKSGHA-AAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
           IG G++G V+ G L++ +   A+K    +  PD   +FL +  ++ +  H N V+L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                  +  E    G     L           GP L  ++ +++   AA G+EYL  K 
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTE--------GPRLKVKELIQMVENAAAGMEYLESK- 113

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
             H IHRD+ + N L+ + +V KI+DF +S +  D               + APE    G
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD 311
           + +++SDV+SFG++L E                 SL       LS  + R+ ++  +   
Sbjct: 172 RYSSESDVWSFGILLWEAF---------------SLGAVPYANLSNQQTREAIEQGVRLP 216

Query: 312 YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
            P      +  +   C +Y+   RP+ S V + LQ
Sbjct: 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 8e-24
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 22/214 (10%)

Query: 73  ALIGEGSYGRVYYGIL-----KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFV 125
            ++G G++G VY G+      K     AIK L  + S + ++E L +  +++ + H + V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
           +LLG C+  +S+V L  +    G L D +   K   G+Q   +L+W       V  AKG+
Sbjct: 73  RLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQY--LLNW------CVQIAKGM 122

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            YL EK    ++HRD+ + NVL+      KI DF L+          H+        + A
Sbjct: 123 SYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179

Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            E  +      KSDV+S+GV + EL+T G KP +
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 98.1 bits (244), Expect = 9e-24
 Identities = 70/205 (34%), Positives = 111/205 (54%), Gaps = 23/205 (11%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
           IG+G +G V  G  + G+  A+K  K DA+ Q    FLA+ S++++L+H N VQLLG  V
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69

Query: 133 -DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            +     +  E+ + GSL D L  R          VL     +K ++   + +EYL    
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEAN- 121

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
             + +HRD+ + NVL+ +D+VAK++DF L+ +    A+    T  L    + APE     
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKL-PVKWTAPEALREK 174

Query: 252 QLNAKSDVYSFGVVLLELLT-GRKP 275
           + + KSDV+SFG++L E+ + GR P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 98.2 bits (244), Expect = 9e-24
 Identities = 76/249 (30%), Positives = 119/249 (47%), Gaps = 27/249 (10%)

Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+   +  +G+G +G V+ G        AIK L       E FL +  ++ +L+H+  V 
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP 65

Query: 127 LLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           L  Y V     + +  EF   GSL D L  ++G      G  L   Q V +A   A G+ 
Sbjct: 66  L--YAVVSEEPIYIVTEFMGKGSLLDFL--KEG-----DGKYLKLPQLVDMAAQIADGMA 116

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYH 243
           Y+      + IHRD++++N+L+ D+ V KIADF L+    D     ++ R    F   + 
Sbjct: 117 YIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWT 170

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP--------VDHTLPRGQQSLVTWATPK 294
           APE A+ G+   KSDV+SFG++L EL+T GR P        V   + RG +       P+
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE 230

Query: 295 LSEDKVRQC 303
              + ++ C
Sbjct: 231 SLHELMKLC 239

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.5 bits (243), Expect = 1e-23
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 16/212 (7%)

Query: 68  NFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHEN 123
           +F     +G+GSYG VY    L      A+K++D         E+ + ++ +++ + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
            +      +DG    +  E+A  G L      +   K  +   ++  Q+  +I +   +G
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLS-----KAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           L+ LHE+    I+HRD+KS+N+L+  +D+ KI D  +S       A+      +GT  Y 
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQIGTPHYM 168

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           APE       + KSD++S G +L E+ T   P
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 98.1 bits (244), Expect = 2e-23
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 19/216 (8%)

Query: 75  IGEGSYGRVYYGIL------KSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G+V+          +     A+K L +AS+   ++F  +  +++ L+H++ V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HGR-----KGVKGAQPGPVLSWQQRVKIAVGA 180
            G C +G   ++ +E+  +G L+  L  HG       G +   PG  L+  Q + IA   
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ-LTLGQMLAIASQI 131

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A G+ YL   A  H +HRD+ + N L+    V KI DF +S             R +   
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            +  PE  +  +   +SD++SFGVVL E+ T G++P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 97.9 bits (244), Expect = 2e-23
 Identities = 71/221 (32%), Positives = 105/221 (47%), Gaps = 24/221 (10%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
           +GEG+ G V    LK +G   A+K +     PD  ++ L ++ +    K    V+  G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 132 VDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV--KIAVGAAKGLEYL 187
           +D +S  +  A E+   GSL D ++ +   +G + G      ++V  KIA    KGL YL
Sbjct: 69  LDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIG------EKVLGKIAESVLKGLSYL 121

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
           H +    IIHRDIK SN+L+      K+ DF +S +  +  A    T   GT  Y APE 
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFT-GTSFYMAPER 174

Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 +  SDV+S G+ LLE+   R P     P G+  L 
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG 212

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 97.4 bits (243), Expect = 2e-23
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 28/216 (12%)

Query: 72  NALIGEGSYGRVYYGIL----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFV 125
             +IG G +G V  G L    K     AIK L A     +  +FL + S++ +  H N +
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +L G        ++  E+  NGSL   L    G          +  Q V +  G A G++
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--------FTVGQLVGMLRGIASGMK 120

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-----VLGTF 240
           YL   ++ + +HRD+ + N+L+  + V K++DF LS +  D  A  ++T+     +  T 
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKIPIRWT- 175

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              APE     +  + SDV+SFG+V+ E+++ G +P
Sbjct: 176 ---APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 96.9 bits (241), Expect = 6e-23
 Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 36/227 (15%)

Query: 75  IGEGSYGRVYYGILKSGH-------------------AAAIKKLDASKQPDEEFLAQVSM 115
           +GEG +G V+   + +                     A  I + DA+K    +FL +V +
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL----------HGRKGVKGAQPG 165
           +SRLK  N ++LLG CVD     +  E+  NG L+  L          +G   V  A   
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-- 223
           P +S+   + +A+  A G++YL   +  + +HRD+ + N L+ ++   KIADF +S    
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
           A D   R+    VL    + A E  + G+    SDV++FGV L E+L
Sbjct: 190 AGDY-YRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 96.3 bits (240), Expect = 9e-23
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 19/214 (8%)

Query: 74  LIGEGSYGRV----YYGILKSGH--AAAIKKL--DASKQPDEEFLAQVSMVSRL-KHENF 124
            +GEG++G+V      G+         A+K L  DA+++   + ++++ M+  + KH+N 
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPVLSWQQRVKIA 177
           + LLG C       +  E+A++G+L D L  R              P   L+ +  V  A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
              A+G+E+L  K     IHRD+ + NVL+ +D V KIADF L+     +     +T   
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
               + APE         +SDV+SFGV+L E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 95.6 bits (239), Expect = 1e-22
 Identities = 67/217 (30%), Positives = 95/217 (43%), Gaps = 45/217 (20%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           +GEG+YG VY     K+G   A+KK  LD     +E      L ++S++  LKH N V+L
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD---NEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           L          L +E+     L   L  R G     P  + S   ++       +GL Y 
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIMYQL------LRGLAYC 114

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS------TRVLGTFG 241
           H      I+HRD+K  N+LI  D V K+ADF L        AR         T  + T  
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGL--------ARAFGIPLRTYTHEVVTLW 163

Query: 242 YHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
           Y APE      L +K      D++S G +  E++TG+
Sbjct: 164 YRAPEIL----LGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 94.9 bits (236), Expect = 1e-22
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 27/209 (12%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G        AIK L       E FLA+ +++ +L+H   V+L    V  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA-VVTQ 72

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+  NGSL D L   +G+K       L+  + + +A   A+G+ ++  K   +
Sbjct: 73  EPIYIITEYMENGSLVDFLKTPEGIK-------LTINKLIDMAAQIAEGMAFIERK---N 122

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTF--GYHAPEY 247
            IHRD++++N+L+ +    KIADF L        ARL     ++ R    F   + APE 
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGL--------ARLIEDNEYTAREGAKFPIKWTAPEA 174

Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              G    KSDV+SFG++L E++T GR P
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 2e-22
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 23/227 (10%)

Query: 62  LKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL- 119
           L + T  F    +IGEG+YG+VY     K+G   AIK +D  +  +EE   + +++ +  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60

Query: 120 KHENFVQLLGYCVDGTSRV------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
            H N     G  +            L  E    GS+ D++ G +          +++   
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--- 117

Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
             I     +GL YLHE     +IHRDIK  N+L+  +   K+ DF +S Q      R ++
Sbjct: 118 --ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172

Query: 234 TRVLGTFGYHAPE-----YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
              +GT  + APE            +A+SDV+S G+  +EL  G+ P
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 94.2 bits (234), Expect = 3e-22
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 23/213 (10%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKL-------DASKQPDEEFLAQVSMVSRLKHENFVQ 126
           ++G+G+YG VY G+   G   A+K++        A+++  E+   +V ++  LKH N VQ
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
            LG C+D  +  +  EF   GS+  IL+      G  P PV       K       G+ Y
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFC-----KYTKQILDGVAY 117

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL----GTFGY 242
           LH      ++HRDIK +NV++  + + K+ DF  + +   +      + +L    GT  +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            APE         KSD++S G  + E+ TG+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 94.7 bits (235), Expect = 4e-22
 Identities = 82/268 (30%), Positives = 126/268 (47%), Gaps = 46/268 (17%)

Query: 67  ENFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLD--ASKQPDEEFLAQVSMVSRL-K 120
           E+     +IGEG++G+V   ++K       AAIK L   AS+    +F  ++ ++ +L  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPVLSWQQR 173
           H N + LLG C +     +A E+A  G+L D L   + +       K       L+ QQ 
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
           ++ A   A G++YL EK     IHRD+ + NVL+ ++  +KIADF LS        R   
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLS--------RGEE 170

Query: 234 TRVLGTFGYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT-GRKP--------VDHT 279
             V  T G     +     LN      KSDV+SFGV+L E+++ G  P        +   
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230

Query: 280 LPRGQQSLVTWATPKLSEDKV----RQC 303
           LP+G +       P+  +D+V    RQC
Sbjct: 231 LPQGYR----MEKPRNCDDEVYELMRQC 254

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 97.6 bits (243), Expect = 4e-22
 Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 26/291 (8%)

Query: 62  LKEITENFGTNALIGEGSYGRVYYG-ILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           + +I  +     +I  G  G  Y G  +K+G    +K+++         +A +    +L+
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG---KLQ 741

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H N V+L+G C       L +E+    +L ++L              LSW++R KIA+G 
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------------LSWERRRKIAIGI 789

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AK L +LH +  P ++  ++    ++I   D        LS   P +      T+   + 
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLRLS--LPGLLCT--DTKCFISS 842

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
            Y APE   T  +  KSD+Y FG++L+ELLTG+ P D        S+V WA    S+  +
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHL 901

Query: 301 RQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
              +D  + GD       + ++  +A  C   +   RP  + V+K L+   
Sbjct: 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952

Length = 968

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 93.7 bits (233), Expect = 5e-22
 Identities = 61/279 (21%), Positives = 123/279 (44%), Gaps = 36/279 (12%)

Query: 75  IGEGSYGR-VYYGILKSGHAAAIKKLDASK-QPDEEFLAQ--VSMVSRLKHENFVQLLGY 130
           +G+G++G    Y   +       K+++ ++    E   A   + ++S L+H N +    +
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV--GAAKGLEYLH 188
            +D  + ++  E+A+ G+L+D +  +KG           +++ + +         + Y+H
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKG---------QLFEEEMVLWYLFQIVSAVSYIH 118

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
           +     I+HRDIK+ N+ +    + K+ DF +S           +  V+GT  Y +PE  
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS--EYSMAETVVGTPYYMSPELC 173

Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL 308
              + N KSD+++ G VL ELLT ++  D T P    +LV          K+ Q     +
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV---------KIVQGNYTPV 221

Query: 309 GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 347
              Y     +++ ++    +Q + + RP    V+     
Sbjct: 222 VSVYS----SELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 93.6 bits (233), Expect = 5e-22
 Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 43/223 (19%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIK-------KLDASKQPDEEFLAQVSMVSRLKHENF 124
             IG G++G+VY  + L +G   A+K            K+  +E    + ++  LKH N 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADE----MKVLELLKHPNL 61

Query: 125 VQLLGYCVDGTSRVLAY-EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA-- 181
           V+  G  V    +V  + E+ S G+L ++L           G +L   + V I V     
Sbjct: 62  VKYYGVEVH-REKVYIFMEYCSGGTLEELLEH---------GRIL--DEHV-IRVYTLQL 108

Query: 182 -KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD----LSNQAPDMAARLHSTRV 236
            +GL YLH      I+HRDIK +N+ +  + V K+ DF     L N    M   + S   
Sbjct: 109 LEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA- 164

Query: 237 LGTFGYHAPEY----AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT  Y APE        G   A +D++S G V+LE+ TG++P
Sbjct: 165 -GTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 93.4 bits (232), Expect = 6e-22
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 27/218 (12%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKL---------DASKQPDEEFLA-QVSMVSRLKH 121
           ALIG GS+G VY G+   SG   A+K++            K+   + LA +++++  L+H
Sbjct: 6   ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN VQ LG  +D     +  E+   GS+  +L+      GA    ++    R  +     
Sbjct: 66  ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQIL----- 116

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP----DMAARLHSTRVL 237
           KGL YLH +    IIHRDIK +N+L+ +    KI+DF +S +                + 
Sbjct: 117 KGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           G+  + APE         K+D++S G +++E+LTG+ P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 78/294 (26%), Positives = 131/294 (44%), Gaps = 34/294 (11%)

Query: 75  IGEGSYGRVY----YGI--LKSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G+V+    Y +   K     A+K L D +    ++F  +  +++ L+HE+ V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGV-----KGAQPGPVLSWQQRVKIAVGA 180
            G C DG   ++ +E+  +G L+  L  HG   +     +  Q    L   Q + IA   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A G+ YL   A  H +HRD+ + N L+  + + KI DF +S               +   
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 299
            +  PE  M  +   +SDV+SFGV+L E+ T G++P              W   +LS  +
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------------WF--QLSNTE 233

Query: 300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 353
           V +C+      + P     ++  +   C Q E   R N+  + K L  L  A P
Sbjct: 234 VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 90.7 bits (225), Expect = 5e-21
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 25/208 (12%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G  ++    AIK ++     +E+F+ +  ++ +L H   VQL G C   
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  EF  NG L + L  R+G        +LS  Q V       +G+EYL   +   
Sbjct: 72  KPLYIVTEFMENGCLLNYLRQRQGKLS--KDMLLSMCQDV------CEGMEYLERNS--- 120

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG------YHAPEYA 248
            IHRD+ + N L+    V K++DF ++    D            + G      +  PE  
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-------DEYTSSSGAKFPVKWSPPEVF 173

Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              + ++KSDV+SFGV++ E+ T G+ P
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 91.5 bits (227), Expect = 5e-21
 Identities = 67/227 (29%), Positives = 108/227 (47%), Gaps = 20/227 (8%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSR-LKHENFVQLLGYCV 132
           IG+G+ G VY  I + +G   AIK+++  +QP +E +    +V R  KH N V  L   +
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  E+ + GSL D++      +G          Q   +     + LE+LH    
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN-- 134

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
             +IHRDIKS N+L+  D   K+ DF    Q  P+ + R   + ++GT  + APE     
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 190

Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSE 297
               K D++S G++ +E++ G  P  +  P R    + T  TP+L  
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN 237

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 91.0 bits (226), Expect = 5e-21
 Identities = 62/238 (26%), Positives = 111/238 (46%), Gaps = 33/238 (13%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKH---ENFVQL 127
           LIG G+YG VY G  + +G   A+K ++     D+  +   +V+++S+L+     N  + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G  + G    +  E+A  GS+  ++         + GP+      V I       L+Y+
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPIAEKYISV-IIREVLVALKYI 117

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-----VLGTFGY 242
           H+     +IHRDIK++N+L+ +    K+ DF +       AA L+         +GT  +
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGV-------AALLNQNSSKRSTFVGTPYW 167

Query: 243 HAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPV-DHTLPRGQQSLVTWATPKLSED 298
            APE    G+  + K+D++S G+ + E+ TG  P  D    R    +     P+L ++
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN 225

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 91.2 bits (226), Expect = 7e-21
 Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 31/220 (14%)

Query: 75  IGEGSYGRVY----YGILKS--GHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG +G+V     YGI KS        A+K L  +A+ +   + ++++ ++  + KH+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP------------VLSWQ 171
            + LLG C       +  E+A+ G+L + L  R+      PGP             LS++
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARR-----PPGPDYTFDITKVPEEQLSFK 134

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
             V  A   A+G+EYL  +     IHRD+ + NVL+ +D+V KIADF L+    D+    
Sbjct: 135 DLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191

Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
            ++       + APE         +SDV+SFG+++ E+ T
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 90.7 bits (225), Expect = 7e-21
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 25/223 (11%)

Query: 75  IGEGSYGRVYY----GILKSGH----AAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           IG+G++GRV+     G+L        A  + K +AS     +F  + ++++   H N V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGR-------------KGVKGAQPGPVLSWQQR 173
           LLG C  G    L +E+ + G L++ L  R                K       LS  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
           + IA   A G+ YL E+     +HRD+ + N L+ ++ V KIADF LS           S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                   +  PE     +   +SDV+++GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 18/204 (8%)

Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
           IGEG++G V+     ++G   A+KK+   +       + L ++  +   +H   V+LL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
              G+  VL  E+     L ++L   +     +P   L   Q         KG+ Y+H  
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEE-----RP---LPEAQVKSYMRMLLKGVAYMHAN 118

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
               I+HRD+K +N+LI  D V KIADF L+    +   RL+S +V  T  Y APE    
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYG 174

Query: 251 GQ-LNAKSDVYSFGVVLLELLTGR 273
            +  +   D+++ G +  ELL G 
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 89.7 bits (222), Expect = 1e-20
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 16/204 (7%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G   +    A+K L       + FL + +++  L+H+  V+L       
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ + GSL D L   +G K   P       + +  +   A+G+ Y+  K   +
Sbjct: 74  EPIYIITEYMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQIAEGMAYIERK---N 123

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            IHRD++++NVL+ +  + KIADF L+    D     ++ R    F   + APE    G 
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 180

Query: 253 LNAKSDVYSFGVVLLELLT-GRKP 275
              KSDV+SFG++L E++T G+ P
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 90.4 bits (224), Expect = 1e-20
 Identities = 74/249 (29%), Positives = 118/249 (47%), Gaps = 27/249 (10%)

Query: 75  IGEGSYGRVYY----GILK---------SGHA--AAIKKL--DASKQPDEEFLAQVSMVS 117
           +GEG +G V+     G+ +          G     A+K L  D +K    +FL ++ ++S
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK---GVKGAQPGPVLSWQQRV 174
           RLK+ N ++LLG CV      +  E+  NG L+  L  R+       A   P +S    +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARLHS 233
            +AV  A G++YL   A  + +HRD+ + N L+ +    KIADF +S N       R+  
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 293
             VL    + A E  + G+    SDV++FGV L E+ T  K   ++L   +Q  V   T 
Sbjct: 190 RAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--VIENTG 246

Query: 294 KLSEDKVRQ 302
           +   ++ RQ
Sbjct: 247 EFFRNQGRQ 255

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 90.4 bits (224), Expect = 1e-20
 Identities = 72/234 (30%), Positives = 115/234 (49%), Gaps = 26/234 (11%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEEFLAQVSM 115
           + ++ L + T+ +     IG+G+YG+VY     K G  AA+K LD     DEE  A+ ++
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI 71

Query: 116 VSRL-KHENFVQLLG--YCVD---GTSRVLAYEFASNGSLHDILHG--RKGVKGAQPGPV 167
           +  L  H N V+  G  Y  D   G    L  E  + GS+ +++ G    G +  +   +
Sbjct: 72  LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA--M 129

Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
           +S+     I  GA  GL++LH      IIHRD+K +N+L+  +   K+ DF +S Q    
Sbjct: 130 ISY-----ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--T 179

Query: 228 AARLHSTRVLGTFGYHAPEYAMTGQ-----LNAKSDVYSFGVVLLELLTGRKPV 276
           + RL     +GT  + APE     Q      +A+ DV+S G+  +EL  G  P+
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 21/215 (9%)

Query: 75  IGEGSYGRVYY----GILKSGHA----AAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG +G+V      GI K         A+K L  DA+ +   + ++++ M+  + KH+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGA-----QPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G+  +      P   L+++  V  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL   A    IHRD+ + NVL+ +D+V KIADF L+    ++     +T  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 71/216 (32%), Positives = 108/216 (50%), Gaps = 29/216 (13%)

Query: 74  LIGEGSYGRVYYG-ILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRL-KHENFVQL 127
           +IGEG++G+V    I K G    AAIK++   ASK    +F  ++ ++ +L  H N + L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGA 180
           LG C       LA E+A +G+L D L   + ++              LS QQ +  A   
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A+G++YL +K     IHRD+ + N+L+ ++ VAKIADF LS        R     V  T 
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKTM 182

Query: 241 GYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT 271
           G     +     LN       SDV+S+GV+L E+++
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 67  ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENF 124
                   IGEGS G V     KS G   A+KK+D  KQ   E L  +V ++   +H N 
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           V++    + G    +  EF   G+L DI+ H R           ++ +Q   + +   K 
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCLAVLKA 127

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           L +LH +    +IHRDIKS ++L+  D   K++DF    Q      R  S  ++GT  + 
Sbjct: 128 LSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWM 182

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           APE         + D++S G++++E++ G  P
Sbjct: 183 APEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 88.7 bits (221), Expect = 2e-20
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 39/219 (17%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G+GS+G+V     K +G   A+K L       ++  E  L + +++SR+ H   V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 130 YCV--DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK----- 182
           +          L  E+A  G L   L                  +  + +   A+     
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHL-----------------SKEGRFSEERARFYAAE 101

Query: 183 ---GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
               LEYLH      II+RD+K  N+L+  D   K+ DF L+ +     +R ++    GT
Sbjct: 102 IVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156

Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
             Y APE  +        D +S GV+L E+LTG+ P   
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 89.0 bits (220), Expect = 2e-20
 Identities = 82/262 (31%), Positives = 123/262 (46%), Gaps = 48/262 (18%)

Query: 74  LIGEGSYGRVYYGILKSG---HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFVQL 127
           +IGEG++G+V    +K       AAIK++   ASK    +F  ++ ++ +L H  N + L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG--------PVLSWQQRVKIAVG 179
           LG C       LA E+A +G+L D L   + V    P           LS QQ +  A  
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G++YL +K     IHRD+ + N+L+ ++ VAKIADF LS        R     V  T
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKT 169

Query: 240 FGYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT-GRKP--------VDHTLPRGQQ 285
            G     +     LN       SDV+S+GV+L E+++ G  P        +   LP+G +
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229

Query: 286 SLVTWATPKLSEDKV----RQC 303
                  P   +D+V    RQC
Sbjct: 230 ----LEKPLNCDDEVYDLMRQC 247

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 89.2 bits (221), Expect = 3e-20
 Identities = 74/290 (25%), Positives = 130/290 (44%), Gaps = 32/290 (11%)

Query: 75  IGEGSYGRVYYGIL--------KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENF 124
           +GEG +G+V    L         +G   A+K L  +  +Q    +  +++++  L HEN 
Sbjct: 12  LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 125 VQLLGYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           V+  G C +   +   L  E+   GSL D L          P   L+  Q +  A    +
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHKLNLAQLLLFAQQICE 118

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTF 240
           G+ YLH +   H IHRD+ + NVL+ +D + KI DF L+   P+     R+        F
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
            Y A E     + +  SDV+SFGV L ELLT       + P+  + ++     +++  ++
Sbjct: 176 WY-AVECLKENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFEEMIGPKQGQMTVVRL 233

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 350
            + ++  +    P     ++  +   C + EA FRP    ++  L+ + +
Sbjct: 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 89.0 bits (220), Expect = 3e-20
 Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 34/281 (12%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYC 131
           IG+GS+G V+ GI  ++    AIK +D  +  DE  +   +++++S+       +  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
           +  T   +  E+   GS  D+L         +PGP L   Q   I     KGL+YLH + 
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSEK 121

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
               IHRDIK++NVL+ +    K+ADF ++ Q  D   ++     +GT  + APE     
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176

Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD 311
             ++K+D++S G+  +EL  G  P     P     L+    P   E            G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE------------GN 224

Query: 312 YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 352
           Y       +      C+  E  FRP    ++K    +  A+
Sbjct: 225 YS----KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.8 bits (220), Expect = 3e-20
 Identities = 74/290 (25%), Positives = 125/290 (43%), Gaps = 45/290 (15%)

Query: 74  LIGEGSYGRVYYGILKSG----HAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G +G V  G LK         AIK L +  +++   +FL++ S++ +  H N + L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G        ++  EF  NG+L   L    G    Q   +    Q V +  G A G++YL
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDG----QFTVI----QLVGMLRGIAAGMKYL 122

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG---TFGYHA 244
              ++ + +HRD+ + N+L+  + V K++DF LS    D  +    T  LG      + A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 303
           PE     +  + SDV+S+G+V+ E+++ G +P              W       D   Q 
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-------------W-------DMSNQD 219

Query: 304 VDARLGGDY----PPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
           V   +  DY    P      +  +   C Q + + RP    +V  L  ++
Sbjct: 220 VINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 88.6 bits (219), Expect = 4e-20
 Identities = 79/245 (32%), Positives = 116/245 (47%), Gaps = 27/245 (11%)

Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA---QVSMVSRLKHE 122
           E+F     IG G+YG VY    + +G  AAIK +    +P E+F     ++ M+   KH 
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL--EPGEDFAVVQQEIIMMKDCKHS 66

Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N V   G  +      +  EF   GSL DI H          GP LS  Q   ++    +
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH--------VTGP-LSESQIAYVSRETLQ 117

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL YLH K     +HRDIK +N+L+ D+   K+ADF +S Q     A+  S   +GT  +
Sbjct: 118 GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYW 172

Query: 243 HAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLS 296
            APE A     G  N   D+++ G+  +EL   + P+    P     L+T   +  PKL 
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL- 231

Query: 297 EDKVR 301
           +DK++
Sbjct: 232 KDKMK 236

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 31/216 (14%)

Query: 75  IGEGSYGRVYYGILKSGHAA---AIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           IG G+YGRVY    K+G      AIKK    K+           +++++  LKHEN V L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 128 LGYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPV---LSWQQRVKIAVGAAK 182
           +   ++   +   L +++A +     I   R+  + + P  +   L WQ           
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------ILN 119

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSN--QAPDMAARLHSTRV 236
           G+ YLH      ++HRD+K +N+L+     +  V KI D  L+    AP +        V
Sbjct: 120 GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LKPLADLDPV 175

Query: 237 LGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLT 271
           + T  Y APE  +  +   K+ D+++ G +  ELLT
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.1 bits (218), Expect = 4e-20
 Identities = 68/215 (31%), Positives = 113/215 (52%), Gaps = 17/215 (7%)

Query: 68  NFGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPDEEFLA---QVSMVSRLKHEN 123
            +     IGEGS+G++Y    KS      IK++D +K P +E  A   +V +++++KH N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
            V       +     +  E+   G L   ++ ++GV  ++   +LSW   V+I++G    
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSW--FVQISLG---- 113

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           L+++H   D  I+HRDIKS N+ +  +  VAK+ DF ++ Q  D +  L  T  +GT  Y
Sbjct: 114 LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYT-CVGTPYY 168

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
            +PE       N K+D++S G VL EL T + P +
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 88.4 bits (219), Expect = 4e-20
 Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 27/222 (12%)

Query: 64  EITENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKL----DASKQPDEEFLAQVSMVSR 118
           E  EN G   ++G+G+YG VY     S     AIK++        QP  E   ++++ S 
Sbjct: 6   EYDEN-GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSY 61

Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
           LKH N VQ LG   +     +  E    GSL  +L  + G        ++ + +++    
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI---- 117

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLH--STR 235
              +GL+YLH+     I+HRDIK  NVL+     V KI+DF  S +     A ++  +  
Sbjct: 118 --LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR----LAGINPCTET 168

Query: 236 VLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKP 275
             GT  Y APE    G     A +D++S G  ++E+ TG+ P
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 88.5 bits (219), Expect = 7e-20
 Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 21/215 (9%)

Query: 75  IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG +G+V      G+ K      +  A  + K DA+++   + ++++ M+  + KH+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVK-----GAQPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++        P   LS++  V  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+     +     +T  
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ T
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 88.3 bits (219), Expect = 9e-20
 Identities = 72/214 (33%), Positives = 108/214 (50%), Gaps = 37/214 (17%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
           IG GS+G VY+   +++    AIKK+  S KQ +E++   + +V  + +L+H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 130 YCVDGTSRVLAYEFASNGSLHDILH-GRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLE 185
             +   +  L  E+   GS  DIL   +K +            Q V+IA    GA +GL 
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDILEVHKKPL------------QEVEIAAICHGALQGLA 129

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF-DLSNQAPDMAARLHSTRVLGTFGYHA 244
           YLH       IHRDIK+ N+L+ +    K+ADF   S  +P       +   +GT  + A
Sbjct: 130 YLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYWMA 179

Query: 245 PE--YAM-TGQLNAKSDVYSFGVVLLELLTGRKP 275
           PE   AM  GQ + K DV+S G+  +E L  RKP
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 87.7 bits (217), Expect = 9e-20
 Identities = 79/305 (25%), Positives = 128/305 (41%), Gaps = 41/305 (13%)

Query: 53  EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK---SGHA---AAIKKLDASKQPD 106
           EV    +  L+E+          G+GS+G VY G  +    G A    A+K ++ S    
Sbjct: 2   EVSREKITLLREL----------GQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 51

Query: 107 E--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
           E  EFL + S++      + V+LLG    G   ++  E  ++G L   L   +      P
Sbjct: 52  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 111

Query: 165 G-PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           G P  + Q+ +++A   A G+ YL+ K     +HRD+ + N ++  D   KI DF ++  
Sbjct: 112 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168

Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283
             +        + L    + APE    G     SD++SFGVVL E+              
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------------- 214

Query: 284 QQSLVTWATPKLSEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIV 341
             SL       LS ++V + V    GG  D P     ++  +  +C Q+    RP    +
Sbjct: 215 -TSLAEQPYQGLSNEQVLKFVMD--GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 271

Query: 342 VKALQ 346
           V  L+
Sbjct: 272 VNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 73/248 (29%), Positives = 112/248 (45%), Gaps = 41/248 (16%)

Query: 43  GAQAVKVQPIEVPAISVDELKEITEN---FGTNALIGEGSYGRVY----YGILKSGHA-- 93
           G + V + P ++P    D   E   N   FG    +G G++G+V     YG+ KS     
Sbjct: 13  GNEYVYIDPTQLP---YDLKWEFPRNNLSFGK--TLGAGAFGKVVEATAYGLSKSDAVMK 67

Query: 94  AAIKKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLH 150
            A+K L  +    E    ++++ ++S L  HEN V LLG C  G   ++  E+   G L 
Sbjct: 68  VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127

Query: 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210
           + L  RK         +LS+  +V      AKG+ +L  K   + IHRD+ + NVL+   
Sbjct: 128 NFLR-RKRESFLTLEDLLSFSYQV------AKGMAFLASK---NCIHRDLAARNVLLTHG 177

Query: 211 DVAKIADFDL-------SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFG 263
            + KI DF L       SN      ARL          + APE         +SDV+S+G
Sbjct: 178 KIVKICDFGLARDIMNDSNYVVKGNARL-------PVKWMAPESIFNCVYTFESDVWSYG 230

Query: 264 VVLLELLT 271
           ++L E+ +
Sbjct: 231 ILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 23/220 (10%)

Query: 62  LKEITENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKLDASKQPDE----EFLA 111
           L+EIT        +G G +G V+    K            +K L   K  DE    EF  
Sbjct: 7   LQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRR 57

Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
           ++ M  +L H+N V+LLG C +     +  E+   G L   L   K        P LS +
Sbjct: 58  ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
           Q+V +    A G+++L   ++   +HRD+ + N L+      K++   LS    +     
Sbjct: 118 QKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174

Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
               ++    + APE       + KSDV+SFGV++ E+ T
Sbjct: 175 LRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 75  IGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYC 131
           IG+GS+G VY GI  ++    AIK +D  +  DE  +   +++++S+       +  G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
           + GT   +  E+   GS  D+L         +PGP L       I     KGL+YLH + 
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIATILREILKGLDYLHSER 121

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
               IHRDIK++NVL+ +    K+ADF ++ Q  D   ++     +GT  + APE     
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176

Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
             + K+D++S G+  +EL  G  P
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 27/214 (12%)

Query: 74  LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G +G V+ GILK       A AIK L    +++  ++FL++ S++ +  H N ++L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G        ++  E+  NG+L   L    G          S  Q V +  G A G++YL
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQLVGMLRGIAAGMKYL 123

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG-----Y 242
              +D + +HRD+ + N+L+  +   K++DF LS    D     ++T    + G     +
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRW 176

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            APE     +  + SDV+SFG+V+ E+++ G +P
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 19/204 (9%)

Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
           IGEGS G V    +KS G   A+KK+D  KQ   E L  +V ++   +HEN V++    +
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            G    +  EF   G+L DI+ H R           ++ +Q   + +   K L  LH + 
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLKALSVLHAQG 136

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              +IHRDIKS ++L+  D   K++DF    Q      R  S  ++GT  + APE     
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRL 191

Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D++S G++++E++ G  P
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 24/210 (11%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL-GYC 131
           +G+G++G+VY    K +G  AA K +    + + E+F+ ++ ++S  KH N V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 132 VDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
            +    +L  EF   G+L  I L   +G+   Q   V              + L +LH  
Sbjct: 73  YENKLWIL-IEFCDGGALDSIMLELERGLTEPQIRYVCRQ---------MLEALNFLHSH 122

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
               +IHRD+K+ N+L+  D   K+ADF +S +      +  +   +GT  + APE    
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVAC 177

Query: 251 GQL-----NAKSDVYSFGVVLLELLTGRKP 275
                   + K+D++S G+ L+EL     P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 85.2 bits (211), Expect = 6e-19
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 20/211 (9%)

Query: 72  NALIGEGSYGRVYYGILKSGH----AAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFV 125
              IGEG +G VY G+  S      A A+K  K   S    E+FL +  ++ +  H + V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +L+G   +    ++  E A  G L   L   K          L     +  +   +  L 
Sbjct: 71  KLIGVITENPVWIV-MELAPLGELRSYLQVNKYS--------LDLASLILYSYQLSTALA 121

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YL  K     +HRDI + NVL+   D  K+ DF LS +  +  +   +++      + AP
Sbjct: 122 YLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS-RYLEDESYYKASKGKLPIKWMAP 177

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           E     +  + SDV+ FGV + E+L  G KP
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 7e-19
 Identities = 63/218 (28%), Positives = 93/218 (42%), Gaps = 30/218 (13%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKH 121
             +    ++GEG+YG V     K +G   AIKK   S+  DE+     L +V ++ +L+H
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRH 59

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV--LSWQQRVKIAVG 179
           EN V L           L +E+    +L ++L    G  G  P  V    WQ        
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPG--GLPPDAVRSYIWQ-------- 108

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
             + + Y H     +IIHRDIK  N+L+ +  V K+ DF  +       A    T  + T
Sbjct: 109 LLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVAT 164

Query: 240 FGYHAPE----YAMTGQLNAKSDVYSFGVVLLELLTGR 273
             Y APE        G      DV++ G ++ ELL G 
Sbjct: 165 RWYRAPELLVGDTNYG---KPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 85.5 bits (212), Expect = 7e-19
 Identities = 69/210 (32%), Positives = 96/210 (45%), Gaps = 29/210 (13%)

Query: 75  IGEGSYGRVYYG-ILKSGHAAAIKKLDASKQPDE---EFLAQVSMVSRLKHENFVQLLGY 130
           IGEG+YG VY      SG   A+KK+    + D      L +++++  L+H N V+L   
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 131 CVDG--TSRVLAYEFASN--GSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLE 185
            V     S  L  E+      SL D +          P P    Q  VK + +   +GL+
Sbjct: 75  VVGKHLDSIFLVMEYCEQDLASLLDNM----------PTPFSESQ--VKCLMLQLLRGLQ 122

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YLHE     IIHRD+K SN+L+ D    KIADF L+      A     T  + T  Y AP
Sbjct: 123 YLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAP 177

Query: 246 E--YAMTGQLNAKSDVYSFGVVLLELLTGR 273
           E     T    A  D+++ G +L ELL  +
Sbjct: 178 ELLLGCTTYTTA-IDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 85.1 bits (210), Expect = 7e-19
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 19/217 (8%)

Query: 75  IGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQL 127
           +GE ++G++Y G L           AIK L     P +  EF  + S+++ L H N V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL-----HGRKGVKGAQPGPV---LSWQQRVKIAVG 179
           LG         + +E+ + G LH+ L     H   G    + G V   L     + IA+ 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A G+EYL   +    +H+D+ + N+LI +    KI+D  LS +           + L  
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
             +  PE  M G+ ++ SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 85.5 bits (211), Expect = 7e-19
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)

Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG +G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+             P   ++++  V  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYC 131
           IG+GS+G V+ GI  ++    AIK +D  +  DE  +   +++++S+       +  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
           + GT   +  E+   GS  D+L         + GP   +Q    +     KGL+YLH + 
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLL---------RAGPFDEFQIATMLK-EILKGLDYLHSEK 121

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
               IHRDIK++NVL+ +    K+ADF ++ Q  D   ++     +GT  + APE     
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQS 176

Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
             ++K+D++S G+  +EL  G  P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 36/226 (15%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSM----VSRLK-HENFVQL 127
           +IGEGS+  V     K +    AIK LD  +   E+ +  V +    ++RL  H   ++L
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
                D  +     E+A NG L   +              L  +     A      LEYL
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---------LDEKCTRFYAAEILLALEYL 118

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADF--------DLSNQAPDMAARLHSTR---- 235
           H K    IIHRD+K  N+L+  D   KI DF        + S ++    A    ++    
Sbjct: 119 HSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 236 ------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                  +GT  Y +PE          SD+++ G ++ ++LTG+ P
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 83.9 bits (207), Expect = 1e-18
 Identities = 68/240 (28%), Positives = 114/240 (47%), Gaps = 25/240 (10%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+          A+K +       E FLA+ +++  L+H+  V+L       
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
              ++  EF + GSL D L   +G K  QP P L     +  +   A+G+ ++ ++   +
Sbjct: 74  PIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAFIEQR---N 122

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            IHRD++++N+L+    V KIADF L+    D     ++ R    F   + APE    G 
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 179

Query: 253 LNAKSDVYSFGVVLLELLT-GRKP--------VDHTLPRGQQSLVTWATPKLSEDKVRQC 303
              KSDV+SFG++L+E++T GR P        V   L RG +       P+   + + +C
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 239

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 72/245 (29%), Positives = 120/245 (48%), Gaps = 26/245 (10%)

Query: 51  PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF 109
           P+    I  D   + ++ +     IG+G+YG+V+  + K +G  AA+K LD     DEE 
Sbjct: 2   PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI 61

Query: 110 LAQVSMVSRLK-HENFVQLLGY-----CVDGTSRVLAYEFASNGSLHDILHG--RKGVKG 161
            A+ +++  L  H N V+  G        +G    L  E  + GS+ D++ G  ++G + 
Sbjct: 62  EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121

Query: 162 AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
            +P  ++++     I   A  GL++LH       IHRD+K +N+L+  +   K+ DF +S
Sbjct: 122 EEP--IIAY-----ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171

Query: 222 NQAPDMAARLHSTRVLGTFGYHAPEY-AMTGQL----NAKSDVYSFGVVLLELLTGRKPV 276
            Q    + RL     +GT  + APE  A   QL    +A+ DV+S G+  +EL  G  P+
Sbjct: 172 AQL--TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Query: 277 DHTLP 281
               P
Sbjct: 230 ADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 31/210 (14%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF------LAQVSMVSRLKHENFVQL 127
           IGEG+YG VY      +G   AIKK+   K   E        L ++ ++  L H N ++L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           L          L +EF        I   ++G+  +     L +Q          +GL + 
Sbjct: 64  LDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYL-YQ--------LLQGLAFC 114

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLH--STRVLGTFGYHA 244
           H      I+HRD+K  N+LI  + V K+ADF L+      +    H   TR      Y A
Sbjct: 115 HSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRA 166

Query: 245 PEYAMT-GQLNAKSDVYSFGVVLLELLTGR 273
           PE  +     +   D++S G +  ELL+ R
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 23/213 (10%)

Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGY 130
           IG+GS+G V     KS G     K++D      +  ++ +++V+++  LKH N V+    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 131 CVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            +D +++ L Y   E+   G L  ++   K  +       + W+   ++ +     L   
Sbjct: 68  IIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLLLA----LYEC 121

Query: 188 HEKADPH--IIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFGY 242
           H ++DP   ++HRD+K +N+ +  ++  K+ DF L+         A     T V GT  Y
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA----KTYV-GTPYY 176

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            +PE       + KSD++S G ++ EL     P
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 60/220 (27%), Positives = 84/220 (38%), Gaps = 39/220 (17%)

Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE---------NF 124
           I +G+YGRV+    KS G   AIK +  +       + + + V ++  E          +
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD------MIRKNQVDQVLTERDILSQAQSPY 54

Query: 125 VQLLGYCVDGTSRV-LAYEFASNGSLHDILH--GRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           V  L Y   G   + L  E+   G L  +L   G            L             
Sbjct: 55  VVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-----------SLDEDVARIYIAEIV 103

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS------NQAPDMAARLHSTR 235
             LEYLH      IIHRD+K  N+LI  +   K+ DF LS       Q           R
Sbjct: 104 LALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           ++GT  Y APE  +    +   D +S G +L E L G  P
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 84.0 bits (207), Expect = 2e-18
 Identities = 67/244 (27%), Positives = 114/244 (46%), Gaps = 29/244 (11%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
           IG+G+ G VY  + + +G   AI++++  +QP +E +    +V R  K+ N V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  E+ + GSL D++      +G          Q   +     + LE+LH    
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN-- 135

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
             +IHRDIKS N+L+  D   K+ DF    Q  P+ + R   + ++GT  + APE     
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 191

Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLS---------EDKVR 301
               K D++S G++ +E++ G  P  +  P R    + T  TP+L           D + 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 302 QCVD 305
           +C+D
Sbjct: 252 RCLD 255

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 83.8 bits (207), Expect = 3e-18
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 26/219 (11%)

Query: 75  IGEGSYGRVYY----GILK-------------SGHAAAIKKL--DASKQPDEEFLAQVSM 115
           +GEG +G V+     G+ K                  A+K L  DA+K    +FL ++ +
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQR 173
           +SRLK  N ++LL  C+      +  E+  NG L+  L  H  +          +S+   
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARLH 232
           + +A   A G++YL   +  + +HRD+ + N L+  +   KIADF +S N       R+ 
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
              VL    + + E  + G+    SDV++FGV L E+LT
Sbjct: 190 GRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 70/224 (31%), Positives = 107/224 (47%), Gaps = 33/224 (14%)

Query: 75  IGEGSYGRVYYGIL------KSGHAAAIKKL-DASKQP-DEEFLAQVSMVSRLKHENFVQ 126
           +GE  +G+VY G L      +   A AIK L D ++ P  EEF  +  M SRL+H N V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGR------------KGVKGAQPGPVLSWQQRV 174
           LLG         + + + S+  LH+ L  R            K VK             V
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF-----V 127

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLH 232
            I    A G+E+L   +  H++H+D+ + NVL+FD    KI+D  L  +  A D    + 
Sbjct: 128 HIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184

Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           ++  L    + +PE  M G+ +  SD++S+GVVL E+ + G +P
Sbjct: 185 NS--LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 19/204 (9%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
           IGEGS G V     K +G   A+KK+D  KQ   E L  +V ++    HEN V +    +
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            G    +  EF   G+L DI+ H R           ++ +Q   + +   + L YLH + 
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCLSVLRALSYLHNQG 138

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              +IHRDIKS ++L+  D   K++DF    Q      +  S  ++GT  + APE     
Sbjct: 139 ---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRL 193

Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D++S G++++E++ G  P
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 83.6 bits (206), Expect = 3e-18
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 20/225 (8%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA-QVSMVSRLKHENFVQLLGYCV 132
           IG+G+ G V+  I + +G   AIK+++  KQP +E +  ++ ++  LK+ N V  L   +
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  E+ + GSL D++              +   Q   +     + LE+LH    
Sbjct: 87  VGDELFVVMEYLAGGSLTDVV----------TETCMDEAQIAAVCRECLQALEFLHAN-- 134

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
             +IHRDIKS NVL+  D   K+ DF    Q  P+ + R   + ++GT  + APE     
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 190

Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKL 295
               K D++S G++ +E++ G  P  +  P R    + T  TP+L
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 82.6 bits (204), Expect = 4e-18
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 32/209 (15%)

Query: 75  IGEGSYGRVYYGIL----KSGHAAAIKKLDASK-QPDE--EFLAQVSMVSRLKHENFVQL 127
           IGEGS+G+    IL    + G    IK+++ SK  P E  E   +V+++S +KH N VQ 
Sbjct: 8   IGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
                +  +  +  ++   G L+  ++ ++GV       +L W   V+I +     L+++
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDW--FVQICLA----LKHV 117

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-----GTFGY 242
           H   D  I+HRDIKS N+ +  D   K+ DF +       A  L+ST  L     GT  Y
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGI-------ARVLNSTVELARTCIGTPYY 167

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
            +PE       N KSD+++ G VL E+ T
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 82.6 bits (204), Expect = 4e-18
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 23/212 (10%)

Query: 74  LIGEGSYGRVYYGILKSGH----AAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G +G V  G LK         AIK L A  +++   +FL++ S++ +  H N + L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G        ++  E+  NGSL   L    G          +  Q V +  G A G++YL
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQLVGMLRGIASGMKYL 122

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG---TFGYHA 244
              +D   +HRD+ + N+L+  + V K++DF LS    D     ++TR  G      + A
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIPIRWTA 177

Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE     +  + SDV+S+G+V+ E+++ G +P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 83.2 bits (205), Expect = 4e-18
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 20/225 (8%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
           IG+G+ G VY  I + +G   AIK+++  +QP +E +    +V R  K+ N V  L   +
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  E+ + GSL D++      +G          Q   +     + L++LH    
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALDFLHSN-- 134

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
             +IHRDIKS N+L+  D   K+ DF    Q  P+ + R   + ++GT  + APE     
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 190

Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKL 295
               K D++S G++ +E++ G  P  +  P R    + T  TP+L
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 38/286 (13%)

Query: 66  TENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD----ASKQPDEEFLAQVSMVSRLK 120
             NF     IG+G +  VY  I L  G   A+KK+        +  ++ L ++ ++ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           H N ++ L   ++     +  E A  G L   I H +K  K   P   + W+  V++   
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTI-WKYFVQLC-- 116

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
               LE++H K    I+HRDIK +NV I    V K+ D  L           HS  ++GT
Sbjct: 117 --SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 299
             Y +PE       N KSD++S G +L E+   + P           +  ++  K    K
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLCK----K 219

Query: 300 VRQCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIV 341
           + +C       DYPP        ++  + + C+  + + RP++S V
Sbjct: 220 IEKC-------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 82.5 bits (203), Expect = 6e-18
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 25/216 (11%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYC 131
           L+G G+YG+VY G  +K+G  AAIK +D +   +EE   +++M+ +  H  N     G  
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 132 VDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +            L  EF   GS+ D++   KG         L  +    I     +GL 
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLS 125

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           +LH+     +IHRDIK  NVL+ ++   K+ DF +S Q      R ++   +GT  + AP
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAP 180

Query: 246 EYAMTGQ-----LNAKSDVYSFGVVLLELLTGRKPV 276
           E     +      + KSD++S G+  +E+  G  P+
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 82.4 bits (203), Expect = 7e-18
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 25/233 (10%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSM 115
           I +  L++    F    ++G G+YG+VY G  +K+G  AAIK +D ++  +EE   +++M
Sbjct: 6   IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65

Query: 116 VSRLKHE-NFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           + +  H  N     G  +  +         L  EF   GS+ D++   KG         L
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-------NAL 118

Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
                  I     +GL +LH      +IHRDIK  NVL+ ++   K+ DF +S Q     
Sbjct: 119 KEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175

Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQ-----LNAKSDVYSFGVVLLELLTGRKPV 276
            R ++   +GT  + APE     +      + +SD++S G+  +E+  G  P+
Sbjct: 176 GRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 81.9 bits (202), Expect = 8e-18
 Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 19/209 (9%)

Query: 75  IGEGSYGRVYYGILKSGHAAA---IKKLDASKQPDEE--FLAQVSMVSRLKHENFVQLLG 129
           IG G +G+V  G    G + A   +K+L AS  PDE+  FL +V     L H N +Q LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
            C++    +L  EF   G L + L   +G+        +   QR  +A   A GL +LH+
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQR--MACEVASGLLWLHQ 118

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA- 248
                 IH D+   N  +  D   KI D+ L+ +       +          + APE   
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 249 ------MTGQLNAKSDVYSFGVVLLELLT 271
                 +      KS+++S GV + EL T
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 82.1 bits (203), Expect = 8e-18
 Identities = 53/135 (39%), Positives = 67/135 (49%), Gaps = 27/135 (20%)

Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P  +L      KIAV   K LEYLH K    +IHRD+K SNVLI  +   K+ DF +S  
Sbjct: 101 PEDILG-----KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGY 153

Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNA-----KSDVYSFGVVLLELLTGRKPVDH 278
             D  A+   T   G   Y APE  +  +LN      KSDV+S G+ ++EL TGR P D 
Sbjct: 154 LVDSVAK---TIDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFPYD- 208

Query: 279 TLPRGQQSLVTWATP 293
                     +W TP
Sbjct: 209 ----------SWKTP 213

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.8 bits (202), Expect = 9e-18
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 37/221 (16%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKL-----DASKQPD--EEFLAQVSMVSRLKHENF 124
             +G G++   Y    +K+G   A+K++      +S+Q +  E    ++ +++RL H + 
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV--GAAK 182
           +++LG   + +   L  E+ + GS+  +L         + G    +++ V I       +
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLS--------KYGA---FKEAVIINYTEQLLR 114

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHST----- 234
           GL YLHE     IIHRD+K +N+LI  D      +IADF     A  +AA+         
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLI--DSTGQRLRIADF---GAAARLAAKGTGAGEFQG 166

Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           ++LGT  + APE     Q     DV+S G V++E+ T + P
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 68/229 (29%), Positives = 109/229 (47%), Gaps = 33/229 (14%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYG-ILKSGHAAAIKKLDASKQPDE--EFLAQV 113
             +++L+ + E       IG G+ G+VY     K+GH  A+K++  +   +E    L  +
Sbjct: 12  ADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL 64

Query: 114 SMVSRLKHE--NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
            +V    H+    V+  GY +  +   +  E  S  +  D L   K ++G  P  +L   
Sbjct: 65  DVVL-KSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKL--LKRIQGPIPEDILG-- 117

Query: 172 QRVKIAVGAAKGLEYLHEKADPH-IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
              K+ V   K L YL EK   H +IHRD+K SN+L+      K+ DF +S +  D  A+
Sbjct: 118 ---KMTVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171

Query: 231 LHSTRVLGTFGYHAPEY----AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
              TR  G   Y APE         + + ++DV+S G+ L+EL TG+ P
Sbjct: 172 ---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 36/271 (13%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAA----AIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQ 126
           ++G G++G VY GI +  G       AIK L+ +  P  + EF+ +  +++ + H + V+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           LLG C+  T + L  +   +G L D +H  K   G+Q   +L+W       V  AKG+ Y
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL--LLNW------CVQIAKGMMY 124

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           L E+    ++HRD+ + NVL+   +  KI DF L+          ++        + A E
Sbjct: 125 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD 305
                +   +SDV+S+GV + EL+T G KP D         + T   P L E   R    
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--------GIPTREIPDLLEKGERL--- 230

Query: 306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRP 336
                  PP     +  V   C   +AD RP
Sbjct: 231 -----PQPPICTIDVYMVMVKCWMIDADSRP 256

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 80.5 bits (198), Expect = 3e-17
 Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 19/207 (9%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
           +G G+YG VY    L +G  AA+K +      D   + Q + MV   KH N V   G  +
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
                 +  E+   GSL DI H          GP LS  Q   +     +GL YLH K  
Sbjct: 77  SREKLWICMEYCGGGSLQDIYH--------VTGP-LSELQIAYVCRETLQGLAYLHSKGK 127

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--- 249
              +HRDIK +N+L+ D+   K+ADF ++ +     A+  S   +GT  + APE A    
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEK 182

Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
            G  N   D+++ G+  +EL   + P+
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 79.9 bits (197), Expect = 5e-17
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 24/218 (11%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIK------KLDASKQPD-EEFLAQVSMVSRLKHENFVQ 126
           ++GEG +G V  G L     + +K      KLD     + EEFL++ + +    H N ++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 127 LLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           L+G C + +S       ++   F  +G LH  L   +     +  P+   Q  +K  V  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL---QTLLKFMVDI 122

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVLG 238
           A G+EYL  +   + IHRD+ + N ++ +D    +ADF LS +  + D   +    ++  
Sbjct: 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-- 177

Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              + A E        +KSDV++FGV + E+ T G+ P
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 79.2 bits (195), Expect = 6e-17
 Identities = 71/276 (25%), Positives = 129/276 (46%), Gaps = 39/276 (14%)

Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V    Y + KS    A+K L   +      +E L + +++ +L +   V+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   K V           +   ++    + G++YL 
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTE---------KNITELVHQVSMGMKYLE 112

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
           E    + +HRD+ + NVL+     AKI+DF LS +A       +  +  G +   ++APE
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALGADENYYKAKTHGKWPVKWYAPE 168

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD 305
                + ++KSDV+SFGV++ E  + G+KP      +G +            ++V Q ++
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY-----KGMKG-----------NEVTQMIE 212

Query: 306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 341
           +    + P +   +M  +  LC  Y  D RP  ++V
Sbjct: 213 SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 79.9 bits (198), Expect = 6e-17
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 31/215 (14%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDE--EFLA--QVSMVSRLKHENFV 125
             +GEG+Y  VY     ++G   AIKK  L   K+  +   F A  ++ ++  LKH N +
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            LL      ++  L +EF     L  ++  +  V    P  + S+           +GLE
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV--LTPADIKSYMLM------TLRGLE 116

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YLH      I+HRD+K +N+LI  D V K+ADF L+        R  + +V+ T  Y AP
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV-TRWYRAP 171

Query: 246 EYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 275
           E        A+      D++S G +  ELL  R P
Sbjct: 172 ELLF----GARHYGVGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.9 bits (195), Expect = 7e-17
 Identities = 38/113 (33%), Positives = 52/113 (46%), Gaps = 14/113 (12%)

Query: 171 QQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
            Q+VK +    K         LEYLH K    IIHRDIK  N+L+ +     I DF+++ 
Sbjct: 92  SQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT 148

Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +         +T   GT GY APE       +   D +S GV   E L G++P
Sbjct: 149 KVTP---DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 78.9 bits (194), Expect = 9e-17
 Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 31/283 (10%)

Query: 75  IGEGSYGRVYYGILKS------GHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQ 126
           +G+GS+G VY GI K           AIK ++ +    E  EFL + S++      + V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL-SWQQRVKIAVGAAKGLE 185
           LLG    G   ++  E  + G L   L   +      P     S ++ +++A   A G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YL+       +HRD+ + N ++ +D   KI DF ++    +        + L    + +P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD 305
           E    G     SDV+SFGVVL E+ T               L       +S ++V + V 
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGMSNEQVLRFVM 235

Query: 306 ARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
              GG  D P      +  +  +C QY    RP+   ++ +++
Sbjct: 236 E--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 79.0 bits (195), Expect = 9e-17
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 38/219 (17%)

Query: 74  LIGEGSYGRVYYGILKSG-----HAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
           L+ EG++GR++YGIL            +K +   AS+      L +  ++  L H+N + 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 127 LLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +L  C+ DG    + Y + + G+L   L   +    A     LS QQ V +A+  A G+ 
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG-EANNPQALSTQQLVHMAIQIACGMS 131

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH-- 243
           YLH++    +IH+DI + N +I ++   KI D  LS             R L    YH  
Sbjct: 132 YLHKRG---VIHKDIAARNCVIDEELQVKITDNALS-------------RDLFPMDYHCL 175

Query: 244 -----------APEYAMTGQLNAKSDVYSFGVVLLELLT 271
                      A E  +  + ++ SDV+SFGV+L EL+T
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 79.4 bits (195), Expect = 1e-16
 Identities = 69/213 (32%), Positives = 111/213 (52%), Gaps = 32/213 (15%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
           IG GS+G VY+   +++    AIKK+  S KQ +E++   + +V  + R+KH N ++  G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEY 186
             +   +  L  E+   GS  D+L   K        P+    Q V+IA    GA +GL Y
Sbjct: 93  CYLREHTAWLVMEYCL-GSASDLLEVHKK-------PL----QEVEIAAITHGALQGLAY 140

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           LH     ++IHRDIK+ N+L+ +    K+ADF     +  +A+  +S   +GT  + APE
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFG----SASIASPANS--FVGTPYWMAPE 191

Query: 247 YAMT---GQLNAKSDVYSFGVVLLELLTGRKPV 276
             +    GQ + K DV+S G+  +EL   + P+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 69/302 (22%), Positives = 127/302 (42%), Gaps = 49/302 (16%)

Query: 75  IGEGSYGRVYYGIL-----KSGHAA-AIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQ 126
           +GEG +G+V          ++G+   A+K L  +    E  + L++ +++ ++ H + ++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR------------- 173
           L G C      +L  E+A  GSL   L   + V    P  + S   R             
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKV---GPSYLGSDGNRNSSYLDNPDERAL 124

Query: 174 -----VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
                +  A   ++G++YL E     ++HRD+ + NVL+ +    KI+DF LS    +  
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL 287
           + +  ++      + A E         +SDV+SFGV+L E++T G  P     P    +L
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL 241

Query: 288 VTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 347
           +                  R+  + P     +M  +   C + E D RP  + + K L+ 
Sbjct: 242 LK--------------TGYRM--ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285

Query: 348 LL 349
           ++
Sbjct: 286 MM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 51/169 (30%), Positives = 71/169 (42%), Gaps = 25/169 (14%)

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           KIAV   K L YL  K +  IIHRD+K SN+L+  +   K+ DF +S Q  D  A+   T
Sbjct: 111 KIAVATVKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---T 165

Query: 235 RVLGTFGYHAPEYAMTGQLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 291
           R  G   Y APE       +    +SDV+S G+ L E+ TG+ P              W 
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KWN 214

Query: 292 TPKLSEDKVRQCVDA---RLGGDYPPKAVAKMAAVAALCVQYEADFRPN 337
           +     D++ Q V      L      +          LC+  +   RP 
Sbjct: 215 SVF---DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK 260

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 33/212 (15%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
           IG GS+G VY+     +    A+KK+  S KQ +E++   + +V  + +LKH N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEY 186
             +   +  L  E+   GS  D+L   K        P+    Q V+IA    GA +GL Y
Sbjct: 89  CYLKEHTAWLVMEYCL-GSASDLLEVHKK-------PL----QEVEIAAITHGALQGLAY 136

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           LH      +IHRDIK+ N+L+ +    K+ADF  ++++        +   +GT  + APE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPE 187

Query: 247 YAMT---GQLNAKSDVYSFGVVLLELLTGRKP 275
             +    GQ + K DV+S G+  +E L  RKP
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 24/218 (11%)

Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRLK 120
           N+    L+G+G++GRVY    + +G   A+K++     S +  +E  A   ++ ++  L+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           HE  VQ  G   D  +  +  E+   GS+ D L           G +     R K     
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--------KAYGALTETVTR-KYTRQI 113

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST---RVL 237
            +G+EYLH      I+HRDIK +N+L       K+ DF  S +          T    V 
Sbjct: 114 LEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTGMKSVT 168

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           GT  + +PE         K+DV+S G  ++E+LT + P
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 74  LIGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQL 127
            +G+G++G V    Y  L+  +G   A+KKL  S      +F  ++ ++  L+H+N V+ 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 128 LGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G C     R   L  E+   GSL D L   +     +   + + Q          KG+E
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGME 122

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG---TFGY 242
           YL  K     +HRD+ + N+L+  ++  KI DF L+   P      +  R  G    F Y
Sbjct: 123 YLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFWY 178

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
            APE     + +  SDV+SFGVVL EL T
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 70/275 (25%), Positives = 129/275 (46%), Gaps = 37/275 (13%)

Query: 75  IGEGSYGRVYYGILKSGHA---AAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G G++G V  G+ K        AIK  K +  K   +E + +  ++ +L +   V+++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
            C +  + +L  E AS G L+  L G+K          ++    V++    + G++YL  
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEG 113

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEY 247
           K   + +HRD+ + NVL+ +   AKI+DF LS +A       +  R  G +   ++APE 
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLS-KALGADDSYYKARSAGKWPLKWYAPEC 169

Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA 306
               + +++SDV+S+G+ + E  + G+KP                  K+   +V   ++ 
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKPYK----------------KMKGPEVMSFIEQ 213

Query: 307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 341
               D P +   +M A+   C  Y+ + RPN + V
Sbjct: 214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 50/142 (35%), Positives = 70/142 (49%), Gaps = 19/142 (13%)

Query: 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV--KIAVGAAKGLEYLHEKADPHI 195
            +  EF   GSL  I   +KG      GP+      +  KIAV   +GL YL+      I
Sbjct: 79  CMCMEFMDCGSLDRIY--KKG------GPI---PVEILGKIAVAVVEGLTYLYNVH--RI 125

Query: 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA 255
           +HRDIK SN+L+      K+ DF +S +  +  A    T V GT  Y +PE    G+   
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFV-GTSTYMSPERIQGGKYTV 181

Query: 256 KSDVYSFGVVLLELLTGRKPVD 277
           KSDV+S G+ ++EL  G+ P  
Sbjct: 182 KSDVWSLGISIIELALGKFPFA 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 51/219 (23%)

Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQ---- 126
           +G+GSYG V     ++ G    IKKL+   AS++  +    +  ++S+LKH N V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 127 ----------LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
                     ++G+C  G                D+ H  K     Q G +L   Q V+ 
Sbjct: 68  WEGEDGLLYIVMGFCEGG----------------DLYHKLK----EQKGKLLPENQVVEW 107

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD----LSNQAPDMAARLH 232
            V  A  L+YLHEK   HI+HRD+K+ NV +   ++ K+ D      L NQ  DMA+ L 
Sbjct: 108 FVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTL- 162

Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
               +GT  Y +PE       N KSDV++ G  + E+ T
Sbjct: 163 ----IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 66/231 (28%), Positives = 102/231 (44%), Gaps = 34/231 (14%)

Query: 75  IGEGSYGRVYY-------GILKSGHAA----------AIKKL--DASKQPDEEFLAQVSM 115
           +GEG +G V+           +   A           A+K L  DAS    E+FL +V +
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP--GPVLSWQQR 173
           +SRL   N  +LLG C       +  E+  NG L+  L                LS+   
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
           + +A   A G+ YL      + +HRD+ + N L+  +   KIADF +S    ++ +  + 
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSSDYY 186

Query: 234 TRVLGT----FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRKPVDH 278
            RV G       + A E  + G+   KSDV++FGV L E+LT    +P +H
Sbjct: 187 -RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.6 bits (193), Expect = 2e-16
 Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 29/210 (13%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
           IG GS+G VY+   +++    AIKK+  S KQ +E++   + +V  + +L+H N +Q  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
             +   +  L  E+   GS  D+L   K     +P   L   +   +  GA +GL YLH 
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDLLEVHK-----KP---LQEVEIAAVTHGALQGLAYLHS 133

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADF-DLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
               ++IHRD+K+ N+L+ +  + K+ DF   S  AP       +   +GT  + APE  
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVI 183

Query: 249 MT---GQLNAKSDVYSFGVVLLELLTGRKP 275
           +    GQ + K DV+S G+  +E L  RKP
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.1 bits (190), Expect = 4e-16
 Identities = 82/301 (27%), Positives = 130/301 (43%), Gaps = 48/301 (15%)

Query: 64  EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL---DASKQPDEEFLAQVSMVSRL 119
           E  EN G   L+GEGSYG V     K +G   AIKK    +  K   +  + ++ M+ +L
Sbjct: 1   EKYENLG---LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL 57

Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +HEN V L+          L +EF  +  L D+     G         L   +  K    
Sbjct: 58  RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---------LDESRVRKYLFQ 108

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-TRVLG 238
             +G+E+ H     +IIHRDIK  N+L+    V K+ DF     A  +AA     T  + 
Sbjct: 109 ILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF---ARTLAAPGEVYTDYVA 162

Query: 239 TFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR----------------KPVDHTLP 281
           T  Y APE  +      ++ D+++ G ++ E+LTG                 K + + +P
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222

Query: 282 RGQQSLVT---WATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM 338
           R Q+       +A  +L E K  + ++ R      PK    +  +A  C++ + D RP+ 
Sbjct: 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRF-----PKLSGLVLDLAKQCLRIDPDDRPSS 277

Query: 339 S 339
           S
Sbjct: 278 S 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 76.6 bits (188), Expect = 6e-16
 Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 36/283 (12%)

Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHE 122
           NF     IG G +  VY    L      A+KK+   +  D    ++ + ++ ++ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N ++ L   ++     +  E A  G L  ++   K  K   P   + W+  V++      
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLC----S 117

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            +E++H +    ++HRDIK +NV I    V K+ D  L           HS  ++GT  Y
Sbjct: 118 AVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ 302
            +PE       N KSD++S G +L E+   + P        + +L +         K+ Q
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSLC------QKIEQ 222

Query: 303 CVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIV 341
           C       DYPP        K+  + ++C+  + D RP++  V
Sbjct: 223 C-------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 55/180 (30%), Positives = 83/180 (46%), Gaps = 20/180 (11%)

Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
           E    GSL  +L  +K   G  P  +L      KI++   +GL YL EK    I+HRD+K
Sbjct: 79  EHMDGGSLDQVL--KKA--GRIPENILG-----KISIAVLRGLTYLREKHK--IMHRDVK 127

Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
            SN+L+      K+ DF +S Q  D  A       +GT  Y +PE         +SD++S
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWS 183

Query: 262 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMA 321
            G+ L+E+  GR P+    P   + L       +SE + ++      G  +PP +   MA
Sbjct: 184 LGLSLVEMAIGRYPIP---PPDAKELEAMFGRPVSEGEAKESHRPVSG--HPPDSPRPMA 238

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
           IGEGS G V     K SG   A+K +D  KQ   E L  +V ++   +H+N V++    +
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  EF   G+L DI+   +          L+ +Q   +     + L YLH +  
Sbjct: 89  VGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG- 137

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
             +IHRDIKS ++L+  D   K++DF    Q + D+  R     ++GT  + APE     
Sbjct: 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISRT 192

Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D++S G++++E++ G  P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 23/208 (11%)

Query: 75  IGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQL 127
           +GEG +G+V           +G   A+K L      +   +   ++ ++  L HEN V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 128 LGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G C +  G    L  EF  +GSL + L   K          ++ +Q++K AV   KG++
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK--------INLKQQLKYAVQICKGMD 123

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH 243
           YL  +     +HRD+ + NVL+  +   KI DF L+               L +  F Y 
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY- 179

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT 271
           APE  +  +    SDV+SFGV L ELLT
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 22/224 (9%)

Query: 62  LKEITENFGTNALIGEGSYGRVYYGI-LKSGH----AAAIKKLDASKQP--DEEFLAQVS 114
           LKE TE F    ++G G++G VY G+ +  G       AIK+L  +  P  ++E L +  
Sbjct: 4   LKE-TE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 115 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
           +++ + + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W    
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW---- 114

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
              V  AKG+ YL E+    ++HRD+ + NVL+      KI DF L+          H+ 
Sbjct: 115 --CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169

Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
                  + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 41/214 (19%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF-----LAQVSMVSRLKHENFVQLL 128
           IGEGSYG V+    + +G   AIKK   S+  D+       L ++ M+ +LKH N V L+
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 129 GYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
              V    R   L +E+  +  L+++    +GV               KI     + + +
Sbjct: 67  E--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPE---------HLIKKIIWQTLQAVNF 115

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS------TRVLGTF 240
            H+    + IHRD+K  N+LI      K+ DF          AR+ +      T  + T 
Sbjct: 116 CHKH---NCIHRDVKPENILITKQGQIKLCDFGF--------ARILTGPGDDYTDYVATR 164

Query: 241 GYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTG 272
            Y APE  + G  Q     DV++ G V  ELLTG
Sbjct: 165 WYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 20/210 (9%)

Query: 74  LIGEGSYGRVYYGI-LKSGHA----AAIKKLD--ASKQPDEEFLAQVSMVSRLKHENFVQ 126
           L+G G +G V+ GI +  G +     AIK +   + +Q  +E    +  +  L H   V+
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           LLG C  G S  L  + +  GSL D +   +      P  +L+W       V  AKG+ Y
Sbjct: 74  LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLD--PQRLLNW------CVQIAKGMYY 124

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           L E     ++HR++ + N+L+  D + +IADF +++       +   +       + A E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
             + G+   +SDV+S+GV + E+++ G +P
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 23/204 (11%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF--LAQVSMVSRLK-HENFVQLLGY 130
           IGEG++  V      K+G   AIK +    +  E+   L ++  + RL  H N ++L+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 131 CVDGTSRVLAYEFA-SNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEYLH 188
             D  +  LA  F   + +L++++ GRK     +P P    ++RVK       K L+++H
Sbjct: 67  LFDRKTGRLALVFELMDMNLYELIKGRK-----RPLP----EKRVKSYMYQLLKSLDHMH 117

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
                 I HRDIK  N+LI  DD+ K+ADF        + ++   T  + T  Y APE  
Sbjct: 118 RNG---IFHRDIKPENILI-KDDILKLADF---GSCRGIYSKPPYTEYISTRWYRAPECL 170

Query: 249 MT-GQLNAKSDVYSFGVVLLELLT 271
           +T G    K D+++ G V  E+L+
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 52/223 (23%)

Query: 74  LIGEGSYGRVYYGIL----KSGHAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG+G +G VY+G L          A+K L+     +  E+FL +  ++    H N + L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL----HG--RKGVKGAQPGPVLSWQQRVKIAVG-- 179
           LG C+            S GS   +L    HG  R  ++     P       VK  +G  
Sbjct: 62  LGICLP-----------SEGSPLVVLPYMKHGDLRNFIRSETHNPT------VKDLIGFG 104

Query: 180 --AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD---------MA 228
              AKG+EYL  K     +HRD+ + N ++ +    K+ADF L+    D           
Sbjct: 105 LQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161

Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           A+L          + A E   T +   KSDV+SFGV+L EL+T
Sbjct: 162 AKL-------PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 23/204 (11%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           +G G+ G VY    L +    A+K   LD + +  ++ ++++ ++ +      +   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                  +  EF   GSL         V    P  VL      +IAV   KGL YL    
Sbjct: 69  FVENRISICTEFMDGGSLD--------VYRKIPEHVLG-----RIAVAVVKGLTYLWSL- 114

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              I+HRD+K SN+L+      K+ DF +S Q  +  A+ +    +GT  Y APE     
Sbjct: 115 --KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY----VGTNAYMAPERISGE 168

Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
           Q    SDV+S G+  +EL  GR P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 36/280 (12%)

Query: 74  LIGEGSYGRVYYGI-LKSGH----AAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
           ++G G++G VY GI +  G       AIK L  + S + ++E L +  +++ +      +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           LLG C+  T + L  +    G L D +   K   G+Q   +L+W       V  AKG+ Y
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQD--LLNW------CVQIAKGMSY 124

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           L E     ++HRD+ + NVL+   +  KI DF L+          H+        + A E
Sbjct: 125 LEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD 305
             +  +   +SDV+S+GV + EL+T G KP D    R          P L E   R    
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGERL--- 230

Query: 306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 345
                  PP     +  +   C   +++ RP    +V   
Sbjct: 231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 20/205 (9%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           +GEG+Y  VY G  + +G   A+K   LDA +      + ++S++  LKHEN V+L    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 132 VDGTSRVLAYEFASNG--SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
                 +L +E+         D  HG +G     P  V S+  ++       KG+ + HE
Sbjct: 68  HTENKLMLVFEYMDKDLKKYMDT-HGVRG--ALDPNTVKSFTYQL------LKGIAFCHE 118

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                ++HRD+K  N+LI      K+ADF L+ +A  +     S  V+ T  Y AP+  +
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLA-RAFGIPVNTFSNEVV-TLWYRAPDVLL 173

Query: 250 TGQLNAKS-DVYSFGVVLLELLTGR 273
             +  + S D++S G ++ E++TGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 43/233 (18%)

Query: 72  NALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF---------------LAQVSM 115
            A +GEG+YG+V       +G   AIKK+   +  ++                 L ++ +
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           ++ +KHEN + L+   V+G    L  +  +   L  ++  +           L+  Q   
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI---------RLTESQVKC 123

Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS------------NQ 223
           I +    GL  LH+    + +HRD+  +N+ I    + KIADF L+            ++
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 224 APDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKP 275
              M  R   T  + T  Y APE  M   + +   D++S G +  ELLTG KP
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KP 232

Length = 335

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLKHENFVQLL 128
           IGEG+YG VY G   K+G   A+KK+    + +EE      + ++S++  L+H N V L 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRL--ESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
              +  +   L +EF S   L   L      +      V S+  ++       +G+ + H
Sbjct: 66  DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI------LQGILFCH 118

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            +    ++HRD+K  N+LI +  V K+ADF L+ +A  +  R+++  V+ T  Y APE  
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVYTHEVV-TLWYRAPEVL 173

Query: 249 MTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           +     +   D++S G +  E+ T +KP+ H
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT-KKPLFH 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 40/285 (14%)

Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKK------LDASKQPDEEFLAQVSMVSRLK 120
           NF     IG G +  VY    L  G   A+KK      +DA  + D   + ++ ++ +L 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD--CIKEIDLLKQLN 60

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H N ++     ++     +  E A  G L  ++   K  K   P   + W+  V++    
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-WKYFVQLC--- 116

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
              LE++H +    ++HRDIK +NV I    V K+ D  L           HS  ++GT 
Sbjct: 117 -SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
            Y +PE       N KSD++S G +L E+   + P        + +L +         K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK------KI 220

Query: 301 RQCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIV 341
            QC       DYPP        ++  +  +C+  + + RP+++ V
Sbjct: 221 EQC-------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 71.6 bits (175), Expect = 3e-14
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 29/219 (13%)

Query: 75  IGEGSYGRVYYGILKSGHA---AAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           +GEG +G V  G L    +    A+K +     ++   E+FL++   +    H N ++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 129 GYCVDGTSR------VLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           G C+           V+   F  +G LH  +L+ R    G  P   L  Q  VK     A
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR---LGDCP-QYLPTQMLVKFMTDIA 122

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD----MAARLHSTRVL 237
            G+EYL  K     IHRD+ + N ++ ++    +ADF LS +  +       R+    V 
Sbjct: 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV- 178

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
               + A E         KSDV+SFGV + E+ T G+ P
Sbjct: 179 ---KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 48/228 (21%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
           +GEG++G VY    +K+G   A+KK+    + D  F    L ++ ++ +LKH N V L+ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLID 74

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV-----LSWQQRVKIAVGAAK-- 182
                    +A E             R  V    P        L     VK+     K  
Sbjct: 75  ---------MAVERPDK-----SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY 120

Query: 183 ------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---------SNQAPDM 227
                 G+ YLHE    HI+HRDIK++N+LI +  + KIADF L         + +    
Sbjct: 121 MLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKS--DVYSFGVVLLELLTGR 273
                 T ++ T  Y  PE  + G+    +  D++  G V  E+ T R
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 71.4 bits (176), Expect = 5e-14
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLA--QVSMVSRLK-HENFVQLLGY 130
           +G+G++G VY    K  G   AIKK+       EE +   +V  + +L  H N V+L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66

Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
             +       +E+   G+L+ ++  RKG        + S   ++       +GL ++H+ 
Sbjct: 67  FRENDELYFVFEYM-EGNLYQLMKDRKGKP-FSESVIRSIIYQI------LQGLAHIHKH 118

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE---- 246
                 HRD+K  N+L+   +V KIADF L   A ++ +R   T  + T  Y APE    
Sbjct: 119 ---GFFHRDLKPENLLVSGPEVVKIADFGL---AREIRSRPPYTDYVSTRWYRAPEILLR 172

Query: 247 ---YAMTGQLNAKSDVYSFGVVLLELLTGR 273
              Y      ++  D+++ G ++ EL T R
Sbjct: 173 STSY------SSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 67/230 (29%), Positives = 112/230 (48%), Gaps = 37/230 (16%)

Query: 58  SVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQ 112
           SVDE +++         I EG+YG VY     K+G   A+KKL   K+  E F    L +
Sbjct: 3   SVDEYEKLNR-------IEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLRE 54

Query: 113 VSMVSRLKHENFVQL----LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           ++++ +L+H N V +    +G  +D    V+ Y          + H  K +      P L
Sbjct: 55  INILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY----------VEHDLKSLMETMKQPFL 104

Query: 169 SWQQRVK-IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
             Q  VK + +    G+ +LH+     I+HRD+K+SN+L+ +  + KI DF L+ +    
Sbjct: 105 --QSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159

Query: 228 AARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKPV 276
                 T+++ T  Y APE  +   + +   D++S G +  ELLT +KP+
Sbjct: 160 LKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.7 bits (173), Expect = 5e-14
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 20/217 (9%)

Query: 75  IGEGSYGRVYYGILKSGHAAA---IKKLDASKQPDEE--FLAQVSMVSRLKHENFVQLLG 129
           IG G +G+V  G + SG+  A   +K+L  S    E+  FL +      L+H N +Q LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
            C + T  +L  EF   G L   L   +  +   P P  + Q+   +A   A GL +LH+
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDP-TTLQR---MACEIALGLLHLHK 118

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA- 248
               + IH D+   N L+  D   KI D+ LS+        +   ++     + APE   
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 249 -MTGQL-----NAKSDVYSFGVVLLELLT-GRKPVDH 278
            + G L       +S+V+S GV + EL   G +P  H
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 71.1 bits (175), Expect = 6e-14
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 53/228 (23%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLK---HEN 123
           A IGEG+YG VY    L +G   A+KK+       EE      L +++++ +L+   H N
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 124 FVQLLGYCV-----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG--PV----LSWQQ 172
            V+LL  C            L +E      L   L      K  +PG  P     L  Q 
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLS-----KCPKPGLPPETIKDLMRQ- 115

Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
                    +G+++LH      I+HRD+K  N+L+  D   KIADF L        AR++
Sbjct: 116 -------LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL--------ARIY 157

Query: 233 S-----TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           S     T V+ T  Y APE  +        D++S G +  EL   R+P
Sbjct: 158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 25/200 (12%)

Query: 90  SGHAAAIKKLDASKQPDEE----FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA-YEFA 144
           +GH  AIK L      +E     F  + ++ +RL H N V LL         + A +E+ 
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
              +L ++L        A  G  L   +  ++ +     L   H +    I+HRD+K  N
Sbjct: 62  PGRTLREVL--------AADGA-LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQN 109

Query: 205 VLIFDDDV---AKIADFDLSNQAPDM--AARLHSTR---VLGTFGYHAPEYAMTGQLNAK 256
           +++    V   AK+ DF +    P +  A     TR   VLGT  Y APE      +   
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169

Query: 257 SDVYSFGVVLLELLTGRKPV 276
           SD+Y++G++ LE LTG++ V
Sbjct: 170 SDLYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 70.3 bits (172), Expect = 8e-14
 Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 18/209 (8%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQ--VSMVSRLKHENFVQLLG 129
           ++G G++G V+    K+     I K    +Q   DE   AQ    ++  L H N ++   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
             ++  + ++  E+A  G+L + +  R          +L +  ++ +A      L ++H 
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLA------LHHVHT 119

Query: 190 KADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
           K    I+HRD+K+ N+L+     V KI DF +S     ++++  +  V+GT  Y +PE  
Sbjct: 120 K---LILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELC 173

Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
                N KSD+++ G VL EL + ++  +
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 19/209 (9%)

Query: 74  LIGEGSYGRVYYGIL----KSGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
           ++G G +G +  G L    K     AI  L A     +   FLA+   + +  H N V+L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G    G + ++  E+ SNG+L   L   +G         L   Q + +  G A G++YL
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYL 123

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
            E      +H+ + +  VL+  D V KI+ F    Q     A   +        + APE 
Sbjct: 124 SEMG---YVHKGLAAHKVLVNSDLVCKISGFR-RLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                 ++ SDV+SFG+V+ E+++ G +P
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 24/204 (11%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLG-YC 131
           +G+G++G+VY    K   A A  K+  +K  +E  +++ ++ +++   H   V+LLG + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 132 VDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
            DG   ++  EF   G++  I L   +G+   +P      Q +V I     + L+YLH  
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIMLELDRGLT--EP------QIQV-ICRQMLEALQYLHSM 129

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
               IIHRD+K+ NVL+  D   K+ADF +S +      R  S   +GT  + APE  M 
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMC 184

Query: 251 GQL-----NAKSDVYSFGVVLLEL 269
             +     + K+D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE----NFVQLLG 129
           +G+G+YG VY  + + +G   A+K++      DE    Q+ M   + H+      V   G
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
                 +  +  E+   GSL D L+         P  VL      +I     KGL++L  
Sbjct: 67  AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFL-- 118

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
           K + +IIHRD+K +NVL+  +   K+ DF +S     + A L  T + G   Y APE   
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN---LVASLAKTNI-GCQSYMAPERIK 174

Query: 250 TGQLNA------KSDVYSFGVVLLELLTGRKP 275
           +G  N       +SDV+S G+ +LE+  GR P
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 37/227 (16%)

Query: 69  FGTNALIGEGSYGRVYYGILK-SGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKH 121
           F     IGEG+YG+VY    K +G   A+KK  LD  K   E F    + ++ ++ +L H
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNH 65

Query: 122 ENFVQLLGYCVDGTSRV----------LAYEFASNGSLHDILHGRKGVKGAQPGPV-LSW 170
            N V L     D    +          L +E+      HD++    G+   + G V  S 
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLM----GL--LESGLVHFSE 115

Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
                      +GL Y H+K   + +HRDIK SN+L+ +    K+ADF L+       +R
Sbjct: 116 DHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 276
            ++ +V+ T  Y  PE  +  +    + DV+S G +L EL T +KP+
Sbjct: 173 PYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 50/230 (21%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           A IG+G++G V+     K+    A+KK+   +   E F    L ++ ++  LKHEN V L
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNL 76

Query: 128 LGYC---VDGTSR-----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +  C       +R      L +EF      HD L G            L   + VK  + 
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCE----HD-LAG------------LLSNKNVKFTLS 119

Query: 180 AAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMA 228
             K        GL Y+H      I+HRD+K++N+LI  D + K+ADF L+   + + +  
Sbjct: 120 EIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176

Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLN--AKSDVYSFGVVLLELLTGRKPV 276
              ++ RV+ T  Y  PE  + G+ +     D++  G ++ E+ T R P+
Sbjct: 177 PNRYTNRVV-TLWYRPPEL-LLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 20/202 (9%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV 132
           +G+G++G+VY    K +G  AA K +D   + + E+++ ++ +++   H N V+LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
              +  +  EF + G++  ++   +        P+   Q RV +     + L YLHE   
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELER-------PLTEPQIRV-VCKQTLEALNYLHEN-- 122

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
             IIHRD+K+ N+L   D   K+ADF +S +      R  S   +GT  + APE  M   
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCET 179

Query: 253 -----LNAKSDVYSFGVVLLEL 269
                 + K+DV+S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.2 bits (166), Expect = 8e-13
 Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 15/135 (11%)

Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
           E    GSL  +L   K +    P  +L      K+++   +GL YL EK    I+HRD+K
Sbjct: 83  EHMDGGSLDQVLKEAKRI----PEEILG-----KVSIAVLRGLAYLREKH--QIMHRDVK 131

Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
            SN+L+      K+ DF +S Q  D  A       +GT  Y +PE       + +SD++S
Sbjct: 132 PSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWS 187

Query: 262 FGVVLLELLTGRKPV 276
            G+ L+EL  GR P+
Sbjct: 188 MGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 9e-13
 Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 20/205 (9%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           I +G++G VY    + +G   AIK L   K+ D     QV+ V   +    +Q       
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVL---KKSDMIAKNQVTNVKAERAIMMIQGES---P 57

Query: 134 GTSRVLAYEFASNGSLH---DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
             ++ L Y F S   L+   + L+G       +    L      +       G+E LH++
Sbjct: 58  YVAK-LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
               IIHRDIK  N+LI      K+ DF LS         L + + +GT  Y APE  + 
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETILG 167

Query: 251 GQLNAKSDVYSFGVVLLELLTGRKP 275
              +  SD +S G V+ E L G  P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 61/255 (23%), Positives = 103/255 (40%), Gaps = 38/255 (14%)

Query: 97  KKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHG 155
           K L +  +    F    S++S+L H++ V+L G CV D    V   E+   G L   LH 
Sbjct: 36  KVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE--EYVKFGPLDVFLHR 93

Query: 156 RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI--FDDDVA 213
            K          L W  ++ +A   A  L YL +K    ++H ++   N+L+  +  +  
Sbjct: 94  EKN------NVSLHW--KLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEG 142

Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLT 271
            +    LS+    +       RV     + APE    GQ  L   +D +SFG  LLE+ +
Sbjct: 143 YVPFIKLSDPGIPITVLSREERVERI-PWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201

Query: 272 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQY 330
            G +P+              +T   SE +       +     P    A++A +   C  Y
Sbjct: 202 NGEEPL--------------STLSSSEKERFY----QDQHRLPMPDCAELANLINQCWTY 243

Query: 331 EADFRPNMSIVVKAL 345
           +   RP+   +++ L
Sbjct: 244 DPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 45/272 (16%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 14  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73

Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           KHEN + LL       S            ++ + H    + GA    ++  Q+     V 
Sbjct: 74  KHENVIGLLDVFTPARS------LEEFNDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 123

Query: 180 -----AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
                  +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 124 FLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 175

Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 293
             + T  Y APE  +     N   D++S G ++ ELLTGR     TL  G   +      
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-----TLFPGTDHI------ 224

Query: 294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAA 325
               D+++  +  RL G    + + K+++ +A
Sbjct: 225 ----DQLKLIL--RLVGTPGAELLKKISSESA 250

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 20/216 (9%)

Query: 68  NFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPD--EEFLAQVSMVSRLKHE 122
           +F    ++G+GS+G+V     K     +A  I K D   Q D  E  + +  +++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 123 NFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            F+  L  C     R+    E+ + G L  + H ++  K  +P       Q V  A   +
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEP-------QAVFYAAEIS 111

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            GL +LH +    II+RD+K  NV++  +   KIADF +  +   M   + +    GT  
Sbjct: 112 VGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTFCGTPD 166

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y APE           D +++GV+L E+L G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 60/212 (28%), Positives = 88/212 (41%), Gaps = 34/212 (16%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL----KHENFVQLLG 129
           +G G+YG+V       +G   AIKKL    Q       +     RL     HEN + LL 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLD 81

Query: 130 -YCVDGTSR-----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
            +    +        L         L++I+  +K          LS      +     +G
Sbjct: 82  VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK----------LSDDHIQFLVYQILRG 130

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHSTRVLGTFGY 242
           L+Y+H      IIHRD+K SN+ + +D   KI DF L+    D M      T  + T  Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWY 181

Query: 243 HAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 273
            APE  +     N   D++S G ++ ELLTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 46/286 (16%)

Query: 75  IGEGSYGRVYYGI---LKSGHAA-----AIKKLDAS-KQPDEEFLAQVSMVSRLKHENFV 125
           +G+G++ +++ GI   +            +K LD S +   E F    SM+S+L H++ V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
              G CV G   ++  E+   GSL   L   K +         SW+  V      AK L 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI------SWKLEV------AKQLA 110

Query: 186 Y-LHEKADPHIIHRDIKSSNVLIFDDDVAKIAD---FDLSNQAPDMAARLHSTRVLGTFG 241
           + LH   D  + H ++ + NVL+  ++  K  +     LS+    +   L    +L    
Sbjct: 111 WALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV-LPKEILLERIP 169

Query: 242 YHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSLVTWATPKLSEDK 299
           +  PE     Q L+  +D +SFG  L E+ +G  KP+                  L   K
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS----------------ALDSQK 213

Query: 300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 345
             Q  + R     P     ++A +   C+ YE DFRP+   +++ L
Sbjct: 214 KLQFYEDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 30/213 (14%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQVSMVSR------LKHENF 124
           ++G+GS+G+V+   LK +    AIK L  D     D+    + +MV +       +H   
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD---VECTMVEKRVLSLAWEHPFL 58

Query: 125 VQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
             L  YC   T   L +  E+ + G L  + H +   K   P            A     
Sbjct: 59  THL--YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATF-------YAAEIIC 107

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL++LH K    I++RD+K  N+L+  D   KIADF +  +  +M     +    GT  Y
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKE--NMLGDAKTCTFCGTPDY 162

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            APE  +  + N   D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 30/217 (13%)

Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQ--PDEEFLAQVSMVSRLKHE 122
           NF     IGEG+YG VY      +G   A+KK  LD   +  P    + ++S++  L H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHP 59

Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP-----VLSWQQRVKIA 177
           N V+LL          L +EF     LH  L  +K +  +         + S+  ++   
Sbjct: 60  NIVKLLDVIHTENKLYLVFEF-----LHQDL--KKFMDASPLSGIPLPLIKSYLFQL--- 109

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
               +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+
Sbjct: 110 ---LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV 162

Query: 238 GTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            T  Y APE  +  +  + + D++S G +  E++T R
Sbjct: 163 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 6/102 (5%)

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           K+++   KGL YL EK    I+HRD+K SN+L+      K+ DF +S Q  D  A     
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 160

Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 46/217 (21%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
           +GEGSY  VY GI + +G   A+K +    +    F A  + S++  LKH N V L    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL---- 68

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVK--------------GAQPGPVLSWQQRVKIA 177
                             HDI+H ++ +                  PG +  +  R+   
Sbjct: 69  ------------------HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FM 109

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
               +GL Y+H +   HI+HRD+K  N+LI      K+ADF L+ +A  + ++ +S+ V+
Sbjct: 110 FQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEVV 165

Query: 238 GTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
            T  Y  P+  +     ++  D++  G + +E+L G+
Sbjct: 166 -TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 64/241 (26%), Positives = 98/241 (40%), Gaps = 56/241 (23%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF------LAQVSMVSRLKHENFVQ 126
           L+G+G  GRV+   LK +G   A+K LD  K+   +       L +  +++ L H     
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLD--KKEMIKRNKVKRVLTEQEILATLDHPFLPT 65

Query: 127 LLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQ-RVKIA-VGAAK 182
           L  Y    T   L    ++   G L  +L         QPG  LS +  R   A V  A 
Sbjct: 66  L--YASFQTETYLCLVMDYCPGGELFRLLQ-------RQPGKCLSEEVARFYAAEVLLA- 115

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA---------------PDM 227
            LEYLH      I++RD+K  N+L+ +     ++DFDLS Q+                  
Sbjct: 116 -LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 228 AARLHSTRVL------------GTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRK 274
           +     +               GT  Y APE  ++G    +  D ++ G++L E+L G  
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTT 230

Query: 275 P 275
           P
Sbjct: 231 P 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 66.0 bits (162), Expect = 4e-12
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 38/218 (17%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVSRLKHENFVQL 127
            IG G+YG V   +  ++G   AIKK+  S   D+   A+     + ++  L+HEN + L
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIGL 64

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDI----------LHGRKGVKGAQPGPVLSWQQRVKIA 177
           L         +L     S    +D+          LH  K +K  QP   L+        
Sbjct: 65  L--------DILRPP--SPEDFNDVYIVTELMETDLH--KVIKSPQP---LTDDHIQYFL 109

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRV 236
               +GL+YLH     ++IHRD+K SN+L+  +   KI DF L+    PD   +   T  
Sbjct: 110 YQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166

Query: 237 LGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           + T  Y APE  ++     K+ D++S G +  ELLT +
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 46/240 (19%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA-----QVSMVS 117
           E+ E + +   +G G+YG V   I  ++G   AIKKL  S+    E  A     +++++ 
Sbjct: 12  ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLK 69

Query: 118 RLKHENFVQLLGYCVDGTS--------RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
            ++HEN + LL       S         V+ Y       L  I+           G  LS
Sbjct: 70  HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIM-----------GHPLS 115

Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMA 228
             +   +      GL+Y+H      IIHRD+K  N+ + +D   KI DF L+  A  +M 
Sbjct: 116 EDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM- 171

Query: 229 ARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287
                T  + T  Y APE  +     N   D++S G ++ E+LTG+     TL +G+  L
Sbjct: 172 -----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK-----TLFKGKDYL 221

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 17/209 (8%)

Query: 69  FGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPDE---EFLAQVSMVSRLKHENF 124
           F    ++GEG+YG V     K      AIKK   S++ +E     L ++ M+  LK EN 
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
           V+L           L +E+     L  +    +   G  P  V S+  ++       K +
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQL------IKAI 113

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            + H+     I+HRDIK  N+LI  +DV K+ DF  +    +  +  + T  + T  Y +
Sbjct: 114 HWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRS 169

Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
           PE  +        D++S G +L EL  G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.1 bits (158), Expect = 5e-12
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 26/220 (11%)

Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRLK 120
           N+    L+G+G++GRVY      +G   A+K++     S +  +E  A   ++ ++  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 121 HENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
           HE  VQ  G   D   R L+   E    GS+ D L       GA     L+     K   
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY----GA-----LTENVTRKYTR 113

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST---R 235
              +G+ YLH      I+HRDIK +N+L       K+ DF  S +   +   L  T    
Sbjct: 114 QILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC--LSGTGMKS 168

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           V GT  + +PE         K+D++S G  ++E+LT + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 65.1 bits (158), Expect = 6e-12
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 24/219 (10%)

Query: 68  NFGTNALIGEGSYGRVY--YGILKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRL 119
           N+    L+G+G++GRVY  Y +  +G   A K++     S +  +E  A   ++ ++  L
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 120 KHENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           +HE  VQ  G   D   + L    E+   GS+ D L       GA    V     R  + 
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQIL- 116

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-V 236
               +G+ YLH      I+HRDIK +N+L       K+ DF  S +   +       R V
Sbjct: 117 ----EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT  + +PE         K+DV+S G  ++E+LT + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 8e-12
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 33/213 (15%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           IGEG+YG VY      +G   A+KK  L+     DE      + ++S++  L H N V+L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLE---TEDEGVPSTAIREISLLKELNHPNIVRL 63

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL----SWQQRVKIAVGAAKG 183
           L          L +EF       D+             P L     +Q          +G
Sbjct: 64  LDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQ--------LLQG 111

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           + Y H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T  Y 
Sbjct: 112 IAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTYTHEVV-TLWYR 166

Query: 244 APEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
           APE  +   Q +   D++S G +  E++  R+P
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 64.6 bits (157), Expect = 8e-12
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 24/223 (10%)

Query: 69  FGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKH 121
           F    ++G+G +G V    LK    S    A+K L A   S    EEFL + + +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 122 ENFVQLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
            N ++L+G  +   ++      ++   F  +G LH  L   +   G +P   L  Q  V+
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR--IGEEPF-TLPLQTLVR 117

Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHS 233
             +  A G+EYL  K   + IHRD+ + N ++ ++    +ADF LS +  + D   +  +
Sbjct: 118 FMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174

Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           +++     + A E          SDV++FGV + E++T G+ P
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G+G +G V    +K +G   A KKLD      ++ ++  L +  ++ ++    F+  L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59

Query: 130 YCVDGTSRV-LAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           Y  +    + L     + G L   +   G          P     + +  A     GLE+
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGE---------PGFPEARAIFYAAQIICGLEH 110

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           LH++    I++RD+K  NVL+ D    +I+D  L   A ++          GT GY APE
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGL---AVELKGGKKIKGRAGTPGYMAPE 164

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                  +   D ++ G  L E++ GR P
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 29/233 (12%)

Query: 68  NFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDAS-----KQPDEEFLAQVSMVSR 118
           NF    ++G G+YG+V+      GH A    A+K L  +      +  E    +  ++  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 119 LKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           ++   F+  L Y     +++ L  ++ + G L   L+ R+             +  V++ 
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT----------ESEVRVY 110

Query: 178 VGA-AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR 235
           +      L++LH+     II+RDIK  N+L+  +    + DF LS +   +   R +S  
Sbjct: 111 IAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-- 165

Query: 236 VLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286
             GT  Y APE    G    +   D +S GV+  ELLTG  P      +  QS
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 53/188 (28%), Positives = 81/188 (43%), Gaps = 39/188 (20%)

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG----Y 242
           +H     H+IHRDIKS+N+L+  + + K+ DF  S     M A   S  V  TF     Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK----MYAATVSDDVGRTFCGTPYY 211

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ 302
            APE       + K+D++S GV+L ELLT ++P D                   E+ + +
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD------------------GEN-MEE 252

Query: 303 CVDARLGGDY---PPKAVAKMAAVAALCVQYEADFRP------NMSIV---VKALQPLLN 350
            +   L G Y   PP    +M  +    +  +   RP      NM I    +  L  ++ 
Sbjct: 253 VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQ 312

Query: 351 ARPGPAGE 358
            +PG +G 
Sbjct: 313 TQPGFSGP 320

Length = 496

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 29/212 (13%)

Query: 74  LIGEGSYGR---VYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLL-G 129
           ++GEGS+GR   V +      +A    +L  S    E+   +  +++++KH N V     
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           +  DG   ++  E+   G L   +  ++G K      +L W  ++ + V      +++HE
Sbjct: 67  FEADGHLYIVM-EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGV------QHIHE 118

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV------LGTFGYH 243
           K    ++HRDIKS N+ +  +   K+ DF         +ARL ++        +GT  Y 
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDFG--------SARLLTSPGAYACTYVGTPYYV 167

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            PE       N KSD++S G +L EL T + P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 22/204 (10%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQ-------PDEEFLAQV--SMVSRLKHENFV 125
           +G+GS+G VY  ++K   A A ++L   K+       P+E   A     ++S+L H   V
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +     ++  +  +  E+     L   L   K       G  LS  Q  +  +    G+ 
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELK-----HTGKTLSENQVCEWFIQLLLGVH 120

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           Y+H++    I+HRD+K+ N+ +  +++ KI DF +S     M +   +T   GT  Y +P
Sbjct: 121 YMHQR---RILHRDLKAKNIFL-KNNLLKIGDFGVSRLL--MGSCDLATTFTGTPYYMSP 174

Query: 246 EYAMTGQLNAKSDVYSFGVVLLEL 269
           E       ++KSD++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 20/204 (9%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
           +GEG+Y  V+ G  K + +  A+K++    +      A  +VS++  LKH N V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEK 190
                  L +E+  +     + +          G ++S    VKI +    +GL Y H++
Sbjct: 73  HTERCLTLVFEYLDSDLKQYLDNC---------GNLMS-MHNVKIFMFQLLRGLSYCHKR 122

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM- 249
               I+HRD+K  N+LI +    K+ADF L+ +A  +  + +S  V+ T  Y  P+  + 
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPDVLLG 177

Query: 250 TGQLNAKSDVYSFGVVLLELLTGR 273
           + + +   D++  G +L E+ TGR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 69/242 (28%), Positives = 106/242 (43%), Gaps = 45/242 (18%)

Query: 64  EITENFGTNALIGEGSYGRV--YYGILKSGHAAAIKKL-------DASKQPDEEFLAQVS 114
           EIT  +     +G G++G V      L +G   AIKK+         +K+   E    + 
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPFSTPVLAKRTYRE----LK 61

Query: 115 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
           ++  L+HEN + L    +     +    E      LH +L  R           L  Q  
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRP----------LEKQFI 110

Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN-QAPDMAARLH 232
                   +GL+Y+H      ++HRD+K SN+LI ++   KI DF L+  Q P M   + 
Sbjct: 111 QYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV- 166

Query: 233 STRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPV----DHTLPRGQQSL 287
           STR      Y APE  +T Q  + + D++S G +  E+L G KP+    DH     Q S+
Sbjct: 167 STRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHV---NQFSI 217

Query: 288 VT 289
           +T
Sbjct: 218 IT 219

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 34/218 (15%)

Query: 73  ALIGEGSYGRVYYGILK-SGHAAAIK--KLDASKQPDE--------EFLAQVSMVSRLKH 121
            ++G+GS+G+V    LK +    A+K  K D   Q D+          LA        KH
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KH 55

Query: 122 ENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
               QL   C     R+    E+ + G L  + H ++  +  +P       +    A   
Sbjct: 56  PFLTQLHS-CFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEP-------RARFYAAEI 105

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
             GL++LHE+    II+RD+K  NVL+  +   KIADF +  +   +   + ++   GT 
Sbjct: 106 VLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG--ILGGVTTSTFCGTP 160

Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVD 277
            Y APE  ++ Q    + D ++ GV+L E+L G+ P +
Sbjct: 161 DYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 37/221 (16%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK------HENFV 125
           A IG G+YG VY      SGH  A+K +      D   L+ V  V+ LK      H N V
Sbjct: 6   AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 126 QLLGYC----VDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           +L+  C     D  ++V L +E        D+    +      P P L  +    +    
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVD----QDL----RTYLDKVPPPGLPAETIKDLMRQF 117

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----TR 235
            +GL++LH      I+HRD+K  N+L+      K+ADF L        AR++S     T 
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL--------ARIYSCQMALTP 166

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 74/270 (27%), Positives = 113/270 (41%), Gaps = 51/270 (18%)

Query: 36  ASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAA 94
           +S ++   + A    P    ++S  EL+ +         IG G+ G VY  I + +G   
Sbjct: 52  SSSSSSSSSSASGSAPSAAKSLS--ELERVNR-------IGSGAGGTVYKVIHRPTGRLY 102

Query: 95  AIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLG-YCVDGTSRVLAYEFASNGSLHD 151
           A+K +  + +     +   ++ ++  + H N V+    +  +G  +VL  EF   GSL  
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL-LEFMDGGSLE- 160

Query: 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211
              G           +   Q    +A     G+ YLH +   HI+HRDIK SN+LI    
Sbjct: 161 ---GTH---------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAK 205

Query: 212 VAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA------KSDVYSF 262
             KIADF +S    Q  D          +GT  Y +PE   T  LN         D++S 
Sbjct: 206 NVKIADFGVSRILAQTMDPC-----NSSVGTIAYMSPERINT-DLNHGAYDGYAGDIWSL 259

Query: 263 GVVLLELLTGRKPVDHTLPRGQQSLVTWAT 292
           GV +LE   GR P       G+Q    WA+
Sbjct: 260 GVSILEFYLGRFP----FGVGRQG--DWAS 283

Length = 353

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 82/329 (24%), Positives = 140/329 (42%), Gaps = 54/329 (16%)

Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKL-DASKQPD--EEFLAQVS 114
           V    +  EN      IG G+YG V   I  +SG   AIKK+  A   P   +  L ++ 
Sbjct: 3   VGSRYKPIEN------IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56

Query: 115 MVSRLKHENFVQLLGYCV----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
           ++   KH+N + +         D     +  +   +  LH I+H        QP   L+ 
Sbjct: 57  ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD------QP---LTE 106

Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDM 227
           +          +GL+Y+H  A+  +IHRD+K SN+L+ +D   +I DF ++     +P  
Sbjct: 107 EHIRYFLYQLLRGLKYIHS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163

Query: 228 AARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRK---PVDHTLPRG 283
                 T  + T  Y APE  ++  +     D++S G +  E+L GR+   P  + + + 
Sbjct: 164 HKY-FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQL 221

Query: 284 QQSLVTWATP------KLSEDKVRQCVDARLGGDYP-------PKAVAKMAAVAALCVQY 330
           +  L    +P      ++  D+VR+ +   L    P       PKA  +   + +  +Q+
Sbjct: 222 KLILSVLGSPSEEVLNRIGSDRVRKYIQN-LPRKQPVPWSKIFPKASPEALDLLSQMLQF 280

Query: 331 EADFRPNMSIVVKALQ-PLLNARPGPAGE 358
           + + R     V +ALQ P L     P  E
Sbjct: 281 DPEERIT---VEQALQHPFLAQYHDPDDE 306

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 13/151 (8%)

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN-QAPDMAARLHSTRVLGTF 240
           +GL+YLH      I+HRDIK  N+L+  + V KI DF L+  + PD     H T+ + T 
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQ 168

Query: 241 GYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--WATPKLSE 297
            Y APE  M  +   +  D++S G +  ELL  R       P  Q  L+T    TP L  
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228

Query: 298 DKVRQCVDAR---LGGDYPPKAVAKMAAVAA 325
            +   C  AR   L G + P ++  +  +++
Sbjct: 229 MR-SACEGARAHILRGPHKPPSLPVLYTLSS 258

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 65/237 (27%), Positives = 104/237 (43%), Gaps = 58/237 (24%)

Query: 64  EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE------FLAQVSMV 116
           ++   +   + IGEG+YG V     K +G   AIKK+     P E        L ++ ++
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKIL 57

Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI----------LHGRKGVKGAQPGP 166
            R KHEN + +L        R  ++E     S +D+          L+  K +K  Q   
Sbjct: 58  RRFKHENIIGILD-----IIRPPSFE-----SFNDVYIVQELMETDLY--KLIK-TQH-- 102

Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
            LS            +GL+Y+H  A+  ++HRD+K SN+L+  +   KI DF L      
Sbjct: 103 -LSNDHIQYFLYQILRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGL------ 152

Query: 227 MAARLHS---------TRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
             AR+           T  + T  Y APE  +  +   K+ D++S G +L E+L+ R
Sbjct: 153 --ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 22/211 (10%)

Query: 74  LIGEGSYGRVYYGILKSGH---AAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLL 128
           ++G+GS+G+V    LK      A  + K D   Q D  E  + +  ++S  ++  F+  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 129 GYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAAKGLEY 186
             C     R+    EF + G L  + H +K  +  +         R +  A      L +
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA--------RARFYAAEITSALMF 111

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           LH+K    II+RD+K  NVL+  +   K+ADF +  +   +     ++   GT  Y APE
Sbjct: 112 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTFCGTPDYIAPE 166

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
                      D ++ GV+L E+L G  P +
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 18/202 (8%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
           +GEGSY  VY G  K +G   A+K +   ++    F A  + S++  LKH N V L    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
               +  L +E+     L   +    G  G  P  V  +  ++       +GL Y+H++ 
Sbjct: 73  HTKETLTLVFEYVHT-DLCQYMDKHPG--GLHPENVKLFLFQL------LRGLSYIHQR- 122

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-T 250
             +I+HRD+K  N+LI D    K+ADF L+ +A  + +  +S  V+ T  Y  P+  + +
Sbjct: 123 --YILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVV-TLWYRPPDVLLGS 178

Query: 251 GQLNAKSDVYSFGVVLLELLTG 272
            + +   D++  G + +E++ G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 61/208 (29%), Positives = 85/208 (40%), Gaps = 26/208 (12%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLKHENFVQLL 128
           +G GS+GRV     K +G   AIK L        KQ       + S++  L H   V ++
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-VAQEKSILMELSHPFIVNMM 84

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS-WQQRVKIAVGAAKGLEYL 187
               D        EF   G L    H RK   G  P  V   +   + +A       EYL
Sbjct: 85  CSFQDENRVYFLLEFVVGGEL--FTHLRKA--GRFPNDVAKFYHAELVLA------FEYL 134

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
           H K    II+RD+K  N+L+ +    K+ DF  + + PD    L      GT  Y APE 
Sbjct: 135 HSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----CGTPEYLAPEV 186

Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             +       D ++ GV+L E + G  P
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.1 bits (151), Expect = 8e-11
 Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 5/93 (5%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL++LH+K    II+RD+K  NVL+  D   KIADF +  +  +M     ++   GT  Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDY 162

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            APE     + N   D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 61.4 bits (150), Expect = 1e-10
 Identities = 65/219 (29%), Positives = 94/219 (42%), Gaps = 32/219 (14%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLK 120
           ++F     +G GS+GRV     K SG   A+K L        KQ  E  L +  ++  ++
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H   V L G   D ++  L  E+   G L   L  RK   G  P PV            A
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RK--SGRFPEPV--------ARFYA 107

Query: 181 AK---GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
           A+    LEYLH      I++RD+K  N+L+  D   KI DF  + +          T  L
Sbjct: 108 AQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTL 158

Query: 238 -GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT  Y APE  ++       D ++ G+++ E+L G  P
Sbjct: 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 64/254 (25%), Positives = 99/254 (38%), Gaps = 62/254 (24%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKL--DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
           LIG+G  G VY           A+KK+  D S+ P   + FL +  + + L H   V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV-------KIAVGA- 180
             C DG        +    +L  +L   K V          WQ+         K +VGA 
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLL---KSV----------WQKESLSKELAEKTSVGAF 115

Query: 181 -------AKGLEYLHEKADPHIIHRDIKSSNVL--------IFDDDVAKIADF---DLSN 222
                     +EY+H K    ++HRD+K  N+L        I D   A        DL +
Sbjct: 116 LSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 223 QAPDMAARLHST-----RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT------ 271
              D     +S+     +++GT  Y APE  +    +  +D+Y+ GV+L ++LT      
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232

Query: 272 ---GRK-PVDHTLP 281
              GRK      + 
Sbjct: 233 RKKGRKISYRDVIL 246

Length = 932

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 29/222 (13%)

Query: 68  NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV-- 125
           NF    ++G G+YG+V+     SGH       D+ K    + L + ++V + K       
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGH-------DSGKLYAMKVLKKATIVQKAKTTEHTRT 53

Query: 126 --QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR-----VKIA 177
             Q+L +       V L Y F ++  LH IL     + G +    LS ++R     V+I 
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL---DYINGGELFTHLSQRERFKEQEVQIY 110

Query: 178 VGA-AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR 235
            G     LE+LH+     II+RDIK  N+L+  +    + DF LS +   D   R +S  
Sbjct: 111 SGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-- 165

Query: 236 VLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKP 275
             GT  Y AP+    G    +   D +S GV++ ELLTG  P
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 25/215 (11%)

Query: 60  DELKEITENFGTNAL--IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVS 117
            + +E+  + G   +  +  GS GRV+    K G    +  L   ++     L +  ++ 
Sbjct: 57  QKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPVV-LKIGQKGTT--LIEAMLLQ 112

Query: 118 RLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
            + H + +++    V G  T  VL +    +  L+  L  R           L   Q + 
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMVLPH---YSSDLYTYLTKRSRP--------LPIDQALI 161

Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
           I     +GL YLH +    IIHRD+K+ N+ I D D   I D   + Q P +A       
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA-QFPVVAPAFLG-- 215

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
           + GT   +APE     + N+K+D++S G+VL E+L
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 19/207 (9%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
           IGEG+YG V+    + +    A+K++   D  +      L ++ ++  LKH+N V+L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
                   L +E+     L        G    +      +Q          KGL + H  
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHSH 118

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
              +++HRD+K  N+LI  +   K+ADF L+ +A  +  R +S  V+ T  Y  P+    
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLWYRPPDVLFG 173

Query: 251 GQLNAKS-DVYSFGVVLLELLTGRKPV 276
            +L + S D++S G +  EL    +P+
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 28/220 (12%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +     +G G+YG V      +     A+KKL    Q          ++ ++  +
Sbjct: 12  EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71

Query: 120 KHENFVQLLGYCVDGTS-----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
           KHEN + LL      TS      V          L++I+  +K          LS +   
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK----------LSDEHVQ 121

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H      IIHRD+K SNV + +D   +I DF L+ QA D       T
Sbjct: 122 FLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMT 173

Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELL G+
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 8/140 (5%)

Query: 139 LAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGA-AKGLEYLHEKADPHI 195
           L Y F + G L+ IL   +G  +       V+  ++ VK  +   A  L++LH      I
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---I 119

Query: 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA 255
           I+RD+K  N+L+ ++   K+ DF LS ++ D   + +S    GT  Y APE         
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQ 177

Query: 256 KSDVYSFGVVLLELLTGRKP 275
            +D +SFGV++ E+LTG  P
Sbjct: 178 SADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 24/212 (11%)

Query: 74  LIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLL 128
           ++G+GS+G+V     K     +A  I K D   Q D  E  + +  +++      F+  L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
             C     R+    E+ + G L  + H ++  K  +P         V  A   A GL +L
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEP-------HAVFYAAEIAIGLFFL 117

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL--SNQAPDMAARLHSTRVLGTFGYHAP 245
           H K    II+RD+K  NV++  +   KIADF +   N       R       GT  Y AP
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----TFCGTPDYIAP 170

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           E           D ++FGV+L E+L G+ P D
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 22/219 (10%)

Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRL 119
            N+    L+G G++G VY      +G   A+K++     S++  +E  A   ++ ++  L
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 120 KHENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           +H+  VQ  G   D   + L+   E+   GS+ D L       GA    V     R  + 
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQIL- 116

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-V 236
               +G+ YLH      I+HRDIK +N+L       K+ DF  S +   +       + V
Sbjct: 117 ----QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT  + +PE         K+DV+S    ++E+LT + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 57/216 (26%), Positives = 87/216 (40%), Gaps = 33/216 (15%)

Query: 73  ALIGEGSYGRV----------YYGI--LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           A++G G +G+V           Y I  LK G   A  ++++       F       +  +
Sbjct: 5   AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET----ANSER 60

Query: 121 HENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           H   V L   C      V    E+A+ G L  ++H    V         S  + V  A  
Sbjct: 61  HPFLVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDV--------FSEPRAVFYAAC 109

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
              GL+YLHE     I++RD+K  N+L+  +   KIADF L  +   M     ++   GT
Sbjct: 110 VVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE--GMGFGDRTSTFCGT 164

Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             + APE           D +  GV++ E+L G  P
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 30/218 (13%)

Query: 73  ALIGEGSYGRVYYG--ILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK------HENF 124
           A IGEG+YG+V+    +   G   A+K++      +   L+ +  V+ L+      H N 
Sbjct: 7   AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 125 VQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           V+L   C V  T R             D+      V    P P +  +    +     +G
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRG 122

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----TRVLG 238
           L++LH      ++HRD+K  N+L+      K+ADF L        AR++S     T V+ 
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTSVVV 171

Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 22/207 (10%)

Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           +G G +GRV    +KS     A+K +       + Q  E   ++  ++    H   V+L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKLY 59

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
               D     +  E+   G L  IL  R        G    +  R  IA       EYLH
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDR--------GLFDEYTARFYIA-CVVLAFEYLH 110

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            +    II+RD+K  N+L+  +   K+ DF  + +      +  +    GT  Y APE  
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-GQKTWT--FCGTPEYVAPEII 164

Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +    +   D +S G++L ELLTGR P
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 35/219 (15%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
           +G G+YG V   +  ++G   AIKKL    Q +   +    ++ ++  +KHEN + LL  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 131 CVDGTSRVLAYEFASNGSLHDI--LHGRKGVKGAQPGPVLSWQQ----RVKIAV-GAAKG 183
                       F  + SL      +      G   G ++  ++    R++  V    KG
Sbjct: 83  ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           L+Y+H      IIHRD+K  N+ + +D   KI DF L+ Q          TR      Y 
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYR 182

Query: 244 APEYAMTGQLNAKS-DVYSFGVVLLELLTGR---KPVDH 278
           APE  +      ++ D++S G ++ E+LTG+   K  DH
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 66/214 (30%), Positives = 97/214 (45%), Gaps = 32/214 (14%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQVSMVSR----LKHEN-FV 125
           ++G+GS+G+V    LK  G   A+K L  D     D+    + +MV +    L  EN F+
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD---VECTMVEKRVLALAWENPFL 58

Query: 126 QLLGYCVDGTSRVLAY--EFASNGSL--HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             L YC   T   L +  EF + G L  H    GR               +    A    
Sbjct: 59  THL-YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-----------FDLYRATFYAAEIV 106

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            GL++LH K    II+RD+K  NV++  D   KIADF +  +  ++     ++   GT  
Sbjct: 107 CGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPD 161

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           Y APE     +     D +SFGV+L E+L G+ P
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)

Query: 75  IGEGSYGRVYYGILKSGHAAA---IKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLG 129
           IG G +G+V    + +    A   +K+L A+    E  EFL Q      L+H N +Q LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
            CV+    +L +E+   G L   L   +  +      +L  Q   ++A   A G+ ++H+
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN--SQLLLLQ---RMACEIAAGVTHMHK 117

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDL--SNQAPDMAARLHSTRVLGTFGYHAPEY 247
               + +H D+   N  +  D   K+ D+ +  S    D               + APE 
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET--EDDKCVPLRWLAPEL 172

Query: 248 A-------MTGQLNAKSDVYSFGVVLLELL 270
                   +T +    S+V++ GV L EL 
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 26/217 (11%)

Query: 74  LIGEGSYGRVYYGILKSGHAA--AIKKLD--------ASKQPDEEFLAQVSMVS----RL 119
            +G G++G VY    K+      A+K+++          ++ D+     VS V+    +L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV-KIAV 178
           +H N V+     ++     +  +      L +  +  K  K          ++R+  I V
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT------EERIWNIFV 120

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
                L YLH+  +  I+HRD+  +N+++ +DD   I DF L+ Q    +     T V+G
Sbjct: 121 QMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVG 175

Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           T  Y  PE         K+DV++FG +L ++ T + P
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 78/352 (22%), Positives = 131/352 (37%), Gaps = 105/352 (29%)

Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLDASKQPDEEFLAQVSMVSRLK-------H 121
           +G G++G+V     +GI KS      A+K L       E      ++++ LK       H
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE----YKALMTELKILIHIGHH 70

Query: 122 ENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGR---------KGVKGAQPGPVLSWQ 171
            N V LLG C   G   ++  E+   G+L + L  +         K  +  +       +
Sbjct: 71  LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130

Query: 172 QR-------------------------------------------VKIAVGAAKGLEYLH 188
           QR                                           +  +   A+G+E+L 
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL- 189

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMA----ARLHSTRVLGTFG 241
             A    IHRD+ + N+L+ +++V KI DF L+    + PD      ARL          
Sbjct: 190 --ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-------PLK 240

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
           + APE         +SDV+SFGV+L E+ + G  P              +   ++ E+  
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP--------------YPGVQIDEEFC 286

Query: 301 RQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
           R+  +  R+    P  A  ++ ++   C     + RP  S +V+ L  LL  
Sbjct: 287 RRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 62/225 (27%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDE--EFLA--QVSMVSRLKHENFVQLLG 129
           +GEGSY  VY G  K +G   A+K++    + +E   F A  + S++  LKH N V    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEI--RLEHEEGAPFTAIREASLLKDLKHANIV---- 66

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGV-------------------KGAQPGPVLSW 170
                             +LHDI+H +K +                    G         
Sbjct: 67  ------------------TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSM------ 102

Query: 171 QQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
              V++ +    +GL Y H++    ++HRD+K  N+LI +    K+ADF L+ +A  + +
Sbjct: 103 -HNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPS 157

Query: 230 RLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
           + +S  V+ T  Y  P+  + + + +   D++  G +  E+ TGR
Sbjct: 158 KTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 29/216 (13%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKL----DASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
           LI E     +Y GI  +     I+         K   +    ++  + R+   N +++ G
Sbjct: 27  LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85

Query: 130 Y---CVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +    VD   R+ L  E+ + G L ++L   K          LS++ ++ +A+   KGL 
Sbjct: 86  FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---------LSFKTKLDMAIDCCKGLY 136

Query: 186 YLHEKAD-PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            L++  + P   ++++ S + L+ ++   KI    L      + +      V     Y +
Sbjct: 137 NLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEK----ILSSPPFKNV-NFMVYFS 188

Query: 245 PEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDH 278
            +       +   K D+YS GVVL E+ TG+ P ++
Sbjct: 189 YKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224

Length = 283

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 44/221 (19%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKL--------DASKQPDEEFLAQVSMVSRLKHENFV 125
           IG G+YG V      ++    AIKK+        DA +      L ++ ++  L HEN +
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-----LREIKLLRHLDHENVI 67

Query: 126 QLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            +    +    R       + YE      LH I      ++ +Q    LS          
Sbjct: 68  AIKD-IMPPPHREAFNDVYIVYELMDT-DLHQI------IRSSQT---LSDDHCQYFLYQ 116

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---SNQAPDMAARLHSTRV 236
             +GL+Y+H     +++HRD+K SN+L+  +   KI DF L   +++  D       TR 
Sbjct: 117 LLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR- 172

Query: 237 LGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPV 276
                Y APE  +   +     DV+S G +  ELL GRKP+
Sbjct: 173 ----WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 40/98 (40%), Positives = 57/98 (58%), Gaps = 9/98 (9%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 239
           GL+Y+H  A+  ++HRD+K  N+L+  D   KI DF L+   ++ P   A    T  + T
Sbjct: 117 GLKYIHS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG-FMTEYVAT 172

Query: 240 FGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 276
             Y APE  ++ Q   K+ DV+S G +L ELL GRKPV
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 61/228 (26%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKL-DA-SKQPDEEFLAQ-----VSMVSRLK-HENFV 125
           +G+G+YG V+  I  ++    A+KK+ DA     D    AQ     +  +  L  H N V
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD----AQRTFREIMFLQELGDHPNIV 70

Query: 126 QLLG----------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           +LL           Y        L +E+     LH ++  R  +        L    +  
Sbjct: 71  KLLNVIKAENDKDIY--------LVFEYMET-DLHAVI--RANI--------LEDVHKRY 111

Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---------SNQAPD 226
           I     K L+Y+H     ++IHRD+K SN+L+  D   K+ADF L         + + P 
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168

Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           +      T  + T  Y APE  +      K  D++S G +L E+L G+
Sbjct: 169 L------TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 24/215 (11%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLK 120
           ++      +G G++GRV+    + S H  A+K +        KQ ++    +  ++  + 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVS 59

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H   ++L     D     +  E+   G L   L               S    +  A   
Sbjct: 60  HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---------FSNSTGLFYASEI 110

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
              LEYLH K    I++RD+K  N+L+  +   K+ DF  + +  D    L      GT 
Sbjct: 111 VCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----CGTP 162

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            Y APE   +   N   D ++ G+++ E+L G  P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 31/219 (14%)

Query: 67  ENFGTNALIGEGSYGRVYYGILKSGH--AAAIKKLDASK-----QPDEEFLAQVSMVSRL 119
           E+F     +G GS+GRV     K+      AIK+ + SK     Q D  F ++  +++ +
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYI 88

Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            H   V L G   D +   L  EF   G     L   K      P  V  +     + + 
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF----PNDVGCFYAAQIVLI- 143

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR---V 236
                EYL      +I++RD+K  N+L+  D   K+ DF          A++  TR   +
Sbjct: 144 ----FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF--------AKVVDTRTYTL 188

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT  Y APE  +       +D ++ G+ + E+L G  P
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 22/205 (10%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
           +GEG+Y  V+ G  K + +  A+K++    +      A  +VS++  LKH N V L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP--GPVLSWQQRVKIAVGAAKGLEYLHE 189
               S  L +E+             K +K      G ++S            +GL Y H 
Sbjct: 74  HTDKSLTLVFEYLD-----------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
           +    ++HRD+K  N+LI +    K+ADF L+ +A  +  + +S  V+ T  Y  P+  +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPDVLL 177

Query: 250 -TGQLNAKSDVYSFGVVLLELLTGR 273
            + + + + D++  G +  E+ +GR
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 32/215 (14%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLKHENF-VQL 127
           IGEG+YG+VY      +G   A+KK     + DEE      L ++S++  L    + V+L
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKK--TRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 128 LGYCVDGT-------SRVLAYEF-ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           L   V+         S  L +E+  S+       +GR   +      + S+  ++     
Sbjct: 67  L--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL----- 119

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMAARLHSTRVLG 238
             KG+ + H+     ++HRD+K  N+L+     + KIAD  L  +A  +  + ++  ++ 
Sbjct: 120 -LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIPVKSYTHEIV- 173

Query: 239 TFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTG 272
           T  Y APE  +     +   D++S G +  E+   
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 44/216 (20%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
           +GEG+Y  VY G  K + +  A+K++    +      A  +VS++  LKH N V      
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGA-------------QPGPVLSWQQRVKIAV 178
                           +LHDI+H  K +                  G  ++         
Sbjct: 68  ----------------TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLF 111

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
              +GL Y H +    ++HRD+K  N+LI +    K+ADF L+ +A  +  + +S  V+ 
Sbjct: 112 QLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVV- 166

Query: 239 TFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
           T  Y  P+  + +   + + D++  G +  E+ TGR
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 29/81 (35%), Positives = 47/81 (58%)

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
           ++HRD+KS+N+ +    + K+ DF  S Q  D  +   ++   GT  Y APE     + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 255 AKSDVYSFGVVLLELLTGRKP 275
            K+D++S GV+L ELLT  +P
Sbjct: 250 KKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 28/235 (11%)

Query: 68  NFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDAS-----KQPDEEFLAQVSMVSR 118
           NF    ++G G+YG+V+     +GH      A+K L  +      +  E    + +++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 119 LKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           ++   F+  L Y     +++ L  ++ S G +   L+ R      +          V+  
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE----------VRFY 110

Query: 178 VGAA-KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR 235
            G     LE+LH+     I++RDIK  N+L+  +    + DF LS +   +   R +S  
Sbjct: 111 SGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-- 165

Query: 236 VLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 289
             GT  Y APE       + K+ D +S G+++ ELLTG  P      R  QS V+
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 27/177 (15%)

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHSTRVL 237
           A+G+E+L   A    IHRD+ + N+L+ +++V KI DF L+    + PD   R  S R+ 
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARL- 238

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS 296
               + APE         +SDV+SFGV+L E+ + G  P              +   +++
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP--------------YPGVQIN 283

Query: 297 EDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 352
           E+  ++  D  R+    P  A  ++  +   C Q +   RP  S +V+ L  LL   
Sbjct: 284 EEFCQRLKDGTRMRA--PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQEN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 17/207 (8%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G+G +G V    ++ +G   A KKL+  +    +  E  + +  +++++ H  F+  L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           Y     + +       NG   D+ +    V    PG      +          GLE+LH+
Sbjct: 60  YAFQTKTDLCLVMTIMNGG--DLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQ 115

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-VLGTFGYHAPEYA 248
           +    II+RD+K  NVL+ +D   +I+D  L   A ++      T+   GT G+ APE  
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGL---AVELKDGQSKTKGYAGTPGFMAPELL 169

Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
              + +   D ++ GV L E++  R P
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 3/106 (2%)

Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
           P LS+   V  +   A G+E+L  K   + +HRD+ + NVLI +  + KI DF L+    
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIM 290

Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
             +  +          + APE          SDV+SFG++L E+ T
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 15/209 (7%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
           +G GS G V+  +        A+KK+  +  Q  +  L ++ ++ RL H+N V++     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGV-----KGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
              S  L  +  S   L+ +   ++ +        + GP+     R+       +GL+Y+
Sbjct: 73  PSGSD-LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLKYI 130

Query: 188 HEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSN-QAPDMAARLHSTRVLGTFGYHAP 245
           H     +++HRD+K +NV I  +D V KI DF L+    P  + + + +  L T  Y +P
Sbjct: 131 HSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187

Query: 246 EYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
              ++     K+ D+++ G +  E+LTG+
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 39/218 (17%)

Query: 74  LIGEGSYGRVYYGILK--SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHEN--FV 125
           +IG G +G VY G  K  +G   A+K LD      KQ +   L +  M+S +   +  F+
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
             + Y      ++    +  + G LH  L  HG           V S  +    A     
Sbjct: 60  VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----------VFSEAEMRFYAAEIIL 108

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHSTRVLG 238
           GLE++H +    +++RD+K +N+L+ +    +I+D     D S + P      H++  +G
Sbjct: 109 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS--VG 157

Query: 239 TFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
           T GY APE    G   ++ +D +S G +L +LL G  P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 44/206 (21%), Positives = 78/206 (37%), Gaps = 38/206 (18%)

Query: 89  KSGHAAAIKKLDASKQPDEEFL---AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145
            +    A+KK++      E+      ++    +L+H N +  +   +  +   +     +
Sbjct: 23  PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82

Query: 146 NGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEYLHEKADPHIIHRDI 200
            GS  D+L  H  +G+              + IA         L+Y+H K     IHR +
Sbjct: 83  YGSCEDLLKTHFPEGLP------------ELAIAFILKDVLNALDYIHSK---GFIHRSV 127

Query: 201 KSSNVLIFDDDVAKIADFDLS--------NQAPDMAARLHSTRVLGTFGYHAPEY---AM 249
           K+S++L+  D    ++    S         Q         S + L    + +PE     +
Sbjct: 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---WLSPEVLQQNL 184

Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKP 275
            G  N KSD+YS G+   EL  G  P
Sbjct: 185 QG-YNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 26/213 (12%)

Query: 74  LIGEGSYGRVYYGILKSG-HAAAIKKLDASKQPDEEFLAQVSMVSRLKH-------ENFV 125
           +IG GSY +V    LK      A+K +      D+E    +  V   KH         F+
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE---DIDWVQTEKHVFEQASSNPFL 58

Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
             L  C   TSR+ L  E+ + G L  + H ++  K       L  +     A      L
Sbjct: 59  VGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRK-------LPEEHARFYAAEICIAL 109

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            +LHE+    II+RD+K  NVL+  D   K+ D+ +  +   +     ++   GT  Y A
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIA 164

Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           PE     +     D ++ GV++ E++ GR P D
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 26/219 (11%)

Query: 68  NFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPDEEFLAQVSMVSRL----- 119
           +F    ++G+GS+G+V     K     +A  I K D   Q D+    + +MV +      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD---VECTMVEKRVLALS 57

Query: 120 KHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
               F+  L  C     R+    E+ + G L  +   ++  +  +P  V         A 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVF-------YAA 108

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
             A GL +LH K    II+RD+K  NV++  +   KIADF +  +  +M   + +    G
Sbjct: 109 EIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTFCG 163

Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           T  Y APE           D ++FGV+L E+L G+ P +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 35/216 (16%)

Query: 74  LIGEGSYGRVYYGILK--SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHEN--FV 125
           +IG G +G VY G  K  +G   A+K LD      KQ +   L +  M+S +   +  F+
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
             + Y      ++    +  + G LH  L        +Q G V S ++    A     GL
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHL--------SQHG-VFSEKEMRFYATEIILGL 110

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHSTRVLGTF 240
           E++H +    +++RD+K +N+L+ +    +I+D     D S + P      H++  +GT 
Sbjct: 111 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS--VGTH 159

Query: 241 GYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKP 275
           GY APE    G   ++ +D +S G +L +LL G  P
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 20/140 (14%)

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           LE+LH++    II+RD+K  N+L+      K+ DF L  ++       H+    GT  Y 
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYM 167

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTG---------RKPVDHTLPRGQQSLVTWATPK 294
           APE  M        D +S G ++ ++LTG         +K +D  L +G+ +L  + TP+
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-KGKLNLPPYLTPE 226

Query: 295 LSEDKVRQC----VDARLGG 310
            + D +++       +RLG 
Sbjct: 227 -ARDLLKKLLKRNPSSRLGA 245

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 18/103 (17%)

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMA----ARLHS 233
           AKG+E+L   A    IHRD+ + N+L+ +++V KI DF L+    + PD      ARL  
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243

Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                   + APE         +SDV+SFGV+L E+ + G  P
Sbjct: 244 -----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 20/207 (9%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGY 130
           +G+G +G V    +K +G   A KKLD     K+  E+       +    +  F+  L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 131 CVDG-TSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
             +  T   L     + G L + I +   G +G +   V+ +  ++        G+ +LH
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQI------TCGILHLH 112

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
                 I++RD+K  NVL+ D    +++D  L+ +  D       T+  GT GY APE  
Sbjct: 113 SMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEIL 166

Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
                +   D ++ G  + E++ GR P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 37/225 (16%)

Query: 75  IGEGSYGRVYYGILKSGHAA---AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           +G G+YG VY    K G      A+K+++ +         +++++  LKH N + L    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVF 67

Query: 132 VDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK------- 182
           +    R   L +++A +   H I   R      +P         V++  G  K       
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP---------VQLPRGMVKSLLYQIL 118

Query: 183 -GLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLS---NQAPDMAARLHST 234
            G+ YLH      ++HRD+K +N+L+  +       KIAD   +   N      A L   
Sbjct: 119 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP- 174

Query: 235 RVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
            V+ TF Y APE  +  +   K+ D+++ G +  ELLT  +P+ H
Sbjct: 175 -VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 6/93 (6%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GLE LH++    I++RD+K  N+L+ D    +I+D  L+   P+   +    RV GT GY
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 167

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            APE     +     D ++ G +L E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 36/103 (34%), Positives = 53/103 (51%), Gaps = 18/103 (17%)

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL-------SNQAPDMAARLHS 233
           A+G+++L  K   + IHRD+ + NVL+ D  VAKI DF L       SN      ARL  
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL-- 276

Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                   + APE         +SDV+S+G++L E+ + G+ P
Sbjct: 277 -----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GLE LH +   + ++RD+K  N+L+ D    +I+D  L+ + P+        RV GT GY
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVGY 167

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            APE     +     D +  G ++ E++ G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.8 bits (126), Expect = 8e-08
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 23/218 (10%)

Query: 75  IGEGSYGRVYYGILKSGHAA---AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           +G G+YG VY    K G      A+K+++ +         +++++  LKH N + L    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVF 67

Query: 132 VDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEYLH 188
           +  + R   L +++A +   H I   R     A   P+   +  VK +      G+ YLH
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHR--ASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 189 EKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
                 ++HRD+K +N+L+  +       KIAD   +   N      A L    V+ TF 
Sbjct: 126 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVTFW 180

Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE  +  +   K+ D+++ G +  ELLT  +P+ H
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 20/208 (9%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLD----ASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           L+G+G++G+V     K +G   A+K L      +K      L +  ++   +H  F+  L
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTAL 60

Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            Y      R+    E+A+ G L   L   +         V S  +           L+YL
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYL 111

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
           H  ++ ++++RD+K  N+++  D   KI DF L  +     A + +    GT  Y APE 
Sbjct: 112 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEV 167

Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                     D +  GVV+ E++ GR P
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 26/213 (12%)

Query: 74  LIGEGSYGRVYYGILKSGHAA-AIKKLDASKQPDEEFLAQVSMVSRLKH-----ENFVQL 127
           +IG GSY +V    LK      A+K +      D+E    +  V   KH      N   L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDE---DIDWVQTEKHVFETASNHPFL 58

Query: 128 LGY--CVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
           +G   C    SR+    EF S G L  + H ++  K       L  +     +   +  L
Sbjct: 59  VGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRK-------LPEEHARFYSAEISLAL 109

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            +LHE+    II+RD+K  NVL+  +   K+ D+ +  +   +     ++   GT  Y A
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYIA 164

Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           PE           D ++ GV++ E++ GR P D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 32/213 (15%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDAS--KQPDE--EFLAQVSMVSRLKHENFVQLLG 129
           +G+G YG+V+    K +G   A+K++  S   + +E    L +  +++  K E  V+LL 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-----AVGAAKGL 184
              D     LA E+   G    +L+          G +     R  +     AV A    
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNL--------GVLSEDHARFYMAEMFEAVDA---- 116

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
             LHE      IHRD+K  N LI      K+ DF LS      A   +S  V+G+  Y A
Sbjct: 117 --LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA---NS--VVGSPDYMA 166

Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           PE       +   D +S G +L E L G  P  
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 38/216 (17%)

Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDAS----KQPDEEFLAQVS-MVSRLKHENFVQLL 128
           IG+GS+G+V     K+ G   A+K L       K+  +  +A+ + ++  +KH   V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---------IAVG 179
                       Y F +   L+ +L    G      G +    QR +          A  
Sbjct: 62  -----------HYSFQTADKLYFVLDYVNG------GELFFHLQRERSFPEPRARFYAAE 104

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A  L YLH     +II+RD+K  N+L+       + DF L  +   +     ++   GT
Sbjct: 105 IASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159

Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             Y APE       +   D +  G VL E+L G  P
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 20/210 (9%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKHENFVQLL 128
           +IG GSY +V    LK +    A+K +      D+E +  V     +  +  +  F+  L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 129 GYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
             C    SR+    E+ + G L  + H ++  K       L  +     +   +  L YL
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK-------LPEEHARFYSAEISLALNYL 112

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
           HE+    II+RD+K  NVL+  +   K+ D+ +  +   +     ++   GT  Y APE 
Sbjct: 113 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEI 167

Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
                     D ++ GV++ E++ GR P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL----KHENFVQLL 128
           L+G+G++G+V     K +G   A+K L       ++ +A     SR+    +H  F+  L
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLTAL 60

Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            Y      R+    E+A+ G L   L   +         V + ++           LEYL
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYL 111

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
           H +    +++RDIK  N+++  D   KI DF L  +     A + +    GT  Y APE 
Sbjct: 112 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 166

Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKPV---DH 278
                     D +  GVV+ E++ GR P    DH
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 50.2 bits (121), Expect = 5e-07
 Identities = 64/227 (28%), Positives = 94/227 (41%), Gaps = 41/227 (18%)

Query: 59  VDELKEIT--ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE-FLAQVSM 115
           V  LK     +         +G +G+V   +LK  H    +KL   K    + F A   M
Sbjct: 10  VQFLKNCEIVKKLKLI----DGKFGKVS--VLK--HKPT-QKLFVQKIIKAKNFNAIEPM 60

Query: 116 VSRL--KHENFVQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
           V +L   + NF++L  Y V  T +  VL  ++  +G L D+L              LS  
Sbjct: 61  VHQLMKDNPNFIKLY-YSV-TTLKGHVLIMDYIKDGDLFDLLKKEGK---------LSEA 109

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAAR 230
           +  KI     + L  LH+    +IIH DIK  NVL     D   + D+ L          
Sbjct: 110 EVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------I 159

Query: 231 LHSTRVL-GTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
           + +     GT  Y +PE  + G     S D ++ GV+  ELLTG+ P
Sbjct: 160 IGTPSCYDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 50.2 bits (120), Expect = 6e-07
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 28/216 (12%)

Query: 74  LIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLL 128
           L+G+G++G+V     K+    +A  I K +     DE    L +  ++   +H  F+  L
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP-FLTAL 60

Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA--AKGLE 185
            Y      R+    E+A+ G L    H  +         V S + R +   GA     L 
Sbjct: 61  KYSFQTHDRLCFVMEYANGGEL--FFHLSRE-------RVFS-EDRARF-YGAEIVSALG 109

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YLH      +++RD+K  N+++  D   KI DF L  +     A + +    GT  Y AP
Sbjct: 110 YLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAP 164

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPV---DH 278
           E           D +  GVV+ E++ GR P    DH
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 44/231 (19%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKL--------DASKQPDEEFLAQVSMVSRLKHENF 124
           +IG+GSYG V   I   +G   AIKK+        DA++      L ++ ++  L+H + 
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-----ILREIKLLRLLRHPDI 61

Query: 125 VQLLGYCVDGTSR-----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           V++    +  + R      + +E   +  LH ++     +   +      +Q        
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT-PEHHQFFLYQ-------- 111

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLG 238
             + L+Y+H     ++ HRD+K  N+L   D   KI DF L+  A  D    +  T  + 
Sbjct: 112 LLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168

Query: 239 TFGYHAPEYAMTGQLNAKS----DVYSFGVVLLELLTGR-----KPVDHTL 280
           T  Y APE  + G   +K     D++S G +  E+LTG+     K V H L
Sbjct: 169 TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 3/108 (2%)

Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
           L  +Q + I     + L YLH +    IIHRD+K+ N+ + + + A + DF  + +    
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                     GT   ++PE        AK+D++S G+VL E+      
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 50.1 bits (119), Expect = 7e-07
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 21/208 (10%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLL 128
           L+G+G++G+V     K SG   A+K L      +K      L +  ++   +H  F+  L
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP-FLTSL 60

Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            Y      R+    E+ + G L   L   +         V S  +           L+YL
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRER---------VFSEDRTRFYGAEIVSALDYL 111

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
           H      I++RD+K  N+++  D   KI DF L  +    AA + +    GT  Y APE 
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEV 166

Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                     D +  GVV+ E++ GR P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 36/126 (28%), Positives = 56/126 (44%), Gaps = 25/126 (19%)

Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
           I  GA +GL YLH+      IHR+IK+S++LI  D +  ++     +    +       +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGL---SHLYSLVRNGQKAK 159

Query: 236 VLGTFGYHAPEYAMTGQ--------------LNAKSDVYSFGVVLLELLTGRKPVDHTLP 281
           V+    Y  P+++ +                 N KSD+YS G+   EL TGR P    + 
Sbjct: 160 VV----YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF-QDML 214

Query: 282 RGQQSL 287
           R Q  L
Sbjct: 215 RTQMLL 220

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 9e-07
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GLE LH +    I++RD+K  N+L+ D    +I+D  L+ + P+        RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            APE     +     D +  G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 34/119 (28%), Positives = 45/119 (37%), Gaps = 30/119 (25%)

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS----------------NQAPDM 227
           L+ +H+      IHRDIK  N+LI  D   K+ADF L                 +     
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 228 AARLHSTR-----------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
              L   R            +GT  Y APE         + D +S GV+L E+L G  P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 34/229 (14%)

Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKLDAS----KQPDEEFLAQVSMVSRLKH 121
           E+F T  LI  G+YG VY    K      A+KK++      +   ++   +  +++  ++
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 122 ENFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
              V +  +C   T R L    E+   G    +L      K     PV   +      V 
Sbjct: 61  PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL------KNIGALPVDMARMYFAETVL 112

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHS----- 233
           A   LEYLH      I+HRD+K  N+LI      K+ DF LS      +   L+      
Sbjct: 113 A---LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 234 -TR------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            TR      V GT  Y APE  +        D ++ G++L E L G  P
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 49/220 (22%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
           IGEG+YG VY    + +    A+KK+   +Q DE      + ++S++  ++H N V+L  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQHGNIVRL-- 66

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGV------------KGAQPGPVLSWQQR-VKI 176
                                D++H  K +            K     P  +   R +K 
Sbjct: 67  --------------------QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT 106

Query: 177 AV-GAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHST 234
            +    +G+ Y H      ++HRD+K  N+LI    +  K+ADF L+ +A  +  R  + 
Sbjct: 107 YLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLA-RAFGIPVRTFTH 162

Query: 235 RVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
            V+ T  Y APE  + +   +   D++S G +  E++  +
Sbjct: 163 EVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 188

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 10/93 (10%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTF 240
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A    M      TR     
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
            Y APE  +        D++S G ++ E++ G 
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 6/93 (6%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GLE L  +    I++RD+K  N+L+ D    +I+D  L+ Q P+        RV GT GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GETVRGRV-GTVGY 167

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            APE     +     D +  G ++ E++ G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 32/214 (14%)

Query: 74  LIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPDEEFLAQVSMVSR------LKHENF 124
           ++G+GS+G+V    LK     +A  + K D   Q D+      +M  +       KH   
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDD---VDCTMTEKRILALAAKHPFL 58

Query: 125 VQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAA 181
             L  +C   T   L +  E+ + G L  +   ++  K  +P        R +  A    
Sbjct: 59  TAL--HCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEP--------RSRFYAAEVT 106

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L +LH      +I+RD+K  N+L+  +   K+ADF +  +   +   + +T   GT  
Sbjct: 107 LALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPD 161

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           Y APE     +     D ++ GV++ E++ G+ P
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 18/103 (17%)

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL-------SNQAPDMAARLHS 233
           AKG+ +L  K   + IHRD+ + N+L+    + KI DF L       SN      ARL  
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278

Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                   + APE         +SDV+S+G++L E+ + G  P
Sbjct: 279 -----PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 6/93 (6%)

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           LE+LH+     I++RD+K  N+L+       + DF LS    ++     +    GT  Y 
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 244 APEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
           APE  +  +   K  D +S GV++ E+  G  P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 7e-06
 Identities = 58/241 (24%), Positives = 107/241 (44%), Gaps = 34/241 (14%)

Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           F    S++S++ H +   + G CV G+  ++  EF  +G L D+   ++  KG  P   +
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKE--KGRVP---V 116

Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD--FDLSNQAPD 226
           +W  ++ +A   A  L YL +K   +++H ++ + N+L+    +A+       LS+    
Sbjct: 117 AW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171

Query: 227 MAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLEL-LTGRKPVDHTLPRGQ 284
             A     RV     + APE    G  L+  +D +SFG  LLE+   G  P+    P  +
Sbjct: 172 FTALSREERV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230

Query: 285 QSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 344
           +        +  E K R           P  +  ++A + + C+ YE   RP+   +++ 
Sbjct: 231 E--------RFYEKKHR----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272

Query: 345 L 345
           L
Sbjct: 273 L 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 15/169 (8%)

Query: 103 KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA 162
           KQ D      V M+   +   +  +     D   R  +Y+ +++  + ++L    G +G 
Sbjct: 181 KQADT--TQYVPMLEIKEASKYSDIQRSNYD---RPASYKGSNDSEVKNLL-SDDGSEGL 234

Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
               +LS+  +V      A+G+E+L  K   + +HRD+ + NVL+    + KI DF L+ 
Sbjct: 235 TTLDLLSFTYQV------ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR 285

Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                +  +          + APE          SDV+S+G++L E+ +
Sbjct: 286 DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 4/92 (4%)

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
           + ++YLHE     IIHRDIK+ N+ I       + DF  +    D+ A  +     GT  
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIA 248

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
            +APE           D++S G+VL E+ T  
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 46/181 (25%), Positives = 62/181 (34%), Gaps = 58/181 (32%)

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF------------------------- 218
           +E +H+      IHRDIK  N+LI  D   K+ DF                         
Sbjct: 114 IESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 219 --------DLSNQAPDMAARLH---STRVL-----GTFGYHAPEYAMTGQLNAKSDVYSF 262
                   ++         R       R L     GT  Y APE  +        D +S 
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 263 GVVLLELLTGRKPVDHTLPRG-QQSLVTWAT-------PKLSEDK----VRQCVDA--RL 308
           GV+L E+L G+ P     P   Q  ++ W T        KLS +     +R C  A  RL
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRL 290

Query: 309 G 309
           G
Sbjct: 291 G 291

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 24/210 (11%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIK----KLDASKQPDEEFLAQVS-MVSRLKHENFVQL 127
           +IG+GS+G+V     K  G   A+K    K+  +++  +  +A+ + ++  +KH  F+  
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP-FLVG 60

Query: 128 LGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAAKGLE 185
           L Y    T ++    +F + G L    H ++     +P        R +  A   A  L 
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEP--------RARFYAAEIASALG 110

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YLH     +I++RD+K  N+L+       + DF L  +    +    +T   GT  Y AP
Sbjct: 111 YLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAP 165

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           E       +   D +  G VL E+L G  P
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 19/161 (11%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSR----LKH 121
           E F     I  G++G+VY G  K +    A+K +  +   ++  + QV    R    L  
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQV-QAERDALALSK 62

Query: 122 ENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
             F+  L Y +   + V L  E+   G +  +LH    + G     +      VK     
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEM-----AVKYISEV 113

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
           A  L+YLH      IIHRD+K  N+LI ++   K+ DF LS
Sbjct: 114 ALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 27/84 (32%), Positives = 39/84 (46%), Gaps = 5/84 (5%)

Query: 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT----G 251
           IHRD+K  N+L+      K+ADF    +  D    +     +GT  Y +PE   +    G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D +S GV L E+L G  P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
            APE  +        D++S G ++ E++ G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 31/86 (36%), Positives = 40/86 (46%), Gaps = 7/86 (8%)

Query: 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY--AMTGQL 253
           +HRDIK  NVLI      K+ADF  S         ++S   +GT  Y APE    M G  
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 254 NAKSDV----YSFGVVLLELLTGRKP 275
                V    +S GV+  E++ GR P
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 32/224 (14%)

Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+F    +IG G++G V          A +K  +A K    + L +  M+ R +   F +
Sbjct: 1   EDFEILKVIGRGAFGEV----------AVVKLKNADKVFAMKILNKWEMLKRAETACFRE 50

Query: 127 LLGYCVDGTSR---VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
                V+G ++    L Y F    +L+ ++    G      G +L+   + +  +     
Sbjct: 51  ERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG------GDLLTLLSKFEDRLPEDMA 104

Query: 184 LEYLHEKA-------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
             YL E           H +HRDIK  N+L+  +   ++ADF    +  +    + S+  
Sbjct: 105 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVA 163

Query: 237 LGTFGYHAPEY--AM---TGQLNAKSDVYSFGVVLLELLTGRKP 275
           +GT  Y +PE   AM    G+   + D +S GV + E+L G  P
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 40/143 (27%), Positives = 53/143 (37%), Gaps = 46/143 (32%)

Query: 196 IHRDIKSSNVLIFDDDVAKIADF--------------------------DLSNQAPD--- 226
           IHRDIK  N+LI  D   K+ DF                          D SN+  D   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 227 ------------MAARLH----STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
                        AAR H    +  ++GT  Y APE  +        D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 271 TGRKPVDHTLP-RGQQSLVTWAT 292
            G+ P     P   Q  ++ W T
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQT 265

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 37/228 (16%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKK-LDASKQPDEEFLAQVSMVSRLKHENFVQLLGY- 130
           +IG GS+G VY  I + +    AIKK L   +  + E L    ++  L H N + L  Y 
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYY 128

Query: 131 ---CVDGTSRVL----AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAAK 182
              C     + +      EF    ++H  +  +   +     P+      VK+ +    +
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYM--KHYARNNHALPLF----LVKLYSYQLCR 181

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            L Y+H K    I HRD+K  N+LI  +    K+ DF     A ++ A   S   + +  
Sbjct: 182 ALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF---GSAKNLLAGQRSVSYICSRF 235

Query: 242 YHAPEYAMTGQLNAKS--DVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287
           Y APE  M G  N  +  D++S G ++ E++ G     + +  GQ S+
Sbjct: 236 YRAPEL-MLGATNYTTHIDLWSLGCIIAEMILG-----YPIFSGQSSV 277

Length = 440

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 48/197 (24%), Positives = 75/197 (38%), Gaps = 26/197 (13%)

Query: 110 LAQVSMVSRLKHE-------NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA 162
           L + S  SR +         N V L  Y V   S  L  + A  G L   +     +   
Sbjct: 26  LRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEE 85

Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
               V  W   + +A      L+ LH +    I+ RD+  +N+L+ D    ++  F   +
Sbjct: 86  C---VKRWAAEMVVA------LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWS 133

Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282
           +  D         +     Y APE     +     D +S G +L ELLTG K +    P 
Sbjct: 134 EVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPS 187

Query: 283 GQQSLVTWATPK-LSED 298
           G  +  T   P+ +SE+
Sbjct: 188 GINTHTTLNIPEWVSEE 204

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 62/255 (24%), Positives = 104/255 (40%), Gaps = 36/255 (14%)

Query: 75  IGEGSYGRVYYGILK---------SGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLK 120
           +G G+  ++Y GIL            +   IK +     P        F    SM+ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H++ V L G CV     ++  EF   G L D+   RK         VL+   + K+A   
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRK-------SDVLTTPWKFKVAKQL 114

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-AKIADF-DLSNQAPDMAARLHSTRVLG 238
           A  L YL +K    ++H ++ + N+L+  + +  +   F  LS+    +   L     + 
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV-LSRQECVE 170

Query: 239 TFGYHAPEYAM-TGQLNAKSDVYSFGVVLLEL-LTGRKPV-DHTL---PRGQQSLVTWAT 292
              + APE    +  L+  +D +SFG  L E+   G  P+ D TL    R  +      T
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVT 230

Query: 293 PKLSE--DKVRQCVD 305
           P   E  D +  C++
Sbjct: 231 PSCKELADLMTHCMN 245

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 23/226 (10%)

Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDASKQPDEEFLAQVS 114
           + +L+   E++    +IG G++G V     KS         + K +  K+ D  F  +  
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 115 MVSRLKHENFV-QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
            +    +  +V QL     D     +  E+   G L +++      +         W + 
Sbjct: 95  DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--------KWAKF 146

Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
               V  A  L+ +H      +IHRD+K  N+L+      K+ADF    +  D    +  
Sbjct: 147 YTAEVVLA--LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRC 200

Query: 234 TRVLGTFGYHAPEYAMT----GQLNAKSDVYSFGVVLLELLTGRKP 275
              +GT  Y +PE   +    G    + D +S GV L E+L G  P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 58/258 (22%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
           ++F +  +IG G++G V     K +GH  A+K L  +   ++E +A +    R + +  V
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI----RAERDILV 56

Query: 126 QLLGYCV--------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           +  G  V        D  +  L  EF   G +  +L  +  +        ++      +A
Sbjct: 57  EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA---ETVLA 113

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---------------- 221
           + A   L +         IHRDIK  N+L+      K++DF L                 
Sbjct: 114 IDAIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164

Query: 222 -NQAPDMAAR-LHSTR---------------VLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264
            N   D + + ++S R                +GT  Y APE  M    N   D +S GV
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224

Query: 265 VLLELLTGRKPVDHTLPR 282
           ++ E+L G  P     P+
Sbjct: 225 IMYEMLIGYPPFCSETPQ 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 6/94 (6%)

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           +H     H +HRDIK  NVL+  +   ++ADF  S    +    + S+  +GT  Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 247 Y--AM---TGQLNAKSDVYSFGVVLLELLTGRKP 275
              AM    G+   + D +S GV + E+L G  P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 24/211 (11%)

Query: 73  ALIGEGSYGRVYYGILKS-GHAAAIKKLDAS----KQPDEEFLAQVS-MVSRLKHENFVQ 126
            +IG+GS+G+V     KS G   A+K L       K+     +A+ + ++  LKH  F+ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP-FLV 59

Query: 127 LLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAAKGL 184
            L Y      ++    ++ + G L    H ++     +P        R +  A   A  +
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEP--------RARFYAAEVASAI 109

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            YLH     +II+RD+K  N+L+       + DF L  +   +     ++   GT  Y A
Sbjct: 110 GYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG--VEPEETTSTFCGTPEYLA 164

Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           PE       +   D +  G VL E+L G  P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 35/124 (28%), Positives = 60/124 (48%), Gaps = 11/124 (8%)

Query: 43  GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AAI 96
           G + + V P+++P  S  E+    +N      +G G++GRV     +G+  S      A+
Sbjct: 15  GHEYIYVDPMQLPYDSAWEMPR--DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAV 72

Query: 97  KKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
           K L ++ +  E+   ++++ ++S L  H N V LLG C  G    +  E+   G L D L
Sbjct: 73  KMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132

Query: 154 HGRK 157
           H  K
Sbjct: 133 HRNK 136

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 56/254 (22%), Positives = 97/254 (38%), Gaps = 50/254 (19%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-- 123
           E+F +  +IG G++G V     K +GH  A+K L  +   ++E +  +     +  E   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 124 --FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
              V++     D  +  L  EF   G +  +L  +           L+ ++         
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD---------TLTEEETQFYIAETV 111

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----------------DLSNQAP 225
             ++ +H+      IHRDIK  N+L+      K++DF                +L++  P
Sbjct: 112 LAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168

Query: 226 D--MAARLHSTR---------------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 268
                  ++S R                +GT  Y APE  M    N   D +S GV++ E
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 269 LLTGRKPVDHTLPR 282
           +L G  P     P+
Sbjct: 229 MLIGYPPFCSETPQ 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 5/92 (5%)

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           LE LH+    ++I+RD+K  N+L+  D    IA  D      +M     +    GT  Y 
Sbjct: 106 LENLHKF---NVIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           APE  +        D ++ GV+L E+LTG  P
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 9/88 (10%)

Query: 75  IGEGSYGRVY----YGILKSGHA--AAIKKLDASKQPDEE--FLAQVSMVSRL-KHENFV 125
           +G G++G+V     +G+ K  +    A+K L AS   DE    ++++ ++S L +H+N V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDIL 153
            LLG C  G   ++  E+   G L + L
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 12/108 (11%)

Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL---- 231
           I  G  K L+Y+H       +HR +K+S++LI  D    ++    +    +   RL    
Sbjct: 106 ILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162

Query: 232 ----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
               +S +VL        +  + G  +AKSD+YS G+   EL  G  P
Sbjct: 163 DFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 31/116 (26%), Positives = 45/116 (38%), Gaps = 36/116 (31%)

Query: 196 IHRDIKSSNVLIFDDDVAKIADFDL---------------------SNQAPDMAARLHST 234
           IHRDIK  N+L+      K++DF L                     SN    ++  + S 
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 235 R---------------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           R                +GT  Y APE  +    N + D +S GV++ E+L G  P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 6/87 (6%)

Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY--AM-- 249
             +HRDIK  NVL+  +   ++ADF  S         + S   +GT  Y +PE   AM  
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180

Query: 250 -TGQLNAKSDVYSFGVVLLELLTGRKP 275
             G+   + D +S GV + E+L G  P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 18/112 (16%)

Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
           P+L  Q R  I       +EY+H+K    +IHRDIK  N+ +  D    + DF       
Sbjct: 264 PLL-KQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDF------- 311

Query: 226 DMAARLHSTRV------LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
             A      R       +GT   ++PE          +D++S G++LL++L+
Sbjct: 312 GTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 47/209 (22%), Positives = 90/209 (43%), Gaps = 22/209 (10%)

Query: 74  LIGEGSYGRVYYGILKSG---HAAAI--KKLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           +IG+GS+G+V     K+    +A  +  KK    K+ ++  +++ +++ +     F+  L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAAKGLEY 186
            +      ++    ++ + G L    H ++     +P        R +  A   A  L Y
Sbjct: 62  HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEP--------RARFYAAEIASALGY 111

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           LH     +I++RD+K  N+L+       + DF L  +  ++     ++   GT  Y APE
Sbjct: 112 LHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPE 166

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                  +   D +  G VL E+L G  P
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 23/226 (10%)

Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDASKQPDEEFLAQVS 114
           + +L+   E++    +IG G++G V     KS         + K +  K+ D  F  +  
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 115 MVSRLKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
            +    +  +V  L Y   D     +  E+   G L +++          P     W + 
Sbjct: 95  DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPE---KWARF 146

Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
               V  A  L+ +H       IHRD+K  N+L+      K+ADF    +  +    +  
Sbjct: 147 YTAEVVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRC 200

Query: 234 TRVLGTFGYHAPEYAMT----GQLNAKSDVYSFGVVLLELLTGRKP 275
              +GT  Y +PE   +    G    + D +S GV L E+L G  P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	361
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
PRK10345	210	hypothetical protein; Provisional	99.87
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
smart00090	237	RIO RIO-like kinase.	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.6
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.56
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.53
KOG1243	690	consensus Protein kinase [General function predict	99.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.44
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.41
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.38
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.38
COG4248	637	Uncharacterized protein with protein kinase and he	99.37
KOG3087	229	consensus Serine/threonine protein kinase [General	99.34
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.26
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.97
PRK09902	216	hypothetical protein; Provisional	98.96
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.94
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.87
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.86
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.82
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.78
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.62
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.61
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.58
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.57
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.55
PF01636	239	APH: Phosphotransferase enzyme family This family	98.54
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.44
PLN02876	822	acyl-CoA dehydrogenase	98.4
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.37
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.3
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.26
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.25
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.21
PRK10593	297	hypothetical protein; Provisional	98.21
PRK05231	319	homoserine kinase; Provisional	98.1
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.09
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.06
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	98.03
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.01
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.93
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.66
KOG2270	520	consensus Serine/threonine protein kinase involved	97.63
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.61
PLN02236	344	choline kinase	97.57
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.55
PRK11768	325	serine/threonine protein kinase; Provisional	97.49
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.46
PLN02756	418	S-methyl-5-thioribose kinase	97.33
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.31
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.25
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.24
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.15
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.14
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.08
PRK12396	409	5-methylribose kinase; Reviewed	97.06
PRK06148	1013	hypothetical protein; Provisional	97.04
COG2334	331	Putative homoserine kinase type II (protein kinase	96.87
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.79
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.7
PTZ00384	383	choline kinase; Provisional	96.54
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.48
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	96.34
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.18

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-56  Score=408.34  Aligned_cols=290  Identities=53%  Similarity=0.903  Sum_probs=258.6

Q ss_pred             ccCccCHHHHHHHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCcceeeeEE
Q 018071           53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYC  131 (361)
Q Consensus        53 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~  131 (361)
                      ....++++++..++++|....+||+|+||.||+|...+|..||||++...... ..+|..|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56679999999999999999999999999999999998899999988775554 66799999999999999999999999


Q ss_pred             EeCC-eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC
Q 018071          132 VDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD  210 (361)
Q Consensus       132 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~  210 (361)
                      .+.. ..+||+||+.+|+|.+.+......       .++|..+++|+.++|.||+|||....++|||||||++|||+|++
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~  213 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED  213 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence            9988 599999999999999999876531       48999999999999999999999988889999999999999999


Q ss_pred             CceEEeccccCCCCcccccccccccc-ccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 018071          211 DVAKIADFDLSNQAPDMAARLHSTRV-LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT  289 (361)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~  289 (361)
                      +.+||+|||+|+..+..  ....... .||.+|+|||++..+..+.++|||||||+|+||++|+.+.+...+.....+..
T Consensus       214 ~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~  291 (361)
T KOG1187|consen  214 FNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE  291 (361)
T ss_pred             CCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence            99999999999765431  1111222 89999999999999999999999999999999999999998777667777899


Q ss_pred             hhcccCCchhhhhhcccccC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          290 WATPKLSEDKVRQCVDARLG-GDYPP-KAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      |..+......+.+++|+.+. ..++. .....+..+..+|++.+|.+||+|.+|++.|+.+...
T Consensus       292 w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  292 WAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            99888888899999999987 66665 6788899999999999999999999999999766554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-55  Score=402.25  Aligned_cols=246  Identities=25%  Similarity=0.414  Sum_probs=219.1

Q ss_pred             hcCCCCCccccCCceEEEEEEE-CCCCEEEEEEcCC----CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .+|...++||+|||+.||.++. .+|+.||+|++.+    ....++.+.+||++.+.|+|||||+++++|++.+++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999997 6999999999987    5556778999999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |+|..++|..+++.++         .+++.+++.++.||+.||.|||+.+   |+|||||..|+|++++.++||+|||+|
T Consensus        98 ELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLA  165 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLA  165 (592)
T ss_pred             EecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccccee
Confidence            9999999999998554         4999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ..+.....  ...+.||||.|+|||++...+++..+||||+||++|.||.|++||+...               -.+.+.
T Consensus       166 t~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~---------------vkety~  228 (592)
T KOG0575|consen  166 TQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT---------------VKETYN  228 (592)
T ss_pred             eeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch---------------HHHHHH
Confidence            98865433  3478999999999999999999999999999999999999999997331               123344


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+....+  ..|...+.+..+||.++|+.||.+|||+++|+.
T Consensus       229 ~Ik~~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  229 KIKLNEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHhcCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            4444444  344577888999999999999999999999995

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-54  Score=377.91  Aligned_cols=249  Identities=27%  Similarity=0.388  Sum_probs=210.4

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC--CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe-eEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS-RVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-~~lv~e~  143 (361)
                      +.+.++.||+|..|+||++.++ +++.+|+|++..  +....+++.+|+++++..+||+||++|+.|.++.. ..|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4445567999999999999988 899999999943  34446789999999999999999999999999884 9999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |++|+|.+++...+         .+++...-.++.+|++||.|||+ .+   ||||||||+||||++.|.+||||||.++
T Consensus       160 MDgGSLd~~~k~~g---------~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~  227 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG---------RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSG  227 (364)
T ss_pred             cCCCCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccH
Confidence            99999999998653         39999999999999999999996 55   9999999999999999999999999998


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .+.+.    ...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+....          .-+-+..
T Consensus       228 ~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~----------~~~Ll~~  293 (364)
T KOG0581|consen  228 ILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD----------IFELLCA  293 (364)
T ss_pred             Hhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC----------HHHHHHH
Confidence            76543    457889999999999999999999999999999999999999999754221110          0111222


Q ss_pred             hcccccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +++. .....|.+ ++.+++.++..||++||.+|||+.++++
T Consensus       294 Iv~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  294 IVDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HhcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2221 12234554 8899999999999999999999999987

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-54  Score=380.45  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=210.8

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--------hHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--------DEEFLAQVSMVSRLKHENFVQLLGYCVD  133 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~e~~~l~~l~hpniv~~~~~~~~  133 (361)
                      +.+.+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+....        .....+|+++|++|+|||||+++++|+.
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            346788999999999999999999976 9999999999764322        2345799999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC---
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---  210 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~---  210 (361)
                      ....|+||||++||+|.+.+..++.         +.+..-..++.|++.|+.|||++|   |+||||||+|||+..+   
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~  315 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAED  315 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcc
Confidence            9999999999999999999987653         788888999999999999999999   9999999999999876   


Q ss_pred             CceEEeccccCCCCccccccccccccccCCCCCCchhhccCCC---CCccceecHHHHHHHHHhCCCCCCCCCCcccchh
Q 018071          211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL---NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL  287 (361)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~  287 (361)
                      ..+||+|||+|+..+.   .....+.|||+.|.|||++.+.++   ..++|+||+||+||-+++|.+||........   
T Consensus       316 ~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---  389 (475)
T KOG0615|consen  316 CLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---  389 (475)
T ss_pred             eEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---
Confidence            6899999999998653   334678999999999999986643   3478999999999999999999975543220   


Q ss_pred             hhhhcccCCchhhhhhcccccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          288 VTWATPKLSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                 -..++...++.  .......+++..+||.+||..||++|||+.|+++
T Consensus       390 -----------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  390 -----------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -----------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                       01122222221  1334567899999999999999999999999886

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-53  Score=385.42  Aligned_cols=257  Identities=28%  Similarity=0.475  Sum_probs=229.9

Q ss_pred             CCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        70 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      ...+.||+|.||.||+|.++....||+|.++......+.|.+|+.+|++|+|+|||+++++|..+..++|||||++.|+|
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL  288 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL  288 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence            34456999999999999999777999999988777778999999999999999999999999998899999999999999


Q ss_pred             HHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccc
Q 018071          150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA  229 (361)
Q Consensus       150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  229 (361)
                      .++|....+       ..+...+.+.++.||++|++||++++   +|||||.+.||||+++..+||+|||+|+...+...
T Consensus       289 l~yLr~~~~-------~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  289 LDYLRTREG-------GLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             HHHhhhcCC-------CccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            999987333       23899999999999999999999998   99999999999999999999999999996554433


Q ss_pred             cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhccccc
Q 018071          230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL  308 (361)
Q Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (361)
                      .... ..--+..|.|||.+..+.++.++|||||||+||||+| |+.|+.                .+++.++.+.++.+.
T Consensus       359 ~~~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~----------------~msn~ev~~~le~Gy  421 (468)
T KOG0197|consen  359 TASE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP----------------GMSNEEVLELLERGY  421 (468)
T ss_pred             eecC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC----------------CCCHHHHHHHHhccC
Confidence            3222 2223668999999999999999999999999999999 999984                567888899999999


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          309 GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       309 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                      +.+.|..|+..+++|+..||+.+|++|||++.+...|+++.....
T Consensus       422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~  466 (468)
T KOG0197|consen  422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE  466 (468)
T ss_pred             cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence            999999999999999999999999999999999999999887543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-53  Score=373.97  Aligned_cols=247  Identities=29%  Similarity=0.413  Sum_probs=203.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ..+|.+.+.||+|+||+||+|+++ ++..||||.+.+..   ...+-+..|+++|+.++|||||.+++++..++.+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            468999999999999999999987 88999999997653   23345788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC------CceEE
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD------DVAKI  215 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~------~~~kl  215 (361)
                      |||+||+|.+||+.++.         +++..++.++.||+.||++||+++   ||||||||+||||+..      -.+||
T Consensus        89 EyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKI  156 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKI  156 (429)
T ss_pred             EeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEe
Confidence            99999999999998753         999999999999999999999998   9999999999999865      46899


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      +|||+|+.+...   ....+.||++.|||||++..+.|+.|+|+||+|++||++++|+.||+...+.+....+..     
T Consensus       157 ADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k-----  228 (429)
T KOG0595|consen  157 ADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK-----  228 (429)
T ss_pred             cccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-----
Confidence            999999987643   234678999999999999999999999999999999999999999986554332221111     


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV  341 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev  341 (361)
                               +.......+...+..+.+++...++.+|.+|-+..+-
T Consensus       229 ---------~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  229 ---------GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             ---------cccccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence                     1111122333344556677777777777777665543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-52  Score=381.15  Aligned_cols=258  Identities=33%  Similarity=0.544  Sum_probs=217.0

Q ss_pred             CCCCccccCCceEEEEEEECCCCE-EEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCC-eeEEEEEeC
Q 018071           70 GTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT-SRVLAYEFA  144 (361)
Q Consensus        70 ~~~~~lg~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~~  144 (361)
                      .+.+.||+|+||+||+|.++ |+. ||+|++......   .++|.+|+.+|.+++|||||+++|++.+.. .+.+||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            34445999999999999999 555 999999764433   458999999999999999999999999887 799999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-ceEEeccccCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQ  223 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~Dfg~a~~  223 (361)
                      ++|+|.+++.....       ..+++..++.++.+|+.||.|||+.+.  ||||||||+|||++.++ ++||+|||+++.
T Consensus       123 ~~GsL~~~l~~~~~-------~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRK-------RKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             CCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCcccee
Confidence            99999999987411       239999999999999999999999962  99999999999999998 999999999987


Q ss_pred             CccccccccccccccCCCCCCchhhc--cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAM--TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .....  ...+...||+.|||||++.  ...|+.++||||||+++|||+||+.||....+               .....
T Consensus       194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---------------~~~~~  256 (362)
T KOG0192|consen  194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---------------VQVAS  256 (362)
T ss_pred             ecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---------------HHHHH
Confidence            54321  2334478999999999999  56999999999999999999999999975433               12223


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                      .++....+...+..++..+..++.+||+.||..||++.+|+..|+.+...-..
T Consensus       257 ~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  257 AVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            33344445556666888899999999999999999999999999999875443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-54  Score=363.75  Aligned_cols=256  Identities=23%  Similarity=0.381  Sum_probs=210.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeee-EEEeCCe-eEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLG-YCVDGTS-RVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~-~~~~~~~-~~lv  140 (361)
                      .+|+++++||+|.||+||++... +|..+|.|.+.-..   ..++++..|+.+|++|+|||||++++ .+.++.. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            56888889999999999999965 89999999997533   34567899999999999999999998 4444444 8899


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEeccCCCCceEeccCCceEEecc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH--IIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      ||||.+|+|.+.++..+..+     ..+++..+|+++.|++.||..+|++ .++  |+||||||.||+|+.+|.+||+||
T Consensus        99 mE~c~~GDLsqmIk~~K~qk-----r~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQK-----RLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             HHhhcccCHHHHHHHHHhcc-----ccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccc
Confidence            99999999999997665332     4599999999999999999999994 233  999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      |+++.+....  ....+.+|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+.+      +          .
T Consensus       173 GL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~----------~  234 (375)
T KOG0591|consen  173 GLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------L----------L  234 (375)
T ss_pred             hhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------H----------H
Confidence            9999875432  23467899999999999999999999999999999999999999997541      1          1


Q ss_pred             hhhhhcccccCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          299 KVRQCVDARLGGDYP-PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      .+.+-+.+.--.++| .-++..+..||..|+..||+.||+...++..++
T Consensus       235 ~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  235 SLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            122222232223345 568999999999999999999999655554443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-53  Score=368.05  Aligned_cols=240  Identities=24%  Similarity=0.310  Sum_probs=205.4

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|+++++||+|+||+||.++.+ +++.+|+|++++...    ..+....|..+|.+++||+||+++-.|++...+|||+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            68999999999999999999976 899999999987443    3457889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+.||.|.-.|+..+.         +++..++.++.+|+.||.|||++|   ||||||||+|||+|.+|+++|+|||++
T Consensus       105 d~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~  172 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLC  172 (357)
T ss_pred             eccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccc
Confidence            99999999999986653         999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +..-..  .....++|||+.|||||++.+.+|+..+|+||||+++|||++|.+||...+...               ...
T Consensus       173 k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~---------------~~~  235 (357)
T KOG0598|consen  173 KEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK---------------MYD  235 (357)
T ss_pred             hhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH---------------HHH
Confidence            865332  223456899999999999999999999999999999999999999997553321               111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP  336 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  336 (361)
                      .+.... ....+.-.+.+.++++.+.|+.||++|.
T Consensus       236 ~I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  236 KILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            222111 1123333677899999999999999995

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-51  Score=372.79  Aligned_cols=253  Identities=24%  Similarity=0.326  Sum_probs=217.3

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS  136 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  136 (361)
                      ..-..+|..++.||+|+|++|++|..+ +++.||||++.+..    .....+.+|-..|.+| .||.|++|+..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            344578999999999999999999966 89999999997643    2234677888899999 79999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      +|+|+||+++|+|.++|+..+.         |++.-++.++.||+.||+|||+.|   ||||||||+|||||++|++||+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikIT  216 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKIT  216 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEe
Confidence            9999999999999999998763         999999999999999999999999   9999999999999999999999


Q ss_pred             ccccCCCCcccccc---------cc--ccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc
Q 018071          217 DFDLSNQAPDMAAR---------LH--STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ  285 (361)
Q Consensus       217 Dfg~a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~  285 (361)
                      |||.|+.+......         ..  ...++||..|.+||++.....+..+|||+|||+||+|+.|.+||.+.++    
T Consensus       217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----  292 (604)
T KOG0592|consen  217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----  292 (604)
T ss_pred             eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----
Confidence            99999877543222         11  2568999999999999999999999999999999999999999975432    


Q ss_pred             hhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          286 SLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                                 .-..+++++-.+  ++++..+..+.+|+++.|..||.+|+|.++|.+.
T Consensus       293 -----------yliFqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  293 -----------YLIFQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -----------HHHHHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                       112233333332  5677777889999999999999999999999874

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.8e-51  Score=349.16  Aligned_cols=262  Identities=25%  Similarity=0.335  Sum_probs=213.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      +.|+.+.++|+|+||.||+++++ ||+.||||++..+..+   .+-.++|+++|++|+|+|+|.++++|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46888899999999999999988 8999999999765443   3456899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      ||+. ++.+.+.....        .++...+..++.|++.|+.|+|+++   +|||||||+||||+.+|.+||||||+|+
T Consensus        82 ~~dh-TvL~eLe~~p~--------G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR  149 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPN--------GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR  149 (396)
T ss_pred             ecch-HHHHHHHhccC--------CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence            9988 55555544432        2889999999999999999999997   9999999999999999999999999999


Q ss_pred             CCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .+..  .....+..+.|.+|.|||.+.+ .+|+..+|||++||++.||++|.+.|.+..+-++...+......+.... .
T Consensus       150 ~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh-q  226 (396)
T KOG0593|consen  150 TLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH-Q  226 (396)
T ss_pred             hhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH-H
Confidence            8753  2233567788999999999987 6999999999999999999999999988777666555554333322211 1


Q ss_pred             hhccc----------ccC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDA----------RLG-----GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~----------~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +++..          ...     ...-+..+..+.++++.||+.||.+|++.++++.
T Consensus       227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11111          000     0111345667899999999999999999999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-50  Score=341.17  Aligned_cols=235  Identities=26%  Similarity=0.368  Sum_probs=209.4

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||.|+||.|.+++.+ +|..+|+|++.+....    .+...+|..+|+.+.||+++++++.+.+.+.+++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            57888999999999999999988 8999999999875433    356778999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||++||.|..++++.++         ++++.++.++.||+.||+|||+.+   |++|||||||||+|.+|.+||+|||+|
T Consensus       124 eyv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFA  191 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFA  191 (355)
T ss_pred             eccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccce
Confidence            99999999999988653         999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....     .-+.||||.|+|||++...+|..++|+|+|||++|||+.|.+||...++               .....
T Consensus       192 K~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---------------~~iY~  251 (355)
T KOG0616|consen  192 KRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---------------IQIYE  251 (355)
T ss_pred             EEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---------------HHHHH
Confidence            876542     4678999999999999999999999999999999999999999976544               22334


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFR  335 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  335 (361)
                      +++...+  .+|.-.+..+.+|+...|+.|-.+|
T Consensus       252 KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  252 KILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            4555444  5677788899999999999999999

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-51  Score=364.16  Aligned_cols=267  Identities=25%  Similarity=0.379  Sum_probs=217.5

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHH--HHHHHHHhcCC-CCCcceeeeEEEeCC-eeE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF--LAQVSMVSRLK-HENFVQLLGYCVDGT-SRV  138 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~e~~~l~~l~-hpniv~~~~~~~~~~-~~~  138 (361)
                      .+.++|.+.+.||.|+||.||+|+.+ +|+.||||++++.-...+++  +||++.|++|+ ||||+++.+++.+.. .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            35578999999999999999999966 89999999998755555544  68999999998 999999999998887 999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +|||||+. +|+++++.+.+        .+++..++.|+.||++||+|+|.+|   +.|||+||||||+.....+||+||
T Consensus        87 fVfE~Md~-NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccc
Confidence            99999965 99999988743        4999999999999999999999999   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhc-cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhh--cccC
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA--TPKL  295 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~--~~~~  295 (361)
                      |+|+.....   ...+..+.|.+|+|||++. .+-|+.+.|+|++||+++|+.+-++.|.+....++..-+-..  .+..
T Consensus       155 GLARev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  155 GLAREVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK  231 (538)
T ss_pred             ccccccccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence            999986432   2357788899999999886 568999999999999999999999999887665544333322  2222


Q ss_pred             Cch----hhhhhcccccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          296 SED----KVRQCVDARLG-------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       296 ~~~----~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      ...    .+...++-.+.       ....+..+.+..+||.+|+.+||.+|||+.+.++.-
T Consensus       232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            211    11111111111       111234788899999999999999999999999843

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-49  Score=357.03  Aligned_cols=277  Identities=25%  Similarity=0.335  Sum_probs=216.0

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeC--CeeE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRV  138 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~  138 (361)
                      ..+.|+.+..||+|+||.||+|+.. +|+.||+|++..+...   ..-..+||.+|++|+||||+++.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            3467778889999999999999965 9999999999765422   34567999999999999999999988776  7899


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      ||+|||+. +|.-++....-        .|++.++..++.||+.||+|||+.|   |+|||||.+|||||++|.+||+||
T Consensus       195 lVFeYMdh-DL~GLl~~p~v--------kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDF  262 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGV--------KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADF  262 (560)
T ss_pred             EEEecccc-hhhhhhcCCCc--------ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccc
Confidence            99999987 89888876431        3999999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |+|+...... ....+..+.|.+|.|||++.|. .|+..+|+||+||||.||+.|++.|.+...-.+...+...-....+
T Consensus       263 GLAr~y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e  341 (560)
T KOG0600|consen  263 GLARFYTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE  341 (560)
T ss_pred             cceeeccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence            9999664332 2335777889999999999976 7999999999999999999999999887765554444322222222


Q ss_pred             hhhh--hhccccc---CCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCC
Q 018071          298 DKVR--QCVDARL---GGDYP-------PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPA  356 (361)
Q Consensus       298 ~~~~--~~~~~~~---~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~  356 (361)
                      +.+.  ++-....   ...+.       ...+....+|+..+|..||.+|.|+.++++  .+.+...|.|.
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~--seyF~t~p~~~  410 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ--SEYFTTEPLPC  410 (560)
T ss_pred             hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--CcccccCCCCC
Confidence            2222  1110000   00111       123566889999999999999999999885  34444444443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.8e-49  Score=328.87  Aligned_cols=275  Identities=26%  Similarity=0.363  Sum_probs=221.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .+|...++||+|.||.||+|+.. +|+.||||+++.....   .....+||+.|+.++|+||+.++++|.+.....||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46888899999999999999965 9999999999765433   3578899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |++. +|...++...        -.++..++..++.++++||+|||++.   |+||||||.|+|++++|.+||+|||+++
T Consensus        82 fm~t-dLe~vIkd~~--------i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr  149 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN--------IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLAR  149 (318)
T ss_pred             eccc-cHHHHhcccc--------cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchh
Confidence            9966 9999998765        34899999999999999999999998   9999999999999999999999999999


Q ss_pred             CCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ........  .+..+-|.+|.|||++.|. .|+..+|+||.||++.||+.|.+-|.+..+-++...+--.......+.+.
T Consensus       150 ~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP  227 (318)
T KOG0659|consen  150 FFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP  227 (318)
T ss_pred             ccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence            87654333  2344779999999999875 79999999999999999999998888776655544333222222222111


Q ss_pred             hhc---c---------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCCC
Q 018071          302 QCV---D---------ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGE  358 (361)
Q Consensus       302 ~~~---~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~~  358 (361)
                      ++.   |         ... ...-+.++....+|+.+||..||.+|+|+.|.++  ...+.+.|.|...
T Consensus       228 ~~~~lpdY~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~~P~pt~~  293 (318)
T KOG0659|consen  228 EMTSLPDYVKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HPYFKSLPLPTPP  293 (318)
T ss_pred             cccccccHHHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhc--chhhhcCCCCCCh
Confidence            111   1         111 1122345667899999999999999999999985  4667767766653

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-49  Score=360.80  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=210.1

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----C--CChHHHHHHHHHHhcCC-CCCcceeeeEEEeCC
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----K--QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGT  135 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~--~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~  135 (361)
                      ...++|.+.+.||+|+||+|++|.+. ++..||+|++.+.    .  ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34579999999999999999999876 8999999977653    1  23456778999999998 999999999999999


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC-CceE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAK  214 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~-~~~k  214 (361)
                      ..++||||+.||+|.+++....         .+.+.++..++.|++.|++|||+.|   |+||||||+|||++.+ +++|
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g---------~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~K  161 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG---------RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLK  161 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC---------CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEE
Confidence            9999999999999999998843         3899999999999999999999998   9999999999999999 9999


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCC-CC-CccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LN-AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      |+|||++....  .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.......        
T Consensus       162 l~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l--------  231 (370)
T KOG0583|consen  162 LSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL--------  231 (370)
T ss_pred             EeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH--------
Confidence            99999998763  2223457889999999999999877 86 688999999999999999999975322111        


Q ss_pred             ccCCchhhhhhcccccCCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHH
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKA-VAKMAAVAALCVQYEADFRPNMSIVV  342 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPs~~evl  342 (361)
                             ...+....+  .+|... +.++..|+.+||..||.+|+|+.+|+
T Consensus       232 -------~~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  232 -------YRKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             -------HHHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                   111222222  334444 78899999999999999999999999

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-49  Score=379.15  Aligned_cols=271  Identities=28%  Similarity=0.478  Sum_probs=235.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      .+-...+.||+|.||+||+|+..      +...||||.++....  .+++|++|++++..|+|||||+++|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34455667999999999999843      456899999976543  3578999999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCC-C----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQ-P----GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~-~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      +|+|||..|||.+||..+....... .    .+.|+..+.+.|+.|||.|+.||-++.   +|||||...|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            9999999999999997765432222 1    345999999999999999999999997   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      ||+|||+++.....++......-.-+.+|||||.+..+.||+++||||+||+|||+++ |+.||.               
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~---------------  707 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY---------------  707 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc---------------
Confidence            9999999998876666655555556889999999999999999999999999999999 999985               


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCC
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPA  356 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~  356 (361)
                       .++++++.+.+..+..-.+|..++.++++|+..||+.+|.+||++.||-..|+...+..+...
T Consensus       708 -glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~  770 (774)
T KOG1026|consen  708 -GLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYS  770 (774)
T ss_pred             -ccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccc
Confidence             356677777777776688999999999999999999999999999999999999988776543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=346.98  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=206.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCcceeeeEEEeCC--eeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGT--SRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e  142 (361)
                      .+|...+.||+|+||.||++... +|...|||.+...... .+.+.+|+.+|++++|||||++++......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            46788889999999999999976 6999999998764222 456889999999999999999999744443  6889999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-CCceEEeccccC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLS  221 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~Dfg~a  221 (361)
                      |+.+|+|.+++....+ +       +++..++.+..||++||+|||++|   ||||||||+|||++. ++.+||+|||++
T Consensus        97 y~~~GsL~~~~~~~g~-~-------l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a  165 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG-K-------LPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLA  165 (313)
T ss_pred             ccCCCcHHHHHHHcCC-C-------CCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccc
Confidence            9999999999988764 2       999999999999999999999998   999999999999999 799999999999


Q ss_pred             CCCcc-ccccccccccccCCCCCCchhhccCC-CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          222 NQAPD-MAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       222 ~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +.... ...........||+.|||||++..+. ...++|||||||++.||+||..||.....              ....
T Consensus       166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~--------------~~~~  231 (313)
T KOG0198|consen  166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE--------------EAEA  231 (313)
T ss_pred             cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc--------------hHHH
Confidence            87653 11122234678999999999999633 33599999999999999999999964200              0111


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      +..+........+|...+....+++.+|++.+|+.|||++++++..
T Consensus       232 ~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  232 LLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             HHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            1112211222356667788899999999999999999999999743

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-48  Score=353.91  Aligned_cols=250  Identities=23%  Similarity=0.294  Sum_probs=206.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|+++++||+|+||.||+|+.+ ||..+|+|+++++.    .....++.|-.+|....+|+||+++-.|.+...+|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            368999999999999999999977 89999999998754    3345678899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||++||++..+|....         .|++..++.++.+++.|++.||+.|   +|||||||+|+|||..|++||+|||+
T Consensus       220 MEylPGGD~mTLL~~~~---------~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGL  287 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKD---------TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGL  287 (550)
T ss_pred             EEecCCccHHHHHHhcC---------cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccc
Confidence            99999999999997765         4999999999999999999999999   99999999999999999999999999


Q ss_pred             CCCCccc----------------------ccc------c-----------------cccccccCCCCCCchhhccCCCCC
Q 018071          221 SNQAPDM----------------------AAR------L-----------------HSTRVLGTFGYHAPEYAMTGQLNA  255 (361)
Q Consensus       221 a~~~~~~----------------------~~~------~-----------------~~~~~~gt~~y~aPE~~~~~~~~~  255 (361)
                      +..+...                      ...      .                 .....+|||.|||||++.+.+|+.
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~  367 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK  367 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence            8532110                      000      0                 011256999999999999999999


Q ss_pred             ccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccc--cCCCCCHHHHHHHHHHHHHccccCCC
Q 018071          256 KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR--LGGDYPPKAVAKMAAVAALCVQYEAD  333 (361)
Q Consensus       256 ~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~  333 (361)
                      .+|+||||||+||||.|.+||....+...               .+.++.-+  +..+-....+.+..+||.+|+. ||+
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T---------------~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~  431 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQET---------------YRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPE  431 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHH
Confidence            99999999999999999999998776543               22222222  1112222345789999999999 999


Q ss_pred             CCCC---HHHHHH
Q 018071          334 FRPN---MSIVVK  343 (361)
Q Consensus       334 ~RPs---~~evl~  343 (361)
                      +|.-   ++||.+
T Consensus       432 ~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  432 NRLGSKGAEEIKK  444 (550)
T ss_pred             HhcCcccHHHHhc
Confidence            9965   666655

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.4e-48  Score=355.50  Aligned_cols=268  Identities=24%  Similarity=0.402  Sum_probs=209.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEE------CCCCEEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCcceeeeEEEeC-C
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDG-T  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~-~  135 (361)
                      .++|++.++||+|+||.||+|.+      .+++.||+|++.....  ....+.+|+.+++.+ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46899999999999999999974      2457899999875332  235688999999999 899999999988754 4


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCC-----------------------------------------------------C
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKG-----------------------------------------------------A  162 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~-----------------------------------------------------~  162 (361)
                      ..+++|||+++|+|.+++........                                                     .
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999999875421100                                                     0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCC
Q 018071          163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY  242 (361)
Q Consensus       163 ~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  242 (361)
                      .....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence            01134888999999999999999999998   999999999999999999999999999865332222222344567889


Q ss_pred             CCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHH
Q 018071          243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMA  321 (361)
Q Consensus       243 ~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  321 (361)
                      +|||++.+..++.++|||||||++|||++ |..||.......               .+...+........+...+..+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---------------EFCQRLKDGTRMRAPENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---------------HHHHHHhcCCCCCCCCCCCHHHH
Confidence            99999999999999999999999999997 999997532211               01111111111122334566799


Q ss_pred             HHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          322 AVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       322 ~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      +|+.+||+.||.+|||+.+|++.|+.++..
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-48  Score=361.04  Aligned_cols=243  Identities=24%  Similarity=0.338  Sum_probs=210.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +-|++++.||.|+-|.|-+|++. ||+.+|||++.+.    ......+.+||-+|+.+.||||++++++|++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            56899999999999999999976 9999999999764    223457889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||++||.|.+++...+.         +++.++..+++||+.|+.|+|..+   |+|||+||+|+||+..+++||+|||+|
T Consensus        92 Eyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMA  159 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMA  159 (786)
T ss_pred             EecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeecccee
Confidence            99999999999977653         999999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCC-CccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN-AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ..-.   ....-.+.||.+.|.|||++.|.+|+ .++||||+|||||.||+|+.||+.++                   +
T Consensus       160 sLe~---~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------------------i  217 (786)
T KOG0588|consen  160 SLEV---PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------------------I  217 (786)
T ss_pred             eccc---CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------------------H
Confidence            7532   22334678999999999999999985 68999999999999999999997432                   2


Q ss_pred             hhhcccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.++.....+  +.|...+.+.++|+.+||..||++|.|++||++
T Consensus       218 r~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  218 RVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             HHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            2222222222  345677888999999999999999999999997

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-48  Score=361.29  Aligned_cols=241  Identities=24%  Similarity=0.352  Sum_probs=207.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|.++++||+|+||+|+++..+ +++.+|||++++..    .+.+..+.|.+++...+ ||.+++++..|....++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            478999999999999999999988 89999999998854    34466778888887774 9999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+.||++..+++...          +++..++.++..|+.||.|||++|   |||||||.+|||+|.+|++||+|||
T Consensus       447 vmey~~Ggdm~~~~~~~~----------F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIHTDV----------FSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             EEEecCCCcEEEEEeccc----------ccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccc
Confidence            999999999666655443          999999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +++.....  .....++||||.|||||++.+..|+..+|+|||||+||||+.|..||.+++..               +-
T Consensus       514 lcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------e~  576 (694)
T KOG0694|consen  514 LCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------EV  576 (694)
T ss_pred             cccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HH
Confidence            99875432  23468899999999999999999999999999999999999999999755432               11


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM  338 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  338 (361)
                      ...++...  ..+|...+.+..+++.++|..+|++|..+
T Consensus       577 FdsI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  577 FDSIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            22222221  24677788899999999999999999866

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-48  Score=354.36  Aligned_cols=248  Identities=26%  Similarity=0.439  Sum_probs=214.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChH-HHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDE-EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      ..|.....||+|..|.||.|... ++..||||++.......+ -+++|+.+|+..+|+|||.+++.|...+.+|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            46778889999999999999965 899999999988766654 4689999999999999999999988889999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      +||+|.+.+....          +++.++..|+.+++.||+|||.+|   |+|||||.+|||++.+|.+||+|||++.++
T Consensus       353 ~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi  419 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI  419 (550)
T ss_pred             CCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence            9999999998765          999999999999999999999999   999999999999999999999999999887


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .....  ...+.+||+.|||||++....|+.++||||||++++||+-|.+||-...+-....++              ..
T Consensus       420 ~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI--------------a~  483 (550)
T KOG0578|consen  420 SEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------AT  483 (550)
T ss_pred             ccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH--------------hh
Confidence            54332  356788999999999999999999999999999999999999999654332111111              11


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.......+...+..+++++.+||+.|+++|+|+.|+|+
T Consensus       484 ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  484 NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            222223455677889999999999999999999999997

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=340.15  Aligned_cols=261  Identities=28%  Similarity=0.368  Sum_probs=211.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|++..+||.|..++||+|++. +++.||||++...+  .....+++|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            368999999999999999999976 88999999996533  334789999999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      ||.+|++.+++.......       +.+..+..|++++++||.|||++|   -||||||+.||||+++|.|||+|||.+.
T Consensus       105 fMa~GS~ldIik~~~~~G-------l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG-------LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             hhcCCcHHHHHHHHcccc-------ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence            999999999998765322       999999999999999999999999   9999999999999999999999999876


Q ss_pred             CCcccccc-ccc-cccccCCCCCCchhhc--cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          223 QAPDMAAR-LHS-TRVLGTFGYHAPEYAM--TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       223 ~~~~~~~~-~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .+-....+ ... ..+.||++|||||++.  ..+|+.|+||||||++..||.+|..||....|..-. +.....+.....
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-l~tLqn~pp~~~  253 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-LLTLQNDPPTLL  253 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-HHHhcCCCCCcc
Confidence            55333221 112 6678999999999965  348999999999999999999999999866543211 111111110000


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                            -..+..+.....+..+++++..||+.||.+|||++++++
T Consensus       254 ------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 ------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                  111112223345668999999999999999999999987

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-48  Score=341.09  Aligned_cols=248  Identities=24%  Similarity=0.372  Sum_probs=211.6

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEE-CCCCEEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      .+..+|++.+.||+|+||.|-+|.. +.|+.||||.++++...    .-.+++||+||..|+||||++++++|++.+...
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            4556899999999999999999996 59999999999875543    336789999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      |||||..+|.|++|+..++.         |++.+++.+++||..|+.|+|.++   ++|||||.+|||+|.++++||+||
T Consensus       130 ivMEYaS~GeLYDYiSer~~---------LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADF  197 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGS---------LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADF  197 (668)
T ss_pred             EEEEecCCccHHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeecc
Confidence            99999999999999988763         999999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |++.....   .....++||++-|.+||++.|.+| .+.+|-|||||+||.|+.|..||++.+.               .
T Consensus       198 GLSNly~~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---------------k  259 (668)
T KOG0611|consen  198 GLSNLYAD---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---------------K  259 (668)
T ss_pred             chhhhhcc---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---------------H
Confidence            99876532   223468999999999999999988 5789999999999999999999975432               1


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      .-++++-...++.+   ..+....-||.+||..||++|.|+++|...
T Consensus       260 ~lvrQIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  260 RLVRQISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HHHHHhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            12233333333222   233457789999999999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-48  Score=318.55  Aligned_cols=248  Identities=27%  Similarity=0.384  Sum_probs=215.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|++++.||+|-||.||+|+.+ ++..||+|++.++.    ....++.+|+++-..|+||||++++++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            478999999999999999999976 88999999997644    3346789999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      +||..+|.|...|...+..       .+++.....++.|++.||.|+|..+   |+||||||+|+|++..+.+||+|||.
T Consensus       101 lEya~~gel~k~L~~~~~~-------~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGw  170 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMK-------RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGW  170 (281)
T ss_pred             EEecCCchHHHHHHhcccc-------cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCc
Confidence            9999999999999855433       3899999999999999999999997   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +...+.    ....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||....               ..+..
T Consensus       171 sV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---------------~~etY  231 (281)
T KOG0580|consen  171 SVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---------------HSETY  231 (281)
T ss_pred             eeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---------------hHHHH
Confidence            876532    23467899999999999999999999999999999999999999997432               22333


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      .++....+  .+|...+....++|.+|+..+|.+|.+..++++.
T Consensus       232 krI~k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  232 KRIRKVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHHHccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            44433333  3456778889999999999999999999998863

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6e-48  Score=351.51  Aligned_cols=243  Identities=29%  Similarity=0.398  Sum_probs=211.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|.+...||+|+||.||+|+.+ +.+.||+|.+.+..+..   ..+.+|++++++++||||+.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999977 89999999998766554   457889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+.| +|..++.....         +++..+..++.+++.||.|||+.+   |+|||+||.|||++.+|.+|+||||+|+
T Consensus        82 ~a~g-~L~~il~~d~~---------lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar  148 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK---------LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLAR  148 (808)
T ss_pred             hhhh-hHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhh
Confidence            9977 99999987652         999999999999999999999998   9999999999999999999999999999


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ....  .....+...|||.|||||++.++.|+..+|+|||||++||+++|++||-..                   .+.+
T Consensus       149 ~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------------------si~~  207 (808)
T KOG0597|consen  149 AMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------------------SITQ  207 (808)
T ss_pred             hccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------------------HHHH
Confidence            8754  233356778999999999999999999999999999999999999999522                   1122


Q ss_pred             hcccccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ++.....  ...|...+..+.+++...|.+||..|.|..+++.
T Consensus       208 Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  208 LVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            2221111  1345577888999999999999999999999886

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.1e-47  Score=327.35  Aligned_cols=263  Identities=23%  Similarity=0.295  Sum_probs=210.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCcceeeeEEE--eCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCV--DGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv  140 (361)
                      ++|+.+..|++|+||.||+|+.+ +++.||+|+++..+...   -.-++||.+|.+++|||||.+..+..  +-+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45667778999999999999977 89999999998755322   24689999999999999999999876  34678999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      ||||+. +|..++...+        ..+...++..++.|++.||+|||...   |+|||||++|+|+++.|.+||+|||+
T Consensus       156 Me~~Eh-DLksl~d~m~--------q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGL  223 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK--------QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGL  223 (419)
T ss_pred             HHHHHh-hHHHHHHhcc--------CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccch
Confidence            999987 9999998765        24999999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      |+..+..  ....+..+-|.+|.|||++.+. .|++..|+||+|||+.||+++++.|.+....++...+.......++..
T Consensus       224 AR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i  301 (419)
T KOG0663|consen  224 AREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI  301 (419)
T ss_pred             hhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence            9987654  3335677889999999999976 799999999999999999999999987766554433332222222211


Q ss_pred             hhhhcc--------------cccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVD--------------ARLGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~--------------~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +..+.+              ..++..+... .+..-.+|+..+|..||.+|.|+++.++
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            111111              1111122222 4567889999999999999999999886

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-48  Score=343.62  Aligned_cols=246  Identities=27%  Similarity=0.443  Sum_probs=210.4

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      .|....+||+|.||.||+|... +++.||+|++....  ...+++.+|+.++..++++||.++|+.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            4666678999999999999966 99999999997643  34468899999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      .||++.+.+....         .+.+..+..++++++.||.|||.++   .+|||||+.|||+..+|.+||+|||++.++
T Consensus        94 ~gGsv~~lL~~~~---------~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN---------ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQL  161 (467)
T ss_pred             cCcchhhhhccCC---------CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeee
Confidence            9999999997654         2588888899999999999999998   999999999999999999999999999887


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......  ..+++||+.|||||++....|+.++||||||++.+||++|.+|+....|.-                +.-++
T Consensus       162 ~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflI  223 (467)
T KOG0201|consen  162 TNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLI  223 (467)
T ss_pred             echhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEec
Confidence            654433  378999999999999998899999999999999999999999997665521                11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      -......+...++..+.+++..||+.||+.||++.++++
T Consensus       224 pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  224 PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            111112223356777999999999999999999999987

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-47  Score=331.89  Aligned_cols=280  Identities=25%  Similarity=0.326  Sum_probs=225.3

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC---CCCChHHHHHHHHHHhcCCCCCcceeeeEEEe-----
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD-----  133 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----  133 (361)
                      ..+...|...+.||+|+||.|+.+..+ +|+.||||++..   .....++..+|+++++.++|+||+.+.+++..     
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            344567777889999999999999977 899999999973   34456788999999999999999999998764     


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      -...|+|+|+| +.+|.+.++.+.         .|+...+..++.|++.||.|+|+.+   |+||||||.|+|++.+..+
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~---------~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~l  164 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQ---------DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDL  164 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCc---------cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCE
Confidence            46789999999 559999998764         3999999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhc-cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      ||+|||+|+...........+..+.|.+|.|||++. ...|+...||||+|||+.||++|+.-|.+...-.+..++....
T Consensus       165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence            999999999875432233347788899999999886 5589999999999999999999999998887766666666555


Q ss_pred             ccCCchhhhhhcccc--------cC-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHhcCCCC
Q 018071          293 PKLSEDKVRQCVDAR--------LG-GDY-----PPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLNARPGP  355 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~--------~~-~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~~~~~~  355 (361)
                      +..+.+.+..+-...        .. ...     -+.......+|+.+||..||.+|+|++|.++  .|..+-.-.-.|
T Consensus       245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            555544444333111        10 111     1245677899999999999999999999997  455554433333

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-46  Score=349.36  Aligned_cols=265  Identities=23%  Similarity=0.378  Sum_probs=208.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEE------CCCCEEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  136 (361)
                      .++|++.+.||+|+||.||+|.+      .++..||+|++.....  ..+.+.+|+.+++.+ +||||+++++++.+...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45789999999999999999973      2466899999865332  335688999999999 89999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCC-------------------------------------------------------
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKG-------------------------------------------------------  161 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------------  161 (361)
                      .++||||+++|+|.+++........                                                       
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999875431100                                                       


Q ss_pred             -----------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcccccc
Q 018071          162 -----------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR  230 (361)
Q Consensus       162 -----------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  230 (361)
                                 ......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                       001124789999999999999999999998   999999999999999999999999998765432222


Q ss_pred             ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC
Q 018071          231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG  309 (361)
Q Consensus       231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (361)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |..||......               ....+.+.....
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---------------~~~~~~~~~~~~  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---------------SKFYKMIKEGYR  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---------------HHHHHHHHhCcc
Confidence            22223345678999999999999999999999999999998 88998643211               111122222222


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          310 GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       310 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ...+...+.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            222333456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.9e-46  Score=349.28  Aligned_cols=266  Identities=26%  Similarity=0.437  Sum_probs=209.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  136 (361)
                      .++|++.+.||+|+||.||+|.+.      ++..||+|.+......  ...+.+|+.+++.+ +|+||+++++++.+...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            458999999999999999998843      3457999999754332  34678999999999 89999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCC---------------------------------------------------------
Q 018071          137 RVLAYEFASNGSLHDILHGRKGV---------------------------------------------------------  159 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------------  159 (361)
                      .++||||+.+|+|.+++......                                                         
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            99999999999999998643210                                                         


Q ss_pred             ----CCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccccccccc
Q 018071          160 ----KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR  235 (361)
Q Consensus       160 ----~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  235 (361)
                          ........+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                00011234888999999999999999999998   99999999999999999999999999876543222112223


Q ss_pred             cccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCH
Q 018071          236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP  314 (361)
Q Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (361)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |+.||......               ..+...+........+.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---------------~~~~~~~~~~~~~~~~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---------------SKFYKMVKRGYQMSRPD  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc---------------HHHHHHHHcccCccCCC
Confidence            345678999999998899999999999999999997 99999643221               11112222222222333


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          315 KAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       315 ~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      ..+..+.+++.+||+.||.+|||+.+|++.|++++
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            34577999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.6e-46  Score=333.56  Aligned_cols=245  Identities=20%  Similarity=0.332  Sum_probs=201.9

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCcceeeeEEEe----CCeeEEEEEeC
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLAYEFA  144 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~~  144 (361)
                      ..||+|++|.||+|... |+.||||++.......    +.+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            57999999999999985 8999999997654433    566799999999999999999999876    45678999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      ++|+|.+++....         .+++...+.++.|++.||.|||+. +   ++||||||+|||+++++.+||+|||+++.
T Consensus       105 ~~g~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~  172 (283)
T PHA02988        105 TRGYLREVLDKEK---------DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKI  172 (283)
T ss_pred             CCCcHHHHHhhCC---------CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhh
Confidence            9999999997643         388999999999999999999985 5   88999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhcc--CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ....     .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.......               ...
T Consensus       173 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---------------~~~  232 (283)
T PHA02988        173 LSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---------------IYD  232 (283)
T ss_pred             hccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---------------HHH
Confidence            4321     123567899999999976  689999999999999999999999997543211               111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      .++........+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       233 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            1111222223344567789999999999999999999999999988753

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=336.80  Aligned_cols=256  Identities=28%  Similarity=0.376  Sum_probs=209.0

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---------------hHHHHHHHHHHhcCCCCCcce
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---------------DEEFLAQVSMVSRLKHENFVQ  126 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------~~~~~~e~~~l~~l~hpniv~  126 (361)
                      ....++|++.+.||+|.||.|-+|+.. +++.||||++.+....               .+...+||.+|+++.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            345689999999999999999999976 8999999999654321               247889999999999999999


Q ss_pred             eeeEEEe--CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCc
Q 018071          127 LLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN  204 (361)
Q Consensus       127 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~N  204 (361)
                      ++++..+  ...+|||+|||..|.+...=..         .+.+++.++++++..++.||+|||.+|   ||||||||+|
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d---------~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsN  240 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD---------KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSN  240 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCC---------cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhh
Confidence            9999864  5788999999998876543211         123899999999999999999999999   9999999999


Q ss_pred             eEeccCCceEEeccccCCCCccc---cccccccccccCCCCCCchhhccCC---C-CCccceecHHHHHHHHHhCCCCCC
Q 018071          205 VLIFDDDVAKIADFDLSNQAPDM---AARLHSTRVLGTFGYHAPEYAMTGQ---L-NAKSDVYSFGVVLLELLTGRKPVD  277 (361)
Q Consensus       205 ill~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~DvwslG~~l~ell~g~~pf~  277 (361)
                      +||+++|++||+|||.+......   .........+|||.|+|||...++.   + +.+.||||+||+||.|+.|+.||.
T Consensus       241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            99999999999999998765221   1111123467999999999988743   3 457799999999999999999996


Q ss_pred             CCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          278 HTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      ....               .+-..++++..+..+-.++....+.+||+++|.+||+.|.+..+|....
T Consensus       321 ~~~~---------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  321 DDFE---------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             cchH---------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            4322               2345566666666666667788899999999999999999999988644

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=344.94  Aligned_cols=270  Identities=27%  Similarity=0.424  Sum_probs=216.9

Q ss_pred             cCHHHHHHHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 018071           57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD  133 (361)
Q Consensus        57 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~  133 (361)
                      .+.++++...++..+...||+|.||+||+|.|.  ..||||++......   .+.|++|+.++++-+|.||+-+.|+|..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            344666666677888899999999999999997  46999999775443   4679999999999999999999999988


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      ... .||..+|+|-+|+.+++..+.        .|.....+.|+.||++|+.|||.++   |||||||..||++.+++.|
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~et--------kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQET--------KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhh--------hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcE
Confidence            776 999999999999999987652        3888999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccC---CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~  290 (361)
                      ||+|||++................|...|||||+++.+   +|+..+||||||+++|||++|..||...........+. 
T Consensus       528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG-  606 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG-  606 (678)
T ss_pred             EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec-
Confidence            99999998754333222333455678899999999743   79999999999999999999999997332211111000 


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                        +.....++.         .....++.++.+|+..||..++++||.+.+|+..|..++...
T Consensus       607 --rG~l~pd~s---------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  607 --RGYLMPDLS---------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             --ccccCccch---------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence              000000000         122356778999999999999999999999999998888754

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-46  Score=330.19  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=212.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.|++++.||.|.-|+||++..+ ++..+|+|++.+..    ....+...|-+||+.++||.++.+|..|+.+...+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            46677788999999999999988 67999999997743    22346677899999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |||.||+|+.+++.+.+.       .+++..++.++.+++.||+|||..|   ||+||||||||||.++|++-|+||.++
T Consensus       157 eyCpGGdL~~LrqkQp~~-------~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS  226 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGK-------RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLS  226 (459)
T ss_pred             ecCCCccHHHHHhhCCCC-------ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccc
Confidence            999999999999876543       4999999999999999999999999   999999999999999999999999987


Q ss_pred             CCCcc---------------------------------ccc---------------------cccccccccCCCCCCchh
Q 018071          222 NQAPD---------------------------------MAA---------------------RLHSTRVLGTFGYHAPEY  247 (361)
Q Consensus       222 ~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~  247 (361)
                      .....                                 ...                     ......++||-.|+|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            43210                                 000                     011234679999999999


Q ss_pred             hccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHc
Q 018071          248 AMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALC  327 (361)
Q Consensus       248 ~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  327 (361)
                      +.|.+.+.++|+|+|||++|||+.|..||.+....               ..+..++...+..+-.+..+..+++||++.
T Consensus       307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~L  371 (459)
T KOG0610|consen  307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKL  371 (459)
T ss_pred             eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence            99999999999999999999999999999866432               334455554444444446778899999999


Q ss_pred             cccCCCCCCC----HHHHHH
Q 018071          328 VQYEADFRPN----MSIVVK  343 (361)
Q Consensus       328 l~~~p~~RPs----~~evl~  343 (361)
                      |.+||.+|..    +.||.+
T Consensus       372 LvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  372 LVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             hccChhhhhccccchHHhhc
Confidence            9999999998    888776

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.6e-46  Score=338.86  Aligned_cols=269  Identities=26%  Similarity=0.378  Sum_probs=205.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-----------------CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcce
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-----------------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQ  126 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~  126 (361)
                      .++|.+.+.||+|+||.||+|.++                 ++..||+|.+.....  ...++.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            368999999999999999999853                 234699999875432  2357889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 018071          127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG----------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII  196 (361)
Q Consensus       127 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iv  196 (361)
                      +++++.+....+++|||+.+++|.+++........          ......+++..++.++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            99999999999999999999999999865432111          111235788999999999999999999998   99


Q ss_pred             eccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh--CCC
Q 018071          197 HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRK  274 (361)
Q Consensus       197 HrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~  274 (361)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999876533222222334456789999999998899999999999999999987  566


Q ss_pred             CCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          275 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       275 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      ||.......   .........     .. .........++.++..+.+++.+||+.+|++|||+.+|.+.|+
T Consensus       241 p~~~~~~~~---~~~~~~~~~-----~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQ---VIENAGEFF-----RD-QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHH---HHHHHHHHh-----hh-ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            776432211   111000000     00 0000011122345677999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-47  Score=343.83  Aligned_cols=250  Identities=22%  Similarity=0.365  Sum_probs=216.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe-eEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS-RVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-~~lv~  141 (361)
                      ++|..++++|+|+||.+++++++ +++.+++|++....   ..++...+|+.++++++|||||.+.+.|++++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57899999999999999999987 78899999997543   334467899999999999999999999998877 99999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      +||+||+|.+.+...++.       .++++.++.|+.|++.|+.|||++.   |+|||||+.|||++.++.|||+|||+|
T Consensus        84 ~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGla  153 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLA  153 (426)
T ss_pred             eecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhh
Confidence            999999999999877643       3999999999999999999999887   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.+....  ....+..||+.|++||++.+.+|..++|||||||++|||++-+++|...+-..               -+.
T Consensus       154 K~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---------------Li~  216 (426)
T KOG0589|consen  154 KILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---------------LIL  216 (426)
T ss_pred             hhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---------------HHH
Confidence            9876543  23467899999999999999999999999999999999999999997543211               111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ++ ......+.+..++.+++.++..||+.+|+.||++.+++..
T Consensus       217 ki-~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  217 KI-NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HH-hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            11 2222456788899999999999999999999999999985

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8e-47  Score=344.24  Aligned_cols=238  Identities=31%  Similarity=0.499  Sum_probs=204.9

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHHHh
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI  152 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~  152 (361)
                      +-||.|+.|.||+|+.+ ++.||||+++.-+      ..+|+.|++|+||||+.+.++|.....++||||||..|.|...
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            45999999999999998 8999999875322      2468999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcccccccc
Q 018071          153 LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH  232 (361)
Q Consensus       153 l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  232 (361)
                      |+...         .+.......|..+||.|+.|||.+.   |||||||.-||||..+..|||+|||-++...+.   ..
T Consensus       203 Lka~~---------~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---ST  267 (904)
T KOG4721|consen  203 LKAGR---------PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---ST  267 (904)
T ss_pred             HhccC---------ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hh
Confidence            98765         3888889999999999999999997   999999999999999999999999999876543   23


Q ss_pred             ccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCC
Q 018071          233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY  312 (361)
Q Consensus       233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (361)
                      ...++||..|||||++...+.+.|+|||||||+|||||||..||..-..    ..+-|           .+-...+..+.
T Consensus       268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIw-----------GVGsNsL~Lpv  332 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIW-----------GVGSNSLHLPV  332 (904)
T ss_pred             hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEE-----------eccCCcccccC
Confidence            4678999999999999999999999999999999999999999963221    11111           11123344567


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          313 PPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       313 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                      |..++..+.-|+++||+..|..||++++|+..|+-
T Consensus       333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            77888999999999999999999999999998853

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-45  Score=332.03  Aligned_cols=262  Identities=27%  Similarity=0.436  Sum_probs=211.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CC-----CEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SG-----HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      ++|++.+.||+|+||.||+|... .+     ..|++|.+.....  ...++.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            47888999999999999999865 22     5799999865432  2356889999999999999999999999988999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQ-------PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD  211 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~  211 (361)
                      ++|||+++++|.+++..........       ....+++..++.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            9999999999999997653221111       1135889999999999999999999998   99999999999999999


Q ss_pred             ceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 018071          212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~  290 (361)
                      .+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......        
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--------  233 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--------  233 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            999999999876533322223344567889999999998899999999999999999998 99999654321        


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                              .+...+........+..++..+.+|+.+||+.+|.+||++.+|++.|+.
T Consensus       234 --------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 --------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                    1222222222233455677889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-46  Score=339.43  Aligned_cols=244  Identities=21%  Similarity=0.307  Sum_probs=204.4

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999977 89999999986432    22356788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+.+++|.+++....         .+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~  148 (291)
T cd05612          81 EYVPGGELFSYLRNSG---------RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFA  148 (291)
T ss_pred             eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcc
Confidence            9999999999997653         2889999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....     ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......               ...
T Consensus       149 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---------------~~~  208 (291)
T cd05612         149 KKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---------------IYE  208 (291)
T ss_pred             hhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHH
Confidence            765321     234578999999999999899999999999999999999999996543211               111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVKA  344 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  344 (361)
                      .+....  ..++...+..+.+|+.+||+.||.+||+     ++++++.
T Consensus       209 ~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         209 KILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            111111  1233445677999999999999999995     8888864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-46  Score=343.37  Aligned_cols=243  Identities=25%  Similarity=0.343  Sum_probs=203.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....    ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57899999999999999999987 78999999986532    23456889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+.+++|.+++....         .+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        98 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~  165 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFA  165 (329)
T ss_pred             cCCCCChHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCc
Confidence            9999999999987653         2889999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....     .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+..               ...
T Consensus       166 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---------------~~~  225 (329)
T PTZ00263        166 KKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---------------IYE  225 (329)
T ss_pred             eEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---------------HHH
Confidence            765331     234679999999999999999999999999999999999999996432211               111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~  343 (361)
                      .+.....  .++...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       226 ~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        226 KILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1111111  223335567899999999999999997     677775

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=369.73  Aligned_cols=262  Identities=28%  Similarity=0.464  Sum_probs=221.9

Q ss_pred             cCCCCCccccCCceEEEEEEEC--CCC----EEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK--SGH----AAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      +-+....||+|.||.||.|...  .+.    .||||.+.+..  ....+|++|..+|+.++|||||+++|++.+....+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            3455678999999999999965  343    49999998753  345689999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ++|||+||+|..||+..+....  ....++..+.+.++.+||+|+.||++++   +|||||...|+||+....+||+|||
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~--~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPF--QPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccC--CCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999988753322  2456999999999999999999999997   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +|+.+.............-...|||||.+..+.++.++|||||||+|||++| |..||...                .+.
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~----------------~n~  911 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR----------------SNF  911 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc----------------chH
Confidence            9996655444444333344679999999999999999999999999999999 99999532                233


Q ss_pred             hhhh-hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          299 KVRQ-CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       299 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      ++.. ++..+ +.+.|..++..+++||..||+.+|++||++..|++.+..+++.
T Consensus       912 ~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  912 EVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             HHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            3333 33444 6788889999999999999999999999999999999888864

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.5e-45  Score=328.02  Aligned_cols=256  Identities=24%  Similarity=0.415  Sum_probs=210.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|++.+.||+|+||.||+|...++..||+|.+.......+.+.+|+.+++.++|+||+++++.+.+....+++|||+.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            36789999999999999999998888899999987665566789999999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....       ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        85 ~~~L~~~l~~~~~-------~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          85 KGSLLDFLKSDEG-------GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             CCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecC
Confidence            9999999875432       23888999999999999999999998   9999999999999999999999999997654


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......                ....+
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----------------~~~~~  217 (261)
T cd05072         155 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD----------------VMSAL  217 (261)
T ss_pred             CCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH----------------HHHHH
Confidence            32211 1223345678999999998899999999999999999998 999996432211                11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ......+.....+..+.+++.+||+.+|++|||++++++.|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11111122233556799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-45  Score=333.32  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=202.7

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .|++.+.||+|+||.||++... +++.||+|.+.+..    .....+.+|+.+++.++|+||+++++++.+....++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677889999999999999975 89999999986532    222457789999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++|+|.+++.....       ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.
T Consensus        81 ~~~~g~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~  150 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-------PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAV  150 (285)
T ss_pred             ecCCCcHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence            9999999888764321       13899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||.........            ..+..
T Consensus       151 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~------------~~~~~  215 (285)
T cd05631         151 QIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR------------EEVDR  215 (285)
T ss_pred             EcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH------------HHHHH
Confidence            643211   123457899999999999999999999999999999999999999754332110            00111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~  343 (361)
                      .+ ......++...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       216 ~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         216 RV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             Hh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            01 00112334456678999999999999999997     788887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.7e-46  Score=340.18  Aligned_cols=240  Identities=22%  Similarity=0.290  Sum_probs=198.7

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      ++||+|+||.||++..+ +|+.||+|++.+..    .....+.+|+.++++++||||+++++++......++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999976 89999999987532    22346778999999999999999999999999999999999999


Q ss_pred             cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccc
Q 018071          148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM  227 (361)
Q Consensus       148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~  227 (361)
                      +|.+++....         .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  148 (323)
T cd05571          81 ELFFHLSRER---------VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence            9999987643         3899999999999999999999998   999999999999999999999999998753221


Q ss_pred             cccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccc
Q 018071          228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR  307 (361)
Q Consensus       228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (361)
                        .......+||+.|+|||++.+..++.++|||||||++|||++|..||.......   +            ...+....
T Consensus       149 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~------------~~~~~~~~  211 (323)
T cd05571         149 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L------------FELILMEE  211 (323)
T ss_pred             --CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---H------------HHHHHcCC
Confidence              112345679999999999999999999999999999999999999996432111   0            01111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          308 LGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       308 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                        ..++...+..+.+++.+||+.||++||     ++.++++
T Consensus       212 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence              123445667899999999999999999     7998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-45  Score=333.30  Aligned_cols=264  Identities=22%  Similarity=0.270  Sum_probs=203.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....   ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47899999999999999999987 78999999986542   234567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |++++.+..+.....         .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~  148 (287)
T cd07848          81 YVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR  148 (287)
T ss_pred             cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence            999877665543221         3899999999999999999999998   9999999999999999999999999998


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ...... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+...........+..
T Consensus       149 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07848         149 NLSEGS-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL  227 (287)
T ss_pred             cccccc-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence            754322 1122345789999999999998999999999999999999999999976433221111111101111111000


Q ss_pred             h---------cccccC------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 C---------VDARLG------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~---------~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .         ..+...      ..+....+..+.+|+.+||+.||++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0         000000      0111234667999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.4e-45  Score=327.78  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=206.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.+.....  ....+.+|+.+++.++||||+++++++..+...++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            57889999999999999999854    466899999876432  234688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++|+|.+++....        ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.++++|||.
T Consensus        85 ~e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~  153 (266)
T cd05064          85 TEYMSNGALDSFLRKHE--------GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRR  153 (266)
T ss_pred             EEeCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcc
Confidence            99999999999987543        13899999999999999999999998   99999999999999999999999998


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +....... ........++..|+|||.+.+..++.++|||||||++||+++ |..||......                .
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----------------~  216 (266)
T cd05064         154 LQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----------------D  216 (266)
T ss_pred             cccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----------------H
Confidence            76532211 111122345678999999999999999999999999999775 99999644321                1


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      +.+.+......+.+..++..+.+++.+||+.+|.+||++++|++.|..+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         217 VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            1111222222234455677899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-45  Score=339.83  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=205.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999987 78999999986532    23356788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        81 e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a  148 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLS  148 (333)
T ss_pred             eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCC
Confidence            9999999999997543         3889999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch-hhhhhcccCCchhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVTWATPKLSEDKV  300 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~  300 (361)
                      .....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... +..+.         
T Consensus       149 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------  214 (333)
T cd05600         149 KGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK---------  214 (333)
T ss_pred             ccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc---------
Confidence            76533     2345679999999999999999999999999999999999999997544322111 00000         


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                       ..+............+..+.+++.+||..+|.+||+++++++.
T Consensus       215 -~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         215 -ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence             0000000000012346779999999999999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.6e-45  Score=336.89  Aligned_cols=264  Identities=22%  Similarity=0.334  Sum_probs=206.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|++.+.||+|+||.||++..+ ++..+|+|.+.....  ..+.+.+|+++++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368999999999999999999987 789999999875432  23578899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++++|.+++....         .+++..+..++.|++.||.|||+.+  +|+||||||+|||+++++.+||+|||++.
T Consensus        84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  152 (331)
T cd06649          84 HMDGGSLDQVLKEAK---------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (331)
T ss_pred             cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence            999999999997643         2889999999999999999999863  39999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc----------
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT----------  292 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~----------  292 (361)
                      .....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................          
T Consensus       153 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (331)
T cd06649         153 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS  228 (331)
T ss_pred             ccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence            65322    1234578999999999999999999999999999999999999996433211100000000          


Q ss_pred             --cc------------------CCchhhhh-hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          293 --PK------------------LSEDKVRQ-CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       293 --~~------------------~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                        +.                  ........ ++............+..+.+|+.+||+.||++|||++++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence              00                  00000000 001000001112356779999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-45  Score=326.25  Aligned_cols=256  Identities=27%  Similarity=0.461  Sum_probs=211.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|.+.+.||+|++|.||+|..++++.||+|.+.......+++.+|+.++++++||||+++++++......+++|||+.
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            46789999999999999999998878899999998766666789999999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....       ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        85 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          85 YGSLLEYLQGGAG-------RALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             CCcHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            9999999976432       23899999999999999999999998   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..... .......+..|+|||.+.+..++.++||||||+++|+|++ |+.||......                .+...+
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~~~~~  217 (261)
T cd05068         155 EDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----------------EVLQQV  217 (261)
T ss_pred             CCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----------------HHHHHH
Confidence            22111 1111223457999999998899999999999999999999 99999643221                111111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ........+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         218 DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            22222233445567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.7e-45  Score=325.96  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=211.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .+|.+.+.||+|+||.||+|..+ +++.||+|.+........++.+|+++++.++||||+++++++......+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            46888889999999999999976 78999999988766556788999999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....       ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        86 ~~~L~~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          86 YGNLLDYLRECNR-------QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             CCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            9999999875432       23899999999999999999999998   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....                .....+
T Consensus       156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----------------~~~~~~  218 (263)
T cd05052         156 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYELL  218 (263)
T ss_pred             cceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHHH
Confidence            32211 1112234568999999998999999999999999999998 99998643221                111112


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      ........+...+..+.+++.+||+.+|++|||+.++++.|+.++
T Consensus       219 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            222223344456678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=310.95  Aligned_cols=265  Identities=24%  Similarity=0.361  Sum_probs=214.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEE-CCCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeC-----CeeE
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TSRV  138 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~  138 (361)
                      .++|.+.+.||+|||+-||+++. .+++.||+|++.... ...+..++|++..++++|||+++++++...+     ...|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            46899999999999999999994 489999999997655 5567889999999999999999999876543     3489


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      |++.|...|+|.+.+...+..     ...+++.+++.|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.||
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~k-----g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIK-----GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             EEeehhccccHHHHHHHHhhc-----CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence            999999999999999876532     235999999999999999999999985 46999999999999999999999999


Q ss_pred             ccCCCCcccccccc-------ccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhh
Q 018071          219 DLSNQAPDMAARLH-------STRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       219 g~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~  288 (361)
                      |.++...-......       ......|..|.|||.+.   +...+.++|||||||+||+|+.|..||+....++..-..
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            99887542211111       12344689999999886   446789999999999999999999999865443322111


Q ss_pred             hhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          289 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      .             +....+..+-...++..+.+++++||+.||.+||++.+++..+++++
T Consensus       254 A-------------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  254 A-------------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             e-------------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            1             11222222223337888999999999999999999999999999886

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.6e-45  Score=324.01  Aligned_cols=251  Identities=26%  Similarity=0.431  Sum_probs=205.8

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++|++.+.||+|+||.||++.++++..+|+|.+.........+.+|+.++++++||||+++++++.+....+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            46888899999999999999988888999999876666667899999999999999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|.+++.....        .+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          84 GCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            999999875431        2889999999999999999999998   99999999999999999999999999876532


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||........               +..+..
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---------------~~~i~~  216 (256)
T cd05114         153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---------------VEMISR  216 (256)
T ss_pred             Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---------------HHHHHC
Confidence            2111 1122335668999999998899999999999999999999 9999965432111               011110


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                       ......+...+..+.+++.+||+.+|.+|||+.++++.|
T Consensus       217 -~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         217 -GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence             001111222356789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.7e-45  Score=332.65  Aligned_cols=263  Identities=22%  Similarity=0.337  Sum_probs=202.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|.+.+.||.|+||.||+|..+ ++..||+|++....  .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57999999999999999999977 89999999986532  2345678999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +.+ +|.+++....        ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus        85 ~~~-~l~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~  152 (288)
T cd07871          85 LDS-DLKQYLDNCG--------NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARA  152 (288)
T ss_pred             CCc-CHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceee
Confidence            975 9999886543        13789999999999999999999998   99999999999999999999999999875


Q ss_pred             CccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh--
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV--  300 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  300 (361)
                      .....  .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........+.+  
T Consensus       153 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07871         153 KSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG  230 (288)
T ss_pred             ccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence            43221  12234568999999999875 56899999999999999999999999765433221111111111111111  


Q ss_pred             -------hhhcccccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 -------RQCVDARLGG----DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 -------~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                             .....+....    ...+..+....+|+.+||+.||.+|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                   1111111100    001123567899999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-46  Score=355.82  Aligned_cols=260  Identities=22%  Similarity=0.305  Sum_probs=213.9

Q ss_pred             hcCCCCCccccCCceEEEEEEECC-CCEEEEEEcCC-CCCChHHHHHHHHHHhcCC-CCCcceeee-EEEe------CCe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDA-SKQPDEEFLAQVSMVSRLK-HENFVQLLG-YCVD------GTS  136 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~-~~~~------~~~  136 (361)
                      .++++.++|.+|||+.||+|.... |..||+|++-. +....+.+.+||.+|+.|+ |+|||.+++ ....      .-.
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            467788899999999999999774 49999998854 4444578899999999996 999999999 3221      134


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      ++|.||||.||.|-|++..+...       .|++.++++|+.++++|+.+||.. .++|||||||-|||||+.+|..|||
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~-------~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQT-------RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhc-------cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence            67999999999999999876532       399999999999999999999999 5779999999999999999999999


Q ss_pred             ccccCCCCcccccccc-------ccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch
Q 018071          217 DFDLSNQAPDMAARLH-------STRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS  286 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~  286 (361)
                      |||.+...-.......       .-...-|+.|+|||++.   +...++|+|||+|||+||-|+....||+...      
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------  262 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------  262 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------
Confidence            9999865322211111       11233589999999874   6689999999999999999999999997431      


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                                   -..+++..+..+-.+.++..+.+||..||+.||.+||++-+|+..+..+.+...
T Consensus       263 -------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  263 -------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             -------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                         234556666666667899999999999999999999999999999988886544

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4e-45  Score=328.49  Aligned_cols=261  Identities=26%  Similarity=0.439  Sum_probs=209.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      ++|.+.+.||+|+||.||+|...      ++..||+|.+......  .+.+.+|+++++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            56888899999999999999864      3578999998764433  467899999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          139 LAYEFASNGSLHDILHGRKGVKG-----AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      ++|||+++++|.+++........     ......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            99999999999999976532110     112345889999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      ||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......         
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---------  232 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---------  232 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---------
Confidence            9999999875432222222234456788999999999999999999999999999998 999986432211         


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                             ....+........+...+..+.+++.+||+.||.+||++.||++.|+
T Consensus       233 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 -------VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                   11111111112223345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.1e-45  Score=343.25  Aligned_cols=267  Identities=22%  Similarity=0.380  Sum_probs=211.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~  136 (361)
                      .++|.+.++||+|+||.||+|...      ++..||||++.....  ..+.+.+|+++++++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            468999999999999999999853      234799999965432  2357889999999996 9999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCC-------------------------------------------------------
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKG-------------------------------------------------------  161 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------------  161 (361)
                      .++|||||++|+|.+++........                                                       
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999999865421000                                                       


Q ss_pred             --------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc
Q 018071          162 --------------------------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       162 --------------------------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~  209 (361)
                                                      ......+++..++.++.||+.||.|||+.+   |+||||||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                            000124888999999999999999999998   999999999999999


Q ss_pred             CCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 018071          210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~  288 (361)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......      
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~------  346 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD------  346 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh------
Confidence            99999999999876533222222234456788999999999899999999999999999997 99998643211      


Q ss_pred             hhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          289 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                               ..+...+........+...+..+.+++.+||+.+|++|||+.+|.+.|+.+++
T Consensus       347 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 ---------STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ---------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                     11111111222223344566789999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-46  Score=343.07  Aligned_cols=263  Identities=31%  Similarity=0.467  Sum_probs=220.3

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEECC--C--CE-EEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILKS--G--HA-AAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG  134 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~  134 (361)
                      -..++-.+.++||+|.||.||+|..+.  +  .. ||+|..+.+    .....++.+|+++|+.++|||||+++|++...
T Consensus       154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~  233 (474)
T KOG0194|consen  154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE  233 (474)
T ss_pred             EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            344566677899999999999999662  2  23 899988742    22346899999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceE
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK  214 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~k  214 (361)
                      ..+++|||+|.||+|.++|.....        .++..+...++.+.+.||+|||+++   ++||||..+|+|++.++.+|
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence            999999999999999999988763        3899999999999999999999998   99999999999999999999


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+|||+++.......  .....--+..|+|||.+..+.|+.++|||||||++||+++ |..||.+..             
T Consensus       303 ISDFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-------------  367 (474)
T KOG0194|consen  303 ISDFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK-------------  367 (474)
T ss_pred             eCccccccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-------------
Confidence            999999887541111  1112234679999999999999999999999999999999 888986432             


Q ss_pred             cCCchhhhhhc-ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCC
Q 018071          294 KLSEDKVRQCV-DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP  355 (361)
Q Consensus       294 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~  355 (361)
                         ...+...+ ...++...+...+..+..++.+||..+|++||||.++.+.|+.+......+
T Consensus       368 ---~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  368 ---NYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             ---HHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence               22333333 667777778888899999999999999999999999999999998765543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-45  Score=334.46  Aligned_cols=238  Identities=20%  Similarity=0.242  Sum_probs=195.6

Q ss_pred             cccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        75 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      ||+|+||.||+|..+ +++.||+|++...    ......+.+|+.++++++||||+++++++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999977 7899999998642    22335678899999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccc
Q 018071          150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA  229 (361)
Q Consensus       150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  229 (361)
                      .+++....         .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-  147 (312)
T cd05585          81 FHHLQREG---------RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-  147 (312)
T ss_pred             HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-
Confidence            99987543         2899999999999999999999998   9999999999999999999999999987542211 


Q ss_pred             cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC
Q 018071          230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG  309 (361)
Q Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (361)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......               .....+....  
T Consensus       148 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---------------~~~~~~~~~~--  209 (312)
T cd05585         148 -DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---------------EMYRKILQEP--  209 (312)
T ss_pred             -CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---------------HHHHHHHcCC--
Confidence             1234567999999999999999999999999999999999999999643221               1111111111  


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 018071          310 GDYPPKAVAKMAAVAALCVQYEADFRPN---MSIVVK  343 (361)
Q Consensus       310 ~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~evl~  343 (361)
                      ..++...+..+.+++.+||+.||.+||+   +.+++.
T Consensus       210 ~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         210 LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            1234456677999999999999999986   455554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-44  Score=323.49  Aligned_cols=256  Identities=28%  Similarity=0.446  Sum_probs=208.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|++.+.||+|+||.||+|.++    +...||+|.+......  ..++.+|+.+++.++||||+++++++.+....+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            57899999999999999999975    2458999998754332  35688899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++.....        .+++..++.++.|++.||.|||+.+   |+|+||||+|||+++++.++|+|||+
T Consensus        84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~  152 (266)
T cd05033          84 TEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL  152 (266)
T ss_pred             EEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccch
Confidence            999999999999976432        3899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.....                ..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----------------~~  216 (266)
T cd05033         153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----------------QD  216 (266)
T ss_pred             hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----------------HH
Confidence            987642222111222345678999999998899999999999999999998 9999854321                11


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      +...+......+.+..++..+.+++.+||+.+|++||++++|++.|+.++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         217 VIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            11111111222233445677999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.1e-45  Score=332.49  Aligned_cols=257  Identities=25%  Similarity=0.431  Sum_probs=207.2

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCC----EEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .+|++.+.||+|+||.||+|.+. ++.    .||+|.+....  ...+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            57999999999999999999864 444    48999986533  2346788999999999999999999998764 5679


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ++||+.+|+|.+++.....        .+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        86 v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG  154 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFG  154 (316)
T ss_pred             eeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccc
Confidence            9999999999999976532        3889999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++...............++..|+|||++.+..++.++|||||||++|||++ |..||......                
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~----------------  218 (316)
T cd05108         155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------------  218 (316)
T ss_pred             ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----------------
Confidence            9987643322222223344678999999999999999999999999999997 99999643221                


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      .+..++........+..++..+.+++.+||+.+|.+||++.+++..|..+...
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         219 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            11222222222223334566799999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.5e-45  Score=323.78  Aligned_cols=255  Identities=29%  Similarity=0.481  Sum_probs=212.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      ..+|.+.+.||.|+||.||+|..+.+..+++|.+..... ....+.+|+.+++.++||||+++++++.+....+++|||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            357889999999999999999988899999999976544 4567889999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++++|.+++......       .+++..++.++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        85 ~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          85 EKGSLLAFLRSPEGQ-------VLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             ccCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence            999999999764322       3899999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ......  .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......                .....
T Consensus       155 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----------------~~~~~  216 (261)
T cd05148         155 KEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----------------EVYDQ  216 (261)
T ss_pred             CCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----------------HHHHH
Confidence            432211  123345678999999998899999999999999999998 89999643321                11111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      +........+..++..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         217 ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            112222233455667899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-45  Score=337.98  Aligned_cols=245  Identities=22%  Similarity=0.301  Sum_probs=203.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-C-CCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-S-GHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|.+.+.||+|+||.||+|.++ + +..||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            357999999999999999999865 3 368999998642    2234567889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+.+|+|.+++....         .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       109 v~Ey~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCC
Confidence            999999999999997653         3899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||....+..               .
T Consensus       177 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---------------~  236 (340)
T PTZ00426        177 FAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---------------I  236 (340)
T ss_pred             CCeecCC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---------------H
Confidence            9876532     1235679999999999999899999999999999999999999997543211               0


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA  344 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  344 (361)
                      ...+....  ..++...+..+.+++.+||+.+|.+|+     +++++++.
T Consensus       237 ~~~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        237 YQKILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            11111111  123344556789999999999999995     89988763

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.7e-44  Score=321.53  Aligned_cols=257  Identities=30%  Similarity=0.486  Sum_probs=209.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|.+.+.||+|+||.||+|.+.+...||+|.+.......+.+.+|+.+++.++||||+++++++. ....+++|||+.
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            3579999999999999999999876678999999876666678999999999999999999999875 456789999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....       ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||.+....
T Consensus        84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          84 KGSLLDFLKGEMG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             CCcHHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            9999999975432       23789999999999999999999998   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..... ......++..|+|||+..+..++.++|||||||++|+|++ |..||.......                ....+
T Consensus       154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----------------~~~~~  216 (262)
T cd05071         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQV  216 (262)
T ss_pred             ccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----------------HHHHH
Confidence            32211 1123345678999999988899999999999999999999 888986442211                11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      ........+...+..+.+++.+||+.+|.+||++.++++.|+++++
T Consensus       217 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~~  262 (262)
T cd05071         217 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  262 (262)
T ss_pred             hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhcC
Confidence            1111123344566789999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.9e-46  Score=324.12  Aligned_cols=268  Identities=22%  Similarity=0.299  Sum_probs=209.8

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCC-----eeEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRVLAY  141 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~lv~  141 (361)
                      .|...+++|.|+||.||+|... +++.||||+.-.+..-   --+|+.+|+.+.|||||++.-+|....     ...+||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            5777889999999999999976 7899999998665542   346899999999999999998886432     235899


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC-CceEEecccc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDL  220 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~-~~~kl~Dfg~  220 (361)
                      ||++. +|.++++....     .+..++...+.-+..||++||.|||+.+   |+||||||.|+|+|.+ |.+||||||.
T Consensus       102 eymP~-tL~~~~r~~~~-----~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTR-----ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HhchH-HHHHHHHHHhh-----cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCc
Confidence            99976 99999875321     1123888889999999999999999988   9999999999999965 8999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      |+.+.....   ..+...|..|+|||.+.|. .|+.+.||||.||++.||+-|++-|.+.....+...+.-.....+.++
T Consensus       173 AK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  173 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             ceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            998755433   3556679999999999976 799999999999999999999999988766555444444334444433


Q ss_pred             hhhhccc------------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHh
Q 018071          300 VRQCVDA------------RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLN  350 (361)
Q Consensus       300 ~~~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~  350 (361)
                      +..+.-.            .+..-.....+.+..+|+.++|+.+|.+|.++.+++.  .++.+..
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            3332211            1111123345678999999999999999999999986  5555554

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.8e-45  Score=334.12  Aligned_cols=241  Identities=22%  Similarity=0.286  Sum_probs=198.6

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      ++||+|+||.||++..+ +++.||+|++.+..    .....+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999976 79999999986532    23356788999999999999999999999999999999999999


Q ss_pred             cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccc
Q 018071          148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM  227 (361)
Q Consensus       148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~  227 (361)
                      +|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~  148 (328)
T cd05593          81 ELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD  148 (328)
T ss_pred             CHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence            9998886543         3899999999999999999999998   999999999999999999999999998753221


Q ss_pred             cccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccc
Q 018071          228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR  307 (361)
Q Consensus       228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (361)
                        .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........               ...+... 
T Consensus       149 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~---------------~~~~~~~-  210 (328)
T cd05593         149 --AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---------------FELILME-  210 (328)
T ss_pred             --ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH---------------HHHhccC-
Confidence              1122456799999999999999999999999999999999999999964322110               0011111 


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 018071          308 LGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA  344 (361)
Q Consensus       308 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  344 (361)
                       ...++...+..+.+++.+||+.||.+||     ++.++++.
T Consensus       211 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 -DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence             1123444567799999999999999997     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.3e-44  Score=333.62  Aligned_cols=268  Identities=23%  Similarity=0.390  Sum_probs=208.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEe-CC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVD-GT  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~-~~  135 (361)
                      .++|++.++||+|+||.||+|...      +++.||+|++......  .+.+.+|+.+++++ +|+||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999999632      4578999998753322  24677899999999 79999999998764 45


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCC----------------------------------------------------CC
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKG----------------------------------------------------AQ  163 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~----------------------------------------------------~~  163 (361)
                      ..+++|||+++++|.+++........                                                    ..
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999999865321100                                                    00


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCC
Q 018071          164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH  243 (361)
Q Consensus       164 ~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  243 (361)
                      ....+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++..+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            0125899999999999999999999998   9999999999999999999999999998764332222233445677899


Q ss_pred             CchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHH
Q 018071          244 APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAA  322 (361)
Q Consensus       244 aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  322 (361)
                      |||++.+..++.++|||||||++|+|++ |..||.......               .+...+........+...+..+.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---------------EFCRRLKEGTRMRAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---------------HHHHHHhccCCCCCCccCCHHHHH
Confidence            9999999999999999999999999998 999996532211               111111111112223345667999


Q ss_pred             HHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          323 VAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       323 li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      ++.+||+.+|++||++.+|++.|+.+++.
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-44  Score=324.89  Aligned_cols=269  Identities=25%  Similarity=0.392  Sum_probs=209.6

Q ss_pred             hcC-CCCCccccCCceEEEEEEE-----CCCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeC--Ce
Q 018071           67 ENF-GTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TS  136 (361)
Q Consensus        67 ~~y-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~  136 (361)
                      ++| .+.+.||+|+||+||++..     .++..||+|.+.....  ....+.+|+++++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 8889999999999988653     2678999999876432  345788999999999999999999987653  45


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .+++|||+++++|.+++....          +++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~~----------l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~  149 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIG  149 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEe
Confidence            789999999999999997543          899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccc-cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          217 DFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |||++.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||...... ............
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~  228 (283)
T cd05080         150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQM  228 (283)
T ss_pred             ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhccccccc
Confidence            999988654322111 112234566799999998888999999999999999999999998643221 111111111111


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      ....+...++.......+...+..+.+++.+||+.+|++|||+++|++.|+.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             chhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            122233333333333445556778999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.1e-45  Score=334.71  Aligned_cols=240  Identities=22%  Similarity=0.299  Sum_probs=197.5

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      +.||+|+||.||++..+ +|..||+|++...    ......+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999976 8999999998653    222346678999999999999999999999999999999999999


Q ss_pred             cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccc
Q 018071          148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM  227 (361)
Q Consensus       148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~  227 (361)
                      +|..++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  148 (323)
T cd05595          81 ELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence            9998886543         3899999999999999999999998   999999999999999999999999998753221


Q ss_pred             cccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccc
Q 018071          228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR  307 (361)
Q Consensus       228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (361)
                        ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......               ....+....
T Consensus       149 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---------------~~~~~~~~~  211 (323)
T cd05595         149 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---------------LFELILMEE  211 (323)
T ss_pred             --CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---------------HHHHHhcCC
Confidence              112234679999999999999999999999999999999999999996432211               011111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          308 LGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       308 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                        ...+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       212 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence              123344567799999999999999998     8888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.6e-44  Score=326.19  Aligned_cols=269  Identities=25%  Similarity=0.400  Sum_probs=212.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+.... .....+.+|+.++++++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            357899999999999999999842      35679999886543 23457889999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceE
Q 018071          139 LAYEFASNGSLHDILHGRKGVKG----AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK  214 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~k  214 (361)
                      ++|||+++++|.+++........    ......+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            99999999999999975432110    111234899999999999999999999998   99999999999999999999


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||........         
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---------  231 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---------  231 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---------
Confidence            999999876543222222334446788999999998899999999999999999998 9999864432110         


Q ss_pred             cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                            ...+.. ......+...+..+.+++.+||+.+|.+|||++++++.|+++....+
T Consensus       232 ------~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~  284 (288)
T cd05093         232 ------IECITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP  284 (288)
T ss_pred             ------HHHHHc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence                  011111 11111122345679999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-44  Score=320.89  Aligned_cols=251  Identities=25%  Similarity=0.423  Sum_probs=205.9

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      .+|++.+.||+|+||.||++.++++..+|+|.+.........+.+|+++++.++||||+++++++.+....++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            35788899999999999999988778999999876655567888999999999999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++.....        .+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        84 ~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          84 GCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence            999999875432        3899999999999999999999998   99999999999999999999999999876532


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........                ...+.
T Consensus       153 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~~~~~  215 (256)
T cd05059         153 DQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV----------------VESVS  215 (256)
T ss_pred             cccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH----------------HHHHH
Confidence            2111 1111223457999999998899999999999999999999 8999964322110                11111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      .......+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       216 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            1112223334567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7e-46  Score=311.07  Aligned_cols=260  Identities=23%  Similarity=0.331  Sum_probs=213.9

Q ss_pred             HHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-----CC----hHHHHHHHHHHhcC-CCCCcceeee
Q 018071           61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-----QP----DEEFLAQVSMVSRL-KHENFVQLLG  129 (361)
Q Consensus        61 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~----~~~~~~e~~~l~~l-~hpniv~~~~  129 (361)
                      .-+.+.+.|+..+.||+|..+.|.++.++ +|..+|+|++....     ..    .+.-.+|+.+|+++ .||+|+++.+
T Consensus        11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D   90 (411)
T KOG0599|consen   11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD   90 (411)
T ss_pred             hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence            34567788999999999999999999877 89999999985421     11    23456789999998 5999999999


Q ss_pred             EEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc
Q 018071          130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       130 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~  209 (361)
                      +++.+...++|+|.|+.|.|.|++...-         .++++..+.|++|+.+|+.|||...   ||||||||+|||+++
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLts~V---------tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILldd  158 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLTSKV---------TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDD  158 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhhhhe---------eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecc
Confidence            9999999999999999999999998654         4999999999999999999999997   999999999999999


Q ss_pred             CCceEEeccccCCCCccccccccccccccCCCCCCchhhc------cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcc
Q 018071          210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM------TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG  283 (361)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~  283 (361)
                      +.++||+|||+++.+....   .-...||||+|+|||.+.      ..+|+..+|+|++||++|.|+.|.+||-+...-.
T Consensus       159 n~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml  235 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML  235 (411)
T ss_pred             ccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence            9999999999999876543   346789999999999885      3478999999999999999999999995431111


Q ss_pred             cchhhhhhcccCCchhhhhhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHh
Q 018071          284 QQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLN  350 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~  350 (361)
                      .               ++-+.+..+  ..+-..+.+....+||.+||+.||.+|.|++|+++  .+.++..
T Consensus       236 M---------------LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  236 M---------------LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             H---------------HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            1               111112211  23334567788999999999999999999999998  4444443

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.7e-44  Score=325.03  Aligned_cols=265  Identities=24%  Similarity=0.410  Sum_probs=210.7

Q ss_pred             cCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      +|++.+.||+|+||.||+|...      ....+++|.+......  ...+.+|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999853      2357889888654322  3568889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCC---------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCc
Q 018071          140 AYEFASNGSLHDILHGRKGVK---------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN  204 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~---------------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~N  204 (361)
                      +|||+.+++|.+++.......               .......+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999986543210               0111235889999999999999999999998   9999999999


Q ss_pred             eEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcc
Q 018071          205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRG  283 (361)
Q Consensus       205 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~  283 (361)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....+. 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999876533222212233445778999999988899999999999999999998 99999654322 


Q ss_pred             cchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          284 QQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                                     .+...+......+.+...+..+.+++.+||+.+|.+||++.++++.|++++..
T Consensus       237 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         237 ---------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             ---------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence                           11122222222233444567899999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2e-44  Score=319.11  Aligned_cols=246  Identities=27%  Similarity=0.476  Sum_probs=199.8

Q ss_pred             ccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHH
Q 018071           74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH  150 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  150 (361)
                      .||+|+||.||+|..+ +++.+|+|.+.....  ....+.+|+++++.++||||+++++++......++||||+.+++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            6999999999999976 899999998764322  2356889999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcccccc
Q 018071          151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR  230 (361)
Q Consensus       151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  230 (361)
                      +++....        ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        82 ~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          82 TFLRTEG--------PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             HHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc
Confidence            9986532        23889999999999999999999998   999999999999999999999999998764322111


Q ss_pred             ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC
Q 018071          231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG  309 (361)
Q Consensus       231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (361)
                      .......++..|+|||.+.++.++.++|||||||++|+|++ |..||......                .....+.....
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----------------~~~~~~~~~~~  214 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----------------QTREAIEQGVR  214 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----------------HHHHHHHcCCC
Confidence            11122233567999999998899999999999999999998 88898643221                11222222222


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          310 GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       310 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2344455678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-44  Score=319.85  Aligned_cols=254  Identities=29%  Similarity=0.465  Sum_probs=208.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|++.+.||+|+||.||+|..+++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||+.
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            4678999999999999999999888888999999876666678999999999999999999999875 456789999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....       ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++....
T Consensus        84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          84 KGSLLDFLKDGEG-------RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            9999999875432       23899999999999999999999998   9999999999999999999999999987653


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                ....+
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----------------~~~~~  216 (260)
T cd05070         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE----------------VLEQV  216 (260)
T ss_pred             Ccccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHH
Confidence            32211 1122335668999999988899999999999999999999 899996432211                11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                      ......+.+...+..+.+++.+||+.+|.+|||+.++.+.|++
T Consensus       217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         217 ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1222223344556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.7e-45  Score=336.48  Aligned_cols=270  Identities=22%  Similarity=0.343  Sum_probs=201.0

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeC-----CeeE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TSRV  138 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~  138 (361)
                      +|++.++||+|+||.||+|..+ ++..||||++....   .....+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888899999999999999976 89999999986422   2234688999999999999999999987643     3479


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +||||+. ++|.+++....         .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 lv~e~~~-~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Df  147 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---------DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDF  147 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---------cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccC
Confidence            9999995 68999886543         3899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccc-cccccccccCCCCCCchhhcc--CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          219 DLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       219 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |+++....... ........||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...........+.......
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~  227 (338)
T cd07859         148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP  227 (338)
T ss_pred             ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99876432211 112244678999999999875  678999999999999999999999997543221111111000000


Q ss_pred             Cchhh--------hhhc---ccccCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHh
Q 018071          296 SEDKV--------RQCV---DARLGGDYP---PKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLN  350 (361)
Q Consensus       296 ~~~~~--------~~~~---~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~  350 (361)
                      .....        ...+   .........   +..+..+.+++.+||+.||++|||++++++  .++.+..
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            10000        0111   000000000   123456889999999999999999999997  3444443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.8e-44  Score=336.34  Aligned_cols=251  Identities=22%  Similarity=0.302  Sum_probs=197.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||+||+|..+ +++.||+|++.+..    .....+.+|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999976 79999999986532    22346778999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.+++....         .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla  148 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---------TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLC  148 (363)
T ss_pred             cCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCc
Confidence            9999999999997643         3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccc---------------------------------cccccccccCCCCCCchhhccCCCCCccceecHHHHHHH
Q 018071          222 NQAPDMAA---------------------------------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE  268 (361)
Q Consensus       222 ~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~e  268 (361)
                      +.......                                 .......+||+.|+|||++.+..++.++|||||||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e  228 (363)
T cd05628         149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE  228 (363)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence            75432110                                 000124579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCC--HHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 018071          269 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQ--YEADFRPNMSIVVKA  344 (361)
Q Consensus       269 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~--~~p~~RPs~~evl~~  344 (361)
                      |++|+.||....+...               ...+........++  ...+..+.+++.+++.  .++..||++++|++.
T Consensus       229 ll~G~~Pf~~~~~~~~---------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         229 MLIGYPPFCSETPQET---------------YKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHhCCCCCCCCCHHHH---------------HHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            9999999975433211               11111100000111  1234567788877553  334456899999884

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-45  Score=340.07  Aligned_cols=250  Identities=23%  Similarity=0.316  Sum_probs=205.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.+..    .....+.+|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999977 89999999986532    33456888999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+.+++|.+++....         .+++..++.++.||+.||+|||+.|   |+||||||+|||++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~  148 (350)
T cd05573          81 EYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLC  148 (350)
T ss_pred             cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCC
Confidence            9999999999997652         3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCcccc---------------------------ccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCC
Q 018071          222 NQAPDMA---------------------------ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK  274 (361)
Q Consensus       222 ~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~  274 (361)
                      .......                           .........||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~  228 (350)
T cd05573         149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP  228 (350)
T ss_pred             ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence            7654322                           0112334679999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccchhhhhhcccCCchhhhhhcc--cccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 018071          275 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVD--ARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-MSIVVKA  344 (361)
Q Consensus       275 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~~  344 (361)
                      ||.......               ....+..  ..+..+.....+..+.+++.+||. +|.+||+ ++++++.
T Consensus       229 Pf~~~~~~~---------------~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         229 PFYSDTLQE---------------TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCHHH---------------HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            997543211               1111111  111111111246779999999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-44  Score=339.46  Aligned_cols=249  Identities=22%  Similarity=0.253  Sum_probs=198.4

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .|.+++.||+|+||+||+|..+ +++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999976 88999999996532    223567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++|+|.+++....         .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~  149 (381)
T cd05626          82 YIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCT  149 (381)
T ss_pred             cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence            999999999987643         3889999999999999999999998   9999999999999999999999999975


Q ss_pred             CCccccc---------------------------------------------cccccccccCCCCCCchhhccCCCCCcc
Q 018071          223 QAPDMAA---------------------------------------------RLHSTRVLGTFGYHAPEYAMTGQLNAKS  257 (361)
Q Consensus       223 ~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~  257 (361)
                      .......                                             .......+||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (381)
T cd05626         150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC  229 (381)
T ss_pred             ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence            4311000                                             0001235799999999999998999999


Q ss_pred             ceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc--cccCCCCCHHHHHHHHHHHHH--ccccCCC
Q 018071          258 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD--ARLGGDYPPKAVAKMAAVAAL--CVQYEAD  333 (361)
Q Consensus       258 DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~--cl~~~p~  333 (361)
                      |||||||++|||++|..||....+...               ...+++  .....+.....+.++.+++.+  |+..++.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~---------------~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~  294 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTET---------------QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERL  294 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHH---------------HHHHHccccccCCCCCCCCCHHHHHHHHHHccCccccc
Confidence            999999999999999999975432211               111111  011111112345678888888  5566666


Q ss_pred             CCCCHHHHHH
Q 018071          334 FRPNMSIVVK  343 (361)
Q Consensus       334 ~RPs~~evl~  343 (361)
                      .||++.++++
T Consensus       295 ~R~~~~~~l~  304 (381)
T cd05626         295 GRNGADDIKA  304 (381)
T ss_pred             CCCCHHHHhc
Confidence            7999999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-44  Score=336.60  Aligned_cols=247  Identities=26%  Similarity=0.350  Sum_probs=195.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|+..+.||+|+||.||+|.++ +++.||||++.....  ....+.+|+++++.++|+||+++++++.+....++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            46777889999999999999976 799999999865432  235788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+..             ...+..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus       154 ~~~~~L~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~  217 (353)
T PLN00034        154 MDGGSLEGTH-------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI  217 (353)
T ss_pred             CCCCcccccc-------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccccccee
Confidence            9999986532             1567788899999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhcc-----CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ......  ......||..|+|||++..     ...+.++|||||||++|||++|+.||..........+.          
T Consensus       218 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~----------  285 (353)
T PLN00034        218 LAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM----------  285 (353)
T ss_pred             cccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH----------
Confidence            532211  1234578999999998743     23456899999999999999999999732211110000          


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                         ..+........+...+..+.+||.+||+.||++|||+.|+++.
T Consensus       286 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        286 ---CAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---HHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0000111112334556779999999999999999999999973

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.9e-44  Score=325.02  Aligned_cols=269  Identities=25%  Similarity=0.409  Sum_probs=213.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|.+.+.||+|+||.||+|...      ++..+++|.+...... .+.+.+|+.++++++||||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            56888899999999999999843      3556899988654322 3568899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          140 AYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                      ||||+++++|.+++.......       .......+++..++.++.||+.||+|||+.+   ++||||||+|||+++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999997643210       0111234899999999999999999999998   999999999999999999


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~  291 (361)
                      ++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......        
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------  233 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--------  233 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence            99999999876543322222344556889999999999999999999999999999998 999986433211        


Q ss_pred             cccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          292 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                              +.+.+........+...+..+.+++.+||+.+|.+|||+++|++.|+++....|.
T Consensus       234 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~  288 (291)
T cd05094         234 --------VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI  288 (291)
T ss_pred             --------HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence                    1111111111122233566799999999999999999999999999999876553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.4e-44  Score=331.49  Aligned_cols=263  Identities=22%  Similarity=0.327  Sum_probs=203.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|++.+.||+|+||.||++.++ ++..+|+|.+.....  ....+.+|+++++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999987 789999998865432  23568899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+.+++|.+++....         .+++..+..++.|++.||.|||+.+  +|+||||||+|||+++++.+||+|||++.
T Consensus        84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  152 (333)
T cd06650          84 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (333)
T ss_pred             cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence            999999999997543         2889999999999999999999752  39999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh------------
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW------------  290 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~------------  290 (361)
                      .....    ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..............            
T Consensus       153 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (333)
T cd06650         153 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS  228 (333)
T ss_pred             hhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence            54321    12345789999999999988999999999999999999999999975432111100000            


Q ss_pred             -------------hcc---cCCchhhhhhcccccCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          291 -------------ATP---KLSEDKVRQCVDARLGGDYP-PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       291 -------------~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                   ...   ......+...+........+ ...+.++.+|+.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                         000   00000000001000000111 124567899999999999999999999986

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=330.08  Aligned_cols=248  Identities=22%  Similarity=0.366  Sum_probs=217.0

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      +.+-|.+.+.||+|.|..|-+|++- +|+.||||++.+.+-+   ...+.+|++.|+.++|||||++|++......+|||
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            4567888899999999999999976 9999999999886544   46789999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec-cCCceEEeccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFD  219 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~-~~~~~kl~Dfg  219 (361)
                      +|+-++|+|++||-+...        .+.+..+.+++.||+.|+.|+|+..   +|||||||+||.+. .-|-+||.|||
T Consensus        96 LELGD~GDl~DyImKHe~--------Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEE--------GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             EEecCCchHHHHHHhhhc--------cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecc
Confidence            999999999999977653        3999999999999999999999997   99999999998765 56899999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCC-CccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN-AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ++..+...   ...++.||...|-|||++.|..|+ +++||||||||||.|++|+.||+..+.               .+
T Consensus       165 FSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---------------SE  226 (864)
T KOG4717|consen  165 FSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---------------SE  226 (864)
T ss_pred             ccccCCCc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---------------hh
Confidence            99876543   235788999999999999999997 467999999999999999999974432               24


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+..++|-.+  ..|...+.+.++||..||..||.+|.+.++|..
T Consensus       227 TLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  227 TLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            4555666655  567788999999999999999999999999875

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.2e-44  Score=322.03  Aligned_cols=259  Identities=24%  Similarity=0.397  Sum_probs=204.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCC----EEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|++.+.||+|+||.||+|.+. ++.    .+++|.+.....  ...++..|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            57888999999999999999975 454    477887754322  23467778888999999999999998754 45788


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ++||+.+|+|.+++.....        .+++..++.++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        86 i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCc
Confidence            9999999999999975432        3899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++...............++..|+|||.+.++.++.++|||||||++|||++ |..||....+...              
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~--------------  220 (279)
T cd05111         155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV--------------  220 (279)
T ss_pred             cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--------------
Confidence            9976543222222334557788999999998899999999999999999998 9999965432211              


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                        .+++........+..++..+.+++.+||..+|.+|||+.|+++.|..+.+..|
T Consensus       221 --~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~  273 (279)
T cd05111         221 --PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP  273 (279)
T ss_pred             --HHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence              11111111111122244568899999999999999999999999999877554

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-45  Score=339.73  Aligned_cols=249  Identities=22%  Similarity=0.309  Sum_probs=200.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||+|..+ +++.||||++....    .....+.+|+.+++.++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999977 79999999996532    22345778999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+.+|+|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  148 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLC  148 (364)
T ss_pred             CCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccc
Confidence            9999999999987643         2899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCcccccc------------------------------------ccccccccCCCCCCchhhccCCCCCccceecHHHH
Q 018071          222 NQAPDMAAR------------------------------------LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV  265 (361)
Q Consensus       222 ~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~  265 (361)
                      .........                                    ......+||+.|+|||++.+..++.++|||||||+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i  228 (364)
T cd05599         149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI  228 (364)
T ss_pred             eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence            654221100                                    00113469999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccc--cCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHH
Q 018071          266 LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR--LGGDYPPKAVAKMAAVAALCVQYEADFRPN---MSI  340 (361)
Q Consensus       266 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~e  340 (361)
                      +|+|++|..||....+...               ...+.+..  +..+.....+..+.+++.+|+. +|.+|++   +.+
T Consensus       229 l~el~~G~~Pf~~~~~~~~---------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~  292 (364)
T cd05599         229 MYEMLVGYPPFCSDNPQET---------------YRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE  292 (364)
T ss_pred             HHHhhcCCCCCCCCCHHHH---------------HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence            9999999999975433211               01111100  1011111245678999999996 9999998   888


Q ss_pred             HHH
Q 018071          341 VVK  343 (361)
Q Consensus       341 vl~  343 (361)
                      +++
T Consensus       293 ll~  295 (364)
T cd05599         293 IKS  295 (364)
T ss_pred             Hhc
Confidence            876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8e-45  Score=349.71  Aligned_cols=253  Identities=19%  Similarity=0.276  Sum_probs=204.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-C-CCEEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-S-GHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ..|.+.+.||+|+||.||+|... + +..||+|.+...... ...+.+|+.+++.++||||+++++++......+|||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            35899999999999999999865 4 678999977543322 34577899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++|+|.+++.....     ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       147 ~~gg~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        147 GSGGDLNKQIKQRLK-----EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             CCCCCHHHHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence            999999998864321     1124889999999999999999999998   99999999999999999999999999986


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      .............+||+.|+|||++.+..++.++|||||||++|+|++|+.||......               ..+..+
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---------------~~~~~~  283 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---------------EIMQQV  283 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHH
Confidence            54332222345567999999999999999999999999999999999999999643211               111111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .... ....+...+..+.+++.+||+.+|++||++.+++.
T Consensus       284 ~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        284 LYGK-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HhCC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1111 11233445677999999999999999999999875

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-44  Score=338.24  Aligned_cols=251  Identities=20%  Similarity=0.275  Sum_probs=202.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ..++|++.+.||+|+||.||++..+ +++.+|+|.+.+.    ......+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3478999999999999999999987 7899999998642    1223457789999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+++|+|.+++....          +++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus       121 v~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         121 VMEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecc
Confidence            999999999999996543          889999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccC----CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      ++....... .......+||+.|+|||++.+.    .++.++|||||||++|+|++|+.||......             
T Consensus       188 ~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------------  253 (370)
T cd05621         188 TCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------------  253 (370)
T ss_pred             cceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------------
Confidence            987653221 1122456799999999999754    3788999999999999999999999754321             


Q ss_pred             CchhhhhhcccccCCCCC--HHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 018071          296 SEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADF--RPNMSIVVKA  344 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~  344 (361)
                        ..+..+++.......+  ...+..+.+++.+||..++.+  |+|+.++++.
T Consensus       254 --~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         254 --GTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --HHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              1112222221111222  234677899999999866544  8999999884

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.9e-44  Score=319.56  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=209.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|++.++||+|+||.||+|..++++.||+|.+.........+.+|+.++++++||||+++++++. ....+++|||+.
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            5689999999999999999999888899999999877766778999999999999999999999874 456899999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....       ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++....
T Consensus        84 ~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          84 NGSLVDFLKTPEG-------IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            9999999865432       23899999999999999999999998   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .... .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.......                +...+
T Consensus       154 ~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~  216 (260)
T cd05067         154 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE----------------VIQNL  216 (260)
T ss_pred             CCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH----------------HHHHH
Confidence            2111 11123345678999999998899999999999999999999 999996443211                11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ........+...+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         217 ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            11222233334566799999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.9e-44  Score=320.22  Aligned_cols=252  Identities=26%  Similarity=0.438  Sum_probs=205.6

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++|.+.+.||+|+||.||++.++.+..+|+|.+.........+.+|+.++++++||||+++++++.+....+++|||+.+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            46888899999999999999987777899999887666667899999999999999999999999988889999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++.....        .+++..++.++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||+++....
T Consensus        84 ~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          84 GCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            999999875432        3899999999999999999999998   99999999999999999999999999875533


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........               ...+ .
T Consensus       153 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---------------~~~~-~  215 (256)
T cd05113         153 DEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---------------VEKV-S  215 (256)
T ss_pred             Ccee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---------------HHHH-h
Confidence            2111 1122335678999999998889999999999999999998 9999964332110               0111 1


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      .......+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       216 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         216 QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11111122234577999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-44  Score=332.76  Aligned_cols=243  Identities=25%  Similarity=0.376  Sum_probs=197.1

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHH---hcCCCCCcceeeeEEEeCCeeEEE
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMV---SRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l---~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      |++.+.||+|+||.||+|..+ +++.||||++.+..    ...+.+.+|++++   +.++||||+++++++.+....++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677889999999999999976 79999999986532    2234566676654   566799999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|..++...          .+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        81 ~E~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~  147 (324)
T cd05589          81 MEYAAGGDLMMHIHTD----------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGL  147 (324)
T ss_pred             EcCCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccC
Confidence            9999999999888643          2899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ++.....  .......+|++.|+|||++.+..++.++|||||||++|+|++|+.||.......               ..
T Consensus       148 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---------------~~  210 (324)
T cd05589         148 CKEGMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---------------VF  210 (324)
T ss_pred             CccCCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---------------HH
Confidence            8753221  112345679999999999999999999999999999999999999997543211               11


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      ..+.....  .++...+..+.+++.+||+.||.+||     ++.++++
T Consensus       211 ~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         211 DSIVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            11111111  23344567789999999999999999     5677665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-44  Score=338.10  Aligned_cols=250  Identities=20%  Similarity=0.271  Sum_probs=203.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|++.+.||+|+||.||++..+ +++.||+|++.+.    ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            468999999999999999999977 7999999998642    12334577899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++|+|.+++....          +++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus       122 ~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         122 MEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccc
Confidence            99999999999987543          788999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccC----CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      +....... .......+||+.|+|||++.+.    .++.++|||||||++|||++|+.||......              
T Consensus       189 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------------  253 (370)
T cd05596         189 CMKMDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------------  253 (370)
T ss_pred             eeeccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------------
Confidence            87653221 1122456799999999998753    4789999999999999999999999754321              


Q ss_pred             chhhhhhcccccCCCCC--HHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 018071          297 EDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADF--RPNMSIVVKA  344 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~  344 (361)
                       ..+..+.+......++  ...+..+.+++.+||+.+|.+  |||++++++.
T Consensus       254 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         254 -GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence             1111222211111122  235678999999999999988  9999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-45  Score=339.96  Aligned_cols=250  Identities=24%  Similarity=0.286  Sum_probs=198.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|.+.+.||+|+||.||++..+ +++.||||++.+..    ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999976 89999999986532    22356788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.+++....         .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla  148 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS  148 (377)
T ss_pred             eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccc
Confidence            9999999999987543         3889999999999999999999998   999999999999999999999999998


Q ss_pred             CCCcccccc---------------------------------------------ccccccccCCCCCCchhhccCCCCCc
Q 018071          222 NQAPDMAAR---------------------------------------------LHSTRVLGTFGYHAPEYAMTGQLNAK  256 (361)
Q Consensus       222 ~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~  256 (361)
                      +........                                             ......+||+.|+|||++.+..++.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  228 (377)
T cd05629         149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE  228 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence            632110000                                             00012569999999999999999999


Q ss_pred             cceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCC--HHHHHHHHHHHHHccccCCCC
Q 018071          257 SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADF  334 (361)
Q Consensus       257 ~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~  334 (361)
                      +|||||||++|||++|..||....+...               +..+........++  ...+..+.+++.+||. +|.+
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~~~~~~---------------~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~  292 (377)
T cd05629         229 CDWWSLGAIMFECLIGWPPFCSENSHET---------------YRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAEN  292 (377)
T ss_pred             eeeEecchhhhhhhcCCCCCCCCCHHHH---------------HHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhh
Confidence            9999999999999999999975433211               11111100001111  1245678999999997 6666


Q ss_pred             C---CCHHHHHHH
Q 018071          335 R---PNMSIVVKA  344 (361)
Q Consensus       335 R---Ps~~evl~~  344 (361)
                      |   +++.++++.
T Consensus       293 r~~r~~~~~~l~h  305 (377)
T cd05629         293 RLGRGGAHEIKSH  305 (377)
T ss_pred             cCCCCCHHHHhcC
Confidence            5   599998874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.7e-45  Score=349.57  Aligned_cols=258  Identities=22%  Similarity=0.312  Sum_probs=207.4

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCC---
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT---  135 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~---  135 (361)
                      +...++|.+.++||+|+||+||+|... +++.||||.+......   ...+.+|+..+..++|+||++++..+....   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            344579999999999999999999966 8999999998654332   346778999999999999999988765332   


Q ss_pred             -----eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC
Q 018071          136 -----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD  210 (361)
Q Consensus       136 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~  210 (361)
                           ..++||||+++|+|.+++.....     ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-----~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAK-----TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSN  179 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCC
Confidence                 36799999999999999875432     1234899999999999999999999998   9999999999999999


Q ss_pred             CceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 018071          211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~  290 (361)
                      +.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......       
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-------  252 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-------  252 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------
Confidence            9999999999876543322223345789999999999999999999999999999999999999996432210       


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                              .+..... ......+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       253 --------~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        253 --------VMHKTLA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             --------HHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                    1111111 11122344567789999999999999999999999863

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.5e-44  Score=323.10  Aligned_cols=262  Identities=27%  Similarity=0.397  Sum_probs=207.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-----CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|++.+.||+|+||.||+|.+.     ++..+++|.+......  ...+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            46888899999999999999842     5678999998753322  2468889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC
Q 018071          140 AYEFASNGSLHDILHGRKGVK--------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD  211 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~--------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~  211 (361)
                      +|||+.+++|.+++.......        .......+++..++.++.|++.||.|||+.+   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999986432110        0011234889999999999999999999998   99999999999999999


Q ss_pred             ceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 018071          212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~  290 (361)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||....+.        
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--------  233 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------  233 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            999999999976533222222334456778999999998899999999999999999998 99998643221        


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                              .+.+.+........+..++..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       234 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 --------EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                    1111121111122333456779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-44  Score=316.60  Aligned_cols=271  Identities=23%  Similarity=0.288  Sum_probs=209.2

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCC-cceeeeEEEeCC------
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGT------  135 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~------  135 (361)
                      ..|.....||+|+||+||+|+.+ +|+.||+|++.....   ......+|+.+++.++|+| |+.+++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34555567999999999999977 899999999976543   3456789999999999999 999999998877      


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..++|+||++. +|.+++.......     ..++...+..++.||+.||+|||+++   |+||||||+||||+++|.+||
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKl  161 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKL  161 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEee
Confidence            78999999965 9999998765321     23667899999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||+|+...-..  ...+..++|.+|.|||++.+. .|+...||||+|||+.||++++..|.+.....+...+-.....
T Consensus       162 aDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt  239 (323)
T KOG0594|consen  162 ADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT  239 (323)
T ss_pred             eccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence            9999998654222  224667889999999999987 7999999999999999999999999877654332222222222


Q ss_pred             CCchhhhhhc---ccc--cCCC-----CCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHh
Q 018071          295 LSEDKVRQCV---DAR--LGGD-----YPP---KAVAKMAAVAALCVQYEADFRPNMSIVVKA--LQPL  348 (361)
Q Consensus       295 ~~~~~~~~~~---~~~--~~~~-----~~~---~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l  348 (361)
                      ..+..+....   +-.  +...     ...   .......+++.+||+.+|.+|.|++..++.  ++.+
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            2222111111   111  1000     111   112478899999999999999999999975  4444

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=331.38  Aligned_cols=250  Identities=24%  Similarity=0.322  Sum_probs=215.4

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCee
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSR  137 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~  137 (361)
                      .+...|++.+.||+|.||.||++..+ +|+.+|+|.+.+...    ....+.+|+.+|+++. |||||.++++|++....
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            45678999999999999999999988 799999999976443    3468899999999998 99999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC----Cce
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD----DVA  213 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~----~~~  213 (361)
                      ++|||+|.||.|.+.+....          +++..+..++.|++.+++|||+.|   |+||||||+|+|+...    +.+
T Consensus       112 ~lvmEL~~GGeLfd~i~~~~----------~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~i  178 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKKH----------YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRI  178 (382)
T ss_pred             EEEEEecCCchHHHHHHHcc----------CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcE
Confidence            99999999999999997651          899999999999999999999998   9999999999999643    479


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |++|||++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|..||.........        
T Consensus       179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~--------  247 (382)
T KOG0032|consen  179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF--------  247 (382)
T ss_pred             EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH--------
Confidence            9999999988754   33457789999999999999999999999999999999999999999765432211        


Q ss_pred             cCCchhhhhhccc--ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          294 KLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       294 ~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                             ..+...  .+..+.....+..+.+++..|+..||.+|+|+.++++.
T Consensus       248 -------~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  248 -------LAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -------HHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                   122222  22344556678889999999999999999999999984

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.7e-44  Score=324.48  Aligned_cols=266  Identities=26%  Similarity=0.424  Sum_probs=211.3

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGT  135 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~  135 (361)
                      ..++|++.+.||+|+||.||++..+      ....+|+|.+......  ..++.+|+.+++++ +||||+++++++....
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3568999999999999999999864      2367999988754322  24678899999999 7999999999999999


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGA-------QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF  208 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~  208 (361)
                      ..+++|||+.+|+|.+++.........       .....+++..++.++.|++.||+|||+.+   |+||||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999999754311000       12345899999999999999999999998   99999999999999


Q ss_pred             cCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchh
Q 018071          209 DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL  287 (361)
Q Consensus       209 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~  287 (361)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......     
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  241 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-----  241 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----
Confidence            999999999999987644322222233345678999999998899999999999999999997 99998643221     


Q ss_pred             hhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          288 VTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                                 .+...+........+...+..+.+|+.+||+.+|.+|||+.++++.|+.++
T Consensus       242 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 -----------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -----------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                       111222222222334445677999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.7e-44  Score=322.79  Aligned_cols=263  Identities=25%  Similarity=0.417  Sum_probs=206.5

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      ..++|++.+.||+|+||.||+|..+      ++..||+|.+.....  ...++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999753      356799998865332  23468899999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKG-AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      .++||||+.+++|.+++........ ......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999875432110 111234788899999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||........   .      
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~------  231 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---L------  231 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H------
Confidence            99999876543222222233456788999999998899999999999999999999 7889864432111   0      


Q ss_pred             CCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                            ....+.. ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       232 ------~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         232 ------RFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ------HHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                  0111111 11223344567999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-44  Score=318.21  Aligned_cols=256  Identities=29%  Similarity=0.483  Sum_probs=211.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|.+.+.||+|+||.||+|..+++..+|+|.+........++.+|+.++++++||||+++++++......+++|||++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            46899999999999999999998878899999998776777889999999999999999999999998889999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....       ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        85 ~~~L~~~i~~~~~-------~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          85 KGSLLDFLKSGEG-------KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             CCCHHHHHhcccc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence            9999999976432       23899999999999999999999998   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......                ....+
T Consensus       155 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----------------~~~~~  217 (261)
T cd05034         155 DDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE----------------VLEQV  217 (261)
T ss_pred             chhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHH
Confidence            32111 1112234568999999998899999999999999999998 999996432211                11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ........+...+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         218 ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence            11111222333466799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.9e-44  Score=326.86  Aligned_cols=264  Identities=22%  Similarity=0.309  Sum_probs=199.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++.....  ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999987 799999999875332  23467889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+. ++|.+++.....        .+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++.
T Consensus        84 ~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~  151 (303)
T cd07869          84 YVH-TDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR  151 (303)
T ss_pred             CCC-cCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcce
Confidence            995 588888765431        3889999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhcccCCchhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWATPKLSEDKV  300 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~  300 (361)
                      ......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......... ..............+
T Consensus       152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (303)
T cd07869         152 AKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW  229 (303)
T ss_pred             eccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhc
Confidence            543211  122445689999999998754 5888999999999999999999999754321110 000000000000000


Q ss_pred             hh------hcccccCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQ------CVDARLGGDYP---------PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~------~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..      ..........+         ...+..+.+|+.+||+.||.+|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00      00000000000         012356889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-44  Score=332.67  Aligned_cols=241  Identities=21%  Similarity=0.291  Sum_probs=196.8

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      +.||+|+||.||++..+ ++..||+|++.+..    .....+.+|+++++.++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999976 89999999986532    22356678999999999999999999999999999999999999


Q ss_pred             cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      +|.+++....         .+++..+..++.||+.||.|||+ .+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~  148 (325)
T cd05594          81 ELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  148 (325)
T ss_pred             cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence            9999886543         38999999999999999999997 66   99999999999999999999999999875322


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      ..  .......||+.|+|||++.+..++.++|||||||++|+|++|..||........               ...+...
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---------------~~~i~~~  211 (325)
T cd05594         149 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---------------FELILME  211 (325)
T ss_pred             CC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---------------HHHHhcC
Confidence            11  122346799999999999999999999999999999999999999964322111               0111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA  344 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  344 (361)
                      .  ..++...+..+.+++.+||+.||++|+     ++.++++.
T Consensus       212 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 E--IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             C--CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            1  123334566799999999999999996     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4e-44  Score=326.53  Aligned_cols=268  Identities=27%  Similarity=0.428  Sum_probs=212.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC--------CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDG  134 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~  134 (361)
                      .++|.+.+.||+|+||.||++...        +...+|+|.+.....  ...++.+|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            468999999999999999999853        235799999875432  235688899999999 799999999999999


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      ...++||||+.+++|.+++.......       .......+++.+++.++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            99999999999999999997653211       0112235899999999999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccch
Q 018071          208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS  286 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~  286 (361)
                      +.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.....     
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence            9999999999999876543221111222334578999999998899999999999999999998 8889864321     


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                                 ..+...+......+.+...+..+.+++.+||+.+|.+|||+.+|++.|+.+++..
T Consensus       249 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         249 -----------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             -----------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence                       1111122222222334455678999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.7e-44  Score=325.07  Aligned_cols=267  Identities=25%  Similarity=0.426  Sum_probs=212.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC--------CCCEEEEEEcCCCC--CChHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG  134 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~  134 (361)
                      .++|.+.+.||+|+||.||+|...        ++..||+|.+....  ....++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            578899999999999999999741        34579999886532  2345788999999999 799999999999999


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      ...+++|||+.+++|.+++........       ......+++..++.++.||+.||.|||+.+   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999976532110       012345889999999999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccch
Q 018071          208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS  286 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~  286 (361)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||......    
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----  246 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  246 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence            9999999999999986643322222233446678999999998899999999999999999998 78888543221    


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                                  .+...+........+..++..+.+++.+||+.+|.+|||+.++++.|++++..
T Consensus       247 ------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 ------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                        11111111122223345567899999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.3e-44  Score=329.40  Aligned_cols=247  Identities=21%  Similarity=0.284  Sum_probs=196.9

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||.||++..+ +++.||+|++.+..    .....+..|..+++.+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999977 78999999997532    2234577899999888 699999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 g~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  148 (329)
T cd05588          81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR  148 (329)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence            99998886543         2899999999999999999999998   99999999999999999999999999875321


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcc--cchhhhhhcccCCchhhhhhc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG--QQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .  .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......        .....+.
T Consensus       149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~  218 (329)
T cd05588         149 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED--------YLFQVIL  218 (329)
T ss_pred             C--CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchH--------HHHHHHH
Confidence            1  112345679999999999999999999999999999999999999996432211  000000        0011111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPN------MSIVVK  343 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs------~~evl~  343 (361)
                      ....  ..+...+..+.+++.+||+.||.+|||      ++++++
T Consensus       219 ~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         219 EKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             cCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            2111  234445677999999999999999997      567664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.1e-44  Score=329.51  Aligned_cols=240  Identities=23%  Similarity=0.339  Sum_probs=196.9

Q ss_pred             CccccCCceEEEEEEE----CCCCEEEEEEcCCC-----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           73 ALIGEGSYGRVYYGIL----KSGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +.||+|+||.||++..    .+++.||+|++...     ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999985    26889999998642     12234577899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +.+++|.+++....         .+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (323)
T cd05584          82 LSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE  149 (323)
T ss_pred             CCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence            99999999987543         2788999999999999999999998   99999999999999999999999999875


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......               .+..+
T Consensus       150 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---------------~~~~~  212 (323)
T cd05584         150 SIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---------------TIDKI  212 (323)
T ss_pred             cccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---------------HHHHH
Confidence            32211  12334679999999999998899999999999999999999999997543211               11111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      ....  ...+...+..+.+++.+||+.+|++||     +++++++
T Consensus       213 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         213 LKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            1111  123344567799999999999999999     7888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-44  Score=324.13  Aligned_cols=262  Identities=21%  Similarity=0.338  Sum_probs=196.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC--CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcC---CCCCcceeeeEEE-----e
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRL---KHENFVQLLGYCV-----D  133 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~hpniv~~~~~~~-----~  133 (361)
                      ++|++.+.||+|+||.||+|...  ++..||+|.+.....   ....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47999999999999999999864  468899998865322   234566787777665   6999999999885     2


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      ....++||||+. ++|.+++.....       ..+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~  149 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI  149 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCE
Confidence            456889999996 599999875432       23899999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWAT  292 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~~~  292 (361)
                      ||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .+.....
T Consensus       150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~  226 (290)
T cd07862         150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  226 (290)
T ss_pred             EEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence            99999998764322   2234567899999999999889999999999999999999999999765432211 1111000


Q ss_pred             ccCCchhhhh-------hcccccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          293 PKLSEDKVRQ-------CVDARLGG---DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       293 ~~~~~~~~~~-------~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       .........       ........   ...+..+..+.+++.+||+.||++|||+.++++
T Consensus       227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 -LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             -CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence             000000000       00000000   011234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1e-43  Score=316.12  Aligned_cols=253  Identities=30%  Similarity=0.485  Sum_probs=206.7

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++|.+...||+|+||.||+|..+.+..+|+|.+.......+.+.+|+.+++.++|||++++++++. ....+++|||+.+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            578899999999999999999887778999998766666678899999999999999999998875 4567899999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++.....       ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.....
T Consensus        85 ~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          85 GSLLDFLKEGDG-------KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             CCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            999999975432       23789999999999999999999998   99999999999999999999999999876533


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                ....+.
T Consensus       155 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~  217 (260)
T cd05069         155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE----------------VLEQVE  217 (260)
T ss_pred             Cccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHH
Confidence            2211 1122345678999999988899999999999999999999 999996543211                111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                      .......+...+..+.+++.+||+.+|.+||++++|++.|+.
T Consensus       218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         218 RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            112223344566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-44  Score=334.97  Aligned_cols=270  Identities=18%  Similarity=0.244  Sum_probs=203.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      ++|.+.+.||+|+||.||++... +++.||+|...     ...+.+|+.++++++||||+++++++......+++||++.
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            57999999999999999999976 89999999753     2357889999999999999999999999999999999995


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                       ++|..++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       167 -~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        167 -TDLYCYLAAKR---------NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             -CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence             68888886543         2889999999999999999999998   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCccc-----chh---hhhhcc---c
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-----QSL---VTWATP---K  294 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~-----~~~---~~~~~~---~  294 (361)
                      ... ........||+.|+|||++.+..++.++|||||||++|+|++|..||-.......     ..+   ......   .
T Consensus       234 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        234 DIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             ccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            211 1122346799999999999999999999999999999999999988743221110     000   000000   0


Q ss_pred             C---Cchhhhhhc----ccccC--CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCC
Q 018071          295 L---SEDKVRQCV----DARLG--GDY-----PPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAG  357 (361)
Q Consensus       295 ~---~~~~~~~~~----~~~~~--~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~  357 (361)
                      .   ....+....    .....  ...     ....+..+.+|+.+||+.||.+|||++|+++  ...+...+.|.+
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~--hp~f~~~~~~~~  387 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD--FAAFQDIPDPYP  387 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc--ChhhccCCCCCC
Confidence            0   000011000    00000  000     0134567999999999999999999999996  334444444444

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.8e-44  Score=330.06  Aligned_cols=245  Identities=23%  Similarity=0.279  Sum_probs=199.2

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCC-CCcceeeeEEEeCCeeEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~  141 (361)
                      +|++.+.||+|+||.||+|..+ +++.||+|++.+.    ....+.+..|+.++..++| ++|+++++++.+....++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5888999999999999999977 7889999998653    2334567789999999976 46888999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---------KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMC  148 (324)
T ss_pred             cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcc
Confidence            9999999999986543         2889999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ......  .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......               .+.
T Consensus       149 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---------------~~~  211 (324)
T cd05587         149 KENIFG--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---------------LFQ  211 (324)
T ss_pred             eecCCC--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---------------HHH
Confidence            643211  112345679999999999999999999999999999999999999997543211               111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM-----SIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~  343 (361)
                      .+....  ..++...+..+.+++.+||+.||.+|++.     +++++
T Consensus       212 ~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         212 SIMEHN--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             HHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            111111  12334456778999999999999999986     56554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3e-44  Score=330.96  Aligned_cols=250  Identities=23%  Similarity=0.288  Sum_probs=199.6

Q ss_pred             cCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCC-----CCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCee
Q 018071           68 NFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSR  137 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~  137 (361)
                      +|++.+.||+|+||.||++...    +++.||+|++.+.     ....+.+..|+.+++.++ ||||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5888999999999999999852    6889999998642     122346778999999994 99999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      ++||||+.+|+|.+++....         .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~D  148 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---------NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTD  148 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEee
Confidence            99999999999999987543         2899999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ||+++....... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||............        
T Consensus       149 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--------  219 (332)
T cd05614         149 FGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--------  219 (332)
T ss_pred             CcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--------
Confidence            999876432211 122346799999999999865 4788999999999999999999999644322111100        


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                         ...+..  .....+...+..+.+++.+||+.||++||     +++++++
T Consensus       220 ---~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         220 ---SRRILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---HHHHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence               001111  11123344567799999999999999999     6778775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.7e-44  Score=338.19  Aligned_cols=251  Identities=22%  Similarity=0.279  Sum_probs=199.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++.+.    ......+.+|+.++++++||||+++++.+.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999976 7999999998652    223456788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.+++....         .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a  148 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC  148 (376)
T ss_pred             eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence            9999999999997643         3889999999999999999999998   999999999999999999999999997


Q ss_pred             CCCcccc-----------------------------------------ccccccccccCCCCCCchhhccCCCCCcccee
Q 018071          222 NQAPDMA-----------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY  260 (361)
Q Consensus       222 ~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  260 (361)
                      .......                                         ........+||+.|+|||++.+..++.++|||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  228 (376)
T cd05598         149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW  228 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence            5321000                                         00011235799999999999999999999999


Q ss_pred             cHHHHHHHHHhCCCCCCCCCCcccch-hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC---
Q 018071          261 SFGVVLLELLTGRKPVDHTLPRGQQS-LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP---  336 (361)
Q Consensus       261 slG~~l~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---  336 (361)
                      ||||++|+|++|+.||....+..... +..|              ............+..+.+++.+|+ .+|.+|+   
T Consensus       229 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~  293 (376)
T cd05598         229 SVGVILYEMLVGQPPFLADTPAETQLKVINW--------------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN  293 (376)
T ss_pred             eccceeeehhhCCCCCCCCCHHHHHHHHhcc--------------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence            99999999999999997554321110 0000              001111111234566788888876 5999999   


Q ss_pred             CHHHHHHH
Q 018071          337 NMSIVVKA  344 (361)
Q Consensus       337 s~~evl~~  344 (361)
                      ++.++++.
T Consensus       294 t~~ell~h  301 (376)
T cd05598         294 GADEIKAH  301 (376)
T ss_pred             CHHHHhCC
Confidence            88998863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.3e-44  Score=328.33  Aligned_cols=240  Identities=20%  Similarity=0.298  Sum_probs=195.6

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||.||+|..+ +++.||+|++.+.    ....+.+..|.+++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999977 7899999998753    22234567788888866 799999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++....         .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~  148 (321)
T cd05591          81 GDLMFQIQRSR---------KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGIL  148 (321)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999886543         2889999999999999999999998   99999999999999999999999999875322


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      .  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........               +..+...
T Consensus       149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---------------~~~i~~~  211 (321)
T cd05591         149 N--GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---------------FESILHD  211 (321)
T ss_pred             C--CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---------------HHHHHcC
Confidence            1  1123456799999999999999999999999999999999999999975432211               1111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCC-------CHHHHHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRP-------NMSIVVK  343 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-------s~~evl~  343 (361)
                      ..  ..+...+..+.+++.+||+.||++||       +++++++
T Consensus       212 ~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         212 DV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            11  12233456789999999999999999       7788775

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.9e-45  Score=334.53  Aligned_cols=249  Identities=22%  Similarity=0.266  Sum_probs=202.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|.+.+.||+|+||.||++..+ +++.||+|++.....    ....+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47889999999999999999977 899999999875322    3356788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.+++.....        .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a  149 (330)
T cd05601          81 EYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSA  149 (330)
T ss_pred             CCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCC
Confidence            99999999999976531        3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhc------cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAM------TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      ........ .......||+.|+|||++.      ...++.++|||||||++|+|++|..||.......            
T Consensus       150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------------  216 (330)
T cd05601         150 ARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------------  216 (330)
T ss_pred             eECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------------
Confidence            76533211 1223457899999999987      4567899999999999999999999996543211            


Q ss_pred             Cchhhhhhcccc--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          296 SEDKVRQCVDAR--LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       296 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         .+..+....  ...+.....+..+.+|+.+||+ +|.+|||+.++++
T Consensus       217 ---~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         217 ---TYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ---HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence               011111110  1111122356778999999998 9999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.6e-44  Score=328.67  Aligned_cols=235  Identities=23%  Similarity=0.317  Sum_probs=192.6

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||.||+|..+ +++.||+|++.+.    ....+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999977 7899999998653    22335667788888776 699999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|.+++....         .+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 g~L~~~i~~~~---------~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~  148 (320)
T cd05590          81 GDLMFHIQKSR---------RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF  148 (320)
T ss_pred             chHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence            99999887653         2899999999999999999999998   99999999999999999999999999875322


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      .  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........               ...+...
T Consensus       149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---------------~~~i~~~  211 (320)
T cd05590         149 N--GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---------------FEAILND  211 (320)
T ss_pred             C--CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---------------HHHHhcC
Confidence            1  1123456799999999999999999999999999999999999999975432110               1111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNM  338 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  338 (361)
                      .  ...+...+..+.+++.+||+.||.+||++
T Consensus       212 ~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         212 E--VVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             C--CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            1  12233456678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-43  Score=316.86  Aligned_cols=259  Identities=25%  Similarity=0.384  Sum_probs=203.9

Q ss_pred             CCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCe-----
Q 018071           69 FGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS-----  136 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-----  136 (361)
                      |.+.++||+|+||.||+|...    ++..||+|++......   ...+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999864    2478999998754332   3468889999999999999999998865544     


Q ss_pred             -eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          137 -RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       137 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                       .+++|||+++++|..++.......   ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl  154 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCV  154 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEE
Confidence             789999999999999986543211   1124899999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......            
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------------  222 (273)
T cd05035         155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------------  222 (273)
T ss_pred             CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence            99999876543222212223345678999999988899999999999999999999 88998643221            


Q ss_pred             CCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                          .+.+.+........+..++..+.+++.+||+.||.+|||+.++++.|++++
T Consensus       223 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         223 ----EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             ----HHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                111111111112234456678999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.5e-44  Score=323.31  Aligned_cols=259  Identities=24%  Similarity=0.408  Sum_probs=208.9

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGT  135 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~  135 (361)
                      ..++|.+.+.||+|+||.||++...      ++..+|+|.+......  .+.+.+|+.+++++ +||||+++++++....
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3468999999999999999999742      4558999988754322  35688999999999 7999999999999999


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..+++|||+.+++|.+++......       .+++.++..++.|++.||.|||+.+   ++|+||||+|||++.++.++|
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l  182 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRES-------FLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI  182 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEE
Confidence            999999999999999999754321       2899999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......            
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------------  250 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------------  250 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------------
Confidence            99999886543322112223446788999999999899999999999999999998 99998643221            


Q ss_pred             CCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                         ......+........+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       251 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         251 ---SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence               111112222222222333456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.4e-44  Score=336.83  Aligned_cols=248  Identities=21%  Similarity=0.244  Sum_probs=197.3

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      +|++.++||+|+||.||+|..+ +++.||+|++.+..    .....+.+|+.+++.++||||+++++.+.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999976 78999999987532    223467889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++|+|.+++....         .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~  149 (382)
T cd05625          82 YIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (382)
T ss_pred             CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCc
Confidence            999999999987543         2889999999999999999999998   9999999999999999999999999975


Q ss_pred             CCcccc---------------------------------------------ccccccccccCCCCCCchhhccCCCCCcc
Q 018071          223 QAPDMA---------------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQLNAKS  257 (361)
Q Consensus       223 ~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  257 (361)
                      ......                                             ........+||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (382)
T cd05625         150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC  229 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence            321000                                             00001235799999999999999999999


Q ss_pred             ceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc--cccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 018071          258 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD--ARLGGDYPPKAVAKMAAVAALCVQYEADFR  335 (361)
Q Consensus       258 DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  335 (361)
                      |||||||++|||++|+.||....+...               ...++.  .....+.....+..+.+++.+|+ .+|.+|
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~---------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R  293 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLET---------------QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDR  293 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHH---------------HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHc
Confidence            999999999999999999975433211               111111  11111112234566788888876 499999


Q ss_pred             CC---HHHHHH
Q 018071          336 PN---MSIVVK  343 (361)
Q Consensus       336 Ps---~~evl~  343 (361)
                      ++   ++++++
T Consensus       294 ~~~~~~~ei~~  304 (382)
T cd05625         294 LGKNGADEIKA  304 (382)
T ss_pred             CCCCCHHHHhc
Confidence            97   888775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-44  Score=320.84  Aligned_cols=262  Identities=27%  Similarity=0.427  Sum_probs=209.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      .++|.+.+.||+|+||.||+|..+      ++..||+|.+......  ...+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            468999999999999999999865      2478999998654322  34678899999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGA-QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      +++|||+++++|.+++......... .....+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            9999999999999999754322111 11234789999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......            
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------------  229 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------------  229 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------------
Confidence            9999876543332222344557889999999998889999999999999999998 999996433211            


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                          ....+........+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       230 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         230 ----VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ----HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                11111111112233345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.7e-44  Score=334.11  Aligned_cols=266  Identities=27%  Similarity=0.449  Sum_probs=210.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCC-CCCcceeeeEEEeCCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~  136 (361)
                      .++|.+.+.||+|+||.||+|.++      ++..||+|++......  .+.+.+|++++.++. ||||+++++++.....
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            357888899999999999999864      3468999999764322  346889999999997 9999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCC--------------------------------------------------------
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVK--------------------------------------------------------  160 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~--------------------------------------------------------  160 (361)
                      .++||||+.+|+|.++++......                                                        
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999997543210                                                        


Q ss_pred             ---------------------------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          161 ---------------------------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       161 ---------------------------------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                                                       .....+.+++..++.++.||+.||.|||+.+   ++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence                                             0011235788899999999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccch
Q 018071          208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS  286 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~  286 (361)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......    
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~----  348 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN----  348 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch----
Confidence            9999999999999876432222112233457889999999998889999999999999999998 89998643211    


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                                 +.....+........+..++..+.+++.+||+.+|.+||++++|++.|+.++
T Consensus       349 -----------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 -----------EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -----------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                       1111112222222334445678999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.9e-44  Score=321.10  Aligned_cols=261  Identities=27%  Similarity=0.377  Sum_probs=206.5

Q ss_pred             cCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      +|.+.+.||+|+||.||+|...      .+..||+|++......  ...+.+|+.+++.++||||+++++++.+....++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4667778999999999999853      3578999998754332  3567889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          140 AYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                      ++||+.+++|.+++.......       .......+++..++.++.|++.||.|||+.+   |+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999999986432110       0111234888999999999999999999998   999999999999999999


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~  291 (361)
                      +||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||......         
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---------  233 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---------  233 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---------
Confidence            99999999886543322222334456789999999998899999999999999999998 88888643221         


Q ss_pred             cccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          292 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                             .+...+.......++..++..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       234 -------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 -------DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                   1111111222223445567779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=9.7e-44  Score=318.18  Aligned_cols=259  Identities=25%  Similarity=0.373  Sum_probs=200.2

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCC--EEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeC------Ce
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGH--AAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------TS  136 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~~  136 (361)
                      |.+.++||+|+||.||+|.+. ++.  .+|+|.++...   ...+.+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            456788999999999999976 333  68999886543   2235678899999999999999999987532      24


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .+++|||+.+|+|.+++......   .....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLG---DCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhccc---CCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEEC
Confidence            68999999999999987533211   11134899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......   +..      
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~------  225 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYD------  225 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH------
Confidence            9999987643322212233456778999999999899999999999999999999 889996432211   111      


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                             .+........+...+..+.+++.+||+.+|++|||+.++++.|+.++
T Consensus       226 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         226 -------YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             -------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                   11111111123345567999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.2e-44  Score=327.47  Aligned_cols=248  Identities=21%  Similarity=0.291  Sum_probs=195.7

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||.||+|..+ +++.||+|++.+..    .....+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999977 78999999987532    2234567888888776 799999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|..++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~  148 (329)
T cd05618          81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  148 (329)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence            99998886543         3899999999999999999999998   99999999999999999999999999875322


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh-hhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR-QCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  305 (361)
                      .  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..........       ......+. .+..
T Consensus       149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-------~~~~~~~~~~i~~  219 (329)
T cd05618         149 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDYLFQVILE  219 (329)
T ss_pred             C--CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc-------cccHHHHHHHHhc
Confidence            1  112345679999999999999999999999999999999999999996322111000       00001111 1111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM------SIVVK  343 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~  343 (361)
                      ..  ...+...+..+.+++.+||+.||.+||++      .++++
T Consensus       220 ~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         220 KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            11  13445566779999999999999999984      56654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-43  Score=320.64  Aligned_cols=267  Identities=25%  Similarity=0.405  Sum_probs=209.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      .++|++.++||+|+||.||+|..+      .+..||+|.+......  ...+.+|+.+++.++||||+++++++.+....
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            578999999999999999999753      2458999988654322  24577899999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          138 VLAYEFASNGSLHDILHGRKGVK-GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      +++|||+.+|+|.+++....... .....+.+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence            99999999999999997543211 1111234678889999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.......            
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------------  229 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------  229 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence            9999876543222222233456778999999998899999999999999999998 788986432211            


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                          +...+........+...+..+.+++.+||+.+|++|||+.++++.|+..+..
T Consensus       230 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         230 ----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             ----HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence                1111111111112233456899999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8e-44  Score=319.79  Aligned_cols=260  Identities=27%  Similarity=0.435  Sum_probs=206.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      .++|.+.+.||+|+||.||+|.+.      ++..|++|.+......  ...+.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            467999999999999999999975      3578999988654322  34688999999999999999999999988899


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC---ceE
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAK  214 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~---~~k  214 (361)
                      +++|||+++++|.+++........  ....+++..++.++.||+.||+|||+.+   ++||||||+||+++.++   .+|
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence            999999999999999976542211  1234899999999999999999999998   99999999999998765   599


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||.......          
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----------  229 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----------  229 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----------
Confidence            999999986532222111223334568999999998899999999999999999997 999997543221          


Q ss_pred             cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                            +...+........+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus       230 ------~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         230 ------VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                  11122222222334455678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.5e-43  Score=316.08  Aligned_cols=258  Identities=22%  Similarity=0.352  Sum_probs=208.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.++||+|+||.||+|..+ +++.||||.+....    .....+.+|+.+++.++||||+++++++.+....++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999976 89999999875422    22346788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++......     ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++
T Consensus        82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccc
Confidence            999999999988643211     123789999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||........              .+.
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--------------~~~  217 (267)
T cd08228         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF--------------SLC  217 (267)
T ss_pred             eeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH--------------HHH
Confidence            76543221  12345688899999999988899999999999999999999999854322110              011


Q ss_pred             hhccc-ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          302 QCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       302 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ..+.. ......+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         218 QKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11111 111112234567899999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.3e-44  Score=326.04  Aligned_cols=240  Identities=23%  Similarity=0.310  Sum_probs=193.3

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||.||+|..+ +++.||+|.+....    ...+.+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999976 78899999986532    2234456677776654 799999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|.+++....         .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~  148 (316)
T cd05592          81 GDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN  148 (316)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence            99999986543         3899999999999999999999998   99999999999999999999999999875422


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......               ....+...
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---------------~~~~i~~~  211 (316)
T cd05592         149 GE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---------------LFDSILND  211 (316)
T ss_pred             CC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---------------HHHHHHcC
Confidence            11  22345679999999999999899999999999999999999999997543211               01111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS-IVVK  343 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~  343 (361)
                        ...++...+..+.+++.+||+.+|.+||++. ++++
T Consensus       212 --~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         212 --RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence              1123344567789999999999999999875 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.8e-43  Score=323.28  Aligned_cols=270  Identities=26%  Similarity=0.422  Sum_probs=211.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC--------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG  134 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~~  134 (361)
                      .++|.+.+.||+|+||.||+|...        ....+|+|.+......  ..++.+|+.+++.+ +||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            368889999999999999999742        3457999988754322  34678899999999 699999999999998


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      ...+++|||+.+|+|.+++.......       .......+++..+..++.|++.||.|||+.+   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            99999999999999999997643210       0112245899999999999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccch
Q 018071          208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS  286 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~  286 (361)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999986543222211222334568999999998899999999999999999999 889986432211   


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                                   +...+........+..++..+.+++.+||+.+|++|||+.++++.|+.+......
T Consensus       245 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~  299 (314)
T cd05099         245 -------------LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE  299 (314)
T ss_pred             -------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence                         1111111111223344566799999999999999999999999999999875443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=335.05  Aligned_cols=266  Identities=27%  Similarity=0.435  Sum_probs=234.0

Q ss_pred             HHHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           60 DELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        60 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      ++++--..+.....+||.|.||.||.|.|+ -...||||.++.+....++|+.|+.+|+.+.|||+|+++++|..+..+|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            444444455666778999999999999988 6788999999988888899999999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      ||.|||..|+|.+||+...+..       ++....++++.||+.|+.||..+.   +|||||...|+|+.++..+|++||
T Consensus       340 IiTEfM~yGNLLdYLRecnr~e-------v~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADF  409 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSE-------VPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADF  409 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhh-------cchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeecc
Confidence            9999999999999998776432       777788999999999999999997   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |+++.+.......+.... -...|.|||-+....++.++|||+|||+|||+.| |-.||.                .+..
T Consensus       410 GLsRlMtgDTYTAHAGAK-FPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP----------------Gidl  472 (1157)
T KOG4278|consen  410 GLSRLMTGDTYTAHAGAK-FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP----------------GIDL  472 (1157)
T ss_pred             chhhhhcCCceecccCcc-CcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC----------------CccH
Confidence            999987554433322211 2567999999999999999999999999999998 888883                4556


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      ..+..+++..++++-|..|+..+++|+.+||+++|.+||++.|+-+.|+.++...
T Consensus       473 SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  473 SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            7788999999999999999999999999999999999999999999999888643

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.4e-44  Score=327.98  Aligned_cols=240  Identities=24%  Similarity=0.294  Sum_probs=196.5

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +|.+.+.||+|+||.||+|..+ +++.||+|++.+..    .....+..|..++..+ .|++|+++++++.+....++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5888999999999999999977 78899999987532    2224566777888777 5899999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~  148 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCc
Confidence            9999999999986543         2889999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....  .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......               .+.
T Consensus       149 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---------------~~~  211 (323)
T cd05616         149 KENMWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---------------LFQ  211 (323)
T ss_pred             eecCCC--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---------------HHH
Confidence            753221  112345679999999999999999999999999999999999999997543211               111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM  338 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  338 (361)
                      .+....  ..++...+..+.+++.+||+.+|.+|++.
T Consensus       212 ~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         212 SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            111111  12344566789999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-44  Score=321.60  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=203.3

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      +|++.++||+|+||.||++... +++.||+|++.....    ....+.+|+.+++.++||||+++++.+.++...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999976 799999999865321    22456789999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+.+|+|.+++.....       ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.
T Consensus        81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~  150 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-------PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAV  150 (285)
T ss_pred             ccCCCcHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCce
Confidence            9999999988864321       23899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ......   ......|++.|+|||++.+..++.++||||+||++|+|++|..||.........            ..+..
T Consensus       151 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~------------~~~~~  215 (285)
T cd05605         151 EIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR------------EEVER  215 (285)
T ss_pred             ecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH------------HHHHH
Confidence            653221   123457899999999999889999999999999999999999999754321110            01111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      .+.. ....++...+..+.+|+.+||+.||.+||     +++++++
T Consensus       216 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         216 RVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             Hhhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            1111 11233445677899999999999999999     8889876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5e-44  Score=333.86  Aligned_cols=254  Identities=19%  Similarity=0.250  Sum_probs=202.9

Q ss_pred             HHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           62 LKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        62 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      +....++|++.+.||+|+||.||++..+ +++.+|+|++.+..    .....+.+|+.+++.++||||+++++.+.+...
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3344589999999999999999999987 88999999986421    223457789999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||+++|+|.+++....          +++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~  184 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA  184 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEE
Confidence            999999999999999987543          888999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccC----CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      |||++....... .......+||+.|+|||++.+.    .++.++|||||||++|+|++|..||.......         
T Consensus       185 DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---------  254 (371)
T cd05622         185 DFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---------  254 (371)
T ss_pred             eCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH---------
Confidence            999987653221 1123456799999999998754    37899999999999999999999997543211         


Q ss_pred             ccCCchhhhhhcccc--cCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 018071          293 PKLSEDKVRQCVDAR--LGGDYPPKAVAKMAAVAALCVQYEADF--RPNMSIVVKA  344 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~  344 (361)
                            ....+....  +..+.....+..+.+++.+||..++.+  |++++++++.
T Consensus       255 ------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         255 ------TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ------HHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                  111121111  111122345677999999999844443  7899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-43  Score=322.24  Aligned_cols=266  Identities=28%  Similarity=0.427  Sum_probs=207.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCC--EEEEEEcCCCC--CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGH--AAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|++.+.||+|+||.||+|.++ ++.  .+++|.+....  .....+.+|+.++.++ +||||+++++++.+....+++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57889999999999999999976 554  45777765422  2235688899999999 899999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          141 YEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      |||+++++|.+++........       ......+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            999999999999975532110       011235899999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      ||+|||++......   .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......   .     
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~-----  232 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L-----  232 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---H-----
Confidence            99999998643211   11122334678999999988889999999999999999998 999996433211   0     


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                              ...+........+...+..+.+|+.+||+.+|++||+++++++.|..+++....
T Consensus       233 --------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~  286 (303)
T cd05088         233 --------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  286 (303)
T ss_pred             --------HHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence                    011111111112223456789999999999999999999999999998876553

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2e-43  Score=314.23  Aligned_cols=255  Identities=24%  Similarity=0.428  Sum_probs=208.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|.+.+.||+|+||.||++..+.+..+++|.+.........+.+|+.+++.++|+||+++++++.+ ...+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            46899999999999999999998778889999987655555688999999999999999999999887 77899999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....       ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++....
T Consensus        84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          84 KGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             CCcHHHHHHhCCc-------cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            9999999976432       23788999999999999999999998   9999999999999999999999999987653


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .... .......++..|+|||++.+..++.++|+|||||++|++++ |..||.......                +...+
T Consensus       154 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----------------~~~~~  216 (260)
T cd05073         154 DNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----------------VIRAL  216 (260)
T ss_pred             CCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHH
Confidence            3211 11222345678999999998889999999999999999998 999996432211                11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ......+.+...+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         217 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            12222223344567799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.1e-43  Score=317.37  Aligned_cols=257  Identities=25%  Similarity=0.426  Sum_probs=205.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCC----EEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|++.++||+|+||+||+|.+. ++.    .||+|.+.....  ...++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            57888999999999999999865 454    489998865332  245688899999999999999999998754 5689


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ++||+++|+|.+++.....        .+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        86 ~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             EEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCC
Confidence            9999999999999875431        3899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......                
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------  218 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----------------  218 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----------------
Confidence            9886643222212222345678999999998899999999999999999998 99998643221                


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      .+...+........+...+..+.+++.+||+.||++||++.++++.|..+...
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         219 EIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             HHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            11112222222223344566799999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.5e-45  Score=322.99  Aligned_cols=248  Identities=31%  Similarity=0.543  Sum_probs=195.1

Q ss_pred             CCccccCCceEEEEEEEC-----CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           72 NALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      .+.||.|.||.||+|.++     .+..|+||.+......  .+.+.+|++.+++++||||+++++++......++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            467999999999999976     4678999999653332  468999999999999999999999999888899999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      .+|+|.+++.....       ..+++..++.++.||+.||.|||+.+   ++|+||+++|||+++++.+||+|||++...
T Consensus        84 ~~g~L~~~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   84 PGGSLDDYLKSKNK-------EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             TTEBHHHHHHHTCT-------TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             cccccccccccccc-------cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            99999999988622       23899999999999999999999997   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      .............+...|+|||.+.+..++.++||||||+++|||++ |+.||.....                ..+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----------------~~~~~~  217 (259)
T PF07714_consen  154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----------------EEIIEK  217 (259)
T ss_dssp             TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----------------HHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------cccccc
Confidence            32222222344556788999999999889999999999999999999 7889854321                111111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      +........+..++..+.+++.+||..+|++|||+++|++.|
T Consensus       218 ~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  218 LKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            122222233445677799999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-43  Score=313.57  Aligned_cols=251  Identities=31%  Similarity=0.511  Sum_probs=208.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|++.+.||.|+||.||+|... ++.||+|.+.......+++.+|+.+++.++|+||+++++++.+....++||||++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            357889999999999999999976 8999999997665556788999999999999999999999998999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++......       .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.++...
T Consensus        84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          84 KGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             CCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence            99999999765421       3899999999999999999999998   9999999999999999999999999988753


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ...     ....++..|+|||.+.++.++.++||||||+++|+|++ |..||......                .+...+
T Consensus       154 ~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~~~~  212 (256)
T cd05039         154 QGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPHV  212 (256)
T ss_pred             ccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH----------------HHHHHH
Confidence            211     12334668999999998899999999999999999997 99999643221                111111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ........+...+..+.+++.+||+.+|++|||+++++++|+.+
T Consensus       213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         213 EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            11122223334567899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-44  Score=329.75  Aligned_cols=237  Identities=22%  Similarity=0.308  Sum_probs=194.6

Q ss_pred             CccccCCceEEEEEEE----CCCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           73 ALIGEGSYGRVYYGIL----KSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      +.||+|+||.||++..    .+|+.||+|++.+..   .....+.+|++++++++||||+++++++.+....++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    268999999987532   233456789999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++....
T Consensus        82 ~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          82 GGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  149 (318)
T ss_pred             CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence            999999986543         3899999999999999999999998   9999999999999999999999999987643


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......               .+..+..
T Consensus       150 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------------~~~~i~~  212 (318)
T cd05582         150 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---------------TMTMILK  212 (318)
T ss_pred             CCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---------------HHHHHHc
Confidence            221  12345679999999999998899999999999999999999999997432211               1111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI  340 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e  340 (361)
                      ..  ...+...+..+.+++.+||+.||++||++.+
T Consensus       213 ~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         213 AK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            11  1233445677999999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.2e-43  Score=320.15  Aligned_cols=266  Identities=29%  Similarity=0.417  Sum_probs=209.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCC--EEEEEEcCCCC--CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGH--AAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|++.++||+|+||.||+|..+ ++.  .+++|.+....  ...+.+.+|+.+++++ +||||+++++++.+....+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57899999999999999999876 443  47888876422  2235788899999999 699999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          141 YEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      |||+++++|.+++........       ......+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            999999999999975432110       011234889999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      ||+|||++.......   .......+..|+|||++.+..++.++|||||||++|+|++ |..||.......         
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---------  226 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---------  226 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence            999999986432211   1122233567999999998899999999999999999997 999996443211         


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                             +...+........+..++..+.+|+.+||+.+|.+|||++++++.|+.+++...+
T Consensus       227 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         227 -------LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             -------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                   1111112222233344567799999999999999999999999999999886544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.8e-43  Score=312.74  Aligned_cols=246  Identities=28%  Similarity=0.467  Sum_probs=198.9

Q ss_pred             ccccCCceEEEEEEEC---CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCC
Q 018071           74 LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      .||+|+||.||+|.++   ++..+|+|++......   .+++.+|+.+++.++||||+++++++. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5999999999999753   6789999998654332   357889999999999999999999875 45678999999999


Q ss_pred             cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccc
Q 018071          148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM  227 (361)
Q Consensus       148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~  227 (361)
                      +|.+++....         .+++..+..++.|++.||+|||+.+   |+||||||.||++++++.+||+|||++......
T Consensus        81 ~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          81 PLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            9999986543         2889999999999999999999998   999999999999999999999999998765432


Q ss_pred             cccc-cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          228 AARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       228 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .... ......++..|+|||.+....++.++|||||||++|||++ |..||......                .+...++
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~~~~i~  212 (257)
T cd05116         149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----------------EVTQMIE  212 (257)
T ss_pred             CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHH
Confidence            2111 1122334678999999988889999999999999999998 99999643221                1122222


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      .....+.+...+..+.++|.+||+.||++||++.+|.+.|+..
T Consensus       213 ~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         213 SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            2222334455677899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.5e-44  Score=325.29  Aligned_cols=239  Identities=23%  Similarity=0.295  Sum_probs=193.1

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||.||+|..+ +++.||+|.+.+.    .........|..++..+ +||||+++++++.+....++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999987 7899999998753    22334566777777754 899999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|..++....         .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 g~L~~~i~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05620          81 GDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF  148 (316)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence            99999886543         2889999999999999999999998   99999999999999999999999999864321


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      .  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||........   .            ..+...
T Consensus       149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~------------~~~~~~  211 (316)
T cd05620         149 G--DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---F------------ESIRVD  211 (316)
T ss_pred             C--CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H------------HHHHhC
Confidence            1  1123456799999999999999999999999999999999999999964432111   0            000000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS-IVV  342 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl  342 (361)
                        ....+...+..+.+++.+||+.||.+||++. +++
T Consensus       212 --~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         212 --TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              0122333456789999999999999999984 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.4e-43  Score=312.97  Aligned_cols=249  Identities=30%  Similarity=0.489  Sum_probs=203.7

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEE-eCCeeEEEEEeCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVLAYEFAS  145 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~  145 (361)
                      ++|.+.+.||+|+||.||++..+ +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. .....+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            57889999999999999999876 8889999886533 3567889999999999999999999764 5567899999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....       ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          84 KGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence            9999999876542       23889999999999999999999998   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..     .....++..|+|||++.+..++.++|||||||++|+|++ |+.||......                .+...+
T Consensus       154 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~----------------~~~~~~  212 (256)
T cd05082         154 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPRV  212 (256)
T ss_pred             cc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHH
Confidence            21     123344668999999998899999999999999999997 99998633211                111111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ........+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            12222233445567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.3e-44  Score=326.41  Aligned_cols=236  Identities=22%  Similarity=0.308  Sum_probs=190.9

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHH-HHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||+||+|..+ +++.||+|++.+..    ....++..|.. +++.++||||+++++.+.+....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999987 89999999986532    22234555554 46788999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|..++....         .+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus        81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~  148 (323)
T cd05575          81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE  148 (323)
T ss_pred             CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence            99999887543         3889999999999999999999998   99999999999999999999999999875322


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      .  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......               ....+...
T Consensus       149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---------------~~~~i~~~  211 (323)
T cd05575         149 H--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---------------MYDNILNK  211 (323)
T ss_pred             C--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---------------HHHHHHcC
Confidence            1  122345679999999999999999999999999999999999999996432211               11111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS  339 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  339 (361)
                      ..  ..++..+..+.+++.+||+.||.+||++.
T Consensus       212 ~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         212 PL--RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            11  22334467799999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.7e-43  Score=315.89  Aligned_cols=266  Identities=27%  Similarity=0.414  Sum_probs=210.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEECC-----CCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEe-CCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKS-----GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~  137 (361)
                      .++|.+.++||+|+||.||+|.+..     +..|++|.+.....  ....+.+|+.+++.++||||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4689999999999999999999764     68899998865332  23567889999999999999999998765 5778


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      +++++|+.+++|.+++....... ......+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGE-ANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccc-cccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999987653211 111235899999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCC
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ||+++...............++..|+|||.+.+..++.++|||||||++|++++ |+.||....+..   +         
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~---------  228 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---M---------  228 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---H---------
Confidence            999986533222212233446778999999998899999999999999999999 999997543211   1         


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                          ...+........+..++..+.+++.+||..+|++|||+.++++.|+.+.+.
T Consensus       229 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         229 ----AAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ----HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                111111111112233456799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.4e-44  Score=325.65  Aligned_cols=240  Identities=23%  Similarity=0.310  Sum_probs=196.3

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||+||+|..+ +++.||+|++.+.    ......+.+|..+++.+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999977 7889999998753    22334567888888887 699999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|..++....         .+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus        81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  148 (318)
T cd05570          81 GDLMFHIQRSG---------RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL  148 (318)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence            99999887653         2899999999999999999999998   99999999999999999999999999865321


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      .  .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......               ....+...
T Consensus       149 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---------------~~~~i~~~  211 (318)
T cd05570         149 G--GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---------------LFQSILED  211 (318)
T ss_pred             C--CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---------------HHHHHHcC
Confidence            1  112234578999999999999999999999999999999999999996432211               01111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNM-----SIVVK  343 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~  343 (361)
                      .  ...+...+..+.+++.+||+.||.+|||+     .++++
T Consensus       212 ~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         212 E--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             C--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            1  12333456779999999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-43  Score=318.76  Aligned_cols=262  Identities=24%  Similarity=0.405  Sum_probs=206.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      .++|...++||+|+||.||++...      ++..+++|.+.... ...+.+.+|+++++.++|+||+++++++.+....+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            357888999999999999999742      46689999886533 33457889999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          139 LAYEFASNGSLHDILHGRKGVK------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                      ++|||+.+++|.+++.......      .......+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            9999999999999997643210      0111234899999999999999999999998   999999999999999999


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~  291 (361)
                      +||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||........       
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------  233 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------  233 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------
Confidence            99999999875432221112233345788999999999999999999999999999998 9999864322111       


Q ss_pred             cccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          292 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                              + ..+........+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus       234 --------~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 --------I-ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --------H-HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                    1 111111111223345567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-43  Score=313.12  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=205.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC------ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|.+.+.||+|++|.||++... ++..+++|.+.....      ....+.+|++++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            47899999999999999999975 799999998865322      12467889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ++||+++++|.+++....         .+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||
T Consensus        82 v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg  149 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---------ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG  149 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence            999999999999987643         2889999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCcccccccc-ccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++.......... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||......               .
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------~  214 (263)
T cd06625         150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---------------A  214 (263)
T ss_pred             cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---------------H
Confidence            9876532211111 13456788999999999988999999999999999999999999643211               1


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ..............+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         215 AIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            1111111222223445566779999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.2e-44  Score=333.06  Aligned_cols=261  Identities=23%  Similarity=0.284  Sum_probs=208.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-C-----CCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H-----ENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h-----pniv~~~~~~~~~~~~~l  139 (361)
                      -+|++.++||+|+||.|.+|... +++.||||++++...-..+...|+.+|..|+ |     -|+|+++++|...++.+|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            37788999999999999999966 8999999999988877788889999999997 4     499999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC--ceEEec
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIAD  217 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~--~~kl~D  217 (361)
                      |+|.++ .+|+++++.+.-..       ++...++.++.||+.||.+||+.+   |||+|||||||||.+-+  .+||+|
T Consensus       266 VfELL~-~NLYellK~n~f~G-------lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKFRG-------LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             eehhhh-hhHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEe
Confidence            999994 59999999886543       999999999999999999999998   99999999999997544  799999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ||.+......     ....+-+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+....++...+.......+.
T Consensus       335 FGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~  409 (586)
T KOG0667|consen  335 FGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP  409 (586)
T ss_pred             cccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence            9999875432     12566788999999999999999999999999999999999999876654432222111000000


Q ss_pred             --------------------------h--------hhhh----hccc-ccC-------CCCCHHHHHHHHHHHHHccccC
Q 018071          298 --------------------------D--------KVRQ----CVDA-RLG-------GDYPPKAVAKMAAVAALCVQYE  331 (361)
Q Consensus       298 --------------------------~--------~~~~----~~~~-~~~-------~~~~~~~~~~l~~li~~cl~~~  331 (361)
                                                .        ..+.    ..+. +..       ...+......+.+++++||.+|
T Consensus       410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d  489 (586)
T KOG0667|consen  410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD  489 (586)
T ss_pred             HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence                                      0        0000    0000 000       0111234567899999999999


Q ss_pred             CCCCCCHHHHHH
Q 018071          332 ADFRPNMSIVVK  343 (361)
Q Consensus       332 p~~RPs~~evl~  343 (361)
                      |.+|+|+.+.++
T Consensus       490 P~~R~tp~qal~  501 (586)
T KOG0667|consen  490 PAERITPAQALN  501 (586)
T ss_pred             chhcCCHHHHhc
Confidence            999999999997

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.8e-43  Score=312.18  Aligned_cols=249  Identities=27%  Similarity=0.411  Sum_probs=205.8

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|.+.+.||+|+||.||+|..+ +++.|++|.+...   ......+.+|+++++.++||||+++++++.+....+++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778889999999999999976 7999999998653   23346788899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++.....       ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~  150 (256)
T cd08529          81 AENGDLHKLLKMQRG-------RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL  150 (256)
T ss_pred             CCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEccccccee
Confidence            999999999976432       23899999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ......  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......               .....+
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~  213 (256)
T cd08529         151 LSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---------------ALILKI  213 (256)
T ss_pred             ccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHH
Confidence            543221  223456889999999999999999999999999999999999999644311               011111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      .. ......+...+..+.+++.+||+.+|++||++.++++.
T Consensus       214 ~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         214 IR-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             Hc-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            11 11122333566789999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-46  Score=307.58  Aligned_cols=249  Identities=21%  Similarity=0.305  Sum_probs=208.1

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC---CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      +.+.|++..+||+|.|+.||++.+. +|+.+|+|++..   +....+++.+|+.+-+.|+||||+++++.+.+....++|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4577888889999999999999977 899999998853   345678899999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC---CceEEec
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKIAD  217 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~---~~~kl~D  217 (361)
                      +|++.|++|..-|-.+.         .+++..+-..+.||++||.|+|.++   |||||+||+|+|+.+.   .-+||+|
T Consensus        89 Fe~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~  156 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLAD  156 (355)
T ss_pred             EecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecc
Confidence            99999999966554442         3888999999999999999999998   9999999999999643   3699999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ||++..+..   ...-..++|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+...               .
T Consensus       157 FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---------------~  218 (355)
T KOG0033|consen  157 FGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---------------H  218 (355)
T ss_pred             cceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---------------H
Confidence            999988763   2233567899999999999999999999999999999999999999965321               1


Q ss_pred             hhhhhhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +-+.+++...+  ..+..+..+++..+|+.+||..||.+|.|+.|.++
T Consensus       219 rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  219 RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            11222222222  23344567788999999999999999999998775

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.8e-43  Score=316.03  Aligned_cols=255  Identities=27%  Similarity=0.451  Sum_probs=204.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CC---CEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SG---HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|++.+.||+|+||.||+|..+ ++   ..||+|.+.....  ..+++..|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            46888999999999999999976 33   3699999875422  245788999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+.+++|.+++.....        .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+
T Consensus        84 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~  152 (269)
T cd05065          84 TEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL  152 (269)
T ss_pred             EecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcc
Confidence            999999999999875432        3899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccc---cCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCC
Q 018071          221 SNQAPDMAARLHSTRVL---GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      +................   .+..|+|||++.+..++.++|||||||++|||++ |..||......              
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------------  218 (269)
T cd05065         153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------------  218 (269)
T ss_pred             ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------------
Confidence            87653322111111111   2457999999998899999999999999999886 99999643221              


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                        .+...+......+.+..++..+.+++.+||+.+|.+||++++|+..|+.+
T Consensus       219 --~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         219 --DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --HHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              11111111112223344567799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.6e-43  Score=323.77  Aligned_cols=240  Identities=24%  Similarity=0.323  Sum_probs=193.5

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      +.||+|+||.||+|..+ +++.||+|++...    .........|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999977 7889999998653    22334566777777764 899999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|.+++....         .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05619          81 GDLMFHIQSCH---------KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML  148 (316)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence            99999987543         2889999999999999999999998   99999999999999999999999999864321


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      .  ........||+.|+|||++.+..++.++|||||||++|+|++|..||........               ...+...
T Consensus       149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---------------~~~i~~~  211 (316)
T cd05619         149 G--DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---------------FQSIRMD  211 (316)
T ss_pred             C--CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHhC
Confidence            1  1122456789999999999998999999999999999999999999965432110               0001000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS-IVVK  343 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~  343 (361)
                        ...++...+..+.+++.+||+.+|.+||++. ++++
T Consensus       212 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         212 --NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             --CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence              0112334556789999999999999999997 6644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.6e-44  Score=326.60  Aligned_cols=238  Identities=21%  Similarity=0.270  Sum_probs=191.3

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHH-HHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      +.||+|+||+||+|..+ +++.||+|++.+..    .....+..|.. +++.++||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999977 78899999986532    22234444544 56778999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++....         .+++..+..++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~  148 (325)
T cd05602          81 GELFYHLQRER---------CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  148 (325)
T ss_pred             CcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence            99999987643         2788999999999999999999998   99999999999999999999999999875422


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      .  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......               .+..+...
T Consensus       149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------~~~~i~~~  211 (325)
T cd05602         149 H--NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---------------MYDNILNK  211 (325)
T ss_pred             C--CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---------------HHHHHHhC
Confidence            1  112345679999999999999999999999999999999999999996433211               01111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV  341 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev  341 (361)
                      .  ...++..+..+.+++.+||+.+|.+||++.+.
T Consensus       212 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  244 (325)
T cd05602         212 P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD  244 (325)
T ss_pred             C--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence            1  12233456779999999999999999998743

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-43  Score=317.54  Aligned_cols=246  Identities=22%  Similarity=0.312  Sum_probs=197.1

Q ss_pred             cccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        75 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      ||+|+||+||++..+ +++.||+|.+.....    ..+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999976 889999999865322    224567899999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccc
Q 018071          150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA  229 (361)
Q Consensus       150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  229 (361)
                      .+++.....     ....+++..++.++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          81 RYHIYNVDE-----ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             HHHHHhccc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            888754321     1234899999999999999999999998   99999999999999999999999999876533221


Q ss_pred             cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC
Q 018071          230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG  309 (361)
Q Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (361)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........           .....+....  
T Consensus       153 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-----------~~~~~~~~~~--  217 (280)
T cd05608         153 --KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-----------ELKQRILNDS--  217 (280)
T ss_pred             --cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-----------HHHHhhcccC--
Confidence              2234578999999999999999999999999999999999999996432211000           0001111111  


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          310 GDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       310 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      ...+...+..+.+++.+||+.||++||     +++++++
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         218 VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            123445677899999999999999999     7788886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.5e-43  Score=314.85  Aligned_cols=256  Identities=27%  Similarity=0.457  Sum_probs=205.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCC---EEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGH---AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|+..+.||+|+||.||+|..+ ++.   .+++|.+.....  ..+.+..|+++++.++||||+++++++.+....++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            57888899999999999999975 333   799999875432  245788999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++.....        .+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        85 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          85 TEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence            999999999999865431        3899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCcccccccc-ccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          221 SNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       221 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +........... ......+..|+|||++.+..++.++|||||||++|+|++ |..||......                
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~----------------  217 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----------------  217 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH----------------
Confidence            876533221111 111223457999999998899999999999999999997 99999543221                


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      .+...+......+.+...+..+.+++.+||+.+|.+||++.+|++.|++++
T Consensus       218 ~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         218 EVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            111111111222233345677999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.9e-44  Score=339.58  Aligned_cols=269  Identities=21%  Similarity=0.279  Sum_probs=199.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeC--------Ce
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--------TS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--------~~  136 (361)
                      .++|.+.++||+|+||.||+|... +++.||||++....   ....+|+.+++.++||||+++++++...        ..
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            468999999999999999999976 78999999886533   2345799999999999999999876432        24


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-ceEE
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKI  215 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl  215 (361)
                      .++||||+++ +|.+++.....     ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++ .+||
T Consensus       142 l~lvmE~~~~-~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        142 LNVVMEFIPQ-TVHKYMKHYAR-----NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             EEEEEecCCc-cHHHHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceee
Confidence            6689999975 78777653221     1124899999999999999999999998   99999999999998665 7999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||+++......   ......||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.........+......
T Consensus       213 ~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~  289 (440)
T PTZ00036        213 CDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT  289 (440)
T ss_pred             eccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999998654321   22345789999999998764 6999999999999999999999999765432211111111111


Q ss_pred             CCchhhhhh------------cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhH
Q 018071          295 LSEDKVRQC------------VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLL  349 (361)
Q Consensus       295 ~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~  349 (361)
                      ...+.+...            ....+...++...+.++.+|+.+||+.||.+|||+.++++  .++.+.
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            111111100            0000111122334567999999999999999999999996  455544

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-43  Score=310.10  Aligned_cols=255  Identities=31%  Similarity=0.476  Sum_probs=207.3

Q ss_pred             CccccCCceEEEEEEEC-C---CCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      +.||+|+||.||+|... .   +..|++|.+......  .+.+.+|+++++.++|+||+++++++.+....+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            46999999999999976 3   889999999765443  56888999999999999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++..............+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999987521100011234899999999999999999999998   99999999999999999999999999987654


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ...........++..|+|||.+.+..++.++||||||+++|+|++ |..||......                .+.+.+.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~~~~~  221 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE----------------EVLEYLR  221 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH----------------HHHHHHH
Confidence            332222345567889999999998899999999999999999999 69999754221                1111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      .......+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         222 KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            12223344556788999999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.7e-43  Score=325.92  Aligned_cols=268  Identities=25%  Similarity=0.391  Sum_probs=206.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEE------CCCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEe-CC
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVD-GT  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~-~~  135 (361)
                      .++|++.++||+|+||.||+|..      .+++.||||.++.....  ...+.+|+.++.++ +||||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            36899999999999999999973      25789999999754322  34678899999999 68999999998764 45


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCC------------------------------------------------------
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKG------------------------------------------------------  161 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------------------------------  161 (361)
                      ..+++|||+++|+|.+++........                                                      
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999999875421100                                                      


Q ss_pred             ----CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccccccccccc
Q 018071          162 ----AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL  237 (361)
Q Consensus       162 ----~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  237 (361)
                          ......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                000124788899999999999999999998   9999999999999999999999999987653322212222334


Q ss_pred             cCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHH
Q 018071          238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKA  316 (361)
Q Consensus       238 gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (361)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  .             ....+........+...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~-------------~~~~~~~~~~~~~~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E-------------FCRRLKEGTRMRAPDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H-------------HHHHHhccCCCCCCCCC
Confidence            5678999999998899999999999999999997 999986432210  0             11111111111222223


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          317 VAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       317 ~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      +..+.+++.+||+.+|++|||+.+|++.|+.+++.
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            45789999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.4e-43  Score=311.04  Aligned_cols=259  Identities=24%  Similarity=0.383  Sum_probs=210.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....    .....+.+|++++++++|+|++++++++......+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999987 89999999886422    22457889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++.....     ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          82 ELADAGDLSRMIKHFKK-----QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             ecCCCCCHHHHHHHhcc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecccee
Confidence            99999999999865321     1124889999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .......  .......++..|+|||.+.+..++.++|||||||++|+|++|..||......    .          ..+.
T Consensus       154 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~----------~~~~  217 (267)
T cd08224         154 RFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----L----------YSLC  217 (267)
T ss_pred             eeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----H----------HHHH
Confidence            7653321  1123456888999999999889999999999999999999999999643211    0          0011


Q ss_pred             hhcccccCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          302 QCVDARLGGDYPP-KAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       302 ~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      +.+........+. ..+..+.+++.+||..+|++|||+.+|++.|+.+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         218 KKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            1111111122233 56678999999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.2e-43  Score=339.33  Aligned_cols=271  Identities=17%  Similarity=0.243  Sum_probs=199.5

Q ss_pred             HHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCC------CCcceeeeEEEeC
Q 018071           62 LKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH------ENFVQLLGYCVDG  134 (361)
Q Consensus        62 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h------pniv~~~~~~~~~  134 (361)
                      +....++|++.++||+|+||+||+|... +++.||||+++...........|+.+++.++|      .+++++++++...
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            3344678999999999999999999976 78899999997544444556677777777654      4588888888754


Q ss_pred             -CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCceEeccCC-
Q 018071          135 -TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDD-  211 (361)
Q Consensus       135 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivHrDikp~Nill~~~~-  211 (361)
                       ...++|||++ +++|.+++....         .+++..+..++.||+.||+|||+ .+   ||||||||+|||++.++ 
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~  270 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDT  270 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCc
Confidence             5788999998 778988886543         38999999999999999999998 47   99999999999998765 


Q ss_pred             ---------------ceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCC
Q 018071          212 ---------------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV  276 (361)
Q Consensus       212 ---------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf  276 (361)
                                     .+||+|||.+.....     .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||
T Consensus       271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        271 VVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             ccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                           499999998764321     234578999999999999999999999999999999999999999


Q ss_pred             CCCCCcccchhhhhhcccCCch--------hhhhhcccc--cCCCC---------------CHHHHHHHHHHHHHccccC
Q 018071          277 DHTLPRGQQSLVTWATPKLSED--------KVRQCVDAR--LGGDY---------------PPKAVAKMAAVAALCVQYE  331 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--~~~~~---------------~~~~~~~l~~li~~cl~~~  331 (361)
                      ...........+......+...        ....+.+..  +....               .......+.+||.+||+.|
T Consensus       346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  425 (467)
T PTZ00284        346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD  425 (467)
T ss_pred             CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence            7654322211111111111100        000010000  00000               0012355789999999999


Q ss_pred             CCCCCCHHHHHH--HHHHhHh
Q 018071          332 ADFRPNMSIVVK--ALQPLLN  350 (361)
Q Consensus       332 p~~RPs~~evl~--~L~~l~~  350 (361)
                      |++|||++|+++  .|.....
T Consensus       426 P~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        426 RQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             hhhCCCHHHHhcCccccccCC
Confidence            999999999997  4554433

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=344.61  Aligned_cols=256  Identities=27%  Similarity=0.460  Sum_probs=227.0

Q ss_pred             cCCCCCccccCCceEEEEEEEC-C---CCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-S---GHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ...|.++||.|.||.||+|.++ .   ...||||.++...  ..+.+|+.|+.||-+++||||++|.|+........||.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3457789999999999999977 3   3579999998754  34568999999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |||++|+|..||+.+.+.        +++.+...+++.|+.|++||-+.+   +|||||...||||+.+-..|++|||++
T Consensus       710 EyMENGsLDsFLR~~DGq--------ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             hhhhCCcHHHHHhhcCCc--------eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence            999999999999988753        899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCcccccccccccc--ccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          222 NQAPDMAARLHSTRV--LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +.+.+.... ..++.  --+.+|.|||.+..+.++.++||||+|+++||.++ |..||-                .+++.
T Consensus       779 Rvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW----------------dmSNQ  841 (996)
T KOG0196|consen  779 RVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW----------------DMSNQ  841 (996)
T ss_pred             eecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc----------------ccchH
Confidence            977543311 11222  23578999999999999999999999999999877 999983                46778


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      ++.+.++..++.+.|.+++..|++|+..||++|-.+||.+.+|+..|++++.+
T Consensus       842 dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  842 DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            88999999999999999999999999999999999999999999999999863

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.9e-43  Score=348.76  Aligned_cols=273  Identities=20%  Similarity=0.287  Sum_probs=212.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.++||+|+||.||+|... +++.||+|++.....    ..+++.+|+.++++++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999976 799999999875322    2357889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          142 EFASNGSLHDILHGRKGVKG--AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||++|++|.+++........  ......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999865321110  011223677888999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccc----------------cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcc
Q 018071          220 LSNQAPDMAA----------------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG  283 (361)
Q Consensus       220 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~  283 (361)
                      +++.......                .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9976521100                001123579999999999999999999999999999999999999996532211


Q ss_pred             cchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhcCCCCC
Q 018071          284 QQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-NMSIVVKALQPLLNARPGPA  356 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~l~~~~~~~~  356 (361)
                      .   . ..          ..+............+..+.+++.+||+.||++|| +++++++.|+..++..+...
T Consensus       239 i---~-~~----------~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~  298 (932)
T PRK13184        239 I---S-YR----------DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWT  298 (932)
T ss_pred             h---h-hh----------hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcccc
Confidence            0   0 00          00000000001123456789999999999999995 78888899999988766543

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.4e-43  Score=317.45  Aligned_cols=263  Identities=26%  Similarity=0.389  Sum_probs=206.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      .++|++.+.||+|+||.||+|..+      ++..||+|.+.....  ...++.+|+.+++.++||||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            367999999999999999999863      578899999875432  235688899999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCc
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGA-------------QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN  204 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~-------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~N  204 (361)
                      +++|||+.+++|.+++.........             .....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            9999999999999999754321110             11234889999999999999999999998   9999999999


Q ss_pred             eEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcc
Q 018071          205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRG  283 (361)
Q Consensus       205 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~  283 (361)
                      |++++++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875432221111223344678999999998899999999999999999997 888885432211


Q ss_pred             cchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          284 QQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                                     .... +........+...+..+.+++.+||+.+|.+|||+.|+++.|++
T Consensus       241 ---------------~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 ---------------VIYY-VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---------------HHHH-HhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                           1111 11111112333456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.9e-43  Score=312.95  Aligned_cols=255  Identities=26%  Similarity=0.436  Sum_probs=205.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-C---CCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|++.+.||+|+||.||+|.++ +   +..+|+|.+.....  ....+.+|+.+++.++||||+++++++.++...+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57889999999999999999864 3   33799999865432  235788899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++.....        .+++.+++.++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||+
T Consensus        84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd05066          84 TEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGL  152 (267)
T ss_pred             EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCc
Confidence            999999999999975431        3899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCcccccccc-ccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          221 SNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       221 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +........... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||........              
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--------------  218 (267)
T cd05066         153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--------------  218 (267)
T ss_pred             ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--------------
Confidence            887643221111 112233568999999998899999999999999999886 9999964432111              


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                       ... +......+.+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       219 -~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         219 -IKA-IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -HHH-HhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence             011 111111122334566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-43  Score=310.50  Aligned_cols=248  Identities=27%  Similarity=0.435  Sum_probs=199.0

Q ss_pred             CccccCCceEEEEEEEC-C---CCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||.||+|.+. +   +..+|+|.+.....  ..+++.+|+.+++.+.||||+++++++. ....+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999854 2   37899999876554  3467889999999999999999999876 4567999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++....         .+++..++.++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||+++....
T Consensus        80 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          80 GPLLKYLKKRR---------EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             CcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence            99999997653         3899999999999999999999998   99999999999999999999999999886543


Q ss_pred             cccccc-ccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          227 MAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       227 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......                +...+
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~----------------~~~~~  211 (257)
T cd05060         148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE----------------VIAML  211 (257)
T ss_pred             CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH----------------HHHHH
Confidence            221111 111223567999999998899999999999999999998 999996443211                11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      ........+..++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus       212 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         212 ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            111122334445677999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.7e-43  Score=310.41  Aligned_cols=247  Identities=26%  Similarity=0.454  Sum_probs=198.8

Q ss_pred             ccccCCceEEEEEEEC---CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCc
Q 018071           74 LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS  148 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  148 (361)
                      .||+|+||.||+|.++   ++..||+|++.....  ..+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999864   455799999865432  2356889999999999999999999875 457899999999999


Q ss_pred             HHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcccc
Q 018071          149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA  228 (361)
Q Consensus       149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~  228 (361)
                      |.+++....        ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        81 L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  149 (257)
T cd05115          81 LNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD  149 (257)
T ss_pred             HHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence            999987543        13899999999999999999999998   9999999999999999999999999987543221


Q ss_pred             ccc-cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          229 ARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       229 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      ... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......                .+...+..
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~~  213 (257)
T cd05115         150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----------------EVMSFIEQ  213 (257)
T ss_pred             cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----------------HHHHHHHC
Confidence            111 1122234578999999998889999999999999999996 99999644221                12222233


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ......+..++..+.+++.+||..+|++||++.+|++.|+.+
T Consensus       214 ~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            333345555678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.3e-44  Score=331.23  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=198.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||++..+ +++.||+|++...    ......+.+|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999976 7999999998642    223456788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.+++....         .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~  148 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---------TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLC  148 (360)
T ss_pred             eCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCC
Confidence            9999999999987543         3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccc---------------------------------cccccccccCCCCCCchhhccCCCCCccceecHHHHHHH
Q 018071          222 NQAPDMAA---------------------------------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE  268 (361)
Q Consensus       222 ~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~e  268 (361)
                      ........                                 .......+||+.|+|||++.+..++.++|||||||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye  228 (360)
T cd05627         149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE  228 (360)
T ss_pred             cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence            75422110                                 000123579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCC--HHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 018071          269 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPN---MSIVVK  343 (361)
Q Consensus       269 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs---~~evl~  343 (361)
                      |++|+.||....+...               ...+........++  ...+..+.+++.+++. +|.+|++   ++++++
T Consensus       229 l~tG~~Pf~~~~~~~~---------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         229 MLIGYPPFCSETPQET---------------YRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             cccCCCCCCCCCHHHH---------------HHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            9999999975543211               11111100000111  1245678888888764 9999985   666665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.4e-43  Score=315.80  Aligned_cols=243  Identities=21%  Similarity=0.277  Sum_probs=193.3

Q ss_pred             cccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        75 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      ||+|+||.||++..+ +|+.||+|.+.....    ....+..|++++++++||||+++++++.++...++||||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999976 799999999864221    223456799999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccc
Q 018071          150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA  229 (361)
Q Consensus       150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  229 (361)
                      .+++.....       ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-  149 (277)
T cd05607          81 KYHIYNVGE-------RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-  149 (277)
T ss_pred             HHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-
Confidence            988865432       13889999999999999999999998   9999999999999999999999999987653321 


Q ss_pred             cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC
Q 018071          230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG  309 (361)
Q Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (361)
                        ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..........           ............
T Consensus       150 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~-----------~~~~~~~~~~~~  216 (277)
T cd05607         150 --TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE-----------ELKRRTLEDEVK  216 (277)
T ss_pred             --eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH-----------HHHHHhhccccc
Confidence              1234568999999999998889999999999999999999999996433211100           001111111110


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018071          310 GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV  342 (361)
Q Consensus       310 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl  342 (361)
                      . .....+.++.+|+.+||+.||++||++.|++
T Consensus       217 ~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         217 F-EHQNFTEESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             c-ccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence            0 1123566799999999999999999996655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9e-44  Score=332.76  Aligned_cols=262  Identities=24%  Similarity=0.318  Sum_probs=200.2

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCC-----eeE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRV  138 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~  138 (361)
                      +|++.+.||+|+||.||++... +++.||+|++.....   ...++.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5788999999999999999975 899999999865322   2357889999999999999999999998766     789


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +||||+. ++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Df  147 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDF  147 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccc
Confidence            9999996 58888775432         3899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |+++...... ........+++.|+|||++.+. .++.++|||||||++|||++|+.||....+......+.........
T Consensus       148 g~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~  226 (372)
T cd07853         148 GLARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL  226 (372)
T ss_pred             cceeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            9987643221 1122345678999999998874 5789999999999999999999999765543222111111011111


Q ss_pred             hhh-------hhhc-ccccCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKV-------RQCV-DARLGG-------DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~-------~~~~-~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..+       ...+ ......       ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            110       0000 000000       111223567899999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.2e-43  Score=313.21  Aligned_cols=260  Identities=22%  Similarity=0.351  Sum_probs=208.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|.+.+.||+|+||.||++..+ ++..++||.+.....    ...++.+|+.+++.++||||+++++++.++...+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999965 899999998865322    2357788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++.....     ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++
T Consensus        82 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          82 ELADAGDLSRMIKHFKK-----QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EecCCCCHHHHHHHhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhh
Confidence            99999999998864321     1124899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ........  ......|+..|+|||.+.+..++.++||||||+++|+|++|..||........ ..            ..
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~------------~~  218 (267)
T cd08229         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL------------CK  218 (267)
T ss_pred             hccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HH------------hh
Confidence            76543221  12345688999999999988999999999999999999999999964322110 00            00


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      .+.........+...+..+.+++.+||+.+|++|||+.+|++.++++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         219 KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             hhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            111111111112346678999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.8e-43  Score=315.20  Aligned_cols=252  Identities=27%  Similarity=0.410  Sum_probs=202.5

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeC------Ce
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG------TS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~------~~  136 (361)
                      ..+.|++.+.||+|+||.||+|..+ +++.||+|.+.........+.+|+.+++++ +||||+++++++...      ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            4567888899999999999999976 789999999977666667889999999998 699999999998753      45


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .+++|||+.+++|.+++.....       ..+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEc
Confidence            7899999999999999876432       23899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~  291 (361)
                      |||++.......  .......|+..|+|||++.     +..++.++|||||||++|+|++|..||....+.....     
T Consensus       154 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----  226 (272)
T cd06637         154 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----  226 (272)
T ss_pred             cCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----
Confidence            999987653221  1234567899999999986     3468889999999999999999999996432211100     


Q ss_pred             cccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          292 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                ...............+..+.+|+.+||+.+|.+|||+.++++
T Consensus       227 ----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         227 ----------LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ----------HHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                      000000111112234567999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.6e-43  Score=328.10  Aligned_cols=263  Identities=22%  Similarity=0.277  Sum_probs=199.2

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCC----
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----  135 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----  135 (361)
                      .+.++|++.+.||+|+||.||++..+ ++..||+|++....   .....+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            35689999999999999999999976 79999999986532   23456788999999999999999999886443    


Q ss_pred             --eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          136 --SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       136 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                        ..++||||+++ +|.+.+...           +++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~  162 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  162 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhcc-----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence              46899999965 676666431           788999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      ||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................
T Consensus       163 kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  239 (359)
T cd07876         163 KILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG  239 (359)
T ss_pred             EEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999998754321   122445789999999999999999999999999999999999999975532111000000000


Q ss_pred             cCCch-------hhhhhccccc--C----------------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          294 KLSED-------KVRQCVDARL--G----------------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       294 ~~~~~-------~~~~~~~~~~--~----------------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      .....       .+........  .                .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000       0000000000  0                00111234668999999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.3e-43  Score=321.87  Aligned_cols=263  Identities=21%  Similarity=0.334  Sum_probs=202.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|.+....  .....+.+|+.++++++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57999999999999999999976 78899999986532  2234678899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++ +|.+++....        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  153 (309)
T cd07872          86 LDK-DLKQYMDDCG--------NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA  153 (309)
T ss_pred             CCC-CHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcccccee
Confidence            975 8888876543        23789999999999999999999998   99999999999999999999999999875


Q ss_pred             CccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .....  .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......................+..
T Consensus       154 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (309)
T cd07872         154 KSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG  231 (309)
T ss_pred             cCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence            43221  11234567899999998875 4689999999999999999999999976544322111111111111111111


Q ss_pred             hcc---------cccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVD---------ARLGG----DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~---------~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +..         .....    ...+..+..+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            100         00000    011234567899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.2e-43  Score=311.25  Aligned_cols=252  Identities=26%  Similarity=0.479  Sum_probs=205.3

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+.........+.+|++++++++|||++++++++......+++|||+.+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            46788889999999999999987788999999887666667899999999999999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++.....        .+++..++.++.|++.+|+|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          84 GCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            999999875432        2789999999999999999999998   99999999999999999999999999875432


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .... ......++..|+|||.+.++.++.++||||||+++|+|++ |..||.......                +.+.+.
T Consensus       153 ~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~  215 (256)
T cd05112         153 DQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE----------------VVETIN  215 (256)
T ss_pred             Cccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----------------HHHHHh
Confidence            2111 1122234678999999998899999999999999999998 999996432211                111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      .......+...+..+.+|+.+||+.+|++|||+.++++.|+
T Consensus       216 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         216 AGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            11111112224567999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.6e-43  Score=323.32  Aligned_cols=240  Identities=23%  Similarity=0.302  Sum_probs=196.0

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +|+..++||+|+||.||+|..+ +++.||+|++.+.    ....+.+..|..+++.+. |++|+++++++.+....++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778889999999999999976 7999999998653    222345778888888886 577888999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        81 Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~  148 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccc
Confidence            9999999999986543         3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......               ....
T Consensus       149 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---------------~~~~  211 (323)
T cd05615         149 KEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---------------ELFQ  211 (323)
T ss_pred             cccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---------------HHHH
Confidence            7542211  1234567999999999999999999999999999999999999999754321               1111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM  338 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  338 (361)
                      .+....  ..++...+..+.+++.+||+.+|.+|++.
T Consensus       212 ~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         212 SIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            121111  12344456778999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5e-43  Score=317.67  Aligned_cols=270  Identities=22%  Similarity=0.344  Sum_probs=206.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-----------------CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcce
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-----------------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQ  126 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~  126 (361)
                      .++|++.+.||+|+||.||++...                 ++..+|+|.+.....  ...++.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357999999999999999998643                 244689999875432  2457889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCc
Q 018071          127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG--AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN  204 (361)
Q Consensus       127 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~N  204 (361)
                      +++++......+++|||+.+++|.+++........  ......+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99999999999999999999999999976542211  112234888999999999999999999998   9999999999


Q ss_pred             eEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh--CCCCCCCCCCc
Q 018071          205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRKPVDHTLPR  282 (361)
Q Consensus       205 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~pf~~~~~~  282 (361)
                      ||+++++.++|+|||++................++..|+|||...++.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999876533222112233445678999999888899999999999999999998  77888643321


Q ss_pred             ccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                      .   .....      .............+.+..++..+.+++.+||+.||.+||++.+|++.|++
T Consensus       241 ~---~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 Q---VIENT------GEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H---HHHHH------HHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   10000      00000000011112233455789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.7e-43  Score=315.83  Aligned_cols=271  Identities=24%  Similarity=0.356  Sum_probs=203.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-----CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEe--CCeeE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRV  138 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~  138 (361)
                      ++|++.+.||+|+||.||++..+     ++..||+|.+..... ..+.+.+|+++++.++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            47888999999999999999742     688999999865432 23578899999999999999999998753  34678


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +||||+++++|.+++.....        .+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~df  152 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF  152 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCC
Confidence            99999999999999865431        3899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccc-cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |++.......... ......++..|+|||++.+..++.++|||||||++|||++|..|+.....................
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05081         153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV  232 (284)
T ss_pred             cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch
Confidence            9998654322111 111222345699999999889999999999999999999988776432110000000000000001


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ..+...+........+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            111222222222233344567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.8e-43  Score=322.85  Aligned_cols=242  Identities=21%  Similarity=0.276  Sum_probs=193.7

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||.||+|..+ +++.||+|++.+..    ...+.+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999976 78999999997532    2234577899998888 599999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|..++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  148 (327)
T cd05617          81 GDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG  148 (327)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence            99998886543         3899999999999999999999998   99999999999999999999999999875321


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      .  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.............+        ....+...
T Consensus       149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~--------~~~~~~~~  218 (327)
T cd05617         149 P--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY--------LFQVILEK  218 (327)
T ss_pred             C--CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHH--------HHHHHHhC
Confidence            1  1123456799999999999999999999999999999999999999964332211111000        01111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNM  338 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  338 (361)
                      .  ...+...+..+.+++.+||+.||.+|+++
T Consensus       219 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         219 P--IRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             C--CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            1  12344456778999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.5e-43  Score=316.24  Aligned_cols=250  Identities=21%  Similarity=0.331  Sum_probs=201.3

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .|++.++||+|+||.||++..+ +++.||+|.+......    ...+.+|+.+++.++|+|++.+++.+.+....++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999977 8999999998653322    2356789999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+.+++|.+++.....       ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.
T Consensus        81 ~~~g~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~  150 (285)
T cd05630          81 LMNGGDLKFHIYHMGE-------AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAV  150 (285)
T ss_pred             ecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeecccee
Confidence            9999999998865432       13889999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ......   ......|+..|+|||++.+..++.++||||+||++|+|++|+.||.........            +....
T Consensus       151 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~------------~~~~~  215 (285)
T cd05630         151 HVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR------------EEVER  215 (285)
T ss_pred             ecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH------------HHHHh
Confidence            543221   123457899999999999999999999999999999999999999753221100            00111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~  343 (361)
                      ... ......+...+..+.+|+.+||+.||++|||     ++++++
T Consensus       216 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         216 LVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            110 0111223345567899999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.3e-43  Score=310.02  Aligned_cols=249  Identities=21%  Similarity=0.319  Sum_probs=204.3

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC--CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      +|++.+.||+|+||.||++..+ ++..+|+|.+...  ....+.+.+|+.+++.++||||+++++.+.++...+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5788899999999999999977 8999999988543  233467888999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++++|.+++.....       ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++...
T Consensus        81 ~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~  150 (255)
T cd08219          81 DGGDLMQKIKLQRG-------KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLL  150 (255)
T ss_pred             CCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceee
Confidence            99999998865432       23789999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ....  .......|++.|+|||++.+..++.++|+||||+++|+|++|..||........               ...+ 
T Consensus       151 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---------------~~~~-  212 (255)
T cd08219         151 TSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---------------ILKV-  212 (255)
T ss_pred             cccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---------------HHHH-
Confidence            3321  122345688999999999988999999999999999999999999964322110               0111 


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ........+...+..+.+++.+||+.+|++|||+.+|+..
T Consensus       213 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         213 CQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1111112334456679999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.1e-43  Score=322.08  Aligned_cols=269  Identities=26%  Similarity=0.424  Sum_probs=211.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC--------CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDG  134 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~  134 (361)
                      ..+|.+.+.||+|+||.||+|...        .+..||+|.+.....  ..+++.+|+.+++++ +||||+++++++.+.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            457999999999999999999742        123689998875332  235788999999999 799999999999999


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      ...+++|||+.+|+|.+++.......       .......+++..++.++.|++.||.|||+.+   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            99999999999999999997643210       0112345889999999999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccch
Q 018071          208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS  286 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~  286 (361)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......    
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----  243 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----  243 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence            9999999999999876543222212223334568999999999999999999999999999998 88898643221    


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                                  .....+......+.+..++..+.+++.+||+.+|.+|||+.++++.|+.++...+
T Consensus       244 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         244 ------------ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             ------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence                        1111111222223334456679999999999999999999999999999985443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.6e-43  Score=321.95  Aligned_cols=251  Identities=18%  Similarity=0.235  Sum_probs=198.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|.+.++||+|+||.||++..+ +++.+|+|.+.+.    ......+.+|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999977 7889999998642    122345778899999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+.+|+|.+++.....        .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a  149 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC  149 (332)
T ss_pred             eccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchh
Confidence            99999999999976431        3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ....... .......+||+.|+|||++.     ...++.++|||||||++|||++|+.||.......             
T Consensus       150 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-------------  215 (332)
T cd05623         150 LKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------------  215 (332)
T ss_pred             eecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-------------
Confidence            7543211 11223457999999999986     3468899999999999999999999996432211             


Q ss_pred             chhhhhhcccccCCCC---CHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 018071          297 EDKVRQCVDARLGGDY---PPKAVAKMAAVAALCVQYEADF--RPNMSIVVKA  344 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~  344 (361)
                        ....+.........   ....+..+.+|+.+|+..++.+  |++++++++.
T Consensus       216 --~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         216 --TYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --HHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              11111111111111   1234677899999988655544  6899999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=307.40  Aligned_cols=247  Identities=28%  Similarity=0.503  Sum_probs=201.3

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHH
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH  150 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  150 (361)
                      ++||+|+||.||++....++.|++|.+......  ...+.+|+++++.++||||+++++++.+....+++|||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            369999999999999777999999988764432  457889999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcccccc
Q 018071          151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR  230 (361)
Q Consensus       151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  230 (361)
                      +++.....        .+++..++.++.+++.||.|||+++   ++||||+|+||+++.++.+||+|||++.........
T Consensus        81 ~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          81 TFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence            99865431        3789999999999999999999998   999999999999999999999999998765422111


Q ss_pred             ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC
Q 018071          231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG  309 (361)
Q Consensus       231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (361)
                      .......++..|+|||.+.++.++.++|||||||++|+|++ |..||.......                ....+.....
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----------------~~~~~~~~~~  213 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----------------TRERIESGYR  213 (251)
T ss_pred             eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----------------HHHHHhcCCC
Confidence            11122334667999999998899999999999999999999 888986443211                1111222222


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          310 GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       310 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      ...+...+..+.+++.+||+.+|.+|||++++++.|+
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            2334445678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=311.85  Aligned_cols=258  Identities=26%  Similarity=0.432  Sum_probs=207.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCC----EEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|++.+.||+|+||.||+|.++ ++.    .+|+|.+......  ..++.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            57888999999999999999965 343    6899988765432  3578889999999999999999999887 78899


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      +|||+.+|+|.+++.....        .+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        86 v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg  154 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFG  154 (279)
T ss_pred             EEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCc
Confidence            9999999999999976432        3899999999999999999999988   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++...............++..|+|||.+....++.++||||||+++||+++ |..||......                
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------  218 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV----------------  218 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH----------------
Confidence            9986543222111122224568999999988899999999999999999998 99999754321                


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      .+.+.+........+..++..+.+++.+||..+|.+||++.++++.|+.+.+..
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         219 EIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            111122222122233345567899999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.9e-43  Score=316.56  Aligned_cols=269  Identities=25%  Similarity=0.373  Sum_probs=207.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-C----------------CCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcce
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-S----------------GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQ  126 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~----------------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~  126 (361)
                      .++|++.+.||+|+||.||+|... .                +..||+|.+.....  ..+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            368999999999999999998854 1                24589999875432  2457888999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCc
Q 018071          127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA--QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN  204 (361)
Q Consensus       127 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~N  204 (361)
                      +++++..+...+++||++.+++|.+++.........  .....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            999999999999999999999999998765421110  11224899999999999999999999998   9999999999


Q ss_pred             eEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh--CCCCCCCCCCc
Q 018071          205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRKPVDHTLPR  282 (361)
Q Consensus       205 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~pf~~~~~~  282 (361)
                      |++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876543322222344556789999999998899999999999999999998  67788543221


Q ss_pred             ccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      .   ...........      .........+..++.++.+++.+||+.+|.+|||+.+|++.|+
T Consensus       241 ~---~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q---VIENAGHFFRD------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H---HHHHHHhcccc------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1   11100000000      0111111223345578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-43  Score=324.87  Aligned_cols=237  Identities=23%  Similarity=0.291  Sum_probs=190.9

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHH-HHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||.||+|..+ +|+.||+|++.+..    .....+..|.. +++.++||||+++++++......++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999976 89999999986532    22234555554 46778999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|..++....         .+++..+..++.||+.||+|||+.|   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~  148 (325)
T cd05604          81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA  148 (325)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence            99998886543         3899999999999999999999998   99999999999999999999999999875322


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      .  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......               ....+...
T Consensus       149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---------------~~~~~~~~  211 (325)
T cd05604         149 Q--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---------------MYDNILHK  211 (325)
T ss_pred             C--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---------------HHHHHHcC
Confidence            1  112345679999999999999999999999999999999999999996442211               11111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI  340 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e  340 (361)
                      ..  ..++..+..+.+++.+||+.+|.+||++.+
T Consensus       212 ~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         212 PL--VLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            11  122335567889999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.9e-43  Score=322.85  Aligned_cols=236  Identities=22%  Similarity=0.295  Sum_probs=190.1

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHH-HHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||.||+|..+ +++.||+|++.+..    .....+..|.. +++.++||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999986 78999999986532    22334555554 57888999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|...+....         .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  148 (321)
T cd05603          81 GELFFHLQRER---------CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE  148 (321)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence            99988886543         3889999999999999999999998   99999999999999999999999999875322


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   +            ...+...
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~------------~~~i~~~  211 (321)
T cd05603         149 PE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---M------------YDNILHK  211 (321)
T ss_pred             CC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---H------------HHHHhcC
Confidence            11  12345679999999999999899999999999999999999999996432110   0            1111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS  339 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  339 (361)
                      .  ...+...+..+.+++.+||+.+|.+||+..
T Consensus       212 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 P--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             C--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1  123344567799999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.5e-42  Score=306.55  Aligned_cols=246  Identities=30%  Similarity=0.484  Sum_probs=199.1

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHH
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH  150 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  150 (361)
                      ++||+|+||.||+|..+++..+|+|.+......  ...+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            369999999999999888899999998654322  346888999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcccccc
Q 018071          151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR  230 (361)
Q Consensus       151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  230 (361)
                      +++.....        .+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          81 SFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence            99865431        3789999999999999999999998   999999999999999999999999998754322111


Q ss_pred             ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC
Q 018071          231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG  309 (361)
Q Consensus       231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (361)
                       ......++..|+|||++.+..++.++||||||+++|++++ |..||.......                ....+.....
T Consensus       150 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~----------------~~~~~~~~~~  212 (250)
T cd05085         150 -SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ----------------AREQVEKGYR  212 (250)
T ss_pred             -cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH----------------HHHHHHcCCC
Confidence             1122344677999999998899999999999999999998 999996442211                1111111112


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          310 GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       310 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      ...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2233345677999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.2e-43  Score=315.65  Aligned_cols=261  Identities=24%  Similarity=0.335  Sum_probs=195.5

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcC---CCCCcceeeeEEEe-----CC
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRL---KHENFVQLLGYCVD-----GT  135 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~-----~~  135 (361)
                      +|++.+.||+|+||+||+|..+ +++.||+|.+....   .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999977 89999999986532   2224566777777665   69999999998764     34


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..+++|||+.+ +|.+++.....       ..+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl  149 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP-------PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKL  149 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            57899999975 89888865432       23899999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~~~~~  294 (361)
                      +|||++.......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||......... .+..... .
T Consensus       150 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~  225 (288)
T cd07863         150 ADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-L  225 (288)
T ss_pred             CccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC-C
Confidence            9999987653221   123456899999999999889999999999999999999999999754332111 1111000 0


Q ss_pred             CCchhhhhhc---cccc-------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 LSEDKVRQCV---DARL-------GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 ~~~~~~~~~~---~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .....+....   ....       .....+..+..+.+++.+||+.||++|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000000   0000       00111234567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-43  Score=316.84  Aligned_cols=269  Identities=25%  Similarity=0.358  Sum_probs=203.6

Q ss_pred             hcCCCCCccccCCceEEEEEEECC---------------CCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeee
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKS---------------GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLG  129 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~  129 (361)
                      ++|++.+.||+|+||.||++....               ...||+|.+.....  ....+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            589999999999999999987541               23589999875422  2356889999999999999999999


Q ss_pred             EEEeCCeeEEEEEeCCCCcHHHhhhcCCCCC---CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceE
Q 018071          130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVK---GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL  206 (361)
Q Consensus       130 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nil  206 (361)
                      ++......++||||+.+++|.+++.......   .......+++..++.++.|++.||.|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999986542110   0011134789999999999999999999998   999999999999


Q ss_pred             eccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh--CCCCCCCCCCccc
Q 018071          207 IFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRKPVDHTLPRGQ  284 (361)
Q Consensus       207 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~pf~~~~~~~~  284 (361)
                      +++++.+||+|||++................++..|+|||.+.++.++.++|||||||++|+|++  |..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999876533222222233455778999999998899999999999999999998  667775432211 


Q ss_pred             chhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          285 QSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                        .......      .............++..+..+.+|+.+||+.+|++|||+.+|++.|++
T Consensus       241 --~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 --VIENTGE------FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             --HHHHHHH------hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence              0000000      000000001111222345679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.2e-43  Score=327.06  Aligned_cols=263  Identities=21%  Similarity=0.262  Sum_probs=200.0

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----  134 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----  134 (361)
                      .+.++|.+.+.||+|+||.||++... +++.||+|++.....   ....+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45689999999999999999999976 789999999875332   235677899999999999999999988643     


Q ss_pred             -CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          135 -TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       135 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                       ...+++|||+++ +|.+.+...           +++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~  158 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence             356899999965 677766432           788999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchh-hhh-h
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-VTW-A  291 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~-~~~-~  291 (361)
                      ||+|||+++.....   .......||..|+|||++.+..++.++|||||||++|+|++|+.||........... ... .
T Consensus       159 kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (355)
T cd07874         159 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG  235 (355)
T ss_pred             EEeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999999765332   122446789999999999999999999999999999999999999975432111000 000 0


Q ss_pred             cccC-----Cchhhhhhcccc----------------c--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          292 TPKL-----SEDKVRQCVDAR----------------L--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       292 ~~~~-----~~~~~~~~~~~~----------------~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      .+..     ....+...++..                .  ....+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0000     000011111100                0  001112234678999999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-42  Score=313.00  Aligned_cols=271  Identities=23%  Similarity=0.387  Sum_probs=205.0

Q ss_pred             hcCCCCCccccCCceEEEEEEE-----CCCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeC--Cee
Q 018071           67 ENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR  137 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~  137 (361)
                      +.|.+.+.||+|+||.||++..     .++..||+|.+.....  ....+.+|+.+++.++||||+++++++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3578889999999999999974     2688999999865432  235788999999999999999999998765  567


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      +++|||+++++|.+++....        ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--------~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~d  152 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD  152 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECC
Confidence            89999999999999986542        13899999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       218 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ||++......... .......++..|+|||.+.+..++.++|||||||++|+|+++..|+......... ..........
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~~~~~~~~~~  231 (284)
T cd05079         153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-MIGPTHGQMT  231 (284)
T ss_pred             CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-hccccccccc
Confidence            9998865432211 1123355677899999999889999999999999999999987765321110000 0000000000


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      .......+......+.+..++..+.+|+.+||+.+|++|||+.++++.|+.++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            01111111111122233446678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.7e-42  Score=316.01  Aligned_cols=262  Identities=21%  Similarity=0.320  Sum_probs=203.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|++.+.||+|+||.||++.+. ++..+|+|.+.....  ...++.+|++++++++||||+++++.+.++...+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999976 788999998865322  234688999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      +++++|.+++....         .+++..+..++.|++.||.|||+. +   ++||||||+|||+++++.+||+|||++.
T Consensus        81 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (308)
T cd06615          81 MDGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG  148 (308)
T ss_pred             cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcc
Confidence            99999999997643         288999999999999999999984 5   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc-----
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE-----  297 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  297 (361)
                      .....    ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.....................     
T Consensus       149 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (308)
T cd06615         149 QLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR  224 (308)
T ss_pred             ccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence            54322    123457899999999998888999999999999999999999999654322211111100000000     


Q ss_pred             ----------------hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          298 ----------------DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       298 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                                      +....++............+..+.+++.+||+.+|++|||+.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                            00000110000000011246679999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-42  Score=309.82  Aligned_cols=256  Identities=28%  Similarity=0.433  Sum_probs=199.9

Q ss_pred             CccccCCceEEEEEEEC-CCC--EEEEEEcCCCC--CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGH--AAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|+||.||+|..+ ++.  .+++|.+....  ...+.+.+|+++++++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36999999999999976 444  46888876432  2345788999999999 799999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          147 GSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       147 g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ++|.+++........       ......+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999999976432110       011235889999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ++.......   .......+..|+|||++.+..++.++|||||||++|+|++ |..||.......               
T Consensus       158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---------------  219 (270)
T cd05047         158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------------  219 (270)
T ss_pred             Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---------------
Confidence            986432111   1122334667999999988899999999999999999997 999996432211               


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                       +...+......+.+...+..+.+++.+||+.+|.+|||+.++++.|+.+++
T Consensus       220 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         220 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             -HHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence             111111111112233345678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.3e-43  Score=321.10  Aligned_cols=251  Identities=19%  Similarity=0.238  Sum_probs=197.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|.+.+.||+|+||.||+++.+ +++.||+|.+.+.    ......+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999977 7899999998652    122345778899999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+.+|+|.+++.....        .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a  149 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSC  149 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccce
Confidence            99999999999976321        3889999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhcc-----CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ........ .......||+.|+|||++.+     +.++.++|||||||++|+|++|+.||.......             
T Consensus       150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------------  215 (331)
T cd05624         150 LKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------------  215 (331)
T ss_pred             eeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-------------
Confidence            76533211 12234579999999999875     468899999999999999999999996443211             


Q ss_pred             chhhhhhcccccCCCCC---HHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 018071          297 EDKVRQCVDARLGGDYP---PKAVAKMAAVAALCVQYEADF--RPNMSIVVKA  344 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~  344 (361)
                        ....+.........+   ...+..+.+++.+||...+.+  |++++++++.
T Consensus       216 --~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         216 --TYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             --HHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence              111111111111111   234567999999999866544  4688888763

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.4e-43  Score=311.02  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=201.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.++||||+++++++......++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            358999999999999999999975 78999999986543 2345678899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++....         .+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||++..
T Consensus        88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~  155 (267)
T cd06646          88 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK  155 (267)
T ss_pred             CCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence            99999999986543         2889999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .....  .......|+..|+|||.+.   ...++.++|||||||++|+|++|..||....+......  .......    
T Consensus       156 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--~~~~~~~----  227 (267)
T cd06646         156 ITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--MSKSNFQ----  227 (267)
T ss_pred             ecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--eecCCCC----
Confidence            53221  1123456889999999885   34578899999999999999999999864332211000  0000000    


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                          ....  ......+..+.+++.+||+.+|++|||++++++.|
T Consensus       228 ----~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         228 ----PPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ----CCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                0000  01123456799999999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-43  Score=320.98  Aligned_cols=251  Identities=19%  Similarity=0.232  Sum_probs=197.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||++..+ +++.||+|++.+.    ....+.+.+|+.+++.++|+||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999976 7999999998642    223355788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+.+|+|.+++....        ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 e~~~g~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~  149 (331)
T cd05597          81 DYYVGGDLLTLLSKFE--------DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSC  149 (331)
T ss_pred             ecCCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCce
Confidence            9999999999996532        13899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhcc-----CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ........ .......||+.|+|||++..     ..++.++|||||||++|+|++|+.||........            
T Consensus       150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------------  216 (331)
T cd05597         150 LRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------------  216 (331)
T ss_pred             eecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------------
Confidence            65432211 11233568999999999873     4578899999999999999999999964322110            


Q ss_pred             chhhhhhcccccCCC---CCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 018071          297 EDKVRQCVDARLGGD---YPPKAVAKMAAVAALCVQYEAD--FRPNMSIVVKA  344 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~--~RPs~~evl~~  344 (361)
                         ...+........   .....+..+.+++.+||..++.  .||+++++++.
T Consensus       217 ---~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         217 ---YGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ---HHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence               011111100001   1122466788999998865443  37899998875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-42  Score=328.09  Aligned_cols=262  Identities=19%  Similarity=0.212  Sum_probs=197.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      ...|.+.+.||+|+||.||++.+. +++.||||...     ...+.+|++++++++|+||+++++++......+++||++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            347999999999999999999977 78899999642     234678999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      . ++|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       243 ~-~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~  310 (461)
T PHA03211        243 R-SDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA  310 (461)
T ss_pred             C-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence            5 689888865431        3899999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCC-CCCccc----chh---hhhhccc--
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH-TLPRGQ----QSL---VTWATPK--  294 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~-~~~~~~----~~~---~~~~~~~--  294 (361)
                      .............||..|+|||++.+..++.++|||||||+||||++|..|+-. ......    ..+   +......  
T Consensus       311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~  390 (461)
T PHA03211        311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD  390 (461)
T ss_pred             ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence            332222222346799999999999999999999999999999999998865432 211110    011   1110000  


Q ss_pred             -CC---chhhhhhcc----cccC----CCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          295 -LS---EDKVRQCVD----ARLG----GDYPP---KAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       295 -~~---~~~~~~~~~----~~~~----~~~~~---~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                       ..   ...+.....    ....    .....   ..+..+.+||.+||+.||.+|||+.|+++.
T Consensus       391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence             00   000000000    0000    00000   223468899999999999999999999873

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.7e-42  Score=314.29  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=204.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ..+|.+.+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|+.+++.++||||+++++.+..+...++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            368999999999999999999975 789999999875433 345788899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++....          +++.++..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        99 ~~~~~L~~~~~~~~----------~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~  165 (296)
T cd06654          99 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (296)
T ss_pred             cCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchh
Confidence            99999999986532          789999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ......  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.....  ...            
T Consensus       166 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--~~~------------  229 (296)
T cd06654         166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LIA------------  229 (296)
T ss_pred             cccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--HHh------------
Confidence            432211  1234568899999999998889999999999999999999999996543321110  000            


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .........+...+..+.+++.+||..+|++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            0000011223345677999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-42  Score=312.53  Aligned_cols=250  Identities=23%  Similarity=0.320  Sum_probs=199.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|++.++||+|+||.||+|... ++..||+|.+......  .+++.+|++++++++||||+++++++......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36888899999999999999965 8999999998654322  35688999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|..+.             .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++..
T Consensus        81 ~~~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~  144 (279)
T cd06619          81 MDGGSLDVYR-------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ  144 (279)
T ss_pred             CCCCChHHhh-------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence            9999986542             1788899999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ....    ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........        .......+
T Consensus       145 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~--------~~~~~~~~  212 (279)
T cd06619         145 LVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM--------PLQLLQCI  212 (279)
T ss_pred             cccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc--------hHHHHHHH
Confidence            5322    12345789999999999988999999999999999999999999965332111000        00001111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      .+...........+..+.+++.+||+.+|.+||+++++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         213 VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             hccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11111111112345678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.5e-42  Score=315.63  Aligned_cols=258  Identities=27%  Similarity=0.455  Sum_probs=204.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCC----EEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|+..+.||+|+||.||+|.+. ++.    .+|+|.+......  ..++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            57888899999999999999865 454    5788988654332  23678899999999999999999998754 4679


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ++||+++|+|.+++.....        .+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        86 v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg  154 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFG  154 (303)
T ss_pred             eehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccc
Confidence            9999999999999875432        3889999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......               
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---------------  219 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---------------  219 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------------
Confidence            9986543222222233445778999999998899999999999999999997 999996432211               


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                       +..++........+..++..+.+++.+||..+|++||++.++++.|+.+.+..
T Consensus       220 -~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         220 -IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             -HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence             11111111111222334567899999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-42  Score=311.97  Aligned_cols=270  Identities=26%  Similarity=0.422  Sum_probs=210.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-----CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEe--CCee
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSR  137 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~  137 (361)
                      ++|.+.+.||+|+||.||++.+.     ++..+|+|.+......  .+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46778889999999999999854     4789999999866553  5688999999999999999999999877  5678


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      +++|||+++++|.+++.....        .+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence            999999999999999976542        3899999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       218 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......... ..........
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~  231 (284)
T cd05038         153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMI  231 (284)
T ss_pred             cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-cccccccccc
Confidence            9999876422111 1112234456799999999889999999999999999999999998643221100 0000000011


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ...+...+........+..++..+.+++.+||+.+|.+|||+.+|+++|+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1222223333333333445567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.9e-43  Score=324.82  Aligned_cols=262  Identities=21%  Similarity=0.263  Sum_probs=199.2

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeC------
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------  134 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------  134 (361)
                      +.++|.+.+.||+|+||.||++... +++.||||++....   .....+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4579999999999999999999976 78999999987532   2345678899999999999999999987543      


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceE
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK  214 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~k  214 (361)
                      ...++||||+++ +|.+++...           +++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence            357999999965 777777432           788999999999999999999998   99999999999999999999


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |+|||+++.....   .......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+......
T Consensus       167 L~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  243 (364)
T cd07875         167 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT  243 (364)
T ss_pred             EEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999999765322   1224457899999999999999999999999999999999999999755432111100000000


Q ss_pred             CCch-------hhhhhcccc---------------c---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          295 LSED-------KVRQCVDAR---------------L---GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       295 ~~~~-------~~~~~~~~~---------------~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ....       .+.......               .   ...........+.+|+.+||+.||.+|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000       000000000               0   001111234578999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-42  Score=326.14  Aligned_cols=263  Identities=17%  Similarity=0.265  Sum_probs=201.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC---CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ...+|.+.+.||+|+||.||++..+   ++..|++|.+...    ....+|+++++.++||||+++++++......+++|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            4568999999999999999999754   4678999988653    24568999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |++. ++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus       166 e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a  232 (392)
T PHA03207        166 PKYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA  232 (392)
T ss_pred             hhcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccc
Confidence            9995 58888884332         3899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhc--c----c
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWAT--P----K  294 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~~~--~----~  294 (361)
                      ................||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....... .+.....  .    .
T Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~  312 (392)
T PHA03207        233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE  312 (392)
T ss_pred             cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence            7664433322334567999999999999999999999999999999999999999765432211 1100000  0    0


Q ss_pred             CCc---hhhhh---hcccccCCCC--C-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          295 LSE---DKVRQ---CVDARLGGDY--P-----PKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       295 ~~~---~~~~~---~~~~~~~~~~--~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ...   ..+..   ......+..+  +     ...+..+.++|.+||..||++|||+.+++..
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000   00000   0000011111  1     1234568899999999999999999999964

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.1e-42  Score=315.46  Aligned_cols=204  Identities=23%  Similarity=0.374  Sum_probs=164.5

Q ss_pred             CCccccCCceEEEEEEEC---CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEe--CCeeEEEEEeCCC
Q 018071           72 NALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVLAYEFASN  146 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~  146 (361)
                      .++||+|+||+||+|..+   ++..||+|.+.... ....+.+|+.++++++||||+++++++..  ....+++|||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            457999999999999865   56889999986543 23567889999999999999999998854  456789999995 


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe----ccCCceEEeccccCC
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSN  222 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill----~~~~~~kl~Dfg~a~  222 (361)
                      ++|.+++..............+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            488888764432221222234899999999999999999999998   9999999999999    456789999999997


Q ss_pred             CCccccc-cccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCC
Q 018071          223 QAPDMAA-RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL  280 (361)
Q Consensus       223 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~  280 (361)
                      ....... ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            6533211 1122456789999999999874 58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-44  Score=323.87  Aligned_cols=251  Identities=20%  Similarity=0.335  Sum_probs=207.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCC---CCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ...|++++.||+||.+.||++...+.+.||+|++...   ......+.+|+..|.+|+ |.+|+++++|-..++.+|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3679999999999999999999888888999987543   334467899999999995 999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||-+. +|..+|......        +....++.+..|++.|+.++|+.|   |||.||||.|+|+- .|.+||+|||+|
T Consensus       440 E~Gd~-DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA  506 (677)
T KOG0596|consen  440 ECGDI-DLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIA  506 (677)
T ss_pred             ecccc-cHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechh
Confidence            99854 999999887643        333378889999999999999999   99999999999984 568999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCC-----------CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-----------LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~  290 (361)
                      ...............+||+.||+||.+....           .+.++||||||||||+|+.|+.||.....         
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------  577 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------  577 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------
Confidence            9988777777778899999999999885432           55789999999999999999999953210         


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHHH-HHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKAV-AKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                           -..++..+.++.-..+++.--. .++.++++.||+.||.+|||+.++++
T Consensus       578 -----~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  578 -----QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -----HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                 1234556666655444443222 23999999999999999999999987

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-42  Score=316.29  Aligned_cols=263  Identities=22%  Similarity=0.334  Sum_probs=201.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|.+....  .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57999999999999999999976 78999999986532  2335678899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +. ++|.+++.....        .+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.+||+|||++..
T Consensus        86 ~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  153 (301)
T cd07873          86 LD-KDLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA  153 (301)
T ss_pred             cc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence            97 589888865432        3889999999999999999999998   99999999999999999999999999875


Q ss_pred             CccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .....  .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.......................+..
T Consensus       154 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (301)
T cd07873         154 KSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG  231 (301)
T ss_pred             cCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence            43211  112334578899999998754 578899999999999999999999976543221111111101111111111


Q ss_pred             hcc---------cccCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVD---------ARLGGD----YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~---------~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +..         +....+    .....+..+.+||.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111         000001    11224567899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-42  Score=309.97  Aligned_cols=252  Identities=29%  Similarity=0.468  Sum_probs=200.8

Q ss_pred             ccccCCceEEEEEEECC-------CCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           74 LIGEGSYGRVYYGILKS-------GHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      .||+|+||.||+|+.+.       +..+++|.+....  .....+.+|+.+++.++||||+++++++......+++|||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            69999999999998652       2579999886543  33567889999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-----ceEEeccc
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFD  219 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-----~~kl~Dfg  219 (361)
                      ++++|.+++.......  .....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||
T Consensus        82 ~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          82 EGGDLLSYLRDARVER--FGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             CCCcHHHHHHHhhhcc--cCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence            9999999997543211  12234889999999999999999999998   99999999999999887     89999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ++................++..|+|||.+.++.++.++|||||||++|+|++ |..||......                
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~----------------  220 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ----------------  220 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH----------------
Confidence            9876543322222233456788999999999999999999999999999998 99999643221                


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      .....+........+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         221 EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            111111111122334456678999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-42  Score=312.72  Aligned_cols=259  Identities=26%  Similarity=0.396  Sum_probs=205.5

Q ss_pred             CHHHHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEe--
Q 018071           58 SVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVD--  133 (361)
Q Consensus        58 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~--  133 (361)
                      +..++....+.|++.+.||.|+||.||+|..+ +++.+|+|.+........++..|+.+++++ +||||+++++++..  
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            34444555688999999999999999999976 789999999876655566788899999998 69999999998853  


Q ss_pred             ----CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc
Q 018071          134 ----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       134 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~  209 (361)
                          ....+++|||+.+|+|.+++......       .+++..++.++.||+.||.|||+.+   ++|+||+|+||++++
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~  156 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-------ALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTE  156 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence                45789999999999999998764422       3788899999999999999999998   999999999999999


Q ss_pred             CCceEEeccccCCCCccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCccc
Q 018071          210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ  284 (361)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~  284 (361)
                      ++.++|+|||++.......  .......|+..|+|||.+.     +..++.++|||||||++|+|++|..||....+...
T Consensus       157 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~  234 (282)
T cd06636         157 NAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA  234 (282)
T ss_pred             CCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence            9999999999987653211  1223466899999999876     34688899999999999999999999964332111


Q ss_pred             chhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          285 QSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..               ..............++..+.+++.+||+.||.+|||+.+|++
T Consensus       235 ~~---------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 LF---------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hh---------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00               000111111112235667999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.4e-42  Score=313.08  Aligned_cols=250  Identities=20%  Similarity=0.307  Sum_probs=200.5

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      |+..++||+|+||+||++... +++.+|+|.+.....    ....+.+|+.+++.++|+||+.+++.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667788999999999999976 899999999865432    223567899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +.+++|.+++.....       ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++..
T Consensus        82 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~  151 (285)
T cd05632          82 MNGGDLKFHIYNMGN-------PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVK  151 (285)
T ss_pred             ccCccHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCccee
Confidence            999999988865332       13899999999999999999999998   99999999999999999999999999865


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      .....   ......|+..|+|||++.+..++.++|+|||||++|+|++|..||............            ...
T Consensus       152 ~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~------------~~~  216 (285)
T cd05632         152 IPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV------------DRR  216 (285)
T ss_pred             cCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------HHh
Confidence            43211   123457899999999999889999999999999999999999999754321110000            000


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVKA  344 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  344 (361)
                      +... ...++...+..+.+|+.+||+.+|++||+     +.+++..
T Consensus       217 ~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         217 VLET-EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             hhcc-ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            0000 01223345667899999999999999999     6777763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-43  Score=320.40  Aligned_cols=261  Identities=26%  Similarity=0.396  Sum_probs=215.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .+...+.+.||+|-||.|.++....+..||+|.++...  ..+.+|.+|+++|.+|+||||+.++++|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            35667888999999999999999878999999997643  3457899999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++|+|.+|+....-       +.+.......|+.||+.|++||.+..   +|||||.+.|+|++.++++||+|||+++.
T Consensus       617 mEnGDLnqFl~ahea-------pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  617 MENGDLNQFLSAHEL-------PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             HhcCcHHHHHHhccC-------cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence            999999999987642       12445566779999999999999997   99999999999999999999999999998


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh--CCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +............+-+.+|||||.+.-++++.++|||+||+++||+++  ...||.....+.   .+         +...
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vv---------en~~  754 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VV---------ENAG  754 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HH---------Hhhh
Confidence            766666655666777899999999999999999999999999999865  778886332211   00         0111


Q ss_pred             hhccccc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          302 QCVDARL---GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       302 ~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      .+.+..-   ....|+-++..+++++.+||+.+.++|||++++...|++.
T Consensus       755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1111111   1234567888999999999999999999999999988765

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=322.96  Aligned_cols=254  Identities=28%  Similarity=0.460  Sum_probs=220.1

Q ss_pred             cCCCCCccccCCceEEEEEEECC-----CCEEEEEEcCCC--CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILKS-----GHAAAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .....+.||+|.||.||+|...+     .-.||||..+.+  ....+.|+.|.-+|+.++||||++++|+|.+ ...|||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            34456789999999999998532     336899998764  3446789999999999999999999999976 468999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      ||.+.-|.|..|++.++.        .|+......++.||+.||.|||+..   +|||||...|||+.+..-+||+|||+
T Consensus       469 mEL~~~GELr~yLq~nk~--------sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKD--------SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             EecccchhHHHHHHhccc--------cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence            999999999999988764        3889999999999999999999997   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ++.+.+....... ...-+..|||||-+....++.++|||.|||.+||+++ |..||.+                ..+..
T Consensus       538 SR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg----------------vkNsD  600 (974)
T KOG4257|consen  538 SRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG----------------VKNSD  600 (974)
T ss_pred             hhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc----------------ccccc
Confidence            9998765544332 3334678999999999999999999999999999987 9999953                34455


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      +..-++.+-+.++|+.|+..++.|+.+||..+|.+||++.++...|.++++
T Consensus       601 VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  601 VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            555667777889999999999999999999999999999999999998886

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.4e-42  Score=306.60  Aligned_cols=248  Identities=26%  Similarity=0.443  Sum_probs=202.2

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----------hHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      +|.+.+.||.|+||.||+|... +++.+|+|.+......          .+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4788899999999999999976 7899999988653221          1357789999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .+++|||+++++|.+++....         .+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~  148 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---------AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKIS  148 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---------CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEec
Confidence            999999999999999997643         2888999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccc----cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          217 DFDLSNQAPDMAA----RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       217 Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      |||+++.......    ........|+..|+|||.+.+..++.++|||||||++|+|++|..||......          
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------  218 (267)
T cd06628         149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----------  218 (267)
T ss_pred             ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----------
Confidence            9999876642111    11112345888999999999888999999999999999999999999643211          


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                           ..+..... ......+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       219 -----~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         219 -----QAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -----HHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                 00111111 1112334456678999999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.7e-42  Score=309.33  Aligned_cols=261  Identities=25%  Similarity=0.420  Sum_probs=206.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      ++|++.+.||+|+||.||+|+.+      +...+++|.+......  .+.+.+|++++++++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999964      3467999988654433  467899999999999999999999999989999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +||||+++++|.+++..............+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999976543222222235899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .          
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~----------  227 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---V----------  227 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---H----------
Confidence            9987543211 112234456778999999988889999999999999999999 888986432211   1          


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                        +............+..++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       228 --~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         228 --LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --HHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence              11111111111122345567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.1e-42  Score=306.49  Aligned_cols=247  Identities=28%  Similarity=0.521  Sum_probs=202.3

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++|.+.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.+++.++|||++++++++... ..+++|||+.+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence            5789999999999999999875 58889999986532 346788999999999999999999998765 47899999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++.....       ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          83 GNLVNFLRTRGR-------ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             CCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            999999976432       23889999999999999999999998   99999999999999999999999999875422


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .     ......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||......                .....+.
T Consensus       153 ~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~  211 (254)
T cd05083         153 G-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK----------------EVKECVE  211 (254)
T ss_pred             c-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH----------------HHHHHHh
Confidence            1     122334568999999998899999999999999999998 99999644321                1112222


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                      .......+..++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         212 KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            222233344566789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-43  Score=323.22  Aligned_cols=261  Identities=26%  Similarity=0.339  Sum_probs=197.8

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----  134 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----  134 (361)
                      .+.++|.+.+.||+|+||.||+|... +++.||+|++.....   ....+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            46689999999999999999999975 889999999875322   234677899999999999999999887533     


Q ss_pred             -CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          135 -TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       135 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                       ...+++++++ +++|.+++....          +++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~  157 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQK----------LSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL  157 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCE
Confidence             4468999998 779998886432          899999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhhhh
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWA  291 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~~  291 (361)
                      ||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+....
T Consensus       158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  232 (343)
T cd07878         158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV  232 (343)
T ss_pred             EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            99999998765321     234578999999999876 57899999999999999999999999654321110 000000


Q ss_pred             c-------ccCCchhhhhhcccccCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          292 T-------PKLSEDKVRQCVDARLGGD------YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       292 ~-------~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .       ...........+.......      ........+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0       0000000011110000000      00112345789999999999999999999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.9e-42  Score=304.82  Aligned_cols=249  Identities=29%  Similarity=0.453  Sum_probs=206.4

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      ++|++.+.||+|+||.||+|..+ ++..+++|.+..... .+++.+|+++++.++||||+++++++.+....++++||+.
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            57899999999999999999987 589999999876433 6789999999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++....        ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++....
T Consensus        82 ~~~L~~~l~~~~--------~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          82 AGSVSDIMKITN--------KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             CCcHHHHHHhCc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            999999986543        23899999999999999999999998   9999999999999999999999999988764


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ....  ......++..|+|||++.+..++.++||||||+++|+|++|+.||....+.......  .          .  .
T Consensus       151 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--~----------~--~  214 (256)
T cd06612         151 DTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--P----------N--K  214 (256)
T ss_pred             cCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--c----------c--C
Confidence            3221  223455788999999999889999999999999999999999999754332110000  0          0  0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .......+...+..+.+++.+||+.+|++|||++++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         215 PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            00011223345677999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.2e-42  Score=307.28  Aligned_cols=255  Identities=24%  Similarity=0.342  Sum_probs=192.9

Q ss_pred             CccccCCceEEEEEEEC---CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCC
Q 018071           73 ALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      +.||+|+||.||+|...   ++..+++|.+......  ...+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36999999999999864   4567999988764432  246888999999999999999999999988999999999999


Q ss_pred             cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccc
Q 018071          148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM  227 (361)
Q Consensus       148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~  227 (361)
                      +|.+++.......    ....++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          81 DLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             cHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence            9999997643211    123677888899999999999999998   999999999999999999999999998754332


Q ss_pred             cccccccccccCCCCCCchhhccC-------CCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          228 AARLHSTRVLGTFGYHAPEYAMTG-------QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       228 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..........++..|+|||++.+.       .++.++||||||+++|||++ |..||............ +.      ..
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~------~~  226 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VR------EQ  226 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-hh------cc
Confidence            222222345678899999988642       35789999999999999996 99999644322110000 00      00


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      ......+.    .....+..+.+++.+|+ .+|++|||+++|++.|.
T Consensus       227 ~~~~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLKLPKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00011111    11123456889999999 58999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.5e-42  Score=307.91  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=205.0

Q ss_pred             hcCCCCCccccCCceEEEEEEECC----CCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|.+.++||+|+||.||+|...+    ...|++|.......  ..+.+.+|+.+++.++||||+++++++.+ ...+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            568888999999999999998652    34689998865432  23578899999999999999999998875 457899


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++....        ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+
T Consensus        85 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          85 MELAPLGELRSYLQVNK--------YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             EEcCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCce
Confidence            99999999999997543        13899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ++....... .......++..|+|||.+....++.++||||||+++|+|++ |..||........   ..          
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~----------  219 (270)
T cd05056         154 SRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IG----------  219 (270)
T ss_pred             eeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH----------
Confidence            876533211 11223334568999999988889999999999999999996 9999965432111   00          


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                        . +........+..++..+.+++.+|+..+|.+|||+.++++.|+.+....
T Consensus       220 --~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         220 --R-IENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             --H-HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence              0 1111111233455678999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.9e-42  Score=304.94  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=194.4

Q ss_pred             CccccCCceEEEEEEEC----CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEE-eCCeeEEEEEeCC
Q 018071           73 ALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVLAYEFAS  145 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~  145 (361)
                      +.||+|+||.||+|.+.    .+..+|+|.+.....  ....+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36999999999999853    345799998854322  2357788999999999999999999775 4556789999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....        .+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          81 HGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999999975431        2677888999999999999999998   9999999999999999999999999987543


Q ss_pred             cccc--cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhC-CCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          226 DMAA--RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       226 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ....  ........++..|+|||.+.+..++.++|||||||++|||++| ..||.......   +             ..
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~-------------~~  213 (262)
T cd05058         150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---I-------------TV  213 (262)
T ss_pred             CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H-------------HH
Confidence            2111  1111234467789999999888999999999999999999995 55664322111   1             11


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      .+........+...+..+.+++.+||+.+|++||++.+|++.|+.+++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         214 YLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            111111111222345679999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-42  Score=312.72  Aligned_cols=262  Identities=27%  Similarity=0.411  Sum_probs=204.4

Q ss_pred             HHHHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEE----
Q 018071           59 VDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV----  132 (361)
Q Consensus        59 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~----  132 (361)
                      .+.+....++|++.+.||+|+||.||++..+ +++.+|+|.+.........+.+|+.+++.+ +||||+++++++.    
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            3444556789999999999999999999976 789999999876554456788899999999 6999999999874    


Q ss_pred             -eCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC
Q 018071          133 -DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD  211 (361)
Q Consensus       133 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~  211 (361)
                       .+...+++|||+++++|.+++.....     ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~  161 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLK-----RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEG  161 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhc-----cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCC
Confidence             34568999999999999998864321     1124889999999999999999999998   99999999999999999


Q ss_pred             ceEEeccccCCCCccccccccccccccCCCCCCchhhcc-----CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch
Q 018071          212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS  286 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~  286 (361)
                      .+||+|||+++......  .......|++.|+|||++..     ..++.++|||||||++|+|++|+.||....+...  
T Consensus       162 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--  237 (286)
T cd06638         162 GVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--  237 (286)
T ss_pred             CEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--
Confidence            99999999987653221  12234568999999998753     4578899999999999999999999965432110  


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      +....          .....  ....+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       238 ~~~~~----------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         238 LFKIP----------RNPPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             Hhhcc----------ccCCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00000          00000  001122234569999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.8e-42  Score=304.64  Aligned_cols=248  Identities=28%  Similarity=0.410  Sum_probs=199.2

Q ss_pred             CccccCCceEEEEEEECC--C--CEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILKS--G--HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++||+|++|.||+|.+.+  +  ..||+|.+.....  ..+.+.+|+.++++++||||+++++++.+ ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            369999999999999652  3  3699999976544  34578899999999999999999999888 889999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++.....       ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        80 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          80 GSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             CcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence            999999976532       23899999999999999999999998   99999999999999999999999999887643


Q ss_pred             cccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          227 MAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       227 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .... .......++..|+|||++.+..++.++|||||||++|+|++ |..||........               +..+.
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---------------~~~~~  214 (257)
T cd05040         150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---------------LKKID  214 (257)
T ss_pred             cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---------------HHHHH
Confidence            2211 11223457789999999998899999999999999999998 9999964322111               00000


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      ........+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       215 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         215 KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             hcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            011111223345677999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-42  Score=307.72  Aligned_cols=246  Identities=27%  Similarity=0.405  Sum_probs=204.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|++.+.||.|+||.||+|... +++.||+|.+....  .....+.+|+.+++.++||||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888899999999999999977 79999999986543  2235688899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +.+++|.+++...          .+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.
T Consensus        81 ~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  147 (274)
T cd06609          81 CGGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQ  147 (274)
T ss_pred             eCCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccccee
Confidence            9999999998764          2899999999999999999999998   99999999999999999999999999877


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      .....  .......++..|+|||++.+..++.++||||||+++|+|++|..||....+....                ..
T Consensus       148 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~----------------~~  209 (274)
T cd06609         148 LTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL----------------FL  209 (274)
T ss_pred             ecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH----------------HH
Confidence            64321  1234567888999999999888999999999999999999999999654321100                00


Q ss_pred             cccccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VDARLGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +........+.. ++..+.+++.+||..+|++|||++++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         210 IPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             hhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            001111111112 5667999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-43  Score=311.59  Aligned_cols=251  Identities=29%  Similarity=0.466  Sum_probs=199.2

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHH---HHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      |++.+.||+|+||+||++... +++.||+|.+.........   ..+|+.++++++||||+++++++.+....+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567889999999999999987 6779999999876544332   345999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      .+++|.+++....         .+++..++.++.||+.||.+||+.+   ++|+||||+||++++++.++|+|||.+...
T Consensus        81 ~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   81 PGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             TTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             ccccccccccccc---------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            9999999998332         2899999999999999999999998   999999999999999999999999998643


Q ss_pred             ccccccccccccccCCCCCCchhhc-cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      .  ..........++..|+|||++. +..++.++||||||+++|+|++|..||...............        ....
T Consensus       149 ~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~--------~~~~  218 (260)
T PF00069_consen  149 S--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKI--------LKRP  218 (260)
T ss_dssp             T--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHH--------HHTH
T ss_pred             c--ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc--------cccc
Confidence            1  1122345567899999999998 888999999999999999999999999754111111111000        0000


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .....  .........+.+++.+||+.||++|||+.++++
T Consensus       219 ~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  219 LPSSS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000  000011267999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.8e-42  Score=306.09  Aligned_cols=249  Identities=26%  Similarity=0.429  Sum_probs=202.1

Q ss_pred             cCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC-------hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      +|.+.+.||.|+||.||+|...+++.+|+|.+......       ...+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            58889999999999999999888999999988653321       24578899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++....         .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        81 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  148 (265)
T cd06631          81 MEFVPGGSISSILNRFG---------PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC  148 (265)
T ss_pred             EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence            99999999999996543         2789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCcccc----ccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          221 SNQAPDMA----ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       221 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      +.......    .........|+..|+|||.+.+..++.++|||||||++|+|++|..||........  .         
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~---------  217 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--M---------  217 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--H---------
Confidence            87542211    11112345688999999999988999999999999999999999999964322110  0         


Q ss_pred             chhhhhhccc-ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          297 EDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       297 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                          ...... ......+..++..+.+++.+||+.+|.+||++.++++
T Consensus       218 ----~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         218 ----FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ----HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                000000 1111233445677999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.4e-42  Score=317.18  Aligned_cols=258  Identities=22%  Similarity=0.309  Sum_probs=193.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      ..+|.+.+.||+|+||.||+|..+ ++..||+|.....     ....|+.++++++||||+++++++......++|||++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            357999999999999999999977 7889999975432     3356899999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      . ++|.+++....        ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       140 ~-~~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        140 S-SDLYTYLTKRS--------RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             C-CcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            5 58888886543        23899999999999999999999998   999999999999999999999999998753


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc--------hhhhhhc----
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--------SLVTWAT----  292 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~--------~~~~~~~----  292 (361)
                      ...   .......||..|+|||++.+..++.++|||||||++|||+++..|+-...+....        .+.....    
T Consensus       208 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~  284 (357)
T PHA03209        208 VVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV  284 (357)
T ss_pred             ccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence            221   1223456899999999999999999999999999999999865554222221100        0000000    


Q ss_pred             --ccCC----chhhhhhccccc--CCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          293 --PKLS----EDKVRQCVDARL--GGDYP-------PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       293 --~~~~----~~~~~~~~~~~~--~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                        ....    .......++...  .....       ...+..+..||.+||+.||.+|||+.|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        285 HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             ChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence              0000    000011111000  00000       122445677999999999999999999986

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.5e-42  Score=303.68  Aligned_cols=248  Identities=25%  Similarity=0.364  Sum_probs=201.6

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEe-CCeeEEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLAYE  142 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e  142 (361)
                      +|++.+.||+|++|.||++..+ +++.||+|.+.....   ..+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999976 788999999865332   23567889999999999999999988764 446789999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++++|.+++.....       ..+++.+++.++.|++.||.+||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~  150 (257)
T cd08223          81 FCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR  150 (257)
T ss_pred             ccCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceE
Confidence            9999999999976432       23899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ......  .......+++.|+|||++.+..++.++||||||+++|+|++|+.||.......               ....
T Consensus       151 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---------------~~~~  213 (257)
T cd08223         151 VLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS---------------LVYR  213 (257)
T ss_pred             EecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHH
Confidence            653221  12344568999999999999999999999999999999999999996432110               0011


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.. ......+...+..+.+++.+||+.+|++|||+.++++
T Consensus       214 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         214 IIE-GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HHh-cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            111 1112234456678999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=320.16  Aligned_cols=238  Identities=21%  Similarity=0.246  Sum_probs=187.6

Q ss_pred             cccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcC---CCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL---KHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        75 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ||+|+||+||+|..+ +++.||+|++.+...    .......|..++..+   +||||+++++++.+....++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999977 799999999864321    123345566666655   699999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 g~L~~~l~~~~---------~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~  148 (330)
T cd05586          81 GELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT  148 (330)
T ss_pred             ChHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence            99999886543         3899999999999999999999998   99999999999999999999999999875422


Q ss_pred             ccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ..  ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||........               ...+..
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---------------~~~i~~  211 (330)
T cd05586         149 DN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---------------YRNIAF  211 (330)
T ss_pred             CC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---------------HHHHHc
Confidence            11  123456799999999998765 589999999999999999999999965322110               111111


Q ss_pred             cccCCCCC-HHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 018071          306 ARLGGDYP-PKAVAKMAAVAALCVQYEADFRP----NMSIVVK  343 (361)
Q Consensus       306 ~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RP----s~~evl~  343 (361)
                      ...  ..+ ...+..+.+++.+||+.||.+||    ++.++++
T Consensus       212 ~~~--~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         212 GKV--RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCC--CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            111  111 12456789999999999999998    5666665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-41  Score=305.63  Aligned_cols=247  Identities=26%  Similarity=0.418  Sum_probs=205.2

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ..|+..+.||.|+||.||+|..+ ++..||+|.+.....  ....+.+|+.+++.++||||+++++.+.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777888999999999999976 789999999875432  235688899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++....          +++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        84 ~~~~~L~~~i~~~~----------l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~  150 (277)
T cd06640          84 LGGGSALDLLRAGP----------FDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             CCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence            99999999986532          888999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      .....  .......++..|+|||++.+..++.++|+|||||++|+|++|..||....+....                ..
T Consensus       151 ~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~  212 (277)
T cd06640         151 LTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FL  212 (277)
T ss_pred             ccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hh
Confidence            53321  1223456788999999999888999999999999999999999999644322110                11


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      +........+...+..+.+++.+||+.+|++||+++++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         213 IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            11111223445677889999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.9e-42  Score=303.45  Aligned_cols=249  Identities=22%  Similarity=0.371  Sum_probs=205.2

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|+..++||.|+||.||.++.. +++.+++|.+....   ....++.+|+.++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999965 79999999886532   3345788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++.....       ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++..
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~  150 (256)
T cd08221          81 ANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI  150 (256)
T ss_pred             cCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEE
Confidence            999999999976532       23899999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ......  ......+++.|+|||.+.+..++.++||||||+++|+|++|..||....+..               ....+
T Consensus       151 ~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---------------~~~~~  213 (256)
T cd08221         151 LGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---------------LVVKI  213 (256)
T ss_pred             cccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---------------HHHHH
Confidence            533221  2345668999999999998889999999999999999999999996433211               11111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ..... ...+...+..+.+++.+||+.+|.+||+++++++.
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         214 VQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HcCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            11111 11223456779999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=306.25  Aligned_cols=247  Identities=29%  Similarity=0.456  Sum_probs=210.8

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCC
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      |.++.+||+|+||.||+|.++ +|..+|||.++.. .+.+++..|+.+|++...|++|++++.+.....+|+|||||..|
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            444557999999999999988 9999999998764 45689999999999999999999999988889999999999999


Q ss_pred             cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccc
Q 018071          148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM  227 (361)
Q Consensus       148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~  227 (361)
                      ++.+.++.++        .+|++.++..++..-+.||+|||...   -+|||||..|||++.+|+.||+|||.+.++.+.
T Consensus       114 SiSDI~R~R~--------K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  114 SISDIMRARR--------KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             cHHHHHHHhc--------CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            9999998765        35999999999999999999999997   899999999999999999999999999887554


Q ss_pred             cccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccc
Q 018071          228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR  307 (361)
Q Consensus       228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (361)
                      ..  ...+..||+.|||||++..-+|+.++||||||++..||.-|++||....|--....+    +          ..+.
T Consensus       183 MA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----P----------T~PP  246 (502)
T KOG0574|consen  183 MA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----P----------TKPP  246 (502)
T ss_pred             HH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----c----------CCCC
Confidence            32  346789999999999999999999999999999999999999999755432100000    0          0111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          308 LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       308 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .....|...+.++.+++++||-.+|++|-|+-++++
T Consensus       247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            122345677889999999999999999999988876

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6e-42  Score=310.75  Aligned_cols=250  Identities=24%  Similarity=0.395  Sum_probs=205.3

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ..++|.+.+.||+|+||.||++... +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            3478999999999999999999975 899999999865433 34567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++++|.+++....          +++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.
T Consensus        97 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~  163 (297)
T cd06656          97 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (297)
T ss_pred             ccCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccce
Confidence            999999999986542          889999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .......  ......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+.......              
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--------------  227 (297)
T cd06656         164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------  227 (297)
T ss_pred             EccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--------------
Confidence            5432211  123456889999999999888999999999999999999999999654332111000              


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..........+...+..+.+++.+||+.+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         228 ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000011123345667899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-41  Score=302.07  Aligned_cols=250  Identities=31%  Similarity=0.482  Sum_probs=202.8

Q ss_pred             CCCCCccccCCceEEEEEEEC-CC----CEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SG----HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.+.+.||+|+||.||++... ++    ..||+|.+.....  ....+..|+.+++.++|+||+++++++.+....+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356788999999999999976 33    8899999976544  3568889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++......       .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++
T Consensus        81 e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~  150 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLS  150 (258)
T ss_pred             eccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCc
Confidence            999999999999765421       1899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ........... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......                .+
T Consensus       151 ~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~----------------~~  213 (258)
T smart00219      151 RDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE----------------EV  213 (258)
T ss_pred             eeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH----------------HH
Confidence            76643321111 12336789999999988889999999999999999998 88888642211                11


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      .+.+........+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      214 LEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            111111112233334667899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.9e-42  Score=309.61  Aligned_cols=245  Identities=27%  Similarity=0.416  Sum_probs=201.2

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      .|...+.||+|+||.||+|... ++..||+|.+....  ...+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4556678999999999999876 78899999886433  22356889999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++++|.+++....          +++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        85 ~~~~L~~~~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06642          85 GGGSALDLLKPGP----------LEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             CCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccc
Confidence            9999999986432          889999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ....  .......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+....                ..+
T Consensus       152 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~  213 (277)
T cd06642         152 TDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL----------------FLI  213 (277)
T ss_pred             cCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH----------------hhh
Confidence            4321  1223456888999999999889999999999999999999999998643321110                001


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ........+...+..+.+++.+||+.+|.+||++.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         214 PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            111111223345677999999999999999999999998

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.7e-42  Score=315.11  Aligned_cols=266  Identities=19%  Similarity=0.277  Sum_probs=197.2

Q ss_pred             CCCccccC--CceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           71 TNALIGEG--SYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        71 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      +.++||+|  +|++||++..+ +|+.||+|++......   .+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45689999  78999999976 8999999998754322   245677999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++++|.+++......       .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.++++||+.....
T Consensus        82 ~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          82 AYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             CCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            999999999654321       2889999999999999999999998   999999999999999999999999865433


Q ss_pred             ccccccc-----cccccccCCCCCCchhhcc--CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC--
Q 018071          225 PDMAARL-----HSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL--  295 (361)
Q Consensus       225 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~--  295 (361)
                      .......     ......++..|+|||++.+  ..++.++|||||||++|+|++|+.||........  .........  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~  229 (327)
T cd08227         152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPC  229 (327)
T ss_pred             ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccc
Confidence            2111100     1123356778999999976  4689999999999999999999999974322110  000000000  


Q ss_pred             -------Cchhh-------------hh---------hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--H
Q 018071          296 -------SEDKV-------------RQ---------CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--A  344 (361)
Q Consensus       296 -------~~~~~-------------~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~  344 (361)
                             ..+.+             ..         ........+.....+..+.+++.+||+.||++|||++++++  .
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~  309 (327)
T cd08227         230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  309 (327)
T ss_pred             cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence                   00000             00         00000001122345678999999999999999999999987  4


Q ss_pred             HHHh
Q 018071          345 LQPL  348 (361)
Q Consensus       345 L~~l  348 (361)
                      ++.+
T Consensus       310 f~~~  313 (327)
T cd08227         310 FKQI  313 (327)
T ss_pred             hhhc
Confidence            4444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-42  Score=344.65  Aligned_cols=257  Identities=20%  Similarity=0.301  Sum_probs=199.9

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEe--CCe
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTS  136 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~  136 (361)
                      ....++|.+.+.||+|+||+||+|... ++..+|+|.+.....   ....+..|+.+++.++||||++++++|.+  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            345679999999999999999999977 788999998865332   23568899999999999999999998864  456


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC----CCeEeccCCCCceEeccC--
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD----PHIIHRDIKSSNVLIFDD--  210 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~----~~ivHrDikp~Nill~~~--  210 (361)
                      ++|||||+++++|.++|......     ...+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.+  
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence            89999999999999999753211     1238999999999999999999998541    249999999999999642  


Q ss_pred             ---------------CceEEeccccCCCCccccccccccccccCCCCCCchhhcc--CCCCCccceecHHHHHHHHHhCC
Q 018071          211 ---------------DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGR  273 (361)
Q Consensus       211 ---------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~  273 (361)
                                     +.+||+|||++.......   ......||+.|+|||++.+  ..++.++|||||||+||+|++|.
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence                           358999999997653221   1234579999999999864  45889999999999999999999


Q ss_pred             CCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          274 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       274 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .||.......               .+...+...... .....+..+.+||..||+.+|.+||++.+++.
T Consensus       241 ~PF~~~~~~~---------------qli~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        241 TPFHKANNFS---------------QLISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCcCCcHH---------------HHHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9996432110               011111111100 11224567999999999999999999999985

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.4e-42  Score=306.66  Aligned_cols=251  Identities=28%  Similarity=0.393  Sum_probs=199.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      ++|.+.+.||+|+||.||+|... +++.||+|.++.... ....+.+|+.+++.++||||+++++.+......+++|||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            57888889999999999999976 799999999865432 2346778999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++++|.+++....         .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++...
T Consensus        89 ~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          89 GGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence            9999999986543         3899999999999999999999998   999999999999999999999999998654


Q ss_pred             ccccccccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ...  ........|+..|+|||++.   ...++.++|||||||++|+|++|..||....+........  .....     
T Consensus       157 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~~~~~-----  227 (267)
T cd06645         157 TAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--KSNFQ-----  227 (267)
T ss_pred             cCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--ccCCC-----
Confidence            321  11224457899999999874   4568899999999999999999999986443221110000  00000     


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         ....  ......+..+.+++.+||+.+|++|||+++|++
T Consensus       228 ---~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         228 ---PPKL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ---CCcc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence               0000  001123456899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.8e-42  Score=305.14  Aligned_cols=255  Identities=25%  Similarity=0.367  Sum_probs=190.4

Q ss_pred             CccccCCceEEEEEEEC---CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCC
Q 018071           73 ALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      +.||+|+||.||+|...   ....+++|.+......  ...+.+|+..++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            35999999999999754   3457888887643322  346788999999999999999999999999999999999999


Q ss_pred             cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccc
Q 018071          148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM  227 (361)
Q Consensus       148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~  227 (361)
                      +|.+++.......    ....++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        81 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  153 (269)
T cd05042          81 DLKNYLRSNRGMV----AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE  153 (269)
T ss_pred             cHHHHHHhccccc----cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccc
Confidence            9999997654211    122567888999999999999999998   999999999999999999999999998654322


Q ss_pred             cccccccccccCCCCCCchhhcc-------CCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          228 AARLHSTRVLGTFGYHAPEYAMT-------GQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       228 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..........++..|+|||++..       ..++.++|||||||++|+|++ |..||....+...  +.....     ..
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~-----~~  226 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQVVR-----EQ  226 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhh-----cc
Confidence            21112233456778999998753       356789999999999999999 7888864322110  000000     00


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      ...+..+    ..+...+..+.+++..|| .||++|||+++|++.|.
T Consensus       227 ~~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 DIKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0000011    122345566788999998 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=302.64  Aligned_cols=240  Identities=23%  Similarity=0.290  Sum_probs=203.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|+.+++||+|.||.|.+++.+ +++.||||++++.-..    ...-+.|-++|+..+||.+..+.-.|.....+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            478899999999999999999987 9999999999875432    23456788899999999999998889999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||..||.|.-.+...+         .+++...+.+-..|+.||.|||+++   ||+||||.+|+|+|.+|++||+|||+
T Consensus       247 MeyanGGeLf~HLsrer---------~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGL  314 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---------VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGL  314 (516)
T ss_pred             EEEccCceEeeehhhhh---------cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeeccc
Confidence            99999999987776554         4999999999999999999999987   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ++.--  .......++||||.|+|||++....|+..+|+|.+||++|||++|+.||........-.++.           
T Consensus       315 CKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----------  381 (516)
T KOG0690|consen  315 CKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----------  381 (516)
T ss_pred             chhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----------
Confidence            98642  23334678999999999999999999999999999999999999999996543322111111           


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP  336 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  336 (361)
                          ...  ..+|...+.+...|+...|..||.+|.
T Consensus       382 ----~ed--~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  382 ----MED--LKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ----hhh--ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence                111  145667778899999999999999995

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-41  Score=308.33  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=200.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      +.|++.++||.|+||.||+|..+ ++..+++|.+..... ..+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            67999999999999999999976 689999999865432 2456888999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++++|..++.....        .+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        92 ~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          92 PGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             CCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence            99999888754331        3899999999999999999999998   999999999999999999999999988654


Q ss_pred             ccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ........++..|+|||++.     ...++.++|||||||++|+|++|..||....+..  .             
T Consensus       161 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~-------------  223 (292)
T cd06644         161 VKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--V-------------  223 (292)
T ss_pred             ccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--H-------------
Confidence            221  11223456889999999885     3457889999999999999999999996432210  0             


Q ss_pred             hhhhccccc-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +..+..... ....+...+..+.+++.+||+.+|++||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         224 LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            011111000 11123345567899999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.7e-42  Score=308.77  Aligned_cols=264  Identities=22%  Similarity=0.292  Sum_probs=199.3

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|.+.+.||+|++|.||+|..+ ++..||+|++....   .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5788899999999999999976 79999999986532   2235688899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +. ++|.+++.....      ...+++..++.++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||++..
T Consensus        81 ~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  150 (285)
T cd07861          81 LS-MDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARA  150 (285)
T ss_pred             CC-CCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceee
Confidence            97 589888865431      124899999999999999999999998   99999999999999999999999999875


Q ss_pred             CccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchh--hhhhccc------
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL--VTWATPK------  294 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~--~~~~~~~------  294 (361)
                      .....  .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...........  ..+..+.      
T Consensus       151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
T cd07861         151 FGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG  228 (285)
T ss_pred             cCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence            43221  112334678899999988754 578999999999999999999999975432211000  0000000      


Q ss_pred             CC-chhhhhhcccccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 LS-EDKVRQCVDARLG---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 ~~-~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .. .............   .......+.++.+++.+||+.||.+|||+.+|++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00 0000000000000   0011224567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=301.64  Aligned_cols=252  Identities=27%  Similarity=0.383  Sum_probs=205.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      ++|++.+.||.|+||.||+|... +++.+++|.+..... ..+.+.+|+.++++++||||+++++++.+....+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57899999999999999999976 788999999875432 3467889999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      .+++|.+++....        ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        83 ~~~~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  151 (262)
T cd06613          83 GGGSLQDIYQVTR--------GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL  151 (262)
T ss_pred             CCCcHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhh
Confidence            9999999987642        13899999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccC---CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .....  ......++..|+|||.+.+.   .++.++||||||+++|+|++|..||....+......  ......      
T Consensus       152 ~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--~~~~~~------  221 (262)
T cd06613         152 TATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--ISKSNF------  221 (262)
T ss_pred             hhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccC------
Confidence            43211  22345688899999999876   889999999999999999999999965432211100  000000      


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                          ...........+..+.+++.+||..+|.+|||+++|+.
T Consensus       222 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         222 ----PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ----CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                00011123456778999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.8e-41  Score=301.46  Aligned_cols=249  Identities=24%  Similarity=0.380  Sum_probs=198.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC------ChHHHHHHHHHHhcCCCCCcceeeeEEEe--CCee
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ------PDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSR  137 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~  137 (361)
                      .+|+..++||+|+||.||+|... ++..|++|.+.....      ....+.+|+.+++.++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            37899999999999999999976 799999998864321      12457789999999999999999998875  3567


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      ++++||+++++|.+++....         .+++...+.++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---------ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence            89999999999999987543         2789999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCccccc-cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          218 FDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       218 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ||++........ ........++..|+|||++.+..++.++|||||||++|+|++|+.||......              
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------------  215 (266)
T cd06651         150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------------  215 (266)
T ss_pred             CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------------
Confidence            999876532111 11122355889999999999888999999999999999999999999643211              


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ..+............+...+..+..++ +||..+|++||++++|++
T Consensus       216 -~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         216 -AAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -HHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence             111111111112234445566778888 688889999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-41  Score=306.47  Aligned_cols=247  Identities=24%  Similarity=0.383  Sum_probs=198.9

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      |++.+.||+|+||.||++..+ ++..+++|.+.... ...+.+.+|+++++.++||||+++++++......++||||+.+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            677788999999999999977 68889999886533 2345688899999999999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|..++....        ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        87 ~~l~~~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          87 GAVDAVMLELE--------RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  155 (282)
T ss_pred             CcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc
Confidence            99998876432        13899999999999999999999998   99999999999999999999999999876432


Q ss_pred             ccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ..  .......++..|+|||++.     +..++.++|||||||++|+|++|..||....+..               .+.
T Consensus       156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---------------~~~  218 (282)
T cd06643         156 TI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---------------VLL  218 (282)
T ss_pred             cc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---------------HHH
Confidence            21  1223456899999999884     4467889999999999999999999996432211               001


Q ss_pred             hhccc-ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..... ......+...+..+.+++.+||+.+|.+||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         219 KIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11000 0011223345677999999999999999999999885

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.7e-42  Score=309.53  Aligned_cols=248  Identities=25%  Similarity=0.411  Sum_probs=203.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      .+|++.+.||.|+||.||++... +++.|++|.+.... ...+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46899999999999999999865 89999999886533 33467888999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      .+++|..++....          +++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++...
T Consensus        99 ~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~  165 (296)
T cd06655          99 AGGSLTDVVTETC----------MDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI  165 (296)
T ss_pred             CCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence            9999999986542          899999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .....  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....+......  ...            
T Consensus       166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~--~~~------------  229 (296)
T cd06655         166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IAT------------  229 (296)
T ss_pred             ccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHh------------
Confidence            33211  12345688999999999988899999999999999999999999965433111000  000            


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ........+...+..+.+++.+||..+|.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            000001123345567999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.9e-42  Score=308.32  Aligned_cols=260  Identities=24%  Similarity=0.320  Sum_probs=205.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|++.+.||+|+||+||++... +++.||+|++....  .....+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57888889999999999999976 78999999876532  2346788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      +++++|.+++....         .+++..+..++.+++.||.|||+. +   ++||||+|+||++++++.++|+|||++.
T Consensus        85 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~  152 (284)
T cd06620          85 MDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSG  152 (284)
T ss_pred             CCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCccc
Confidence            99999999886543         389999999999999999999974 5   9999999999999999999999999986


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .....    ......|+..|+|||++.+..++.++|||||||++|+|++|..||....+........    ....+.+..
T Consensus       153 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~----~~~~~~~~~  224 (284)
T cd06620         153 ELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP----MGILDLLQQ  224 (284)
T ss_pred             chhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh----hHHHHHHHH
Confidence            54221    1234578999999999988899999999999999999999999997544321100000    000011111


Q ss_pred             hcccccCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          303 CVDARLGGDYP-PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       303 ~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                      ++.... ...+ ...+..+.+++.+||+.||.+|||+.|+++...-
T Consensus       225 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         225 IVQEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             HhhccC-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            111111 1111 2256679999999999999999999999986433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8e-42  Score=308.15  Aligned_cols=251  Identities=23%  Similarity=0.382  Sum_probs=202.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|++.+.||+|+||.||++..+ ++..||+|.+.....  ....+.+|+.++++++||||+++++.+......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999987 899999998865322  235788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      +++++|..++.....      ...+++..+..++.|++.||.|||+. +   |+|+||||+||++++++.+||+|||++.
T Consensus        81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  151 (286)
T cd06622          81 MDAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSG  151 (286)
T ss_pred             cCCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence            999999998875321      12389999999999999999999974 6   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccC------CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG------QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      .....    ......++..|+|||.+.+.      .++.++|||||||++|+|++|..||.........           
T Consensus       152 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-----------  216 (286)
T cd06622         152 NLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-----------  216 (286)
T ss_pred             cccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-----------
Confidence            65322    12345678899999998654      3578999999999999999999999643221100           


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ..+..+... .....+..++..+.+++.+||+.+|++||+++++++
T Consensus       217 -~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         217 -AQLSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -HHHHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence             111111111 112344557788999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=292.01  Aligned_cols=252  Identities=20%  Similarity=0.244  Sum_probs=203.9

Q ss_pred             HHhhcCCCC-CccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEe----CCe
Q 018071           64 EITENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVD----GTS  136 (361)
Q Consensus        64 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~----~~~  136 (361)
                      .++++|.+. ++||-|-.|.|-.+.++ +++.+|+|++..+.    ..++|++..-.. .|||||.++++|++    ...
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            467888875 57999999999999987 99999999986543    556778776555 59999999998864    355


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC---Cce
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVA  213 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~---~~~  213 (361)
                      +.+|||.++||.|...+..++..       .+++.++..|+.||..|+.|||+..   |.||||||+|+|....   ..+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~-------afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~l  203 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQ-------AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPL  203 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccc-------cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcce
Confidence            67999999999999999888754       3999999999999999999999997   9999999999999754   479


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      ||+|||+|+....   .....+.|-|+.|.|||++....|+...|+||+||++|-|++|.+||......           
T Consensus       204 KLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-----------  269 (400)
T KOG0604|consen  204 KLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----------  269 (400)
T ss_pred             EecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-----------
Confidence            9999999987543   22346788899999999999999999999999999999999999999654332           


Q ss_pred             cCCchhhhhhcccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          294 KLSEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .++.+--.++....+..  +-....+....++|+.+|+.+|.+|.|+++++.
T Consensus       270 aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  270 AISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            11222222222222211  122456788899999999999999999999986

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=310.51  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=204.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||+|... +++.||+|.+......    .+.+..|+++++.++||||+++++.+.+....+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999977 6999999999764332    346788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+.+++|.+++.....       ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++
T Consensus        81 e~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~  150 (316)
T cd05574          81 DYCPGGELFRLLQRQPG-------KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLS  150 (316)
T ss_pred             EecCCCCHHHHHHhCCC-------CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchh
Confidence            99999999999875432       23899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCcccccc---------------------------ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCC
Q 018071          222 NQAPDMAAR---------------------------LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK  274 (361)
Q Consensus       222 ~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~  274 (361)
                      .........                           .......||..|+|||++.+..++.++||||||+++|+|++|..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~  230 (316)
T cd05574         151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT  230 (316)
T ss_pred             hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence            654321100                           01123468899999999998889999999999999999999999


Q ss_pred             CCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 018071          275 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN----MSIVVK  343 (361)
Q Consensus       275 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs----~~evl~  343 (361)
                      ||.......               .+..+.............+..+.+++.+||..+|++|||    +++++.
T Consensus       231 pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         231 PFKGSNRDE---------------TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCCchHH---------------HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            996443211               111122222111112225678999999999999999999    888776

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=321.27  Aligned_cols=243  Identities=28%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .|.-++.||.|+||.||.|++. +.+.||||++.-+..    .-++++.|+..|++++|||++.+.++|..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3555667999999999999965 899999999865322    23678999999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      ||- |+-.|++.-.+        .++-+.++..|..+.+.||+|||+.+   .||||||..|||+++.|.|||+|||.+.
T Consensus       107 YCl-GSAsDlleVhk--------KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAs  174 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSAS  174 (948)
T ss_pred             HHh-ccHHHHHHHHh--------ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchh
Confidence            994 58888886554        24899999999999999999999998   9999999999999999999999999986


Q ss_pred             CCccccccccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ....      ..+++|||.|||||++.   .+.|+-++||||||++..||.-.++|+-..+.-               .-
T Consensus       175 i~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM---------------SA  233 (948)
T KOG0577|consen  175 IMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---------------SA  233 (948)
T ss_pred             hcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH---------------HH
Confidence            5432      36789999999999986   568999999999999999999999997543221               11


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +..+....-..-..+..+..+.+++..||+.-|.+|||.+++++
T Consensus       234 LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  234 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            11222111111123566788999999999999999999999876

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=341.53  Aligned_cols=273  Identities=22%  Similarity=0.270  Sum_probs=225.4

Q ss_pred             HHHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC---C-CCChHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 018071           60 DELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA---S-KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG  134 (361)
Q Consensus        60 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~  134 (361)
                      .+++--.++|+++++||+|+||.|.+++.+ +++.||+|++.+   - .....-|..|-.+|..-+.+-|++++-.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344445689999999999999999999987 899999999976   2 33445678888999988999999999999999


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceE
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK  214 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~k  214 (361)
                      .++|+||||++||+|..++.+..         .+++..++.++..|..||.-||+.|   +|||||||+|||||..|++|
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---------~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---------RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---------CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEe
Confidence            99999999999999999998765         2999999999999999999999999   99999999999999999999


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhc----c-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM----T-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT  289 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~  289 (361)
                      |+|||.+-.+... ........+|||-|++||++.    + +.|+..+|+||+||++|||+.|..||....-        
T Consensus       216 LADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--------  286 (1317)
T KOG0612|consen  216 LADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--------  286 (1317)
T ss_pred             eccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------
Confidence            9999998877543 334456788999999999996    2 4689999999999999999999999963321        


Q ss_pred             hhcccCCchhhhhhcccccCCCCC--HHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH-------HHhHhcCCCCCC
Q 018071          290 WATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPN---MSIVVKAL-------QPLLNARPGPAG  357 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs---~~evl~~L-------~~l~~~~~~~~~  357 (361)
                             -+.+.++++-.-...+|  ...+....+||.+.+. +|+.|..   ++++...-       ..|.+..||..|
T Consensus       287 -------veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP  358 (1317)
T KOG0612|consen  287 -------VETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP  358 (1317)
T ss_pred             -------HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence                   13344444443333444  4578889999998774 7888888   88887632       566678888888


Q ss_pred             CCCC
Q 018071          358 ESAS  361 (361)
Q Consensus       358 ~~~~  361 (361)
                      +.+|
T Consensus       359 evss  362 (1317)
T KOG0612|consen  359 EVSS  362 (1317)
T ss_pred             cCCC
Confidence            7665

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.1e-41  Score=303.15  Aligned_cols=253  Identities=25%  Similarity=0.425  Sum_probs=199.7

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---C--------hHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---P--------DEEFLAQVSMVSRLKHENFVQLLGYCVDGT  135 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~--------~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  135 (361)
                      +|.+.+.||.|+||.||+|... +++.+|+|.+.....   .        .+.+.+|+.+++.++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5788899999999999999866 789999998753211   0        135778999999999999999999999999


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..++||||+.+++|.+++....         .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l  149 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKI  149 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEE
Confidence            9999999999999999987652         2889999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCC--CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      +|||+++...............|+..|+|||.+....  ++.++|+||||+++|+|++|..||.......  ......  
T Consensus       150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~--  225 (272)
T cd06629         150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFKLG--  225 (272)
T ss_pred             eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHHhh--
Confidence            9999987654322222234456889999999987654  8899999999999999999999995332110  000000  


Q ss_pred             cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         .    ...............+..+.+++.+||+.+|.+|||+.+|++
T Consensus       226 ---~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         226 ---N----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             ---c----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence               0    000000111122234678999999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-42  Score=307.97  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=203.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|++.+.||.|+||.||++..+ ++..+|+|.+..... ..+.+.+|++++++++||||+++++++.++...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            357888999999999999999976 789999999865432 235688899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++....        ..+++..++.++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++..
T Consensus        84 ~~~~~L~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~  152 (280)
T cd06611          84 CDGGALDSIMLELE--------RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK  152 (280)
T ss_pred             cCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence            99999999987543        13899999999999999999999998   99999999999999999999999998866


Q ss_pred             CccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .....  .......+++.|+|||.+.     +..++.++||||||+++|+|++|+.||.......  .+           
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~-----------  217 (280)
T cd06611         153 NKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VL-----------  217 (280)
T ss_pred             hcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HH-----------
Confidence            43221  1223456899999999875     3457789999999999999999999996543211  01           


Q ss_pred             hhhhhcccc-cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          299 KVRQCVDAR-LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       299 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                        ..+.... .....+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       218 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         218 --LKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --HHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence              1111100 0112233456779999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.2e-41  Score=302.02  Aligned_cols=258  Identities=24%  Similarity=0.372  Sum_probs=199.8

Q ss_pred             CCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCC------
Q 018071           69 FGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------  135 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------  135 (361)
                      |.+.++||+|+||.||+|..+    ++..||||.+......   .+++.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999854    4788999998754322   346788999999999999999999886532      


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..+++++|+.+|+|.+++.......   ....+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl  154 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGE---EPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCV  154 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEE
Confidence            2368899999999998875432111   1123889999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||+++...............+++.|++||.+....++.++|||||||++|+|++ |..||........   ..+    
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~----  227 (273)
T cd05074         155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNY----  227 (273)
T ss_pred             CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHH----
Confidence            99999886543222222233445678999999998899999999999999999999 8899864432111   000    


Q ss_pred             CCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                              +... .....+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       228 --------~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         228 --------LIKG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             --------HHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    0000 00111223456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-41  Score=311.24  Aligned_cols=202  Identities=23%  Similarity=0.385  Sum_probs=163.1

Q ss_pred             CccccCCceEEEEEEEC---CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEE--eCCeeEEEEEeCCCC
Q 018071           73 ALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV--DGTSRVLAYEFASNG  147 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e~~~~g  147 (361)
                      .+||+|+||.||+|..+   ++..||+|.+.... ....+.+|+.+++.++||||+++++++.  .+...+++|||+.+ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            57999999999999965   45789999886543 3346788999999999999999999885  35677899999965 


Q ss_pred             cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe----ccCCceEEeccccCCC
Q 018071          148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSNQ  223 (361)
Q Consensus       148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill----~~~~~~kl~Dfg~a~~  223 (361)
                      +|.+++..............+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            88888754332221122234899999999999999999999998   9999999999999    4667899999999986


Q ss_pred             Ccccccc-ccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCC
Q 018071          224 APDMAAR-LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHT  279 (361)
Q Consensus       224 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~  279 (361)
                      ....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            5432211 122345789999999998764 5899999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4e-41  Score=300.19  Aligned_cols=249  Identities=24%  Similarity=0.364  Sum_probs=199.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC------ChHHHHHHHHHHhcCCCCCcceeeeEEEeC--Cee
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ------PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR  137 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~  137 (361)
                      .+|.+.++||+|+||.||++..+ ++..||+|.+.....      ..+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999976 799999998754221      124678899999999999999999988763  467


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      +++|||+++++|.+++....         .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---------ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECc
Confidence            89999999999999987543         2788999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       218 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ||++......... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||......              
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------------  215 (265)
T cd06652         150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--------------  215 (265)
T ss_pred             CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--------------
Confidence            9998765321111 1123456889999999998888999999999999999999999999633111              


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ...............+...+..+.+++.+|+. +|.+||++++|++
T Consensus       216 -~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         216 -AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence             01111111111233456667788999999995 9999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.1e-41  Score=301.20  Aligned_cols=252  Identities=23%  Similarity=0.387  Sum_probs=204.6

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      +|+..+.||+|+||.||++... +++.+|+|++.....       ..+.+.+|++++++++|+||+++++++.+....++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999965 899999999865331       13568889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-ceEEecc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADF  218 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~Df  218 (361)
                      ||||+.+++|.+++....         .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+||
T Consensus        81 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~df  148 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADF  148 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccc
Confidence            999999999999987543         3889999999999999999999998   99999999999998776 5999999


Q ss_pred             ccCCCCcccccc--ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          219 DLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       219 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      |++.........  .......++..|+|||.+.+..++.++||||||+++|+|++|..||..........          
T Consensus       149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----------  218 (268)
T cd06630         149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA----------  218 (268)
T ss_pred             ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH----------
Confidence            998765432111  11234568889999999988889999999999999999999999996433211111          


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                        ..............+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       219 --~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         219 --LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --HHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              111111112223455667788999999999999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=302.76  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=203.2

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCC------e
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGT------S  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~------~  136 (361)
                      .+++|++.+.||+|+||.||+|..+ +++.+++|++.........+.+|+.+++++ .|+||+++++++.+..      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            3579999999999999999999986 788999999887666667889999999999 6999999999997644      4


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .+++|||+++++|.+++.....     ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRK-----KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEEC
Confidence            8999999999999999865331     1124899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhcc-----CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~  291 (361)
                      |||++.......  .......|+..|+|||++..     ..++.++|||||||++|+|++|..||....+...       
T Consensus       156 d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------  226 (275)
T cd06608         156 DFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-------  226 (275)
T ss_pred             CCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-------
Confidence            999987543322  12234568899999998753     3467889999999999999999999964322110       


Q ss_pred             cccCCchhhhhhccccc-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          292 TPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                              +.++..... ....+...+..+.+++.+||..||++|||+.++++
T Consensus       227 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         227 --------LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             --------HHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                    011111100 11122345678999999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.7e-41  Score=304.50  Aligned_cols=263  Identities=24%  Similarity=0.308  Sum_probs=201.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....   ...+.+.+|+.+++.++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47889999999999999999987 79999999886432   223567899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++++|..++....         .+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.
T Consensus        81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (286)
T cd07847          81 YCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFAR  148 (286)
T ss_pred             ccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccce
Confidence            999988887765432         2899999999999999999999998   9999999999999999999999999988


Q ss_pred             CCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh-hcccCC----
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-ATPKLS----  296 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~----  296 (361)
                      .......  ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.............. ......    
T Consensus       149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (286)
T cd07847         149 ILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ  226 (286)
T ss_pred             ecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            6543221  1234457889999999876 4688999999999999999999999975543221111100 000000    


Q ss_pred             ---c-hhhhhhcccccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          297 ---E-DKVRQCVDARLGGD-----YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       297 ---~-~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         . ........+.....     ..+..+..+.+++.+||+.+|++|||+.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence               0 00000000000000     01123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.5e-41  Score=307.19  Aligned_cols=260  Identities=28%  Similarity=0.407  Sum_probs=203.8

Q ss_pred             HHHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeC---
Q 018071           60 DELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG---  134 (361)
Q Consensus        60 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~---  134 (361)
                      .++....++|.+.+.||+|+||.||++..+ +++.+|+|.+.........+.+|+.+++++ +|||++++++++...   
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            344445789999999999999999999976 789999999876555556788899999999 799999999998753   


Q ss_pred             --CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          135 --TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       135 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                        ...++||||+++++|.+++.....     ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~  166 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLI-----CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence              357999999999999998864321     1123899999999999999999999998   999999999999999999


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccC-----CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchh
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL  287 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~  287 (361)
                      +||+|||++........  ......|+..|+|||.+...     .++.++|||||||++|+|++|+.||....+...  +
T Consensus       167 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~  242 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--L  242 (291)
T ss_pred             EEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--H
Confidence            99999999876543221  12345688999999988643     368899999999999999999999964432111  1


Q ss_pred             hhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          288 VTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..+..            ........+......+.+++.+||+.+|++||++.++++
T Consensus       243 ~~~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         243 FKIPR------------NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHhc------------CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11000            000001112334567999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-41  Score=299.94  Aligned_cols=246  Identities=24%  Similarity=0.411  Sum_probs=202.0

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC------ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      +|+..++||+|+||.||+|..+ +++.|++|.+.....      ..+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999987 899999998865331      235688899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      +||+++++|.+++....         .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        81 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~  148 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGM  148 (258)
T ss_pred             EEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcc
Confidence            99999999999987543         2889999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCC-CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +.......   ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||....+..  ..            
T Consensus       149 ~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~------------  211 (258)
T cd06632         149 AKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AV------------  211 (258)
T ss_pred             ceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HH------------
Confidence            87653322   224566889999999988766 8999999999999999999999996443111  01            


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ............+...+..+.+++.+||+.+|.+||+++++++
T Consensus       212 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         212 -FKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -HHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             1111101111233445677899999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.7e-41  Score=299.64  Aligned_cols=248  Identities=23%  Similarity=0.360  Sum_probs=203.6

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|++.+.||+|+||.||++... +++.|++|.+....   ....++.+|+.+++.++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888899999999999999976 78999999986432   2335788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +.+++|.+++.....       ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~  150 (256)
T cd08218          81 CEGGDLYKKINAQRG-------VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV  150 (256)
T ss_pred             CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceee
Confidence            999999999875432       13789999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ......  ......|++.|+|||++.+..++.++|+|||||++|+|++|..||......               +.+..+
T Consensus       151 ~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---------------~~~~~~  213 (256)
T cd08218         151 LNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---------------NLVLKI  213 (256)
T ss_pred             cCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---------------HHHHHH
Confidence            533211  123456888999999999889999999999999999999999999643211               111111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.. .....+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       214 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         214 IRG-SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             hcC-CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            111 111233455677999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2e-41  Score=306.32  Aligned_cols=243  Identities=24%  Similarity=0.358  Sum_probs=203.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|.+.+.||+|+||.||++... +++.+|+|.+....    .....+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999976 78999999986532    23356888999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++....         .+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~  148 (290)
T cd05580          81 EYVPGGELFSHLRKSG---------RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFA  148 (290)
T ss_pred             ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCc
Confidence            9999999999987653         3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ......     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||......               ....
T Consensus       149 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~  208 (290)
T cd05580         149 KRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---------------QIYE  208 (290)
T ss_pred             cccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHH
Confidence            875432     23456899999999998888999999999999999999999999643311               0111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      .+....  ...+...+..+.+++.+||..+|.+|+     +++++++
T Consensus       209 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         209 KILEGK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             HHhcCC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            111111  123344567899999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.5e-41  Score=300.25  Aligned_cols=237  Identities=23%  Similarity=0.446  Sum_probs=186.9

Q ss_pred             ccccCCceEEEEEEECC-------------CCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           74 LIGEGSYGRVYYGILKS-------------GHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .||+|+||.||+|+..+             ...+++|.+..... ....+.+|+.+++.++||||+++++++......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            58999999999998542             23589998765432 23467888999999999999999999999889999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc-------
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-------  212 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~-------  212 (361)
                      +|||+++++|..++....        ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.       
T Consensus        82 v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~  150 (262)
T cd05077          82 VEEFVEFGPLDLFMHRKS--------DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPF  150 (262)
T ss_pred             EEecccCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCce
Confidence            999999999998886533        13899999999999999999999998   999999999999987664       


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhc-cCCCCCccceecHHHHHHHHH-hCCCCCCCCCCcccchhhhh
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELL-TGRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell-~g~~pf~~~~~~~~~~~~~~  290 (361)
                      ++++|||++.....      .....++..|+|||.+. +..++.++|||||||++|+|+ +|..||.........     
T Consensus       151 ~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-----  219 (262)
T cd05077         151 IKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-----  219 (262)
T ss_pred             eEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-----
Confidence            89999999865422      12345788999999887 567899999999999999998 588888643221110     


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                                 ........  .....+..+.+|+.+||+.||.+||++.+|++.|
T Consensus       220 -----------~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 -----------RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -----------HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                       00011110  1111245689999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.8e-41  Score=301.78  Aligned_cols=246  Identities=27%  Similarity=0.418  Sum_probs=202.0

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      -|++.+.||+|+||.||+|..+ ++..+|+|.+.....  ....+.+|+.++++++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4677888999999999999876 789999998765332  2356888999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++++|.+++....          +++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        85 ~~~~l~~~i~~~~----------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06641          85 GGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL  151 (277)
T ss_pred             CCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceec
Confidence            9999999986532          889999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ....  .......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+..                ....+
T Consensus       152 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----------------~~~~~  213 (277)
T cd06641         152 TDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK----------------VLFLI  213 (277)
T ss_pred             ccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH----------------HHHHH
Confidence            3321  12234568889999999988889999999999999999999999996432211                00111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ........+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         214 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1111112333456779999999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3e-41  Score=299.11  Aligned_cols=247  Identities=21%  Similarity=0.336  Sum_probs=202.1

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|++.+.||+|+||.||++... ++..+|+|.+....   .....+.+|+.+++.++||||+++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888899999999999999976 89999999986532   2345788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC-CceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~-~~~kl~Dfg~a~  222 (361)
                      +++++|.+++.....       ..+++..+..++.|++.+|.|||+++   ++|+||+|+||+++++ +.+||+|||++.
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~  150 (256)
T cd08220          81 APGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK  150 (256)
T ss_pred             CCCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence            999999999976432       23899999999999999999999998   9999999999999855 468999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ......   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||........               ...
T Consensus       151 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---------------~~~  212 (256)
T cd08220         151 ILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---------------VLK  212 (256)
T ss_pred             ecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---------------HHH
Confidence            654321   12335688999999999988899999999999999999999999965432110               011


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ... ......+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       213 ~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         213 IMS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            111 1111233345677999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.2e-41  Score=299.39  Aligned_cols=251  Identities=20%  Similarity=0.318  Sum_probs=203.8

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEe--CCeeEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVLAY  141 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~  141 (361)
                      +|++.+.||.|+||.||++... ++..+|+|.+.....   ..+.+..|+.+++.++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5888899999999999999966 789999999865432   23467889999999999999999998763  45678999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-----hcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH-----EKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      ||+++++|.+++.....     ....+++..++.++.||+.||.|||     +.+   ++|+||+|+||++++++.+||+
T Consensus        81 e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          81 EYCEGGDLAQLIQKCKK-----ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             hhccCCCHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEe
Confidence            99999999999875421     1134899999999999999999999     666   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      |||++........  ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....               
T Consensus       153 d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------------  215 (265)
T cd08217         153 DFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---------------  215 (265)
T ss_pred             cccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---------------
Confidence            9999887643221  12345689999999999988899999999999999999999999975431               


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                       ..+.+.+........+...+..+.+++.+||+.+|.+|||+.+|++.
T Consensus       216 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         216 -LQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             11111222222223455667889999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.9e-41  Score=302.02  Aligned_cols=251  Identities=26%  Similarity=0.392  Sum_probs=203.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|+..+.||+|+||.||++..+ +++.+++|.+....  ....++.+|++++++++||||+++++++......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788889999999999999987 78999999987643  2345688999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      +.+++|.+++....        ..+++..+..++.|++.||+|||+ .+   ++|+||||+||++++++.++|+|||.+.
T Consensus        81 ~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~  149 (265)
T cd06605          81 MDGGSLDKILKEVQ--------GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSG  149 (265)
T ss_pred             cCCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccch
Confidence            99999999997653        238899999999999999999999 87   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ......    .....++..|+|||.+.+..++.++||||||+++|+|++|..||..........          .+.+..
T Consensus       150 ~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----------~~~~~~  215 (265)
T cd06605         150 QLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI----------FELLQY  215 (265)
T ss_pred             hhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH----------HHHHHH
Confidence            653221    122678899999999999899999999999999999999999996442211100          011111


Q ss_pred             hcccccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.... ....+.. .+..+.++|.+||..+|++|||+.+++.
T Consensus       216 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         216 IVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HhcCC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            11111 1122222 6677999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=305.57  Aligned_cols=264  Identities=24%  Similarity=0.324  Sum_probs=202.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|++.+.||+|+||.||+|..+ +++.|++|++....   ...+.+.+|+++++.++|+||+++++++.+....+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999977 78999999986532   234678899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |++++.+..+.....         .+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.
T Consensus        81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~  148 (288)
T cd07833          81 YVERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFAR  148 (288)
T ss_pred             cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence            998876666554322         2899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc----
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE----  297 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  297 (361)
                      ....... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||.....................    
T Consensus       149 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd07833         149 ALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE  227 (288)
T ss_pred             ccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence            7644322 122346678999999999887 8899999999999999999999999754322111100000000000    


Q ss_pred             -----h-----hhhhhcccc-cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 -----D-----KVRQCVDAR-LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 -----~-----~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                           .     ......+.. ....++..++..+.+++.+||+.+|++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                 0     000000000 000122234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.1e-41  Score=308.43  Aligned_cols=254  Identities=22%  Similarity=0.281  Sum_probs=200.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||++..+ +++.|++|.+.....    ....+.+|+++++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46889999999999999999987 789999999865432    2346778999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||++|++|.+++....         .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        81 e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~  148 (305)
T cd05609          81 EYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLS  148 (305)
T ss_pred             ecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCc
Confidence            9999999999996543         3899999999999999999999998   999999999999999999999999988


Q ss_pred             CCCcccc-------------ccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhh
Q 018071          222 NQAPDMA-------------ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       222 ~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~  288 (361)
                      +......             .........++..|+|||.+.+..++.++|||||||++|+|++|..||.+.....     
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-----  223 (305)
T cd05609         149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-----  223 (305)
T ss_pred             cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence            6321000             0001123457889999999988899999999999999999999999996432211     


Q ss_pred             hhhcccCCchhhhhhcccccCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          289 TWATPKLSEDKVRQCVDARLGG-DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                                ............ ......+..+.+++.+||+.+|++||+..++.+.|+.
T Consensus       224 ----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         224 ----------LFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ----------HHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                      011111111000 0111356679999999999999999997666655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-42  Score=316.95  Aligned_cols=248  Identities=24%  Similarity=0.326  Sum_probs=211.5

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      -...|.+.+.||+|.|+.|.++++. ++..||||.+.++...   .+.+.+|+++|+.++|||||+++.+.+....+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4578999999999999999999977 8999999999875543   35688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+.+|.+.+++.....         +.+..+..++.|+..|++|||+++   |||||||++||||+.+.++||+|||+
T Consensus       134 ~eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgf  201 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGF  201 (596)
T ss_pred             EEeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccc
Confidence            999999999999988763         777899999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +..+..   .....+.||++.|.|||++.+..| ++.+|+||+|++||.|+.|..||++..-....              
T Consensus       202 S~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr--------------  264 (596)
T KOG0586|consen  202 STFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR--------------  264 (596)
T ss_pred             ceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc--------------
Confidence            987643   334577899999999999999877 57899999999999999999999754321110              


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                       ...+...+  ..+--.+.+..++|+++|-.+|.+|++++++.+.
T Consensus       265 -~rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  265 -PRVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             -chheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence             01111122  2333455678999999999999999999999873

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5e-41  Score=298.24  Aligned_cols=237  Identities=24%  Similarity=0.495  Sum_probs=190.5

Q ss_pred             CccccCCceEEEEEEEC-CC----------CEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           73 ALIGEGSYGRVYYGILK-SG----------HAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~----------~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.||+|+||.||+|..+ ++          ..+++|.+.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            36999999999999976 33          258888876554446788999999999999999999999888 7789999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-------ceE
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-------VAK  214 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-------~~k  214 (361)
                      ||+.+++|.+++.....        .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++       .+|
T Consensus        80 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~k  148 (259)
T cd05037          80 EYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIK  148 (259)
T ss_pred             EcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEE
Confidence            99999999999976542        3889999999999999999999998   99999999999999888       799


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccC--CCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~  291 (361)
                      |+|||++.....      .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||....+......  +.
T Consensus       149 l~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~--~~  220 (259)
T cd05037         149 LSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF--YQ  220 (259)
T ss_pred             eCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH--Hh
Confidence            999999876533      2234567789999999876  78999999999999999999 5778765432111110  00


Q ss_pred             cccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          292 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                                   ...   ..+......+.+++.+||..+|.+|||+.+|++.|
T Consensus       221 -------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 -------------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             -------------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                         000   00111126789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-41  Score=306.71  Aligned_cols=262  Identities=20%  Similarity=0.272  Sum_probs=197.2

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|++.+.||+|+||.||+|..+ +|+.||+|++.....   ....+.+|+.++++++||||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999987 799999999865322   234677899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +. ++|.+++.....        .+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        81 ~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~  148 (284)
T cd07839          81 CD-QDLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARA  148 (284)
T ss_pred             CC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhc
Confidence            96 488887764321        3899999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcc-cchhhhhhcccCCchh--
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG-QQSLVTWATPKLSEDK--  299 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~--  299 (361)
                      .....  .......++..|+|||++.+. .++.++|||||||++|+|++|..||....... ....+...........  
T Consensus       149 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd07839         149 FGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP  226 (284)
T ss_pred             cCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence            53221  112345678999999998765 47899999999999999999999864322211 0000000000000000  


Q ss_pred             -hhhhcccccC---------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 -VRQCVDARLG---------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 -~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       +....+....         ....+..+..+.+++.+||+.||.+|||++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             0000000000         0112234677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-41  Score=307.61  Aligned_cols=248  Identities=26%  Similarity=0.423  Sum_probs=199.1

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .|.....||+|+||.||++... ++..||||.+.... ...+.+.+|+.+++.++||||+++++.+......++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3444456999999999999976 78999999986533 234568899999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++....          +++..++.++.||+.||.|||+.+   ++||||||+||++++++.++|+|||++....
T Consensus       103 ~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (292)
T cd06658         103 GGALTDIVTHTR----------MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             CCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence            999999885432          889999999999999999999998   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ...  .......|+..|+|||.+.+..++.++||||||+++|||++|..||....+.....            .+.....
T Consensus       170 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------------~~~~~~~  235 (292)
T cd06658         170 KEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR------------RIRDNLP  235 (292)
T ss_pred             ccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------HHHhcCC
Confidence            221  11234568999999999988899999999999999999999999996432211000            0111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ...  ......+..+.+++.+||..+|.+|||++++++.
T Consensus       236 ~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         236 PRV--KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             Ccc--ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111  1112345678999999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.2e-41  Score=305.22  Aligned_cols=274  Identities=25%  Similarity=0.345  Sum_probs=207.9

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC------hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      +|.+.+.||+|+||.||+|..+ +++.|++|.+......      ...+..|+++++.++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788889999999999999976 7999999999764322      34567899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+ +++|.+++....        ..+++..++.++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~e~~-~~~L~~~i~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~  148 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--------IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGL  148 (298)
T ss_pred             Eccc-CCCHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEcccee
Confidence            9999 889999997543        13899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +........  ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||....+..................
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (298)
T cd07841         149 ARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN  226 (298)
T ss_pred             eeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence            876543221  1233456788999998865 4678999999999999999999888865443211100000000000000


Q ss_pred             ------hhhhcccccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCC
Q 018071          300 ------VRQCVDARLGGD-----YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAG  357 (361)
Q Consensus       300 ------~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~  357 (361)
                            +...........     .....+..+.+++.+||+.+|.+|||+.++++  ...+...+.|.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~~~~~~~  293 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HPYFSNDPAPTP  293 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--CccccCCCCCCC
Confidence                  000000000001     11234677899999999999999999999996  667776666665

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.5e-41  Score=298.75  Aligned_cols=256  Identities=30%  Similarity=0.395  Sum_probs=205.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|++.+.||.|+||+||+|... ++..+++|++.....  ....+.+|++.++.++|+||+++++.+......+++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999976 788999999865332  346788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++.....      ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~  151 (267)
T cd06610          81 LSGGSLLDIMKSSYP------RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSAS  151 (267)
T ss_pred             cCCCcHHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence            999999999976431      123899999999999999999999998   99999999999999999999999999876


Q ss_pred             Cccccccc--cccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          224 APDMAARL--HSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       224 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ........  ......|+..|+|||++... .++.++|+|||||++|+|++|+.||....+..  .+.......      
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~------  223 (267)
T cd06610         152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQND------  223 (267)
T ss_pred             hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcCC------
Confidence            54322211  22345688999999998877 78999999999999999999999997543321  111110000      


Q ss_pred             hhhcccccCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDY-PPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                          ...+.... ....+..+.+++.+||+.||++|||++++++
T Consensus       224 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 ----PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ----CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                00110111 1245677999999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.5e-41  Score=302.62  Aligned_cols=251  Identities=27%  Similarity=0.359  Sum_probs=195.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHH-HhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSM-VSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~-l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|++.+.||+|+||.||++..+ +|+.||+|++.....  ...++..|+.. ++.++||||+++++++..+...+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47889999999999999999977 799999999876432  23455666665 566789999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |++ ++|.+++......     ...+++..++.++.||+.||+|||++ +   ++||||||+||+++.++.+||+|||++
T Consensus        81 ~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~  151 (283)
T cd06617          81 VMD-TSLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGIS  151 (283)
T ss_pred             hhc-ccHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence            996 5888887653211     13489999999999999999999987 6   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhcc----CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT----GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .......   ......|+..|+|||.+.+    ..++.++|+|||||++|+|++|+.||......              .
T Consensus       152 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------------~  214 (283)
T cd06617         152 GYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--------------F  214 (283)
T ss_pred             ccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--------------H
Confidence            7653221   1233568899999998864    45788999999999999999999999532110              0


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.+...............++..+.+++.+||..+|.+||++.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         215 QQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111111111100111235677999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.5e-41  Score=299.95  Aligned_cols=253  Identities=21%  Similarity=0.332  Sum_probs=188.7

Q ss_pred             ccccCCceEEEEEEECCC---CEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCc
Q 018071           74 LIGEGSYGRVYYGILKSG---HAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS  148 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  148 (361)
                      .||+|+||.||++...++   ..+++|.+....  ...+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999985433   356677765433  234678999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcccc
Q 018071          149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA  228 (361)
Q Consensus       149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~  228 (361)
                      |.+++......     ...+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        82 L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          82 LKSYLSQEQWH-----RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             HHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch
Confidence            99999764321     123677788899999999999999998   9999999999999999999999999976432211


Q ss_pred             ccccccccccCCCCCCchhhcc-------CCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          229 ARLHSTRVLGTFGYHAPEYAMT-------GQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       229 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .........++..|+|||++..       ..++.++|||||||++|||++ |..||.......   .....   . .+..
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~---~-~~~~  226 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNHV---I-KDQQ  226 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---H-hhcc
Confidence            1122345668899999998743       245789999999999999997 567885432211   00000   0 0000


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      ....++.    .+...+..+.+++..|| .+|++||++++|++.|.
T Consensus       227 ~~~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         227 VKLFKPQ----LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cccCCCc----cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1111111    12234567888999999 67999999999998773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-41  Score=304.17  Aligned_cols=263  Identities=23%  Similarity=0.346  Sum_probs=197.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|++.+.||+|++|.||+|..+ +++.||+|.+.....  ....+.+|+++++.++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67899999999999999999977 789999999865322  234577899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +.+ +|.+++.....        .+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        85 ~~~-~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  152 (291)
T cd07844          85 LDT-DLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARA  152 (291)
T ss_pred             CCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccc
Confidence            975 99998875432        3889999999999999999999998   99999999999999999999999999865


Q ss_pred             CccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcc-cchhhhhhcccCCchhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG-QQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  301 (361)
                      ......  ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||....... ..............+...
T Consensus       153 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07844         153 KSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP  230 (291)
T ss_pred             cCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence            422111  1223356889999999875 468899999999999999999999996543111 100000000000011110


Q ss_pred             hhccc------ccC-------CCCCHHH--HHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDA------RLG-------GDYPPKA--VAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~------~~~-------~~~~~~~--~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .....      ...       .......  ...+.+++.+||+.+|++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000      000       0000011  256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-41  Score=302.63  Aligned_cols=237  Identities=27%  Similarity=0.508  Sum_probs=188.9

Q ss_pred             ccccCCceEEEEEEEC-CC-------CEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           74 LIGEGSYGRVYYGILK-SG-------HAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      .||+|+||.||+|..+ .+       ..+++|.+..... ..+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            6999999999999864 22       3488888765332 2357788999999999999999999999989999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc--------eEEe
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--------AKIA  216 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~--------~kl~  216 (361)
                      ++|+|.+++.....        .+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.        ++++
T Consensus        82 ~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~  150 (258)
T cd05078          82 KFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLS  150 (258)
T ss_pred             CCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEec
Confidence            99999999976542        3889999999999999999999998   999999999999987765        6999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCC-CCCCCCCCcccchhhhhhccc
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR-KPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~-~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |||++.....      .....++..|+|||++.+ ..++.++|||||||++|+|++|. .||....+...          
T Consensus       151 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~----------  214 (258)
T cd05078         151 DPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK----------  214 (258)
T ss_pred             ccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH----------
Confidence            9998865432      233567889999999986 45899999999999999999985 56543222110          


Q ss_pred             CCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                            .......  ...+......+.+++.+||+.+|++|||++++++.|
T Consensus       215 ------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         215 ------LQFYEDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ------HHHHHcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                  0111111  122333446789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-42  Score=319.94  Aligned_cols=272  Identities=24%  Similarity=0.372  Sum_probs=209.7

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC--CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeC------CeeE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------TSRV  138 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~~~~  138 (361)
                      .|.....||+|+||.||+++++ +|+.||||.+.+  .....+...+|+++|++|+|+|||+++++-++.      ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            4566678999999999999976 999999999976  345667889999999999999999999875543      3457


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc--CC--ceE
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DD--VAK  214 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~--~~--~~k  214 (361)
                      ++||||.||+|...+.......      .|++.+.+.++..+..||.|||+++   |+||||||.||++..  +|  ..|
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~------GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAY------GLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             EEEeecCCCcHHHHhcCccccc------CCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEe
Confidence            9999999999999997654332      3999999999999999999999998   999999999999853  23  479


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc-
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-  292 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~-  292 (361)
                      |+|||.|+.+.+..   ...+..||..|.+||++.. +.|+..+|.|||||++|+.+||..||.+...+....-+.|.. 
T Consensus       165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~  241 (732)
T KOG4250|consen  165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII  241 (732)
T ss_pred             eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh
Confidence            99999999886543   5688999999999999984 789999999999999999999999997654432211111211 


Q ss_pred             ccCCch-------hhhhhcccccCCCCC----HHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHhHhc
Q 018071          293 PKLSED-------KVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRP--NMSIVVKALQPLLNA  351 (361)
Q Consensus       293 ~~~~~~-------~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RP--s~~evl~~L~~l~~~  351 (361)
                      .+....       ....-++-....+++    +.....+...+..+|..+|.+|-  ...+....++++++.
T Consensus       242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            111100       000011111111222    33445567788889999999998  888888888888764

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-41  Score=326.69  Aligned_cols=272  Identities=17%  Similarity=0.233  Sum_probs=192.0

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC--CCCEEEEE------------------EcCCCCCChHHHHHHHHHHhcCCCC
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK--SGHAAAIK------------------KLDASKQPDEEFLAQVSMVSRLKHE  122 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~e~~~l~~l~hp  122 (361)
                      ..+.++|++.+.||+|+||+||++..+  ++...++|                  .+.........+.+|+.++++++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            346689999999999999999998754  22222222                  1111222234678999999999999


Q ss_pred             CcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 018071          123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS  202 (361)
Q Consensus       123 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp  202 (361)
                      ||+++++++.+....+++++++. ++|.+++......    .........++.++.||+.||.|||+.+   |+||||||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~----~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP  295 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD----WKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKL  295 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc----ccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence            99999999999999999999995 5787777543211    0112446778899999999999999998   99999999


Q ss_pred             CceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCC-CCCCCC
Q 018071          203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP-VDHTLP  281 (361)
Q Consensus       203 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p-f~~~~~  281 (361)
                      +|||++.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||++|||++|..+ |.....
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~  374 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG  374 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence            99999999999999999997654321 1122346799999999999999999999999999999999998764 433222


Q ss_pred             cccchhhhhhcc------cCC--chhhhhhcccccCC----CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          282 RGQQSLVTWATP------KLS--EDKVRQCVDARLGG----DYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       282 ~~~~~~~~~~~~------~~~--~~~~~~~~~~~~~~----~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .....+......      .+.  ...+...++.....    ..+     ...+..+.+++.+||+.||.+|||+.|+++
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111111111100      000  00111111110000    000     012345778899999999999999999986

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.8e-41  Score=300.32  Aligned_cols=253  Identities=23%  Similarity=0.371  Sum_probs=199.7

Q ss_pred             cCCCCCccccCCceEEEEEEEC--CCCEEEEEEcCCCC-----------CChHHHHHHHHHHhc-CCCCCcceeeeEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASK-----------QPDEEFLAQVSMVSR-LKHENFVQLLGYCVD  133 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----------~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~  133 (361)
                      +|++.+.||+|+||.||+|..+  +++.+|+|.+....           ....++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4788889999999999999976  47889999875321           112356678887765 789999999999999


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCceEeccCCc
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivHrDikp~Nill~~~~~  212 (361)
                      ....+++|||+++++|.+++......     ...+++..++.++.|++.+|.|||+ .+   ++|+||+|+||++++++.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~  152 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDK  152 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCc
Confidence            99999999999999999988542211     1248999999999999999999996 55   999999999999999999


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      +||+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......         
T Consensus       153 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---------  220 (269)
T cd08528         153 VTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---------  220 (269)
T ss_pred             EEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---------
Confidence            9999999987654322   2345668899999999998889999999999999999999999996432211         


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                            ....+.+...........+..+.+++.+||+.||++||++.|+..++.
T Consensus       221 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         221 ------LATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ------HHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                  011111111111111134567999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=314.36  Aligned_cols=277  Identities=23%  Similarity=0.316  Sum_probs=204.4

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeC-----Ce
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~  136 (361)
                      +.++|.+.+.||+|+||.||+|... +++.||+|.+....  .....+.+|+.+++.++||||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            4578999999999999999999976 89999999986422  2335678899999999999999999987644     35


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++++||+.+ +|.+++....          +++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~~----------l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~  148 (336)
T cd07849          83 VYIVQELMET-DLYKLIKTQH----------LSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC  148 (336)
T ss_pred             EEEEehhccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence            7899999965 8888876543          899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccc-cccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          217 DFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |||++.......... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..................
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~  228 (336)
T cd07849         149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT  228 (336)
T ss_pred             cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            999987653221111 1234568999999998764 46899999999999999999999999643321110000000001


Q ss_pred             CCchhhhhhccccc-----------CCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhHhcCCCC
Q 018071          295 LSEDKVRQCVDARL-----------GGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA--LQPLLNARPGP  355 (361)
Q Consensus       295 ~~~~~~~~~~~~~~-----------~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~~~~~~~  355 (361)
                      ...+.+..+.+...           ...   ..+..+..+.+++.+||+.+|++|||+.++++.  |+......+.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~  305 (336)
T cd07849         229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEP  305 (336)
T ss_pred             CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcc
Confidence            11111111111100           000   012235678999999999999999999999985  66555433333

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-40  Score=346.07  Aligned_cols=268  Identities=26%  Similarity=0.486  Sum_probs=214.5

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ..+...|...++||+|+||.||+|..+ ++..||+|++......   ...|++++++++||||+++++++.+....++||
T Consensus       686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            344567888899999999999999975 8999999998654332   235688999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.++++.            ++|..+..++.|++.||+|||....++|+||||||+||+++.++..++. ||..
T Consensus       763 Ey~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~  829 (968)
T PLN00113        763 EYIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP  829 (968)
T ss_pred             eCCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence            99999999999952            7899999999999999999996544459999999999999999888775 6654


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ...+..|...........
T Consensus       830 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  902 (968)
T PLN00113        830 GLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLD  902 (968)
T ss_pred             ccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchh
Confidence            33211      12346789999999999999999999999999999999999999643322 223444443333333344


Q ss_pred             hhcccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          302 QCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       302 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                      .++++.+..  ..+.....++.+++.+||+.+|++|||+++|++.|+.+.+..+
T Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence            555555433  3445667788999999999999999999999999999987544

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.3e-41  Score=302.36  Aligned_cols=237  Identities=24%  Similarity=0.457  Sum_probs=186.5

Q ss_pred             ccccCCceEEEEEEEC-------------------------CCCEEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCccee
Q 018071           74 LIGEGSYGRVYYGILK-------------------------SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQL  127 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~  127 (361)
                      .||+|+||.||+|.+.                         ....|++|.+...... ..++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999742                         1235889988654322 3467888999999999999999


Q ss_pred             eeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       128 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      ++++.+....++||||+++|+|..++....        ..+++..+..++.||+.||+|||+.+   |+||||||+|||+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill  150 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--------GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILL  150 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEE
Confidence            999999999999999999999999986533        13889999999999999999999998   9999999999999


Q ss_pred             ccCC-------ceEEeccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHH-hCCCCCCC
Q 018071          208 FDDD-------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELL-TGRKPVDH  278 (361)
Q Consensus       208 ~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell-~g~~pf~~  278 (361)
                      +..+       .+|++|||++.....      .....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||..
T Consensus       151 ~~~~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         151 ARLGLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             eccCcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence            8654       489999998764322      123456788999998875 56899999999999999985 69999975


Q ss_pred             CCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          279 TLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      ..+.....                ......  ..+......+.+++.+||+.+|++|||+.+|++.|
T Consensus       225 ~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         225 RTPSEKER----------------FYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             cChHHHHH----------------HHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            43321111                111111  11112234689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.2e-41  Score=299.49  Aligned_cols=251  Identities=27%  Similarity=0.399  Sum_probs=198.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++++.....||+|+||.||+|... ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++++..+...++++||
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   86 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ   86 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence            445555568999999999999966 788999998865432 345788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-CCceEEecccc
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVL--SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDL  220 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~Dfg~  220 (361)
                      +.+++|.+++.....        .+  ++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.++|+|||+
T Consensus        87 ~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~  155 (268)
T cd06624          87 VPGGSLSALLRSKWG--------PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT  155 (268)
T ss_pred             CCCCCHHHHHHHhcc--------cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence            999999999875421        14  78888999999999999999998   999999999999976 67999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccC--CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +........  ......|+..|+|||++.+.  .++.++||||||+++|+|++|+.||........   ..+        
T Consensus       156 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~--------  222 (268)
T cd06624         156 SKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMF--------  222 (268)
T ss_pred             heecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHh--------
Confidence            875532111  12334578999999998754  478999999999999999999999964321110   000        


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         ...........+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       223 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         223 ---KVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ---hhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence               000001112234456677999999999999999999999885

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-40  Score=296.64  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=207.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|++.+.||+|++|.||+|..+ +++.|++|++.....  ....+.+|+.++.+++|+|++++++++......+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999987 699999999876543  356789999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      +++++|.+++....         .+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~  148 (264)
T cd06623          81 MDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISK  148 (264)
T ss_pred             cCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccce
Confidence            99999999997642         38999999999999999999999 88   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .......  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........            ...
T Consensus       149 ~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~------------~~~  214 (264)
T cd06623         149 VLENTLD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL------------MQA  214 (264)
T ss_pred             ecccCCC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH------------HHH
Confidence            6543221  12345678999999999988999999999999999999999999965432111111            111


Q ss_pred             hcccccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +. .......+.. .+..+.+++.+||..+|++|||+.++++
T Consensus       215 ~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         215 IC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             Hh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            11 1111122333 6678999999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.3e-41  Score=302.39  Aligned_cols=250  Identities=25%  Similarity=0.395  Sum_probs=204.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|.+.+.||+|+||.||++... ++..|++|.+.... ...+.+.+|+.+++.++||||+++++++......++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            368999999999999999999865 78999999986433 3345788899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++....          +++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        98 ~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~  164 (293)
T cd06647          98 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (293)
T ss_pred             CCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence            99999999987543          789999999999999999999998   99999999999999999999999998865


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ......  ......|++.|+|||.+.+..++.++|||||||++|++++|+.||....+......  ..            
T Consensus       165 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~--~~------------  228 (293)
T cd06647         165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IA------------  228 (293)
T ss_pred             cccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee--hh------------
Confidence            533221  22345688899999999888899999999999999999999999975433211100  00            


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      .........+...+..+.+++.+||+.+|++||++.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         229 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000111223455679999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=299.35  Aligned_cols=245  Identities=23%  Similarity=0.388  Sum_probs=199.3

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC--CCChHHHHHHHHHHhcCC---CCCcceeeeEEEeCCeeEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS--KQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .|++.+.||+|+||.||+|... +++.|++|.+...  .....++.+|+.+++.++   |||++++++++......+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777889999999999999975 8999999998653  233457888999999986   999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++...          .+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++
T Consensus        82 e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06917          82 EYAEGGSVRTLMKAG----------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA  148 (277)
T ss_pred             ecCCCCcHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCce
Confidence            999999999998653          2899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .......  .......|+..|+|||.+.++ .++.++|+|||||++|+|++|..||...........             
T Consensus       149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------------  213 (277)
T cd06917         149 ALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------------  213 (277)
T ss_pred             eecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------------
Confidence            7654322  122345688999999988754 578999999999999999999999975432211000             


Q ss_pred             hhhcccccCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPP-KAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         +........+. ..+..+.+++.+||+.+|.+||++.++++
T Consensus       214 ---~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         214 ---IPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ---cccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence               00000001111 14567999999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.6e-41  Score=305.68  Aligned_cols=247  Identities=25%  Similarity=0.361  Sum_probs=198.5

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      |.....||+|+||.||++... +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..+...+++|||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999976 79999999986532 3345788899999999999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++....          +++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus       103 ~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~  169 (297)
T cd06659         103 GALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  169 (297)
T ss_pred             CCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence            99999875532          899999999999999999999998   99999999999999999999999999875432


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      ..  .......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+...  +.... ..         ...
T Consensus       170 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~-~~---------~~~  235 (297)
T cd06659         170 DV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKRLR-DS---------PPP  235 (297)
T ss_pred             cc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHh-cc---------CCC
Confidence            21  112346689999999999988999999999999999999999999964332111  00000 00         000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      .  .......+..+.+++.+||+.+|.+||+++++++.
T Consensus       236 ~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         236 K--LKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             C--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0  01112345568999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-42  Score=318.11  Aligned_cols=243  Identities=27%  Similarity=0.402  Sum_probs=202.8

Q ss_pred             ccccCCceEEEEEEEC-CCCEEEEEEcCC-CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHHH
Q 018071           74 LIGEGSYGRVYYGILK-SGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD  151 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~  151 (361)
                      +||+|+||+||.|+.. +...+|||.++. .....+-+.+||.+.+.|+|.|||+++|.+.+++..-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999977 677899999975 34445678899999999999999999999999999899999999999999


Q ss_pred             hhhcCCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec-cCCceEEeccccCCCCcccc
Q 018071          152 ILHGRKGVKGAQPGPVL--SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMA  228 (361)
Q Consensus       152 ~l~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~-~~~~~kl~Dfg~a~~~~~~~  228 (361)
                      +++..=+        ++  .+..+-.+..||++||.|||++.   |||||||-+||||+ -.|.+||+|||-++.+... 
T Consensus       662 LLrskWG--------PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-  729 (1226)
T KOG4279|consen  662 LLRSKWG--------PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-  729 (1226)
T ss_pred             HHHhccC--------CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-
Confidence            9976532        14  67888899999999999999997   99999999999996 4789999999999876432 


Q ss_pred             ccccccccccCCCCCCchhhccC--CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          229 ARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       229 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                       +..+.++.||..|||||++..+  +|+.++|||||||++.||.||++||--...+           .   --+-++-.-
T Consensus       730 -nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-----------q---AAMFkVGmy  794 (1226)
T KOG4279|consen  730 -NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-----------Q---AAMFKVGMY  794 (1226)
T ss_pred             -CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-----------h---Hhhhhhcce
Confidence             2335678899999999999855  7999999999999999999999999422110           0   011111122


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..-.+.|.+.+.+..++|.+|+.++|.+||++.++++
T Consensus       795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            2234678889999999999999999999999999986

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8e-41  Score=301.38  Aligned_cols=263  Identities=23%  Similarity=0.319  Sum_probs=201.4

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|++.+.||+|+||.||+|... +++.|++|++....   .....+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5888999999999999999976 79999999987543   2245788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      + +++|.+++....        ..+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        81 ~-~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~  148 (286)
T cd07832          81 M-PSDLSEVLRDEE--------RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARL  148 (286)
T ss_pred             c-CCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence            9 999999986543        23899999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch----
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED----  298 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  298 (361)
                      ...... .......|+..|+|||++.+. .++.++||||+||++|+|++|..||......................    
T Consensus       149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07832         149 FSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG  227 (286)
T ss_pred             ccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence            543221 122345689999999998754 46899999999999999999988886543221110000000000000    


Q ss_pred             -----hhhhhccccc-C---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 -----KVRQCVDARL-G---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 -----~~~~~~~~~~-~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                           ....+..... .   ....+..+..+.+++.+||+.+|++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                 0000000000 0   0011233578999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=307.15  Aligned_cols=247  Identities=22%  Similarity=0.335  Sum_probs=206.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.|..-++||+||||.||-++.+ +|+.||+|.+.+..    ....-.++|-.|+.+++.+.||.+--.|+..+.++||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            57788899999999999999977 99999999986532    23345678999999999999999998999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ..|+||+|.-.|.+...       +.+++..++.++.+|+.||++||+.+   ||+||+||+|||+|+.|+++|+|+|+|
T Consensus       265 tlMNGGDLkfHiyn~g~-------~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-------PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             EeecCCceeEEeeccCC-------CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceE
Confidence            99999999888876652       34999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ..++....   ....+||.+|||||++.++.|+...|+|||||+||||+.|+.||...-.            +...+++.
T Consensus       335 vei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke------------Kvk~eEvd  399 (591)
T KOG0986|consen  335 VEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE------------KVKREEVD  399 (591)
T ss_pred             EecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh------------hhhHHHHH
Confidence            88765432   3455899999999999999999999999999999999999999953211            12222222


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS  339 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  339 (361)
                      +.+-. ....++...+++...|....|..||.+|....
T Consensus       400 rr~~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  400 RRTLE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHhc-chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            22211 12356778899999999999999999997544

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2e-41  Score=305.34  Aligned_cols=263  Identities=25%  Similarity=0.371  Sum_probs=200.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++.....   ..+.+.+|+++++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999986 789999999865332   23567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++++|..+.....         .+++..++.++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++.
T Consensus        81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~  148 (286)
T cd07846          81 FVDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR  148 (286)
T ss_pred             cCCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeee
Confidence            999988888765432         2899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhcccCCc---
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWATPKLSE---  297 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~---  297 (361)
                      ......  .......++..|+|||++.+ ..++.++||||||+++|+|++|..||......... .+..+.......   
T Consensus       149 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (286)
T cd07846         149 TLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE  226 (286)
T ss_pred             eccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence            653322  12234567899999999875 45788999999999999999999999644321110 000000000000   


Q ss_pred             ----hhh-hhhcccccC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 ----DKV-RQCVDARLG-----GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ----~~~-~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                          ..+ .........     ....+..+..+.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                000 000000000     0012234677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.3e-41  Score=299.52  Aligned_cols=246  Identities=24%  Similarity=0.312  Sum_probs=204.0

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      +|++.+.||.|+||.||+|..+ +++.||+|.+.+..    ...+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999977 79999999987533    234678899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+.+++|.+++....         .+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++.
T Consensus        81 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~  148 (258)
T cd05578          81 LLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIAT  148 (258)
T ss_pred             CCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccccc
Confidence            999999999997652         2889999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ......   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........             +..
T Consensus       149 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------------~~~  212 (258)
T cd05578         149 KVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-------------IRA  212 (258)
T ss_pred             ccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH-------------HHH
Confidence            654321   2234568889999999998889999999999999999999999997554321111             111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM--SIVV  342 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~--~evl  342 (361)
                      .... .....+...+..+.+++.+||+.+|.+||++  ++++
T Consensus       213 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         213 KQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             Hhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1111 1223444566889999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2e-40  Score=295.24  Aligned_cols=249  Identities=25%  Similarity=0.429  Sum_probs=201.3

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|.+.+.||+|+||.||++... ++..|++|.+.....   ..+.+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888899999999999999976 789999999876544   346788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++....         .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..
T Consensus        81 ~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~  148 (264)
T cd06626          81 CSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK  148 (264)
T ss_pred             CCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccc
Confidence            99999999987543         2788999999999999999999998   99999999999999999999999999876


Q ss_pred             Ccccccccc--ccccccCCCCCCchhhccCC---CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          224 APDMAARLH--STRVLGTFGYHAPEYAMTGQ---LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       224 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .........  .....++..|+|||++.+..   ++.++||||||+++|+|++|..||.........   .+        
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~---~~--------  217 (264)
T cd06626         149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI---MF--------  217 (264)
T ss_pred             cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH---HH--------
Confidence            543222111  12356788999999998766   889999999999999999999999643211100   00        


Q ss_pred             hhhhhcccccCCCCCH--HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 KVRQCVDARLGGDYPP--KAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                          .+........+.  ..+..+.+++.+||+.+|.+|||+.+++.
T Consensus       218 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         218 ----HVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ----HHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                000001111122  23667899999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.8e-40  Score=308.34  Aligned_cols=262  Identities=21%  Similarity=0.270  Sum_probs=199.9

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----  134 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----  134 (361)
                      .+.++|++.+.||+|+||.||+|... +++.||+|.+.+..   .....+.+|+.+++.++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            45689999999999999999999976 89999999986532   2234677899999999999999999987643     


Q ss_pred             -CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          135 -TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       135 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                       ...++||||+.+ +|.+.+...           +++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~  157 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  157 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence             356999999954 888887532           788899999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhhh-h
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTW-A  291 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~-~  291 (361)
                      ||+|||++.......   ......++..|+|||++.+..++.++|||||||++|+|++|+.||......... .+... .
T Consensus       158 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  234 (353)
T cd07850         158 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG  234 (353)
T ss_pred             EEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999997653321   123456789999999999999999999999999999999999999754321110 00000 0


Q ss_pred             cc--------------------cCCchhhhhhccccc----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          292 TP--------------------KLSEDKVRQCVDARL----GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       292 ~~--------------------~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+                    ......+.+......    ....+...+..+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00                    000000001111000    00112234667899999999999999999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.6e-41  Score=310.36  Aligned_cols=271  Identities=23%  Similarity=0.318  Sum_probs=203.8

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCcceeeeEEEeC-----C
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----T  135 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~  135 (361)
                      +.++|.+.+.||+|+||+||+|... +++.||||.+...   ......+.+|+.+++.++||||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            3568999999999999999999976 8999999998653   22335677899999999999999999987644     3


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..++++||+. ++|.+++....         .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL  149 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKI  149 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence            4799999995 68988886543         3899999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||++.......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..................
T Consensus       150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  227 (337)
T cd07858         150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS  227 (337)
T ss_pred             CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999987654321  12334567899999998875 46899999999999999999999999754321111111000000


Q ss_pred             --------CCchhhhhhcccccC------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhHh
Q 018071          295 --------LSEDKVRQCVDARLG------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA--LQPLLN  350 (361)
Q Consensus       295 --------~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~~  350 (361)
                              .........+.....      ....+..+..+.+++.+||+.+|++|||++++++.  |..+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence                    000111111110000      00112356778999999999999999999999985  555433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.4e-40  Score=301.37  Aligned_cols=266  Identities=21%  Similarity=0.267  Sum_probs=197.2

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCe-----
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS-----  136 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~-----  136 (361)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.....   ....+.+|+.+++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999976 799999998865332   2357888999999995 6999999999886655     


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-CCceEE
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKI  215 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl  215 (361)
                      .+++|||+++ +|.+++......    ....+++..++.++.||+.||.|||+.+   |+||||+|+||+++. ++.+||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl  152 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKI  152 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEE
Confidence            7999999976 898888654321    1124899999999999999999999998   999999999999998 889999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhcc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWATP  293 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~~~~  293 (361)
                      +|||++........  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+.... .+.... .
T Consensus       153 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~-~  229 (295)
T cd07837         153 ADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL-G  229 (295)
T ss_pred             eecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh-C
Confidence            99999875432111  1233456889999998875 45789999999999999999999999754322110 000000 0


Q ss_pred             cCCchhhhhhccccc-------C----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          294 KLSEDKVRQCVDARL-------G----GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~-------~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...........+...       .    ....+..+..+.++|.+||+.||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000000000000       0    0011235677999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-40  Score=297.79  Aligned_cols=258  Identities=27%  Similarity=0.358  Sum_probs=200.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeC--CeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~  141 (361)
                      ++|+..+.||.|++|.||++..+ +++.+|+|.+.....  ...++.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788889999999999999986 789999999875433  345788999999999999999999988643  4689999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++.....     ....+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          81 EYCEGGSLDSIYKKVKK-----RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             EecCCCCHHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccc
Confidence            99999999988754321     1124889999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCc--ccchhhhhhcccCCchh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR--GQQSLVTWATPKLSEDK  299 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~  299 (361)
                      .......    .....++..|+|||.+.+..++.++|||||||++|+|++|..||......  .......+..... ...
T Consensus       153 ~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~  227 (287)
T cd06621         153 GELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-NPE  227 (287)
T ss_pred             ccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-chh
Confidence            6543211    12345788999999999999999999999999999999999999754321  1111111111000 000


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +    ....  ......+..+.+++.+||+.+|.+|||+.|+++
T Consensus       228 ~----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         228 L----KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             h----ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0    0000  001234667999999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3e-40  Score=297.89  Aligned_cols=251  Identities=27%  Similarity=0.408  Sum_probs=206.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++.|++.+.||+|+||.||++..+ ++..+++|++.........+.+|+++++.++|+|++++++.+......++++||
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            4567888899999999999999987 789999999976554566788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++....        ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        97 ~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          97 MDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             cCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            99999999998753        13899999999999999999999998   99999999999999999999999998765


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ......  ......++..|+|||++.+..++.++|+||||+++|+|++|..||....+...               ...+
T Consensus       166 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---------------~~~~  228 (286)
T cd06614         166 LTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---------------LFLI  228 (286)
T ss_pred             hccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHH
Confidence            432211  12344578899999999988899999999999999999999999964332111               0011


Q ss_pred             cccccC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VDARLG-GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...... ...+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            111110 1112235677999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.3e-40  Score=303.70  Aligned_cols=274  Identities=26%  Similarity=0.338  Sum_probs=202.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeC--CeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~l  139 (361)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|.+......   ...+.+|+.++++++|+||+++++++.+.  ...++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            368999999999999999999976 7999999998643221   23567899999999999999999998754  56899


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+.+ +|.+++....        ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||
T Consensus        86 v~e~~~~-~l~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--------TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccc
Confidence            9999965 8888886543        23899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ++........  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||....+......+..........
T Consensus       154 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  231 (309)
T cd07845         154 LARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES  231 (309)
T ss_pred             eeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            9876543221  1223345788999999875 468899999999999999999999997654432211111100000000


Q ss_pred             hhhhhcc-----------cccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCC
Q 018071          299 KVRQCVD-----------ARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP  355 (361)
Q Consensus       299 ~~~~~~~-----------~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~  355 (361)
                      ....+..           ....  .......+..+.++|.+||+.||++|||++++++  ...+...+.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~--h~~f~~~~~~  299 (309)
T cd07845         232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE--SSYFKEKPLP  299 (309)
T ss_pred             hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc--ChhhccCCCC
Confidence            0000000           0000  0000113567889999999999999999999996  3444444443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.7e-41  Score=301.37  Aligned_cols=262  Identities=22%  Similarity=0.312  Sum_probs=198.3

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|++.+.||.|+||.||+|..+ ++..||||++.....   ....+.+|++++++++||||+++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999976 799999998865322   235788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +. ++|.+++.....       ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~-~~l~~~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~  149 (284)
T cd07860          81 LH-QDLKKFMDASPL-------SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA  149 (284)
T ss_pred             cc-cCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhh
Confidence            95 589888865432       23899999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccCC-CCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhcccCCc----
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWATPKLSE----  297 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~----  297 (361)
                      .....  .......++..|+|||++.+.. ++.++|||||||++|+|++|+.||......... ............    
T Consensus       150 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07860         150 FGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG  227 (284)
T ss_pred             cccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence            53221  1123345788999999887644 688999999999999999999999754321110 000000000000    


Q ss_pred             --------hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 --------DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                              .....+..... ....+..+..+.++|.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         228 VTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                    00000000000 0011224566889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.6e-40  Score=300.44  Aligned_cols=264  Identities=21%  Similarity=0.272  Sum_probs=197.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      +++|.+.+.||+|+||.||+|..+ ++..|++|.+.....  ....+.+|+.+++.++|+||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            368999999999999999999976 799999999865432  23467889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+. ++|.+++....        ..+.+..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++
T Consensus        84 ~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  151 (291)
T cd07870          84 YMH-TDLAQYMIQHP--------GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR  151 (291)
T ss_pred             ccc-CCHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence            995 67777765432        12778889999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC-Cchhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL-SEDKV  300 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~  300 (361)
                      .......  ......+++.|+|||++.+. .++.++|||||||++|+|++|..||....+........+..... .....
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  229 (291)
T cd07870         152 AKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW  229 (291)
T ss_pred             ccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence            5432211  12334578999999998764 58889999999999999999999997544321110000100000 00000


Q ss_pred             ------hhhcccccCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 ------RQCVDARLGGDYP---------PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ------~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                            ............+         ...+..+.+++.+|++.||.+|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                  0000000000000         012457889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.7e-40  Score=306.65  Aligned_cols=273  Identities=23%  Similarity=0.331  Sum_probs=203.6

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC---CCChHHHHHHHHHHhcC-CCCCcceeeeEEEe--CCe
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVD--GTS  136 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~--~~~  136 (361)
                      .+.++|++.+.||+|+||.||+|..+ +++.+|+|++...   ......+.+|+.+++++ +||||+++++++..  ...
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            35678999999999999999999976 7899999988542   22334677899999999 99999999998864  346


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||+. ++|.+++....          +.+..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~  149 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRANI----------LEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLA  149 (337)
T ss_pred             EEEEecccc-cCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence            799999997 59999886542          889999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCcccccc---ccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          217 DFDLSNQAPDMAAR---LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       217 Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      |||++.........   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....+...........
T Consensus       150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~  229 (337)
T cd07852         150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI  229 (337)
T ss_pred             eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99998765432211   12234568999999998765 467889999999999999999999997543322111111100


Q ss_pred             ccCCchh--------hhhhccc----cc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhHh
Q 018071          293 PKLSEDK--------VRQCVDA----RL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA--LQPLLN  350 (361)
Q Consensus       293 ~~~~~~~--------~~~~~~~----~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~~  350 (361)
                      .......        ...+++.    ..  .....+..+..+.+++.+||+.+|.+|||+.++++.  ++.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence            1111000        0001110    00  001112246779999999999999999999999973  444433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.7e-40  Score=294.27  Aligned_cols=241  Identities=22%  Similarity=0.317  Sum_probs=199.5

Q ss_pred             cccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           75 IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        75 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      ||.|+||.||++..+ +++.+++|.+.+..    ...+.+.+|+.+++.++||||+++++++.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999976 69999999986533    2235788999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccc
Q 018071          150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA  229 (361)
Q Consensus       150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  229 (361)
                      .+++....         .+++..+..++.||+.||+|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-  147 (262)
T cd05572          81 WTILRDRG---------LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-  147 (262)
T ss_pred             HHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-
Confidence            99997653         2889999999999999999999998   9999999999999999999999999988764322 


Q ss_pred             cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC
Q 018071          230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG  309 (361)
Q Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (361)
                        ......++..|++||.+.+..++.++|+||||+++|+|++|..||.......             ......+......
T Consensus       148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~  212 (262)
T cd05572         148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-------------MEIYNDILKGNGK  212 (262)
T ss_pred             --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-------------HHHHHHHhccCCC
Confidence              2234568899999999988889999999999999999999999997543211             1111222221222


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018071          310 GDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK  343 (361)
Q Consensus       310 ~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~  343 (361)
                      ..++...+..+.+++.+||+.+|.+||+     ++|+++
T Consensus       213 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         213 LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            3344445778999999999999999999     777776

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.3e-40  Score=295.22  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=201.6

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|.+.+.||+|+||.||++..+ ++..+|+|.+....   ...+.+.+|+.+++.++|+||+++++.+.+....++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999977 78999999986532   3345678999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-ceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~Dfg~a~  222 (361)
                      +.+++|.+++.....       ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++ .+||+|||.+.
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~  150 (257)
T cd08225          81 CDGGDLMKRINRQRG-------VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR  150 (257)
T ss_pred             CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccch
Confidence            999999999875432       23799999999999999999999998   99999999999999886 46999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .......  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.......               ....
T Consensus       151 ~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------------~~~~  213 (257)
T cd08225         151 QLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ---------------LVLK  213 (257)
T ss_pred             hccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---------------HHHH
Confidence            6543211  1233468899999999988889999999999999999999999996432211               1111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..... .....+..+..+.+++.+||+.+|++|||+.++++
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         214 ICQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             Hhccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11111 11222344567999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.7e-40  Score=300.56  Aligned_cols=263  Identities=23%  Similarity=0.337  Sum_probs=200.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeC--CeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv  140 (361)
                      ++|++.+.||.|+||.||+|..+ +++.+++|.++.....   ...+.+|+.++++++||||+++++++...  ...+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999987 7899999998654322   23567899999999999999999998877  889999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+.+ +|.+++.....        .+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+
T Consensus        85 ~e~~~~-~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             ehhcCc-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCc
Confidence            999975 99998875432        3899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhhh-hcc----
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTW-ATP----  293 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~-~~~----  293 (361)
                      +.......  .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......... .+... ..+    
T Consensus       153 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
T cd07843         153 AREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI  230 (293)
T ss_pred             eeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence            87654322  122345578899999998764 4689999999999999999999999754332110 00000 000    


Q ss_pred             --------cCCchhhhhhcccccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          294 --------KLSEDKVRQCVDARLGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       294 --------~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                              ..............+...++.. .+..+.+++.+||+.+|++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                    0000000000011111122222 4667899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.8e-40  Score=298.11  Aligned_cols=247  Identities=25%  Similarity=0.409  Sum_probs=199.0

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .|...+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|+.+++.++||||+++++++......++++||+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3445568999999999999975 789999998864332 23567889999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++....          +++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus       100 ~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~  166 (285)
T cd06648         100 GGALTDIVTHTR----------MNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS  166 (285)
T ss_pred             CCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence            999999987632          889999999999999999999998   9999999999999999999999999876543


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ....  ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+......            +.....
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~------------~~~~~~  232 (285)
T cd06648         167 KEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR------------IRDNLP  232 (285)
T ss_pred             cCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH------------HHhcCC
Confidence            2211  12335689999999999988899999999999999999999999965332111000            000000


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...  ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus       233 ~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         233 PKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            000  111224567999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.5e-40  Score=296.19  Aligned_cols=243  Identities=23%  Similarity=0.332  Sum_probs=195.4

Q ss_pred             cccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           75 IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        75 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      ||+|+||+||++..+ +++.||+|.+....    .....+..|+++++.++||||+++++++......++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999876 79999999986532    2234567899999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccc
Q 018071          150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA  229 (361)
Q Consensus       150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  229 (361)
                      .+++.....       ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....   
T Consensus        81 ~~~l~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---  147 (277)
T cd05577          81 KYHIYNVGE-------PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---  147 (277)
T ss_pred             HHHHHHcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---
Confidence            999876542       23899999999999999999999998   99999999999999999999999999876432   


Q ss_pred             cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC
Q 018071          230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG  309 (361)
Q Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (361)
                      ........++..|+|||.+.+..++.++|||||||++|+|++|+.||..........            .+..... ...
T Consensus       148 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------------~~~~~~~-~~~  214 (277)
T cd05577         148 GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE------------ELKRRTL-EMA  214 (277)
T ss_pred             CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH------------HHHhccc-ccc
Confidence            112234567889999999988889999999999999999999999996543211110            0111000 011


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          310 GDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       310 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      ...+...+..+.+++.+||+.+|.+||     ++.++++
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            123344567799999999999999999     6666765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.9e-40  Score=289.05  Aligned_cols=248  Identities=31%  Similarity=0.473  Sum_probs=203.6

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      +|.+.+.||+|++|.||++..+ ++..+++|++..... ....+.+|+.+++.++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778889999999999999987 789999999976543 45678999999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++....        ..+++..+..++.|++.||.+||+.+   ++|+||+|+||++++++.++|+|||.+....
T Consensus        81 ~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  149 (253)
T cd05122          81 GGSLKDLLKSTN--------QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS  149 (253)
T ss_pred             CCcHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence            999999987653        13899999999999999999999987   9999999999999999999999999987664


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ....   .....++..|+|||.+.+..++.++||||||+++|+|++|..||...........  ..          .  .
T Consensus       150 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~----------~--~  212 (253)
T cd05122         150 DTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK--IA----------T--N  212 (253)
T ss_pred             cccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH--HH----------h--c
Confidence            3221   3456688999999999988899999999999999999999999964422110000  00          0  0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...........+..+.+++.+||+.||++|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000111112567999999999999999999999885

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.5e-40  Score=293.18  Aligned_cols=248  Identities=26%  Similarity=0.407  Sum_probs=205.8

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|++.+.||+|+||.||++..+ +++.+++|.+....   ....++.+|+.+++.++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999876 88999999987533   2234677899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++.....     ....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..
T Consensus        81 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          81 APFGDLSKAISKRKK-----KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             cCCCCHHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhh
Confidence            999999999876321     1134899999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ....    ......++..|++||.+.+..++.++|+||||+++|+|++|+.||......                .....
T Consensus       153 ~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~  212 (256)
T cd08530         153 LKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----------------DLRYK  212 (256)
T ss_pred             hccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHH
Confidence            6433    223456789999999999989999999999999999999999999643321                11111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +........+...+..+.+++.+||+.+|++|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         213 VQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1222222344567788999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5e-40  Score=291.12  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=207.1

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeC--CeeEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLAY  141 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~  141 (361)
                      +|...+.||+|++|.||+|..+ ++..|++|++....   ...+.+.+|+.++++++||||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778889999999999999987 89999999987654   2356788999999999999999999999988  8899999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++....         .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+
T Consensus        81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             EecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccE
Confidence            9999999999997653         3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ................++..|+|||.+.+..++.++||||||+++|+|++|..||.......              ..+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------------~~~~  214 (260)
T cd06606         149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--------------AALY  214 (260)
T ss_pred             EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--------------HHHH
Confidence            76644322111344568899999999998889999999999999999999999997543110              0111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...........+...+..+.+++.+||+.+|.+||++.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         215 KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            111111222344455788999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.2e-40  Score=296.01  Aligned_cols=241  Identities=22%  Similarity=0.316  Sum_probs=190.1

Q ss_pred             ccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhc---CCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSR---LKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~---l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      +||+|+||.||++... +++.+|+|.+.+....    ...+.+|..+++.   .+||||+.+++++...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999976 7899999988653321    1233444444333   479999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++....         .+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||++....
T Consensus        81 ~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          81 GGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            999999887543         3899999999999999999999998   9999999999999999999999999986543


Q ss_pred             cccccccccccccCCCCCCchhhc-cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..    ......|+..|+|||.+. +..++.++||||+||++|+|++|..||..........+             ... 
T Consensus       149 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-------------~~~-  210 (279)
T cd05633         149 KK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------DRM-  210 (279)
T ss_pred             cc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-------------HHH-
Confidence            21    123356899999999987 45689999999999999999999999965432211111             110 


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA  344 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  344 (361)
                      ........+...+..+.+++.+||+.||.+||     |++++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         211 TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            01112234455677899999999999999999     59999883

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1e-40  Score=307.73  Aligned_cols=266  Identities=23%  Similarity=0.350  Sum_probs=201.4

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEE----eCCe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCV----DGTS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~----~~~~  136 (361)
                      +.++|++.+.||+|+||.||+|..+ ++..||+|++....   .....+.+|+.+++.++||||+++++++.    ....
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            3478999999999999999999976 79999999986532   23456788999999999999999998875    3356


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||+. ++|.+++....         .+++..++.++.||+.||.|||+.+   ++||||||+||++++++.+||+
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~  149 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIG  149 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEec
Confidence            799999995 58998886543         2899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCcccccc--ccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          217 DFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       217 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |||++.........  .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.................
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g  229 (334)
T cd07855         150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG  229 (334)
T ss_pred             ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence            99998764322111  11234578999999999865 4689999999999999999999999975433211111111111


Q ss_pred             cCC--------chhhhhhcccc-cCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          294 KLS--------EDKVRQCVDAR-LGGDY-----PPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       294 ~~~--------~~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...        .+.+....+.. .....     .+..+..+.+++.+||+.+|.+|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            111        11111111100 00111     1234678999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-40  Score=301.10  Aligned_cols=268  Identities=24%  Similarity=0.340  Sum_probs=198.5

Q ss_pred             cCCCCCccccCCceEEEEEEEC---CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeC--CeeE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK---SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRV  138 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~  138 (361)
                      +|++.+.||+|+||.||+|..+   ++..||+|.+....    ...+.+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999975   47899999987632    2235678899999999999999999999988  8899


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc----CCceE
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD----DDVAK  214 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~----~~~~k  214 (361)
                      +||||+++ +|.+++.......    ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.    ++.+|
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCC----CcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEE
Confidence            99999965 7777765433211    124899999999999999999999998   999999999999999    89999


Q ss_pred             EeccccCCCCccccc-cccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccch------
Q 018071          215 IADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS------  286 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~------  286 (361)
                      |+|||++........ ........++..|+|||.+.+. .++.++|||||||++|+|++|+.||..........      
T Consensus       153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
T cd07842         153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD  232 (316)
T ss_pred             ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHH
Confidence            999999886543222 1123345688999999988764 58899999999999999999999997554332000      


Q ss_pred             -hhhhh--cccCCc---------hhhhhhcccccCCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          287 -LVTWA--TPKLSE---------DKVRQCVDARLGGDYP---------P--KAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       287 -~~~~~--~~~~~~---------~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       +....  ......         .......+......++         .  ..+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             00000  000000         0000000000000111         0  23456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-42  Score=315.77  Aligned_cols=249  Identities=24%  Similarity=0.380  Sum_probs=204.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC-CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      +-|.|++.||.|+||.||+|..+ ++-..|.|++.. +....++++-||+||....||+||++++.|...+.+++..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            45677778999999999999988 666778888864 4445678999999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      .||-+...+-.-.        ..|.+.++..++.|++.||.|||++.   |||||||..|||++-+|.++|+|||.+...
T Consensus       112 ~GGAVDaimlEL~--------r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG--------RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             CCchHhHHHHHhc--------cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence            9999988876543        24999999999999999999999997   999999999999999999999999998654


Q ss_pred             ccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..  .......+.|||+|||||+..     ..+|+.++||||||++|.||..+.+|....++-               ..
T Consensus       181 ~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---------------RV  243 (1187)
T KOG0579|consen  181 KS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---------------RV  243 (1187)
T ss_pred             hh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---------------HH
Confidence            32  233457899999999999764     568999999999999999999999996432221               11


Q ss_pred             hhhhccccc-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.++..... ..-.|...+..+.+++++||..||..||++.++++
T Consensus       244 llKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  244 LLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            111111111 11234566788999999999999999999999986

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.8e-40  Score=297.95  Aligned_cols=245  Identities=27%  Similarity=0.393  Sum_probs=196.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.|.+.+.||+|+||.||+|... +++.||+|.+.....    ..+++.+|+++++.++||||+++++++.+....++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888899999999999999976 799999998864322    1246788999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+. |+|.+++....        ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++
T Consensus        95 e~~~-g~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~  162 (307)
T cd06607          95 EYCL-GSASDILEVHK--------KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSA  162 (307)
T ss_pred             HhhC-CCHHHHHHHcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcc
Confidence            9996 57777775432        13899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .....      .....++..|+|||++.   ...++.++||||||+++|+|++|..||..........            
T Consensus       163 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------------  224 (307)
T cd06607         163 SLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------  224 (307)
T ss_pred             eecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------------
Confidence            65432      13456788999999874   3568899999999999999999999996443211100            


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                         .+.........+...+..+.+++.+||+.+|++||++.+|+..
T Consensus       225 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         225 ---HIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ---HHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               0000000011122356679999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.3e-40  Score=295.80  Aligned_cols=264  Identities=22%  Similarity=0.311  Sum_probs=201.4

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      +|++.+.||.|++|.||+|..+ ++..||+|++.....  ....+.+|+.++++++||||+++++++.+....++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999987 799999999876432  2456778999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      .+ +|.+++.....      ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++...
T Consensus        81 ~~-~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~  150 (284)
T cd07836          81 DK-DLKKYMDTHGV------RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAF  150 (284)
T ss_pred             Cc-cHHHHHHhcCC------CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence            75 89888865431      124899999999999999999999998   999999999999999999999999998754


Q ss_pred             ccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ....  .......++..|++||.+.+. .++.++|||||||++|+|++|..||...........+...........+..+
T Consensus       151 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07836         151 GIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI  228 (284)
T ss_pred             cCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence            3211  112334578899999988764 5788999999999999999999999765432211111000000111111111


Q ss_pred             cc-cccC-----------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VD-ARLG-----------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~-~~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+ ..+.           ....+..+..+.+++.+||+.+|.+||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00 0000           0111234677899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-41  Score=312.98  Aligned_cols=242  Identities=24%  Similarity=0.392  Sum_probs=193.7

Q ss_pred             CCccccCCceEEEEEEEC-CCCEEEEEEc-----CCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe--eEEEEEe
Q 018071           72 NALIGEGSYGRVYYGILK-SGHAAAIKKL-----DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS--RVLAYEF  143 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~-----~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~--~~lv~e~  143 (361)
                      ..+||+|+|-+||+|... +|-.||=-.+     .++....++|..|+.+|+.|+||||++++.+|.+...  ..+|.|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            346999999999999976 6766653322     2233445899999999999999999999999987655  7799999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-CCceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~Dfg~a~  222 (361)
                      +..|+|..|+.+.+.         ++...+..|++||+.||.|||++ +++|||||||.+||+|+. .|.|||+|+|+|+
T Consensus       125 ~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT  194 (632)
T ss_pred             ccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHH
Confidence            999999999988764         88899999999999999999999 688999999999999974 5899999999998


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .....    +.....|||.|||||+.. ..|+..+||||||++++||+|+..||.--...  ..+...+........+.+
T Consensus       195 l~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIYKKV~SGiKP~sl~k  267 (632)
T KOG0584|consen  195 LLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIYKKVTSGIKPAALSK  267 (632)
T ss_pred             Hhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHHHHHHcCCCHHHhhc
Confidence            76432    235589999999999776 79999999999999999999999999632211  111111111111122222


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +            ...+++++|.+||.. ..+|||+.|+++
T Consensus       268 V------------~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  268 V------------KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             c------------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            2            135699999999999 999999999996

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-40  Score=291.73  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=200.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC------CChHHHHHHHHHHhcCCCCCcceeeeEEEeC--Cee
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK------QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR  137 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~  137 (361)
                      .+|++.+.||+|+||.||+|..+ ++..|++|.+....      .....+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999976 79999999875321      1224678899999999999999999998754  467


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      ++++||+++++|.+++....         .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---------ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECc
Confidence            89999999999999987543         2789999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCccccc-cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          218 FDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       218 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ||+++....... ........++..|+|||++.+..++.++|+|||||++|+|++|+.||......              
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------------  215 (264)
T cd06653         150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------------  215 (264)
T ss_pred             cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------------
Confidence            999876532111 11123456889999999999888999999999999999999999999643211              


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ..+.+..........+...+..+.+++.+||+ +|.+||++.+++.
T Consensus       216 -~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         216 -AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence             11112222222233556677889999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-39  Score=291.49  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=198.4

Q ss_pred             CHHHHHHHhhcCCCCCcc--ccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 018071           58 SVDELKEITENFGTNALI--GEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVD  133 (361)
Q Consensus        58 ~~~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~  133 (361)
                      +..+.....++|++.+.+  |+|+||.||++..+ ++..+|+|.+........    |+.....+ +||||+++++.+..
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEec
Confidence            345556667888888887  99999999999976 889999999865432211    22222223 69999999999999


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-c
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-V  212 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-~  212 (361)
                      ....++||||+++++|.+++....         .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++ .
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~  148 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDR  148 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCe
Confidence            999999999999999999997653         2899999999999999999999998   99999999999999998 9


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      ++|+|||++.....      .....++..|+|||++.+..++.++||||||+++|+|++|..||........ ..     
T Consensus       149 ~~l~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~-----  216 (267)
T PHA03390        149 IYLCDYGLCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DL-----  216 (267)
T ss_pred             EEEecCccceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hH-----
Confidence            99999999876432      1234688999999999998999999999999999999999999974322210 00     


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-MSIVVK  343 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~  343 (361)
                           ..+......  ....+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus       217 -----~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        217 -----ESLLKRQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -----HHHHHhhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                 111111111  11233356778999999999999999996 688874

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=313.39  Aligned_cols=248  Identities=27%  Similarity=0.414  Sum_probs=210.0

Q ss_pred             CCCccccCCceEEEEEEEC--CCC--EEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           71 TNALIGEGSYGRVYYGILK--SGH--AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        71 ~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      +.++||+|.||.|++|.|.  +|+  .||||.+.....  ...+|++|+.+|-+|+|||++++||+..+ ....+|||++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            3457999999999999987  444  589999976543  35789999999999999999999999887 6778999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ..|+|.+.|++...       ..|.......++.||+.||.||.+++   +|||||...|+|+.....|||+|||+.+.+
T Consensus       193 plGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             ccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence            99999999987321       23788888999999999999999998   999999999999999999999999999988


Q ss_pred             ccccccc-cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          225 PDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       225 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      +...... .....--...|.|||.++...++.++|||+|||++|||++ |..||-+..                .-.+.+
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----------------g~qIL~  326 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----------------GIQILK  326 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC----------------HHHHHH
Confidence            6543322 2223334678999999999999999999999999999999 889996443                344556


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      .+|.+-+.+-+..|++.++++++.||..+|.+|||+..|.+.+
T Consensus       327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            6676666777888999999999999999999999999997544

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.5e-40  Score=299.95  Aligned_cols=267  Identities=22%  Similarity=0.323  Sum_probs=197.1

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCC-----
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----  135 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----  135 (361)
                      ..++|++.+.||+|+||.||+|..+ +++.||+|.+.....   ....+.+|+.++++++||||+++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3468999999999999999999977 799999998864322   2235678999999999999999999887543     


Q ss_pred             ---eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          136 ---SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       136 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                         ..++||||+.+ +|.+++....        ..+++.+++.++.||+.||.|||+.+   ++|+||||+||+++.++.
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~  157 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKN--------VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGI  157 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCc
Confidence               45999999964 8888876542        13899999999999999999999998   999999999999999999


Q ss_pred             eEEeccccCCCCcccccc--ccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 018071          213 AKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT  289 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~  289 (361)
                      +||+|||++.........  .......++..|+|||++.+. .++.++||||||+++|+|++|..||....+......+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~  237 (310)
T cd07865         158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS  237 (310)
T ss_pred             EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999998765332211  112345678899999988764 47889999999999999999999997654432222211


Q ss_pred             hhcccCCchhhhhh-----cc-cccCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          290 WATPKLSEDKVRQC-----VD-ARLGGDY---------PPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       290 ~~~~~~~~~~~~~~-----~~-~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ........+.....     .+ .......         +...+..+.++|.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            11111111000000     00 0000000         0012345779999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.4e-39  Score=297.94  Aligned_cols=248  Identities=27%  Similarity=0.396  Sum_probs=198.4

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .|...+.||+|+||.||++... ++..+|+|.+......    ...+.+|+.+++.++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4677788999999999999976 7899999998653222    2467889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+.+ +|.+++....        ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++.
T Consensus       106 ~~~g-~l~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~  173 (317)
T cd06635         106 YCLG-SASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS  173 (317)
T ss_pred             CCCC-CHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCcc
Confidence            9965 7877775432        13899999999999999999999998   9999999999999999999999999886


Q ss_pred             CCccccccccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ....      .....|+..|+|||++.   ++.++.++|||||||++|+|++|..||.......               .
T Consensus       174 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---------------~  232 (317)
T cd06635         174 IASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------------A  232 (317)
T ss_pred             ccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---------------H
Confidence            5432      23456889999999874   4568899999999999999999999986432111               1


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ...+.............+..+.+++.+||+.+|.+||++.++++.+..+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence            1111111111112234556799999999999999999999999865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.1e-39  Score=293.42  Aligned_cols=258  Identities=25%  Similarity=0.323  Sum_probs=194.3

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCC-CCCcceeeeEEEeC--CeeEEEEE
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVDG--TSRVLAYE  142 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~e  142 (361)
                      |++.+.||+|+||.||+|..+ +++.||+|++.....  ......+|+.+++++. |+|++++++++.+.  ...++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            667889999999999999976 799999999875422  2234567888898885 99999999999887  88999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+. ++|.+++....        ..+++..++.++.|++.||+|||+.+   ++||||+|+||+++. +.+||+|||++.
T Consensus        81 ~~~-~~l~~~l~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          81 LMD-MNLYELIKGRK--------RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             cCC-ccHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccc
Confidence            996 48888876543        13899999999999999999999998   999999999999999 999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ......   ......++..|+|||.+.. ..++.++|||||||++|+|++|..||....+.+......-...... ..+.
T Consensus       148 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~  223 (282)
T cd07831         148 GIYSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD-AEVL  223 (282)
T ss_pred             ccccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCC-HHHH
Confidence            653321   1233557899999997754 4578899999999999999999999976543211000000000000 0000


Q ss_pred             hhcccc--cCC-----------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDAR--LGG-----------DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~--~~~-----------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ......  ...           ......+..+.+++.+||+.+|++|||++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000000  000           011245788999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=288.78  Aligned_cols=246  Identities=30%  Similarity=0.484  Sum_probs=203.9

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|++.+.||+|++|.||++..+ +++.|++|.+.....   ....+.+|++++++++|||++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5788899999999999999976 788999999976543   345788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++....         .+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  148 (254)
T cd06627          81 AENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK  148 (254)
T ss_pred             CCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccccee
Confidence            99999999987652         3899999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ......  ......++..|+|||.+.+..++.++||||+|+++|+|++|..||....+..               .....
T Consensus       149 ~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~---------------~~~~~  211 (254)
T cd06627         149 LNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA---------------ALFRI  211 (254)
T ss_pred             cCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH---------------HHHHH
Confidence            643222  1234568899999999988888999999999999999999999996432110               00000


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      . .......+...+..+.+++.+||..+|++|||+.+++.
T Consensus       212 ~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         212 V-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             h-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            0 01112233445678999999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.8e-40  Score=297.77  Aligned_cols=264  Identities=18%  Similarity=0.262  Sum_probs=197.4

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|++.+.||+|++|.||+|..+ +++.||+|.+.....   ....+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57889999999999999999976 789999999865332   23567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-CCceEEeccccC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLS  221 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~Dfg~a  221 (361)
                      |++ ++|.+++......       .+++..++.++.||+.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++
T Consensus        82 ~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~  150 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDF-------AKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLA  150 (294)
T ss_pred             ccc-ccHHHHHHhCCCC-------CcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccc
Confidence            996 5888887554321       2678889999999999999999998   999999999999985 557999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .......  ...+...+++.|+|||.+.+. .++.++|||||||++|+|++|..||......+................+
T Consensus       151 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (294)
T PLN00009        151 RAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW  228 (294)
T ss_pred             cccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            7643221  112344578899999988764 5789999999999999999999999754332111000000000000000


Q ss_pred             h------hhcc--cccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 R------QCVD--ARLGG----DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~------~~~~--~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .      ....  .....    ...+..+..+.+++.+||+.+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0      0000  00000    011234566899999999999999999999986

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.5e-40  Score=289.35  Aligned_cols=250  Identities=25%  Similarity=0.410  Sum_probs=206.3

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|.+.+.||+|+||.||++... ++..+++|++....   .....+.+|+++++.++|||++++++.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999976 79999999987643   3345788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++.....     ....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          81 ADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             cCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceee
Confidence            999999999876531     1134899999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      .....  .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.......               .....
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---------------~~~~~  215 (258)
T cd08215         153 LSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---------------LALKI  215 (258)
T ss_pred             cccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---------------HHHHH
Confidence            54332  12334578899999999998899999999999999999999999996443211               00111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      . .......+...+..+.+++.+||+.+|++|||+.++++
T Consensus       216 ~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         216 L-KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             h-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1 11122333455677999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.1e-41  Score=330.08  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=192.8

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----  134 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----  134 (361)
                      .+...+|+.+.+||+||||.||+++++ +|+.||||+|....  .....+.+|++.+.+|+|||||+++..|.+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            356678999999999999999999999 99999999997653  3335788999999999999999986432210     


Q ss_pred             --------------------------------------------------------------------------------
Q 018071          135 --------------------------------------------------------------------------------  134 (361)
Q Consensus       135 --------------------------------------------------------------------------------  134 (361)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHH
Q 018071          135 ----------------------------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA  180 (361)
Q Consensus       135 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi  180 (361)
                                                        ..+||-||||+..+|.+++..+...        -.....|+++++|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreI  706 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREI  706 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHH
Confidence                                              1237889999987778888766410        1367889999999


Q ss_pred             HHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc----c------------ccccccccccccCCCCCC
Q 018071          181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP----D------------MAARLHSTRVLGTFGYHA  244 (361)
Q Consensus       181 ~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~----~------------~~~~~~~~~~~gt~~y~a  244 (361)
                      ++||.|+|++|   +|||||||.||++++++.|||+|||+++...    .            .......+..+||.-|+|
T Consensus       707 lEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA  783 (1351)
T KOG1035|consen  707 LEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA  783 (1351)
T ss_pred             HHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence            99999999999   9999999999999999999999999998621    0            011223467889999999


Q ss_pred             chhhccC---CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCC--CCCHHHHHH
Q 018071          245 PEYAMTG---QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG--DYPPKAVAK  319 (361)
Q Consensus       245 PE~~~~~---~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  319 (361)
                      ||++.+.   .|+.|+|+||||++|+||+.   ||...-.+.              ..+..+-+..+..  ++.......
T Consensus       784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa--------------~iL~~LR~g~iP~~~~f~~~~~~~  846 (1351)
T KOG1035|consen  784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA--------------SILTNLRKGSIPEPADFFDPEHPE  846 (1351)
T ss_pred             HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHH--------------HHHHhcccCCCCCCcccccccchH
Confidence            9999765   49999999999999999987   464221110              0111111111111  122233445


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHH
Q 018071          320 MAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       320 l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      -..+|.+|++.||.+|||+.|++.
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhh
Confidence            678999999999999999999885

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=296.39  Aligned_cols=261  Identities=22%  Similarity=0.294  Sum_probs=198.3

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      |++.+.||.|++|.||+|..+ +|..||+|++.....   ....+.+|+++++.++|||++++++++.+....+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677889999999999999976 899999999875432   2356888999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      + ++|.+++.....       ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835          81 D-LDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             C-cCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            5 689999876542       23899999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhcccCCch----
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWATPKLSED----  298 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~----  298 (361)
                      .....  ......++..|+|||++.+. .++.++||||||+++|+|++|..||......... ...... ......    
T Consensus       150 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~  226 (283)
T cd07835         150 GVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL-GTPDEDVWPG  226 (283)
T ss_pred             CCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChHHhhh
Confidence            32211  12334568899999988764 5789999999999999999999999754321110 000000 000000    


Q ss_pred             -----hhhhhcccc---cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 -----KVRQCVDAR---LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 -----~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                           .........   ......+..+..+.+++.+||+.+|.+|||++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                 000000000   000112234567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-39  Score=295.03  Aligned_cols=258  Identities=18%  Similarity=0.219  Sum_probs=186.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-C---CCEEEEEEcCCCCCCh--H----------HHHHHHHHHhcCCCCCcceeee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQPD--E----------EFLAQVSMVSRLKHENFVQLLG  129 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~--~----------~~~~e~~~l~~l~hpniv~~~~  129 (361)
                      .++|.+.++||+|+||.||+|.+. +   +..+|+|.........  +          ....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            468999999999999999999976 3   4566777543322111  1          1122334456678999999998


Q ss_pred             EEEeCC----eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCce
Q 018071          130 YCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV  205 (361)
Q Consensus       130 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Ni  205 (361)
                      .+....    ..+++++++. .++.+.+....         ..++..++.++.|++.||+|||+.+   |+||||||+||
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Ni  157 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---------CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENI  157 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhc---------cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence            765443    3467888774 36766665432         1578889999999999999999998   99999999999


Q ss_pred             EeccCCceEEeccccCCCCccccc-----cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCC
Q 018071          206 LIFDDDVAKIADFDLSNQAPDMAA-----RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL  280 (361)
Q Consensus       206 ll~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~  280 (361)
                      |++.++.++|+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999999999999876532111     111233569999999999999999999999999999999999999997552


Q ss_pred             CcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          281 PRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      ....  .....    ..+.+..+.....   .....+..+.+++..|++.+|++||++.++++.|
T Consensus       238 ~~~~--~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        238 HNGN--LIHAA----KCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             cchH--HHHHh----HHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            2111  00000    0011111111111   1123357799999999999999999999999876

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=296.94  Aligned_cols=280  Identities=29%  Similarity=0.416  Sum_probs=219.6

Q ss_pred             cCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhc--CCCCCcceeeeEEEeCC----eeEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR--LKHENFVQLLGYCVDGT----SRVLAY  141 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~~~----~~~lv~  141 (361)
                      ...+..+||+|.||.||+|.+. ++.||||++..  ...+.|..|-++.+.  ++|+||++++++-....    .++||+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            3445567999999999999988 79999999864  334678888777665  47999999999866544    789999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCCeEeccCCCCceEeccCCceEE
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA------DPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      +|.+.|+|.+||..+.          ++|....+++..+++||+|||+.-      ++.|+|||||..||||.+++..-|
T Consensus       288 ~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             eeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence            9999999999999875          999999999999999999999853      457999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccC-CCC-----CccceecHHHHHHHHHhCCCCCC-CCCCcccchhh
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLN-----AKSDVYSFGVVLLELLTGRKPVD-HTLPRGQQSLV  288 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DvwslG~~l~ell~g~~pf~-~~~~~~~~~~~  288 (361)
                      +|||+|..+.........-..+||.+|||||++.+. ++.     .+.||||+|.+||||++.-.-+. +..+.-+..+.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            999999877543333333447899999999999865 333     36799999999999999665544 23333333344


Q ss_pred             hhhcccCCchhhhhhccccc-CCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCCCCC
Q 018071          289 TWATPKLSEDKVRQCVDARL-GGDYPP-----KAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGESA  360 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~~~~  360 (361)
                      .......+-++++..+-... +..++.     .....+.+.+..||+.||+-|.|+.=+.+.+..+....+.+.++|.
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~~~~~s~  515 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWEDSSGESS  515 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCccCCccc
Confidence            34445555666666654333 222322     2356789999999999999999999999999999988877666544

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.3e-40  Score=298.98  Aligned_cols=251  Identities=27%  Similarity=0.370  Sum_probs=193.0

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|...+.||+|+||.||++... +++.+|+|.+.....  ....+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999976 789999999875432  2356788999999996 99999999999988999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      +.. +|.++......    .....+++..+..++.|++.||+|||+. +   ++||||||+||++++++.+||+|||++.
T Consensus        85 ~~~-~l~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          85 MDI-SLDKFYKYVYE----VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             ccC-CHHHHHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhH
Confidence            854 66554321100    0012389999999999999999999975 6   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccC---CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ......   ......|+..|+|||++.+.   .++.++|||||||++|+|++|+.||.....     ...         .
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~---------~  219 (288)
T cd06616         157 QLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFD---------Q  219 (288)
T ss_pred             HhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHH---------H
Confidence            543221   12334678899999998866   689999999999999999999999964321     000         0


Q ss_pred             hhhhc---ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCV---DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.+..   .+.+....+..++..+.+|+.+||+.+|++|||+++|++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         220 LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             HhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            01110   011111222345677999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.3e-40  Score=296.90  Aligned_cols=266  Identities=23%  Similarity=0.299  Sum_probs=198.5

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCC----
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----  135 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----  135 (361)
                      ...++|++.+.||+|+||.||+|..+ +++.||+|++....   .....+.+|+.+++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34678999999999999999999987 78999999986532   22356778999999999999999999887654    


Q ss_pred             ------eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc
Q 018071          136 ------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       136 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~  209 (361)
                            ..++++||+++ +|.+++....        ..+++..++.++.|++.||+|||+.+   |+|+||||+||++++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~  151 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--------VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNN  151 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence                  78999999976 7777776532        13899999999999999999999998   999999999999999


Q ss_pred             CCceEEeccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhh
Q 018071          210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~  288 (361)
                      ++.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~  230 (302)
T cd07864         152 KGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI  230 (302)
T ss_pred             CCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999999876543221 11223346788999998865 35789999999999999999999999754322111111


Q ss_pred             hhhcccCCchhhhhhcc--------------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          289 TWATPKLSEDKVRQCVD--------------ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..............+.+              ..... .....+..+.+++.+||+.+|.+|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHhCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            10000000000000000              00000 01123567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-42  Score=337.30  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=207.0

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++-+|.-...||.|.||.||.|... +|+..|+|.+.-...   ....+.+|.+++..++|||+|+++++-.+.+..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            34557888889999999999999855 899999998864332   33567899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      .||||++|+|.+++...+         ..++.....+..|++.|+.|||+.|   ||||||||+||+++.+|.+|++|||
T Consensus      1312 FMEyC~~GsLa~ll~~gr---------i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR---------IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred             HHHHhccCcHHHHHHhcc---------hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccc
Confidence            999999999999997654         2566667778889999999999999   9999999999999999999999999


Q ss_pred             cCCCCccccccc--cccccccCCCCCCchhhccC---CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          220 LSNQAPDMAARL--HSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       220 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      .|..+.......  .-....||+.|||||++.+.   +...++|||||||++.||+||+.||....-             
T Consensus      1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------------- 1446 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------------- 1446 (1509)
T ss_pred             ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------------
Confidence            998875542111  12356799999999999854   567789999999999999999999953211             


Q ss_pred             CCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                        +..+.--+..+-...+|...+.+-++++..||..||++|.++.++++.
T Consensus      1447 --e~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1447 --EWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             --hhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence              111111112222345677788899999999999999999998887763

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8e-40  Score=296.08  Aligned_cols=250  Identities=26%  Similarity=0.426  Sum_probs=199.1

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHH
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH  150 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  150 (361)
                      .+||+|+||.||++..+ +++.||+|++.... .....+.+|+.+++.++|+||+++++++......+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            46999999999999976 89999999986433 23456888999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcccccc
Q 018071          151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR  230 (361)
Q Consensus       151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  230 (361)
                      +++....          +++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......  
T Consensus       106 ~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--  170 (292)
T cd06657         106 DIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  170 (292)
T ss_pred             HHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--
Confidence            9875432          889999999999999999999998   9999999999999999999999999886553221  


Q ss_pred             ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCC
Q 018071          231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG  310 (361)
Q Consensus       231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (361)
                      .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........            +.......+  
T Consensus       171 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~------------~~~~~~~~~--  236 (292)
T cd06657         171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM------------IRDNLPPKL--  236 (292)
T ss_pred             ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------HHhhCCccc--
Confidence            112345688999999999888899999999999999999999999964322111000            000001111  


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          311 DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       311 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                      ......+..+.+++.+||+.+|.+||++.++++  .+++....
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~  277 (292)
T cd06657         237 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAG  277 (292)
T ss_pred             CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc--ChHHhccC
Confidence            011234566899999999999999999999987  34444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=281.88  Aligned_cols=247  Identities=24%  Similarity=0.381  Sum_probs=196.5

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEEeC
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      .+.+..||.|+.|.|+++..+ +|...|||.+......  .++++..+.++..-. +|+||+.+|+|..+..+++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            344556999999999999987 7999999999775433  356777777766554 899999999999999999999998


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                       ...+..++.....        ++++..+-++...++.||.||.++.  .|+|||+||+|||+|+.|++||||||++-.+
T Consensus       174 -s~C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  174 -STCAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             -HHHHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccccee
Confidence             4466666665442        3888888999999999999999876  6999999999999999999999999998776


Q ss_pred             ccccccccccccccCCCCCCchhhcc---CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      -+..   ..+..+|-+.|||||.+.-   ..|+.++||||||++|+||.||+.||.+...              .-+.+.
T Consensus       243 vdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--------------dFe~lt  305 (391)
T KOG0983|consen  243 VDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--------------DFEVLT  305 (391)
T ss_pred             eccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--------------cHHHHH
Confidence            4422   2356678899999998863   3689999999999999999999999975422              122233


Q ss_pred             hhccccc-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+++... ..+....++..+.+++..||+.|+.+||.+.++++
T Consensus       306 kvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  306 KVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            3333211 01112236788999999999999999999999886

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.8e-40  Score=295.83  Aligned_cols=248  Identities=25%  Similarity=0.353  Sum_probs=204.2

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|.+.+.||+|+||.||++..+ ++..|++|++.++.    .....+.+|+.++++++ ||||+++++++.+....+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999977 89999999987632    22356788999999998 99999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      ||++++++|.+++....         .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~  148 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGT  148 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcc
Confidence            99999999999997653         3999999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccc------------------cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCc
Q 018071          221 SNQAPDMAA------------------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR  282 (361)
Q Consensus       221 a~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~  282 (361)
                      +........                  ........++..|+|||++.+..++.++||||||++++++++|..||......
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  228 (280)
T cd05581         149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY  228 (280)
T ss_pred             ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            876543221                  01223456789999999998888999999999999999999999999744210


Q ss_pred             ccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 018071          283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM----SIVVK  343 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~----~evl~  343 (361)
                                     ........  .....+...+..+.+++.+||+.+|.+|||+    +++++
T Consensus       229 ---------------~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 ---------------LTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---------------HHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                           00111111  1123344556779999999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.6e-40  Score=303.54  Aligned_cols=265  Identities=26%  Similarity=0.355  Sum_probs=200.1

Q ss_pred             HHHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeC-
Q 018071           60 DELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG-  134 (361)
Q Consensus        60 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-  134 (361)
                      .++..+.++|.+.+.||+|+||.||++... +++.||+|++.....   ..+.+.+|+.++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            455667899999999999999999999865 899999999875322   235677899999999999999999987643 


Q ss_pred             -----CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc
Q 018071          135 -----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       135 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~  209 (361)
                           ...+++++++ +++|.+++....          +++..++.++.|++.||+|||+.+   |+||||||+||++++
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~  155 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE  155 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence                 3467888887 779988886532          899999999999999999999998   999999999999999


Q ss_pred             CCceEEeccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhh
Q 018071          210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~  288 (361)
                      ++.+||+|||++.....     ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............
T Consensus       156 ~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (345)
T cd07877         156 DCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI  230 (345)
T ss_pred             CCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999876432     1234567899999998876 56889999999999999999999999654322111100


Q ss_pred             -hhhc-------ccCCchhhhhh---cccccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          289 -TWAT-------PKLSEDKVRQC---VDARLGGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       289 -~~~~-------~~~~~~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ....       ...........   +.......   .....+..+.+++.+||+.+|.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence             0000       00000000000   00000000   00123556899999999999999999999997

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3e-39  Score=290.29  Aligned_cols=240  Identities=23%  Similarity=0.333  Sum_probs=189.1

Q ss_pred             ccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHH---HHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVS---MVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~---~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      +||+|+||.||++... +++.||+|.+.+....    ...+..|..   .++...||||+++++++.+....++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999965 7899999998653221    112334433   3444579999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      |++|.+++....         .+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        81 g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          81 GGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            999999886542         3899999999999999999999998   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..    ......|+..|+|||.+.++ .++.++||||+||++|+|++|+.||...........             ....
T Consensus       149 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-------------~~~~  211 (278)
T cd05606         149 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------DRMT  211 (278)
T ss_pred             cc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-------------HHHh
Confidence            22    12345789999999998754 689999999999999999999999975422211110             0000


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                       .......+...+..+.+++.+||..+|.+||     ++.++++
T Consensus       212 -~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         212 -LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence             0011123334567899999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9e-40  Score=293.98  Aligned_cols=261  Identities=23%  Similarity=0.310  Sum_probs=200.6

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      |.+.+.||+|++|.||++... +++.+++|.+......   ...+.+|+.++++++|+||+++++++.++...++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567788999999999999976 7999999998654332   457788999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++ +|.+++....        ..+++..++.++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||.+...
T Consensus        81 ~~-~l~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~  148 (283)
T cd05118          81 DT-DLYKLIKDRQ--------RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSF  148 (283)
T ss_pred             CC-CHHHHHHhhc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence            75 8888876642        13899999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ....  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.......................+...
T Consensus       149 ~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd05118         149 GSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF  226 (283)
T ss_pred             CCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence            4322  112334578899999998876 7899999999999999999999999654432111110000000000000110


Q ss_pred             cc-----------cc--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VD-----------AR--LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~-----------~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+           ..  ......+..+..+.++|.+||+.||.+||++++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00           00  001122345778999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-39  Score=298.00  Aligned_cols=258  Identities=23%  Similarity=0.327  Sum_probs=192.7

Q ss_pred             ccccC--CceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCC
Q 018071           74 LIGEG--SYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        74 ~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      .||+|  +||+||++.+. +|+.||+|.+......   .+.+.+|+.+++.++||||+++++++..+...+++|||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999976 8999999998754332   256788999999999999999999999999999999999999


Q ss_pred             cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccc
Q 018071          148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM  227 (361)
Q Consensus       148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~  227 (361)
                      +|.+++.....       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++++||+.+......
T Consensus        85 ~l~~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~  154 (328)
T cd08226          85 SANSLLKTYFP-------EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRN  154 (328)
T ss_pred             CHHHHHHhhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence            99999876532       13889999999999999999999998   999999999999999999999999864332111


Q ss_pred             cccc-----cccccccCCCCCCchhhccC--CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc-c-----
Q 018071          228 AARL-----HSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP-K-----  294 (361)
Q Consensus       228 ~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~-~-----  294 (361)
                      ....     ......++..|+|||++.+.  .++.++|||||||++|+|++|..||........  ....... .     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~  232 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLD  232 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCcc
Confidence            1000     01112346679999999764  578999999999999999999999975432110  0000000 0     


Q ss_pred             ---CC------------------chhh-----hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 ---LS------------------EDKV-----RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 ---~~------------------~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         ..                  ....     .......+..+.+..++..+.+|+.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               00                  0000     0011111122233456788999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=293.86  Aligned_cols=262  Identities=23%  Similarity=0.325  Sum_probs=198.5

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeC--CeeEEEEE
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLAYE  142 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e  142 (361)
                      |++.+.||+|+||.||+|... +++.+|+|++....   .....+.+|+.+++.++|||++++++++.+.  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            677889999999999999977 68999999997653   2235688899999999999999999999887  88999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++ +|.+++....        ..+++..++.++.||+.||+|||+.+   ++|+||+|+||++++++.+||+|||++.
T Consensus        81 ~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          81 YMDH-DLTGLLDSPE--------VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             cccc-cHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccccee
Confidence            9975 8988886542        23899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.........................
T Consensus       149 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07840         149 PYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP  227 (287)
T ss_pred             eccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence            6543221 11233456889999998765 467899999999999999999999997554322111110000000000000


Q ss_pred             hhcc------cccCC--------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVD------ARLGG--------DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~------~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...+      .....        .....++..+.+++.+||+.+|.+||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000      00000        001112667899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.7e-40  Score=290.58  Aligned_cols=242  Identities=24%  Similarity=0.368  Sum_probs=195.6

Q ss_pred             cccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        75 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      ||.|+||.||++... +++.+++|.+.....    ..+.+.+|++++++++||||+++++.+......+++|||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 699999999875432    345688899999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccc
Q 018071          150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA  229 (361)
Q Consensus       150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  229 (361)
                      .+++....         .+++..+..++.||+.||+|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~  148 (265)
T cd05579          81 ASLLENVG---------SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ  148 (265)
T ss_pred             HHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence            99997643         2899999999999999999999998   99999999999999999999999999875432211


Q ss_pred             ------cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          230 ------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       230 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                            ........++..|+|||.+....++.++||||||+++|+|++|..||....+..               ....+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---------------~~~~~  213 (265)
T cd05579         149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---------------IFQNI  213 (265)
T ss_pred             cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---------------HHHHH
Confidence                  112234567889999999988889999999999999999999999996443211               11111


Q ss_pred             cccccCCCCCHH--HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          304 VDARLGGDYPPK--AVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       304 ~~~~~~~~~~~~--~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      .....  ..+..  .+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus       214 ~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         214 LNGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             hcCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            11111  11222  267799999999999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=296.23  Aligned_cols=240  Identities=25%  Similarity=0.315  Sum_probs=202.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .+|..+.+||+|+||.|.++..+ +.+.+|||+++++-.    +.+--+.|-++|... +-|.+++++..|..-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            57889999999999999999987 788999999987432    223334566666665 468999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+.||+|--.|++...         +.+..+..++.+|+-||-+||++|   |++||||.+|||++.+|++||+|||+
T Consensus       429 MEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             EEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccc
Confidence            999999999777766553         888899999999999999999999   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ++.--  .......++||||.|+|||++..++|+.++|+||+||+||||+.|+.||++....               +-.
T Consensus       497 cKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---------------elF  559 (683)
T KOG0696|consen  497 CKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---------------ELF  559 (683)
T ss_pred             ccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHH
Confidence            98642  2344567899999999999999999999999999999999999999999865432               223


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN  337 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  337 (361)
                      +.+.+...  .+|...+.+...+.+..|..+|.+|..
T Consensus       560 ~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  560 QAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence            33334332  577788899999999999999999953

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-39  Score=300.76  Aligned_cols=274  Identities=25%  Similarity=0.323  Sum_probs=201.2

Q ss_pred             HhhcCCC-CCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh---------------HHHHHHHHHHhcCCCCCccee
Q 018071           65 ITENFGT-NALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---------------EEFLAQVSMVSRLKHENFVQL  127 (361)
Q Consensus        65 ~~~~y~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~e~~~l~~l~hpniv~~  127 (361)
                      +.++|.. .+.||.|+||+||+|..+ +++.||+|++.......               ..+.+|+++++.++||||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            3467764 577999999999999976 79999999986532221               247789999999999999999


Q ss_pred             eeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       128 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      ++++......+++|||+. ++|.+++....         .+++..+..++.|++.||.|||+.+   ++|+||+|+||++
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill  152 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFI  152 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEE
Confidence            999999999999999996 58999886543         3899999999999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCcccc------------ccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCC
Q 018071          208 FDDDVAKIADFDLSNQAPDMA------------ARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK  274 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~  274 (361)
                      +.++.++|+|||++.......            .........++..|+|||.+.+. .++.++|||||||++|+|++|..
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~  232 (335)
T PTZ00024        153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP  232 (335)
T ss_pred             CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            999999999999987653110            01112234568899999998764 47899999999999999999999


Q ss_pred             CCCCCCCcccchhhhhhcccCCchhhhhhcc--------cccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          275 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVD--------ARLG---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       275 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ||...........+...........+....+        ....   .......+..+.+++.+||+.+|++|||+++++.
T Consensus       233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            9975543221110000000000000000000        0000   0011123567899999999999999999999996


Q ss_pred             HHHHhHhcCC
Q 018071          344 ALQPLLNARP  353 (361)
Q Consensus       344 ~L~~l~~~~~  353 (361)
                        .+.++..+
T Consensus       313 --~~~~~~~~  320 (335)
T PTZ00024        313 --HEYFKSDP  320 (335)
T ss_pred             --CcccCCCC
Confidence              34444333

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=289.26  Aligned_cols=240  Identities=23%  Similarity=0.276  Sum_probs=189.6

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHH-HhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSM-VSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~-l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      +.||.|+||.||+|... +++.||+|.+.+....    ...+..|..+ ....+|||++++++++.+....++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999976 7899999998754321    1233445444 3455899999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++....         .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        82 ~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  149 (260)
T cd05611          82 GDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE  149 (260)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence            99999987543         2889999999999999999999998   99999999999999999999999998875432


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                            .....++..|+|||.+.+..++.++||||||+++|+|++|..||........               .......
T Consensus       150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~  208 (260)
T cd05611         150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---------------FDNILSR  208 (260)
T ss_pred             ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---------------HHHHHhc
Confidence                  2345688999999999888899999999999999999999999964332110               0000000


Q ss_pred             c--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          307 R--LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       307 ~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      .  ........++..+.+++.+||+.+|++||++..+.+.|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            0  11112224567799999999999999999876555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.2e-40  Score=284.11  Aligned_cols=207  Identities=27%  Similarity=0.405  Sum_probs=175.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-C----CCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEe-CCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-S----GHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~  136 (361)
                      ...|+..+.||+|+||.||+|..+ +    ...+|||+++..+.   ......+|+.+++.++|||++.+..++.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            357999999999999999999633 2    33799999976532   23567889999999999999999999877 888


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC----Cc
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD----DV  212 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~----~~  212 (361)
                      +++++||.+. +|.+.|+-.+..+.    ..++...+..|++||+.|+.|||++-   |+||||||.||||..+    |.
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence            9999999988 99999987665443    35899999999999999999999998   9999999999999877    89


Q ss_pred             eEEeccccCCCCccccccc-cccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCC
Q 018071          213 AKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL  280 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~  280 (361)
                      |||+|||+++...+.-... ....++-|.+|.|||++.|. .|+.+.|||++|||+.||++-.+.|.+..
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            9999999998765433322 34567789999999999976 68999999999999999999998886543

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-40  Score=300.81  Aligned_cols=270  Identities=24%  Similarity=0.324  Sum_probs=205.7

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCC-----eeE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRV  138 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~  138 (361)
                      +|.+.+.||+|+||.||+|... +++.|++|++....   ...+.+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999976 69999999987532   23467889999999999999999999988765     789


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      ++|||+. ++|.+++....         .+++..++.++.||+.||+|||+.|   |+|+||||+|||++.++.++|+||
T Consensus        81 lv~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~df  147 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDF  147 (330)
T ss_pred             EEecchh-hhHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence            9999997 48988886543         3899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccc-cccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          219 DLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       219 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      |++........ ........++..|+|||++.+. .++.++||||||+++|+|++|..||...........+.-......
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  227 (330)
T cd07834         148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS  227 (330)
T ss_pred             CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence            99876543221 0112345678999999999887 889999999999999999999999976543221111110000000


Q ss_pred             --------chhhhhhccccc-C-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhHh
Q 018071          297 --------EDKVRQCVDARL-G-----GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA--LQPLLN  350 (361)
Q Consensus       297 --------~~~~~~~~~~~~-~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~~  350 (361)
                              .......+.... .     ....+..+..+.+++.+||+.+|.+|||++++++.  |+.+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                    011111111000 0     00112346778999999999999999999999973  554444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.5e-39  Score=294.12  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=195.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.|...+.||+|+||.||+|..+ ++..+++|.+.....    ...++.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34667778999999999999976 788999998864221    2346778999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+. |+|.+++....        ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        95 e~~~-~~l~~~~~~~~--------~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~  162 (308)
T cd06634          95 EYCL-GSASDLLEVHK--------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA  162 (308)
T ss_pred             EccC-CCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccc
Confidence            9996 58887775432        13889999999999999999999998   999999999999999999999999988


Q ss_pred             CCCccccccccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .....      .....++..|+|||.+.   ...++.++|||||||++|+|++|..||.......               
T Consensus       163 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------------  221 (308)
T cd06634         163 SIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------------  221 (308)
T ss_pred             eeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---------------
Confidence            65432      23456789999999975   3467889999999999999999999985432111               


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      ..................+..+.+++.+||+.+|.+||+++++++..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            01111111111111234567799999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.6e-40  Score=303.22  Aligned_cols=264  Identities=21%  Similarity=0.280  Sum_probs=195.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeC---------
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG---------  134 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~---------  134 (361)
                      .++|.+.+.||.|+||.||+|..+ +++.||+|++.... ...+.+.+|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            478999999999999999999976 79999999986543 3345688899999999999999999776543         


Q ss_pred             -----CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc
Q 018071          135 -----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       135 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~  209 (361)
                           ...+++|||+. ++|.+++....          +++..++.++.||+.||.|||+.+   |+||||||+||+++.
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~  149 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQGP----------LSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT  149 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence                 35789999996 58988886432          889999999999999999999998   999999999999974


Q ss_pred             -CCceEEeccccCCCCcccccc-ccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch
Q 018071          210 -DDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS  286 (361)
Q Consensus       210 -~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~  286 (361)
                       ++.+||+|||++......... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||....+.....
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~  229 (342)
T cd07854         150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ  229 (342)
T ss_pred             CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence             567899999998754321111 11123457889999998764 568889999999999999999999997554322111


Q ss_pred             hhhhhcccCCchhhhhh--------cccccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          287 LVTWATPKLSEDKVRQC--------VDARLGGD-----YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~--------~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ......+..........        ........     ..+..+..+.+++.+||+.||.+|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            11111011110000000        00000000     11234567889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=298.91  Aligned_cols=247  Identities=22%  Similarity=0.340  Sum_probs=200.8

Q ss_pred             HHhhcCCC--CCccccCCceEEEEEEEC-CCCEEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           64 EITENFGT--NALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        64 ~~~~~y~~--~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      .+..-|++  .++||+|.||+||-|+++ +|+.||||++.+-   ......++.|+.||+.+.||.||.+...|+..+..
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv  638 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV  638 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence            34444554  368999999999999977 9999999999763   33446789999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHh-hhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC---ce
Q 018071          138 VLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VA  213 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~---~~  213 (361)
                      ++|||-+.| +..+. +...++        +|++.....++.||+.||.|||.++   |+|+||||+|||+.+..   .+
T Consensus       639 FVVMEKl~G-DMLEMILSsEkg--------RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQv  706 (888)
T KOG4236|consen  639 FVVMEKLHG-DMLEMILSSEKG--------RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQV  706 (888)
T ss_pred             EEEehhhcc-hHHHHHHHhhcc--------cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCce
Confidence            999999966 55554 444332        4999999999999999999999997   99999999999997653   79


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      ||||||+|+.+++..   .....+||+.|+|||+++..+|....|+||+|||+|.-++|..||+.+..            
T Consensus       707 KlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd------------  771 (888)
T KOG4236|consen  707 KLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED------------  771 (888)
T ss_pred             eeccccceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc------------
Confidence            999999999886533   34678999999999999999999999999999999999999999963321            


Q ss_pred             cCCchhhhhhc-ccccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          294 KLSEDKVRQCV-DARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       294 ~~~~~~~~~~~-~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                            +.+.+ +..+.  .....+.+....+||...|+..-.+|.|....+.
T Consensus       772 ------IndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  772 ------INDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             ------hhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence                  11111 11111  1222456777899999999999999999876554

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-39  Score=300.44  Aligned_cols=267  Identities=25%  Similarity=0.349  Sum_probs=198.9

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeC------
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------  134 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------  134 (361)
                      +.++|.+.+.||+|+||.||+|... +++.||+|++....   .....+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            3579999999999999999999976 79999999986532   2234678899999999999999999988754      


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceE
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK  214 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~k  214 (361)
                      ...++|+||+.. +|.+++..           .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+|
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~k  157 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELK  157 (342)
T ss_pred             ceEEEEeccccc-CHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence            346899999964 77766531           2889999999999999999999998   99999999999999999999


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+|||+++.....     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.................
T Consensus       158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  232 (342)
T cd07879         158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  232 (342)
T ss_pred             EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999998764321     233467889999999876 4688999999999999999999999975432111111100000


Q ss_pred             cCCchhhh--------hhccc--cc-CCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHhc
Q 018071          294 KLSEDKVR--------QCVDA--RL-GGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLNA  351 (361)
Q Consensus       294 ~~~~~~~~--------~~~~~--~~-~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~~  351 (361)
                      ........        ..+..  .. ...   ..+..+..+.+++.+||+.||.+||++++++.  .++.+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            00000000        00000  00 000   01123456889999999999999999999995  46665543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-39  Score=299.85  Aligned_cols=264  Identities=23%  Similarity=0.318  Sum_probs=200.9

Q ss_pred             HHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEe-CCe
Q 018071           62 LKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTS  136 (361)
Q Consensus        62 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~  136 (361)
                      +..++++|++.+.||+|+||.||+|..+ +++.||+|++.+..   ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456789999999999999999999976 89999999886432   234578889999999999999999998865 567


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++++||+ +++|.+++....          +++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~  150 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSRP----------LEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKIC  150 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeC
Confidence            88999999 568988886532          788889999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |||++.....     ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+........-.....
T Consensus       151 dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~  225 (328)
T cd07856         151 DFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP  225 (328)
T ss_pred             ccccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999875422     1233457889999998765 578999999999999999999999996543321111100000000


Q ss_pred             Cchhhh--------hhc-ccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          296 SEDKVR--------QCV-DARLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       296 ~~~~~~--------~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ..+...        ..+ ........+     +..+..+.++|.+||+.+|++|||+++++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111000        000 111111111     1235779999999999999999999999853

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-39  Score=301.11  Aligned_cols=262  Identities=25%  Similarity=0.345  Sum_probs=198.5

Q ss_pred             HHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCC--
Q 018071           62 LKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT--  135 (361)
Q Consensus        62 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--  135 (361)
                      +..+.++|.+.+.||+|+||.||++... ++..||+|++.....   ....+.+|+.+++.++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3446789999999999999999999966 899999999864322   2346789999999999999999999887543  


Q ss_pred             ----eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC
Q 018071          136 ----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD  211 (361)
Q Consensus       136 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~  211 (361)
                          ..++||||+ +++|.+++....          +++..++.++.|++.||+|||+.+   |+||||||+||++++++
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~  155 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHEK----------LSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDC  155 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence                358999999 779988886432          899999999999999999999998   99999999999999999


Q ss_pred             ceEEeccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc-hhhh
Q 018071          212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVT  289 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~  289 (361)
                      .++|+|||++......     .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||......... ....
T Consensus       156 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~  230 (343)
T cd07880         156 ELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK  230 (343)
T ss_pred             CEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999998765321     233467889999999876 46889999999999999999999999754321110 0000


Q ss_pred             hhcccCCch--------hhhhhcccc--cC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          290 WATPKLSED--------KVRQCVDAR--LG----GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       290 ~~~~~~~~~--------~~~~~~~~~--~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      . .......        .........  ..    .......+..+.+++.+||+.||.+|||+.++++
T Consensus       231 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         231 V-TGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             h-cCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0 0000000        000000000  00    0011233456899999999999999999999995

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=281.23  Aligned_cols=262  Identities=23%  Similarity=0.407  Sum_probs=206.0

Q ss_pred             HHHHHHHhhcCCCCCccccCCceEEEEEE-ECCCCEEEEEEcCCCC-CChHHHHHHHHHHhcCC-CCCcceeeeEEEeCC
Q 018071           59 VDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGT  135 (361)
Q Consensus        59 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~  135 (361)
                      +.++..++++     +||+|+++.|--+. ..+|..||||++.+.. ..+.++.+|++++...+ |+||++++++|+++.
T Consensus        75 F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            5666666664     79999999999988 5599999999998753 45678999999999985 999999999999999


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC---c
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---V  212 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~---~  212 (361)
                      ..|||||-|.||+|...|.+++.         +++.++..+...|+.||.|||.+|   |.|||+||+|||..+..   -
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsP  217 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRKH---------FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSP  217 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCc
Confidence            99999999999999999987763         999999999999999999999999   99999999999997765   4


Q ss_pred             eEEeccccCCCCccc-----cccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCc
Q 018071          213 AKIADFDLSNQAPDM-----AARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR  282 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~  282 (361)
                      +|||||.+.......     .......+.+|+..|||||+..     ...|+.++|.||||||||-|++|.+||.+....
T Consensus       218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~  297 (463)
T KOG0607|consen  218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA  297 (463)
T ss_pred             eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence            899999886543211     1122234678999999999763     236899999999999999999999999865542


Q ss_pred             ccchhhhhhcccCC---chhhh-hhcccccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          283 GQQSLVTWATPKLS---EDKVR-QCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       283 ~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +=    -|.....=   ...+- .+-+..+  ++|    ...+.+..+++...|..++.+|.++..++.
T Consensus       298 dC----GWdrGe~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  298 DC----GWDRGEVCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cC----CccCCCccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            10    01000000   01111 1112222  223    356788899999999999999999998876

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.9e-39  Score=295.87  Aligned_cols=266  Identities=24%  Similarity=0.342  Sum_probs=195.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCC------
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT------  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------  135 (361)
                      .++|.+.+.||+|+||.||+|..+ +++.+|+|++.....   ....+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999977 789999998864322   2346778999999999999999999875433      


Q ss_pred             --eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          136 --SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       136 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                        ..+++|||+.+ +|...+....        ..+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~  154 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS--------VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGIL  154 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence              46899999965 7777765432        23899999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCcccccc---------ccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcc
Q 018071          214 KIADFDLSNQAPDMAAR---------LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG  283 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~  283 (361)
                      +|+|||++.........         ...+...+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.......
T Consensus       155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~  234 (311)
T cd07866         155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID  234 (311)
T ss_pred             EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999998754322111         111334678899999988754 58899999999999999999999997654432


Q ss_pred             cchhhhhhcccCCchh------hhhhcccccCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          284 QQSLVTWATPKLSEDK------VRQCVDARLGGDYP-------PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ....+...........      +....+.......+       ......+.+++.+||+.+|.+|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            2111111000000000      00000000000011       112356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.1e-39  Score=293.25  Aligned_cols=253  Identities=21%  Similarity=0.278  Sum_probs=188.6

Q ss_pred             CceEEEEEEEC-CCCEEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHHHhhh
Q 018071           79 SYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH  154 (361)
Q Consensus        79 ~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  154 (361)
                      ++|.||.++.. +++.||+|++...   ......+.+|+.+++.++||||+++++++.+....+++|||+.+++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            34445555544 6999999998654   2334578899999999999999999999999999999999999999999997


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccc-----
Q 018071          155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-----  229 (361)
Q Consensus       155 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-----  229 (361)
                      .....       .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||.+........     
T Consensus        92 ~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          92 THFPE-------GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             Hhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            64322       2889999999999999999999998   99999999999999999999999998865432111     


Q ss_pred             cccccccccCCCCCCchhhcc--CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc----CC-------
Q 018071          230 RLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK----LS-------  296 (361)
Q Consensus       230 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~----~~-------  296 (361)
                      ........++..|+|||++..  ..++.++|||||||++|+|++|..||........  +.......    ..       
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhh
Confidence            111233457788999999875  3688999999999999999999999975432111  10000000    00       


Q ss_pred             chhhhh----hc----ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          297 EDKVRQ----CV----DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       297 ~~~~~~----~~----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...+..    ..    ............+..+.+++.+||+.||++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            000000    00    000111233455678999999999999999999999998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.3e-38  Score=291.02  Aligned_cols=242  Identities=27%  Similarity=0.422  Sum_probs=193.5

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      |...+.||+|+||+||+|... +++.|++|.+.....    ....+.+|+.+++.++|||++++++++.+....+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666778999999999999976 799999999865322    124678899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +. ++|.+++....        ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..
T Consensus       103 ~~-~~l~~~l~~~~--------~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~  170 (313)
T cd06633         103 CL-GSASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK  170 (313)
T ss_pred             CC-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcc
Confidence            95 57888775433        13889999999999999999999998   99999999999999999999999998864


Q ss_pred             CccccccccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ...      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||..........              
T Consensus       171 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~--------------  230 (313)
T cd06633         171 SSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------------  230 (313)
T ss_pred             cCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH--------------
Confidence            321      23456889999999984   4568889999999999999999999986543211110              


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ...............+..+.+++.+||+.+|.+||++.++++
T Consensus       231 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         231 -HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             -HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000000011112234456899999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=286.88  Aligned_cols=260  Identities=25%  Similarity=0.350  Sum_probs=195.2

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcC---CCCCcceeeeEEEeCCe-----
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRL---KHENFVQLLGYCVDGTS-----  136 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~-----  136 (361)
                      |++.+.||+|+||.||+|..+ +++.||+|.+......   ...+.+|+.+++++   +|||++++++++.+...     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            667789999999999999987 6999999999643222   23566787777665   59999999999987776     


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .+++|||+.+ +|.+++.....       ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~  149 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-------PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIA  149 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEe
Confidence            8999999965 89888865432       13899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch-hhhhhcccC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVTWATPKL  295 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~-~~~~~~~~~  295 (361)
                      |||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++|..||.......... +..... ..
T Consensus       150 dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~  225 (287)
T cd07838         150 DFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG-LP  225 (287)
T ss_pred             ccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcC-CC
Confidence            999987653321   1223457889999999999899999999999999999999999997544321100 000000 00


Q ss_pred             Cchhh-------hhhcccccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          296 SEDKV-------RQCVDARLG---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       296 ~~~~~-------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .....       .........   ....+..+..+.+++.+||+.||.+||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00000       000000000   1112244677899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4e-39  Score=290.88  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=200.3

Q ss_pred             cCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCC-----CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCee
Q 018071           68 NFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASK-----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~  137 (361)
                      +|.+.+.||+|+||.||++...    +++.||+|.+.+..     .....+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778889999999999999843    57889999986432     2234678899999999 599999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      ++||||+.+++|.+++....         .+++..++.++.|++.+|.|||+.+   ++||||+|+||+++.++.++|+|
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d  148 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTD  148 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEE
Confidence            99999999999999986542         2889999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccCC--CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      ||++......... ......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||.........  .       
T Consensus       149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~-------  218 (288)
T cd05583         149 FGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--S-------  218 (288)
T ss_pred             Ccccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--H-------
Confidence            9998765432211 123356889999999987654  788999999999999999999999633211100  0       


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                        .........  ....+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       219 --~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         219 --EISRRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             --HHHHHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence              000111111  113344456779999999999999999998888776643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-39  Score=287.97  Aligned_cols=261  Identities=24%  Similarity=0.370  Sum_probs=197.0

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEEeC
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      |.+.+.||+|+||.||+|... +++.|+||++.....  ......+|+..+++++ ||||+++++++.++...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            667889999999999999986 688999999876433  2234567899999998 999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                       +++|.+++.....       ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        81 -~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~  149 (283)
T cd07830          81 -EGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI  149 (283)
T ss_pred             -CCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceec
Confidence             7799998876531       23899999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhc-cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch-hhhhhcccCCch----
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVTWATPKLSED----  298 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~----  298 (361)
                      ....   ......++..|+|||++. ...++.++|+||||+++|+|++|..||.......... ............    
T Consensus       150 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd07830         150 RSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG  226 (283)
T ss_pred             cCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence            3321   123456788999999875 4468899999999999999999999996554322110 000000000000    


Q ss_pred             -hhhhhcccccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 -KVRQCVDARLG-------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 -~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ......+....       ....+..+..+.+++.+||+.+|++|||++|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence             00000000000       0001112467999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.4e-39  Score=289.07  Aligned_cols=250  Identities=24%  Similarity=0.315  Sum_probs=197.5

Q ss_pred             cCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCC-----CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCee
Q 018071           68 NFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASK-----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~  137 (361)
                      +|++.+.||.|+||.||+|...    +|..||+|.+....     ...+++.+|+.+++++ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788899999999999999863    68999999986532     2235678899999999 599999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      ++||||+++++|.+++....         .+++..+..++.|++.||.|||+.+   ++||||+|+|||+++++.+||+|
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d  148 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD  148 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEee
Confidence            99999999999999987543         2889999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccC--CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      ||++........ .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.........          
T Consensus       149 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----------  217 (290)
T cd05613         149 FGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ----------  217 (290)
T ss_pred             Cccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH----------
Confidence            999876533211 112345688999999998753  5788999999999999999999999643221110          


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                        ..+...+... ...++...+..+.+++.+||+.+|.+||     ++++++.
T Consensus       218 --~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         218 --AEISRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             --HHHHHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence              0011111000 1123444567799999999999999997     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-40  Score=258.89  Aligned_cols=262  Identities=21%  Similarity=0.306  Sum_probs=206.2

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +|.-.++||+|.+|+||+|+.+ +++.||+|.++.+..+   ....++|+-+++.+.|.|||+++++...+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4555667999999999999976 8999999998764433   35789999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      |.. +|..+.....+        .++...++.++.|++.||.++|+..   +.|||+||.|+||+.+|.+||+|||+++.
T Consensus        83 cdq-dlkkyfdslng--------~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglara  150 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNG--------DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARA  150 (292)
T ss_pred             hhH-HHHHHHHhcCC--------cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhh
Confidence            954 99998876543        3889999999999999999999997   99999999999999999999999999988


Q ss_pred             CccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ++-..  ......+-|.+|.+|.++.+. .|++..|+||-||++.|+.. |++.|.+..-.++..-+.+......++.+.
T Consensus       151 fgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp  228 (292)
T KOG0662|consen  151 FGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP  228 (292)
T ss_pred             cCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence            65432  123445679999999999876 58999999999999999988 777776655444443344444444444333


Q ss_pred             hhc---ccccCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCV---DARLGGDYP---------PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~---~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+.   |-..-.-++         +.....-++++.+.|..+|..|.+++..++
T Consensus       229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            322   221111111         223334578999999999999999998775

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.3e-39  Score=296.61  Aligned_cols=263  Identities=21%  Similarity=0.243  Sum_probs=193.6

Q ss_pred             cCCCCCccccCCceEEEEEEEC-C--CCEEEEEEcCCCC---CChHHHHHHHHHHhcC-CCCCcceeeeEEEeC----Ce
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-S--GHAAAIKKLDASK---QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG----TS  136 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~----~~  136 (361)
                      +|.+.+.||+|+||.||++... +  +..||+|++....   ...+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778889999999999999976 5  7899999986532   2245678899999999 599999999875432    45


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .+++++|+. ++|.+++....         .+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~  147 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC  147 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeC
Confidence            688899985 58998886543         3899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccc--cccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          217 DFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       217 Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |||+++.......  ........|+..|+|||.+.+ ..++.++||||+||++|+|++|..||.................
T Consensus       148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  227 (332)
T cd07857         148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG  227 (332)
T ss_pred             cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence            9999976543211  111234568999999998765 4689999999999999999999999975432111000000000


Q ss_pred             cCCchhhhhhcc-----------cccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          294 KLSEDKVRQCVD-----------ARLGGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       294 ~~~~~~~~~~~~-----------~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ....+.+..+..           ......   ..+..+..+.+++.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000           000000   11123567999999999999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.7e-40  Score=302.22  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=199.7

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe---
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS---  136 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~---  136 (361)
                      .+.++|.+.+.||+|+||.||+|... ++..||+|++....   .....+.+|+.+++.++|||++++++++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            45789999999999999999999987 78999999986532   223567789999999999999999988765544   


Q ss_pred             ---eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          137 ---RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       137 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                         .++|+||+ +++|.+++....          +++..++.++.|++.||.|||+.+   |+||||+|+||++++++.+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~  157 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQK----------LSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL  157 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence               89999999 669999987532          899999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      +|+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.-..
T Consensus       158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~  232 (343)
T cd07851         158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV  232 (343)
T ss_pred             EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence            99999998765332     234567889999998865 367899999999999999999999997543321111000000


Q ss_pred             ccCC--------chhhhhhccccc---CCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          293 PKLS--------EDKVRQCVDARL---GGDY---PPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       293 ~~~~--------~~~~~~~~~~~~---~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ....        .+.....+....   ...+   ....+..+.+++.+||+.+|.+|||+.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0000        011111111000   0011   1123677999999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.3e-39  Score=284.77  Aligned_cols=249  Identities=21%  Similarity=0.315  Sum_probs=195.6

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC------CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS------KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      +|.+.+.||+|+||.||++... .+..+++|.++..      .....++..|+.+++.++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5888899999999999999876 4555666655431      12233566789999999999999999999998999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++.....     ....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++ +.++|+|||+
T Consensus        81 ~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          81 TEYCEGRDLDCKLEELKH-----TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             EEeCCCCCHHHHHHHHhh-----cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCc
Confidence            999999999998865321     1134899999999999999999999998   999999999999975 5699999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +.......  .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......               ...
T Consensus       152 ~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------------~~~  214 (260)
T cd08222         152 SRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---------------SVV  214 (260)
T ss_pred             eeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---------------HHH
Confidence            87653221  1223456788999999998888999999999999999999999999632210               000


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .... .......+..++..+.+++.+||+.+|++||++.++++
T Consensus       215 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         215 LRIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHHH-cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1111 11112234456778999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-38  Score=289.29  Aligned_cols=249  Identities=26%  Similarity=0.420  Sum_probs=193.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|++.+.||+|+||.||+|.++ +++.||||.+.....  ...++..|+.++.++. ||||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            67889999999999999999987 599999999875432  2345667777676664 9999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |+. ++|.+++.....        .+++..+..++.|++.||+|||+. +   |+||||+|+||++++++.+||+|||++
T Consensus        95 ~~~-~~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          95 LMS-TCLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             ccC-cCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccc
Confidence            985 477777655321        389999999999999999999974 6   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCC----CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ........   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||...... .             
T Consensus       163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~-------------  225 (296)
T cd06618         163 GRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-F-------------  225 (296)
T ss_pred             hhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-H-------------
Confidence            76533211   22345788999999987553    788999999999999999999999642111 0             


Q ss_pred             hhhhhhccccc-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          298 DKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       298 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      +.+..+..... .......++..+.+++.+||+.+|.+||+++++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         226 EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00111111110 001111345679999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=301.68  Aligned_cols=240  Identities=20%  Similarity=0.299  Sum_probs=200.3

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      +++.|.+...+|.|+|+.|-.+... ++...++|++.+...   +..+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            5678999999999999999999976 899999999977632   344677666665 69999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe-ccCCceEEeccccC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLS  221 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill-~~~~~~kl~Dfg~a  221 (361)
                      .+.|+-|.+.+...+          .....+..|+++|+.|+.|||++|   ||||||||+|||+ ++.++++|+|||.+
T Consensus       397 ~l~g~ell~ri~~~~----------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a  463 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP----------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFW  463 (612)
T ss_pred             hccccHHHHHHHhcc----------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechh
Confidence            999998888876654          333788899999999999999998   9999999999999 69999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....     ..+.+-|..|.|||++....|+.++||||||++||+|++|+.||......               ..+.
T Consensus       464 ~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------------~ei~  523 (612)
T KOG0603|consen  464 SELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------------IEIH  523 (612)
T ss_pred             hhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------------HHHH
Confidence            876543     34567789999999999999999999999999999999999999743221               1111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..+.   .+.+....+....+|+.+||+.||.+||++.++..
T Consensus       524 ~~i~---~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  524 TRIQ---MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             Hhhc---CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            1111   12233567888999999999999999999999986

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=307.52  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=218.6

Q ss_pred             CCCCccccCCceEEEEEEEC-C----CCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           70 GTNALIGEGSYGRVYYGILK-S----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        70 ~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ...++||.|+||+||+|.+- .    +-+||||++......  ..++++|+.+|.+++|||++++++++..+. .-||.+
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34578999999999999864 3    347899998764433  578999999999999999999999998765 779999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++|+|.++++..++        .+..+..+.|..||++||.|||.++   +|||||...||||.+-.++||.|||+++
T Consensus       778 ~mP~G~LlDyvr~hr~--------~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~  846 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRD--------NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAK  846 (1177)
T ss_pred             hcccchHHHHHHHhhc--------cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhh
Confidence            9999999999988764        3888999999999999999999998   9999999999999999999999999999


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .+.............-.+.|||-|.+....|+.++|||||||++||++| |..|+.+                ++.+++.
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g----------------i~~~eI~  910 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG----------------IPAEEIP  910 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC----------------CCHHHhh
Confidence            8765444333333444678999999999999999999999999999999 9999864                3456677


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      ++++...+...|+.++..++.++.+||..|+..||+++++...+....+
T Consensus       911 dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  911 DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            7777777778899999999999999999999999999999998877654

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=285.17  Aligned_cols=261  Identities=26%  Similarity=0.330  Sum_probs=199.6

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      |+..+.||+|+||.||+|... +++.+++|.+....   ...+.+..|+.+++.++|+|++++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566778999999999999977 69999999987642   23457788999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      . ++|.+++....        ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||++...
T Consensus        81 ~-~~l~~~i~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~  148 (282)
T cd07829          81 D-MDLKKYLDKRP--------GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF  148 (282)
T ss_pred             C-cCHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccccc
Confidence            7 59999997652        13899999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      .....  ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+...........+..+
T Consensus       149 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07829         149 GIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV  226 (282)
T ss_pred             CCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence            43221  22334567889999998876 8899999999999999999999999764422111000000000000100000


Q ss_pred             ccc-----cc-------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VDA-----RL-------GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~~-----~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+.     ..       .....+..+..+.+++.+||+.+|++||++++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000     00       00011123567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-40  Score=285.90  Aligned_cols=263  Identities=16%  Similarity=0.270  Sum_probs=205.2

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-C-C----CcceeeeEEEeCCee
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H-E----NFVQLLGYCVDGTSR  137 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h-p----niv~~~~~~~~~~~~  137 (361)
                      +.++|.+.+.+|+|+||.|-.+..+ ++..||+|+++.-..-++..+-|+++++++. + |    -+|++.+||...++.
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            4789999999999999999999966 7899999999876666677788999999994 2 2    367888889999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc--------
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--------  209 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~--------  209 (361)
                      +||+|.+ |-++.+++..+...       +++...++.++.|+++++++||+.+   ++|.||||+|||+.+        
T Consensus       167 Civfell-G~S~~dFlk~N~y~-------~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYI-------PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCcc-------ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEec
Confidence            9999999 66999999876543       4899999999999999999999998   999999999999842        


Q ss_pred             ------------CCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCC
Q 018071          210 ------------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD  277 (361)
Q Consensus       210 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~  277 (361)
                                  +..++|+|||.|+.-..     .....+.|..|.|||++.+-+++.++||||+||||.|+.+|...|.
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence                        23589999999976432     2366788999999999999999999999999999999999999997


Q ss_pred             CCCCcccchhhhhhcccCCchhhhhh-------------------------ccccc----CCCCCHHHHHHHHHHHHHcc
Q 018071          278 HTLPRGQQSLVTWATPKLSEDKVRQC-------------------------VDARL----GGDYPPKAVAKMAAVAALCV  328 (361)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~----~~~~~~~~~~~l~~li~~cl  328 (361)
                      .....+.....+.....++..-+.+.                         .+.-.    ..........+|.+|+++||
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            54422222222211111111111110                         00000    01112244567999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 018071          329 QYEADFRPNMSIVVK  343 (361)
Q Consensus       329 ~~~p~~RPs~~evl~  343 (361)
                      ..||.+|+|+.|++.
T Consensus       391 ~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  391 EFDPARRITLREALS  405 (415)
T ss_pred             ccCccccccHHHHhc
Confidence            999999999999985

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=310.15  Aligned_cols=268  Identities=26%  Similarity=0.421  Sum_probs=218.8

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC----C----CCEEEEEEcCCCCC--ChHHHHHHHHHHhcCC-CCCcceeeeEEEe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK----S----GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLK-HENFVQLLGYCVD  133 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~~~~~~~~  133 (361)
                      ..++..+.+.||+|.||.|++|..+    .    ...||||.++....  ..+.+..|+++|+.+. ||||+.+++++..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3445566779999999999999843    1    45799999876433  3568899999999995 9999999999999


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCC-----CCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceE
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGA-----QPG--PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL  206 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-----~~~--~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nil  206 (361)
                      ....++|+||+..|+|.++++..+.....     ...  ..++..+.+.++.||+.|++||++..   +|||||...|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence            99999999999999999999887611100     111  24999999999999999999999997   999999999999


Q ss_pred             eccCCceEEeccccCCCCccccccc-cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCccc
Q 018071          207 IFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQ  284 (361)
Q Consensus       207 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~  284 (361)
                      +.++..+||+|||+++......... ..+...-...|||||.+....|+.++||||||++|||+++ |..||.+..    
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~----  526 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP----  526 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC----
Confidence            9999999999999998654433222 1111112456999999999999999999999999999999 888985311    


Q ss_pred             chhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          285 QSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                                 ....+.+.+..+.+.+.|..++.+++++++.||+.+|++||++.++.+.|...+.
T Consensus       527 -----------~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  527 -----------PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             -----------cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence                       1233445677777888888999999999999999999999999999999998654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-39  Score=284.37  Aligned_cols=274  Identities=25%  Similarity=0.391  Sum_probs=213.1

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhc--CCCCCcceeeeEEEeC----Ce
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR--LKHENFVQLLGYCVDG----TS  136 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~~----~~  136 (361)
                      +.+.++..+.+.||+|.||.||+|.|+ |+.||||++..  .+.+.+.+|.++.+.  |+|+||+.+++.-..+    ..
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            456778888999999999999999999 99999999854  445678888888876  4999999999875432    45


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCCeEeccCCCCceEeccCC
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-----KADPHIIHRDIKSSNVLIFDDD  211 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-----~~~~~ivHrDikp~Nill~~~~  211 (361)
                      ++||.+|.+.|+|+|||....          ++....++++..++.||++||.     +|.+.|.|||||..||||.++|
T Consensus       284 LwLvTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             EEEeeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence            789999999999999998764          9999999999999999999997     4778899999999999999999


Q ss_pred             ceEEeccccCCCCcccc--ccccccccccCCCCCCchhhccC-C---C--CCccceecHHHHHHHHHhCCCCCCCCCCcc
Q 018071          212 VAKIADFDLSNQAPDMA--ARLHSTRVLGTFGYHAPEYAMTG-Q---L--NAKSDVYSFGVVLLELLTGRKPVDHTLPRG  283 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~---~--~~~~DvwslG~~l~ell~g~~pf~~~~~~~  283 (361)
                      ..-|+|+|+|.......  -.......+||.+|||||++... +   +  -..+||||||.++||+...-.- .+...+-
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~-ggi~eey  432 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES-GGIVEEY  432 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc-CCEehhh
Confidence            99999999987543321  22234678899999999998643 1   1  2368999999999999762210 0011111


Q ss_pred             cchhhhhhcccCCchhhhhhc-ccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          284 QQSLVTWATPKLSEDKVRQCV-DARLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      ...+..+.....+.+++++++ ..+++...|     ......+.+|++.||..+|.-|.|+=-|.+.|.++.+
T Consensus       433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            112223344445556666665 444444333     3566788999999999999999999999999999885

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=278.25  Aligned_cols=235  Identities=26%  Similarity=0.334  Sum_probs=194.4

Q ss_pred             cccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        75 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      ||+|+||.||++... +++.+++|.+.....    ....+..|+.+++.++||||+++++.+..+...+++|||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999977 699999999876433    234788899999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccc
Q 018071          150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA  229 (361)
Q Consensus       150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  229 (361)
                      .+++....         .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-  147 (250)
T cd05123          81 FSHLSKEG---------RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-  147 (250)
T ss_pred             HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-
Confidence            99997653         2899999999999999999999987   9999999999999999999999999987653321 


Q ss_pred             cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC
Q 018071          230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG  309 (361)
Q Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (361)
                       .......++..|+|||.+.+...+.++|+||||+++|+|++|..||......               .....+...  .
T Consensus       148 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---------------~~~~~~~~~--~  209 (250)
T cd05123         148 -SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---------------EIYEKILKD--P  209 (250)
T ss_pred             -CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---------------HHHHHHhcC--C
Confidence             1234556888999999998888999999999999999999999999643221               011111111  1


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 018071          310 GDYPPKAVAKMAAVAALCVQYEADFRPNMSI  340 (361)
Q Consensus       310 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e  340 (361)
                      ...+...+..+.+++.+||..||++||++.+
T Consensus       210 ~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         210 LRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2334444677999999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.1e-38  Score=312.73  Aligned_cols=145  Identities=28%  Similarity=0.392  Sum_probs=130.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|.+.+.||+|+||.||+|... +++.||||++......    ...+..|+.+++.++||||+++++++......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            368999999999999999999987 8999999998754322    25678899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+.+++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        83 mEy~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl  150 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL  150 (669)
T ss_pred             EeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence            99999999999997543         2889999999999999999999998   99999999999999999999999998


Q ss_pred             CC
Q 018071          221 SN  222 (361)
Q Consensus       221 a~  222 (361)
                      ++
T Consensus       151 s~  152 (669)
T cd05610         151 SK  152 (669)
T ss_pred             Cc
Confidence            75

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=287.65  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=204.8

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh--------HHHHHHHHHHhcCCCCCcceeeeEEE-eC
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--------EEFLAQVSMVSRLKHENFVQLLGYCV-DG  134 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~hpniv~~~~~~~-~~  134 (361)
                      +.++|-++.+||+|||+.||+|..- ..+.||+|+-...+.++        +...+|.+|.+.|.||.||+++++|. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            4567888889999999999999954 67889999865544433        34568999999999999999999986 66


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc---CC
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DD  211 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~---~~  211 (361)
                      ..++-|+|||+|.+|.-||+..+         .+++.+++.|+.||+.||.||... .++|||-||||.|||+.+   -|
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhk---------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHK---------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhh---------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence            78889999999999999998876         399999999999999999999998 567999999999999965   46


Q ss_pred             ceEEeccccCCCCccccccc-----cccccccCCCCCCchhhccC----CCCCccceecHHHHHHHHHhCCCCCCCCCCc
Q 018071          212 VAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTG----QLNAKSDVYSFGVVLLELLTGRKPVDHTLPR  282 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~  282 (361)
                      .+||.|||+++.+.+.....     ......||.+|++||++--+    ..+.++||||+|||+|+.+.|+.||.+...+
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            89999999999876543332     23567899999999998643    5788999999999999999999999865432


Q ss_pred             ccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .  .+..+       ..+....+  ...+.-+..+.+...+|.+||+.--++|....++..
T Consensus       691 Q--dILqe-------NTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  691 Q--DILQE-------NTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             H--HHHhh-------hchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            1  11111       11111111  112333456788999999999999999988887764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=277.68  Aligned_cols=248  Identities=21%  Similarity=0.297  Sum_probs=200.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|.++++||+|+|..|.+++++ +.+.||+|++++.-    .+..-...|-.+..+. +||.+|-++..|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            368999999999999999999976 89999999987632    2233345566666665 69999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      |.||++||+|--.+...+.         ++++.++.+..+|+.||.|||+.|   ||+||||.+|||++..|++||.|+|
T Consensus       329 vieyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             EEEEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccc
Confidence            9999999999766665542         999999999999999999999999   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +++..-.  ......++||||.|+|||++++..|...+|+|+|||+++||+.|+.||+--.-+..        ...+++-
T Consensus       397 mcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~--------d~ntedy  466 (593)
T KOG0695|consen  397 MCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP--------DMNTEDY  466 (593)
T ss_pred             hhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc--------ccchhHH
Confidence            9986432  22345789999999999999999999999999999999999999999973221110        0111222


Q ss_pred             hhh-hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 018071          300 VRQ-CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN  337 (361)
Q Consensus       300 ~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  337 (361)
                      +-+ +++..+  ..|...+.....+++.-|++||.+|..
T Consensus       467 lfqvilekqi--riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  467 LFQVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             HHHHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence            222 233333  456667777888999999999999853

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.4e-38  Score=275.06  Aligned_cols=220  Identities=20%  Similarity=0.225  Sum_probs=178.9

Q ss_pred             CCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcC
Q 018071           78 GSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR  156 (361)
Q Consensus        78 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~  156 (361)
                      |.+|.||++..+ +++.||+|++....    ...+|...+....||||+++++++.+....+++|||+++++|.+++...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            899999999976 89999999997643    2334445555567999999999999999999999999999999998654


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcccccccccccc
Q 018071          157 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV  236 (361)
Q Consensus       157 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  236 (361)
                      .         .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++++|||.+......     ....
T Consensus        80 ~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~  142 (237)
T cd05576          80 L---------NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGE  142 (237)
T ss_pred             c---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccC
Confidence            3         2899999999999999999999998   999999999999999999999999987654332     1234


Q ss_pred             ccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHH
Q 018071          237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKA  316 (361)
Q Consensus       237 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (361)
                      .++..|+|||.+.+..++.++||||+|+++|+|++|..||.......                     ........+...
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~~~~~~~~  201 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTTLNIPEWV  201 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccccCCcccC
Confidence            45778999999988889999999999999999999998875321100                     000011233445


Q ss_pred             HHHHHHHHHHccccCCCCCCCHH
Q 018071          317 VAKMAAVAALCVQYEADFRPNMS  339 (361)
Q Consensus       317 ~~~l~~li~~cl~~~p~~RPs~~  339 (361)
                      +..+.+++.+||+.||.+||++.
T Consensus       202 ~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         202 SEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CHHHHHHHHHHccCCHHHhcCCC
Confidence            67799999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=275.69  Aligned_cols=258  Identities=25%  Similarity=0.326  Sum_probs=196.3

Q ss_pred             CccCHHHHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcC-CCCCcceeeeE
Q 018071           55 PAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGY  130 (361)
Q Consensus        55 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~~~~~  130 (361)
                      -.|+-++++.+.       .||.|.||+|++-.++ +|+..|||+++...  ...++++.|.+...+- +.||||+++|.
T Consensus        59 ~~F~~~~Lqdlg-------~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   59 HTFTSDNLQDLG-------EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccchHHHHH-------HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            345555555554       5999999999999987 89999999997644  3456788888765554 69999999999


Q ss_pred             EEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC
Q 018071          131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD  210 (361)
Q Consensus       131 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~  210 (361)
                      +..++.+|+.||+|+- +|..+-..-..    .....+++..+-.|......||.||...-  +|||||+||+|||++..
T Consensus       132 ~F~EGdcWiCMELMd~-SlDklYk~vy~----vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~  204 (361)
T KOG1006|consen  132 LFSEGDCWICMELMDI-SLDKLYKRVYS----VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRH  204 (361)
T ss_pred             hhcCCceeeeHHHHhh-hHHHHHHHHHH----HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecC
Confidence            9999999999999954 66544321110    01123888888889999999999999875  69999999999999999


Q ss_pred             CceEEeccccCCCCccccccccccccccCCCCCCchhhcc--CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhh
Q 018071          211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~  288 (361)
                      |.+||||||++-++.+...   .+..+|-..|||||.+..  .+|+.++||||||++|||+.||..|+.+....      
T Consensus       205 G~vKLCDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv------  275 (361)
T KOG1006|consen  205 GDVKLCDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV------  275 (361)
T ss_pred             CCEeeecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH------
Confidence            9999999999887654322   355678889999999863  36999999999999999999999999643221      


Q ss_pred             hhhcccCCchhhhhhcccccC-CCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          289 TWATPKLSEDKVRQCVDARLG-GDYP---PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                              -+.+.+++..... ...+   ..++..+..+|.-||.+|-..||.+.++++
T Consensus       276 --------feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  276 --------FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             --------HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence                    0111122111100 0111   246778999999999999999999999886

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=294.14  Aligned_cols=240  Identities=22%  Similarity=0.303  Sum_probs=204.6

Q ss_pred             cCCCCCccccCCceEEEEEEECC-CCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      +++.+..||-|+||.|=++..++ ...+|+|.+++..    ...+.+..|-++|...+.|.||++|-.|.++..+|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            44555679999999999999773 3358999887643    234567889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      -|-||.|+..++.+..         +....+..++..+++|++|||+++   ||+|||||+|++++.+|-+||.|||+|+
T Consensus       501 aClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             hhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHH
Confidence            9999999999988763         889999999999999999999998   9999999999999999999999999999


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .+....   .+-++||||.|.|||++.+.+++.++|.||||+++|||++|.+||.+.++-...+++...           
T Consensus       569 ki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-----------  634 (732)
T KOG0614|consen  569 KIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-----------  634 (732)
T ss_pred             HhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-----------
Confidence            876533   346799999999999999999999999999999999999999999877664433332211           


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN  337 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  337 (361)
                          .-...+|...+....+||++.-+.+|.+|..
T Consensus       635 ----id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  635 ----IDKIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ----hhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                1122466677788999999999999999976

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=296.12  Aligned_cols=252  Identities=29%  Similarity=0.462  Sum_probs=211.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEE-----eCCeeE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV-----DGTSRV  138 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~-----~~~~~~  138 (361)
                      ++.|++..+||.|.+|.||+++.+ +++..|+|+........+++..|.++++.+ .|||++.+++++.     .++.+|
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            467899999999999999999966 899999999988777788899999999998 5999999999886     357899


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      ||||||.+|+..|++++..+.       .+.|..+.+|++.++.||.+||...   ++|||||-.|||++.++.|||+||
T Consensus        98 LVMEfC~gGSVTDLVKn~~g~-------rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTKGN-------RLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             EEeeccCCccHHHHHhhhccc-------chhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeee
Confidence            999999999999999877643       4999999999999999999999987   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhcc-----CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |++.++...  .....+..||+.|||||++.-     ..|+.++|+||||++..||.-|.+|+....|.-....+    +
T Consensus       168 GvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I----p  241 (953)
T KOG0587|consen  168 GVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----P  241 (953)
T ss_pred             eeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC----C
Confidence            999887543  233567889999999999863     35788999999999999999999999765442111100    0


Q ss_pred             cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .          ++......+..-+..+.++|..||..|.++||++.++++
T Consensus       242 R----------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  242 R----------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             C----------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            0          111222335567888999999999999999999999876

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-39  Score=269.14  Aligned_cols=265  Identities=24%  Similarity=0.384  Sum_probs=202.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCcceeeeEEEe--------C
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVD--------G  134 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--------~  134 (361)
                      +.|+-..+||+|.||.||+|+.+ +|+.||+|++-..   ..-....++|+++|..|.|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34555668999999999999976 7888999977432   2223567899999999999999999987753        3


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceE
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK  214 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~k  214 (361)
                      ...++||.+|+. +|.-++....        ..++..++.+++.++..||.|+|+..   |+|||+|++|+||+.+|.+|
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~--------vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilk  164 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK--------VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILK  164 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc--------ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEE
Confidence            457899999987 8988887654        23899999999999999999999997   99999999999999999999


Q ss_pred             EeccccCCCCcccc--ccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 018071          215 IADFDLSNQAPDMA--ARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       215 l~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~  291 (361)
                      |+|||+++.+....  .....+..+-|.+|.+||.+.|. .|+++.|||.-||++.||.+|.+-+.+...+.+..++...
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L  244 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL  244 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence            99999997653322  12223556679999999999864 7999999999999999999999999877666555554432


Q ss_pred             --------cccCCchhhhhhcccc-cCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          292 --------TPKLSEDKVRQCVDAR-LGGDY---------PPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       292 --------~~~~~~~~~~~~~~~~-~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                              ++...+-.+.+.++.. +....         +-.-.....+|+.++|..||.+|+.+.+++.
T Consensus       245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                    2222221222222111 10000         0011346779999999999999999999875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-37  Score=285.62  Aligned_cols=204  Identities=24%  Similarity=0.312  Sum_probs=174.4

Q ss_pred             CCCCCccccCCceEEEEEEE-CCCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           69 FGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      |..++.||-|+||.|.++.. .+...||+|.+++.+.    .......|-.||....++-||+|+-.|.+.+.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            45567899999999999984 4788899999976432    234567789999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      ++||++-.+|....         .|.+..++.++.++..|+++.|..|   +|||||||+|||||.+|++||.|||+++-
T Consensus       711 IPGGDmMSLLIrmg---------IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMG---------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             cCCccHHHHHHHhc---------cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence            99999999887664         3889999999999999999999999   99999999999999999999999999864


Q ss_pred             Ccccc----------------------------------------ccccccccccCCCCCCchhhccCCCCCccceecHH
Q 018071          224 APDMA----------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFG  263 (361)
Q Consensus       224 ~~~~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  263 (361)
                      +....                                        .+...-..+||+.|+|||++...+|+..+|+||.|
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG  858 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence            32110                                        00111235699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCccc
Q 018071          264 VVLLELLTGRKPVDHTLPRGQ  284 (361)
Q Consensus       264 ~~l~ell~g~~pf~~~~~~~~  284 (361)
                      ||||||+.|+.||-...+.+.
T Consensus       859 vil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCcc
Confidence            999999999999987766543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=267.71  Aligned_cols=273  Identities=23%  Similarity=0.322  Sum_probs=230.1

Q ss_pred             HHHHHHHhhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeE
Q 018071           59 VDELKEITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGY  130 (361)
Q Consensus        59 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~  130 (361)
                      ..++..-..+++...++-+|.||.||.|.++      +.+.|.+|.++.....  ...++.|.-.+..+.|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3344455578888899999999999999765      2345677777654333  3467888889999999999999998


Q ss_pred             EEe-CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc
Q 018071          131 CVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       131 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~  209 (361)
                      +.+ ....++++.+..-|+|..|+...++.+ ..-...++..+...++.|++.|++|||+.+   |||.||...|++|++
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~-~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDD-PSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCC-CccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            864 466788899999999999998665332 223345888899999999999999999998   999999999999999


Q ss_pred             CCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 018071          210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~  288 (361)
                      .-.+||+|=.+++.+-..+........-.+..||+||.+....|+..+|||||||+||||+| |+.|+.           
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya-----------  500 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA-----------  500 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc-----------
Confidence            99999999999998876677766777777889999999999999999999999999999999 999984           


Q ss_pred             hhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          289 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                           .+...++...+..+++...|-+++.++..++..||...|++||++++++.-|.++-.+
T Consensus       501 -----eIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  501 -----EIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             -----ccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence                 3445667777788888888889999999999999999999999999999999887654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.2e-35  Score=289.16  Aligned_cols=268  Identities=18%  Similarity=0.205  Sum_probs=172.8

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-C----CCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeE------EEe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-S----GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGY------CVD  133 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~------~~~  133 (361)
                      ..++|++.++||+|+||.||+|.+. +    +..||+|++..... .+....+  .++...+.++..++..      ...
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence            3578999999999999999999976 5    78999998754322 1111111  1122222222222211      235


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCC-----------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVK-----------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS  202 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp  202 (361)
                      ....++||||+.+++|.+++.......           ............+..++.||+.||.|||+.+   |+||||||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP  283 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP  283 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence            667899999999999999987542100           0001111234456789999999999999998   99999999


Q ss_pred             CceEecc-CCceEEeccccCCCCccccccccccccccCCCCCCchhhccC----------------------CCCCccce
Q 018071          203 SNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----------------------QLNAKSDV  259 (361)
Q Consensus       203 ~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv  259 (361)
                      +|||++. ++.+||+|||+++...... ........+++.|+|||.+...                      .++.++||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            9999986 5799999999997653321 1223456789999999976422                      23456799


Q ss_pred             ecHHHHHHHHHhCCCCCCCCCCcccchhhh-hhcccCCchhhhhhcccccCCCCC------HHHHHHHHHHHHHccccCC
Q 018071          260 YSFGVVLLELLTGRKPVDHTLPRGQQSLVT-WATPKLSEDKVRQCVDARLGGDYP------PKAVAKMAAVAALCVQYEA  332 (361)
Q Consensus       260 wslG~~l~ell~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~~p  332 (361)
                      |||||+||||+++..|++....    .+.. ..........+...+......+..      ........+|+.+||+.||
T Consensus       363 wSlGviL~el~~~~~~~~~~~~----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLI----QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHH----HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            9999999999998776542110    0000 000111111112222221110000      0112234589999999999


Q ss_pred             CCCCCHHHHHH
Q 018071          333 DFRPNMSIVVK  343 (361)
Q Consensus       333 ~~RPs~~evl~  343 (361)
                      ++|||+.++++
T Consensus       439 ~kR~ta~e~L~  449 (566)
T PLN03225        439 RQRISAKAALA  449 (566)
T ss_pred             ccCCCHHHHhC
Confidence            99999999997

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=265.17  Aligned_cols=264  Identities=23%  Similarity=0.348  Sum_probs=206.5

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeC-----CeeE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TSRV  138 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~  138 (361)
                      +.+-.+.||.|.||.||.+... +|+.||+|++..--   ...+++.+|++++.-++|.|++..++...-.     ...|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4556678999999999999965 89999999986522   2346889999999999999999998876533     3456


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      ++.|.+.. +|+..|....         .++...+.-++.||++||+|||+.+   |.||||||.|+|++++..+|||||
T Consensus       134 V~TELmQS-DLHKIIVSPQ---------~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDF  200 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQ---------ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDF  200 (449)
T ss_pred             HHHHHHHh-hhhheeccCC---------CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccc
Confidence            78888855 8888876542         3888899999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |+++.... ....+.+..+-|..|.|||++.|. .|+...||||+||++.||+..+..|....|..+..++.-.....+.
T Consensus       201 GLARvee~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~  279 (449)
T KOG0664|consen  201 GLARTWDQ-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ  279 (449)
T ss_pred             ccccccch-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence            99987654 344456777789999999999976 7999999999999999999999999988887776666644444444


Q ss_pred             hhhhhhcc--------cccCCC---------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          298 DKVRQCVD--------ARLGGD---------YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       298 ~~~~~~~~--------~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      +.++..-+        .....+         -+.....+...++.+++..||..|.+..+.+..+
T Consensus       280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            33332221        111111         1112334567788889999999999988876543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.9e-35  Score=256.32  Aligned_cols=235  Identities=31%  Similarity=0.416  Sum_probs=192.7

Q ss_pred             CceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhc
Q 018071           79 SYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG  155 (361)
Q Consensus        79 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  155 (361)
                      +||.||+|... +++.+++|++......  .+.+.+|++.+++++|+||+++++++......++++||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 6899999998764432  47889999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccccccccc
Q 018071          156 RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR  235 (361)
Q Consensus       156 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  235 (361)
                      ..         .+++..++.++.+++.+|.+||+.+   ++|+||+|.||++++++.++|+|||.+.......   ....
T Consensus        81 ~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~  145 (244)
T smart00220       81 RG---------RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTT  145 (244)
T ss_pred             cc---------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---cccc
Confidence            43         1789999999999999999999998   9999999999999999999999999988764322   2345


Q ss_pred             cccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHH
Q 018071          236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPK  315 (361)
Q Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (361)
                      ..++..|++||.+.+..++.++||||||+++|+|++|..||......               ....+.+...........
T Consensus       146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~  210 (244)
T smart00220      146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---------------LELFKKIGKPKPPFPPPE  210 (244)
T ss_pred             ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHHHHhccCCCCcccc
Confidence            66788999999999888999999999999999999999999642110               111111111111111111


Q ss_pred             --HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          316 --AVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       316 --~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                        .+..+.+++.+||..+|++||++.++++
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence              5567999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=275.43  Aligned_cols=270  Identities=20%  Similarity=0.273  Sum_probs=183.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEE-----------------CCCCEEEEEEcCCCCCC-hH--------------HHHHHH
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL-----------------KSGHAAAIKKLDASKQP-DE--------------EFLAQV  113 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~-~~--------------~~~~e~  113 (361)
                      .++|.+.++||+|+||+||+|..                 ..++.||||++...... .+              ....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999964                 23568999998643221 12              233466


Q ss_pred             HHHhcCCCCCc-----ceeeeEEEe--------CCeeEEEEEeCCCCcHHHhhhcCCCCC---------------CCCCC
Q 018071          114 SMVSRLKHENF-----VQLLGYCVD--------GTSRVLAYEFASNGSLHDILHGRKGVK---------------GAQPG  165 (361)
Q Consensus       114 ~~l~~l~hpni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------~~~~~  165 (361)
                      .++.+++|.++     ++++++|..        ....+|||||+.+++|.++++......               .....
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766544     667777653        356799999999999999987532110               11112


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCc
Q 018071          166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP  245 (361)
Q Consensus       166 ~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  245 (361)
                      ..+++..++.++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++....... ........+|+.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence            34678889999999999999999998   9999999999999999999999999987543221 1112223458899999


Q ss_pred             hhhccCC--------------------C--CCccceecHHHHHHHHHhCCC-CCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          246 EYAMTGQ--------------------L--NAKSDVYSFGVVLLELLTGRK-PVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       246 E~~~~~~--------------------~--~~~~DvwslG~~l~ell~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      |.+....                    |  ..+.||||+||++|+|++|.. ||........ .+..   .......++.
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~---~~~~~~~~r~  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQ---YDNDLNRWRM  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhh---ccchHHHHHh
Confidence            9875432                    1  134799999999999999886 6643211000 0000   0000011111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEA---DFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPs~~evl~  343 (361)
                      ..............+....+|+.++|..+|   .+|+|++|+++
T Consensus       456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            111222222233456778999999998766   68999999986

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=238.36  Aligned_cols=201  Identities=30%  Similarity=0.375  Sum_probs=164.8

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +...+..||+|++|.|-+-++. +|...|+|.+...-  +...+.++|+++..+. .+|.+|.+++........++.||.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            3344456999999999988876 89999999997643  3345778888876665 699999999998889999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      |. .+|..+-...-.     .+..+++..+-+|+..+..||.|||++-  .++|||+||+||||+.+|++|+||||.+-.
T Consensus       127 M~-tSldkfy~~v~~-----~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  127 MD-TSLDKFYRKVLK-----KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             hh-hhHHHHHHHHHh-----cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence            95 488766543321     1234889999999999999999999986  699999999999999999999999999877


Q ss_pred             CccccccccccccccCCCCCCchhhcc----CCCCCccceecHHHHHHHHHhCCCCCCCC
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMT----GQLNAKSDVYSFGVVLLELLTGRKPVDHT  279 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~ell~g~~pf~~~  279 (361)
                      +.+.-.   .+...|-..|||||.+..    ..|+-++||||||+++.||.+++.||+..
T Consensus       199 L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  199 LVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             ehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            654322   233567788999998863    37999999999999999999999999743

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.3e-35  Score=265.99  Aligned_cols=267  Identities=20%  Similarity=0.243  Sum_probs=207.5

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCC------CCcceeeeEEEeCC
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH------ENFVQLLGYCVDGT  135 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h------pniv~~~~~~~~~~  135 (361)
                      +.+-.+|.+....|+|-|++|..|... .|..||||+|.....-.+.=+.|+++|++|+.      -+.++++-.|...+
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            346678999999999999999999965 68899999999887777777899999999952      47899999999999


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-ceE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAK  214 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-~~k  214 (361)
                      ++|||+|.+ ..+|.++|...+..      -.|....++.++.|+..||..|...|   |+|.||||+||||++.. .+|
T Consensus       508 HLClVFE~L-slNLRevLKKyG~n------vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRN------VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcc------cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence            999999998 55999999877543      23888999999999999999999998   99999999999998754 689


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |||||.|.......    -+...-+..|.|||++.|..|+...|+||+||+||||.||+..|.+..-.....+..-...+
T Consensus       578 LCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  578 LCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK  653 (752)
T ss_pred             eccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence            99999987664432    23344566899999999999999999999999999999999999765433222222221222


Q ss_pred             CCchh--------------------------------hhhhccc------ccCC--CCC---HHHHHHHHHHHHHccccC
Q 018071          295 LSEDK--------------------------------VRQCVDA------RLGG--DYP---PKAVAKMAAVAALCVQYE  331 (361)
Q Consensus       295 ~~~~~--------------------------------~~~~~~~------~~~~--~~~---~~~~~~l~~li~~cl~~~  331 (361)
                      +++.-                                +...+.+      .+..  .++   +.....+.+|+.+||..|
T Consensus       654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence            21100                                0000000      0000  122   345678899999999999


Q ss_pred             CCCCCCHHHHHH
Q 018071          332 ADFRPNMSIVVK  343 (361)
Q Consensus       332 p~~RPs~~evl~  343 (361)
                      |++|.|..+.++
T Consensus       734 P~KRit~nqAL~  745 (752)
T KOG0670|consen  734 PEKRITVNQALK  745 (752)
T ss_pred             hhhcCCHHHHhc
Confidence            999999999875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-35  Score=276.29  Aligned_cols=246  Identities=25%  Similarity=0.359  Sum_probs=187.2

Q ss_pred             CCCCccccCCceE-EEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCCCC
Q 018071           70 GTNALIGEGSYGR-VYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        70 ~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      .-.+++|.|+-|+ ||+|... |+.||||++-....  .-..+|+..++.- .|||||++++.-.+.+..||..|.|.. 
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~--~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-  587 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF--DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-  587 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH--HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence            3345699998876 7999988 89999998854332  3457899999988 599999999998899999999999965 


Q ss_pred             cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc---C--CceEEeccccCC
Q 018071          148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---D--DVAKIADFDLSN  222 (361)
Q Consensus       148 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~---~--~~~kl~Dfg~a~  222 (361)
                      +|.+++.... ....    .......+.++.|++.||++||+.+   ||||||||.||||+.   +  ..++|+|||+++
T Consensus       588 sL~dlie~~~-~d~~----~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  588 SLQDLIESSG-LDVE----MQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             hHHHHHhccc-cchh----hcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            9999998741 1100    0111456788999999999999998   999999999999986   3  378999999999


Q ss_pred             CCccccc-cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhC-CCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          223 QAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       223 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .+..... ........||-+|+|||++....-+.++|||||||++|+.++| .+||.....++...+.    ..   ..+
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~----~~---~~L  732 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT----GN---YTL  732 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc----Cc---cce
Confidence            8754322 2224567799999999999998888899999999999999985 9999754332111000    00   000


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..       .....++  +..+||.+|++.+|..||++.+|+.
T Consensus       733 ~~-------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 VH-------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ee-------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            00       0111112  7899999999999999999999974

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-34  Score=256.02  Aligned_cols=131  Identities=22%  Similarity=0.375  Sum_probs=115.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-----C---CCcceeeeEEE----e
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----H---ENFVQLLGYCV----D  133 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h---pniv~~~~~~~----~  133 (361)
                      ++|.+.++||-|.|++||++... +.+.||+|+.+....-.+..+.||++|++++     |   ..||++++.|.    .
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            78999999999999999999966 7899999999877777788899999999984     2   37999999986    4


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      +.++++|+|++ |.+|..+|.......       ++...+..|+.||+.||.|||...  .|||.||||+|||+
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~YrG-------lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNYRG-------LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCCCC-------CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            68899999999 669999987665432       999999999999999999999997  79999999999998

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.7e-34  Score=236.88  Aligned_cols=269  Identities=17%  Similarity=0.276  Sum_probs=201.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeEEEeC--CeeEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDG--TSRVLAY  141 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~  141 (361)
                      .++|++.+.+|+|-++.|+.|..- +++.++||+++.-  ..+.+.+|+++|+.|+ ||||++++++..+.  ....||+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            468899999999999999999954 7899999998643  3457899999999997 99999999998754  4567999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC-CceEEecccc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDL  220 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~-~~~kl~Dfg~  220 (361)
                      ||+++.+...+..            .++...++.++.+++.||.|+|+.|   |+|||+||.|++|+.. -.++|+|+|+
T Consensus       115 E~v~n~Dfk~ly~------------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGL  179 (338)
T KOG0668|consen  115 EYVNNTDFKQLYP------------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGL  179 (338)
T ss_pred             hhhccccHHHHhh------------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecch
Confidence            9999988777653            3888999999999999999999999   9999999999999865 4799999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc-----
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK-----  294 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~-----  294 (361)
                      |......   ....-.+.+..|--||.+-. ..|+.+.|+|||||+|..|+..+.||-+...... .+...+.-.     
T Consensus       180 AEFYHp~---~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el  255 (338)
T KOG0668|consen  180 AEFYHPG---KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDEL  255 (338)
T ss_pred             HhhcCCC---ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHH
Confidence            9865322   12234556778899998864 5789999999999999999999999965432211 111111000     


Q ss_pred             ---------CCchhhhhhcccccCCCC--------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHhcCCCC
Q 018071          295 ---------LSEDKVRQCVDARLGGDY--------PPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLNARPGP  355 (361)
Q Consensus       295 ---------~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~~~~~~  355 (361)
                               .-......++....+...        ..-.+.+..+++.+.|..|-.+|+|+.|.+.  .+....++...+
T Consensus       256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~~  335 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESSR  335 (338)
T ss_pred             HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhcc
Confidence                     001122222222111111        1112467899999999999999999999987  566666655544

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=264.72  Aligned_cols=195  Identities=24%  Similarity=0.385  Sum_probs=170.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChH---------HHHHHHHHHhcCC---CCCcceeeeEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDE---------EFLAQVSMVSRLK---HENFVQLLGYCVD  133 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---------~~~~e~~~l~~l~---hpniv~~~~~~~~  133 (361)
                      .+|...+.+|+|+||.|++|.++ ....|+||.+.+.+.-..         .+-.||.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46899999999999999999988 677899999877543322         2346999999997   9999999999999


Q ss_pred             CCeeEEEEEeC-CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          134 GTSRVLAYEFA-SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       134 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                      ++.+||+||.- +|-+|.++|....         .+++.++..|+.|++.|+++||++|   |||||||-+||.++.+|-
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp---------~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP---------RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC---------ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence            99999999974 4569999998764         4999999999999999999999999   999999999999999999


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCC-CccceecHHHHHHHHHhCCCCCC
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN-AKSDVYSFGVVLLELLTGRKPVD  277 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~pf~  277 (361)
                      +||+|||.+.....    .....++||..|.|||++.|..|- ..-|||+||++||.++....||.
T Consensus       709 ~klidfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEEeeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999866433    235678999999999999998884 56799999999999999999884

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=243.91  Aligned_cols=259  Identities=20%  Similarity=0.232  Sum_probs=198.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCcceeeeEEEeC------C
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------T  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~  135 (361)
                      ..+|.-++.+|.|.- .|..+... .+..||+|++...   ....++..+|...+..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            357888888999988 77777755 7999999988543   22335678899999999999999999988643      4


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..|+|||++. .+|.+.+...           ++-..+.+++.|++.|++|||+.|   |+||||||+||++..++.+||
T Consensus        95 e~y~v~e~m~-~nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi  159 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILME-----------LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKI  159 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheee
Confidence            5689999995 4999988733           777889999999999999999999   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      .|||+++.....   -..+..+.|..|.|||++.+..|...+||||+||++.||++|..-|.+....++...+.......
T Consensus       160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP  236 (369)
T ss_pred             ccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence            999999865332   23466778999999999999999999999999999999999999997554333222211111111


Q ss_pred             Cchhhhhh-----------------------cccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          296 SEDKVRQC-----------------------VDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       296 ~~~~~~~~-----------------------~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ....+.++                       -|..+..  +.++.....+++++.+||..||++|.|++++++
T Consensus       237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            11111100                       0111110  111223456889999999999999999999987

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=236.20  Aligned_cols=252  Identities=21%  Similarity=0.326  Sum_probs=193.8

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeE-EEeCCeeEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGY-CVDGTSRVLAY  141 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~-~~~~~~~~lv~  141 (361)
                      +.+.|.+.+.||+|.||.+-++.++ +.+.+++|.+........+|.+|...--.|. |.||+..+++ |+..+.+++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4467888899999999999999998 8899999999988888899999998877775 8999998874 56777888999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc--CCceEEeccc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFD  219 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~--~~~~kl~Dfg  219 (361)
                      ||++.|+|..-+...+          +.+.....++.|+++||.|+|++.   +||||||.+||||-.  ..++||||||
T Consensus       102 E~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             ccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence            9999999999887754          888999999999999999999997   999999999999953  3489999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccC-----CCCCccceecHHHHHHHHHhCCCCCCCCCCccc--chhhhhhc
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ--QSLVTWAT  292 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~--~~~~~~~~  292 (361)
                      ..+..+..-     ...--+..|.+||.....     ...+.+|||.||+++|..++|..||+.....+.  .....|..
T Consensus       169 ~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~  243 (378)
T KOG1345|consen  169 LTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK  243 (378)
T ss_pred             cccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc
Confidence            988754322     222345678999976532     346788999999999999999999984432222  12222322


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      .+..  .+.+.         -...+..+.++.++-|..++++|=-..++.++.
T Consensus       244 rk~~--~~P~~---------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  244 RKNP--ALPKK---------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ccCc--cCchh---------hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            2221  11110         112356688899999999999995444544443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.1e-31  Score=229.62  Aligned_cols=209  Identities=33%  Similarity=0.547  Sum_probs=183.1

Q ss_pred             cccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHHH
Q 018071           75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD  151 (361)
Q Consensus        75 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~  151 (361)
                      ||+|.+|.||++... +++.+++|++......  ...+.+|+..++.++|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999976 5999999999765542  4678999999999999999999999999899999999999899999


Q ss_pred             hhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-CCceEEeccccCCCCcccccc
Q 018071          152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAAR  230 (361)
Q Consensus       152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~  230 (361)
                      ++....        ..+++..++.++.+++.+|.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........ 
T Consensus        81 ~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-  148 (215)
T cd00180          81 LLKENE--------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-  148 (215)
T ss_pred             HHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence            987652        13889999999999999999999998   999999999999999 89999999999876533211 


Q ss_pred             ccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC
Q 018071          231 LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG  309 (361)
Q Consensus       231 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (361)
                       ......+...|++||.+... .++.+.|+|++|+++++|                                        
T Consensus       149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------  187 (215)
T cd00180         149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------  187 (215)
T ss_pred             -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence             12345578899999999877 888999999999999999                                        


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          310 GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       310 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                              ..+.+++.+|++.+|.+||++.++++.
T Consensus       188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                    458999999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-33  Score=262.35  Aligned_cols=252  Identities=26%  Similarity=0.364  Sum_probs=203.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|+.+.++|.|++|.||+++.+ +++..|+|+++.... +..-+.+|+-+++..+||||+.+++-+......++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            468999999999999999999976 899999999986543 345677899999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      |.||+|.+.-+...         .+++.++..++++.+++|+|||+.|   =+|||||-.|||+++.|.+|++|||.+.+
T Consensus        94 cgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQ  161 (829)
T ss_pred             cCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhh
Confidence            99999998876554         3999999999999999999999998   89999999999999999999999999877


Q ss_pred             CccccccccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +..  .-.....+.||+.|||||+..   .+.|...+|||++|++..|+---+.|-....+..-..+.+-  ..+...  
T Consensus       162 ita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk--S~~qpp--  235 (829)
T KOG0576|consen  162 ITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK--SGFQPP--  235 (829)
T ss_pred             hhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc--cCCCCC--
Confidence            643  233356789999999999874   56899999999999999999887777533222111111110  000000  


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ..       .-...-+..+.++++.||-.+|.+||+++-++.
T Consensus       236 -~l-------kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 -TL-------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -cc-------cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence             00       011234567999999999999999999988764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=1e-31  Score=238.55  Aligned_cols=266  Identities=22%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             HHHHhhcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCe
Q 018071           62 LKEITENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS  136 (361)
Q Consensus        62 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~  136 (361)
                      +..+.+.|..+.+||+|+|++||++...    ..+.||+|.+...... .++..|+++|..+. +.||+++.+.+..++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3456678999999999999999999843    4788999998764433 57899999999995 8999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-CCceEE
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKI  215 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl  215 (361)
                      ..+|+||++.....++...            ++..++..+++.++.||.++|.+|   ||||||||.|+|.+. .+.-.|
T Consensus       110 v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             eEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceE
Confidence            9999999999999888864            788999999999999999999999   999999999999974 467899


Q ss_pred             eccccCCCCcccc------------------------------------------ccccccccccCCCCCCchhhcc-CC
Q 018071          216 ADFDLSNQAPDMA------------------------------------------ARLHSTRVLGTFGYHAPEYAMT-GQ  252 (361)
Q Consensus       216 ~Dfg~a~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~  252 (361)
                      +|||++.......                                          .....-...||++|.|||++.. ..
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            9999986110000                                          0000112569999999999875 46


Q ss_pred             CCCccceecHHHHHHHHHhCCCCCCCCCCccc--chhh-------------------hhh-cccCCchhhhhhcccc---
Q 018071          253 LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ--QSLV-------------------TWA-TPKLSEDKVRQCVDAR---  307 (361)
Q Consensus       253 ~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~--~~~~-------------------~~~-~~~~~~~~~~~~~~~~---  307 (361)
                      .++++||||.|||++.+++++.||-.......  ..+.                   .|. ........+....+..   
T Consensus       255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~  334 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE  334 (418)
T ss_pred             cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence            78899999999999999999999954322111  0110                   111 0000001111111111   


Q ss_pred             --cC--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          308 --LG--------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       308 --~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                        ..        .......+..+.+|+.+|+..||.+|.|+++.++
T Consensus       335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence              00        1111223557899999999999999999999886

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.6e-30  Score=224.03  Aligned_cols=198  Identities=35%  Similarity=0.511  Sum_probs=171.7

Q ss_pred             CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      |.+.+.||.|++|.||++... +++.+++|.+.....  ..+.+.+|++.+++++|+|++++++++......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            566788999999999999987 589999999976543  35688899999999999999999999998899999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....        .+++..++.++.+++.+|.+||+.+   ++|+||+|.||+++.++.++|+|||++....
T Consensus        81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~  149 (225)
T smart00221       81 GGDLFDYLRKKGG--------KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIH  149 (225)
T ss_pred             CCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence            9999999976531        1788999999999999999999998   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCCCCchhh-ccCCCCCccceecHHHHHHHHHhCCCCCCC
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYA-MTGQLNAKSDVYSFGVVLLELLTGRKPVDH  278 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~ell~g~~pf~~  278 (361)
                      ..... ......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       150 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      150 RDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             Ccccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            32211 22445678899999998 666788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-29  Score=218.04  Aligned_cols=260  Identities=21%  Similarity=0.281  Sum_probs=210.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      -.|.++++||+|+||..+.|..- +++.||||.-+ .+....++..|.+..+.|. .++|.+.+-+..++.+-.||||++
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            37999999999999999999954 89999999654 3445568899999999985 799999998888888889999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC-----CceEEeccc
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-----DVAKIADFD  219 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~-----~~~kl~Dfg  219 (361)
                       |.+|.|++.-..+        .++.+++..++.|++.-++|+|++.   +|+|||||+|+||..-     ..+.|+|||
T Consensus       107 -GPSLEDLFD~CgR--------~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGR--------RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             -CcCHHHHHHHhcC--------cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEecc
Confidence             7899998876653        3999999999999999999999997   9999999999999743     369999999


Q ss_pred             cCCCCcccccccc-----ccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          220 LSNQAPDMAARLH-----STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       220 ~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|+...+.....+     .+...||.+||+-....|...+.+.|+-|||-+++..|-|..||.+.-....+         
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK---------  245 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK---------  245 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH---------
Confidence            9998755433222     45678999999999999999999999999999999999999999865433211         


Q ss_pred             CCchhhhhhcccccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          295 LSEDKVRQCVDARLG---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                         .+..++-+..-.   .+.....+.++..-+.-.-..+-.+-|.++-+...+.+++..
T Consensus       246 ---~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  246 ---EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             ---HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence               222222222211   122334677788888888888999999999999998888854

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.4e-30  Score=265.23  Aligned_cols=196  Identities=19%  Similarity=0.230  Sum_probs=138.1

Q ss_pred             cCCC-CCcceeeeEE-------EeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 018071          118 RLKH-ENFVQLLGYC-------VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE  189 (361)
Q Consensus       118 ~l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~  189 (361)
                      .++| +||++++++|       .+....++++|++ +++|.+++....        ..+++.+++.++.||+.||.|||+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~   98 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--------RSVDAFECFHVFRQIVEIVNAAHS   98 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--------ccccHHHHHHHHHHHHHHHHHHHh
Confidence            3445 5777788776       2334567888988 569999997532        238999999999999999999999


Q ss_pred             cCCCCeEeccCCCCceEeccCC-------------------ceEEeccccCCCCccccc--------------ccccccc
Q 018071          190 KADPHIIHRDIKSSNVLIFDDD-------------------VAKIADFDLSNQAPDMAA--------------RLHSTRV  236 (361)
Q Consensus       190 ~~~~~ivHrDikp~Nill~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~  236 (361)
                      +|   |+||||||+||||+..+                   .+||+|||+++.......              .......
T Consensus        99 ~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (793)
T PLN00181         99 QG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA  175 (793)
T ss_pred             CC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence            98   99999999999996544                   455666666543211000              0001124


Q ss_pred             ccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHH
Q 018071          237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKA  316 (361)
Q Consensus       237 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (361)
                      +||+.|+|||++.+..|+.++|||||||+||||++|..|+.....    .+....         .....     +.....
T Consensus       176 ~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~---------~~~~~-----~~~~~~  237 (793)
T PLN00181        176 MEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLR---------HRVLP-----PQILLN  237 (793)
T ss_pred             CCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHH---------HhhcC-----hhhhhc
Confidence            689999999999999999999999999999999999888642110    000000         00000     000112


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          317 VAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       317 ~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ......++.+||+.+|.+||++.++++
T Consensus       238 ~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        238 WPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            334668889999999999999999986

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-30  Score=213.58  Aligned_cols=263  Identities=21%  Similarity=0.293  Sum_probs=210.3

Q ss_pred             HhhcCCCCCccccCCceEEEEEEE-CCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ..++|.+++.||.|+||.+|+|.. .+|+.||||.-.. .....++..|.++.+.|+ ...|..+..+..+...-.+||+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            457899999999999999999995 4899999997543 444567889999999997 4788888888888999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc---CCceEEeccc
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFD  219 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~---~~~~kl~Dfg  219 (361)
                      .+ |.+|.+++.-...        .++..+++.++-|++.-++|+|..+   +|||||||+|+|+.-   ...+.|+|||
T Consensus        92 LL-GPsLEdLfnfC~R--------~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSR--------RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             cc-CccHHHHHHHHhh--------hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEecc
Confidence            99 8899998876543        3899999999999999999999998   999999999999964   3479999999


Q ss_pred             cCCCCccccccc-----cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          220 LSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       220 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +++...+.....     ......||.+|.+-..+.+...+.+.|+-|+|.+|..+.-|..||++..+....         
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~---------  230 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK---------  230 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH---------
Confidence            998765443322     245678999999998888888999999999999999999999999876543221         


Q ss_pred             CCchhhhhhcccccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          295 LSEDKVRQCVDARLGG---DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                         .+...+.+.....   ......|.++...+.-|-..--++-|.+.-+.+.++-|+...
T Consensus       231 ---QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l  288 (341)
T KOG1163|consen  231 ---QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL  288 (341)
T ss_pred             ---HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence               1122222222211   122345677888999999999999999999988887777543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=7.5e-28  Score=220.34  Aligned_cols=262  Identities=21%  Similarity=0.262  Sum_probs=198.6

Q ss_pred             cCCCCCccccCCceEEEEEEECC--CCEEEEEEcCCCCCC-hHHHHHHHHHHhcCCC----CCcceeeeEE-EeCCeeEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILKS--GHAAAIKKLDASKQP-DEEFLAQVSMVSRLKH----ENFVQLLGYC-VDGTSRVL  139 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h----pniv~~~~~~-~~~~~~~l  139 (361)
                      +|.+.+.||+|+||.||++....  ...+|+|........ ...+..|+.++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            89999999999999999999764  357888887653222 2267888998888862    6899999988 47778899


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC-----CceE
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-----DVAK  214 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~-----~~~k  214 (361)
                      ||+.+ |.+|.++......       ..++..+++.++.|++.+|++||+.|   ++||||||+|+++...     ..+.
T Consensus        99 VM~l~-G~sL~dl~~~~~~-------~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~  167 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPP-------GRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLY  167 (322)
T ss_pred             EEecc-CccHHHHHHhCCC-------CCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEE
Confidence            99999 7899998865542       24999999999999999999999999   9999999999999865     3699


Q ss_pred             EeccccCCCCc--cccc-----ccc-ccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch
Q 018071          215 IADFDLSNQAP--DMAA-----RLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS  286 (361)
Q Consensus       215 l~Dfg~a~~~~--~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~  286 (361)
                      |.|||+++...  ....     ... .....||..|+++....+...+.+.|+||++.++.+++.|..||..........
T Consensus       168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~  247 (322)
T KOG1164|consen  168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS  247 (322)
T ss_pred             EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence            99999998322  1111     001 234559999999999999999999999999999999999999996543221100


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                                  .+.+..............+..+..+...+-..+...+|.+..+...|++.....
T Consensus       248 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  248 ------------KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             ------------HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence                        001110000000012223455666666666789999999999999999888765

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1e-28  Score=206.55  Aligned_cols=168  Identities=21%  Similarity=0.186  Sum_probs=127.1

Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|.+++..+..        .+++..++.++.||+.||.|||+.+         ||+|||++.++.+|+  ||++.....
T Consensus         1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~   61 (176)
T smart00750        1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP   61 (176)
T ss_pred             CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence            689999976431        3999999999999999999999885         999999999999999  999876432


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                             ....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+..+...         ....
T Consensus        62 -------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~---------~~~~  124 (176)
T smart00750       62 -------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNG---------MPAD  124 (176)
T ss_pred             -------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHH---------hccC
Confidence                   123689999999999999999999999999999999999999964322110 00000000         0000


Q ss_pred             ccC-CCCCHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          307 RLG-GDYPPKAVA--KMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       307 ~~~-~~~~~~~~~--~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      ... ...+.....  .+.+++.+||+.+|.+||++.++++.+..+..
T Consensus       125 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      125 DPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             CccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            000 011223333  69999999999999999999999998877654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=2.4e-27  Score=216.87  Aligned_cols=166  Identities=19%  Similarity=0.186  Sum_probs=128.9

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC--CCCEEEEEEcCCCC------CChHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASK------QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG  134 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~  134 (361)
                      ..+.++|.+.++||+|+||+||+|.++  +++.+|||++....      .....+.+|++++++++|+|++..+..   .
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence            446689999999999999999999865  57778999875321      123568899999999999999853322   2


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccC-CCCceEeccCCce
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI-KSSNVLIFDDDVA  213 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDi-kp~Nill~~~~~~  213 (361)
                      ...++||||++|++|... ..            ..   ...++.|++++|.|||+.|   |+|||| ||+|||++.++.+
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~------------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP------------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc------------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCE
Confidence            457999999999999632 11            11   1367889999999999998   999999 9999999999999


Q ss_pred             EEeccccCCCCccccccc------cccccccCCCCCCchhhcc
Q 018071          214 KIADFDLSNQAPDMAARL------HSTRVLGTFGYHAPEYAMT  250 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~  250 (361)
                      ||+|||+++.........      .-+...+++.|+|||.+..
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999999998654322111      1145678889999998853

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=195.21  Aligned_cols=243  Identities=23%  Similarity=0.387  Sum_probs=194.3

Q ss_pred             ccccCCceEEEEEEECCCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHH
Q 018071           74 LIGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH  150 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  150 (361)
                      +|.+...|..|+|++. |..+++|++....   ...++|..|.-.++.+.||||+.+++.|....+..++..||+.|+|+
T Consensus       197 kl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly  275 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY  275 (448)
T ss_pred             hhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence            5889999999999998 7777888876533   33457888999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe--ccccCCCCcccc
Q 018071          151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA--DFDLSNQAPDMA  228 (361)
Q Consensus       151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~--Dfg~a~~~~~~~  228 (361)
                      +.++....       ...+..++.+++..+++|++|||+.. +-|.---|....++||++...+|.  |--++.+     
T Consensus       276 nvlhe~t~-------vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq-----  342 (448)
T KOG0195|consen  276 NVLHEQTS-------VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-----  342 (448)
T ss_pred             HHHhcCcc-------EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence            99987653       34788899999999999999999985 224444688899999999877764  3222211     


Q ss_pred             ccccccccccCCCCCCchhhccCCCC---CccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          229 ARLHSTRVLGTFGYHAPEYAMTGQLN---AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       229 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                          .....-.|.||+||.+...+-+   ..+|+|||.+++|||.|...||....+-               +--.++.-
T Consensus       343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm---------------ecgmkial  403 (448)
T KOG0195|consen  343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM---------------ECGMKIAL  403 (448)
T ss_pred             ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch---------------hhhhhhhh
Confidence                1223347899999999866543   4679999999999999999999744331               11123334


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      .+++...|+..+..+..|+.-|++.||.+||.+..|+-.|+++.
T Consensus       404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            45666788899999999999999999999999999999888753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=4.9e-27  Score=228.35  Aligned_cols=252  Identities=17%  Similarity=0.260  Sum_probs=185.6

Q ss_pred             CCCCccccCCceEEEEEEEC-CCCEEEEEEcC----CCCCCh---HHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           70 GTNALIGEGSYGRVYYGILK-SGHAAAIKKLD----ASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        70 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~---~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ....++|.|.+|.|+.+... ..+..+.|...    ......   ..+..|+-+-..+.|||++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34567999999988877644 44445555433    111111   12455666777789999988877766655555559


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |||++ +|..++....         .+...++..++.|++.|++|+|+.|   |.|||+|++|++++.+|.+||+|||.+
T Consensus       401 E~~~~-Dlf~~~~~~~---------~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---------KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAA  467 (601)
T ss_pred             hcccH-HHHHHHhccc---------ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcc
Confidence            99999 9999998762         2888899999999999999999999   999999999999999999999999998


Q ss_pred             CCCcccccc--ccccccccCCCCCCchhhccCCCCCc-cceecHHHHHHHHHhCCCCCCCCCCcccch-hhhhhcccCCc
Q 018071          222 NQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAK-SDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVTWATPKLSE  297 (361)
Q Consensus       222 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~  297 (361)
                      .........  ......+|+..|+|||.+.+..|++. .||||.|++++.|++|+.||......+... ...+.......
T Consensus       468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~  547 (601)
T KOG0590|consen  468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF  547 (601)
T ss_pred             eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence            765433332  44567889999999999999999875 599999999999999999997544332221 00000000000


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...         .......+.+.+.+|.+||+.+|.+|.|+++|++
T Consensus       548 ~~~---------~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EGP---------NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cCh---------HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000         0122345677899999999999999999999986

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1e-24  Score=198.88  Aligned_cols=260  Identities=29%  Similarity=0.412  Sum_probs=197.1

Q ss_pred             CCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCC-CcceeeeEEEeCCeeEEEEEe
Q 018071           69 FGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHE-NFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp-niv~~~~~~~~~~~~~lv~e~  143 (361)
                      |.+.+.||.|+||.||++...  ..+++|.+.....    ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999987  8899999876433    256788999999999988 799999999877778999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-ceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~Dfg~a~  222 (361)
                      +.++++.+++......      ..+.......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.+.
T Consensus        80 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          80 VDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             CCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            9999999777654311      13889999999999999999999998   99999999999999988 79999999987


Q ss_pred             CCccccccc----cccccccCCCCCCchhhcc---CCCCCccceecHHHHHHHHHhCCCCCCCCCCc-ccchhhhhhccc
Q 018071          223 QAPDMAARL----HSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR-GQQSLVTWATPK  294 (361)
Q Consensus       223 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~-~~~~~~~~~~~~  294 (361)
                      .........    ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||...... ............
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  230 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL  230 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence            554332221    2467789999999999987   57889999999999999999999997644321 000000000000


Q ss_pred             CCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ...     .................+.+++..|+..+|..|.+..+....
T Consensus       231 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 PTP-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CCc-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000     000000000002223578899999999999999998887754

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=2.5e-25  Score=189.84  Aligned_cols=172  Identities=14%  Similarity=0.191  Sum_probs=135.0

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHH----------HHHHHHHHhcCCCCCcceeeeEEEe
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE----------FLAQVSMVSRLKHENFVQLLGYCVD  133 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~hpniv~~~~~~~~  133 (361)
                      -+.++|.+.++||.|+||.||++.. ++..+|+|.+.......+.          +.+|+..+.++.|++|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3668999999999999999999766 5778999999754333322          5789999999999999999988663


Q ss_pred             C--------CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCce
Q 018071          134 G--------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV  205 (361)
Q Consensus       134 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Ni  205 (361)
                      .        ...+|+|||++|.+|.++..             +++    ....+++.+|..||+.|   ++|||++|+||
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Ni  166 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNF  166 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHE
Confidence            3        35789999999999988732             333    24568999999999998   99999999999


Q ss_pred             EeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh
Q 018071          206 LIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT  271 (361)
Q Consensus       206 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~  271 (361)
                      +++.+| ++|+|||...........              ..++....|..++|+|+||+++..+..
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999988 999999987654221110              113445567789999999999876543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=9e-26  Score=210.47  Aligned_cols=231  Identities=26%  Similarity=0.322  Sum_probs=187.7

Q ss_pred             ccccCCceEEEEEE----ECCCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           74 LIGEGSYGRVYYGI----LKSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      ++|.|.||.|+++.    ...+..+|+|++.+...   .......|-.++...+ ||.+++++-.++.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999999876    33588899998865321   1224556777888886 9999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      ||.|...+.....         +.+.....+...++.+++++|+.+   ++|||+|++||+++.+|++++.|||+++..-
T Consensus        81 gg~lft~l~~~~~---------f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v  148 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM---------FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV  148 (612)
T ss_pred             cchhhhccccCCc---------hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhH
Confidence            9999887766542         777888888899999999999999   9999999999999999999999999988653


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ..      +..|||..|||||++.  .+...+|.||+|++++||++|..||..                   +.+..+..
T Consensus       149 ~~------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------------~~~~~Il~  201 (612)
T KOG0603|consen  149 KE------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------------DTMKRILK  201 (612)
T ss_pred             hh------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------------HHHHHHhh
Confidence            32      2239999999999998  788899999999999999999999963                   23333333


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM--SIVVKAL  345 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~--~evl~~L  345 (361)
                      ..+  ..|...+...+.++..++..+|..|.-.  ..+.+.+
T Consensus       202 ~~~--~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik  241 (612)
T KOG0603|consen  202 AEL--EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK  241 (612)
T ss_pred             hcc--CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence            332  5677788889999999999999999755  3444433

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=3.3e-24  Score=180.71  Aligned_cols=138  Identities=20%  Similarity=0.189  Sum_probs=107.2

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcCCCCC---C-------hHH-----------------HHHHHHHHhcCCCCCc
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---P-------DEE-----------------FLAQVSMVSRLKHENF  124 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~-------~~~-----------------~~~e~~~l~~l~hpni  124 (361)
                      .+.||+|+||.||+|...+|+.||+|+++....   .       ...                 ...|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999999988899999999865321   1       112                 2348999999987776


Q ss_pred             ceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeEeccCCCC
Q 018071          125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL-HEKADPHIIHRDIKSS  203 (361)
Q Consensus       125 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~ivHrDikp~  203 (361)
                      .....+..  ...+|||||++|+++...+....         .+++..++.++.|++.+|.++ |+.|   |+||||||+
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~  147 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY  147 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence            44333322  23389999999877655432221         288999999999999999999 6888   999999999


Q ss_pred             ceEeccCCceEEeccccCCCC
Q 018071          204 NVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       204 Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      |||++ ++.++|+|||++...
T Consensus       148 NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         148 NLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             HEEEE-CCcEEEEEccccccC
Confidence            99998 578999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=2.7e-25  Score=217.42  Aligned_cols=246  Identities=19%  Similarity=0.238  Sum_probs=181.7

Q ss_pred             cCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCC--CChHHH---HHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK--QPDEEF---LAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~---~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      +|...+.||++.|=+|.+|+++.|. |+||++-+..  .....+   ++|++ ...+++||.+.+..+.....-.|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777889999999999999988676 9999886543  223333   44444 455689999999888777777789989


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |..+ +|+|.+..+.         .+..-+-..|+.|++.||..+|..|   |+|+|||.+||||++-+-+.|+||..-+
T Consensus       102 yvkh-nLyDRlSTRP---------FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP---------FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             HHhh-hhhhhhccch---------HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence            9866 9999987653         4788888899999999999999998   9999999999999999999999998765


Q ss_pred             CC--ccccc---cccccccccCCCCCCchhhccC----------C-CCCccceecHHHHHHHHHh-CCCCCCCCCCcccc
Q 018071          223 QA--PDMAA---RLHSTRVLGTFGYHAPEYAMTG----------Q-LNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ  285 (361)
Q Consensus       223 ~~--~~~~~---~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~  285 (361)
                      ..  ++...   .....+......|+|||.+...          . .+++-||||+||++.||++ |++||+-+      
T Consensus       169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------  242 (1431)
T KOG1240|consen  169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------  242 (1431)
T ss_pred             CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------
Confidence            32  11111   0011222334579999987532          1 5677899999999999998 78998522      


Q ss_pred             hhhhhhcc-cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          286 SLVTWATP-KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       286 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      .+..|... ....+.+.+.++           ...+++++..|++.||.+|.++++.++.-
T Consensus       243 QL~aYr~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  243 QLLAYRSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             HHHhHhccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            22222211 111122222221           12589999999999999999999999873

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=3.6e-23  Score=174.98  Aligned_cols=139  Identities=18%  Similarity=0.172  Sum_probs=110.4

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcCCCCCC---------------------------hHHHHHHHHHHhcCCCCCc
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------------------------DEEFLAQVSMVSRLKHENF  124 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~hpni  124 (361)
                      .+.||+|+||.||+|...+|+.||||++......                           ...+..|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5689999999999999878999999998754211                           1123578899999999987


Q ss_pred             ceeeeEEEeCCeeEEEEEeCCCCcHHHh-hhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCC
Q 018071          125 VQLLGYCVDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKS  202 (361)
Q Consensus       125 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivHrDikp  202 (361)
                      .....+...  ..+|||||++|+++... +...          .++...+..++.|++.+|.++|+ .|   |+||||||
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP  146 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----------PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSE  146 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhc----------cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCh
Confidence            555444333  24899999988755433 3322          27788999999999999999999 88   99999999


Q ss_pred             CceEeccCCceEEeccccCCCCcc
Q 018071          203 SNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       203 ~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      +|||++ ++.++|+|||++.....
T Consensus       147 ~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         147 YNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             hhEEEE-CCCEEEEEcccceecCC
Confidence            999998 88999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=3.9e-23  Score=172.76  Aligned_cols=186  Identities=15%  Similarity=0.125  Sum_probs=142.1

Q ss_pred             CCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChH-----HHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEEe
Q 018071           70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE-----EFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        70 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .+..+|++|+||+||++.. .+..++.+.+........     .+.+|+++|++|. |+++.+++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3456799999999997776 588899888877665433     5789999999995 5889999886    346899999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccC-CCCceEeccCCceEEeccccCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI-KSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDi-kp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      +.|.+|.+.+..                ....++.|++.+|.++|+.|   |+|||| ||+|||++.++.++|+|||++.
T Consensus        80 I~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~  140 (218)
T PRK12274         80 LAGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV  140 (218)
T ss_pred             ecCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence            999888654311                11357789999999999998   999999 7999999999999999999998


Q ss_pred             CCcccccc----c-------cccccccCCCCCCchhhccC-CCC-CccceecHHHHHHHHHhCCCCCCCC
Q 018071          223 QAPDMAAR----L-------HSTRVLGTFGYHAPEYAMTG-QLN-AKSDVYSFGVVLLELLTGRKPVDHT  279 (361)
Q Consensus       223 ~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~~l~ell~g~~pf~~~  279 (361)
                      ........    .       .......++.|++|+...-. ..+ ...++++.|+-+|.++|+..++-.+
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            55432210    0       01123367888888865432 334 4668999999999999999887543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-23  Score=186.18  Aligned_cols=199  Identities=20%  Similarity=0.237  Sum_probs=145.8

Q ss_pred             CCCCcceeeeEEEe---------------------------CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHH
Q 018071          120 KHENFVQLLGYCVD---------------------------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ  172 (361)
Q Consensus       120 ~hpniv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~  172 (361)
                      +|||||.+..+|.+                           +..+|+||..++. +|..++-.+.          .+...
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----------~s~r~  342 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----------RSYRT  342 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----------CchHH
Confidence            59999999877654                           3456899999866 9999997765          67788


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec--cCC--ceEEeccccCCCCccc----cccccccccccCCCCCC
Q 018071          173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF--DDD--VAKIADFDLSNQAPDM----AARLHSTRVLGTFGYHA  244 (361)
Q Consensus       173 ~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~--~~~--~~kl~Dfg~a~~~~~~----~~~~~~~~~~gt~~y~a  244 (361)
                      ..-++.|+++|+.|||++|   |.|||+|.+|||+.  +++  .+.|+|||++-.-...    ......-..-|....||
T Consensus       343 ~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA  419 (598)
T KOG4158|consen  343 GRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA  419 (598)
T ss_pred             HHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence            8889999999999999999   99999999999994  333  5899999997543221    11112233457788999


Q ss_pred             chhhccCC------CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHH
Q 018071          245 PEYAMTGQ------LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVA  318 (361)
Q Consensus       245 PE~~~~~~------~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (361)
                      ||+....+      --.++|.|+.|.+.||+++...||.+.. ........|.          +---    ...+..++.
T Consensus       420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Yq----------e~qL----Palp~~vpp  484 (598)
T KOG4158|consen  420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTYQ----------ESQL----PALPSRVPP  484 (598)
T ss_pred             hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhhh----------hhhC----CCCcccCCh
Confidence            99886432      1248999999999999999999996521 1111111111          1111    134455667


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          319 KMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       319 ~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                      .+++|+...|+.||.+|++..-....|.-
T Consensus       485 ~~rqlV~~lL~r~pskRvsp~iAANvl~L  513 (598)
T KOG4158|consen  485 VARQLVFDLLKRDPSKRVSPNIAANVLNL  513 (598)
T ss_pred             HHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence            79999999999999999998877666643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=3.9e-23  Score=205.37  Aligned_cols=253  Identities=22%  Similarity=0.259  Sum_probs=186.9

Q ss_pred             HHHHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC---CCCcceeeeEEEeCCeeE
Q 018071           62 LKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        62 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~  138 (361)
                      ++.-...|.|.+.||+|+||.||+|...+|+.||+|+-+....+  +|.--.+++.+|+   -+.|+.+...+...+..+
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            33445789999999999999999999888999999987655443  2322334455554   345666666666777889


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-------CC
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-------DD  211 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-------~~  211 (361)
                      ||+||.+.|+|.+++...+         .++|..+..+..|++..++.||..+   |||+||||+|+||..       .-
T Consensus       771 lv~ey~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             eeeeccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCccc
Confidence            9999999999999998544         4999999999999999999999998   999999999999952       33


Q ss_pred             ceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 018071          212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~  291 (361)
                      .++|+|||.+-.+.-.......+..++|-.+-.+|+..|..++..+|.|.|+.+++.||.|+.-=  ......     |.
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~~-----~~  911 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGSS-----WM  911 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCcc-----ee
Confidence            69999999987664333344567788999999999999999999999999999999999997531  000000     00


Q ss_pred             cccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          292 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                          ....+.+..+.           .-+.+++..+|+.|-..=|...++...|+..+.
T Consensus       912 ----~~~~~~Ry~~~-----------~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  912 ----VKTNFPRYWKR-----------DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             ----ccccchhhhhH-----------HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence                00001111111           225667777777555555777777777766654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=4.1e-23  Score=181.45  Aligned_cols=236  Identities=19%  Similarity=0.241  Sum_probs=147.5

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCC----------CCcceeeeEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKH----------ENFVQLLGYCV  132 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h----------pniv~~~~~~~  132 (361)
                      .+.....||.|+|+.||.+.+. +++.+|+|+.....    ...+++.+|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3445668999999999999987 89999999875432    223456666544444322          12222222221


Q ss_pred             ---------eC---C-----eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 018071          133 ---------DG---T-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI  195 (361)
Q Consensus       133 ---------~~---~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i  195 (361)
                               ..   .     +.+++|.-+ -++|.+++..-....  .....+.....+.+..|+++.+++||+.|   +
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~--~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l  166 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA--QTHSPLAFAARLSLTVQMIRLVANLHSYG---L  166 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc--cccchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence                     11   1     235778777 448887764311100  00112444555677799999999999999   9


Q ss_pred             EeccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccC--------CCCCccceecHHHHHH
Q 018071          196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--------QLNAKSDVYSFGVVLL  267 (361)
Q Consensus       196 vHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslG~~l~  267 (361)
                      +|+||+|+|++++.+|.++|+||+.....+....     ....+..|.+||.....        .++.+.|.|+||+++|
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly  241 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY  241 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence            9999999999999999999999997665433211     13345789999976432        4788899999999999


Q ss_pred             HHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 018071          268 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFR  335 (361)
Q Consensus       268 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  335 (361)
                      .|.+|..||+...+......                    .-..|. +.++.++.||..+|+.||.+|
T Consensus       242 ~lWC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  242 SLWCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999975533211100                    112355 788889999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=3.5e-21  Score=163.87  Aligned_cols=133  Identities=16%  Similarity=0.197  Sum_probs=103.7

Q ss_pred             CCCccccCCceEEEEEEEC-CCCEEEEEEcCCC-CCChHHHHHHHHHHhcC-----CCCCcceeeeEEEeCC---eeE-E
Q 018071           71 TNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-KQPDEEFLAQVSMVSRL-----KHENFVQLLGYCVDGT---SRV-L  139 (361)
Q Consensus        71 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l-----~hpniv~~~~~~~~~~---~~~-l  139 (361)
                      -.++||+|+||.||.  +. ++.. +||++... ....+.+.+|+.+++.+     .||||++++++++++.   ..+ +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            346799999999996  44 4444 69988653 23456789999999999     5799999999998764   333 7


Q ss_pred             EEEe--CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeEeccCCCCceEecc----CCc
Q 018071          140 AYEF--ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL-EYLHEKADPHIIHRDIKSSNVLIFD----DDV  212 (361)
Q Consensus       140 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~~ivHrDikp~Nill~~----~~~  212 (361)
                      |+||  +.+++|.+++....          +++.  ..++.|++.++ +|||+++   |+||||||+|||++.    ++.
T Consensus        83 I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             EecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCc
Confidence            8999  55799999996532          5554  35677888777 9999998   999999999999974    337


Q ss_pred             eEEeccccC
Q 018071          213 AKIADFDLS  221 (361)
Q Consensus       213 ~kl~Dfg~a  221 (361)
                      ++|+||+.+
T Consensus       148 ~~LiDg~G~  156 (210)
T PRK10345        148 PVVCDNIGE  156 (210)
T ss_pred             EEEEECCCC
Confidence            999995544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.86  E-value=1.4e-22  Score=198.25  Aligned_cols=207  Identities=25%  Similarity=0.332  Sum_probs=147.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .+|..++.|..|++|.||+++++ +.+.+|+| +.+...    +.+.  ++....+|.+|                    
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn--ilt~a~npfvv--------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN--ILTFAGNPFVV--------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc--cccccCCccee--------------------
Confidence            58999999999999999999988 78889994 433221    1111  22333344443                    


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                       |+-...+...+.         ++.        +++.+++|||+.|   |+|||+||+|++|+.-|++|+.|||+++...
T Consensus       136 -gDc~tllk~~g~---------lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 -GDCATLLKNIGP---------LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             -chhhhhcccCCC---------Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhh
Confidence             344444443321         332        2378899999998   9999999999999999999999999976432


Q ss_pred             ccc-------------ccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          226 DMA-------------ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       226 ~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      ...             .....+..+||+.|+|||++...+|...+|+|++|+|+||.+.|..||.++.++...       
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf-------  267 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-------  267 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH-------
Confidence            111             111235679999999999999999999999999999999999999999887654321       


Q ss_pred             ccCCchhhhhhccc-ccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 018071          293 PKLSEDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRP  336 (361)
Q Consensus       293 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  336 (361)
                              .+++.. ..-.+-....+.+.++++.+.|+.+|..|-
T Consensus       268 --------g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  268 --------GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             --------hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                    111100 000111233456799999999999999995

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=9.7e-21  Score=176.74  Aligned_cols=217  Identities=25%  Similarity=0.382  Sum_probs=162.6

Q ss_pred             HhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 018071          116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI  195 (361)
Q Consensus       116 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i  195 (361)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.+.+....        ..+++.....+++.|+.||.|||...   |
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--------~~~d~~F~~s~~rdi~~Gl~ylh~s~---i   69 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--------IKLDYFFILSFIRDISKGLAYLHNSP---I   69 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--------cCccHHHHHHHHHHHHHHHHHHhcCc---c
Confidence            457889999999999999999999999999999999998743        23899999999999999999999885   4


Q ss_pred             -EeccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCC-------CCCccceecHHHHHH
Q 018071          196 -IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-------LNAKSDVYSFGVVLL  267 (361)
Q Consensus       196 -vHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~~l~  267 (361)
                       .|+.++..|++++....+||.|||+.................-...|.|||.+.+..       .+.+.||||+|++++
T Consensus        70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~  149 (484)
T KOG1023|consen   70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY  149 (484)
T ss_pred             eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence             999999999999999999999999977653211111111122345799999997641       466789999999999


Q ss_pred             HHHhCCCCCCCCCCccc-chhhhhhcccCCchhhhhhcccccCCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          268 ELLTGRKPVDHTLPRGQ-QSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       268 ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      |+++.+.||........ ..++.+...         .-...++....  ......+..++..||..+|.+||+++.|-..
T Consensus       150 ei~~r~~~~~~~~~~~~~~eii~~~~~---------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~  220 (484)
T KOG1023|consen  150 EILFRSGPFDLRNLVEDPDEIILRVKK---------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK  220 (484)
T ss_pred             HHHhccCccccccccCChHHHHHHHHh---------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence            99999999975332211 112221111         00000111111  1334479999999999999999999999999


Q ss_pred             HHHhHhcC
Q 018071          345 LQPLLNAR  352 (361)
Q Consensus       345 L~~l~~~~  352 (361)
                      ++.+....
T Consensus       221 ~~~~~~~~  228 (484)
T KOG1023|consen  221 LLTINKGG  228 (484)
T ss_pred             hhhhcccc
Confidence            88877653

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=1.1e-21  Score=179.99  Aligned_cols=171  Identities=27%  Similarity=0.360  Sum_probs=129.9

Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..++.|++|...+|.+||..++..      ...++...+.++.|++.|++|   ++   .+|||+||.||+...+..+||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~------e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG------EERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc------cccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhh
Confidence            568999999999999999755432      236778889999999999999   66   999999999999999999999


Q ss_pred             eccccCCCCcccc----ccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 018071          216 ADFDLSNQAPDMA----ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       216 ~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~  290 (361)
                      .|||+........    .....+...||.+||+||++.+..|+.++|||+||++|+||+. -..+|...           
T Consensus       398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------  466 (516)
T KOG1033|consen  398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------  466 (516)
T ss_pred             hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------
Confidence            9999987654433    2334567789999999999999999999999999999999998 33333210           


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHH---HHHHHHHHHHccccCCCCCCCHHH
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKA---VAKMAAVAALCVQYEADFRPNMSI  340 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~cl~~~p~~RPs~~e  340 (361)
                             ..+..+-+.    .+|+..   -..-+.|+.+++...|.+||++.+
T Consensus       467 -------~t~~d~r~g----~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  467 -------ATLTDIRDG----IIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             -------HhhhhhhcC----CCChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence                   001111111    122111   123468999999999999995444

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=2.2e-20  Score=162.79  Aligned_cols=143  Identities=17%  Similarity=0.165  Sum_probs=110.8

Q ss_pred             hcCCCCCccccCCceEEEEEE--ECCCCEEEEEEcCCCCCC-------------------------hHHHHHHHHHHhcC
Q 018071           67 ENFGTNALIGEGSYGRVYYGI--LKSGHAAAIKKLDASKQP-------------------------DEEFLAQVSMVSRL  119 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l  119 (361)
                      .-|.+.+.||+|+||.||+|.  ..+|+.||+|++......                         ...+.+|+.+++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358899999999999999998  458999999998653210                         02346799999999


Q ss_pred             CCC--CcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 018071          120 KHE--NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH  197 (361)
Q Consensus       120 ~hp--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH  197 (361)
                      .+.  .+.+++++    ...++||||++|.+|........         .+....+..++.|++.+|.+||+.+  .|+|
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH  172 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYKEG--ELVH  172 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHhcC--CEEe
Confidence            753  23444432    23589999999988876542221         2566677899999999999999885  4999


Q ss_pred             ccCCCCceEeccCCceEEeccccCCCCc
Q 018071          198 RDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       198 rDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      |||||+||+++ ++.++|+|||.+....
T Consensus       173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      173 GDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            99999999999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.3e-19  Score=156.05  Aligned_cols=133  Identities=22%  Similarity=0.338  Sum_probs=112.7

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCC---------hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +.||+|++|.||+|.. .|..+++|+.......         ...+.+|+.++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 5788999976532211         13567899999999999988877777777888999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      ++|++|.+++...            .. .+..++.+++.+|.++|+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998642            22 78899999999999999998   99999999999999 78999999998764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2.8e-19  Score=152.45  Aligned_cols=129  Identities=23%  Similarity=0.367  Sum_probs=106.0

Q ss_pred             ccccCCceEEEEEEECCCCEEEEEEcCCCCC-C--------hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-P--------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~--------~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      .||+|+||.||+|.+. +..+++|....... .        ..++.+|+++++.++|+++.....++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999964 78899998643221 1        145678999999999887665555666677789999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +|++|.+++....          .      .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998875421          1      78899999999999998   99999999999999 88999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=2.9e-19  Score=152.17  Aligned_cols=136  Identities=16%  Similarity=0.167  Sum_probs=107.9

Q ss_pred             cCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC-----------------------hHHHHHHHHHHhcCCCCC-
Q 018071           68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-----------------------DEEFLAQVSMVSRLKHEN-  123 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~e~~~l~~l~hpn-  123 (361)
                      .|.+.+.||+|+||.||++..++|+.||||++......                       ......|+.++..+.|++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            48888999999999999999888999999987543210                       113567888888887764 


Q ss_pred             -cceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 018071          124 -FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS  202 (361)
Q Consensus       124 -iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp  202 (361)
                       +...++    ....+++|||++|++|.++...               .....++.+++.++.++|+.+   |+||||+|
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p  153 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE  153 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence             444443    2455899999999998765321               234578889999999999998   99999999


Q ss_pred             CceEeccCCceEEeccccCCCCc
Q 018071          203 SNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       203 ~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +||+++.++.++|+|||++....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999986553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=5.1e-19  Score=172.71  Aligned_cols=137  Identities=22%  Similarity=0.333  Sum_probs=111.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEE-cCCCCC--------ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKK-LDASKQ--------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~--------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      ...|...+.||+|+||+||++.+... .+++|+ +.+...        ..+++.+|+++++.++|++++....++.+...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            44567788999999999999987633 344443 222111        12457889999999999999988888777778


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||++|++|.+++.                 ....++.+++.+|.+||+.+   ++||||||+|||+ +++.++|+
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~li  469 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLI  469 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEE
Confidence            899999999999998874                 23578899999999999998   9999999999999 67899999


Q ss_pred             ccccCCCC
Q 018071          217 DFDLSNQA  224 (361)
Q Consensus       217 Dfg~a~~~  224 (361)
                      |||+++..
T Consensus       470 DFGla~~~  477 (535)
T PRK09605        470 DFGLGKYS  477 (535)
T ss_pred             eCcccccC
Confidence            99998753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=5.7e-20  Score=179.13  Aligned_cols=251  Identities=22%  Similarity=0.274  Sum_probs=190.9

Q ss_pred             cCCCCCccccCCceEEEEEEEC--CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .|.+.+.||+|.|+.|-.....  ....+|+|.+......   ......|..+-+.+. |+|++.+++...+.+..++++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            5666677999999999988754  4556777766543322   233445777777776 999999999999999999999


Q ss_pred             EeCCCCcHHHhh-hcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeEeccCCCCceEeccCC-ceEEecc
Q 018071          142 EFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH-EKADPHIIHRDIKSSNVLIFDDD-VAKIADF  218 (361)
Q Consensus       142 e~~~~g~L~~~l-~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~ivHrDikp~Nill~~~~-~~kl~Df  218 (361)
                      +|..|+++.+.+ ....        ...+...+-.++.|+..++.|+| ..+   +.||||||+|.+++..+ .++++||
T Consensus       101 ~~s~g~~~f~~i~~~~~--------~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDS--------TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             CcccccccccccccCCc--------cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence            999999998887 3322        12556667788999999999999 887   99999999999999999 9999999


Q ss_pred             ccCCCCcc-cccccccccccc-CCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          219 DLSNQAPD-MAARLHSTRVLG-TFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       219 g~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |+|..... ..........+| ++.|+|||...+. ......|+||+|+++..+++|..||........ ..        
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~--------  240 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RY--------  240 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cc--------
Confidence            99988766 444444566778 9999999998885 446788999999999999999999975443321 11        


Q ss_pred             Cchhhhhhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          296 SEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       296 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                           ..+.+...  ..............++.+++..+|..|.+.+++..
T Consensus       241 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  241 -----SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -----eeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                 11111110  11223344566888999999999999999988763

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.75  E-value=2.3e-17  Score=144.06  Aligned_cols=133  Identities=15%  Similarity=0.203  Sum_probs=103.8

Q ss_pred             Cccc-cCCceEEEEEEECCCCEEEEEEcCCCC--------------CChHHHHHHHHHHhcCCCCCc--ceeeeEEEeCC
Q 018071           73 ALIG-EGSYGRVYYGILKSGHAAAIKKLDASK--------------QPDEEFLAQVSMVSRLKHENF--VQLLGYCVDGT  135 (361)
Q Consensus        73 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~hpni--v~~~~~~~~~~  135 (361)
                      .+|| .||.|+||.+... +..+++|.+....              .....+.+|+.++..|+|++|  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 8999999999876 7889999874311              123467889999999988775  66776644322


Q ss_pred             ----eeEEEEEeCCC-CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC
Q 018071          136 ----SRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD  210 (361)
Q Consensus       136 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~  210 (361)
                          ..++|||+++| .+|.+++....          ++..    .+.+|+.+|.+||+.|   |+||||||+|||++.+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~  178 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPD  178 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCC
Confidence                22599999997 68998886432          4443    3568999999999999   9999999999999998


Q ss_pred             CceEEeccccCCC
Q 018071          211 DVAKIADFDLSNQ  223 (361)
Q Consensus       211 ~~~kl~Dfg~a~~  223 (361)
                      +.++|+|||.+..
T Consensus       179 ~~v~LIDfg~~~~  191 (239)
T PRK01723        179 GKFWLIDFDRGEL  191 (239)
T ss_pred             CCEEEEECCCccc
Confidence            9999999998765

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=5.5e-18  Score=142.95  Aligned_cols=135  Identities=18%  Similarity=0.234  Sum_probs=97.5

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcCCCCCCh---HH----------------------HHHHHHHHhcCCCC--Cc
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EE----------------------FLAQVSMVSRLKHE--NF  124 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~----------------------~~~e~~~l~~l~hp--ni  124 (361)
                      .+.||+|+||+||+|...+++.||||++.......   ..                      ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            56799999999999998889999999886532211   11                      12455555555433  24


Q ss_pred             ceeeeEEEeCCeeEEEEEeCCCCcHHH-hhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCC
Q 018071          125 VQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKS  202 (361)
Q Consensus       125 v~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivHrDikp  202 (361)
                      .+.++.    ...+++|||++++.+.. .+....          .. ..+..++.+++.++.++|. .+   |+|+||||
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p  143 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSE  143 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCCh
Confidence            444433    24589999999855421 121110          11 5678899999999999999 87   99999999


Q ss_pred             CceEeccCCceEEeccccCCCCc
Q 018071          203 SNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       203 ~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +||+++ ++.++|+|||.+....
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             hhEEEE-CCcEEEEECccccccc
Confidence            999999 8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=8.6e-17  Score=130.27  Aligned_cols=136  Identities=20%  Similarity=0.225  Sum_probs=113.0

Q ss_pred             CCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCC--CCcceeeeEEEeCCeeEEEEEeCCCCc
Q 018071           71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH--ENFVQLLGYCVDGTSRVLAYEFASNGS  148 (361)
Q Consensus        71 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g~  148 (361)
                      +.+.||+|.++.||++... +..+++|....... ...+..|+..++.++|  .++.+++.+....+..+++|||+.++.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            3567999999999999986 47899999866443 5678899999999976  589999988887788999999998876


Q ss_pred             HHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      +..+                +......++.+++.+|.++|......++|+|++|+||+++..+.++++|||.+...
T Consensus        80 ~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          80 LDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            6543                33555678889999999999863334999999999999999899999999988653

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=1.3e-15  Score=142.81  Aligned_cols=250  Identities=22%  Similarity=0.250  Sum_probs=186.2

Q ss_pred             HhhcCCCCCcccc--CCceEEEEEEE--C-CCCEEEEEEcCC---CCCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCC
Q 018071           65 ITENFGTNALIGE--GSYGRVYYGIL--K-SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGT  135 (361)
Q Consensus        65 ~~~~y~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~  135 (361)
                      ....|.+.+.+|.  |.+|.||.+..  + ++..+|+|+-..   .......-.+|+.....++ |+|.++.+..+...+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3456778889999  99999999987  4 788999997432   1223334456777777774 999999999999999


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeEeccCCCCceEeccC-
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK----GLEYLHEKADPHIIHRDIKSSNVLIFDD-  210 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~~ivHrDikp~Nill~~~-  210 (361)
                      ..++-.|+| +.+|..+.+...        ..++...++..+.+...    ||.++|...   ++|-|+||+||++..+ 
T Consensus       192 ~lfiqtE~~-~~sl~~~~~~~~--------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  192 ILFIQTELC-GESLQSYCHTPC--------NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDW  259 (524)
T ss_pred             cceeeeccc-cchhHHhhhccc--------ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccc
Confidence            999999999 468888887654        23777788888888888    999999997   9999999999999999 


Q ss_pred             CceEEeccccCCCCccccccc---cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchh
Q 018071          211 DVAKIADFDLSNQAPDMAARL---HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL  287 (361)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~  287 (361)
                      ...+++|||+...+....-..   ......|...|++||... +.++...|||++|.++.+..++..++....      .
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~  332 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK------N  332 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC------C
Confidence            789999999988775433111   112336788999999655 578899999999999999999887653210      0


Q ss_pred             hhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          288 VTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..|          .++-..-+..++....+..+..++..|++.+|-.|++.+.+..
T Consensus       333 ~~W----------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  333 SSW----------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             CCc----------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            001          0100001122233334556777999999999999999887765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.60  E-value=5.9e-15  Score=139.80  Aligned_cols=141  Identities=21%  Similarity=0.254  Sum_probs=98.4

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcCCCCCC---------------------------h--------------HHHH
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------------------------D--------------EEFL  110 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~--------------~~~~  110 (361)
                      .+.||.|++|.||+|+.++|+.||||+....-..                           .              -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3679999999999999999999999997543100                           0              0233


Q ss_pred             HHHHHHhcC----CCCCcceeeeEE-EeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHH-HH
Q 018071          111 AQVSMVSRL----KHENFVQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK-GL  184 (361)
Q Consensus       111 ~e~~~l~~l----~hpniv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~-al  184 (361)
                      +|+..+.++    +|.+-+.+-.++ ......+|||||++|++|.++......        ...   ...++.+++. .+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--------~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--------GLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--------CCC---HHHHHHHHHHHHH
Confidence            455544444    232223332222 234557899999999999887653210        022   2345555555 47


Q ss_pred             HHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       185 ~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ..+|..|   ++|+|++|.||+++.++.++++|||++..+..
T Consensus       271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8889888   99999999999999999999999999877643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=1.4e-15  Score=132.20  Aligned_cols=205  Identities=22%  Similarity=0.320  Sum_probs=141.3

Q ss_pred             HHHhcCCCCCcceeeeEEEeC-----CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 018071          114 SMVSRLKHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH  188 (361)
Q Consensus       114 ~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH  188 (361)
                      ..+-.+.|.|||+++.|+.+.     ....++.||+..|+|.++|+..+...     ..+......+|+.||+.||.|||
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-----~a~~~~~wkkw~tqIlsal~yLh  193 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-----KALFQKAWKKWCTQILSALSYLH  193 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-----hhhhHHHHHHHHHHHHhhhhhhh
Confidence            445556799999999998754     44689999999999999997654321     34788888899999999999999


Q ss_pred             hcCCCCeEeccCCCCceEeccCCceEEeccc--cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHH
Q 018071          189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFD--LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL  266 (361)
Q Consensus       189 ~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg--~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l  266 (361)
                      +. ++.|+|+++..+-|++..+|-+|+.--.  .....-............+-++|.+||.-...+.+..+|||++|...
T Consensus       194 s~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA  272 (458)
T KOG1266|consen  194 SC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA  272 (458)
T ss_pred             cc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence            98 6789999999999999999988885211  11100000011111223466889999987777788899999999999


Q ss_pred             HHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          267 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       267 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+|..+..--......   ...     ......+......           ..-+.++.+|++..|..||+|++++.
T Consensus       273 lemailEiq~tnseS~---~~~-----ee~ia~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  273 LEMAILEIQSTNSESK---VEV-----EENIANVIIGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHHheeccCCCcce---eeh-----hhhhhhheeeccC-----------ccccCcCcccccCCCCCCcchhhhhc
Confidence            9999887642211100   000     0000000001111           12456788999999999999999874

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.56  E-value=3.3e-14  Score=117.81  Aligned_cols=130  Identities=17%  Similarity=0.129  Sum_probs=97.2

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcc-eeeeEEEeCCeeEEEEEeCCCCcHHH
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV-QLLGYCVDGTSRVLAYEFASNGSLHD  151 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~g~L~~  151 (361)
                      +.|+.|.++.||++... +..|++|...........+..|+.+++.+.+.+++ +++.+  .....++||||++|.++.+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence            46899999999999876 78899998765443334567899999988655544 44443  3334589999999987754


Q ss_pred             hhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      .    .          ..   ...++.+++.+|+.||+.+  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        81 ~----~----------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 E----D----------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             c----c----------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            3    0          11   1245678999999999986  12259999999999998 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.53  E-value=1.1e-14  Score=139.54  Aligned_cols=145  Identities=14%  Similarity=0.208  Sum_probs=95.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEECC-CCEEEEEEcCCCCCC-----------------------------------hH--
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQP-----------------------------------DE--  107 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----------------------------------~~--  107 (361)
                      ..+|+. +.||+|++|.||+|+.++ |+.||||++...-..                                   .+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999986 999999998643100                                   01  


Q ss_pred             ----HHHHHHHHHhcC----CCCCcceeeeEEE-eCCeeEEEEEeCCCCcHHHhh--hcCCCCCCCCCCCCCCHHHHHHH
Q 018071          108 ----EFLAQVSMVSRL----KHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKI  176 (361)
Q Consensus       108 ----~~~~e~~~l~~l----~hpniv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~l~~~~~~~i  176 (361)
                          ++.+|+..+.++    .+.+.+.+-.++. .....+|||||++|+++.++-  .....     ....+....+..+
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-----d~~~la~~~v~~~  272 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-----DMKLLAERGVEVF  272 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-----CHHHHHHHHHHHH
Confidence                123344444433    2333333333332 245678999999999998742  22110     0011444444455


Q ss_pred             HHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC----ceEEeccccCCCCcc
Q 018071          177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPD  226 (361)
Q Consensus       177 ~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~----~~kl~Dfg~a~~~~~  226 (361)
                      +.|+.       ..|   ++|+|++|.||+++.+|    .++++|||++..+..
T Consensus       273 ~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQVF-------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHH-------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            55544       466   99999999999999888    999999999876643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.49  E-value=4.5e-13  Score=127.10  Aligned_cols=168  Identities=18%  Similarity=0.258  Sum_probs=127.3

Q ss_pred             EEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCC
Q 018071           86 GILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ  163 (361)
Q Consensus        86 ~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~  163 (361)
                      |..+ ++.+|.|+.++.+.. ......+-++.++.++||||+++++.++.....|||.|-+.  .|..++..        
T Consensus        31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------  100 (690)
T KOG1243|consen   31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------  100 (690)
T ss_pred             cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------
Confidence            4434 788899988876544 22346677899999999999999999999999999999983  67777765        


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCC
Q 018071          164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH  243 (361)
Q Consensus       164 ~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  243 (361)
                          +....+..-+.||+.||.|||+.+  +++|++|.-..|+|+..|..||++|.++..........  ....--..|.
T Consensus       101 ----l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~  172 (690)
T KOG1243|consen  101 ----LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFD  172 (690)
T ss_pred             ----hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhccc
Confidence                456677788899999999999877  69999999999999999999999999876543222100  1111112355


Q ss_pred             CchhhccCCCCCccceecHHHHHHHHHhCC
Q 018071          244 APEYAMTGQLNAKSDVYSFGVVLLELLTGR  273 (361)
Q Consensus       244 aPE~~~~~~~~~~~DvwslG~~l~ell~g~  273 (361)
                      .|+.+....  ...|.|.|||++++++.|.
T Consensus       173 ~P~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  173 DPEEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            666433211  4569999999999999993

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=6e-14  Score=131.61  Aligned_cols=248  Identities=19%  Similarity=0.157  Sum_probs=177.3

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC--CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~  138 (361)
                      ...+|..+..||.|.|+.|+....+  ++..|++|.+.+.-..   ...-..|+-+...+. |.+++.+...|......+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            3457888899999999999988754  7889999988653322   222345666666664 888998888887778888


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC-CceEEec
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIAD  217 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~-~~~kl~D  217 (361)
                      +-.|||+++++...+...         ..+.+...+.+..|++.++.++|+..   ++|+|+||+||++.++ +.-++.|
T Consensus       343 ip~e~~~~~s~~l~~~~~---------~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~  410 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTS---------QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD  410 (524)
T ss_pred             CchhhhcCcchhhhhHHH---------HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence            999999999887665221         12777888999999999999999998   9999999999999886 7889999


Q ss_pred             cccCCCCccccccccccccccCCCCC--CchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYH--APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      ||+...+...     .....+.-++.  ++.......+..+.|++|||..+.+.+++..--...                
T Consensus       411 ~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----------------  469 (524)
T KOG0601|consen  411 FGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----------------  469 (524)
T ss_pred             ccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccc----------------
Confidence            9987643211     11122233444  455555668889999999999999999986532110                


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                        ..+..+....+  ...+.....+..+.+.++..++..||.+.++......+.
T Consensus       470 --~~~~~i~~~~~--p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  470 --VQSLTIRSGDT--PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             --ccceeeecccc--cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence              00111111111  111223367888999999999999999998876655443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.44  E-value=2.4e-12  Score=107.77  Aligned_cols=136  Identities=18%  Similarity=0.176  Sum_probs=98.1

Q ss_pred             CCccccCCceEEEEEEECC-------CCEEEEEEcCCCC-----------------------CChHHH----HHHHHHHh
Q 018071           72 NALIGEGSYGRVYYGILKS-------GHAAAIKKLDASK-----------------------QPDEEF----LAQVSMVS  117 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-----------------------~~~~~~----~~e~~~l~  117 (361)
                      ...||.|--+.||.|...+       +..+|||+.+.+.                       .....+    .+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998542       4799999873211                       001122    37889998


Q ss_pred             cCC--CCCcceeeeEEEeCCeeEEEEEeCCCCcHH-HhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCC
Q 018071          118 RLK--HENFVQLLGYCVDGTSRVLAYEFASNGSLH-DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL-HEKADP  193 (361)
Q Consensus       118 ~l~--hpniv~~~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~  193 (361)
                      ++.  .-++.+.+++    ..-+|||||+.+..+. ..+...          .++......+..+++.+|..| |+.+  
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H~~g--  145 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYKECN--  145 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence            885  3456666654    4568999999764332 122221          155566778889999999999 8887  


Q ss_pred             CeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       194 ~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                       +||+||++.|||+. ++.+.|+|||.+....
T Consensus       146 -lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         146 -LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             -eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence             99999999999996 5789999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=4.6e-12  Score=102.68  Aligned_cols=130  Identities=20%  Similarity=0.310  Sum_probs=100.1

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEc-CCCCCC--------hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKL-DASKQP--------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~--------~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ..+++|+-+.+|.+.+. |..+++|.- ++....        ..+..+|++++.++.--.|....-+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35889999999999876 545666643 333221        13566799999988655555555566678888999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      ++|..|.+++...                ...++..+-.-+.-||..|   |+|+||.++||++.+++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888653                1356777778888999998   99999999999997665 99999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.38  E-value=1e-13  Score=136.92  Aligned_cols=246  Identities=20%  Similarity=0.238  Sum_probs=169.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.+.+.+-+-+|.++.++.+.-. +|...++|.......    ..+....+-.++-...+|-++...--+.-....+|++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            46677778999999999988855 565556665433221    1122222222222234565555444444556778999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      +|..+++|...++....         .+..-++.....+..++++||...   +.|||++|.|+|+..+|+.++.|||..
T Consensus       884 ~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             HHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccc
Confidence            99999999998887642         455555666777889999999986   899999999999999999999999843


Q ss_pred             CCCccc-----------------------------cccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhC
Q 018071          222 NQAPDM-----------------------------AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG  272 (361)
Q Consensus       222 ~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g  272 (361)
                      ......                             +.........||+.|.+||.+.+......+|+|++|++++|.++|
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence            221100                             000112346689999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccchhhhhhcccCCchhhhhhcccccC-CCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 018071          273 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG-GDYPPKAVAKMAAVAALCVQYEADFRPNMS  339 (361)
Q Consensus       273 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  339 (361)
                      ..||+...++..               +..+...... ..-+...+...++++...+..+|.+|-.+.
T Consensus      1032 ~pp~na~tpq~~---------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQI---------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCcchhhh---------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999986655321               1111111110 112334566788999999999999997665

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.38  E-value=7.2e-12  Score=108.36  Aligned_cols=141  Identities=20%  Similarity=0.271  Sum_probs=108.0

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCC--CCcceeeeEEEeC---CeeEEEEEeCC
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKH--ENFVQLLGYCVDG---TSRVLAYEFAS  145 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~---~~~~lv~e~~~  145 (361)
                      +.|+.|..+.||++...+|..+++|.......  ....+..|+++++.+.+  .++.+++.+....   ...+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999987668999998865443  35678899999999975  4456777776543   25689999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA----------------------------------  191 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------------------------------  191 (361)
                      |.++.+.+...          .++......++.+++.+|..||+..                                  
T Consensus        84 G~~l~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          84 GRVLRDRLLRP----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             CEecCCCCCCC----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            98887755321          1666777777888888888887531                                  


Q ss_pred             -------------------CCCeEeccCCCCceEecc--CCceEEeccccCCC
Q 018071          192 -------------------DPHIIHRDIKSSNVLIFD--DDVAKIADFDLSNQ  223 (361)
Q Consensus       192 -------------------~~~ivHrDikp~Nill~~--~~~~kl~Dfg~a~~  223 (361)
                                         ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               134799999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.37  E-value=6e-11  Score=107.19  Aligned_cols=263  Identities=18%  Similarity=0.195  Sum_probs=162.8

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeE------EEeCCe-eEEEEEe
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGY------CVDGTS-RVLAYEF  143 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~------~~~~~~-~~lv~e~  143 (361)
                      ...||+|+-+.+|-.-.-  ...+.|++.......+.  +.+.+|... .||-+-.=+.|      .-+.+. .-+.|..
T Consensus        16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             CccccCCccceeeecchh--hchhheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            456999999999954322  22355776554333222  223333333 46543321111      112222 4577887


Q ss_pred             CCCC-cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          144 ASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       144 ~~~g-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      +.+. ....+.+..   ...++.+...|...+++++.++.+.+-||..|   .+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus        92 v~g~~pI~~~y~p~---tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          92 VSGKEPIHMIYSPA---TRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             CCCccchhhhcCch---hhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            7664 233333222   23455677999999999999999999999999   8999999999999999999999744321


Q ss_pred             CCccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhC-CCCCCCCCCcccc--hhhhhhccc
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQ--SLVTWATPK  294 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g-~~pf~~~~~~~~~--~~~~~~~~~  294 (361)
                      ..   .........+|...|.+||...     +..-+...|.|.||+++++++.| ++||.+.......  ....    .
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~----~  238 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET----D  238 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh----h
Confidence            11   1222334567899999999765     33456788999999999999986 9999864321110  0000    0


Q ss_pred             CCchhhhhhccccc-----CCCCC-HHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHHHHhHhc
Q 018071          295 LSEDKVRQCVDARL-----GGDYP-PKAVAKMAAVAALCVQY--EADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       295 ~~~~~~~~~~~~~~-----~~~~~-~~~~~~l~~li~~cl~~--~p~~RPs~~evl~~L~~l~~~  351 (361)
                      +....+...-+.+.     ....| ...+..+..|..+|+..  ++.-|||++-++..|..+..+
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            00000000111110     01112 23466788899999853  367899999999988777643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.34  E-value=1.7e-11  Score=99.05  Aligned_cols=142  Identities=21%  Similarity=0.262  Sum_probs=106.4

Q ss_pred             CCCccccCCceEEEEEEECCCCEEEEEEcC-CCCC--------ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           71 TNALIGEGSYGRVYYGILKSGHAAAIKKLD-ASKQ--------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        71 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~--------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ...+|-+|+-+.|+++.+. |+.+.||.-. +...        ..++..+|++.+.++.--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5567889999999999987 8888888542 2211        1256788999998886555555555667777788999


Q ss_pred             EeCCC-CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC---ceEEec
Q 018071          142 EFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIAD  217 (361)
Q Consensus       142 e~~~~-g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~---~~kl~D  217 (361)
                      ||++| -++.+++.......       ........++..|-+.+.-||..+   |+|+||..+||++..++   .+.++|
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId  159 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID  159 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence            99977 37788876543211       222333688899999999999998   99999999999997665   358999


Q ss_pred             cccCCC
Q 018071          218 FDLSNQ  223 (361)
Q Consensus       218 fg~a~~  223 (361)
                      ||++..
T Consensus       160 fgls~~  165 (229)
T KOG3087|consen  160 FGLSSV  165 (229)
T ss_pred             ecchhc
Confidence            999754

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.26  E-value=1.3e-10  Score=107.40  Aligned_cols=219  Identities=14%  Similarity=0.143  Sum_probs=149.9

Q ss_pred             ceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEE----eCCeeEEEEEeCCC-CcHHHh
Q 018071           80 YGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCV----DGTSRVLAYEFASN-GSLHDI  152 (361)
Q Consensus        80 ~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~----~~~~~~lv~e~~~~-g~L~~~  152 (361)
                      -.+.|++..+ +|..|++|++.-.+ ........-+++++++.|+|||++.+++.    .+..+++|++|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3678999976 89999999993221 11123344578899999999999999876    45678899999876 477665


Q ss_pred             hhcCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          153 LHGRKGVK------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       153 l~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      --......      ....+...++..+|.++.|+..||.++|+.|   +..+-|.|.+||++.+.+++|...|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            43322111      1233445888999999999999999999999   99999999999999999999998887554322


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCC-CCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV-DHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ..              .  |.+.   --.+-|.=-||.+++.|.+|..-- ..+..                   .+.  
T Consensus       446 d~--------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~-------------------~~s--  485 (655)
T KOG3741|consen  446 DP--------------T--EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDST-------------------QSS--  485 (655)
T ss_pred             CC--------------C--cchh---HHhhhhHHHHHHHHHHHhhcccccccccch-------------------HHH--
Confidence            11              0  1111   123568889999999999986431 10000                   000  


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                        -.......++.++++++.-....++++ -++.+++.+
T Consensus       486 --~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  486 --HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             --HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence              000123345666777777777777765 566666654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.20  E-value=7e-10  Score=98.13  Aligned_cols=139  Identities=15%  Similarity=0.055  Sum_probs=99.3

Q ss_pred             ccccCCceEEEEEEECCCCEEEEEEcCCCC------------CChHHHHHHHHHHhcCCC--CCcceeeeEEEe-----C
Q 018071           74 LIGEGSYGRVYYGILKSGHAAAIKKLDASK------------QPDEEFLAQVSMVSRLKH--ENFVQLLGYCVD-----G  134 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~-----~  134 (361)
                      ++-......|+++... |+.|.||......            .....+.+|+..+.++..  -.....+++.+.     .
T Consensus        29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            4544455557777664 7889999764322            111247788888888743  233445555543     2


Q ss_pred             CeeEEEEEeCCCC-cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc----
Q 018071          135 TSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD----  209 (361)
Q Consensus       135 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~----  209 (361)
                      ...+||+|++++. +|.+++.....       ...+......++.+++..+.-||..|   |+|+|+++.|||++.    
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~-------~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~  177 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWAT-------NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG  177 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC
Confidence            3568999999886 79988853211       12456677899999999999999999   999999999999975    


Q ss_pred             ---CCceEEeccccCCC
Q 018071          210 ---DDVAKIADFDLSNQ  223 (361)
Q Consensus       210 ---~~~~kl~Dfg~a~~  223 (361)
                         ++.+.|+||+.+..
T Consensus       178 ~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        178 REEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCCceEEEEECCcccc
Confidence               46899999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=2.7e-10  Score=95.08  Aligned_cols=124  Identities=21%  Similarity=0.272  Sum_probs=80.9

Q ss_pred             EEEEEEECCCCEEEEEEcCCCCC----------------------C-----hHHHHHHHHHHhcCCCC--CcceeeeEEE
Q 018071           82 RVYYGILKSGHAAAIKKLDASKQ----------------------P-----DEEFLAQVSMVSRLKHE--NFVQLLGYCV  132 (361)
Q Consensus        82 ~Vy~~~~~~~~~vavK~~~~~~~----------------------~-----~~~~~~e~~~l~~l~hp--niv~~~~~~~  132 (361)
                      .||.|...+|..+|+|+.+....                      .     .....+|.+.|.++..-  ++.+.+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999988899999998743210                      0     12456799999999754  45666644  


Q ss_pred             eCCeeEEEEEeCC--CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCCeEeccCCCCceEecc
Q 018071          133 DGTSRVLAYEFAS--NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY-LHEKADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       133 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~~~ivHrDikp~Nill~~  209 (361)
                      .  .-+|||||++  |..+..+....           ++......++.+++..+.. +|..|   |+|+|+.+.|||+++
T Consensus        79 ~--~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~  142 (188)
T PF01163_consen   79 N--RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDD  142 (188)
T ss_dssp             E--TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEET
T ss_pred             e--CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeec
Confidence            2  3479999998  65555443322           2233445677777775555 57887   999999999999988


Q ss_pred             CCceEEeccccCCCC
Q 018071          210 DDVAKIADFDLSNQA  224 (361)
Q Consensus       210 ~~~~kl~Dfg~a~~~  224 (361)
                      + .+.|+|||.+...
T Consensus       143 ~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  143 G-KVYIIDFGQAVDS  156 (188)
T ss_dssp             T-CEEE--GTTEEET
T ss_pred             c-eEEEEecCcceec
Confidence            7 9999999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.97  E-value=5.2e-09  Score=90.16  Aligned_cols=135  Identities=17%  Similarity=0.211  Sum_probs=98.7

Q ss_pred             CCCCCccccCCceEEEEEEECCCCEEEEEEcCCCC-----------------------CChHHHHHHHHHHhcCCCC--C
Q 018071           69 FGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-----------------------QPDEEFLAQVSMVSRLKHE--N  123 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~e~~~l~~l~hp--n  123 (361)
                      +.++..||.|--+.||.|....|..+|||.=+...                       ..+....+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45667899999999999999999999999542110                       0112456899999998644  6


Q ss_pred             cceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCC
Q 018071          124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS  203 (361)
Q Consensus       124 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~  203 (361)
                      +.+.+++    +.-.+|||+++|-.|...-              +.....-.++..|+.-+..+-..|   +||+|+.+-
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSef  231 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEF  231 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchh
Confidence            6766655    4557999999997765442              122333345555555555555677   999999999


Q ss_pred             ceEeccCCceEEeccccCCCC
Q 018071          204 NVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       204 Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ||+++++|.+.++||--+...
T Consensus       232 NIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         232 NILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             eEEEecCCCEEEEeCcccccC
Confidence            999999999999999876554

>PRK09902 hypothetical protein; Provisional

Probab=98.96  E-value=3.3e-08  Score=83.15  Aligned_cols=138  Identities=13%  Similarity=0.081  Sum_probs=103.4

Q ss_pred             ccccCCceEEEEEEECCCCEEEEEEcCC----C---CCChHHHHHHHHHHhcCCC--CCcceeeeEEE-e----CCeeEE
Q 018071           74 LIGEGSYGRVYYGILKSGHAAAIKKLDA----S---KQPDEEFLAQVSMVSRLKH--ENFVQLLGYCV-D----GTSRVL  139 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~----~---~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~-~----~~~~~l  139 (361)
                      --|+||.+.|+..... |..+-+|+-..    +   +.....|.+|+..+.+|..  -.+.+.. ++. .    .-..+|
T Consensus        25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            3678999999998876 55788997652    1   3356789999999988852  2244444 332 1    123579


Q ss_pred             EEEeCCC-CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc--eEEe
Q 018071          140 AYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--AKIA  216 (361)
Q Consensus       140 v~e~~~~-g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~--~kl~  216 (361)
                      |+|-+.| .+|.+++.....       ...+......++.+++..++-||+.|   +.|+|+.+.||+++.++.  ++++
T Consensus       103 VTe~L~g~~~L~~~l~~~~~-------~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lI  172 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAV-------SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFL  172 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCc-------CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEE
Confidence            9998754 488888865431       12567777899999999999999998   999999999999987777  9999


Q ss_pred             ccccCCC
Q 018071          217 DFDLSNQ  223 (361)
Q Consensus       217 Dfg~a~~  223 (361)
                      ||.-++.
T Consensus       173 DlEk~r~  179 (216)
T PRK09902        173 DLEKSRR  179 (216)
T ss_pred             Ehhccch
Confidence            9987654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.94  E-value=3.1e-10  Score=108.48  Aligned_cols=150  Identities=17%  Similarity=0.294  Sum_probs=104.0

Q ss_pred             HHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcccccccc-------ccccccCCCCCCchhhccC
Q 018071          179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-------STRVLGTFGYHAPEYAMTG  251 (361)
Q Consensus       179 qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~  251 (361)
                      +++.|+.|+|...  .+||++|.|++|.++..+..||+.|+++...........       .-...-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4558999999876  699999999999999999999999998765433111000       0111235579999999998


Q ss_pred             CCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHcccc
Q 018071          252 QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQY  330 (361)
Q Consensus       252 ~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  330 (361)
                      ..+.++|+||+||++|.+.. |+.-+.........             ......+..-...+....+.++++=+.+++..
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-------------SFSRNLLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchh-------------hhhhcccccccccccccCcHHHHHHHHHHhcC
Confidence            88899999999999999995 44444322111100             00111111111223355677899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 018071          331 EADFRPNMSIVVK  343 (361)
Q Consensus       331 ~p~~RPs~~evl~  343 (361)
                      ++..||++.++..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999998777654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.87  E-value=1.9e-08  Score=96.40  Aligned_cols=141  Identities=21%  Similarity=0.262  Sum_probs=92.9

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCC---------------------------h--------H------HHHH
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------------------------D--------E------EFLA  111 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~--------~------~~~~  111 (361)
                      ..|+.++-|.||+|.+++|+.||||+....-..                           .        +      ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            578999999999999999999999997432110                           0        0      1334


Q ss_pred             HHHHHhcCC-----CCCcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 018071          112 QVSMVSRLK-----HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY  186 (361)
Q Consensus       112 e~~~l~~l~-----hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  186 (361)
                      |...+.+++     .|++.--.-|++-.....|+|||++|-.+.+.......        .++.+.+.....++.  +..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--------g~d~k~ia~~~~~~f--~~q  280 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--------GIDRKELAELLVRAF--LRQ  280 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--------CCCHHHHHHHHHHHH--HHH
Confidence            555555542     23332222233445677899999999988887422211        144333333333322  222


Q ss_pred             hhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       187 LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      +-..|   ++|.|..|.||+++.+|++-+.|||+...+..
T Consensus       281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            22345   99999999999999999999999999876654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=3.8e-08  Score=84.16  Aligned_cols=107  Identities=22%  Similarity=0.228  Sum_probs=83.6

Q ss_pred             hHHHHHHHHHHhcCC--CCCcceeeeEEEeC----CeeEEEEEeCCCC-cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHH
Q 018071          106 DEEFLAQVSMVSRLK--HENFVQLLGYCVDG----TSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAV  178 (361)
Q Consensus       106 ~~~~~~e~~~l~~l~--hpniv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~  178 (361)
                      .....+|...+..|.  .-.+...+++.+..    ...+||+|++++. +|.+++.....         ++......++.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll~  125 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELLR  125 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHHH
Confidence            456788888877774  33355566665542    2458999999884 79998876321         45566788999


Q ss_pred             HHHHHHHHhhhcCCCCeEeccCCCCceEeccCC---ceEEeccccCCCC
Q 018071          179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQA  224 (361)
Q Consensus       179 qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~---~~kl~Dfg~a~~~  224 (361)
                      +++..+.-||+.|   |+|+|+++.|||++.++   .+.++||+-++..
T Consensus       126 ~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  126 ALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999   99999999999999887   8999999977653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.82  E-value=7e-08  Score=81.53  Aligned_cols=137  Identities=15%  Similarity=0.194  Sum_probs=92.5

Q ss_pred             HhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHH----------HHHHHHHHhcCC---CCCcceeeeEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE----------FLAQVSMVSRLK---HENFVQLLGYC  131 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~---hpniv~~~~~~  131 (361)
                      +.++|.+.+++-......|.+.... |+.+++|.........++          ..+.+..+.+++   -..+..++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            4578888888888888888877776 799999987653332222          223333333332   22333322222


Q ss_pred             E-----eCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceE
Q 018071          132 V-----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL  206 (361)
Q Consensus       132 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nil  206 (361)
                      +     .....+++|||++|..|.+...             +++    .+...+.+++.-||+.|   ++|+|..|.|++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFl  167 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFL  167 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEE
Confidence            2     2345568999999988876532             332    24456778899999999   999999999999


Q ss_pred             eccCCceEEeccccCCC
Q 018071          207 IFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       207 l~~~~~~kl~Dfg~a~~  223 (361)
                      +++++ ++++||+..+.
T Consensus       168 v~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  168 VSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             EECCc-EEEEECccccc
Confidence            98655 99999987553

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.78  E-value=1.9e-07  Score=80.90  Aligned_cols=71  Identities=17%  Similarity=0.162  Sum_probs=54.0

Q ss_pred             ccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCC--CcceeeeEEEeCCeeEEEEEeCCCCc
Q 018071           74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLGYCVDGTSRVLAYEFASNGS  148 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--niv~~~~~~~~~~~~~lv~e~~~~g~  148 (361)
                      .||+|..+.||+.   .+..+++|..... .......+|.++++.+..-  .+.+.+.+........++||+++|.+
T Consensus         8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         8 QTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            5899999999984   2556788987653 3445678999999988633  34677777777777889999999863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.62  E-value=2.3e-08  Score=95.05  Aligned_cols=181  Identities=17%  Similarity=0.141  Sum_probs=132.5

Q ss_pred             ccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCC-cceeeeEEEeCCeeEEEEEeCCCC-cHHH
Q 018071           74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAYEFASNG-SLHD  151 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~e~~~~g-~L~~  151 (361)
                      -+++|+++.+++.+....+....+.+...    ....-++++|.+++||| .+..++-+..+...++.++++.++ +...
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~  324 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL  324 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence            47889999999887442233335554333    34566889999999999 677777677778888999999876 2222


Q ss_pred             hhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccccc
Q 018071          152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL  231 (361)
Q Consensus       152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  231 (361)
                      .+..        .+-.+...+...+.+.-+++++++|+.-   =+|||    ||+..+ +..+..||+....+....   
T Consensus       325 ~~~~--------se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---  385 (829)
T KOG0576|consen  325 EMTV--------SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---  385 (829)
T ss_pred             cCCh--------hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence            1111        1112445555667777788999999874   58998    777655 678999999987765433   


Q ss_pred             cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCC
Q 018071          232 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD  277 (361)
Q Consensus       232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~  277 (361)
                      ......+|+.++|||......+....|+|++|+-..+|.-|.+|-.
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            3466789999999999999999999999999998778877777754

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.61  E-value=7.9e-07  Score=76.10  Aligned_cols=153  Identities=16%  Similarity=0.205  Sum_probs=103.8

Q ss_pred             CccCHHHHHHHhhcCCCCCccc---cCCceEEEEEEECCCCEEEEEEcCCCCCC--------------------hH----
Q 018071           55 PAISVDELKEITENFGTNALIG---EGSYGRVYYGILKSGHAAAIKKLDASKQP--------------------DE----  107 (361)
Q Consensus        55 ~~~~~~~~~~~~~~y~~~~~lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~----  107 (361)
                      -..+...+..+.++..+....|   .|--+.||+|...++..+|+|++......                    ..    
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            3345666777777777665554   56677899999888999999998543211                    11    


Q ss_pred             -HHHHHHHHHhcCC--CCCcceeeeEEEeCCeeEEEEEeCCCCc-HHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q 018071          108 -EFLAQVSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASNGS-LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG  183 (361)
Q Consensus       108 -~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  183 (361)
                       -...|+..|+++.  +-.+.+.+.+.    .-.|||||+.... -.-.|..          ..+...++..+..++++.
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----------v~~e~~e~~~~~~~~v~~  178 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----------VPLELEEAEGLYEDVVEY  178 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----------CCcCchhHHHHHHHHHHH
Confidence             1235777777763  34455555543    3479999995421 1111111          123334677788888888


Q ss_pred             HHHhhh-cCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          184 LEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       184 l~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +.-|-. .+   +||+||..-|||+. ++.+.|+|||-+....
T Consensus       179 ~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         179 MRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            888887 55   99999999999998 8899999999887654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.58  E-value=1.2e-06  Score=84.00  Aligned_cols=137  Identities=20%  Similarity=0.248  Sum_probs=90.7

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCCh--------------------------------H------HHHHHHH
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD--------------------------------E------EFLAQVS  114 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------------~------~~~~e~~  114 (361)
                      +.||.-+.|.||+|+.++|+.||||+-...-...                                +      +|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5799999999999999999999999864321110                                0      2344544


Q ss_pred             HHhcC----CCCC------cceeeeEEEeCCeeEEEEEeCCCCcHHHh--hhcCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q 018071          115 MVSRL----KHEN------FVQLLGYCVDGTSRVLAYEFASNGSLHDI--LHGRKGVKGAQPGPVLSWQQRVKIAVGAAK  182 (361)
Q Consensus       115 ~l~~l----~hpn------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  182 (361)
                      ...++    .|-+      |.+++  +.-.....|+||||+|..+.|.  |...+          ++...+..-+.+...
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~g----------i~~~~i~~~l~~~~~  314 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRG----------ISPHDILNKLVEAYL  314 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcC----------CCHHHHHHHHHHHHH
Confidence            33333    3444      23332  2234567899999999877554  44443          666655555544432


Q ss_pred             HHHHhhhcCCCCeEeccCCCCceEecc----CCceEEeccccCCCCcc
Q 018071          183 GLEYLHEKADPHIIHRDIKSSNVLIFD----DDVAKIADFDLSNQAPD  226 (361)
Q Consensus       183 al~~LH~~~~~~ivHrDikp~Nill~~----~~~~kl~Dfg~a~~~~~  226 (361)
                      -+  +=..|   ++|+|-.|.||++..    ++.+.+.|||+...+..
T Consensus       315 ~q--If~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  315 EQ--IFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HH--HHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            22  22334   999999999999983    66899999999877654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.57  E-value=4.9e-07  Score=73.18  Aligned_cols=128  Identities=18%  Similarity=0.258  Sum_probs=91.2

Q ss_pred             CCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcc-eeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV-QLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        71 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      ..+.|++|++|.||++.++ |..+|+|+-. .+..+..+..|++++..+.--++. +++.|.    .-++.|||++|..|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L   99 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRR-RDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEec-CCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence            4567999999999999998 6789999654 455667899999999998765554 344442    23466999999888


Q ss_pred             HHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC-CCceEeccCCceEEeccccCCC
Q 018071          150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK-SSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDik-p~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      .++-...            +-    +-+..++++---|-..|   |-|..|. |...+|.+++.+.|+||..|+.
T Consensus       100 ~~~~~~~------------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGG------------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcc------------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            7765431            11    22334455545566666   9999987 5555555666999999998874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.55  E-value=1.5e-06  Score=76.33  Aligned_cols=74  Identities=15%  Similarity=0.069  Sum_probs=53.4

Q ss_pred             cccCCc-eEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEEeCCCCcHHH
Q 018071           75 IGEGSY-GRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHD  151 (361)
Q Consensus        75 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~  151 (361)
                      |-.|.. ..||+.... +..+.+|+.....  ...+.+|+++++.+. +-.+.+++++.......++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444554 789999765 5788889875543  346778998888874 4446677777766667899999999977754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.54  E-value=7.8e-07  Score=77.29  Aligned_cols=77  Identities=16%  Similarity=0.191  Sum_probs=56.2

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCC--CcceeeeEEE---eCCeeEEEEEeCCCC
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLGYCV---DGTSRVLAYEFASNG  147 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--niv~~~~~~~---~~~~~~lv~e~~~~g  147 (361)
                      +.|+.|..+.||++...+ ..+++|..... .....+.+|..+++.+...  .+.+++.+..   .....+++|++++|.
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            468999999999999886 69999987654 3456788888888888532  3556665443   334568999999998


Q ss_pred             cHHH
Q 018071          148 SLHD  151 (361)
Q Consensus       148 ~L~~  151 (361)
                      .+..
T Consensus        81 ~~~~   84 (239)
T PF01636_consen   81 PLDD   84 (239)
T ss_dssp             EHHH
T ss_pred             cccc
Confidence            7766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.44  E-value=7.1e-06  Score=69.19  Aligned_cols=131  Identities=17%  Similarity=0.229  Sum_probs=92.9

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcCCCC-----------------CChHHHHHHHHHHhcCC------CCCcceee
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASK-----------------QPDEEFLAQVSMVSRLK------HENFVQLL  128 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~e~~~l~~l~------hpniv~~~  128 (361)
                      ...||+|+.=.||.  +.......||+.....                 ....+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            34699999999994  4456677888886544                 12346667776655554      78999999


Q ss_pred             eEEEeCCeeEEEEEeCCC------CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 018071          129 GYCVDGTSRVLAYEFASN------GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS  202 (361)
Q Consensus       129 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp  202 (361)
                      |+.+.+...-+|+|.+.+      .+|.+++....          ++. .....+.   +-.+||-+..   |+.+|++|
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~  146 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-ELRQALD---EFKRYLLDHH---IVIRDLNP  146 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HHHHHHH---HHHHHHHHcC---CeecCCCc
Confidence            999999999999998753      27888885543          555 4444444   4445666665   99999999


Q ss_pred             CceEeccCC----ceEEec-cccC
Q 018071          203 SNVLIFDDD----VAKIAD-FDLS  221 (361)
Q Consensus       203 ~Nill~~~~----~~kl~D-fg~a  221 (361)
                      .||++....    .+.|+| ||..
T Consensus       147 ~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ccEEEEecCCCceEEEEEeCCCCc
Confidence            999996433    577777 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.40  E-value=4.4e-06  Score=86.04  Aligned_cols=77  Identities=14%  Similarity=0.254  Sum_probs=56.8

Q ss_pred             CCccccCCceEEEEEEECCC---CEEEEEEcCCCC--CChHHHHHHHHHHhcCC-CCCc--ceeeeEEEeC---CeeEEE
Q 018071           72 NALIGEGSYGRVYYGILKSG---HAAAIKKLDASK--QPDEEFLAQVSMVSRLK-HENF--VQLLGYCVDG---TSRVLA  140 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~-hpni--v~~~~~~~~~---~~~~lv  140 (361)
                      .+.|+.|.++.+|+.....+   ..+++|+.....  .....+.+|+++++.+. |+++  .+++.++.+.   ...|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45688999999999887643   468888765432  23357889999999995 6654  7777777654   457899


Q ss_pred             EEeCCCCc
Q 018071          141 YEFASNGS  148 (361)
Q Consensus       141 ~e~~~~g~  148 (361)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.37  E-value=6.5e-06  Score=71.83  Aligned_cols=73  Identities=14%  Similarity=0.105  Sum_probs=48.4

Q ss_pred             CccccCCceEEEEEEECC--CCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           73 ALIGEGSYGRVYYGILKS--GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      +.|..|-...+|++...+  +..|++|+........-...+|+.+++.+...++ .+++..+.    ..++|||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            457788889999998764  6789999776433222334578888888853333 34443322    2489999998665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.30  E-value=3.7e-06  Score=70.49  Aligned_cols=100  Identities=30%  Similarity=0.364  Sum_probs=80.0

Q ss_pred             HHHHHHhcCCC-CCcceeeeEEEeCCeeEEEEEeCCCCcHHHh---hhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 018071          111 AQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAYEFASNGSLHDI---LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY  186 (361)
Q Consensus       111 ~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  186 (361)
                      .|.-+++.+++ +++.+++|+|    ..+++.||...+++...   +...         -..+|..+.+|+.++++.+.+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~---------~~~~w~~R~~iA~~lL~~l~~   74 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQF---------LQSPWEQRAKIALQLLELLEE   74 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccc---------cccCHHHHHHHHHHHHHHHHH
Confidence            47888888875 6999999998    34688999987665422   1111         126899999999999999999


Q ss_pred             hhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       187 LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      ++......+.-.|++++|+-++++|++|++|...+..
T Consensus        75 l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   75 LDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             HhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            9986544589999999999999999999999987543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.26  E-value=9.7e-06  Score=70.83  Aligned_cols=73  Identities=12%  Similarity=0.127  Sum_probs=45.2

Q ss_pred             CccccCCce-EEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCC---CcceeeeEEEeC---CeeEEEEEeCC
Q 018071           73 ALIGEGSYG-RVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE---NFVQLLGYCVDG---TSRVLAYEFAS  145 (361)
Q Consensus        73 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp---niv~~~~~~~~~---~~~~lv~e~~~  145 (361)
                      ..|+.|+.. .||+.    +..+++|.... ......+.+|.++++.+...   .+.+.++.....   ...+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            357777765 58976    23577786543 33445788999999887531   233444433221   23478999999


Q ss_pred             CCcHH
Q 018071          146 NGSLH  150 (361)
Q Consensus       146 ~g~L~  150 (361)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            86653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.25  E-value=1.9e-05  Score=71.55  Aligned_cols=161  Identities=17%  Similarity=0.195  Sum_probs=92.1

Q ss_pred             HHHHHHhhcCCC-----CCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCC--Ccceeee---
Q 018071           60 DELKEITENFGT-----NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLG---  129 (361)
Q Consensus        60 ~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--niv~~~~---  129 (361)
                      +++..+.++|.+     .+.|..|....+|+.... +..+++|+...  .....+..|+.++..+.+.  .+.+++.   
T Consensus         2 ~~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~   78 (296)
T cd05153           2 EELASFLADYDLGELLSFEGISAGIENTNYFVTTD-SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRD   78 (296)
T ss_pred             HHHHHHHHHcCCCchhheecccCccccceEEEEeC-CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCC
Confidence            355566666664     345677877899998765 45788898764  3445677788888777432  2344433   


Q ss_pred             ---EEEeCCeeEEEEEeCCCCcHHH--------------hhhcCC-CCCCC-CCCCCCCHHHHH----------HHHHHH
Q 018071          130 ---YCVDGTSRVLAYEFASNGSLHD--------------ILHGRK-GVKGA-QPGPVLSWQQRV----------KIAVGA  180 (361)
Q Consensus       130 ---~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~-~~~~~-~~~~~l~~~~~~----------~i~~qi  180 (361)
                         +....+..++++++++|..+..              .++... ..... .......|....          .....+
T Consensus        79 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  158 (296)
T cd05153          79 GEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL  158 (296)
T ss_pred             CcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence               1233456689999999865421              111110 00000 000111211110          011123


Q ss_pred             HHHHHHhhhc----CCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          181 AKGLEYLHEK----ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       181 ~~al~~LH~~----~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      ..++.++.+.    ....++|+|+.|.||++++++.+.|+||+.+..
T Consensus       159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3344444431    122499999999999999987789999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.21  E-value=1.6e-05  Score=70.36  Aligned_cols=141  Identities=11%  Similarity=0.079  Sum_probs=78.2

Q ss_pred             cccCCceEEEEEEECCCCEEEEEEcCCCCCCh-HHHHHHHHHHhcCCCCCc-ceeeeEEEeCCeeEEEEEeCCCCcHHHh
Q 018071           75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGSLHDI  152 (361)
Q Consensus        75 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~L~~~  152 (361)
                      +..|-.+.+|+... ++..+++|......... -...+|..+++.+...++ .+++...  .  .++||||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence            56688889998874 47788899765432221 245778888888864333 3333332  2  3689999998665321


Q ss_pred             --------------hhcCCCCCCCCCCCCCCHHH-HHHHHHHH---------HHHHHHhhhc-----CCCCeEeccCCCC
Q 018071          153 --------------LHGRKGVKGAQPGPVLSWQQ-RVKIAVGA---------AKGLEYLHEK-----ADPHIIHRDIKSS  203 (361)
Q Consensus       153 --------------l~~~~~~~~~~~~~~l~~~~-~~~i~~qi---------~~al~~LH~~-----~~~~ivHrDikp~  203 (361)
                                    +..-....  .....++... +..+..++         ...+..+-..     ....++|+|+.|.
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQP--RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence                          11100000  0111122211 11111111         1112222111     1224899999999


Q ss_pred             ceEeccCCceEEeccccCCC
Q 018071          204 NVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       204 Nill~~~~~~kl~Dfg~a~~  223 (361)
                      ||++++++ +.|+||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=98.21  E-value=3.4e-05  Score=69.81  Aligned_cols=76  Identities=16%  Similarity=0.040  Sum_probs=56.0

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCC---CCcceeeeEEEe---CCeeEEEEEeCC
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH---ENFVQLLGYCVD---GTSRVLAYEFAS  145 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h---pniv~~~~~~~~---~~~~~lv~e~~~  145 (361)
                      .+.||.|..+.||.....++ .+.+|..+ .......+..|...++.|..   -.+.++++++..   .+..+||||+++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~   96 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR   96 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence            34699999999999876645 46667643 32244688899999988852   367788887754   356899999999


Q ss_pred             CCcH
Q 018071          146 NGSL  149 (361)
Q Consensus       146 ~g~L  149 (361)
                      |.++
T Consensus        97 G~~~  100 (297)
T PRK10593         97 GVSV  100 (297)
T ss_pred             CEec
Confidence            8754

>PRK05231 homoserine kinase; Provisional

Probab=98.10  E-value=0.00022  Score=65.27  Aligned_cols=165  Identities=18%  Similarity=0.202  Sum_probs=88.9

Q ss_pred             ccCHHHHHHHhhcCCC-----CCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-----CCCcc
Q 018071           56 AISVDELKEITENFGT-----NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----HENFV  125 (361)
Q Consensus        56 ~~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----hpniv  125 (361)
                      .++.+++..+...|.+     .+.|+.|....+|+....+| .+++|+..  ......+..|+.+++.|.     .|.++
T Consensus         6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcce
Confidence            4566777777778866     24566777789999987655 68889875  223344445555555553     23333


Q ss_pred             eee---eEEEeCCeeEEEEEeCCCCcHH-----------Hhh---hcCCC-CCCCCC-CCCCCH-HHHH-----------
Q 018071          126 QLL---GYCVDGTSRVLAYEFASNGSLH-----------DIL---HGRKG-VKGAQP-GPVLSW-QQRV-----------  174 (361)
Q Consensus       126 ~~~---~~~~~~~~~~lv~e~~~~g~L~-----------~~l---~~~~~-~~~~~~-~~~l~~-~~~~-----------  174 (361)
                      ...   .+....+..+++++|++|..+.           ..+   +.... ...... ...+.+ ....           
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            211   0122355678999999886431           111   11110 000000 001111 1111           


Q ss_pred             -HHHHH-HHHHHHHhhhc----CCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          175 -KIAVG-AAKGLEYLHEK----ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       175 -~i~~q-i~~al~~LH~~----~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                       ..+.+ +...++.+...    -...++|+|+.|.||+++.+...-|+||+.+..
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             11111 11122333211    122499999999999998766668999998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.09  E-value=0.00019  Score=65.42  Aligned_cols=165  Identities=18%  Similarity=0.221  Sum_probs=92.4

Q ss_pred             cCHHHHHHHhhcCCCC-----CccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCC--Ccceeee
Q 018071           57 ISVDELKEITENFGTN-----ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLG  129 (361)
Q Consensus        57 ~~~~~~~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--niv~~~~  129 (361)
                      .+.+++..+.+.|.+.     +.++.|....+|+....++ .+++|+..... ...++..|+.++..|...  .+.+++.
T Consensus         7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~   84 (307)
T TIGR00938         7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVK   84 (307)
T ss_pred             CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence            4567777777778663     4577777789999876544 67788765422 234556677777666321  2333332


Q ss_pred             E------EEeCCeeEEEEEeCCCCcHH-----------H---hhhcCCCCCCCC-CC--CCCCHHHHH------------
Q 018071          130 Y------CVDGTSRVLAYEFASNGSLH-----------D---ILHGRKGVKGAQ-PG--PVLSWQQRV------------  174 (361)
Q Consensus       130 ~------~~~~~~~~lv~e~~~~g~L~-----------~---~l~~~~~~~~~~-~~--~~l~~~~~~------------  174 (361)
                      .      ....+..+++++|++|..+.           .   .++.....-... ..  ..-.|....            
T Consensus        85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~  164 (307)
T TIGR00938        85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA  164 (307)
T ss_pred             CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence            1      12245678999999885431           1   111111000000 00  001111100            


Q ss_pred             HHHHHHHHHHHHhhh----cCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          175 KIAVGAAKGLEYLHE----KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       175 ~i~~qi~~al~~LH~----~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      .....+...++++..    .-...++|+|+.+.||+++.++...|+||+.+..
T Consensus       165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            011123334555532    1123499999999999999988778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.06  E-value=4.4e-05  Score=63.98  Aligned_cols=124  Identities=24%  Similarity=0.364  Sum_probs=86.0

Q ss_pred             hcCCCCCccccCCc-eEEEEEEECCCCEEEEEEcCC---CC-------------------CChHHHHHHHHHHhcC---C
Q 018071           67 ENFGTNALIGEGSY-GRVYYGILKSGHAAAIKKLDA---SK-------------------QPDEEFLAQVSMVSRL---K  120 (361)
Q Consensus        67 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~-------------------~~~~~~~~e~~~l~~l---~  120 (361)
                      .+++.++.||.|.- |.||+++.. |..+|+|....   ..                   .-..-|..|.+...+|   .
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            68888999999999 999999988 88999999321   00                   0012356777766666   4


Q ss_pred             CCCc--ceeeeEEEeC------------------CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHH
Q 018071          121 HENF--VQLLGYCVDG------------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA  180 (361)
Q Consensus       121 hpni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi  180 (361)
                      +.++  |+++||..=.                  ....||.||.....                  .+...    -+.+|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------~~~~~----~~~~~  173 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------PLQIR----DIPQM  173 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------ccchh----HHHHH
Confidence            5566  8999886311                  11246666654432                  02222    34467


Q ss_pred             HHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       181 ~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      .+-|..+|..|   |+-+|+++.|..     .-||+|||.+
T Consensus       174 ~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  174 LRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            77788999998   999999999986     3389999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=98.03  E-value=4.2e-05  Score=69.46  Aligned_cols=73  Identities=19%  Similarity=0.169  Sum_probs=48.8

Q ss_pred             ccccCCceEEEEEEECC-------CCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCeeEEEEEeCC
Q 018071           74 LIGEGSYGRVYYGILKS-------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .|..|-...+|++...+       ++.+++|+............+|.++++.+...++ .+++.++.    ..+|+||++
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i~   80 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFIP   80 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhheeC
Confidence            46667778999988654       5789999976654443466788888888753333 34444443    236899998


Q ss_pred             CCcHH
Q 018071          146 NGSLH  150 (361)
Q Consensus       146 ~g~L~  150 (361)
                      |..+.
T Consensus        81 G~~l~   85 (302)
T cd05156          81 SRTLT   85 (302)
T ss_pred             CCcCC
Confidence            87653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.01  E-value=0.00021  Score=66.75  Aligned_cols=74  Identities=15%  Similarity=0.107  Sum_probs=53.4

Q ss_pred             CccccCCceEEEEEEECCC-CEEEEEEcCCC--------CCChHHHHHHHHHHhcCC---CCCcceeeeEEEeCCeeEEE
Q 018071           73 ALIGEGSYGRVYYGILKSG-HAAAIKKLDAS--------KQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~--------~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~lv  140 (361)
                      +.||.|.++.||++...+| +.++||.-...        ....++...|.+.|+.+.   ..++.+++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999998866 48999975311        123456778888888763   2456667666  44567899


Q ss_pred             EEeCCCCc
Q 018071          141 YEFASNGS  148 (361)
Q Consensus       141 ~e~~~~g~  148 (361)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.93  E-value=3.3e-05  Score=78.90  Aligned_cols=195  Identities=19%  Similarity=0.245  Sum_probs=136.0

Q ss_pred             HHHHHHHhcCCCCCcceeeeEEEeCCeeE----EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 018071          110 LAQVSMVSRLKHENFVQLLGYCVDGTSRV----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE  185 (361)
Q Consensus       110 ~~e~~~l~~l~hpniv~~~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~  185 (361)
                      .-|.+.+....|+|++.++.|..+....-    +..++|...++...+....         .++....+.+..++..||.
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---------~i~~~~~r~~~~~~~~GL~  300 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---------SIPLETLRILHQKLLEGLA  300 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---------ccCHHHHHHHHHHHhhhHH
Confidence            44667788889999999999876543332    4467787778877776543         3888899999999999999


Q ss_pred             HhhhcCCCCeEeccCCCC---ceEeccCCceEEe--ccccCCCCccccccccccccccCCCCCCchhhccCCCCC--ccc
Q 018071          186 YLHEKADPHIIHRDIKSS---NVLIFDDDVAKIA--DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA--KSD  258 (361)
Q Consensus       186 ~LH~~~~~~ivHrDikp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~D  258 (361)
                      |+|+..   ..|.-+...   +.-++..+.+.++  ||+.++.......   .....-+..+.++|......+..  ..|
T Consensus       301 ~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~d  374 (1351)
T KOG1035|consen  301 YLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTD  374 (1351)
T ss_pred             HHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhH
Confidence            999985   666555554   4555666777777  9998877654332   22333456678888776655544  479


Q ss_pred             eecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 018071          259 VYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM  338 (361)
Q Consensus       259 vwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  338 (361)
                      +|.+|.++..+..|..+-....                  ....+.+.        .....+.....+|+..++++|+++
T Consensus       375 L~~lgll~~~~~~~~~i~~~~~------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~  428 (1351)
T KOG1035|consen  375 LWCLGLLLLQLSQGEDISEKSA------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSA  428 (1351)
T ss_pred             HHHHHHHHhhhhhcCccccccc------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccch
Confidence            9999999999999876532110                  01111111        111157788899999999999999


Q ss_pred             HHHHHHH
Q 018071          339 SIVVKAL  345 (361)
Q Consensus       339 ~evl~~L  345 (361)
                      .+++...
T Consensus       429 ~~ll~~~  435 (1351)
T KOG1035|consen  429 LELLTHP  435 (1351)
T ss_pred             hhhhhch
Confidence            9998754

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.66  E-value=2.1e-06  Score=89.33  Aligned_cols=161  Identities=12%  Similarity=-0.008  Sum_probs=118.4

Q ss_pred             HHHHHHHHhcCCCCCcceeeeEEE--eCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 018071          109 FLAQVSMVSRLKHENFVQLLGYCV--DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY  186 (361)
Q Consensus       109 ~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  186 (361)
                      ...|...++...|+++.....-..  +....+.+++|+.+|.+.+.|.+...     ..+.+...-+.....+...+..-
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e-----e~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE-----ESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc-----cCCcchhchHHHHHHHHHhccch
Confidence            334555566678988877665443  34456789999999999999876532     22334444444444444666666


Q ss_pred             hhhcC--CCCeEeccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHH
Q 018071          187 LHEKA--DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV  264 (361)
Q Consensus       187 LH~~~--~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  264 (361)
                      +|+..  ....+|+++|+-|.+|..+..+|++++|+.+....  .....+...+++.|++|++...-.++.++|+|..|+
T Consensus      1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred             hhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence            66543  33579999999999999999999999999983211  122345677889999999999989999999999999


Q ss_pred             HHHHHHhCCCCC
Q 018071          265 VLLELLTGRKPV  276 (361)
Q Consensus       265 ~l~ell~g~~pf  276 (361)
                      .+|+..-|..+|
T Consensus      1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHhcccHHH
Confidence            999999888877

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.63  E-value=0.00048  Score=62.54  Aligned_cols=140  Identities=21%  Similarity=0.230  Sum_probs=95.1

Q ss_pred             CCCccccCCceEEEEEEECCCCEEEEEEcCCCC-----C------------------ChH----HHHHHHHHHhcCCCCC
Q 018071           71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-----Q------------------PDE----EFLAQVSMVSRLKHEN  123 (361)
Q Consensus        71 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~------------------~~~----~~~~e~~~l~~l~hpn  123 (361)
                      +.+.|..|--+.||.|...+|..+|||+++.+-     .                  +++    -...|++.|.+++.-.
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            345677888899999998899999999874211     0                  011    1235777777776444


Q ss_pred             cceeeeEEEeCCeeEEEEEeCCCCc-HHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 018071          124 FVQLLGYCVDGTSRVLAYEFASNGS-LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS  202 (361)
Q Consensus       124 iv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp  202 (361)
                      |.-.--...  ..-+|||+|+.... -...|..          ..++...+..+-.|++.-+.-|-+.+  ++||.||.-
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd----------~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSE  293 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD----------ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSE  293 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCccccc----------ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhh
Confidence            322111111  23469999994311 1122222          23778888889999999999998887  699999999


Q ss_pred             CceEeccCCceEEeccccCCCCc
Q 018071          203 SNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       203 ~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      -|+|+ .+|.+.|+|-+-+....
T Consensus       294 fN~Ly-hdG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  294 FNLLY-HDGKLYIIDVSQSVEHD  315 (520)
T ss_pred             hhheE-ECCEEEEEEccccccCC
Confidence            99998 56789999998776543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.61  E-value=5.8e-05  Score=67.19  Aligned_cols=144  Identities=15%  Similarity=0.147  Sum_probs=97.8

Q ss_pred             CHHHHHHHhh---cCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCC---------C----------C----hHHHHH
Q 018071           58 SVDELKEITE---NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK---------Q----------P----DEEFLA  111 (361)
Q Consensus        58 ~~~~~~~~~~---~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~----------~----~~~~~~  111 (361)
                      .+--++.+.+   -+.++..||-|--+.||.+-...|++.++|.-+...         .          +    +-...+
T Consensus        80 DyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~k  159 (465)
T KOG2268|consen   80 DYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATK  159 (465)
T ss_pred             hHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHH
Confidence            3334444443   356778899999999999999889999999532110         0          0    113456


Q ss_pred             HHHHHhcCC-C-CCcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 018071          112 QVSMVSRLK-H-ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE  189 (361)
Q Consensus       112 e~~~l~~l~-h-pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~  189 (361)
                      |+..|+.|. | =.+.+.+++    +.-++|||++.|.+|.+.-+-            ....   .+...+..-+.-|-.
T Consensus       160 EfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------------~d~~---~ly~~lm~~Iv~la~  220 (465)
T KOG2268|consen  160 EFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV------------EDPP---TLYDDLMGLIVRLAN  220 (465)
T ss_pred             HHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec------------CChH---HHHHHHHHHHHHHHH
Confidence            888888874 3 224444443    455789999999888665322            1222   334444455566777


Q ss_pred             cCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       190 ~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      .|   +||+|+.-=||++++++.++++||--...
T Consensus       221 ~G---lIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  221 HG---LIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             cC---ceecccchheeEEecCCCEEEeechHhhc
Confidence            77   99999999999999999999999976543

>PLN02236 choline kinase

Probab=97.57  E-value=0.00085  Score=62.03  Aligned_cols=143  Identities=15%  Similarity=0.214  Sum_probs=79.9

Q ss_pred             ccccCCceEEEEEEECC-----CCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCeeEEEEEeCCCC
Q 018071           74 LIGEGSYGRVYYGILKS-----GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      .|-.|-...+|++...+     ++.|++|+........-...+|..+++.+..-++ .++++.+..+    .|.+|+++.
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~  118 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR  118 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence            45557788999987542     4689999886543222233678888888754333 3445554322    579999876


Q ss_pred             cHHHh-----------------hhcCCCCCCCCCCCCCCHHHHHHHHHHH-----------------HHHHHHh----hh
Q 018071          148 SLHDI-----------------LHGRKGVKGAQPGPVLSWQQRVKIAVGA-----------------AKGLEYL----HE  189 (361)
Q Consensus       148 ~L~~~-----------------l~~~~~~~~~~~~~~l~~~~~~~i~~qi-----------------~~al~~L----H~  189 (361)
                      +|...                 ++....   ........+..+..+..++                 ...+..|    ..
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~---~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDM---PGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCC---CCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            65311                 111110   0000011223333332221                 1111111    11


Q ss_pred             -cCCCCeEeccCCCCceEecc-CCceEEeccccCCC
Q 018071          190 -KADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQ  223 (361)
Q Consensus       190 -~~~~~ivHrDikp~Nill~~-~~~~kl~Dfg~a~~  223 (361)
                       .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             11234899999999999986 46899999998754

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.55  E-value=0.0011  Score=59.88  Aligned_cols=137  Identities=16%  Similarity=0.227  Sum_probs=82.1

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcCC---CCCChHHHHHHHHHHhcCCC--CCcceeeeEEEeCC--eeEEEEEeC
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKH--ENFVQLLGYCVDGT--SRVLAYEFA  144 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~~--~~~lv~e~~  144 (361)
                      ...+-.|.-..+|..... ++.++++ .+.   .........+|..+++.+.-  --+...+++|.++.  ..+.||+|+
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            334433433445555444 8888888 332   11223456678888887742  33455566666655  679999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHH-HHHHHHHHHhhh----------------------------------
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA-VGAAKGLEYLHE----------------------------------  189 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~-~qi~~al~~LH~----------------------------------  189 (361)
                      +|..+.+.+....          ..    ..++ ..++..|+-||+                                  
T Consensus       108 eGe~~~~~~~~~~----------~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~  173 (321)
T COG3173         108 EGEVVWSALPPES----------LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKEL  173 (321)
T ss_pred             cceeccCcCCccc----------ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhc
Confidence            9854332221110          00    1111 234444444444                                  


Q ss_pred             ----------------c-----CCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          190 ----------------K-----ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       190 ----------------~-----~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                                      .     +...++|+|+.+.|++++.++.+=|.||+++...
T Consensus       174 ~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         174 GGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             cCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                            2     1246999999999999999998999999998764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=97.49  E-value=0.012  Score=54.10  Aligned_cols=96  Identities=17%  Similarity=0.159  Sum_probs=60.4

Q ss_pred             ccCccCHHHHHHHhhcCCCC---C-ccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCC--Ccce
Q 018071           53 EVPAISVDELKEITENFGTN---A-LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQ  126 (361)
Q Consensus        53 ~~~~~~~~~~~~~~~~y~~~---~-~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--niv~  126 (361)
                      +.+.++.+.+..+...+.+.   + ..=.+.-..||+....++..+++|+.........++..|+..+..|...  .++.
T Consensus         7 ~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~   86 (325)
T PRK11768          7 PFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVA   86 (325)
T ss_pred             CCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCC
Confidence            34556777777766666442   0 1112455779999888788999998876555667788888887766321  1222


Q ss_pred             ee---e--EEEeCCeeEEEEEeCCCCc
Q 018071          127 LL---G--YCVDGTSRVLAYEFASNGS  148 (361)
Q Consensus       127 ~~---~--~~~~~~~~~lv~e~~~~g~  148 (361)
                      ..   +  +...++..+.++++++|..
T Consensus        87 p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         87 PLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            11   1  2233456788999998753

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.46  E-value=0.0031  Score=57.96  Aligned_cols=71  Identities=18%  Similarity=0.141  Sum_probs=48.7

Q ss_pred             ccccCCceEEEEEEECCC-CEEEEEEcCC--------CCCChHHHHHHHHHHhcCC--CC-CcceeeeEEEeCCeeEEEE
Q 018071           74 LIGEGSYGRVYYGILKSG-HAAAIKKLDA--------SKQPDEEFLAQVSMVSRLK--HE-NFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~--------~~~~~~~~~~e~~~l~~l~--hp-niv~~~~~~~~~~~~~lv~  141 (361)
                      .||.|....||++....| +.|+||.-..        -+....+..-|...|+...  .| .+.+++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            489999999999997644 6899996421        1233456677888887764  34 34445443  556667999


Q ss_pred             EeCCC
Q 018071          142 EFASN  146 (361)
Q Consensus       142 e~~~~  146 (361)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.33  E-value=0.0048  Score=57.71  Aligned_cols=72  Identities=11%  Similarity=0.166  Sum_probs=50.1

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcCC-----CC---CChHHHHHHHHHHhcCC---CCCcceeeeEEEeCCeeEEE
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLDA-----SK---QPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~-----~~---~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~lv  140 (361)
                      .+.||.|....||+.... +..++||.-..     ..   ....+...|...|+.+.   ..++.+++.++.  ...+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            346899999999998875 56799997652     11   13344555677776664   247777887765  446789


Q ss_pred             EEeCCC
Q 018071          141 YEFASN  146 (361)
Q Consensus       141 ~e~~~~  146 (361)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.31  E-value=0.0033  Score=56.23  Aligned_cols=31  Identities=19%  Similarity=0.416  Sum_probs=25.9

Q ss_pred             CeEeccCCCCceEeccCCc-eEEeccccCCCC
Q 018071          194 HIIHRDIKSSNVLIFDDDV-AKIADFDLSNQA  224 (361)
Q Consensus       194 ~ivHrDikp~Nill~~~~~-~kl~Dfg~a~~~  224 (361)
                      .++|+|+.|.|||+++++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997555 569999987653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.25  E-value=0.0017  Score=58.25  Aligned_cols=72  Identities=14%  Similarity=0.159  Sum_probs=47.1

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC---CCCcceeeeEEEeCCeeEEEEEeCCCC
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~~g  147 (361)
                      +.|+.|....+|+.. .+++.+.+|.-.  ......+..|..-|+.|.   --.+.+.+++....+..+|+|||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            458889999999988 568899999865  333357788888887773   446778888887777789999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.24  E-value=0.0032  Score=57.87  Aligned_cols=146  Identities=15%  Similarity=0.164  Sum_probs=78.2

Q ss_pred             ccccCCceEEEEEEECC----CCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCeeEEEEEeCCCCc
Q 018071           74 LIGEGSYGRVYYGILKS----GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGS  148 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~  148 (361)
                      .|..|-...+|+.....    +..|++|+........-...+|..+++.+..-++ .++++++. +.   +|.+|+++.+
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~   96 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART   96 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence            45557778899887542    2489999876543322234578888888864444 34555542 22   5889987765


Q ss_pred             HHH--------------hhhcCCCCCCCCCCCCCCHHHHHHHHHHH-------------------------HHHHHHhh-
Q 018071          149 LHD--------------ILHGRKGVKGAQPGPVLSWQQRVKIAVGA-------------------------AKGLEYLH-  188 (361)
Q Consensus       149 L~~--------------~l~~~~~~~~~~~~~~l~~~~~~~i~~qi-------------------------~~al~~LH-  188 (361)
                      |..              .+..-...........-.+..+..+..++                         +..+..+. 
T Consensus        97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~  176 (330)
T PLN02421         97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD  176 (330)
T ss_pred             CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence            421              11110000000000011222222222221                         11111121 


Q ss_pred             hcC-CCCeEeccCCCCceEecc-CCceEEeccccCCC
Q 018071          189 EKA-DPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQ  223 (361)
Q Consensus       189 ~~~-~~~ivHrDikp~Nill~~-~~~~kl~Dfg~a~~  223 (361)
                      ..+ ..-++|.|+.+.|||+++ ++.++++||..|..
T Consensus       177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            111 123789999999999975 57899999998754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.15  E-value=0.0062  Score=55.48  Aligned_cols=30  Identities=13%  Similarity=0.217  Sum_probs=27.4

Q ss_pred             CeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       194 ~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      .++|+|+.++|||++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            499999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.14  E-value=0.0016  Score=55.78  Aligned_cols=29  Identities=31%  Similarity=0.572  Sum_probs=20.8

Q ss_pred             CeEeccCCCCceEe-ccCCceEEeccccCC
Q 018071          194 HIIHRDIKSSNVLI-FDDDVAKIADFDLSN  222 (361)
Q Consensus       194 ~ivHrDikp~Nill-~~~~~~kl~Dfg~a~  222 (361)
                      -++|.|+.+.|||+ +.++.++|+||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            38899999999999 888999999999874

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.08  E-value=0.02  Score=52.09  Aligned_cols=29  Identities=28%  Similarity=0.441  Sum_probs=25.0

Q ss_pred             CeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       194 ~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      .++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            4899999999999987 6789999996543

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.06  E-value=0.0049  Score=57.34  Aligned_cols=73  Identities=14%  Similarity=0.117  Sum_probs=50.7

Q ss_pred             CCccccCCceEEEEEEECC-CCEEEEEEcC----CC---CCChHHHHHHHHHHhcCC--CC-CcceeeeEEEeCCeeEEE
Q 018071           72 NALIGEGSYGRVYYGILKS-GHAAAIKKLD----AS---KQPDEEFLAQVSMVSRLK--HE-NFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~----~~---~~~~~~~~~e~~~l~~l~--hp-niv~~~~~~~~~~~~~lv  140 (361)
                      .+.||.|.-..||++...+ ++.|+||.-.    ..   +-+..+..-|.+.|+.+.  .| .+.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3468999999999999753 5689999642    11   233467778888888764  35 34455544  55666799


Q ss_pred             EEeCCC
Q 018071          141 YEFASN  146 (361)
Q Consensus       141 ~e~~~~  146 (361)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999854

>PRK06148 hypothetical protein; Provisional

Probab=97.04  E-value=0.026  Score=59.72  Aligned_cols=168  Identities=17%  Similarity=0.244  Sum_probs=90.5

Q ss_pred             ccCccCHHHHHH-HhhcCCCC---CccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcC-------CC
Q 018071           53 EVPAISVDELKE-ITENFGTN---ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-------KH  121 (361)
Q Consensus        53 ~~~~~~~~~~~~-~~~~y~~~---~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-------~h  121 (361)
                      ..|.++.+++.. +.+.|.+.   +.|+ |..-.+|+....+|..+++|+..... .......|...+..|       .-
T Consensus         7 ~~p~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpv   84 (1013)
T PRK06148          7 PAPEFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPV   84 (1013)
T ss_pred             CCCCCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCc
Confidence            446677777754 34666653   3453 45688999988888899999987542 333444454555433       22


Q ss_pred             CCcceeee-----EEEe-CC--eeEEEEEeCCCCcHHHhh-----------------hcC-CCCCCCCCCCCCCHH----
Q 018071          122 ENFVQLLG-----YCVD-GT--SRVLAYEFASNGSLHDIL-----------------HGR-KGVKGAQPGPVLSWQ----  171 (361)
Q Consensus       122 pniv~~~~-----~~~~-~~--~~~lv~e~~~~g~L~~~l-----------------~~~-~~~~~~~~~~~l~~~----  171 (361)
                      |.+++..+     .... +.  ..+-+++|++|..+.+..                 +.. .+.........+.|.    
T Consensus        85 P~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~  164 (1013)
T PRK06148         85 PRLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHA  164 (1013)
T ss_pred             CeeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccc
Confidence            33333221     1111 12  456789999997665411                 000 000000000112221    


Q ss_pred             -------------HHHHHHHHHHHHHH-----HhhhcCCCCeEeccCCCCceEeccCC--ceE-EeccccCCC
Q 018071          172 -------------QRVKIAVGAAKGLE-----YLHEKADPHIIHRDIKSSNVLIFDDD--VAK-IADFDLSNQ  223 (361)
Q Consensus       172 -------------~~~~i~~qi~~al~-----~LH~~~~~~ivHrDikp~Nill~~~~--~~k-l~Dfg~a~~  223 (361)
                                   ..+.++.+++....     .+.+. ...+||.|+.+.|||++.++  .+. |+|||-+..
T Consensus       165 ~~l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        165 GRARDRLHFIDDPEDRALVERFLARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             hhhhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence                         12223333333222     12111 22499999999999999775  555 999998764

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.87  E-value=0.028  Score=51.38  Aligned_cols=143  Identities=20%  Similarity=0.254  Sum_probs=83.5

Q ss_pred             CceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCC---CC---cceeee----EEEeCCeeEEEEEeCCCCc
Q 018071           79 SYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH---EN---FVQLLG----YCVDGTSRVLAYEFASNGS  148 (361)
Q Consensus        79 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h---pn---iv~~~~----~~~~~~~~~lv~e~~~~g~  148 (361)
                      .-..||+....+|.. ++|+.... ....++..|...++.|.-   +-   +...-|    ........+-+++|++|..
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~  114 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP  114 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence            567799998886666 99998877 677788888888887732   11   222212    1111236778899999876


Q ss_pred             HHH---------------hhhcC-CCCC--CCCCCCCCCHHH-------------HHHHHHHHHHHHHHhhhcC----CC
Q 018071          149 LHD---------------ILHGR-KGVK--GAQPGPVLSWQQ-------------RVKIAVGAAKGLEYLHEKA----DP  193 (361)
Q Consensus       149 L~~---------------~l~~~-~~~~--~~~~~~~l~~~~-------------~~~i~~qi~~al~~LH~~~----~~  193 (361)
                      +..               .|+.. ++.+  .........|..             -.....++...+..+.+.-    ..
T Consensus       115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~  194 (331)
T COG2334         115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA  194 (331)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence            662               01111 0111  111111223320             0123333444444444421    11


Q ss_pred             C---eEeccCCCCceEeccCCc-eEEeccccCCC
Q 018071          194 H---IIHRDIKSSNVLIFDDDV-AKIADFDLSNQ  223 (361)
Q Consensus       194 ~---ivHrDikp~Nill~~~~~-~kl~Dfg~a~~  223 (361)
                      .   +||+|+.|.||+++.+.. .-++||+-+..
T Consensus       195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             ccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            2   899999999999998884 89999997654

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.79  E-value=0.0039  Score=56.71  Aligned_cols=73  Identities=19%  Similarity=0.233  Sum_probs=57.3

Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      ....|++|++- |+++. .+.            ...+.+++.++++.+..+.-+..+-  ++=|||+.-.||||+ +|++
T Consensus       298 ~~y~yl~~kdh-gt~is-~ik------------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~Gnv  360 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS-IIK------------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNV  360 (488)
T ss_pred             ceEEEEEEecC-Cceee-eee------------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCce
Confidence            34456777775 44443 222            2568899999999999888888765  689999999999999 9999


Q ss_pred             EEeccccCCC
Q 018071          214 KIADFDLSNQ  223 (361)
Q Consensus       214 kl~Dfg~a~~  223 (361)
                      .|+||-+++.
T Consensus       361 tLIDfklsRl  370 (488)
T COG5072         361 TLIDFKLSRL  370 (488)
T ss_pred             EEEEeeeeec
Confidence            9999999984

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.70  E-value=0.0043  Score=58.88  Aligned_cols=72  Identities=21%  Similarity=0.343  Sum_probs=48.5

Q ss_pred             EEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeC-CeeEEEEEeCCCCcHHHhhhcCC
Q 018071           83 VYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-TSRVLAYEFASNGSLHDILHGRK  157 (361)
Q Consensus        83 Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~  157 (361)
                      ++.|..+.|..+ ..-++... ....++....+++.+.|+|..+++++.... ....+|||++ +.+|.+.+..+.
T Consensus         5 ~~~a~~~~~~~c-~nglplt~-~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen    5 TFFAQEKPGDVC-SNGLPLTP-NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             EEehhcCCCccc-cCCCcCCC-cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            455555555544 33333322 223566678889999999999999886533 3467899999 669999887653

>PTZ00384 choline kinase; Provisional

Probab=96.54  E-value=0.03  Score=52.47  Aligned_cols=74  Identities=19%  Similarity=0.241  Sum_probs=44.3

Q ss_pred             CccccCCceEEEEEEECCC--C-----EEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCeeEEEEEeC
Q 018071           73 ALIGEGSYGRVYYGILKSG--H-----AAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~--~-----~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~  144 (361)
                      +.|..|-.+.+|++....+  .     .|.++.........-+..+|+.+++.+...++ .++++.+.    -+++.||+
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efI  131 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWV  131 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEe
Confidence            3455677889999975532  2     24444432222212234568888888865444 44555543    25899999


Q ss_pred             CCCcHH
Q 018071          145 SNGSLH  150 (361)
Q Consensus       145 ~~g~L~  150 (361)
                      +|.+|.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            987653

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.48  E-value=0.02  Score=48.71  Aligned_cols=102  Identities=17%  Similarity=0.171  Sum_probs=63.9

Q ss_pred             EEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCH
Q 018071           93 AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW  170 (361)
Q Consensus        93 ~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~  170 (361)
                      ...+|+++..+-  ...-+..+..++.++.  .|+++..-  +...+-++.|+|.....                  .. 
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------------~~-  143 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------------NF-  143 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------------ch-
Confidence            344555544322  2344567777777654  56776632  34455689999843111                  11 


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       171 ~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                        .-.+... +.+|.-.|+. +.+.+|+|-.|+||+-|..|.+||.|=+..
T Consensus       144 --~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  144 --SNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             --hHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence              1111111 3567788855 336999999999999999999999998753

The function of this family is unknown.

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=96.34  E-value=0.036  Score=48.71  Aligned_cols=78  Identities=18%  Similarity=0.078  Sum_probs=55.0

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC-CCcHHH
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS-NGSLHD  151 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-~g~L~~  151 (361)
                      ..+..|..+.|+.+...+|+..++|+.........+... ...|+..+-...|++++.-  .....+.+|.+. +.+|.+
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g-~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~   84 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARG-EAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLAS   84 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhH-HhHhheeCCCCceeeeccc--cccchhhhhhccCCCchhh
Confidence            456678999999999889999999987654432222222 2447777778889998874  345678899984 446665


Q ss_pred             hh
Q 018071          152 IL  153 (361)
Q Consensus       152 ~l  153 (361)
                      ..
T Consensus        85 ~~   86 (253)
T PF04655_consen   85 LP   86 (253)
T ss_pred             cc
Confidence            44

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.18  E-value=0.018  Score=53.35  Aligned_cols=61  Identities=20%  Similarity=0.157  Sum_probs=43.7

Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF  208 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~  208 (361)
                      ...++-+|..|-++..++....          .++.....++.-.+.|+-.+--..  +++|.|+.|.||++-
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~----------~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS----------QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhccc----------ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence            3457777888889999887654          455556666666666655544443  499999999999994

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	361
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-47
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-47
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-46
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-45
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-39
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-24
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-23
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-22
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-22
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-22
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-20
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-20
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-20
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-19
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-19
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-19
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-19
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-19
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-19
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-19
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-19
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-19
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-19
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-19
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-18
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-18
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-18
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-18
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-18
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-18
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-18
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-18
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-18
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-18
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-18
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-18
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-18
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-18
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-18
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-18
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-18
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-18
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-18
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-18
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-18
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-18
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-18
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-18
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-18
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-17
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-16
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-14
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		9e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		4e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-04
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-04
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-04

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 108/297 (36%), Positives = 162/297 (54%), Gaps = 9/297 (3%)
Query: 51  PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLD-ASKQPDEEF 109
           P E   + + +L+E T NF    LIG G +G+VY G+L+ G   A+K+    S Q  EEF
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 110 LAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
             ++  +S  +H + V L+G+C +    +L Y++  NG+L   L+G        P   +S
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-----SDLPTMSMS 137
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
           W+QR++I +GAA+GL YLH +A   IIHRD+KS N+L+ ++ V KI DF +S +  ++  
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQ 194
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 289
                 V GT GY  PEY + G+L  KSDVYSFGVVL E+L  R  +  +LPR   +L  
Sbjct: 195 THLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 290 WATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
           WA    +  ++ Q VD  L     P            C+   ++ RP+M  V+  L+
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 108/297 (36%), Positives = 162/297 (54%), Gaps = 9/297 (3%)
Query: 51  PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLD-ASKQPDEEF 109
           P E   + + +L+E T NF    LIG G +G+VY G+L+ G   A+K+    S Q  EEF
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 110 LAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
             ++  +S  +H + V L+G+C +    +L Y++  NG+L   L+G        P   +S
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-----SDLPTMSMS 137
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
           W+QR++I +GAA+GL YLH +A   IIHRD+KS N+L+ ++ V KI DF +S +  ++  
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 289
                 V GT GY  PEY + G+L  KSDVYSFGVVL E+L  R  +  +LPR   +L  
Sbjct: 195 THLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 290 WATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
           WA    +  ++ Q VD  L     P            C+   ++ RP+M  V+  L+
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 163/300 (54%), Gaps = 14/300 (4%)
Query: 53  EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFL 110
           ++   S+ EL+  ++NF    ++G G +G+VY G L  G   A+K+L   +    + +F 
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
            +V M+S   H N ++L G+C+  T R+L Y + +NGS+   L  R      +  P L W
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER-----PESQPPLDW 138
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
            +R +IA+G+A+GL YLH+  DP IIHRD+K++N+L+ ++  A + DF L+ +  D    
Sbjct: 139 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDX 197
Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS---- 286
                V GT G+ APEY  TG+ + K+DV+ +GV+LLEL+TG++  D  L R        
Sbjct: 198 HVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD--LARLANDDDVM 255
Query: 287 LVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
           L+ W    L E K+   VD  L G+Y             LC Q     RP MS VV+ L+
Sbjct: 256 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 162/300 (54%), Gaps = 14/300 (4%)
Query: 53  EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFL 110
           ++   S+ EL+  ++NF    ++G G +G+VY G L  G   A+K+L   +    + +F 
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
            +V M+S   H N ++L G+C+  T R+L Y + +NGS+   L  R      +  P L W
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER-----PESQPPLDW 130
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
            +R +IA+G+A+GL YLH+  DP IIHRD+K++N+L+ ++  A + DF L+ +  D    
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDX 189
Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS---- 286
                V G  G+ APEY  TG+ + K+DV+ +GV+LLEL+TG++  D  L R        
Sbjct: 190 HVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD--LARLANDDDVM 247
Query: 287 LVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
           L+ W    L E K+   VD  L G+Y             LC Q     RP MS VV+ L+
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 98/250 (39%), Positives = 145/250 (58%), Gaps = 23/250 (9%)
Query: 45  QAVKVQPIEVPAISVDELKEITENFGTNAL------IGEGSYGRVYYGILKSGHAAAIKK 98
           ++++V      + S  ELK +T NF    +      +GEG +G VY G + +    A+KK
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKK 61
Query: 99  LDA-----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
           L A     +++  ++F  ++ ++++ +HEN V+LLG+  DG    L Y +  NGSL D L
Sbjct: 62  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
               G       P LSW  R KIA GAA G+ +LHE    H IHRDIKS+N+L+ +   A
Sbjct: 122 SCLDGT------PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTA 172
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
           KI+DF L+  +   A  +  +R++GT  Y APE A+ G++  KSD+YSFGVVLLE++TG 
Sbjct: 173 KISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGL 231
Query: 274 KPVD-HTLPR 282
             VD H  P+
Sbjct: 232 PAVDEHREPQ 241

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 98/250 (39%), Positives = 144/250 (57%), Gaps = 23/250 (9%)
Query: 45  QAVKVQPIEVPAISVDELKEITENFGTNAL------IGEGSYGRVYYGILKSGHAAAIKK 98
           ++++V      + S  ELK +T NF    +      +GEG +G VY G + +    A+KK
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKK 61
Query: 99  LDA-----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
           L A     +++  ++F  ++ ++++ +HEN V+LLG+  DG    L Y +  NGSL D L
Sbjct: 62  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
               G       P LSW  R KIA GAA G+ +LHE    H IHRDIKS+N+L+ +   A
Sbjct: 122 SCLDGT------PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTA 172
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
           KI+DF L+  +   A  +   R++GT  Y APE A+ G++  KSD+YSFGVVLLE++TG 
Sbjct: 173 KISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGL 231
Query: 274 KPVD-HTLPR 282
             VD H  P+
Sbjct: 232 PAVDEHREPQ 241

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 97/239 (40%), Positives = 139/239 (58%), Gaps = 23/239 (9%)
Query: 56  AISVDELKEITENFGTNAL------IGEGSYGRVYYGILKSGHAAAIKKLDA-----SKQ 104
           + S  ELK +T NF    +      +GEG +G VY G + +    A+KKL A     +++
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTEE 66
Query: 105 PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
             ++F  ++ ++++ +HEN V+LLG+  DG    L Y +  NGSL D L    G      
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT----- 121
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
            P LSW  R KIA GAA G+ +LHE    H IHRDIKS+N+L+ +   AKI+DF L+  +
Sbjct: 122 -PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARAS 177
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD-HTLPR 282
              A  +   R++GT  Y APE A+ G++  KSD+YSFGVVLLE++TG   VD H  P+
Sbjct: 178 EKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 235

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 97/239 (40%), Positives = 138/239 (57%), Gaps = 23/239 (9%)
Query: 56  AISVDELKEITENFGTNAL------IGEGSYGRVYYGILKSGHAAAIKKLDA-----SKQ 104
           + S  ELK +T NF    +       GEG +G VY G + +    A+KKL A     +++
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTEE 63
Query: 105 PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
             ++F  ++ + ++ +HEN V+LLG+  DG    L Y +  NGSL D L    G      
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT----- 118
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
            P LSW  R KIA GAA G+ +LHE    H IHRDIKS+N+L+ +   AKI+DF L+  +
Sbjct: 119 -PPLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARAS 174
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD-HTLPR 282
              A  +  +R++GT  Y APE A+ G++  KSD+YSFGVVLLE++TG   VD H  P+
Sbjct: 175 EKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 232

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 137/289 (47%), Gaps = 30/289 (10%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G V+      G   A+K L   D   +   EFL +V+++ RL+H N V  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
               +  +  E+ S GSL+ +LH + G +       L  ++R+ +A   AKG+ YLH + 
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH-KSGAREQ-----LDERRRLSMAYDVAKGMNYLHNR- 156
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
           +P I+HRD+KS N+L+      K+ DF LS      +  L S    GT  + APE     
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK-VRQCVDARLGG 310
             N KSDVYSFGV+L EL T ++P  +  P    + V +   +L   + +   V A + G
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 311 DYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARPGPAGES 359
                           C   E   RP+ + ++  L+PL+ +   P   S
Sbjct: 275 ----------------CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 137/289 (47%), Gaps = 30/289 (10%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G V+      G   A+K L   D   +   EFL +V+++ RL+H N V  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
               +  +  E+ S GSL+ +LH + G +       L  ++R+ +A   AKG+ YLH + 
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH-KSGAREQ-----LDERRRLSMAYDVAKGMNYLHNR- 156
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
           +P I+HR++KS N+L+      K+ DF LS      +  L S    GT  + APE     
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK-VRQCVDARLGG 310
             N KSDVYSFGV+L EL T ++P  +  P    + V +   +L   + +   V A + G
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 311 DYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARPGPAGES 359
                           C   E   RP+ + ++  L+PL+ +   P   S
Sbjct: 275 ----------------CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/217 (33%), Positives = 106/217 (48%), Gaps = 32/217 (14%)
Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR-------LKHENFVQ 126
           +IG G +G+VY      G   A+K   A   PDE+    +  V +       LKH N + 
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKA--ARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L G C+   +  L  EFA  G L+ +L G++      P  +++W      AV  A+G+ Y
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNW------AVQIARGMNY 120
Query: 187 LHEKADPHIIHRDIKSSNVLI--------FDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
           LH++A   IIHRD+KSSN+LI          + + KI DF L+ +      R       G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAG 176
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            + + APE       +  SDV+S+GV+L ELLTG  P
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 36/285 (12%)
Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           ++G G++G V     ++   A IK++++  +  + F+ ++  +SR+ H N V+L G C++
Sbjct: 16  VVGRGAFGVVCKAKWRAKDVA-IKQIESESE-RKAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
               V+  E+A  GSL+++LHG      A+P P  +    +   +  ++G+ YLH     
Sbjct: 74  PVCLVM--EYAEGGSLYNVLHG------AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 125
Query: 194 HIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
            +IHRD+K  N+L+     V KI DF     A D+  + H T   G+  + APE      
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDF---GTACDI--QTHMTNNKGSAAWMAPEVFEGSN 180
Query: 253 LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY 312
            + K DV+S+G++L E++T RKP D     G    + WA                  G  
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV---------------HNGTR 223
Query: 313 PPXXXXXXXXXXXL---CVQYEADFRPNMSIVVKALQPLLNARPG 354
           PP           L   C   +   RP+M  +VK +  L+   PG
Sbjct: 224 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 268

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 36/285 (12%)
Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           ++G G++G V     ++   A IK++++  +  + F+ ++  +SR+ H N V+L G C++
Sbjct: 15  VVGRGAFGVVCKAKWRAKDVA-IKQIESESE-RKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
               V+  E+A  GSL+++LHG      A+P P  +    +   +  ++G+ YLH     
Sbjct: 73  PVCLVM--EYAEGGSLYNVLHG------AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 194 HIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
            +IHRD+K  N+L+     V KI DF     A D+  + H T   G+  + APE      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDF---GTACDI--QTHMTNNKGSAAWMAPEVFEGSN 179
Query: 253 LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY 312
            + K DV+S+G++L E++T RKP D     G    + WA                  G  
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV---------------HNGTR 222
Query: 313 PPXXXXXXXXXXXL---CVQYEADFRPNMSIVVKALQPLLNARPG 354
           PP           L   C   +   RP+M  +VK +  L+   PG
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 70
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S GSL D L G       + G  L   Q V +A   A G+ Y
Sbjct: 71  LYA-VVSEEPIYIVTEYMSKGSLLDFLKG-------ETGKYLRLPQLVDMAAQIASGMAY 122
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D     ++ R    F   + A
Sbjct: 123 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTA 176
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 177 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 118/249 (47%), Gaps = 20/249 (8%)
Query: 33  AYHASEAAPKGAQAVKVQPIEVP---AISVDELKEITENFGTNALIGEGSYGRVYYGILK 89
           AY++  A     +   V P   P    ++ D  +   E+      +G+G +G V+ G   
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206
Query: 90  SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149
                AIK L       E FL +  ++ +L+HE  VQL    V      +  E+ S GSL
Sbjct: 207 GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSL 265
Query: 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209
            D L G       + G  L   Q V +A   A G+ Y+      + +HRD++++N+L+ +
Sbjct: 266 LDFLKG-------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE 315
Query: 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLL 267
           + V K+ADF L+    D     ++ R    F   + APE A+ G+   KSDV+SFG++L 
Sbjct: 316 NLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 372
Query: 268 ELLT-GRKP 275
           EL T GR P
Sbjct: 373 ELTTKGRVP 381

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 118/249 (47%), Gaps = 20/249 (8%)
Query: 33  AYHASEAAPKGAQAVKVQPIEVP---AISVDELKEITENFGTNALIGEGSYGRVYYGILK 89
           AY++  A     +   V P   P    ++ D  +   E+      +G+G +G V+ G   
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206
Query: 90  SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149
                AIK L       E FL +  ++ +L+HE  VQL    V      +  E+ S GSL
Sbjct: 207 GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSL 265
Query: 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209
            D L G       + G  L   Q V +A   A G+ Y+      + +HRD++++N+L+ +
Sbjct: 266 LDFLKG-------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE 315
Query: 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLL 267
           + V K+ADF L+    D     ++ R    F   + APE A+ G+   KSDV+SFG++L 
Sbjct: 316 NLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 372
Query: 268 ELLT-GRKP 275
           EL T GR P
Sbjct: 373 ELTTKGRVP 381

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 118/249 (47%), Gaps = 20/249 (8%)
Query: 33  AYHASEAAPKGAQAVKVQPIEVP---AISVDELKEITENFGTNALIGEGSYGRVYYGILK 89
           AY++  A     +   V P   P    ++ D  +   E+      +G+G +G V+ G   
Sbjct: 230 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 289
Query: 90  SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149
                AIK L       E FL +  ++ +L+HE  VQL    V      +  E+ S GSL
Sbjct: 290 GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSL 348
Query: 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209
            D L G       + G  L   Q V +A   A G+ Y+      + +HRD++++N+L+ +
Sbjct: 349 LDFLKG-------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE 398
Query: 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLL 267
           + V K+ADF L+    D     ++ R    F   + APE A+ G+   KSDV+SFG++L 
Sbjct: 399 NLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 455
Query: 268 ELLT-GRKP 275
           EL T GR P
Sbjct: 456 ELTTKGRVP 464

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 66
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S GSL D L G       + G  L   Q V +A   A G+ Y
Sbjct: 67  LYA-VVSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAY 118
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D     ++ R    F   + A
Sbjct: 119 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTA 172
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 173 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 125/272 (45%), Gaps = 24/272 (8%)
Query: 14  KAADNGNAYMVK----SSAGTDGAYHASEAAPKGAQAVKVQPIEVP---AISVDELKEIT 66
           +  D+G  Y+      SS     AY++  A     +   V P   P    ++ D  +   
Sbjct: 125 RKLDSGGFYITSRTQFSSLQQLVAYYSKHADGLCHRLTNVCPTSKPQTQGLAKDAWEIPR 184
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQ 244
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S GSL D L G       + G  L   Q V +A   A G+ Y
Sbjct: 245 LYA-VVSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAY 296
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L     D     ++ R    F   + A
Sbjct: 297 VERM---NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNE---YTARQGAKFPIKWTA 350
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 351 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S GSL D L G       + G  L   Q V +A   A G+ Y
Sbjct: 78  LYA-VVSEEPIYIVIEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D     ++ R    F   + A
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTA 183
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 68
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S GSL D L G       + G  L   Q V +A   A G+ Y
Sbjct: 69  LYA-VVSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAY 120
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D     ++ R    F   + A
Sbjct: 121 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTA 174
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 119/249 (47%), Gaps = 20/249 (8%)
Query: 33  AYHASEAAPKGAQAVKVQPIEVP---AISVDELKEITENFGTNALIGEGSYGRVYYGILK 89
           AY++  A     +   V P   P    ++ D  +   E+      +G+G +G V+ G   
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206
Query: 90  SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149
                AIK L       E FL +  ++ +L+HE  VQL     +    ++  E+ S GSL
Sbjct: 207 GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVG-EYMSKGSL 265
Query: 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209
            D L G       + G  L   Q V +A   A G+ Y+      + +HRD++++N+L+ +
Sbjct: 266 LDFLKG-------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE 315
Query: 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLL 267
           + V K+ADF L+    D     ++ R    F   + APE A+ G+   KSDV+SFG++L 
Sbjct: 316 NLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 372
Query: 268 ELLT-GRKP 275
           EL T GR P
Sbjct: 373 ELTTKGRVP 381

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S GSL D L G       + G  L   Q V +A   A G+ Y
Sbjct: 78  LYA-VVSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D     ++ R    F   + A
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTA 183
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S GSL D L G       + G  L   Q V +A   A G+ Y
Sbjct: 78  LYA-VVSEEPIYIVCEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D     ++ R    F   + A
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTA 183
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 67
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L     +    ++  E+ S GSL D L G       + G  L   Q V +A   A G+ Y
Sbjct: 68  LYAVVSEEPIXIVT-EYMSKGSLLDFLKG-------ETGKYLRLPQLVDMAAQIASGMAY 119
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D      + R    F   + A
Sbjct: 120 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX---TARQGAKFPIKWTA 173
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 174 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S GSL D L G       + G  L   Q V +A   A G+ Y
Sbjct: 78  LYA-VVSEEPIYIVIEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D      + R    F   + A
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX---TARQGAKFPIKWTA 183
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +++HE  VQ
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQ 77
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S GSL D L G       + G  L   Q V +A   A G+ Y
Sbjct: 78  LYA-VVSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D     ++ R    F   + A
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTA 183
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 31/291 (10%)
Query: 75  IGEGSYGRVY----YGIL--KSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G+V+    Y +   +     A+K L DAS    ++F  +  +++ L+HE+ V+ 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGP--VLSWQQRVKIAVGAAKG 183
            G CV+G   ++ +E+  +G L+  L  HG   V  A+  P   L+  Q + IA   A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           + YL   A  H +HRD+ + N L+ ++ + KI DF +S               +    + 
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ 302
            PE  M  +   +SDV+S GVVL E+ T G++P              W   +LS ++V +
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------------WY--QLSNNEVIE 241
Query: 303 CVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
           C+        P             C Q E   R N+  +   LQ L  A P
Sbjct: 242 CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S G L D L G       + G  L   Q V +A   A G+ Y
Sbjct: 78  LYA-VVSEEPIYIVMEYMSKGCLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D     ++ R    F   + A
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTA 183
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S GSL D L G       + G  L   Q V +A   A G+ Y
Sbjct: 78  LYA-VVSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD+ ++N+L+ ++ V K+ADF L+    D     ++ R    F   + A
Sbjct: 130 VERM---NYVHRDLAAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTA 183
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ S G L D L G       + G  L   Q V +A   A G+ Y
Sbjct: 78  LYA-VVSEEPIYIVTEYMSKGCLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D     ++ R    F   + A
Sbjct: 130 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTA 183
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ + GSL D L G       + G  L   Q V ++   A G+ Y
Sbjct: 75  LYA-VVSEEPIYIVTEYMNKGSLLDFLKG-------ETGKYLRLPQLVDMSAQIASGMAY 126
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D     ++ R    F   + A
Sbjct: 127 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTA 180
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L    V      +  E+ + GSL D L G       + G  L   Q V ++   A G+ Y
Sbjct: 75  LYA-VVSEEPIYIVTEYMNKGSLLDFLKG-------ETGKYLRLPQLVDMSAQIASGMAY 126
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           +      + +HRD++++N+L+ ++ V K+ADF L+    D      + R    F   + A
Sbjct: 127 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---WTARQGAKFPIKWTA 180
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE A+ G+   KSDV+SFG++L EL T GR P
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G        AIK L       E FL +  ++ +LKH+  VQL    V  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYA-VVSE 75
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ + GSL D L   +G     P         V +A   A G+ Y+      +
Sbjct: 76  EPIYIVTEYMNKGSLLDFLKDGEGRALKLPN-------LVDMAAQVAAGMAYIERM---N 125
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            IHRD++S+N+L+ +  + KIADF L+    D      + R    F   + APE A+ G+
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIEDNEX---TARQGAKFPIKWTAPEAALYGR 182
Query: 253 LNAKSDVYSFGVVLLELLT-GRKP 275
              KSDV+SFG++L EL+T GR P
Sbjct: 183 FTIKSDVWSFGILLTELVTKGRVP 206

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           IG G +G V+ G   +    AIK +      +E+F+ +  ++ +L H   VQL G C++ 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               L +EF  +G L D L  ++G+  A+          + + +   +G+ YL E     
Sbjct: 78  APICLVFEFMEHGCLSDYLRTQRGLFAAET--------LLGMCLDVCEGMAYLEEAC--- 126
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
           +IHRD+ + N L+ ++ V K++DF ++    D      ST       + +PE     + +
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 255 AKSDVYSFGVVLLELLT-GRKPVDH 278
           +KSDV+SFGV++ E+ + G+ P ++
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYEN 210

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           IG G +G V+ G   +    AIK +      +E+F+ +  ++ +L H   VQL G C++ 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               L +EF  +G L D L  ++G+  A+          + + +   +G+ YL E     
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAET--------LLGMCLDVCEGMAYLEEAC--- 123
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
           +IHRD+ + N L+ ++ V K++DF ++    D      ST       + +PE     + +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 255 AKSDVYSFGVVLLELLT-GRKPVDH 278
           +KSDV+SFGV++ E+ + G+ P ++
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           IG G +G V+ G   +    AIK +      +E+F+ +  ++ +L H   VQL G C++ 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               L +EF  +G L D L  ++G+  A+          + + +   +G+ YL E +   
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAET--------LLGMCLDVCEGMAYLEEAS--- 123
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
           +IHRD+ + N L+ ++ V K++DF ++    D      ST       + +PE     + +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 255 AKSDVYSFGVVLLELLT-GRKPVDH 278
           +KSDV+SFGV++ E+ + G+ P ++
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           IG G +G V+ G   +    AIK +      +E+F+ +  ++ +L H   VQL G C++ 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               L +EF  +G L D L  ++G+  A+          + + +   +G+ YL E     
Sbjct: 73  APICLVFEFMEHGCLSDYLRTQRGLFAAET--------LLGMCLDVCEGMAYLEEAC--- 121
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
           +IHRD+ + N L+ ++ V K++DF ++    D      ST       + +PE     + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 255 AKSDVYSFGVVLLELLT-GRKPVDH 278
           +KSDV+SFGV++ E+ + G+ P ++
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYEN 205

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 32  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                  +  ++    SL+  LH  +             ++ + IA   A+G++YLH K+
Sbjct: 90  T-APQLAIVTQWCEGSSLYHHLHASE--------TKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D+  KI DF L+ +    +      ++ G+  + APE     
Sbjct: 141 ---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
             N    +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 129/242 (53%), Gaps = 41/242 (16%)
Query: 56  AISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQV 113
           A+++ ELK +         IG+G +G V  G  + G+  A+K  K DA+ Q    FLA+ 
Sbjct: 189 ALNMKELKLLQT-------IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEA 237
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGR-KGVKGAQPGPVLSWQ 171
           S++++L+H N VQLLG  V+    + +  E+ + GSL D L  R + V G   G  L   
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG---GDCL--- 291
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
             +K ++   + +EYL      + +HRD+ + NVL+ +D+VAK++DF L+ +A       
Sbjct: 292 --LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------ 340
Query: 232 HSTRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG------RKPVDHTLPRG 283
            ST+  G     + APE     + + KSDV+SFG++L E+ +       R P+   +PR 
Sbjct: 341 -STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
Query: 284 QQ 285
           ++
Sbjct: 400 EK 401

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 75
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 76  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 127
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D     ++ R    
Sbjct: 128 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAK 181
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           F   + APE    G    KSDV+SFG++L E++T GR P
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 129/242 (53%), Gaps = 41/242 (16%)
Query: 56  AISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQV 113
           A+++ ELK +         IG+G +G V  G  + G+  A+K  K DA+ Q    FLA+ 
Sbjct: 17  ALNMKELKLLQT-------IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEA 65
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGR-KGVKGAQPGPVLSWQ 171
           S++++L+H N VQLLG  V+    + +  E+ + GSL D L  R + V G   G  L   
Sbjct: 66  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG---GDCL--- 119
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
             +K ++   + +EYL      + +HRD+ + NVL+ +D+VAK++DF L+ +A       
Sbjct: 120 --LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------ 168
Query: 232 HSTRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG------RKPVDHTLPRG 283
            ST+  G     + APE     + + KSDV+SFG++L E+ +       R P+   +PR 
Sbjct: 169 -STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
Query: 284 QQ 285
           ++
Sbjct: 228 EK 229

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 129/242 (53%), Gaps = 41/242 (16%)
Query: 56  AISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQV 113
           A+++ ELK +         IG+G +G V  G  + G+  A+K  K DA+ Q    FLA+ 
Sbjct: 2   ALNMKELKLLQT-------IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEA 50
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGR-KGVKGAQPGPVLSWQ 171
           S++++L+H N VQLLG  V+    + +  E+ + GSL D L  R + V G   G  L   
Sbjct: 51  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG---GDCL--- 104
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
             +K ++   + +EYL      + +HRD+ + NVL+ +D+VAK++DF L+ +A       
Sbjct: 105 --LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------ 153
Query: 232 HSTRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG------RKPVDHTLPRG 283
            ST+  G     + APE     + + KSDV+SFG++L E+ +       R P+   +PR 
Sbjct: 154 -STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 212
Query: 284 QQ 285
           ++
Sbjct: 213 EK 214

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 32  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 ++  ++    SL+  LH  +             ++ + IA   A+G++YLH K+
Sbjct: 90  TKPQLAIVT-QWCEGSSLYHHLHASE--------TKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D+  KI DF L+ +    +      ++ G+  + APE     
Sbjct: 141 ---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
             N    +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 65
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 66  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 117
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D     ++ R    
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAK 171
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           F   + APE    G    KSDV+SFG++L E++T GR P
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 70
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 71  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 122
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D     ++ R    
Sbjct: 123 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAK 176
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           F   + APE    G    KSDV+SFG++L E++T GR P
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 71
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 72  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 123
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D     ++ R    
Sbjct: 124 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAK 177
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           F   + APE    G    KSDV+SFG++L E++T GR P
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 125/241 (51%), Gaps = 39/241 (16%)
Query: 56  AISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQV 113
           A+++ ELK +         IG+G +G V  G  + G+  A+K  K DA+ Q    FLA+ 
Sbjct: 8   ALNMKELKLLQT-------IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEA 56
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
           S++++L+H N VQLLG  V+    + +  E+ + GSL D L  R          VL    
Sbjct: 57  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDC 109
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
            +K ++   + +EYL      + +HRD+ + NVL+ +D+VAK++DF L+ +A        
Sbjct: 110 LLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-------S 159
Query: 233 STRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG------RKPVDHTLPRGQ 284
           ST+  G     + APE       + KSDV+SFG++L E+ +       R P+   +PR +
Sbjct: 160 STQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 219
Query: 285 Q 285
           +
Sbjct: 220 K 220

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 120/259 (46%), Gaps = 25/259 (9%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 60
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 61  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 112
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D     ++ R    
Sbjct: 113 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAK 166
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP--------VDHTLPRGQQSLV 288
           F   + APE    G    KSDV+SFG++L E++T GR P        V   L RG + + 
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 226
Query: 289 TWATPKLSEDKVRQCVDAR 307
               P+     +R C   R
Sbjct: 227 PDNCPEELYQLMRLCWKER 245

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 73
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 74  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 125
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D      + R    
Sbjct: 126 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAK 179
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           F   + APE    G    KSDV+SFG++L E++T GR P
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 71
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 72  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 123
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D      + R    
Sbjct: 124 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAK 177
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           F   + APE    G    KSDV+SFG++L E++T GR P
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           IG G +G V+ G   +    AIK +      +++F+ +  ++ +L H   VQL G C++ 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               L +EF  +G L D L  ++G+  A        +  + + +   +G+ YL E     
Sbjct: 95  APICLVFEFMEHGCLSDYLRTQRGLFAA--------ETLLGMCLDVCEGMAYLEEAC--- 143
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
           +IHRD+ + N L+ ++ V K++DF ++    D      ST       + +PE     + +
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 255 AKSDVYSFGVVLLELLT-GRKPVDH 278
           +KSDV+SFGV++ E+ + G+ P ++
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYEN 227

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 74
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 75  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 126
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D      + R    
Sbjct: 127 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAK 180
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           F   + APE    G    KSDV+SFG++L E++T GR P
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 86  EPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVL-----LYMATQISSAMEYLEKK--- 135
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVL-----LYMATQISSAMEYLEKK--- 130
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 86  EPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 135
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVL-----LYMATQISSAMEYLEKK--- 130
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 65
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 66  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 117
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D      + R    
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAK 171
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           F   + APE    G    KSDV+SFG++L E++T GR P
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 67
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 68  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 119
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D      + R    
Sbjct: 120 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAK 173
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           F   + APE    G    KSDV+SFG++L E++T GR P
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 81  EPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVL-----LYMATQISSAMEYLEKK--- 130
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 79  EPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVL-----LYMATQISSAMEYLEKK--- 128
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL 253
           + IHRD+ + N L+ ++ + K+ADF LS          H+        + APE     + 
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAYNKF 187
Query: 254 NAKSDVYSFGVVLLELLT 271
           + KSDV++FGV+L E+ T
Sbjct: 188 SIKSDVWAFGVLLWEIAT 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 81  EPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVL-----LYMATQISSAMEYLEKK--- 130
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 65
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 66  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 117
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D      + R    
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAK 171
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           F   + APE    G    KSDV+SFG++L E++T GR P
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 86  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 135
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           DE +   E       +G G +G V+ G        A+K L       + FLA+ +++ +L
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 66
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H+  V+L          ++  E+  NGSL D L    G+K       L+  + + +A  
Sbjct: 67  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQ 118
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A+G+ ++ E+   + IHRD++++N+L+ D    KIADF L+    D      + R    
Sbjct: 119 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAK 172
Query: 240 F--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           F   + APE    G    KSDV+SFG++L E++T GR P
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 85  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 134
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 192 KFSIKSDVWAFGVLLWEIAT 211

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 86  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 135
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 83  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 132
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 189
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 81  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 130
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 20  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 ++  ++    SL+  LH  +             ++ + IA   A+G++YLH K+
Sbjct: 78  TKPQLAIVT-QWCEGSSLYHHLHASE--------TKFEMKKLIDIARQTARGMDYLHAKS 128
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D+  KI DF L+      +      ++ G+  + APE     
Sbjct: 129 ---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
             N    +SDVY+FG+VL EL+TG+ P  +   R Q
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 221

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 82  EPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 131
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL 253
           + IHRD+ + N L+ ++ + K+ADF LS          H+        + APE     + 
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAYNKF 190
Query: 254 NAKSDVYSFGVVLLELLT 271
           + KSDV++FGV+L E+ T
Sbjct: 191 SIKSDVWAFGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 86  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 135
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL 253
           + IHRD+ + N L+ ++ + K+ADF LS          H+        + APE     + 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAYNKF 194
Query: 254 NAKSDVYSFGVVLLELLT 271
           + KSDV++FGV+L E+ T
Sbjct: 195 SIKSDVWAFGVLLWEIAT 212

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 112/230 (48%), Gaps = 19/230 (8%)
Query: 75  IGEGSYGRVYYGILKSGHAAAI-KKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           IG GS+G VY G      A  I K +D + +  + F  +V+++ + +H N +  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
               ++  ++    SL+  LH ++              Q + IA   A+G++YLH K   
Sbjct: 104 DNLAIVT-QWCEGSSLYKHLHVQE--------TKFQMFQLIDIARQTAQGMDYLHAK--- 151
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL 253
           +IIHRD+KS+N+ + +    KI DF L+      +      +  G+  + APE       
Sbjct: 152 NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211
Query: 254 NA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSE 297
           N    +SDVYS+G+VL EL+TG  P  H   R Q   +    +A+P LS+
Sbjct: 212 NPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK 261

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           IG G +G V+ G   +    AIK +      +E+F+ +  ++ +L H   VQL G C++ 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               L  EF  +G L D L  ++G+  A+          + + +   +G+ YL E     
Sbjct: 76  APICLVTEFMEHGCLSDYLRTQRGLFAAET--------LLGMCLDVCEGMAYLEEAC--- 124
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
           +IHRD+ + N L+ ++ V K++DF ++    D      ST       + +PE     + +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 255 AKSDVYSFGVVLLELLT-GRKPVDH 278
           +KSDV+SFGV++ E+ + G+ P ++
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYEN 208

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 12/216 (5%)
Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSM 115
           +S+D+ +    +      +G G YG VY G+ K      A+K L       EEFL + ++
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 60
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           +  +KH N VQLLG C       +  EF + G+L D L  R+  +      VL     + 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVL-----LY 113
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
           +A   +  +EYL +K   + IHRD+ + N L+ ++ + K+ADF LS          H+  
Sbjct: 114 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGA 170
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                 + APE     + + KSDV++FGV+L E+ T
Sbjct: 171 KF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 81  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 130
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 94  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 143
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 144 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 200
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 201 KFSIKSDVWAFGVLLWEIAT 220

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 83  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 132
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 189
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT 209

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 25/253 (9%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
           K+  E F     +GEGSYG VY  I K +G   AIK++       +E + ++S++ +   
Sbjct: 25  KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQQCDS 83
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            + V+  G     T   +  E+   GS+ DI+  R           L+  +   I     
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR--------NKTLTEDEIATILQSTL 135
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
           KGLEYLH       IHRDIK+ N+L+  +  AK+ADF ++ Q  D  A+     V+GT  
Sbjct: 136 KGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK--RNXVIGTPF 190
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV------TWATPKL 295
           + APE       N  +D++S G+  +E+  G+ P     P     ++      T+  P+L
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL 250
Query: 296 SEDK----VRQCV 304
             D     V+QC+
Sbjct: 251 WSDNFTDFVKQCL 263

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 82  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 131
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAPAGAKFPIKWTAPESLAYN 188
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT 208

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 138/291 (47%), Gaps = 47/291 (16%)
Query: 75  IGEGSYGRVYYG-ILKSGHAAAIKKL---DASKQPD-----EEFLAQVSMVSRLKHENFV 125
           IG+G +G V+ G ++K     AIK L   D+  + +     +EF  +V ++S L H N V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +L G   +    V+  EF   G L+  L     +  A P   + W  ++++ +  A G+E
Sbjct: 87  KLYGLMHNPPRMVM--EFVPCGDLYHRL-----LDKAHP---IKWSVKLRLMLDIALGIE 136
Query: 186 YLHEKADPHIIHRDIKSSNVLI--FDDD---VAKIADFDLSNQAPDMAARLHSTR-VLGT 239
           Y+  + +P I+HRD++S N+ +   D++    AK+ADF LS Q+      +HS   +LG 
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS------VHSVSGLLGN 189
Query: 240 FGYHAPEY--AMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 297
           F + APE   A       K+D YSF ++L  +LTG  P D     G+   +      + E
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-YSYGKIKFIN----MIRE 244
Query: 298 DKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPL 348
           + +R  +      D PP           LC   +   RP+ S +VK L  L
Sbjct: 245 EGLRPTIPE----DCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 116/244 (47%), Gaps = 25/244 (10%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G        A+K L       + FLA+ +++ +L+H+  V+L       
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 76
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
              ++  E+  NGSL D L    G+K       L+  + + +A   A+G+ ++ E+   +
Sbjct: 77  PIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER---N 125
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            IHR+++++N+L+ D    KIADF L+    D     ++ R    F   + APE    G 
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 182
Query: 253 LNAKSDVYSFGVVLLELLT-GRKP--------VDHTLPRGQQSLVTWATPKLSEDKVRQC 303
              KSDV+SFG++L E++T GR P        V   L RG + +     P+     +R C
Sbjct: 183 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 242
Query: 304 VDAR 307
              R
Sbjct: 243 WKER 246

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 83  EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 132
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAPAGAKFPIKWTAPESLAYN 189
Query: 252 QLNAKSDVYSFGVVLLELLT 271
           + + KSDV++FGV+L E+ T
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT 209

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 12/216 (5%)
Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSM 115
           +S+D+ +    +      +G G +G VY G+ K      A+K L       EEFL + ++
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 60
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           +  +KH N VQLLG C       +  EF + G+L D L  R+  +      VL     + 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVL-----LY 113
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
           +A   +  +EYL +K   + IHRD+ + N L+ ++ + K+ADF LS          H+  
Sbjct: 114 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA 170
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                 + APE     + + KSDV++FGV+L E+ T
Sbjct: 171 KF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 138/291 (47%), Gaps = 47/291 (16%)
Query: 75  IGEGSYGRVYYG-ILKSGHAAAIKKL---DASKQPD-----EEFLAQVSMVSRLKHENFV 125
           IG+G +G V+ G ++K     AIK L   D+  + +     +EF  +V ++S L H N V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +L G   +    V+  EF   G L+  L     +  A P   + W  ++++ +  A G+E
Sbjct: 87  KLYGLMHNPPRMVM--EFVPCGDLYHRL-----LDKAHP---IKWSVKLRLMLDIALGIE 136
Query: 186 YLHEKADPHIIHRDIKSSNVLI--FDDD---VAKIADFDLSNQAPDMAARLHSTR-VLGT 239
           Y+  + +P I+HRD++S N+ +   D++    AK+ADF LS Q+      +HS   +LG 
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS------VHSVSGLLGN 189
Query: 240 FGYHAPEY--AMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 297
           F + APE   A       K+D YSF ++L  +LTG  P D     G+   +      + E
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-YSYGKIKFIN----MIRE 244
Query: 298 DKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPL 348
           + +R  +      D PP           LC   +   RP+ S +VK L  L
Sbjct: 245 EGLRPTIPE----DCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 75  IGEGSYGRVY----YGIL--KSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G+V+    + +L  +     A+K L +AS+   ++F  +  +++ L+H++ V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HG-----RKGVKGAQPGPVLSWQQRVKIAVGA 180
            G C +G   ++ +E+  +G L+  L  HG       G +   PGP L   Q + +A   
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAVASQV 144
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A G+ YL   A  H +HRD+ + N L+    V KI DF +S             R +   
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            +  PE  +  +   +SDV+SFGVVL E+ T G++P
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 75  IGEGSYGRVY----YGIL--KSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G+V+    + +L  +     A+K L +AS+   ++F  +  +++ L+H++ V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HG-----RKGVKGAQPGPVLSWQQRVKIAVGA 180
            G C +G   ++ +E+  +G L+  L  HG       G +   PGP L   Q + +A   
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAVASQV 138
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A G+ YL   A  H +HRD+ + N L+    V KI DF +S             R +   
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            +  PE  +  +   +SDV+SFGVVL E+ T G++P
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 33/279 (11%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 288 EPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVL-----LYMATQISSAMEYLEKK--- 337
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHR++ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 252 QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG 310
           + + KSDV++FGV+L E+ T G  P                 P +   +V + ++     
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRM 438
Query: 311 DYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLL 349
           + P             C Q+    RP+ + + +A + + 
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 75  IGEGSYGRVY----YGIL--KSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G+V+    + +L  +     A+K L +AS+   ++F  +  +++ L+H++ V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HG-----RKGVKGAQPGPVLSWQQRVKIAVGA 180
            G C +G   ++ +E+  +G L+  L  HG       G +   PGP L   Q + +A   
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAVASQV 167
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A G+ YL   A  H +HRD+ + N L+    V KI DF +S             R +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            +  PE  +  +   +SDV+SFGVVL E+ T G++P
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G  G V+ G        A+K L       + FLA+ +++ +L+H+  V+L       
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
              ++  E+  NGSL D L    G+K       L+  + + +A   A+G+ ++ E+   +
Sbjct: 81  PIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER---N 129
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            IHRD++++N+L+ D    KIADF L+    D      + R    F   + APE    G 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEX---TAREGAKFPIKWTAPEAINYGT 186
Query: 253 LNAKSDVYSFGVVLLELLT-GRKP 275
              KSDV+SFG++L E++T GR P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  E+   G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 100 EPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVL-----LYMATQISSAMEYLEKK--- 149
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHRD+ + N L+ ++ V K+ADF LS     M    ++      F   + APE     
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 206
Query: 252 QLNAKSDVYSFGVVLLELLT-GRKP 275
             + KSDV++FGV+L E+ T G  P
Sbjct: 207 TFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 33/279 (11%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L  R+  +      VL     + +A   +  +EYL +K   
Sbjct: 327 EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 376
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
           + IHR++ + N L+ ++ + K+ADF LS     M    ++      F   + APE     
Sbjct: 377 NFIHRNLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 433
Query: 252 QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG 310
           + + KSDV++FGV+L E+ T G  P                 P +   +V + ++     
Sbjct: 434 KFSIKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRM 477
Query: 311 DYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLL 349
           + P             C Q+    RP+ + + +A + + 
Sbjct: 478 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 516

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 34/294 (11%)
Query: 75  IGEGSYGRVY----YGI--LKSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G+V+    Y +   K     A+K L D +    ++F  +  +++ L+HE+ V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGV-----KGAQPGPVLSWQQRVKIAVGA 180
            G C DG   ++ +E+  +G L+  L  HG   +     +  Q    L   Q + IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A G+ YL   A  H +HRD+ + N L+  + + KI DF +S               +   
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 299
            +  PE  M  +   +SDV+SFGV+L E+ T G++P              W   +LS  +
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------------WF--QLSNTE 243
Query: 300 VRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
           V +C+      + P             C Q E   R N+  + K L  L  A P
Sbjct: 244 VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKATP 297

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      G+ K      +  A  + K DA+++   + ++++ M+  + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGA-----QPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   LS +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+     +     +T  
Sbjct: 156 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G G +G V+          A+K +       E FLA+ +++  L+H+  V+
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 74
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L          ++  EF + GSL D L   +G K  QP P L     +  +   A+G+ +
Sbjct: 75  LHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAF 126
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           + ++   + IHRD++++N+L+    V KIADF L+    D     ++ R    F   + A
Sbjct: 127 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTA 180
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE    G    KSDV+SFG++L+E++T GR P
Sbjct: 181 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V YG  +  +  AIK +      ++EF+ +  ++  L HE  VQL G C   
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ +NG L + L  R+     Q       QQ +++     + +EYL  K    
Sbjct: 92  RPIFIITEYMANGCLLNYL--REMRHRFQT------QQLLEMCKDVCEAMEYLESK---Q 140
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            +HRD+ + N L+ D  V K++DF LS    D     +++ V   F   +  PE  M  +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK 197
Query: 253 LNAKSDVYSFGVVLLELLT-GRKPVDH 278
            ++KSD+++FGV++ E+ + G+ P + 
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V YG  +  +  AIK +      ++EF+ +  ++  L HE  VQL G C   
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 75
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ +NG L + L  R+     Q       QQ +++     + +EYL  K    
Sbjct: 76  RPIFIITEYMANGCLLNYL--REMRHRFQT------QQLLEMCKDVCEAMEYLESK---Q 124
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            +HRD+ + N L+ D  V K++DF LS    D     +++ V   F   +  PE  M  +
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK 181
Query: 253 LNAKSDVYSFGVVLLELLT-GRKPVD 277
            ++KSD+++FGV++ E+ + G+ P +
Sbjct: 182 FSSKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V YG  +  +  AIK +      ++EF+ +  ++  L HE  VQL G C   
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 82
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ +NG L + L  R+     Q       QQ +++     + +EYL  K    
Sbjct: 83  RPIFIITEYMANGCLLNYL--REMRHRFQT------QQLLEMCKDVCEAMEYLESK---Q 131
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            +HRD+ + N L+ D  V K++DF LS    D     +++ V   F   +  PE  M  +
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK 188
Query: 253 LNAKSDVYSFGVVLLELLT-GRKPVD 277
            ++KSD+++FGV++ E+ + G+ P +
Sbjct: 189 FSSKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V YG  +  +  AIK +      ++EF+ +  ++  L HE  VQL G C   
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ +NG L + L  R+     Q       QQ +++     + +EYL  K    
Sbjct: 77  RPIFIITEYMANGCLLNYL--REMRHRFQT------QQLLEMCKDVCEAMEYLESK---Q 125
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            +HRD+ + N L+ D  V K++DF LS    D     +++ V   F   +  PE  M  +
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK 182
Query: 253 LNAKSDVYSFGVVLLELLT-GRKPVD 277
            ++KSD+++FGV++ E+ + G+ P +
Sbjct: 183 FSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V YG  +  +  AIK +      ++EF+ +  ++  L HE  VQL G C   
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ +NG L + L  R+     Q       QQ +++     + +EYL  K    
Sbjct: 72  RPIFIITEYMANGCLLNYL--REMRHRFQT------QQLLEMCKDVCEAMEYLESK---Q 120
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            +HRD+ + N L+ D  V K++DF LS    D     +++ V   F   +  PE  M  +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK 177
Query: 253 LNAKSDVYSFGVVLLELLT-GRKPVD 277
            ++KSD+++FGV++ E+ + G+ P +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 137/291 (47%), Gaps = 47/291 (16%)
Query: 75  IGEGSYGRVYYG-ILKSGHAAAIKKL---DASKQPD-----EEFLAQVSMVSRLKHENFV 125
           IG+G +G V+ G ++K     AIK L   D+  + +     +EF  +V ++S L H N V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +L G   +    V+  EF   G L+  L     +  A P   + W  ++++ +  A G+E
Sbjct: 87  KLYGLMHNPPRMVM--EFVPCGDLYHRL-----LDKAHP---IKWSVKLRLMLDIALGIE 136
Query: 186 YLHEKADPHIIHRDIKSSNVLI--FDDD---VAKIADFDLSNQAPDMAARLHSTR-VLGT 239
           Y+  + +P I+HRD++S N+ +   D++    AK+ADF  S Q+      +HS   +LG 
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS------VHSVSGLLGN 189
Query: 240 FGYHAPEY--AMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 297
           F + APE   A       K+D YSF ++L  +LTG  P D     G+   +      + E
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-YSYGKIKFIN----MIRE 244
Query: 298 DKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPL 348
           + +R  +      D PP           LC   +   RP+ S +VK L  L
Sbjct: 245 EGLRPTIPE----DCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+L H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 95  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 152
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 153 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 209
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 254
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 255 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
Query: 346 Q 346
           +
Sbjct: 315 E 315

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      G+ K      +  A  + K DA+++   + ++++ M+  + KH+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGA-----QPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   LS +  V  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+     +     +T  
Sbjct: 149 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ T
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      G+ K      +  A  + K DA+++   + ++++ M+  + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGA-----QPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   LS +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+     +     +T  
Sbjct: 156 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V YG  +  +  AIK +      ++EF+ +  ++  L HE  VQL G C   
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ +NG L + L  R+     Q       QQ +++     + +EYL  K    
Sbjct: 92  RPIFIITEYMANGCLLNYL--REMRHRFQT------QQLLEMCKDVCEAMEYLESK---Q 140
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            +HRD+ + N L+ D  V K++DF LS    D      ++ V   F   +  PE  M  +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSK 197
Query: 253 LNAKSDVYSFGVVLLELLT-GRKPVDH 278
            ++KSD+++FGV++ E+ + G+ P + 
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      G+ K      +  A  + K DA+++   + ++++ M+  + KH+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGA-----QPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   LS +  V  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+     +     +T  
Sbjct: 145 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ T
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+L H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 81  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 138
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 139 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 195
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 196 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 240
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300
Query: 346 Q 346
           +
Sbjct: 301 E 301

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      G+ K      +  A  + K DA+++   + ++++ M+  + KH+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVK-----GAQPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++        P   LS +  V  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+     +     +T  
Sbjct: 141 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ T
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G G +G V+          A+K +       E FLA+ +++  L+H+  V+
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L          ++  EF + GSL D L   +G K  QP P L     +  +   A+G+ +
Sbjct: 248 LHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAF 299
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           + ++   + IHRD++++N+L+    V KIADF L+    D     ++ R    F   + A
Sbjct: 300 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTA 353
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE    G    KSDV+SFG++L+E++T GR P
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      G+ K      +  A  + K DA+++   + ++++ M+  + KH+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGA-----QPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   LS +  V  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+     +     +T  
Sbjct: 148 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ T
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      G+ K      +  A  + K DA+++   + ++++ M+  + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVK-----GAQPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++        P   LS +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+     +     +T  
Sbjct: 156 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      G+ K      +  A  + K DA+++   + ++++ M+  + KH+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGA-----QPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   LS +  V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+     +     +T  
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ T
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 123/280 (43%), Gaps = 35/280 (12%)
Query: 75  IGEGSYGRVYYGILKSGHA-AAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
           IG G++G V+ G L++ +   A+K    +  PD   +FL +  ++ +  H N V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                  +  E    G     L      +GA+    L  +  +++   AA G+EYL  K 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR----TEGAR----LRVKTLLQMVGDAAAGMEYLESKC 233
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
               IHRD+ + N L+ + +V KI+DF +S +  D               + APE    G
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 252 QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG 310
           + +++SDV+SFG++L E  + G  P                 P LS  + R+ V+   GG
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPY----------------PNLSNQQTREFVEK--GG 332
Query: 311 DYPPXXXXXXXXXXXL--CVQYEADFRPNMSIVVKALQPL 348
             P            +  C  YE   RP+ S + + LQ +
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      G+ K      +  A  + K DA+++   + ++++ M+  + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGA-----QPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   LS +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+     +     +T  
Sbjct: 156 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 136/291 (46%), Gaps = 43/291 (14%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 16  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 ++  ++    SL+  LH  +              + + IA   A+G++YLH K+
Sbjct: 74  TKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D   KI DF L+ +    +      ++ G+  + APE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVR-QCV 304
             N    +SDVY+FG+VL EL+TG+ P  +   R Q   +    + +P LS  KVR  C 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--KVRSNCP 239
Query: 305 DA--RLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
            A  RL  +               C++ + D RP    ++ +++ L  + P
Sbjct: 240 KAMKRLMAE---------------CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 12  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 71
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 72  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 129
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 130 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 186
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 187 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 231
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 232 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291
Query: 346 Q 346
           +
Sbjct: 292 E 292

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 136/291 (46%), Gaps = 43/291 (14%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 44  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 ++  ++    SL+  LH  +              + + IA   A+G++YLH K+
Sbjct: 102 TKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D   KI DF L+ +    +      ++ G+  + APE     
Sbjct: 153 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVR-QCV 304
             N    +SDVY+FG+VL EL+TG+ P  +   R Q   +    + +P LS  KVR  C 
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--KVRSNCP 267
Query: 305 DA--RLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
            A  RL  +               C++ + D RP    ++ +++ L  + P
Sbjct: 268 KAMKRLMAE---------------CLKKKRDERPLFPQILASIELLARSLP 303

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRP-RPSQPS-SL 137
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 138 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 239
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 240 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
Query: 346 Q 346
           +
Sbjct: 300 E 300

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 123/280 (43%), Gaps = 35/280 (12%)
Query: 75  IGEGSYGRVYYGILKSGHA-AAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
           IG G++G V+ G L++ +   A+K    +  PD   +FL +  ++ +  H N V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                  +  E    G     L      +GA+    L  +  +++   AA G+EYL  K 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR----TEGAR----LRVKTLLQMVGDAAAGMEYLESKC 233
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
               IHRD+ + N L+ + +V KI+DF +S +  D               + APE    G
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 252 QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG 310
           + +++SDV+SFG++L E  + G  P                 P LS  + R+ V+   GG
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPY----------------PNLSNQQTREFVEK--GG 332
Query: 311 DYPPXXXXXXXXXXXL--CVQYEADFRPNMSIVVKALQPL 348
             P            +  C  YE   RP+ S + + LQ +
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 137
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 138 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 239
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 240 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
Query: 346 Q 346
           +
Sbjct: 300 E 300

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRP-RPSQPS-SL 152
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 153 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 209
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 254
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 255 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
Query: 346 Q 346
           +
Sbjct: 315 E 315

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 136/291 (46%), Gaps = 43/291 (14%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 36  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 ++  ++    SL+  LH  +              + + IA   A+G++YLH K+
Sbjct: 94  TKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAKS 144
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D   KI DF L+ +    +      ++ G+  + APE     
Sbjct: 145 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVR-QCV 304
             N    +SDVY+FG+VL EL+TG+ P  +   R Q   +    + +P LS  KVR  C 
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--KVRSNCP 259
Query: 305 DA--RLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
            A  RL  +               C++ + D RP    ++ +++ L  + P
Sbjct: 260 KAMKRLMAE---------------CLKKKRDERPLFPQILASIELLARSLP 295

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 37  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 96
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 97  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 154
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 155 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 211
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 212 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 256
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 257 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316
Query: 346 Q 346
           +
Sbjct: 317 E 317

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 138
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 139 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIY 195
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 196 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 240
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300
Query: 346 Q 346
           +
Sbjct: 301 E 301

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 138
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 139 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 195
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 196 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 240
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300
Query: 346 Q 346
           +
Sbjct: 301 E 301

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 27  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 86
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 87  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 144
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 145 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 201
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 202 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 246
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 247 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 306
Query: 346 Q 346
           +
Sbjct: 307 E 307

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V YG  +  +  AIK +      ++EF+ +  ++  L HE  VQL G C   
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ +NG L + L  R+     Q       QQ +++     + +EYL  K    
Sbjct: 77  RPIFIITEYMANGCLLNYL--REMRHRFQT------QQLLEMCKDVCEAMEYLESK---Q 125
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT---FGYHAPEYAMTG 251
            +HRD+ + N L+ D  V K++DF LS    D      S+R  G+     +  PE  M  
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSR--GSKFPVRWSPPEVLMYS 181
Query: 252 QLNAKSDVYSFGVVLLELLT-GRKPVD 277
           + ++KSD+++FGV++ E+ + G+ P +
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEI-TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 47  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 106
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 107 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 164
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 165 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 221
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 222 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 266
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 267 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 326
Query: 346 Q 346
           +
Sbjct: 327 E 327

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 38  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 97
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 98  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 155
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 156 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 212
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
                      +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 213 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 257
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 258 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317
Query: 346 Q 346
           +
Sbjct: 318 E 318

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G G +G V+          A+K +       E FLA+ +++  L+H+  V+
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 241
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L          ++  EF + GSL D L   +G K  QP P L     +  +   A+G+ +
Sbjct: 242 LHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAF 293
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHA 244
           + ++   + IHRD++++N+L+    V KIADF L+             RV   F   + A
Sbjct: 294 IEQR---NYIHRDLRAANILVSASLVCKIADFGLA-------------RVGAKFPIKWTA 337
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE    G    KSDV+SFG++L+E++T GR P
Sbjct: 338 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDA--SKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD 94
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 152
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 153 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 209
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
             +        +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 254
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 255 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
Query: 346 Q 346
           +
Sbjct: 315 E 315

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 32/301 (10%)
Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLD--ASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +       S    A+K L    S+Q + +
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L   +  + +QP   L
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SL 178
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 179 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
                      +    +  PE  M G   +K+D +SFGV+L E+                
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------- 280
Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKAL 345
           SL     P  S  +V + V +    D P             C Q++ + RPN +I+++ +
Sbjct: 281 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340
Query: 346 Q 346
           +
Sbjct: 341 E 341

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 112/215 (52%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++    ++T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 127/287 (44%), Gaps = 36/287 (12%)
Query: 74  LIGEGSYGRVYYGILKSGHA-----AAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQ 126
           +IG G +G VY G+LK+         AIK L A  +++   +FL +  ++ +  H N ++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L G        ++  E+  NG+L   L  + G          S  Q V +  G A G++Y
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRGIAAGMKY 162
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT-FGYHAP 245
           L   A+ + +HRD+ + N+L+  + V K++DF LS    D     ++T        + AP
Sbjct: 163 L---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV 304
           E     +  + SDV+SFG+V+ E++T G +P              W   +LS  +V + +
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERPY-------------W---ELSNHEVMKAI 263
Query: 305 DARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNA 351
           +       P             C Q E   RP  + +V  L  L+ A
Sbjct: 264 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 21  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 ++  ++    SL+  LH  +              + + IA   A+G++YLH K+
Sbjct: 79  TKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D   KI DF L+      +      ++ G+  + APE     
Sbjct: 130 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVR-QCV 304
             N    +SDVY+FG+VL EL+TG+ P  +   R Q   +    + +P LS  KVR  C 
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--KVRSNCP 244
Query: 305 DA--RLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
            A  RL  +               C++ + D RP    ++ +++ L  + P
Sbjct: 245 KAMKRLMAE---------------CLKKKRDERPLFPQILASIELLARSLP 280

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 16  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 ++  ++    SL+  LH  +              + + IA   A+G++YLH K+
Sbjct: 74  TKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D   KI DF L+      +      ++ G+  + APE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVR-QCV 304
             N    +SDVY+FG+VL EL+TG+ P  +   R Q   +    + +P LS  KVR  C 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--KVRSNCP 239
Query: 305 DA--RLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
            A  RL  +               C++ + D RP    ++ +++ L  + P
Sbjct: 240 KAMKRLMAE---------------CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 134/291 (46%), Gaps = 43/291 (14%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 16  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                  +  ++    SL+  LH  +              + + IA   A+G++YLH K+
Sbjct: 74  T-APQLAIVTQWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D   KI DF L+      +      ++ G+  + APE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVR-QCV 304
             N    +SDVY+FG+VL EL+TG+ P  +   R Q   +    + +P LS  KVR  C 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--KVRSNCP 239
Query: 305 DA--RLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
            A  RL  +               C++ + D RP    ++ +++ L  + P
Sbjct: 240 KAMKRLMAE---------------CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 21  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 ++  ++    SL+  LH  +              + + IA   A+G++YLH K+
Sbjct: 79  TKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D   KI DF L+      +      ++ G+  + APE     
Sbjct: 130 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVR-QCV 304
             N    +SDVY+FG+VL EL+TG+ P  +   R Q   +    + +P LS  KVR  C 
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--KVRSNCP 244
Query: 305 DA--RLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
            A  RL  +               C++ + D RP    ++ +++ L  + P
Sbjct: 245 KAMKRLMAE---------------CLKKKRDERPLFPQILASIELLARSLP 280

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 18  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 ++  ++    SL+  LH  +              + + IA   A+G++YLH K+
Sbjct: 76  TKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAKS 126
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D   KI DF L+      +      ++ G+  + APE     
Sbjct: 127 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVR-QCV 304
             N    +SDVY+FG+VL EL+TG+ P  +   R Q   +    + +P LS  KVR  C 
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--KVRSNCP 241
Query: 305 DA--RLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
            A  RL  +               C++ + D RP    ++ +++ L  + P
Sbjct: 242 KAMKRLMAE---------------CLKKKRDERPLFPQILASIELLARSLP 277

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 43  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 ++  ++    SL+  LH  +              + + IA   A+G++YLH K+
Sbjct: 101 TKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAKS 151
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D   KI DF L+      +      ++ G+  + APE     
Sbjct: 152 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVR-QCV 304
             N    +SDVY+FG+VL EL+TG+ P  +   R Q   +    + +P LS  KVR  C 
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--KVRSNCP 266
Query: 305 DA--RLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
            A  RL  +               C++ + D RP    ++ +++ L  + P
Sbjct: 267 KAMKRLMAE---------------CLKKKRDERPLFPQILASIELLARSLP 302

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG GS+G VY G  K     A+K L+ +    Q  + F  +V ++ + +H N +  +GY 
Sbjct: 44  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 ++  ++    SL+  LH  +              + + IA   A+G++YLH K+
Sbjct: 102 TKPQLAIVT-QWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              IIHRD+KS+N+ + +D   KI DF L+      +      ++ G+  + APE     
Sbjct: 153 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 252 QLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVR-QCV 304
             N    +SDVY+FG+VL EL+TG+ P  +   R Q   +    + +P LS  KVR  C 
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--KVRSNCP 267
Query: 305 DA--RLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP 353
            A  RL  +               C++ + D RP    ++ +++ L  + P
Sbjct: 268 KAMKRLMAE---------------CLKKKRDERPLFPQILASIELLARSLP 303

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G   +    A+K L       + FL + +++  L+H+  V+L       
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 79
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  EF + GSL D L   +G K   P       + +  +   A+G+ Y+  K   +
Sbjct: 80  EPIYIITEFMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQIAEGMAYIERK---N 129
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            IHRD++++NVL+ +  + KIADF L+    D     ++ R    F   + APE    G 
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGC 186
Query: 253 LNAKSDVYSFGVVLLELLT-GRKP 275
              KS+V+SFG++L E++T G+ P
Sbjct: 187 FTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG +G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG +G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G   +    A+K L       + FL + +++  L+H+  V+L       
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE 80
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ + GSL D L   +G K   P       + +  +   A+G+ Y+  K   +
Sbjct: 81  EPIYIITEYMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQIAEGMAYIERK---N 130
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
            IHRD++++NVL+ +  + KIADF L+    D     ++ R    F   + APE    G 
Sbjct: 131 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGC 187
Query: 253 LNAKSDVYSFGVVLLELLT-GRKP 275
              KSDV+SFG++L E++T G+ P
Sbjct: 188 FTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 110/224 (49%), Gaps = 33/224 (14%)
Query: 75  IGEGSYGRVYYGIL------KSGHAAAIKKL-DASKQP-DEEFLAQVSMVSRLKHENFVQ 126
           +GE  +G+VY G L      +   A AIK L D ++ P  EEF  +  + +RL+H N V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGR------------KGVKGAQPGPVLSWQQRV 174
           LLG         + + + S+G LH+ L  R            + VK A   P       V
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF-----V 148
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLH 232
            +    A G+EYL   +  H++H+D+ + NVL++D    KI+D  L  +  A D    L 
Sbjct: 149 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205
Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           ++  L    + APE  M G+ +  SD++S+GVVL E+ + G +P
Sbjct: 206 NS--LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG +G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG +G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 110/224 (49%), Gaps = 33/224 (14%)
Query: 75  IGEGSYGRVYYGIL------KSGHAAAIKKL-DASKQP-DEEFLAQVSMVSRLKHENFVQ 126
           +GE  +G+VY G L      +   A AIK L D ++ P  EEF  +  + +RL+H N V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGR------------KGVKGAQPGPVLSWQQRV 174
           LLG         + + + S+G LH+ L  R            + VK A   P       V
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF-----V 131
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLH 232
            +    A G+EYL   +  H++H+D+ + NVL++D    KI+D  L  +  A D    L 
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           ++  L    + APE  M G+ +  SD++S+GVVL E+ + G +P
Sbjct: 189 NS--LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 74  LIGEGSYGRVYYGILKSG---HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFVQL 127
           +IGEG++G+V    +K       AAIK++   ASK    +F  ++ ++ +L H  N + L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGA 180
           LG C       LA E+A +G+L D L   + ++              LS QQ +  A   
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A+G++YL +K     IHRD+ + N+L+ ++ VAKIADF LS        R     V  T 
Sbjct: 152 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKTM 200
Query: 241 GYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT 271
           G     +     LN       SDV+S+GV+L E+++
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V +IADF L+    ++     +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 74  LIGEGSYGRVYYGILKSG---HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFVQL 127
           +IGEG++G+V    +K       AAIK++   ASK    +F  ++ ++ +L H  N + L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGA 180
           LG C       LA E+A +G+L D L   + ++              LS QQ +  A   
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A+G++YL +K     IHRD+ + N+L+ ++ VAKIADF LS        R     V  T 
Sbjct: 142 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKTM 190
Query: 241 GYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT 271
           G     +     LN       SDV+S+GV+L E+++
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 30/240 (12%)
Query: 55  PAISVDE-----LKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE 108
           PA S+DE     L++    F    L+G G+YG+VY G  +K+G  AAIK +D +   +EE
Sbjct: 7   PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE 66
Query: 109 FLAQVSMVSRLKH-ENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKG 161
              +++M+ +  H  N     G  +            L  EF   GS+ D++   KG   
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--- 123
Query: 162 AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
                 L  +    I     +GL +LH+     +IHRDIK  NVL+ ++   K+ DF +S
Sbjct: 124 ----NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-----LNAKSDVYSFGVVLLELLTGRKPV 276
            Q      R ++   +GT  + APE     +      + KSD++S G+  +E+  G  P+
Sbjct: 177 AQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 114/244 (46%), Gaps = 29/244 (11%)
Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
           IG+G+ G VY  + + +G   AI++++  +QP +E +    +V R  K+ N V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  E+ + GSL D++      +G          Q   +     + LE+LH    
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN-- 135
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
             +IHRDIKS N+L+  D   K+ DF    Q  P+ + R   + ++GT  + APE     
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SEMVGTPYWMAPEVVTRK 191
Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLS---------EDKVR 301
               K D++S G++ +E++ G  P  +  P R    + T  TP+L           D + 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 302 QCVD 305
           +C+D
Sbjct: 252 RCLD 255

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 74  LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G +G V  G LK         AIK L +  +++   +FL++ S++ +  H N + L
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G     T  ++  EF  NGSL   L    G          +  Q V +  G A G++YL
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYL 151
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG---TFGYHA 244
              AD + +HRD+ + N+L+  + V K++DF LS    D  +    T  LG      + A
Sbjct: 152 ---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 208
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE     +  + SDV+S+G+V+ E+++ G +P
Sbjct: 209 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 114/244 (46%), Gaps = 29/244 (11%)
Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
           IG+G+ G VY  + + +G   AI++++  +QP +E +    +V R  K+ N V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  E+ + GSL D++      +G          Q   +     + LE+LH    
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN-- 135
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
             +IHRDIKS N+L+  D   K+ DF    Q  P+ + R   + ++GT  + APE     
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 191
Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLS---------EDKVR 301
               K D++S G++ +E++ G  P  +  P R    + T  TP+L           D + 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 302 QCVD 305
           +C+D
Sbjct: 252 RCLD 255

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
           IG+G+ G VY  + + +G   AI++++  +QP +E +    +V R  K+ N V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  E+ + GSL D++      +G          Q   +     + LE+LH    
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN-- 135
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
             +IHRDIKS N+L+  D   K+ DF    Q  P+ + R   + ++GT  + APE     
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRK 191
Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKL 295
               K D++S G++ +E++ G  P  +  P R    + T  TP+L
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 74  LIGEGSYGRVYYGILKSG---HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFVQL 127
           +IGEG++G+V    +K       AAIK++   ASK    +F  ++ ++ +L H  N + L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGA 180
           LG C       LA E+A +G+L D L   + ++              LS QQ +  A   
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A+G++YL +K     IHR++ + N+L+ ++ VAKIADF LS        R     V  T 
Sbjct: 149 ARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLS--------RGQEVYVKKTM 197
Query: 241 GYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT 271
           G     +     LN       SDV+S+GV+L E+++
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
           IG+G+ G VY  + + +G   AI++++  +QP +E +    +V R  K+ N V  L   +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  E+ + GSL D++      +G          Q   +     + LE+LH    
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN-- 136
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
             +IHRDIKS N+L+  D   K+ DF    Q  P+ + R   + ++GT  + APE     
Sbjct: 137 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRK 192
Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKL 295
               K D++S G++ +E++ G  P  +  P R    + T  TP+L
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 237

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +   +AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
           IGEGS G V    ++S G   A+KK+D  KQ   E L  +V ++   +HEN V++    +
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            G    +  EF   G+L DI+ H R           ++ +Q   + +   + L  LH + 
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQG 267
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              +IHRDIKS ++L+  D   K++DF    Q      R     ++GT  + APE     
Sbjct: 268 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRL 322
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D++S G++++E++ G  P
Sbjct: 323 PYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 75  IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V      GI     K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGAQ-----PGPVLSWQQRVKI 176
            + LLG C       +   +AS G+L + L  R+  G++ +      P   ++++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL   A    IHRD+ + NVL+ +++V KIADF L+    ++     +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 37/286 (12%)
Query: 74  LIGEGSYGRVYYGILKS----GHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G +G V  G LK+        AIK L    +++   EFL++ S++ + +H N ++L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G   +    ++  EF  NG+L   L    G          +  Q V +  G A G+ YL
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDG--------QFTVIQLVGMLRGIASGMRYL 134
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG---TFGYHA 244
            E +    +HRD+ + N+L+  + V K++DF LS    + ++    T  LG      + A
Sbjct: 135 AEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTA 191
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 303
           PE     +  + SD +S+G+V+ E+++ G +P              W    +S   V   
Sbjct: 192 PEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY-------------W---DMSNQDVINA 235
Query: 304 VDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLL 349
           ++       PP            C Q + + RP    VV AL  ++
Sbjct: 236 IEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 281

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 26/228 (11%)
Query: 67  ENFGTNALIGEGSYGRVY----YGILKSGHA--AAIKKLD--ASKQPDEEFLAQVSMVSR 118
           EN     ++G G++G+V     YGI K+G +   A+K L   A     E  ++++ M+++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 119 L-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR--------------KGVKGAQ 163
           L  HEN V LLG C       L +E+   G L + L  +              K ++  +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
              VL+++  +  A   AKG+E+L  K+    +HRD+ + NVL+    V KI DF L+  
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
               +  +          + APE    G    KSDV+S+G++L E+ +
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
           IGEGS G V    ++S G   A+KK+D  KQ   E L  +V ++   +HEN V++    +
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            G    +  EF   G+L DI+ H R           ++ +Q   + +   + L  LH + 
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQG 190
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              +IHRDIKS ++L+  D   K++DF    Q      R     ++GT  + APE     
Sbjct: 191 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRL 245
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D++S G++++E++ G  P
Sbjct: 246 PYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 134/310 (43%), Gaps = 46/310 (14%)
Query: 55  PAISVDELKEITENF-GTNALIGEGSYGRVYYGILKS----GHAAAIKKLDA--SKQPDE 107
           P  S++  KEI  ++     +IG G +G V  G LK+        AIK L    +++   
Sbjct: 1   PWGSMEFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR 60
Query: 108 EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
           EFL++ S++ + +H N ++L G   +    ++  EF  NG+L   L    G         
Sbjct: 61  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG--------Q 112
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
            +  Q V +  G A G+ YL E +    +HRD+ + N+L+  + V K++DF LS    + 
Sbjct: 113 FTVIQLVGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN 169
Query: 228 AARLHSTRVLG---TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRG 283
           ++    T  LG      + APE     +  + SD +S+G+V+ E+++ G +P        
Sbjct: 170 SSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY------- 222
Query: 284 QQSLVTWATPKLSEDKVRQCVDARLGGDY----PPXXXXXXXXXXXLCVQYEADFRPNMS 339
                 W       D   Q V   +  DY    PP            C Q + + RP   
Sbjct: 223 ------W-------DMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFP 269
Query: 340 IVVKALQPLL 349
            VV AL  ++
Sbjct: 270 QVVSALDKMI 279

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
           IGEGS G V    ++S G   A+KK+D  KQ   E L  +V ++   +HEN V++    +
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            G    +  EF   G+L DI+ H R           ++ +Q   + +   + L  LH + 
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQG 145
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              +IHRDIKS ++L+  D   K++DF    Q      R     ++GT  + APE     
Sbjct: 146 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRL 200
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D++S G++++E++ G  P
Sbjct: 201 PYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
           IGEGS G V    ++S G   A+KK+D  KQ   E L  +V ++   +HEN V++    +
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            G    +  EF   G+L DI+ H R           ++ +Q   + +   + L  LH + 
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQG 147
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              +IHRDIKS ++L+  D   K++DF    Q      R     ++GT  + APE     
Sbjct: 148 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRL 202
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D++S G++++E++ G  P
Sbjct: 203 PYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 74  LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G  G V YG L+         AIK L A  +++   +FL++ S++ +  H N ++L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G    G   ++  E+  NGSL   L    G          +  Q V +  G   G+ YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYL 167
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHSTRVLGTFGYHA 244
              +D   +HRD+ + NVL+  + V K++DF LS      PD A      ++     + A
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTA 222
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE       ++ SDV+SFGVV+ E+L  G +P
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
           IGEGS G V    ++S G   A+KK+D  KQ   E L  +V ++   +HEN V++    +
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            G    +  EF   G+L DI+ H R           ++ +Q   + +   + L  LH + 
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQG 136
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              +IHRDIKS ++L+  D   K++DF    Q      R     ++GT  + APE     
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRL 191
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D++S G++++E++ G  P
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
           IGEGS G V    ++S G   A+KK+D  KQ   E L  +V ++   +HEN V++    +
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            G    +  EF   G+L DI+ H R           ++ +Q   + +   + L  LH + 
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQG 140
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              +IHRDIKS ++L+  D   K++DF    Q      R     ++GT  + APE     
Sbjct: 141 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRL 195
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D++S G++++E++ G  P
Sbjct: 196 PYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
           IG+G+ G VY  + + +G   AI++++  +QP +E +    +V R  K+ N V  L   +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  E+ + GSL D++      +G          Q   +     + LE+LH    
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN-- 136
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
             +IHR+IKS N+L+  D   K+ DF    Q  P+ + R   + ++GT  + APE     
Sbjct: 137 -QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 192
Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKL 295
               K D++S G++ +E++ G  P  +  P R    + T  TP+L
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 237

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 74  LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G  G V YG L+         AIK L A  +++   +FL++ S++ +  H N ++L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G    G   ++  E+  NGSL   L    G          +  Q V +  G   G+ YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYL 167
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHSTRVLGTFGYHA 244
              +D   +HRD+ + NVL+  + V K++DF LS      PD A      ++     + A
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRWTA 222
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE       ++ SDV+SFGVV+ E+L  G +P
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 120/282 (42%), Gaps = 29/282 (10%)
Query: 75  IGEGSYGRVYYG----ILKSGHA---AAIKKLDASKQPDE--EFLAQVSMVSRLKHENFV 125
           +G+GS+G VY G    I+K G A    A+K ++ S    E  EFL + S++      + V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG-PVLSWQQRVKIAVGAAKGL 184
           +LLG    G   ++  E  ++G L   L   +      PG P  + Q+ +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            YL+ K     +HRD+ + N ++  D   KI DF ++    +        + L    + A
Sbjct: 144 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV 304
           PE    G     SD++SFGVVL E+                SL       LS ++V + V
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFV 245
Query: 305 DARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 D P            +C Q+  + RP    +V  L+
Sbjct: 246 MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 140/315 (44%), Gaps = 42/315 (13%)
Query: 52  IEVPAISVDEL-KEI-TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SK 103
            E P  +V E  KE+   N   + ++G G +G V  G LK       + AIK L    ++
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +   +FL + S++ +  H N ++L G        ++  E+  NGSL   L  RK    AQ
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ 143
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
              +    Q V +  G A G++YL   +D   +HRD+ + N+LI  + V K++DF LS  
Sbjct: 144 FTVI----QLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 224 APDMAARLHSTRVLGT-FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281
             D     ++TR       + +PE     +  + SDV+S+G+VL E+++ G +P      
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----- 251
Query: 282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMS 339
                   W   ++S   V + VD   G   PP           +  C Q + + RP   
Sbjct: 252 --------W---EMSNQDVIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 340 IVVKALQPLLNARPG 354
            +V  L  L+   PG
Sbjct: 299 QIVSILDKLIR-NPG 312

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 29/282 (10%)
Query: 75  IGEGSYGRVYYG----ILKSGHA---AAIKKLDASKQPDE--EFLAQVSMVSRLKHENFV 125
           +G+GS+G VY G    I+K G A    A+K ++ S    E  EFL + S++      + V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG-PVLSWQQRVKIAVGAAKGL 184
           +LLG    G   ++  E  ++G L   L   +      PG P  + Q+ +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            YL+ K     +HRD+ + N ++  D   KI DF ++    + A      + L    + A
Sbjct: 144 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV 304
           PE    G     SD++SFGVVL E+                SL       LS ++V + V
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFV 245
Query: 305 DARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 D P            +C Q+    RP    +V  L+
Sbjct: 246 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 74  LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G +G V  G LK       A AIK L    +++   +FL + S++ +  H N V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G    G   ++  EF  NG+L   L    G          +  Q V +  G A G+ YL
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDG--------QFTVIQLVGMLRGIAAGMRYL 161
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG-----Y 242
              AD   +HRD+ + N+L+  + V K++DF LS    D    +++T    T G     +
Sbjct: 162 ---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT----TGGKIPVRW 214
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            APE     +  + SDV+S+G+V+ E+++ G +P
Sbjct: 215 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 140/315 (44%), Gaps = 42/315 (13%)
Query: 52  IEVPAISVDEL-KEI-TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SK 103
            E P  +V E  KE+   N   + ++G G +G V  G LK       + AIK L    ++
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +   +FL + S++ +  H N ++L G        ++  E+  NGSL   L  RK    AQ
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ 143
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
              +    Q V +  G A G++YL   +D   +HRD+ + N+LI  + V K++DF LS  
Sbjct: 144 FTVI----QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 224 APDMAARLHSTRVLGT-FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281
             D     ++TR       + +PE     +  + SDV+S+G+VL E+++ G +P      
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----- 251
Query: 282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMS 339
                   W   ++S   V + VD   G   PP           +  C Q + + RP   
Sbjct: 252 --------W---EMSNQDVIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 340 IVVKALQPLLNARPG 354
            +V  L  L+   PG
Sbjct: 299 QIVSILDKLIR-NPG 312

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/314 (27%), Positives = 140/314 (44%), Gaps = 42/314 (13%)
Query: 53  EVPAISVDEL-KEI-TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQ 104
           E P  +V E  KE+   N   + ++G G +G V  G LK       + AIK L    +++
Sbjct: 29  EDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 105 PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
              +FL + S++ +  H N ++L G        ++  E+  NGSL   L  RK    AQ 
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQF 144
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
             +    Q V +  G A G++YL   +D   +HRD+ + N+LI  + V K++DF LS   
Sbjct: 145 TVI----QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 225 PDMAARLHSTRVLGT-FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282
            D     ++TR       + +PE     +  + SDV+S+G+VL E+++ G +P       
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMSI 340
                  W   ++S   V + VD   G   PP           +  C Q + + RP    
Sbjct: 252 -------W---EMSNQDVIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 341 VVKALQPLLNARPG 354
           +V  L  L+   PG
Sbjct: 300 IVSILDKLIR-NPG 312

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 140/315 (44%), Gaps = 42/315 (13%)
Query: 52  IEVPAISVDEL-KEI-TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SK 103
            E P  +V E  KE+   N   + ++G G +G V  G LK       + AIK L    ++
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +   +FL + S++ +  H N ++L G        ++  E+  NGSL   L  RK    AQ
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ 143
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
              +    Q V +  G A G++YL   +D   +HRD+ + N+LI  + V K++DF LS  
Sbjct: 144 FTVI----QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 224 APDMAARLHSTRVLGT-FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281
             D     ++TR       + +PE     +  + SDV+S+G+VL E+++ G +P      
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----- 251
Query: 282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMS 339
                   W   ++S   V + VD   G   PP           +  C Q + + RP   
Sbjct: 252 --------W---EMSNQDVIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 340 IVVKALQPLLNARPG 354
            +V  L  L+   PG
Sbjct: 299 QIVSILDKLIR-NPG 312

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/314 (27%), Positives = 140/314 (44%), Gaps = 42/314 (13%)
Query: 53  EVPAISVDEL-KEI-TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQ 104
           E P  +V E  KE+   N   + ++G G +G V  G LK       + AIK L    +++
Sbjct: 29  EDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 105 PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
              +FL + S++ +  H N ++L G        ++  E+  NGSL   L  RK    AQ 
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQF 144
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
             +    Q V +  G A G++YL   +D   +HRD+ + N+LI  + V K++DF LS   
Sbjct: 145 TVI----QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 225 PDMAARLHSTRVLGT-FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282
            D     ++TR       + +PE     +  + SDV+S+G+VL E+++ G +P       
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMSI 340
                  W   ++S   V + VD   G   PP           +  C Q + + RP    
Sbjct: 252 -------W---EMSNQDVIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 341 VVKALQPLLNARPG 354
           +V  L  L+   PG
Sbjct: 300 IVSILDKLIR-NPG 312

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 74  LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G +G V  G LK         AIK L +  +++   +FL++ S++ +  H N + L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G     T  ++  EF  NGSL   L    G          +  Q V +  G A G++YL
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYL 125
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG---TFGYHA 244
              AD + +HR + + N+L+  + V K++DF LS    D  +    T  LG      + A
Sbjct: 126 ---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           PE     +  + SDV+S+G+V+ E+++ G +P
Sbjct: 183 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 119/282 (42%), Gaps = 29/282 (10%)
Query: 75  IGEGSYGRVYYG----ILKSGHA---AAIKKLDASKQPDE--EFLAQVSMVSRLKHENFV 125
           +G+GS+G VY G    I+K G A    A+K ++ S    E  EFL + S++      + V
Sbjct: 22  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG-PVLSWQQRVKIAVGAAKGL 184
           +LLG    G   ++  E  ++G L   L   +      PG P  + Q+ +++A   A G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            YL+ K     +HRD+ + N ++  D   KI DF ++    +        + L    + A
Sbjct: 141 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV 304
           PE    G     SD++SFGVVL E+                SL       LS ++V + V
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFV 242
Query: 305 DARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 D P            +C Q+    RP    +V  L+
Sbjct: 243 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 87/314 (27%), Positives = 140/314 (44%), Gaps = 42/314 (13%)
Query: 53  EVPAISVDEL-KEI-TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQ 104
           E P  +V E  KE+   N   + ++G G +G V  G LK       + AIK L    +++
Sbjct: 27  EDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 86
Query: 105 PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
              +FL + S++ +  H N ++L G        ++  E+  NGSL   L  RK    AQ 
Sbjct: 87  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQF 142
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
             +    Q V +  G A G++YL   +D   +HRD+ + N+LI  + V K++DF LS   
Sbjct: 143 TVI----QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 195
Query: 225 PDMAARLHSTRVLGT-FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282
            D     ++TR       + +PE     +  + SDV+S+G+VL E+++ G +P       
Sbjct: 196 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 249
Query: 283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMSI 340
                  W   ++S   V + VD   G   PP           +  C Q + + RP    
Sbjct: 250 -------W---EMSNQDVIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 297
Query: 341 VVKALQPLLNARPG 354
           +V  L  L+   PG
Sbjct: 298 IVSILDKLIR-NPG 310

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 119/282 (42%), Gaps = 29/282 (10%)
Query: 75  IGEGSYGRVYYG----ILKSGHA---AAIKKLDASKQPDE--EFLAQVSMVSRLKHENFV 125
           +G+GS+G VY G    I+K G A    A+K ++ S    E  EFL + S++      + V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG-PVLSWQQRVKIAVGAAKGL 184
           +LLG    G   ++  E  ++G L   L   +      PG P  + Q+ +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            YL+ K     +HRD+ + N ++  D   KI DF ++    +        + L    + A
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV 304
           PE    G     SD++SFGVVL E+                SL       LS ++V + V
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFV 245
Query: 305 DARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 D P            +C Q+    RP    +V  L+
Sbjct: 246 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 130/297 (43%), Gaps = 40/297 (13%)
Query: 68  NFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKH 121
           N   + ++G G +G V  G LK       + AIK L    +++   +FL + S++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L G        ++  E+  NGSL   L        AQ   +    Q V +  G A
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----AQFTVI----QLVGMLRGIA 128
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT-F 240
            G++YL   +D   +HRD+ + N+LI  + V K++DF LS    D     ++TR      
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 299
            + +PE     +  + SDV+S+G+VL E+++ G +P              W   ++S   
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQD 229
Query: 300 VRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMSIVVKALQPLLNARPG 354
           V + VD   G   PP           +  C Q + + RP    +V  L  L+   PG
Sbjct: 230 VIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR-NPG 283

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 130/297 (43%), Gaps = 40/297 (13%)
Query: 68  NFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKH 121
           N   + ++G G +G V  G LK       + AIK L    +++   +FL + S++ +  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L G        ++  E+  NGSL   L        AQ   +    Q V +  G A
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----AQFTVI----QLVGMLRGIA 145
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT-F 240
            G++YL   +D   +HRD+ + N+LI  + V K++DF LS    D     ++TR      
Sbjct: 146 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 202
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 299
            + +PE     +  + SDV+S+G+VL E+++ G +P              W   ++S   
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQD 246
Query: 300 VRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMSIVVKALQPLLNARPG 354
           V + VD   G   PP           +  C Q + + RP    +V  L  L+   PG
Sbjct: 247 VIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR-NPG 300

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 75  IGEGSYGRVYY----GIL--KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
           IGEG++GRV+     G+L  +     A+K L  +AS     +F  + ++++   + N V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRK--------------GVKGAQPG-PVLSWQ 171
           LLG C  G    L +E+ + G L++ L                    + + PG P LS  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
           +++ IA   A G+ YL E+     +HRD+ + N L+ ++ V KIADF LS          
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                     +  PE     +   +SDV+++GVVL E+ + G +P
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 74  LIGEGSYGRVYYGILKSGHAAAIK------KLDASKQPD-EEFLAQVSMVSRLKHENFVQ 126
           ++GEG +G V  G LK     ++K      KLD S Q + EEFL++ + +    H N ++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 127 LLGYCVDGTSR-----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           LLG C++ +S+     ++   F   G LH  L   +   G +  P+   Q  +K  V  A
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL---QTLLKFMVDIA 157
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+EYL  +   + +HRD+ + N ++ DD    +ADF LS +                  
Sbjct: 158 LGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           + A E        +KSDV++FGV + E+ T
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 124/289 (42%), Gaps = 34/289 (11%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHEN 123
           E F     IG+GS+G V+ GI  ++    AIK +D  +  DE    Q  ++++S+     
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
             +  G  +  T   +  E+   GS  D+L         +PGP L   Q   I     KG
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKG 131
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           L+YLH +     IHRDIK++NVL+ +    K+ADF ++ Q  D   ++     +GT  + 
Sbjct: 132 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWM 186
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 303
           APE       ++K+D++S G+  +EL  G  P     P     L+    P          
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---------- 236
Query: 304 VDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNAR 352
               L G+Y              C+  E  FRP    ++K    L NA+
Sbjct: 237 --PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
           IGEGS G V     K +G   A+KK+D  KQ   E L  +V ++    H+N V +    +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            G    +  EF   G+L DI+ H R           ++ +Q   + +   + L YLH + 
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCLSVLRALSYLHNQG 161
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              +IHRDIKS ++L+  D   K++DF    Q      +     ++GT  + APE     
Sbjct: 162 ---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISRL 216
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D++S G++++E++ G  P
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 124/289 (42%), Gaps = 34/289 (11%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHEN 123
           E F     IG+GS+G V+ GI  ++    AIK +D  +  DE    Q  ++++S+     
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
             +  G  +  T   +  E+   GS  D+L         +PGP L   Q   I     KG
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKG 116
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           L+YLH +     IHRDIK++NVL+ +    K+ADF ++ Q  D   ++     +GT  + 
Sbjct: 117 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWM 171
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 303
           APE       ++K+D++S G+  +EL  G  P     P     L+    P          
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---------- 221
Query: 304 VDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNAR 352
               L G+Y              C+  E  FRP    ++K    L NA+
Sbjct: 222 --PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 140/315 (44%), Gaps = 42/315 (13%)
Query: 52  IEVPAISVDEL-KEI-TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SK 103
            E P  +V E  KE+   N   + ++G G +G V  G LK       + AIK L    ++
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +   +FL + S++ +  H N ++L G        ++  E+  NGSL   L  RK    AQ
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ 143
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
              +    Q V +  G A G++YL   +D   +HRD+ + N+LI  + V K++DF L+  
Sbjct: 144 FTVI----QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARV 196
Query: 224 APDMAARLHSTRVLGT-FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281
             D     ++TR       + +PE     +  + SDV+S+G+VL E+++ G +P      
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----- 251
Query: 282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMS 339
                   W   ++S   V + VD   G   PP           +  C Q + + RP   
Sbjct: 252 --------W---EMSNQDVIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 340 IVVKALQPLLNARPG 354
            +V  L  L+   PG
Sbjct: 299 QIVSILDKLIR-NPG 312

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 124/289 (42%), Gaps = 34/289 (11%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHEN 123
           E F     IG+GS+G V+ GI  ++    AIK +D  +  DE    Q  ++++S+     
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
             +  G  +  T   +  E+   GS  D+L         +PGP L   Q   I     KG
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKG 116
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           L+YLH +     IHRDIK++NVL+ +    K+ADF ++ Q  D   ++     +GT  + 
Sbjct: 117 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWM 171
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 303
           APE       ++K+D++S G+  +EL  G  P     P     L+    P          
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---------- 221
Query: 304 VDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNAR 352
               L G+Y              C+  E  FRP    ++K    L NA+
Sbjct: 222 --PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 119/282 (42%), Gaps = 29/282 (10%)
Query: 75  IGEGSYGRVYYG----ILKSGHA---AAIKKLDASKQPDE--EFLAQVSMVSRLKHENFV 125
           +G+GS+G VY G    I+K G A    A+K ++ S    E  EFL + S++      + V
Sbjct: 24  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG-PVLSWQQRVKIAVGAAKGL 184
           +LLG    G   ++  E  ++G L   L   +      PG P  + Q+ +++A   A G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            YL+ K     +HRD+ + N ++  D   KI DF ++    +        + L    + A
Sbjct: 143 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV 304
           PE    G     SD++SFGVVL E+                SL       LS ++V + V
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFV 244
Query: 305 DARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 D P            +C Q+    RP    +V  L+
Sbjct: 245 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 127/293 (43%), Gaps = 42/293 (14%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHEN 123
           E F     IG+GS+G V+ GI  ++    AIK +D  +  DE    Q  ++++S+     
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
             +  G  +  T   +  E+   GS  D+L         +PGP L   Q   I     KG
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKG 136
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           L+YLH +     IHRDIK++NVL+ +    K+ADF ++ Q  D   ++     +GT  + 
Sbjct: 137 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWM 191
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK---- 299
           APE       ++K+D++S G+  +EL  G  P     P     L+    P   E      
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP 251
Query: 300 VRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNAR 352
           +++ V+A                    C+  E  FRP    ++K    L NA+
Sbjct: 252 LKEFVEA--------------------CLNKEPSFRPTAKELLKHKFILRNAK 284

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 113/244 (46%), Gaps = 19/244 (7%)
Query: 42  KGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AA 95
           +G     + P ++P     E       FG    +G G++G+V     +G+ K       A
Sbjct: 23  EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVA 80
Query: 96  IKKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI 152
           +K L ++   DE+   ++++ ++S L +HEN V LLG C  G   ++  E+   G L + 
Sbjct: 81  VKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 140
Query: 153 LHGRKGVKGAQPG-----PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207
           L  +  V    P        LS +  +  +   A+G+ +L   A  + IHRD+ + NVL+
Sbjct: 141 LRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 197
Query: 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 267
            +  VAKI DF L+    + +  +          + APE         +SDV+S+G++L 
Sbjct: 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
Query: 268 ELLT 271
           E+ +
Sbjct: 258 EIFS 261

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 74  LIGEGSYGRVYYGI-LKSGHAA----AIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQ 126
           ++G G++G VY GI +  G       AIK L+ +  P  + EF+ +  +++ + H + V+
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           LLG C+  T + L  +   +G L + +H  K   G+Q   +L+W       V  AKG+ Y
Sbjct: 105 LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQL--LLNW------CVQIAKGMMY 155
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           L E+    ++HRD+ + NVL+   +  KI DF L+          ++        + A E
Sbjct: 156 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
                +   +SDV+S+GV + EL+T G KP D
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 119/282 (42%), Gaps = 29/282 (10%)
Query: 75  IGEGSYGRVYYG----ILKSGHA---AAIKKLDASKQPDE--EFLAQVSMVSRLKHENFV 125
           +G+GS+G VY G    I+K G A    A+K ++ S    E  EFL + S++      + V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG-PVLSWQQRVKIAVGAAKGL 184
           +LLG    G   ++  E  ++G L   L   +      PG P  + Q+ +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            YL+ K     +HRD+ + N ++  D   KI DF ++    +        + L    + A
Sbjct: 144 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV 304
           PE    G     SD++SFGVVL E+                SL       LS ++V + V
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFV 245
Query: 305 DARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 D P            +C Q+    RP    +V  L+
Sbjct: 246 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 139/315 (44%), Gaps = 42/315 (13%)
Query: 52  IEVPAISVDEL-KEI-TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SK 103
            E P  +V E  KE+   N   + ++G G +G V  G LK       + AIK L    ++
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +   +FL + S++ +  H N ++L G        ++  E+  NGSL   L  RK    AQ
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK--HDAQ 143
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
              +    Q V +  G A G++YL   +D   +HRD+ + N+LI  + V K++DF L   
Sbjct: 144 FTVI----QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
Query: 224 APDMAARLHSTRVLGT-FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281
             D     ++TR       + +PE     +  + SDV+S+G+VL E+++ G +P      
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----- 251
Query: 282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMS 339
                   W   ++S   V + VD   G   PP           +  C Q + + RP   
Sbjct: 252 --------W---EMSNQDVIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 340 IVVKALQPLLNARPG 354
            +V  L  L+   PG
Sbjct: 299 QIVSILDKLIR-NPG 312

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 87/314 (27%), Positives = 139/314 (44%), Gaps = 42/314 (13%)
Query: 53  EVPAISVDEL-KEI-TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQ 104
           E P  +V E  KE+   N   + ++G G +G V  G LK       + AIK L    +++
Sbjct: 29  EDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 105 PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
              +FL + S++ +  H N ++L G        ++  E   NGSL   L  RK    AQ 
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RK--HDAQF 144
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
             +    Q V +  G A G++YL   +D   +HRD+ + N+LI  + V K++DF LS   
Sbjct: 145 TVI----QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 225 PDMAARLHSTRVLGT-FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282
            D     ++TR       + +PE     +  + SDV+S+G+VL E+++ G +P       
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMSI 340
                  W   ++S   V + VD   G   PP           +  C Q + + RP    
Sbjct: 252 -------W---EMSNQDVIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 341 VVKALQPLLNARPG 354
           +V  L  L+   PG
Sbjct: 300 IVSILDKLIR-NPG 312

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 85/315 (26%), Positives = 137/315 (43%), Gaps = 42/315 (13%)
Query: 52  IEVPAISVDEL-KEI-TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SK 103
            E P  +V E  KE+   N   + ++G G +G V  G LK       + AIK L    ++
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +   +FL + S++ +  H N ++L G        ++  E   NGSL   L        AQ
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD----AQ 143
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
              +    Q V +  G A G++YL   +D   +HRD+ + N+LI  + V K++DF LS  
Sbjct: 144 FTVI----QLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 224 APDMAARLHSTRVLGT-FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281
             D     ++TR       + +PE     +  + SDV+S+G+VL E+++ G +P      
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----- 251
Query: 282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMS 339
                   W   ++S   V + VD   G   PP           +  C Q + + RP   
Sbjct: 252 --------W---EMSNQDVIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 340 IVVKALQPLLNARPG 354
            +V  L  L+   PG
Sbjct: 299 QIVSILDKLIR-NPG 312

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 74  LIGEGSYGRVYYGI-LKSGHAA----AIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQ 126
           ++G G++G VY GI +  G       AIK L+ +  P  + EF+ +  +++ + H + V+
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           LLG C+  T + L  +   +G L + +H  K   G+Q   +L+W       V  AKG+ Y
Sbjct: 82  LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQL--LLNW------CVQIAKGMMY 132
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           L E+    ++HRD+ + NVL+   +  KI DF L+          ++        + A E
Sbjct: 133 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
                +   +SDV+S+GV + EL+T G KP D
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 31/298 (10%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL--- 168
           + S++      + V+LLG    G   ++  E  + G L   L   +     +  PVL   
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPP 129
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +  
Sbjct: 130 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD 186
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 187 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 231
Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V      D P            +C QY    RP+   ++ +++
Sbjct: 232 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ + + L H
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNH 64
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 124/293 (42%), Gaps = 26/293 (8%)
Query: 75  IGEGSYGRVYYGILK-----SGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG +G+V           +G   A+K L  DA  Q    +  ++ ++  L HE+ ++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 128 LGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G C D    S  L  E+   GSL D L          P   +   Q +  A    +G+ 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL----------PRHSIGLAQLLLFAQQICEGMA 148
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG--TFGYH 243
           YLH +   H IHRD+ + NVL+ +D + KI DF L+   P+     +  R  G     ++
Sbjct: 149 YLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEXYRVREDGDSPVFWY 204
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 303
           APE     +    SDV+SFGV L ELLT       + P     L+  A  +++  ++ + 
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263
Query: 304 VDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARPGPA 356
           ++       P             C + EA FRP    ++  L+ +     G A
Sbjct: 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 114
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 115 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 125/300 (41%), Gaps = 35/300 (11%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL--- 168
           + S++      + V+LLG    G   ++  E  + G L   L   +     +  PVL   
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPP 120
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +  
Sbjct: 121 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD 177
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 178 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 222
Query: 289 TWATPKLSEDKVRQCVDARLGG--DYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V    GG  D P            +C QY    RP+   ++ +++
Sbjct: 223 EQPYQGLSNEQVLRFVME--GGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 280

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 120/282 (42%), Gaps = 29/282 (10%)
Query: 75  IGEGSYGRVYYG----ILKSGHA---AAIKKLDASKQPDE--EFLAQVSMVSRLKHENFV 125
           +G+GS+G VY G    I+K G A    A+K ++ S    E  EFL + S++      + V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG-PVLSWQQRVKIAVGAAKGL 184
           +LLG    G   ++  E  ++G L   L   +      PG P  + Q+ +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            YL+ K     +HR++ + N ++  D   KI DF ++    +        + L    + A
Sbjct: 144 AYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV 304
           PE    G     SD++SFGVVL E+                SL       LS ++V + V
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFV 245
Query: 305 DARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 D P            +C Q+  + RP    +V  L+
Sbjct: 246 MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G ++         K  Q       Q+        A
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVY---------KELQKLSKFDEQRTATYITELA 123
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 124 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 176
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 129/297 (43%), Gaps = 40/297 (13%)
Query: 68  NFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKH 121
           N   + ++G G +G V  G LK       + AIK L    +++   +FL + S++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L G        ++  E   NGSL   L        AQ   +    Q V +  G A
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD----AQFTVI----QLVGMLRGIA 128
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT-F 240
            G++YL   +D   +HRD+ + N+LI  + V K++DF LS    D     ++TR      
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 299
            + +PE     +  + SDV+S+G+VL E+++ G +P              W   ++S   
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQD 229
Query: 300 VRQCVDARLGGDYPPXXXXXXXXXXXL--CVQYEADFRPNMSIVVKALQPLLNARPG 354
           V + VD   G   PP           +  C Q + + RP    +V  L  L+   PG
Sbjct: 230 VIKAVDE--GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR-NPG 283

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 120/282 (42%), Gaps = 29/282 (10%)
Query: 75  IGEGSYGRVYYG----ILKSGHA---AAIKKLDASKQPDE--EFLAQVSMVSRLKHENFV 125
           +G+GS+G VY G    I+K G A    A+K ++ S    E  EFL + S++      + V
Sbjct: 26  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG-PVLSWQQRVKIAVGAAKGL 184
           +LLG    G   ++  E  ++G L   L   +      PG P  + Q+ +++A   A G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            YL+ K     +HR++ + N ++  D   KI DF ++    +        + L    + A
Sbjct: 145 AYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV 304
           PE    G     SD++SFGVVL E+                SL       LS ++V + V
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFV 246
Query: 305 DARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 D P            +C Q+  + RP    +V  L+
Sbjct: 247 MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 34/214 (15%)
Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
           IG GS+G VY+   +++    AIKK+  S KQ +E++   + +V  + +L+H N +Q  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEY 186
             +   +  L  E+   GS  D+L   K        P+    Q V+IA    GA +GL Y
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKK-------PL----QEVEIAAVTHGALQGLAY 169
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADF-DLSNQAPDMAARLHSTRVLGTFGYHAP 245
           LH     ++IHRD+K+ N+L+ +  + K+ DF   S  AP       +   +GT  + AP
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAP 219
Query: 246 EYAMT---GQLNAKSDVYSFGVVLLELLTGRKPV 276
           E  +    GQ + K DV+S G+  +EL   + P+
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNH 64
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 172
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 64  EITENFGTNALIGEGSYGRVYYG-ILKSGHAAAIKKLDASKQPD----EEFLAQVSMVSR 118
           E  E+F    L+G+GS+  VY    + +G   AIK +D          +    +V +  +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
           LKH + ++L  Y  D     L  E   NG ++  L  R  VK         +  ++    
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQI---- 121
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
               G+ YLH      I+HRD+  SN+L+  +   KIADF L+ Q   M    H T + G
Sbjct: 122 --ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYT-LCG 174
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           T  Y +PE A       +SDV+S G +   LL GR P D
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 34/214 (15%)
Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
           IG GS+G VY+   +++    AIKK+  S KQ +E++   + +V  + +L+H N +Q  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEY 186
             +   +  L  E+   GS  D+L   K        P+    Q V+IA    GA +GL Y
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDLLEVHKK-------PL----QEVEIAAVTHGALQGLAY 130
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADF-DLSNQAPDMAARLHSTRVLGTFGYHAP 245
           LH     ++IHRD+K+ N+L+ +  + K+ DF   S  AP       +   +GT  + AP
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAP 180
Query: 246 EYAMT---GQLNAKSDVYSFGVVLLELLTGRKPV 276
           E  +    GQ + K DV+S G+  +EL   + P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 94  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 144
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 145 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 197
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 122/298 (40%), Gaps = 31/298 (10%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP---GPVL 168
           + S++      + V+LLG    G   ++  E  + G L   L   +      P    P L
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +  
Sbjct: 138 S--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 237
Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V      D P            +C QY    RP+   ++ +++
Sbjct: 238 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 118
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTELCGTLD 171
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 121/294 (41%), Gaps = 40/294 (13%)
Query: 75  IGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQL 127
           +GEG +G+V           +G   A+K L      +   +   ++ ++  L HEN V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 128 LGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G C +  G    L  EF  +GSL + L   K          ++ +Q++K AV   KG++
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGMD 128
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN--QAPDMAARLHSTRVLGTFGYH 243
           YL  +     +HRD+ + NVL+  +   KI DF L+   +       +   R    F Y 
Sbjct: 129 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY- 184
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT----GRKPVDHTL----PRGQQSLVTWATPKL 295
           APE  M  +    SDV+SFGV L ELLT       P+   L    P   Q  VT     L
Sbjct: 185 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 244
Query: 296 SEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLL 349
            E K   C         PP            C +++   R +   +++  + LL
Sbjct: 245 KEGKRLPC---------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 289

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 121/294 (41%), Gaps = 40/294 (13%)
Query: 75  IGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQL 127
           +GEG +G+V           +G   A+K L      +   +   ++ ++  L HEN V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 128 LGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G C +  G    L  EF  +GSL + L   K          ++ +Q++K AV   KG++
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGMD 140
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN--QAPDMAARLHSTRVLGTFGYH 243
           YL  +     +HRD+ + NVL+  +   KI DF L+   +       +   R    F Y 
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY- 196
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT----GRKPVDHTL----PRGQQSLVTWATPKL 295
           APE  M  +    SDV+SFGV L ELLT       P+   L    P   Q  VT     L
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256
Query: 296 SEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLL 349
            E K   C         PP            C +++   R +   +++  + LL
Sbjct: 257 KEGKRLPC---------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 31/298 (10%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL--- 168
           + S++      + V+LLG    G   ++  E  + G L   L   +     +  PVL   
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPP 122
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +  
Sbjct: 123 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 179
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 224
Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V      D P            +C QY    RP+   ++ +++
Sbjct: 225 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 93/222 (41%), Gaps = 25/222 (11%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGILKSG-HAAAIKKLDASKQPDE----EFLAQVSMVS 117
           K   ++F     +G+G +G VY    K      A+K L  S+   E    +   ++ + S
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVK 175
            L+H N +++  Y  D     L  EFA  G L+  L  HGR              Q+   
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-----------FDEQRSAT 119
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
                A  L Y HE+    +IHRDIK  N+L+      KIADF  S  AP +  R     
Sbjct: 120 FMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX---- 172
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           + GT  Y  PE       + K D++  GV+  E L G  P D
Sbjct: 173 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 113/244 (46%), Gaps = 19/244 (7%)
Query: 42  KGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AA 95
           +G     + P ++P     E       FG    +G G++G+V     +G+ K       A
Sbjct: 23  EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVA 80
Query: 96  IKKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI 152
           +K L ++   DE+   ++++ ++S L +HEN V LLG C  G   ++  E+   G L + 
Sbjct: 81  VKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 140
Query: 153 LHGRKGVKGAQPGPVL-----SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207
           L  +  V    P   +     S +  +  +   A+G+ +L   A  + IHRD+ + NVL+
Sbjct: 141 LRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 197
Query: 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 267
            +  VAKI DF L+    + +  +          + APE         +SDV+S+G++L 
Sbjct: 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
Query: 268 ELLT 271
           E+ +
Sbjct: 258 EIFS 261

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 122/298 (40%), Gaps = 31/298 (10%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP---GPVL 168
           + S++      + V+LLG    G   ++  E  + G L   L   +      P    P L
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +  
Sbjct: 128 S--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 182
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 183 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 227
Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V      D P            +C QY    RP+   ++ +++
Sbjct: 228 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 123
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 124 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 176
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 31/298 (10%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL--- 168
           + S++      + V+LLG    G   ++  E  + G L   L   +     +  PVL   
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPP 135
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +  
Sbjct: 136 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 237
Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V      D P            +C QY    RP+   ++ +++
Sbjct: 238 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 118
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 171
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 121
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 174
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 31/298 (10%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL--- 168
           + S++      + V+LLG    G   ++  E  + G L   L   +     +  PVL   
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPP 128
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +  
Sbjct: 129 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 185
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 230
Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V      D P            +C QY    RP+   ++ +++
Sbjct: 231 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 25  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 84
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 85  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 135
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 136 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 188
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 19/227 (8%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFL 110
           ++VP +  + + +  E F     IG+GS+G V+ GI  ++    AIK +D  +  DE   
Sbjct: 9   VQVPGMQ-NNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED 67
Query: 111 AQ--VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
            Q  ++++S+       +  G  + G+   +  E+   GS  D+L           GP  
Sbjct: 68  IQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA---------GPFD 118
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
            +Q    +     KGL+YLH +     IHRDIK++NVL+ +    K+ADF ++ Q  D  
Sbjct: 119 EFQIATMLK-EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD-- 172
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            ++     +GT  + APE       ++K+D++S G+  +EL  G  P
Sbjct: 173 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 31/298 (10%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL--- 168
           + S++      + V+LLG    G   ++  E  + G L   L   +     +  PVL   
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPP 128
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +  
Sbjct: 129 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 185
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 230
Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V      D P            +C QY    RP+   ++ +++
Sbjct: 231 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 31/298 (10%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL--- 168
           + S++      + V+LLG    G   ++  E  + G L   L   +     +  PVL   
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPP 129
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +  
Sbjct: 130 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 186
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 187 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 231
Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V      D P            +C QY    RP+   ++ +++
Sbjct: 232 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 75  IGEGSYGR-VYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGY 130
           IGEGS+G+ +     + G    IK+++ S+   +  EE   +V++++ +KH N VQ    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
             +  S  +  ++   G L   ++ +KGV   Q   +L W  ++ +A      L+++H  
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLA------LKHVH-- 142
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPEY 247
            D  I+HRDIKS N+ +  D   ++ DF ++   N   ++A        +GT  Y +PE 
Sbjct: 143 -DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-----RACIGTPYYLSPEI 196
Query: 248 AMTGQLNAKSDVYSFGVVLLELLT 271
                 N KSD+++ G VL EL T
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCT 220

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 31/298 (10%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 68
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL--- 168
           + S++      + V+LLG    G   ++  E  + G L   L   +     +  PVL   
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPP 126
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +  
Sbjct: 127 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 183
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 184 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 228
Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V      D P            +C QY    RP+   ++ +++
Sbjct: 229 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 286

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 118
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTXLCGTLD 171
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 12  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 71
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 122
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 123 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 175
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 118
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLD 171
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 119
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLD 172
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 123
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 124 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 176
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 7   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 66
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 67  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 117
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 118 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 170
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 171 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 117/246 (47%), Gaps = 21/246 (8%)
Query: 42  KGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AA 95
           +G     + P ++P     E       FG    +G G++G+V     +G+ K       A
Sbjct: 23  EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVA 80
Query: 96  IKKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI 152
           +K L ++   DE+   ++++ ++S L +HEN V LLG C  G   ++  E+   G L + 
Sbjct: 81  VKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 140
Query: 153 LHGRK--GVKGA-----QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205
           L  ++  G++ +      P   LS +  +  +   A+G+ +L   A  + IHRD+ + NV
Sbjct: 141 LRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNV 197
Query: 206 LIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV 265
           L+ +  VAKI DF L+    + +  +          + APE         +SDV+S+G++
Sbjct: 198 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 257
Query: 266 LLELLT 271
           L E+ +
Sbjct: 258 LWEIFS 263

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 118
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLD 171
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 123
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 124 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLD 176
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 121
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 174
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 93/222 (41%), Gaps = 25/222 (11%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGILKSG-HAAAIKKLDASKQPDE----EFLAQVSMVS 117
           K   ++F     +G+G +G VY    K      A+K L  S+   E    +   ++ + S
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVK 175
            L+H N +++  Y  D     L  EFA  G L+  L  HGR              Q+   
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-----------FDEQRSAT 118
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
                A  L Y HE+    +IHRDIK  N+L+      KIADF  S  AP +  R     
Sbjct: 119 FMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX---- 171
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           + GT  Y  PE       + K D++  GV+  E L G  P D
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V  G  K  +  A+K +      ++EF  +   + +L H   V+  G C   
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ SNG L + L  R   KG +P       Q +++     +G+ +L       
Sbjct: 76  YPIYIVTEYISNGCLLNYL--RSHGKGLEPS------QLLEMCYDVCEGMAFLESH---Q 124
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
            IHRD+ + N L+  D   K++DF ++    D    + S        + APE     + +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 255 AKSDVYSFGVVLLELLT-GRKPVD 277
           +KSDV++FG+++ E+ + G+ P D
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 22/219 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    + S    A+K L  ++      + +   +V + S L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++         +  Q       Q+        A
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVY---------RELQKLSRFDEQRTATYITELA 122
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+  +   KIADF  S  AP        T + GT  
Sbjct: 123 NALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS----RRTTLCGTLD 175
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD-HT 279
           Y  PE       + K D++S GV+  E L G  P + HT
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 31/298 (10%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL--- 168
           + S++      + V+LLG    G   ++  E  + G L   L   +     +  PVL   
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPP 157
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +  
Sbjct: 158 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 214
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 215 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 259
Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V      D P            +C QY    RP+   ++ +++
Sbjct: 260 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 317

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 119
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS----RRTTLSGTLD 172
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 74  LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G +G V  G LK         AIK L    +++   +FL + S++ +  H N + L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G        ++  E+  NGSL   L    G          +  Q V +  G + G++YL
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ--------FTVIQLVGMLRGISAGMKYL 140
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT-FGYHAPE 246
              +D   +HRD+ + N+LI  + V K++DF LS    D     ++TR       + APE
Sbjct: 141 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 197
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                +  + SDV+S+G+V+ E+++ G +P
Sbjct: 198 AIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G ++         K  Q       Q+        A
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVY---------KELQKLSKFDEQRTATYITELA 123
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP          + GT  
Sbjct: 124 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLXGTLD 176
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 74  LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G +G V  G LK         AIK L A  + +   +FL++ S++ +  H N + L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G        ++  E+  NGSL   L    G          +  Q V +  G   G++YL
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGR--------FTVIQLVGMLRGIGSGMKYL 147
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT-FGYHAPE 246
              +D   +HRD+ + N+L+  + V K++DF +S    D     ++TR       + APE
Sbjct: 148 ---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 204
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                +  + SDV+S+G+V+ E+++ G +P
Sbjct: 205 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 112/240 (46%), Gaps = 15/240 (6%)
Query: 42  KGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AA 95
           +G     + P ++P     E       FG    +G G++G+V     +G+ K       A
Sbjct: 15  EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVA 72
Query: 96  IKKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI 152
           +K L ++   DE+   ++++ ++S L +HEN V LLG C  G   ++  E+   G L + 
Sbjct: 73  VKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 132
Query: 153 LHGRKGVK-GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211
           L  +       + G  L  +  +  +   A+G+ +L   A  + IHRD+ + NVL+ +  
Sbjct: 133 LRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGH 189
Query: 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           VAKI DF L+    + +  +          + APE         +SDV+S+G++L E+ +
Sbjct: 190 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 74  LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G +G V  G LK         AIK L A  + +   +FL++ S++ +  H N + L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G        ++  E+  NGSL   L    G          +  Q V +  G   G++YL
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGR--------FTVIQLVGMLRGIGSGMKYL 132
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT-FGYHAPE 246
              +D   +HRD+ + N+L+  + V K++DF +S    D     ++TR       + APE
Sbjct: 133 ---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 189
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                +  + SDV+S+G+V+ E+++ G +P
Sbjct: 190 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYHA 244
           L  K     IHRD+ + N+L+ +++  KI DF L+   P         +  G     ++A
Sbjct: 130 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYA 185
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT 271
           PE     + +  SDV+SFGVVL EL T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 112/240 (46%), Gaps = 15/240 (6%)
Query: 42  KGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AA 95
           +G     + P ++P     E       FG    +G G++G+V     +G+ K       A
Sbjct: 23  EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVA 80
Query: 96  IKKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI 152
           +K L ++   DE+   ++++ ++S L +HEN V LLG C  G   ++  E+   G L + 
Sbjct: 81  VKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 140
Query: 153 LHGRKGVK-GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211
           L  +       + G  L  +  +  +   A+G+ +L   A  + IHRD+ + NVL+ +  
Sbjct: 141 LRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGH 197
Query: 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           VAKI DF L+    + +  +          + APE         +SDV+S+G++L E+ +
Sbjct: 198 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 135
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 136 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 192
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 74  LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
           +IG G +G V  G LK         AIK L A  + +   +FL++ S++ +  H N + L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G        ++  E+  NGSL   L    G          +  Q V +  G   G++YL
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGR--------FTVIQLVGMLRGIGSGMKYL 126
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT-FGYHAPE 246
              +D   +HRD+ + N+L+  + V K++DF +S    D     ++TR       + APE
Sbjct: 127 ---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 183
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                +  + SDV+S+G+V+ E+++ G +P
Sbjct: 184 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 132
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 133 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 134
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 135 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 191
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHENFVQLLGYC 131
           IG+GS+G VY GI   +    AIK +D  +  DE    Q  ++++S+       +  G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
           +  T   +  E+   GS  D+L         +PGP L       I     KGL+YLH + 
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIATILREILKGLDYLHSER 136
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
               IHRDIK++NVL+ +    K+ADF ++ Q  D   ++     +GT  + APE     
Sbjct: 137 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQS 191
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
             + K+D++S G+  +EL  G  P
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPP 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 160
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 161 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 217
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 130 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 122/298 (40%), Gaps = 31/298 (10%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLD--ASKQPDEEFLA 111
           DE +   E    +  +G+GS+G VY G+ K           AIK ++  AS +   EFL 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL--- 168
           + S++      + V+LLG    G   ++  E  + G L   L   +     +  PVL   
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPP 122
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  + +++A   A G+ YL+       +HRD+ + N  + +D   KI DF ++    +  
Sbjct: 123 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETD 179
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
                 + L    + +PE    G     SDV+SFGVVL E+ T               L 
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LA 224
Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
                 LS ++V + V      D P            +C QY    RP+   ++ +++
Sbjct: 225 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 136
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 137 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 193
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 120
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIA+F  S  AP        T + GT  
Sbjct: 121 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLD 173
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  EF   GSL + L   K  +      +L +  ++       KG+EY
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 132
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 133 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 130 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 128
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 129 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 185
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 186 ESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 127
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 128 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 184
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 133
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 134 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 190
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 147
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 148 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 147
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 148 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 120/283 (42%), Gaps = 26/283 (9%)
Query: 75  IGEGSYGRVYYGILK-----SGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
           +GEG +G+V           +G   A+K L A   P     +  ++ ++  L HE+ ++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 128 LGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G C D    S  L  E+   GSL D L          P   +   Q +  A    +G+ 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----------PRHSIGLAQLLLFAQQICEGMA 131
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH 243
           YLH +   H IHR++ + NVL+ +D + KI DF L+   P+     +  R  G     ++
Sbjct: 132 YLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWY 187
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 303
           APE     +    SDV+SFGV L ELLT       + P     L+  A  +++  ++ + 
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 246
Query: 304 VDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
           ++       P             C + EA FRP    ++  L+
Sbjct: 247 LERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 91/220 (41%), Gaps = 29/220 (13%)
Query: 67  ENFGTNALIGEGSYGRVYYG---------ILKSGHAAAIKKLDASKQPDEEFLAQVSMVS 117
           E+F     +G+G +G VY            LK    A ++K     Q   E    V + S
Sbjct: 5   EDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRRE----VEIQS 60
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
            L+H N ++L GY  D T   L  E+A  G+++         +  Q       Q+     
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVY---------RELQKLSKFDEQRTATYI 111
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
              A  L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + 
Sbjct: 112 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLC 164
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           GT  Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 165 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 121
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIA+F  S  AP        T + GT  
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLD 174
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 96/219 (43%), Gaps = 27/219 (12%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 94  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 144
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR---VLG 238
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP       S+R   + G
Sbjct: 145 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-------SSRRDDLCG 194
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           T  Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 16/218 (7%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
             E++     +GEG+ G V   + + +  A A+K +D  +  D  E    ++ +   L H
Sbjct: 4   FVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           EN V+  G+  +G  + L  E+ S G L D +    G+    P P     QR    + A 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPD---AQRFFHQLMA- 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  
Sbjct: 116 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
           Y APE     + +A+  DV+S G+VL  +L G  P D 
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 120/283 (42%), Gaps = 26/283 (9%)
Query: 75  IGEGSYGRVYYGILK-----SGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
           +GEG +G+V           +G   A+K L A   P     +  ++ ++  L HE+ ++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 128 LGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G C D    S  L  E+   GSL D L          P   +   Q +  A    +G+ 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----------PRHSIGLAQLLLFAQQICEGMA 131
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH 243
           YLH +   H IHR++ + NVL+ +D + KI DF L+   P+     +  R  G     ++
Sbjct: 132 YLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWY 187
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 303
           APE     +    SDV+SFGV L ELLT       + P     L+  A  +++  ++ + 
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 246
Query: 304 VDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQ 346
           ++       P             C + EA FRP    ++  L+
Sbjct: 247 LERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 120
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP          + GT  
Sbjct: 121 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLD 173
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
           IGEGS G V     K SG   A+K +D  KQ   E L  +V ++   +H N V++    +
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  EF   G+L DI+   +          L+ +Q   +     + L YLH +  
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQG- 161
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
             +IHRDIKS ++L+  D   K++DF    Q + D+  R     ++GT  + APE     
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KXLVGTPYWMAPEVISRS 216
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
               + D++S G++++E++ G  P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVS-------MVSRL 119
           ++F     +G GS+GRV+  +++S H      +   K+     L QV        M+S +
Sbjct: 6   QDFQILRTLGTGSFGRVH--LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            H   +++ G   D     +  ++   G L  +L  RK  +   P PV  +      A  
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRF--PNPVAKF-----YAAE 114
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
               LEYLH K    II+RD+K  N+L+  +   KI DF  +   PD+   L      GT
Sbjct: 115 VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXL-----CGT 166
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             Y APE   T   N   D +SFG+++ E+L G  P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 121
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP          + GT  
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLD 174
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 106/209 (50%), Gaps = 21/209 (10%)
Query: 75  IGEGSYGRVYYGILKSGH-----AAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G G++G V  G+ +        A  + K    K   EE + +  ++ +L +   V+L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
            C    + +L  E A  G LH  L G++     +  PV       ++    + G++YL E
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKR-----EEIPV---SNVAELLHQVSMGMKYLEE 128
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEY 247
           K   + +HRD+ + NVL+ +   AKI+DF LS +A       ++ R  G +   ++APE 
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLS-KALGADDSYYTARSAGKWPLKWYAPEC 184
Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
               + +++SDV+S+GV + E L+ G+KP
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 119
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP  ++R  +  + GT  
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRDT--LCGTLD 172
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 118
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP          + GT  
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLD 171
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L   K  +      +L +  ++       KG+EY
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGMEY 130
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYHA 244
           L  K     IHR++ + N+L+ +++  KI DF L+   P      +  +  G     ++A
Sbjct: 131 LGTK---RYIHRNLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYA 186
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT 271
           PE     + +  SDV+SFGVVL EL T
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 27/224 (12%)
Query: 74  LIGEGSYGR-VYYGILKSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           ++G+G +G+ +     ++G    +K+L    ++    FL +V ++  L+H N ++ +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                     E+   G+L  I+   K +    P     W QRV  A   A G+ YLH   
Sbjct: 77  YKDKRLNFITEYIKGGTLRGII---KSMDSQYP-----WSQRVSFAKDIASGMAYLHSM- 127
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR------------VLGT 239
             +IIHRD+ S N L+ ++    +ADF L+    D   +    R            V+G 
Sbjct: 128 --NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD-HTLPR 282
             + APE       + K DV+SFG+VL E++ GR   D   LPR
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPR 228

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 118
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP          + GT  
Sbjct: 119 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLD 171
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 121
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP          + GT  
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLD 174
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 96/219 (43%), Gaps = 27/219 (12%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 121
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR---VLG 238
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP       S+R   + G
Sbjct: 122 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-------SSRRDDLCG 171
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           T  Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    + S    A+K L  ++      + +   +V + S L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++         +  Q       Q+        A
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVY---------RELQKLSRFDEQRTATYITELA 122
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+  +   KIADF  S  AP  ++R  +  + GT  
Sbjct: 123 NALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP--SSRRDT--LCGTLD 175
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD-HT 279
           Y  PE       + K D++S GV+  E L G  P + HT
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 75  IGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V    Y  L+  +G   A+KKL  S +    +F  ++ ++  L+H+N V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           G C     R   L  E+   GSL D L      +      +L +  ++       KG+EY
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAH--AERIDHIKLLQYTSQI------CKGMEY 132
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+ +++  KI DF L+   P D               ++AP
Sbjct: 133 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
           E     + +  SDV+SFGVVL EL T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++      + +   +V + S L+H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L         Q       Q+        A
Sbjct: 68  PNILRLYGYFHDSTRVYLILEYAPLGTVYREL---------QKLSKFDEQRTATYITELA 118
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP          + GT  
Sbjct: 119 NALSYCHSKK---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLD 171
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       + K D++S GV+  E L G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 90/216 (41%), Gaps = 21/216 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDE----EFLAQVSMVSRLKH 121
           ++F     +G+G +G VY    K  H   A+K L  S+   E    +   ++ + + L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L  Y  D     L  E+A  G L+         K  Q       Q+   I    A
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELY---------KELQKSCTFDEQRTATIMEELA 133
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP     L    + GT  
Sbjct: 134 DALMYCHGKK---VIHRDIKPENLLLGLKGELKIADFGWSVHAPS----LRRKTMCGTLD 186
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           Y  PE       N K D++  GV+  ELL G  P +
Sbjct: 187 YLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 28/253 (11%)
Query: 42  KGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AA 95
           +G     + P ++P     E       FG    +G G++G+V     +G+ K       A
Sbjct: 8   EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVA 65
Query: 96  IKKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI 152
           +K L ++   DE+   ++++ ++S L +HEN V LLG C  G   ++  E+   G L + 
Sbjct: 66  VKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 125
Query: 153 LH-------GRKGVKGAQP-------GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           L        G     G  P       G  L  +  +  +   A+G+ +L  K   + IHR
Sbjct: 126 LRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHR 182
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSD 258
           D+ + NVL+ +  VAKI DF L+    + +  +          + APE         +SD
Sbjct: 183 DVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD 242
Query: 259 VYSFGVVLLELLT 271
           V+S+G++L E+ +
Sbjct: 243 VWSYGILLWEIFS 255

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 78  GSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS- 136
           G +G V+   L + + A +K      +   +   +V  +  +KHEN +Q +G    GTS 
Sbjct: 35  GRFGCVWKAQLLNEYVA-VKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93
Query: 137 ---RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-- 191
                L   F   GSL D L             V+SW +   IA   A+GL YLHE    
Sbjct: 94  DVDLWLITAFHEKGSLSDFLKAN----------VVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 192 -----DPHIIHRDIKSSNVLIFDDDVAKIADFDLS--NQAPDMAARLHSTRVLGTFGYHA 244
                 P I HRDIKS NVL+ ++  A IADF L+   +A   A   H    +GT  Y A
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ--VGTRRYMA 201
Query: 245 PEYAMTGQLN------AKSDVYSFGVVLLEL 269
           PE  + G +N       + D+Y+ G+VL EL
Sbjct: 202 PE-VLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 86  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 136
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 137 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 126
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 78  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 128
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 79  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 129
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 126
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 83  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 133
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 21/209 (10%)
Query: 75  IGEGSYGRVYYGILKSGH-----AAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G G++G V  G+ +        A  + K    K   EE + +  ++ +L +   V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
            C    + +L  E A  G LH  L G++     +  PV       ++    + G++YL E
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKR-----EEIPV---SNVAELLHQVSMGMKYLEE 454
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEY 247
           K   + +HR++ + NVL+ +   AKI+DF LS +A       ++ R  G +   ++APE 
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLS-KALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
               + +++SDV+S+GV + E L+ G+KP
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 79  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 129
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 79  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 129
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 82  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 132
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 133 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQY--LLNW------CVQI 126
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T + L  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 127
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T + L  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 79  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 129
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 70  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 120
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 121 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 101 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 151
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 152 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 73/138 (52%), Gaps = 13/138 (9%)
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  E+    +L DI+H          GP ++ ++ +++   A + L + H+     IIHR
Sbjct: 93  IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSHQNG---IIHR 140
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQLNAKS 257
           D+K +N+LI   +  K+ DF ++    D    +  T  V+GT  Y +PE A    ++A+S
Sbjct: 141 DVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 258 DVYSFGVVLLELLTGRKP 275
           DVYS G VL E+LTG  P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T + L  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 76  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 126
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T + L  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 128
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T + L  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 130
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T + L  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQY--LLNW------CVQI 127
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 19/218 (8%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKH 121
           E  EN G   ++G+G+YG VY G  L +    AIK++ +   +  +    ++++   LKH
Sbjct: 20  EYDEN-GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH 78
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           +N VQ LG   +     +  E    GSL  +L        ++ GP+   +Q +       
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR-------SKWGPLKDNEQTIGFYTKQI 131
Query: 182 -KGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            +GL+YLH   D  I+HRDIK  NVLI     V KI+DF  S +   +     +    GT
Sbjct: 132 LEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186
Query: 240 FGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKP 275
             Y APE    G       +D++S G  ++E+ TG+ P
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 74  LIGEGSYGRVYYGI-------LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           ++G G++G VY GI       +K   A  + + + S + ++E L +  +++ +      +
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           LLG C+  T + L  +    G L D +   +G  G+Q   +L+W  ++      AKG+ Y
Sbjct: 84  LLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQD--LLNWCMQI------AKGMSY 134
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           L    D  ++HRD+ + NVL+   +  KI DF L+          H+        + A E
Sbjct: 135 LE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
             +  +   +SDV+S+GV + EL+T G KP D
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 23/247 (9%)
Query: 43  GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AAI 96
           G   V + P ++P     E      +FG    +G G++G+V     YG++KS  A   A+
Sbjct: 17  GNNXVXIDPTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAV 74
Query: 97  KKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
           K L  S    E    ++++ ++S L  H N V LLG C  G   ++  E+   G L + L
Sbjct: 75  KMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 134
Query: 154 H-GRKGVKGAQPGPVL--------SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
              R     ++  P +          +  +  +   AKG+ +L  K   + IHRD+ + N
Sbjct: 135 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 191
Query: 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264
           +L+    + KI DF L+    + +  +          + APE         +SDV+S+G+
Sbjct: 192 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 251
Query: 265 VLLELLT 271
            L EL +
Sbjct: 252 FLWELFS 258

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 75  IGEGSYGRVYYGILK-----SGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
           +GEG +G+V           +G   A+K L     P     +  ++ ++  L HE+ V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 128 LGYCVD-GTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G C D G   V L  E+   GSL D L          P   +   Q +  A    +G+ 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----------PRHCVGLAQLLLFAQQICEGMA 125
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH 243
           YLH +   H IHR + + NVL+ +D + KI DF L+   P+     +  R  G     ++
Sbjct: 126 YLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWY 181
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT 271
           APE     +    SDV+SFGV L ELLT
Sbjct: 182 APECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 75  IGEGSYGRVYYGILK-----SGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
           +GEG +G+V           +G   A+K L     P     +  ++ ++  L HE+ V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 128 LGYCVD-GTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G C D G   V L  E+   GSL D L          P   +   Q +  A    +G+ 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----------PRHCVGLAQLLLFAQQICEGMA 126
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH 243
           YLH +   H IHR + + NVL+ +D + KI DF L+   P+     +  R  G     ++
Sbjct: 127 YLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWY 182
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT 271
           APE     +    SDV+SFGV L ELLT
Sbjct: 183 APECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-QPD--EEFLAQVSMVSRLKHEN 123
           N+     IG+G++ +V     + +G   A+K +D ++  P   ++   +V ++  L H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            V+L        +  L  E+AS G + D L  HGR   K A+      ++Q V       
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----KFRQIVS------ 125
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             ++Y H+K   +I+HRD+K+ N+L+  D   KIADF  SN+   +  +L +    G+  
Sbjct: 126 -AVQYCHQK---YIVHRDLKAENLLLDGDMNIKIADFGFSNEFT-VGNKLDT--FCGSPP 178
Query: 242 YHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVD 277
           Y APE     + +  + DV+S GV+L  L++G  P D
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           +G G+Y  VY G+ K+ G   A+K  KLD+ +      + ++S++  LKHEN V+L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 132 VDGTSRVLAYEFASNGSLHDILHGR---KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
                  L +EF  N  L   +  R      +G +   V  +Q ++       +GL + H
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL------LQGLAFCH 125
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
           E     I+HRD+K  N+LI      K+ DF L+ +A  +     S+ V+ T  Y AP+  
Sbjct: 126 ENK---ILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVNTFSSEVV-TLWYRAPDVL 180
Query: 249 MTGQLNAKS-DVYSFGVVLLELLTGR 273
           M  +  + S D++S G +L E++TG+
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 73/138 (52%), Gaps = 13/138 (9%)
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  E+    +L DI+H          GP ++ ++ +++   A + L + H+     IIHR
Sbjct: 93  IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSHQNG---IIHR 140
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQLNAKS 257
           D+K +N++I   +  K+ DF ++    D    +  T  V+GT  Y +PE A    ++A+S
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 258 DVYSFGVVLLELLTGRKP 275
           DVYS G VL E+LTG  P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKH 121
           E  EN G   ++G+G+YG VY G  L +    AIK++ +   +  +    ++++   LKH
Sbjct: 6   EYDEN-GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH 64
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           +N VQ LG   +     +  E    GSL  +L  + G       P+   +Q +       
Sbjct: 65  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG-------PLKDNEQTIGFYTKQI 117
Query: 182 -KGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            +GL+YLH   D  I+HRDIK  NVLI     V KI+DF  S +   +     +    GT
Sbjct: 118 LEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 172
Query: 240 FGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKP 275
             Y APE    G       +D++S G  ++E+ TG+ P
Sbjct: 173 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 73/138 (52%), Gaps = 13/138 (9%)
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  E+    +L DI+H          GP ++ ++ +++   A + L + H+     IIHR
Sbjct: 93  IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSHQNG---IIHR 140
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQLNAKS 257
           D+K +N++I   +  K+ DF ++    D    +  T  V+GT  Y +PE A    ++A+S
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 258 DVYSFGVVLLELLTGRKP 275
           DVYS G VL E+LTG  P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 105/220 (47%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+GH  A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D  A   +T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVAT 185
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
           R      Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 73/138 (52%), Gaps = 13/138 (9%)
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  E+    +L DI+H          GP ++ ++ +++   A + L + H+     IIHR
Sbjct: 93  IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSHQNG---IIHR 140
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQLNAKS 257
           D+K +N++I   +  K+ DF ++    D    +  T  V+GT  Y +PE A    ++A+S
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 258 DVYSFGVVLLELLTGRKP 275
           DVYS G VL E+LTG  P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 23/247 (9%)
Query: 43  GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AAI 96
           G   V + P ++P     E      +FG    +G G++G+V     YG++KS  A   A+
Sbjct: 24  GNNYVYIDPTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAV 81
Query: 97  KKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
           K L  S    E    ++++ ++S L  H N V LLG C  G   ++  E+   G L + L
Sbjct: 82  KMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 141
Query: 154 H-GRKGVKGAQPGPVL--------SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
              R     ++  P +          +  +  +   AKG+ +L   A  + IHRD+ + N
Sbjct: 142 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARN 198
Query: 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264
           +L+    + KI DF L+    + +  +          + APE         +SDV+S+G+
Sbjct: 199 ILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 258
Query: 265 VLLELLT 271
            L EL +
Sbjct: 259 FLWELFS 265

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 73/138 (52%), Gaps = 13/138 (9%)
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  E+    +L DI+H          GP ++ ++ +++   A + L + H+     IIHR
Sbjct: 93  IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSHQNG---IIHR 140
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQLNAKS 257
           D+K +N++I   +  K+ DF ++    D    +  T  V+GT  Y +PE A    ++A+S
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 258 DVYSFGVVLLELLTGRKP 275
           DVYS G VL E+LTG  P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 123/292 (42%), Gaps = 33/292 (11%)
Query: 43  GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AAI 96
           G   V + P ++P     E      +FG    +G G++G+V     YG++KS  A   A+
Sbjct: 1   GNNYVYIDPTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAV 58
Query: 97  KKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
           K L  S    E    ++++ ++S L  H N V LLG C  G   ++  E+   G L + L
Sbjct: 59  KMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
Query: 154 H-GRKGVKGAQPGPVL--------SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
              R     ++  P +          +  +  +   AKG+ +L  K   + IHRD+ + N
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175
Query: 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264
           +L+    + KI DF L+    + +  +          + APE         +SDV+S+G+
Sbjct: 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 265 VLLELLT------GRKPVD----HTLPRGQQSLVTWATPKLSEDKVRQCVDA 306
            L EL +         PVD      +  G + L     P    D ++ C DA
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDA 287

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 105/235 (44%), Gaps = 32/235 (13%)
Query: 53  EVPAISVDELK----EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP-- 105
           E P     EL     E+ E + T + +G G+YG V     +KSG   A+KKL    Q   
Sbjct: 33  ERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSII 92
Query: 106 -DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
             +    ++ ++  +KHEN + LL      TS            ++ + H    + GA  
Sbjct: 93  HAKRTYRELRLLKHMKHENVIGLLDVFTPATS------LEEFNDVYLVTH----LMGADL 142
Query: 165 GPVLSWQQRVK-----IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219
             ++  Q+        +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF 
Sbjct: 143 NNIVKCQKLTDDHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFG 199
Query: 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
           L+    D       T  + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 200 LARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 105/220 (47%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+GH  A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D  A   +T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVAT 185
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
           R      Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 105/220 (47%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+GH  A+KKL    Q     +    ++ ++  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 75  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 124
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D  A   +T
Sbjct: 125 FLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVAT 181
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
           R      Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 182 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 30/220 (13%)
Query: 67  ENFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDAS--KQPDEEFLAQVSMVSRLKHEN 123
           EN G    +G G+ G+V+     K+GH  A+K++  S  K+ ++  L  + +V  LK  +
Sbjct: 28  ENLGE---MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV--LKSHD 82
Query: 124 ---FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
               VQ  G  +  T   +A E    G+  + L  +K ++G  P  +L      K+ V  
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELM--GTCAEKL--KKRMQGPIPERILG-----KMTVAI 133
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            K L YL EK    +IHRD+K SN+L+ +    K+ DF +S +  D  A+    R  G  
Sbjct: 134 VKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCA 188
Query: 241 GYHAPEYA-----MTGQLNAKSDVYSFGVVLLELLTGRKP 275
            Y APE            + ++DV+S G+ L+EL TG+ P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 144
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM-AARLHS-TRVLGTFG 241
           ++YL  K     +HRD+ + N ++ +    K+ADF L+    D     +H+ T       
Sbjct: 145 MKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK 201
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 75  IGEGSYGRVYYGILK--SGHAAAIK----KLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
           +G+GS+G V  G     SG   ++     K D   QP+  ++F+ +V+ +  L H N ++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGAAKGL 184
           L G  +    +++  E A  GSL D L   +G  + G      LS     + AV  A+G+
Sbjct: 86  LYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGT-----LS-----RYAVQVAEGM 134
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP--DMAARLHSTRVLGTFGY 242
            YL  K     IHRD+ + N+L+   D+ KI DF L    P  D    +   R +  F +
Sbjct: 135 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAW 190
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            APE   T   +  SD + FGV L E+ T G++P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 75  IGEGSYGRVYYGILK--SGHAAAIK----KLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
           +G+GS+G V  G     SG   ++     K D   QP+  ++F+ +V+ +  L H N ++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGAAKGL 184
           L G  +    +++  E A  GSL D L   +G  + G      LS     + AV  A+G+
Sbjct: 76  LYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGT-----LS-----RYAVQVAEGM 124
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP--DMAARLHSTRVLGTFGY 242
            YL  K     IHRD+ + N+L+   D+ KI DF L    P  D    +   R +  F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAW 180
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            APE   T   +  SD + FGV L E+ T G++P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 73  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 123
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A+G+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 124 AEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 23/247 (9%)
Query: 43  GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AAI 96
           G   V + P ++P     E      +FG    +G G++G+V     YG++KS  A   A+
Sbjct: 24  GNNYVYIDPTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAV 81
Query: 97  KKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
           K L  S    E    ++++ ++S L  H N V LLG C  G   ++  E+   G L + L
Sbjct: 82  KMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 141
Query: 154 H-GRKGVKGAQPGPVL--------SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
              R     ++  P +          +  +  +   AKG+ +L  K   + IHRD+ + N
Sbjct: 142 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 198
Query: 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264
           +L+    + KI DF L+    + +  +          + APE         +SDV+S+G+
Sbjct: 199 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 258
Query: 265 VLLELLT 271
            L EL +
Sbjct: 259 FLWELFS 265

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 40/285 (14%)
Query: 68  NFGTNALIGEGSYGRVYYG-ILKSGHAAAIKK------LDASKQPDEEFLAQVSMVSRLK 120
           NF     IG G +  VY    L  G   A+KK      +DA  + D   + ++ ++ +L 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD--CIKEIDLLKQLN 90
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H N ++     ++     +  E A  G L  ++   K  K   P   + W+  V++    
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-WKYFVQLC--- 146
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
              LE++H +    ++HRDIK +NV I    V K+ D  L           HS  ++GT 
Sbjct: 147 -SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 200
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
            Y +PE       N KSD++S G +L E+   + P        + +L +         K+
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK------KI 250
Query: 301 RQCVDARLGGDYPPX----XXXXXXXXXXLCVQYEADFRPNMSIV 341
            QC       DYPP               +C+  + + RP+++ V
Sbjct: 251 EQC-------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 75  IGEGSYGRVYYGILKS----GHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S      A AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKFS--------LDLASLILYAYQLSTALAYLE 128
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+  +D  K+ DF LS    D      S   L    + APE  
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL-PIKWMAPESI 184
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              +  + SDV+ FGV + E+L  G KP
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 73/138 (52%), Gaps = 13/138 (9%)
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  E+    +L DI+H          GP ++ ++ +++   A + L + H+     IIHR
Sbjct: 110 IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSHQNG---IIHR 157
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-VLGTFGYHAPEYAMTGQLNAKS 257
           D+K +N++I   +  K+ DF ++    D    +  T  V+GT  Y +PE A    ++A+S
Sbjct: 158 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 217
Query: 258 DVYSFGVVLLELLTGRKP 275
           DVYS G VL E+LTG  P
Sbjct: 218 DVYSLGCVLYEVLTGEPP 235

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 75  IGEGSYGRVYYGILK--SGHAAAIK----KLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
           +G+GS+G V  G     SG   ++     K D   QP+  ++F+ +V+ +  L H N ++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGAAKGL 184
           L G  +    +++  E A  GSL D L   +G  + G      LS     + AV  A+G+
Sbjct: 80  LYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGT-----LS-----RYAVQVAEGM 128
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP--DMAARLHSTRVLGTFGY 242
            YL  K     IHRD+ + N+L+   D+ KI DF L    P  D    +   R +  F +
Sbjct: 129 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAW 184
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            APE   T   +  SD + FGV L E+ T G++P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 28/244 (11%)
Query: 40  APKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKK 98
            P+G+   + +P          + E+ E +   + +G G+YG V      K+GH  A+KK
Sbjct: 15  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKK 74
Query: 99  LDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155
           L    Q     +    ++ ++  +KHEN + LL   V   +R L  EF     ++ + H 
Sbjct: 75  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD--VFTPARSLE-EF---NDVYLVTH- 127
Query: 156 RKGVKGAQPGPVLSWQQRVK-----IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210
              + GA    ++  Q+        +     +GL+Y+H  AD  IIHRD+K SN+ + +D
Sbjct: 128 ---LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNED 181
Query: 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLEL 269
              KI DF L+    D       T  + T  Y APE  +     N   D++S G ++ EL
Sbjct: 182 CELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 270 LTGR 273
           LTGR
Sbjct: 237 LTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 28/244 (11%)
Query: 40  APKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKK 98
            P+G+   + +P          + E+ E +   + +G G+YG V      K+GH  A+KK
Sbjct: 14  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKK 73
Query: 99  LDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155
           L    Q     +    ++ ++  +KHEN + LL   V   +R L  EF     ++ + H 
Sbjct: 74  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD--VFTPARSLE-EF---NDVYLVTH- 126
Query: 156 RKGVKGAQPGPVLSWQQRVK-----IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210
              + GA    ++  Q+        +     +GL+Y+H  AD  IIHRD+K SN+ + +D
Sbjct: 127 ---LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNED 180
Query: 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLEL 269
              KI DF L+    D       T  + T  Y APE  +     N   D++S G ++ EL
Sbjct: 181 CELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 235
Query: 270 LTGR 273
           LTGR
Sbjct: 236 LTGR 239

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 23/247 (9%)
Query: 43  GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AAI 96
           G   V + P ++P     E      +FG    +G G++G+V     YG++KS  A   A+
Sbjct: 19  GNNYVYIDPTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAV 76
Query: 97  KKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
           K L  S    E    ++++ ++S L  H N V LLG C  G   ++  E+   G L + L
Sbjct: 77  KMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 136
Query: 154 H-GRKGVKGAQPGPVL--------SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
              R     ++  P +          +  +  +   AKG+ +L  K   + IHRD+ + N
Sbjct: 137 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 193
Query: 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264
           +L+    + KI DF L+    + +  +          + APE         +SDV+S+G+
Sbjct: 194 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 253
Query: 265 VLLELLT 271
            L EL +
Sbjct: 254 FLWELFS 260

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 68  NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           +F    LIG G +G+V+    +  G    IK++  + +  E    +V  +++L H N V 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER---EVKALAKLDHVNIVH 68
Query: 127 LLGYCVDG-----------TSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
             G C DG           +SR       +  EF   G+L   +  R+G K  +   +  
Sbjct: 69  YNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
           ++Q         KG++Y+H K    +I+RD+K SN+ + D    KI DF L     +   
Sbjct: 128 FEQ-------ITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
           R  S    GT  Y +PE   +     + D+Y+ G++L ELL
Sbjct: 178 RXRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 67  ENFGTNALIGEGSYGRVYY---GILKSGHAA-AIKKLDASKQPDEEFLAQVSMVSRLKHE 122
           E +    ++G+GS+G V      I +  +A   I K  A  +     L +V ++ +L H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N ++L     D +S  +  E  + G L D +  RK           S     +I      
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFS 132
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSN---QAPDMAARLHSTR 235
           G+ Y+H+    +I+HRD+K  N+L+     D D+ KI DF LS    Q   M  R+    
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRI---- 184
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             GT  Y APE  + G  + K DV+S GV+L  LL+G  P
Sbjct: 185 --GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   A +G G+YG V      K+GH  A+KKL    Q     +    ++ ++  +
Sbjct: 29  EVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 88
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 89  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 138
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 139 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 190
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 191 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AI +L  +  P  ++E L +  +++ + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 110 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 160
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 161 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 67  ENFGTNALIGEGSYGRVYY---GILKSGHAA-AIKKLDASKQPDEEFLAQVSMVSRLKHE 122
           E +    ++G+GS+G V      I +  +A   I K  A  +     L +V ++ +L H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N ++L     D +S  +  E  + G L D +  RK           S     +I      
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFS 132
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSN---QAPDMAARLHSTR 235
           G+ Y+H+    +I+HRD+K  N+L+     D D+ KI DF LS    Q   M  R+    
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRI---- 184
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             GT  Y APE  + G  + K DV+S GV+L  LL+G  P
Sbjct: 185 --GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 75  IGEGSYGRVYYGILK--SGHAAAIK----KLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
           +G+GS+G V  G     SG   ++     K D   QP+  ++F+ +V+ +  L H N ++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGAAKGL 184
           L G  +    +++  E A  GSL D L   +G  + G      LS     + AV  A+G+
Sbjct: 86  LYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGT-----LS-----RYAVQVAEGM 134
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP--DMAARLHSTRVLGTFGY 242
            YL  K     IHRD+ + N+L+   D+ KI DF L    P  D    +   R +  F +
Sbjct: 135 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAW 190
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            APE   T   +  SD + FGV L E+ T G++P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 75  IGEGSYGRVYYGILK--SGHAAAIK----KLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
           +G+GS+G V  G     SG   ++     K D   QP+  ++F+ +V+ +  L H N ++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGAAKGL 184
           L G  +    +++  E A  GSL D L   +G  + G      LS     + AV  A+G+
Sbjct: 76  LYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGT-----LS-----RYAVQVAEGM 124
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP--DMAARLHSTRVLGTFGY 242
            YL  K     IHRD+ + N+L+   D+ KI DF L    P  D    +   R +  F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAW 180
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            APE   T   +  SD + FGV L E+ T G++P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-QPD--EEFLAQVSMVSRLKHEN 123
           N+     IG+G++ +V     + +G   AIK +D ++  P   ++   +V ++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            V+L        +  L  E+AS G + D L  HGR   K A+      ++Q V       
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS----KFRQIVS------ 122
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             ++Y H+K    I+HRD+K+ N+L+  D   KIADF  SN+   +  +L +    G+  
Sbjct: 123 -AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDT--FCGSPP 175
Query: 242 YHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVD 277
           Y APE     + +  + DV+S GV+L  L++G  P D
Sbjct: 176 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++  G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 83  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 133
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++  G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 126
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 126
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF  +          H+       
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 78  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 128
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF  +          H+       
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 163
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           ++YL  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 164 MKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 220
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 221 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 75  IGEGSYGRVYYGILKS----GHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S      A AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 128
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+  +D  K+ DF LS    D +    +++      + APE  
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 184
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              +  + SDV+ FGV + E+L  G KP
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 145
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           ++YL  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 146 MKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 75  IGEGSYGRVYYGILK--SGHAAAIK----KLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
           +G+GS+G V  G     SG   ++     K D   QP+  ++F+ +V+ +  L H N ++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGAAKGL 184
           L G  +    +++  E A  GSL D L   +G  + G      LS     + AV  A+G+
Sbjct: 80  LYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGT-----LS-----RYAVQVAEGM 128
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP--DMAARLHSTRVLGTFGY 242
            YL  K     IHRD+ + N+L+   D+ KI DF L    P  D    +   R +  F +
Sbjct: 129 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAW 184
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            APE   T   +  SD + FGV L E+ T G++P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 75  IGEGSYGRVYYGILK--SGHAAAIK----KLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
           +G+GS+G V  G     SG   ++     K D   QP+  ++F+ +V+ +  L H N ++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGAAKGL 184
           L G  +    +++  E A  GSL D L   +G  + G      LS     + AV  A+G+
Sbjct: 76  LYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGT-----LS-----RYAVQVAEGM 124
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP--DMAARLHSTRVLGTFGY 242
            YL  K     IHRD+ + N+L+   D+ KI DF L    P  D    +   R +  F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAW 180
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            APE   T   +  SD + FGV L E+ T G++P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIK---KLDASKQPDEEFLA---QVSMVSRLKHENFVQ 126
           ++G G +G V+ G+ +  G +  I    K+   K   + F A    +  +  L H + V+
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           LLG C  G+S  L  ++   GSL D +   +G  G  P  +L+W       V  AKG+ Y
Sbjct: 98  LLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALG--PQLLLNW------GVQIAKGMYY 148
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           L E     ++HR++ + NVL+      ++ADF +++  P    +L  +       + A E
Sbjct: 149 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT 271
               G+   +SDV+S+GV + EL+T
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 137
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           ++YL  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 138 MKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 194
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 195 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 164
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-RLHS-TRVLGTFG 241
           ++YL  K     +HRD+ + N ++ +    K+ADF L+    D     +H+ T       
Sbjct: 165 MKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 221
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 222 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 145
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-RLHS-TRVLGTFG 241
           ++YL  K     +HRD+ + N ++ +    K+ADF L+    D     +H+ T       
Sbjct: 146 MKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 142
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-RLHS-TRVLGTFG 241
           ++YL  K     +HRD+ + N ++ +    K+ADF L+    D     +H+ T       
Sbjct: 143 MKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 199
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 140
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           ++YL  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 141 MKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 28/244 (11%)
Query: 40  APKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKK 98
            P+G+   + +P          + E+ E +   + +G G+YG V      K+GH  A+KK
Sbjct: 15  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKK 74
Query: 99  LDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155
           L    Q     +    ++ ++  +KHEN + LL   V   +R L  EF     ++ + H 
Sbjct: 75  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD--VFTPARSLE-EF---NDVYLVTH- 127
Query: 156 RKGVKGAQPGPVLSWQQRVK-----IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210
              + GA    ++  Q+        +     +GL+Y+H  AD  IIHRD+K SN+ + +D
Sbjct: 128 ---LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNED 181
Query: 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLEL 269
              KI DF L+    D      +TR      Y APE  +     N   D++S G ++ EL
Sbjct: 182 CELKILDFGLARHTDDEMXGXVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 270 LTGR 273
           LTGR
Sbjct: 237 LTGR 240

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T +++  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 83  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 133
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF  +          H+       
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 143
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-RLHS-TRVLGTFG 241
           ++YL  K     +HRD+ + N ++ +    K+ADF L+    D     +H+ T       
Sbjct: 144 MKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 200
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL---DASKQPDEEFLAQVSMVSRL 119
           E  EN G   L+GEGSYG V     K +G   AIKK    D  K   +  + ++ ++ +L
Sbjct: 25  EKYENLG---LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +HEN V LL  C       L +EF  +  L D+     G         L +Q   K    
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---------LDYQVVQKYLFQ 132
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVL 237
              G+ + H     +IIHRDIK  N+L+    V K+ DF  +    AP     ++   V 
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---GEVYDDEV- 185
Query: 238 GTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTG 272
            T  Y APE  +      K+ DV++ G ++ E+  G
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 144
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           ++YL  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 145 MKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 201
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T + L  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 128
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF  +          H+       
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T + L  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 130
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF  +          H+       
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 25/229 (10%)
Query: 56  AISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLA 111
           A S DE   I  N+     IG+G++ +V     + +G   A+K +D ++      ++   
Sbjct: 4   ATSADEQPHIG-NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLS 169
           +V ++  L H N V+L        +  L  E+AS G + D L  HGR   K A+      
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----K 118
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
           ++Q V         ++Y H+K    I+HRD+K+ N+L+  D   KIADF  SN+      
Sbjct: 119 FRQIVS-------AVQYCHQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGN 167
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVD 277
           +L +    G+  Y APE     + +  + DV+S GV+L  L++G  P D
Sbjct: 168 KLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 67  ENFGTNALIGEGSYGRVYY---GILKSGHAA-AIKKLDASKQPDEEFLAQVSMVSRLKHE 122
           E +    ++G+GS+G V      I +  +A   I K  A  +     L +V ++ +L H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N ++L     D +S  +  E  + G L D +  RK           S     +I      
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFS 132
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSN---QAPDMAARLHSTR 235
           G+ Y+H+    +I+HRD+K  N+L+     D D+ KI DF LS    Q   M  R+    
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRI---- 184
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             GT  Y APE  + G  + K DV+S GV+L  LL+G  P
Sbjct: 185 --GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++G G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T + L  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 128
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF  +          H+       
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIK---KLDASKQPDEEFLA---QVSMVSRLKHENFVQ 126
           ++G G +G V+ G+ +  G +  I    K+   K   + F A    +  +  L H + V+
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           LLG C  G+S  L  ++   GSL D +   +G  G  P  +L+W       V  AKG+ Y
Sbjct: 80  LLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALG--PQLLLNW------GVQIAKGMYY 130
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           L E     ++HR++ + NVL+      ++ADF +++  P    +L  +       + A E
Sbjct: 131 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT 271
               G+   +SDV+S+GV + EL+T
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 68  NFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK 120
            F    ++  G++G VY G+      K     AIK+L  +  P  ++E L +  +++ + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           + +  +LLG C+  T + L  +    G L D +   K   G+Q   +L+W       V  
Sbjct: 83  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY--LLNW------CVQI 133
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           AKG+ YL    D  ++HRD+ + NVL+      KI DF L+          H+       
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
            + A E  +      +SDV+S+GV + EL+T G KP D
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 25/229 (10%)
Query: 56  AISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLA 111
           A S DE   I  N+     IG+G++ +V     + +G   A+K +D ++      ++   
Sbjct: 4   ATSADEQPHIG-NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLS 169
           +V ++  L H N V+L        +  L  E+AS G + D L  HGR   K A+      
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----K 118
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
           ++Q V         ++Y H+K    I+HRD+K+ N+L+  D   KIADF  SN+      
Sbjct: 119 FRQIVS-------AVQYCHQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGN 167
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVD 277
           +L +    G+  Y APE     + +  + DV+S GV+L  L++G  P D
Sbjct: 168 KLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 75  IGEGSYGRVYYGILKSGH----AAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S      A AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 75  GVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 125
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+  +D  K+ DF LS    D +    +++      + APE  
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 181
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              +  + SDV+ FGV + E+L  G KP
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKP 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 75  IGEGSYGRVYYGILKS----GHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S      A AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 83  GVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 133
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+  +D  K+ DF LS    D +    +++      + APE  
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 189
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              +  + SDV+ FGV + E+L  G KP
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKP 217

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 75  IGEGSYGRVYYGILKS----GHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S      A AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 106 GVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 156
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+  +D  K+ DF LS    D +    +++      + APE  
Sbjct: 157 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 212
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              +  + SDV+ FGV + E+L  G KP
Sbjct: 213 NFRRFTSASDVWMFGVCMWEILMHGVKP 240

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-QPD--EEFLAQVSMVSRLKHEN 123
           N+     IG+G++ +V     + +G   AIK +D ++  P   ++   +V ++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            V+L        +  L  E+AS G + D L  HGR   K A+      ++Q V       
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS----KFRQIVS------ 125
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             ++Y H+K    I+HRD+K+ N+L+  D   KIADF  SN+   +  +L +    G   
Sbjct: 126 -AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDA--FCGAPP 178
Query: 242 YHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVD 277
           Y APE     + +  + DV+S GV+L  L++G  P D
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHE 122
           E++     IG GSYGR      KS G     K+LD     + E    +++V+++  LKH 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 123 NFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           N V+     +D T+  L    E+   G L  ++      KG +    L  +  +++    
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQL 120
Query: 181 AKGLEYLHEKAD--PHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTR 235
              L+  H ++D    ++HRD+K +NV +      K+ DF L+   N   D A       
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEF---- 176
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 269
            +GT  Y +PE       N KSD++S G +L EL
Sbjct: 177 -VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKK--LDASKQ--PDEEFLAQVSMVSRLK 120
           + E +     +GEG+YG VY      G   A+K+  LDA  +  P    + ++S++  L 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELH 77
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV-G 179
           H N V L+          L +EF        +   + G++ +Q          +KI +  
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQ----------IKIYLYQ 127
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
             +G+ + H+     I+HRD+K  N+LI  D   K+ADF L+ +A  +  R ++  V+ T
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTHEVV-T 182
Query: 240 FGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
             Y AP+  M + + +   D++S G +  E++TG+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+GH  A+KKL    Q     +    ++ ++  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 75  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 124
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 125 FLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 176
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 48/234 (20%)
Query: 68  NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           +F    LIG G +G+V+    +  G    I+++   K  +E+   +V  +++L H N V 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV---KYNNEKAEREVKALAKLDHVNIVH 69
Query: 127 LLGYCVDG------------------------TSR------VLAYEFASNGSLHDILHGR 156
             G C DG                        +SR       +  EF   G+L   +  R
Sbjct: 70  YNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 157 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216
           +G K  +   +  ++Q         KG++Y+H K    +IHRD+K SN+ + D    KI 
Sbjct: 129 RGEKLDKVLALELFEQ-------ITKGVDYIHSKK---LIHRDLKPSNIFLVDTKQVKIG 178
Query: 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
           DF L     +   R   TR  GT  Y +PE   +     + D+Y+ G++L ELL
Sbjct: 179 DFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKK--LDASKQ--PDEEFLAQVSMVSRLK 120
           + E +     +GEG+YG VY      G   A+K+  LDA  +  P    + ++S++  L 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELH 77
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV-G 179
           H N V L+          L +EF        +   + G++ +Q          +KI +  
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQ----------IKIYLYQ 127
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
             +G+ + H+     I+HRD+K  N+LI  D   K+ADF L+ +A  +  R ++  V+ T
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTHEVV-T 182
Query: 240 FGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
             Y AP+  M + + +   D++S G +  E++TG+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 75  IGEGSYGRVYYGILKS----GHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S      A AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 128
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+  +D  K+ DF LS    D +    +++      + APE  
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 184
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              +  + SDV+ FGV + E+L  G KP
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 75  IGEGSYGRVYYGILKSGH----AAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S      A AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 80  GVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 130
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+  +D  K+ DF LS    D +    +++      + APE  
Sbjct: 131 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 186
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              +  + SDV+ FGV + E+L  G KP
Sbjct: 187 NFRRFTSASDVWMFGVCMWEILMHGVKP 214

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+GH  A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 108/235 (45%), Gaps = 32/235 (13%)
Query: 53  EVPAISVDELK----EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP-- 105
           E P     EL     E+ E +   + +G G+YG V      K+GH  A+KKL    Q   
Sbjct: 10  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 69
Query: 106 -DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
             +    ++ ++  +KHEN + LL   V   +R L  EF     ++ + H    + GA  
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADL 119
Query: 165 GPVLSWQQRVK-----IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219
             ++  Q+        +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF 
Sbjct: 120 NNIVKCQKLTDDHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFG 176
Query: 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
           L+    D       T  + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 177 LARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 75  IGEGSYGRVYYGILKSGH----AAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S      A AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 81  GVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 131
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+  +D  K+ DF LS    D +    +++      + APE  
Sbjct: 132 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 187
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              +  + SDV+ FGV + E+L  G KP
Sbjct: 188 NFRRFTSASDVWMFGVCMWEILMHGVKP 215

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 143
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           +++L  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 144 MKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 200
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 146
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           +++L  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 147 MKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVK 203
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 145
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           +++L  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 146 MKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 204
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           +++L  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 205 MKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 150
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           +++L  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 151 MKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 207
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 208 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 146
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           +++L  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 147 MKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 203
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 72  NALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENF 124
           N +IG G +G VY+G L     K  H A +K L+      E  +FL +  ++    H N 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 125 VQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
           + LLG C+    S ++   +  +G L      R  ++     P +  +  +   +  AKG
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTV--KDLIGFGLQVAKG 145
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFG 241
           +++L  K     +HRD+ + N ++ +    K+ADF L+    D    +  + T       
Sbjct: 146 MKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + A E   T +   KSDV+SFGV+L EL+T   P
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 75  IGEGSYGRVYYGILKS----GHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S      A AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFLQVRKFS--------LDLASLILYAYQLSTALAYLE 508
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+  +D  K+ DF LS    D +    +++      + APE  
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 564
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              +  + SDV+ FGV + E+L  G KP
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+GH  A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFYLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 109/229 (47%), Gaps = 25/229 (10%)
Query: 56  AISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLA 111
           A S DE   I  N+     IG+G++ +V     + +G   A+K +D ++      ++   
Sbjct: 4   ATSADEQPHIG-NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLS 169
           +V ++  L H N V+L        +  L  E+AS G + D L  HGR   K A+      
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----K 118
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
           ++Q V         ++Y H+K    I+HRD+K+ N+L+  D   KIADF  SN+      
Sbjct: 119 FRQIVS-------AVQYCHQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGN 167
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVD 277
           +L +    G   Y APE     + +  + DV+S GV+L  L++G  P D
Sbjct: 168 KLDA--FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 25/229 (10%)
Query: 56  AISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLA 111
           A S DE   I  N+     IG+G++ +V     + +G   A++ +D ++      ++   
Sbjct: 4   ATSADEQPHIG-NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR 62
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLS 169
           +V ++  L H N V+L        +  L  E+AS G + D L  HGR   K A+      
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----K 118
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
           ++Q V         ++Y H+K    I+HRD+K+ N+L+  D   KIADF  SN+      
Sbjct: 119 FRQIVS-------AVQYCHQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGN 167
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVD 277
           +L +    G+  Y APE     + +  + DV+S GV+L  L++G  P D
Sbjct: 168 KLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKL-DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V   YY + K     A+K L + +  P   +E LA+ +++ +L +   V+++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   + VK          +  +++    + G++YL 
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 144
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
           E    + +HRD+ + NVL+     AKI+DF LS +A       +  +  G +   ++APE
Sbjct: 145 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWYAPE 200
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                + ++KSDV+SFGV++ E  + G+KP
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKL-DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V   YY + K     A+K L + +  P   +E LA+ +++ +L +   V+++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   + VK          +  +++    + G++YL 
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 144
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
           E    + +HRD+ + NVL+     AKI+DF LS +A       +  +  G +   ++APE
Sbjct: 145 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWYAPE 200
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                + ++KSDV+SFGV++ E  + G+KP
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 56  AISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLA 111
           A S DE   I  N+     IG+G++ +V     + +G   A+K +D ++      ++   
Sbjct: 4   ATSADEQPHIG-NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLS 169
           +V +   L H N V+L        +  L  E+AS G + D L  HGR   K A+      
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARA----K 118
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
           ++Q V         ++Y H+K    I+HRD+K+ N+L+  D   KIADF  SN+      
Sbjct: 119 FRQIVS-------AVQYCHQK---FIVHRDLKAENLLLDADXNIKIADFGFSNEFT-FGN 167
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVD 277
           +L +    G   Y APE     + +  + DV+S GV+L  L++G  P D
Sbjct: 168 KLDA--FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKL-DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V   YY + K     A+K L + +  P   +E LA+ +++ +L +   V+++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   + VK          +  +++    + G++YL 
Sbjct: 93  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 142
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
           E    + +HRD+ + NVL+     AKI+DF LS +A       +  +  G +   ++APE
Sbjct: 143 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWYAPE 198
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                + ++KSDV+SFGV++ E  + G+KP
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 20/208 (9%)
Query: 75  IGEGSYGRVYYGILKS----GHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S      A AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKFS--------LDLASLILYAYQLSTALAYLE 128
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+   D  K+ DF LS    D +    +++      + APE  
Sbjct: 129 SK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 184
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              +  + SDV+ FGV + E+L  G KP
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKL-DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V   YY + K     A+K L + +  P   +E LA+ +++ +L +   V+++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   + VK          +  +++    + G++YL 
Sbjct: 85  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 134
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
           E    + +HRD+ + NVL+     AKI+DF LS +A       +  +  G +   ++APE
Sbjct: 135 E---SNFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWYAPE 190
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                + ++KSDV+SFGV++ E  + G+KP
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKL-DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V   YY + K     A+K L + +  P   +E LA+ +++ +L +   V+++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   + VK          +  +++    + G++YL 
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 124
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
           E    + +HRD+ + NVL+     AKI+DF LS +A       +  +  G +   ++APE
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWYAPE 180
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                + ++KSDV+SFGV++ E  + G+KP
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKL-DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V   YY + K     A+K L + +  P   +E LA+ +++ +L +   V+++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   + VK          +  +++    + G++YL 
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 128
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
           E    + +HRD+ + NVL+     AKI+DF LS +A       +  +  G +   ++APE
Sbjct: 129 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWYAPE 184
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                + ++KSDV+SFGV++ E  + G+KP
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKL-DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V   YY + K     A+K L + +  P   +E LA+ +++ +L +   V+++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   + VK          +  +++    + G++YL 
Sbjct: 73  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 122
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
           E    + +HRD+ + NVL+     AKI+DF LS +A       +  +  G +   ++APE
Sbjct: 123 E---SNFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWYAPE 178
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                + ++KSDV+SFGV++ E  + G+KP
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKL-DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V   YY + K     A+K L + +  P   +E LA+ +++ +L +   V+++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   + VK          +  +++    + G++YL 
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 128
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
           E    + +HRD+ + NVL+     AKI+DF LS +A       +  +  G +   ++APE
Sbjct: 129 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENXYKAQTHGKWPVKWYAPE 184
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                + ++KSDV+SFGV++ E  + G+KP
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 25/229 (10%)
Query: 56  AISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLA 111
           A S DE   I  N+     IG+G++ +V     + +G   A++ +D ++      ++   
Sbjct: 4   ATSADEQPHIG-NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR 62
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLS 169
           +V ++  L H N V+L        +  L  E+AS G + D L  HGR   K A+      
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----K 118
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
           ++Q V         ++Y H+K    I+HRD+K+ N+L+  D   KIADF  SN+      
Sbjct: 119 FRQIVS-------AVQYCHQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGN 167
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVD 277
           +L      G+  Y APE     + +  + DV+S GV+L  L++G  P D
Sbjct: 168 KLDE--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKL-DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V   YY + K     A+K L + +  P   +E LA+ +++ +L +   V+++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   + VK          +  +++    + G++YL 
Sbjct: 438 GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 487
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
           E    + +HRD+ + NVL+     AKI+DF LS +A       +  +  G +   ++APE
Sbjct: 488 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWYAPE 543
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                + ++KSDV+SFGV++ E  + G+KP
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKL-DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V   YY + K     A+K L + +  P   +E LA+ +++ +L +   V+++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   + VK          +  +++    + G++YL 
Sbjct: 437 GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 486
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
           E    + +HRD+ + NVL+     AKI+DF LS +A       +  +  G +   ++APE
Sbjct: 487 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWYAPE 542
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                + ++KSDV+SFGV++ E  + G+KP
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 25/223 (11%)
Query: 71  TNALIGEGSYGRVYYGIL----KSGHAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHENF 124
           ++ +IG+G +G VY+G      ++    AIK L      Q  E FL +  ++  L H N 
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 125 VQLLGYCV--DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           + L+G  +  +G   VL   +  +G L       + ++  Q  P +  +  +   +  A+
Sbjct: 85  LALIGIMLPPEGLPHVLL-PYMCHGDL------LQFIRSPQRNPTV--KDLISFGLQVAR 135
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD---MAARLHSTRVLGT 239
           G+EYL E+     +HRD+ + N ++ +    K+ADF L+    D    + + H    L  
Sbjct: 136 GMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281
             + A E   T +   KSDV+SFGV+L ELLT G  P  H  P
Sbjct: 193 -KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N V+LL          L +EF S   L D +     + G  P P++             +
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDA-SALTGI-PLPLIK-----SYLFQLLQ 116
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T  Y
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLWY 171
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            APE  +  +  + + D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRL 119
           E  ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIA 177
            H N V+LL          L +EF     LH  L            P P++         
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYL 116
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
               +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+
Sbjct: 117 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV 172
Query: 238 GTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            T  Y APE  +  +  + + D++S G +  E++T R
Sbjct: 173 -TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 75  IGEGSYGRVYYGILKSGHA-AAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
           +G+G++G+VY    K     AA K +D  S++  E+++ ++ +++   H N V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
              +  +  EF + G++  ++     ++  +P   L+  Q   +       L YLH   D
Sbjct: 105 YENNLWILIEFCAGGAVDAVM-----LELERP---LTESQIQVVCKQTLDALNYLH---D 153
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
             IIHRD+K+ N+L   D   K+ADF +S +      R  S   +GT  + APE  M   
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCET 211
Query: 253 -----LNAKSDVYSFGVVLLEL 269
                 + K+DV+S G+ L+E+
Sbjct: 212 SKDRPYDYKADVWSLGITLIEM 233

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N V+LL          L +EF S   L D +     + G  P P++             +
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDA-SALTGI-PLPLIK-----SYLFQLLQ 117
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T  Y
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLWY 172
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            APE  +  +  + + D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRL 119
           E  ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIA 177
            H N V+LL          L +EF     LH  L            P P++         
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYL 116
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
               +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+
Sbjct: 117 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV 172
Query: 238 GTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            T  Y APE  +  +  + + D++S G +  E++T R
Sbjct: 173 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 94  AAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151
            AIK+++  K     +E L ++  +S+  H N V      V      L  +  S GS+ D
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211
           I+      KG     VL       I     +GLEYLH+      IHRD+K+ N+L+ +D 
Sbjct: 98  IIK-HIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 153
Query: 212 VAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLL 267
             +IADF +S       D+         +GT  + APE     +  + K+D++SFG+  +
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 213
Query: 268 ELLTGRKPVDHTLPRGQQSLVT 289
           EL TG  P  H  P  +  ++T
Sbjct: 214 ELATGAAPY-HKYPPMKVLMLT 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 75  IGEGSYGRVYYGILKSGHA-AAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
           +G+G++G+VY    K     AA K +D  S++  E+++ ++ +++   H N V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
              +  +  EF + G++  ++     ++  +P   L+  Q   +       L YLH   D
Sbjct: 105 YENNLWILIEFCAGGAVDAVM-----LELERP---LTESQIQVVCKQTLDALNYLH---D 153
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
             IIHRD+K+ N+L   D   K+ADF +S +      R  S   +GT  + APE  M   
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMCET 211
Query: 253 -----LNAKSDVYSFGVVLLEL 269
                 + K+DV+S G+ L+E+
Sbjct: 212 SKDRPYDYKADVWSLGITLIEM 233

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 89/194 (45%), Gaps = 11/194 (5%)
Query: 94  AAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151
            AIK+++  K     +E L ++  +S+  H N V      V      L  +  S GS+ D
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211
           I+      KG     VL       I     +GLEYLH+      IHRD+K+ N+L+ +D 
Sbjct: 103 IIK-HIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 158
Query: 212 VAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLL 267
             +IADF +S       D+         +GT  + APE     +  + K+D++SFG+  +
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 268 ELLTGRKPVDHTLP 281
           EL TG  P  H  P
Sbjct: 219 ELATGAAPY-HKYP 231

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 114/248 (45%), Gaps = 33/248 (13%)
Query: 40  APKGAQAVKVQPIEVPAISVDELK----EITENFGTNALIGEGSYGRVYYGI-LKSGHAA 94
            P+G+  +++   E P     EL     E+ E +   + +G G+YG V      K+G   
Sbjct: 15  VPRGSHMLEMSQ-ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRV 73
Query: 95  AIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151
           A+KKL    Q     +    ++ ++  +KHEN + LL   V   +R L  EF     ++ 
Sbjct: 74  AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD--VFTPARSLE-EF---NDVYL 127
Query: 152 ILHGRKGVKGAQPGPVLSWQQRVK-----IAVGAAKGLEYLHEKADPHIIHRDIKSSNVL 206
           + H    + GA    ++  Q+        +     +GL+Y+H  AD  IIHRD+K SN+ 
Sbjct: 128 VTH----LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLA 180
Query: 207 IFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVV 265
           + +D   KI DF L+    D       T  + T  Y APE  +     N   D++S G +
Sbjct: 181 VNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 235
Query: 266 LLELLTGR 273
           + ELLTGR
Sbjct: 236 MAELLTGR 243

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 20/208 (9%)
Query: 75  IGEGSYGRVYYGILKS----GHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S      A AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFLQVRKFS--------LDLASLILYAYQLSTALAYLE 508
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+   D  K+ DF LS    D +    +++      + APE  
Sbjct: 509 SK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 564
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              +  + SDV+ FGV + E+L  G KP
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 106/237 (44%), Gaps = 25/237 (10%)
Query: 47  VKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS--K 103
           +K+ P +    + ++LK++ E       IG G+YG V   + K SG   A+K++ ++  +
Sbjct: 9   LKISPEQHWDFTAEDLKDLGE-------IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 104 QPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA 162
           +  ++ L  + +V R     + VQ  G         +  E  S        +    +   
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV 121
Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
            P  +L      KI +   K L +L E     IIHRDIK SN+L+      K+ DF +S 
Sbjct: 122 IPEEILG-----KITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG 174
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEY----AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           Q  D  A+   TR  G   Y APE     A     + +SDV+S G+ L EL TGR P
Sbjct: 175 QLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 68/138 (49%), Gaps = 15/138 (10%)
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  E    GSL  +L   K +    P  +L      K+++   +GL YL EK    I+HR
Sbjct: 91  ICMEHMDGGSLDQVLKEAKRI----PEEILG-----KVSIAVLRGLAYLREKH--QIMHR 139
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSD 258
           D+K SN+L+      K+ DF +S Q  D  A       +GT  Y APE       + +SD
Sbjct: 140 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMAPERLQGTHYSVQSD 195
Query: 259 VYSFGVVLLELLTGRKPV 276
           ++S G+ L+EL  GR P+
Sbjct: 196 IWSMGLSLVELAVGRYPI 213

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+GH  A+KKL    Q     +    ++ ++  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++   +       
Sbjct: 75  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCAKLTDDHVQ 124
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 125 FLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 176
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 111/244 (45%), Gaps = 28/244 (11%)
Query: 40  APKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKK 98
            P+G+   + +P          + E+ E +   + +G G+YG V      K+G   A+KK
Sbjct: 14  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 73
Query: 99  LDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155
           L    Q     +    ++ ++  +KHEN + LL   V   +R L  EF     ++ + H 
Sbjct: 74  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD--VFTPARSLE-EF---NDVYLVTH- 126
Query: 156 RKGVKGAQPGPVLSWQQRVK-----IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210
              + GA    ++  Q+        +     +GL+Y+H  AD  IIHRD+K SN+ + +D
Sbjct: 127 ---LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNED 180
Query: 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLEL 269
              KI DF L+    D       T  + T  Y APE  +     N   D++S G ++ EL
Sbjct: 181 CELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 235
Query: 270 LTGR 273
           LTGR
Sbjct: 236 LTGR 239

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHE 122
           E++     IG GSYGR      KS G     K+LD     + E    +++V+++  LKH 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 123 NFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           N V+     +D T+  L    E+   G L  ++      KG +    L  +  +++    
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQL 120
Query: 181 AKGLEYLHEKAD--PHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTR 235
              L+  H ++D    ++HRD+K +NV +      K+ DF L+   N     A       
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF---- 176
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 269
            +GT  Y +PE       N KSD++S G +L EL
Sbjct: 177 -VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 111/244 (45%), Gaps = 28/244 (11%)
Query: 40  APKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKK 98
            P+G+   + +P          + E+ E +   + +G G+YG V      K+G   A+KK
Sbjct: 15  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 74
Query: 99  LDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155
           L    Q     +    ++ ++  +KHEN + LL   V   +R L  EF     ++ + H 
Sbjct: 75  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD--VFTPARSLE-EF---NDVYLVTH- 127
Query: 156 RKGVKGAQPGPVLSWQQRVK-----IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210
              + GA    ++  Q+        +     +GL+Y+H  AD  IIHRD+K SN+ + +D
Sbjct: 128 ---LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNED 181
Query: 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLEL 269
              KI DF L+    D       T  + T  Y APE  +     N   D++S G ++ EL
Sbjct: 182 CELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 270 LTGR 273
           LTGR
Sbjct: 237 LTGR 240

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + IG G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 24  EVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 84  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 133
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 134 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMT 185
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 63  KEITENFGTNALIGEGSYGRVYYG---ILKSGHAAAIKKLDASKQPDEE----FLAQVSM 115
           K I E +     +G G    VY     IL      AIK +    +  EE    F  +V  
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNI--KVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
            S+L H+N V ++    +     L  E+    +L + +           GP LS    + 
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAIN 115
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
                  G+++ H   D  I+HRDIK  N+LI  +   KI DF ++ +A    +   +  
Sbjct: 116 FTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNH 171
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           VLGT  Y +PE A     +  +D+YS G+VL E+L G  P +
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 81/177 (45%), Gaps = 29/177 (16%)
Query: 119 LKHENFVQLLGYCVDGTSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
           +KHEN +Q +     G++      L   F   GSL D L G           +++W +  
Sbjct: 66  MKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGN----------IITWNELC 115
Query: 175 KIAVGAAKGLEYLHEKA--------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
            +A   ++GL YLHE           P I HRD KS NVL+  D  A +ADF L+ +   
Sbjct: 116 HVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEP 175
Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLN------AKSDVYSFGVVLLELLTGRKPVD 277
                 +   +GT  Y APE  + G +N       + D+Y+ G+VL EL++  K  D
Sbjct: 176 GKPPGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N V+LL          L +EF  +  L D +     + G  P P++             +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDA-SALTGI-PLPLIK-----SYLFQLLQ 114
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T  Y
Sbjct: 115 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLWY 169
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            APE  +  +  + + D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYC 131
           IGEG+YG VY      G   A+KK+   K+ +      + ++S++  LKH N V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 132 VDGTSRVLAYEFASN--GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
                 VL +E        L D+  G  G++       L         +    G+ Y H 
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFL---------LQLLNGIAYCH- 117
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
             D  ++HRD+K  N+LI  +   KIADF L+ +A  +  R ++  V+ T  Y AP+  M
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 250 -TGQLNAKSDVYSFGVVLLELLTG 272
            + + +   D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP------VLSWQQRVKIAV 178
            LLG C   G   ++  EF   G+L   L  ++        P       L+ +  +  + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHSTR 235
             AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    R
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRKGDAR 211
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           +     + APE         +SDV+SFGV+L E+ +
Sbjct: 212 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYC 131
           IGEG+YG VY      G   A+KK+   K+ +      + ++S++  LKH N V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 132 VDGTSRVLAYEFASN--GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
                 VL +E        L D+  G  G++       L         +    G+ Y H 
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFL---------LQLLNGIAYCH- 117
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
             D  ++HRD+K  N+LI  +   KIADF L+ +A  +  R ++  V+ T  Y AP+  M
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 250 -TGQLNAKSDVYSFGVVLLELLTG 272
            + + +   D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 115/250 (46%), Gaps = 40/250 (16%)
Query: 56  AISVDELKEITE--------NFGTNALIGEGSYGRV-----YYGILKSGHAA-AIKKLDA 101
           ++SVD  K + +        N      +GEG +G+V     ++   ++G+   A+K L  
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 102 SKQPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV 159
           +  P E  + L++ +++ ++ H + ++L G C      +L  E+A  GSL   L   + V
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 160 KGAQPGPV------------------LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
               PG +                  L+    +  A   ++G++YL   A+  ++HRD+ 
Sbjct: 124 ---GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLA 177
Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
           + N+L+ +    KI+DF LS    +  + +  ++      + A E         +SDV+S
Sbjct: 178 ARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWS 237
Query: 262 FGVVLLELLT 271
           FGV+L E++T
Sbjct: 238 FGVLLWEIVT 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 115/250 (46%), Gaps = 40/250 (16%)
Query: 56  AISVDELKEITE--------NFGTNALIGEGSYGRV-----YYGILKSGHAA-AIKKLDA 101
           ++SVD  K + +        N      +GEG +G+V     ++   ++G+   A+K L  
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 102 SKQPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV 159
           +  P E  + L++ +++ ++ H + ++L G C      +L  E+A  GSL   L   + V
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 160 KGAQPGPV------------------LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
               PG +                  L+    +  A   ++G++YL E +   ++HRD+ 
Sbjct: 124 G---PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLA 177
Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
           + N+L+ +    KI+DF LS    +  + +  ++      + A E         +SDV+S
Sbjct: 178 ARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWS 237
Query: 262 FGVVLLELLT 271
           FGV+L E++T
Sbjct: 238 FGVLLWEIVT 247

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 81  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 130
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 131 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMT 182
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 75  IGEGSYGRVYYGILKSGHA-AAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
           +G+G++G+VY    K     AA K +D  S++  E+++ ++ +++   H N V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
              +  +  EF + G++  ++     ++  +P   L+  Q   +       L YLH   D
Sbjct: 105 YENNLWILIEFCAGGAVDAVM-----LELERP---LTESQIQVVCKQTLDALNYLH---D 153
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
             IIHRD+K+ N+L   D   K+ADF +S +      R      +GT  + APE  M   
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDXFIGTPYWMAPEVVMCET 211
Query: 253 -----LNAKSDVYSFGVVLLEL 269
                 + K+DV+S G+ L+E+
Sbjct: 212 SKDRPYDYKADVWSLGITLIEM 233

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T 
Sbjct: 113 LQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 167
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 106/246 (43%), Gaps = 35/246 (14%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKK-LDASKQP--DEEFLAQVSMVSRLK 120
           + E +     IGEGSYG V+    + +G   AIKK L++   P   +  L ++ M+ +LK
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H N V LL          L +E+  +  LH++   ++GV       + +WQ         
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSI-TWQ--------T 111
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            + + + H+    + IHRD+K  N+LI    V K+ DF  +      +   +    + T 
Sbjct: 112 LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATR 166
Query: 241 GYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG----------------RKPVDHTLPRG 283
            Y +PE  +   Q     DV++ G V  ELL+G                RK +   +PR 
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226
Query: 284 QQSLVT 289
           QQ   T
Sbjct: 227 QQVFST 232

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHE 122
           E++     IG GSYGR      KS G     K+LD     + E    +++V+++  LKH 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 123 NFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           N V+     +D T+  L    E+   G L  ++      KG +    L  +  +++    
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQL 120
Query: 181 AKGLEYLHEKAD--PHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTR 235
              L+  H ++D    ++HRD+K +NV +      K+ DF L+   N     A       
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF---- 176
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 269
            +GT  Y +PE       N KSD++S G +L EL
Sbjct: 177 -VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 20/221 (9%)
Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSM 115
           V ELK+  ++F   + +G G+ G V+    K SG   A K +    +P    + + ++ +
Sbjct: 62  VGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 119
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           +        V   G         +  E    GSL  +L       G  P  +L      K
Sbjct: 120 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILG-----K 170
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
           +++   KGL YL EK    I+HRD+K SN+L+      K+ DF +S Q  D  A      
Sbjct: 171 VSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NS 224
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
            +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYG-ILKSGHAAAIKKL--DASKQPDEEFLAQVSMVS 117
           ++K   E+F  + ++G+GS+G+V+     K+    AIK L  D     D+    + +MV 
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMVE 68
Query: 118 R----LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
           +    L  E+      +C   T   L +       + + L+G   +   Q        + 
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFF-------VMEYLNGGDLMYHIQSCHKFDLSRA 121
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
              A     GL++LH K    I++RD+K  N+L+  D   KIADF +  +  +M     +
Sbjct: 122 TFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKT 176
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
               GT  Y APE  +  + N   D +SFGV+L E+L G+ P 
Sbjct: 177 NEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 85  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 134
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 135 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMT 186
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYC 131
           IGEG+YG VY      G   A+KK+   K+ +      + ++S++  LKH N V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 132 VDGTSRVLAYEFASN--GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
                 VL +E        L D+  G  G++       L         +    G+ Y H 
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFL---------LQLLNGIAYCH- 117
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
             D  ++HRD+K  N+LI  +   KIADF L+ +A  +  R ++  ++ T  Y AP+  M
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 250 -TGQLNAKSDVYSFGVVLLELLTG 272
            + + +   D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 115/250 (46%), Gaps = 40/250 (16%)
Query: 56  AISVDELKEITE--------NFGTNALIGEGSYGRV-----YYGILKSGHAA-AIKKLDA 101
           ++SVD  K + +        N      +GEG +G+V     ++   ++G+   A+K L  
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 102 SKQPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV 159
           +  P E  + L++ +++ ++ H + ++L G C      +L  E+A  GSL   L   + V
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 160 KGAQPGPV------------------LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
               PG +                  L+    +  A   ++G++YL   A+  ++HRD+ 
Sbjct: 124 ---GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLA 177
Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
           + N+L+ +    KI+DF LS    +  + +  ++      + A E         +SDV+S
Sbjct: 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWS 237
Query: 262 FGVVLLELLT 271
           FGV+L E++T
Sbjct: 238 FGVLLWEIVT 247

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 84  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 133
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 134 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMT 185
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 90  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 139
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 140 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMT 191
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 25/242 (10%)
Query: 38  EAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAI 96
           E   K  +A   Q  +V  +  D+ ++I+E       +G G+ G V+    K SG   A 
Sbjct: 11  EQQRKRLEAFLTQKQKVGELKDDDFEKISE-------LGAGNGGVVFKVSHKPSGLVMAR 63
Query: 97  KKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH 154
           K +    +P    + + ++ ++        V   G         +  E    GSL  +L 
Sbjct: 64  KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 123
Query: 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214
                 G  P  +L      K+++   KGL YL EK    I+HRD+K SN+L+      K
Sbjct: 124 K----AGRIPEQILG-----KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIK 172
Query: 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 274
           + DF +S Q  D  A       +GT  Y +PE       + +SD++S G+ L+E+  GR 
Sbjct: 173 LCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228
Query: 275 PV 276
           P+
Sbjct: 229 PI 230

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 86  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 135
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 136 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMT 187
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKXQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 67  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 116
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T 
Sbjct: 117 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 171
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 167
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 111
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T 
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 166
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 111
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T 
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 166
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 105/204 (51%), Gaps = 24/204 (11%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLG-YC 131
           +G+G++G+VY    K   A A  K+  +K  +E  +++ ++ +++   H   V+LLG Y 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 132 VDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
            DG   ++  EF   G++  I L   +G+   +P   +  +Q ++        L +LH K
Sbjct: 79  HDGKLWIM-IEFCPGGAVDAIMLELDRGL--TEPQIQVVCRQMLE-------ALNFLHSK 128
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
               IIHRD+K+ NVL+  +   ++ADF +S  A ++         +GT  + APE  M 
Sbjct: 129 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 251 GQL-----NAKSDVYSFGVVLLEL 269
             +     + K+D++S G+ L+E+
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 86  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 135
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 136 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMT 187
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 86  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 135
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 136 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMT 187
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 167
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHM 90
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 91  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 140
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 141 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 192
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 64  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 113
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T 
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 168
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 167
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 114/259 (44%), Gaps = 43/259 (16%)
Query: 29  GTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELK----EITENFGTNALIGEGSYGRVY 84
           GT+  Y  S A+            E P     EL     E+ E +   + +G G+YG V 
Sbjct: 14  GTENLYFQSNASQ-----------ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVC 62
Query: 85  YGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140
                K+G   A+KKL    Q     +    ++ ++  +KHEN + LL   V   +R L 
Sbjct: 63  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD--VFTPARSLE 120
Query: 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-----IAVGAAKGLEYLHEKADPHI 195
            EF     ++ + H    + GA    ++  Q+        +     +GL+Y+H  AD  I
Sbjct: 121 -EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-SAD--I 169
Query: 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLN 254
           IHRD+K SN+ + +D   KI DF L+    D      +TR      Y APE  +     N
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRAPEIMLNWMHYN 224
Query: 255 AKSDVYSFGVVLLELLTGR 273
              D++S G ++ ELLTGR
Sbjct: 225 QTVDIWSVGCIMAELLTGR 243

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLG-YC 131
           +G+G++G+VY    K   A A  K+  +K  +E  +++ ++ +++   H   V+LLG Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 132 VDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
            DG   ++  EF   G++  I L   +G+   Q   V              + L +LH K
Sbjct: 87  HDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVVCR---------QMLEALNFLHSK 136
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
               IIHRD+K+ NVL+  +   ++ADF +S  A ++         +GT  + APE  M 
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 251 GQL-----NAKSDVYSFGVVLLEL 269
             +     + K+D++S G+ L+E+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 91  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 140
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 141 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 192
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILKSGHA----AAIKKLDASKQPDEEFLAQVSMVSRLK 120
           ++E +     +G G+YG V     K  H       I+K   S   + + L +V+++  L 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H N ++L  +  D  +  L  E    G L D +  R          ++            
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK---------QV 145
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDLS----NQAPDMAARLHS 233
             G+ YLH+    +I+HRD+K  N+L+     D + KI DF LS    NQ   M  R   
Sbjct: 146 LSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKER--- 198
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
              LGT  Y APE  +  + + K DV+S GV+L  LL G  P
Sbjct: 199 ---LGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 91  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 140
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 141 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 192
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 86  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 135
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 136 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 187
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 85  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 134
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 135 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 186
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 90  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 139
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 140 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 191
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 81  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 130
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 131 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 182
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 76  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 125
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 126 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 177
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 81  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 130
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 131 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 182
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHEN 123
           N+     IG+G++ +V     + +G   A+K +D ++      ++   +V ++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            V+L        +  L  E+AS G + D L  HG    K A+      ++Q V       
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARA----KFRQIVS------ 117
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             ++Y H+K    I+HRD+K+ N+L+  D   KIADF  SN+      +L +    G+  
Sbjct: 118 -AVQYCHQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDT--FCGSPP 170
Query: 242 YHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVD 277
           Y APE     + +  + DV+S GV+L  L++G  P D
Sbjct: 171 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKSQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L     D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDSELKILDFGLCRHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYG-ILKSGHAAAIKKL--DASKQPDEEFLAQVSMVS 117
           ++K   E+F  + ++G+GS+G+V+     K+    AIK L  D     D+    + +MV 
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMVE 67
Query: 118 R----LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
           +    L  E+      +C   T   L +       + + L+G   +   Q        + 
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFF-------VMEYLNGGDLMYHIQSCHKFDLSRA 120
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
              A     GL++LH K    I++RD+K  N+L+  D   KIADF +  +  +M     +
Sbjct: 121 TFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKT 175
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
               GT  Y APE  +  + N   D +SFGV+L E+L G+ P 
Sbjct: 176 NXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N V+LL          L +EF S   L   +     + G  P P++             +
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDA-SALTGI-PLPLIK-----SYLFQLLQ 117
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T  Y
Sbjct: 118 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLWY 172
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            APE  +  +  + + D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 76
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 77  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 126
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 127 FLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 178
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 84  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 133
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 134 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 185
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 18  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 77
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 78  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 127
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 128 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 179
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 180 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 76  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 125
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 126 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 177
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 75  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 124
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 125 FLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 176
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           K+++   KGL YL EK    I+HRD+K SN+L+      K+ DF +S Q  D  A     
Sbjct: 127 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 180
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 181 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 84  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 133
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 134 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 185
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 65  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 114
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 115 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 169
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N V+LL          L +EF S   L   +     + G  P P++             +
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDA-SALTGI-PLPLIK-----SYLFQLLQ 115
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T  Y
Sbjct: 116 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLWY 170
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            APE  +  +  + + D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 65  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 114
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 115 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 169
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           K+++   KGL YL EK    I+HRD+K SN+L+      K+ DF +S Q  D  A     
Sbjct: 108 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 161
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 81  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 130
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 131 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 182
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKXQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 18/225 (8%)
Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           +G G++G V+    +S G    IK +  D S+ P E+  A++ ++  L H N +++    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            D  +  +  E    G L +     + V     G  LS     ++       L Y H + 
Sbjct: 90  EDYHNMYIVMETCEGGELLE-----RIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 192 DPHIIHRDIKSSNVLIFDDDV---AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
             H++H+D+K  N+L  D       KI DF L   A    +  HST   GT  Y APE  
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGL---AELFKSDEHSTNAAGTALYMAPE-V 197
Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 293
               +  K D++S GVV+  LLTG  P   T     Q   T+  P
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           K+++   KGL YL EK    I+HRD+K SN+L+      K+ DF +S Q  D  A     
Sbjct: 108 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 161
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 66  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 115
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 170
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 65  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 114
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 115 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 169
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 107/235 (45%), Gaps = 32/235 (13%)
Query: 53  EVPAISVDELK----EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP-- 105
           E P     EL     E+ E +   + +G G+YG V      K+G   A+KKL    Q   
Sbjct: 10  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 106 -DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
             +    ++ ++  +KHEN + LL   V   +R L  EF     ++ + H    + GA  
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADL 119
Query: 165 GPVLSWQQRVK-----IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219
             ++  Q+        +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI DF 
Sbjct: 120 NNIVKCQKLTDDHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFG 176
Query: 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
           L+    D       T  + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 177 LARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 66  NIVKLLDVIHTENKLYLVFEF-----LHQDLKTFMDASALTGIPLPLIK-----SYLFQL 115
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 170
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 66  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 115
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 170
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           K+++   KGL YL EK    I+HRD+K SN+L+      K+ DF +S Q  D  A     
Sbjct: 108 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 161
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 64  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 113
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 168
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 75  IGEGSYGRVYYGILKSGHA-AAIK-----KLDASKQPD---------EEFLAQVSMVSRL 119
           +G G+YG V     K+GH+  AIK     + D  +  D         EE   ++S++  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            H N ++L     D     L  EF   G L + +  R          ++           
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK---------Q 154
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AKIADFDLSNQ-APDMAARLHSTR 235
              G+ YLH+    +I+HRDIK  N+L+ + +     KI DF LS+  + D   R     
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR--- 208
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
            LGT  Y APE  +  + N K DV+S GV++  LL G  P 
Sbjct: 209 -LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           K+++   KGL YL EK    I+HRD+K SN+L+      K+ DF +S Q  D  A     
Sbjct: 108 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 161
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           K+++   KGL YL EK    I+HRD+K SN+L+      K+ DF +S Q  D  A     
Sbjct: 108 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 161
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 111
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 166
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 167
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 111
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 166
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 167
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 167
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 64  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 113
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 168
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 67  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 116
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 117 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 171
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 167
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-VKGAQPGPV----LSWQQRVKIAVG 179
            LLG C   G   ++  EF   G+L   L  ++      +P  +    L+ +  +  +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHSTRV 236
            AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    R+
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRKGDARL 212
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
                + APE         +SDV+SFGV+L E+ +
Sbjct: 213 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 32/214 (14%)
Query: 75  IGEGSYGRVYYGI---------LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
           +GEGS+G+V             LK      +KK D   + + E    +S +  L+H + +
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPHII 72
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +L       T  V+  E+A  G L D +  +K +   +      + Q++  A+      E
Sbjct: 73  KLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGR---RFFQQIICAI------E 122
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           Y H      I+HRD+K  N+L+ D+   KIADF LSN   D    L ++   G+  Y AP
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTS--CGSPNYAAP 176
Query: 246 EYAMTGQLNA--KSDVYSFGVVLLELLTGRKPVD 277
           E  + G+L A  + DV+S G+VL  +L GR P D
Sbjct: 177 E-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 64  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 113
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T 
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TL 168
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 22/229 (9%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPD--EEF 109
           P+ ++D +K    NF    ++G+GS+G+V     K     +A  I K D   Q D  E  
Sbjct: 9   PSNNLDRVKLTDFNFLM--VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECT 66
Query: 110 LAQVSMVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           + +  +++ L    F+  L  C     R+    E+ + G L  + H ++  K  +P    
Sbjct: 67  MVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEP---- 120
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
              Q V  A   + GL +LH++    II+RD+K  NV++  +   KIADF +  +   M 
Sbjct: 121 ---QAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH--MM 172
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
             + +    GT  Y APE           D +++GV+L E+L G+ P D
Sbjct: 173 DGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           IG+G YG V+ G  + G   A+K    +++       ++     ++HEN +  +   + G
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 135 TSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE- 189
           T       L  ++  NGSL+D L              L  +  +K+A  +  GL +LH  
Sbjct: 104 TGSWTQLYLITDYHENGSLYDYLKS----------TTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 190 ----KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH---STRVLGTFGY 242
               +  P I HRD+KS N+L+  +    IAD  L+ +       +    +TRV GT  Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRY 212
Query: 243 HAPEYAMTGQLNAK-------SDVYSFGVVLLEL 269
             PE  +   LN         +D+YSFG++L E+
Sbjct: 213 MPPE-VLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 20/222 (9%)
Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQV 113
           +++ ELK+  ++F   + +G G+ G V+    K SG   A K +    +P    + + ++
Sbjct: 1   MALGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 58
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
            ++        V   G         +  E    GSL  +L       G  P  +L     
Sbjct: 59  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILG---- 110
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
            K+++   KGL YL EK    I+HRD+K SN+L+      K+ DF +S Q  D  A    
Sbjct: 111 -KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA---- 163
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
              +GT  Y +PE       + +SD++S G+ L+E+  GR P
Sbjct: 164 NEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-VKGAQPGP------VLSWQQRVKIA 177
            LLG C   G   ++  EF   G+L   L  ++      +  P       L+ +  +  +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHST 234
              AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 212
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 213 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
           +G G +G V   I + +G   AIK+      P   E +  ++ ++ +L H N V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA-REV 80
Query: 132 VDGTSRV-------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
            DG  ++       LA E+   G L   L+  +   G + GP+ +      +    +  L
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT------LLSDISSAL 134
Query: 185 EYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            YLHE     IIHRD+K  N+++       + KI D      A ++      T  +GT  
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL---GYAKELDQGELCTEFVGTLQ 188
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
           Y APE     +     D +SFG +  E +TG +P    LP  Q
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF---LPNWQ 228

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
           +G G +G V   I + +G   AIK+      P   E +  ++ ++ +L H N V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA-REV 81
Query: 132 VDGTSRV-------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
            DG  ++       LA E+   G L   L+  +   G + GP+ +      +    +  L
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT------LLSDISSAL 135
Query: 185 EYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            YLHE     IIHRD+K  N+++       + KI D      A ++      T  +GT  
Sbjct: 136 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL---GYAKELDQGELCTEFVGTLQ 189
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
           Y APE     +     D +SFG +  E +TG +P    LP  Q
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF---LPNWQ 229

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 38/217 (17%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-D 133
           +G+G YG V+ G L  G + A+K   +  +       ++     L+H+N   +LG+   D
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDN---ILGFIASD 71
Query: 134 GTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            TSR       L   +  +GSL+D L  R+ ++     P L+    +++AV AA GL +L
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQ-RQTLE-----PHLA----LRLAVSAACGLAHL 121
Query: 188 H-----EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 239
           H      +  P I HRD KS NVL+  +    IAD  L+   +Q  D     ++ RV GT
Sbjct: 122 HVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GT 180
Query: 240 FGYHAPEYAMTGQLNAK-------SDVYSFGVVLLEL 269
             Y APE  +  Q+          +D+++FG+VL E+
Sbjct: 181 KRYMAPE-VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-VKGAQPGP------VLSWQQRVKIA 177
            LLG C   G   ++  EF   G+L   L  ++      +  P       L+ +  +  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHST 234
              AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRKGDA 201
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 202 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-VKGAQPGP------VLSWQQRVKIA 177
            LLG C   G   ++  EF   G+L   L  ++      +  P       L+ +  +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHST 234
              AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRKGDA 210
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 211 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI D+ L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDYGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-VKGAQPGP------VLSWQQRVKIA 177
            LLG C   G   ++  EF   G+L   L  ++      +  P       L+ +  +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHST 234
              AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-XVRKGDA 210
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 211 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-VKGAQPGP------VLSWQQRVKIA 177
            LLG C   G   ++  EF   G+L   L  ++      +  P       L+ +  +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHST 234
              AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRKGDA 201
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 202 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSM----VSRLKHENFVQLLG 129
           +G G++G+V  G  + +GH  A+K L+  K    + + ++      +   +H + ++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 130 YCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
                +   +  E+ S G L D +  +GR           L  ++  ++      G++Y 
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR-----------LDEKESRRLFQQILSGVDYC 132
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
           H      ++HRD+K  NVL+     AKIADF LSN   D      S    G+  Y APE 
Sbjct: 133 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPE- 185
Query: 248 AMTGQLNA--KSDVYSFGVVLLELLTGRKPVD 277
            ++G+L A  + D++S GV+L  LL G  P D
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 68  NFGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE 122
           +F    ++G+GS+G+V+  + K     SGH  A+K L           A + +  R++ +
Sbjct: 29  HFELLKVLGQGSFGKVFL-VRKVTRPDSGHLYAMKVLKK---------ATLKVRDRVRTK 78
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGA 180
               +L          L Y F + G L+ IL   +G  +       V+  ++ VK  +  
Sbjct: 79  MERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 138
Query: 181 -AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A GL++LH      II+RD+K  N+L+ ++   K+ DF LS +A D   + +S    GT
Sbjct: 139 LALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGT 193
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             Y APE       +  +D +S+GV++ E+LTG  P
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-VKGAQPGP------VLSWQQRVKIA 177
            LLG C   G   ++  EF   G+L   L  ++      +  P       L+ +  +  +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHST 234
              AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 247
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 248 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSM----VSRLKHENFVQLLG 129
           +G G++G+V  G  + +GH  A+K L+  K    + + ++      +   +H + ++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 130 YCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
                T   +  E+ S G L D +  HGR          V   + R ++       ++Y 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGR----------VEEMEAR-RLFQQILSAVDYC 127
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
           H      ++HRD+K  NVL+     AKIADF LSN   D    L ++   G+  Y APE 
Sbjct: 128 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNYAAPE- 180
Query: 248 AMTGQLNA--KSDVYSFGVVLLELLTGRKPVD 277
            ++G+L A  + D++S GV+L  LL G  P D
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-VKGAQPGP------VLSWQQRVKIA 177
            LLG C   G   ++  EF   G+L   L  ++      +  P       L+ +  +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHST 234
              AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 210
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 211 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+ K+    + +      + ++S++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 167
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+ K+    + +      + ++S++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ--PGPVLSWQQRVKIAVGA 180
           N V+LL          L +EF     LH  L            P P++            
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 111
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
            +GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T 
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 166
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            Y APE  +  +  + + D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-VKGAQPGP------VLSWQQRVKIA 177
            LLG C   G   ++  EF   G+L   L  ++      +  P       L+ +  +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHST 234
              AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 201
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 202 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSM----VSRLKHENFVQLLG 129
           +G G++G+V  G  + +GH  A+K L+  K    + + ++      +   +H + ++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 130 YCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
                T   +  E+ S G L D +  HGR          V   + R ++       ++Y 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGR----------VEEMEAR-RLFQQILSAVDYC 127
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
           H      ++HRD+K  NVL+     AKIADF LSN   D      S    G+  Y APE 
Sbjct: 128 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPE- 180
Query: 248 AMTGQLNA--KSDVYSFGVVLLELLTGRKPVD 277
            ++G+L A  + D++S GV+L  LL G  P D
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-VKGAQPGP------VLSWQQRVKIA 177
            LLG C   G   ++  EF   G+L   L  ++      +  P       L+ +  +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHST 234
              AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 201
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 202 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIK---KLDASKQPDEE-FLAQVSMVSRL 119
            ++ +    ++G+GS+G V     K +G   A+K   K    ++ D+E  L +V ++ +L
Sbjct: 30  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            H N ++L  +  D     L  E  + G L D +  RK                 +I   
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---------RIIRQ 140
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRV 236
              G+ Y+H+     I+HRD+K  N+L+     D   +I DF LS       A       
Sbjct: 141 VLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDK 194
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           +GT  Y APE  + G  + K DV+S GV+L  LL+G  P +
Sbjct: 195 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPG---PVLSWQQRVKIAVGAA 181
            LLG C   G   ++  EF   G+L   L  ++             L+ +  +  +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHSTRVLG 238
           KG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    R+  
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARL-- 208
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
              + APE         +SDV+SFGV+L E+ +
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 75  IGEGSYGRVY----YGILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFV 125
           +G G++G+V     +GI K+      A+K L   A+       ++++ ++  + H  N V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPG---PVLSWQQRVKIAVGAA 181
            LLG C   G   ++  EF   G+L   L  ++             L+ +  +  +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHSTRVLG 238
           KG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + PD   R    R+  
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY-VRKGDARL-- 208
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
              + APE         +SDV+SFGV+L E+ +
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 31/225 (13%)
Query: 66  TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE------FLAQVSMVSRL 119
           T  +   A IG G+YG VY    +  H+     L + + P+ E       + +V+++ RL
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 120 K---HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           +   H N V+L+  C   TSR    E         +    +      P P L  +    +
Sbjct: 61  EAFEHPNVVRLMDVC--ATSRT-DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR- 235
                +GL++LH      I+HRD+K  N+L+      K+ADF L        AR++S + 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQM 166
Query: 236 ----VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
               V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 167 ALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 50/236 (21%)
Query: 68  NFGTNALIGEGSYGRVYYGILKSGHAA-----AIKKLDASKQPDEEFLAQVSMVSRLKHE 122
           +F   A++G+G++G+V    +K+ +A      AIKK+  +++     L++V +++ L H+
Sbjct: 7   DFEEIAVLGQGAFGQV----VKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 123 -------------NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
                        NFV+ +      ++  +  E+  NG+L+D++H     +         
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE----Y 118
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL--------- 220
           W+   +I     + L Y+H +    IIHRD+K  N+ I +    KI DF L         
Sbjct: 119 WRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 221 -----SNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELL 270
                S   P  +  L  T  +GT  Y A E    TG  N K D+YS G++  E++
Sbjct: 172 ILKLDSQNLPGSSDNL--TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 31/225 (13%)
Query: 66  TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE------FLAQVSMVSRL 119
           T  +   A IG G+YG VY    +  H+     L + + P+ E       + +V+++ RL
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 120 K---HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           +   H N V+L+  C   TSR    E         +    +      P P L  +    +
Sbjct: 61  EAFEHPNVVRLMDVC--ATSRT-DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR- 235
                +GL++LH      I+HRD+K  N+L+      K+ADF L        AR++S + 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQM 166
Query: 236 ----VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
               V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 167 ALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 98/237 (41%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR--------KIGSFDETCTRFYTA-EIV 142
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE       +  SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFR----AGNEYLIFQKIIKLEYD 252

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 31/225 (13%)
Query: 66  TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE------FLAQVSMVSRL 119
           T  +   A IG G+YG VY    +  H+     L + + P+ E       + +V+++ RL
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 120 K---HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           +   H N V+L+  C   TSR    E         +    +      P P L  +    +
Sbjct: 61  EAFEHPNVVRLMDVC--ATSRT-DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR- 235
                +GL++LH      I+HRD+K  N+L+      K+ADF L        AR++S + 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQM 166
Query: 236 ----VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
               V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 167 ALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 28/231 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRL 119
           E+ + + +   +G G+YG V   I K SG   AIKKL    Q +   +    ++ ++  +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 120 KHENFVQLLGYCVDGTSRVLAYEF-ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
           +HEN + LL      +S    Y+F      +   L    G+K ++        ++++  V
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSE--------EKIQYLV 132
Query: 179 -GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
               KGL+Y+H      ++HRD+K  N+ + +D   KI DF L+  A         T  +
Sbjct: 133 YQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD-----AEMTGYV 184
Query: 238 GTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287
            T  Y APE  ++    N   D++S G ++ E+LTG+     TL +G+  L
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-----TLFKGKDYL 230

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 24/225 (10%)
Query: 75  IGEGSYGRV-YYGILKSGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV 132
           +GEG +  V     L  GH  A+K++   +Q D EE   +  M     H N ++L+ YC+
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 133 DGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
                     L   F   G+L + +   K       G  L+  Q + + +G  +GLE +H
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLK-----DKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG-------TFG 241
            K      HRD+K +N+L+ D+    + D    NQA            L        T  
Sbjct: 152 AKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 242 YHAPE-YAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283
           Y APE +++     ++ ++DV+S G VL  ++ G  P D    +G
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIK---KLDASKQPDEE-FLAQVSMVSRL 119
            ++ +    ++G+GS+G V     K +G   A+K   K    ++ D+E  L +V ++ +L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            H N ++L  +  D     L  E  + G L D +  RK                 +I   
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---------RIIRQ 134
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRV 236
              G+ Y+H+     I+HRD+K  N+L+     D   +I DF LS      A++    ++
Sbjct: 135 VLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKI 189
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
            GT  Y APE  + G  + K DV+S GV+L  LL+G  P +
Sbjct: 190 -GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIK---KLDASKQPDEE-FLAQVSMVSRL 119
            ++ +    ++G+GS+G V     K +G   A+K   K    ++ D+E  L +V ++ +L
Sbjct: 47  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            H N ++L  +  D     L  E  + G L D +  RK           S     +I   
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQ 157
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRV 236
              G+ Y+H+     I+HRD+K  N+L+     D   +I DF LS       A       
Sbjct: 158 VLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDK 211
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           +GT  Y APE  + G  + K DV+S GV+L  LL+G  P +
Sbjct: 212 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIK---KLDASKQPDEE-FLAQVSMVSRL 119
            ++ +    ++G+GS+G V     K +G   A+K   K    ++ D+E  L +V ++ +L
Sbjct: 48  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            H N ++L  +  D     L  E  + G L D +  RK           S     +I   
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQ 158
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRV 236
              G+ Y+H+     I+HRD+K  N+L+     D   +I DF LS       A       
Sbjct: 159 VLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDK 212
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           +GT  Y APE  + G  + K DV+S GV+L  LL+G  P +
Sbjct: 213 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 30/226 (13%)
Query: 66  TENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF------LAQVSMVSR 118
           T  +   A IG G+YG VY      SGH  A+K +                + +V+++ R
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 119 LK---HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           L+   H N V+L+  C   TSR    E         +    +      P P L  +    
Sbjct: 68  LEAFEHPNVVRLMDVC--ATSRT-DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD 124
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-- 233
           +     +GL++LH      I+HRD+K  N+L+      K+ADF L        AR++S  
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQ 173
Query: 234 ---TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
              T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 27/237 (11%)
Query: 60  DELKEITEN-------FGTNALIGEGSYGRVYYGILKSGHAAAIK------KLDASKQPD 106
           DELKE  E+       F    ++G+G +G V    LK    + +K      K D     D
Sbjct: 9   DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD 68
Query: 107 -EEFLAQVSMVSRLKHENFVQLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGV 159
            EEFL + + +    H +  +L+G  +   ++      ++   F  +G LH  L   +  
Sbjct: 69  IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR-- 126
Query: 160 KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219
            G  P   L  Q  V+  V  A G+EYL  +   + IHRD+ + N ++ +D    +ADF 
Sbjct: 127 IGENPFN-LPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFG 182
Query: 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           LS +                  + A E          SDV++FGV + E++T G+ P
Sbjct: 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 99/248 (39%), Gaps = 58/248 (23%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVS 114
           P++ +D LK +        LIG G YG VY G L      A+K    + + +      + 
Sbjct: 8   PSLDLDNLKLLE-------LIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKNIY 59
Query: 115 MVSRLKHENFVQLL----GYCVDG-TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
            V  ++H+N  + +        DG    +L  E+  NGSL   L                
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----------D 109
Query: 170 WQQRVKIAVGAAKGLEYLHEKA------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           W    ++A    +GL YLH +        P I HRD+ S NVL+ +D    I+DF LS  
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS-- 167
Query: 224 APDMAARLHSTRV-------------LGTFGYHAPEYAMTGQLNAKS--------DVYSF 262
                 RL   R+             +GT  Y APE  + G +N +         D+Y+ 
Sbjct: 168 -----MRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYAL 221
Query: 263 GVVLLELL 270
           G++  E+ 
Sbjct: 222 GLIYWEIF 229

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/307 (22%), Positives = 122/307 (39%), Gaps = 46/307 (14%)
Query: 66  TENFGTNALIGEGSYGRVYYGILKS--------GHAAAIKKLD-ASKQPDEEFLAQVSMV 116
            E+   N  +G+G++ +++ G+ +              +K LD A +   E F    SM+
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           S+L H++ V   G CV G   +L  EF   GSL   L   K          + W  ++++
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCIN------ILW--KLEV 118
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD---FDLSNQAPDMAARLHS 233
           A   A  + +L E     +IH ++ + N+L+  ++  K  +     LS+  P ++  +  
Sbjct: 119 AKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSD--PGISITVLP 173
Query: 234 TRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 290
             +L       P   +     LN  +D +SFG  L E+ + G KP+         +L + 
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--------SALDSQ 225
Query: 291 ATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLN 350
              +  ED+             P             C+ YE D RP+   +++ L  L  
Sbjct: 226 RKLQFYEDR----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275
Query: 351 ARPGPAG 357
               P G
Sbjct: 276 PDLVPRG 282

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI  F L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILGFGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 34/234 (14%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRL 119
           E+ + + +   +G G+YG V   I K SG   AIKKL    Q +   +    ++ ++  +
Sbjct: 39  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 98
Query: 120 KHENFVQLLGYCVDGTSRVLAYEF-----ASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
           +HEN + LL      +S    Y+F          L  I+           G   S ++  
Sbjct: 99  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM-----------GMEFSEEKIQ 147
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     KGL+Y+H      ++HRD+K  N+ + +D   KI DF L+       A    T
Sbjct: 148 YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMT 199
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287
             + T  Y APE  ++    N   D++S G ++ E+LTG+     TL +G+  L
Sbjct: 200 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-----TLFKGKDYL 248

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N V+LL          L +E   +  L   +     + G  P P++             +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDA-SALTGI-PLPLIK-----SYLFQLLQ 113
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+ T  Y
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TLWY 168
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            APE  +  +  + + D++S G +  E++T R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 142
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP----FRAGNEGLIFAKIIKLEYD 252

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 21/241 (8%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVS 117
           K+  E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++S
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           RL H  FV+L     D         +A NG L   +         + G       R   A
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA 117
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
                 LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +
Sbjct: 118 -EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 173
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 297
           GT  Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  
Sbjct: 174 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEY 229
Query: 298 D 298
           D
Sbjct: 230 D 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 140
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 250

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 145
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 146 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLIFQKIIKLEYD 255

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 143
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLIFQKIIKLEYD 253

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 147
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 148 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 257

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 21/241 (8%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVS 117
           K+  E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++S
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           RL H  FV+L     D         +A NG L   +         + G       R   A
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA 116
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
                 LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +
Sbjct: 117 -EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 172
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 297
           GT  Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  
Sbjct: 173 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEY 228
Query: 298 D 298
           D
Sbjct: 229 D 229

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 143
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLIFQKIIKLEYD 253

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 142
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEGLIFAKIIKLEYD 252

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 142
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 252

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI D  L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDRGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 142
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 252

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 140
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 250

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 142
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLIFQKIIKLEYD 252

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 21/241 (8%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVS 117
           K+  E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           RL H  FV+L     D         +A NG L   +         + G       R   A
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA 115
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
                 LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +
Sbjct: 116 -EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 171
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 297
           GT  Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEY 227
Query: 298 D 298
           D
Sbjct: 228 D 228

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/132 (38%), Positives = 67/132 (50%), Gaps = 13/132 (9%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           KIAV   K LE+LH K    +IHRD+K SNVLI      K+ DF +S    D  A+   T
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK---T 211
Query: 235 RVLGTFGYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SL 287
              G   Y APE  +  +LN      KSD++S G+ ++EL   R P D      QQ   +
Sbjct: 212 IDAGCKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 270
Query: 288 VTWATPKLSEDK 299
           V   +P+L  DK
Sbjct: 271 VEEPSPQLPADK 282

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI D  L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDAGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLL 128
           +G G+YG V   Y   L+     A+KKL    Q          ++ ++  LKHEN + LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
                 TS     E  S   L   L G   +        LS +    +     +GL+Y+H
Sbjct: 94  DVFTPATS----IEDFSEVYLVTTLMG-ADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
                 IIHRD+K SNV + +D   +I DF L+ QA +       T  + T  Y APE  
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EMTGYVATRWYRAPEIM 200
Query: 249 MTG-QLNAKSDVYSFGVVLLELLTGR 273
           +     N   D++S G ++ ELL G+
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-- 132
           IG+G +G V+ G  + G   A+K   + ++      A++     L+HEN   +LG+    
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHEN---ILGFIAAD 105
Query: 133 -----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
                  T   L  ++  +GSL D L+             ++ +  +K+A+  A GL +L
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHL 155
Query: 188 H-----EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 239
           H      +  P I HRD+KS N+L+  +    IAD  L+   + A D      + RV GT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GT 214
Query: 240 FGYHAPEYAMTGQLNAK-------SDVYSFGVVLLEL 269
             Y APE  +   +N K       +D+Y+ G+V  E+
Sbjct: 215 KRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 21/241 (8%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVS 117
           K+  E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++S
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           RL H  FV+L     D         +A NG L   +         + G       R   A
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA 114
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
                 LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +
Sbjct: 115 -EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 170
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 297
           GT  Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  
Sbjct: 171 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEY 226
Query: 298 D 298
           D
Sbjct: 227 D 227

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N V+LL          L +E   +  L   +     + G  P P++             +
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDA-SALTGI-PLPLIK-----SYLFQLLQ 117
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R +   V+ T  Y
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLWY 172
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            APE  +  +  + + D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 140
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 250

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 40/218 (18%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-- 132
           IG+G +G V+ G  + G   A+K   + ++      A++     L+HEN   +LG+    
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHEN---ILGFIAAD 67
Query: 133 -----DGTSRVLAYEFASNGSLHDILHGRK-GVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
                  T   L  ++  +GSL D L+     V+G            +K+A+  A GL +
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----------IKLALSTASGLAH 116
Query: 187 LH-----EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLG 238
           LH      +  P I HRD+KS N+L+  +    IAD  L+   + A D      + RV G
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-G 175
Query: 239 TFGYHAPEYAMTGQLNAK-------SDVYSFGVVLLEL 269
           T  Y APE  +   +N K       +D+Y+ G+V  E+
Sbjct: 176 TKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-- 132
           IG+G +G V+ G  + G   A+K   + ++      A++     L+HEN   +LG+    
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHEN---ILGFIAAD 72
Query: 133 -----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
                  T   L  ++  +GSL D L+             ++ +  +K+A+  A GL +L
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNR----------YTVTVEGMIKLALSTASGLAHL 122
Query: 188 H-----EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 239
           H      +  P I HRD+KS N+L+  +    IAD  L+   + A D      + RV GT
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GT 181
Query: 240 FGYHAPEYAMTGQLNAK-------SDVYSFGVVLLEL 269
             Y APE  +   +N K       +D+Y+ G+V  E+
Sbjct: 182 KRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 40/218 (18%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-- 132
           IG+G +G V+ G  + G   A+K   + ++      A++     L+HEN   +LG+    
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHEN---ILGFIAAD 66
Query: 133 -----DGTSRVLAYEFASNGSLHDILHGRK-GVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
                  T   L  ++  +GSL D L+     V+G            +K+A+  A GL +
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----------IKLALSTASGLAH 115
Query: 187 LH-----EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLG 238
           LH      +  P I HRD+KS N+L+  +    IAD  L+   + A D      + RV G
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-G 174
Query: 239 TFGYHAPEYAMTGQLNAK-------SDVYSFGVVLLEL 269
           T  Y APE  +   +N K       +D+Y+ G+V  E+
Sbjct: 175 TKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 124
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 125 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 234

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-- 132
           IG+G +G V+ G  + G   A+K   + ++      A++     L+HEN   +LG+    
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHEN---ILGFIAAD 92
Query: 133 -----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
                  T   L  ++  +GSL D L+             ++ +  +K+A+  A GL +L
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHL 142
Query: 188 H-----EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 239
           H      +  P I HRD+KS N+L+  +    IAD  L+   + A D      + RV GT
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GT 201
Query: 240 FGYHAPEYAMTGQLNAK-------SDVYSFGVVLLEL 269
             Y APE  +   +N K       +D+Y+ G+V  E+
Sbjct: 202 KRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-- 132
           IG+G +G V+ G  + G   A+K   + ++      A++     L+HEN   +LG+    
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHEN---ILGFIAAD 69
Query: 133 -----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
                  T   L  ++  +GSL D L+             ++ +  +K+A+  A GL +L
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNR----------YTVTVEGMIKLALSTASGLAHL 119
Query: 188 H-----EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 239
           H      +  P I HRD+KS N+L+  +    IAD  L+   + A D      + RV GT
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GT 178
Query: 240 FGYHAPEYAMTGQLNAK-------SDVYSFGVVLLEL 269
             Y APE  +   +N K       +D+Y+ G+V  E+
Sbjct: 179 KRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           E+   N ++GEG +G VY G+       K   A    K D +    E+F+++  ++  L 
Sbjct: 24  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 83
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           H + V+L+G   +  + ++  E    G L H +   +  +K      VL+    V  ++ 
Sbjct: 84  HPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLK------VLT---LVLYSLQ 133
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
             K + YL      + +HRDI   N+L+   +  K+ DF LS    D      S   L  
Sbjct: 134 ICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-P 189
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
             + +PE     +    SDV+ F V + E+L+ G++P
Sbjct: 190 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 75  IGEGSYGRV---YYGIL--KSGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
           +G+G++G V    Y  L   +G   A+K+L  S  PD++  F  ++ ++  L  +  V+ 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKY 77
Query: 128 LG--YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G  Y     S  L  E+  +G L D L   +    A    + S Q          KG+E
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 129
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH 243
           YL  +     +HRD+ + N+L+  +   KIADF L+   P +    +  R  G     ++
Sbjct: 130 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWY 185
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT 271
           APE       + +SDV+SFGVVL EL T
Sbjct: 186 APESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 139
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 249

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           E+   N ++GEG +G VY G+       K   A    K D +    E+F+++  ++  L 
Sbjct: 8   EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 67
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           H + V+L+G   +  + ++  E    G L H +   +  +K      VL+    V  ++ 
Sbjct: 68  HPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLK------VLT---LVLYSLQ 117
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
             K + YL      + +HRDI   N+L+   +  K+ DF LS    D      S   L  
Sbjct: 118 ICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-P 173
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
             + +PE     +    SDV+ F V + E+L+ G++P
Sbjct: 174 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+  V     L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 139
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 249

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---- 175
           KHEN + LL   V   +R L  EF     ++ + H    + GA    ++  Q+       
Sbjct: 79  KHENVIGLLD--VFTPARSLE-EF---NDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 128
Query: 176 -IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H  AD  IIHRD+K SN+ + +D   KI D  L+    D       T
Sbjct: 129 FLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDGGLARHTDD-----EMT 180
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
             + T  Y APE  +     N   D++S G ++ ELLTGR
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
           E+   N ++GEG +G VY G+       K   A    K D +    E+F+++  ++  L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           H + V+L+G   +  + ++  E    G L H +   +  +K      VL+    V  ++ 
Sbjct: 72  HPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLK------VLT---LVLYSLQ 121
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
             K + YL      + +HRDI   N+L+   +  K+ DF LS    D      S   L  
Sbjct: 122 ICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-P 177
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
             + +PE     +    SDV+ F V + E+L+ G++P
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 75  IGEGSYGRV---YYGIL--KSGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
           +G+G++G V    Y  L   +G   A+K+L  S  PD++  F  ++ ++  L  +  V+ 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKY 76
Query: 128 LG--YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G  Y     S  L  E+  +G L D L   +    A    + S Q          KG+E
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 128
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH 243
           YL  +     +HRD+ + N+L+  +   KIADF L+   P +    +  R  G     ++
Sbjct: 129 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWY 184
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT 271
           APE       + +SDV+SFGVVL EL T
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIK----KLDASKQPDEEFLAQVSMVSRLKHE 122
           N+     +GEGS+G+V       +G   A+K    K+ A          ++S +  L+H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           + ++L          ++  E+A N     I+   K          +S Q+  +       
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK----------MSEQEARRFFQQIIS 114
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            +EY H      I+HRD+K  N+L+ +    KIADF LSN   D      S    G+  Y
Sbjct: 115 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 168
Query: 243 HAPEYAMTGQLNA--KSDVYSFGVVLLELLTGRKPVD 277
            APE  ++G+L A  + DV+S GV+L  +L  R P D
Sbjct: 169 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 75  IGEGSYGRV---YYGIL--KSGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
           +G+G++G V    Y  L   +G   A+K+L  S  PD++  F  ++ ++  L  +  V+ 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKY 89
Query: 128 LG--YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G  Y     S  L  E+  +G L D L   +    A    + S Q          KG+E
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 141
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH 243
           YL  +     +HRD+ + N+L+  +   KIADF L+   P +    +  R  G     ++
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWY 197
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT 271
           APE       + +SDV+SFGVVL EL T
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLL 128
           +G G+YG V   Y   L+     A+KKL    Q          ++ ++  LKHEN + LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
                 TS     E  S   L   L G   +        LS +    +     +GL+Y+H
Sbjct: 94  DVFTPATS----IEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
                 IIHRD+K SNV + +D   +I DF L+ QA +       T  + T  Y APE  
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EMTGYVATRWYRAPEIM 200
Query: 249 MTG-QLNAKSDVYSFGVVLLELLTGR 273
           +     N   D++S G ++ ELL G+
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 24/221 (10%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIK---KLDASKQPDEE-FLAQVSMVSRL 119
            ++ +    ++G+GS+G V     K +G   A+K   K    ++ D+E  L +V ++ +L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            H N  +L  +  D     L  E  + G L D +  RK                 +I   
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---------RIIRQ 134
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRV 236
              G+ Y H+     I+HRD+K  N+L+     D   +I DF LS       A       
Sbjct: 135 VLSGITYXHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKXKDK 188
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           +GT  Y APE  + G  + K DV+S GV+L  LL+G  P +
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 30/231 (12%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYG--ILKSGHAAAIKKLDASKQPDEEFLAQVSMVS 117
           D L    + +   A IGEG+YG+V+    +   G   A+K++      +   L+ +  V+
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 118 RLKH------ENFVQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
            L+H       N V+L   C V  T R             D+      V    P P +  
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPT 119
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
           +    +     +GL++LH      ++HRD+K  N+L+      K+ADF L        AR
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------AR 168
Query: 231 LHS-----TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           ++S     T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF--LAQVSMVSRLKH 121
           I+ +F   +L+GEG+YG V     K +G   AIKK++   +P      L ++ ++   KH
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 122 ENFVQLLGY----CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           EN + +         +  + V   +      LH ++  +          +LS        
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ----------MLSDDHIQYFI 118
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-------- 229
               + ++ LH     ++IHRD+K SN+LI  +   K+ DF L+    + AA        
Sbjct: 119 YQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 276
           +   T  + T  Y APE  +T    +++ DV+S G +L EL   R+P+
Sbjct: 176 QSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIK----KLDASKQPDEEFLAQVSMVSRLKHE 122
           N+     +GEGS+G+V       +G   A+K    K+ A          ++S +  L+H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           + ++L          ++  E+A N     I+   K          +S Q+  +       
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK----------MSEQEARRFFQQIIS 118
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            +EY H      I+HRD+K  N+L+ +    KIADF LSN   D      S    G+  Y
Sbjct: 119 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 172
Query: 243 HAPEYAMTGQLNA--KSDVYSFGVVLLELLTGRKPVD 277
            APE  ++G+L A  + DV+S GV+L  +L  R P D
Sbjct: 173 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 13/211 (6%)
Query: 68  NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQL 127
            F    ++G+GS+G+V+  ++K    +  ++L A K   +   A + +  R++ +    +
Sbjct: 25  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKK---ATLKVRDRVRTKMERDI 79
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGA-AKGL 184
           L          L Y F + G L+ IL   +G  +       V+  ++ VK  +   A  L
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
           ++LH      II+RD+K  N+L+ ++   K+ DF LS ++ D   + +S    GT  Y A
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 194
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           PE          +D +SFGV++ E+LTG  P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF--LAQVSMVSRLKH 121
           I+ +F   +L+GEG+YG V     K +G   AIKK++   +P      L ++ ++   KH
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 122 ENFVQLLGY----CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           EN + +         +  + V   +      LH ++  +          +LS        
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ----------MLSDDHIQYFI 118
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-------- 229
               + ++ LH     ++IHRD+K SN+LI  +   K+ DF L+    + AA        
Sbjct: 119 YQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 276
           +   T  + T  Y APE  +T    +++ DV+S G +L EL   R+P+
Sbjct: 176 QSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 67  ENFGTNALIGEGSYGR-VYYGILKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           E+F    ++GEGS+   V    L +    AIK L+      E  +  V+    ++SRL H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
             FV+L     D         +A NG L   +         + G       R   A    
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------KIGSFDETCTRFYTA-EIV 140
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    IIHRD+K  N+L+ +D   +I DF  +      + +  +   +GT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           Y +PE          SD+++ G ++ +L+ G  P       G + L+     KL  D
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 250

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIK----KLDASKQPDEEFLAQVSMVSRLKHE 122
           N+     +GEGS+G+V       +G   A+K    K+ A          ++S +  L+H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           + ++L          ++  E+A N     I+   K          +S Q+  +       
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK----------MSEQEARRFFQQIIS 124
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            +EY H      I+HRD+K  N+L+ +    KIADF LSN   D      S    G+  Y
Sbjct: 125 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 178
Query: 243 HAPEYAMTGQLNA--KSDVYSFGVVLLELLTGRKPVD 277
            APE  ++G+L A  + DV+S GV+L  +L  R P D
Sbjct: 179 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 68  NFGTNALIGEGSYGRVYYGI-LKSGHAAAIK----KLDASKQPDEEFLAQVSMVSRLKHE 122
           N+     +GEGS+G+V       +G   A+K    K+ A          ++S +  L+H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           + ++L          ++  E+A N     I+   K          +S Q+  +       
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK----------MSEQEARRFFQQIIS 123
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            +EY H      I+HRD+K  N+L+ +    KIADF LSN   D      S    G+  Y
Sbjct: 124 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 177
Query: 243 HAPEYAMTGQLNA--KSDVYSFGVVLLELLTGRKPVD 277
            APE  ++G+L A  + DV+S GV+L  +L  R P D
Sbjct: 178 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 50/236 (21%)
Query: 68  NFGTNALIGEGSYGRVYYGILKSGHAA-----AIKKLDASKQPDEEFLAQVSMVSRLKHE 122
           +F   A++G+G++G+V    +K+ +A      AIKK+  +++     L++V +++ L H+
Sbjct: 7   DFEEIAVLGQGAFGQV----VKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 123 -------------NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
                        NFV+ +      ++  +  E+  N +L+D++H     +         
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE----Y 118
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL--------- 220
           W+   +I     + L Y+H +    IIHRD+K  N+ I +    KI DF L         
Sbjct: 119 WRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 221 -----SNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELL 270
                S   P  +  L  T  +GT  Y A E    TG  N K D+YS G++  E++
Sbjct: 172 ILKLDSQNLPGSSDNL--TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 34/228 (14%)
Query: 68  NFGTNALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF 124
           +F     +G G +G V+    K     +A    +L   +   E+ + +V  +++L+H   
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 125 VQLLGYCVDGTS---------RVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
           V+     ++  +         +V  Y   +     +L D ++GR  ++  +    L    
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH--- 122
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD------ 226
              I +  A+ +E+LH K    ++HRD+K SN+    DDV K+ DF L            
Sbjct: 123 ---IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 227 ----MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
               M A    T  +GT  Y +PE       + K D++S G++L ELL
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 30/231 (12%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYG--ILKSGHAAAIKKLDASKQPDEEFLAQVSMVS 117
           D L    + +   A IGEG+YG+V+    +   G   A+K++      +   L+ +  V+
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 118 RLKH------ENFVQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
            L+H       N V+L   C V  T R             D+      V    P P +  
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPT 119
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
           +    +     +GL++LH      ++HRD+K  N+L+      K+ADF L        AR
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------AR 168
Query: 231 LHS-----TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           ++S     T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLL 128
           +G G+YG V   Y   L+     A+KKL    Q          ++ ++  LKHEN + LL
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
                 TS     E  S   L   L G   +        LS +    +     +GL+Y+H
Sbjct: 86  DVFTPATS----IEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
                 IIHRD+K SNV + +D   +I DF L+ QA +       T  + T  Y APE  
Sbjct: 141 SAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADE-----EMTGYVATRWYRAPEIM 192
Query: 249 MTG-QLNAKSDVYSFGVVLLELLTGR 273
           +     N   D++S G ++ ELL G+
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 46/307 (14%)
Query: 66  TENFGTNALIGEGSYGRVYYGILKS--------GHAAAIKKLD-ASKQPDEEFLAQVSMV 116
            E+   N  +G+G++ +++ G+ +              +K LD A +   E F    SM+
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           S+L H++ V   G C  G   +L  EF   GSL   L   K          + W  ++++
Sbjct: 67  SKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCIN------ILW--KLEV 118
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD---FDLSNQAPDMAARLHS 233
           A   A  + +L E     +IH ++ + N+L+  ++  K  +     LS+  P ++  +  
Sbjct: 119 AKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSD--PGISITVLP 173
Query: 234 TRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 290
             +L       P   +     LN  +D +SFG  L E+ + G KP+         +L + 
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--------SALDSQ 225
Query: 291 ATPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLN 350
              +  ED+             P             C+ YE D RP+   +++ L  L  
Sbjct: 226 RKLQFYEDR----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275
Query: 351 ARPGPAG 357
               P G
Sbjct: 276 PDLVPRG 282

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 30/231 (12%)
Query: 60  DELKEITENFGTNALIGEGSYGRVYYG--ILKSGHAAAIKKLDASKQPDEEFLAQVSMVS 117
           D L    + +   A IGEG+YG+V+    +   G   A+K++      +   L+ +  V+
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 118 RLKH------ENFVQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
            L+H       N V+L   C V  T R             D+      V    P P +  
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPT 119
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
           +    +     +GL++LH      ++HRD+K  N+L+      K+ADF L        AR
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------AR 168
Query: 231 LHS-----TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           ++S     T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 13/211 (6%)
Query: 68  NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQL 127
            F    ++G+GS+G+V+  ++K    +  ++L A K   +   A + +  R++ +    +
Sbjct: 26  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKK---ATLKVRDRVRTKMERDI 80
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGA-AKGL 184
           L          L Y F + G L+ IL   +G  +       V+  ++ VK  +   A  L
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
           ++LH      II+RD+K  N+L+ ++   K+ DF LS ++ D   + +S    GT  Y A
Sbjct: 141 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 195
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           PE          +D +SFGV++ E+LTG  P
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 13/211 (6%)
Query: 68  NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQL 127
            F    ++G+GS+G+V+  ++K    +  ++L A K   +   A + +  R++ +    +
Sbjct: 25  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKK---ATLKVRDRVRTKMERDI 79
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGA-AKGL 184
           L          L Y F + G L+ IL   +G  +       V+  ++ VK  +   A  L
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
           ++LH      II+RD+K  N+L+ ++   K+ DF LS ++ D   + +S    GT  Y A
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 194
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           PE          +D +SFGV++ E+LTG  P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 107/259 (41%), Gaps = 26/259 (10%)
Query: 29  GTDGAYHASEAAPKGAQAVKVQPI-----EVPAISVDELKEITENFGTNALIGEGSYGRV 83
           G  G+  A+ A P    +  V P      E+P + VD      + +     +G+G + + 
Sbjct: 1   GPLGSMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDP--RTMKRYMRGRFLGKGGFAKC 58
Query: 84  YYGI---LKSGHAAAI--KKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138
           Y       K   A  +  K +       E+   ++++   L + + V   G+  D     
Sbjct: 59  YEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVY 118
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  E     SL ++   RK V   +P      +Q ++       G++YLH      +IHR
Sbjct: 119 VVLEICRRRSLLELHKRRKAV--TEPEARYFMRQTIQ-------GVQYLHNN---RVIHR 166
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSD 258
           D+K  N+ + DD   KI DF L+ +      R  +  + GT  Y APE       + + D
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSFEVD 224
Query: 259 VYSFGVVLLELLTGRKPVD 277
           ++S G +L  LL G+ P +
Sbjct: 225 IWSLGCILYTLLVGKPPFE 243

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 87/176 (49%), Gaps = 20/176 (11%)
Query: 105 PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGA 162
           P E+   +++++ +L H N V+L+    D       + +E  + G + +       V   
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-------VPTL 131
Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
           +P   LS  Q         KG+EYLH +    IIHRDIK SN+L+ +D   KIADF +SN
Sbjct: 132 KP---LSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKS-DVYSFGVVLLELLTGRKP 275
           +     A L +T  +GT  + APE     +   + K+ DV++ GV L   + G+ P
Sbjct: 186 EFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 106/259 (40%), Gaps = 26/259 (10%)
Query: 29  GTDGAYHASEAAPKGAQAVKVQPI-----EVPAISVDELKEITENFGTNALIGEGSYGRV 83
           G  G+  A+ A P    +  V P      E+P + VD      + +     +G+G + + 
Sbjct: 1   GPLGSMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDP--RTMKRYMRGRFLGKGGFAKC 58
Query: 84  YYGI---LKSGHAAAI--KKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138
           Y       K   A  +  K +       E+   ++++   L + + V   G+  D     
Sbjct: 59  YEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVY 118
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  E     SL ++   RK V   +P      +Q ++       G++YLH      +IHR
Sbjct: 119 VVLEICRRRSLLELHKRRKAV--TEPEARYFMRQTIQ-------GVQYLHNN---RVIHR 166
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSD 258
           D+K  N+ + DD   KI DF L+ +      R     + GT  Y APE       + + D
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPEVLCKKGHSFEVD 224
Query: 259 VYSFGVVLLELLTGRKPVD 277
           ++S G +L  LL G+ P +
Sbjct: 225 IWSLGCILYTLLVGKPPFE 243

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 38/224 (16%)
Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           A IG+G++G V+     K+G   A+KK+    +  E F    L ++ ++  LKHEN V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNL 82
Query: 128 LGYCVDGTSRV--------LAYEFASN---GSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           +  C    S          L ++F  +   G L ++L     VK       LS  +RV  
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFT-----LSEIKRVMQ 132
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHS 233
            +    GL Y+H      I+HRD+K++NVLI  D V K+ADF L+   + A +     + 
Sbjct: 133 ML--LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 234 TRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPV 276
            RV+ T  Y  PE  +  +      D++  G ++ E+ T R P+
Sbjct: 188 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 106/259 (40%), Gaps = 26/259 (10%)
Query: 29  GTDGAYHASEAAPKGAQAVKVQPI-----EVPAISVDELKEITENFGTNALIGEGSYGRV 83
           G  G+  A+ A P    +  V P      E+P + VD      + +     +G+G + + 
Sbjct: 1   GPLGSMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDP--RTMKRYMRGRFLGKGGFAKC 58
Query: 84  YYGI---LKSGHAAAI--KKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138
           Y       K   A  +  K +       E+   ++++   L + + V   G+  D     
Sbjct: 59  YEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVY 118
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  E     SL ++   RK V   +P      +Q ++       G++YLH      +IHR
Sbjct: 119 VVLEICRRRSLLELHKRRKAV--TEPEARYFMRQTIQ-------GVQYLHNN---RVIHR 166
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSD 258
           D+K  N+ + DD   KI DF L+ +      R     + GT  Y APE       + + D
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGHSFEVD 224
Query: 259 VYSFGVVLLELLTGRKPVD 277
           ++S G +L  LL G+ P +
Sbjct: 225 IWSLGCILYTLLVGKPPFE 243

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 25/219 (11%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKLDASKQ-PDEEFLAQVSMVSRL-K 120
           + T+ +     IG GSY      I K+ +   A+K +D SK+ P EE    + ++ R  +
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQ 74
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H N + L     DG    +  E    G L D +  +K     +   VL            
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL---------FTI 125
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDD----DVAKIADFDLSNQAPDMAARLHSTRV 236
            K +EYLH +    ++HRD+K SN+L  D+    +  +I DF  + Q       L +   
Sbjct: 126 TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
              F   APE       +A  D++S GV+L  +LTG  P
Sbjct: 183 TANFV--APEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRV---YYGIL--KSGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
           +G+G++G V    Y  L   +G   A+K+L  S  PD++  F  ++ ++  L  +  V+ 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKY 73
Query: 128 LG--YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            G  Y        L  E+  +G L D L   +    A    + S Q          KG+E
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ--------ICKGME 125
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHA 244
           YL  +     +HRD+ + N+L+  +   KIADF L+   P D    +          ++A
Sbjct: 126 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYA 182
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT 271
           PE       + +SDV+SFGVVL EL T
Sbjct: 183 PESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 100/223 (44%), Gaps = 29/223 (13%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV- 125
           ENF    ++G G+YG+V+     SGH       D  K    + L + ++V + K      
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGH-------DTGKLYAMKVLKKATIVQKAKTTEHTR 106
Query: 126 ---QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR-----VKI 176
              Q+L +       V L Y F +   LH IL     + G +    LS ++R     V+I
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLIL---DYINGGELFTHLSQRERFTEHEVQI 163
Query: 177 AVGA-AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHST 234
            VG     LE+LH+     II+RDIK  N+L+  +    + DF LS +   D   R +  
Sbjct: 164 YVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD- 219
Query: 235 RVLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKP 275
              GT  Y AP+    G    +   D +S GV++ ELLTG  P
Sbjct: 220 -FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 75  IGEGSYGRVYYGILKSGHA-AAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
           IGEG+YG V+    +  H   A+K++   D  +      L ++ ++  LKH+N V+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
                   L +EF  +  L        G     P  V S+  ++       KGL + H +
Sbjct: 70  LHSDKKLTLVFEFC-DQDLKKYFDSCNG--DLDPEIVKSFLFQL------LKGLGFCHSR 120
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
              +++HRD+K  N+LI  +   K+ADF L+ +A  +  R +S  V+ T  Y  P+    
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLADFGLA-RAFGIPVRCYSAEVV-TLWYRPPDVLFG 175
Query: 251 GQLNAKS-DVYSFGVVLLELLTGRKPV 276
            +L + S D++S G +  EL    +P+
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 38/224 (16%)
Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           A IG+G++G V+     K+G   A+KK+    +  E F    L ++ ++  LKHEN V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNL 82
Query: 128 LGYCVDGTSRV--------LAYEFASN---GSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           +  C    S          L ++F  +   G L ++L     VK       LS  +RV  
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFT-----LSEIKRVMQ 132
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHS 233
            +    GL Y+H      I+HRD+K++NVLI  D V K+ADF L+   + A +     + 
Sbjct: 133 ML--LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 234 TRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPV 276
            RV+ T  Y  PE  +  +      D++  G ++ E+ T R P+
Sbjct: 188 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 38/224 (16%)
Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           A IG+G++G V+     K+G   A+KK+    +  E F    L ++ ++  LKHEN V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNL 82
Query: 128 LGYCVDGTSRV--------LAYEFASN---GSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           +  C    S          L ++F  +   G L ++L     VK       LS  +RV  
Sbjct: 83  IEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL-----VKFT-----LSEIKRVMQ 132
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHS 233
            +    GL Y+H      I+HRD+K++NVLI  D V K+ADF L+   + A +     + 
Sbjct: 133 ML--LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 234 TRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPV 276
            RV+ T  Y  PE  +  +      D++  G ++ E+ T R P+
Sbjct: 188 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           EE   +VS++ ++ H N + L     + T  VL  E  S G L D L  ++         
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------- 111
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            LS ++          G+ YLH K    I H D+K  N+++ D ++     K+ DF L++
Sbjct: 112 -LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D    +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 38/224 (16%)
Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           A IG+G++G V+     K+G   A+KK+    +  E F    L ++ ++  LKHEN V L
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNL 81
Query: 128 LGYCVDGTSRV--------LAYEFASN---GSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           +  C    S          L ++F  +   G L ++L     VK       LS  +RV  
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFT-----LSEIKRVMQ 131
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHS 233
            +    GL Y+H      I+HRD+K++NVLI  D V K+ADF L+   + A +     + 
Sbjct: 132 ML--LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 234 TRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPV 276
            RV+ T  Y  PE  +  +      D++  G ++ E+ T R P+
Sbjct: 187 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 75  IGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLG 129
           IGEG+YG V   Y  + K+    AIKK+   +     +  L ++ ++ R +HEN + +  
Sbjct: 51  IGEGAYGMVSSAYDHVRKT--RVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
                T   +   +     +   L+  K +K  Q    LS            +GL+Y+H 
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLY--KLLKSQQ----LSNDHICYFLYQILRGLKYIHS 162
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAPEYA 248
               +++HRD+K SN+LI      KI DF L+  A P+       T  + T  Y APE  
Sbjct: 163 A---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIM 219
Query: 249 MTGQLNAKS-DVYSFGVVLLELLTGR 273
           +  +   KS D++S G +L E+L+ R
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/132 (37%), Positives = 66/132 (50%), Gaps = 13/132 (9%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           KIAV   K LE+LH K    +IHRD+K SNVLI      K+ DF +S    D  A+    
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 235 RVLGTFGYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SL 287
              G   Y APE  +  +LN      KSD++S G+ ++EL   R P D      QQ   +
Sbjct: 171 ---GCKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
Query: 288 VTWATPKLSEDK 299
           V   +P+L  DK
Sbjct: 227 VEEPSPQLPADK 238

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 30/228 (13%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF--LAQVSMVSRLKH 121
           I+ +F   +L+GEG+YG V     K +G   AIKK++   +P      L ++ ++   KH
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 122 ENFVQLLGY----CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           EN + +         +  + V   +      LH ++  +          +LS        
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ----------MLSDDHIQYFI 118
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-------- 229
               + ++ LH     ++IHRD+K SN+LI  +   K+ DF L+    + AA        
Sbjct: 119 YQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 276
           +      + T  Y APE  +T    +++ DV+S G +L EL   R+P+
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 108/249 (43%), Gaps = 31/249 (12%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE----FLAQVSMVSRLKHENFVQLLG 129
           +G G+YG V     K +G   AIK +  S           L +V+++ +L H N ++L  
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           +  D  +  L  E    G L D +  R+         ++              G  YLH+
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---------QVLSGTTYLHK 139
Query: 190 KADPHIIHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
               +I+HRD+K  N+L+     D + KI DF LS    ++  ++     LGT  Y APE
Sbjct: 140 H---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKER--LGTAYYIAPE 193
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKPV-----DHTLPRGQQSLVTWATPKLSE--DK 299
             +  + + K DV+S GV+L  LL G  P         L R ++   ++  P  ++  D+
Sbjct: 194 -VLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDE 252
Query: 300 VRQCVDARL 308
            +Q V   L
Sbjct: 253 AKQLVKLML 261

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           EE   +VS++ ++ H N + L     + T  VL  E  S G L D L  ++         
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------- 111
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            LS ++          G+ YLH K    I H D+K  N+++ D ++     K+ DF L++
Sbjct: 112 -LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D    +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           EE   +VS++ ++ H N + L     + T  VL  E  S G L D L  ++         
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------- 111
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            LS ++          G+ YLH K    I H D+K  N+++ D ++     K+ DF L++
Sbjct: 112 -LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D    +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           EE   +VS++ ++ H N + L     + T  VL  E  S G L D L  ++         
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------- 111
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            LS ++          G+ YLH K    I H D+K  N+++ D ++     K+ DF L++
Sbjct: 112 -LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D    +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 26/231 (11%)
Query: 50  QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEF 109
           QP+EV   SV +  +I E  G+      G++G V+  + K+     + K   +  P +++
Sbjct: 40  QPVEVKQGSVYDYYDILEELGS------GAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 93
Query: 110 LA--QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
               ++S++++L H   + L     D    VL  EF S G L D +        A     
Sbjct: 94  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--------AAEDYK 145
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQA- 224
           +S  + +     A +GL+++HE +   I+H DIK  N++      +  KI DF L+ +  
Sbjct: 146 MSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           PD   ++ +     T  + APE      +   +D+++ GV+   LL+G  P
Sbjct: 203 PDEIVKVTT----ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           EE   +VS++ ++ H N + L     + T  VL  E  S G L D L  ++         
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------- 111
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            LS ++          G+ YLH K    I H D+K  N+++ D ++     K+ DF L++
Sbjct: 112 -LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D    +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 168 EIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHEN 123
           E      LIG+G +G+VY+G  +     AI+ +D  +  +++   F  +V    + +HEN
Sbjct: 33  EQLEIGELIGKGRFGQVYHG--RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
            V  +G C+      +        +L+ ++   K         VL   +  +IA    KG
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKG 142
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA--RLHSTRVLGTFG 241
           + YLH K    I+H+D+KS NV  +D+    I DF L + +  + A  R    R+   + 
Sbjct: 143 MGYLHAKG---ILHKDLKSKNVF-YDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 242 YH-APEYAMTGQL-----------NAKSDVYSFGVVLLEL 269
            H APE  +  QL           +  SDV++ G +  EL
Sbjct: 199 CHLAPE--IIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           EE   +VS++ ++ H N + L     + T  VL  E  S G L D L  ++         
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------- 111
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            LS ++          G+ YLH K    I H D+K  N+++ D ++     K+ DF L++
Sbjct: 112 -LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D    +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPD--EEFLAQVSMVSRLKH 121
           +NF    ++G+GS+G+V    +K     +A  + K D   Q D  E  + +  ++S  ++
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 122 ENFVQLLGYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVG 179
             F+  L  C     R+    EF + G L  + H +K  +  +         R +  A  
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDE--------ARARFYAAE 132
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
               L +LH+K    II+RD+K  NVL+  +   K+ADF +  +   +   + +    GT
Sbjct: 133 IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG--ICNGVTTATFCGT 187
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
             Y APE           D ++ GV+L E+L G  P +
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKLDASKQ-PDEEFLAQVSMVSRL-K 120
           + T+ +     IG GSY      I K+ +   A+K +D SK+ P EE    + ++ R  +
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEE----IEILLRYGQ 74
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H N + L     DG    +  E    G L D +  +K     +   VL            
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVL---------FTI 125
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDD----DVAKIADFDLSNQAPDMAARLHSTRV 236
            K +EYLH +    ++HRD+K SN+L  D+    +  +I DF  + Q       L +   
Sbjct: 126 TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY 182
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
              F   APE       +A  D++S GV+L   LTG  P
Sbjct: 183 TANFV--APEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 110/255 (43%), Gaps = 33/255 (12%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE----FLAQVSMVSRLKHENFVQLLG 129
           +G G+YG V     K +G   AIK +  S           L +V+++ +L H N ++L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           +  D  +  L  E    G L D +  R+         ++              G  YLH+
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---------QVLSGTTYLHK 122
Query: 190 KADPHIIHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
               +I+HRD+K  N+L+     D + KI DF LS    ++  ++     LGT  Y APE
Sbjct: 123 H---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKER--LGTAYYIAPE 176
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKPV-----DHTLPRGQQSLVTWATPKLSE--DK 299
             +  + + K DV+S GV+L  LL G  P         L R ++   ++  P  ++  D+
Sbjct: 177 -VLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDE 235
Query: 300 VRQCVDARLGGDYPP 314
            +Q V   L   Y P
Sbjct: 236 AKQLVKLMLT--YEP 248

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 86/185 (46%), Gaps = 21/185 (11%)
Query: 97  KKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH 154
           ++L +S++    EE   +V+++  ++H N + L     + T  VL  E  S G L D L 
Sbjct: 41  RRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA 100
Query: 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-- 212
            ++          L+  +  +       G+ YLH K    I H D+K  N+++ D +V  
Sbjct: 101 EKES---------LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPN 148
Query: 213 --AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
              K+ DF ++++   + A      + GT  + APE      L  ++D++S GV+   LL
Sbjct: 149 PRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
Query: 271 TGRKP 275
           +G  P
Sbjct: 206 SGASP 210

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 18/226 (7%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 31  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRT 88
Query: 110 LAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
           L ++ ++ R +HEN +      ++   R    E   +  L   L G    K  +    LS
Sbjct: 89  LREIKILLRFRHENIIG-----INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LS 142
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMA 228
                       +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A PD  
Sbjct: 143 NDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHD 199
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
                T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 200 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 75  IGEGSYGRVYYGILKSGHA-AAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
           IGEG+YG V+    +  H   A+K++   D  +      L ++ ++  LKH+N V+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKG-AQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
                   L +EF       D+        G   P  V S+  ++       KGL + H 
Sbjct: 70  LHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQL------LKGLGFCHS 119
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
           +   +++HRD+K  N+LI  +   K+A+F L+ +A  +  R +S  V+ T  Y  P+   
Sbjct: 120 R---NVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 250 TGQLNAKS-DVYSFGVVLLELLTGRKPV 276
             +L + S D++S G +  EL    +P+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 86/185 (46%), Gaps = 21/185 (11%)
Query: 97  KKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH 154
           ++L +S++    EE   +V+++  ++H N + L     + T  VL  E  S G L D L 
Sbjct: 48  RRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA 107
Query: 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-- 212
            ++          L+  +  +       G+ YLH K    I H D+K  N+++ D +V  
Sbjct: 108 EKES---------LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPN 155
Query: 213 --AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
              K+ DF ++++   + A      + GT  + APE      L  ++D++S GV+   LL
Sbjct: 156 PRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 271 TGRKP 275
           +G  P
Sbjct: 213 SGASP 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 75  IGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
           +G G+YG V   +  ++G   AIKKL    Q +   +    ++ ++  ++HEN + LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 131 CV------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV-GAAKG 183
                   D T   L   F        + H + G            + R++  V    KG
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG------------EDRIQFLVYQMLKG 140
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           L Y+H      IIHRD+K  N+ + +D   KI DF L+ QA         TR      Y 
Sbjct: 141 LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WYR 192
Query: 244 APEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           APE  +      ++ D++S G ++ E++TG+
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 36/216 (16%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-D 133
           +G+G YG V+ G  + G   A+K   +  +       ++     L+HEN   +LG+   D
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHEN---ILGFIASD 100
Query: 134 GTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            TSR       L   +   GSL+D L              L     ++I +  A GL +L
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQL----------TTLDTVSCLRIVLSIASGLAHL 150
Query: 188 H-----EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 239
           H      +  P I HRD+KS N+L+  +    IAD  L+   +Q+ +     ++ RV GT
Sbjct: 151 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GT 209
Query: 240 FGYHAPEYA-MTGQLNA-----KSDVYSFGVVLLEL 269
             Y APE    T Q++      + D+++FG+VL E+
Sbjct: 210 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/132 (37%), Positives = 64/132 (48%), Gaps = 13/132 (9%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           KIAV   K LE+LH K    +IHRD+K SNVLI      K  DF +S    D  A+    
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 235 RVLGTFGYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SL 287
              G   Y APE  +  +LN      KSD++S G+  +EL   R P D      QQ   +
Sbjct: 198 ---GCKPYXAPE-RINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV 253
Query: 288 VTWATPKLSEDK 299
           V   +P+L  DK
Sbjct: 254 VEEPSPQLPADK 265

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 36/216 (16%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-D 133
           +G+G YG V+ G  + G   A+K   +  +       ++     L+HEN   +LG+   D
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHEN---ILGFIASD 71
Query: 134 GTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            TSR       L   +   GSL+D L              L     ++I +  A GL +L
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQL----------TTLDTVSCLRIVLSIASGLAHL 121
Query: 188 H-----EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 239
           H      +  P I HRD+KS N+L+  +    IAD  L+   +Q+ +     ++ RV GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GT 180
Query: 240 FGYHAPEYA-MTGQLNA-----KSDVYSFGVVLLEL 269
             Y APE    T Q++      + D+++FG+VL E+
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 86/185 (46%), Gaps = 21/185 (11%)
Query: 97  KKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH 154
           ++L +S++    EE   +V+++  ++H N + L     + T  VL  E  S G L D L 
Sbjct: 62  RRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA 121
Query: 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-- 212
            ++          L+  +  +       G+ YLH K    I H D+K  N+++ D +V  
Sbjct: 122 EKES---------LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPN 169
Query: 213 --AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
              K+ DF ++++   + A      + GT  + APE      L  ++D++S GV+   LL
Sbjct: 170 PRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 226
Query: 271 TGRKP 275
           +G  P
Sbjct: 227 SGASP 231

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 36/216 (16%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-D 133
           +G+G YG V+ G  + G   A+K   +  +       ++     L+HEN   +LG+   D
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHEN---ILGFIASD 71
Query: 134 GTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            TSR       L   +   GSL+D L              L     ++I +  A GL +L
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQL----------TTLDTVSCLRIVLSIASGLAHL 121
Query: 188 H-----EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 239
           H      +  P I HRD+KS N+L+  +    IAD  L+   +Q+ +     ++ RV GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GT 180
Query: 240 FGYHAPEYA-MTGQLNA-----KSDVYSFGVVLLEL 269
             Y APE    T Q++      + D+++FG+VL E+
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 53  EVPAISVDELKEITENFGTNALIGEGSYGRVYYGI---LKSGHAAAI--KKLDASKQPDE 107
           E+P + VD      + +     +G+G + + Y       K   A  +  K +       E
Sbjct: 14  EIPDVLVDP--RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE 71
Query: 108 EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
           +   ++++   L + + V   G+  D     +  E     SL ++   RK V   +P   
Sbjct: 72  KMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAV--TEPEAR 129
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
              +Q ++       G++YLH      +IHRD+K  N+ + DD   KI DF L+ +    
Sbjct: 130 YFMRQTIQ-------GVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD 179
Query: 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
             R     + GT  Y APE       + + D++S G +L  LL G+ P +
Sbjct: 180 GER--KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 26/231 (11%)
Query: 50  QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE 108
           QP+E+    V +  +I E  GT      G++G V+    + +G+  A K +    + D+E
Sbjct: 146 QPVEIKHDHVLDHYDIHEELGT------GAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 109 FL-AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
            +  ++  +S L+H   V L     D    V+ YEF S G L +        K A     
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE--------KVADEHNK 251
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDLSNQA- 224
           +S  + V+      KGL ++HE    + +H D+K  N++      +  K+ DF L+    
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           P  + ++      GT  + APE A    +   +D++S GV+   LL+G  P
Sbjct: 309 PKQSVKV----TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H  F+  L Y  +  + +       NG   DI +    V    PG    +Q+   I   A
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGG--DIRYHIYNVDEDNPG----FQEPRAIFYTA 296
Query: 181 --AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
               GLE+LH++   +II+RD+K  NVL+ DD   +I+D  L+ +    A +  +    G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAG 351
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           T G+ APE  +  + +   D ++ GV L E++  R P 
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H  F+  L Y  +  + +       NG   DI +    V    PG    +Q+   I   A
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGG--DIRYHIYNVDEDNPG----FQEPRAIFYTA 296
Query: 181 --AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
               GLE+LH++   +II+RD+K  NVL+ DD   +I+D  L+ +    A +  +    G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAG 351
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           T G+ APE  +  + +   D ++ GV L E++  R P 
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H  F+  L Y  +  + +       NG   DI +    V    PG    +Q+   I   A
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGG--DIRYHIYNVDEDNPG----FQEPRAIFYTA 296
Query: 181 --AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
               GLE+LH++   +II+RD+K  NVL+ DD   +I+D  L+ +    A +  +    G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAG 351
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           T G+ APE  +  + +   D ++ GV L E++  R P 
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 68  NFGTNAL-IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
           ++ T+ L +G GS+G V+    K +G   A+KK+       EE +A   + S       V
Sbjct: 93  HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTS----PRIV 148
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA-KGL 184
            L G   +G    +  E    GSL  ++      +G  P      + R    +G A +GL
Sbjct: 149 PLYGAVREGPWVNIFMELLEGGSLGQLVK----EQGCLP------EDRALYYLGQALEGL 198
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDV-AKIADFDLS-NQAPDMAAR--LHSTRVLGTF 240
           EYLH +    I+H D+K+ NVL+  D   A + DF  +    PD   +  L    + GT 
Sbjct: 199 EYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTE 255
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            + APE  +    +AK DV+S   ++L +L G  P
Sbjct: 256 THMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H  F+  L Y  +  + +       NG   DI +    V    PG    +Q+   I   A
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGG--DIRYHIYNVDEDNPG----FQEPRAIFYTA 296
Query: 181 --AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
               GLE+LH++   +II+RD+K  NVL+ DD   +I+D  L+ +    A +  +    G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAG 351
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           T G+ APE  +  + +   D ++ GV L E++  R P 
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRT 68
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 120
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 121 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVAD 175
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 176 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 50/236 (21%)
Query: 68  NFGTNALIGEGSYGRVYYGILKSGHAA-----AIKKLDASKQPDEEFLAQVSMVSRLKHE 122
           +F   A++G+G++G+V    +K+ +A      AIKK+  +++     L++V +++ L H+
Sbjct: 7   DFEEIAVLGQGAFGQV----VKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQ 62
Query: 123 -------------NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
                        NFV+        ++  +  E+  N +L+D++H     +         
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE----Y 118
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL--------- 220
           W+   +I     + L Y+H +    IIHR++K  N+ I +    KI DF L         
Sbjct: 119 WRLFRQIL----EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 221 -----SNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELL 270
                S   P  +  L  T  +GT  Y A E    TG  N K D YS G++  E +
Sbjct: 172 ILKLDSQNLPGSSDNL--TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 26/231 (11%)
Query: 50  QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE 108
           QP+E+    V +  +I E  GT      G++G V+    + +G+  A K +    + D+E
Sbjct: 40  QPVEIKHDHVLDHYDIHEELGT------GAFGVVHRVTERATGNNFAAKFVMTPHESDKE 93
Query: 109 FL-AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
            +  ++  +S L+H   V L     D    V+ YEF S G L +        K A     
Sbjct: 94  TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE--------KVADEHNK 145
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDLSNQA- 224
           +S  + V+      KGL ++HE    + +H D+K  N++      +  K+ DF L+    
Sbjct: 146 MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 202
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           P  + ++      GT  + APE A    +   +D++S GV+   LL+G  P
Sbjct: 203 PKQSVKV----TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 68  NFGTNAL-IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
           ++ T+ L +G GS+G V+    K +G   A+KK+       EE +A   + S       V
Sbjct: 74  HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTS----PRIV 129
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA-KGL 184
            L G   +G    +  E    GSL  ++      +G  P      + R    +G A +GL
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLVK----EQGCLP------EDRALYYLGQALEGL 179
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDV-AKIADFDLS-NQAPDMAAR--LHSTRVLGTF 240
           EYLH +    I+H D+K+ NVL+  D   A + DF  +    PD   +  L    + GT 
Sbjct: 180 EYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTE 236
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            + APE  +    +AK DV+S   ++L +L G  P
Sbjct: 237 THMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRT 68
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 120
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 121 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVAD 175
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 176 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 31  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRT 88
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 89  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 140
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 141 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 195
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 196 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRT 72
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 124
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 125 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVAD 179
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHE 122
           I + F    ++G G++  V+    + +G   A+K +  S    D     +++++ ++KHE
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N V L       T   L  +  S G L D +  R GV   +   ++   Q+V  AV    
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVI--QQVLSAV---- 119
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
             +YLHE     I+HRD+K  N+L     ++    I DF LS     M      +   GT
Sbjct: 120 --KYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGT 170
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GY APE       +   D +S GV+   LL G  P
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYXQRT 72
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 124
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 125 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVAD 179
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRT 70
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 71  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 122
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 123 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 177
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 178 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 19  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRT 76
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 77  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 128
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 129 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 183
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 184 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRT 68
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 120
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 121 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 175
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 176 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRT 68
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 120
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 121 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 175
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 176 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 75  IGEGSYGRVYYGILKSGHA----AAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
           IG GS+  VY G+            ++    +K   + F  +   +  L+H N V+    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 131 ---CVDGTS-RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
               V G    VL  E  ++G+L   L   K  K  +   + SW +++       KGL++
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYL---KRFKVXKIKVLRSWCRQI------LKGLQF 144
Query: 187 LHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           LH +  P IIHRD+K  N+ I       KI D  L+       A+     V+GT  + AP
Sbjct: 145 LHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFXAP 199
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           E     + +   DVY+FG   LE  T   P
Sbjct: 200 E-XYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRT 68
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 120
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 121 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVAD 175
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 176 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 109/253 (43%), Gaps = 28/253 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 9   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRT 66
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 67  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 118
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 119 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 173
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRK--PVDHTLP 281
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R   P  H L 
Sbjct: 174 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 233
Query: 282 RGQQSLVTWATPK 294
           +    L    +P+
Sbjct: 234 QLNHILGILGSPE 246

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 68  NFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPDEEFLAQVSMVSRL----- 119
           +F    ++G+GS+G+V     K     +A  I K D   Q D+    + +MV +      
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMVEKRVLALP 398
Query: 120 KHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
               F+  L  C     R+    E+ + G L  + H ++  +  +P  V         A 
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVF-------YAA 449
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
             A GL +L  K    II+RD+K  NV++  +   KIADF +  +  ++   + +    G
Sbjct: 450 EIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKXFCG 504
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           T  Y APE           D ++FGV+L E+L G+ P +
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 16  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRT 73
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 74  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 125
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 126 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 180
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 181 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 17  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRT 74
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 75  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 126
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 127 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 181
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 182 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 8   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRT 65
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 66  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 117
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 118 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 172
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 173 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRT 72
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 124
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 125 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKLDASKQ-PDEEFLAQVSMVSRL-KH 121
            ++ +     IG GSY      + K+ +   A+K +D SK+ P EE    + ++ R  +H
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEE----IEILLRYGQH 80
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N + L     DG    L  E    G L D +  +K     +   VL         +G  
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH-------TIG-- 131
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDD----DVAKIADFDLSNQAPDMAARLHSTRVL 237
           K +EYLH +    ++HRD+K SN+L  D+    +  +I DF  + Q       L +    
Sbjct: 132 KTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYT 188
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             F   APE       +   D++S G++L  +L G  P
Sbjct: 189 ANFV--APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKL------DASKQPDEEFLAQVSMVSRLKHENFVQ 126
            +GEG +  VY    K +    AIKK+      +A    +   L ++ ++  L H N + 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 127 LLGYCVDGTSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           LL           A+   SN SL  D +     V       VL+        +   +GLE
Sbjct: 77  LLD----------AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVLGTFGYH 243
           YLH+     I+HRD+K +N+L+ ++ V K+ADF L+    +P+   R +  +V+ T  Y 
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---RAYXHQVV-TRWYR 179
Query: 244 APEYAMTGQL-NAKSDVYSFGVVLLELL 270
           APE     ++     D+++ G +L ELL
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 9   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRT 66
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 67  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 118
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 119 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 173
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 174 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRT 72
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH-------- 124
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 125 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 71  TNALIGEGSYGRVYYGI-LKSGHAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHENFVQL 127
           T+ L+GEG+Y +V   + L++G   A+K ++  A       F    ++     ++N ++L
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           + +  D T   L +E    GS+   +  +K           + ++  ++    A  L++L
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILAHIQKQKH---------FNEREASRVVRDVAAALDFL 127
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLS-----NQAPDMAARLHSTRVLGT 239
           H K    I HRD+K  N+L    +     KI DFDL      N +         T   G+
Sbjct: 128 HTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGS 184
Query: 240 FGYHAPEYA--MTGQ---LNAKSDVYSFGVVLLELLTGRKP 275
             Y APE     T Q    + + D++S GVVL  +L+G  P
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFL-----------AQVSM 115
           E F    ++G+G YG+V+   ++    A   K+ A K   +  +           A+ ++
Sbjct: 17  ECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           +  +KH   V L+     G    L  E+ S G L   L  R+G+          +   + 
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE-REGI--FMEDTACFYLAEIS 131
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
           +A+G      +LH+K    II+RD+K  N+++      K+ DF L  ++       H+  
Sbjct: 132 MALG------HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-- 180
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             GT  Y APE  M    N   D +S G ++ ++LTG  P
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKLDASKQ-PDEEFLAQVSMVSRL-KH 121
            ++ +     IG GSY      + K+ +   A+K +D SK+ P EE    + ++ R  +H
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEE----IEILLRYGQH 80
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N + L     DG    L  E    G L D +  +K     +   VL         +G  
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH-------TIG-- 131
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDD----DVAKIADFDLSNQAPDMAARLHSTRVL 237
           K +EYLH +    ++HRD+K SN+L  D+    +  +I DF  + Q       L +    
Sbjct: 132 KTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--C 186
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            T  + APE       +   D++S G++L  +L G  P
Sbjct: 187 YTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 14/171 (8%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   ++S+   L H++ V   G+  D     +  E     SL ++   RK +   +P  
Sbjct: 66  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEA 123
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
               +Q V        G +YLH      +IHRD+K  N+ + +D   KI DF L+ +   
Sbjct: 124 RYYLRQIVL-------GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 173
Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
              R  +  + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 174 DGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 68  NFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPDEEFLAQVSMVSRL----- 119
           +F    ++G+GS+G+V     K     +A  I K D   Q D+    + +MV +      
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMVEKRVLALP 77
Query: 120 KHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
               F+  L  C     R+    E+ + G L  + H ++  +  +P  V         A 
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVF-------YAA 128
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
             A GL +L  K    II+RD+K  NV++  +   KIADF +  +  ++   + +    G
Sbjct: 129 EIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKXFCG 183
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           T  Y APE           D ++FGV+L E+L G+ P +
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 102/235 (43%), Gaps = 31/235 (13%)
Query: 48  KVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD 106
           K++P++       E +E          +G GS+G V+    K +G   A+KK+       
Sbjct: 45  KLKPVDY------EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV 98
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           EE +A   + S       V L G   +G    +  E    GSL  ++       G  P  
Sbjct: 99  EELVACAGLSS----PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLP-- 148
Query: 167 VLSWQQRVKIAVGAA-KGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFD--LSN 222
               + R    +G A +GLEYLH +    I+H D+K+ NVL+  D   A + DF   L  
Sbjct: 149 ----EDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201
Query: 223 QAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           Q PD   +  L    + GT  + APE  M    +AK D++S   ++L +L G  P
Sbjct: 202 Q-PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 35/231 (15%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----------KQPDEEFLAQVSM 115
           EN+    ++G G    V   I K +    A+K +D +          ++  E  L +V +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 116 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
           + ++  H N +QL       T   L ++    G L D L  +           LS ++  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---------VTLSEKETR 127
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           KI     + +  LH+    +I+HRD+K  N+L+ DD   K+ DF  S Q  D   +L S 
Sbjct: 128 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRS- 182
Query: 235 RVLGTFGYHAPEYAMTGQLN-------AKSDVYSFGVVLLELLTGRKPVDH 278
            V GT  Y APE  +   +N        + D++S GV++  LL G  P  H
Sbjct: 183 -VCGTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 14/171 (8%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   ++S+   L H++ V   G+  D     +  E     SL ++   RK +   +P  
Sbjct: 62  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEA 119
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
               +Q V        G +YLH      +IHRD+K  N+ + +D   KI DF L+ +   
Sbjct: 120 RYYLRQIVL-------GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 169
Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
              R     + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 170 DGER--KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 14/171 (8%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   ++S+   L H++ V   G+  D     +  E     SL ++   RK +   +P  
Sbjct: 62  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEA 119
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
               +Q V        G +YLH      +IHRD+K  N+ + +D   KI DF L+ +   
Sbjct: 120 RYYLRQIVL-------GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 169
Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
              R     + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 170 DGER--KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 16/172 (9%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   ++S+   L H++ V   G+  D     +  E     SL ++   RK +   +P  
Sbjct: 86  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEA 143
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
               +Q V        G +YLH      +IHRD+K  N+ + +D   KI DF L+ +   
Sbjct: 144 RYYLRQIVL-------GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193
Query: 227 MAARLHSTRVL-GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
              R    +VL GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 194 DGER---KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 16/172 (9%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   ++S+   L H++ V   G+  D     +  E     SL ++   RK +   +P  
Sbjct: 84  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEA 141
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
               +Q V        G +YLH      +IHRD+K  N+ + +D   KI DF L+ +   
Sbjct: 142 RYYLRQIVL-------GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 191
Query: 227 MAARLHSTRVL-GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
              R    +VL GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 192 DGER---KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 21/143 (14%)
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  +     +L D ++ R  ++  + G  L       I +  A+ +E+LH K    ++HR
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLH------IFIQIAEAVEFLHSKG---LMHR 188
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQ-----------APDMAARLHSTRVLGTFGYHAPEY 247
           D+K SN+    DDV K+ DF L               P  A   H  +V GT  Y +PE 
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQV-GTKLYMSPEQ 247
Query: 248 AMTGQLNAKSDVYSFGVVLLELL 270
                 + K D++S G++L ELL
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELL 270

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 102/235 (43%), Gaps = 31/235 (13%)
Query: 48  KVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD 106
           K++P++       E +E          +G GS+G V+    K +G   A+KK+       
Sbjct: 61  KLKPVDY------EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV 114
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           EE +A   + S       V L G   +G    +  E    GSL  ++       G  P  
Sbjct: 115 EELVACAGLSS----PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLP-- 164
Query: 167 VLSWQQRVKIAVGAA-KGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFD--LSN 222
               + R    +G A +GLEYLH +    I+H D+K+ NVL+  D   A + DF   L  
Sbjct: 165 ----EDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 217
Query: 223 QAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           Q PD   +  L    + GT  + APE  M    +AK D++S   ++L +L G  P
Sbjct: 218 Q-PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 68/132 (51%), Gaps = 11/132 (8%)
Query: 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202
           F  + SL D+    +   G    P+ + +  +  +   A+G+E+L  +     IHRD+ +
Sbjct: 173 FQEDKSLSDV-EEEEDSDGFYKEPI-TMEDLISYSFQVARGMEFLSSR---KCIHRDLAA 227
Query: 203 SNVLIFDDDVAKIADFDLSN---QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDV 259
            N+L+ +++V KI DF L+    + PD   R   TR+     + APE       + KSDV
Sbjct: 228 RNILLSENNVVKICDFGLARDIYKNPDY-VRKGDTRL--PLKWMAPESIFDKIYSTKSDV 284
Query: 260 YSFGVVLLELLT 271
           +S+GV+L E+ +
Sbjct: 285 WSYGVLLWEIFS 296

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AI+K+   +     +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIRKISPFEHQTYCQRT 72
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 124
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 125 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L              G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 119 FLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 16/172 (9%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   ++S+   L H++ V   G+  D     +  E     SL ++   RK +   +P  
Sbjct: 60  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEA 117
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
               +Q V        G +YLH      +IHRD+K  N+ + +D   KI DF L+ +   
Sbjct: 118 RYYLRQIVL-------GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167
Query: 227 MAARLHSTRVL-GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
              R    +VL GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 168 DGER---KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFL-----------AQVSM 115
           E F    ++G+G YG+V+   ++    A   K+ A K   +  +           A+ ++
Sbjct: 17  ECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           +  +KH   V L+     G    L  E+ S G L   L  R+G+          +   + 
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE-REGI--FMEDTACFYLAEIS 131
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
           +A+G      +LH+K    II+RD+K  N+++      K+ DF L  ++       H   
Sbjct: 132 MALG------HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHX-- 180
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             GT  Y APE  M    N   D +S G ++ ++LTG  P
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 110
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 111 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 113/268 (42%), Gaps = 40/268 (14%)
Query: 33  AYHASEAAPKGAQAVKVQPI----EVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL 88
           A   ++A PKG + +  Q +    E+P  +    KE  + +    +IG G    V   + 
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAA--AKEFYQKYDPKDVIGRGVSSVVRRCVH 115
Query: 89  K-SGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLK---------HENFVQLLGYCVDGTSR 137
           + +GH  A+K ++ + ++   E L +V   +R +         H + + L+      +  
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 197
            L ++    G L D L  +           LS ++   I     + + +LH     +I+H
Sbjct: 176 FLVFDLMRKGELFDYLTEKVA---------LSEKETRSIMRSLLEAVSFLHAN---NIVH 223
Query: 198 RDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ---- 252
           RD+K  N+L+ D+   +++DF  S +  P    R     + GT GY APE          
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR----ELCGTPGYLAPEILKCSMDETH 279
Query: 253 --LNAKSDVYSFGVVLLELLTGRKPVDH 278
                + D+++ GV+L  LL G  P  H
Sbjct: 280 PGYGKEVDLWACGVILFTLLAGSPPFWH 307

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 102/235 (43%), Gaps = 31/235 (13%)
Query: 48  KVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD 106
           K++P++       E +E          +G GS+G V+    K +G   A+KK+       
Sbjct: 59  KLKPVDY------EYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV 112
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           EE +A   + S       V L G   +G    +  E    GSL  ++       G  P  
Sbjct: 113 EELVACAGLSS----PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLP-- 162
Query: 167 VLSWQQRVKIAVGAA-KGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFD--LSN 222
               + R    +G A +GLEYLH +    I+H D+K+ NVL+  D   A + DF   L  
Sbjct: 163 ----EDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 215
Query: 223 QAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           Q PD   +  L    + GT  + APE  M    +AK D++S   ++L +L G  P
Sbjct: 216 Q-PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 105/236 (44%), Gaps = 41/236 (17%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPD---EEFLAQVSMVSRLK 120
           + +N+    LIG GSYG VY    K+     AIKK++   +     +  L ++++++RLK
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH-GRKGVKGAQPGPVLSWQQRVK-IAV 178
            +  ++L    +     +L ++      L+ +L      +K     P+   ++ +K I  
Sbjct: 84  SDYIIRLYDLII--PDDLLKFD-----ELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY 136
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS----------------- 221
               G  ++HE     IIHRD+K +N L+  D   K+ DF L+                 
Sbjct: 137 NLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 222 NQAP-----DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLT 271
           N+ P     ++  +L S  V  T  Y APE  +  +   KS D++S G +  ELL 
Sbjct: 194 NEEPGPHNKNLKKQLTSHVV--TRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 110
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 111 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 110
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 111 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 109
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 110 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 166 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 110
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 111 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 110
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 111 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 110
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 111 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 112/260 (43%), Gaps = 39/260 (15%)
Query: 31  DGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK- 89
           + A+ A+  A K    +K +  +V    V +  EI E       IG G+YG V     + 
Sbjct: 26  EPAHTAASVAAKNLALLKARSFDV-TFDVGDEYEIIET------IGNGAYGVVSSARRRL 78
Query: 90  SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY-EFAS 145
           +G   AIKK+  +       +  L ++ ++   KH+N + +     D     + Y EF S
Sbjct: 79  TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI----KDILRPTVPYGEFKS 134
Query: 146 --------NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 197
                      LH I+H       +QP   L+ +          +GL+Y+H      +IH
Sbjct: 135 VYVVLDLMESDLHQIIHS------SQP---LTLEHVRYFLYQLLRGLKYMHSA---QVIH 182
Query: 198 RDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMT-GQLN 254
           RD+K SN+L+ ++   KI DF ++       A  +   T  + T  Y APE  ++  +  
Sbjct: 183 RDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYT 242
Query: 255 AKSDVYSFGVVLLELLTGRK 274
              D++S G +  E+L  R+
Sbjct: 243 QAIDLWSVGCIFGEMLARRQ 262

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 109
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 110 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 166 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 110
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 111 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 68  NFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENF 124
           NF T   + E   G ++ G  + G+   +K L   D S +   +F  +   +    H N 
Sbjct: 13  NFLTK--LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 125 VQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           + +LG C    +    L   +   GSL+++LH            V+   Q VK A+  A+
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-------VVDQSQAVKFALDMAR 122
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLSNQAPDMAARLHSTRVLGTF 240
           G+ +LH   +P I    + S +V+I +D  A+I  AD   S Q+P    R+++       
Sbjct: 123 GMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP---GRMYAP------ 172
Query: 241 GYHAPEYAMTG--QLNAKS-DVYSFGVVLLELLTGRKP 275
            + APE         N +S D++SF V+L EL+T   P
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 110
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 111 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 110
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 111 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 40/241 (16%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPD---EEFLAQVSMVSRL 119
           ++ +N+    LIG GSYG VY    K+ +   AIKK++   +     +  L ++++++RL
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH-GRKGVKGAQPGPVLSWQQRVK-IA 177
           K +  ++L          ++  +      L+ +L      +K     P+   +Q VK I 
Sbjct: 85  KSDYIIRL-------HDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTIL 137
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDM------- 227
                G +++HE     IIHRD+K +N L+  D   KI DF L+   N   D+       
Sbjct: 138 YNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLE 194
Query: 228 -------------AARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
                          +   T  + T  Y APE  +  +    S D++S G +  ELL   
Sbjct: 195 EKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMM 254
Query: 274 K 274
           K
Sbjct: 255 K 255

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++ +   +   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L              G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 119 FLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 68  NFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKH 121
           +F  + +IG G +G VY G  K  +G   A+K LD      KQ +   L +  M+S +  
Sbjct: 190 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 122 EN--FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
            +  F+  + Y      ++    +  + G LH  L        +Q G V S       A 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--------SQHG-VFSEADMRFYAA 299
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHST 234
               GLE++H +    +++RD+K +N+L+ +    +I+D     D S + P      H++
Sbjct: 300 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS 350
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
             +GT GY APE    G   ++ +D +S G +L +LL G  P
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 68  NFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKH 121
           +F  + +IG G +G VY G  K  +G   A+K LD      KQ +   L +  M+S +  
Sbjct: 190 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 122 EN--FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
            +  F+  + Y      ++    +  + G LH  L        +Q G V S       A 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--------SQHG-VFSEADMRFYAA 299
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHST 234
               GLE++H +    +++RD+K +N+L+ +    +I+D     D S + P      H++
Sbjct: 300 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS 350
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
             +GT GY APE    G   ++ +D +S G +L +LL G  P
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----------KQPDEEFLAQVSM 115
           EN+    ++G G    V   I K +    A+K +D +          ++  E  L +V +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 116 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
           + ++  H N +QL       T   L ++    G L D L  +           LS ++  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---------VTLSEKETR 114
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           KI     + +  LH+    +I+HRD+K  N+L+ DD   K+ DF  S Q  D   +L   
Sbjct: 115 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRE- 169
Query: 235 RVLGTFGYHAPEYAMTGQLN-------AKSDVYSFGVVLLELLTGRKPVDH 278
            V GT  Y APE  +   +N        + D++S GV++  LL G  P  H
Sbjct: 170 -VCGTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 218

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRT 70
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++   +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 71  LREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 122
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 123 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVAD 177
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 178 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 68  NFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKH 121
           +F  + +IG G +G VY G  K  +G   A+K LD      KQ +   L +  M+S +  
Sbjct: 189 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 122 EN--FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
            +  F+  + Y      ++    +  + G LH  L        +Q G V S       A 
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--------SQHG-VFSEADMRFYAA 298
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHST 234
               GLE++H +    +++RD+K +N+L+ +    +I+D     D S + P      H++
Sbjct: 299 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS 349
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
             +GT GY APE    G   ++ +D +S G +L +LL G  P
Sbjct: 350 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 68  NFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKH 121
           +F  + +IG G +G VY G  K  +G   A+K LD      KQ +   L +  M+S +  
Sbjct: 190 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 122 EN--FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
            +  F+  + Y      ++    +  + G LH  L        +Q G V S       A 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--------SQHG-VFSEADMRFYAA 299
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHST 234
               GLE++H +    +++RD+K +N+L+ +    +I+D     D S + P      H++
Sbjct: 300 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS 350
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
             +GT GY APE    G   ++ +D +S G +L +LL G  P
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----------KQPDEEFLAQVSM 115
           EN+    ++G G    V   I K +    A+K +D +          ++  E  L +V +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 116 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
           + ++  H N +QL       T   L ++    G L D L  +           LS ++  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---------VTLSEKETR 127
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           KI     + +  LH+    +I+HRD+K  N+L+ DD   K+ DF  S Q  D   +L   
Sbjct: 128 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRE- 182
Query: 235 RVLGTFGYHAPEYAMTGQLN-------AKSDVYSFGVVLLELLTGRKPVDH 278
            V GT  Y APE  +   +N        + D++S GV++  LL G  P  H
Sbjct: 183 -VCGTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 106/249 (42%), Gaps = 36/249 (14%)
Query: 32  GAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKS 90
           G   A    P G+ +V   P    A S+D  + IT+       +GEG+YG VY  I   +
Sbjct: 10  GTLEAQTQGP-GSMSVSAAP---SATSIDRYRRITK-------LGEGTYGEVYKAIDTVT 58
Query: 91  GHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147
               AIK++    + +      + +VS++  L+H N ++L           L +E+A N 
Sbjct: 59  NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117
Query: 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207
              D+       K     P +S +           G+ + H +     +HRD+K  N+L+
Sbjct: 118 ---DL------KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLL 165
Query: 208 FDDD-----VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYS 261
              D     V KI DF L+ +A  +  R  +  ++ T  Y  PE  +  +  + S D++S
Sbjct: 166 SVSDASETPVLKIGDFGLA-RAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWS 223
Query: 262 FGVVLLELL 270
              +  E+L
Sbjct: 224 IACIWAEML 232

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRT 72
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 124
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 125 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD          + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 180 PDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 16  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRT 73
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++ R +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 74  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 125
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 126 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 180
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD          + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 181 PDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 22/226 (9%)
Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASK------QPDEEFLAQVSMVSRLKHENFVQ 126
           +IG+G++  V   I + +G   A+K +D +K         E+   + S+   LKH + V+
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 127 LL-GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           LL  Y  DG    + +EF     L       + VK A  G V S            + L 
Sbjct: 91  LLETYSSDGML-YMVFEFMDGADL-----CFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           Y H   D +IIHRD+K  NVL+   + +   K+ DF ++ Q  + +  +   RV GT  +
Sbjct: 145 YCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE-SGLVAGGRV-GTPHF 199
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
            APE           DV+  GV+L  LL+G  P   T  R  + ++
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII 245

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
           +GEG+Y  VY G  K + +  A+K++    +      A  +VS++  LKH N V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
               S  L +E+  +  L   L           G +++            +GL Y H + 
Sbjct: 70  HTEKSLTLVFEYL-DKDLKQYLD--------DCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-T 250
              ++HRD+K  N+LI +    K+ADF L+ +A  +  + +   V+ T  Y  P+  + +
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYDNEVV-TLWYRPPDILLGS 175
Query: 251 GQLNAKSDVYSFGVVLLELLTGR 273
              + + D++  G +  E+ TGR
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGR 198

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 112/260 (43%), Gaps = 39/260 (15%)
Query: 31  DGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK- 89
           + A+ A+  A K    +K +  +V    V +  EI E       IG G+YG V     + 
Sbjct: 25  EPAHTAASVAAKNLALLKARSFDV-TFDVGDEYEIIET------IGNGAYGVVSSARRRL 77
Query: 90  SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY-EFAS 145
           +G   AIKK+  +       +  L ++ ++   KH+N + +     D     + Y EF S
Sbjct: 78  TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI----KDILRPTVPYGEFKS 133
Query: 146 --------NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 197
                      LH I+H       +QP   L+ +          +GL+Y+H      +IH
Sbjct: 134 VYVVLDLMESDLHQIIHS------SQP---LTLEHVRYFLYQLLRGLKYMHSA---QVIH 181
Query: 198 RDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMT-GQLN 254
           RD+K SN+L+ ++   KI DF ++       A  +   T  + T  Y APE  ++  +  
Sbjct: 182 RDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYT 241
Query: 255 AKSDVYSFGVVLLELLTGRK 274
              D++S G +  E+L  R+
Sbjct: 242 QAIDLWSVGCIFGEMLARRQ 261

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
           E+   +VS++  ++H N + L     + T  +L  E  + G L D L  ++         
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES-------- 110
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLSN 222
            L+ ++  +       G+ YLH      I H D+K  N+++ D +V     KI DF L++
Sbjct: 111 -LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  D      +  + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 167 KI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 26/230 (11%)
Query: 55  PAISVDELKEITENFGTNALIGEGSYGRV---YYGILKSGHAAAIKKLDASKQPD--EEF 109
           P +   ++ ++   +   + IGEG+YG V   Y  + K     AIKK+   +     +  
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRT 70
Query: 110 LAQVSMVSRLKHENFV----QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           L ++ ++   +HEN +     +    ++    V   +      L+ +L  +         
Sbjct: 71  LREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------- 122
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA- 224
             LS            +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A 
Sbjct: 123 --LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 177
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           PD       T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 178 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 34/241 (14%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK---------QPDEEFLAQ 112
           K + + +  +  +G G+ G V      K+    AIK +   K          P      +
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
           + ++ +L H   +++  +  D     +  E    G L D + G K +K A     L + Q
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--LYFYQ 122
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAA 229
            + +AV      +YLHE     IIHRD+K  NVL+    +D + KI DF  S    + + 
Sbjct: 123 ML-LAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 171
Query: 230 RLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286
            L  T + GT  Y APE  +   T   N   D +S GV+L   L+G  P      R Q S
Sbjct: 172 -LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVS 227
Query: 287 L 287
           L
Sbjct: 228 L 228

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 34/241 (14%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK---------QPDEEFLAQ 112
           K + + +  +  +G G+ G V      K+    AIK +   K          P      +
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
           + ++ +L H   +++  +  D     +  E    G L D + G K +K A     L + Q
Sbjct: 65  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--LYFYQ 121
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAA 229
            + +AV      +YLHE     IIHRD+K  NVL+    +D + KI DF  S    + + 
Sbjct: 122 ML-LAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 170
Query: 230 RLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286
            L  T + GT  Y APE  +   T   N   D +S GV+L   L+G  P      R Q S
Sbjct: 171 -LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVS 226
Query: 287 L 287
           L
Sbjct: 227 L 227

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 34/241 (14%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK---------QPDEEFLAQ 112
           K + + +  +  +G G+ G V      K+    AIK +   K          P      +
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
           + ++ +L H   +++  +  D     +  E    G L D + G K +K A     L + Q
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--LYFYQ 122
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAA 229
            + +AV      +YLHE     IIHRD+K  NVL+    +D + KI DF  S    + + 
Sbjct: 123 ML-LAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 171
Query: 230 RLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286
            L  T + GT  Y APE  +   T   N   D +S GV+L   L+G  P      R Q S
Sbjct: 172 -LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVS 227
Query: 287 L 287
           L
Sbjct: 228 L 228

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 34/241 (14%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK---------QPDEEFLAQ 112
           K + + +  +  +G G+ G V      K+    AIK +   K          P      +
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
           + ++ +L H   +++  +  D     +  E    G L D + G K +K A     L + Q
Sbjct: 72  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--LYFYQ 128
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAA 229
            + +AV      +YLHE     IIHRD+K  NVL+    +D + KI DF  S    + + 
Sbjct: 129 ML-LAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 177
Query: 230 RLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286
            L  T + GT  Y APE  +   T   N   D +S GV+L   L+G  P      R Q S
Sbjct: 178 -LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVS 233
Query: 287 L 287
           L
Sbjct: 234 L 234

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 19/218 (8%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
           K    +F    L+G+G++G+V     K +G   A+K L       ++ +A     SR+  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 122 EN---FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
                F+  L Y      R+    E+A+ G L   L   +         V + ++     
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYG 111
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
                 LEYLH +    +++RDIK  N+++  D   KI DF L  +     A + +    
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FC 166
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           GT  Y APE           D +  GVV+ E++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 34/241 (14%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK---------QPDEEFLAQ 112
           K + + +  +  +G G+ G V      K+    AIK +   K          P      +
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
           + ++ +L H   +++  +  D     +  E    G L D + G K +K A     L + Q
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--LYFYQ 122
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAA 229
            + +AV      +YLHE     IIHRD+K  NVL+    +D + KI DF  S    + + 
Sbjct: 123 ML-LAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 171
Query: 230 RLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286
            L  T + GT  Y APE  +   T   N   D +S GV+L   L+G  P      R Q S
Sbjct: 172 -LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVS 227
Query: 287 L 287
           L
Sbjct: 228 L 228

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 19/218 (8%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
           K    +F    L+G+G++G+V     K +G   A+K L       ++ +A     SR+  
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 122 EN---FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
                F+  L Y      R+    E+A+ G L   L   +         V + ++     
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYG 114
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
                 LEYLH +    +++RDIK  N+++  D   KI DF L  +     A + +    
Sbjct: 115 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FC 169
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           GT  Y APE           D +  GVV+ E++ GR P
Sbjct: 170 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           ++F    +IG GSY +V    LK +    A+K +      D+E +  V     +  +  +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 122 ENFVQLLGYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
             F+  L  C    SR+    E+ + G L  + H ++  K       L  +     +   
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK-------LPEEHARFYSAEI 119
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           +  L YLHE+    II+RD+K  NVL+  +   K+ D+ +  +   +     ++   GT 
Sbjct: 120 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTP 174
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
            Y APE           D ++ GV++ E++ GR P D
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 19/218 (8%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
           K    +F    L+G+G++G+V     K +G   A+K L       ++ +A     SR+  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 122 EN---FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
                F+  L Y      R+    E+A+ G L   L   +         V + ++     
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYG 111
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
                 LEYLH +    +++RDIK  N+++  D   KI DF L  +     A + +    
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FC 166
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           GT  Y APE           D +  GVV+ E++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 35/236 (14%)
Query: 51  PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPDEEF 109
           P+++P +   +  E+ ++      IG G++G       K  +   A+K ++  ++ DE  
Sbjct: 9   PMDLPIMHDSDRYELVKD------IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENV 62
Query: 110 LAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV 167
             ++     L+H N V+     +  T   +  E+AS G L + +   GR     A+    
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR---- 118
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQA 224
             +QQ +        G+ Y H      + HRD+K  N L+ D   A   KIADF  S   
Sbjct: 119 FFFQQLI-------SGVSYAHAM---QVAHRDLKLENTLL-DGSPAPRLKIADFGYSK-- 165
Query: 225 PDMAARLHS--TRVLGTFGYHAPEYAMTGQLNAK-SDVYSFGVVLLELLTGRKPVD 277
              A+ LHS     +GT  Y APE  +  + + K +DV+S GV L  +L G  P +
Sbjct: 166 ---ASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           ++F    +IG GSY +V    LK +    A+K +      D+E +  V     +  +  +
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 122 ENFVQLLGYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
             F+  L  C    SR+    E+ + G L  + H ++  K       L  +     +   
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK-------LPEEHARFYSAEI 115
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           +  L YLHE+    II+RD+K  NVL+  +   K+ D+ +  +   +     ++   GT 
Sbjct: 116 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTP 170
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
            Y APE           D ++ GV++ E++ GR P D
Sbjct: 171 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           ++F    +IG GSY +V    LK +    A+K +      D+E +  V     +  +  +
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 122 ENFVQLLGYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
             F+  L  C    SR+    E+ + G L  + H ++  K       L  +     +   
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK-------LPEEHARFYSAEI 130
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           +  L YLHE+    II+RD+K  NVL+  +   K+ D+ +  +   +     ++   GT 
Sbjct: 131 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTP 185
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
            Y APE           D ++ GV++ E++ GR P D
Sbjct: 186 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           IG GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      K+ADF  + +      +  +  + GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRTWXLCGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 105/220 (47%), Gaps = 14/220 (6%)
Query: 94  AAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI 152
            AIKK+  +  Q  +  L ++ ++ RL H+N V++        S+ L  +  S   L+ +
Sbjct: 39  VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ-LTDDVGSLTELNSV 97
Query: 153 LHGRKGVKG-----AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207
              ++ ++       + GP+L    R+       +GL+Y+H     +++HRD+K +N+ I
Sbjct: 98  YIVQEYMETDLANVLEQGPLLEEHARL-FMYQLLRGLKYIHSA---NVLHRDLKPANLFI 153
Query: 208 FDDD-VAKIADFDLSN-QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGV 264
             +D V KI DF L+    P  + + H +  L T  Y +P   ++     K+ D+++ G 
Sbjct: 154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 213
Query: 265 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV 304
           +  E+LTG+          Q  L+  + P + E+  ++ +
Sbjct: 214 IFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELL 253

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QA 224
           L+ +  +  +   AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + 
Sbjct: 188 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           PD   R    R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 245 PDY-VRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QA 224
           L+ +  +  +   AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + 
Sbjct: 197 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           PD   R    R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 254 PDY-VRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QA 224
           L+ +  +  +   AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + 
Sbjct: 190 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           PD   R    R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 247 PDY-VRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QA 224
           L+ +  +  +   AKG+E+L   A    IHRD+ + N+L+ + +V KI DF L+    + 
Sbjct: 195 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           PD   R    R+     + APE         +SDV+SFGV+L E+ +
Sbjct: 252 PDY-VRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           IG GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      K+ADF  + +      +  +  + GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRTWXLCGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+A  G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N++I      K+ DF L+ +      +  +  + GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKR-----VKGRTWXLCGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 68  NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN--- 123
           +F    L+G+G++G+V     K +G   A+K L       ++ +A     SR+       
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 124 FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           F+  L Y      R+    E+A+ G L   L   +         V + ++          
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIVS 121
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            LEYLH +    +++RDIK  N+++  D   KI DF L  +     A +      GT  Y
Sbjct: 122 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCGTPEY 176
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            APE           D +  GVV+ E++ GR P
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 23/218 (10%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKLDASKQPD-EEFLAQVSMVSRLKH 121
           +I + +     IG GS+G V   + K      A KK+      D + F  ++ ++  L H
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 65
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
            N ++L     D T   L  E  + G L + ++H R          V       +I    
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR----------VFRESDAARIMKDV 115
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAARLHSTRVL 237
              + Y H+    ++ HRD+K  N L      D   K+ DF L+  A     ++  T+V 
Sbjct: 116 LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA--ARFKPGKMMRTKV- 169
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           GT  Y +P+  + G    + D +S GV++  LL G  P
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           IG GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      K+ADF  + +      +  +  + GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRTWXLCGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 101/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 7   VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 62
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D+++                
Sbjct: 63  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDVVYLNLVLDYVPETVYRVA 109
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 110 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 162
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 163 KLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 273 R 273
           +
Sbjct: 220 Q 220

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           IG G++G       K S    A+K ++  ++ DE    ++     L+H N V+     + 
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 134 GTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            T   +  E+AS G L + +   GR     A+      +QQ +        G+ Y H   
Sbjct: 86  PTHLAIVMEYASGGELFERICNAGRFSEDEAR----FFFQQLI-------SGVSYCHAM- 133
Query: 192 DPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHS--TRVLGTFGYHAPE 246
              + HRD+K  N L+ D   A   KI DF  S      ++ LHS     +GT  Y APE
Sbjct: 134 --QVCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 185
Query: 247 YAMTGQLNAK-SDVYSFGVVLLELLTGRKPVD 277
             +  + + K +DV+S GV L  +L G  P +
Sbjct: 186 VLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 217

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 19/218 (8%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
           K    +F    L+G+G++G+V     K +G   A+K L       ++ +A     SR+  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 122 EN---FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
                F+  L Y      R+    E+A+ G L   L   +         V + ++     
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYG 111
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
                 LEYLH +    +++RDIK  N+++  D   KI DF L  +     A +      
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FC 166
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           GT  Y APE           D +  GVV+ E++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKH 121
           ++F    +IG GSY +V    LK +    A++ +      D+E +  V     +  +  +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 122 ENFVQLLGYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
             F+  L  C    SR+    E+ + G L  + H ++  K       L  +     +   
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK-------LPEEHARFYSAEI 162
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           +  L YLHE+    II+RD+K  NVL+  +   K+ D+ +  +   +     ++   GT 
Sbjct: 163 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTP 217
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
            Y APE           D ++ GV++ E++ GR P D
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 19/218 (8%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
           K    +F    L+G+G++G+V     K +G   A+K L       ++ +A     SR+  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 122 EN---FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
                F+  L Y      R+    E+A+ G L   L   +         V + ++     
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYG 111
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
                 LEYLH +    +++RDIK  N+++  D   KI DF L  +     A +      
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FC 166
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           GT  Y APE           D +  GVV+ E++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 23/218 (10%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKLDASKQPD-EEFLAQVSMVSRLKH 121
           +I + +     IG GS+G V   + K      A KK+      D + F  ++ ++  L H
Sbjct: 23  DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 82
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
            N ++L     D T   L  E  + G L + ++H R          V       +I    
Sbjct: 83  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR----------VFRESDAARIMKDV 132
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAARLHSTRVL 237
              + Y H+    ++ HRD+K  N L      D   K+ DF L+  A     ++  T+V 
Sbjct: 133 LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA--ARFKPGKMMRTKV- 186
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           GT  Y +P+  + G    + D +S GV++  LL G  P
Sbjct: 187 GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 223

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 68  NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN--- 123
           +F    L+G+G++G+V     K +G   A+K L       ++ +A     SR+       
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 124 FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           F+  L Y      R+    E+A+ G L   L   +         V + ++          
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIVS 116
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            LEYLH +    +++RDIK  N+++  D   KI DF L  +     A +      GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCGTPEY 171
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            APE           D +  GVV+ E++ GR P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 102/241 (42%), Gaps = 34/241 (14%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK---------QPDEEFLAQ 112
           K + + +  +  +G G+ G V      K+    AI+ +   K          P      +
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
           + ++ +L H   +++  +  D     +  E    G L D + G K +K A     L + Q
Sbjct: 191 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--LYFYQ 247
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAA 229
            + +AV      +YLHE     IIHRD+K  NVL+    +D + KI DF  S    + + 
Sbjct: 248 ML-LAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 296
Query: 230 RLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286
            L  T + GT  Y APE  +   T   N   D +S GV+L   L+G  P      R Q S
Sbjct: 297 -LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVS 352
Query: 287 L 287
           L
Sbjct: 353 L 353

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 74  LIGEGSYGRVYY-GILKSGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYC 131
           ++G G +G+V+      +G   A K +      D EE   ++S++++L H N +QL    
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 VL  E+   G L D +   +     +   +L  +Q         +G+ ++H+  
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQ-------ICEGIRHMHQM- 206
Query: 192 DPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYA 248
             +I+H D+K  N+L  + D    KI DF L+ +  P    +++     GT  + APE  
Sbjct: 207 --YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FGTPEFLAPEVV 260
Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
               ++  +D++S GV+   LL+G  P
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
            ++ ++ +L H   +++  +  D     +  E    G L D + G K +K A     L +
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--LYF 259
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDM 227
            Q + +AV      +YLHE     IIHRD+K  NVL+    +D + KI DF  S    + 
Sbjct: 260 YQML-LAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 309
Query: 228 AARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
           +  L  T + GT  Y APE  +   T   N   D +S GV+L   L+G  P      R Q
Sbjct: 310 S--LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQ 364
Query: 285 QSL 287
            SL
Sbjct: 365 VSL 367

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GLE LH +    I++RD+K  N+L+ D    +I+D  L+   P+   +    RV GT GY
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 351
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
            APE     +     D ++ G +L E++ G+ P   
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 75  IGEGSYG--RVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
           IG G++G  R+    L +    A+K ++     DE    ++     L+H N V+     +
Sbjct: 28  IGSGNFGVARLMRDKL-TKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 133 DGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
             T   +  E+AS G L++ +   GR     A+      +QQ +        G+ Y H  
Sbjct: 87  TPTHLAIIMEYASGGELYERICNAGRFSEDEAR----FFFQQLL-------SGVSYCHSM 135
Query: 191 ADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHS--TRVLGTFGYHAP 245
               I HRD+K  N L+ D   A   KI DF  S      ++ LHS     +GT  Y AP
Sbjct: 136 ---QICHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAP 186
Query: 246 EYAMTGQLNAK-SDVYSFGVVLLELLTGRKPVD 277
           E  +  + + K +DV+S GV L  +L G  P +
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GLE LH +    I++RD+K  N+L+ D    +I+D  L+   P+   +    RV GT GY
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 351
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
            APE     +     D ++ G +L E++ G+ P   
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 40/223 (17%)
Query: 68  NFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENF 124
           NF T   + E   G ++ G  + G+   +K L   D S +   +F  +   +    H N 
Sbjct: 13  NFLTK--LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 125 VQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           + +LG C    +    L   +   GSL+++LH            V+   Q VK A+  A+
Sbjct: 70  LPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNF-------VVDQSQAVKFALDXAR 122
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLSNQAPDMAARLHSTRVLGTF 240
           G  +LH   +P I    + S +V I +D  A+I  AD   S Q+P               
Sbjct: 123 GXAFLH-TLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRX------------ 169
Query: 241 GYHAPEYAMTGQLNAK--------SDVYSFGVVLLELLTGRKP 275
             +AP +     L  K        +D +SF V+L EL+T   P
Sbjct: 170 --YAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVP 210

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 23/210 (10%)
Query: 68  NFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
            FG   L+ E + GR Y   ILK       K++  +K      L +  ++   +H  F+ 
Sbjct: 160 TFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTLTENRVLQNSRHP-FLT 211
Query: 127 LLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            L Y      R+    E+A+ G L   L   +         V S  +           L+
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALD 262
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YLH  ++ ++++RD+K  N+++  D   KI DF L  +     A + +    GT  Y AP
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 318
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           E           D +  GVV+ E++ GR P
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + A+
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFAE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 23/210 (10%)
Query: 68  NFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
            FG   L+ E + GR Y   ILK       K++  +K      L +  ++   +H  F+ 
Sbjct: 163 TFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTLTENRVLQNSRHP-FLT 214
Query: 127 LLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            L Y      R+    E+A+ G L   L   +         V S  +           L+
Sbjct: 215 ALKYSFQTHDRLCFVMEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALD 265
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YLH  ++ ++++RD+K  N+++  D   KI DF L  +     A + +    GT  Y AP
Sbjct: 266 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 321
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           E           D +  GVV+ E++ GR P
Sbjct: 322 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+A  G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N++I      K+ DF  + +      +  +  + GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+A  G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N++I      ++ DF L+ +      +  +  + GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 197 HRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHSTRVLGTFGYHAPEYAMTGQLNA 255
           HRD+K  N+L+  DD A + DF +++   D    +L +T  +GT  Y APE         
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT--VGTLYYXAPERFSESHATY 214
Query: 256 KSDVYSFGVVLLELLTGRKP 275
           ++D+Y+   VL E LTG  P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 22/219 (10%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLA---QVSMVSRL 119
           + ++N+     +G+G++  V   + K+ G   A K ++  K    +F     +  +  +L
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H N V+L     + +   L ++  + G L + +  R+    A     +  QQ ++    
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI--QQILE---- 115
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRV 236
               + Y H      I+HR++K  N+L+         K+ADF L+ +  D  A  H    
Sbjct: 116 ---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHG--F 166
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT GY +PE       +   D+++ GV+L  LL G  P
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     K +G+  A+K LD  K    +  E  L +  +   +     V+L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+A  G +    H R+  + ++P            A       EYLH 
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 159
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      K+ADF  + +       L      GT  Y APE  +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 212
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 42/229 (18%)
Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKL-DASKQPD--EEFLAQVSMVSRLK-HENFVQLLG 129
           +G+G+YG V+  I  ++G   A+KK+ DA +     +    ++ +++ L  HEN V LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 130 YCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
                  R   L +++     LH ++             +L    +  +     K ++YL
Sbjct: 77  VLRADNDRDVYLVFDYME-TDLHAVIRAN----------ILEPVHKQYVVYQLIKVIKYL 125
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-------------- 233
           H      ++HRD+K SN+L+  +   K+ADF LS    ++    ++              
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 234 -----TRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 276
                T  + T  Y APE  +      K  D++S G +L E+L G KP+
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 14  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 69
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 70  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 127
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI +    ++ DF  + +
Sbjct: 128 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKR 177
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 178 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 22/219 (10%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLA---QVSMVSRL 119
           + ++N+     +G+G++  V   + K+ G   A K ++  K    +F     +  +  +L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H N V+L     + +   L ++  + G L + +  R+    A     +  QQ ++    
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI--QQILE---- 116
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRV 236
               + Y H      I+HR++K  N+L+         K+ADF L+ +  D  A  H    
Sbjct: 117 ---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHG--F 167
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT GY +PE       +   D+++ GV+L  LL G  P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 75  IGEGSYGRVYYGILKSGHAA---AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           +G G+YG VY    K G      A+K+++ +         +++++  LKH N + L    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVF 87
Query: 132 VDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK------- 182
           +    R   L +++A +   H I   R      +P         V++  G  K       
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP---------VQLPRGMVKSLLYQIL 138
Query: 183 -GLEYLHEKADPHIIHRDIKSSNVLIF----DDDVAKIADF---DLSNQAPDMAARLHST 234
            G+ YLH      ++HRD+K +N+L+     +    KIAD     L N      A L   
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP- 194
Query: 235 RVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
            V+ TF Y APE  +  +   K+ D+++ G +  ELLT  +P+ H
Sbjct: 195 -VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 237

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 27/228 (11%)
Query: 55  PAISVDELKEITE----NFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEEF 109
           P ++++E + +       FG   L+ E + GR Y   ILK       K++  +K      
Sbjct: 5   PRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHT 57
Query: 110 LAQVSMVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           L +  ++   +H  F+  L Y      R+    E+A+ G L   L   +         V 
Sbjct: 58  LTENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---------VF 107
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S  +           L+YLH  ++ ++++RD+K  N+++  D   KI DF L  +     
Sbjct: 108 SEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 165
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           A +      GT  Y APE           D +  GVV+ E++ GR P 
Sbjct: 166 ATMKX--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+A  G +    H R+  +  +P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFXEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N++I      K+ DF  + +      +  +  + GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 18/167 (10%)
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
           +++++ ++KH N V L      G    L  +  S G L D +   KG    +    L +Q
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQ 124
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMA 228
                       ++YLH   D  I+HRD+K  N+L +   +D    I+DF LS +  D  
Sbjct: 125 --------VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPG 172
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + L +    GT GY APE       +   D +S GV+   LL G  P
Sbjct: 173 SVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 22/219 (10%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLA---QVSMVSRL 119
           + ++N+     +G+G++  V   + K+ G   A K ++  K    +F     +  +  +L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H N V+L     + +   L ++  + G L + +  R+    A     +  QQ ++    
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI--QQILE---- 116
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRV 236
               + Y H      I+HR++K  N+L+         K+ADF L+ +  D  A  H    
Sbjct: 117 ---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHG--F 167
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT GY +PE       +   D+++ GV+L  LL G  P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 18/167 (10%)
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
           +++++ ++KH N V L      G    L  +  S G L D +   KG    +    L +Q
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQ 124
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMA 228
                       ++YLH   D  I+HRD+K  N+L +   +D    I+DF LS +  D  
Sbjct: 125 --------VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPG 172
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + L +    GT GY APE       +   D +S GV+   LL G  P
Sbjct: 173 SVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 18/167 (10%)
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
           +++++ ++KH N V L      G    L  +  S G L D +   KG    +    L +Q
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQ 124
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMA 228
                       ++YLH   D  I+HRD+K  N+L +   +D    I+DF LS +  D  
Sbjct: 125 --------VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPG 172
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + L +    GT GY APE       +   D +S GV+   LL G  P
Sbjct: 173 SVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                 +  +  + GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 V-----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 41  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 96
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 97  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 143
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 144 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 196
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 197 KLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253
Query: 273 R 273
           +
Sbjct: 254 Q 254

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 104/251 (41%), Gaps = 47/251 (18%)
Query: 43  GAQAVKVQPI-EVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLD 100
           GA   KV  +   P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+ 
Sbjct: 1   GAMGSKVTTVVATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 58
Query: 101 ASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH------ 154
             K+       ++ ++ +L H N V+L             Y F S+G   D ++      
Sbjct: 59  QDKRFKNR---ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLD 103
Query: 155 ---------GRKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSN 204
                     R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N
Sbjct: 104 YVPETVYRVARHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQN 156
Query: 205 VLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSF 262
           +L+  D  V K+ DF  + Q   +     +   + +  Y APE         +  DV+S 
Sbjct: 157 LLLDPDTAVLKLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSA 213
Query: 263 GVVLLELLTGR 273
           G VL ELL G+
Sbjct: 214 GCVLAELLLGQ 224

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 18/167 (10%)
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
           +++++ ++KH N V L      G    L  +  S G L D +   KG    +    L +Q
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQ 124
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMA 228
                       ++YLH   D  I+HRD+K  N+L +   +D    I+DF LS +  D  
Sbjct: 125 --------VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPG 172
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + L +    GT GY APE       +   D +S GV+   LL G  P
Sbjct: 173 SVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 43  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 98
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 99  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 145
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 146 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 198
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 199 KLCDFGSAKQ---LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 255
Query: 273 R 273
           +
Sbjct: 256 Q 256

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     K +G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+A  G +    H R+  + ++P            A       EYLH 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 159
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N++I      K+ DF  + +      +  +  + GT  Y APE  +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 28  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 83
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 141
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 142 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 191
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 192 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 45  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 100
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 101 -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 147
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 148 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 200
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 201 KLCDFGSAKQ---LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 257
Query: 273 R 273
           +
Sbjct: 258 Q 258

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 41  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 96
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 97  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 143
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 144 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 196
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 197 KLCDFGSAKQ---LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253
Query: 273 R 273
           +
Sbjct: 254 Q 254

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 106/254 (41%), Gaps = 25/254 (9%)
Query: 29  GTDGAYHASEAAPKGAQAVKVQPIEVPAISVD--ELKEITENFGTNALIGEGSYGRVYYG 86
           GT+  Y  S ++   + A     + VP   +D      +++ F   + +G G+   VY  
Sbjct: 14  GTENLYFQSMSSVTASAAPGTASL-VPDYWIDGSNRDALSDFFEVESELGRGATSIVYRC 72
Query: 87  ILKSGHAA-AIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144
             K      A+K L   K  D++ +  ++ ++ RL H N ++L       T   L  E  
Sbjct: 73  KQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130
Query: 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
           + G L D    R   KG       S +          + + YLHE     I+HRD+K  N
Sbjct: 131 TGGELFD----RIVEKG-----YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPEN 178
Query: 205 VLIFD---DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
           +L      D   KIADF LS     +  ++    V GT GY APE         + D++S
Sbjct: 179 LLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWS 235
Query: 262 FGVVLLELLTGRKP 275
            G++   LL G +P
Sbjct: 236 VGIITYILLCGFEP 249

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 35  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 90
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 91  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 137
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 138 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 190
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 191 KLCDFGSAKQ---LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 247
Query: 273 R 273
           +
Sbjct: 248 Q 248

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXLX-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 22/219 (10%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLA---QVSMVSRL 119
           + ++N+     +G+G++  V   + K+ G   A K ++  K    +F     +  +  +L
Sbjct: 26  KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +H N V+L     + +   L ++  + G L + +  R+    A     +  QQ ++    
Sbjct: 86  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI--QQILE---- 139
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRV 236
               + Y H      I+HR++K  N+L+         K+ADF L+ +  D  A  H    
Sbjct: 140 ---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHG--F 190
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT GY +PE       +   D+++ GV+L  LL G  P
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 26  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 81
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 82  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 128
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 129 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 181
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 182 KLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 238
Query: 273 R 273
           +
Sbjct: 239 Q 239

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 20  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 75
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 76  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 122
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 123 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 175
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 176 KLCDFGSAKQ---LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 232
Query: 273 R 273
           +
Sbjct: 233 Q 233

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 23/211 (10%)
Query: 68  NFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
            FG   L+ E + GR Y   ILK       K++  +K      L +  ++   +H  F+ 
Sbjct: 21  TFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTLTENRVLQNSRHP-FLT 72
Query: 127 LLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            L Y      R+    E+A+ G L   L   +         V S  +           L+
Sbjct: 73  ALKYSFQTHDRLCFVMEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALD 123
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YLH  ++ ++++RD+K  N+++  D   KI DF L  +     A +      GT  Y AP
Sbjct: 124 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX--FCGTPEYLAP 179
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           E           D +  GVV+ E++ GR P 
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 86  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 141
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 142 -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 188
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 189 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 241
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 242 KLCDFGSAKQ---LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 298
Query: 273 R 273
           +
Sbjct: 299 Q 299

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 7   VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 62
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 63  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 110 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 162
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 163 KLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 273 R 273
           +
Sbjct: 220 Q 220

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 48  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 103
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 161
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 162 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 211
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 212 VKGATWTL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 19  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 74
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 75  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 121
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 122 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 174
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 175 KLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231
Query: 273 R 273
           +
Sbjct: 232 Q 232

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 23/211 (10%)
Query: 68  NFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
            FG   L+ E + GR Y   ILK       K++  +K      L +  ++   +H  F+ 
Sbjct: 20  TFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTLTENRVLQNSRHP-FLT 71
Query: 127 LLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            L Y      R+    E+A+ G L   L   +         V S  +           L+
Sbjct: 72  ALKYSFQTHDRLCFVMEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALD 122
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YLH  ++ ++++RD+K  N+++  D   KI DF L  +     A +      GT  Y AP
Sbjct: 123 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX--FCGTPEYLAP 178
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
           E           D +  GVV+ E++ GR P 
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 15  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 70
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 71  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 117
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 118 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 170
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 171 KLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 227
Query: 273 R 273
           +
Sbjct: 228 Q 228

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 12  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 67
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 68  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 114
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 115 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 167
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 168 KLCDFGSAKQ---LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 224
Query: 273 R 273
           +
Sbjct: 225 Q 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 19  VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 74
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 75  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 121
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 122 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 174
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 175 KLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231
Query: 273 R 273
           +
Sbjct: 232 Q 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 8   VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 63
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 64  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 110
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 111 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 163
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 164 KLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 220
Query: 273 R 273
           +
Sbjct: 221 Q 221

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQVSMVSRL 119
           ++I + F     +G G++  V     K +G   A+K +   A K  +     +++++ ++
Sbjct: 18  EDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKI 77
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           KHEN V L           L  +  S G L D +   KG    +    L  Q        
Sbjct: 78  KHENIVALEDIYESPNHLYLVMQLVSGGELFDRI-VEKGFYTEKDASTLIRQ-------- 128
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK---IADFDLSNQAPDMAARLHSTRV 236
               + YLH      I+HRD+K  N+L +  D      I+DF LS    +    + ST  
Sbjct: 129 VLDAVYYLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMST-A 182
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT GY APE       +   D +S GV+   LL G  P
Sbjct: 183 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 35/236 (14%)
Query: 51  PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF 109
           P+++P +   +  E+ ++      IG G++G       K S    A+K ++  ++ DE  
Sbjct: 9   PMDLPIMHDSDRYELVKD------IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENV 62
Query: 110 LAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV 167
             ++     L+H N V+     +  T   +  E+AS G L + +   GR     A+    
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR---- 118
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQA 224
             +QQ +        G+ Y H      + HRD+K  N L+ D   A   KI  F  S   
Sbjct: 119 FFFQQLI-------SGVSYCHAM---QVCHRDLKLENTLL-DGSPAPRLKICAFGYSK-- 165
Query: 225 PDMAARLHS--TRVLGTFGYHAPEYAMTGQLNAK-SDVYSFGVVLLELLTGRKPVD 277
              ++ LHS     +GT  Y APE  +  + + K +DV+S GV L  +L G  P +
Sbjct: 166 ---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  +  +
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 7   VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 62
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 63  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 110 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 162
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 163 KLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 273 R 273
           +
Sbjct: 220 Q 220

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+A  G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N++I      ++ DF  + +      +  +  + GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K+      
Sbjct: 7   VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-- 62
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 63  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 110 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 162
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 163 KLCDFGSAKQ---LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 273 R 273
           +
Sbjct: 220 Q 220

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +      +L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+A  G +    H R+  + ++P            A       EYLH 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 159
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N++I      K+ DF  + +      +  +  + GT  Y APE  +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 22  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 77
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  +  +
Sbjct: 78  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXE 135
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 136 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 185
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 186 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +      +L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+A  G +    H R+  + ++P            A       EYLH 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 159
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N++I      K+ DF  + +      +  +  + GT  Y APE  +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+ + G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 35/236 (14%)
Query: 51  PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF 109
           P+++P +   +  E+ ++      IG G++G       K S    A+K ++  ++ DE  
Sbjct: 9   PMDLPIMHDSDRYELVKD------IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENV 62
Query: 110 LAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV 167
             ++     L+H N V+     +  T   +  E+AS G L + +   GR     A+    
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR---- 118
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQA 224
             +QQ +        G+ Y H      + HRD+K  N L+ D   A   KI  F  S   
Sbjct: 119 FFFQQLI-------SGVSYCHAM---QVCHRDLKLENTLL-DGSPAPRLKICAFGYSK-- 165
Query: 225 PDMAARLHS--TRVLGTFGYHAPEYAMTGQLNAK-SDVYSFGVVLLELLTGRKPVD 277
              ++ LHS     +GT  Y APE  +  + + K +DV+S GV L  +L G  P +
Sbjct: 166 ---SSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  +  +
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 48  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 103
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  +  +
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXE 161
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 162 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 211
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                 +  +  + GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 212 V-----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  +  +
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 32/232 (13%)
Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR 118
           V +++   E+F    +IG G++G V          A +K  +A K    + L +  M+ R
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEV----------AVVKLKNADKVFAMKILNKWEMLKR 115
Query: 119 LKHENFVQLLGYCVDGTSR---VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
            +   F +     V+G S+    L Y F  + +L+ ++    G      G +L+   + +
Sbjct: 116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG------GDLLTLLSKFE 169
Query: 176 IAVGAAKGLEYLHEKA-------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
             +       YL E           H +HRDIK  N+L+  +   ++ADF    +  +  
Sbjct: 170 DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-D 228
Query: 229 ARLHSTRVLGTFGYHAPEY--AM---TGQLNAKSDVYSFGVVLLELLTGRKP 275
             + S+  +GT  Y +PE   AM    G+   + D +S GV + E+L G  P
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +      +L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+A  G +    H R+  +  +P            A       EYLH 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFXEPHARF-------YAAQIVLTFEYLH- 159
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N++I      K+ DF  + +      +  +  + GT  Y APE  +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 159
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 212
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 159
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEYLAPEIIL 212
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ ++  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +      +  +  + GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N++I      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +      +  +  + GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 144
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEYLAPEIIL 197
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +     A  D++S G ++ EL+ G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K       
Sbjct: 7   VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-- 62
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 63  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPATVYRVA 109
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 110 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 162
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 163 KLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 273 R 273
           +
Sbjct: 220 Q 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K       
Sbjct: 7   VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-- 62
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 63  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 110 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 162
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 163 KLCDFGSAKQ---LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 273 R 273
           +
Sbjct: 220 Q 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 46/241 (19%)
Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E++  +    +IG GS+G VY   L  SG   AIKK+   K       
Sbjct: 7   VATPGQGPDRPQEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-- 62
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH---------------G 155
            ++ ++ +L H N V+L             Y F S+G   D ++                
Sbjct: 63  -ELQIMRKLDHCNIVRL------------RYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 156 RKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213
           R   +  Q  PV+     VK+ +    + L Y+H      I HRDIK  N+L+  D  V 
Sbjct: 110 RHYSRAKQTLPVIY----VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 162
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 272
           K+ DF  + Q   +     +   + +  Y APE         +  DV+S G VL ELL G
Sbjct: 163 KLCDFGSAKQ---LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 273 R 273
           +
Sbjct: 220 Q 220

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  +  +P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  +  +P            A       EYLH 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARF-------YAAQIVLTFEYLH- 159
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 212
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYY-GILKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     +++G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  +  +P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +      +  +  + GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     K +G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 151
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 204
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     K +G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 179
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 232
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     K +G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 159
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 212
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     K +G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 159
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 212
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     K +G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 159
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 212
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     K +G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     K +G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 21/214 (9%)
Query: 74  LIGEGSYGRVYYGI----LKSGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
           L+GEGSYG+V   +    L       +KK    + P+ E     ++ ++ RL+H+N +QL
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 128 LG--YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           +   Y  +     +  E+   G + ++L        + P       Q          GLE
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCG-MQEMLD-------SVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YLH +    I+H+DIK  N+L+      KI+   ++      AA        G+  +  P
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 246 EYA--MTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           E A  +      K D++S GV L  + TG  P +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     K +G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  + ++P            A       EYLH 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 158
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 211
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE----------FLAQV 113
           E ++ + T + +G G++G V+  + K  +   + K    ++  E+             ++
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL-----HGRKGVKGAQPGPVL 168
           +++SR++H N +++L    +     L  E   +GS  D+      H R      +P    
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLD----EPLASY 134
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
            ++Q V  AVG      YL  K    IIHRDIK  N++I +D   K+ DF   + A    
Sbjct: 135 IFRQLVS-AVG------YLRLK---DIIHRDIKDENIVIAEDFTIKLIDF--GSAAYLER 182
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKP 275
            +L  T   GT  Y APE  M       + +++S GV L  L+    P
Sbjct: 183 GKLFYT-FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A   +     T  + T  Y
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVTRYY 189
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S G ++ EL+ G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT  Y AP   ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK-HENFVQLL 128
           ++GEG++ RV   I L +    A+K ++  KQP         +V M+ + + H N ++L+
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIE--KQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
            +  +     L +E    GS+   +H R+     +   V+            A  L++LH
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---------DVASALDFLH 128
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLS-------NQAPDMAARLHSTRVLG 238
            K    I HRD+K  N+L    +     KI DFDL        + +P     L +    G
Sbjct: 129 NKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP--CG 183
Query: 239 TFGYHAPEYAMTGQLNA-----KSDVYSFGVVLLELLTGRKP 275
           +  Y APE        A     + D++S GV+L  LL+G  P
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 23/219 (10%)
Query: 65  ITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-K 120
           +T+ +     IG+G++  V   + L +GH  A K ++  K    D + L + + + RL K
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H N V+L     +     L ++  + G L + +  R+    A     +  QQ ++  +  
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI--QQILEAVL-- 117
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKIADFDLSNQAP-DMAARLHSTRV 236
                + H+     ++HRD+K  N+L+         K+ADF L+ +   D  A       
Sbjct: 118 -----HCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT GY +PE           D+++ GV+L  LL G  P
Sbjct: 168 -GTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 35/236 (14%)
Query: 51  PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF 109
           P+++P +   +  E+ ++      IG G++G       K S    A+K ++  ++     
Sbjct: 9   PMDLPIMHDSDRYELVKD------IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANV 62
Query: 110 LAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV 167
             ++     L+H N V+     +  T   +  E+AS G L + +   GR     A+    
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR---- 118
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQA 224
             +QQ +        G+ Y H      + HRD+K  N L+ D   A   KI DF  S   
Sbjct: 119 FFFQQLI-------SGVSYCHAM---QVCHRDLKLENTLL-DGSPAPRLKICDFGYSK-- 165
Query: 225 PDMAARLHS--TRVLGTFGYHAPEYAMTGQLNAK-SDVYSFGVVLLELLTGRKPVD 277
              ++ LHS     +GT  Y APE  +  + + K +DV+S GV L  +L G  P +
Sbjct: 166 ---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G GS+GRV     K +G+  A+K LD  K    +  E  L +  ++  +     V+L  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              D ++  +  E+   G +    H R+  +  +P            A       EYLH 
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARF-------YAAQIVLTFEYLH- 151
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
                +I+RD+K  N+LI      ++ DF  + +       L      GT  Y APE  +
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEIIL 204
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
           +   N   D ++ GV++ E+  G  P 
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASK------QPDEEFLAQVSMVSRLKHENFVQ 126
           +IG+G +  V   I + +G   A+K +D +K         E+   + S+   LKH + V+
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 127 LL-GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           LL  Y  DG    + +EF     L       + VK A  G V S            + L 
Sbjct: 93  LLETYSSDGM-LYMVFEFMDGADL-----CFEIVKRADAGFVYSEAVASHYMRQILEALR 146
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           Y H   D +IIHRD+K   VL+   + +   K+  F ++ Q  + +  +   RV GT  +
Sbjct: 147 YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRV-GTPHF 201
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
            APE           DV+  GV+L  LL+G  P   T  R  + ++
Sbjct: 202 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII 247

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASK------QPDEEFLAQVSMVSRLKHENFVQ 126
           +IG+G +  V   I + +G   A+K +D +K         E+   + S+   LKH + V+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 127 LL-GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           LL  Y  DG    + +EF     L       + VK A  G V S            + L 
Sbjct: 91  LLETYSSDGM-LYMVFEFMDGADL-----CFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           Y H   D +IIHRD+K   VL+   + +   K+  F ++ Q  + +  +   RV GT  +
Sbjct: 145 YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRV-GTPHF 199
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
            APE           DV+  GV+L  LL+G  P   T  R  + ++
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII 245

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCV 132
           +GEGS+      +  KS  A A+K +  SK+ +     +++ +   + H N V+L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
           D     L  E  + G L + +  +K     +   ++               + ++H   D
Sbjct: 77  DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR---------KLVSAVSHMH---D 124
Query: 193 PHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
             ++HRD+K  N+L  D++     KI DF  +   P     L +     T  Y APE   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLN 182
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKP 275
               +   D++S GV+L  +L+G+ P
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 67  ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
           + F    + G+G++G V  G  KS G + AIKK+    +     L  +  ++ L H N V
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIV 82
Query: 126 QLLGY--CVDGTSRVLAYEFASNGSLHDILHG---RKGVKGAQPGPVLSWQQRVKIAV-G 179
           QL  Y   +    R   Y       + D LH        +   P P+L     +K+ +  
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL-----IKVFLFQ 137
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADF----DLSNQAPDMAARLHST 234
             + +  LH  +  ++ HRDIK  NVL+ + D   K+ DF     LS   P++A      
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA------ 190
Query: 235 RVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTG 272
             + +  Y APE     Q      D++S G +  E++ G
Sbjct: 191 -YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S G ++ E++ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 29/212 (13%)
Query: 75  IGEGSYGRVYYGILKSGHAA---AIKKLDASKQPDEE----FLAQVSMVSRLKHENFVQL 127
           IG+GS+G+V   I++        A+K ++  K  +         ++ ++  L+H   V L
Sbjct: 23  IGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA-AKGLEY 186
                D     +  +    G L    H ++ V   +        + VK+ +      L+Y
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKE--------ETVKLFICELVMALDY 130
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           L  +    IIHRD+K  N+L+ +     I DF+++   P        T + GT  Y APE
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAPE 184
Query: 247 YAMTGQ---LNAKSDVYSFGVVLLELLTGRKP 275
              + +    +   D +S GV   ELL GR+P
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI--LKSG--HAAAIKKLDASKQPDEEFLAQVSMVSRL 119
           +++  F     IGEG++  VY     L+ G     A+K L  +  P     A++  ++  
Sbjct: 18  QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIR-IAAELQCLTVA 76
Query: 120 KHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
             ++ V  + YC      V +A  +  + S  DIL+             LS+Q+  +  +
Sbjct: 77  GGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS------------LSFQEVREYML 124
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA--DFDLSNQAPD---------- 226
              K L+ +H+     I+HRD+K SN L ++  + K A  DF L+    D          
Sbjct: 125 NLFKALKRIHQFG---IVHRDVKPSNFL-YNRRLKKYALVDFGLAQGTHDTKIELLKFVQ 180
Query: 227 ----------------MAARLHSTRVLGTFGYHAPEYAMTGQLNAKS--DVYSFGVVLLE 268
                           ++ R       GT G+ APE  +T   N  +  D++S GV+ L 
Sbjct: 181 SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE-VLTKCPNQTTAIDMWSAGVIFLS 239
Query: 269 LLTGRKP 275
           LL+GR P
Sbjct: 240 LLSGRYP 246

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 96/258 (37%), Gaps = 47/258 (18%)
Query: 62  LKEITENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKLDASK------QPDEEFLAQVS 114
           L E+ + +     IG+GSYG V   I     A  AIK ++ +K      +  E    +V 
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 115 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH-------------------- 154
           ++ +L H N  +L     D     L  E    G L D L+                    
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 155 -----GRKGVKGAQPG--PVLSWQQRVKIAVGAAK----GLEYLHEKADPHIIHRDIKSS 203
                  + + G+  G    L + QR K+     +     L YLH +    I HRDIK  
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPE 197
Query: 204 NVLIFDDDV--AKIADFDLSNQAPDM--AARLHSTRVLGTFGYHAPEYAMTGQ--LNAKS 257
           N L   +     K+ DF LS +   +        T   GT  + APE   T       K 
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 258 DVYSFGVVLLELLTGRKP 275
           D +S GV+L  LL G  P
Sbjct: 258 DAWSAGVLLHLLLMGAVP 275

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 26/233 (11%)
Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---- 103
           ++  E P+ +  +L    + F     +G GS+GRV     K SG+  A+K LD  K    
Sbjct: 27  LKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
           +  E  L +  ++  +     V+L     D ++  +  E+ + G +    H R+  + ++
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSE 140
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
           P            A       EYLH      +I+RD+K  N+LI      ++ DF  + +
Sbjct: 141 PHARF-------YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
                  L      GT    APE  ++   N   D ++ GV++ E+  G  P 
Sbjct: 191 VKGRTWXL-----CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A            + T  Y
Sbjct: 140 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRYY 193
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            APE  +        D++S G ++ E++ G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLD---ASKQPDEEFLAQVSMVSRLKH--ENFVQLLG 129
           IG G   +V+  + +     AIK ++   A  Q  + +  +++ +++L+   +  ++L  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           Y +      +  E   N  L+  L  +K +          W+++          LE +H 
Sbjct: 80  YEITDQYIYMVME-CGNIDLNSWLKKKKSID--------PWERKSY----WKNMLEAVHT 126
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAPEYA 248
                I+H D+K +N LI  D + K+ DF ++NQ  PD  + +  ++V GT  Y  PE A
Sbjct: 127 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPE-A 183
Query: 249 MTGQLNAKS------------DVYSFGVVLLELLTGRKPVDHTL 280
           +    +++             DV+S G +L  +  G+ P    +
Sbjct: 184 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 227

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 32/232 (13%)
Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR 118
           V E++   E+F    +IG G++G V          A +K  +  +    + L +  M+ R
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEV----------AVVKMKNTERIYAMKILNKWEMLKR 115
Query: 119 LKHENFVQLLGYCVDGTSR---VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
            +   F +     V+G  +    L Y F     L+ ++    G      G +L+   + +
Sbjct: 116 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVG------GDLLTLLSKFE 169
Query: 176 IAVGAAKGLEYLHEKA-------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
             +       Y+ E           H +HRDIK  NVL+  +   ++ADF    +  D  
Sbjct: 170 DKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMND-D 228
Query: 229 ARLHSTRVLGTFGYHAPEY--AM---TGQLNAKSDVYSFGVVLLELLTGRKP 275
             + S+  +GT  Y +PE   AM    G+   + D +S GV + E+L G  P
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 32/232 (13%)
Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR 118
           V E++   E+F    +IG G++G V          A +K  +  +    + L +  M+ R
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEV----------AVVKMKNTERIYAMKILNKWEMLKR 131
Query: 119 LKHENFVQLLGYCVDGTSR---VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
            +   F +     V+G  +    L Y F     L+ ++    G      G +L+   + +
Sbjct: 132 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVG------GDLLTLLSKFE 185
Query: 176 IAVGAAKGLEYLHEKA-------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
             +       Y+ E           H +HRDIK  NVL+  +   ++ADF    +  D  
Sbjct: 186 DKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMND-D 244
Query: 229 ARLHSTRVLGTFGYHAPEY--AM---TGQLNAKSDVYSFGVVLLELLTGRKP 275
             + S+  +GT  Y +PE   AM    G+   + D +S GV + E+L G  P
Sbjct: 245 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKH--ENFVQLLG 129
           IG G   +V+  + +     AIK +   +A  Q  + +  +++ +++L+   +  ++L  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           Y +      +  E   N  L+  L  +K +          W+++          LE +H 
Sbjct: 76  YEITDQYIYMVME-CGNIDLNSWLKKKKSID--------PWERKSY----WKNMLEAVHT 122
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAPEYA 248
                I+H D+K +N LI  D + K+ DF ++NQ  PD  + +  ++V GT  Y  PE A
Sbjct: 123 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPE-A 179
Query: 249 MTGQLNAKS------------DVYSFGVVLLELLTGRKPVDHTL 280
           +    +++             DV+S G +L  +  G+ P    +
Sbjct: 180 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 223

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKH--ENFVQLLG 129
           IG G   +V+  + +     AIK +   +A  Q  + +  +++ +++L+   +  ++L  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           Y +      +  E   N  L+  L  +K +          W+++          LE +H 
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSID--------PWERKSY----WKNMLEAVHT 170
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAPEYA 248
                I+H D+K +N LI  D + K+ DF ++NQ  PD  + +  ++V GT  Y  PE A
Sbjct: 171 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPE-A 227
Query: 249 MTGQLNAKS------------DVYSFGVVLLELLTGRKPVDHTL 280
           +    +++             DV+S G +L  +  G+ P    +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 52/245 (21%)
Query: 64  EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--------DASKQPDEEFLAQVS 114
           +I + +    LIG GSYG V     K      AIKK+        D  +      L +++
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR-----ILREIA 104
Query: 115 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH-GRKGVKGAQPGPVLSWQQR 173
           +++RL H++ V++L         V+  +      L+ +L       K     PV   +  
Sbjct: 105 ILNRLNHDHVVKVLDI-------VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELH 157
Query: 174 VK-IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL----------SN 222
           +K +      G++Y+H      I+HRD+K +N L+  D   K+ DF L          ++
Sbjct: 158 IKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 223 QAP--------DMAARLHSTRV-------LGTFGYHAPEYAMTGQLNAKS-DVYSFGVVL 266
           Q P        ++    H+  +       + T  Y APE  +  +   ++ DV+S G + 
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 267 LELLT 271
            ELL 
Sbjct: 275 AELLN 279

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKH--ENFVQLLG 129
           IG G   +V+  + +     AIK +   +A  Q  + +  +++ +++L+   +  ++L  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           Y +      +  E   N  L+  L  +K +          W+++          LE +H 
Sbjct: 96  YEITDQYIYMVME-CGNIDLNSWLKKKKSID--------PWERKSY----WKNMLEAVHT 142
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAPEYA 248
                I+H D+K +N LI  D + K+ DF ++NQ  PD  + +  ++V GT  Y  PE A
Sbjct: 143 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPE-A 199
Query: 249 MTGQLNAKS------------DVYSFGVVLLELLTGRKPVDHTL 280
           +    +++             DV+S G +L  +  G+ P    +
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 67  ENFG-----TNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDE---EFLAQVSMVS 117
           ENF      T+  +G G +  V   I KS G   A K L   ++  +   E L +++++ 
Sbjct: 24  ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 118 RLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
             K    V  L    + TS + L  E+A+ G +  +          +   ++S    +++
Sbjct: 84  LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC-------LPELAEMVSENDVIRL 136
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVL---IFDDDVAKIADFDLSNQAPDMAARLHS 233
                +G+ YLH+    +I+H D+K  N+L   I+     KI DF +S +    A  L  
Sbjct: 137 IKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-ACELR- 191
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             ++GT  Y APE      +   +D+++ G++   LLT   P
Sbjct: 192 -EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 88/223 (39%), Gaps = 23/223 (10%)
Query: 62  LKEITENFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDASKQPDEEFLAQVSMVS 117
           L+   E++    +IG G++G V     K+         + K +  K+ D  F  +   + 
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 118 RLKHENFV-QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
              +  +V QL     D     +  E+   G L +++      +         W +    
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--------KWAKFYTA 181
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
            V  A  L+ +H      +IHRD+K  N+L+      K+ADF    +  D    +H    
Sbjct: 182 EVVLA--LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVHCDTA 235
Query: 237 LGTFGYHAPEYAMT----GQLNAKSDVYSFGVVLLELLTGRKP 275
           +GT  Y +PE   +    G    + D +S GV L E+L G  P
Sbjct: 236 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 36/298 (12%)
Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE 122
            +   F     IG GS+G +Y G  +++    AI KL+  K    + L +  +   L+  
Sbjct: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAI-KLENVKTKHPQLLYESKIYRILQGG 62
Query: 123 NFV-QLLGYCVDGTSRVLAYEFASNGSLHDILH--GRKGVKGAQPGPVLSWQQRVKIAVG 179
             +  +  + V+G   VL  +     SL D+ +   RK          LS +  + +A  
Sbjct: 63  TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK----------LSLKTVLMLADQ 111
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK---IADFDLSNQAPDMAARLH---- 232
               +E++H K+    +HRDIK  N L+     A    I DF L+ +  D +   H    
Sbjct: 112 MINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
Query: 233 -STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 291
            +  + GT  Y +    +  + + + D+ S G VL+  L G  P    L  G +      
Sbjct: 169 ENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW-QGLKAGTKK---QK 224
Query: 292 TPKLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLL 349
             K+SE KV   ++A   G YP             C     D +P+ S + +  + L 
Sbjct: 225 YEKISEKKVATSIEALCRG-YP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 36/222 (16%)
Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK-HENFVQLL 128
           ++GEG++ RV   I L +    A+K ++  KQP         +V M+ + + H N ++L+
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIE--KQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
            +  +     L +E    GS+   +H R+     +   V+            A  L++LH
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---------DVASALDFLH 128
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLS-------NQAPDMAARLHSTRVLG 238
            K    I HRD+K  N+L    +     KI DF L        + +P     L +    G
Sbjct: 129 NKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTP--CG 183
Query: 239 TFGYHAPEYAMTGQLNA-----KSDVYSFGVVLLELLTGRKP 275
           +  Y APE        A     + D++S GV+L  LL+G  P
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 98/224 (43%), Gaps = 34/224 (15%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKH--ENFVQLLG 129
           IG G   +V+  + +     AIK +   +A  Q  + +  +++ +++L+   +  ++L  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           Y +      +  E   N  L+  L  +K +    P    S+ + +         LE +H 
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSI---DPWERKSYWKNM---------LEAVHT 170
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAPEYA 248
                I+H D+K +N LI  D + K+ DF ++NQ  PD  + +  ++V GT  Y  PE A
Sbjct: 171 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPE-A 227
Query: 249 MTGQLNAKS------------DVYSFGVVLLELLTGRKPVDHTL 280
           +    +++             DV+S G +L  +  G+ P    +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 137 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 190
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 232

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 98/224 (43%), Gaps = 34/224 (15%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKH--ENFVQLLG 129
           IG G   +V+  + +     AIK +   +A  Q  + +  +++ +++L+   +  ++L  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           Y +      +  E   N  L+  L  +K +    P    S+ + +         LE +H 
Sbjct: 77  YEITDQYIYMVME-CGNIDLNSWLKKKKSI---DPWERKSYWKNM---------LEAVHT 123
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAPEYA 248
                I+H D+K +N LI  D + K+ DF ++NQ  PD  + +  ++V GT  Y  PE A
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPE-A 180
Query: 249 MTGQLNAKS------------DVYSFGVVLLELLTGRKPVDHTL 280
           +    +++             DV+S G +L  +  G+ P    +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 227

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 227

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 143 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 196
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 238

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 96/224 (42%), Gaps = 34/224 (15%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKH--ENFVQLLG 129
           IG G   +V+  + +     AIK +   +A  Q  + +  +++ +++L+   +  ++L  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           Y +      +  E   N  L+  L  +K +          W+++          LE +H 
Sbjct: 96  YEITDQYIYMVME-CGNIDLNSWLKKKKSID--------PWERKSY----WKNMLEAVHT 142
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAPEYA 248
                I+H D+K +N LI  D + K+ DF ++NQ  PD    +  ++V GT  Y  PE A
Sbjct: 143 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDXXXVVKDSQV-GTVNYMPPE-A 199
Query: 249 MTGQLNAKS------------DVYSFGVVLLELLTGRKPVDHTL 280
           +    +++             DV+S G +L  +  G+ P    +
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A         T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 227

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 89/232 (38%), Gaps = 31/232 (13%)
Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD------------ 106
           + EL  +   +     I  GSYG V  G+   G   AIK++  +                
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGA 162
           +  L ++ +++   H N + L    V        ++          L  ++H ++ V   
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
           Q      +   +        GL  LHE     ++HRD+   N+L+ D++   I DF+L+ 
Sbjct: 134 QHIQYFMYHILL--------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGR 273
           +     A  + T  +    Y APE  M  +      D++S G V+ E+   +
Sbjct: 183 ED---TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 89/232 (38%), Gaps = 31/232 (13%)
Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD------------ 106
           + EL  +   +     I  GSYG V  G+   G   AIK++  +                
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 107 EEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGA 162
           +  L ++ +++   H N + L    V        ++          L  ++H ++ V   
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
           Q      +   +        GL  LHE     ++HRD+   N+L+ D++   I DF+L+ 
Sbjct: 134 QHIQYFMYHILL--------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGR 273
           +     A  + T  +    Y APE  M  +      D++S G V+ E+   +
Sbjct: 183 ED---TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 92/230 (40%), Gaps = 36/230 (15%)
Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLK-HENFVQLLGY 130
           ++ EG +  VY    + SG   A+K+L ++++  +   + +V  + +L  H N VQ   +
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ---F 91
Query: 131 CV----------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           C            G +  L       G L + L      K    GP LS    +KI    
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-----KMESRGP-LSCDTVLKIFYQT 145
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----------DLSNQAPDMAAR 230
            + ++++H +  P IIHRD+K  N+L+ +    K+ DF          D S  A   A  
Sbjct: 146 CRAVQHMHRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 231 LHSTRVLGTFGYHAPEYA---MTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
                   T  Y  PE         +  K D+++ G +L  L   + P +
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 43/287 (14%)
Query: 40  APKGAQAVKVQPIEVPAISVDELKEITEN-FGTNALIGEGSYGRVYYGILKSGH-AAAIK 97
            P+G+       +    ++  + KE  E+ +    L+G G +G VY GI  S +   AIK
Sbjct: 15  VPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 74
Query: 98  KLDASKQPDEEFL-------AQVSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-G 147
            ++  +  D   L        +V ++ ++       ++LL +     S VL  E      
Sbjct: 75  HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 134
Query: 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207
            L D +  R G    +      WQ            LE +    +  ++HRDIK  N+LI
Sbjct: 135 DLFDFITER-GALQEELARSFFWQV-----------LEAVRHCHNCGVLHRDIKDENILI 182
Query: 208 -FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVV 265
             +    K+ DF       D       T   GT  Y  PE+    + + +S  V+S G++
Sbjct: 183 DLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238
Query: 266 LLELLTGRKPVDH--TLPRGQ-----------QSLVTWATPKLSEDK 299
           L +++ G  P +H   + RGQ           Q L+ W       D+
Sbjct: 239 LYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 285

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 27/221 (12%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILKS---GHAAAI---KKLDASKQPDEEFLAQVSMVSR 118
            T+++     +G+G++  V   + K+    +AA I   KKL A    D + L + + + R
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSAR---DHQKLEREARICR 85
Query: 119 L-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           L KH N V+L     +     L ++  + G L + +  R+    A     +         
Sbjct: 86  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH-------- 137
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKIADFDLSNQAPDMAARLHST 234
               + LE ++      I+HRD+K  N+L+         K+ADF L+ +           
Sbjct: 138 ----QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG- 192
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
              GT GY +PE           D+++ GV+L  LL G  P
Sbjct: 193 -FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/228 (21%), Positives = 95/228 (41%), Gaps = 42/228 (18%)
Query: 75  IGEGSYGRV--------YYGILKSGHAAAIKKLDASKQPDE---------EFLAQVSMVS 117
           + +G + ++        +Y + K   +   KK D +K  ++         +F  ++ +++
Sbjct: 39  LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
            +K+E  +   G   +     + YE+  N S+         +K  +   VL       I 
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSI---------LKFDEYFFVLDKNYTCFIP 149
Query: 178 VGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
           +   K           Y+H   + +I HRD+K SN+L+  +   K++DF  S    D   
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--K 205
Query: 230 RLHSTRVLGTFGYHAPE-YAMTGQLN-AKSDVYSFGVVLLELLTGRKP 275
           ++  +R  GT+ +  PE ++     N AK D++S G+ L  +     P
Sbjct: 206 KIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 108/268 (40%), Gaps = 55/268 (20%)
Query: 32  GAYHASEAAPKGAQAVKVQPIEVPAISVDELK------EITENFGTNA-LIGEGSYGRVY 84
           G++  S A   G   VK+ P++ P   +  L       E  E   TN  +IG GS+G V+
Sbjct: 1   GSFTMSNAPLNG---VKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVF 57
Query: 85  YGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144
              L      AIKK+   K+     L  + +V   KH N V L  +            F 
Sbjct: 58  QAKLVESDEVAIKKVLQDKRFKNRELQIMRIV---KHPNVVDLKAF------------FY 102
Query: 145 SNGSLHDILH---------------GRKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLH 188
           SNG   D +                 R   K  Q  P+L     +K+ +    + L Y+H
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML----LIKLYMYQLLRSLAYIH 158
Query: 189 EKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
                 I HRDIK  N+L+     V K+ DF     A  + A   +   + +  Y APE 
Sbjct: 159 SIG---ICHRDIKPQNLLLDPPSGVLKLIDF---GSAKILIAGEPNVSXICSRYYRAPEL 212
Query: 248 AMTGQLNAKS--DVYSFGVVLLELLTGR 273
            + G  N  +  D++S G V+ EL+ G+
Sbjct: 213 -IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLD---ASKQPDEEFLAQVSMVSRLKH--ENFVQLLG 129
           IG G   +V+  + +     AIK ++   A  Q  + +  +++ +++L+   +  ++L  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           Y +      +  E   N  L+  L  +K +    P    S+ + +         LE +H 
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSI---DPWERKSYWKNM---------LEAVHT 170
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAPEYA 248
                I+H D+K +N LI  D + K+ DF ++NQ  PD  + +  ++V G   Y  PE A
Sbjct: 171 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPE-A 227
Query: 249 MTGQLNAKS------------DVYSFGVVLLELLTGRKPVDHTL 280
           +    +++             DV+S G +L  +  G+ P    +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A    + +    V+  + Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRY-Y 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQ 233

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 101/257 (39%), Gaps = 42/257 (16%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 17  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 76
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 77  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 135
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 136 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 184
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 185 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 240
Query: 285 ----------QSLVTWA 291
                     Q L+ W 
Sbjct: 241 FFRQRVSXECQHLIRWC 257

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 65  ITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-K 120
           +T+ +     +G+G++  V   + + +G   A K ++  K    D + L + + + RL K
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H N V+L     +     L ++  + G L + +  R+    A     +   Q++      
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI---QQI------ 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAP-DMAARLHSTRV 236
              LE ++      I+HRD+K  N+L+         K+ADF L+ +   D  A       
Sbjct: 113 ---LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG---F 166
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT GY +PE           D+++ GV+L  LL G  P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 101/257 (39%), Gaps = 42/257 (16%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 17  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 76
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 77  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 135
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 136 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 184
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 185 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 240
Query: 285 ----------QSLVTWA 291
                     Q L+ W 
Sbjct: 241 FFRQRVSSECQHLIRWC 257

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 65  ITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-K 120
           +T+ +     +G+G++  V   + + +G   A K ++  K    D + L + + + RL K
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H N V+L     +     L ++  + G L + +  R+    A     +   Q++      
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI---QQI------ 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAP-DMAARLHSTRV 236
              LE ++      I+HRD+K  N+L+         K+ADF L+ +   D  A       
Sbjct: 113 ---LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT GY +PE           D+++ GV+L  LL G  P
Sbjct: 168 -GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 101/257 (39%), Gaps = 42/257 (16%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 77
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 136
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 137 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 185
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 186 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241
Query: 285 ----------QSLVTWA 291
                     Q L+ W 
Sbjct: 242 FFRQRVSSECQHLIRWC 258

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 101/257 (39%), Gaps = 42/257 (16%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 77
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 136
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 137 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 185
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 186 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241
Query: 285 ----------QSLVTWA 291
                     Q L+ W 
Sbjct: 242 FFRQRVSXECQHLIRWC 258

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 101/257 (39%), Gaps = 42/257 (16%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 2   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 61
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYE-FASNGSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITER-GALQEELARSFF 120
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 121 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 169
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 170 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 225
Query: 285 ----------QSLVTWA 291
                     Q L+ W 
Sbjct: 226 FFRQRVSSECQHLIRWC 242

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 101/257 (39%), Gaps = 42/257 (16%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 77
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 136
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 137 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 185
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 186 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241
Query: 285 ----------QSLVTWA 291
                     Q L+ W 
Sbjct: 242 FFRQRVSXECQHLIRWC 258

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 103/265 (38%), Gaps = 42/265 (15%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 50  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 109
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 110 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 168
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 169 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 217
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 218 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 273
Query: 285 ----------QSLVTWATPKLSEDK 299
                     Q L+ W       D+
Sbjct: 274 FFRQRVSXECQHLIRWCLALRPSDR 298

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 103/265 (38%), Gaps = 42/265 (15%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 45  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 104
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 105 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 163
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 164 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 212
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 213 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 268
Query: 285 ----------QSLVTWATPKLSEDK 299
                     Q L+ W       D+
Sbjct: 269 FFRQRVSXECQHLIRWCLALRPSDR 293

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 103/265 (38%), Gaps = 42/265 (15%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 45  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 104
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 105 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 163
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 164 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 212
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 213 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 268
Query: 285 ----------QSLVTWATPKLSEDK 299
                     Q L+ W       D+
Sbjct: 269 FFRQRVSSECQHLIRWCLALRPSDR 293

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVL--IFD--DDVAKIADFDLSNQAPDMAARLHSTRVLG 238
           GL+Y+H +    IIH DIK  NVL  I D  +++ +I   DL N         H T  + 
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYTNSIQ 197
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
           T  Y +PE  +       +D++S   ++ EL+TG
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVL--IFD--DDVAKIADFDLSNQAPDMAARLHSTRVLG 238
           GL+Y+H +    IIH DIK  NVL  I D  +++ +I   DL N         H T  + 
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYTNSIQ 197
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
           T  Y +PE  +       +D++S   ++ EL+TG
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 103/265 (38%), Gaps = 42/265 (15%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 89
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 148
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 149 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 197
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 198 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 253
Query: 285 ----------QSLVTWATPKLSEDK 299
                     Q L+ W       D+
Sbjct: 254 FFRQRVSSECQHLIRWCLALRPSDR 278

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 101/257 (39%), Gaps = 42/257 (16%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 2   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 61
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 120
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 121 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 169
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 170 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 225
Query: 285 ----------QSLVTWA 291
                     Q L+ W 
Sbjct: 226 FFRQRVSSECQHLIRWC 242

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 104/267 (38%), Gaps = 42/267 (15%)
Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL------- 110
           + E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L       
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 111 AQVSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPV 167
            +V ++ ++       ++LL +     S VL  E       L D +  R G    +    
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARS 119
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPD 226
             WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D
Sbjct: 120 FFWQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 168
Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRG 283
                  T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RG
Sbjct: 169 TVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224
Query: 284 Q-----------QSLVTWATPKLSEDK 299
           Q           Q L+ W       D+
Sbjct: 225 QVFFRQRVSSECQHLIRWCLALRPSDR 251

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+++LH      IIHRD+K SN+++  D   KI DF L+  A    + +    V+  + Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRY-Y 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
            APE  +        D++S G ++ E      L  GR  +D 
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 233

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 103/265 (38%), Gaps = 42/265 (15%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 121
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 122 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 170
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 171 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 226
Query: 285 ----------QSLVTWATPKLSEDK 299
                     Q L+ W       D+
Sbjct: 227 FFRQRVSSECQHLIRWCLALRPSDR 251

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 103/265 (38%), Gaps = 42/265 (15%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 1   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 60
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 61  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 119
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 120 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 168
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 169 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 224
Query: 285 ----------QSLVTWATPKLSEDK 299
                     Q L+ W       D+
Sbjct: 225 FFRQRVSSECQHLIRWCLALRPSDR 249

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 104/267 (38%), Gaps = 42/267 (15%)
Query: 59  VDELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL------- 110
           + E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L       
Sbjct: 23  MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 111 AQVSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPV 167
            +V ++ ++       ++LL +     S VL  E       L D +  R G    +    
Sbjct: 83  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARS 141
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPD 226
             WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D
Sbjct: 142 FFWQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 190
Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRG 283
                  T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RG
Sbjct: 191 TVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 246
Query: 284 Q-----------QSLVTWATPKLSEDK 299
           Q           Q L+ W       D+
Sbjct: 247 QVFFRQRVSXECQHLIRWCLALRPSDR 273

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 101/257 (39%), Gaps = 42/257 (16%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 121
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 122 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 170
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ- 284
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ 
Sbjct: 171 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 226
Query: 285 ----------QSLVTWA 291
                     Q L+ W 
Sbjct: 227 FFRQRVSSECQHLIRWC 243

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 101/261 (38%), Gaps = 42/261 (16%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPDEEFL-------AQVSMV 116
           +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +V ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 117 SRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQR 173
            ++       ++LL +     S VL  E       L D +  R G    +      WQ  
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQ-- 118
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLH 232
                   + + + H      ++HRDIK  N+LI  +    K+ DF       D      
Sbjct: 119 ------VLEAVRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 166
Query: 233 STRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ----- 284
            T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ     
Sbjct: 167 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 225
Query: 285 ------QSLVTWATPKLSEDK 299
                 Q L+ W       D+
Sbjct: 226 RVSXECQHLIRWCLALRPSDR 246

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 29/231 (12%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 89
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 148
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 149 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 197
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H
Sbjct: 198 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 29/231 (12%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 90
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 91  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 149
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 150 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 198
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H
Sbjct: 199 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 29/231 (12%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 89
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 148
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 149 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 197
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H
Sbjct: 198 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 29/231 (12%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 90
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 91  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 149
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 150 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 198
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H
Sbjct: 199 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 29/231 (12%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 89
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 148
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 149 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 197
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H
Sbjct: 198 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 29/231 (12%)
Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILKSGH-AAAIKKLDASKQPDEEFL-------AQ 112
           E + +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 90
Query: 113 VSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLS 169
           V ++ ++       ++LL +     S VL  E       L D +  R G    +      
Sbjct: 91  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 149
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMA 228
           WQ            LE +    +  ++HRDIK  N+LI  +    K+ DF       D  
Sbjct: 150 WQV-----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 198
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
                T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H
Sbjct: 199 Y----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 101/261 (38%), Gaps = 42/261 (16%)
Query: 65  ITENFGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPDEEFL-------AQVSMV 116
           +   +    L+G G +G VY GI  S +   AIK ++  +  D   L        +V ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 117 SRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQR 173
            ++       ++LL +     S VL  E       L D +  R G    +      WQ  
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQV- 119
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLH 232
                     LE +    +  ++HRDIK  N+LI  +    K+ DF       D      
Sbjct: 120 ----------LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 166
Query: 233 STRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH--TLPRGQ----- 284
            T   GT  Y  PE+    + + +S  V+S G++L +++ G  P +H   + RGQ     
Sbjct: 167 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 225
Query: 285 ------QSLVTWATPKLSEDK 299
                 Q L+ W       D+
Sbjct: 226 RVSSECQHLIRWCLALRPSDR 246
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	361
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-142
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-138
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-132
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-84
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-67
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-64
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-63
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-63
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-60
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-59
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-58
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-57
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-57
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-56
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-46
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-42
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-41
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-40
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-40
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-40
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-39
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-39
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-38
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-38
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-37
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-36
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-35
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-34
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-34
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-33
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-33
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-33
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-27
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-04
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-24
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-21
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-13
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  404 bits (1041), Expect = e-142
 Identities = 115/317 (36%), Positives = 177/317 (55%), Gaps = 11/317 (3%)

Query: 36  ASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAA 95
           A+ +      +  + P E   + + +L+E T NF    LIG G +G+VY G+L+ G   A
Sbjct: 8   ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67

Query: 96  IKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH 154
           +K+    S Q  EEF  ++  +S  +H + V L+G+C +    +L Y++  NG+L   L+
Sbjct: 68  LKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127

Query: 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214
           G        P   +SW+QR++I +GAA+GL YLH +A   IIHRD+KS N+L+ ++ V K
Sbjct: 128 GSDL-----PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179

Query: 215 IADFDLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
           I DF +S +  ++  + H ST V GT GY  PEY + G+L  KSDVYSFGVVL E+L  R
Sbjct: 180 ITDFGISKKGTELD-QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 274 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEAD 333
             +  +LPR   +L  WA    +  ++ Q VD  L     P+++ K    A  C+   ++
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298

Query: 334 FRPNMSIVVKALQPLLN 350
            RP+M  V+  L+  L 
Sbjct: 299 DRPSMGDVLWKLEYALR 315

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  394 bits (1015), Expect = e-138
 Identities = 109/293 (37%), Positives = 165/293 (56%), Gaps = 12/293 (4%)

Query: 58  SVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQ-PDEEFLAQVSM 115
           S+ EL+  ++NF    ++G G +G+VY G L  G   A+K+L     Q  + +F  +V M
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80

Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           +S   H N ++L G+C+  T R+L Y + +NGS+   L  R   +     P L W +R +
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQR 135

Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-ST 234
           IA+G+A+GL YLH+  DP IIHRD+K++N+L+ ++  A + DF L+          H +T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTT 193

Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS--LVTWAT 292
            V GT G+ APEY  TG+ + K+DV+ +GV+LLEL+TG++  D           L+ W  
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

Query: 293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 345
             L E K+   VD  L G+Y  + V ++  VA LC Q     RP MS VV+ L
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  379 bits (976), Expect = e-132
 Identities = 112/319 (35%), Positives = 174/319 (54%), Gaps = 26/319 (8%)

Query: 45  QAVKVQPIEVPAISVDELKEITENF------GTNALIGEGSYGRVYYGILKSGHAAAIKK 98
           ++++V      + S  ELK +T NF           +GEG +G VY G +      A+KK
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKK 61

Query: 99  LDA-----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
           L A     +++  ++F  ++ ++++ +HEN V+LLG+  DG    L Y +  NGSL D L
Sbjct: 62  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121

Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
               G       P LSW  R KIA GAA G+ +LHE    H IHRDIKS+N+L+ +   A
Sbjct: 122 SCLDG------TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTA 172

Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
           KI+DF L+  +   A  + ++R++GT  Y APE  + G++  KSD+YSFGVVLLE++TG 
Sbjct: 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGL 231

Query: 274 KPVDHTLPRGQQSLVTWATPKLSEDK-VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEA 332
             VD    R  Q L+        E+K +   +D ++  D    +V  M +VA+ C+  + 
Sbjct: 232 PAVDEH--REPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKK 288

Query: 333 DFRPNMSIVVKALQPLLNA 351
           + RP++  V + LQ +  +
Sbjct: 289 NKRPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  256 bits (656), Expect = 7e-84
 Identities = 72/314 (22%), Positives = 116/314 (36%), Gaps = 33/314 (10%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
           +  + L   +       +   G +G V+   L      A+K      +   +   +V  +
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72

Query: 117 SRLKHENFVQLLGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
             +KHEN +Q +G    G        L   F   GSL D L             V+SW +
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VVSWNE 122

Query: 173 RVKIAVGAAKGLEYLHEKAD-------PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
              IA   A+GL YLHE          P I HRDIKS NVL+ ++  A IADF L+ +  
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTG-----QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280
              +   +   +GT  Y APE              + D+Y+ G+VL EL +     D  +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 281 PRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAV------AKMAAVAALCVQYEADF 334
                          S + +++ V  +                A +      C  ++A+ 
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 335 RPNMSIVVKALQPL 348
           R +   V + +  +
Sbjct: 303 RLSAGCVGERITQM 316

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  214 bits (546), Expect = 2e-67
 Identities = 75/300 (25%), Positives = 131/300 (43%), Gaps = 37/300 (12%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
           I   E++           +G G++G V     +     AIK++++  +  + F+ ++  +
Sbjct: 5   IDYKEIEVEEV-------VGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQL 55

Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           SR+ H N V+L G C++    V+  E+A  GSL+++LHG +      P P  +    +  
Sbjct: 56  SRVNHPNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAE------PLPYYTAAHAMSW 107

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTR 235
            +  ++G+ YLH      +IHRD+K  N+L+     V KI DF  +          H T 
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTN 162

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 295
             G+  + APE       + K DV+S+G++L E++T RKP D       +  + WA    
Sbjct: 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHN- 219

Query: 296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP 355
                      R            + ++   C   +   RP+M  +VK +  L+   PG 
Sbjct: 220 ---------GTRP--PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  204 bits (522), Expect = 6e-64
 Identities = 91/307 (29%), Positives = 138/307 (44%), Gaps = 35/307 (11%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQV 113
           I   +L    +       IG GS+G V+      G   A+K L   D   +   EFL +V
Sbjct: 34  IPWCDLNIKEK-------IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREV 85

Query: 114 SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
           +++ RL+H N V  +G      +  +  E+ S GSL+ +LH             L  ++R
Sbjct: 86  AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG------AREQLDERRR 139

Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
           + +A   AKG+ YLH + +P I+HR++KS N+L+      K+ DF LS           S
Sbjct: 140 LSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198

Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 293
               GT  + APE       N KSDVYSFGV+L EL T ++P  + L   Q   V  A  
Sbjct: 199 AA--GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQ---VVAAV- 251

Query: 294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 353
                   +    RL  + P     ++AA+   C   E   RP+ + ++  L+PL+ +  
Sbjct: 252 ------GFK--CKRL--EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

Query: 354 GPAGESA 360
            P   S 
Sbjct: 302 PPPNRSD 308

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  203 bits (518), Expect = 1e-63
 Identities = 80/313 (25%), Positives = 133/313 (42%), Gaps = 54/313 (17%)

Query: 53  EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPD----- 106
            +P ++ +E++   +       IG+G +G V+ G L       AIK L            
Sbjct: 12  RLPTLADNEIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64

Query: 107 ---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
              +EF  +V ++S L H N V+L G   +    V+  EF   G L+  L  +       
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP---- 118

Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADF 218
               + W  ++++ +  A G+EY+  + +P I+HRD++S N+ +   D      AK+ADF
Sbjct: 119 ----IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL---NAKSDVYSFGVVLLELLTGRKP 275
            LS Q+         + +LG F + APE  +  +      K+D YSF ++L  +LTG  P
Sbjct: 174 GLSQQSVHS-----VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGP 227

Query: 276 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFR 335
            D     G+   +     +            R     P     ++  V  LC   +   R
Sbjct: 228 FDE-YSYGKIKFINMIREE----------GLRP--TIPEDCPPRLRNVIELCWSGDPKKR 274

Query: 336 PNMSIVVKALQPL 348
           P+ S +VK L  L
Sbjct: 275 PHFSYIVKELSEL 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  201 bits (513), Expect = 6e-63
 Identities = 65/306 (21%), Positives = 120/306 (39%), Gaps = 54/306 (17%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQV 113
           I   +L  +T+       + E   G ++ G  + G+   +K L   D S +   +F  + 
Sbjct: 7   IDFKQLNFLTK-------LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEEC 58

Query: 114 SMVSRLKHENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
             +    H N + +LG C    +        +   GSL+++LH            V+   
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQS 111

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
           Q VK A+  A+G+ +LH   +P I    + S +V+I +D  A+I+  D+           
Sbjct: 112 QAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS-------F 163

Query: 232 HSTRVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287
            S   +    + APE A+  +        +D++SF V+L EL+T   P            
Sbjct: 164 QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD--------- 213

Query: 288 VTWATPKLSEDKVRQCV---DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 344
                  LS  ++   V     R     PP     ++ +  +C+  +   RP   ++V  
Sbjct: 214 -------LSNMEIGMKVALEGLRP--TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264

Query: 345 LQPLLN 350
           L+ + +
Sbjct: 265 LEKMQD 270

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  201 bits (512), Expect = 4e-62
 Identities = 71/340 (20%), Positives = 116/340 (34%), Gaps = 55/340 (16%)

Query: 51  PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFL 110
               P++ +D LK +        LIG G YG VY G L      A+K    S    + F+
Sbjct: 4   AASEPSLDLDNLKLLE-------LIGRGRYGAVYKGSLD-ERPVAVKVF--SFANRQNFI 53

Query: 111 A--QVSMVSRLKHENFVQLLGYCVDGTSRV-----LAYEFASNGSLHDILHGRKGVKGAQ 163
               +  V  ++H+N  + +      T+       L  E+  NGSL   L          
Sbjct: 54  NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------ 107

Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHE------KADPHIIHRDIKSSNVLIFDDDVAKIAD 217
                 W    ++A    +GL YLH          P I HRD+ S NVL+ +D    I+D
Sbjct: 108 ----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163

Query: 218 FDLS------NQAPDMAARLHSTRVLGTFGYHAPEYAM-------TGQLNAKSDVYSFGV 264
           F LS                 +   +GT  Y APE                + D+Y+ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

Query: 265 VLLELLTGRKPVDH--TLPRGQQSLVTWATPKLSEDKVRQCVDAR-----LGGDYP--PK 315
           +  E+      +    ++P  Q +  T      + + ++  V            +     
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283

Query: 316 AVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP 355
           AV  +      C   +A+ R       + +  L+      
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  200 bits (510), Expect = 4e-62
 Identities = 65/296 (21%), Positives = 110/296 (37%), Gaps = 39/296 (13%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV 132
           +G+G +G+      + +G    +K+L    +     FL +V ++  L+H N ++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
                    E+   G+L  I+                W QRV  A   A G+ YLH    
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQ--------YPWSQRVSFAKDIASGMAYLHSM-- 127

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLS------------NQAPDMAARLHSTRVLGTF 240
            +IIHRD+ S N L+ ++    +ADF L+             ++     R     V+G  
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
            + APE       + K DV+SFG+VL E++         LPR     +           +
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV------RGFL 240

Query: 301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPA 356
            +          PP        +   C   + + RP+   +   L+ L     G  
Sbjct: 241 DRYC--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  198 bits (506), Expect = 6e-62
 Identities = 69/214 (32%), Positives = 98/214 (45%), Gaps = 28/214 (13%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD-----EEFLAQVSMVSRLKHENFVQLLG 129
           IG G +G+VY      G   A+K        D     E    +  + + LKH N + L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
            C+   +  L  EFA  G L+ +L G++          +     V  AV  A+G+ YLH+
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHD 123

Query: 190 KADPHIIHRDIKSSNVLI--------FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
           +A   IIHRD+KSSN+LI          + + KI DF L+        R       G + 
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYA 179

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + APE       +  SDV+S+GV+L ELLTG  P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  194 bits (495), Expect = 1e-59
 Identities = 69/325 (21%), Positives = 123/325 (37%), Gaps = 44/325 (13%)

Query: 51  PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFL 110
           P+ V      +++ + +       IG+G YG V+ G  + G   A+K    +++      
Sbjct: 28  PLLVQRTIAKQIQMVKQ-------IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE 79

Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGP 166
            ++     ++HEN +  +   + GT          ++  NGSL+D L             
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--------- 130

Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKAD-----PHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
            L  +  +K+A  +  GL +LH +       P I HRD+KS N+L+  +    IAD  L+
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189

Query: 222 --NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA-------KSDVYSFGVVLLELLTG 272
               +      +     +GT  Y  PE  +   LN         +D+YSFG++L E+   
Sbjct: 190 VKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR- 247

Query: 273 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV---DARL---GGDYPPKAVAKMAAVAAL 326
           R      +   Q           S + +R+ V     R          + + +M  +   
Sbjct: 248 RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE 307

Query: 327 CVQYEADFRPNMSIVVKALQPLLNA 351
           C  +    R     V K L  +  +
Sbjct: 308 CWAHNPASRLTALRVKKTLAKMSES 332

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  191 bits (488), Expect = 4e-59
 Identities = 76/301 (25%), Positives = 137/301 (45%), Gaps = 42/301 (13%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQV 113
           I   ++            IG GS+G VY G    G  A +K L     + Q  + F  +V
Sbjct: 21  IPDGQITVGQR-------IGSGSFGTVYKGKWH-GDVA-VKMLNVTAPTPQQLQAFKNEV 71

Query: 114 SMVSRLKHENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
            ++ + +H N +  +GY    T+  LA   ++    SL+  LH  +             +
Sbjct: 72  GVLRKTRHVNILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHASE--------TKFEMK 120

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
           + + IA   A+G++YLH K    IIHRD+KS+N+ + +D+  KI DF L+ +    +   
Sbjct: 121 KLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177

Query: 232 HSTRVLGTFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
              ++ G+  + APE      +   + +SDVY+FG+VL EL+TG+ P  +   R Q   +
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---I 234

Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 348
                +           +++  + P     +M  + A C++ + D RP+   ++  ++ L
Sbjct: 235 IEMVGR----GSLSPDLSKVRSNCPK----RMKRLMAECLKKKRDERPSFPRILAEIEEL 286

Query: 349 L 349
            
Sbjct: 287 A 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  189 bits (482), Expect = 5e-58
 Identities = 63/299 (21%), Positives = 111/299 (37%), Gaps = 37/299 (12%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
            +G+G YG V+ G  + G   A+K   +  +       ++     L+HEN +  +   + 
Sbjct: 15  CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73

Query: 134 GTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
                        +   GSL+D L              L     ++I +  A GL +LH 
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHI 123

Query: 190 -----KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
                +  P I HRD+KS N+L+  +    IAD  L+   +Q+ +     ++ RV GT  
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKR 182

Query: 242 YHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 295
           Y APE               + D+++FG+VL E+   R   +  +   +           
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDP 241

Query: 296 SEDKVRQCV---DARL---GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 348
           S + +R+ V     R       +    +  +A +   C       R     + K L  +
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  188 bits (479), Expect = 2e-57
 Identities = 64/301 (21%), Positives = 107/301 (35%), Gaps = 54/301 (17%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYC 131
           IG+G +G+VY+G        AI+ +D  +  +   + F  +V    + +HEN V  +G C
Sbjct: 41  IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
           +      +        +L+ ++   K         VL   +  +IA    KG+ YLH K 
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAK- 149

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPEYA 248
              I+H+D+KS NV   D+    I DF L                    G   + APE  
Sbjct: 150 --GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 249 MTGQLNA---------KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-----PK 294
                +           SDV++ G +  EL     P     P      + W       P 
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEA---IIWQMGTGMKPN 262

Query: 295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 354
           LS+                     +++ +   C  +E + RP  + ++  L+ L      
Sbjct: 263 LSQI------------GMGK----EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306

Query: 355 P 355
            
Sbjct: 307 L 307

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  185 bits (472), Expect = 4e-56
 Identities = 69/301 (22%), Positives = 118/301 (39%), Gaps = 39/301 (12%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
            IG+G +G V+ G  + G   A+K   + ++      A++     L+HEN +  +     
Sbjct: 49  SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107

Query: 134 GTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
                       ++  +GSL D L+             ++ +  +K+A+  A GL +LH 
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHM 157

Query: 190 KAD-----PHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
           +       P I HRD+KS N+L+  +    IAD  L+   + A D      + RV GT  
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKR 216

Query: 242 YHAPEYAMTGQLNA-------KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
           Y APE  +   +N        ++D+Y+ G+V  E+   R  +       Q          
Sbjct: 217 YMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSD 274

Query: 295 LSEDKVRQCV---DARL---GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 348
            S +++R+ V     R          +A+  MA +   C       R     + K L  L
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

Query: 349 L 349
            
Sbjct: 335 S 335

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  160 bits (407), Expect = 4e-46
 Identities = 73/294 (24%), Positives = 117/294 (39%), Gaps = 61/294 (20%)

Query: 75  IGEGSYGRVYYGILKSGHAA-AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           IG G++G V+ G L++ +   A+K            +FL +  ++ +  H N V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                  +  E    G     L           G  L  +  +++   AA G+EYL  K 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTLLQMVGDAAAGMEYLESK- 232

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH-------- 243
               IHRD+ + N L+ + +V KI+DF +S             R      Y         
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMS-------------REEADGVYAASGGLRQV 277

Query: 244 -----APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 297
                APE    G+ +++SDV+SFG++L E  + G  P                 P LS 
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY----------------PNLSN 321

Query: 298 DKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
            + R+ V+   RL    P      +  +   C  YE   RP+ S + + LQ + 
Sbjct: 322 QQTREFVEKGGRL--PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  147 bits (373), Expect = 3e-42
 Identities = 66/292 (22%), Positives = 123/292 (42%), Gaps = 57/292 (19%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           IG G +G V+ G   +    AIK +      +E+F+ +  ++ +L H   VQL G C++ 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               L  EF  +G L D L  ++G        + + +  + + +   +G+ YL E     
Sbjct: 76  APICLVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEA---C 124

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH----------- 243
           +IHRD+ + N L+ ++ V K++DF ++             R +    Y            
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMT-------------RFVLDDQYTSSTGTKFPVKW 171

Query: 244 -APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVR 301
            +PE     + ++KSDV+SFGV++ E+ + G+ P                    S  +V 
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY----------------ENRSNSEVV 215

Query: 302 QCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
           + +    RL    P  A   +  +   C +   + RP  S +++ L  +  +
Sbjct: 216 EDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  146 bits (371), Expect = 1e-41
 Identities = 76/309 (24%), Positives = 129/309 (41%), Gaps = 64/309 (20%)

Query: 75  IGEGSYGRVYYGILKSGHAA------AIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G+V+     +          A+K L D +    ++F  +  +++ L+HE+ V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPVLSWQQRVKIAVGA 180
            G C DG   ++ +E+  +G L+  L             +  Q    L   Q + IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A G+ YL  +   H +HRD+ + N L+  + + KI DF +S             R + + 
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS-------------RDVYST 186

Query: 241 GYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 286
            Y+              PE  M  +   +SDV+SFGV+L E+ T G++P           
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW---------- 236

Query: 287 LVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 344
                  +LS  +V +C+     L  + P     ++  V   C Q E   R N+  + K 
Sbjct: 237 ------FQLSNTEVIECITQGRVL--ERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKI 288

Query: 345 LQPLLNARP 353
           L  L  A P
Sbjct: 289 LHALGKATP 297

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  149 bits (379), Expect = 3e-41
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 37/283 (13%)

Query: 75  IGEGSYGRVYYGILKSGHAA-AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287

Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L              +S    + +A   +  +EYL +K   
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK--- 337

Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH--APEYAMTG 251
           + IHR++ + N L+ ++ + K+ADF LS          ++      F     APE     
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYN 394

Query: 252 QLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RL 308
           + + KSDV++FGV+L E+ T G  P                 P +   +V + ++   R+
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRM 438

Query: 309 GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
             + P     K+  +   C Q+    RP+ + + +A + +   
Sbjct: 439 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  149 bits (377), Expect = 3e-41
 Identities = 85/325 (26%), Positives = 136/325 (41%), Gaps = 36/325 (11%)

Query: 33  AYHASEAAPKGAQAVKVQPIEVPAIS--VDELKEIT-ENFGTNALIGEGSYGRVYYGILK 89
           AY++  A     +   V P   P       +  EI  E+      +G+G +G V+ G   
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206

Query: 90  SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149
                AIK L       E FL +  ++ +L+HE  VQL     +    ++  E+ S GSL
Sbjct: 207 GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSL 265

Query: 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209
            D L G         G  L   Q V +A   A G+ Y+      + +HRD++++N+L+ +
Sbjct: 266 LDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE 315

Query: 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 269
           + V K+ADF L+    D               + APE A+ G+   KSDV+SFG++L EL
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374

Query: 270 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAAL 326
            T GR P                 P +   +V   V+   R+    PP+    +  +   
Sbjct: 375 TTKGRVPY----------------PGMVNREVLDQVERGYRM--PCPPECPESLHDLMCQ 416

Query: 327 CVQYEADFRPNMSIVVKALQPLLNA 351
           C + E + RP    +   L+    +
Sbjct: 417 CWRKEPEERPTFEYLQAFLEDYFTS 441

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  144 bits (365), Expect = 4e-41
 Identities = 61/292 (20%), Positives = 110/292 (37%), Gaps = 57/292 (19%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V  G  K  +  A+K +      ++EF  +   + +L H   V+  G C   
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ SNG L + L           G  L   Q +++     +G+ +L       
Sbjct: 76  YPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQLLEMCYDVCEGMAFLESH---Q 124

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH----------- 243
            IHRD+ + N L+  D   K++DF ++             R +    Y            
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMT-------------RYVLDDQYVSSVGTKFPVKW 171

Query: 244 -APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVR 301
            APE     + ++KSDV++FG+++ E+ + G+ P                    +  +V 
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY----------------DLYTNSEVV 215

Query: 302 QCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
             V    RL    P  A   +  +   C     + RP    ++ +++PL   
Sbjct: 216 LKVSQGHRL--YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  148 bits (376), Expect = 5e-41
 Identities = 86/333 (25%), Positives = 148/333 (44%), Gaps = 58/333 (17%)

Query: 33  AYHASEAAPKGAQAVKVQPIEVPAISVDELK----EIT-ENFGTNALIGEGSYGRVYYGI 87
            ++ ++A     + +K + +E    + DE       +  +       IG+G +G V  G 
Sbjct: 154 EHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD 213

Query: 88  LKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY---E 142
            + G+  A+K  K DA+    + FLA+ S++++L+H N VQLLG  V+    +  Y   E
Sbjct: 214 YR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL--YIVTE 267

Query: 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202
           + + GSL D L  R          VL     +K ++   + +EYL      + +HRD+ +
Sbjct: 268 YMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAA 317

Query: 203 SNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYH--APEYAMTGQLNAKSDV 259
            NVL+ +D+VAK++DF L         +   ST+  G       APE     + + KSDV
Sbjct: 318 RNVLVSEDNVAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369

Query: 260 YSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKA 316
           +SFG++L E+ + GR P                 P++    V   V+   ++  D P   
Sbjct: 370 WSFGILLWEIYSFGRVPY----------------PRIPLKDVVPRVEKGYKM--DAPDGC 411

Query: 317 VAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
              +  V   C   +A  RP    + + L+ + 
Sbjct: 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  143 bits (364), Expect = 7e-41
 Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 57/291 (19%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V YG  +  +  AIK +      ++EF+ +  ++  L HE  VQL G C   
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ +NG L + L   +             QQ +++     + +EYL  K    
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---Q 140

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH----------- 243
            +HRD+ + N L+ D  V K++DF LS             R +    Y            
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLS-------------RYVLDDEYTSSVGSKFPVRW 187

Query: 244 -APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVR 301
             PE  M  + ++KSD+++FGV++ E+ + G+ P                  + +  +  
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY----------------ERFTNSETA 231

Query: 302 QCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 350
           + +    RL    P  A  K+  +   C   +AD RP   I++  +  +++
Sbjct: 232 EHIAQGLRL--YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  144 bits (365), Expect = 2e-40
 Identities = 74/321 (23%), Positives = 126/321 (39%), Gaps = 60/321 (18%)

Query: 57  ISVDELKEIT-ENFGTNALIGEGSYGRVYYGILKSG------HAAAIKKL--DASKQPDE 107
           + V +  E+  E    +  +G+GS+G VY G+ K           AIK +   AS +   
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73

Query: 108 EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-GP 166
           EFL + S++      + V+LLG    G   ++  E  + G L   L   +      P   
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133

Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
             S  + +++A   A G+ YL+       +HRD+ + N ++ +D   KI DF ++     
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT----- 185

Query: 227 MAARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-G 272
                   R +    Y+             +PE    G     SDV+SFGVVL E+ T  
Sbjct: 186 --------RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237

Query: 273 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQY 330
            +P                   LS ++V + V     L  D P      +  +  +C QY
Sbjct: 238 EQPY----------------QGLSNEQVLRFVMEGGLL--DKPDNCPDMLFELMRMCWQY 279

Query: 331 EADFRPNMSIVVKALQPLLNA 351
               RP+   ++ +++  +  
Sbjct: 280 NPKMRPSFLEIISSIKEEMEP 300

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  142 bits (360), Expect = 4e-40
 Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 28/215 (13%)

Query: 72  NALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQL 127
           +  IG GS+  VY G+  ++    A  +L   K    E   F  +  M+  L+H N V+ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 128 LGYCVDGTSR----VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
                         VL  E  ++G+L   L                +  +          
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----------MKIKVLRSWCRQIL 139

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           KGL++LH +  P IIHRD+K  N+ I       KI D  L+       A+     V+GT 
Sbjct: 140 KGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTP 194

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            + APE     + +   DVY+FG+ +LE+ T   P
Sbjct: 195 EFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  147 bits (372), Expect = 5e-40
 Identities = 76/280 (27%), Positives = 122/280 (43%), Gaps = 33/280 (11%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQL     + 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
              ++  E+ S GSL D L G         G  L   Q V +A   A G+ Y+      +
Sbjct: 335 PIYIVT-EYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---N 383

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
            +HRD++++N+L+ ++ V K+ADF L+    D               + APE A+ G+  
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFT 442

Query: 255 AKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGD 311
            KSDV+SFG++L EL T GR P                 P +   +V   V+   R+   
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPY----------------PGMVNREVLDQVERGYRM--P 484

Query: 312 YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
            PP+    +  +   C + E + RP    +   L+    +
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  141 bits (359), Expect = 5e-40
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 57/293 (19%)

Query: 75  IGEGSYGRVYYGILKSGHAA-AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
           +G G YG VY G+ K      A+K L       EEFL + +++  +KH N VQLLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80

Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
                +  EF + G+L D L              +S    + +A   +  +EYL +K   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK--- 130

Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---------- 243
           + IHRD+ + N L+ ++ + K+ADF LS             R++    Y           
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKFPIK 177

Query: 244 --APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
             APE     + + KSDV++FGV+L E+ T G  P                 P +   +V
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQV 221

Query: 301 RQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
            + ++   R+  + P     K+  +   C Q+    RP+ + + +A + +   
Sbjct: 222 YELLEKDYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  142 bits (359), Expect = 9e-40
 Identities = 83/338 (24%), Positives = 137/338 (40%), Gaps = 41/338 (12%)

Query: 34  YHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK---- 89
           +H         + +   P +        LK+I +       +GEG +G+V          
Sbjct: 5   HHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRD-------LGEGHFGKVSLYCYDPTND 57

Query: 90  -SGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY---EF 143
            +G   A+K L  DA  Q    +  ++ ++  L HE+ ++  G C D  +  L     E+
Sbjct: 58  GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL-QLVMEY 116

Query: 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203
              GSL D L              +   Q +  A    +G+ YLH +   H IHRD+ + 
Sbjct: 117 VPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAAR 163

Query: 204 NVLIFDDDVAKIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
           NVL+ +D + KI DF L+   P+     R+        F Y APE     +    SDV+S
Sbjct: 164 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWS 222

Query: 262 FGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVA 318
           FGV L ELLT             +   +     +++  ++ + ++   RL    P K  A
Sbjct: 223 FGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTELLERGERL--PRPDKCPA 278

Query: 319 KMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPA 356
           ++  +   C + EA FRP    ++  L+ +     G A
Sbjct: 279 EVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  140 bits (356), Expect = 1e-39
 Identities = 75/307 (24%), Positives = 113/307 (36%), Gaps = 65/307 (21%)

Query: 75  IGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
           +GE  +G+VY G L            AIK L   A     EEF  +  + +RL+H N V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPVLSWQQRVKIAVG 179
           LLG         + + + S+G LH+ L  R                  L     V +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
            A G+EYL      H++H+D+ + NVL++D    KI+D  L              R +  
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF-------------REVYA 180

Query: 240 FGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 285
             Y+             APE  M G+ +  SD++S+GVVL E+ + G +P          
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY--------- 231

Query: 286 SLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 343
                     S   V + +     L    P    A + A+   C       RP    +  
Sbjct: 232 -------CGYSNQDVVEMIRNRQVL--PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 282

Query: 344 ALQPLLN 350
            L+   N
Sbjct: 283 RLRAWGN 289

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  142 bits (359), Expect = 1e-39
 Identities = 79/321 (24%), Positives = 133/321 (41%), Gaps = 64/321 (19%)

Query: 58  SVDELKEIT-ENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEE 108
           S+ +LKE+  +N      +G G++G VY G +            A+K L    S+Q + +
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79

Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
           FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L  R+          L
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL--RETRPRPSQPSSL 137

Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
           +    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++    
Sbjct: 138 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---- 190

Query: 226 DMAARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT- 271
                    R +    Y+              PE  M G   +K+D +SFGV+L E+ + 
Sbjct: 191 ---------RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241

Query: 272 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQ 329
           G  P                 P  S  +V + V +  R+  D P      +  +   C Q
Sbjct: 242 GYMPY----------------PSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQ 283

Query: 330 YEADFRPNMSIVVKALQPLLN 350
           ++ + RPN +I+++ ++    
Sbjct: 284 HQPEDRPNFAIILERIEYCTQ 304

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  140 bits (356), Expect = 2e-39
 Identities = 75/334 (22%), Positives = 125/334 (37%), Gaps = 67/334 (20%)

Query: 41  PKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAA----AI 96
           P+  QAV+   I   ++ V   + I          G G +G VY+G L          A+
Sbjct: 9   PELVQAVQHVVIGPSSLIVHFNEVI----------GRGHFGCVYHGTLLDNDGKKIHCAV 58

Query: 97  KKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA-YEFASNGSLHDIL 153
           K L          +FL +  ++    H N + LLG C+      L    +  +G L + +
Sbjct: 59  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118

Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
                          + +  +   +  AKG++YL  K     +HRD+ + N ++ +    
Sbjct: 119 RNET--------HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTV 167

Query: 214 KIADFDLSNQAPDMAAR-LHST---RVLGTFGYH------APEYAMTGQLNAKSDVYSFG 263
           K+ADF L+        R ++      V    G        A E   T +   KSDV+SFG
Sbjct: 168 KVADFGLA--------RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 219

Query: 264 VVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKM 320
           V+L EL+T G  P                 P ++   +   +    RL    P      +
Sbjct: 220 VLLWELMTRGAPPY----------------PDVNTFDITVYLLQGRRL--LQPEYCPDPL 261

Query: 321 AAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 354
             V   C   +A+ RP+ S +V  +  + +   G
Sbjct: 262 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (354), Expect = 2e-39
 Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 45/283 (15%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           IG+G +G V  G  + G+  A+K +       + FLA+ S++++L+H N VQLLG  V+ 
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVIVEE 86

Query: 135 TSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
              + +  E+ + GSL D L  R          VL     +K ++   + +EYL      
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN--- 136

Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYH--APEYAMT 250
           + +HRD+ + NVL+ +D+VAK++DF L         +   ST+  G       APE    
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEALRE 188

Query: 251 GQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--R 307
            + + KSDV+SFG++L E+ + GR P                 P++    V   V+   +
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPY----------------PRIPLKDVVPRVEKGYK 232

Query: 308 LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 350
           +  D P      +  V   C   +A  RP+   + + L+ +  
Sbjct: 233 M--DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  141 bits (357), Expect = 2e-39
 Identities = 74/308 (24%), Positives = 127/308 (41%), Gaps = 63/308 (20%)

Query: 75  IGEGSYGRVYYGILKSGHAA------AIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG++G+V+     +          A+K L +AS+   ++F  +  +++ L+H++ V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV------LSWQQRVKIAVGAA 181
            G C +G   ++ +E+  +G L+  L           G        L   Q + +A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+ YL      H +HRD+ + N L+    V KI DF +S             R + +  
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS-------------RDIYSTD 212

Query: 242 YH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL 287
           Y+              PE  +  +   +SDV+SFGVVL E+ T G++P            
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW----------- 261

Query: 288 VTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 345
                 +LS  +   C+     L  + P     ++ A+   C Q E   R ++  V   L
Sbjct: 262 -----YQLSNTEAIDCITQGREL--ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

Query: 346 QPLLNARP 353
           Q L  A P
Sbjct: 315 QALAQAPP 322

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  141 bits (357), Expect = 3e-39
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 46/222 (20%)

Query: 75  IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +G G++G VY G+            AIK+L    S + ++E L +  +++ + + +  +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           LG C+  T +++  +    G L D +   K          +  Q  +   V  AKG+ YL
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---- 243
            ++    ++HRD+ + NVL+      KI DF L+             ++LG         
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLLGAEEKEYHAE 177

Query: 244 ---------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                    A E  +      +SDV+S+GV + EL+T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  141 bits (358), Expect = 4e-39
 Identities = 80/324 (24%), Positives = 134/324 (41%), Gaps = 64/324 (19%)

Query: 55  PAISVDELKEIT-ENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKL--DASKQP 105
              S+ +LKE+  +N      +G G++G VY G +            A+K L    S+Q 
Sbjct: 58  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 117

Query: 106 DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
           + +FL +  ++S+  H+N V+ +G  +    R +  E  + G L   L  R+        
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQP 175

Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSN 222
             L+    + +A   A G +YL E    H IHRDI + N L+       VAKI DF ++ 
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA- 231

Query: 223 QAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLEL 269
                       R +   GY+              PE  M G   +K+D +SFGV+L E+
Sbjct: 232 ------------RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

Query: 270 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAAL 326
            + G  P                 P  S  +V + V +  R+  D P      +  +   
Sbjct: 280 FSLGYMPY----------------PSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQ 321

Query: 327 CVQYEADFRPNMSIVVKALQPLLN 350
           C Q++ + RPN +I+++ ++    
Sbjct: 322 CWQHQPEDRPNFAIILERIEYCTQ 345

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  140 bits (355), Expect = 4e-39
 Identities = 83/350 (23%), Positives = 133/350 (38%), Gaps = 68/350 (19%)

Query: 27  SAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDEL-KEIT-ENFGTNALIGEGSYGRVY 84
           S+G +  Y   +  P+     +    E P  +     +EI         +IG G  G V 
Sbjct: 8   SSGRENLYFQGKL-PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVC 66

Query: 85  YGILKSGHAA----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138
           YG L+         AIK L    +++   +FL++ S++ +  H N ++L G    G   +
Sbjct: 67  YGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126

Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
           +  E+  NGSL   L    G          +  Q V +  G   G+ YL +      +HR
Sbjct: 127 IVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLRGVGAGMRYLSDL---GYVHR 175

Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG--TFGYH------------A 244
           D+ + NVL+  + V K++DF LS             RVL       +            A
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLS-------------RVLEDDPDAAYTTTGGKIPIRWTA 222

Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 303
           PE       ++ SDV+SFGVV+ E+L  G +P                   ++   V   
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY----------------WNMTNRDVISS 266

Query: 304 VDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
           V+   RL    P      +  +   C   +   RP  S +V  L  L+ +
Sbjct: 267 VEEGYRL--PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  139 bits (353), Expect = 7e-39
 Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 28/293 (9%)

Query: 75  IGEGSYGRVYYGIL-----KSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V           +G   A+KKL  ++++   +F  ++ ++  L+H+N V+  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 129 GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           G C     R L     E+   GSL D L   K          +   + ++      KG+E
Sbjct: 109 GVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 159

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFGYH 243
           YL  K     IHRD+ + N+L+ +++  KI DF L+   P      ++        F Y 
Sbjct: 160 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY- 215

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 303
           APE     + +  SDV+SFGVVL EL T  +          + +      ++    + + 
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275

Query: 304 VDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 354
           +    RL    P     ++  +   C     + RP+   +   +  + +   G
Sbjct: 276 LKNNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  140 bits (355), Expect = 1e-38
 Identities = 81/319 (25%), Positives = 134/319 (42%), Gaps = 49/319 (15%)

Query: 47  VKVQPIEVPAISVDEL-KEIT-ENFGTNALIGEGSYGRVYYGILKSGHAA----AIKKL- 99
           V     E P  +V E  KE+   N   + ++G G +G V  G LK         AIK L 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82

Query: 100 -DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG 158
              +++   +FL + S++ +  H N ++L G        ++  E+  NGSL   L     
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142

Query: 159 VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218
                     +  Q V +  G A G++YL +      +HRD+ + N+LI  + V K++DF
Sbjct: 143 Q--------FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF 191

Query: 219 DLSNQAPDMAARLHSTR-----VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 272
            L     D     ++TR     +  T    +PE     +  + SDV+S+G+VL E+++ G
Sbjct: 192 GLGRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247

Query: 273 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQY 330
            +P                  ++S   V + VD   RL    P    A +  +   C Q 
Sbjct: 248 ERPY----------------WEMSNQDVIKAVDEGYRL--PPPMDCPAALYQLMLDCWQK 289

Query: 331 EADFRPNMSIVVKALQPLL 349
           + + RP    +V  L  L+
Sbjct: 290 DRNNRPKFEQIVSILDKLI 308

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  139 bits (352), Expect = 1e-38
 Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 55/306 (17%)

Query: 75  IGEGSYGRVYYGILK-----SGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V           +G   A+K+L  +      +F  ++ ++  L  +  V+  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 129 GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           G       + L     E+  +G L D L   +          L   + +  +    KG+E
Sbjct: 91  GVSYGPGRQSL-RLVMEYLPSGCLRDFLQRHR--------ARLDASRLLLYSSQICKGME 141

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG--YH 243
           YL  +     +HRD+ + N+L+  +   KIADF L+             ++L      Y 
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLA-------------KLLPLDKDYYV 185

Query: 244 ------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 290
                       APE       + +SDV+SFGVVL EL T   K    +       ++  
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGC 243

Query: 291 ATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 348
                +  ++ + ++   RL    PP   A++  +  LC       RP+ S +   L  L
Sbjct: 244 ERDVPALSRLLELLEEGQRL--PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

Query: 349 LNARPG 354
            +   G
Sbjct: 302 WSGSRG 307

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  137 bits (348), Expect = 1e-38
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 43/285 (15%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+ G        A+K L       + FLA+ +++ +L+H+  V+L       
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--- 77

Query: 135 TSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            ++   Y   E+  NGSL D L           G  L+  + + +A   A+G+ ++ E+ 
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAFIEER- 128

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH--APEYAM 249
             + IHRD++++N+L+ D    KIADF L+    D     ++ R    F     APE   
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAIN 183

Query: 250 TGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-- 306
            G    KSDV+SFG++L E++T GR P                 P ++  +V Q ++   
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPY----------------PGMTNPEVIQNLERGY 227

Query: 307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
           R+    P     ++  +  LC +   + RP    +   L+    A
Sbjct: 228 RM--VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  139 bits (352), Expect = 2e-38
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 23/264 (8%)

Query: 19  GNAYMVKSSAGT--DGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIG 76
           G A+ + S A T   G+       P+      V   E       E +E          +G
Sbjct: 8   GQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVG 67

Query: 77  EGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT 135
            GS+G V+     ++G   A+KK+       EE    +   + L     V L G   +G 
Sbjct: 68  RGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAVREGP 123

Query: 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 195
              +  E    GSL  ++  ++   G  P               A +GLEYLH +    I
Sbjct: 124 WVNIFMELLEGGSLGQLI--KQM--GCLPEDRAL-----YYLGQALEGLEYLHTR---RI 171

Query: 196 IHRDIKSSNVLIFDD-DVAKIADFDLSNQ-APDMAARLHSTR--VLGTFGYHAPEYAMTG 251
           +H D+K+ NVL+  D   A + DF  +    PD   +   T   + GT  + APE  M  
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
             +AK D++S   ++L +L G  P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP 255

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  138 bits (351), Expect = 2e-38
 Identities = 76/292 (26%), Positives = 128/292 (43%), Gaps = 48/292 (16%)

Query: 75  IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           IG G +G VY G+LK+         AIK L    +++   +FL +  ++ +  H N ++L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G        ++  E+  NG+L   L  + G          S  Q V +  G A G++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRGIAAGMKYL 163

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-----VLGTFGY 242
                 + +HRD+ + N+L+  + V K++DF LS    D     ++T      +  T   
Sbjct: 164 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT--- 217

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVR 301
            APE     +  + SDV+SFG+V+ E++T G +P                  +LS  +V 
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGERPY----------------WELSNHEVM 260

Query: 302 QCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
           + ++   RL    P    + +  +   C Q E   RP  + +V  L  L+ A
Sbjct: 261 KAINDGFRL--PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  137 bits (348), Expect = 2e-38
 Identities = 66/305 (21%), Positives = 120/305 (39%), Gaps = 52/305 (17%)

Query: 75  IGEGSYGRVYYGILK-----SGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           +G+G++G V           +G   A+KKL  ++++   +F  ++ ++  L+H+N V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 129 GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           G C     R L     E+   GSL D L   K          +   + ++      KG+E
Sbjct: 78  GVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 128

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL--GTFGYH 243
           YL  K     IHRD+ + N+L+ +++  KI DF L+             +VL      + 
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLT-------------KVLPQDKEFFK 172

Query: 244 ------------APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 291
                       APE     + +  SDV+SFGVVL EL T  +          + +    
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232

Query: 292 TPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
             ++    + + +    RL    P     ++  +   C     + RP+   +   +  + 
Sbjct: 233 QGQMIVFHLIELLKNNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290

Query: 350 NARPG 354
           +   G
Sbjct: 291 DNMAG 295

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  138 bits (350), Expect = 2e-38
 Identities = 72/307 (23%), Positives = 126/307 (41%), Gaps = 65/307 (21%)

Query: 75  IGEGSYGRVYYGILKSGHAA----AIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG +G V  G LK         A+K +   ++S++  EEFL++ + +    H N ++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 128 LGYCVDGTSRVLAY-----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           LG C++ +S+ +        F   G LH  L   +          +  Q  +K  V  A 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL---ETGPKHIPLQTLLKFMVDIAL 158

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           G+EYL  +   + +HRD+ + N ++ DD    +ADF LS             + + +  Y
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS-------------KKIYSGDY 202

Query: 243 H-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV 288
           +             A E        +KSDV++FGV + E+ T G  P             
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY------------ 250

Query: 289 TWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
               P +   ++   +    RL    P   + ++  +   C + +   RP  S++   L+
Sbjct: 251 ----PGVQNHEMYDYLLHGHRL--KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304

Query: 347 PLLNARP 353
            LL + P
Sbjct: 305 KLLESLP 311

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  141 bits (357), Expect = 3e-38
 Identities = 67/282 (23%), Positives = 120/282 (42%), Gaps = 37/282 (13%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V+          A+K +       E FLA+ +++  L+H+  V+L       
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 255

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
              ++  EF + GSL D L   +       G      + +  +   A+G+ ++ ++   +
Sbjct: 256 PIYIIT-EFMAKGSLLDFLKSDE-------GSKQPLPKLIDFSAQIAEGMAFIEQR---N 304

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH--APEYAMTGQ 252
            IHRD++++N+L+    V KIADF L+    D     ++ R    F     APE    G 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 361

Query: 253 LNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLG 309
              KSDV+SFG++L+E++T GR P                 P +S  +V + ++   R+ 
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPY----------------PGMSNPEVIRALERGYRM- 404

Query: 310 GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
              P     ++  +   C +   + RP    +   L     A
Sbjct: 405 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  138 bits (349), Expect = 4e-38
 Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 66/309 (21%)

Query: 75  IGEGSYGRVYYGILK----SGHAAAIK--KLDASKQPD-EEFLAQVSMVSRLKHENFVQL 127
           +G+G +G V    LK    S    A+K  K D     D EEFL + + +    H +  +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 128 LGYCVDGTSRVLAY------EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
           +G  +   ++           F  +G LH  L   +     +    L  Q  V+  V  A
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI---GENPFNLPLQTLVRFMVDIA 147

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            G+EYL  +   + IHRD+ + N ++ +D    +ADF LS             R + +  
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS-------------RKIYSGD 191

Query: 242 YH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL 287
           Y+             A E          SDV++FGV + E++T G+ P            
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY----------- 240

Query: 288 VTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 345
                  +   ++   +    RL    PP+ + ++  +   C   +   RP+ + +   L
Sbjct: 241 -----AGIENAEIYNYLIGGNRL--KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293

Query: 346 QPLLNARPG 354
           + +L     
Sbjct: 294 ENILGHLSV 302

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (351), Expect = 4e-38
 Identities = 72/339 (21%), Positives = 123/339 (36%), Gaps = 77/339 (22%)

Query: 41  PKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAA----AI 96
           P+  QAV+   I   ++ V   + I          G G +G VY+G L          A+
Sbjct: 73  PELVQAVQHVVIGPSSLIVHFNEVI----------GRGHFGCVYHGTLLDNDGKKIHCAV 122

Query: 97  KKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL-AYEFASNGSLHDIL 153
           K L          +FL +  ++    H N + LLG C+      L    +  +G L + +
Sbjct: 123 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182

Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
                          + +  +   +  AKG+++L  K     +HRD+ + N ++ +    
Sbjct: 183 RNET--------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTV 231

Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYH---------------APEYAMTGQLNAKSD 258
           K+ADF L+             R +    +                A E   T +   KSD
Sbjct: 232 KVADFGLA-------------RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 278

Query: 259 VYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPK 315
           V+SFGV+L EL+T G  P                 P ++   +   +    RL    P  
Sbjct: 279 VWSFGVLLWELMTRGAPPY----------------PDVNTFDITVYLLQGRRL--LQPEY 320

Query: 316 AVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 354
               +  V   C   +A+ RP+ S +V  +  + +   G
Sbjct: 321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  137 bits (346), Expect = 5e-38
 Identities = 67/305 (21%), Positives = 112/305 (36%), Gaps = 67/305 (21%)

Query: 75  IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IG+G +G VY+G            AIK        Q  E FL +  ++  L H N + L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 129 GYCVDGTSRVLA-YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           G  +           +  +G L   +          P    + +  +   +  A+G+EYL
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKDLISFGLQVARGMEYL 140

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---- 243
            E+     +HRD+ + N ++ +    K+ADF L+             R +    Y+    
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLA-------------RDILDREYYSVQQ 184

Query: 244 -----------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 291
                      A E   T +   KSDV+SFGV+L ELLT G  P                
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY--------------- 229

Query: 292 TPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
              +    +   +    RL    P      +  V   C + +   RP   ++V  ++ ++
Sbjct: 230 -RHIDPFDLTHFLAQGRRL--PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286

Query: 350 NARPG 354
           +A  G
Sbjct: 287 SALLG 291

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  137 bits (346), Expect = 6e-38
 Identities = 68/302 (22%), Positives = 119/302 (39%), Gaps = 56/302 (18%)

Query: 75  IGEGSYGRVYYGILK-----SGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +GEG +G+V           +G   A+K L  ++      +   ++ ++  L HEN V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 128 LGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
            G C +     +     EF  +GSL + L   K          ++ +Q++K AV   KG+
Sbjct: 89  KGICTEDGGNGI-KLIMEFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGM 139

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL--GTFGY 242
           +YL  +     +HRD+ + NVL+  +   KI DF L+             + +      Y
Sbjct: 140 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT-------------KAIETDKEYY 183

Query: 243 H------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT 289
                        APE  M  +    SDV+SFGV L ELLT             +    T
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243

Query: 290 WATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 347
                ++   +   +    RL    PP    ++  +   C +++   R +   +++  + 
Sbjct: 244 HGQMTVTR--LVNTLKEGKRL--PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299

Query: 348 LL 349
           LL
Sbjct: 300 LL 301

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  136 bits (344), Expect = 6e-38
 Identities = 65/305 (21%), Positives = 110/305 (36%), Gaps = 64/305 (20%)

Query: 75  IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           +GEG +G VY G+  +        A+K  K D +    E+F+++  ++  L H + V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +     +  E    G L   L   K          L     V  ++   K + YL 
Sbjct: 80  GII-EEEPTWIIMELYPYGELGHYLERNKNS--------LKVLTLVLYSLQICKAMAYLE 130

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH----- 243
                + +HRDI   N+L+   +  K+ DF LS             R +    Y+     
Sbjct: 131 SI---NCVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVT 174

Query: 244 -------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL 295
                  +PE     +    SDV+ F V + E+L+ G++P                   L
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF----------------FWL 218

Query: 296 SEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 353
               V   ++   RL    P      +  +   C  Y+   RP  + +V +L  +     
Sbjct: 219 ENKDVIGVLEKGDRL--PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276

Query: 354 GPAGE 358
             A E
Sbjct: 277 DIAME 281

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  136 bits (344), Expect = 7e-38
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 45/221 (20%)

Query: 75  IGEGSYGRVYYGILKSGHAA---AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G G++G V  G+ +        AIK L     K   EE + +  ++ +L +   V+L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
            C    + +L  E A  G LH  L G++          +      ++    + G++YL E
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 128

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH---- 243
           K   + +HRD+ + NVL+ +   AKI+DF LS             + LG     Y     
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLS-------------KALGADDSYYTARSA 172

Query: 244 --------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                   APE     + +++SDV+S+GV + E L+ G+KP
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  136 bits (344), Expect = 7e-38
 Identities = 67/315 (21%), Positives = 120/315 (38%), Gaps = 72/315 (22%)

Query: 75  IGEGSYGRVYYGILKSGHAA--------AIKKL-DASKQPDEEFLAQVSMVSRLKHENFV 125
           +G+G++ +++ G+ +              +K L  A +   E F    SM+S+L H++ V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
              G CV G   +L  EF   GSL   L   K          ++   ++++A   A  + 
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--------INILWKLEVAKQLAAAMH 127

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDD--------VAKIADFDLSNQAPDMAARLHSTRVL 237
           +L E     +IH ++ + N+L+  ++          K++D  +S               +
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------------ITV 171

Query: 238 GTFGYH-------APEYAMTGQL-NAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV 288
                         PE     +  N  +D +SFG  L E+ + G KP+            
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL------------ 219

Query: 289 TWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
                 L   +  Q  +   +L     PKA A++A +   C+ YE D RP+   +++ L 
Sbjct: 220 ----SALDSQRKLQFYEDRHQL---PAPKA-AELANLINNCMDYEPDHRPSFRAIIRDLN 271

Query: 347 PLLNARPGPAGESAS 361
            L      P G    
Sbjct: 272 SLFTPDLVPRGSHHH 286

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  135 bits (341), Expect = 2e-37
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 18/208 (8%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYC 131
           ++G+G+YG VY G  L +    AIK++        + L + +++   LKH+N VQ LG  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            +     +  E    GSL  +L  + G         +             +GL+YLH+  
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIG-----FYTKQILEGLKYLHDN- 141

Query: 192 DPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE---Y 247
              I+HRDIK  NVLI     V KI+DF  S +   +     +    GT  Y APE    
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDK 197

Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
              G     +D++S G  ++E+ TG+ P
Sbjct: 198 GPRG-YGKAADIWSLGCTIIEMATGKPP 224

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  136 bits (344), Expect = 3e-37
 Identities = 73/319 (22%), Positives = 125/319 (39%), Gaps = 73/319 (22%)

Query: 75  IGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
           IGEG++GRV+                A+K L  +AS     +F  + ++++   + N V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRK---------------GVKGAQPGPVLSWQ 171
           LLG C  G    L +E+ + G L++ L                       +   P LS  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
           +++ IA   A G+ YL E+     +HRD+ + N L+ ++ V KIADF LS          
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS---------- 221

Query: 232 HSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
              R + +  Y+              PE     +   +SDV+++GVVL E+ + G +P  
Sbjct: 222 ---RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY- 277

Query: 278 HTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFR 335
                            ++ ++V   V     L    P     ++  +  LC       R
Sbjct: 278 ---------------YGMAHEEVIYYVRDGNIL--ACPENCPLELYNLMRLCWSKLPADR 320

Query: 336 PNMSIVVKALQPLLNARPG 354
           P+   + + LQ +     G
Sbjct: 321 PSFCSIHRILQRMCERAEG 339

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  135 bits (343), Expect = 3e-37
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 46/222 (20%)

Query: 75  IGEGSYGRVYYGILKSGHAA-----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +G G +G V+ G+      +      IK  +  + +Q  +     +  +  L H + V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           LG C   + +++  ++   GSL D +   +G         L  Q  +   V  AKG+ YL
Sbjct: 81  LGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQIAKGMYYL 131

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---- 243
            E     ++HR++ + NVL+      ++ADF ++              +L          
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVA-------------DLLPPDDKQLLYS 175

Query: 244 ---------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                    A E    G+   +SDV+S+GV + EL+T G +P
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  135 bits (342), Expect = 3e-37
 Identities = 57/230 (24%), Positives = 92/230 (40%), Gaps = 30/230 (13%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYC 131
            +GEG +  V     L  GH  A+K++   +Q D E   +   M     H N ++L+ YC
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 132 VDGTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           +              F   G+L + +   K       G  L+  Q + + +G  +GLE +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLK-----DKGNFLTEDQILWLLLGICRGLEAI 150

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-------GTF 240
           H        HRD+K +N+L+ D+    + D    NQA            L        T 
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 241 GYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
            Y APE      + +  +   ++DV+S G VL  ++ G  P D    +G 
Sbjct: 208 SYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  135 bits (342), Expect = 3e-37
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 46/222 (20%)

Query: 75  IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
           +G G++G VY G+            AIK+L    S + ++E L +  +++ + + +  +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           LG C+  T +++  +    G L D +   K          +  Q  +   V  AKG+ YL
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---- 243
            ++    ++HRD+ + NVL+      KI DF L+             ++LG         
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLLGAEEKEYHAE 177

Query: 244 ---------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                    A E  +      +SDV+S+GV + EL+T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (341), Expect = 4e-37
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 15/207 (7%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ----VSMVSRLKHENFVQLL 128
            IG G +  VY    L  G   A+KK+      D +  A     + ++ +L H N ++  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
              ++     +  E A  G L  ++   K     +   ++  +   K  V     LE++H
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTVWKYFVQLCSALEHMH 153

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            +    ++HRDIK +NV I    V K+ D  L           HS  ++GT  Y +PE  
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 208

Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
                N KSD++S G +L E+   + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  135 bits (341), Expect = 7e-37
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
            IGEGS+G+       + G    IK+++ S+   +E      +V++++ +KH N VQ   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
              +  S  +  ++   G L   ++ +KGV            Q +   V     L+++H+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-------FQEDQILDWFVQICLALKHVHD 143

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPE 246
           +    I+HRDIKS N+ +  D   ++ DF ++   N   ++A       + GT  Y +PE
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA----RACI-GTPYYLSPE 195

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                  N KSD+++ G VL EL T +  
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHA 224

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  133 bits (338), Expect = 1e-36
 Identities = 80/301 (26%), Positives = 134/301 (44%), Gaps = 50/301 (16%)

Query: 74  LIGEGSYGRVYYGILKSGHA---AAIKKL--DASKQPDEEFLAQVSMVSRL-KHENFVQL 127
           +IGEG++G+V    +K       AAIK++   ASK    +F  ++ ++ +L  H N + L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPVLSWQQRVKIAVGA 180
           LG C       LA E+A +G+L D L   +                 LS QQ +  A   
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A+G++YL +K     IHRD+ + N+L+ ++ VAKIADF LS        R     V  T 
Sbjct: 152 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKTM 200

Query: 241 G-----YHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 294
           G     + A E          SDV+S+GV+L E+++ G  P                   
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY----------------CG 244

Query: 295 LSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 352
           ++  ++ + +    RL  + P     ++  +   C + +   RP+ + ++ +L  +L  R
Sbjct: 245 MTCAELYEKLPQGYRL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302

Query: 353 P 353
            
Sbjct: 303 K 303

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  132 bits (335), Expect = 1e-36
 Identities = 62/220 (28%), Positives = 89/220 (40%), Gaps = 44/220 (20%)

Query: 75  IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S        AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 83  GVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 133

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH----- 243
            K     +HRDI + NVL+  +D  K+ DF LS             R +    Y+     
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKASKG 177

Query: 244 -------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                  APE     +  + SDV+ FGV + E+L  G KP
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  132 bits (335), Expect = 2e-36
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 47/222 (21%)

Query: 75  IGEGSYGRVYYGILKSGHAA---AIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V  G  +        A+K L          +E LA+ +++ +L +   V+++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C +  S +L  E A  G L+  L   +          +  +  +++    + G++YL 
Sbjct: 85  GIC-EAESWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 134

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG--YH--- 243
           E    + +HRD+ + NVL+     AKI+DF LS             + L      Y    
Sbjct: 135 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-------------KALRADENYYKAQT 178

Query: 244 ---------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                    APE     + ++KSDV+SFGV++ E  + G+KP
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  133 bits (337), Expect = 3e-36
 Identities = 43/221 (19%), Positives = 89/221 (40%), Gaps = 30/221 (13%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENF--VQLL 128
            IG G   +V+  + +     AIK ++  +  ++    +  +++ +++L+  +   ++L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
            Y +      +  E   N  L+  L  +K          +   +R        + +  +H
Sbjct: 76  DYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 125

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE-- 246
           +     I+H D+K +N L   D + K+ DF ++NQ       +     +GT  Y  PE  
Sbjct: 126 QH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 247 ---------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
                         +++ KSDV+S G +L  +  G+ P   
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  131 bits (333), Expect = 3e-36
 Identities = 63/224 (28%), Positives = 93/224 (41%), Gaps = 48/224 (21%)

Query: 75  IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
           +G+GS+G V  G   +        A+K  K D   QP+  ++F+ +V+ +  L H N ++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L G  +      +  E A  GSL D L   +G                + AV  A+G+ Y
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGY 136

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG--YH- 243
           L  K     IHRD+ + N+L+   D+ KI DF L              R L      Y  
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLM-------------RALPQNDDHYVM 180

Query: 244 -----------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                      APE   T   +  SD + FGV L E+ T G++P
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  131 bits (332), Expect = 3e-36
 Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 33/219 (15%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
           LIG G +G+V+       G    IK++  +    E+   +V  +++L H N V   G   
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWD 74

Query: 133 DGTSRVLAY----------------EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
                                    EF   G+L   +  R+G K       L     +++
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-------LDKVLALEL 127

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
                KG++Y+H K    +I+RD+K SN+ + D    KI DF L     +   R   TR 
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRS 181

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT  Y +PE   +     + D+Y+ G++L ELL     
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  137 bits (347), Expect = 4e-36
 Identities = 74/284 (26%), Positives = 110/284 (38%), Gaps = 40/284 (14%)

Query: 75  IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
           IGEG +G V+ GI  S        AIK  K   S    E+FL +   + +  H + V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G   +    ++  E  + G L   L  RK          L     +  A   +  L YL 
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFLQVRK--------FSLDLASLILYAYQLSTALAYLE 508

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
            K     +HRDI + NVL+  +D  K+ DF LS    D      S   L      APE  
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI 564

Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA- 306
              +  + SDV+ FGV + E+L  G KP                   +  + V   ++  
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPF----------------QGVKNNDVIGRIENG 608

Query: 307 -RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
            RL    PP     + ++   C  Y+   RP  + +   L  +L
Sbjct: 609 ERL--PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  132 bits (333), Expect = 5e-36
 Identities = 43/221 (19%), Positives = 89/221 (40%), Gaps = 30/221 (13%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENF--VQLL 128
            IG G   +V+  + +     AIK ++  +  ++    +  +++ +++L+  +   ++L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
            Y +      +  E   N  L+  L  +K          +   +R        + +  +H
Sbjct: 95  DYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 144

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE-- 246
           +     I+H D+K +N L   D + K+ DF ++NQ       +     +GT  Y  PE  
Sbjct: 145 QH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 247 ---------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
                         +++ KSDV+S G +L  +  G+ P   
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  133 bits (336), Expect = 5e-36
 Identities = 73/311 (23%), Positives = 128/311 (41%), Gaps = 68/311 (21%)

Query: 75  IGEGSYGRVYYGIL--------KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG +G+V             K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+             P   ++++  V  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL  +     IHRD+ + NVL+ +++V KIADF L+             R 
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA-------------RD 252

Query: 237 LGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282
           +    Y+             APE         +SDV+SFGV++ E+ T G  P       
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP------- 305

Query: 283 GQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 340
                     P +  +++ + +    R+  D P     ++  +   C       RP    
Sbjct: 306 ---------YPGIPVEELFKLLKEGHRM--DKPANCTNELYMMMRDCWHAVPSQRPTFKQ 354

Query: 341 VVKALQPLLNA 351
           +V+ L  +L  
Sbjct: 355 LVEDLDRILTL 365

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  131 bits (332), Expect = 6e-36
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 18/226 (7%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
           IG+G+ G VY  + + +G   AI++++  +QP +E +   + ++   K+ N V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
            G    +  E+ + GSL D++              +   Q   +     + LE+LH    
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN-- 135

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
             +IHRDIKS N+L+  D   K+ DF    Q     ++  +  ++GT  + APE      
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192

Query: 253 LNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSE 297
              K D++S G++ +E++ G  P  +  P R    + T  TP+L  
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  132 bits (333), Expect = 9e-36
 Identities = 73/315 (23%), Positives = 129/315 (40%), Gaps = 68/315 (21%)

Query: 75  IGEGSYGRVYYGIL--------KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V             K     A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+             P   ++++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
               A+G+EYL  +     IHRD+ + NVL+ +++V KIADF L+             R 
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA-------------RD 206

Query: 237 LGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282
           +    Y+             APE         +SDV+SFGV++ E+ T G  P       
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP------- 259

Query: 283 GQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 340
                     P +  +++ + +    R+  D P     ++  +   C       RP    
Sbjct: 260 ---------YPGIPVEELFKLLKEGHRM--DKPANCTNELYMMMRDCWHAVPSQRPTFKQ 308

Query: 341 VVKALQPLLNARPGP 355
           +V+ L  +L      
Sbjct: 309 LVEDLDRILTLTTNE 323

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  130 bits (329), Expect = 1e-35
 Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 34/223 (15%)

Query: 74  LIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGY 130
            +G G +G V+    K      AIK++    +     + + +V  +++L+H   V+    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 131 CVDGTSRVLAY------------EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
            ++  +                 +     +L D ++GR  ++  +    L         +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI------FL 125

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----------DLSNQAPDMA 228
             A+ +E+LH K    ++HRD+K SN+    DDV K+ DF          +       M 
Sbjct: 126 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
           A    T  +GT  Y +PE       + K D++S G++L ELL 
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  132 bits (334), Expect = 2e-35
 Identities = 42/223 (18%), Positives = 89/223 (39%), Gaps = 34/223 (15%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENF--VQLL 128
            IG G   +V+  + +     AIK ++  +  ++    +  +++ +++L+  +   ++L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS--WQQRVKIAVGAAKGLEY 186
            Y +      +  E   N  L+  L  +K +            W+  +       + +  
Sbjct: 123 DYEITDQYIYMVMECG-NIDLNSWLKKKKSI----DPWERKSYWKNML-------EAVHT 170

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           +H+     I+H D+K +N L   D + K+ DF ++NQ       +     +G   Y  PE
Sbjct: 171 IHQH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 247 -----------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
                           +++ KSDV+S G +L  +  G+ P   
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  131 bits (332), Expect = 2e-35
 Identities = 77/311 (24%), Positives = 128/311 (41%), Gaps = 68/311 (21%)

Query: 75  IGEGSYGRVYYGILKSGHAA--------AIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
           +GEG++G+V                   A+K L  DA+++   + ++++ M+  + KH+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPVLSWQQRVKI 176
            + LLG C       +  E+AS G+L + L  R+             P   LS +  V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+             R 
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA-------------RD 240

Query: 237 LGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282
           +    Y+             APE         +SDV+SFGV+L E+ T G  P       
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP------- 293

Query: 283 GQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 340
                     P +  +++ + +    R+  D P     ++  +   C       RP    
Sbjct: 294 ---------YPGVPVEELFKLLKEGHRM--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 342

Query: 341 VVKALQPLLNA 351
           +V+ L  ++  
Sbjct: 343 LVEDLDRIVAL 353

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  128 bits (325), Expect = 3e-35
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 23/214 (10%)

Query: 74  LIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
            IG GSYGR      KS G     K+LD     + E    +++V+++  LKH N V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 130 YCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
             +D T+  L Y   E+   G L  ++      KG +    L  +  +++       L+ 
Sbjct: 73  RIIDRTNTTL-YIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 187 LHEKADP--HIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
            H ++D    ++HRD+K +NV +      K+ DF L+   N     A     T V GT  
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA----KTFV-GTPY 181

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           Y +PE       N KSD++S G +L EL     P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  129 bits (327), Expect = 4e-35
 Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 21/235 (8%)

Query: 48  KVQPIEVPAISVDELKEI------TENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD 100
            VQ    P   + +L E        E F     +GEGSYG VY  I  ++G   AIK++ 
Sbjct: 4   TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63

Query: 101 ASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK 160
                 +E + ++S++ +    + V+  G     T   +  E+   GS+ DI+  R    
Sbjct: 64  VESDL-QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT- 121

Query: 161 GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220
                  L+  +   I     KGLEYLH       IHRDIK+ N+L+  +  AK+ADF +
Sbjct: 122 -------LTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171

Query: 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           + Q  D  A+ ++  V+GT  + APE       N  +D++S G+  +E+  G+ P
Sbjct: 172 AGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  134 bits (338), Expect = 5e-35
 Identities = 70/299 (23%), Positives = 129/299 (43%), Gaps = 65/299 (21%)

Query: 75  IGEGSYGRVYYGILKSGHAA---AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
           +G G++G V  G+ +        AIK L     K   EE + +  ++ +L +   V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
            C    + +L  E A  G LH  L G++          +      ++    + G++YL E
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 454

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH---- 243
           K   + +HR++ + NVL+ +   AKI+DF LS             + LG     Y     
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLS-------------KALGADDSYYTARSA 498

Query: 244 --------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 294
                   APE     + +++SDV+S+GV + E L+ G+KP                  K
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY----------------KK 542

Query: 295 LSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
           +   +V   ++   R+  + PP+   ++ A+ + C  Y+ + RP+   V + ++    +
Sbjct: 543 MKGPEVMAFIEQGKRM--ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (324), Expect = 7e-35
 Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 22/210 (10%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFL------AQVSMVSRLKHENFV 125
             +G G    VY           AIK +    +  EE L            S+L H+N V
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN--SSQLSHQNIV 74

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            ++    +     L  E+    +L + +           GP LS    +        G++
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAINFTNQILDGIK 125

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           + H+     I+HRDIK  N+LI  +   KI DF ++ +A    +   +  VLGT  Y +P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSP 181

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           E A     +  +D+YS G+VL E+L G  P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  127 bits (322), Expect = 1e-34
 Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 25/209 (11%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
            +G+G +G VY     +S    A+K L  ++        Q+     + S L+H N ++L 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 129 GYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           GY  D T   L  E+A  G+++  L    +              Q+        A  L Y
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSK-----------FDEQRTATYITELANALSY 124

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
            H K    +IHRDIK  N+L+      KIADF  S  AP       +  + GT  Y  PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTD-LCGTLDYLPPE 177

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                  + K D++S GV+  E L G+ P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  128 bits (324), Expect = 1e-34
 Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 27/254 (10%)

Query: 34  YHASEAAPKGAQAVKVQPIEVPAISVDE----LKEI------TENFGTNALIGEGSYGRV 83
           +H    +       +    +   ++ ++    L+ +           +   IGEGS G V
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIV 61

Query: 84  YYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAY 141
                  SG   A+K +D  KQ   E L   V ++   +H N V++    + G    +  
Sbjct: 62  CLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121

Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
           EF   G+L DI+   +          L+ +Q   +     + L YLH +    +IHRDIK
Sbjct: 122 EFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK 168

Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
           S ++L+  D   K++DF    Q      +  S  ++GT  + APE         + D++S
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWS 226

Query: 262 FGVVLLELLTGRKP 275
            G++++E++ G  P
Sbjct: 227 LGIMVIEMVDGEPP 240

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  126 bits (318), Expect = 5e-34
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
           IG+GS+G V+ GI  ++    AIK +D  +  D  E+   +++++S+       +  G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
           +  T   +  E+   GS  D+L         +PGP L   Q   I     KGL+YLH + 
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSE- 138

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
               IHRDIK++NVL+ +    K+ADF ++ Q  D   + ++   +GT  + APE     
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194

Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
             ++K+D++S G+  +EL  G  P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP 218

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  125 bits (317), Expect = 7e-34
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 20/208 (9%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
           +G+G++G+VY     ++G  AA K ++   + + E     + +++   H   V+LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
                 +  EF   G++  I+              L+  Q   +     + L +LH K  
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG--------LTEPQIQVVCRQMLEALNFLHSK-- 136

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
             IIHRD+K+ NVL+  +   ++ADF +S +      +  S   +GT  + APE  M   
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCET 193

Query: 253 L-----NAKSDVYSFGVVLLELLTGRKP 275
           +     + K+D++S G+ L+E+     P
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPP 221

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  126 bits (318), Expect = 8e-34
 Identities = 67/317 (21%), Positives = 122/317 (38%), Gaps = 73/317 (23%)

Query: 75  IGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
           +GEG +G+V                 A+K L  +AS     + L++ +++ ++ H + ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ---------------PGPVLSWQ 171
           L G C      +L  E+A  GSL   L   + V                       L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
             +  A   ++G++YL E     ++HRD+ + N+L+ +    KI+DF LS          
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS---------- 197

Query: 232 HSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
              R +     +             A E         +SDV+SFGV+L E++T G  P  
Sbjct: 198 ---RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-- 252

Query: 278 HTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFR 335
                          P +  +++   +    R+  + P     +M  +   C + E D R
Sbjct: 253 --------------YPGIPPERLFNLLKTGHRM--ERPDNCSEEMYRLMLQCWKQEPDKR 296

Query: 336 PNMSIVVKALQPLLNAR 352
           P  + + K L+ ++  R
Sbjct: 297 PVFADISKDLEKMMVKR 313

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  125 bits (317), Expect = 8e-34
 Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 38/235 (16%)

Query: 65  ITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN 123
              +F   A++G+G++G+V            AIKK+  +++     L++V +++ L H+ 
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQY 63

Query: 124 FVQLLGYCVDGTSRVLAY-------------EFASNGSLHDILHGRKGVKGAQPGPVLSW 170
            V+     ++  + V                E+  NG+L+D++H                
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN--------QQR 115

Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
            +  ++     + L Y+H +    IIHRD+K  N+ I +    KI DF L+         
Sbjct: 116 DEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 231 LHS------------TRVLGTFGYHAPE-YAMTGQLNAKSDVYSFGVVLLELLTG 272
           L              T  +GT  Y A E    TG  N K D+YS G++  E++  
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  127 bits (320), Expect = 9e-34
 Identities = 66/292 (22%), Positives = 111/292 (38%), Gaps = 29/292 (9%)

Query: 37  SEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAA 95
            E   K  +A   Q  +V  +  D+ ++I+E       +G G+ G V+    K SG   A
Sbjct: 10  DEQQRKRLEAFLTQKQKVGELKDDDFEKISE-------LGAGNGGVVFKVSHKPSGLVMA 62

Query: 96  IKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151
            K +            Q+     ++        V   G         +  E    GSL  
Sbjct: 63  RKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211
           +L     +    P  +L      K+++   KGL YL EK    I+HRD+K SN+L+    
Sbjct: 121 VLKKAGRI----PEQILG-----KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRG 169

Query: 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
             K+ DF +S Q  D  A    + V GT  Y +PE       + +SD++S G+ L+E+  
Sbjct: 170 EIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225

Query: 272 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAV 323
           GR P+     +  + +        + +   +        +          A+
Sbjct: 226 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  126 bits (319), Expect = 1e-33
 Identities = 41/222 (18%), Positives = 82/222 (36%), Gaps = 30/222 (13%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLD--------------ASKQPDEEFLAQV----SMV 116
           + +G + ++     K     A+KK +                K   +           ++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           + +K+E  +   G   +     + YE+  N S+         +       +     +  I
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-CI 156

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
                    Y+H +   +I HRD+K SN+L+  +   K++DF  S    D   ++  +R 
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSR- 211

Query: 237 LGTFGYHAPEYAMTGQL---NAKSDVYSFGVVLLELLTGRKP 275
            GT+ +  PE   + +     AK D++S G+ L  +     P
Sbjct: 212 -GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  125 bits (316), Expect = 1e-33
 Identities = 70/267 (26%), Positives = 105/267 (39%), Gaps = 40/267 (14%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSM 115
           +  D+L+ I E       +G G+YG V       SG   A+K++ A+   + +   ++ M
Sbjct: 4   VKADDLEPIME-------LGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLM 54

Query: 116 -----VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
                +  +     V   G         +  E   + SL              P  +L  
Sbjct: 55  DLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG- 112

Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
               KIAV   K LE+LH K    +IHRD+K SNVLI      K+ DF +S    D  A+
Sbjct: 113 ----KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166

Query: 231 LHSTRVLGTFGYHAPE----YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP--RGQ 284
                  G   Y APE           + KSD++S G+ ++EL   R P D      +  
Sbjct: 167 ---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223

Query: 285 QSLVTWATPKLSEDK--------VRQC 303
           + +V   +P+L  DK          QC
Sbjct: 224 KQVVEEPSPQLPADKFSAEFVDFTSQC 250

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  125 bits (317), Expect = 1e-33
 Identities = 71/260 (27%), Positives = 116/260 (44%), Gaps = 32/260 (12%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSM 115
           I +  L++    F    L+G G+YG+VY G  +K+G  AAIK +D +   +EE   +++M
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73

Query: 116 VSRL-KHENFVQLLG-YCVDGTSRVLAY-----EFASNGSLHDILHGRKGVKGAQPGPVL 168
           + +   H N     G +       +        EF   GS+ D++   KG         L
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-------L 126

Query: 169 SWQQRVKIAV---GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
             +    IA       +GL +LH+     +IHRDIK  NVL+ ++   K+ DF +S Q  
Sbjct: 127 KEEW---IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180

Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQL-----NAKSDVYSFGVVLLELLTGRKPVDHTL 280
               R ++   +GT  + APE     +      + KSD++S G+  +E+  G  P+    
Sbjct: 181 RTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238

Query: 281 P-RGQQSLVTWATPKLSEDK 299
           P R    +     P+L   K
Sbjct: 239 PMRALFLIPRNPAPRLKSKK 258

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  125 bits (316), Expect = 2e-33
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 26/215 (12%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFL------AQVSMVSRLKHENFV 125
            ++G G    V+    L+     A+K L A    D  F       AQ    + L H   V
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHPAIV 75

Query: 126 QLLGY-CVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            +      +  +  L Y   E+    +L DI+H          GP ++ ++ +++   A 
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADAC 126

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST-RVLGTF 240
           + L + H+     IIHRD+K +N++I   +  K+ DF ++    D    +  T  V+GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            Y +PE A    ++A+SDVYS G VL E+LTG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  125 bits (317), Expect = 2e-33
 Identities = 76/267 (28%), Positives = 115/267 (43%), Gaps = 29/267 (10%)

Query: 47  VKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP 105
           +K+ P +    + ++LK++ E       IG G+YG V   + K SG   A+K++ ++   
Sbjct: 9   LKISPEQHWDFTAEDLKDLGE-------IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 106 DE--EFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA 162
            E  + L  + +V R       VQ  G         +  E   + S          V   
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD 120

Query: 163 Q-PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
             P  +L      KI +   K L +L E     IIHRDIK SN+L+      K+ DF +S
Sbjct: 121 VIPEEILG-----KITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGIS 173

Query: 222 NQAPDMAARLHSTRVLGTFGYHAPE----YAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
            Q  D  A+   TR  G   Y APE     A     + +SDV+S G+ L EL TGR P  
Sbjct: 174 GQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230

Query: 278 --HTLPRGQQSLVTWATPKLSEDKVRQ 302
             +++      +V    P+LS  + R+
Sbjct: 231 KWNSVFDQLTQVVKGDPPQLSNSEERE 257

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  125 bits (316), Expect = 2e-33
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 42/228 (18%)

Query: 75  IGEGSYGRVY----YGILKSGHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
           +G G++G+V     +G+ K       A+K L   A     E  ++++ ++S L +HEN V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-----GPVLSWQQRVKIAVGA 180
            LLG C  G   ++  E+   G L + L  +  V    P         S +  +  +   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
           A+G+ +L  K   + IHRD+ + NVL+ +  VAKI DF L        AR     ++   
Sbjct: 174 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL--------ARD----IMNDS 218

Query: 241 GYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
            Y             APE         +SDV+S+G++L E+ + G  P
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  123 bits (312), Expect = 3e-33
 Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 18/207 (8%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
           L+G+GS+  VY    + +G   AIK +D         + +V     +  +LKH + ++L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
            Y  D     L  E   NG ++  L  R            S  +          G+ YLH
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--------FSENEARHFMHQIITGMLYLH 129

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
                 I+HRD+  SN+L+  +   KIADF L+ Q      + ++    GT  Y +PE A
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIA 184

Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
                  +SDV+S G +   LL GR P
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPP 211

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  123 bits (312), Expect = 5e-33
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 48/233 (20%)

Query: 75  IGEGSYGRVY----YGILKSGHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
           +G G++G+V     YG++KS  A   A+K L   A     E  ++++ ++S L  H N V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ---------PGPVLSWQQRVKI 176
            LLG C  G   ++  E+   G L + L  ++                   L  +  +  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           +   AKG+ +L  K   + IHRD+ + N+L+    + KI DF L+             R 
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA-------------RD 194

Query: 237 LGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
           +     +             APE         +SDV+S+G+ L EL + G  P
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  123 bits (312), Expect = 5e-33
 Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 47/232 (20%)

Query: 75  IGEGSYGRVYYGILK------SGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
           +G G++G+V            +    A+K L   A+       ++++ ++  +  H N V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGPVLSWQQRVKIA 177
            LLG C   G   ++  EF   G+L   L  ++                 L+ +  +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
              AKG+E+L  +     IHRD+ + N+L+ + +V KI DF L+             R +
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA-------------RDI 198

Query: 238 GTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                +             APE         +SDV+SFGV+L E+ + G  P
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  123 bits (310), Expect = 6e-33
 Identities = 63/209 (30%), Positives = 87/209 (41%), Gaps = 25/209 (11%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
            +G+G +G VY     ++    A+K L  S+   E    Q+     + S L+H N +++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 129 GYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
            Y  D     L  EFA  G L+  L  HGR              Q+        A  L Y
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGR-----------FDEQRSATFMEELADALHY 129

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
            HE+    +IHRDIK  N+L+      KIADF  S  AP    R  +    GT  Y  PE
Sbjct: 130 CHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTM--CGTLDYLPPE 182

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                  + K D++  GV+  E L G  P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  122 bits (308), Expect = 3e-32
 Identities = 56/250 (22%), Positives = 91/250 (36%), Gaps = 23/250 (9%)

Query: 32  GAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKS 90
           G       A  GA A      E+P + VD        +     +G+G + + +      +
Sbjct: 8   GKAGVPGVAAPGAPAAAPPAKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADT 65

Query: 91  GHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146
               A K +  S         ++    S+   L H++ V   G+  D     +  E    
Sbjct: 66  KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125

Query: 147 GSLHDILHGRKGVKGAQPGPVLSWQQRV-KIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205
            SL ++   RK +           +            G +YLH      +IHRD+K  N+
Sbjct: 126 RSLLELHKRRKALT----------EPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNL 172

Query: 206 LIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV 265
            + +D   KI DF L+ +      R       GT  Y APE       + + DV+S G +
Sbjct: 173 FLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCI 230

Query: 266 LLELLTGRKP 275
           +  LL G+ P
Sbjct: 231 MYTLLVGKPP 240

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  121 bits (305), Expect = 5e-32
 Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 21/214 (9%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE---FLAQVSMVSRL-KH 121
           ++F   + +G GSYG V+    K  G   A+K+  +  +  ++    LA+V    ++ +H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
              V+L     +G    L  E     SL               G  L   Q         
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--------AWGASLPEAQVWGYLRDTL 167

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L +LH +    ++H D+K +N+ +      K+ DF L  +     A     +  G   
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPR 221

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           Y APE  + G     +DV+S G+ +LE+    + 
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  120 bits (303), Expect = 8e-32
 Identities = 51/231 (22%), Positives = 87/231 (37%), Gaps = 23/231 (9%)

Query: 53  EVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA 111
           E+P + VD        +     +G+G + + +      +    A K +  S         
Sbjct: 3   EIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60

Query: 112 QV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
           ++    S+   L H++ V   G+  D     +  E     SL ++   RK +        
Sbjct: 61  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT------- 113

Query: 168 LSWQQRV-KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
              +            G +YLH      +IHRD+K  N+ + +D   KI DF L+ +   
Sbjct: 114 ---EPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167

Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
              R       GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 168 DGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (303), Expect = 1e-31
 Identities = 50/210 (23%), Positives = 77/210 (36%), Gaps = 22/210 (10%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFL------AQVSMVSRLKHENFV 125
            L+G G  G VY           A+K +  +   D  F       A+     RL+  + V
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREART--AGRLQEPHVV 97

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
            +  +        +     +   L  +L  +        GP L+  + V I       L+
Sbjct: 98  PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--------GP-LAPPRAVAIVRQIGSALD 148

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
             H        HRD+K  N+L+  DD A + DF ++  A            +GT  Y AP
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYMAP 204

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           E         ++D+Y+   VL E LTG  P
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPP 234

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  120 bits (302), Expect = 1e-31
 Identities = 73/273 (26%), Positives = 115/273 (42%), Gaps = 26/273 (9%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
           IG G+   V            AIK+++  K     +E L ++  +S+  H N V      
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEYLH 188
           V      L  +  S GS+ DI+         + G  L       IA       +GLEYLH
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDEST---IATILREVLEGLEYLH 138

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR--VLGTFGYHAP 245
           +      IHRD+K+ N+L+ +D   +IADF +S   A       +  R   +GT  + AP
Sbjct: 139 KN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

Query: 246 EYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSEDKVRQC 303
           E     +  + K+D++SFG+  +EL TG  P     P +     +    P L      + 
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKE 255

Query: 304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRP 336
           +  + G     K+  KM    +LC+Q + + RP
Sbjct: 256 MLKKYG-----KSFRKM---ISLCLQKDPEKRP 280

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  120 bits (303), Expect = 2e-31
 Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 53/238 (22%)

Query: 75  IGEGSYGRVY----YGILKSGHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
           +G G++G+V     YGI K+G +   A+K L   A     E  ++++ M+++L  HEN V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDIL--------------HGRKGVKGAQPGPVLSWQ 171
            LLG C       L +E+   G L + L                +K ++  +   VL+++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
             +  A   AKG+E+L  K     +HRD+ + NVL+    V KI DF L+          
Sbjct: 173 DLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA---------- 219

Query: 232 HSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
              R + +   +             APE    G    KSDV+S+G++L E+ + G  P
Sbjct: 220 ---RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  120 bits (302), Expect = 2e-31
 Identities = 69/296 (23%), Positives = 121/296 (40%), Gaps = 32/296 (10%)

Query: 13  HKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTN 72
           H    +        +    GA    +  P G +A  ++  +V  +   +  +  + F   
Sbjct: 5   HHHHHHDYDIPTTENLYFQGA---MDPMPAGGRAGSLKDPDVAELFFKD--DPEKLFSDL 59

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ----VSMVSRLKHENFVQL 127
             IG GS+G VY+   +++    AIKK+  S +   E        V  + +L+H N +Q 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
            G  +   +  L  E+   GS  D+L   K          L   +   +  GA +GL YL
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--------LQEVEIAAVTHGALQGLAYL 170

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
           H     ++IHRD+K+ N+L+ +  + K+ DF  ++    MA        +GT  + APE 
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI---MAPA---NSFVGTPYWMAPEV 221

Query: 248 AMTGQL---NAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSEDK 299
            +       + K DV+S G+  +EL   + P+ +         +    +P L    
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 277

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  120 bits (303), Expect = 3e-31
 Identities = 40/214 (18%), Positives = 73/214 (34%), Gaps = 23/214 (10%)

Query: 75  IGEG--SYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF---LAQVSMVSRLKHENFVQLL 128
           IG+G      V       +G    +++++     +E       ++ +     H N V   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
              +      +   F + GS  D++              ++      I  G  K L+Y+H
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLI------CTHFMDG-MNELAIAYILQGVLKALDYIH 145

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-----GTFGYH 243
                  +HR +K+S++LI  D    ++    +        R                + 
Sbjct: 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 244 APEYAMTGQL--NAKSDVYSFGVVLLELLTGRKP 275
           +PE         +AKSD+YS G+   EL  G  P
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  120 bits (302), Expect = 1e-30
 Identities = 50/240 (20%), Positives = 92/240 (38%), Gaps = 35/240 (14%)

Query: 55  PAISVDELKEITE-------NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS--KQP 105
           P++  D+  E T        +F    ++G G+ G + Y  +      A+K++        
Sbjct: 5   PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA 64

Query: 106 DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
           D E    V ++    +H N ++      D   + +A E  +  +L + +         Q 
Sbjct: 65  DRE----VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--------EQK 111

Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFD 219
                  + + +      GL +LH     +I+HRD+K  N+LI   +      A I+DF 
Sbjct: 112 DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168

Query: 220 LSNQ-APDMAARLHSTRVLGTFGYHAPEY---AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           L  + A    +    + V GT G+ APE              D++S G V   +++    
Sbjct: 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (298), Expect = 1e-30
 Identities = 47/250 (18%), Positives = 84/250 (33%), Gaps = 30/250 (12%)

Query: 47  VKVQPIEVPAISVD-ELKEITENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKL 99
                 ++PAI    E +  ++    + L+GEG++ +VY       + A       +K  
Sbjct: 44  TFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ 103

Query: 100 DASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR 156
                   EF     ++ RLK      F++     +     VL  E  S G+L + ++  
Sbjct: 104 K--PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161

Query: 157 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--- 213
           K      P  V+     +  A+     +E +H+     IIH DIK  N ++ +  +    
Sbjct: 162 K----NTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214

Query: 214 --------KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV 265
                    + D   S            T    T G+   E       N + D +     
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274

Query: 266 LLELLTGRKP 275
           +  +L G   
Sbjct: 275 VYCMLFGTYM 284

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  117 bits (295), Expect = 2e-30
 Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 36/256 (14%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSM 115
             +++L+ + E       +G G+ G+V+    + +GH  A+K++  S   ++E   ++ M
Sbjct: 22  AEINDLENLGE-------MGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILM 72

Query: 116 -----VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
                +        VQ  G  +  T   +A E     +       +  +    P  +L  
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI----PERILG- 127

Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
               K+ V   K L YL EK    +IHRD+K SN+L+ +    K+ DF +S +  D  A+
Sbjct: 128 ----KMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181

Query: 231 LHSTRVLGTFGYHAPE-----YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP--RG 283
               R  G   Y APE            + ++DV+S G+ L+EL TG+ P  +       
Sbjct: 182 ---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238

Query: 284 QQSLVTWATPKLSEDK 299
              ++    P L    
Sbjct: 239 LTKVLQEEPPLLPGHM 254

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  117 bits (294), Expect = 2e-30
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 30/232 (12%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGY 130
           ++G+G+   V+ G  K +G   AIK  +     +P +  + +  ++ +L H+N V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 131 CVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
             + T+R  VL  EF   GSL+ +L       G      L   + + +      G+ +L 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLIVLRDVVGGMNHLR 129

Query: 189 EKADPHIIHRDIKSSNVLIF----DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
           E     I+HR+IK  N++         V K+ DF  + +  D   +  S  + GT  Y  
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS--LYGTEEYLH 183

Query: 245 PE--------YAMTGQLNAKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSL 287
           P+             +  A  D++S GV      TG  P      PR  + +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  120 bits (303), Expect = 3e-30
 Identities = 54/216 (25%), Positives = 82/216 (37%), Gaps = 24/216 (11%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP-DEEFLAQ-VSMVSRLKHENFVQLL--- 128
           +G G +G V   I   +G   AIK+      P + E     + ++ +L H N V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 129 ---GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
                       +LA E+   G L   L+  +   G      L       +    +  L 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG------LKEGPIRTLLSDISSALR 135

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           YLHE     IIHRD+K  N+++       + KI D   + +       L +  V GT  Y
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFV-GTLQY 189

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
            APE     +     D +SFG +  E +TG +P   
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  117 bits (295), Expect = 5e-30
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 30/232 (12%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGY 130
           ++G+G+   V+ G  K +G   AIK  +     +P +  + +  ++ +L H+N V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 131 CVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
             + T+R  VL  EF   GSL+ +L       G      L   + + +      G+ +L 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLIVLRDVVGGMNHLR 129

Query: 189 EKADPHIIHRDIKSSNVLIF----DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
           E     I+HR+IK  N++         V K+ DF  + +  D   +  S  + GT  Y  
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS--LYGTEEYLH 183

Query: 245 PE--------YAMTGQLNAKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSL 287
           P+             +  A  D++S GV      TG  P      PR  + +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  116 bits (291), Expect = 1e-29
 Identities = 32/283 (11%), Positives = 61/283 (21%), Gaps = 44/283 (15%)

Query: 37  SEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAA 95
             AA   A    V P          L +          +  G    V+    ++     A
Sbjct: 32  EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91

Query: 96  IKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLLGYC-------------------- 131
           +K      +     L ++       +RL  E+  +                         
Sbjct: 92  LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151

Query: 132 ------VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
                     + +L    AS   L  +                       +     +   
Sbjct: 152 SPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAA 208

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
            L  K    ++H      N+ I  D    + D     +                  Y   
Sbjct: 209 NLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPR 260

Query: 246 EYAM--TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286
           E+    T       + +  G+ +  +     P     P  + S
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  113 bits (284), Expect = 4e-29
 Identities = 40/221 (18%), Positives = 76/221 (34%), Gaps = 27/221 (12%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRL-KHENFVQLL 128
            IG G +G V+  +    G   AIK+         +    L +V   + L +H + V+  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
               +    ++  E+ + GSL D +     +        L       + +   +GL Y+H
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLLLQVGRGLRYIH 132

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD------------MAARLHSTRV 236
                 ++H DIK SN+ I    +   A  +                      R+ S +V
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 237 L-GTFGYHAPE-YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             G   + A E          K+D+++  + ++        
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  112 bits (282), Expect = 2e-28
 Identities = 52/225 (23%), Positives = 85/225 (37%), Gaps = 30/225 (13%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLK-HENFVQLLGY 130
           ++ EG +  VY    + SG   A+K+L ++++     + Q V  + +L  H N VQ    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 131 CVDGTSR-------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
              G           L       G L + L   +          LS    +KI     + 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP------LSCDTVLKIFYQTCRA 148

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----------DLSNQAPDMAARLHS 233
           ++++H +  P IIHRD+K  N+L+ +    K+ DF          D S  A   A     
Sbjct: 149 VQHMHRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 234 TRVLGTFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                T  Y  PE         +  K D+++ G +L  L   + P
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  109 bits (275), Expect = 4e-27
 Identities = 46/236 (19%), Positives = 90/236 (38%), Gaps = 31/236 (13%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H 121
           + +     +  ++G GS G V +     G   A+K++       +  L ++ +++    H
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDH 68

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++            +A E   N +L D++  +      +   +      + +    A
Sbjct: 69  PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN--VSDENLKLQKEYNPISLLRQIA 125

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLI-------------FDDDVAKIADFDLSNQ--APD 226
            G+ +LH      IIHRD+K  N+L+              ++    I+DF L  +  +  
Sbjct: 126 SGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 227 MAARLHSTRVLGTFGYHAPE-------YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            + R +     GT G+ APE            +L    D++S G V   +L+  K 
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  110 bits (277), Expect = 9e-27
 Identities = 41/223 (18%), Positives = 78/223 (34%), Gaps = 33/223 (14%)

Query: 73  ALIGEGSYGRVYYG--ILKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLL 128
             I  G  G +Y       +G    +K L  S   +     +A+   ++ + H + VQ+ 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 129 --GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
                 D     + Y   E+    SL      +           L   + +   +     
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLEILPA 194

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST-RVLGTFGY 242
           L YLH      +++ D+K  N+++ ++ + K+ D           +R++S   + GT G+
Sbjct: 195 LSYLHSI---GLVYNDLKPENIMLTEEQL-KLIDLGA-------VSRINSFGYLYGTPGF 243

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
            APE          +D+Y+ G  L  L       +     G  
Sbjct: 244 QAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  108 bits (270), Expect = 9e-27
 Identities = 31/307 (10%), Positives = 84/307 (27%), Gaps = 55/307 (17%)

Query: 35  HASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHA 93
              ++A     +  +     P     EL E         ++G+            ++G +
Sbjct: 41  EYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGES 100

Query: 94  AAIKKLDASKQPDEE-----------------------------FLAQVSMVSRLKHENF 124
             +     +++P                                F+    +V   + +  
Sbjct: 101 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 160

Query: 125 VQLLGYCVDGT--SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           +++     D    SR   Y      +L     G   +  +     L    R+++ +   +
Sbjct: 161 IRVRLDERDMWVLSRFFLYPRMQ-SNLQTF--GEVLLSHSSTHKSLVHHARLQLTLQVIR 217

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            L  LH      ++H  ++  ++++       +  F+   +               + G+
Sbjct: 218 LLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVSRGF 268

Query: 243 HAPEYAMT-----------GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 291
             PE                 +    D ++ G+V+  +     P+      G    +  +
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS 328

Query: 292 TPKLSED 298
              + + 
Sbjct: 329 CKNIPQP 335

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  104 bits (262), Expect = 5e-26
 Identities = 64/245 (26%), Positives = 91/245 (37%), Gaps = 55/245 (22%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-----------------QPDEEFLAQVSM 115
            IG+GSYG V            A+K L   K                       +     
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 116 VSR----------LKHENFVQLLGYCV-DGTSRVLAY---EFASNGSLHDIL-HGRKGVK 160
           + +          L H N V+L    V D  +    Y   E  + G + ++         
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---- 133

Query: 161 GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220
                  LS  Q         KG+EYLH +    IIHRDIK SN+L+ +D   KIADF +
Sbjct: 134 -------LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN---AKSDVYSFGVVLLELLTGRKP-V 276
           SN+     A L +T   GT  + APE     +        DV++ GV L   + G+ P +
Sbjct: 184 SNEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

Query: 277 DHTLP 281
           D  + 
Sbjct: 242 DERIM 246

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  103 bits (259), Expect = 2e-25
 Identities = 40/142 (28%), Positives = 63/142 (44%), Gaps = 21/142 (14%)

Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGLEYLHEKADPHIIHRDI 200
           +     +L D ++ R  ++  + G  L    Q   IA    + +E+LH K    ++HRD+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQ---IA----EAVEFLHSK---GLMHRDL 190

Query: 201 KSSNVLIFDDDVAKIADF----------DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
           K SN+    DDV K+ DF          +       M A    T  +GT  Y +PE    
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250

Query: 251 GQLNAKSDVYSFGVVLLELLTG 272
              + K D++S G++L ELL  
Sbjct: 251 NNYSHKVDIFSLGLILFELLYS 272

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 39.9 bits (93), Expect = 8e-04
 Identities = 14/63 (22%), Positives = 29/63 (46%), Gaps = 3/63 (4%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHEN 123
            +F     +G G +G V+    K      AIK++    +    E+ + +V  +++L+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 124 FVQ 126
            V+
Sbjct: 66  IVR 68

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  103 bits (259), Expect = 6e-25
 Identities = 27/304 (8%), Positives = 81/304 (26%), Gaps = 48/304 (15%)

Query: 34  YHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGH 92
               ++A     +  +     P     EL E         ++G+            ++G 
Sbjct: 45  SEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGE 104

Query: 93  AAAIKKLDASKQPDEEFLAQ--------------------------VSMVSRLKHENFVQ 126
           +  +     +++P    + Q                          +     +K     +
Sbjct: 105 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164

Query: 127 LLGYCVDGTSRVLAYEF-------ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           ++   +D     +   F       ++  +  ++L        +     L    R+++ + 
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----LVHHARLQLTLQ 219

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
             + L  LH      ++H  ++  ++++       +  F+        +A     R    
Sbjct: 220 VIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAVSPIGRGFAP 275

Query: 240 FGYHAPE-----YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
               A             +    D ++ G+ +  +     P       G    +  +   
Sbjct: 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN 335

Query: 295 LSED 298
           + + 
Sbjct: 336 IPQP 339

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (250), Expect = 2e-24
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 31/220 (14%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-QPDEEFLAQV----SMVSRLKHENFVQL 127
           L+GEGSYG+V   +  ++    A+K L   K +      A V     ++ RL+H+N +QL
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 128 LGYCVDGTSR--VLAYEFASNGS--LHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           +    +   +   +  E+   G   + D +   R  V  A       + Q +        
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH----GYFCQLID------- 120

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA--RLHSTRVLGTF 240
           GLEYLH +    I+H+DIK  N+L+      KI+   ++      AA     +++  G+ 
Sbjct: 121 GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSP 175

Query: 241 GYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVDH 278
            +  PE A         K D++S GV L  + TG  P + 
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 98.8 bits (247), Expect = 5e-24
 Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 24/212 (11%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHENFVQLLGY 130
            +GEG+YG V   +   +  A A+K +D  +  D     +  + +   L HEN V+  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 131 CVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
             +G  + L  E+ S G L D +          AQ      + Q +        G+ YLH
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----RFFHQLMA-------GVVYLH 122

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHSTRVLGTFGYHAPEY 247
                 I HRDIK  N+L+ + D  KI+DF L+         RL +    GT  Y APE 
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE- 177

Query: 248 AMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 277
            +  +       DV+S G+VL  +L G  P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 98.0 bits (245), Expect = 1e-23
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 31/215 (14%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
            +G G++G+V  G    +GH  A+K L+  K    + + ++      +   +H + ++L 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76

Query: 129 GYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
            Y V  T     +  E+ S G L D +  HGR     A       +QQ +         +
Sbjct: 77  -YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----RRLFQQILS-------AV 124

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
           +Y H      ++HRD+K  NVL+     AKIADF LSN   D    L ++   G+  Y A
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNYAA 178

Query: 245 PEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 277
           PE  ++G+L    + D++S GV+L  LL G  P D
Sbjct: 179 PE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 97.4 bits (243), Expect = 3e-23
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 31/218 (14%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASK--QPDEEFLAQ-VSMVSRLKHENFVQLLGY 130
           IG+G++ +V     + +G   AIK +D ++      + L + V ++  L H N V+L  +
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80

Query: 131 CVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
            V  T +   L  E+AS G + D L  HGR   K A+      ++Q V         ++Y
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS----KFRQIVS-------AVQY 129

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
            H+K    I+HRD+K+ N+L+  D   KIADF  SN+              G   Y APE
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPYAAPE 183

Query: 247 YAMTGQL--NAKSDVYSFGVVLLELLTGRKP-VDHTLP 281
               G+     + DV+S GV+L  L++G  P     L 
Sbjct: 184 -LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 32/216 (14%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHENFVQLLGY 130
            +GEG+YG V   +   +  A A+K +D  +  D     +  + +   L HEN V+  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 131 CVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
             +G  + L  E+ S G L D +          AQ      + Q +        G+ YLH
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----RFFHQLMA-------GVVYLH 122

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHSTRVLGTFGYHAPE- 246
                 I HRDIK  N+L+ + D  KI+DF L+         RL +    GT  Y APE 
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

Query: 247 -----YAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
                +          DV+S G+VL  +L G  P D
Sbjct: 179 LKRREFH--A---EPVDVWSCGIVLTAMLAGELPWD 209

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 96.3 bits (240), Expect = 9e-23
 Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 34/260 (13%)

Query: 35  HASEAAPKGAQAVKVQPIEVPAISVDELKEITE-NFGTNALIGEGSYGRVYYGI-LKSGH 92
           H+S   P+G+       +    ++  + KE  E  +    L+G G +G VY GI +    
Sbjct: 10  HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69

Query: 93  AAAIKKLDASKQPDEEFLAQVSMVSR-------LKHE--NFVQLLGYCVDGTSRVLAYEF 143
             AIK ++  +  D   L   + V         +       ++LL +     S VL  E 
Sbjct: 70  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129

Query: 144 ASN-GSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI 200
                 L D     G            L  +          + + + H      ++HRDI
Sbjct: 130 PEPVQDLFDFITERGA-----------LQEELARSFFWQVLEAVRHCHNC---GVLHRDI 175

Query: 201 KSSNVLIFDDDV-AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA-KSD 258
           K  N+LI  +    K+ DF       D    +++    GT  Y  PE+    + +   + 
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKD---TVYTDFD-GTRVYSPPEWIRYHRYHGRSAA 231

Query: 259 VYSFGVVLLELLTGRKPVDH 278
           V+S G++L +++ G  P +H
Sbjct: 232 VWSLGILLYDMVCGDIPFEH 251

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 63/251 (25%), Positives = 101/251 (40%), Gaps = 25/251 (9%)

Query: 34  YHASEAAPKGAQAVKVQPIEVPAISVDELKE--ITENFGTNALIGEGSYGRVYYGILK-S 90
           +H    +           ++         K+  ++E +     +G G+YG V     K +
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 91  GHAAAIK---KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147
               AIK   K   S   + + L +V+++  L H N ++L  +  D  +  L  E    G
Sbjct: 62  HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121

Query: 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207
            L D +  R            +      I      G+ YLH+    +I+HRD+K  N+L+
Sbjct: 122 ELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLL 169

Query: 208 FDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264
              +   + KI DF LS    +          LGT  Y APE  +  + + K DV+S GV
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGV 225

Query: 265 VLLELLTGRKP 275
           +L  LL G  P
Sbjct: 226 ILFILLAGYPP 236

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 96.3 bits (240), Expect = 1e-22
 Identities = 62/218 (28%), Positives = 90/218 (41%), Gaps = 39/218 (17%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
            IG G++G         +    A+K ++     DE    ++     L+H N V+     V
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF--KEV 84

Query: 133 DGTSRVLAY--EFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
             T   LA   E+AS G L++ +   GR     A+      +QQ +        G+ Y H
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR----FFFQQLL-------SGVSYCH 133

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
                 I HRD+K  N L+ D   A   KI DF  S  +    ++  ST  +GT  Y AP
Sbjct: 134 SM---QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL-HSQPKST--VGTPAYIAP 186

Query: 246 E------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           E      Y   G     +DV+S GV L  +L G  P +
Sbjct: 187 EVLLRQEYD--G---KIADVWSCGVTLYVMLVGAYPFE 219

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 31/215 (14%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
            +G G++G+V  G    +GH  A+K L+  K    + + ++      +   +H + ++L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81

Query: 129 GYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
            Y V  T     +  E+ S G L D +  +GR   K +       +QQ +        G+
Sbjct: 82  -YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES----RRLFQQILS-------GV 129

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
           +Y H      ++HRD+K  NVL+     AKIADF LSN   D    L ++   G+  Y A
Sbjct: 130 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNYAA 183

Query: 245 PEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 277
           PE  ++G+L    + D++S GV+L  LL G  P D
Sbjct: 184 PE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 94.1 bits (234), Expect = 8e-22
 Identities = 62/263 (23%), Positives = 84/263 (31%), Gaps = 47/263 (17%)

Query: 57  ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIK-----KLDASKQPDEEFL 110
                L E+ + +     IG+GSYG V   I   +    AIK     K+      D E +
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75

Query: 111 AQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
              V ++ +L H N  +L     D     L  E    G L D L+        +    + 
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135

Query: 170 WQQRVKIAVG------------------------AAK-------GLEYLHEKADPHIIHR 198
             Q                                +         L YLH +    I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHR 192

Query: 199 DIKSSNVLIFDDDVA--KIADFDLSN--QAPDMAARLHSTRVLGTFGYHAPE--YAMTGQ 252
           DIK  N L   +     K+ DF LS      +       T   GT  + APE        
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252

Query: 253 LNAKSDVYSFGVVLLELLTGRKP 275
              K D +S GV+L  LL G  P
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVP 275

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 92.7 bits (231), Expect = 9e-22
 Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 18/219 (8%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD--ASKQPDEEFLAQVSMVSRL 119
             I + F     +G G++G V+    + SG    IK ++   S+ P E+  A++ ++  L
Sbjct: 18  GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77

Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            H N +++     D  +  +  E    G L + +   +          LS     ++   
Sbjct: 78  DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQ 132

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHSTRV 236
               L Y H +   H++H+D+K  N+L  D       KI DF L+           +   
Sbjct: 133 MMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA 187

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT  Y APE      +  K D++S GVV+  LLTG  P
Sbjct: 188 -GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 24/221 (10%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD----ASKQPDEEFLAQVSMVS 117
              ++ +    ++G+GS+G V     K +G   A+K +       K   E  L +V ++ 
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81

Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           +L H N ++L  +  D     L  E  + G L D +  RK           S     +I 
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---------RFSEVDAARII 132

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHST 234
                G+ Y+H+     I+HRD+K  N+L+         +I DF LS             
Sbjct: 133 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---K 186

Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             +GT  Y APE  + G  + K DV+S GV+L  LL+G  P
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 46/225 (20%)

Query: 75  IGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
           +G G+YG VY    K        A+K+++ +         +++++  LKH N + L    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKVF 87

Query: 132 VDGTSR--VLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           +    R   L +++A     HD   I+   +  K  +    L       +      G+ Y
Sbjct: 88  LSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAARL---------HS 233
           LH      ++HRD+K +N+L+  +       KIAD           ARL           
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------ARLFNSPLKPLADL 192

Query: 234 TRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
             V+ TF Y APE      L A+      D+++ G +  ELLT  
Sbjct: 193 DPVVVTFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE 233

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 53/255 (20%), Positives = 103/255 (40%), Gaps = 18/255 (7%)

Query: 25  KSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY 84
               G       + ++        +     P     +   + +++  +  +G G++G V+
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174

Query: 85  YGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142
               ++ G+  A K +    + D+E + + +  +S L+H   V L     D    V+ YE
Sbjct: 175 RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234

Query: 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202
           F S G L + +              +S  + V+      KGL ++HE    + +H D+K 
Sbjct: 235 FMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKP 283

Query: 203 SNVLIF--DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY 260
            N++      +  K+ DF L+     +  +       GT  + APE A    +   +D++
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340

Query: 261 SFGVVLLELLTGRKP 275
           S GV+   LL+G  P
Sbjct: 341 SVGVLSYILLSGLSP 355

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 92.0 bits (229), Expect = 2e-21
 Identities = 46/222 (20%), Positives = 75/222 (33%), Gaps = 35/222 (15%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSR-----------LKH 121
           L+G+G +G V+ G  L      AIK +  ++      L+                    H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGS-LHD--ILHGRKGVKGAQPGPVLSWQQRVKIAV 178
              ++LL +       +L  E       L D     G            L          
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-----------LGEGPSRCFFG 146

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVL 237
                +++ H +    ++HRDIK  N+LI      AK+ DF       D           
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDF--D 199

Query: 238 GTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDH 278
           GT  Y  PE+    Q     + V+S G++L +++ G  P + 
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 32/215 (14%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
            +GEGS+G+V      K+    A+K +        +   +V    S +  L+H + ++L 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74

Query: 129 GYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
            Y V  T    V+  E+A  G L D +    R             +QQ +         +
Sbjct: 75  -YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEG----RRFFQQIIC-------AI 121

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
           EY H      I+HRD+K  N+L+ D+   KIADF LSN   D    L ++   G+  Y A
Sbjct: 122 EYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTS--CGSPNYAA 175

Query: 245 PEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 277
           PE  + G+L    + DV+S G+VL  +L GR P D
Sbjct: 176 PE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 67/259 (25%), Positives = 102/259 (39%), Gaps = 37/259 (14%)

Query: 35  HASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHA 93
           H+S       Q + + P         +  +I E++     +G G+YG V     K     
Sbjct: 7   HSSGRENLYFQGIAINP---GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63

Query: 94  AAIKKLDASK-------------QPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVL 139
            AIK +  S+             +   E +   +S++  L H N ++L     D     L
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123

Query: 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 199
             EF   G L + +  R                   I      G+ YLH+    +I+HRD
Sbjct: 124 VTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLHKH---NIVHRD 171

Query: 200 IKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAK 256
           IK  N+L+ + +     KI DF LS+       +L     LGT  Y APE  +  + N K
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKLRD--RLGTAYYIAPE-VLKKKYNEK 227

Query: 257 SDVYSFGVVLLELLTGRKP 275
            DV+S GV++  LL G  P
Sbjct: 228 CDVWSCGVIMYILLCGYPP 246

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 23/220 (10%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIK---KLDASKQPDEEFLAQVSMVSR 118
               E +    ++G+GS+G V     + +    A+K   K  A  +     L +V ++ +
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77

Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
           L H N ++L     D +S  +  E  + G L D +  RK           S     +I  
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIK 128

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTR 235
               G+ Y+H+    +I+HRD+K  N+L+   +     KI DF LS        ++    
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKD-- 182

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            +GT  Y APE  + G  + K DV+S GV+L  LL+G  P
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 34/243 (13%)

Query: 50  QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIK-----KLDASK 103
           + +E+  ++  E  E ++ + T + +G G++G V+  +  +      +K     K+    
Sbjct: 8   KAVELEGLAACE-GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66

Query: 104 QPDEEFLAQV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS-LHD--ILHGR 156
             ++  L +V    +++SR++H N +++L    +     L  E   +G  L      H R
Sbjct: 67  WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR 126

Query: 157 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216
                      L       I       + YL  K    IIHRDIK  N++I +D   K+ 
Sbjct: 127 -----------LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLI 172

Query: 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRK 274
           DF  +        +L  T   GT  Y APE  + G      + +++S GV L  L+    
Sbjct: 173 DFGSAAYLER--GKLFYTFC-GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEEN 228

Query: 275 PVD 277
           P  
Sbjct: 229 PFC 231

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 27/208 (12%), Positives = 51/208 (24%), Gaps = 48/208 (23%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKHENFVQL 127
              G     + +  +        A+  +D      ++ L +       +SR+      ++
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           L         ++  E+   GSL ++           P P       ++     A   +  
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSP----VGAIRAMQSLAAAADAA 145

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
           H      +       S V +  D                          L          
Sbjct: 146 HRA---GVALSIDHPSRVRVSIDGDVV----------------------LAYPATMPDA- 179

Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                 N + D+   G  L  LL  R P
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWP 201

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 87.2 bits (217), Expect = 1e-19
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 23/218 (10%)

Query: 64  EITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKH 121
            I + F    ++G G++  V+    +  G   A+K +  S    +  L   ++++ ++KH
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           EN V L       T   L  +  S G L D IL   +GV         + +    +    
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGV--------YTEKDASLVIQQV 115

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVL 237
              ++YLHE     I+HRD+K  N+L     ++    I DF LS    +    + +    
Sbjct: 116 LSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMST--AC 168

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           GT GY APE       +   D +S GV+   LL G  P
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 20/218 (9%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLK 120
             + + +     +G G++G V+  + K+ G     K ++     D+  +   +S++++L 
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H   + L     D    VL  EF S G L D +              +S  + +     A
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAEVINYMRQA 158

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQA-PDMAARLHSTRVL 237
            +GL+++HE     I+H DIK  N++      +  KI DF L+ +  PD   ++      
Sbjct: 159 CEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV----TT 211

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            T  + APE      +   +D+++ GV+   LL+G  P
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.5 bits (215), Expect = 1e-19
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 25/219 (11%)

Query: 64  EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKH 121
           +I + +     IG GS+G V   + K +    A KK+      D +   Q + ++  L H
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 65

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            N ++L     D T   L  E  + G L +  +         A         + +K  + 
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMKDVLS 117

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A   + Y H+    ++ HRD+K  N L      D   K+ DF L+ +      ++  T+V
Sbjct: 118 A---VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKV 169

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            GT  Y +P+  + G    + D +S GV++  LL G  P
Sbjct: 170 -GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 59/261 (22%), Positives = 97/261 (37%), Gaps = 41/261 (15%)

Query: 32  GAYHASEAAPKGAQAVKVQP----IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI 87
           G++  S A   G +   +      I+V A      ++    +    +IG GS+G V+   
Sbjct: 1   GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60

Query: 88  LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV------LAY 141
           L      AIKK+    Q       ++ ++  +KH N V L  +      +       L  
Sbjct: 61  LVESDEVAIKKV---LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117

Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVL-----SWQQRVKIAVGAAKGLEYLHEKADPHII 196
           E+    +++     R   K  Q  P+L      +Q          + L Y+H      I 
Sbjct: 118 EYVPE-TVYRAS--RHYAKLKQTMPMLLIKLYMYQ--------LLRSLAYIHSI---GIC 163

Query: 197 HRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLH--STRVLGTFGYHAPEYAMTGQL 253
           HRDIK  N+L+     V K+ DF  +         +    +R      Y APE       
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATN 218

Query: 254 -NAKSDVYSFGVVLLELLTGR 273
                D++S G V+ EL+ G+
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQ 239

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.4 bits (215), Expect = 2e-19
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 39/216 (18%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           IGEG+YG V+     ++    A+K+  LD      E      L ++ ++  LKH+N V+L
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRL 66

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGLEY 186
                      L +EF     L        G     P  V S+  Q +K       GL +
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLK-------GLGF 116

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN--QAPDMAARLHSTRVLGTFGYHA 244
            H +   +++HRD+K  N+LI  +   K+A+F L+     P    R +S  V+ T  Y  
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVV-TLWYRP 169

Query: 245 PEYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 275
           P+        AK      D++S G +  EL    +P
Sbjct: 170 PDVL----FGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 38/213 (17%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQLL 128
           +GEG+YG VY      G   A+K+  LD     DE      + ++S++  L H N V L+
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLD---AEDEGIPSTAIREISLLKELHHPNIVSLI 85

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGLEYL 187
                     L +EF     L  +L   K   G Q   +  +  Q ++       G+ + 
Sbjct: 86  DVIHSERCLTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLR-------GVAHC 135

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVLGTFGYHAP 245
           H+     I+HRD+K  N+LI  D   K+ADF L+     P    R ++  V+ T  Y AP
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV---RSYTHEVV-TLWYRAP 188

Query: 246 EYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
           +      + +K      D++S G +  E++TG+
Sbjct: 189 DVL----MGSKKYSTSVDIWSIGCIFAEMITGK 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.0 bits (214), Expect = 2e-19
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 38/213 (17%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQLL 128
           IGEG+YG VY      G   A+KK  L+      E      + ++S++  LKH N V+L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLY 66

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEYL 187
                    VL +E        D+    K +     G + S     K   +    G+ Y 
Sbjct: 67  DVIHTKKRLVLVFEHLD----QDL----KKLLDVCEGGLESVT--AKSFLLQLLNGIAYC 116

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN--QAPDMAARLHSTRVLGTFGYHAP 245
           H++    ++HRD+K  N+LI  +   KIADF L+     P    R ++  ++ T  Y AP
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIV-TLWYRAP 169

Query: 246 EYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
           +      + +K      D++S G +  E++ G 
Sbjct: 170 DVL----MGSKKYSTTIDIWSVGCIFAEMVNGT 198

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 21/218 (9%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
           KE+ E +     +G G +G V+  +  S       K +            ++S+++  +H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
            N + L          V+ +EF S   + + I               L+ ++ V      
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQV 111

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQ-APDMAARLHSTRVL 237
            + L++LH     +I H DI+  N++      +  KI +F  + Q  P    RL    + 
Sbjct: 112 CEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LF 164

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
               Y+APE      ++  +D++S G ++  LL+G  P
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 86.3 bits (214), Expect = 8e-19
 Identities = 52/231 (22%), Positives = 84/231 (36%), Gaps = 36/231 (15%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ--------- 112
           K + + +  +  +G G+ G V     +      AI+ +   K                  
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190

Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSW 170
           + ++ +L H   +++  +  D     +  E    G L D  + + R      +       
Sbjct: 191 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK------- 242

Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDM 227
                        ++YLHE     IIHRD+K  NVL+   +   + KI DF  S    + 
Sbjct: 243 ----LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295

Query: 228 AARLHSTRVLGTFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +  L  T   GT  Y APE      T   N   D +S GV+L   L+G  P
Sbjct: 296 S--LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 59/247 (23%), Positives = 96/247 (38%), Gaps = 21/247 (8%)

Query: 43  GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIK---- 97
           G+  +      +  ++ D+     + +    +IG+G +  V   I +  G   A+K    
Sbjct: 1   GSPGISGGGGGILDMADDD-VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDV 59

Query: 98  -KLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155
            K  +S     E L +  S+   LKH + V+LL          + +EF     L   +  
Sbjct: 60  AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI-- 117

Query: 156 RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA-- 213
              VK A  G V S            + L Y H+    +IIHRD+K   VL+   + +  
Sbjct: 118 ---VKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAP 171

Query: 214 -KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
            K+  F ++ Q  +          +GT  + APE           DV+  GV+L  LL+G
Sbjct: 172 VKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

Query: 273 RKPVDHT 279
             P   T
Sbjct: 230 CLPFYGT 236

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           +G G+Y  VY G+   +G   A+K+  LD+    +E      + ++S++  LKHEN V+L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTPSTAIREISLMKELKHENIVRL 68

Query: 128 LGYCVDGTSRVLAYEFASN--GSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGL 184
                      L +EF  N      D        +G +   V  +  Q         +GL
Sbjct: 69  YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ-------LLQGL 121

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
            + HE     I+HRD+K  N+LI      K+ DF L+ +A  +     S+ V+ T  Y A
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVNTFSSEVV-TLWYRA 176

Query: 245 PEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
           P+      + +++     D++S G +L E++TG+
Sbjct: 177 PDVL----MGSRTYSTSIDIWSCGCILAEMITGK 206

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 39/219 (17%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLK---HENF 124
           IG G+YG VY      SGH  A+K   +              + +V+++ RL+   H N 
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 125 VQLLGYCVDGTSRV-----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           V+L+  C    +       L +E        D+    +      P P L  +    +   
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVD----QDL----RTYLDKAPPPGLPAETIKDLMRQ 128

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----T 234
             +GL++LH      I+HRD+K  N+L+      K+ADF L        AR++S     T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQMALT 177

Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
            V+ T  Y APE  +        D++S G +  E+   +
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 47/224 (20%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           IG+G++G V+     K+G   A+KK  ++  K   E F    L ++ ++  LKHEN V L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNL 81

Query: 128 LGYCVDGTSRV--------LAYEFASNGSLHDILHGRKGVKG--AQPGPVLSWQQRVKIA 177
           +  C    S          L ++F      HD+        G  +      +  +  ++ 
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCE----HDL-------AGLLSNVLVKFTLSEIKRVM 130

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHST 234
                GL Y+H      I+HRD+K++NVLI  D V K+ADF L+   + A +     ++ 
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 235 RVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
           RV+ T  Y  PE      L  +      D++  G ++ E+ T  
Sbjct: 188 RVV-TLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRS 226

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 27/222 (12%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSR 118
               E +    ++G+GS+G V     +      A+K ++ +     D   + + V ++ +
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77

Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKI 176
           L H N ++L     D +S  +  E  + G L D  I   R            S     +I
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----------FSEHDAARI 126

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHS 233
                 G+ Y+H+    +I+HRD+K  N+L+   +     KI DF LS            
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMK 181

Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            R+ GT  Y APE  + G  + K DV+S GV+L  LL+G  P
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 57/236 (24%), Positives = 87/236 (36%), Gaps = 37/236 (15%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK---------QPDEEFLAQ 112
               EN+    ++G G    V   I K      A+K +D +          Q   E   +
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72

Query: 113 -VSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVL 168
            V ++ ++  H N +QL       T   L ++    G L D                  L
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----------L 121

Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
           S ++  KI     + +  LH+    +I+HRD+K  N+L+ DD   K+ DF  S Q     
Sbjct: 122 SEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-- 176

Query: 229 ARLHSTRVLGTFGYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
                    GT  Y APE               + D++S GV++  LL G  P  H
Sbjct: 177 GEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 60/240 (25%), Positives = 92/240 (38%), Gaps = 64/240 (26%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
           +    ++    +IG GS+G VY   L  SG   AIKK+    Q       ++ ++ +L H
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNRELQIMRKLDH 106

Query: 122 ENFVQLLGYCVDGTSRV-------LAYEFASNGSLHDILHGRKGVKGAQPGPVL-----S 169
            N V+L  Y    +          L  ++    +++ +   R   +  Q  PV+      
Sbjct: 107 CNIVRLR-YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA--RHYSRAKQTLPVIYVKLYM 162

Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMA 228
           +Q          + L Y+H      I HRDIK  N+L+  D  V K+ DF          
Sbjct: 163 YQ--------LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS-------- 203

Query: 229 ARLHS----------TRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
           A+             +R      Y APE  +     A       DV+S G VL ELL G+
Sbjct: 204 AKQLVRGEPNVSYICSRY-----YRAPE-LI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 28/217 (12%)

Query: 68  NFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFV 125
                 ++G G +G+V+     + G   A K +      D+E +   +S++++L H N +
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
           QL          VL  E+   G L D I+              L+    +       +G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII---------DESYNLTELDTILFMKQICEGI 200

Query: 185 EYLHEKADPHIIHRDIKSSNVLIF--DDDVAKIADFDLSNQAPDMAARLHSTRVL----G 238
            ++H+    +I+H D+K  N+L    D    KI DF L+        R      L    G
Sbjct: 201 RHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLA-------RRYKPREKLKVNFG 250

Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           T  + APE      ++  +D++S GV+   LL+G  P
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 65/270 (24%), Positives = 101/270 (37%), Gaps = 27/270 (10%)

Query: 12  MHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGT 71
           MH    + +          +  + +  +    A       +    I       +++ F  
Sbjct: 1   MHH---HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEV 57

Query: 72  NALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLG 129
            + +G G+   VY    K      A+K L   K  D++ +   + ++ RL H N ++L  
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 130 YCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
                T   L  E  + G L D I+   KG          S +          + + YLH
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIV--EKGY--------YSERDAADAVKQILEAVAYLH 165

Query: 189 EKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           E     I+HRD+K  N+L      D   KIADF LS         L  T   GT GY AP
Sbjct: 166 EN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVC-GTPGYCAP 219

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           E         + D++S G++   LL G +P
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 42/217 (19%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           +GEG +  VY      +    AIKK  L    +  +      L ++ ++  L H N + L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 128 LGYCVDGTSRVLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKG 183
           L      ++  L ++F       D   I+     V    P  + ++            +G
Sbjct: 78  LDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLT--PSHIKAYMLM-------TLQG 124

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVLGTFG 241
           LEYLH+     I+HRD+K +N+L+ ++ V K+ADF L+    +P+   R ++ +V+ T  
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---RAYTHQVV-TRW 177

Query: 242 YHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
           Y APE        A+      D+++ G +L ELL   
Sbjct: 178 YRAPELL----FGARMYGVGVDMWAVGCILAELLLRV 210

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 40/222 (18%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLK 120
           E +     +GEG+Y  VY G  K + +  A+K++   +   EE      + +VS++  LK
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 58

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSW-QQRVKI 176
           H N V L        S  L +E+       D    L             V  +  Q ++ 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGN--IINMHNVKLFLFQLLR- 111

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
                 GL Y H +    ++HRD+K  N+LI +    K+ADF L+ +A  +  + +   V
Sbjct: 112 ------GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYDNEV 161

Query: 237 LGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
           + T  Y  P+      L +       D++  G +  E+ TGR
Sbjct: 162 V-TLWYRPPDIL----LGSTDYSTQIDMWGVGCIFYEMATGR 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 27/216 (12%)

Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKH 121
           E +    L+GEGSYG V       +G   AIKK   S   D+      + ++ ++ +L+H
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRH 83

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGA 180
           EN V LL  C       L +EF  + ++ D L       G     V  +  Q +      
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN--GLDYQVVQKYLFQII------ 134

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS--NQAPDMAARLHSTRVLG 238
             G+ + H     +IIHRDIK  N+L+    V K+ DF  +    AP     ++   V  
Sbjct: 135 -NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---EVYDDEVA- 186

Query: 239 TFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
           T  Y APE  +   +     DV++ G ++ E+  G 
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 79.9 bits (198), Expect = 3e-17
 Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 22/220 (10%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSR 118
            + ++N+     +G+G++  V   + K+ G   A K ++  K    D + L +   +  +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61

Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
           L+H N V+L     + +   L ++  + G L + +  R+           S         
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQ 112

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTR 235
              + + Y H      I+HR++K  N+L+         K+ADF L+ +  D  +      
Sbjct: 113 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGF 167

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
             GT GY +PE       +   D+++ GV+L  LL G  P
Sbjct: 168 A-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 38/260 (14%)

Query: 37  SEAAPKGAQAVKVQPIEVPAISVD--ELKEITENFGTNALIGEGSYGRVYYGILKS-GHA 93
           ++A PKG + +  Q +       D    KE  + +    +IG G    V   + ++ GH 
Sbjct: 62  NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121

Query: 94  AAIKKLDASK--QPDEEFLAQVSMVSR----LK----HENFVQLLGYCVDGTSRVLAYEF 143
            A+K ++ +      E+         R    L+    H + + L+      +   L ++ 
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181

Query: 144 ASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
              G L D                  LS ++   I     + + +LH     +I+HRD+K
Sbjct: 182 MRKGELFDYLTEKVA-----------LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLK 227

Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE------YAMTGQLNA 255
             N+L+ D+   +++DF  S                GT GY APE               
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEP--GEKLRELC-GTPGYLAPEILKCSMDETHPGYGK 284

Query: 256 KSDVYSFGVVLLELLTGRKP 275
           + D+++ GV+L  LL G  P
Sbjct: 285 EVDLWACGVILFTLLAGSPP 304

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 60/216 (27%), Positives = 88/216 (40%), Gaps = 43/216 (19%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
           IGEGSYG V+      +G   AIKK   S+  D       L ++ M+ +LKH N V LL 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLE 69

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHG-RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
                    L +E+      H +LH   +  +G     V S   +        + + + H
Sbjct: 70  VFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQT------LQAVNFCH 119

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS------TRVLGTFGY 242
           +    + IHRD+K  N+LI    V K+ DF          ARL +         + T  Y
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGF--------ARLLTGPSDYYDDEVATRWY 168

Query: 243 HAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
            +PE      +         DV++ G V  ELL+G 
Sbjct: 169 RSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 54/253 (21%), Positives = 91/253 (35%), Gaps = 40/253 (15%)

Query: 36  ASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAA 94
           A      G+      P +      +       +F    ++GEGS+  V       +    
Sbjct: 6   AEPRPGAGSLQHAQPPPQPRKKRPE-------DFKFGKILGEGSFSTVVLARELATSREY 58

Query: 95  AIKKLD----ASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH 150
           AIK L+      +        +  ++SRL H  FV+L     D         +A NG L 
Sbjct: 59  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118

Query: 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKS 202
             +                 ++         +         LEYLH K    IIHRD+K 
Sbjct: 119 KYI-----------------RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKP 158

Query: 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSF 262
            N+L+ +D   +I DF  +      + +  +   +GT  Y +PE          SD+++ 
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 218

Query: 263 GVVLLELLTGRKP 275
           G ++ +L+ G  P
Sbjct: 219 GCIIYQLVAGLPP 231

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 30/219 (13%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLK-HENFVQLLGY 130
           ++GEG++ RV   I   +    A+K ++         + + V M+ + + H N ++L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
             +     L +E    GS+   +H R+           +  +   +    A  L++LH K
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHNK 130

Query: 191 ADPHIIHRDIKSSNVLIFD-DDVA--KIADFDLS------NQAPDMAARLHSTRVLGTFG 241
               I HRD+K  N+L    + V+  KI DFDL            ++     T   G+  
Sbjct: 131 ---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAE 186

Query: 242 YHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 275
           Y APE        A       D++S GV+L  LL+G  P
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 33/228 (14%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR--- 118
           +++ + +     +G G +  V     KS G   A K +   +            + R   
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 119 ----LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
               + H N + L     + T  VL  E  S G L D L  ++          LS ++  
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEAT 118

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAPDM 227
                   G+ YLH K    I H D+K  N+++ D ++     K+ DF L+       + 
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175

Query: 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                   + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 176 ------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 79.3 bits (196), Expect = 8e-17
 Identities = 54/231 (23%), Positives = 83/231 (35%), Gaps = 36/231 (15%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ--------- 112
           K + + +  +  +G G+ G V     +      AIK +   K                  
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSW 170
           + ++ +L H   +++  +  D     +  E    G L D  + + R           L  
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-----------LKE 113

Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDM 227
                        ++YLHE     IIHRD+K  NVL+   +   + KI DF  S    + 
Sbjct: 114 ATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170

Query: 228 AARLHSTRVLGTFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
              L  T   GT  Y APE      T   N   D +S GV+L   L+G  P
Sbjct: 171 --SLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 79.7 bits (197), Expect = 9e-17
 Identities = 52/245 (21%), Positives = 99/245 (40%), Gaps = 25/245 (10%)

Query: 40  APKGAQAVKVQPIEVPA-ISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIK 97
            P  A     Q +   +   ++   + ++N+     +G+G++  V   + K+ G   A K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60

Query: 98  KLDASK--QPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD-IL 153
            ++  K    D + L +   +  +L+H N V+L     + +   L ++  + G L + I+
Sbjct: 61  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120

Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DD 210
              +           S            + + Y H      I+HR++K  N+L+      
Sbjct: 121 --AREF--------YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG 167

Query: 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
              K+ADF L+ +  D  +        GT GY +PE       +   D+++ GV+L  LL
Sbjct: 168 AAVKLADFGLAIEVND--SEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224

Query: 271 TGRKP 275
            G  P
Sbjct: 225 VGYPP 229

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 79.2 bits (196), Expect = 9e-17
 Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 27/225 (12%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR--- 118
           +++ + +     +G G +  V     KS G   A K +   +            + R   
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 119 ----LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
               + H N + L     + T  VL  E  S G L D L  ++          LS ++  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEAT 118

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLSNQAPDMAAR 230
                   G+ YLH K    I H D+K  N+++ D ++     K+ DF L+++   +   
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDG 172

Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +    + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 46/221 (20%), Positives = 83/221 (37%), Gaps = 23/221 (10%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSR 118
              TE +     +G+G++  V   +    G   A   ++  K    D + L +   +   
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66

Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIA 177
           LKH N V+L     +     L ++  + G L + I+   +           S        
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AREY--------YSEADASHCI 116

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHST 234
               + + + H+     ++HR++K  N+L+         K+ADF L+ +           
Sbjct: 117 QQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG- 172

Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
              GT GY +PE           D+++ GV+L  LL G  P
Sbjct: 173 -FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 43/220 (19%)

Query: 75  IGEGSYGRVYYG--ILKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLK---HEN 123
           IGEG+YG+V+    +   G   A+K+  +   +   E      + +V+++  L+   H N
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE---EGMPLSTIREVAVLRHLETFEHPN 75

Query: 124 FVQLL----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
            V+L         D  +++ L +E        D+           P P +  +    +  
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVD----QDL----TTYLDKVPEPGVPTETIKDMMF 127

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS----- 233
              +GL++LH      ++HRD+K  N+L+      K+ADF L        AR++S     
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMAL 176

Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
           T V+ T  Y APE  +        D++S G +  E+   +
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 50/230 (21%), Positives = 86/230 (37%), Gaps = 37/230 (16%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR--- 118
           + + + + T   +G G +  V     KS G   A K +   +            + R   
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 119 ----LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQ 172
               ++H N + L     + T  +L  E  + G L D                  L+ ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----------LTEEE 115

Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAP 225
             +       G+ YLH      I H D+K  N+++ D +V     KI DF L+   +   
Sbjct: 116 ATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           +         + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 173 EF------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 23/231 (9%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRL-K 120
            + T+ +     IG GSY      I K+     A+K +D SK+   E   ++ ++ R  +
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQ 74

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H N + L     DG    +  E    G L D +  +K           S ++   +    
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---------FFSEREASAVLFTI 125

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAARLHSTRV 236
            K +EYLH +    ++HRD+K SN+L  D+       +I DF  + Q       L  T  
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM-TPC 181

Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287
             T  + APE       +A  D++S GV+L  +LTG  P  +      + +
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 76.4 bits (189), Expect = 5e-16
 Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 33/226 (14%)

Query: 65  ITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR----- 118
           + +++     +G G +  V     K  G   A K +   +            + R     
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 119 --LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
             ++H N + L     + T  VL  E  S G L D L  ++          L+  +  + 
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQF 113

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAPDMAA 229
                 G+ YLH K    I H D+K  N+++ D +V     K+ DF ++       +   
Sbjct: 114 LKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-- 168

Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                 + GT  + APE      L  ++D++S GV+   LL+G  P
Sbjct: 169 ----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 21/206 (10%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCV 132
           +GEGS+      + K S  A A+K +    + + +   +++ +   + H N V+L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFH 76

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
           D     L  E  + G L + +  +K           S  +   I       + ++H+   
Sbjct: 77  DQLHTFLVMELLNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHDV-- 125

Query: 193 PHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
             ++HRD+K  N+L  D++     KI DF  +   P     L +     T  Y APE   
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLN 182

Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKP 275
               +   D++S GV+L  +L+G+ P
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVP 208

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 22/224 (9%)

Query: 61  ELKEIT-ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQV--S 114
           E + +  + F    ++G G +G V+   +K +G   A KKL     K+      A V   
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237

Query: 115 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
           +++++    F+  L Y  +  + + L     + G +   ++        +  P    + R
Sbjct: 238 ILAKVHSR-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-----NVDEDNPGFQ-EPR 290

Query: 174 VKI-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
                     GLE+LH++   +II+RD+K  NVL+ DD   +I+D  L+ +      +  
Sbjct: 291 AIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347

Query: 233 STRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
                GT G+ APE  + G+    S D ++ GV L E++  R P
Sbjct: 348 -GYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 77.6 bits (191), Expect = 9e-16
 Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 29/220 (13%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQV-----SMVSR 118
            +F  + +IG G +G VY      +G   A+K L     K    E LA       S+VS 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 119 LKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI- 176
                F+  + Y      ++    +  + G LH  L                 +  ++  
Sbjct: 249 GDCP-FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----------EADMRFY 297

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
           A     GLE++H +    +++RD+K +N+L+ +    +I+D  L+              V
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV 351

Query: 237 LGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
            GT GY APE    G     S D +S G +L +LL G  P
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 43/218 (19%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
           +GEG+YG VY  I   +    AIK+  L+  +   E      + +VS++  L+H N ++L
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE---EGVPGTAIREVSLLKELQHRNIIEL 98

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
                      L +E+A N  L   +     V       + S+  ++        G+ + 
Sbjct: 99  KSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDV---SMRVIKSFLYQL------INGVNFC 148

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVA-----KIADFDL--SNQAPDMAARLHSTRVLGTF 240
           H +     +HRD+K  N+L+   D +     KI DF L  +   P    R  +  ++ T 
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI---RQFTHEII-TL 201

Query: 241 GYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
            Y  PE      L ++      D++S   +  E+L   
Sbjct: 202 WYRPPEIL----LGSRHYSTSVDIWSIACIWAEMLMKT 235

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 43/221 (19%), Positives = 86/221 (38%), Gaps = 32/221 (14%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H 121
              +++     +G G Y  V+  I + +     +K L   K   ++   ++ ++  L+  
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGG 90

Query: 122 ENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
            N + L     D  SR  A   E  +N     +               L+          
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYE 138

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLS---NQAPDMAARLHSTR 235
             K L+Y H      I+HRD+K  NV+I  +    ++ D+ L+   +   +   R+ ++R
Sbjct: 139 ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASR 194

Query: 236 VLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
                 +  PE  +  Q+   S D++S G +L  ++  ++P
Sbjct: 195 Y-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 38/230 (16%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKK--LDASKQPDEEFLAQVSMVSRL 119
           ++  + F    + G+G++G V  G  K +G + AIKK   D   +  E  L  +  ++ L
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDLAVL 76

Query: 120 KHENFVQLLGYCVDGTSR--------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
            H N VQL                   +  E+  + +LH     R   +     P +  +
Sbjct: 77  HHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC--RNYYRRQVAPPPILIK 132

Query: 172 ----QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPD 226
               Q         + +  LH  +  ++ HRDIK  NVL+ + D   K+ DF  + +   
Sbjct: 133 VFLFQ-------LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184

Query: 227 MAARLH--STRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
               +    +R      Y APE     Q    + D++S G +  E++ G 
Sbjct: 185 SEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 29/212 (13%)

Query: 74  LIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYC 131
           ++G G  G+V     +  G   A+K L  S +  +E    V    +     + V +L   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCILDVY 91

Query: 132 VDGTSRVLAY----EFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
            +            E    G L   I    +G +        + ++  +I       +++
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQA------FTEREAAEIMRDIGTAIQF 143

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           LH     +I HRD+K  N+L    +   V K+ DF  + +          T    T  Y 
Sbjct: 144 LHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPC-YTPYYV 196

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           APE     + +   D++S GV++  LL G  P
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 52/239 (21%), Positives = 87/239 (36%), Gaps = 55/239 (23%)

Query: 64  EITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-------DEEFLAQ---- 112
            +   +     I  GSYG V  G+   G   AIK++  +           + FL +    
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 113 -VSMVSRLKHENFVQLLG-------------YCVDGTSRVLAYEFASNGSLHDILHGRKG 158
            + +++   H N + L               Y V         E      L  ++H ++ 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLV--------TELMRT-DLAQVIHDQR- 128

Query: 159 VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218
                   V+S Q           GL  LHE A   ++HRD+   N+L+ D++   I DF
Sbjct: 129 -------IVISPQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDF 178

Query: 219 DLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
           +L+       +       T  +    Y APE  M  +   K  D++S G V+ E+   +
Sbjct: 179 NLAREDTADANK------THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 29/226 (12%)

Query: 61  ELKEIT-ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQV--S 114
           E + +T   F    ++G+G +G V    ++ +G   A KKL     K+   E +A     
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236

Query: 115 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSL--HDILHGRKGVKGAQPGPVLSWQ 171
           ++ ++    FV  L Y  +    + L     + G L  H    G+ G            +
Sbjct: 237 ILEKVNSR-FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP----------E 285

Query: 172 QRVKI-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
            R    A     GLE LH +    I++RD+K  N+L+ D    +I+D  L+   P+   +
Sbjct: 286 ARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQ 340

Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
               RV GT GY APE  +  +    S D ++ G +L E++ G+ P
Sbjct: 341 TIKGRV-GTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 32/222 (14%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
            + + +     IG G+ G V            AIKKL  S+    +  A+     + ++ 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMK 116

Query: 118 RLKHENFVQLLGYCVDGTSRV------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
            + H+N + LL       +        L  E   + +L  ++              L  +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ--------ME---LDHE 164

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
           +   +      G+++LH      IIHRD+K SN+++  D   KI DF L+  A       
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SF 218

Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
             T  + T  Y APE  +        D++S G ++ E++  +
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 44/248 (17%), Positives = 80/248 (32%), Gaps = 52/248 (20%)

Query: 65  ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKK--LDASKQPDEEFLAQVSMVSRLKH 121
            ++ +     +G GS+G V       SG   A+KK   D   +  E     + ++  L H
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE-----LDIMKVLDH 59

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW----------- 170
            N ++L+ Y               +                +   V              
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 171 -----QQRVKIAVGAA----------------KGLEYLHEKADPHIIHRDIKSSNVLIF- 208
                 + +K  + +                 + + ++H      I HRDIK  N+L+  
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176

Query: 209 DDDVAKIADFDLSNQAPDMAARLH--STRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVV 265
            D+  K+ DF  + +       +    +R      Y APE  +         D++S G V
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCV 231

Query: 266 LLELLTGR 273
             EL+ G+
Sbjct: 232 FGELILGK 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 32/222 (14%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
            + + +     IG G+ G V            AIKKL  S+    +  A+     + ++ 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMK 79

Query: 118 RLKHENFVQLL-----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
            + H+N + LL        ++    V +  E     +L  ++              L  +
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--------ME---LDHE 127

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
           +   +      G+++LH      IIHRD+K SN+++  D   KI DF L   A       
Sbjct: 128 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSF 181

Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
             T  + T  Y APE  +        D++S G ++ E++ G 
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 4/113 (3%)

Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
               L+ +  +  +   AKG+E+L  +     IHRD+ + N+L+ + +V KI DF L+  
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242

Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
                  +          + APE         +SDV+SFGV+L E+ + G  P
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 34/223 (15%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
           E+ E +   + +G G+YG V      K+G   A+KKL  S+       A+     + ++ 
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLK 83

Query: 118 RLKHENFVQLL-----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
            +KHEN + LL        ++  + V L         L++I+  +K          L+  
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDD 132

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
               +     +GL+Y+H      IIHRD+K SN+ + +D   KI DF L+    D     
Sbjct: 133 HVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189

Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            +TR      Y APE  +      ++ D++S G ++ ELLTGR
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 37/224 (16%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
           E+ + + +   +G G+YG V   I  +SG   AIKKL  S+    E  A+     + ++ 
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLK 78

Query: 118 RLKHENFVQLL-----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
            ++HEN + LL        +       L   F     L  I+  +            S +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK-----------FSEE 126

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAAR 230
           +   +     KGL+Y+H      ++HRD+K  N+ + +D   KI DF L+ +   +M   
Sbjct: 127 KIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--- 180

Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
              T  + T  Y APE  ++     ++ D++S G ++ E+LTG+
Sbjct: 181 ---TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 36/224 (16%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
           E+   +     +G G+YG V   +  ++G   AIKKL   +    E  A+     + ++ 
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLK 79

Query: 118 RLKHENFVQLLGYCVDGTSRV------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
            ++HEN + LL       +        L   F     L  ++         +    L   
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-------HEK---LGED 128

Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAAR 230
           +   +     KGL Y+H      IIHRD+K  N+ + +D   KI DF L+     +M   
Sbjct: 129 RIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--- 182

Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
              T  + T  Y APE  +      ++ D++S G ++ E++TG+
Sbjct: 183 ---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 29/213 (13%)

Query: 75  IGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSRLKH-ENFVQLLG 129
           +G G +  V   I KS G   A K L   +  Q     +   ++++   K     + L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 130 YCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
              + +  +L  E+A+ G +    L         +   ++S    +++     +G+ YLH
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCL--------PELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLS---NQAPDMAARLHSTRVLGTFGY 242
           +    +I+H D+K  N+L+         KI DF +S     A ++        ++GT  Y
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL------REIMGTPEY 199

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            APE      +   +D+++ G++   LLT   P
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 33/229 (14%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
           ++   +     +G G  G V+  +        AIKK+  +         +     + ++ 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS----VKHALREIKIIR 63

Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI----------LHGRKGVKGAQPGPV 167
           RL H+N V++    +  +   L  +  S   L+ +          L     V    P   
Sbjct: 64  RLDHDNIVKVFE-ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN---VLEQGP--- 116

Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLS-NQAP 225
           L  +          +GL+Y+H     +++HRD+K +N+ I  +D V KI DF L+    P
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
             + + H +  L T  Y +P   ++     K+ D+++ G +  E+LTG+
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 30/223 (13%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
           ++   +   + IGEG+YG V       +    AIKK+      + +   Q     + ++ 
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILL 80

Query: 118 RLKHENFVQLLGYCVDGTSRV-----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
           R +HEN + +       T        +  +      L+ +L         Q    LS   
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK-------TQH---LSNDH 129

Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARL 231
                    +GL+Y+H  A+  ++HRD+K SN+L+      KI DF L+    PD     
Sbjct: 130 ICYFLYQILRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
             T  + T  Y APE  +  +   KS D++S G +L E+L+ R
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 50/261 (19%), Positives = 91/261 (34%), Gaps = 28/261 (10%)

Query: 25  KSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY 84
                T    H     P        Q      + + +   I +   T+ ++G G  G+V 
Sbjct: 20  PPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVL 79

Query: 85  YGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY- 141
               K +    A+K L    +   E    V +  R  +  + V+++    +  +      
Sbjct: 80  QIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDVYENLYAGRKCLL 135

Query: 142 ---EFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 197
              E    G L   I          +     + ++  +I     + ++YLH     +I H
Sbjct: 136 IVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 184

Query: 198 RDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
           RD+K  N+L        + K+ DF  + +         +T    T  Y APE     + +
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPC-YTPYYVAPEVLGPEKYD 241

Query: 255 AKSDVYSFGVVLLELLTGRKP 275
              D++S GV++  LL G  P
Sbjct: 242 KSCDMWSLGVIMYILLCGYPP 262

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 51/244 (20%), Positives = 88/244 (36%), Gaps = 39/244 (15%)

Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD----ASK 103
           +   +     + +L+   E++    +IG G++G V     K +    A+K L       +
Sbjct: 51  LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 110

Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
                F  +  +++       VQL             Y F  +  L+ ++    G     
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLF------------YAFQDDRYLYMVMEYMPG----- 153

Query: 164 PGPVLSWQQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215
            G +++      +    A+         L+ +H       IHRD+K  N+L+      K+
Sbjct: 154 -GDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKL 209

Query: 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE----YAMTGQLNAKSDVYSFGVVLLELLT 271
           ADF    +          T V GT  Y +PE        G    + D +S GV L E+L 
Sbjct: 210 ADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

Query: 272 GRKP 275
           G  P
Sbjct: 269 GDTP 272

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 68.3 bits (167), Expect = 7e-13
 Identities = 56/300 (18%), Positives = 102/300 (34%), Gaps = 55/300 (18%)

Query: 25  KSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELK---EITENFGTNALIGEGSYG 81
            +     G  H    + +  Q  K      P  S+       +I + +    LIG GSYG
Sbjct: 8   AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYG 67

Query: 82  RVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVSRLKHENFVQLLGYCVDGT 135
            V            AIKK+   +  ++    +     +++++RL H++ V++L   +   
Sbjct: 68  HVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125

Query: 136 SRV-----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
                   +  E A +     +               L+      +      G++Y+H  
Sbjct: 126 VEKFDELYVVLEIADS-DFKKLFRTP------VY---LTELHIKTLLYNLLVGVKYVHS- 174

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---------NQAPDMAARLHSTRVLGTFG 241
           A   I+HRD+K +N L+  D   K+ DF L+         N    ++ R     ++    
Sbjct: 175 AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232

Query: 242 YHAPEYAMTGQ------------LNAKS-----DVYSFGVVLLELLTGRKPVDHTLPRGQ 284
               +  +TG             L  ++     DV+S G +  ELL   K          
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 9/96 (9%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            L+YL  +    IIHRD+K  N+L+ +     I DF+++   P       +T + GT  Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPY 180

Query: 243 HAPE--YAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
            APE   +  G   + + D +S GV   ELL GR+P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 53/238 (22%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
            I+ +F   +L+GEG+YG V       +G   AIKK++     D+   A      + ++ 
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILK 64

Query: 118 RLKHENFVQLLG-------------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
             KHEN + +               Y +         E      LH ++         Q 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYII--------QELMQT-DLHRVIS-------TQM 108

Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
              LS            + ++ LH  ++  +IHRD+K SN+LI  +   K+ DF L+   
Sbjct: 109 ---LSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162

Query: 225 PDMAARLHSTRVLGTFG--------YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
            + AA         +          Y APE  +T    +++ DV+S G +L EL   R
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 34/222 (15%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-- 123
             F    L+G+G++G+V     K +G   A+K L   K    E +     V+    EN  
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL--KK----EVIVAKDEVAHTLTENRV 201

Query: 124 -------FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
                  F+  L Y      R+    E+A+ G L    H  +    ++         R +
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSED--------RAR 251

Query: 176 I-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
                    L+YLH + +  +++RD+K  N+++  D   KI DF L  +     A + + 
Sbjct: 252 FYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 308

Query: 235 RVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
              GT  Y APE  +      ++ D +  GVV+ E++ GR P
Sbjct: 309 -FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.7 bits (159), Expect = 4e-12
 Identities = 43/248 (17%), Positives = 77/248 (31%), Gaps = 54/248 (21%)

Query: 66  TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---------DASKQPDEEFLAQVSMV 116
           TE       IGEG +G V+  I       AIK +          + ++  EE L ++ + 
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 117 SRL---------KHENFVQLLG-YCVDGT---SRVLAYEF--ASNGSLHDILHGRKGVKG 161
             L         + E F+ L   +CV G+     + A++   ++ GS +D     K  + 
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 162 --------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207
                              + S      I       L            HRD+   NVL+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLL 195

Query: 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP--EYAMTGQLNAKSDVYSFGVV 265
               + K+                  +  + + G      +Y ++        V+    +
Sbjct: 196 KKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244

Query: 266 LLELLTGR 273
             +L TG 
Sbjct: 245 DEDLFTGD 252

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 50/238 (21%), Positives = 94/238 (39%), Gaps = 42/238 (17%)

Query: 58  SVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEE-FLAQ 112
            V +++   E+F    +IG G++G V    LK +    A+K L+     K+ +   F  +
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124

Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
             ++     +    L             Y F  + +L+ ++    G      G +L+   
Sbjct: 125 RDVLVNGDSKWITTLH------------YAFQDDNNLYLVMDYYVG------GDLLTLLS 166

Query: 173 RV--KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
           +   ++    A+         ++ +H+    H +HRDIK  N+L+  +   ++ADF    
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCL 223

Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 275
           +  +      S  V GT  Y +PE     +          D +S GV + E+L G  P
Sbjct: 224 KLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 42/224 (18%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLK 120
           + F     +G GS+GRV     K SG+  A+K LD       KQ  E  L +  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-EHTLNEKRILQAVN 99

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
               V+L     D ++  +  E+ + G +   L                 ++  + +   
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------------RRIGRFSEPH 142

Query: 181 AK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
           A+          EYLH      +I+RD+K  N+LI      ++ DF  + +         
Sbjct: 143 ARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----- 194

Query: 233 STRVL-GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            T  L GT    APE  ++   N   D ++ GV++ E+  G  P
Sbjct: 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 45/249 (18%), Positives = 89/249 (35%), Gaps = 44/249 (17%)

Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD----ASK 103
           +Q  E   + + E++   ++F    +IG G++  V    +K +G   A+K ++      +
Sbjct: 43  LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102

Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
                F  +  ++         QL             + F     L+ ++    G     
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQL------------HFAFQDENYLYLVMEYYVG----- 145

Query: 164 PGPVLSWQQRV--KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
            G +L+   +   +I    A+         ++ +H       +HRDIK  N+L+      
Sbjct: 146 -GDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHI 201

Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY-------SFGVVL 266
           ++ADF    +       + S   +GT  Y +PE          +  Y       + GV  
Sbjct: 202 RLADFGSCLKL-RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260

Query: 267 LELLTGRKP 275
            E+  G+ P
Sbjct: 261 YEMFYGQTP 269

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 61.4 bits (150), Expect = 8e-11
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 7/94 (7%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            L++LH      II+RD+K  N+L+ ++   K+ DF LS ++ D   + +S    GT  Y
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192

Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
            APE  +  + + +S D +SFGV++ E+LTG  P
Sbjct: 193 MAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 53/252 (21%), Positives = 90/252 (35%), Gaps = 63/252 (25%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
            + +N+    LIG GSYG VY      +    AIKK+  ++  ++    +     +++++
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILN 80

Query: 118 RLKHENFVQLLG-------------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
           RLK +  ++L               Y V         E A +  L  +            
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIV--------LEIADS-DLKKLFKTP------IF 125

Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
              L+ +    I      G  ++HE +   IIHRD+K +N L+  D   K+ DF L+   
Sbjct: 126 ---LTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 225 PDMAARLHSTRVLGTFG--------------------YHAPEYAMTGQLNAKS-DVYSFG 263
                      +                         Y APE  +  +   KS D++S G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

Query: 264 VVLLELLTGRKP 275
            +  ELL   + 
Sbjct: 240 CIFAELLNMLQS 251

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 60.2 bits (147), Expect = 2e-10
 Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 7/94 (7%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            L +LH+K    II+RD+K  N+++      K+ DF L  ++       H+    GT  Y
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187

Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
            APE  +    + ++ D +S G ++ ++LTG  P
Sbjct: 188 MAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 50/217 (23%), Positives = 78/217 (35%), Gaps = 33/217 (15%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
           IGEGS+G ++ G  L +    AIK     S  P      +              +  +  
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGIPNVYYFGQ 76

Query: 133 DGTSRVLAYEFASNG-SLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
           +G   VL  +    G SL D+L   GRK           S +     A      ++ +HE
Sbjct: 77  EGLHNVLVIDLL--GPSLEDLLDLCGRK----------FSVKTVAMAAKQMLARVQSIHE 124

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAK-----IADFDLSNQAPDMAARLH-----STRVLGT 239
           K    +++RDIK  N LI   +        + DF +     D   + H        + GT
Sbjct: 125 K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

Query: 240 FGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
             Y        G + + + D+ + G V +  L G  P
Sbjct: 182 ARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 36/223 (16%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDE--------EFLAQVSM 115
            +F    ++G+GS+G+V     K +    A+K L  D   Q D+          LA    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 399

Query: 116 VSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
               K     QL   C     R+    E+ + G L  + H ++  +  +P          
Sbjct: 400 ----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEP--------HA 444

Query: 175 KI-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
              A   A GL +L  K    II+RD+K  NV++  +   KIADF +  +  ++   + +
Sbjct: 445 VFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTT 499

Query: 234 TRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
               GT  Y APE  +  Q   KS D ++FGV+L E+L G+ P
Sbjct: 500 KTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 41/211 (19%), Positives = 73/211 (34%), Gaps = 49/211 (23%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
           +G G  G+V     K +    A+K L    +   E    V +  R  +  + V+++    
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDVYE 81

Query: 133 DGTSRVLAY----EFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           +  +         E    G L   I          +     + ++  +I     + ++YL
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAIQYL 133

Query: 188 HEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
           H     +I HRD+K  N+L        + K+ DF     A +           G   Y  
Sbjct: 134 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE---------TTGE-KY-- 175

Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                    +   D++S GV++  LL G  P
Sbjct: 176 ---------DKSCDMWSLGVIMYILLCGYPP 197

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 59.9 bits (146), Expect = 3e-10
 Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 50/230 (21%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-- 123
           ++F    +IG GSY +V    LK +    A+K +   K    E +     +  ++ E   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV--KK----ELVNDDEDIDWVQTEKHV 62

Query: 124 --------FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
                   F+  L  C    SR+    E+ + G L    H                Q++ 
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FH---------------MQRQR 105

Query: 175 KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
           K+    A+         L YLHE+    II+RD+K  NVL+  +   K+ D+ +  +   
Sbjct: 106 KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162

Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
                 +    GT  Y APE  + G+    S D ++ GV++ E++ GR P
Sbjct: 163 PGDTTST--FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 51/214 (23%), Positives = 82/214 (38%), Gaps = 29/214 (13%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYCV 132
           IG GS+G +Y G  + +G   AIK  +  K    +   +  +   ++       +     
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75

Query: 133 DGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
           +G   V+  E     SL D+     RK           S +  + +A      +EY+H K
Sbjct: 76  EGDYNVMVMELLGP-SLEDLFNFCSRK----------FSLKTVLLLADQMISRIEYIHSK 124

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAK---IADFDLSNQAPDMAARLH-----STRVLGTFGY 242
              + IHRD+K  N L+          I DF L+ +  D     H     +  + GT  Y
Sbjct: 125 ---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

Query: 243 HAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
            A      G + + + D+ S G VL+    G  P
Sbjct: 182 -ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 59.5 bits (145), Expect = 4e-10
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 7/94 (7%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            LEYLH +    +++RDIK  N+++  D   KI DF L  +     A + +    GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171

Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
            APE  +      ++ D +  GVV+ E++ GR P
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 52/247 (21%), Positives = 94/247 (38%), Gaps = 61/247 (24%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
            +   +     +G+G+YG V+  I  ++G   A+KK+           AQ     + +++
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILT 63

Query: 118 RLK-HENFVQLLG----------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
            L  HEN V LL           Y V        +++     LH ++        A    
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLV--------FDYMET-DLHAVIR-------ANI-- 105

Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQ 223
            L    +  +     K ++YLH      ++HRD+K SN+L+  +   K+ADF LS     
Sbjct: 106 -LEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTG------------QLNAKS-----DVYSFGVVL 266
              +   +  +    T  +   +  +T              L +       D++S G +L
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221

Query: 267 LELLTGR 273
            E+L G+
Sbjct: 222 GEILCGK 228

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 50/230 (21%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-- 123
           ++F    +IG GSY +V    LK +    A++ +   K    E +     +  ++ E   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV--KK----ELVNDDEDIDWVQTEKHV 105

Query: 124 --------FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
                   F+  L  C    SR+    E+ + G L    H                Q++ 
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FH---------------MQRQR 148

Query: 175 KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
           K+    A+         L YLHE+    II+RD+K  NVL+  +   K+ D+ +  +   
Sbjct: 149 KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205

Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
                 +    GT  Y APE  + G+    S D ++ GV++ E++ GR P
Sbjct: 206 PGDTTST--FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 7/94 (7%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            L +LH+K    II+RD+K  NVL+  +   K+ADF +  +   +   + +    GT  Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDY 190

Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
            APE  +   L   + D ++ GV+L E+L G  P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 7/94 (7%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL++LH K    I++RD+K  N+L+  D   KIADF +  +     A+ ++    GT  Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 184

Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
            APE  + GQ    S D +SFGV+L E+L G+ P
Sbjct: 185 IAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 7/94 (7%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
            L YLH     +I++RD+K  N+L+       + DF L  +  ++     ++   GT  Y
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEY 205

Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
            APE  +  Q   ++ D +  G VL E+L G  P
Sbjct: 206 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 10/97 (10%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-GTFG 241
            LE+LH+     II+RDIK  N+L+  +    + DF LS +   +A          GT  
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETERAYDFCGTIE 225

Query: 242 YHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           Y AP+      +G   A  D +S GV++ ELLTG  P
Sbjct: 226 YMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASP 261

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 33/217 (15%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
           IG G++G +  G  L +    AIK     S+ P      +         +   Q+  +  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGIPQVYYFGP 75

Query: 133 DGTSRVLAYEFASNG-SLHDI--LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
            G    +  E    G SL D+  L  R            S +  + IA+     +EY+H 
Sbjct: 76  CGKYNAMVLELL--GPSLEDLFDLCDRT----------FSLKTVLMIAIQLISRMEYVHS 123

Query: 190 KADPHIIHRDIKSSNVLI-----FDDDVAKIADFDLSNQAPDMAARLH-----STRVLGT 239
           K   ++I+RD+K  N LI         V  I DF L+ +  D   + H        + GT
Sbjct: 124 K---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180

Query: 240 FGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
             Y        G + + + D+ + G + +  L G  P
Sbjct: 181 ARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 52/282 (18%), Positives = 91/282 (32%), Gaps = 61/282 (21%)

Query: 31  DGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LK 89
              +H S     G + +  Q +  P   V +       +     IG G +G +Y      
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDM-EGNQWVLGKKIGSGGFGLIYLAFPTN 60

Query: 90  SGHAAAIK--KLDASKQP--DEEF-----LAQVSMVSRLKHENFVQLLG-----YC---- 131
                A    K++  +      E      +A+   + +      +  LG           
Sbjct: 61  KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120

Query: 132 -VDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
               + R +  E      L  I   +G           VL      ++ +     LEY+H
Sbjct: 121 FKGRSYRFMVMERLGI-DLQKISGQNGTFKKST-----VL------QLGIRMLDVLEYIH 168

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLSNQAPDMAARLH----STRVL-GTFG 241
           E      +H DIK++N+L+   +  ++  AD+ LS +               +   GT  
Sbjct: 169 EN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT-- 223

Query: 242 YHAPEYAMTGQLNA--------KSDVYSFGVVLLELLTGRKP 275
               E+     L+A        +SDV   G  +L  L G+ P
Sbjct: 224 ---IEFT---SLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 7/94 (7%)

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL +L  K    II+RD+K  NV++  +   KIADF +  +         +    GT  Y
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 187

Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
            APE  +  Q   KS D ++FGV+L E+L G+ P
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 40/242 (16%), Positives = 75/242 (30%), Gaps = 63/242 (26%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIK-----KLDASKQPDEEFLAQVSMVSRLKHE-NFVQL 127
            IG+G +G +Y   + S  +         K++ S                L  E  F Q 
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG------------PLFTELKFYQR 89

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP--------GP----VLSWQQR-- 173
                     +   +    G       G     G           G     +     +  
Sbjct: 90  AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149

Query: 174 -----VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLSNQAPD 226
                +++++     LEY+HE      +H DIK+SN+L+   +  ++   D+ L+ +   
Sbjct: 150 SRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206

Query: 227 MAARLH-----STRVLGTFGYHAPEYAMTGQLNA--------KSDVYSFGVVLLELLTGR 273
                           GT      E+     ++A        + D+   G  +++ LTG 
Sbjct: 207 EGVHKAYAADPKRCHDGT-----IEFT---SIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

Query: 274 KP 275
            P
Sbjct: 259 LP 260

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 56.4 bits (137), Expect = 4e-09
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 44/225 (19%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLK 120
           ++F     +G GS+GRV+    + +G   A+K L        KQ  E    +  M+S + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV-EHTNDERLMLSIVT 64

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSL--HDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
           H   +++ G   D     +  ++   G L                    L   QR    V
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-----------------LRKSQRFPNPV 107

Query: 179 G---AAK---GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
               AA+    LEYLH K    II+RD+K  N+L+  +   KI DF  +   PD+     
Sbjct: 108 AKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----- 159

Query: 233 STRVL-GTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
            T  L GT  Y APE  ++ +   KS D +SFG+++ E+L G  P
Sbjct: 160 -TYTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 13/98 (13%)

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA------KIADFDLSNQAPDMAARLHSTR 235
            GL+Y+H +    IIH DIK  NVL+   D        KIAD   +    +       TR
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
                 Y +PE  +       +D++S   ++ EL+TG 
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 29/214 (13%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCV 132
           IG GS+G +Y G  +++    AIK  +  K    + L +  +   L+       +  + V
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73

Query: 133 DGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
           +G   VL  +     SL D+     RK          LS +  + +A      +E++H K
Sbjct: 74  EGDYNVLVMDLLGP-SLEDLFNFCSRK----------LSLKTVLMLADQMINRVEFVHSK 122

Query: 191 ADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLH-----STRVLGTFGY 242
                +HRDIK  N L+      +   I DF L+ +  D +   H     +  + GT  Y
Sbjct: 123 ---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 243 HAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
            A      G + + + D+ S G VL+  L G  P
Sbjct: 180 -ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 43/286 (15%), Positives = 88/286 (30%), Gaps = 63/286 (22%)

Query: 32  GAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTN----ALIGEGSYGRVYYGI 87
             +H S     G + +  Q +     ++     +T+  G      +     + G +Y   
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAA 62

Query: 88  -LKSGHAAAIK-------KLDASKQP------------DEEFLAQVSMVSRLKHENFVQL 127
              +    +         KLDA                    + +   +           
Sbjct: 63  PTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC 122

Query: 128 LGY-CVDGTSRVLAYEFASNGSLHDILH--GRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
           +G+       R L        SL   L    +          VLS +  +++A      L
Sbjct: 123 MGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKH---------VLSERSVLQVACRLLDAL 172

Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLSNQAPD----MAARLHSTRVL- 237
           E+LHE      +H ++ + N+ +  +D +++  A +  + +       +A    S     
Sbjct: 173 EFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE 229

Query: 238 GTFGYHAPEYAMTGQLNA--------KSDVYSFGVVLLELLTGRKP 275
           G       E+     ++         +SD+ S G  +L+ L G  P
Sbjct: 230 GD-----LEFI---SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 47/221 (21%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIK----KLDASKQPDEEFLAQVSMVSRLKHE----- 122
            +IG+GS+G+V      K     A+K    +    +Q  EE    + ++  L+ +     
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNT 158

Query: 123 -NFVQLLGY-------CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
            N + +L         C       + +E  S  +L++++   K           S     
Sbjct: 159 MNVIHMLENFTFRNHIC-------MTFELLSM-NLYELIKKNKFQG-------FSLPLVR 203

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQAPDMAARLH 232
           K A    + L+ LH      IIH D+K  N+L+     +  K+ DF  S           
Sbjct: 204 KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI 260

Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
            +R    F Y APE  +  +     D++S G +L ELLTG 
Sbjct: 261 QSR----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 26/136 (19%), Positives = 41/136 (30%), Gaps = 46/136 (33%)

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV----- 236
           +GL+YLH K    IIH DIK  N+L+  ++         + +     A   S        
Sbjct: 157 QGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 237 ----------------------LGTFG-----------------YHAPEYAMTGQLNAKS 257
                                 +   G                 Y + E  +    N  +
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274

Query: 258 DVYSFGVVLLELLTGR 273
           D++S   +  EL TG 
Sbjct: 275 DIWSTACMAFELATGD 290

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 53/231 (22%), Positives = 86/231 (37%), Gaps = 49/231 (21%)

Query: 65  ITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIK----KLDASKQPDEEFLAQVSMVSRL 119
             + +  ++LIG+GS+G+V            AIK    K     Q   E    V ++  +
Sbjct: 52  WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELM 107

Query: 120 KHE------NFVQLLGY-------CVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQP 164
                      V L  +       C       L +E  S  +L+D+L     +G      
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNFRG------ 153

Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSN 222
              +S     K A      L +L    +  IIH D+K  N+L+ +   +  KI DF  S 
Sbjct: 154 ---VSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209

Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
           Q            +   F Y +PE  +    +   D++S G +L+E+ TG 
Sbjct: 210 QLGQR----IYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 1e-05
 Identities = 59/393 (15%), Positives = 118/393 (30%), Gaps = 156/393 (39%)

Query: 49  VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE 108
           VQ +    +S +E+  I  +   +A+   G+  R+++ +L        K ++   + + +
Sbjct: 38  VQDMPKSILSKEEIDHIIMS--KDAV--SGTL-RLFWTLLSKQEEMVQKFVEEVLRINYK 92

Query: 109 FLA--------QVSM-----------------------VSRLKHENFVQLLGYCVDGTSR 137
           FL         Q SM                       VSRL+   +++L         R
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP--YLKL---------R 141

Query: 138 VLAYEFASNGSLHDILHGRKG---------------VKGAQPGPVLSWQQRVKIAVGAA- 181
               E     ++  ++ G  G               V+      +  W     + +    
Sbjct: 142 QALLELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-W-----LNLKNCN 193

Query: 182 ------KGLEYLHEKADP----------HIIHR--DIKSS-----------NVLIFDDDV 212
                 + L+ L  + DP          +I  R   I++            N L+   +V
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV 253

Query: 213 --AKIAD-FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 269
             AK  + F+L            S ++L           +T +    +D       L   
Sbjct: 254 QNAKAWNAFNL------------SCKIL-----------LTTRFKQVTD------FLSAA 284

Query: 270 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVA----KMAAVAA 325
            T    +DH       +L    TP   +  + + +D R   D P + +     +++ +A 
Sbjct: 285 TTTHISLDHH----SMTL----TPDEVKSLLLKYLDCRP-QDLPREVLTTNPRRLSIIAE 335

Query: 326 LC----------VQYEAD-FRPNMSIVVKALQP 347
                            D     +   +  L+P
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP 368

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 47/245 (19%), Positives = 81/245 (33%), Gaps = 75/245 (30%)

Query: 73  ALIGEGSYGRVYYGI-LKSGHAAAIK----KLDASKQPDEEFLAQVSMVSRLKHE----- 122
             +G+G++GRV     + +    A+K        ++    E      ++ +++++     
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNN 96

Query: 123 NFVQLLGY-------CVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQR 173
           N V+  G        C       L +E     SL++I+  +   G            +  
Sbjct: 97  NIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNNYNG---------FHIEDI 139

Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
               +   K L YL +     + H D+K  N+L+ D    K                  +
Sbjct: 140 KLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 234 TRV---LGTFG-----------------YHAPE------YAMTGQLNAKSDVYSFGVVLL 267
                 L  FG                 Y APE      + +       SD++SFG VL 
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDV------SSDMWSFGCVLA 250

Query: 268 ELLTG 272
           EL TG
Sbjct: 251 ELYTG 255

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 37/115 (32%)

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV-LGTF 240
             L +LH   +  + H D+K  N+L  + +   + +   S +       + +T + +  F
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK----SVKNTSIRVADF 186

Query: 241 G-----------------YHAPE------YAMTGQLNAKSDVYSFGVVLLELLTG 272
           G                 Y  PE      +A         DV+S G +L E   G
Sbjct: 187 GSATFDHEHHTTIVATRHYRPPEVILELGWAQ------PCDVWSIGCILFEYYRG 235

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	361
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.55
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.31
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.13
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.93
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.76
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.73
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.61
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.55
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.45
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.35
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	98.15
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	98.06
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.04
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.03
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.0
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.98
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.75
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.74
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.74
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.66
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.66
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.58
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.42
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.04
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.02
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.6
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.44
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.11
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.04

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.6e-63  Score=446.23  Aligned_cols=269  Identities=26%  Similarity=0.437  Sum_probs=221.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||++.... ...++|.+|+++|++++|||||+++++|.++...+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888999999999999999864      47889999997543 234679999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          140 AYEFASNGSLHDILHGRKGV----KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      |||||++|+|.++|......    ........++|.+++.++.||+.||+|||+++   ||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            99999999999999764310    00112235999999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.....             
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------------  236 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------------  236 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------------
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------------
Confidence            99999976544333333455679999999999999999999999999999999998 9999965322             


Q ss_pred             CCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                         ..+...+......+.|..++.++.+|+.+||+.||++|||+++|.+.|+.+.+..|.
T Consensus       237 ---~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~  293 (299)
T 4asz_A          237 ---NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV  293 (299)
T ss_dssp             ---HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred             ---HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence               122222222333345666778899999999999999999999999999999887764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.1e-62  Score=445.91  Aligned_cols=267  Identities=24%  Similarity=0.403  Sum_probs=212.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|.+.++||+|+||+||+|+++      ++..||||++.... ...++|.+|+++|++++|||||+++++|.+....+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56778889999999999999864      47889999997543 234679999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          140 AYEFASNGSLHDILHGRKGVKG------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      |||||++|+|.++++.......      ......++|.+++.++.||+.||+|||+.+   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999986542211      112245999999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      ||+|||+++...........+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||.....           
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----------  266 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----------  266 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----------
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----------
Confidence            9999999987654444444456789999999999999999999999999999999999 9999964322           


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                           ..+...+......+.|..++..+.+|+.+||+.||++|||++||++.|+.+.+.-
T Consensus       267 -----~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          267 -----TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             -----HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             -----HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence                 1122222222334556667788999999999999999999999999999998753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.4e-62  Score=439.46  Aligned_cols=263  Identities=27%  Similarity=0.377  Sum_probs=219.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      .++++.+.||+|+||+||+|.+.      +++.||||++....  ...++|.+|+.++++++|||||+++++|.++...+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            35667788999999999999863      56789999996532  34578999999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC
Q 018071          139 LAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD  211 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~  211 (361)
                      ||||||++|+|.++|........       ......+++..++.++.||+.||+|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999976532111       111235999999999999999999999998   99999999999999999


Q ss_pred             ceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 018071          212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~  290 (361)
                      .+||+|||+++...........+..+||+.|||||++.++.|+.++|||||||+||||+| |..||.+...         
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---------  253 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---------  253 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---------
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---------
Confidence            999999999987654444444566789999999999999999999999999999999998 8999965422         


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                             ..+...+..+...+.|..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       254 -------~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          254 -------QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -------HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                   222233333344456667788899999999999999999999999999865

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.1e-62  Score=440.67  Aligned_cols=247  Identities=23%  Similarity=0.327  Sum_probs=212.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.++||+|+||+||+|+++ +++.||||++.+.    ....+.+.+|++++++++|||||++++++.++...||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999987 8999999999642    344578999999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |||+||+|.+++....         .+++..++.++.||+.||+|||+++   |+||||||+|||++++|.+||+|||+|
T Consensus       112 Ey~~gG~L~~~i~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla  179 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA  179 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence            9999999999997654         3999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.+..........+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.......               .+.
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---------------~~~  244 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---------------IFA  244 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------HHH
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHH
Confidence            87654333344567899999999999999999999999999999999999999997543211               112


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV  342 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl  342 (361)
                      .+....+  .++...+.++.+||.+||+.||++|||++|++
T Consensus       245 ~i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          245 KIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            2222221  34445667899999999999999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-61  Score=442.96  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=206.2

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|++++.||+|+||+||+|+++ +|+.||||++.+....   .+.+.+|+.++++++|||||++++++.++...|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999987 8999999999765433   3578899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      ||+||+|.++|...+..       .+++..++.++.||+.||+|||+++   ||||||||+||||+++|.+||+|||+|+
T Consensus       104 y~~gg~L~~~i~~~~~~-------~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~  173 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIAR  173 (350)
T ss_dssp             CCTTCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred             CCCCCcHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccce
Confidence            99999999999765432       3799999999999999999999998   9999999999999999999999999998


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ......  ...+..+||+.|||||++.+..|+.++|||||||+||||++|+.||.......               .+..
T Consensus       174 ~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---------------~~~~  236 (350)
T 4b9d_A          174 VLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---------------LVLK  236 (350)
T ss_dssp             CCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------------HHHH
T ss_pred             eecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---------------HHHH
Confidence            765322  12356789999999999999999999999999999999999999997543211               1111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ++.... ...+...+.++.+||.+||+.||.+|||++|+++
T Consensus       237 i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          237 IISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            221111 1234456678999999999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.7e-61  Score=431.29  Aligned_cols=259  Identities=28%  Similarity=0.440  Sum_probs=207.0

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +++.+.+.||+|+||+||+|+++  ..||||+++.....   .++|.+|+.++++++|||||++++++.+ +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            57788899999999999999876  35999998754333   3578999999999999999999998864 568999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      |+||+|.+++.....        .+++.+++.++.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+.
T Consensus       113 ~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          113 CEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             CSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             CCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            999999999976532        3999999999999999999999998   99999999999999999999999999987


Q ss_pred             CccccccccccccccCCCCCCchhhcc---CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .............+||+.|||||++.+   +.|+.++|||||||+||||+||+.||........               +
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---------------~  246 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---------------I  246 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---------------H
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---------------H
Confidence            654433334566789999999999974   3689999999999999999999999975432211               1


Q ss_pred             hhhccccc----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          301 RQCVDARL----GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       301 ~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                      ...+....    ....+..++..+.+|+.+||+.||++|||+.+|++.|+.|....|.
T Consensus       247 ~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          247 IFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             HHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             HHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            11111111    1123445677899999999999999999999999999988766543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.4e-61  Score=439.98  Aligned_cols=247  Identities=24%  Similarity=0.374  Sum_probs=210.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC-CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      +.|++.+.||+|+||+||+|.++ +|+.||||++... ....+.+.+|+.+|+.++|||||++++++.+++..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999987 8999999999653 334567889999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      +||+|.+++....          +++..++.++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+..
T Consensus       154 ~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~  220 (346)
T 4fih_A          154 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV  220 (346)
T ss_dssp             TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceec
Confidence            9999999997643          999999999999999999999998   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ....  ...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||....+....               ..+.
T Consensus       221 ~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---------------~~i~  283 (346)
T 4fih_A          221 SKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---------------KMIR  283 (346)
T ss_dssp             CSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---------------HHHH
T ss_pred             CCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---------------HHHH
Confidence            4322  2245689999999999999999999999999999999999999999754322111               1111


Q ss_pred             ccc-cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          305 DAR-LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       305 ~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.. .....+...+.++.+||.+||+.||++|||++|+++
T Consensus       284 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          284 DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            110 011223445678999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.8e-61  Score=436.74  Aligned_cols=255  Identities=23%  Similarity=0.278  Sum_probs=211.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      +.|.+.++||+|+||.||+|+++ +|+.||||++......    .+|+.+++.++|||||++++++.++...|||||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            56888889999999999999987 8999999999764432    469999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-ceEEeccccCCCC
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQA  224 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~Dfg~a~~~  224 (361)
                      ||+|.+++....         .+++..++.++.||+.||+|||+++   ||||||||+||||+.+| ++||+|||+|+..
T Consensus       134 gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          134 GGSLGQLIKQMG---------CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             TCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            999999997654         3999999999999999999999998   99999999999999987 6999999999866


Q ss_pred             cccccc---ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          225 PDMAAR---LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       225 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ......   ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+...          
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----------  271 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE----------  271 (336)
T ss_dssp             ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS----------
T ss_pred             cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC----------
Confidence            432211   1234568999999999999999999999999999999999999999765433221111100          


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                          .......++.++..+.+||.+||+.||.+|||+.|+++.|...++.
T Consensus       272 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          272 ----PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             ----CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence                0000123445677899999999999999999999999999888764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.3e-60  Score=418.81  Aligned_cols=244  Identities=24%  Similarity=0.334  Sum_probs=194.2

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++.+..    .....+.+|+.++++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999976 89999999996532    23457899999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||| +|+|.+++....         .+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|
T Consensus        93 Ey~-~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla  159 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---------KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLS  159 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred             eCC-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCC
Confidence            999 679999987654         3999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +......   .....+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.......               .+
T Consensus       160 ~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---------------~~  221 (275)
T 3hyh_A          160 NIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---------------LF  221 (275)
T ss_dssp             ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------HH
T ss_pred             eecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---------------HH
Confidence            8754322   2356789999999999998876 579999999999999999999997542211               11


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..+.....  .++...+.++.+|+.+||+.||++|||++|+++
T Consensus       222 ~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          222 KNISNGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHHTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCC--CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11111111  234445677999999999999999999999987

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.6e-60  Score=440.74  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=210.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      +.|++.+.||+|+||.||+|.++ +|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999987 89999999997543 34567899999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      +||+|.+++....          +++..+..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+..
T Consensus       231 ~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~  297 (423)
T 4fie_A          231 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV  297 (423)
T ss_dssp             TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred             CCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceEC
Confidence            9999999997653          999999999999999999999998   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ....  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..+....               ..+.
T Consensus       298 ~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---------------~~i~  360 (423)
T 4fie_A          298 SKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---------------KMIR  360 (423)
T ss_dssp             CSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---------------HHHH
T ss_pred             CCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---------------HHHH
Confidence            4322  2345689999999999999999999999999999999999999999754332111               1111


Q ss_pred             ccc-cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          305 DAR-LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       305 ~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.. .....+...+..+.+||.+||+.||++|||+.|+++
T Consensus       361 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          361 DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            110 011223345677999999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.5e-59  Score=431.56  Aligned_cols=277  Identities=23%  Similarity=0.351  Sum_probs=225.9

Q ss_pred             HHHHHHHhhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCC-CCcceeee
Q 018071           59 VDELKEITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKH-ENFVQLLG  129 (361)
Q Consensus        59 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h-pniv~~~~  129 (361)
                      .++++.-.++|++.+.||+|+||+||+|.+.      +++.||||.+......  .+.+.+|+++|++++| ||||++++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            3444444578999999999999999999864      2357999999764432  3578999999999975 89999999


Q ss_pred             EEEeC-CeeEEEEEeCCCCcHHHhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC
Q 018071          130 YCVDG-TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK  201 (361)
Q Consensus       130 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDik  201 (361)
                      +|.+. ...+||||||++|+|.++|+......       .......+++..++.++.||+.||+|||+++   |||||||
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK  212 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  212 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence            98764 56899999999999999997653211       1112345899999999999999999999998   9999999


Q ss_pred             CCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCC
Q 018071          202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL  280 (361)
Q Consensus       202 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~  280 (361)
                      |+|||+++++.+||+|||+|+...........+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+..
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654444444566789999999999999999999999999999999998 999997542


Q ss_pred             CcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          281 PRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                      ..               ..+...+....+...|..++.++.+++.+||+.||++|||+.+|++.|+.++++..
T Consensus       293 ~~---------------~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          293 ID---------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             CS---------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HH---------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            21               22233333344445666677889999999999999999999999999999998653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2e-59  Score=424.12  Aligned_cols=275  Identities=23%  Similarity=0.330  Sum_probs=206.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCC----eeEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----SRVLAY  141 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~lv~  141 (361)
                      .++|.+.+.||+|+||+||+|+++ |+.||||++.........+..|+..+.+++|||||++++++.++.    ..+|||
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            357888899999999999999985 899999999654322222334566667889999999999998653    579999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeEeccCCCCceEeccCCceEEe
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-----DPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      |||++|+|.++++...          +++..++.++.|++.||+|||+++     .++||||||||+||||++++.+||+
T Consensus        81 Ey~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~  150 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             ECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             cCCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence            9999999999998654          899999999999999999999871     2249999999999999999999999


Q ss_pred             ccccCCCCccccc--cccccccccCCCCCCchhhccC------CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhh
Q 018071          217 DFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTG------QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       217 Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~  288 (361)
                      |||+++.......  .......+||+.|||||++.+.      .|+.++|||||||+||||+||..||........ .+.
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-p~~  229 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYY  229 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc-cch
Confidence            9999876432221  1123456899999999999764      367899999999999999999988864332111 111


Q ss_pred             hhhcccCCchhhhh-hcccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          289 TWATPKLSEDKVRQ-CVDARLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       289 ~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      ...........+.. +.+..++...+     ...+..+.+|+.+||+.||++|||+.+|++.|+.+.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            11111111122222 22333333333     246678999999999999999999999999999988754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-59  Score=416.34  Aligned_cols=245  Identities=25%  Similarity=0.394  Sum_probs=197.2

Q ss_pred             CCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEe----CCeeEEEE
Q 018071           70 GTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLAY  141 (361)
Q Consensus        70 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~  141 (361)
                      ++.++||+|+||+||+|.++ ++..||+|++.....   ..+.+.+|++++++++|||||++++++.+    ....+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999987 899999999865332   23578999999999999999999999875    34579999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-CCceEEecccc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDL  220 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~Dfg~  220 (361)
                      |||+||+|.+++....         .+++..++.++.||+.||+|||+++ ++||||||||+||||++ +|.+||+|||+
T Consensus       109 Ey~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGl  178 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             ECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred             eCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcC
Confidence            9999999999997654         3999999999999999999999874 34999999999999985 78999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      |+....    ......+||+.|||||++.+ .|+.++|||||||++|||++|+.||.......  .+..           
T Consensus       179 a~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~-----------  240 (290)
T 3fpq_A          179 ATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR-----------  240 (290)
T ss_dssp             GGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH-----------
T ss_pred             CEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHH-----------
Confidence            975432    22356789999999998865 69999999999999999999999996432211  1110           


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       .+.........+...+.++.+||.+||+.||++|||++|+++
T Consensus       241 -~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          241 -RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             111110001112223456999999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.2e-60  Score=423.65  Aligned_cols=246  Identities=22%  Similarity=0.306  Sum_probs=200.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|++.+.||+|+||+||+|+..    +++.||||++.+..   ....++.+|+.++++++|||||++++++.++...||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999863    57899999996532   223468889999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      |||||+||+|.+++....         .+++..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||
T Consensus       104 vmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFG  171 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG  171 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred             EEEcCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccc
Confidence            999999999999997654         3999999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +|+......  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.....               .
T Consensus       172 la~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---------------~  234 (304)
T 3ubd_A          172 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---------------T  234 (304)
T ss_dssp             EEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------H
T ss_pred             cceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---------------H
Confidence            998653322  23456789999999999999999999999999999999999999997543221               1


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM-----SIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~  343 (361)
                      +..+.....  .+|...+.++.+||.+||+.||++|||+     +|+++
T Consensus       235 ~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          235 MTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHHHcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            112222221  3444567789999999999999999984     67765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2e-57  Score=409.30  Aligned_cols=248  Identities=23%  Similarity=0.386  Sum_probs=190.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCC-------
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGT-------  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-------  135 (361)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++......  .+.+.+|+++|++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            467999999999999999999987 8999999998654332  357889999999999999999999987544       


Q ss_pred             -----eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC
Q 018071          136 -----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD  210 (361)
Q Consensus       136 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~  210 (361)
                           ..|+|||||++|+|.+++......      ....+..++.++.||+.||+|||+++   |+||||||+||||+.+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~  154 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTI------EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMD  154 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSG------GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCC------ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCC
Confidence                 368999999999999999865421      12567788999999999999999998   9999999999999999


Q ss_pred             CceEEeccccCCCCcccccc----------ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCC
Q 018071          211 DVAKIADFDLSNQAPDMAAR----------LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL  280 (361)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~  280 (361)
                      +.+||+|||+|+........          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||....
T Consensus       155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~  231 (299)
T 4g31_A          155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM  231 (299)
T ss_dssp             CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence            99999999999876432211          12245689999999999999999999999999999999996   774211


Q ss_pred             CcccchhhhhhcccCCchhhhhhcccccCCCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          281 PRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP---KAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .    ..          ..+..+.    ....++   ..+..+.+|+.+||+.||.+|||+.|+++
T Consensus       232 ~----~~----------~~~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 E----RV----------RTLTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             H----HH----------HHHHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H----HH----------HHHHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0    00          0011111    112332   33456788999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-56  Score=416.36  Aligned_cols=265  Identities=22%  Similarity=0.343  Sum_probs=205.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEe------CC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD------GT  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~  135 (361)
                      .++|++++.||+|+||+||+|.++ +|+.||||++.+....   .+.+.+|+++|+.++|||||++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            468999999999999999999987 8999999999765433   2467899999999999999999998764      36


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..|||||||+ |+|.+++....         .+++..+..++.||+.||.|||+++   ||||||||+|||++.+|.+||
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~---------~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki  199 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ---------PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKI  199 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEE
Confidence            7899999995 68999997653         3999999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCcccc--ccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          216 ADFDLSNQAPDMA--ARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       216 ~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      +|||+++.+....  ........+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.........+....
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~  279 (398)
T 4b99_A          200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL  279 (398)
T ss_dssp             CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred             eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            9999998764321  22234568999999999998875 56999999999999999999999998665433222221111


Q ss_pred             ccCCch--------hhhhhccccc-CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          293 PKLSED--------KVRQCVDARL-GGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       293 ~~~~~~--------~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ......        .....+.... ....+     +..+.++.+||.+||+.||.+|||++|+++
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            111111        0111110000 00111     123567899999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.5e-54  Score=399.19  Aligned_cols=264  Identities=21%  Similarity=0.292  Sum_probs=200.3

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~  138 (361)
                      .+.++|++.+.||+|+||+||+|+.+    +++.||+|++.+.. ...++.+|+++++.+ +||||+++++++.+.+..+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            35688999999999999999999854    57889999986543 345788999999998 6999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC-CceEEec
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIAD  217 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~-~~~kl~D  217 (361)
                      +|||||+||+|.+++..            +++.+++.++.||+.||+|||++|   |+||||||+|||++.+ +.+||+|
T Consensus        97 lvmE~~~g~~L~~~~~~------------l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           97 IAMPYLEHESFLDILNS------------LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             EEEECCCCCCHHHHHTT------------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             EEEeCCCcccHHHHHcC------------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence            99999999999999842            899999999999999999999998   9999999999999877 7999999


Q ss_pred             cccCCCCcccc--------------------------ccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHH
Q 018071          218 FDLSNQAPDMA--------------------------ARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELL  270 (361)
Q Consensus       218 fg~a~~~~~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell  270 (361)
                      ||+|+......                          .....+..+||+.|+|||++.+. .|+.++||||+||++|||+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence            99997543211                          01112446899999999999876 5899999999999999999


Q ss_pred             hCCCCCCCCCCccc-chhh-hhh------------------cccCCchhhhhhccc------------------ccCCCC
Q 018071          271 TGRKPVDHTLPRGQ-QSLV-TWA------------------TPKLSEDKVRQCVDA------------------RLGGDY  312 (361)
Q Consensus       271 ~g~~pf~~~~~~~~-~~~~-~~~------------------~~~~~~~~~~~~~~~------------------~~~~~~  312 (361)
                      +|+.||........ ...+ ...                  .............+.                  ......
T Consensus       242 ~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  321 (361)
T 4f9c_A          242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG  321 (361)
T ss_dssp             HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred             HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence            99999964332110 0000 000                  000000000000000                  000011


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          313 PPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       313 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ....+.++.+|+.+||+.||.+|||++|+++
T Consensus       322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          322 WNEVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1234567899999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.2e-53  Score=387.50  Aligned_cols=288  Identities=38%  Similarity=0.670  Sum_probs=243.5

Q ss_pred             CHHHHHHHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           58 SVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        58 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      +..++....++|++.+.||+|+||.||+|.+++++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            33344556789999999999999999999988899999999876433 34678999999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||+++|+|.+++.....     ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDL-----PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCC-----CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEEC
T ss_pred             EEEEEEcCCCCcHHHHHhccCC-----CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEe
Confidence            9999999999999999975432     1234899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........|......
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            99998754433222233456689999999999999999999999999999999999999987766655555555443334


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                      ...+...++.......++..+..+.+++.+||+.||++|||+.++++.|+.+++...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            445556666666677888999999999999999999999999999999999987543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.1e-54  Score=417.55  Aligned_cols=247  Identities=23%  Similarity=0.338  Sum_probs=203.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHH---HHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQ---VSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e---~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      ++|++.++||+|+||.||+|+.+ +|+.||||++.+.    ........+|   +.+++.++|||||+++++|.+...+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            68999999999999999999987 8999999999642    2223334444   56677789999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      ||||||+||+|.++|....         .+++..++.++.||+.||+|||++|   ||||||||+||||+.+|++||+||
T Consensus       269 lVmEy~~GGdL~~~l~~~~---------~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DF  336 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL  336 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccc
Confidence            9999999999999997654         3999999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |+|+.....    ...+.+||+.|||||++.. ..|+.++|||||||++|||++|+.||..........+          
T Consensus       337 GlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i----------  402 (689)
T 3v5w_A          337 GLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----------  402 (689)
T ss_dssp             TTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH----------
T ss_pred             ceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----------
Confidence            999765432    2356799999999999974 5899999999999999999999999964332211111          


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~  343 (361)
                        ...+....  ..++...+.++.+||.+||+.||.+|++     ++||++
T Consensus       403 --~~~i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          403 --DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             --HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             --HHhhcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence              11111111  2345556778999999999999999998     678776

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.6e-53  Score=414.81  Aligned_cols=250  Identities=21%  Similarity=0.294  Sum_probs=209.4

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      +.++|++.+.||+|+||.||+|..+ +|+.||+|++..... ..+.+.+|+.+|+.++|||||++++++.+....+||||
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3478999999999999999999987 899999999866432 34578899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC--CceEEecccc
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD--DVAKIADFDL  220 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~--~~~kl~Dfg~  220 (361)
                      ||+||+|.++|.....        .+++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+
T Consensus       235 ~~~gg~L~~~i~~~~~--------~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~  303 (573)
T 3uto_A          235 FMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL  303 (573)
T ss_dssp             CCCCCBHHHHHTCTTS--------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred             ecCCCcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccc
Confidence            9999999999865432        3999999999999999999999998   9999999999999854  8999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ++.+....   .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.......               
T Consensus       304 a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~---------------  365 (573)
T 3uto_A          304 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---------------  365 (573)
T ss_dssp             CEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---------------
T ss_pred             eeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---------------
Confidence            98764322   235678999999999999999999999999999999999999999754332111               


Q ss_pred             hhhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..+.....  ........+..+.+||.+||+.||.+|||+.|+++
T Consensus       366 ~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          366 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111  11112234667999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.2e-51  Score=375.99  Aligned_cols=290  Identities=37%  Similarity=0.652  Sum_probs=243.1

Q ss_pred             ccCccCHHHHHHHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeE
Q 018071           53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGY  130 (361)
Q Consensus        53 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~  130 (361)
                      ....++..++....++|.+.+.||+|+||.||+|..++++.||+|++....  .....+.+|+++++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            345688899999999999999999999999999998889999999997643  223478999999999999999999999


Q ss_pred             EEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC
Q 018071          131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD  210 (361)
Q Consensus       131 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~  210 (361)
                      +.+....++||||+++|+|.+++......     ...+++..++.++.|++.||.|||+...++|+||||||+|||++.+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~  170 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE  170 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence            99999999999999999999999875422     2349999999999999999999999911129999999999999999


Q ss_pred             CceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCC--Ccccchhh
Q 018071          211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL--PRGQQSLV  288 (361)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~--~~~~~~~~  288 (361)
                      +.+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....  ........
T Consensus       171 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  249 (326)
T 3uim_A          171 FEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL  249 (326)
T ss_dssp             CCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred             CCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence            999999999997653322 222345569999999999999899999999999999999999999996321  12223344


Q ss_pred             hhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          289 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      .|.........+..+.+.......+...+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            455555555666777777777788899999999999999999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.2e-51  Score=375.52  Aligned_cols=273  Identities=26%  Similarity=0.319  Sum_probs=217.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCC----eeEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----SRVLAY  141 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~lv~  141 (361)
                      .++|++.++||+|+||+||+|.+. ++.||||++...........+|+.++++++||||+++++++.+..    ..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            368999999999999999999987 899999999765544556677899999999999999999998744    369999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------CCCCeEeccCCCCceEeccCC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK----------ADPHIIHRDIKSSNVLIFDDD  211 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------~~~~ivHrDikp~Nill~~~~  211 (361)
                      ||+++|+|.+++....          +++..++.++.|++.||.|||+.          +   |+||||||+|||++.++
T Consensus       102 e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A          102 AFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             ECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTC
T ss_pred             ecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCC
Confidence            9999999999997653          89999999999999999999998          7   99999999999999999


Q ss_pred             ceEEeccccCCCCccccccccccccccCCCCCCchhhccC-----CCCCccceecHHHHHHHHHhCCCCCCCCCCcccch
Q 018071          212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS  286 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~  286 (361)
                      .+||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|+|++|+.||..........
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            9999999999755433322233456799999999999863     45678899999999999999999998765543333


Q ss_pred             hhhhhcccCCchhhhhhcc-cccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          287 LVTWATPKLSEDKVRQCVD-ARLGGDY-----PPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      +............+...+. .......     ....+..+.+|+.+||+.||++|||+.+|++.|+.+.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            3322222222222222221 1111111     1245677999999999999999999999999999987653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.9e-50  Score=376.24  Aligned_cols=267  Identities=25%  Similarity=0.424  Sum_probs=218.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC--------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG  134 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~~  134 (361)
                      .++|.+.+.||+|+||.||+|.+.        ++..||+|++......  .+.+.+|+.+++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            478999999999999999999852        4567999999764322  35688999999999 899999999999999


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      ...++||||+++|+|.+++.......       .......+++..++.++.||+.||+|||+.+   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            99999999999999999998654210       0112235899999999999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccch
Q 018071          208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS  286 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~  286 (361)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......    
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----  312 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  312 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence            9999999999999976544333333345567889999999999999999999999999999999 99999653221    


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                                  .+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus       313 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          313 ------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             ------------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                        12222222223344556677899999999999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.4e-50  Score=366.50  Aligned_cols=268  Identities=31%  Similarity=0.448  Sum_probs=207.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|++.+.||+|+||+||+|... ++.||+|++.......   +++.+|+.++++++||||+++++++.+....++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            578999999999999999999875 8899999997654433   468899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++|+|.+++......      ..+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++
T Consensus       115 ~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             cCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            99999999999764311      13899999999999999999999884 239999999999999999999999999997


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .....  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........               ...
T Consensus       188 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~---------------~~~  250 (309)
T 3p86_A          188 LKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---------------VAA  250 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH---------------HHH
T ss_pred             ccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHH
Confidence            54332  1223456799999999999999999999999999999999999999975432111               111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCCC
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGE  358 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~~  358 (361)
                      +.........+...+..+.+|+.+||+.||.+|||+.++++.|+.+++...+|+..
T Consensus       251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~  306 (309)
T 3p86_A          251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR  306 (309)
T ss_dssp             HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence            11111222344556677999999999999999999999999999999877666554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.6e-50  Score=362.70  Aligned_cols=249  Identities=23%  Similarity=0.389  Sum_probs=209.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC-CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|++.+.||+|+||+||+|... +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            468999999999999999999975 8999999998653 33456788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++....          +++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        99 ~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (297)
T 3fxz_A           99 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (297)
T ss_dssp             CTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence            99999999997653          899999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||....+........              
T Consensus       166 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--------------  229 (297)
T 3fxz_A          166 ITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--------------  229 (297)
T ss_dssp             CCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--------------
T ss_pred             cCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------
Confidence            54322  12345679999999999999999999999999999999999999996543221111000              


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .........+...+..+.+++.+||+.||.+|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          230 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0111111233445677999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-50  Score=359.39  Aligned_cols=257  Identities=25%  Similarity=0.457  Sum_probs=218.5

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++|++.+.||+|+||.||+|.+.++..||+|++.......+++.+|+.++++++||||+++++++.+....++||||+++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   89 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence            68899999999999999999998889999999988777778899999999999999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++.....        .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           90 GCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             CBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence            999999976442        3899999999999999999999998   99999999999999999999999999876533


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .. ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......                .+...+.
T Consensus       159 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----------------~~~~~~~  221 (269)
T 4hcu_A          159 DQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----------------EVVEDIS  221 (269)
T ss_dssp             HH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHHHH
T ss_pred             cc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----------------HHHHHHh
Confidence            22 112334556788999999999999999999999999999999 99999754321                1111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      .......+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          222 TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            1222233344567799999999999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=370.43  Aligned_cols=265  Identities=28%  Similarity=0.432  Sum_probs=214.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-C---CCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|.+.+.||+|+||.||+|.+. +   +..||||++.....  ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            468999999999999999999975 3   44599999976433  23578899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+++++|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       128 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg  196 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFG  196 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred             EeeCCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCC
Confidence            9999999999999965432        3899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCc
Q 018071          220 LSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       220 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      +++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....                
T Consensus       197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----------------  260 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----------------  260 (325)
T ss_dssp             SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----------------
T ss_pred             cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----------------
Confidence            99765432211 11233456788999999999999999999999999999999 9999964322                


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCC
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAG  357 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~  357 (361)
                      ..+...+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.+++......+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~  320 (325)
T 3kul_A          261 RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA  320 (325)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC----
T ss_pred             HHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccccc
Confidence            122222222333344556677899999999999999999999999999999987665544

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=367.95  Aligned_cols=264  Identities=26%  Similarity=0.430  Sum_probs=215.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      ++|.+.++||+|+||+||+|.++ +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            68999999999999999999987 79999999886532 33467889999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++++|.+++.....        .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           90 KGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             TTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             CCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            99999999986432        3899999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccc------------cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          225 PDMAARL------------HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       225 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      .......            ......||+.|+|||++.+..++.++||||||+++|+|++|..||....+......     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-----  233 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-----  233 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-----
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-----
Confidence            3322110            11256799999999999999999999999999999999999999865433221100     


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCC
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP  355 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~  355 (361)
                           .......+..    .+..++..+.+++.+||+.||++|||+.++++.|+.+....+.+
T Consensus       234 -----~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~  287 (310)
T 3s95_A          234 -----LNVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH  287 (310)
T ss_dssp             -----BCHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred             -----hhhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence                 0111111111    22334456999999999999999999999999999988754433

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-50  Score=378.38  Aligned_cols=259  Identities=26%  Similarity=0.452  Sum_probs=216.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|.+.+.||+|+||.||+|.++ +++.||||++......  .+++.+|+.++++++||||+++++++.+....++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            468889999999999999999987 8999999998754322  2467889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++|+|.+++.....        .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       193 ~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             CCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             cCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            9999999999976431        3899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ...............+++.|+|||++.+..++.++|||||||++|||++ |..||....                ...+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~----------------~~~~~  325 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS----------------NQQTR  325 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC----------------HHHHH
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----------------HHHHH
Confidence            6433222222223345778999999999999999999999999999998 999996432                22233


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      ..+........+..++..+.+|+.+||+.||++|||+++|++.|+.+.+.
T Consensus       326 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          326 EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            33333334445556677899999999999999999999999999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.6e-50  Score=359.33  Aligned_cols=259  Identities=25%  Similarity=0.442  Sum_probs=216.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|++.+.||+|+||.||++.++++..||+|++.......+++.+|+++++.++||||+++++++.+....++||||++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            46899999999999999999999988899999998877777889999999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....        .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       103 ~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A          103 NGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             TCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            9999999976432        3899999999999999999999998   9999999999999999999999999987653


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......                .....+
T Consensus       172 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~----------------~~~~~~  234 (283)
T 3gen_A          172 DDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----------------ETAEHI  234 (283)
T ss_dssp             CHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----------------HHHHHH
T ss_pred             cccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh----------------HHHHHH
Confidence            3221 12234456788999999999999999999999999999998 99999644321                111112


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      ........+...+..+.+++.+||+.+|.+|||+.++++.|++++...
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          235 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            222222333444577999999999999999999999999999998764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.7e-50  Score=356.02  Aligned_cols=258  Identities=23%  Similarity=0.368  Sum_probs=216.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|++.+.||+|+||.||+|..+++..||+|++.......+++.+|+.++++++||||+++++++.+....++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            46899999999999999999999988899999998877777889999999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....        .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        87 ~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           87 NGCLLNYLRSHGK--------GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             TCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred             CCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecc
Confidence            9999999976532        3899999999999999999999998   9999999999999999999999999987553


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......                ....+
T Consensus       156 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~~~  218 (268)
T 3sxs_A          156 DDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----------------VVLKV  218 (268)
T ss_dssp             TTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH----------------HHHHH
T ss_pred             hhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH----------------HHHHH
Confidence            3221 12233456778999999999899999999999999999999 999996443211                11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      ........+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       219 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          219 SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            11111222333456799999999999999999999999999988654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.2e-50  Score=365.74  Aligned_cols=246  Identities=24%  Similarity=0.336  Sum_probs=207.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++......   .+.+.+|+++++.++||||+++++++.+....++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468999999999999999999985 8999999998654332   356789999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        94 e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a  161 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS  161 (328)
T ss_dssp             CCCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred             ECCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCc
Confidence            9999999999997653         2899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCC-CccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN-AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ......   ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........               .
T Consensus       162 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------------~  223 (328)
T 3fe3_A          162 NEFTVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL---------------R  223 (328)
T ss_dssp             GGGSSS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------------H
T ss_pred             eecCCC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH---------------H
Confidence            754322   223567899999999999988775 789999999999999999999975432111               1


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..+.....  ..+...+..+.+|+.+||+.||.+|||++++++
T Consensus       224 ~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          224 ERVLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111111  233345677999999999999999999999987

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.6e-49  Score=363.54  Aligned_cols=246  Identities=22%  Similarity=0.299  Sum_probs=208.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.++||+|+||.||+|..+ +++.||+|++.+.    ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            68999999999999999999987 8999999998652    344567889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||++||+|.+++....         .+++..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||++
T Consensus        85 E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a  152 (337)
T 1o6l_A           85 EYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccch
Confidence            9999999999987653         3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....  .......+||+.|+|||++.+..++.++|||||||++|||++|..||.......               ...
T Consensus       153 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------------~~~  215 (337)
T 1o6l_A          153 KEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---------------LFE  215 (337)
T ss_dssp             BCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------HHH
T ss_pred             hhcccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---------------HHH
Confidence            764221  122356789999999999999999999999999999999999999996432211               111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      .+....  ..++...+..+.+||.+||+.||.+||     ++++|++
T Consensus       216 ~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          216 LILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            111111  123445567899999999999999999     8999987

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.7e-50  Score=364.76  Aligned_cols=254  Identities=25%  Similarity=0.333  Sum_probs=207.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.++|++.+.||+|+||.||+|..+ +++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            3478999999999999999999987 899999999865332  2356889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        85 e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  152 (323)
T 3tki_A           85 EYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA  152 (323)
T ss_dssp             ECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EcCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecc
Confidence            9999999999997553         3899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ...............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ..             
T Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~-------------  218 (323)
T 3tki_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY-------------  218 (323)
T ss_dssp             EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HH-------------
T ss_pred             ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HH-------------
Confidence            76543333333456789999999999988776 7789999999999999999999975433211 11             


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ..+.............+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          219 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            11111111111123345678999999999999999999999873

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-49  Score=369.73  Aligned_cols=270  Identities=27%  Similarity=0.421  Sum_probs=221.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC--------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG  134 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~~  134 (361)
                      .++|.+.+.||+|+||.||+|...        .+..||+|++......  ...+.+|+++++.+ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            478999999999999999999853        3357999999765332  25688999999999 899999999999999


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      ...++||||+++|+|.+++.......       .......+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            99999999999999999998654211       0112235999999999999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccch
Q 018071          208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS  286 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~  286 (361)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....     
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-----  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999987654433333455667899999999999999999999999999999999 9999964322     


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                                 ..+...+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.++...+.
T Consensus       300 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          300 -----------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             -----------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             -----------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                       122222222223334445667899999999999999999999999999999975543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.7e-50  Score=382.35  Aligned_cols=262  Identities=24%  Similarity=0.417  Sum_probs=220.3

Q ss_pred             HhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      ..++|.+.+.||+|+||.||+|.++++..||||++.......+.+.+|+.+++.++||||+++++++. ....++||||+
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            45788899999999999999999988899999999877667789999999999999999999999986 56789999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      .+|+|.+++......       .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       265 ~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          265 AKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             TTCBHHHHHHSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             CCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            999999999754321       2889999999999999999999998   999999999999999999999999999765


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ...... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||.....                ..+...
T Consensus       335 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----------------~~~~~~  397 (454)
T 1qcf_A          335 EDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----------------PEVIRA  397 (454)
T ss_dssp             CCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------HHHHHH
T ss_pred             CCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence            432211 1233446788999999999999999999999999999999 9999964322                122222


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                      +........+..++..+.+|+.+||+.||++|||+++|++.|+.+......
T Consensus       398 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~  448 (454)
T 1qcf_A          398 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES  448 (454)
T ss_dssp             HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence            333333445556778899999999999999999999999999999875543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.6e-48  Score=351.61  Aligned_cols=285  Identities=37%  Similarity=0.598  Sum_probs=229.5

Q ss_pred             ccCccCHHHHHHHhhcCCCC------CccccCCceEEEEEEECCCCEEEEEEcCCCC-----CChHHHHHHHHHHhcCCC
Q 018071           53 EVPAISVDELKEITENFGTN------ALIGEGSYGRVYYGILKSGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLKH  121 (361)
Q Consensus        53 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h  121 (361)
                      ....++..++..++++|...      +.||+|+||.||+|.. +++.||+|++....     ...+.+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45678999999999998877      8999999999999987 48999999986532     224678899999999999


Q ss_pred             CCcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC
Q 018071          122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK  201 (361)
Q Consensus       122 pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDik  201 (361)
                      |||+++++++.+....++||||+++++|.+++......      ..+++..++.++.||+.||.|||+.+   |+|||||
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlk  160 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIK  160 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence            99999999999999999999999999999999754321      24899999999999999999999998   9999999


Q ss_pred             CCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCC
Q 018071          202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP  281 (361)
Q Consensus       202 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~  281 (361)
                      |+||+++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||.....
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            9999999999999999999876543322223345679999999998865 588999999999999999999999976543


Q ss_pred             cccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      .......... .......+...++..+ ...+...+..+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus       240 ~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          240 PQLLLDIKEE-IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SSBTTHHHHH-HHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             hHHHHHHHHH-hhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            3211111000 0001112333333333 34577888999999999999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-50  Score=371.66  Aligned_cols=264  Identities=25%  Similarity=0.403  Sum_probs=215.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      .++|.+.+.||+|+||.||+|.+.      ++..||||++.....  ...++.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            468999999999999999999943      567899999965432  234688999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC---ceE
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAK  214 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~---~~k  214 (361)
                      ++||||+++|+|.+++.......  .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .+|
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             EEEEEeCCCCCHHHHHHhhcccc--CccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence            99999999999999998754321  12235899999999999999999999998   99999999999999555   599


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....            
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------------  292 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------------  292 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------------
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------------
Confidence            999999875433222233445678999999999999999999999999999999998 9999965422            


Q ss_pred             cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                          ..+...+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.+
T Consensus       293 ----~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          293 ----QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             ----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence                11222222222233444556779999999999999999999999999988875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-49  Score=384.24  Aligned_cols=259  Identities=27%  Similarity=0.429  Sum_probs=221.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      .++|.+.+.||+|+||.||+|.++ ++..||||++.......+++.+|+.++++++||||+++++++.+....++||||+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            467888999999999999999987 6899999999877777789999999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++|+|.+++.....       ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       299 ~~g~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          299 TYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             TTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             CCCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999976432       23899999999999999999999998   999999999999999999999999999875


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ..... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....                ..+...
T Consensus       369 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~----------------~~~~~~  431 (495)
T 1opk_A          369 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYEL  431 (495)
T ss_dssp             TTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG----------------GGHHHH
T ss_pred             cCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence            43221 12233456788999999999999999999999999999999 9999964322                222333


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      +........+..++..+.+|+.+||+.||.+|||+.+|++.|+.++..
T Consensus       432 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          432 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            344444455666778899999999999999999999999999988653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.3e-49  Score=364.67  Aligned_cols=247  Identities=23%  Similarity=0.353  Sum_probs=207.5

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      +.++|.+.+.||+|+||.||+|..+ +|+.||+|++.+...       ..+.+.+|+.+++.++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            4578999999999999999999987 899999999865432       24678999999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC----c
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V  212 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~----~  212 (361)
                      .++||||++||+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~  157 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH  157 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccC
Confidence            999999999999999997543         3899999999999999999999998   99999999999998877    7


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      +||+|||++......   ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........        
T Consensus       158 vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--------  226 (361)
T 2yab_A          158 IKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--------  226 (361)
T ss_dssp             EEECCCSSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--------
T ss_pred             EEEEecCCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--------
Confidence            999999999765432   123456799999999999999999999999999999999999999975432111        


Q ss_pred             ccCCchhhhhhcccccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          293 PKLSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                             +..+.....  .++    ...+..+.+||.+||..||.+|||+.++++
T Consensus       227 -------~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          227 -------LANITAVSY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -------HHHHHTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -------HHHHHhcCC--CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                   111111111  112    123567999999999999999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.1e-50  Score=370.02  Aligned_cols=278  Identities=23%  Similarity=0.352  Sum_probs=221.7

Q ss_pred             cCHHHHHHHhhcCCCCCccccCCceEEEEEEE-----C-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCccee
Q 018071           57 ISVDELKEITENFGTNALIGEGSYGRVYYGIL-----K-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQL  127 (361)
Q Consensus        57 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~  127 (361)
                      +...++....++|.+.+.||+|+||.||+|.+     . +++.||||++......  .+.+.+|+++++++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34455555678999999999999999999983     2 5689999999764332  34688999999999 78999999


Q ss_pred             eeEEEeCCe-eEEEEEeCCCCcHHHhhhcCCCCCC---------------------------------------------
Q 018071          128 LGYCVDGTS-RVLAYEFASNGSLHDILHGRKGVKG---------------------------------------------  161 (361)
Q Consensus       128 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~---------------------------------------------  161 (361)
                      ++++.+... .++||||+++|+|.+++........                                             
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987544 8999999999999999986542100                                             


Q ss_pred             ------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccc
Q 018071          162 ------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA  229 (361)
Q Consensus       162 ------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  229 (361)
                                  ......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                        000123899999999999999999999998   99999999999999999999999999987644333


Q ss_pred             cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhccccc
Q 018071          230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL  308 (361)
Q Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (361)
                      ........||+.|+|||++.+..++.++|||||||++|+|++ |..||......               ..+...+....
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------------~~~~~~~~~~~  313 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---------------EEFCRRLKEGT  313 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---------------HHHHHHHHHTC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh---------------HHHHHHHHcCC
Confidence            333455678999999999999999999999999999999998 99999754321               11112222222


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          309 GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       309 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      ....+...+..+.+++.+||+.||.+|||+.++++.|+.++++.
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            23334445677999999999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.6e-49  Score=379.51  Aligned_cols=265  Identities=28%  Similarity=0.463  Sum_probs=217.6

Q ss_pred             HhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      ..++|.+.+.||+|+||.||+|.++.+..||||++.......+.+.+|+.++++++||||+++++++.+ ...++||||+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            346788999999999999999999877889999998766667889999999999999999999999866 6789999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++|+|.+++.....       ..+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++..
T Consensus       261 ~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          261 SKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             TTCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             cCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceec
Confidence            99999999975322       13899999999999999999999998   999999999999999999999999999876


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ..... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.....                ..+...
T Consensus       331 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----------------~~~~~~  393 (452)
T 1fmk_A          331 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLDQ  393 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHH
T ss_pred             CCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence            43221 11233456789999999999999999999999999999999 9999964322                122222


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCC
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAG  357 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~  357 (361)
                      +......+.+..++..+.+|+.+||+.||++|||+++|++.|+.++....+..-
T Consensus       394 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~  447 (452)
T 1fmk_A          394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ  447 (452)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccc
Confidence            333334455666778899999999999999999999999999999876655443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.6e-50  Score=362.79  Aligned_cols=273  Identities=23%  Similarity=0.336  Sum_probs=212.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEE----C-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEe--CCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL----K-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~----~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~  137 (361)
                      .++|++.+.||+|+||.||+|.+    . +++.||+|++..... ..+.+.+|+.++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            47899999999999999999984    2 789999999875432 23578899999999999999999999864  3568


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      ++||||+++++|.+++.....        .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~D  157 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD  157 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred             EEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEcc
Confidence            999999999999999976542        3899999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC-
Q 018071          218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL-  295 (361)
Q Consensus       218 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~-  295 (361)
                      ||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||......    ......... 
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~  233 (295)
T 3ugc_A          158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQ  233 (295)
T ss_dssp             CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCC
T ss_pred             CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccc
Confidence            9999876432211 1223445778899999999999999999999999999999999998532111    000000000 


Q ss_pred             ---CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          296 ---SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       296 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                         ....+...+........+..++..+.+++.+||+.||++|||+.++++.|+.+.+..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          234 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             cchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence               0112222333333344556677889999999999999999999999999999987643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-49  Score=361.51  Aligned_cols=248  Identities=18%  Similarity=0.236  Sum_probs=209.1

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +.++|.+.+.||+|+||.||+|..+ +++.||+|.+.........+.+|+.+++.++||||+++++++.+....++||||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            3578999999999999999999987 789999999976655566788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc--CCceEEeccccC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDLS  221 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~--~~~~kl~Dfg~a  221 (361)
                      +++++|.+++....        ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||++
T Consensus        83 ~~g~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a  151 (321)
T 1tki_A           83 ISGLDIFERINTSA--------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             CCCCBHHHHHTSSS--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             CCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence            99999999997543        23899999999999999999999998   999999999999987  789999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......               .+.
T Consensus       152 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------------~~~  213 (321)
T 1tki_A          152 RQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---------------IIE  213 (321)
T ss_dssp             EECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------------HHH
T ss_pred             eECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---------------HHH
Confidence            7654322   2345679999999999998889999999999999999999999997543211               111


Q ss_pred             hhcccccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+.....  ..+    ...+..+.+++.+||..||.+|||+.++++
T Consensus       214 ~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          214 NIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHcCCC--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111111  111    123567999999999999999999999998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3e-49  Score=368.42  Aligned_cols=259  Identities=26%  Similarity=0.434  Sum_probs=203.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|.+.+.||+|+||.||+|..+    ++..||||++.....  ..+++.+|+.++++++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            368999999999999999999865    577899999976432  23578899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+++++|.+++....        ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       124 v~e~~~~~sL~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg  192 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFG  192 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEeCCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCc
Confidence            999999999999997643        23899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccc-cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCc
Q 018071          220 LSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       220 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      +++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.....                
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----------------  256 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------------  256 (373)
T ss_dssp             ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----------------
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----------------
Confidence            998764322111 1222345788999999999999999999999999999998 9999964322                


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      ..+...+........+..++..+.+++.+||+.||.+||++.+|++.|+.++..
T Consensus       257 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          257 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            122222233333334445667899999999999999999999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3e-49  Score=359.65  Aligned_cols=268  Identities=24%  Similarity=0.404  Sum_probs=218.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEE------CCCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      .++|.+.+.||+|+||.||+|..      .++..||+|++......  .+.+.+|+.+++.++||||+++++++.+....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            57899999999999999999986      24588999999754332  35788999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKG---------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS  202 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp  202 (361)
                      ++||||+++++|.+++........               ......+++..++.++.||+.||.|||+.+   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999986542100               001234899999999999999999999998   99999999


Q ss_pred             CceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCC
Q 018071          203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP  281 (361)
Q Consensus       203 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~  281 (361)
                      +|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999876543333333345567889999999999999999999999999999999 9999975433


Q ss_pred             cccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      ..                +...+........+..++..+.+++.+||+.||.+|||+.++++.|+.++...
T Consensus       259 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  313 (314)
T 2ivs_A          259 ER----------------LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR  313 (314)
T ss_dssp             GG----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HH----------------HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence            21                11222222222344456678999999999999999999999999999998753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.8e-49  Score=363.61  Aligned_cols=257  Identities=25%  Similarity=0.430  Sum_probs=206.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCE----EEEEEcCCC--CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHA----AAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      .++|++.++||+|+||+||+|.+. +++.    ||+|.+...  ....+++.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            368999999999999999999965 4543    588887543  234578999999999999999999999998754 78


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +++||+.+|+|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Df  161 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred             EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccC
Confidence            99999999999999976542        3899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......               
T Consensus       162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------------  226 (327)
T 3poz_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------------  226 (327)
T ss_dssp             THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---------------
T ss_pred             cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---------------
Confidence            99875433322223344567889999999999999999999999999999999 99999754322               


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                       .+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       227 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          227 -EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -GHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             2223333333334455567789999999999999999999999999998874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.2e-49  Score=373.97  Aligned_cols=254  Identities=29%  Similarity=0.476  Sum_probs=214.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCC-eeEEEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-SRVLAYEFA  144 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~~  144 (361)
                      .++|.+.+.||+|+||.||+|.++ ++.||||++.... ..+.+.+|+.++++++||||+++++++.+.. ..++||||+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            367888999999999999999987 8899999997654 5678999999999999999999999987665 789999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++|+|.+++.....       ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       270 ~~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          270 AKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             TTCBHHHHHHHHCT-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            99999999986542       23789999999999999999999998   999999999999999999999999998754


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ...     .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......                .+...
T Consensus       340 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----------------~~~~~  398 (450)
T 1k9a_A          340 SST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPR  398 (450)
T ss_dssp             C-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT----------------THHHH
T ss_pred             ccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHH
Confidence            221     123467889999999999999999999999999999998 99999643221                12222


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      +........+..++..+.+||.+||+.||.+|||+.+|++.|+.+....
T Consensus       399 i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          399 VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence            3333344556667788999999999999999999999999999988653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.4e-49  Score=354.27  Aligned_cols=263  Identities=22%  Similarity=0.339  Sum_probs=209.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|++.+.||+|+||.||+|... ++..||+|++......    .+.+.+|+.++++++||||+++++++.+....++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            468999999999999999999976 8999999998553322    25678999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++....         .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~  157 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---------PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGI  157 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCC
Confidence            99999999999997653         3899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +....... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||........  ..........  ..
T Consensus       158 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~~--~~  232 (294)
T 4eqm_A          158 AKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVP--NV  232 (294)
T ss_dssp             STTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHSSCCC--CH
T ss_pred             cccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhhccCC--Cc
Confidence            98764322 1223456799999999999999999999999999999999999999975432110  0000000000  00


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhcCC
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-NMSIVVKALQPLLNARP  353 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~l~~~~~  353 (361)
                              ........+..+.+++.+||+.||.+|| +++++.+.|+.++....
T Consensus       233 --------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          233 --------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             --------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             --------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence                    0011223456799999999999999998 99999999998876543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.5e-49  Score=354.95  Aligned_cols=260  Identities=27%  Similarity=0.426  Sum_probs=221.4

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ..++|.+.+.||+|+||.||+|.++ ++..||+|++.......+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            3578999999999999999999987 689999999987776778899999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++++|.+++.....       ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        91 ~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           91 MTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             CTTEEHHHHHHHCCT-------TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             CCCCcHHHHHHhccc-------CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            999999999976432       23899999999999999999999998   99999999999999999999999999976


Q ss_pred             CccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ..... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......                .+..
T Consensus       161 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----------------~~~~  223 (288)
T 3kfa_A          161 MTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYE  223 (288)
T ss_dssp             SCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----------------GHHH
T ss_pred             ccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHH
Confidence            54322 122334557889999999999999999999999999999999 99999654321                1222


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      .+........+..++..+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus       224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          224 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            2222333344455667899999999999999999999999999998864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.1e-49  Score=364.82  Aligned_cols=253  Identities=21%  Similarity=0.274  Sum_probs=200.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      .++|.+.+.||+|+||+||++..+ +++.||+|++.......+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            468999999999999999999987 8999999999877766788999999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc--eEEeccccCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--AKIADFDLSN  222 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~--~kl~Dfg~a~  222 (361)
                      ++|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.  +||+|||+++
T Consensus        99 ~~~~L~~~l~~~~---------~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           99 SGGELYERICNAG---------RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             CSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             CCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            9999999987643         2899999999999999999999998   999999999999987765  9999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCc-cceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAK-SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .....   .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.........           ...+.
T Consensus       167 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-----------~~~~~  232 (361)
T 3uc3_A          167 SSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-----------RKTIQ  232 (361)
T ss_dssp             -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-----------HHHHH
T ss_pred             ccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-----------HHHHH
Confidence            53221   12345679999999999998888766 89999999999999999999754332111           01111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      .+.......+.....+..+.+||.+||+.||.+|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            2222222112222345679999999999999999999999973

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-49  Score=364.86  Aligned_cols=271  Identities=25%  Similarity=0.383  Sum_probs=214.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      ..++|.+.+.||+|+||.||+|...      +++.||+|++......  .+.+.+|+.+++.++||||+++++++.+...
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            4589999999999999999999974      3488999999764332  3568899999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKG---------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK  201 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDik  201 (361)
                      .++||||+++++|.+++........               ......+++..++.++.||+.||.|||+.+   |+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            9999999999999999976431100               001135999999999999999999999998   9999999


Q ss_pred             CCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCC
Q 018071          202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL  280 (361)
Q Consensus       202 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~  280 (361)
                      |+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999865433222223345668899999999999999999999999999999999 999996432


Q ss_pred             CcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          281 PRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                      ..                .+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+.+....
T Consensus       282 ~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          282 HE----------------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG  339 (343)
T ss_dssp             HH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred             hH----------------HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence            21                11111111111233445567899999999999999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.9e-48  Score=355.91  Aligned_cols=261  Identities=24%  Similarity=0.363  Sum_probs=213.3

Q ss_pred             CccCHHHHHHHhhc----------CCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCC
Q 018071           55 PAISVDELKEITEN----------FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHE  122 (361)
Q Consensus        55 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hp  122 (361)
                      +.++.++++..++.          |...+.||+|+||.||+|..+ +|+.||||++.... ...+.+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45777888777654          667779999999999999987 89999999987543 3456788999999999999


Q ss_pred             CcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 018071          123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS  202 (361)
Q Consensus       123 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp  202 (361)
                      ||+++++++......++||||+++++|.+++....          +++..++.++.|++.||.|||+.+   |+||||||
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp  169 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQG---VIHRDIKS  169 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence            99999999999999999999999999999987543          899999999999999999999998   99999999


Q ss_pred             CceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCc
Q 018071          203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR  282 (361)
Q Consensus       203 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~  282 (361)
                      +|||++.++.+||+|||++.......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus       170 ~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~  247 (321)
T 2c30_A          170 DSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV  247 (321)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             HHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999987653321  1234567999999999999999999999999999999999999999754321


Q ss_pred             ccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ..   ..         .+.......  .......+..+.+++.+||+.||++|||+.++++.
T Consensus       248 ~~---~~---------~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          248 QA---MK---------RLRDSPPPK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HH---HH---------HHHHSSCCC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HH---HH---------HHhcCCCCC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11   00         000000000  01122345679999999999999999999999873

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.1e-49  Score=349.41  Aligned_cols=257  Identities=25%  Similarity=0.445  Sum_probs=217.1

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++|.+.+.||+|+||.||+|.+.++..||+|++.......+.+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH   87 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence            57889999999999999999998889999999988777778899999999999999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      ++|.+++.....        .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        88 ~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           88 GCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             CBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999976532        3899999999999999999999998   99999999999999999999999999876432


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .. ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.......                ....+.
T Consensus       157 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~~i~  219 (267)
T 3t9t_A          157 DQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----------------VVEDIS  219 (267)
T ss_dssp             HH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------HHHHHH
T ss_pred             cc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH----------------HHHHHh
Confidence            21 112234557789999999999999999999999999999999 899996532211                111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      .......+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       220 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          220 TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1112223334567799999999999999999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-49  Score=362.32  Aligned_cols=272  Identities=25%  Similarity=0.405  Sum_probs=216.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCC--CCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDAS--KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  136 (361)
                      .++|.+.+.||+|+||.||+|...      ++..||+|++...  ....+.+.+|+.+++++ +||||+++++++.....
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            478999999999999999999962      4668999999753  23456889999999999 89999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVK--------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS  202 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp  202 (361)
                      .++||||+++|+|.+++.......              .......+++..++.++.||+.||.|||+.+   |+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence            999999999999999997654210              0011134899999999999999999999998   99999999


Q ss_pred             CceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCC
Q 018071          203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP  281 (361)
Q Consensus       203 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~  281 (361)
                      +|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999999987644333333445667889999999999999999999999999999998 9999975432


Q ss_pred             cccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCC
Q 018071          282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP  355 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~  355 (361)
                      .               ..+...+........+...+..+.+|+.+||+.||.+|||+.++++.|+.++...+..
T Consensus       281 ~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  339 (344)
T 1rjb_A          281 D---------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA  339 (344)
T ss_dssp             S---------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred             H---------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence            1               1122222223333344455678999999999999999999999999999998766543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=366.51  Aligned_cols=247  Identities=22%  Similarity=0.328  Sum_probs=203.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|++.++||+|+||.||+|..+ +++.||||++.+.    ....+.+.+|..+++.+ +||||+++++++.+....++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999987 7999999998652    23446678899999988 69999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||++||+|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR---------RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccc
Confidence            999999999999997654         2999999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +++.....  .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......               .
T Consensus       170 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---------------~  232 (353)
T 3txo_A          170 MCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---------------L  232 (353)
T ss_dssp             TCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------H
T ss_pred             ceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---------------H
Confidence            99754322  223456789999999999999899999999999999999999999997543211               1


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM------SIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~  343 (361)
                      ...+.....  .++...+..+.+++.+||+.||.+||++      +++++
T Consensus       233 ~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          233 FEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            122222221  2344456779999999999999999998      77765

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.4e-49  Score=366.51  Aligned_cols=255  Identities=21%  Similarity=0.295  Sum_probs=206.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|++.++||+|+||.||+|+.+ +++.||+|++.+..    ...+.+..|..+++++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            368999999999999999999987 78999999987532    2234678899999887 89999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+++|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||
T Consensus       131 V~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEcCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecc
Confidence            999999999999997654         2999999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch-
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED-  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  298 (361)
                      +++.....  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........       ..... 
T Consensus       199 la~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-------~~~~~~  269 (396)
T 4dc2_A          199 MCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDY  269 (396)
T ss_dssp             TCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHH
T ss_pred             eeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-------hhhHHH
Confidence            99763221  223456789999999999999999999999999999999999999996432211000       00011 


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM------SIVVK  343 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~  343 (361)
                      ....+....  ..++...+..+.+||.+||+.||.+||++      ++|++
T Consensus       270 ~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          270 LFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             HHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             HHHHHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            111122222  23455567789999999999999999996      56655

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-48  Score=355.70  Aligned_cols=243  Identities=26%  Similarity=0.372  Sum_probs=208.2

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            68999999999999999999987 8999999998652    234567889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||++
T Consensus        86 e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a  153 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFA  153 (318)
T ss_dssp             CCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcc
Confidence            9999999999997653         3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +....     .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......               ....
T Consensus       154 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------------~~~~  213 (318)
T 1fot_A          154 KYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---------------KTYE  213 (318)
T ss_dssp             EECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---------------HHHH
T ss_pred             eecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---------------HHHH
Confidence            76432     234568999999999999999999999999999999999999999643221               1112


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      .++....  .++...+..+.+++.+||+.||.+||     +++++++
T Consensus       214 ~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          214 KILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            2222221  23445567899999999999999999     8999886

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-48  Score=355.33  Aligned_cols=247  Identities=21%  Similarity=0.325  Sum_probs=206.6

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      +.++|.+.+.||+|+||.||+|..+ +++.||+|++.....       ..+.+.+|+.+++.++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4578999999999999999999987 799999999865332       34678999999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC----c
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V  212 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~----~  212 (361)
                      .++||||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~  156 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR  156 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCC
T ss_pred             EEEEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCC
Confidence            999999999999999997543         3899999999999999999999998   99999999999999887    7


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      +||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........       
T Consensus       157 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------  226 (326)
T 2y0a_A          157 IKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------  226 (326)
T ss_dssp             EEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------
T ss_pred             EEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-------
Confidence            9999999987653221   234567999999999999999999999999999999999999999654321110       


Q ss_pred             ccCCchhhhhhcccccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          293 PKLSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                              ..+....  ...+    ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       227 --------~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          227 --------ANVSAVN--YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             --------HHHHHTC--CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --------HHHHhcC--CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                    0110000  0111    123567899999999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.8e-49  Score=356.11  Aligned_cols=270  Identities=23%  Similarity=0.387  Sum_probs=220.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEE------CCCCEEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  136 (361)
                      .++|.+.+.||+|+||.||+|.+      .++..||+|++.....  ..+.+.+|+.+++++ +||||+++++++.+...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            47899999999999999999985      2578999999976543  236788999999999 89999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCC---------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVK---------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      .++||||+++|+|.+++.......         .......+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            999999999999999997654210         0011224899999999999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccch
Q 018071          208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS  286 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~  286 (361)
                      +.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||......    
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  254 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----  254 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch----
Confidence            9999999999999987654433333345567889999999999999999999999999999999 99999754321    


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                                 ..+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.++....
T Consensus       255 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          255 -----------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             -----------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             -----------hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence                       11122222222223344456779999999999999999999999999999998654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1e-48  Score=350.43  Aligned_cols=261  Identities=27%  Similarity=0.443  Sum_probs=216.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|++.+.||+|+||.||+|..+++..||+|.+.......+.+.+|+++++.++||||+++++++. ....++||||++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   90 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence            4689999999999999999999988889999999877767788999999999999999999999876 456899999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +++|.+++.....       ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....
T Consensus        91 ~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           91 NGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             TCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            9999999975421       12899999999999999999999998   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......                .+...+
T Consensus       161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----------------~~~~~~  223 (279)
T 1qpc_A          161 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----------------EVIQNL  223 (279)
T ss_dssp             SSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHH
T ss_pred             Cccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----------------HHHHHH
Confidence            3221 12234456889999999998899999999999999999999 99999643221                111111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                      ........+..++..+.+++.+||+.||++|||+.++++.|+.++.....
T Consensus       224 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             hcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            12222233445567899999999999999999999999999999876543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.1e-49  Score=361.79  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=207.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCE----EEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHA----AAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|++.++||+|+||.||+|.+. +++.    ||+|.+....  ...+.+.+|+.+++.++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57999999999999999999976 5554    7888775432  23356788999999999999999999986 456889


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+.+|+|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             EEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCC
Confidence            9999999999999976532        3889999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++...............||..|+|||++.+..++.++|||||||++|+|++ |..||.......               
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---------------  225 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---------------  225 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---------------
T ss_pred             cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---------------
Confidence            9987654433333455678889999999999999999999999999999999 999997543221               


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                       +...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       226 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          226 -VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -HHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -HHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence             111222222222333345568999999999999999999999999998874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=358.01  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=206.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCE----EEEEEcCC--CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHA----AAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      .++|++.++||+|+||.||+|.+. +++.    |++|.+..  .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            368999999999999999999976 5554    57777654  2345578999999999999999999999998764 78


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      ++++|+.+|+|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~Df  161 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred             EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccC
Confidence            99999999999999976542        3899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||......               
T Consensus       162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---------------  226 (327)
T 3lzb_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------------  226 (327)
T ss_dssp             TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---------------
T ss_pred             cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---------------
Confidence            99987644333333344567889999999999999999999999999999999 99999754322               


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                       .+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       227 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          227 -EISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -GHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             -HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             2222333333334455566789999999999999999999999999999874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=364.21  Aligned_cols=249  Identities=23%  Similarity=0.327  Sum_probs=207.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|++.++||+|+||.||+|..+ +++.||+|++.+.    ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            368999999999999999999987 7999999998642    34456788999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+.||+|.+++....         .+++..++.++.||+.||.|||+.|   |+||||||+|||++.+|.+||+|||+
T Consensus        94 ~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~  161 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV---------HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNI  161 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccce
Confidence            99999999999997653         3999999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhcc---CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ++.....   ......+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||..........+..        
T Consensus       162 a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~--------  230 (384)
T 4fr4_A          162 AAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH--------  230 (384)
T ss_dssp             CEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH--------
T ss_pred             eeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH--------
Confidence            9765332   22356789999999999974   468999999999999999999999997543322111111        


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-MSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~  343 (361)
                          .+...  ...++...+..+.+||.+||+.||.+||+ +++|++
T Consensus       231 ----~~~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          231 ----TFETT--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ----HHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ----HHhhc--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                11111  12344456678999999999999999998 777765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.3e-49  Score=358.81  Aligned_cols=264  Identities=23%  Similarity=0.364  Sum_probs=198.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCC---EEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCee-
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGH---AAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR-  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~-  137 (361)
                      .++|.+.+.||+|+||.||+|..+ ++.   .||+|++....   ...+.+.+|+.++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            468999999999999999999966 333   89999997642   2346788999999999999999999999877655 


Q ss_pred             -----EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          138 -----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       138 -----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                           ++||||+.+++|.+++.......   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccc---cccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence                 89999999999999986543211   1124899999999999999999999998   999999999999999999


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~  291 (361)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......        
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------  247 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------  247 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--------
Confidence            99999999987644333333344567889999999999999999999999999999999 999997543221        


Q ss_pred             cccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          292 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                              +...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+++.
T Consensus       248 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          248 --------IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             --------HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --------HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                    1111111112233445567799999999999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.3e-48  Score=356.66  Aligned_cols=261  Identities=19%  Similarity=0.250  Sum_probs=212.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|.+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.+++.+ +||||+++++++......++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            468999999999999999999975 89999999986543 334688999999999 899999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc-----eEEecc
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-----AKIADF  218 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~-----~kl~Df  218 (361)
                      + +++|.+++....        ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.     +||+||
T Consensus        87 ~-~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           87 L-GPSLEDLFDLCD--------RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             C-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             C-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            9 899999998642        13999999999999999999999998   999999999999998887     999999


Q ss_pred             ccCCCCccccccc-----cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          219 DLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       219 g~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+++.........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............    
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~----  230 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ----  230 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH----
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH----
Confidence            9997653322111     1246789999999999999999999999999999999999999997654322211111    


Q ss_pred             cCCchhhhhhcccccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          294 KLSEDKVRQCVDARLGGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                              .+.+......   .....+ .+.+++..||+.||.+||++.+|++.|+.+++..
T Consensus       231 --------~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          231 --------KIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             --------HHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             --------HHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence                    1100000000   001123 7999999999999999999999999999998754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-48  Score=348.55  Aligned_cols=252  Identities=29%  Similarity=0.491  Sum_probs=200.2

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCC-----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|.+.+.||+|+||.||+|.+. ++.||+|++.....     ..+.+.+|+++++.++||||+++++++.+....++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            68899999999999999999986 89999999865332     2367889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc--------CCce
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--------DDVA  213 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~--------~~~~  213 (361)
                      ||+++++|.+++....          +++..++.++.|++.||.|||+.+..+|+||||||+|||++.        ++.+
T Consensus        86 e~~~~~~L~~~~~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           86 EFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             ECCTTEEHHHHHTSSC----------CCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             EcCCCCCHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence            9999999999986443          899999999999999999999986445889999999999986        7789


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      ||+|||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......          
T Consensus       156 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------  221 (271)
T 3dtc_A          156 KITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----------  221 (271)
T ss_dssp             EECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH----------
T ss_pred             EEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------
Confidence            999999997654322    234578999999999999999999999999999999999999996432211          


Q ss_pred             cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                           ..............+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       222 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          222 -----VAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -----HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -----HHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                 11112222223334455667899999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1e-48  Score=356.16  Aligned_cols=265  Identities=21%  Similarity=0.296  Sum_probs=204.4

Q ss_pred             HhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.++|++.+.||+|+||+||+|..++++.||+|++......   ...+.+|+.++++++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            45899999999999999999999988999999999754322   357889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++ +|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        99 e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a  166 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLA  166 (311)
T ss_dssp             ECCSE-EHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cCCCC-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCc
Confidence            99975 88888865432        3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........+
T Consensus       167 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  244 (311)
T 3niz_A          167 RAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW  244 (311)
T ss_dssp             EETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred             eecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence            7653221  12345678999999999886 56899999999999999999999999765443322111110000000000


Q ss_pred             h------hhcccccC--CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 R------QCVDARLG--GD-----YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~------~~~~~~~~--~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .      ...+....  ..     ..+..+.++.+|+.+||+.||.+|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0      00000000  00     11223467899999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.5e-48  Score=369.35  Aligned_cols=251  Identities=19%  Similarity=0.251  Sum_probs=207.4

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .+.++|++.+.||+|+||.||+|..+ +|+.+|+|++......   .+.+.+|+.+++.++||||+++++++.+....++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            46789999999999999999999976 8999999998765432   3568899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec---cCCceEEe
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIA  216 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~---~~~~~kl~  216 (361)
                      ||||+.+|+|.+++....         .+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+
T Consensus        88 v~E~~~gg~L~~~i~~~~---------~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~  155 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA  155 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred             EEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence            999999999999987654         3899999999999999999999998   99999999999998   45789999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      |||++.......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........            
T Consensus       156 DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~------------  221 (444)
T 3soa_A          156 DFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL------------  221 (444)
T ss_dssp             CCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------------
T ss_pred             cCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH------------
Confidence            999997664322  123456899999999999999999999999999999999999999964432111            


Q ss_pred             chhhhhhcccccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          297 EDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       297 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         ...+......  .+.....+..+.+|+.+||+.||.+|||+.++++
T Consensus       222 ---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          222 ---YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ---HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               1111111111  1111244677999999999999999999999987

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.6e-49  Score=361.14  Aligned_cols=277  Identities=27%  Similarity=0.400  Sum_probs=218.9

Q ss_pred             hcC-CCCCccccCCceEEEEEEEC-----CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEe--CCe
Q 018071           67 ENF-GTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTS  136 (361)
Q Consensus        67 ~~y-~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~  136 (361)
                      ++| ++.+.||+|+||+||++.++     +++.||||++......  .+.+.+|+++++.++||||+++++++.+  ...
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            455 89999999999999998643     6889999999765322  3568899999999999999999999987  467


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||+++++|.+++....          +++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~  176 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIG  176 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEEC
Confidence            899999999999999997653          899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          217 DFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       217 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |||++......... .......+|..|+|||++.+..++.++||||||+++|+|++|..||...... ......+.....
T Consensus       177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~  255 (318)
T 3lxp_A          177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQM  255 (318)
T ss_dssp             CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHH
T ss_pred             CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccch
Confidence            99999765432211 1234456888999999999999999999999999999999999998632110 000000111111


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCC
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAG  357 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~  357 (361)
                      ....+...+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+......|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p  317 (318)
T 3lxp_A          256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP  317 (318)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred             hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence            12233444444445555666778899999999999999999999999999999886655544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.9e-49  Score=371.84  Aligned_cols=250  Identities=19%  Similarity=0.256  Sum_probs=207.1

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC----CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ..++|++.++||+|+||.||+|..+ +++.||+|++.+    .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            3478999999999999999999987 799999999864    22334568899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||++||+|.+++....          +++..++.++.||+.||+|||+.+   |+||||||+|||++.+|.+||+|||
T Consensus       147 V~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             EECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence            999999999999997643          899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCC----CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      +++...... .......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.......            
T Consensus       214 ~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------------  280 (410)
T 3v8s_A          214 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------  280 (410)
T ss_dssp             TCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------------
T ss_pred             eeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------------
Confidence            997654322 11234678999999999998765    8899999999999999999999997543221            


Q ss_pred             Cchhhhhhcccc--cCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 018071          296 SEDKVRQCVDAR--LGGDYPPKAVAKMAAVAALCVQYEADF--RPNMSIVVK  343 (361)
Q Consensus       296 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~  343 (361)
                         ....++...  +..+.....+..+.+||.+||..+|.+  ||++++|++
T Consensus       281 ---~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          281 ---TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             ---HHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             ---HHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence               111121111  111111235677999999999999988  999999997

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.3e-48  Score=359.18  Aligned_cols=251  Identities=20%  Similarity=0.298  Sum_probs=207.7

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .+.++|.+.+.||+|+||.||+|..+ ++..||+|++......   .+.+.+|+.+++.++||||+++++++.+....++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            45789999999999999999999987 7999999999765433   3567899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC---ceEEe
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIA  216 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~---~~kl~  216 (361)
                      ||||+.+|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       106 v~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~  173 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA  173 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEe
Confidence            999999999999987543         3899999999999999999999998   99999999999998654   59999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      |||++.......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........            
T Consensus       174 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------------  238 (362)
T 2bdw_A          174 DFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------------  238 (362)
T ss_dssp             CCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------
T ss_pred             ecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------------
Confidence            999998764322   23456799999999999999999999999999999999999999965432111            


Q ss_pred             chhhhhhcccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          297 EDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       297 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                         ...+.......  ......+..+.+|+.+||+.||.+|||+.++++.
T Consensus       239 ---~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          239 ---YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ---HHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---HHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               11111111111  1112345679999999999999999999998863

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.6e-48  Score=348.23  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=201.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|++.+.||+|+||.||+|...    .+..||+|++......  .+.+.+|+.++++++||||+++++++. ....++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            478999999999999999999975    2457999998754322  356889999999999999999999974 567899


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+++++|.+++.....        .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        93 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccc
Confidence            9999999999999976531        3899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........              
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--------------  226 (281)
T 1mp8_A          162 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--------------  226 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------------
T ss_pred             cccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--------------
Confidence            9987643221 12234557789999999999999999999999999999997 9999975432211              


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                        ...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+++.
T Consensus       227 --~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          227 --IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             --HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence              111111112234445667899999999999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-48  Score=358.89  Aligned_cols=245  Identities=24%  Similarity=0.324  Sum_probs=205.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++...    ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            368999999999999999999975 8999999998642    23346789999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+ +|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        88 ~E~~-~g~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~  154 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK---------RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL  154 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred             EECC-CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEecc
Confidence            9999 679999887653         2899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +.......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........              
T Consensus       155 s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--------------  217 (336)
T 3h4j_B          155 SNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--------------  217 (336)
T ss_dssp             TBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------------
T ss_pred             ceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------------
Confidence            97654322   2345679999999999988776 68999999999999999999999754322110              


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ..+...  ....+...+..+.+|+.+||+.||.+|||++++++
T Consensus       218 -~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          218 -KKVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             -CCCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             -HHHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             000000  11233345677999999999999999999999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-47  Score=350.78  Aligned_cols=275  Identities=20%  Similarity=0.286  Sum_probs=215.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCC--eeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT--SRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv  140 (361)
                      .++|.+.++||+|+||+||+|..+ +++.||||++....  ...+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            468999999999999999999987 79999999987532  34567889999999999999999999998665  77999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe----ccCCceEEe
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIA  216 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill----~~~~~~kl~  216 (361)
                      |||+++++|.+++......      ..+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+
T Consensus        88 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT  158 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred             EeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEc
Confidence            9999999999999865421      23899999999999999999999998   9999999999999    778889999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhc--------cCCCCCccceecHHHHHHHHHhCCCCCCCCCCccc-chh
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--------TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSL  287 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~-~~~  287 (361)
                      |||+++......   ......||+.|+|||++.        +..++.++|||||||++|+|++|+.||........ ...
T Consensus       159 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  235 (319)
T 4euu_A          159 DFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (319)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred             cCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence            999997654322   224567999999999986        56889999999999999999999999975433221 111


Q ss_pred             hhhhcccCCchh---hhhhc--------ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          288 VTWATPKLSEDK---VRQCV--------DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       288 ~~~~~~~~~~~~---~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      ............   +....        +.......+...+..+.+++.+||+.||++|||++|+++...+-....
T Consensus       236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~  311 (319)
T 4euu_A          236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG  311 (319)
T ss_dssp             HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred             HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence            111000000000   00000        011122456788999999999999999999999999999887665433

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-48  Score=354.38  Aligned_cols=266  Identities=26%  Similarity=0.420  Sum_probs=208.6

Q ss_pred             HHHHHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcC--CCCCcceeeeEEEeC----
Q 018071           61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL--KHENFVQLLGYCVDG----  134 (361)
Q Consensus        61 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l--~hpniv~~~~~~~~~----  134 (361)
                      ....+.++|++.+.||+|+||.||+|..+ ++.||||++....  ...+.+|.+++..+  +||||+++++++...    
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            33456789999999999999999999987 9999999985432  34555666666554  899999999999887    


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc--------CCCCeEeccCCCCceE
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK--------ADPHIIHRDIKSSNVL  206 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~~~ivHrDikp~Nil  206 (361)
                      ...++||||+++|+|.+++....          +++..++.++.|++.||.|||+.        +   |+||||||+|||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nil  174 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNIL  174 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEE
T ss_pred             CceEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEE
Confidence            78899999999999999997653          89999999999999999999998        7   999999999999


Q ss_pred             eccCCceEEeccccCCCCcccccc--ccccccccCCCCCCchhhccCCCCCc------cceecHHHHHHHHHhC------
Q 018071          207 IFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAK------SDVYSFGVVLLELLTG------  272 (361)
Q Consensus       207 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~~l~ell~g------  272 (361)
                      ++.++.+||+|||++.........  .......||+.|+|||++.+..++..      +|||||||++|||++|      
T Consensus       175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~  254 (337)
T 3mdy_A          175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI  254 (337)
T ss_dssp             ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence            999999999999998654332211  11235679999999999988776665      9999999999999999      


Q ss_pred             ----CCCCCCCCCcccchhhhhhcccCCchhhhhhc-ccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018071          273 ----RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV-DARLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVV  342 (361)
Q Consensus       273 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl  342 (361)
                          ..||....+...           ....+...+ ........+     ..++..+.+|+.+||+.||.+|||+.+|+
T Consensus       255 ~~~~~~p~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  323 (337)
T 3mdy_A          255 VEEYQLPYHDLVPSDP-----------SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK  323 (337)
T ss_dssp             CCCCCCTTTTTSCSSC-----------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cccccccHhhhcCCCC-----------chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence                555543222111           111111111 111222222     26788899999999999999999999999


Q ss_pred             HHHHHhHhcCC
Q 018071          343 KALQPLLNARP  353 (361)
Q Consensus       343 ~~L~~l~~~~~  353 (361)
                      +.|+.+.+...
T Consensus       324 ~~L~~l~~~~~  334 (337)
T 3mdy_A          324 KTLAKMSESQD  334 (337)
T ss_dssp             HHHHHHHHTTT
T ss_pred             HHHHHHHhhcc
Confidence            99999988653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=352.34  Aligned_cols=248  Identities=26%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---------------------------ChHHHHHHHHHHh
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------------------------PDEEFLAQVSMVS  117 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------------------------~~~~~~~e~~~l~  117 (361)
                      .++|.+.+.||+|+||.||+|..+ +++.||||++.....                           ..+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            368999999999999999999976 789999999865321                           1246889999999


Q ss_pred             cCCCCCcceeeeEEEe--CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 018071          118 RLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI  195 (361)
Q Consensus       118 ~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i  195 (361)
                      +++||||+++++++.+  ....++||||+++++|.+++...          .+++..++.++.||+.||.|||+.+   |
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i  158 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLHYQK---I  158 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence            9999999999999986  56889999999999998875433          3999999999999999999999998   9


Q ss_pred             EeccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCC---CCCccceecHHHHHHHHHhC
Q 018071          196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ---LNAKSDVYSFGVVLLELLTG  272 (361)
Q Consensus       196 vHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g  272 (361)
                      +||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..   ++.++|||||||++|+|++|
T Consensus       159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             eccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            999999999999999999999999987654321  1234567999999999998665   37789999999999999999


Q ss_pred             CCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          273 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       273 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.||.......   +            ...+.......+.....+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~pf~~~~~~~---~------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          237 QCPFMDERIMC---L------------HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCSSCCSSHHH---H------------HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCCccHHH---H------------HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            99996432111   0            01111111111112234567999999999999999999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.8e-49  Score=361.36  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=207.3

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~  138 (361)
                      ..++|.+.++||+|+||.||+|..+ +++.||+|++.+.    ....+.+..|..+++.+ +||||+++++++.+....+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4579999999999999999999987 7999999999653    34456788899998876 8999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +||||++||+|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.+|.+||+||
T Consensus        95 lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEC
Confidence            9999999999999997643         2899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      |+++.....  .......+||+.|+|||++.+..++.++|||||||++|||++|..||........              
T Consensus       163 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--------------  226 (345)
T 1xjd_A          163 GMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--------------  226 (345)
T ss_dssp             TTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------
T ss_pred             hhhhhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH--------------
Confidence            999764321  1224567899999999999999999999999999999999999999975432111              


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS-IVVK  343 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~  343 (361)
                       +..+....  ..++...+..+.+|+.+||+.||.+||++. +|++
T Consensus       227 -~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          227 -FHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             -HHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -HHHHHhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence             11111111  123344567799999999999999999997 6654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.2e-48  Score=347.27  Aligned_cols=267  Identities=17%  Similarity=0.200  Sum_probs=214.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++.+....++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            468999999999999999999975 89999999986433 345688999999999 799999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc-----eEEecc
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-----AKIADF  218 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~-----~kl~Df  218 (361)
                      + +++|.+++.....        .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.     +||+||
T Consensus        88 ~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           88 L-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             c-CCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            9 9999999976531        3899999999999999999999998   999999999999987775     999999


Q ss_pred             ccCCCCcccccc-----ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          219 DLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       219 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            999765432211     123456799999999999999999999999999999999999999976543222111110000


Q ss_pred             cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                      .......     ..    ....++..+.+++.+||+.||.+|||+++|++.|+.+++....
T Consensus       236 ~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          236 KKQSTPL-----RE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             HHHHSCH-----HH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hccCccH-----HH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            0000000     00    0112356799999999999999999999999999999986554

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8e-49  Score=381.83  Aligned_cols=262  Identities=29%  Similarity=0.473  Sum_probs=220.6

Q ss_pred             HhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      ..++|.+.+.||+|+||.||+|.++.+..||||++.......+++.+|+.+|++++||||+++++++.+ ...+|||||+
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            356788899999999999999999877889999998766667889999999999999999999999866 6789999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      .+|+|.+++.....       ..+++..++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++..
T Consensus       344 ~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          344 SKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             TTEEHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             cCCcHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            99999999975322       13899999999999999999999998   999999999999999999999999999876


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ..... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.....                ..+...
T Consensus       414 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----------------~~~~~~  476 (535)
T 2h8h_A          414 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLDQ  476 (535)
T ss_dssp             CCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----------------HHHHHH
T ss_pred             CCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence            43221 11233456789999999999999999999999999999999 9999964321                122222


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                      +........+..++..+.+||.+||+.||++|||+++|++.|+.++....+
T Consensus       477 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          477 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence            333334455566778899999999999999999999999999999875544

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-48  Score=358.64  Aligned_cols=243  Identities=22%  Similarity=0.309  Sum_probs=208.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999987 8999999998642    234567889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||++
T Consensus       121 e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a  188 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccc
Confidence            9999999999997653         2899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....     ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......               ....
T Consensus       189 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---------------~~~~  248 (350)
T 1rdq_E          189 KRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---------------QIYE  248 (350)
T ss_dssp             EECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------HHHH
T ss_pred             eeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---------------HHHH
Confidence            765321     24568999999999999999999999999999999999999999754321               1111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~  343 (361)
                      .+.....  .++...+..+.++|.+||+.||.+||+     +++|++
T Consensus       249 ~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          249 KIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            2222211  234455677999999999999999998     888876

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.8e-48  Score=358.24  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=205.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC------CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA------SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      +.++|++.+.||+|+||.||+|..+ +++.||||++..      .....+.+.+|+.+++.++||||+++++++.+....
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4578999999999999999999987 899999999853      122457899999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc---eE
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AK  214 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~---~k  214 (361)
                      ++||||+++++|.+++......     ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.   +|
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEE
T ss_pred             EEEEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEE
Confidence            9999999999998887654211     123899999999999999999999998   999999999999987654   99


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |+|||++.......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.....             
T Consensus       174 l~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------  238 (351)
T 3c0i_A          174 LGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------------  238 (351)
T ss_dssp             ECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------------
T ss_pred             EecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------------
Confidence            99999997654321  123456799999999999999999999999999999999999999964311             


Q ss_pred             CCchhhhhhcccccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 LSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         .....+.....  ..+    ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       239 ---~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          239 ---RLFEGIIKGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ---HHHHHHHHTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---HHHHHHHcCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               00111111111  111    123567999999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=357.22  Aligned_cols=251  Identities=20%  Similarity=0.373  Sum_probs=201.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCCh---HHHHHHHHHHhcCCC--CCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKH--ENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h--pniv~~~~~~~~~~~~~lv  140 (361)
                      .++|++.+.||+|+||.||++..++++.||||++.......   +.+.+|+.+++.++|  |||+++++++.+....++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            46799999999999999999998889999999987654332   567899999999976  9999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      ||+ .+++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+
T Consensus        88 ~e~-~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~  153 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGI  153 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred             EeC-CCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccc
Confidence            995 5789999998653         3899999999999999999999998   99999999999996 67899999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhcc-----------CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT  289 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~  289 (361)
                      ++..............+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||......       
T Consensus       154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------  226 (343)
T 3dbq_A          154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------  226 (343)
T ss_dssp             SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------
T ss_pred             ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------
Confidence            987654433333456789999999999875           67889999999999999999999999643211       


Q ss_pred             hhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          290 WATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                             ...+...++.......+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       227 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          227 -------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             -------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                   112233333333344444455679999999999999999999999874

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.1e-48  Score=348.31  Aligned_cols=263  Identities=20%  Similarity=0.266  Sum_probs=202.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|++.+.||+|+||+||+|..+ +++.||+|++......   ...+.+|+.++++++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999987 7999999999754332   3678899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++ +|.+++....        ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        82 ~~~~-~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~  149 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN--------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             CCSE-EHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCC-CHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence            9976 6666665432        13999999999999999999999998   9999999999999999999999999997


Q ss_pred             CCccccccccccccccCCCCCCchhhccCC-CCCccceecHHHHHHHHHhCCCCCCCCCCc-ccchhhhhhcccCCchhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLPR-GQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  300 (361)
                      .....  ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+...........+
T Consensus       150 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~  227 (292)
T 3o0g_A          150 AFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             ECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred             ecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence            65322  12234567899999999998765 899999999999999999988886432211 110000000001111110


Q ss_pred             hhhc---c---------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCV---D---------ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~---~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ....   +         ........+..+..+.+|+.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000   0         00011222345677999999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-48  Score=362.13  Aligned_cols=244  Identities=21%  Similarity=0.285  Sum_probs=195.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHH-HhcCCCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSM-VSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~-l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|++.++||+|+||.||+|+.+ +++.||+|++.+..    .....+..|..+ ++.++||||+++++++.+....++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            368999999999999999999987 78999999996532    223456667666 567899999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||++||+|.+++....         .+++..++.++.||+.||+|||+++   |+||||||+|||++.+|++||+|||
T Consensus       117 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG  184 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG  184 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCc
Confidence            999999999999997653         2899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +++.....  .......+||+.|+|||++.+..++.++|||||||++|||++|..||......               +.
T Consensus       185 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---------------~~  247 (373)
T 2r5t_A          185 LCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---------------EM  247 (373)
T ss_dssp             BCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---------------HH
T ss_pred             cccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---------------HH
Confidence            98753221  22345678999999999999999999999999999999999999999643221               11


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI  340 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e  340 (361)
                      ...++....  .++...+..+.+||.+||+.||.+||++.+
T Consensus       248 ~~~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          248 YDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHHHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             HHHHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            122222211  233445677999999999999999999853

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.9e-48  Score=355.79  Aligned_cols=269  Identities=25%  Similarity=0.417  Sum_probs=216.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC--------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG  134 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~~  134 (361)
                      .++|.+.+.||+|+||.||+|.+.        ++..||+|++......  .+.+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999999863        5678999999764332  35688999999999 899999999999999


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      ...++||||+++++|.+++........       ......+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999986542110       011234899999999999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccch
Q 018071          208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS  286 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~  286 (361)
                      +.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......    
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  266 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  266 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence            9999999999999876543332223344567889999999999899999999999999999999 99999644221    


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                                  .+...+........+..++..+.+++.+||+.+|.+|||+.++++.|+.++...+
T Consensus       267 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          267 ------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             ------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence                        1111122222223344556779999999999999999999999999999987543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.8e-48  Score=354.83  Aligned_cols=253  Identities=21%  Similarity=0.304  Sum_probs=200.7

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCC-----
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----  135 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----  135 (361)
                      .+.++|++.+.||+|+||.||+|..+ +++.||||++....  ...+.+.+|+.++++++||||+++++++.+..     
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            35678999999999999999999987 89999999986533  33467899999999999999999999986543     


Q ss_pred             ----------------------------------------------------eeEEEEEeCCCCcHHHhhhcCCCCCCCC
Q 018071          136 ----------------------------------------------------SRVLAYEFASNGSLHDILHGRKGVKGAQ  163 (361)
Q Consensus       136 ----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~  163 (361)
                                                                          ..++||||+++++|.+++......    
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----  158 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL----  158 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG----
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc----
Confidence                                                                379999999999999999875432    


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccc----------cccc
Q 018071          164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA----------RLHS  233 (361)
Q Consensus       164 ~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~----------~~~~  233 (361)
                        ....+..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......          ....
T Consensus       159 --~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          159 --EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             --GGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             --cchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence              23677789999999999999999998   99999999999999999999999999876543221          1122


Q ss_pred             cccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCC
Q 018071          234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP  313 (361)
Q Consensus       234 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (361)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..|+...     .            ......... ......
T Consensus       234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~------------~~~~~~~~~-~~~~~~  295 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----V------------RIITDVRNL-KFPLLF  295 (332)
T ss_dssp             CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----H------------HHHHHHHTT-CCCHHH
T ss_pred             cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----H------------HHHHHhhcc-CCCccc
Confidence            4467999999999999999999999999999999999987764210     0            000011111 001112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          314 PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       314 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...+..+.+++.+||+.||.+|||+.++++
T Consensus       296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          296 TQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            344567899999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.6e-49  Score=363.74  Aligned_cols=275  Identities=20%  Similarity=0.263  Sum_probs=213.6

Q ss_pred             ccCccCHHHHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-----CCCcce
Q 018071           53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----HENFVQ  126 (361)
Q Consensus        53 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~  126 (361)
                      +...++..+...+.++|.+.++||+|+||.||+|... +++.||||++.........+..|+.+++.++     ||||++
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            3344555555566789999999999999999999986 8999999999765555567788999999986     999999


Q ss_pred             eeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceE
Q 018071          127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL  206 (361)
Q Consensus       127 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nil  206 (361)
                      +++++......++||||+ +++|.+++......       .+++..++.++.||+.||+|||+.+   |+||||||+|||
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  169 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-------GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENIL  169 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEE
Confidence            999999999999999999 88999999865422       3899999999999999999999998   999999999999


Q ss_pred             ecc-------------------------CCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceec
Q 018071          207 IFD-------------------------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS  261 (361)
Q Consensus       207 l~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  261 (361)
                      ++.                         ++.+||+|||+++....     ......||+.|+|||++.+..++.++||||
T Consensus       170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  244 (360)
T 3llt_A          170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWS  244 (360)
T ss_dssp             ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred             EccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHH
Confidence            975                         78999999999875432     224567899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc---------cccCCCC-----------------C--
Q 018071          262 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD---------ARLGGDY-----------------P--  313 (361)
Q Consensus       262 lG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~-----------------~--  313 (361)
                      |||++|+|++|+.||...........+.................         .......                 +  
T Consensus       245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  324 (360)
T 3llt_A          245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY  324 (360)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred             HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence            99999999999999976543222111111111111111100000         0000000                 0  


Q ss_pred             -HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          314 -PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       314 -~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          325 KIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             011256889999999999999999999975

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.5e-48  Score=350.54  Aligned_cols=257  Identities=24%  Similarity=0.392  Sum_probs=201.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhc--CCCCCcceeeeEEEe----CCeeE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR--LKHENFVQLLGYCVD----GTSRV  138 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~----~~~~~  138 (361)
                      +.++|++.+.||+|+||+||+|.. +++.||||++...  ....+.+|.+++..  ++||||+++++++..    ....+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            457899999999999999999998 5999999998653  34556667777666  789999999998754    24578


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeEeccCCCCceEeccC
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH--------EKADPHIIHRDIKSSNVLIFDD  210 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~ivHrDikp~Nill~~~  210 (361)
                      +||||+++|+|.+++....          +++..++.++.||+.||+|||        +.+   |+||||||+|||++.+
T Consensus        83 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKN  149 (301)
T ss_dssp             EEECCCTTCBHHHHHTTCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTT
T ss_pred             EehhhccCCCHHHHHhhcc----------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCC
Confidence            9999999999999996543          999999999999999999999        777   9999999999999999


Q ss_pred             CceEEeccccCCCCcccccc--ccccccccCCCCCCchhhccC------CCCCccceecHHHHHHHHHhC----------
Q 018071          211 DVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG------QLNAKSDVYSFGVVLLELLTG----------  272 (361)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g----------  272 (361)
                      +.+||+|||+++........  .......||+.|+|||++.+.      .++.++|||||||++|||++|          
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            99999999998654322111  112345799999999999876      455789999999999999999          


Q ss_pred             CCCCCCCCCcccchhhhhhcccCCchhhhhhc-ccccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          273 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV-DARLGGD-----YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       273 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                      ..||....+....           ...+...+ .......     .+...+..+.+|+.+||+.||.+|||+.+|++.|+
T Consensus       230 ~~pf~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  298 (301)
T 3q4u_A          230 KPPFYDVVPNDPS-----------FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT  298 (301)
T ss_dssp             CCTTTTTSCSSCC-----------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccccccCCCCcc-----------hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence            7777543322111           01111111 0111111     12357788999999999999999999999999998


Q ss_pred             Hh
Q 018071          347 PL  348 (361)
Q Consensus       347 ~l  348 (361)
                      .+
T Consensus       299 ~i  300 (301)
T 3q4u_A          299 KI  300 (301)
T ss_dssp             HH
T ss_pred             cc
Confidence            76

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.5e-48  Score=358.16  Aligned_cols=247  Identities=22%  Similarity=0.286  Sum_probs=207.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|++.++||+|+||.||+|..+ +++.||+|++.+.    ....+.+..|..++..+ +||||+++++++.+....++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            478999999999999999999987 6899999998652    34456788999999988 79999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||++||+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||
T Consensus        99 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCC
Confidence            999999999999997643         2899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +++.....  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......               ..
T Consensus       167 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---------------~~  229 (353)
T 2i0e_A          167 MCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---------------EL  229 (353)
T ss_dssp             TCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------HH
T ss_pred             cccccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---------------HH
Confidence            99764221  12245678999999999999999999999999999999999999999754321               11


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~  343 (361)
                      ...+.....  .++...+..+.+|+.+||+.||.+||+     +++|++
T Consensus       230 ~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          230 FQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            122222221  234456678999999999999999995     577765

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=7.2e-48  Score=355.28  Aligned_cols=254  Identities=21%  Similarity=0.296  Sum_probs=205.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++.+....    .+.+.+|..+++++ +||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            68999999999999999999987 7999999999764322    24577899999888 899999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        89 ~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~  156 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM  156 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred             EeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccc
Confidence            99999999999997653         2899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh-
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK-  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  299 (361)
                      ++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........       ...... 
T Consensus       157 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------~~~~~~~  227 (345)
T 3a8x_A          157 CKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDYL  227 (345)
T ss_dssp             CBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHH
T ss_pred             cccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc-------cccHHHH
Confidence            97642211  22356789999999999999999999999999999999999999996432111000       000011 


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM------SIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~  343 (361)
                      ...+....  ..++...+..+.+|+.+||+.||.+||++      .++++
T Consensus       228 ~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          228 FQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             HHHHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            11122222  13445567789999999999999999996      56654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-48  Score=347.85  Aligned_cols=261  Identities=25%  Similarity=0.439  Sum_probs=213.3

Q ss_pred             hcCCCCC-ccccCCceEEEEEEEC---CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNA-LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|.+.+ .||+|+||.||+|..+   ++..||+|++.....  ..+.+.+|+.+++.++||||+++++++ .....++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            5676766 8999999999999854   678899999976432  345788999999999999999999999 55678999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++....        ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        88 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             EECCTTEEHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEeCCCCCHHHHHHhCC--------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccc
Confidence            99999999999996543        23899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccc-cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          221 SNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       221 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......                
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------  220 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------------  220 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----------------
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----------------
Confidence            876532221 112234457889999999998899999999999999999998 99999654321                


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCC
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP  355 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~  355 (361)
                      .+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.++.+...+
T Consensus       221 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          221 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence            111222222223445566778999999999999999999999999999998755443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-48  Score=356.31  Aligned_cols=270  Identities=24%  Similarity=0.390  Sum_probs=215.9

Q ss_pred             HHHHhhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 018071           62 LKEITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD  133 (361)
Q Consensus        62 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~  133 (361)
                      ++...++|.+.+.||+|+||.||+|.++      +++.||+|.+......  ...+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            3345678999999999999999999854      4788999999754432  3468899999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVK-GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                      ....++||||+++++|.+++....... .......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCe
Confidence            999999999999999999987532100 0001123789999999999999999999998   999999999999999999


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~  291 (361)
                      +||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......         
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---------  247 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---------  247 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---------
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---------
Confidence            99999999986544333333345567899999999999999999999999999999999 89999643221         


Q ss_pred             cccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          292 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                             .+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.++.
T Consensus       248 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          248 -------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                   1111111111122334556779999999999999999999999999988754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-47  Score=349.27  Aligned_cols=268  Identities=25%  Similarity=0.365  Sum_probs=203.3

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCe-
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS-  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-  136 (361)
                      ..++|.+.+.||+|+||.||+|...    ++..||+|.+......   .+.+.+|+.++++++||||+++++++.+... 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3578999999999999999999854    3458999999765433   2568899999999999999999999986543 


Q ss_pred             ----eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          137 ----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       137 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                          .++||||+++++|.+++......   .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLE---TGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBT---TSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhh---cCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence                49999999999999998543211   11234999999999999999999999998   999999999999999999


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~  291 (361)
                      +||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......        
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------  257 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--------  257 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------
Confidence            99999999987644332233345567889999999999999999999999999999999 899996543221        


Q ss_pred             cccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          292 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                              +...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+++..|.
T Consensus       258 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~  312 (313)
T 3brb_A          258 --------MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD  312 (313)
T ss_dssp             --------HHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             --------HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence                    1111111112233445567799999999999999999999999999999987663

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=359.30  Aligned_cols=250  Identities=23%  Similarity=0.308  Sum_probs=192.9

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .+.++|++.+.||+|+||.||+|..+ +++.||||++.... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            35678999999999999999999987 78999999987543 34578889999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc---CCceEEeccc
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFD  219 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~---~~~~kl~Dfg  219 (361)
                      |+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||
T Consensus       129 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             CCCSCBHHHHHTTCS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             eCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCc
Confidence            999999999987543         3899999999999999999999998   999999999999975   8899999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|..||........              .
T Consensus       197 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------------~  259 (349)
T 2w4o_A          197 LSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--------------M  259 (349)
T ss_dssp             -------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--------------H
T ss_pred             cccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--------------H
Confidence            98865332   123456799999999999999999999999999999999999999964332110              0


Q ss_pred             hhhhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +..+.....  ..+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       260 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          260 FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111111  11122345677999999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.2e-48  Score=352.06  Aligned_cols=266  Identities=24%  Similarity=0.356  Sum_probs=203.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCcceeeeEEEeCCe----
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTS----  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpniv~~~~~~~~~~~----  136 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++.......    ..+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            578999999999999999999975 89999999997643332    467899999999999999999999876543    


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~  158 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM  158 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEEC
T ss_pred             cEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEe
Confidence            399999999999999997653         3899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          217 DFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       217 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........          
T Consensus       159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~----------  228 (311)
T 3ork_A          159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----------  228 (311)
T ss_dssp             CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----------
T ss_pred             eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH----------
Confidence            99999865432221 2234467999999999999999999999999999999999999999754322110          


Q ss_pred             CchhhhhhcccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHH-HHHHHHHhHhcCCCCCCC
Q 018071          296 SEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSI-VVKALQPLLNARPGPAGE  358 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~e-vl~~L~~l~~~~~~~~~~  358 (361)
                           ..........  ......+..+.+++.+||+.||.+||+..+ +...|.......++..+.
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~  289 (311)
T 3ork_A          229 -----YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK  289 (311)
T ss_dssp             -----HHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCC
T ss_pred             -----HHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCc
Confidence                 0011000000  001124567999999999999999996555 555777777666655543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.8e-48  Score=351.27  Aligned_cols=265  Identities=23%  Similarity=0.327  Sum_probs=192.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++....  ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999976 79999999986533  334688999999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |++ ++|.+++.......   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 ~~~-~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR  156 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             ecC-CCHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccce
Confidence            997 59999986543211   1124899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc----
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE----  297 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  297 (361)
                      ......  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.........    
T Consensus       157 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          157 AFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             ETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred             ecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence            653221  123456789999999999864 6899999999999999999999999765432211111100000000    


Q ss_pred             -----------------hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 -----------------DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 -----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                       ..+.+.+....    ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                             00111111111    1123457999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.3e-48  Score=351.95  Aligned_cols=270  Identities=24%  Similarity=0.406  Sum_probs=214.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEE-----CCCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeC--Ce
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~  136 (361)
                      .++|++.+.||+|+||.||+|.+     .+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35789999999999999999983     378999999987533  3447889999999999999999999999876  66


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||+++++|.+++.....        .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~  168 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIG  168 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEEC
Confidence            8999999999999999965432        3899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccc-cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc--
Q 018071          217 DFDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP--  293 (361)
Q Consensus       217 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~--  293 (361)
                      |||++........ ........||..|+|||++.+..++.++||||||+++|+|++|..|+.....    .......+  
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~  244 (302)
T 4e5w_A          169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTH  244 (302)
T ss_dssp             CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCC
T ss_pred             cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcc
Confidence            9999876543221 1223456688899999999999999999999999999999999998642210    00000001  


Q ss_pred             -cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          294 -KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       294 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                       ......+...+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             GGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             cccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence             111122333333334445566677889999999999999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-47  Score=344.18  Aligned_cols=253  Identities=30%  Similarity=0.496  Sum_probs=207.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh--------HHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--------EEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      ++|++.+.||+|+||.||+|... +++.||+|++.......        +.+.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            68999999999999999999986 89999999986543221        67889999999999999999999986554  


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc-----
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-----  212 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~-----  212 (361)
                      ++||||+++++|.+++....        ..+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.     
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKA--------HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             eEEEEecCCCCHHHHHhccc--------CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCcee
Confidence            79999999999999886543        23899999999999999999999884 23999999999999988776     


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhc--cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~  290 (361)
                      +||+|||+++....     ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||.........     
T Consensus       168 ~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----  237 (287)
T 4f0f_A          168 AKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-----  237 (287)
T ss_dssp             EEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-----
T ss_pred             EEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-----
Confidence            99999999875433     234567899999999984  456789999999999999999999999754322111     


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                              ..............+..++..+.+++.+||+.||.+|||++++++.|+.+
T Consensus       238 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          238 --------FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             --------HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             --------HHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                    11112222333344555677899999999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-48  Score=370.48  Aligned_cols=253  Identities=19%  Similarity=0.241  Sum_probs=206.3

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      ...++|++.++||+|+||+||+|..+ +++.||+|++.+.    ......+.+|+.++..++||||+++++++.+....+
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            34579999999999999999999987 7899999998641    223345889999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +||||+++|+|.+++....        ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       151 lV~Ey~~gg~L~~~l~~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFE--------DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            9999999999999997642        13999999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+++...... .......+||+.|+|||++.     ...|+.++|||||||++|||++|+.||........         
T Consensus       220 Gla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---------  289 (437)
T 4aw2_A          220 GSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---------  289 (437)
T ss_dssp             TTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---------
T ss_pred             hhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---------
Confidence            9997653322 12234568999999999997     45789999999999999999999999975432211         


Q ss_pred             cCCchhhhhhcccccCCCCC---HHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 018071          294 KLSEDKVRQCVDARLGGDYP---PKAVAKMAAVAALCVQYEADF--RPNMSIVVK  343 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~--RPs~~evl~  343 (361)
                            ...++.......++   ...+..+.+||.+||..+|++  ||+++++++
T Consensus       290 ------~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          290 ------YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ------HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ------HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence                  11111111000111   224667999999999888888  999999987

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9e-48  Score=352.35  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=198.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEE----CCCCEEEEEEcCCCC-----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL----KSGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      .++|++.+.||+|+||.||++..    .+++.||+|++.+..     .....+.+|+.+++.++||||+++++++.+...
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36899999999999999999997    479999999997642     233567889999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~  163 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---------IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLT  163 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEEC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEE
Confidence            999999999999999997653         3899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      |||+++......  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......             
T Consensus       164 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------  228 (327)
T 3a62_A          164 DFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-------------  228 (327)
T ss_dssp             CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------------
T ss_pred             eCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-------------
Confidence            999987643221  12345679999999999999999999999999999999999999997543211             


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                        .+..+.....  ..+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       229 --~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          229 --TIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --HHHHHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --HHHHHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence              1111222111  23444567799999999999999999     7778876

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.5e-48  Score=360.70  Aligned_cols=250  Identities=20%  Similarity=0.365  Sum_probs=201.7

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCC--CCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK--HENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|.+.+.||+|+||.||+|..++++.||||++......   .+.+.+|+.+++.++  ||||+++++++......++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            469999999999999999999888999999998764433   356889999999996  599999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      | +.+++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||++
T Consensus       136 E-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             E-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             e-cCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            9 55889999998654         3889999999999999999999998   99999999999995 589999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhcc-----------CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~  290 (361)
                      +..............+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||......        
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------  273 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--------  273 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--------
Confidence            87654333333456789999999999875           36889999999999999999999999643211        


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                            ...+..+++.......+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       274 ------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          274 ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                  112233333333333444445679999999999999999999999863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.8e-48  Score=347.82  Aligned_cols=263  Identities=22%  Similarity=0.310  Sum_probs=200.3

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|++.+.||+|+||.||+|..++++.||+|++.....   ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57899999999999999999998899999999865432   236788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +++ +|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        82 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA  149 (288)
T ss_dssp             CSE-EHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             cCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence            975 99999876432        3899999999999999999999998   99999999999999999999999999864


Q ss_pred             CccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ....  ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...........+..
T Consensus       150 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T 1ob3_A          150 FGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (288)
T ss_dssp             HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cCcc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence            3221  1123445789999999999764 589999999999999999999999976433211111000000000000000


Q ss_pred             h-----cccccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 C-----VDARLG-------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~-----~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .     .+....       .......+..+.+|+.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0     000000       0111234567899999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.8e-48  Score=348.94  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=208.8

Q ss_pred             hhcCCCCC-ccccCCceEEEEEEE--C-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           66 TENFGTNA-LIGEGSYGRVYYGIL--K-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        66 ~~~y~~~~-~lg~G~~g~Vy~~~~--~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      .++|.+.+ .||+|+||.||+|.+  + +++.||+|++......   .+++.+|+.+++.++||||+++++++ .....+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            46788887 999999999999964  2 5789999999764322   46788999999999999999999998 567789


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +||||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        94 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred             EEEEeCCCCCHHHHHHhCc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence            9999999999999997653         3899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCC
Q 018071          219 DLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       219 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      |++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......              
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------------  227 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------------  227 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------------
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------------
Confidence            998765332211 11233456789999999998899999999999999999999 99999654321              


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                        .+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus       228 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          228 --EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             --HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence              12222222222334455677899999999999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.7e-48  Score=355.63  Aligned_cols=268  Identities=26%  Similarity=0.419  Sum_probs=215.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CC-----CEEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SG-----HAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  136 (361)
                      .++|.+.+.||+|+||.||+|... ++     ..||+|.+.....  ..+.+.+|+.+++.+ +||||+++++++.+...
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            478999999999999999999975 33     4799999976443  235688999999999 89999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKG-----AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD  211 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~  211 (361)
                      .++||||+++|+|.+++........     ......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence            9999999999999999875421000     001234899999999999999999999998   99999999999999999


Q ss_pred             ceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 018071          212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~  290 (361)
                      .+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......        
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------  273 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--------  273 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--------
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--------
Confidence            999999999986544332223344567889999999999999999999999999999998 99999754321        


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                             ..+...+........+...+..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       274 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          274 -------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             -------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence                   112222222222233444567799999999999999999999999999988764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.9e-48  Score=350.39  Aligned_cols=257  Identities=26%  Similarity=0.478  Sum_probs=204.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CC-------CEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SG-------HAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      .++|.+.+.||+|+||.||+|..+ ++       ..||+|++.... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            468999999999999999999966 44       479999986533 345678999999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc----
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----  212 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~----  212 (361)
                      .++||||+++++|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.    
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~  155 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTG  155 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGT
T ss_pred             CEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccc
Confidence            9999999999999999976542        3899999999999999999999998   999999999999998887    


Q ss_pred             ----eEEeccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCC-CCCCCCCcccch
Q 018071          213 ----AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRK-PVDHTLPRGQQS  286 (361)
Q Consensus       213 ----~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~-pf~~~~~~~~~~  286 (361)
                          +||+|||++......      ....||+.|+|||++.+ ..++.++|||||||++|+|++|.. ||.......   
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---  226 (289)
T 4fvq_A          156 NPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---  226 (289)
T ss_dssp             BCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---
T ss_pred             ccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH---
Confidence                999999998765332      33557899999999987 679999999999999999999654 443221110   


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCC
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAG  357 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~  357 (361)
                                   ........  ...+...+..+.+++.+||+.||.+|||+.++++.|+.+++...++.+
T Consensus       227 -------------~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~  282 (289)
T 4fvq_A          227 -------------KLQFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG  282 (289)
T ss_dssp             -------------HHHHHHTT--CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--------
T ss_pred             -------------HHHHhhcc--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCC
Confidence                         00111110  111222345689999999999999999999999999999986655544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=346.85  Aligned_cols=259  Identities=26%  Similarity=0.475  Sum_probs=203.3

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++|++.+.||+|+||.||+|.++ ++.||+|++... ...+.+.+|+.++++++||||+++++++.  +..++||||+++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~   83 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG   83 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence            57899999999999999999986 889999998643 34567899999999999999999999876  347899999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc-eEEeccccCCCCc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-AKIADFDLSNQAP  225 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~-~kl~Dfg~a~~~~  225 (361)
                      ++|.+++......      +.+++..++.++.|++.||.|||+.+..+|+||||||+|||++.++. +||+|||++....
T Consensus        84 ~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           84 GSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             CBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             CCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            9999999765321      23789999999999999999999932223999999999999998886 7999999987653


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ..     .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........              +...+.
T Consensus       158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--------------~~~~~~  218 (307)
T 2eva_A          158 TH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--------------IMWAVH  218 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--------------HHHHHH
T ss_pred             cc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--------------HHHHHh
Confidence            21     23456899999999999999999999999999999999999999743221110              000011


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                      .......+...+..+.+++.+||+.||.+|||++++++.|+.+.+..+.
T Consensus       219 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          219 NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            1111222334556799999999999999999999999999999875543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=347.60  Aligned_cols=264  Identities=23%  Similarity=0.309  Sum_probs=200.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++......   .+.+.+|+.++++++||||+++++++.+....++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            468999999999999999999987 7999999998765443   346778999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++....         .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        82 e~~~~~~l~~~~~~~~---------~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  149 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR---------GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA  149 (311)
T ss_dssp             ECCSEEHHHHHHHTSS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EeCCCchHHHHHhhhc---------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence            9999999999887543         2899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .......  .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||........................
T Consensus       150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  227 (311)
T 4agu_A          150 RLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ  227 (311)
T ss_dssp             EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence            7654221  12345678999999999986 57899999999999999999999999765433221111111001000000


Q ss_pred             hhh-----cc-cccC---CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQC-----VD-ARLG---GDY-----PPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~-----~~-~~~~---~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...     .. ....   ...     .+..+..+.+|+.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000     00 0000   000     0234566899999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=346.97  Aligned_cols=265  Identities=24%  Similarity=0.335  Sum_probs=202.5

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC------CChHHHHHHHHHHhcCC---CCCcceeeeEEEeC
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK------QPDEEFLAQVSMVSRLK---HENFVQLLGYCVDG  134 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~  134 (361)
                      +.++|++.+.||+|+||+||+|..+ +++.||+|++....      .....+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4689999999999999999999975 89999999986422      22356778888877775   99999999999876


Q ss_pred             C-----eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc
Q 018071          135 T-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       135 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~  209 (361)
                      .     ..+++|||+. ++|.+++.....       ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~  155 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-------PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS  155 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECT
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcC
Confidence            5     5789999996 599999976543       23899999999999999999999998   999999999999999


Q ss_pred             CCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 018071          210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT  289 (361)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~  289 (361)
                      ++.+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus       156 ~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (308)
T 3g33_A          156 GGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF  232 (308)
T ss_dssp             TSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred             CCCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999865432   22355779999999999999999999999999999999999999997654322211111


Q ss_pred             hhcccCCchhhhhhc---ccccC--CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          290 WATPKLSEDKVRQCV---DARLG--GD-----YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~---~~~~~--~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..........+....   ...+.  ..     ..+..+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            100000000000000   00000  00     01234567899999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-47  Score=356.98  Aligned_cols=271  Identities=18%  Similarity=0.245  Sum_probs=207.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEECC------CCEEEEEEcCCCCCC------------hHHHHHHHHHHhcCCCCCccee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLDASKQP------------DEEFLAQVSMVSRLKHENFVQL  127 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~hpniv~~  127 (361)
                      .++|.+.+.||+|+||.||+|.++.      ++.||||++......            ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999999763      478999998654321            1223445566777889999999


Q ss_pred             eeEEEeC----CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCC
Q 018071          128 LGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS  203 (361)
Q Consensus       128 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~  203 (361)
                      ++++...    ...++||||+ +++|.+++.....        .+++..++.++.||+.||+|||+.+   |+||||||+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~  181 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKAS  181 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHH
Confidence            9998764    4579999999 9999999976532        3999999999999999999999998   999999999


Q ss_pred             ceEec--cCCceEEeccccCCCCccccccc-----cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCC
Q 018071          204 NVLIF--DDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV  276 (361)
Q Consensus       204 Nill~--~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf  276 (361)
                      |||++  .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf  261 (364)
T 3op5_A          182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW  261 (364)
T ss_dssp             GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999  88999999999997654322111     123456999999999999999999999999999999999999999


Q ss_pred             CCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          277 DHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                      ........  ......... ...+..+++..+.   ...++..+.+++..||+.+|.+||++.+|++.|+.++.....
T Consensus       262 ~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          262 EDNLKDPK--YVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             GGGTTCHH--HHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cccccCHH--HHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            74322111  111100000 1122223222221   112356799999999999999999999999999999875443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-47  Score=376.47  Aligned_cols=251  Identities=25%  Similarity=0.442  Sum_probs=206.0

Q ss_pred             ccccCCceEEEEEEEC---CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCc
Q 018071           74 LIGEGSYGRVYYGILK---SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS  148 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  148 (361)
                      .||+|+||.||+|.++   ++..||||++....  ...+++.+|++++++++||||+++++++.. ...++||||+.+|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   46679999997643  345789999999999999999999999976 56899999999999


Q ss_pred             HHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcccc
Q 018071          149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA  228 (361)
Q Consensus       149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~  228 (361)
                      |.+++....        ..+++..++.++.||+.||+|||+.+   |+||||||+||||++++.+||+|||+++......
T Consensus       422 L~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          422 LHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             HHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             HHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            999997543        23899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          229 AR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       229 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      .. .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....                ..+...+..
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----------------~~~~~~i~~  554 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----------------PEVMAFIEQ  554 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS----------------HHHHHHHHT
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH----------------HHHHHHHHc
Confidence            11 11223446789999999999999999999999999999998 9999965432                222333333


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      ......+..++..+.+|+.+||+.+|++|||+.+|++.|+.+....
T Consensus       555 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          555 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            4444566667788999999999999999999999999999987643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.6e-48  Score=352.12  Aligned_cols=277  Identities=23%  Similarity=0.349  Sum_probs=219.5

Q ss_pred             CHHHHHHHhhcCCCCCccccCCceEEEEEEE------CCCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceee
Q 018071           58 SVDELKEITENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLL  128 (361)
Q Consensus        58 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~  128 (361)
                      ...++....++|.+.+.||+|+||.||+|.+      .+++.||+|++......  .+.+.+|+.+++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3344444568999999999999999999984      25789999999764432  34688999999999 699999999


Q ss_pred             eEEEeCC-eeEEEEEeCCCCcHHHhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccC
Q 018071          129 GYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI  200 (361)
Q Consensus       129 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDi  200 (361)
                      +++.... ..++||||+++++|.+++........       ......+++..++.++.||+.||.|||+.+   |+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence            9987654 48999999999999999986542100       001123889999999999999999999998   999999


Q ss_pred             CCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCC
Q 018071          201 KSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHT  279 (361)
Q Consensus       201 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~  279 (361)
                      ||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987644333333445668899999999999999999999999999999998 99999654


Q ss_pred             CCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          280 LPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      ....               .+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+++..
T Consensus       255 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KIDE---------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCSH---------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chhH---------------HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            3211               111111111122233345667999999999999999999999999999998754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.9e-48  Score=349.58  Aligned_cols=269  Identities=21%  Similarity=0.332  Sum_probs=203.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.....    ....+.+|+.+++.++||||+++++++.+....++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            468999999999999999999976 899999999875322    235688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++......     ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus       111 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             EecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence            9999999999998653211     123899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +.......  .......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .+            .
T Consensus       183 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~------------~  247 (310)
T 2wqm_A          183 GRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL------------C  247 (310)
T ss_dssp             ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HH------------H
T ss_pred             eeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HH------------H
Confidence            87654322  122345789999999999999999999999999999999999999964322110 00            0


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCC
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAG  357 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~  357 (361)
                      ..+.............+..+.+++.+||+.||.+|||+.+|++.|+.+.+....|..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          248 KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             HHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             HHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence            111111111111233456799999999999999999999999999999988777653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.4e-47  Score=357.71  Aligned_cols=266  Identities=17%  Similarity=0.253  Sum_probs=204.9

Q ss_pred             hhcCCCCCccccC--CceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEG--SYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|++.++||+|  +||.||+|..+ +++.||||++......   .+.+.+|+.+++.++||||+++++++.+....++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4689999999999  99999999987 8999999999754332   3567789999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+++|+|.+++......       .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       104 v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMD-------GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEccCCCCHHHHHhhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccc
Confidence            99999999999999765322       3899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccc-----cccccccccCCCCCCchhhcc--CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          220 LSNQAPDMAA-----RLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       220 ~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      ++........     ........||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.........  .....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~  251 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLN  251 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC--
T ss_pred             cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhc
Confidence            8765422111     111233578999999999987  67999999999999999999999999764332211  00000


Q ss_pred             ccCC---------chh-------------hhhhcc---------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 018071          293 PKLS---------EDK-------------VRQCVD---------ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV  341 (361)
Q Consensus       293 ~~~~---------~~~-------------~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev  341 (361)
                      ....         ...             ......         .......+...+..+.+|+.+||+.||.+|||+.++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            0000         000             000000         000012234456779999999999999999999999


Q ss_pred             HH
Q 018071          342 VK  343 (361)
Q Consensus       342 l~  343 (361)
                      ++
T Consensus       332 l~  333 (389)
T 3gni_B          332 LN  333 (389)
T ss_dssp             TT
T ss_pred             hc
Confidence            86

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.3e-47  Score=340.82  Aligned_cols=253  Identities=26%  Similarity=0.354  Sum_probs=208.0

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.++|++.+.||+|+||.||+|..+ +++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            5678999999999999999999987 89999999986432  33467889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++....         .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        85 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  152 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA  152 (276)
T ss_dssp             ECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence            9999999999986543         3899999999999999999999998   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ................||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ .+..+          
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----------  221 (276)
T 2yex_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----------  221 (276)
T ss_dssp             EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH----------
T ss_pred             cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh----------
Confidence            76543322223455678999999999987765 7789999999999999999999975433211 11111          


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         .............+..+.+++.+||+.||.+|||+.++++
T Consensus       222 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          222 ---KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---hhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               1111111112234567899999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-47  Score=341.12  Aligned_cols=253  Identities=23%  Similarity=0.357  Sum_probs=209.7

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeC--CeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~  141 (361)
                      ++|.+.+.||+|+||.||+|.++ ++.||+|++......   .+.+.+|+.++++++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            68999999999999999999987 899999999765433   34688999999999999999999999876  7789999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++|+|.+++.....       ..+++..++.++.||+.||.|||+.+ ..++||||||+|||++.++.++|+|||++
T Consensus        89 e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTN-------FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             ECCTTCBHHHHHHSCSS-------CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             cccCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccce
Confidence            99999999999986542       23899999999999999999999873 23999999999999999999999999886


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCC---ccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....       .....||+.|+|||++.+..++.   ++|||||||++|+|++|+.||......               .
T Consensus       161 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------~  218 (271)
T 3kmu_A          161 FSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM---------------E  218 (271)
T ss_dssp             CTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH---------------H
T ss_pred             eeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH---------------H
Confidence            5432       23456899999999998766555   799999999999999999999643221               1


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      ..............+...+..+.+++.+||+.||.+|||++++++.|+.+.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          219 IGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1122222223334455567789999999999999999999999999998754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.9e-47  Score=350.21  Aligned_cols=267  Identities=27%  Similarity=0.422  Sum_probs=212.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEE--EEEEcCCC--CCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAA--AIKKLDAS--KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~v--avK~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|.+.+.||+|+||.||+|..+ ++..+  |+|.+...  ....+.+.+|+.+++++ +||||+++++++.+....++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999999976 66654  99988642  23446789999999999 899999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          141 YEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      |||+++++|.+++........       ......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            999999999999976530000       001124899999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      ||+|||+++.....   .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......          
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----------  248 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----------  248 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----------
Confidence            99999998753321   12234567889999999998899999999999999999998 99999654321          


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCC
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP  355 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~  355 (361)
                            .+...+........+...+..+.+++.+||+.||.+|||++++++.|+.+++.....
T Consensus       249 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  305 (327)
T 1fvr_A          249 ------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  305 (327)
T ss_dssp             ------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred             ------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence                  111111222222334455677999999999999999999999999999999876543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.4e-47  Score=345.06  Aligned_cols=260  Identities=27%  Similarity=0.486  Sum_probs=196.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|.+.+.||+|+||.||+|..+  ..||+|++......   .+.+.+|+.++++++||||++++++. .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            468999999999999999999865  35999998765433   35688999999999999999999965 5567899999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++++|.+++....        ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       100 ~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  168 (289)
T 3og7_A          100 WCEGSSLYHHLHASE--------TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT  168 (289)
T ss_dssp             CCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             ecCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence            999999999996543        23899999999999999999999998   9999999999999999999999999997


Q ss_pred             CCccccccccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...............||+.|+|||++.   +..++.++||||||+++|+|++|+.||........  +........    
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~----  242 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGS----  242 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHTS----
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcccc----
Confidence            654333333345567999999999987   56788899999999999999999999975432111  111000000    


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                          .... .......++..+.+|+.+||+.+|.+|||+.++++.|+.+.+
T Consensus       243 ----~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          243 ----LSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ----CCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ----cCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                0000 011223456779999999999999999999999999998764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-47  Score=360.07  Aligned_cols=267  Identities=22%  Similarity=0.328  Sum_probs=194.9

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCC-CCCcceeeeEEEeCC--e
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK-HENFVQLLGYCVDGT--S  136 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~--~  136 (361)
                      .+.++|++.+.||+|+||.||+|..+ +++.||||++......   .+++.+|+.+++.+. ||||+++++++....  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            46789999999999999999999976 8999999998654322   356788999999997 999999999997544  6


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||++ ++|.+++....          +++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRANI----------LEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHTC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEecccC-cCHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEec
Confidence            899999997 59999997643          899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccc-------------------cccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCC
Q 018071          217 DFDLSNQAPDM-------------------AARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPV  276 (361)
Q Consensus       217 Dfg~a~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf  276 (361)
                      |||+++.....                   ......+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            99998754221                   01112345689999999999986 67999999999999999999999999


Q ss_pred             CCCCCcccchhhhhhcccCCchhhhh--------hcc----------cccCCC------------CCHHHHHHHHHHHHH
Q 018071          277 DHTLPRGQQSLVTWATPKLSEDKVRQ--------CVD----------ARLGGD------------YPPKAVAKMAAVAAL  326 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~----------~~~~~~------------~~~~~~~~l~~li~~  326 (361)
                      .+.........+.-.......+.+..        .++          ......            .....+..+.+|+.+
T Consensus       232 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  311 (388)
T 3oz6_A          232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK  311 (388)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence            76543322111111101111110000        000          000000            001235678999999


Q ss_pred             ccccCCCCCCCHHHHHHH
Q 018071          327 CVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       327 cl~~~p~~RPs~~evl~~  344 (361)
                      ||+.||.+|||++|+++.
T Consensus       312 ~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          312 LLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HCCSSGGGSCCHHHHTTS
T ss_pred             hhccCcccCCCHHHHhCC
Confidence            999999999999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-48  Score=359.32  Aligned_cols=250  Identities=21%  Similarity=0.274  Sum_probs=206.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      +.++|++.+.||+|+||.||+|..+ +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            3578999999999999999999987 899999999865432 33578899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc--CCceEEecccc
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDL  220 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~--~~~~kl~Dfg~  220 (361)
                      |+.+|+|.+++....        ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+
T Consensus       129 ~~~gg~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~  197 (387)
T 1kob_A          129 FLSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL  197 (387)
T ss_dssp             CCCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             cCCCCcHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence            999999999987543        13899999999999999999999998   999999999999974  46899999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||........               +
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---------------~  259 (387)
T 1kob_A          198 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---------------L  259 (387)
T ss_dssp             CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---------------H
T ss_pred             ceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---------------H
Confidence            97654321   22445799999999999999999999999999999999999999975432111               0


Q ss_pred             hhhcccc--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDAR--LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..+....  .........+..+.+||.+||+.||.+|||+.++++
T Consensus       260 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          260 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            1111110  111122345667999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-47  Score=350.35  Aligned_cols=258  Identities=28%  Similarity=0.448  Sum_probs=205.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-C----CCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-S----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ++|.+.+.||+|+||.||+|..+ +    +..||+|++......  ...+.+|+.+++.++||||+++++++.+....++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            56778899999999999999865 2    235999998764332  3468899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+++++|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       124 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCC
Confidence            9999999999999976432        3899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCc
Q 018071          220 LSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       220 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ++......... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....                
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----------------  256 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------  256 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------
T ss_pred             cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----------------
Confidence            99875432211 11223446788999999999999999999999999999999 9999964322                


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      ..+...+........+..++..+.+++.+||+.||.+||++.++++.|+.+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          257 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            111122222222233445667899999999999999999999999999998864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9e-48  Score=366.91  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=198.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC----CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|++.++||+|+||.||+|..+ +++.||||++..    .......+.+|+.+++.++||||+++++++.+....++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            468999999999999999999977 899999999864    233345678899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      |||+++|+|.+++....         .+++..++.++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||
T Consensus       227 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             EeeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCC
Confidence            99999999999997654         38999999999999999999998 77   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +++......  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........               
T Consensus       295 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---------------  357 (446)
T 4ejn_A          295 LCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---------------  357 (446)
T ss_dssp             CCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------------
T ss_pred             CceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---------------
Confidence            998643222  223567899999999999999999999999999999999999999964432111               


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      ...+....  ..++...+..+.+||.+||+.||.+||     +++++++
T Consensus       358 ~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          358 FELILMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            11111111  123444567799999999999999999     9999987

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-47  Score=364.99  Aligned_cols=246  Identities=23%  Similarity=0.344  Sum_probs=207.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|.+.+.||+|+||.||+|.++ +|+.||||++...    ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            368999999999999999999987 8999999998642    23346789999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~  162 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL  162 (476)
T ss_dssp             EECCSSEEHHHHTTSSS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             EeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccc
Confidence            99999999999997543         3899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +......   ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......               .
T Consensus       163 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---------------~  224 (476)
T 2y94_A          163 SNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---------------L  224 (476)
T ss_dssp             CEECCTT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---------------H
T ss_pred             hhhcccc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---------------H
Confidence            8765332   12345689999999999998776 689999999999999999999997543211               1


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...+.+...  ..+...+..+.+|+.+||+.||.+|||++++++
T Consensus       225 ~~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          225 FKKICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            111212111  223334567999999999999999999999997

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-47  Score=343.80  Aligned_cols=254  Identities=25%  Similarity=0.390  Sum_probs=208.6

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEe---------
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD---------  133 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~---------  133 (361)
                      .+.++|++.+.||+|+||.||+|..+ +++.||+|++....   ..+.+|+++++.++||||+++++++..         
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            46789999999999999999999987 89999999986543   467789999999999999999998864         


Q ss_pred             -------CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceE
Q 018071          134 -------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL  206 (361)
Q Consensus       134 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nil  206 (361)
                             ....++||||+++++|.+++.....       ..+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil  154 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-------EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIF  154 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEE
Confidence                   4457899999999999999976532       13899999999999999999999998   999999999999


Q ss_pred             eccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch
Q 018071          207 IFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS  286 (361)
Q Consensus       207 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~  286 (361)
                      ++.++.+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||...       
T Consensus       155 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------  224 (284)
T 2a19_B          155 LVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------  224 (284)
T ss_dssp             EEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------
T ss_pred             EcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------
Confidence            9999999999999987654321   234457899999999999999999999999999999999999887311       


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                                ......+....    .+...+..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus       225 ----------~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          225 ----------SKFFTDLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             ----------HHHHHHHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             ----------HHHHHHhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence                      00111111111    2223455689999999999999999999999999988765443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.6e-47  Score=358.43  Aligned_cols=252  Identities=18%  Similarity=0.241  Sum_probs=195.2

Q ss_pred             HhhcCCCC-CccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHh-cCCCCCcceeeeEEEe----CCee
Q 018071           65 ITENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVS-RLKHENFVQLLGYCVD----GTSR  137 (361)
Q Consensus        65 ~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~-~l~hpniv~~~~~~~~----~~~~  137 (361)
                      +.++|.+. ++||+|+||+||++..+ +++.||||++..    ...+.+|+.++. ..+||||+++++++..    ....
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            34677776 68999999999999987 899999999853    346778888874 4589999999999875    5678


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc---CCceE
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAK  214 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~---~~~~k  214 (361)
                      ++||||++||+|.+++.....       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+|
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~k  204 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK  204 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEE
T ss_pred             EEEEEeCCCCcHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEE
Confidence            999999999999999986532       23899999999999999999999998   999999999999997   78999


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |+|||+++.....   ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.........         
T Consensus       205 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---------  272 (400)
T 1nxk_A          205 LTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------  272 (400)
T ss_dssp             ECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC---------
T ss_pred             EEecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc---------
Confidence            9999998764322   1235678999999999999999999999999999999999999999765432210         


Q ss_pred             CCchhhhhhcccccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          295 LSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                        ......+......  .......+..+.+||.+||+.||.+|||+.++++.
T Consensus       273 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          273 --PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             --CSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --HHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0000111111111  11112356779999999999999999999999974

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.7e-48  Score=355.78  Aligned_cols=275  Identities=23%  Similarity=0.324  Sum_probs=216.2

Q ss_pred             hcCCCCCccccCCceEEEEEEE-----CCCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEE--eCCeeE
Q 018071           67 ENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCV--DGTSRV  138 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~  138 (361)
                      ++|++.+.||+|+||.||+|.+     .++..||+|++..... ..+.+.+|+.++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            6899999999999999999984     3788999999976432 2356889999999999999999999887  456789


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +||||+++++|.+++.....        .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       103 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Df  171 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADF  171 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCG
T ss_pred             EEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccc
Confidence            99999999999999976432        2899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccc-cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |++........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...........
T Consensus       172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~  250 (327)
T 3lxl_A          172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPAL  250 (327)
T ss_dssp             GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHH
T ss_pred             ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccH
Confidence            99976533221 11234456888899999999999999999999999999999999998532211000 00000011111


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                      ..+...+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            23334444444455666777889999999999999999999999999999886443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-47  Score=342.45  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=208.9

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CC---CEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCee-EEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SG---HAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR-VLA  140 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~-~lv  140 (361)
                      .|.+.++||+|+||.||+|.+. ++   ..||+|.+......  .+.+.+|+.+++.++||||+++++++.+.... +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4566789999999999999854 33   37999998764332  35788999999999999999999999866555 999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+.+++|.+++....        ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~  170 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ--------RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGL  170 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred             EecccCCCHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCC
Confidence            99999999999997643        23899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCcccc--ccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCC-CCCCCcccchhhhhhcccCCc
Q 018071          221 SNQAPDMA--ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV-DHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       221 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ++......  .........+|+.|+|||.+.+..++.++||||||+++|+|++|..|| ......               
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---------------  235 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---------------  235 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---------------
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---------------
Confidence            98654322  112234566889999999999999999999999999999999965554 322211               


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                       .+...+........+...+..+.+++.+||+.||.+|||++++++.|+.++++...
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          236 -DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             -GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             -HHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence             11222222222233444567799999999999999999999999999999986543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-47  Score=343.10  Aligned_cols=254  Identities=29%  Similarity=0.481  Sum_probs=204.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeC-CeeEEEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-TSRVLAYEFA  144 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~  144 (361)
                      .++|++.+.||+|+||.||++..+ ++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+. ...++||||+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            468999999999999999999886 8999999987543 457889999999999999999999987544 4789999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++++|.+++.....       ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        98 ~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           98 AKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             TTEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             CCCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            99999999976432       12789999999999999999999998   999999999999999999999999998764


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ...     .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......                .+...
T Consensus       168 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----------------~~~~~  226 (278)
T 1byg_A          168 SST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPR  226 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----------------GHHHH
T ss_pred             ccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHH
Confidence            332     233467889999999999999999999999999999998 99999644221                11111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      +........+..++..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          227 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            2222223344456678999999999999999999999999999987643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=352.32  Aligned_cols=243  Identities=23%  Similarity=0.313  Sum_probs=205.0

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---------ChHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------PDEEFLAQVSMVSRLKHENFVQLLGYCVD  133 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpniv~~~~~~~~  133 (361)
                      .+.++|.+.+.||+|+||.||+|..+ +++.||||++.....         ..+.+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            46789999999999999999999976 899999999876432         23457789999999999999999999999


Q ss_pred             CCeeEEEEEeCCCC-cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          134 GTSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       134 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                      ....++||||+.+| +|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~  168 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP---------RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT  168 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence            99999999998776 9999997653         3999999999999999999999998   999999999999999999


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~  291 (361)
                      +||+|||++.......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....          
T Consensus       169 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------  235 (335)
T 3dls_A          169 IKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------  235 (335)
T ss_dssp             EEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------
T ss_pred             EEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------
Confidence            9999999987654321   2345679999999999998877 7899999999999999999999953211          


Q ss_pred             cccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          292 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                                 ......  ..+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       236 -----------~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 -----------TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----------GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----------HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       001111  1122245679999999999999999999999984

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.5e-47  Score=347.44  Aligned_cols=264  Identities=22%  Similarity=0.312  Sum_probs=200.5

Q ss_pred             hhcCCCC-CccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEE
Q 018071           66 TENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        66 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .+.|.+. ++||+|+||.||+|... +++.||||++.... ...+.+.+|+.++.++ +||||+++++++.+....++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4678884 78999999999999966 89999999996543 3457889999999885 7999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc---eEEecc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AKIADF  218 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~---~kl~Df  218 (361)
                      ||+++++|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.   +||+||
T Consensus        91 e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Df  158 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDF  158 (316)
T ss_dssp             ECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred             EcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence            9999999999997653         2899999999999999999999998   999999999999998776   999999


Q ss_pred             ccCCCCccccc-----cccccccccCCCCCCchhhcc-----CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhh
Q 018071          219 DLSNQAPDMAA-----RLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       219 g~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~  288 (361)
                      |++........     .......+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||............
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  238 (316)
T 2ac3_A          159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR  238 (316)
T ss_dssp             TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred             cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence            99876532111     111234569999999999875     46889999999999999999999999765433211000


Q ss_pred             hhhcccCCchhhhhhcccccCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          289 TWATPKLSEDKVRQCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ....+.........+.....  ..+.    ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          239 GEACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             --CCHHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccchhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            00000000001111111111  2222    24567999999999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4e-47  Score=343.31  Aligned_cols=261  Identities=25%  Similarity=0.378  Sum_probs=207.2

Q ss_pred             hcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEE-eCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~l  139 (361)
                      .+|++.++||+|+||.||+|...    ....+|+|.+.....  ..+.+.+|+.++++++||||+++++++. .....++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            57888999999999999999864    233689999876433  2356889999999999999999999864 5567899


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+++++|.+++....        ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       105 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             EEeCCCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccc
Confidence            999999999999997643        23899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccc--cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCC
Q 018071          220 LSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       220 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      +++.......  ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||........            
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~------------  241 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------------  241 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH------------
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH------------
Confidence            9987643321  112344567889999999999999999999999999999999 5566654322211            


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                          ...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+++....
T Consensus       242 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          242 ----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             ----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             ----HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                111111111122333456799999999999999999999999999999986543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-47  Score=353.32  Aligned_cols=265  Identities=25%  Similarity=0.277  Sum_probs=205.3

Q ss_pred             HHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC------CCChHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 018071           61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS------KQPDEEFLAQVSMVSRLKHENFVQLLGYCVD  133 (361)
Q Consensus        61 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~  133 (361)
                      ++..+.++|++.+.||+|+||.||+|..+ ++..||+|++...      ....+.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34667899999999999999999999986 8899999998542      3345678999999999999999999999999


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCC-------------------------------CCCCCCCCHHHHHHHHHHHHH
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKG-------------------------------AQPGPVLSWQQRVKIAVGAAK  182 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------~~~~~~l~~~~~~~i~~qi~~  182 (361)
                      ....++||||+++|+|.+++........                               ......+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            9999999999999999999863211000                               000112467888999999999


Q ss_pred             HHHHhhhcCCCCeEeccCCCCceEeccCC--ceEEeccccCCCCccccc--cccccccccCCCCCCchhhcc--CCCCCc
Q 018071          183 GLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMT--GQLNAK  256 (361)
Q Consensus       183 al~~LH~~~~~~ivHrDikp~Nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~  256 (361)
                      ||+|||+.+   |+||||||+|||++.++  .+||+|||++........  ........||+.|+|||++.+  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999998   99999999999998776  899999999875432111  112345679999999999975  678999


Q ss_pred             cceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCC--CCHHHHHHHHHHHHHccccCCCC
Q 018071          257 SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADF  334 (361)
Q Consensus       257 ~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~  334 (361)
                      +|||||||++|+|++|+.||.......               ....+........  .....+..+.+|+.+||+.||.+
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDAD---------------TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHH---------------HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHH---------------HHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence            999999999999999999997543221               1111111111111  11124567999999999999999


Q ss_pred             CCCHHHHHH
Q 018071          335 RPNMSIVVK  343 (361)
Q Consensus       335 RPs~~evl~  343 (361)
                      |||+.++++
T Consensus       322 Rps~~~~l~  330 (345)
T 3hko_A          322 RFDAMRALQ  330 (345)
T ss_dssp             SCCHHHHHH
T ss_pred             CCCHHHHhc
Confidence            999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.5e-47  Score=350.61  Aligned_cols=254  Identities=20%  Similarity=0.272  Sum_probs=184.8

Q ss_pred             hhcCCCC---CccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTN---ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~---~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|++.   +.||+|+||.||+|..+ +++.||||++...  ....+.+|+.+++.+. ||||+++++++.+....++|
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            4556654   78999999999999987 7999999998643  3467889999999997 99999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC---ceEEec
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIAD  217 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~---~~kl~D  217 (361)
                      |||+++|+|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++   .+||+|
T Consensus        85 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~D  152 (325)
T 3kn6_A           85 MELLNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIID  152 (325)
T ss_dssp             ECCCCSCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECC
T ss_pred             EEccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEec
Confidence            99999999999997653         3899999999999999999999998   99999999999998766   899999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ||+++.....  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...........        ..
T Consensus       153 fg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------~~  222 (325)
T 3kn6_A          153 FGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS--------AV  222 (325)
T ss_dssp             CTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC--------HH
T ss_pred             cccceecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc--------HH
Confidence            9998754322  1223456789999999999999999999999999999999999999975433211000        00


Q ss_pred             hhhhhhcccccCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.+..+........  .....+..+.+|+.+||+.||.+|||++++++
T Consensus       223 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          223 EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            11111212111111  11234678999999999999999999999885

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=347.06  Aligned_cols=245  Identities=20%  Similarity=0.260  Sum_probs=194.8

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh---HHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l  139 (361)
                      +.++|++.++||+|+||+||+|..+ +++.||||++.......   .....|+..+..+ +||||+++++++.+....++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            4578999999999999999999987 89999999987644433   2344555555544 89999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+ +++|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       135 v~e~~-~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCT
T ss_pred             EEecc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccce
Confidence            99999 6699998876532        3999999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..||....                  .
T Consensus       203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------------------~  260 (311)
T 3p1a_A          203 LLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------------------G  260 (311)
T ss_dssp             TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------------------H
T ss_pred             eeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------------------H
Confidence            987653322   2345679999999998876 79999999999999999999977663210                  1


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...+.........+...+..+.+++.+||+.||++|||++++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          261 WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11111111111111224567999999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.4e-47  Score=345.38  Aligned_cols=247  Identities=23%  Similarity=0.355  Sum_probs=206.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      +.++|.+.+.||+|+||.||+|..+ +++.||+|++.....       ..+.+.+|+.+++.++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            4678999999999999999999987 799999999865332       24678999999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC----c
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V  212 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~----~  212 (361)
                      .++||||+++++|.+++....         .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++    .
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~  157 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH  157 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence            999999999999999997643         3899999999999999999999998   99999999999999888    7


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      +||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||........        
T Consensus       158 ~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------  226 (321)
T 2a2a_A          158 IKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--------  226 (321)
T ss_dssp             EEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--------
T ss_pred             EEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH--------
Confidence            9999999987654321   23456799999999999999999999999999999999999999965432111        


Q ss_pred             ccCCchhhhhhcccccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          293 PKLSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                             +..+.....  ..+    ...+..+.+++.+||+.||.+|||+.++++
T Consensus       227 -------~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          227 -------LANITSVSY--DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -------HHHHHTTCC--CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -------HHHHHhccc--ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   111111100  111    123567999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-47  Score=355.54  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=199.5

Q ss_pred             cCCCCCccccCCceEEEEEEEC--C--CCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEe-CCeeEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK--S--GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLA  140 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv  140 (361)
                      .|.+.++||+|+||.||+|.+.  +  +..||+|.+.....  ..+++.+|+.++++++||||+++++++.+ ....++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999864  2  24689999875333  23678899999999999999999998754 5678999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++|+|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       170 ~e~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~  238 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL  238 (373)
T ss_dssp             EECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EECCCCCCHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccc
Confidence            999999999999976432        3889999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCcccccc--ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCc
Q 018071          221 SNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       221 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ++........  .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..........           
T Consensus       239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-----------  307 (373)
T 3c1x_A          239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-----------  307 (373)
T ss_dssp             -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-----------
T ss_pred             cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-----------
Confidence            9865332211  11234557889999999999999999999999999999999 677886443221111           


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                           .+........+..++..+.+++.+||+.||.+|||+.++++.|+.++.....
T Consensus       308 -----~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          308 -----YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             -----HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence                 1111111223344567799999999999999999999999999999976543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-48  Score=364.40  Aligned_cols=252  Identities=18%  Similarity=0.199  Sum_probs=204.1

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      ...++|++.++||+|+||.||+|..+ +++.||||++.+..    ...+.+.+|..++..++||||+++++++.+....+
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            34588999999999999999999987 89999999986421    22345788999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +||||++||+|.+++.....        .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++++||+||
T Consensus       138 lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence            99999999999999976431        3899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhc-------cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-------TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~  291 (361)
                      |+++...... .......+||+.|+|||++.       +..|+.++|||||||++|||++|+.||........       
T Consensus       207 Gla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------  278 (412)
T 2vd5_A          207 GSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-------  278 (412)
T ss_dssp             TTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------
T ss_pred             hhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-------
Confidence            9997653321 11234568999999999997       35789999999999999999999999975432211       


Q ss_pred             cccCCchhhhhhcccc--cC-CCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 018071          292 TPKLSEDKVRQCVDAR--LG-GDYPPKAVAKMAAVAALCVQYEADFR---PNMSIVVK  343 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~evl~  343 (361)
                              ...++...  +. ...+...+..+.+||.+||. +|.+|   |++++|++
T Consensus       279 --------~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          279 --------YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             --------HHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             --------HHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence                    11111110  10 01123456779999999999 99998   68999876

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-47  Score=353.46  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=204.3

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .+.++|++.+.||+|+||.||+|..+ +++.||+|++.+....   ..+|++++.++ +||||+++++++.+....++||
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46789999999999999999999987 7999999999765432   35688888887 7999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC----CceEEec
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD----DVAKIAD  217 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~----~~~kl~D  217 (361)
                      ||++||+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||+.++    +.+||+|
T Consensus        96 E~~~gg~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~D  163 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK---------FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD  163 (342)
T ss_dssp             CCCCSCBHHHHHHTCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred             eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence            9999999999987653         3899999999999999999999998   9999999999998543    3599999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ||+++......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+.         
T Consensus       164 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---------  232 (342)
T 2qr7_A          164 FGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---------  232 (342)
T ss_dssp             CTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH---------
T ss_pred             CCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH---------
Confidence            99987653322  1234568999999999999888999999999999999999999999753221111111         


Q ss_pred             hhhhhhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         ..+.....  ........+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          233 ---ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ---HHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---HHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               11111111  11223445678999999999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.6e-47  Score=340.80  Aligned_cols=266  Identities=20%  Similarity=0.309  Sum_probs=207.3

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEE-EeCCeeEEEE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC-VDGTSRVLAY  141 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~lv~  141 (361)
                      .+.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+|+.+++.++|++++..+.++ .+....++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            45689999999999999999999975 89999999865433 234688899999999988777666655 6778889999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe---ccCCceEEecc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADF  218 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill---~~~~~~kl~Df  218 (361)
                      ||+ +++|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||+   ++++.+||+||
T Consensus        85 e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Df  152 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             ECC-CCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred             Ecc-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecC
Confidence            999 8999999975432        3899999999999999999999998   9999999999999   78999999999


Q ss_pred             ccCCCCcccccc-----ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          219 DLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       219 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............    
T Consensus       153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----  228 (296)
T 4hgt_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----  228 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH----
T ss_pred             ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh----
Confidence            999765432211     12245679999999999999999999999999999999999999997654332211111    


Q ss_pred             cCCchhhhhhcccccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          294 KLSEDKVRQCVDARLGGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                              .+........   .....+..+.+++.+||+.||++|||+++|++.|+.+++....
T Consensus       229 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          229 --------RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             --------HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             --------hhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence                    1111000000   0012356799999999999999999999999999999986543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=351.35  Aligned_cols=271  Identities=24%  Similarity=0.356  Sum_probs=202.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHH--HhcCCCCCcceeeeEEEe-----CCeeE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSM--VSRLKHENFVQLLGYCVD-----GTSRV  138 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~--l~~l~hpniv~~~~~~~~-----~~~~~  138 (361)
                      .++|++.+.||+|+||.||+|.. +++.||||++....  ...+..|.++  +..++||||+++++.+..     ....+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            36899999999999999999987 48999999986433  3444455444  445899999999986542     23568


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------CCCCeEeccCCCCceEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK---------ADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------~~~~ivHrDikp~Nill~~  209 (361)
                      +||||+++|+|.+++....          .++..++.++.||+.||.|||+.         +   |+||||||+|||++.
T Consensus        89 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~  155 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKN  155 (336)
T ss_dssp             EEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECT
T ss_pred             EEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcC
Confidence            9999999999999997654          68999999999999999999998         7   999999999999999


Q ss_pred             CCceEEeccccCCCCcccc------ccccccccccCCCCCCchhhcc-------CCCCCccceecHHHHHHHHHhCCCCC
Q 018071          210 DDVAKIADFDLSNQAPDMA------ARLHSTRVLGTFGYHAPEYAMT-------GQLNAKSDVYSFGVVLLELLTGRKPV  276 (361)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~g~~pf  276 (361)
                      ++.+||+|||+++......      .........||+.|+|||++.+       ..++.++|||||||++|||++|..||
T Consensus       156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            9999999999997553221      1112235579999999999986       35667899999999999999998776


Q ss_pred             CCCCCccc--chhhhhhcccCCchhhhhhc-ccccCCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          277 DHTLPRGQ--QSLVTWATPKLSEDKVRQCV-DARLGGDY------PPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       277 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                      ........  ..+............+...+ .......+      ....+..+.+||.+||+.||++|||+.++++.|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            43322111  11111111111111111111 11111122      23467789999999999999999999999999999


Q ss_pred             hHhcC
Q 018071          348 LLNAR  352 (361)
Q Consensus       348 l~~~~  352 (361)
                      ++...
T Consensus       316 ll~~~  320 (336)
T 3g2f_A          316 LMMIW  320 (336)
T ss_dssp             HHHCC
T ss_pred             HHHHH
Confidence            99643

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-47  Score=356.65  Aligned_cols=274  Identities=22%  Similarity=0.294  Sum_probs=216.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCC--eeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT--SRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv  140 (361)
                      .++|.+.++||+|+||.||+|.++ +++.||||++....  ...+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            468999999999999999999987 79999999987532  33567889999999999999999999998755  77999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe----ccCCceEEe
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIA  216 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill----~~~~~~kl~  216 (361)
                      |||+++|+|.+++......      ..+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+
T Consensus        88 ~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             EecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEe
Confidence            9999999999999765321      23899999999999999999999998   9999999999999    777889999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhcc--------CCCCCccceecHHHHHHHHHhCCCCCCCCCCcc-cchh
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--------GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG-QQSL  287 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~-~~~~  287 (361)
                      |||+++......   ......||+.|+|||++.+        ..++.++|||||||++|+|++|+.||....... ....
T Consensus       159 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  235 (396)
T 4eut_A          159 DFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (396)
T ss_dssp             CGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred             cCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence            999997654322   2345679999999999875        567889999999999999999999997543321 1111


Q ss_pred             hh-hhcccCC--chhhhhhc--------ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          288 VT-WATPKLS--EDKVRQCV--------DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       288 ~~-~~~~~~~--~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      .. .......  ...+....        +.......+...+..+.+++.+||+.||++|||+.++++.++.+++.
T Consensus       236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            11 1111100  00000000        01112245578889999999999999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-47  Score=347.92  Aligned_cols=262  Identities=20%  Similarity=0.263  Sum_probs=202.2

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++......    .+.+.+|+.+++.++||||+++++++.+....++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3579999999999999999999987 7999999998754322    2568899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+++++|.+++....         .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       112 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg  179 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG---------PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFG  179 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCC
T ss_pred             EEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCc
Confidence            999999999999997653         3899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ++....... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......   .+            
T Consensus       180 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~------------  243 (309)
T 2h34_A          180 IASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VM------------  243 (309)
T ss_dssp             C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HH------------
T ss_pred             cCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HH------------
Confidence            987654321 11234567899999999999999999999999999999999999999743221   00            


Q ss_pred             hhhhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhcCCCC
Q 018071          300 VRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRP-NMSIVVKALQPLLNARPGP  355 (361)
Q Consensus       300 ~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~l~~~~~~~  355 (361)
                       ...+....  ....+...+..+.+++.+||+.||++|| |++++++.|+.++......
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~  301 (309)
T 2h34_A          244 -GAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD  301 (309)
T ss_dssp             -HHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred             -HHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence             00110000  0112234456799999999999999999 9999999999887755443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-47  Score=350.99  Aligned_cols=264  Identities=25%  Similarity=0.406  Sum_probs=208.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEE-----C-CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL-----K-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~-----~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      .++|.+.+.||+|+||.||+|.+     . ++..||+|++.....  ...++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            47899999999999999999983     2 678999999965332  235688999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc---CCceE
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAK  214 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~---~~~~k  214 (361)
                      ++||||+++++|.+++.......  .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   +..+|
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             EEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999998764221  12234899999999999999999999998   999999999999984   44699


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||......           
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------  252 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----------  252 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----------
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-----------
Confidence            999999864322222222345668899999999999999999999999999999998 99999643221           


Q ss_pred             cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                           .+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       253 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          253 -----EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             -----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence                 1111111222223344556779999999999999999999999999988775

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.5e-47  Score=340.14  Aligned_cols=257  Identities=23%  Similarity=0.360  Sum_probs=206.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|.+.+.||+|+||.||+|.+.    ++..||+|.+.....  ..+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            468999999999999999999854    234699999876432  34678899999999999999999999765 45689


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+.+++|.+++....        ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        90 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK--------NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT--------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             EEecCCCCCHHHHHHhcc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccC
Confidence            999999999999997643        23899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........              
T Consensus       159 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--------------  223 (281)
T 3cc6_A          159 LSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--------------  223 (281)
T ss_dssp             GGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--------------
T ss_pred             CCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--------------
Confidence            9876543221 12234557889999999999999999999999999999998 9999964332211              


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                        ...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       224 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          224 --IGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             --HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence              111111111223334567799999999999999999999999999998764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-46  Score=336.69  Aligned_cols=255  Identities=20%  Similarity=0.314  Sum_probs=209.9

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC-CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .+.++|.+.+.||+|+||.||+|..+ ++..+|+|++... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            45688999999999999999999987 7889999998653 344678999999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe---ccCCceEEecc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADF  218 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill---~~~~~~kl~Df  218 (361)
                      ||+++++|.+++....         .+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+||
T Consensus        86 e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Df  153 (277)
T 3f3z_A           86 ELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDF  153 (277)
T ss_dssp             ECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             eccCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEec
Confidence            9999999999987653         3899999999999999999999998   9999999999999   78889999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      |++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.......               
T Consensus       154 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------  214 (277)
T 3f3z_A          154 GLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---------------  214 (277)
T ss_dssp             TTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------
T ss_pred             ccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH---------------
Confidence            9987543221   2345679999999998865 49999999999999999999999997543211               


Q ss_pred             hhhhhcccccCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHhc
Q 018071          299 KVRQCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLNA  351 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~~  351 (361)
                      ....+.....  ..+.    ..+..+.+++.+||+.||.+|||+.++++  .++..++.
T Consensus       215 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          215 VMLKIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             HHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             HHHHHHhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence            1111111111  1122    23567999999999999999999999997  45554443

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=350.52  Aligned_cols=258  Identities=18%  Similarity=0.208  Sum_probs=210.1

Q ss_pred             hhcCCCCCccccCCceEEEEEE------ECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC---CCCcceeeeEEEeCCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGI------LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~  136 (361)
                      .++|.+.++||+|+||.||+|.      ..+++.||+|++...  ...++.+|+.++++++   |+||+++++++.....
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~  141 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG  141 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence            4689999999999999999994      347999999998653  4567888888888886   8999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-------
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-------  209 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-------  209 (361)
                      .++||||+++|+|.+++......    ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.       
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNT----PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTS----TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred             cEEEEeccCCCcHHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence            99999999999999999753211    1134999999999999999999999998   999999999999998       


Q ss_pred             ----CCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc
Q 018071          210 ----DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ  285 (361)
Q Consensus       210 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~  285 (361)
                          ++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......  
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--  292 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--  292 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence                89999999999965433223333456789999999999999999999999999999999999999995321110  


Q ss_pred             hhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHhHhcCC
Q 018071          286 SLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFR-PNMSIVVKALQPLLNARP  353 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Ps~~evl~~L~~l~~~~~  353 (361)
                                  ..    +...+. ..  ..+..+.+++..||+.+|.+| |+++++.+.|+.+++...
T Consensus       293 ------------~~----~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~  342 (365)
T 3e7e_A          293 ------------CK----PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY  342 (365)
T ss_dssp             ------------EE----ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             ------------ee----echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence                        00    001010 11  125568899999999999998 789999999999887654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.6e-47  Score=353.34  Aligned_cols=264  Identities=19%  Similarity=0.230  Sum_probs=200.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCCC------------hHHHHHHHHHHhcCCCCCcceeee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP------------DEEFLAQVSMVSRLKHENFVQLLG  129 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~hpniv~~~~  129 (361)
                      .++|.+.+.||+|+||.||+|...    ++..+|+|++......            ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999975    5789999998765321            234667888899999999999999


Q ss_pred             EEEe----CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCce
Q 018071          130 YCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV  205 (361)
Q Consensus       130 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Ni  205 (361)
                      ++..    ....++||||+ +++|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  182 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANL  182 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHE
Confidence            9987    78899999999 999999997654         3899999999999999999999998   99999999999


Q ss_pred             EeccCC--ceEEeccccCCCCcccccc-----ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCC
Q 018071          206 LIFDDD--VAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH  278 (361)
Q Consensus       206 ll~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~  278 (361)
                      |++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999887  9999999999765332211     112456799999999999999999999999999999999999999964


Q ss_pred             CCCcccchhhh--hhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          279 TLPRGQQSLVT--WATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       279 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      ...........  ....... ..+.....       ....+..+.+++.+||+.||.+|||+++|++.|+.+.-
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          263 NLKDPVAVQTAKTNLLDELP-QSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             GTTCHHHHHHHHHHHHHTTT-HHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cccccHHHHHHHHhhccccc-HHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            22111100000  0000000 00001000       01245579999999999999999999999999987653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.2e-46  Score=337.95  Aligned_cols=267  Identities=19%  Similarity=0.306  Sum_probs=212.4

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEE-EeCCeeEEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC-VDGTSRVLAYE  142 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e  142 (361)
                      +.++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.+++.++|++++..+.++ .+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            3578999999999999999999975 89999999986543 335789999999999988876666554 67788899999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe---ccCCceEEeccc
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFD  219 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill---~~~~~~kl~Dfg  219 (361)
                      |+ +++|.+++.....        .+++..++.++.||+.||+|||+.+   |+||||||+|||+   +.++.+||+|||
T Consensus        86 ~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             CC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             ec-CCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence            99 8899999974431        3899999999999999999999998   9999999999999   488899999999


Q ss_pred             cCCCCcccccc-----ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          220 LSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       220 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      ++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-----  228 (296)
T 3uzp_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-----  228 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH-----
T ss_pred             CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh-----
Confidence            98765432211     11245679999999999999999999999999999999999999997644322211111     


Q ss_pred             CCchhhhhhcccccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCC
Q 018071          295 LSEDKVRQCVDARLGGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPA  356 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~  356 (361)
                             .+........   ....++..+.+++.+||+.||.+|||+.+|++.|+.++.......
T Consensus       229 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~  286 (296)
T 3uzp_A          229 -------RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             -------HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred             -------hhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence                   1100000000   012234679999999999999999999999999999998766543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.4e-47  Score=349.90  Aligned_cols=246  Identities=26%  Similarity=0.410  Sum_probs=202.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .+.|.+.+.||+|+||.||+|... +++.||||++......    .+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            456999999999999999999975 8999999998754332    24688999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+. |+|.+++.....        .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       133 ~e~~~-g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  200 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS  200 (348)
T ss_dssp             EECCS-EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             EecCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccC
Confidence            99997 588888864331        3899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      +.....      .....||+.|+|||++.   +..++.++|||||||++|||++|+.||.......              
T Consensus       201 a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------  260 (348)
T 1u5q_A          201 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------------  260 (348)
T ss_dssp             CBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------------
T ss_pred             ceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------------
Confidence            876532      23467999999999985   5678999999999999999999999996443211              


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                       .+..+.........+...+..+.+++.+||+.||.+|||++++++.
T Consensus       261 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          261 -ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             0111111111111222345679999999999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.5e-47  Score=339.23  Aligned_cols=246  Identities=28%  Similarity=0.410  Sum_probs=204.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|++.+.||+|+||.||+|..+ ++..||+|++...    ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            468999999999999999999977 7889999998542    23346788999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        88 ~e~~~~~~l~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~  155 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW  155 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCE
T ss_pred             EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccc
Confidence            99999999999997653         2899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||........               .
T Consensus       156 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~  216 (279)
T 3fdn_A          156 SVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---------------Y  216 (279)
T ss_dssp             ESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---------------H
T ss_pred             cccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---------------H
Confidence            8654332    12456789999999999999999999999999999999999999974332111               1


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ..+..  .....+...+..+.+|+.+||+.||.+|||++++++.
T Consensus       217 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          217 KRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HHHHH--TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             HHHHh--CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11111  1112334456679999999999999999999999984

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.6e-47  Score=363.10  Aligned_cols=261  Identities=20%  Similarity=0.234  Sum_probs=197.6

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeC------
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------  134 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------  134 (361)
                      +.++|++.+.||+|+||+||+|... +++.||||++....   ...+++.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3578999999999999999999977 89999999997532   2245788999999999999999999999654      


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceE
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK  214 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~k  214 (361)
                      ...++||||+++ +|.+.+...           +++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+|
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~~-----------l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred             CeEEEEEeCCCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence            456999999976 577766432           899999999999999999999998   99999999999999999999


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |+|||+++.....   ...+..+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+......
T Consensus       205 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~  281 (464)
T 3ttj_A          205 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  281 (464)
T ss_dssp             ECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             EEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999999865432   2235678999999999999999999999999999999999999999765432211111100000


Q ss_pred             CCc-------hhhhhhcccccC-CC-----------------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 LSE-------DKVRQCVDARLG-GD-----------------YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 ~~~-------~~~~~~~~~~~~-~~-----------------~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...       ......++.... ..                 .....+..+.+|+.+||+.||.+|||++|+++
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000       111111111100 00                 01123677999999999999999999999987

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.5e-47  Score=369.14  Aligned_cols=252  Identities=21%  Similarity=0.327  Sum_probs=209.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|.+.++||+|+||.||+|..+ +|+.||+|++.+.    ......+.+|+.+++.++||||+++++++.+....++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999987 8999999998642    33456788999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||++||+|.+++.....       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||+
T Consensus       263 mEy~~gg~L~~~l~~~~~-------~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ-------AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEcCCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccc
Confidence            999999999999976542       23899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ++......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.........            ..+
T Consensus       333 a~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~------------~~i  397 (576)
T 2acx_A          333 AVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR------------EEV  397 (576)
T ss_dssp             CEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH------------HHH
T ss_pred             ceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH------------HHH
Confidence            97654321   224568999999999999999999999999999999999999999754332111            111


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      ...+.. ....++...+..+.+||.+||+.||.+||     ++++|++
T Consensus       398 ~~~i~~-~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          398 ERLVKE-VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHhhc-ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            111110 11233445667899999999999999999     7888876

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9e-47  Score=365.35  Aligned_cols=249  Identities=27%  Similarity=0.375  Sum_probs=203.2

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--------------CChHHHHHHHHHHhcCCCCCcceee
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--------------QPDEEFLAQVSMVSRLKHENFVQLL  128 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~hpniv~~~  128 (361)
                      .+.++|.+.+.||+|+||+||+|..+ ++..||+|++.+..              ...+.+.+|+.+++.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            35689999999999999999999987 78999999986533              2346788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec
Q 018071          129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF  208 (361)
Q Consensus       129 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~  208 (361)
                      +++.+....++|||||++|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~  180 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLE  180 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEe
Confidence            99999999999999999999999987653         2899999999999999999999998   99999999999998


Q ss_pred             cCC---ceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc
Q 018071          209 DDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ  285 (361)
Q Consensus       209 ~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~  285 (361)
                      .++   .+||+|||++......   ......+||+.|+|||++. +.++.++|||||||++|+|++|..||........ 
T Consensus       181 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-  255 (504)
T 3q5i_A          181 NKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-  255 (504)
T ss_dssp             STTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-
T ss_pred             cCCCCccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            876   6999999999765432   1234567999999999887 4699999999999999999999999975433211 


Q ss_pred             hhhhhhcccCCchhhhhhcccccCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          286 SLVTWATPKLSEDKVRQCVDARLGGDY--PPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                    +..+.........  ....+..+.+|+.+||+.||.+|||++++++
T Consensus       256 --------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          256 --------------IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             --------------HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------------HHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                          1111111110000  0123567999999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.2e-47  Score=339.70  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=199.5

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC--CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.++|.+.+.||+|+||.||+|..+ ++..+|+|++...  ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            4578999999999999999999986 7999999998653  334578999999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe---ccCCceEEecc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADF  218 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill---~~~~~~kl~Df  218 (361)
                      ||+++++|.+++......     ...+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+||
T Consensus       100 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A          100 ETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EeCCCCcHHHHHHhhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEee
Confidence            999999999988543210     123899999999999999999999998   9999999999999   45678999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      |++.......   ......||+.|+|||++. ..++.++||||||+++|+|++|+.||...............       
T Consensus       172 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------  240 (285)
T 3is5_A          172 GLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-------  240 (285)
T ss_dssp             CCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------
T ss_pred             ecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-------
Confidence            9997654322   234567899999999875 57899999999999999999999999754322111111110       


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                            ....... ....+..+.+++.+||+.||.+|||+.++++
T Consensus       241 ------~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          241 ------EPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ------CCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ------Ccccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  0000000 0113456889999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.3e-46  Score=344.76  Aligned_cols=267  Identities=24%  Similarity=0.400  Sum_probs=213.1

Q ss_pred             HHHHHHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhc--CCCCCcceeeeEEEeCC--
Q 018071           60 DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR--LKHENFVQLLGYCVDGT--  135 (361)
Q Consensus        60 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~~~--  135 (361)
                      ..-..+.++|.+.+.||+|+||.||+|... ++.||||++...  ....+.+|+++++.  ++||||+++++++....  
T Consensus        35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           35 LVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             eecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            334567789999999999999999999985 999999998643  34577888888887  68999999999998776  


Q ss_pred             --eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeEeccCCCCce
Q 018071          136 --SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH--------EKADPHIIHRDIKSSNV  205 (361)
Q Consensus       136 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~ivHrDikp~Ni  205 (361)
                        ..++||||+++|+|.+++....          +++..++.++.|++.||.|||        +.+   |+||||||+||
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI  178 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI  178 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred             cceeEEEEeecCCCcHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence              7899999999999999997643          899999999999999999999        776   99999999999


Q ss_pred             EeccCCceEEeccccCCCCcccccc--ccccccccCCCCCCchhhccC------CCCCccceecHHHHHHHHHhC-----
Q 018071          206 LIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG------QLNAKSDVYSFGVVLLELLTG-----  272 (361)
Q Consensus       206 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g-----  272 (361)
                      |++.++.+||+|||++.........  .......||+.|+|||++.+.      .++.++|||||||++|+|++|     
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence            9999999999999998654322111  123456799999999999865      234689999999999999999     


Q ss_pred             -----CCCCCCCCCcccchhhhhhcccCCchhhhh-hcccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHH
Q 018071          273 -----RKPVDHTLPRGQQSLVTWATPKLSEDKVRQ-CVDARLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIV  341 (361)
Q Consensus       273 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~ev  341 (361)
                           ..||....+...           ....+.. +.........+     ...+..+.+|+.+||+.||.+|||+.+|
T Consensus       259 ~~~~~~~p~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSDP-----------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             BCCCCCCTTTTTSCSSC-----------CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cccccccCccccCcCcc-----------cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence                 677754432211           0111111 11222222222     3667889999999999999999999999


Q ss_pred             HHHHHHhHhcCC
Q 018071          342 VKALQPLLNARP  353 (361)
Q Consensus       342 l~~L~~l~~~~~  353 (361)
                      ++.|+.+.++..
T Consensus       328 ~~~L~~i~~~~~  339 (342)
T 1b6c_B          328 KKTLSQLSQQEG  339 (342)
T ss_dssp             HHHHHHHHHTTC
T ss_pred             HHHHHHHHHHhc
Confidence            999999987653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9e-47  Score=365.25  Aligned_cols=254  Identities=21%  Similarity=0.318  Sum_probs=208.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|.+.++||+|+||.||+|..+ +|+.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67889999999999999999987 8999999998642    234567889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||++||+|.+++.....     ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||++
T Consensus       265 E~~~gg~L~~~l~~~~~-----~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDE-----DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             CCCTTCBHHHHHHTSST-----TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EeccCCCHHHHHHHhhc-----ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeeccee
Confidence            99999999999876431     1234999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.........           .....
T Consensus       337 ~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-----------~~~~~  403 (543)
T 3c4z_A          337 VELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-----------KELKQ  403 (543)
T ss_dssp             EECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-----------HHHHH
T ss_pred             eeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-----------HHHHH
Confidence            7654322  1234468999999999999999999999999999999999999999754321110           01111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM-----SIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~  343 (361)
                      .+....  ..++...+..+.+|+.+||+.||.+||++     ++|++
T Consensus       404 ~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          404 RVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             HHhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            112211  13445567789999999999999999975     66664

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.7e-47  Score=338.31  Aligned_cols=249  Identities=20%  Similarity=0.299  Sum_probs=205.6

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      +.++|++.+.||+|+||.||+|..+ +++.||+|++......   .+.+.+|+.++++++||||+++++++.+....++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            4579999999999999999999987 7999999998654333   35678899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc---eEEec
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AKIAD  217 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~---~kl~D  217 (361)
                      |||+.+++|.+++....         .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|
T Consensus        84 ~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~D  151 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD  151 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEee
Confidence            99999999998887653         3899999999999999999999998   999999999999987665   99999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........            
T Consensus       152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------------  216 (284)
T 3kk8_A          152 FGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY------------  216 (284)
T ss_dssp             CTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------------
T ss_pred             ceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH------------
Confidence            99986553322   224467899999999999999999999999999999999999999654321111            


Q ss_pred             hhhhhhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         ..+.....  ........+..+.+++.+||+.||.+|||+.++++
T Consensus       217 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          217 ---AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ---HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---HHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               11111111  11111234567999999999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=349.66  Aligned_cols=255  Identities=27%  Similarity=0.416  Sum_probs=201.8

Q ss_pred             HHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEe------
Q 018071           62 LKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVD------  133 (361)
Q Consensus        62 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~------  133 (361)
                      +....++|++.+.||+|+||.||+|.+. +++.||+|++.........+.+|+.+++++ +||||+++++++..      
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            3445689999999999999999999986 899999999987666778899999999999 79999999999987      


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      ....++||||+++++|.+++......       .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence            46789999999999999999765321       3899999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhh
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~  288 (361)
                      ||+|||++.......  .......||+.|+|||++.     +..++.++|||||||++|+|++|..||.........   
T Consensus       169 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---  243 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---  243 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---
T ss_pred             EEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH---
Confidence            999999987654321  1234567899999999987     567899999999999999999999999644321110   


Q ss_pred             hhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          289 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                  ..+.........+...+..+.+++.+||..||.+|||+.++++
T Consensus       244 ------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          244 ------------FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ------------HHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ------------HHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                        0010111111112234567999999999999999999999987

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=351.21  Aligned_cols=271  Identities=23%  Similarity=0.344  Sum_probs=213.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEE-----CCCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeC--Cee
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~  137 (361)
                      .++|++.+.||+|+||.||++..     .+++.||+|++..... ..+.+.+|+.++++++||||+++++++...  ...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46799999999999999999984     3789999999976433 235788999999999999999999988654  368


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      ++||||+++++|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~D  188 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD  188 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred             EEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEec
Confidence            999999999999999976532        3899999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC-
Q 018071          218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL-  295 (361)
Q Consensus       218 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~-  295 (361)
                      ||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.....    .+........ 
T Consensus       189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~  264 (326)
T 2w1i_A          189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQ  264 (326)
T ss_dssp             CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCC
T ss_pred             CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccc
Confidence            9998765432211 112334577889999999998999999999999999999999999853210    0000000000 


Q ss_pred             ---CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          296 ---SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       296 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                         ....+...+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+..+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          265 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence               01112223333333344556678899999999999999999999999999998764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-46  Score=337.75  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=210.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|.+.+.||+|+||.||+|... ++..||+|++...    ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            368999999999999999999987 7889999998542    23446789999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~  160 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG---------RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGW  160 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccc
Confidence            99999999999997653         2899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +......    ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......               ..
T Consensus       161 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------~~  221 (284)
T 2vgo_A          161 SVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---------------TH  221 (284)
T ss_dssp             CEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---------------HH
T ss_pred             cccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---------------HH
Confidence            8654321    2245678999999999999999999999999999999999999996432211               11


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHh
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLN  350 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~  350 (361)
                      ..+....  ...+...+..+.+++.+||+.||.+|||++++++  .++....
T Consensus       222 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          222 RRIVNVD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHHHTTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHHhccc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            1111111  1233445677999999999999999999999997  4444333

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=352.30  Aligned_cols=243  Identities=22%  Similarity=0.301  Sum_probs=195.5

Q ss_pred             CCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      .++||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            567999999999999976 79999999987643 3346789999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe--ccCCceEEeccccCCCCccc
Q 018071          150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI--FDDDVAKIADFDLSNQAPDM  227 (361)
Q Consensus       150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill--~~~~~~kl~Dfg~a~~~~~~  227 (361)
                      .+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++.....
T Consensus       174 ~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          174 FDRIIDESY--------NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             HHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             HHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            998865431        3899999999999999999999998   9999999999999  56678999999998765432


Q ss_pred             cccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccc
Q 018071          228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR  307 (361)
Q Consensus       228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (361)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|..||........               +..++...
T Consensus       243 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---------------~~~i~~~~  304 (373)
T 2x4f_A          243 E---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET---------------LNNILACR  304 (373)
T ss_dssp             C---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---------------HHHHHHTC
T ss_pred             c---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHhcc
Confidence            2   23445799999999999988999999999999999999999999975432211               11111111


Q ss_pred             cC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          308 LG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       308 ~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..  .......+..+.+||.+||+.||.+|||+.++++
T Consensus       305 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          305 WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            10  0111234567999999999999999999999997

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.4e-47  Score=375.14  Aligned_cols=250  Identities=26%  Similarity=0.418  Sum_probs=205.0

Q ss_pred             CccccCCceEEEEEEEC---CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      +.||+|+||.||+|.+.   +++.||||+++....   ..+++.+|+.++++++||||+++++++.. ...++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            37999999999999653   568899999975332   24689999999999999999999999864 568899999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus       454 g~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          454 GPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             CCHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            99999997653         3899999999999999999999998   99999999999999999999999999875533


Q ss_pred             ccc-cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          227 MAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       227 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....                ..+...+
T Consensus       522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----------------~~~~~~i  585 (635)
T 4fl3_A          522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------SEVTAML  585 (635)
T ss_dssp             -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHHH
T ss_pred             CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHH
Confidence            221 112334457889999999999999999999999999999998 9999964322                2233334


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      ........+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       586 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          586 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            44444455666778899999999999999999999999999998753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-46  Score=340.17  Aligned_cols=249  Identities=27%  Similarity=0.409  Sum_probs=208.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .+.|.+.+.||+|+||.||+|... +++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            357999999999999999999976 79999999986543  345788999999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++++|.+++....          +++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus       101 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  167 (303)
T 3a7i_A          101 YLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG  167 (303)
T ss_dssp             CCTTEEHHHHHTTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence            999999999997532          899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||........                ..
T Consensus       168 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~  229 (303)
T 3a7i_A          168 QLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV----------------LF  229 (303)
T ss_dssp             ECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HH
T ss_pred             ecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH----------------HH
Confidence            654322  123456789999999999999999999999999999999999999964332110                01


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL  345 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  345 (361)
                      .+........+..++..+.+++.+||+.||.+|||+.++++..
T Consensus       230 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          230 LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             HHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             HhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            1111111122334456799999999999999999999998743

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.8e-47  Score=337.35  Aligned_cols=248  Identities=27%  Similarity=0.390  Sum_probs=185.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|.+.+.||+|+||.||+|... +++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            468999999999999999999975 8999999998642    23346789999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++....        ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        90 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~  158 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--------KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGL  158 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTT
T ss_pred             EecCCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecc
Confidence            99999999999997643        23899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........               +
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~  221 (278)
T 3cok_A          159 ATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------------L  221 (278)
T ss_dssp             CEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------
T ss_pred             eeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---------------H
Confidence            876532211  12346789999999999998999999999999999999999999975432211               0


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .......  ...+...+..+.+++.+||+.||.+|||++++++
T Consensus       222 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          222 NKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            0111111  1223345567999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.3e-47  Score=348.88  Aligned_cols=264  Identities=19%  Similarity=0.258  Sum_probs=195.5

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ..++|++.+.||+|+||+||+|... +++.||||++......   .+.+.+|+.++++++||||+++++++.+....++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3578999999999999999999976 8999999999754322   34677999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec-----cCCceEE
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-----DDDVAKI  215 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~-----~~~~~kl  215 (361)
                      |||+++ +|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++     .++.+||
T Consensus       112 ~e~~~~-~L~~~~~~~~---------~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl  178 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNP---------DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKI  178 (329)
T ss_dssp             EECCSE-EHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred             EecCCC-CHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEE
Confidence            999975 9999997654         2899999999999999999999998   99999999999994     4556999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||+++.....  ........||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+......
T Consensus       179 ~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  256 (329)
T 3gbz_A          179 GDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL  256 (329)
T ss_dssp             CCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             CcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence            999998654321  1123456789999999999875 5899999999999999999999999765432211111100000


Q ss_pred             CCchhhhhh------cc--cccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 LSEDKVRQC------VD--ARLGGD-----YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 ~~~~~~~~~------~~--~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .........      ..  ......     .+...+..+.+|+.+||+.||.+|||++++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000000000      00  000000     01113567899999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.3e-46  Score=361.04  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=205.8

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC---CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .+.++|++.++||+|+||+||+|..+ +++.||||++.+   .......+.+|+.++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            45789999999999999999999987 899999999854   23456789999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec---cCCceEEe
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIA  216 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~---~~~~~kl~  216 (361)
                      ||||+.+++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++   .++.+||+
T Consensus        99 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~  166 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII  166 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEE
Confidence            999999999999887653         2899999999999999999999998   99999999999995   45679999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      |||+++......   .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||........            
T Consensus       167 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------------  230 (486)
T 3mwu_A          167 DFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------------  230 (486)
T ss_dssp             SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------
T ss_pred             ECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------------
Confidence            999998654321   2345679999999999876 599999999999999999999999975432111            


Q ss_pred             chhhhhhcccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          297 EDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       297 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                         +..+.......  +.....+..+.+||.+||+.||.+|||+.++++.
T Consensus       231 ---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          231 ---LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ---HHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ---HHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               11111111111  1112346679999999999999999999999973

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=351.49  Aligned_cols=269  Identities=17%  Similarity=0.231  Sum_probs=209.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEECC---------CCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcce----------
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKS---------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ----------  126 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~----------  126 (361)
                      .++|.+.+.||+|+||.||+|....         ++.||+|.+...    +.+.+|++++++++||||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            3689999999999999999999763         789999998654    46889999999999999987          


Q ss_pred             -----eeeEEEe-CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccC
Q 018071          127 -----LLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI  200 (361)
Q Consensus       127 -----~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDi  200 (361)
                           +++++.. ....++||||+ +++|.+++.....       ..+++..++.++.||+.||.|||+.+   |+||||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Di  185 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-------HVLSERSVLQVACRLLDALEFLHENE---YVHGNV  185 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCC
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCC
Confidence                 6777776 78889999999 9999999986521       13999999999999999999999998   999999


Q ss_pred             CCCceEeccCC--ceEEeccccCCCCccccccc-----cccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCC
Q 018071          201 KSSNVLIFDDD--VAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR  273 (361)
Q Consensus       201 kp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~  273 (361)
                      ||+|||++.++  .+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  265 (352)
T 2jii_A          186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF  265 (352)
T ss_dssp             CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999998  99999999998764332111     123457999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          274 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       274 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                      .||....+.... +..... .. ...........   ......+..+.+++.+||+.||.+|||+++|++.|+.+++...
T Consensus       266 ~pf~~~~~~~~~-~~~~~~-~~-~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          266 LPWTNCLPNTED-IMKQKQ-KF-VDKPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             CTTGGGTTCHHH-HHHHHH-HH-HHSCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CCcccCCcCHHH-HHHHHH-hc-cCChhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            999754321110 100000 00 00000000000   0001235679999999999999999999999999999998765


Q ss_pred             CC
Q 018071          354 GP  355 (361)
Q Consensus       354 ~~  355 (361)
                      ..
T Consensus       340 ~~  341 (352)
T 2jii_A          340 VS  341 (352)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=350.76  Aligned_cols=263  Identities=22%  Similarity=0.332  Sum_probs=198.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|++......  ...+.+|+.+++.++||||+++++++.+....++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999987 8999999998653322  12455799999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      ++ ++|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        82 ~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  149 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA  149 (324)
T ss_dssp             CS-EEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred             cc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccc
Confidence            97 599998876532        3899999999999999999999998   99999999999999999999999999876


Q ss_pred             CccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .....  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........+..
T Consensus       150 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (324)
T 3mtl_A          150 KSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG  227 (324)
T ss_dssp             C--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence            53221  22345578999999999886 5789999999999999999999999976543322211111111111111111


Q ss_pred             hcc---------cccCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVD---------ARLGGD----YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~---------~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...         ......    ..+..+..+.+|+.+||+.||.+|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            100         000000    11234567899999999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-47  Score=350.95  Aligned_cols=259  Identities=23%  Similarity=0.307  Sum_probs=198.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCC------
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------  135 (361)
                      .++|.+.+.||+|+||.||+|..+ +|+.||||++......   .+++.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            478999999999999999999986 8999999999654333   356789999999999999999999997653      


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..++||||+ +++|.+++....          +++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl  169 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI  169 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred             eEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEE
Confidence            459999999 789999997643          899999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||+++....     ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus       170 ~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  244 (367)
T 1cm8_A          170 LDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  244 (367)
T ss_dssp             CCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             Eeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999876432     1345678999999999987 68999999999999999999999999765432221111111111


Q ss_pred             CCchh--------hhhhccc---ccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 LSEDK--------VRQCVDA---RLG---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 ~~~~~--------~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...+.        ....+..   ...   .......+..+.+|+.+||+.||.+|||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            11111        1111000   000   0112334567999999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.3e-46  Score=356.34  Aligned_cols=265  Identities=22%  Similarity=0.328  Sum_probs=209.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCC-CCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|.+.++||+|+||.||+|.+. +++.||||++..... ..++.+|+++++.++| +++..+..++.+....+|||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~   84 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL   84 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence            578999999999999999999975 899999998765432 3468899999999986 5666666677788899999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe---ccCCceEEecccc
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDL  220 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill---~~~~~~kl~Dfg~  220 (361)
                      + +++|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+||||   +.++.+||+|||+
T Consensus        85 ~-g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGl  152 (483)
T 3sv0_A           85 L-GPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (483)
T ss_dssp             C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             C-CCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCc
Confidence            9 8899999975432        3999999999999999999999998   9999999999999   6889999999999


Q ss_pred             CCCCcccccc-----ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          221 SNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       221 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      ++........     .......||+.|+|||++.+..++.++|||||||+||+|++|+.||................   
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~---  229 (483)
T 3sv0_A          153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS---  229 (483)
T ss_dssp             CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH---
T ss_pred             ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh---
Confidence            9765432221     11236779999999999999999999999999999999999999997654432211111100   


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                       ...+...+..     ....++.++.+|+.+||+.+|++||++.+|++.|+.++...
T Consensus       230 -~~~~~~~~~~-----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          230 -EKKVATSIEA-----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             -HHHHHSCHHH-----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -hccccccHHH-----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence             0000000000     00123467999999999999999999999999999997643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3e-47  Score=350.03  Aligned_cols=247  Identities=21%  Similarity=0.313  Sum_probs=206.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|.+.+.||+|+||.||++... +++.||+|++.....    ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            478999999999999999999987 789999999865322    235688899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       120 ~e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~  187 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL  187 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EecCCCCCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccC
Confidence            99999999999987643         3899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +.......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......               ..
T Consensus       188 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------~~  250 (335)
T 2owb_A          188 ATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---------------TY  250 (335)
T ss_dssp             CEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------------HH
T ss_pred             ceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---------------HH
Confidence            87653221  12345679999999999999999999999999999999999999996442211               01


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..+....  ...+...+..+.+|+.+||+.||.+|||++++++
T Consensus       251 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          251 LRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHHHHTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHhcCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111111  1223344567899999999999999999999997

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.5e-47  Score=346.23  Aligned_cols=262  Identities=19%  Similarity=0.288  Sum_probs=209.1

Q ss_pred             ccCHHHHHHHhhcCCCC-CccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCC-CCCcceeee
Q 018071           56 AISVDELKEITENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLK-HENFVQLLG  129 (361)
Q Consensus        56 ~~~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~-hpniv~~~~  129 (361)
                      ++.+...+.+.++|.+. +.||+|+||.||+|..+ +++.||+|++....   .....+.+|+.+++.+. ||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34444556778889988 89999999999999987 79999999987533   23468899999999995 699999999


Q ss_pred             EEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc
Q 018071          130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       130 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~  209 (361)
                      ++.+....++||||+.+|+|.+++.....       ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~  166 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELA-------EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSS  166 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESC
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEec
Confidence            99999999999999999999999865432       23899999999999999999999998   999999999999987


Q ss_pred             ---CCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch
Q 018071          210 ---DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS  286 (361)
Q Consensus       210 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~  286 (361)
                         ++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus       167 ~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  243 (327)
T 3lm5_A          167 IYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL  243 (327)
T ss_dssp             BTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence               7899999999997654321   2345679999999999999999999999999999999999999996543221110


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+..             .............+..+.+++.+||+.||.+|||++++++
T Consensus       244 ~i~~-------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          244 NISQ-------------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHH-------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHh-------------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            0000             0111111222345677999999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=338.80  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=200.4

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC-----CCChHHHHHHHHHHhcCCCCCcceeeeEEE--eCCe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLKHENFVQLLGYCV--DGTS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~  136 (361)
                      +.++|.+.+.||+|+||.||++..+ +++.||+|++...     ......+.+|+.+++.++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4679999999999999999999976 7899999998653     234567899999999999999999999984  4567


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||++++ |.+++.....       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~  151 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPE-------KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKIS  151 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTT-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEehhccCC-HHHHHHhCcc-------cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEee
Confidence            89999999875 7777765432       23899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCC--CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |||++................||+.|+|||++.+..  ++.++||||||+++|+|++|..||........          
T Consensus       152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------  221 (305)
T 2wtk_C          152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL----------  221 (305)
T ss_dssp             CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------
T ss_pred             ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH----------
Confidence            999987654322222334567899999999998654  37799999999999999999999975422110          


Q ss_pred             CCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                           ...+....  ...+..++..+.+++.+||+.||.+|||++++++.
T Consensus       222 -----~~~i~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          222 -----FENIGKGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -----HHHHHHCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----HHHHhcCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 11111111  12233455679999999999999999999999973

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.9e-46  Score=360.93  Aligned_cols=253  Identities=25%  Similarity=0.351  Sum_probs=203.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      +.++|++.+.||+|+||+||+|..+ ++..||+|++.+.   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            5678999999999999999999987 8999999998653   33457889999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC---CceEEec
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKIAD  217 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~---~~~kl~D  217 (361)
                      ||||.+|+|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++..   +.+||+|
T Consensus       115 ~e~~~~g~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D  182 (494)
T 3lij_A          115 MECYKGGELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD  182 (494)
T ss_dssp             EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence            99999999999887653         2899999999999999999999998   9999999999999764   4599999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ||++......   ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.........            
T Consensus       183 fG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------------  246 (494)
T 3lij_A          183 FGLSAVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL------------  246 (494)
T ss_dssp             CTTCEECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------------
T ss_pred             CCCCeECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH------------
Confidence            9998765432   1234567999999999876 57999999999999999999999999754332111            


Q ss_pred             hhhhhhcccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHh
Q 018071          298 DKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPL  348 (361)
Q Consensus       298 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l  348 (361)
                         ..+.......  +.....+..+.+|+.+||+.||.+|||+.++++  .++..
T Consensus       247 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          247 ---RKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             ---HHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             ---HHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence               1111111110  011234567999999999999999999999987  34443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2e-46  Score=354.64  Aligned_cols=249  Identities=22%  Similarity=0.351  Sum_probs=194.3

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---------CChHHHHHHHHHHhcCCCCCcceeeeEEE
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---------QPDEEFLAQVSMVSRLKHENFVQLLGYCV  132 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~e~~~l~~l~hpniv~~~~~~~  132 (361)
                      ..+.++|.+.+.||+|+||.||+|..+ +++.||+|++.+..         .....+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            456789999999999999999999977 78999999986422         11235789999999999999999999975


Q ss_pred             eCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-
Q 018071          133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-  211 (361)
Q Consensus       133 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-  211 (361)
                       ....++||||+++|+|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++ 
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~  277 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE  277 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS
T ss_pred             -cCceEEEEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC
Confidence             456899999999999999887543         3899999999999999999999998   99999999999997554 


Q ss_pred             --ceEEeccccCCCCccccccccccccccCCCCCCchhhcc---CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch
Q 018071          212 --VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS  286 (361)
Q Consensus       212 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~  286 (361)
                        .+||+|||+++.....   ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||........  
T Consensus       278 ~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--  352 (419)
T 3i6u_A          278 DCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--  352 (419)
T ss_dssp             SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--
T ss_pred             cceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--
Confidence              5999999999876432   22345789999999999863   5788999999999999999999999975432211  


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                   +...+..... ...+    ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       353 -------------~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 -------------LKDQITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -------------HHHHHHTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -------------HHHHHhcCCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                         0111111100 1111    23567999999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.1e-46  Score=334.84  Aligned_cols=255  Identities=21%  Similarity=0.337  Sum_probs=207.4

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      +.++|.+.+.||+|+||.||+|..+ +++.||+|++.....       ..+.+.+|+.++++++||||+++++++.+...
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            3578999999999999999999987 799999999865321       35678999999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC----c
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V  212 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~----~  212 (361)
                      .++||||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+||+++.++    .
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~  150 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPR  150 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCC
T ss_pred             EEEEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCc
Confidence            999999999999999997643         3899999999999999999999998   99999999999998877    8


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      +||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.........       
T Consensus       151 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------  220 (283)
T 3bhy_A          151 IKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-------  220 (283)
T ss_dssp             EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------
T ss_pred             eEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH-------
Confidence            9999999987653321   224456899999999999999999999999999999999999999754321110       


Q ss_pred             ccCCchhhhhhcccccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhHhc
Q 018071          293 PKLSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLNA  351 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~~  351 (361)
                              ..+....  ...+    ...+..+.+++.+||+.||.+|||+.++++  .++.+...
T Consensus       221 --------~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          221 --------TNISAVN--YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             --------HHHHTTC--CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             --------HHhHhcc--cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence                    0010000  0111    123567999999999999999999999998  56665544

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.1e-46  Score=346.39  Aligned_cols=254  Identities=21%  Similarity=0.355  Sum_probs=206.8

Q ss_pred             HHHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---------hHHHHHHHHHHhcC-CCCCcceee
Q 018071           60 DELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---------DEEFLAQVSMVSRL-KHENFVQLL  128 (361)
Q Consensus        60 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l-~hpniv~~~  128 (361)
                      .....+.++|.+.+.||+|+||.||+|..+ +|+.||||++......         .+.+.+|+.+++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344567789999999999999999999987 8999999998654321         34577899999999 799999999


Q ss_pred             eEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec
Q 018071          129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF  208 (361)
Q Consensus       129 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~  208 (361)
                      +++......++||||+++++|.+++....         .+++..++.++.||+.||.|||+.|   |+||||||+|||++
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~  234 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLD  234 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            99999999999999999999999997643         3899999999999999999999998   99999999999999


Q ss_pred             cCCceEEeccccCCCCccccccccccccccCCCCCCchhhcc------CCCCCccceecHHHHHHHHHhCCCCCCCCCCc
Q 018071          209 DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT------GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR  282 (361)
Q Consensus       209 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~  282 (361)
                      .++.+||+|||++.......   .....+||+.|+|||++.+      ..++.++|||||||++|+|++|..||......
T Consensus       235 ~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  311 (365)
T 2y7j_A          235 DNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI  311 (365)
T ss_dssp             TTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence            99999999999987654321   2345689999999999864      35889999999999999999999999643221


Q ss_pred             ccchhhhhhcccCCchhhhhhcccccCCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..               +..+.........+  ...+..+.+++.+||+.||.+|||+.++++
T Consensus       312 ~~---------------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          312 LM---------------LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HH---------------HHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH---------------HHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            10               01111111100000  123456999999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-46  Score=374.86  Aligned_cols=247  Identities=22%  Similarity=0.287  Sum_probs=209.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC----CCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA----SKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|++.++||+|+||.||+|..+ +++.||||++.+    .....+.+..|..++..+ +||+|+++++++.+....+|
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            468999999999999999999987 789999999864    234456788899999988 69999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+++|+|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       420 V~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEeCcCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecc
Confidence            999999999999998654         2999999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +++.....  .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......               +.
T Consensus       488 la~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---------------~~  550 (674)
T 3pfq_A          488 MCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---------------EL  550 (674)
T ss_dssp             TCEECCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------HH
T ss_pred             eeeccccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---------------HH
Confidence            98753221  12245678999999999999999999999999999999999999999754321               11


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM-----SIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~  343 (361)
                      +..++....  .++...+.++.+||.+||+.||.+||++     ++|++
T Consensus       551 ~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          551 FQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            222222222  3455567789999999999999999998     67665

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-46  Score=359.65  Aligned_cols=265  Identities=22%  Similarity=0.311  Sum_probs=186.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeC-----Ce
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~  136 (361)
                      .++|++.++||+|+||+||+|..+ +++.||||++......   .+++.+|+.+++.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999977 8999999998764333   35688999999999999999999998533     56


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||+ +++|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~  198 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV---------YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVC  198 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEecc-ccchhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeec
Confidence            89999998 569999987643         3999999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCcccccc-------------------------ccccccccCCCCCCchhhc-cCCCCCccceecHHHHHHHHH
Q 018071          217 DFDLSNQAPDMAAR-------------------------LHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELL  270 (361)
Q Consensus       217 Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell  270 (361)
                      |||+++........                         ...+..+||+.|+|||++. +..|+.++|||||||++|||+
T Consensus       199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell  278 (458)
T 3rp9_A          199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL  278 (458)
T ss_dssp             CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence            99999865322110                         1234567899999999864 667999999999999999999


Q ss_pred             h-----------CCCCCCCCCCccc--------------------chhhhhhcccCCch--------hhhhhccc---cc
Q 018071          271 T-----------GRKPVDHTLPRGQ--------------------QSLVTWATPKLSED--------KVRQCVDA---RL  308 (361)
Q Consensus       271 ~-----------g~~pf~~~~~~~~--------------------~~~~~~~~~~~~~~--------~~~~~~~~---~~  308 (361)
                      +           |+.+|.+......                    ...+.........+        .....+..   ..
T Consensus       279 tg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  358 (458)
T 3rp9_A          279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE  358 (458)
T ss_dssp             TTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCC
T ss_pred             HhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCC
Confidence            9           5666644321000                    00000000000000        00000000   00


Q ss_pred             C---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          309 G---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       309 ~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .   ....+..+..+.+||.+||..||.+|||++|+++
T Consensus       359 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          359 GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0   0011233667899999999999999999999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=347.11  Aligned_cols=268  Identities=23%  Similarity=0.298  Sum_probs=200.1

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC------ChHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT  135 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  135 (361)
                      ....++|.+.+.||+|+||.||+|..+ +|+.||+|++.....      ..+.+.+|+.+++.++||||+++++++.+..
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            445689999999999999999999976 799999999965322      1246889999999999999999999999999


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..++||||+++ +|.+++....        ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  153 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNS--------LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKL  153 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCC--------SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             ceEEEEEcCCC-CHHHHHHhcC--------cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEE
Confidence            99999999976 8988887543        23888999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||+++......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+......
T Consensus       154 ~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~  231 (346)
T 1ua2_A          154 ADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT  231 (346)
T ss_dssp             CCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             EecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9999998764322  223456789999999999764 5899999999999999999999999765432211111000000


Q ss_pred             CCchhhh------hhcccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          295 LSEDKVR------QCVDARLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       295 ~~~~~~~------~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      .....+.      ..+........+     ...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000000      000000000111     2335679999999999999999999999873

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.4e-47  Score=346.00  Aligned_cols=268  Identities=25%  Similarity=0.398  Sum_probs=208.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEe----CCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~l  139 (361)
                      .++|++.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            368999999999999999999985 89999999885432 234678899999999999999999999872    347789


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+.+++|.+++......     ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       108 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred             EEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecC
Confidence            99999999999998763211     124899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCcccccc-------ccccccccCCCCCCchhhccCC---CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 018071          220 LSNQAPDMAAR-------LHSTRVLGTFGYHAPEYAMTGQ---LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT  289 (361)
Q Consensus       220 ~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~  289 (361)
                      ++.........       .......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||.......      
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------  253 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG------  253 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT------
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc------
Confidence            88654321111       0112355799999999987654   6889999999999999999999995211100      


Q ss_pred             hhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCC
Q 018071          290 WATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP  355 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~  355 (361)
                              ..+...+......+.+...+..+.+++.+||+.||.+|||+.++++.|+.+....|..
T Consensus       254 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          254 --------DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             --------SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             --------chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence                    0111111112222233445677999999999999999999999999999886555443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.5e-47  Score=363.91  Aligned_cols=248  Identities=25%  Similarity=0.383  Sum_probs=206.4

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      +.++|++.++||+|+||.||+|..+ +++.||||++.+.    ....+.+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4678999999999999999999987 8999999998653    2345678999999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe---ccCCceEEe
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIA  216 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill---~~~~~~kl~  216 (361)
                      ||||+.+++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+
T Consensus       104 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~  171 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII  171 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS---------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence            999999999999987653         3899999999999999999999998   9999999999999   567899999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      |||++......   ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||........            
T Consensus       172 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------------  235 (484)
T 3nyv_A          172 DFGLSTHFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI------------  235 (484)
T ss_dssp             CTTHHHHBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------
T ss_pred             eeeeeEEcccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH------------
Confidence            99998654322   12345679999999999876 799999999999999999999999975432211            


Q ss_pred             chhhhhhcccccCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          297 EDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         +..+........  .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       236 ---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          236 ---LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ---HHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence               111111111111  11245677999999999999999999999997

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.1e-46  Score=338.56  Aligned_cols=249  Identities=22%  Similarity=0.332  Sum_probs=206.0

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .+.++|.+.+.||+|+||.||++..+ +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            35689999999999999999999987 899999999976432 3456889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe---ccCCceEEecc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADF  218 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill---~~~~~~kl~Df  218 (361)
                      ||+++++|.+++....         .+++..++.++.|++.||.|||+.+   |+||||||+||++   ++++.+||+||
T Consensus        86 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Df  153 (304)
T 2jam_A           86 QLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDF  153 (304)
T ss_dssp             CCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred             EcCCCccHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccC
Confidence            9999999999987643         2899999999999999999999998   9999999999999   78889999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      |++......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||........              
T Consensus       154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------  215 (304)
T 2jam_A          154 GLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL--------------  215 (304)
T ss_dssp             STTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------------
T ss_pred             CcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--------------
Confidence            998764321    22445789999999999999999999999999999999999999965432110              


Q ss_pred             hhhhhcccc--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 KVRQCVDAR--LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ...+....  .........+..+.+++.+||+.||.+|||+.++++
T Consensus       216 -~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          216 -FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             -HHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             -HHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             11111111  111222345677999999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-46  Score=349.64  Aligned_cols=262  Identities=23%  Similarity=0.339  Sum_probs=205.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|++.+.||+|+||.||+|..+ ++..||+|++......  .+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            368999999999999999999987 8999999998764322  3578899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |+++++|.+++....         .+++..++.++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++
T Consensus       112 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~  179 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS  179 (360)
T ss_dssp             CCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             CCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCC
Confidence            999999999997653         289999999999999999999996 7   999999999999999999999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh-----------
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-----------  290 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~-----------  290 (361)
                      .....    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............           
T Consensus       180 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3eqc_A          180 GQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  255 (360)
T ss_dssp             HHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred             ccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence            64322    123456799999999999999999999999999999999999999975432211100000           


Q ss_pred             ------------hc---ccCC-chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          291 ------------AT---PKLS-EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       291 ------------~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                  ..   +... ......+.............+..+.+|+.+||+.||.+|||++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                        00   0000 00111111111111112234667999999999999999999999987

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.7e-46  Score=344.92  Aligned_cols=275  Identities=21%  Similarity=0.309  Sum_probs=206.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEe--------
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD--------  133 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~--------  133 (361)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++.....   ....+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            368999999999999999999986 899999999865332   24578899999999999999999999887        


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      ....++||||+++ +|.+.+.....        .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~  163 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL  163 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence            4468999999975 88777765432        3899999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCcccc--ccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 018071          214 KIADFDLSNQAPDMA--ARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~  290 (361)
                      ||+|||+++......  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  243 (351)
T 3mi9_A          164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  243 (351)
T ss_dssp             EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            999999987543211  1122345678999999999886 4689999999999999999999999986544322222211


Q ss_pred             hcccCCchhhhhh--------cccccCCCCC--H-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          291 ATPKLSEDKVRQC--------VDARLGGDYP--P-----KAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       291 ~~~~~~~~~~~~~--------~~~~~~~~~~--~-----~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                      .............        ..........  .     ..+..+.+|+.+||+.||.+|||++|+++.  ..+...+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~~~~  320 (351)
T 3mi9_A          244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH--DFFWSDPM  320 (351)
T ss_dssp             HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGGSSSC
T ss_pred             HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC--CCcCCCCC
Confidence            1111111110000        0000000000  0     014568899999999999999999999973  44444333

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-46  Score=344.04  Aligned_cols=264  Identities=25%  Similarity=0.357  Sum_probs=201.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++......   .+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            368999999999999999999987 7999999998654433   245778999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  171 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---------GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA  171 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCcchHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCc
Confidence            9999998888866443         2899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch--
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED--  298 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  298 (361)
                      .......  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......................  
T Consensus       172 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (331)
T 4aaa_A          172 RTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ  249 (331)
T ss_dssp             --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence            7654322  123456789999999999875 78999999999999999999999997654322111111000000000  


Q ss_pred             -------hhhhhcccccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 -------KVRQCVDARLGGDY-----PPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 -------~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                             .......+......     .+..+..+.+|+.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   00000001111111     1234677999999999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.6e-46  Score=335.69  Aligned_cols=247  Identities=18%  Similarity=0.273  Sum_probs=200.8

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~  138 (361)
                      .+.++|++.+.||+|+||.||+|..+ +++.||+|++.....   ...++.+|+..+..+ +||||+++++++.+....+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            35689999999999999999999987 899999999875432   245688899999999 8999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC--------
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD--------  210 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~--------  210 (361)
                      +||||+++++|.+++......     ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+        
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~  159 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRI-----MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASE  159 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------
T ss_pred             EEEEecCCCcHHHHHHhhccc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccc
Confidence            999999999999999764210     023899999999999999999999998   9999999999999844        


Q ss_pred             -----------CceEEeccccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCC
Q 018071          211 -----------DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDH  278 (361)
Q Consensus       211 -----------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~  278 (361)
                                 ..+||+|||++......      ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+..
T Consensus       160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          160 EGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             ----------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             ccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence                       47999999998765331      234589999999999866 667899999999999999999887642


Q ss_pred             CCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          279 TLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..                  ....+.. ......+...+..+.+++.+||+.||.+|||+.++++
T Consensus       234 ~~------------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          234 GD------------------QWHEIRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             SH------------------HHHHHHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hh------------------HHHHHHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            11                  0111111 1112233345677999999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.6e-46  Score=353.58  Aligned_cols=199  Identities=27%  Similarity=0.401  Sum_probs=167.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeC-----Ce
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~  136 (361)
                      .++|.+.++||+|+||.||+|..+ +++.||||++......   .+++.+|+++++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            478999999999999999999987 7899999999764333   35788999999999999999999998765     57


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||++ ++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~  171 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVC  171 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEecCC-cCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEc
Confidence            899999996 59999997643         3899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCcccccc--------------------ccccccccCCCCCCchhh-ccCCCCCccceecHHHHHHHHHhCCCC
Q 018071          217 DFDLSNQAPDMAAR--------------------LHSTRVLGTFGYHAPEYA-MTGQLNAKSDVYSFGVVLLELLTGRKP  275 (361)
Q Consensus       217 Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~ell~g~~p  275 (361)
                      |||+++........                    ...+..+||+.|+|||++ ....++.++|||||||++|||++|..|
T Consensus       172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            99999765432111                    123567899999999986 456799999999999999999986665


Q ss_pred             CC
Q 018071          276 VD  277 (361)
Q Consensus       276 f~  277 (361)
                      |.
T Consensus       252 ~~  253 (432)
T 3n9x_A          252 HI  253 (432)
T ss_dssp             TC
T ss_pred             cc
Confidence            54

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4e-46  Score=336.17  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=207.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|.+.+.||+|+||.||++..+ +++.||+|++.....    ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            478999999999999999999987 789999999865322    235678899999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++....         .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        94 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  161 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL  161 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccC
Confidence            99999999999987643         3899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      +.......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......               ..
T Consensus       162 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------~~  224 (294)
T 2rku_A          162 ATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---------------TY  224 (294)
T ss_dssp             CEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------------HH
T ss_pred             ceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------------HH
Confidence            87653221  12345678999999999999899999999999999999999999996543211               01


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ..+....  ...+...+..+.+++.+||+.||++|||++++++.
T Consensus       225 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          225 LRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1111111  12233455679999999999999999999999973

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.7e-46  Score=356.15  Aligned_cols=201  Identities=23%  Similarity=0.310  Sum_probs=175.8

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcC------CCCCcceeeeEEEeCCee
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL------KHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l------~hpniv~~~~~~~~~~~~  137 (361)
                      +..+|++.++||+|+||.||+|... +++.||||++.........+.+|+.+++.+      +|+||+++++++......
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            3568999999999999999999977 789999999976554456778888888776      577999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc--eEE
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--AKI  215 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~--~kl  215 (361)
                      ++||||+. ++|.+++......       .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.  +||
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL  243 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQ-------GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKV  243 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEE
T ss_pred             EEEEeccC-CCHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEE
Confidence            99999995 5999998765432       3899999999999999999999998   999999999999999987  999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCC
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP  281 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~  281 (361)
                      +|||++.....     .....+||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       244 ~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          244 IDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             CCCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99999865322     23456789999999999999999999999999999999999999976543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-46  Score=347.42  Aligned_cols=254  Identities=24%  Similarity=0.318  Sum_probs=205.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEE----CCCCEEEEEEcCCCC-----CChHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL----KSGHAAAIKKLDASK-----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGT  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~  135 (361)
                      .++|++.+.||+|+||.||+|..    .+++.||||++....     ...+.+.+|+.+++.+ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36899999999999999999997    378999999986532     3345677899999999 6999999999999999


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..++||||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl  200 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL  200 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEE
Confidence            9999999999999999997653         2899999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccC--CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      +|||+++...... .......+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...........+     
T Consensus       201 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-----  274 (355)
T 1vzo_A          201 TDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-----  274 (355)
T ss_dssp             SCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH-----
T ss_pred             eeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH-----
Confidence            9999987653322 1223456799999999999863  5789999999999999999999999754322111100     


Q ss_pred             cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 018071          294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKAL  345 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L  345 (361)
                            ...+...  ...++...+..+.+|+.+||+.||.+||     |++++++..
T Consensus       275 ------~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          275 ------SRRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ------HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ------HHHHhcc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                  0111111  1233445567799999999999999999     999998743

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.3e-46  Score=343.96  Aligned_cols=265  Identities=21%  Similarity=0.278  Sum_probs=204.9

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeC-----Ce
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~  136 (361)
                      +.++|++.+.||+|+||.||+|... ++..||||++......  .+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3568999999999999999999977 8899999999754332  25788999999999999999999998754     46


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||+. ++|.+++....          +++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~  170 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC  170 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEcccC-cCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEE
Confidence            899999996 59999997643          899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCcccccc-ccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          217 DFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       217 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |||++......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  250 (364)
T 3qyz_A          171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS  250 (364)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred             eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999765432221 11245689999999998764 45899999999999999999999999765443322111111111


Q ss_pred             CCchhhhhhc--------ccc-cCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 LSEDKVRQCV--------DAR-LGGDY-----PPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 ~~~~~~~~~~--------~~~-~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...+.+..+.        ... .....     .+..+..+.+|+.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1111111100        000 00011     1233567999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-46  Score=338.47  Aligned_cols=260  Identities=26%  Similarity=0.377  Sum_probs=199.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC--CCC--EEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK--SGH--AAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      .++|++.+.||+|+||.||+|.+.  +++  .||+|++....    ...+.+.+|+.++++++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            368999999999999999999854  333  68999986532    22357889999999999999999999987654 8


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      ++||||+.+++|.+++.....        .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~D  164 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD  164 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred             eeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcc
Confidence            899999999999999976432        3899999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCccccc-cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccC
Q 018071          218 FDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       218 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      ||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......            
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------  232 (291)
T 1u46_A          165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------------  232 (291)
T ss_dssp             CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------------
T ss_pred             ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------------
Confidence            999876543221 112234567889999999999899999999999999999999 999997543211            


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                         .+..+.........+..++..+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus       233 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          233 ---ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             ---HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             ---HHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence               111111122222333455677999999999999999999999999999887644

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=336.07  Aligned_cols=252  Identities=27%  Similarity=0.405  Sum_probs=202.1

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            34578999999999999999999987 79999999987643 45788999999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++++|.+++....        ..+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus       105 ~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  173 (314)
T 3com_A          105 YCGAGSVSDIIRLRN--------KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAG  173 (314)
T ss_dssp             CCTTEEHHHHHHHHT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccch
Confidence            999999999987432        23899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||..........  ..          ..
T Consensus       174 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~----------~~  239 (314)
T 3com_A          174 QLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF--MI----------PT  239 (314)
T ss_dssp             ECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HH----------HH
T ss_pred             hhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH--HH----------hc
Confidence            653321  12345678999999999999999999999999999999999999997443211000  00          00


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                        ........+...+..+.+++.+||+.||.+|||+.++++
T Consensus       240 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          240 --NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             --SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              000011123334567999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-46  Score=335.41  Aligned_cols=258  Identities=21%  Similarity=0.321  Sum_probs=204.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEe--CCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~l  139 (361)
                      .++|++.+.||+|+||.||++..+ +++.||+|++......   .+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999987 8999999999764432   3568899999999999999999998854  578899


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeEeccCCCCceEeccCCceEEec
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--DPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      ||||+++++|.+++......     ...+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|
T Consensus        85 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d  159 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  159 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred             EEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence            99999999999999754311     124899999999999999999999985  12399999999999999999999999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ||++........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......              
T Consensus       160 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------  223 (279)
T 2w5a_A          160 FGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------------  223 (279)
T ss_dssp             CCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------
T ss_pred             Cchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--------------
Confidence            999865432211  1234578999999999999999999999999999999999999997542211              


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ  346 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  346 (361)
                        +...+........+..++..+.+++.+||+.||.+|||+.+|++.+.
T Consensus       224 --~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          224 --LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             --HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             --HHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence              11111111112234455678999999999999999999999987543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.3e-46  Score=347.93  Aligned_cols=272  Identities=19%  Similarity=0.268  Sum_probs=201.2

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEe--------
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD--------  133 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--------  133 (361)
                      ....++|.+.+.||+|+||.||+|... +|+.||||++......   ..+|+.+++.++||||+++++++..        
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            345679999999999999999999976 8999999998654332   3479999999999999999999854        


Q ss_pred             ------------------------------CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q 018071          134 ------------------------------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG  183 (361)
Q Consensus       134 ------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  183 (361)
                                                    ....++||||+++ +|.+.+.....     ....+++..++.++.||+.|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIR-----SGRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHH
Confidence                                          3347899999974 88777754211     01249999999999999999


Q ss_pred             HHHhhhcCCCCeEeccCCCCceEec-cCCceEEeccccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceec
Q 018071          184 LEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYS  261 (361)
Q Consensus       184 l~~LH~~~~~~ivHrDikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws  261 (361)
                      |.|||+.|   |+||||||+|||++ .++.+||+|||+++......   ......||+.|+|||++.+. .++.++||||
T Consensus       154 L~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  227 (383)
T 3eb0_A          154 VGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWS  227 (383)
T ss_dssp             HHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence            99999998   99999999999998 68899999999997653322   23456789999999998875 5899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc------------ccccCCCCCHHHHHHHHHHHHHccc
Q 018071          262 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV------------DARLGGDYPPKAVAKMAAVAALCVQ  329 (361)
Q Consensus       262 lG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~  329 (361)
                      |||++|+|++|+.||...........+.........+.+....            ...+....+...+..+.+|+.+||+
T Consensus       228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  307 (383)
T 3eb0_A          228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR  307 (383)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence            9999999999999997654332211111111111111111100            0000011233356679999999999


Q ss_pred             cCCCCCCCHHHHHH--HHHHhH
Q 018071          330 YEADFRPNMSIVVK--ALQPLL  349 (361)
Q Consensus       330 ~~p~~RPs~~evl~--~L~~l~  349 (361)
                      .||.+|||+.|+++  .++.+.
T Consensus       308 ~dP~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          308 YEPDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             SSGGGSCCHHHHHTSGGGHHHH
T ss_pred             CChhhCCCHHHHhcCHHHHHHH
Confidence            99999999999986  444443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.2e-45  Score=335.70  Aligned_cols=249  Identities=22%  Similarity=0.332  Sum_probs=198.6

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---------ChHHHHHHHHHHhcCCCCCcceeeeEEE
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------PDEEFLAQVSMVSRLKHENFVQLLGYCV  132 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpniv~~~~~~~  132 (361)
                      ..+.++|.+.+.||+|+||.||+|..+ +++.||||++.....         ....+.+|+.+++.++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            346689999999999999999999987 789999999865321         1235789999999999999999999987


Q ss_pred             eCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       133 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                      ... .++||||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~  152 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE  152 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSS
T ss_pred             CCc-eEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCC
Confidence            654 899999999999999986543         3899999999999999999999998   999999999999987664


Q ss_pred             ---eEEeccccCCCCccccccccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch
Q 018071          213 ---AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS  286 (361)
Q Consensus       213 ---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~  286 (361)
                         +||+|||++.......   ......||+.|+|||++.   ...++.++|||||||++|+|++|..||........  
T Consensus       153 ~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--  227 (322)
T 2ycf_A          153 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--  227 (322)
T ss_dssp             SCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--
T ss_pred             CCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--
Confidence               9999999987653321   123467899999999974   45789999999999999999999999975432211  


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.             ..+..... ...    ...+..+.+++.+||+.||.+|||+.++++
T Consensus       228 ~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 LK-------------DQITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HH-------------HHHHHTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HH-------------HHHHhCcc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            00             00000000 011    123567999999999999999999999984

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.1e-45  Score=342.44  Aligned_cols=260  Identities=21%  Similarity=0.231  Sum_probs=194.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCC------
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------  135 (361)
                      .++|.+.+.||+|+||.||+|... +++.||||++......   .+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            478999999999999999999977 7999999998754332   346789999999999999999999997654      


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..++||||+++ +|.+++...           +++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl  168 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI  168 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEEcCCC-CHHHHHhhc-----------cCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEE
Confidence            78999999965 888888532           899999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc--
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP--  293 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~--  293 (361)
                      +|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....  
T Consensus       169 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          169 LDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  245 (371)
T ss_dssp             CCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred             EEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999999865432   123456799999999999999999999999999999999999999976543211110000000  


Q ss_pred             --------------------cCCchhhhhhcccccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          294 --------------------KLSEDKVRQCVDARLGG---DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       294 --------------------~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                          ......+..........   ......+..+.+|+.+||+.||.+|||++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                                00000000011000000   011234678999999999999999999999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-45  Score=342.91  Aligned_cols=272  Identities=20%  Similarity=0.253  Sum_probs=195.5

Q ss_pred             HHHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe--
Q 018071           60 DELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS--  136 (361)
Q Consensus        60 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~--  136 (361)
                      .......++|.+.+.||+|+||.||+|..+ +++.||||++...........++++.++.++||||+++++++.....  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            344566789999999999999999999986 79999999987766666678888999999999999999999876433  


Q ss_pred             -----eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCCeEeccCCCCceEecc
Q 018071          137 -----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH--EKADPHIIHRDIKSSNVLIFD  209 (361)
Q Consensus       137 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~~~ivHrDikp~Nill~~  209 (361)
                           .++||||+.+ +|.+.+.....     ....+++..++.++.|++.||.|||  +.+   |+||||||+|||++.
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYR-----RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNE  166 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEET
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeC
Confidence                 7899999976 55544432110     1123899999999999999999999  887   999999999999997


Q ss_pred             -CCceEEeccccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchh
Q 018071          210 -DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL  287 (361)
Q Consensus       210 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~  287 (361)
                       ++.+||+|||+++......   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  243 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE  243 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence             8999999999998764322   23456789999999998765 489999999999999999999999976543222111


Q ss_pred             hhhhcccCCchhhhhhccc---------------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          288 VTWATPKLSEDKVRQCVDA---------------RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +...........+..+...               ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111011111111110000               0001122235678999999999999999999999997

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.9e-45  Score=337.13  Aligned_cols=256  Identities=17%  Similarity=0.275  Sum_probs=201.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeEEEe--CCeeEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVD--GTSRVLAY  141 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~  141 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++..  ...+.+.+|+.+++.++ ||||+++++++.+  ....++||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            368999999999999999999976 899999999864  34578999999999997 9999999999987  67789999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-ceEEecccc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDL  220 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~Dfg~  220 (361)
                      ||+.+++|.+++..            +++..++.++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|||+
T Consensus       113 e~~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             ECCCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eccCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence            99999999999853            889999999999999999999998   99999999999999777 899999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch-
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED-  298 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  298 (361)
                      ++......   ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+.... ...... 
T Consensus       178 a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~-~~~~~~~  252 (330)
T 3nsz_A          178 AEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIA-KVLGTED  252 (330)
T ss_dssp             CEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHH-HHHCHHH
T ss_pred             ceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHH-HhcCCch
Confidence            97543221   2345678999999999987 6789999999999999999999999954332111 000000 000000 


Q ss_pred             --------------hhhhhccc--------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 --------------KVRQCVDA--------RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 --------------~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                    ........        ......+...+..+.+||.+||+.||.+|||++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                          00000000        0111112234677999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.3e-47  Score=352.32  Aligned_cols=250  Identities=11%  Similarity=0.155  Sum_probs=192.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHH---HHhcCCCCCcceee-------eE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVS---MVSRLKHENFVQLL-------GY  130 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~---~l~~l~hpniv~~~-------~~  130 (361)
                      .++|.+.+.||+|+||.||+|..+ +|+.||||++...    ....+.+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            367888999999999999999965 7999999998642    223467889995   45555799999998       66


Q ss_pred             EEeCCe-----------------eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 018071          131 CVDGTS-----------------RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP  193 (361)
Q Consensus       131 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~  193 (361)
                      +.+.+.                 .+++|||+ +|+|.+++.......  .....+++..++.++.||+.||+|||+.+  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  226 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG--  226 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT--TTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc--cccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            665532                 78999999 679999997643211  00122456888899999999999999998  


Q ss_pred             CeEeccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccC-----------CCCCccceecH
Q 018071          194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----------QLNAKSDVYSF  262 (361)
Q Consensus       194 ~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dvwsl  262 (361)
                       |+||||||+|||++.++.+||+|||+++....     .....+| +.|+|||++.+.           .++.++|||||
T Consensus       227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl  299 (377)
T 3byv_A          227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL  299 (377)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred             -eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence             99999999999999999999999999875332     2345667 999999999987           89999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018071          263 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV  342 (361)
Q Consensus       263 G~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl  342 (361)
                      ||++|+|++|+.||..........               .+...      ....+..+.+|+.+||+.||.+|||+.+++
T Consensus       300 G~il~elltg~~Pf~~~~~~~~~~---------------~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  358 (377)
T 3byv_A          300 GLVIYWIWCADLPITKDAALGGSE---------------WIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM  358 (377)
T ss_dssp             HHHHHHHHHSSCCC------CCSG---------------GGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred             HHHHHHHHHCCCCCcccccccchh---------------hhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence            999999999999996543221110               11110      012346699999999999999999999998


Q ss_pred             H--HHHHh
Q 018071          343 K--ALQPL  348 (361)
Q Consensus       343 ~--~L~~l  348 (361)
                      +  .++.+
T Consensus       359 ~hp~f~~~  366 (377)
T 3byv_A          359 ETPEYEQL  366 (377)
T ss_dssp             TSHHHHHH
T ss_pred             hChHHHHH
Confidence            6  44444

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.5e-46  Score=347.47  Aligned_cols=271  Identities=21%  Similarity=0.314  Sum_probs=201.9

Q ss_pred             CHHHHHHHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC------------hHHHHHHHHHHhcCCCCCcc
Q 018071           58 SVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP------------DEEFLAQVSMVSRLKHENFV  125 (361)
Q Consensus        58 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~hpniv  125 (361)
                      ...++..+.++|.+.+.||+|+||.||+|...++..||||++......            .+.+.+|+.+++.++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            456778889999999999999999999999888999999998653221            16789999999999999999


Q ss_pred             eeeeEEEeC-----CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccC
Q 018071          126 QLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI  200 (361)
Q Consensus       126 ~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDi  200 (361)
                      ++++++...     ...++||||+. |+|.+++....        ..+++..++.++.||+.||.|||+.+   |+||||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl  160 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--------IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDL  160 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCC
Confidence            999998543     36799999997 58888887543        23899999999999999999999998   999999


Q ss_pred             CCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCC
Q 018071          201 KSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHT  279 (361)
Q Consensus       201 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~  279 (361)
                      ||+|||++.++.+||+|||++......   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          161 HPGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             CGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ChHHEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999754322   22345678999999999887 67899999999999999999999999765


Q ss_pred             CCcccchhhhhhcccCC--------chhhhhhcccccCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          280 LPRGQQSLVTWATPKLS--------EDKVRQCVDARLGG-------DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       280 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ........+........        .......+......       ...+..+..+.+|+.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            42211111100000000        01111111111110       011233567999999999999999999999987

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1e-45  Score=339.50  Aligned_cols=262  Identities=18%  Similarity=0.286  Sum_probs=206.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEE-C-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCC------CcceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGIL-K-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE------NFVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp------niv~~~~~~~~~~~~  137 (361)
                      .++|++.+.||+|+||.||+|.. + +++.||+|++.......+.+.+|+.+++.++|+      +++++++++.+....
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            47899999999999999999997 3 788999999976554456788999999988765      499999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc--------
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--------  209 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~--------  209 (361)
                      ++||||+ +++|.+++......       .+++..++.++.||+.||+|||+.+   |+||||||+|||++.        
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFL-------PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred             EEEEcCC-CCCHHHHHHhcCCC-------CCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccC
Confidence            9999999 88999999765421       3889999999999999999999998   999999999999987        


Q ss_pred             -----------CCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCC
Q 018071          210 -----------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH  278 (361)
Q Consensus       210 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~  278 (361)
                                 ++.+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                       66899999999875432     12456789999999999999999999999999999999999999976


Q ss_pred             CCCcccchhhhhhcccCCchhhh--------------------------hhccc-ccCCCCCHHHHHHHHHHHHHccccC
Q 018071          279 TLPRGQQSLVTWATPKLSEDKVR--------------------------QCVDA-RLGGDYPPKAVAKMAAVAALCVQYE  331 (361)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~  331 (361)
                      .....................+.                          ..... ..........+..+.+|+.+||+.|
T Consensus       237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            54322211111111111100000                          00000 0001223456788999999999999


Q ss_pred             CCCCCCHHHHHH
Q 018071          332 ADFRPNMSIVVK  343 (361)
Q Consensus       332 p~~RPs~~evl~  343 (361)
                      |.+|||+.|+++
T Consensus       317 P~~Rpt~~ell~  328 (339)
T 1z57_A          317 PAKRITLREALK  328 (339)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             cccccCHHHHhc
Confidence            999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-45  Score=346.87  Aligned_cols=260  Identities=20%  Similarity=0.246  Sum_probs=204.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC--------CCCcceeeeEEE----
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK--------HENFVQLLGYCV----  132 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--------hpniv~~~~~~~----  132 (361)
                      .++|++.++||+|+||+||+|... +++.||||++.......+.+.+|+.+++.++        |+||+++++++.    
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            478999999999999999999976 7899999999765555567889999999885        788999999987    


Q ss_pred             eCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCC
Q 018071          133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDD  211 (361)
Q Consensus       133 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~  211 (361)
                      +....++||||+ +++|.+++.....       ..+++..++.++.||+.||.|||++ +   |+||||||+|||++.++
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~  184 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNY-------QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred             CCceEEEEEecc-CccHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence            556789999999 5577766654432       2389999999999999999999998 8   99999999999998775


Q ss_pred             -------------------------------------------------ceEEeccccCCCCccccccccccccccCCCC
Q 018071          212 -------------------------------------------------VAKIADFDLSNQAPDMAARLHSTRVLGTFGY  242 (361)
Q Consensus       212 -------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  242 (361)
                                                                       .+||+|||++.....     ......||+.|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y  259 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQY  259 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGG
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcc
Confidence                                                             799999999876532     13456789999


Q ss_pred             CCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccch----hhh--hhcccCCchh----------------h
Q 018071          243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS----LVT--WATPKLSEDK----------------V  300 (361)
Q Consensus       243 ~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~----~~~--~~~~~~~~~~----------------~  300 (361)
                      +|||++.+..++.++|||||||++|+|++|+.||..........    +..  ..........                +
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            99999999999999999999999999999999997654332110    000  0000000000                0


Q ss_pred             -----------hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 -----------RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 -----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                 ...+..  ....+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       340 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                       000000  11346778889999999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.5e-46  Score=334.31  Aligned_cols=258  Identities=24%  Similarity=0.284  Sum_probs=191.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh--H-HHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--E-EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~-~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++.......  . .+.++...++.++||||+++++++.+....++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            478999999999999999999986 89999999997643322  2 2334455578889999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      ||+++ +|.+++.....     ....+++..++.++.||+.||.|||+. +   |+||||||+|||++.++.+||+|||+
T Consensus        86 e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVID-----KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             ECCSE-EHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             ehhcc-chHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCC
Confidence            99975 88887754211     012499999999999999999999998 8   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhh----ccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCC
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYA----MTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      +.......   ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||......              
T Consensus       157 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------------  219 (290)
T 3fme_A          157 SGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--------------  219 (290)
T ss_dssp             ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--------------
T ss_pred             cccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--------------
Confidence            97654322   22345799999999996    4567899999999999999999999999643211              


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhH
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLL  349 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~  349 (361)
                      ...+...+............+..+.+++.+||+.||.+|||+.++++  .++...
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          220 FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            11111222222211222345667999999999999999999999998  444433

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-45  Score=329.91  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=197.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      .++|.+.+.||+|+||.||+|..+ +++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            368999999999999999999987 8999999998542    23456788999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        90 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~  157 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG---------RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL  157 (276)
T ss_dssp             EECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred             EeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccc
Confidence            99999999999997653         2899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +.......   ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......   .            
T Consensus       158 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~------------  219 (276)
T 2h6d_A          158 SNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---L------------  219 (276)
T ss_dssp             GGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H------------
T ss_pred             ccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---H------------
Confidence            87654321   1234578999999999987765 689999999999999999999996432111   0            


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...+....  ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus       220 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          220 FKKIRGGV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhhcCc--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            01111111  1123334567999999999999999999999997

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=330.76  Aligned_cols=251  Identities=27%  Similarity=0.380  Sum_probs=199.9

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      +|....+||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4455568999999999999976 78999999987643 335678999999999999999999999999999999999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-CCceEEeccccCCCC
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQA  224 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~Dfg~a~~~  224 (361)
                      +++|.+++......      ..+++..++.++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||++...
T Consensus       103 ~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A          103 GGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             CCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            99999999765321      23678999999999999999999998   999999999999987 899999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhccCC--CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ....  .......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||........              .+..
T Consensus       174 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------~~~~  237 (295)
T 2clq_A          174 AGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--------------AMFK  237 (295)
T ss_dssp             CC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--------------HHHH
T ss_pred             CCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--------------HHHh
Confidence            3221  1234567899999999997653  88999999999999999999999953221100              0000


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..........+...+..+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          238 VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             hccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00111122344456678999999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.3e-45  Score=335.80  Aligned_cols=252  Identities=20%  Similarity=0.360  Sum_probs=200.2

Q ss_pred             HhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCC--CCCcceeeeEEEeCCeeEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK--HENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~l  139 (361)
                      ..++|.+.+.||+|+||.||++..++++.||+|++......   .+.+.+|+.++++++  ||||+++++++.+....++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            45789999999999999999999888999999998654333   356889999999997  5999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||| +.+++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||
T Consensus       106 v~e-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg  171 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG  171 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             EEe-cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeecc
Confidence            999 55789999997653         3899999999999999999999998   99999999999996 4899999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhcc-----------CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~  288 (361)
                      ++................||+.|+|||++.+           ..++.++||||||+++|+|++|..||......      
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------  245 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------  245 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------
Confidence            9987654333323345679999999999875           46888999999999999999999999643221      


Q ss_pred             hhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          289 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                              ...+...++.......+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       246 --------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          246 --------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             --------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                    112223333333333444446679999999999999999999999974

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=342.92  Aligned_cols=264  Identities=21%  Similarity=0.302  Sum_probs=191.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCC-CCCcceeeeEEE--------eC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLK-HENFVQLLGYCV--------DG  134 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~--------~~  134 (361)
                      ..+|++.++||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            358999999999999999999976 89999999885433 22456889999999996 999999999985        33


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceE
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK  214 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~k  214 (361)
                      ...+++|||+. |+|.+++......      ..+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEE
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEE
Confidence            45789999995 6999988653211      23999999999999999999999873 2399999999999999999999


Q ss_pred             EeccccCCCCccccccc----------cccccccCCCCCCchhh---ccCCCCCccceecHHHHHHHHHhCCCCCCCCCC
Q 018071          215 IADFDLSNQAPDMAARL----------HSTRVLGTFGYHAPEYA---MTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP  281 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~  281 (361)
                      |+|||++..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            99999998764322110          11245689999999998   566789999999999999999999999964322


Q ss_pred             cccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCC
Q 018071          282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPA  356 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~  356 (361)
                      ..                   ++............+..+.+|+.+||+.||.+|||+.++++.|+.+....+...
T Consensus       259 ~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~  314 (337)
T 3ll6_A          259 LR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP  314 (337)
T ss_dssp             --------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred             HH-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence            10                   111111111122233458899999999999999999999999999988665443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.8e-46  Score=350.68  Aligned_cols=261  Identities=23%  Similarity=0.291  Sum_probs=195.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeC------CeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------TSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~~~~l  139 (361)
                      .+|.+.++||+|+||.||+|.++ +++.||||++.....   ...+|+++++.++||||+++++++...      ...++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            47999999999999999999987 799999999865432   234799999999999999999988542      23579


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC-CceEEecc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADF  218 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~-~~~kl~Df  218 (361)
                      ||||+++ +|.+++.....     ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.+ +.+||+||
T Consensus       131 v~e~~~~-~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSR-----AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             ehhcccc-cHHHHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccc
Confidence            9999976 67666543211     0124999999999999999999999998   9999999999999955 67899999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.........
T Consensus       202 G~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          202 GSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR  278 (420)
T ss_dssp             TTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             hhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9997653321   23456789999999999765 7999999999999999999999999765432211111111111111


Q ss_pred             hhhhhhcccccC--------C-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCVDARLG--------G-----DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~~--------~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.+... +....        .     .++...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       279 ~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          279 EQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            111111 11000        0     012234577999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=345.84  Aligned_cols=284  Identities=19%  Similarity=0.286  Sum_probs=191.9

Q ss_pred             HHhhcCCC-CCccccCCceEEEEEEEC---CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEe--CCee
Q 018071           64 EITENFGT-NALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSR  137 (361)
Q Consensus        64 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~  137 (361)
                      .+.+.|++ .++||+|+||+||+|.++   ++..||||++.... ....+.+|+.+++.++||||+++++++..  ....
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            34566777 458999999999999965   68899999997543 34578899999999999999999999965  6788


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe----ccCCce
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVA  213 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill----~~~~~~  213 (361)
                      ++||||+.+ +|.+++..............+++..++.++.||+.||.|||+.+   |+||||||+||||    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence            999999965 88888764321111111224899999999999999999999998   9999999999999    677899


Q ss_pred             EEeccccCCCCccccc-cccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCccc-------
Q 018071          214 KIADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-------  284 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~-------  284 (361)
                      ||+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||........       
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            9999999987643211 1223457899999999999874 589999999999999999999999975543210       


Q ss_pred             chhhhh--hcccCCchhhh-------------hhcccccCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHH
Q 018071          285 QSLVTW--ATPKLSEDKVR-------------QCVDARLGGDYP---------PKAVAKMAAVAALCVQYEADFRPNMSI  340 (361)
Q Consensus       285 ~~~~~~--~~~~~~~~~~~-------------~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPs~~e  340 (361)
                      ..+...  .........+.             ....... ....         ...+..+.+||.+||+.||.+|||++|
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY-TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGG-TTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCC-CcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            000000  00000000000             0000000 0000         011456889999999999999999999


Q ss_pred             HHHHHHHhHhcCCCC
Q 018071          341 VVKALQPLLNARPGP  355 (361)
Q Consensus       341 vl~~L~~l~~~~~~~  355 (361)
                      +++  ...+...+.|
T Consensus       331 ~L~--hp~f~~~~~~  343 (405)
T 3rgf_A          331 AMQ--DPYFLEDPLP  343 (405)
T ss_dssp             HHT--SGGGTSSSCC
T ss_pred             Hhc--ChhhccCCCC
Confidence            997  3444444433

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-45  Score=343.41  Aligned_cols=259  Identities=25%  Similarity=0.355  Sum_probs=186.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeC------C
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG------T  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~  135 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||||++......   .+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999976 8999999999764332   35678999999999999999999998754      5


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..+++||++ +++|.+++....          +++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL  173 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  173 (367)
T ss_dssp             CCEEEEECC-CEECC-----CC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             eEEEEeccc-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEE
Confidence            679999999 679999886532          999999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus       174 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  248 (367)
T 2fst_X          174 LDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  248 (367)
T ss_dssp             CC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             eecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999999765321     345678999999999987 68999999999999999999999999765432221111111011


Q ss_pred             --------CCchhhhhhcccccCC-CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 --------LSEDKVRQCVDARLGG-DYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 --------~~~~~~~~~~~~~~~~-~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                              .........+...... ..+     ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                    1111111111111000 000     123567899999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-45  Score=333.33  Aligned_cols=250  Identities=24%  Similarity=0.299  Sum_probs=204.7

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC----------ChHHHHHHHHHHhcCC-CCCcceeeeEE
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----------PDEEFLAQVSMVSRLK-HENFVQLLGYC  131 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~e~~~l~~l~-hpniv~~~~~~  131 (361)
                      .+.++|++.+.||+|+||.||+|..+ +++.||+|++.....          ..+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            45689999999999999999999987 789999999865431          1245778999999995 99999999999


Q ss_pred             EeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC
Q 018071          132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD  211 (361)
Q Consensus       132 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~  211 (361)
                      .+....++||||+++++|.+++....         .+++..++.++.||+.||.|||+.+   ++||||||+||+++.++
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~  161 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDM  161 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCC
Confidence            99999999999999999999997653         3899999999999999999999998   99999999999999999


Q ss_pred             ceEEeccccCCCCccccccccccccccCCCCCCchhhc------cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc
Q 018071          212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM------TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ  285 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~  285 (361)
                      .+||+|||++.......   ......||+.|+|||++.      ...++.++||||||+++|+|++|..||........ 
T Consensus       162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-  237 (298)
T 1phk_A          162 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-  237 (298)
T ss_dssp             CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-
T ss_pred             cEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-
Confidence            99999999987653221   234567899999999985      45688999999999999999999999964322110 


Q ss_pred             hhhhhhcccCCchhhhhhcccccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          286 SLVTWATPKLSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                    ...+......  .+.....+..+.+++.+||+.||.+|||+.++++
T Consensus       238 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          238 --------------LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --------------HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --------------HHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                          1111111111  1111345677999999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.7e-46  Score=349.85  Aligned_cols=252  Identities=11%  Similarity=0.048  Sum_probs=183.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcC--CCCCcceee-------eEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRL--KHENFVQLL-------GYCV  132 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l--~hpniv~~~-------~~~~  132 (361)
                      .+|.+.+.||+|+||.||+|.+. +++.||||++......    .+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            46889999999999999999977 8999999999875432    34566775444444  699988755       4554


Q ss_pred             eC-----------------CeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHH------HHHHHHHHHHHHHhhh
Q 018071          133 DG-----------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR------VKIAVGAAKGLEYLHE  189 (361)
Q Consensus       133 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~  189 (361)
                      ..                 ...++||||++ |+|.+++.....        .+.+..+      +.++.||+.||+|||+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~~vk~~i~~qi~~aL~~LH~  212 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--------VYVFRGDEGILALHILTAQLIRLAANLQS  212 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--------SCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--------ccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            33                 33799999998 799999986431        1444455      6788999999999999


Q ss_pred             cCCCCeEeccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhcc--CCCCCccceecHHHHHH
Q 018071          190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLL  267 (361)
Q Consensus       190 ~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~  267 (361)
                      ++   |+||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|
T Consensus       213 ~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~  284 (371)
T 3q60_A          213 KG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY  284 (371)
T ss_dssp             TT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH
T ss_pred             CC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH
Confidence            98   999999999999999999999999998765321     124557799999999987  67999999999999999


Q ss_pred             HHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          268 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       268 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +|++|+.||....+.......        ....................+..+.+|+.+||+.||++|||+.++++
T Consensus       285 elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          285 RVWCLFLPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHSSCSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHhCCCCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999999999765433211110        00000111111111222345677999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.2e-45  Score=364.91  Aligned_cols=258  Identities=27%  Similarity=0.410  Sum_probs=208.6

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      ..++|++.+.||+|+||.||+|.+.    .+..||+|++......  .+.+.+|+.++++++||||+++++++. ....+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            3578999999999999999999975    2457999998754332  357889999999999999999999985 45689


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +||||+++|+|.+++....        ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       467 lv~E~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRK--------FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTT--------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred             EEEEcCCCCcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence            9999999999999997643        13899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......              
T Consensus       536 G~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--------------  600 (656)
T 2j0j_A          536 GLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------------  600 (656)
T ss_dssp             CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------------
T ss_pred             CCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--------------
Confidence            99987643221 12234567889999999999999999999999999999997 999997543211              


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                        +...+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+++.
T Consensus       601 --~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          601 --VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             --HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence              1111111222234455667899999999999999999999999999998764

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-45  Score=334.37  Aligned_cols=251  Identities=23%  Similarity=0.366  Sum_probs=200.2

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC-CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ..++|++.+.||+|+||.||+|..+ ++..||+|++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3578999999999999999999987 7999999998654 3445788999999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++++|.+++.....        .+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        97 ~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             CCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             eCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence            9999999999875331        3899999999999999999999998   9999999999999999999999999865


Q ss_pred             CCccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....  ........||+.|+|||++.     +..++.++||||||+++|+|++|..||........             
T Consensus       166 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------  230 (302)
T 2j7t_A          166 KNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-------------  230 (302)
T ss_dssp             HHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------------
T ss_pred             ccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-------------
Confidence            32111  11224457899999999984     56789999999999999999999999975432110             


Q ss_pred             hhhhhhcccc-cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCVDAR-LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                        ...+.... .....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       231 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          231 --LLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --HHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --HHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              00111000 001123345667999999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.9e-45  Score=329.87  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=197.7

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEe----CCeeE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRV  138 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~  138 (361)
                      +.|.+.+.||+|+||.||+|... ++..||+|++.....   ..+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45788889999999999999976 788999999865432   23568899999999999999999999875    45689


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec-cCCceEEec
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIAD  217 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~-~~~~~kl~D  217 (361)
                      +||||+++++|.+++....         .+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|
T Consensus       106 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EEEEecCCCCHHHHHHHcc---------CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEee
Confidence            9999999999999997643         2899999999999999999999883 2399999999999998 789999999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ||++......    ......||+.|+|||++. +.++.++|||||||++|+|++|+.||........  ...        
T Consensus       176 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~--------  240 (290)
T 1t4h_A          176 LGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR--------  240 (290)
T ss_dssp             TTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH--------
T ss_pred             CCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HHH--------
Confidence            9998654322    234567899999999876 4699999999999999999999999964322111  100        


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                          .+.........+...+..+.+++.+||+.||.+|||+.++++
T Consensus       241 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          241 ----RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                010100001111223356999999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4e-46  Score=337.22  Aligned_cols=267  Identities=25%  Similarity=0.349  Sum_probs=187.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....  ...+++.+|+.++++++||||+++++++......++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            478999999999999999999965 79999999986532  334678899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++++|.+++....... ......+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        94 ~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKG-EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTT-TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hccCCchHHHHHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999986421100 011234899999999999999999999998   9999999999999999999999999876


Q ss_pred             CCcccc---ccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          223 QAPDMA---ARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       223 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ......   .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............   ......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~  246 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL---QNDPPS  246 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH---TSSCCC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh---ccCCCc
Confidence            543211   1111244678999999999876 578999999999999999999999997654322111000   000000


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ......+.    ......+..+.+++.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          247 LETGVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000111    112233467999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-45  Score=346.37  Aligned_cols=263  Identities=19%  Similarity=0.244  Sum_probs=195.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe------eEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS------RVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~------~~l  139 (361)
                      ..+|.+.++||+|+||.||+|....+..+|+|++......   ..+|+.+++.++||||+++++++.....      .++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            4689999999999999999999886667999988654332   2369999999999999999999865433      789


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec-cCCceEEecc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADF  218 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~-~~~~~kl~Df  218 (361)
                      ||||++++ +.+.+.....     ....+++..++.++.||+.||+|||+.+   |+||||||+|||++ .++.+||+||
T Consensus       116 v~e~~~~~-l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYAK-----LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             EEECCSEE-HHHHHHHHHH-----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EeeccCcc-HHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence            99999774 4443322110     0123899999999999999999999998   99999999999999 7999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |+++......   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.........
T Consensus       187 G~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  263 (394)
T 4e7w_A          187 GSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR  263 (394)
T ss_dssp             TTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             CCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9997653222   23456789999999999765 5899999999999999999999999765432221111111111111


Q ss_pred             hhhhhhc----ccccC--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCV----DARLG--------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~----~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +.+....    ...+.        ..++...+..+.+|+.+||+.||.+|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            1111110    00000        0112234567999999999999999999999997

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6e-46  Score=338.71  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=200.1

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|++.+.||+|+||.||+|..+.  .+|+|++....   ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            4789999999999999999999863  49999986532   233567789999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+++++|.+++....        ..+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||++.
T Consensus       110 ~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             CCCSEEHHHHTTSSC--------CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             cccCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            999999999997643        23899999999999999999999998   99999999999998 6799999999987


Q ss_pred             CCcccc---ccccccccccCCCCCCchhhcc---------CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 018071          223 QAPDMA---ARLHSTRVLGTFGYHAPEYAMT---------GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       223 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~  290 (361)
                      ......   .........||+.|+|||++.+         ..++.++|||||||++|+|++|+.||........   .  
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~--  252 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---I--  252 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH---H--
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H--
Confidence            543211   1112234568999999999874         3578899999999999999999999975432111   0  


Q ss_pred             hcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          291 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                                ..+.............+..+.+++.+||+.||.+|||+.++++.|+.+.+....
T Consensus       253 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          253 ----------WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             ----------HHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             ----------HHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                      000000000011112345699999999999999999999999999999876543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-45  Score=332.42  Aligned_cols=253  Identities=23%  Similarity=0.410  Sum_probs=196.3

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEe----------
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD----------  133 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----------  133 (361)
                      +.++|++.+.||+|+||.||+|... +++.||+|++.......+.+.+|+.+++.++||||+++++++.+          
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            5678999999999999999999976 89999999996654445678899999999999999999998865          


Q ss_pred             ---CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC
Q 018071          134 ---GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD  210 (361)
Q Consensus       134 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~  210 (361)
                         ....++||||+++++|.+++....        ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~  152 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN--------LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES  152 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC--------GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc--------cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCC
Confidence               356789999999999999997543        13788999999999999999999998   9999999999999999


Q ss_pred             CceEEeccccCCCCccccc------------cccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCC
Q 018071          211 DVAKIADFDLSNQAPDMAA------------RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVD  277 (361)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~  277 (361)
                      +.+||+|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||.
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence            9999999999976542210            1123456789999999999864 78999999999999999998   553


Q ss_pred             CCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          278 HTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ....  ......         .+. .....+...++...+..+.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~--~~~~~~---------~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          230 TGME--RVNILK---------KLR-SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             SHHH--HHHHHH---------HHH-STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cchh--HHHHHH---------hcc-ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            1100  000000         000 00111222344455677999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-45  Score=340.41  Aligned_cols=261  Identities=19%  Similarity=0.257  Sum_probs=203.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC----h--------------HHHHHHHHHHhcCCCCCccee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP----D--------------EEFLAQVSMVSRLKHENFVQL  127 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~--------------~~~~~e~~~l~~l~hpniv~~  127 (361)
                      .++|.+.+.||+|+||.||+|.. +++.||+|++......    .              +.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 8999999998542111    1              789999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEeCCCCcHHHh------hhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccC
Q 018071          128 LGYCVDGTSRVLAYEFASNGSLHDI------LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDI  200 (361)
Q Consensus       128 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivHrDi  200 (361)
                      ++++.+....++||||+++++|.++      +....       ...+++..++.++.||+.||.|||+ .+   |+||||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl  178 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-------TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDV  178 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-------CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCC
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-------ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCC
Confidence            9999999999999999999999998      44321       1349999999999999999999999 87   999999


Q ss_pred             CCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccC-CCCC-ccceecHHHHHHHHHhCCCCCCC
Q 018071          201 KSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNA-KSDVYSFGVVLLELLTGRKPVDH  278 (361)
Q Consensus       201 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~~l~ell~g~~pf~~  278 (361)
                      ||+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||..
T Consensus       179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  254 (348)
T 2pml_X          179 KPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL  254 (348)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999998765332    23456789999999999877 6766 99999999999999999999975


Q ss_pred             CCCcccchhhh-hhcc--cCCch--hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          279 TLPRGQQSLVT-WATP--KLSED--KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       279 ~~~~~~~~~~~-~~~~--~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .....  .+.. ....  .....  ..................+..+.+|+.+||+.||.+|||+.++++
T Consensus       255 ~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          255 KISLV--ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SSCSH--HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCcHH--HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            44311  1111 0000  00000  000000000000111345677999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.4e-46  Score=346.96  Aligned_cols=259  Identities=25%  Similarity=0.360  Sum_probs=199.1

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCee---
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR---  137 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~---  137 (361)
                      +.++|.+.+.||+|+||.||+|..+ +|+.||||++......   ...+.+|+.+++.++||||+++++++......   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            4578999999999999999999977 8999999999764433   35788999999999999999999999877655   


Q ss_pred             ---EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceE
Q 018071          138 ---VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK  214 (361)
Q Consensus       138 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~k  214 (361)
                         ++||||+. ++|.+++...           +++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+|
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k  184 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGME-----------FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK  184 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred             eeEEEEEcccc-ccHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence               99999997 5898887432           899999999999999999999998   99999999999999999999


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus       185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  259 (371)
T 4exu_A          185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  259 (371)
T ss_dssp             ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999999765322     345678999999999987 6899999999999999999999999976542211111100000


Q ss_pred             cCCc--------hhhhhhcc---cccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          294 KLSE--------DKVRQCVD---ARLGGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       294 ~~~~--------~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ....        ........   ......   ..+..+..+.+|+.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            0000        00000000   000000   11234577999999999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=336.54  Aligned_cols=276  Identities=20%  Similarity=0.310  Sum_probs=199.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEE----------
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCV----------  132 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~----------  132 (361)
                      +.++|.+.+.||+|+||.||+|..+ +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            3578999999999999999999987 69999999986543 23457889999999999999999999873          


Q ss_pred             ----eCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec
Q 018071          133 ----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF  208 (361)
Q Consensus       133 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~  208 (361)
                          +....++||||++ |+|.+++....          +++..++.++.||+.||+|||+.+   |+||||||+|||++
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQGP----------LLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN  154 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhcCC----------ccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence                4467899999997 59999986532          899999999999999999999998   99999999999997


Q ss_pred             -cCCceEEeccccCCCCccccc-cccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccc
Q 018071          209 -DDDVAKIADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ  285 (361)
Q Consensus       209 -~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~  285 (361)
                       +++.+||+|||++........ ........+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  234 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM  234 (320)
T ss_dssp             TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             567999999999986543211 112344567999999998875 67899999999999999999999999765432211


Q ss_pred             hhhhhhcccCCchhhhhhcc-------cccC-CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          286 SLVTWATPKLSEDKVRQCVD-------ARLG-GD-----YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~-------~~~~-~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      ..+....+........+...       .... ..     ..+..+..+.+++.+||+.||.+|||++++++  ...++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~  312 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS--HPYMSIY  312 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SHHHHTT
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC--Ccccccc
Confidence            11111111111111111100       0000 00     11234677999999999999999999999987  2344444


Q ss_pred             CCCC
Q 018071          353 PGPA  356 (361)
Q Consensus       353 ~~~~  356 (361)
                      +.|.
T Consensus       313 ~~p~  316 (320)
T 2i6l_A          313 SFPM  316 (320)
T ss_dssp             CC--
T ss_pred             cCcc
Confidence            4443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.1e-45  Score=327.88  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=204.8

Q ss_pred             HHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        63 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      ..+.++|.+.+.||+|+||.||+|..+ +++.||+|++...   ....+.+.+|+.++++++||||+++++++.+....+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            456789999999999999999999987 8999999998542   334578899999999999999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC---CceEE
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKI  215 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~---~~~kl  215 (361)
                      +||||+.+++|.+++....         .+++..++.++.||+.||.|||+.+   ++||||||+||+++.+   +.+||
T Consensus        98 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL  165 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI  165 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             EEEEccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEE
Confidence            9999999999999886543         2899999999999999999999998   9999999999999764   46999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      +|||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|..||........           
T Consensus       166 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----------  230 (287)
T 2wei_A          166 IDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-----------  230 (287)
T ss_dssp             CSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------
T ss_pred             eccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-----------
Confidence            9999987653321   1234568999999998875 589999999999999999999999975432111           


Q ss_pred             CchhhhhhcccccCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          296 SEDKVRQCVDARLGGDY--PPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                          ...+.........  ....+..+.+++.+||+.||.+|||+.++++
T Consensus       231 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          231 ----LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ----HHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----HHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                0111111111111  1234567999999999999999999999997

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.6e-45  Score=339.28  Aligned_cols=202  Identities=24%  Similarity=0.315  Sum_probs=173.4

Q ss_pred             HHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CC-----CcceeeeEEEeCCe
Q 018071           64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HE-----NFVQLLGYCVDGTS  136 (361)
Q Consensus        64 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp-----niv~~~~~~~~~~~  136 (361)
                      .+.++|.+.+.||+|+||+||+|..+ +++.||||++........++..|+.+++.++ |+     +|+++++++.....
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            34679999999999999999999977 7899999999765444566778888888875 44     49999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh--cCCCCeEeccCCCCceEec--cCCc
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE--KADPHIIHRDIKSSNVLIF--DDDV  212 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~~~~ivHrDikp~Nill~--~~~~  212 (361)
                      .++||||+. ++|.+++......       .+++..++.++.||+.||.|||.  .+   |+||||||+|||++  .++.
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFR-------GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcC-------CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCc
Confidence            999999996 5999999765422       28999999999999999999995  55   99999999999995  4778


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCC
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP  281 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~  281 (361)
                      +||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus       200 ~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             EEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999876532     13456789999999999999999999999999999999999999986543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.8e-45  Score=332.74  Aligned_cols=265  Identities=20%  Similarity=0.312  Sum_probs=202.7

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC--CCCEEEEEEcCCCC---CChHHHHHHHHHHhcC---CCCCcceeeeEEE----
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASK---QPDEEFLAQVSMVSRL---KHENFVQLLGYCV----  132 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l---~hpniv~~~~~~~----  132 (361)
                      ..++|++.+.||+|+||.||+|...  +++.||+|++....   .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3578999999999999999999983  68899999986422   2234567788777666   8999999999987    


Q ss_pred             -eCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC
Q 018071          133 -DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD  211 (361)
Q Consensus       133 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~  211 (361)
                       .....++||||+. |+|.+++.....       ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~  157 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG  157 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT-------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCC
Confidence             4567899999997 599999976542       23899999999999999999999998   99999999999999999


Q ss_pred             ceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 018071          212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA  291 (361)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~  291 (361)
                      .+||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...
T Consensus       158 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~  234 (326)
T 1blx_A          158 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV  234 (326)
T ss_dssp             CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            99999999998764322   234567899999999999999999999999999999999999999765432111111000


Q ss_pred             cccCCchhhhh-------hccc---ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          292 TPKLSEDKVRQ-------CVDA---RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       292 ~~~~~~~~~~~-------~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ........+..       ....   ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000000000       0000   0001122334567999999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.3e-45  Score=335.71  Aligned_cols=262  Identities=16%  Similarity=0.266  Sum_probs=203.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CC-CEEEEEEcCCCCCChHHHHHHHHHHhcCCCCC------cceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SG-HAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN------FVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn------iv~~~~~~~~~~~~  137 (361)
                      .++|++.+.||+|+||.||+|... ++ ..||+|++.......+.+.+|+.+++.++|++      ++.+++++......
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            578999999999999999999976 44 68999999765555567888999999987665      89999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe----------
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----------  207 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill----------  207 (361)
                      ++||||+ +++|.+++.....       ..+++..++.++.||+.||.|||+.+   |+||||||+|||+          
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENNF-------QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred             EEEEecc-CCChHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccc
Confidence            9999999 6677777765432       23899999999999999999999998   9999999999999          


Q ss_pred             ---------ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCC
Q 018071          208 ---------FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH  278 (361)
Q Consensus       208 ---------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~  278 (361)
                               +.++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                     6678999999999875332     22456799999999999999999999999999999999999999976


Q ss_pred             CCCcccchhhhhhcccCCchhhhhh--------------------------ccc-ccCCCCCHHHHHHHHHHHHHccccC
Q 018071          279 TLPRGQQSLVTWATPKLSEDKVRQC--------------------------VDA-RLGGDYPPKAVAKMAAVAALCVQYE  331 (361)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~-~~~~~~~~~~~~~l~~li~~cl~~~  331 (361)
                      .....................+...                          ... ..........+..+.+|+.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            5432211111111111110000000                          000 0001122345678999999999999


Q ss_pred             CCCCCCHHHHHH
Q 018071          332 ADFRPNMSIVVK  343 (361)
Q Consensus       332 p~~RPs~~evl~  343 (361)
                      |.+|||+.++++
T Consensus       322 P~~Rpt~~e~l~  333 (355)
T 2eu9_A          322 PAQRITLAEALL  333 (355)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             hhhCcCHHHHhc
Confidence            999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=335.24  Aligned_cols=258  Identities=25%  Similarity=0.351  Sum_probs=198.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCe-----
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS-----  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-----  136 (361)
                      .++|.+.+.||+|+||.||+|..+ +|+.||||++......   ...+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            468999999999999999999986 8999999999764433   3567899999999999999999999987654     


Q ss_pred             -eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          137 -RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       137 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                       .++||||+. ++|.+++..           .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl  167 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI  167 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEE
T ss_pred             eEEEEecccc-CCHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEE
Confidence             499999997 588887743           2899999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      +|||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......
T Consensus       168 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  242 (353)
T 3coi_A          168 LDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  242 (353)
T ss_dssp             CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred             eecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999999865321     244678999999999987 68899999999999999999999999765432111111000000


Q ss_pred             CC--------chhhhhhcc---cccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 LS--------EDKVRQCVD---ARLG---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 ~~--------~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ..        .......+.   ....   ....+..+..+.+|+.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00        000000000   0000   1122345678999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.3e-45  Score=337.79  Aligned_cols=265  Identities=25%  Similarity=0.341  Sum_probs=201.3

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeC-----Ce
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~  136 (361)
                      +.++|.+.+.||+|+||.||+|..+ +|+.||||++......  ...+.+|+.+++.++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3578999999999999999999987 7999999999654322  34678999999999999999999987654     67


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .++||||+. ++|.+++....          +++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~  154 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQM----------LSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC  154 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEeccC-ccHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence            899999996 59999987643          899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccc--------cccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchh
Q 018071          217 DFDLSNQAPDMAARL--------HSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL  287 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~  287 (361)
                      |||++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus       155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  234 (353)
T 2b9h_A          155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL  234 (353)
T ss_dssp             CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999987653221110        1234578999999998764 6789999999999999999999999976542211111


Q ss_pred             hh-hhc-c-------cCCchhhhhhcccccCC-C-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          288 VT-WAT-P-------KLSEDKVRQCVDARLGG-D-----YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       288 ~~-~~~-~-------~~~~~~~~~~~~~~~~~-~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +. ... +       ..........+...... .     ..+..+..+.+|+.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00 000 0       00001111111110000 0     01234567899999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=333.67  Aligned_cols=244  Identities=21%  Similarity=0.348  Sum_probs=192.8

Q ss_pred             HHHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------ChHHHHHHHHHHhcC----CCCCcceee
Q 018071           61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRL----KHENFVQLL  128 (361)
Q Consensus        61 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l----~hpniv~~~  128 (361)
                      +...+.++|.+.+.||+|+||.||+|... +++.||+|++.....       ....+.+|+.+++++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            44567789999999999999999999976 789999999965432       123456788888888    899999999


Q ss_pred             eEEEeCCeeEEEEEe-CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          129 GYCVDGTSRVLAYEF-ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       129 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      +++.+....++|||+ +.+++|.+++....         .+++..++.++.||+.||.|||+.+   |+||||||+||++
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  172 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG---------PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILI  172 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEE
Confidence            999999999999999 78999999997653         2899999999999999999999998   9999999999999


Q ss_pred             c-cCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCC-CccceecHHHHHHHHHhCCCCCCCCCCcccc
Q 018071          208 F-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN-AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ  285 (361)
Q Consensus       208 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~pf~~~~~~~~~  285 (361)
                      + .++.+||+|||++......    ......||..|+|||++.+..+. .++|||||||++|+|++|+.||....     
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----  243 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----  243 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred             eCCCCeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----
Confidence            9 8899999999998765432    23456689999999999877764 48999999999999999999995321     


Q ss_pred             hhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          286 SLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .                +....  ...+...+..+.+++.+||+.||++|||++++++
T Consensus       244 ~----------------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 E----------------ILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             H----------------HHHTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             H----------------Hhhhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0                01111  1223345567999999999999999999999997

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.4e-45  Score=339.05  Aligned_cols=266  Identities=18%  Similarity=0.243  Sum_probs=205.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-----------CCCcceeeeEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----------HENFVQLLGYCVD  133 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~~~~~~~~  133 (361)
                      .++|.+.+.||+|+||.||+|... +++.||||++.........+.+|+.++++++           ||||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            368999999999999999999976 8999999999765555567889999998886           8999999999876


Q ss_pred             CC----eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEec
Q 018071          134 GT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIF  208 (361)
Q Consensus       134 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~  208 (361)
                      ..    ..+++||++ +++|.+++......       .+++..++.++.||+.||+|||++ +   |+||||||+|||++
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~  166 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLME  166 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEE
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhcc-------CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEe
Confidence            54    788999999 88999999765422       289999999999999999999998 8   99999999999995


Q ss_pred             c------CCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCc
Q 018071          209 D------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR  282 (361)
Q Consensus       209 ~------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~  282 (361)
                      .      .+.+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence            3      44899999999876532     124457899999999999999999999999999999999999999755422


Q ss_pred             cc----chhhhhh--cccCCch---------------------------hhhhhcccccCCCCCHHHHHHHHHHHHHccc
Q 018071          283 GQ----QSLVTWA--TPKLSED---------------------------KVRQCVDARLGGDYPPKAVAKMAAVAALCVQ  329 (361)
Q Consensus       283 ~~----~~~~~~~--~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  329 (361)
                      ..    ..+....  ....+..                           .+......  ...++...+..+.+||.+||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~  319 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQ  319 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGC
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhc
Confidence            11    0000000  0000000                           00011111  124567889999999999999


Q ss_pred             cCCCCCCCHHHHHH--HHHHhH
Q 018071          330 YEADFRPNMSIVVK--ALQPLL  349 (361)
Q Consensus       330 ~~p~~RPs~~evl~--~L~~l~  349 (361)
                      .||.+|||+.++++  .++...
T Consensus       320 ~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          320 LDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             SSTTTCBCHHHHHTCGGGTTCT
T ss_pred             cCccccCCHHHHhhChhhhccc
Confidence            99999999999997  444443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1e-44  Score=333.35  Aligned_cols=250  Identities=19%  Similarity=0.267  Sum_probs=175.8

Q ss_pred             HhhcCCCCC-ccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHH-HHHhcCCCCCcceeeeEEEe----CCee
Q 018071           65 ITENFGTNA-LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQV-SMVSRLKHENFVQLLGYCVD----GTSR  137 (361)
Q Consensus        65 ~~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~-~~l~~l~hpniv~~~~~~~~----~~~~  137 (361)
                      +.++|.+.+ +||+|+||.||+|..+ +++.||+|++....    ...+|+ ..++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            467899954 6999999999999987 89999999986532    233333 44666789999999999876    4557


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc---CCceE
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAK  214 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~---~~~~k  214 (361)
                      ++||||+++|+|.+++.....       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+|
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~k  171 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLK  171 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C-------CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEE
T ss_pred             EEEEeccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEE
Confidence            899999999999999986542       23999999999999999999999998   999999999999986   44599


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |+|||++......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........        
T Consensus       172 l~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--------  239 (336)
T 3fhr_A          172 LTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--------  239 (336)
T ss_dssp             ECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred             Eeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--------
Confidence            9999998754321    2245678999999999988899999999999999999999999996543321100        


Q ss_pred             CCchhhhhhcc--cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 LSEDKVRQCVD--ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         .....+..  ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus       240 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          240 ---GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             --------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               00000000  01111112345677999999999999999999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.2e-44  Score=329.76  Aligned_cols=252  Identities=28%  Similarity=0.375  Sum_probs=178.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHH-HHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|.+.+.||+|+||.||+|..+ +++.||||++......  ..++..|+. +++.++||||+++++++.+....++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            68999999999999999999987 8999999999764332  234556665 6777899999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |+.+ +|.+++......    ....+++..++.++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSV----LDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             CCSE-EHHHHHHHHHHT----TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             ecCC-ChHHHHHHHHhh----hcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            9975 888877531100    012389999999999999999999998 8   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhh----ccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYA----MTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .......   ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||........             
T Consensus       174 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------------  237 (327)
T 3aln_A          174 GQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------------  237 (327)
T ss_dssp             CC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------
T ss_pred             eeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------------
Confidence            8764322   22345789999999998    456789999999999999999999999975322100             


Q ss_pred             hhhhhhcc---cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCVD---ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       .+..+..   ..+........+..+.+|+.+||+.||.+|||+.++++
T Consensus       238 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          238 -QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ---CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence             0000110   01111111234567999999999999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.3e-45  Score=335.39  Aligned_cols=243  Identities=21%  Similarity=0.360  Sum_probs=200.6

Q ss_pred             HHHHhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------ChHHHHHHHHHHhcCC--CCCcceeeeEE
Q 018071           62 LKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLK--HENFVQLLGYC  131 (361)
Q Consensus        62 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~--hpniv~~~~~~  131 (361)
                      ...+.++|++.+.||+|+||.||+|... +++.||||++.....       ..+.+.+|+.++++++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            3446789999999999999999999976 899999999865322       2245678999999996  59999999999


Q ss_pred             EeCCeeEEEEEeCCC-CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec-c
Q 018071          132 VDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-D  209 (361)
Q Consensus       132 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~-~  209 (361)
                      .+....++|||++.+ ++|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++ +
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN  185 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC
Confidence            999999999999976 89999997643         3899999999999999999999998   99999999999999 7


Q ss_pred             CCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhh
Q 018071          210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV  288 (361)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~  288 (361)
                      ++.+||+|||++......    ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....     . 
T Consensus       186 ~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~-  255 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-  255 (320)
T ss_dssp             TTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-
T ss_pred             CCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h-
Confidence            899999999998765432    2244678999999999987766 6788999999999999999999953210     0 


Q ss_pred             hhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          289 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                     ....  ...+...+..+.+|+.+||+.||.+|||++++++
T Consensus       256 ---------------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 ---------------IRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---------------HHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------------hccc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                           0000  0112234567999999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.2e-44  Score=324.70  Aligned_cols=249  Identities=22%  Similarity=0.335  Sum_probs=180.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh--HH-HHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EE-FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~-~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .++|++.+.||+|+||.||+|..+ +++.||||++.......  .+ +.++..+++.++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            468999999999999999999987 89999999997654332  22 334455678889999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      ||+ ++.+..+.....        ..+++..++.++.||+.||.|||+. +   |+||||||+|||++.++.+||+|||+
T Consensus       104 e~~-~~~~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~  171 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ--------GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGI  171 (318)
T ss_dssp             CCC-SEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ecc-CCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCC
Confidence            999 556666654322        1389999999999999999999995 7   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      +.......   ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||.......            
T Consensus       172 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------------  236 (318)
T 2dyl_A          172 SGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF------------  236 (318)
T ss_dssp             C-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH------------
T ss_pred             chhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH------------
Confidence            87654321   234457899999999994     4578899999999999999999999997432211            


Q ss_pred             Cchhhhhhccccc-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          296 SEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       296 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                        ..+..+..... ........+..+.+++.+||+.||.+|||+.++++
T Consensus       237 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          237 --EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             --HHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --HHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              00111111100 00111224567999999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1e-43  Score=337.55  Aligned_cols=257  Identities=20%  Similarity=0.281  Sum_probs=189.7

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      +.|.+.++||+|+||+||.+...+|+.||||++...  ..+.+.+|+.+++++ +||||+++++++.+....++||||+.
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            456667889999999998877678999999998643  235678899999876 89999999999999999999999995


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC-------------Cc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-------------DV  212 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~-------------~~  212 (361)
                       |+|.+++.........  .....+..++.++.||+.||+|||+.+   |+||||||+|||++.+             +.
T Consensus        93 -gsL~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           93 -LNLQDLVESKNVSDEN--LKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             -EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             -CCHHHHHhccCCCchh--hhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence             5999999765421100  011234456789999999999999998   9999999999999754             48


Q ss_pred             eEEeccccCCCCcccccc--ccccccccCCCCCCchhhcc-------CCCCCccceecHHHHHHHHHh-CCCCCCCCCCc
Q 018071          213 AKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMT-------GQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR  282 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~  282 (361)
                      +||+|||+++........  ......+||+.|+|||++.+       ..++.++|||||||++|||++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            999999999765432211  11235679999999999976       578999999999999999999 99999643321


Q ss_pred             ccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .. .+.   .....        ............+..+.+|+.+||+.||.+|||+.+|++
T Consensus       247 ~~-~i~---~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 ES-NII---RGIFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HH-HHH---HTCCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH-HHh---cCCCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            10 000   00000        001111234567889999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=335.87  Aligned_cols=247  Identities=21%  Similarity=0.269  Sum_probs=188.1

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .+|.+.++||+|+||+||.....+++.||||++....  ...+.+|+.+++.+ +||||+++++++.+....++||||+.
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            4688889999999999776556679999999986533  23467899999999 79999999999999999999999996


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc---C--CceEEecccc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---D--DVAKIADFDL  220 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~---~--~~~kl~Dfg~  220 (361)
                       |+|.+++.....        .+.+..++.++.||+.||.|||+.+   |+||||||+|||++.   +  ..+||+|||+
T Consensus       102 -g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A          102 -ATLQEYVEQKDF--------AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             -EEHHHHHHSSSC--------CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             -CCHHHHHHhcCC--------CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence             599999976542        1444556789999999999999998   999999999999953   2  3578999999


Q ss_pred             CCCCccccc-cccccccccCCCCCCchhhc---cCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccC
Q 018071          221 SNQAPDMAA-RLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       221 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      ++....... .......+||+.|+|||++.   ...++.++|||||||++|+|++ |..||.........          
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~----------  239 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN----------  239 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH----------
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH----------
Confidence            987643221 12234567999999999997   4567889999999999999999 99999543221100          


Q ss_pred             Cchhhhhhcccc-c-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          296 SEDKVRQCVDAR-L-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       296 ~~~~~~~~~~~~-~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                            ...... . ........+..+.+|+.+||+.||.+|||+.++++
T Consensus       240 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          240 ------ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ------HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                  000000 0 01112345667899999999999999999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.5e-43  Score=314.00  Aligned_cols=234  Identities=17%  Similarity=0.149  Sum_probs=187.1

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      +.++|++.+.||+|+||.||+|... +++.||||++.......    +.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3478999999999999999999987 69999999998754433    678899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||++|++|.+++...           ....++..++.||+.||+|||+.|   |+||||||+|||++.+|.+||++++
T Consensus       109 v~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             EEEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc
Confidence            99999999999998542           455678899999999999999998   9999999999999999999998544


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                                            |++       .++.++|||||||++|+|++|+.||.............   ..... .
T Consensus       175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~-~  221 (286)
T 3uqc_A          175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAG-Q  221 (286)
T ss_dssp             ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTS-C
T ss_pred             ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhcc-C
Confidence                                  233       36889999999999999999999998654322110000   00000 0


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      ...  ..    ......+..+.+++.+||+.||.+| |+.++++.|+.+....
T Consensus       222 ~~~--~~----~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          222 PIE--PA----DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             BCC--HH----HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             CCC--hh----hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            000  00    0112345669999999999999999 9999999999987543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.1e-43  Score=344.11  Aligned_cols=270  Identities=23%  Similarity=0.329  Sum_probs=205.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEe------CCe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD------GTS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~~  136 (361)
                      .++|++.+.||+|+||.||+|.++ +|+.||||++......  .+.+.+|+.++++++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            478999999999999999999976 7999999998754322  3568899999999999999999998755      677


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc---e
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---A  213 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~---~  213 (361)
                      .++||||+++|+|.+++......      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.   +
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~v  163 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIH  163 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEE
T ss_pred             EEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeE
Confidence            79999999999999999865321      23888999999999999999999998   999999999999997764   9


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      ||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......     ..|...
T Consensus       164 KL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~  235 (676)
T 3qa8_A          164 KIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGK  235 (676)
T ss_dssp             EECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTT
T ss_pred             EEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhh
Confidence            999999998754322   234567999999999999999999999999999999999999999653211     011000


Q ss_pred             cCCc--------hhhhhhc----ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHhHhcC
Q 018071          294 KLSE--------DKVRQCV----DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI-----VVKALQPLLNAR  352 (361)
Q Consensus       294 ~~~~--------~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e-----vl~~L~~l~~~~  352 (361)
                      ....        ......+    ............+..+.+++.+||..||++|||+.+     +.+.++.+++..
T Consensus       236 i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            0000        0000000    001112344567889999999999999999999988     566777777543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-42  Score=346.69  Aligned_cols=240  Identities=19%  Similarity=0.315  Sum_probs=194.4

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC--CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe----
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS----  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~----  136 (361)
                      +.++|++.+.||+|+||.||+|.++  +++.||||++.....  ....+.+|+.++++++||||+++++++.+...    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            3479999999999999999999976  689999999865432  23467899999999999999999999987655    


Q ss_pred             -eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          137 -RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       137 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                       .+|||||++|++|.+++..           .+++..++.++.||+.||.|||+.+   |+||||||+|||++.+ .+||
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             EEEEEEECCCCEECC----C-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEE
T ss_pred             eeEEEEEeCCCCcHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEE
Confidence             6999999999999887754           2899999999999999999999998   9999999999999875 8999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      +|||+++.....      ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.......           .
T Consensus       223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~  284 (681)
T 2pzi_A          223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------L  284 (681)
T ss_dssp             CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------C
T ss_pred             EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------c
Confidence            999998765331      456799999999998765 4889999999999999999998886321100           0


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhH
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-NMSIVVKALQPLL  349 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~l~  349 (361)
                      .            ........+..+.+||.+||+.||.+|| +++++...|..++
T Consensus       285 ~------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          285 P------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             C------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             c------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            0            0001123346789999999999999999 5677777776654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.5e-41  Score=307.17  Aligned_cols=228  Identities=18%  Similarity=0.305  Sum_probs=180.8

Q ss_pred             HhhcCCCC-CccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHH-hcCCCCCcceeeeEEEe----CCee
Q 018071           65 ITENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMV-SRLKHENFVQLLGYCVD----GTSR  137 (361)
Q Consensus        65 ~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~hpniv~~~~~~~~----~~~~  137 (361)
                      +.++|.+. ++||+|+||.||+|..+ +++.||+|++..    ...+.+|+.++ +.++||||+++++++..    ....
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            34678877 78999999999999986 899999999854    35678888887 55689999999999887    6778


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc---CCceE
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAK  214 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~---~~~~k  214 (361)
                      ++||||+++++|.+++.....       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+|
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTT-------CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEE
T ss_pred             EEEEeecCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEE
Confidence            999999999999999987542       23899999999999999999999998   999999999999998   78999


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |+|||++....                        +..++.++|||||||++|+|++|..||..........        
T Consensus       161 l~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--------  208 (299)
T 3m2w_A          161 LTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--------  208 (299)
T ss_dssp             ECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--------
T ss_pred             Eeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--------
Confidence            99999875321                        2356789999999999999999999996543211000        


Q ss_pred             CCchhhhhhcccccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          295 LSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         .....+....  ...+    ...+..+.+++.+||+.||.+|||+.++++
T Consensus       209 ---~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          209 ---GMKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ---CSCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---HHHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               0000000000  0111    124677999999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-41  Score=321.15  Aligned_cols=244  Identities=11%  Similarity=0.144  Sum_probs=180.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHHHHHHhcCCC-CCc---------ce-----
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKH-ENF---------VQ-----  126 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h-pni---------v~-----  126 (361)
                      ++|...++||+|+||+||+|.+. +|+.||||++....    ...+.+.+|+.+++.++| +|.         +.     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45778889999999999999976 89999999987322    234678999999999976 221         11     


Q ss_pred             -------eeeEEEe-----CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 018071          127 -------LLGYCVD-----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH  194 (361)
Q Consensus       127 -------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~  194 (361)
                             +..++..     ....+++|+++ +++|.+++.......  .....+++..++.++.||+.||+|||+.+   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence                   1111111     22456777776 679999885221000  01123888899999999999999999998   


Q ss_pred             eEeccCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhh----------ccCCCCCccceecHHH
Q 018071          195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA----------MTGQLNAKSDVYSFGV  264 (361)
Q Consensus       195 ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~  264 (361)
                      |+||||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++|||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            999999999999999999999999998765432     345677 999999999          5556888999999999


Q ss_pred             HHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          265 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       265 ~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ++|+|++|+.||........               ...++...  ..    .+..+.+|+.+||+.||++|||+.++++
T Consensus       306 il~elltg~~Pf~~~~~~~~---------------~~~~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGG---------------SEWIFRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSC---------------SGGGGSSC--CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHCCCCCCCcchhhh---------------HHHHHhhc--cc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999999975432211               11111110  12    2466999999999999999999776643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.7e-42  Score=318.51  Aligned_cols=239  Identities=18%  Similarity=0.206  Sum_probs=183.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCC---------ChHHHHHHHHHHhcCC---------CCCccee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---------PDEEFLAQVSMVSRLK---------HENFVQL  127 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~---------hpniv~~  127 (361)
                      .++|++.+.||+|+||+||+|.. +|+.||||++.....         ..+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46899999999999999999998 589999999975432         2367889999988885         7777777


Q ss_pred             eeEEE------------------------------eCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHH
Q 018071          128 LGYCV------------------------------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA  177 (361)
Q Consensus       128 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~  177 (361)
                      .+++.                              +....++||||+++|++.+.+...          .+++..++.++
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----------~~~~~~~~~i~  167 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----------LSSLATAKSIL  167 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----------CCCHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----------CCCHHHHHHHH
Confidence            66543                              267899999999999776666432          28999999999


Q ss_pred             HHHHHHHHHhh-hcCCCCeEeccCCCCceEeccCC--------------------ceEEeccccCCCCcccccccccccc
Q 018071          178 VGAAKGLEYLH-EKADPHIIHRDIKSSNVLIFDDD--------------------VAKIADFDLSNQAPDMAARLHSTRV  236 (361)
Q Consensus       178 ~qi~~al~~LH-~~~~~~ivHrDikp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~  236 (361)
                      .||+.||.||| +.+   |+||||||+|||++.++                    .+||+|||+++....       ...
T Consensus       168 ~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~  237 (336)
T 2vuw_A          168 HQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIV  237 (336)
T ss_dssp             HHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEE
T ss_pred             HHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcE
Confidence            99999999999 898   99999999999999887                    899999999975432       345


Q ss_pred             ccCCCCCCchhhccCCCCCccceecHHHH-HHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc--ccccCCCCC
Q 018071          237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVV-LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV--DARLGGDYP  313 (361)
Q Consensus       237 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  313 (361)
                      +||+.|+|||++.+.. +.++|||||+++ .+++++|..||...         .|...  ..+.+....  ........+
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~--~~~~~~~~~~~~~~~~~~~~  305 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHY--LTDKMLKQMTFKTKCNTPAM  305 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHH--HHHHHHHTCCCSSCCCSHHH
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhH--HHHhhhhhhccCcccchhhh
Confidence            7999999999998766 889999998777 77788899998310         00000  000000000  011111123


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018071          314 PKAVAKMAAVAALCVQYEADFRPNMSIVV  342 (361)
Q Consensus       314 ~~~~~~l~~li~~cl~~~p~~RPs~~evl  342 (361)
                      ...+..+.+||.+||+.|     |++|++
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            467889999999999976     898887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1e-34  Score=283.46  Aligned_cols=183  Identities=16%  Similarity=0.074  Sum_probs=130.3

Q ss_pred             cccCCceEEEEEEEC-CCCEEEEEEcCCCCC-----------ChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEEE
Q 018071           75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-----------PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        75 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      .+.|++|.+..++.. .|+.+++|++.+...           ..+++.+|+++|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            566777777666543 699999999965421           125689999999999 6999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||++|++|.++|....         .++..   .|+.||+.||+|||++|   ||||||||+||||+++|.+||+|||++
T Consensus       322 Eyv~G~~L~d~i~~~~---------~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlA  386 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE---------EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSI  386 (569)
T ss_dssp             ECCCSEEHHHHHHTTC---------CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred             ecCCCCcHHHHHHhCC---------CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccC
Confidence            9999999999998654         25544   57899999999999999   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCC
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP  275 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p  275 (361)
                      +......  ......+||+.|+|||++.+ .+...+|+||+|++++++.++..+
T Consensus       387 r~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          387 VTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             eeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            8764322  23456789999999999875 567789999999998877655443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.5e-30  Score=252.66  Aligned_cols=184  Identities=16%  Similarity=0.150  Sum_probs=146.6

Q ss_pred             CCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC---------hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        70 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ...++||+|+||.||++.. .+..+++|+.......         .+++.+|++++++++||||+++..++......+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4466899999999999954 4888999987543222         23478999999999999999776677788888999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++++|.+++..                 ++.++.|++.||+|||+++   |+||||||+|||+++  .+||+|||+
T Consensus       418 mE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl  475 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL  475 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred             EECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence            999999999999864                 3489999999999999998   999999999999998  999999999


Q ss_pred             CCCCccccccc-----cccccccCCCCCCchhhcc--CCCCCccceecHHHHHHHHHhCCCCC
Q 018071          221 SNQAPDMAARL-----HSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPV  276 (361)
Q Consensus       221 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf  276 (361)
                      ++.........     .....+||+.|+|||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            98765432211     1246789999999999986  57888999999999999888877765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.9e-26  Score=206.06  Aligned_cols=145  Identities=14%  Similarity=0.097  Sum_probs=116.7

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCC-------------------ChHHHHHHHHHHhcCCCCCccee
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-------------------PDEEFLAQVSMVSRLKHENFVQL  127 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~hpniv~~  127 (361)
                      ..|.+.+.||+|+||.||+|.+.+|+.||+|.+.....                   ....+.+|+.++++++  | +++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            34556699999999999999998899999999864321                   1346889999999999  4 566


Q ss_pred             eeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       128 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      .+++.. +..++||||++|++|.+ +..               .....++.|++.||.|||+.|   |+||||||+|||+
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl  226 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV---------------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV  226 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC---------------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch---------------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence            665543 45699999999999988 421               123469999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhcc
Q 018071          208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT  250 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  250 (361)
                      + ++.+||+|||+++.               +..++|||++..
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            9 99999999998753               345789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=1.9e-22  Score=177.87  Aligned_cols=135  Identities=19%  Similarity=0.195  Sum_probs=105.3

Q ss_pred             CCCCCccccCCceEEEEEEE-CCCCE--EEEEEcCCCCCC-------------------------hHHHHHHHHHHhcCC
Q 018071           69 FGTNALIGEGSYGRVYYGIL-KSGHA--AAIKKLDASKQP-------------------------DEEFLAQVSMVSRLK  120 (361)
Q Consensus        69 y~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~  120 (361)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||++......                         ...+.+|+.+++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999998 58999  999987543211                         125788999999998


Q ss_pred             CCCc--ceeeeEEEeCCeeEEEEEeCCC-C----cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCC
Q 018071          121 HENF--VQLLGYCVDGTSRVLAYEFASN-G----SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH-EKAD  192 (361)
Q Consensus       121 hpni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~  192 (361)
                      |+++  ..++.+    ...+|||||+.+ |    +|.++...            .++..+..++.|++.+|.||| +.| 
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~g-  191 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEAE-  191 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence            8764  333332    356899999942 3    67666432            224457789999999999999 888 


Q ss_pred             CCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       193 ~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                        |+||||||+|||++.  .++|+|||++...
T Consensus       192 --ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 --LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             --EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             --EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence              999999999999988  9999999998653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=2.1e-20  Score=171.66  Aligned_cols=142  Identities=13%  Similarity=0.166  Sum_probs=102.3

Q ss_pred             HHHHhhc---CCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCC---------------ChHH--------HHHHHHH
Q 018071           62 LKEITEN---FGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---------------PDEE--------FLAQVSM  115 (361)
Q Consensus        62 ~~~~~~~---y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~--------~~~e~~~  115 (361)
                      +..+.++   |.+.+.||+|+||.||+|...+|+.||||+++....               ....        ..+|...
T Consensus        87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n  166 (397)
T 4gyi_A           87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF  166 (397)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence            4455554   889999999999999999988999999998753210               0111        1245666


Q ss_pred             HhcCCCCCcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 018071          116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI  195 (361)
Q Consensus       116 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i  195 (361)
                      |.++.+.++.-..-+...  ..+|||||++|++|.++...               .....++.||+.+|.+||+.|   |
T Consensus       167 L~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~---------------~~~~~l~~qll~~l~~lH~~g---I  226 (397)
T 4gyi_A          167 MKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV---------------PDPASLYADLIALILRLAKHG---L  226 (397)
T ss_dssp             HHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC---------------SCHHHHHHHHHHHHHHHHHTT---E
T ss_pred             HHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhccc---------------HHHHHHHHHHHHHHHHHHHCC---C
Confidence            666644433222112122  23799999999888765321               123568899999999999998   9


Q ss_pred             EeccCCCCceEeccCC----------ceEEeccccCCC
Q 018071          196 IHRDIKSSNVLIFDDD----------VAKIADFDLSNQ  223 (361)
Q Consensus       196 vHrDikp~Nill~~~~----------~~kl~Dfg~a~~  223 (361)
                      |||||||.|||+++++          .+.|+||+-+..
T Consensus       227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999999999998877          389999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.55  E-value=2.4e-14  Score=126.04  Aligned_cols=146  Identities=18%  Similarity=0.121  Sum_probs=115.0

Q ss_pred             HHHHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCC-CChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEE
Q 018071           62 LKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        62 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l  139 (361)
                      +......|.+...++.|+++.||++... +..+++|...... .....+.+|+.+++.+. +.++.++++++.+....++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            4455678988888999999999999865 7899999986421 23346889999999884 6778899999998899999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA----------------------------  191 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------------------------  191 (361)
                      |||+++|.+|.+.+..              ......++.+++.+|..||+..                            
T Consensus        88 v~e~i~G~~l~~~~~~--------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED--------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             EEECCSSEEHHHHCCT--------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             EEEecCCeehhhccCC--------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence            9999999999876421              1123467889999999999810                            


Q ss_pred             ----------------------------CCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          192 ----------------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       192 ----------------------------~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                                                  ...++|+|++|.|||+++++.+.|+||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                        0248999999999999876666799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.39  E-value=6.3e-13  Score=116.50  Aligned_cols=136  Identities=13%  Similarity=0.049  Sum_probs=99.5

Q ss_pred             cCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCC--cceeeeEEEeCCeeEEEEEeCC
Q 018071           68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN--FVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .|.+..+.+.|..+.||++...+|..+++|.....  ....+.+|+.+++.+.+.+  +.+++.+....+..++||||++
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~   98 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   98 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence            44443334466679999998777888999987654  2346788999998886444  5568888887778899999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA----------------------------------  191 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------------------------------  191 (361)
                      |.+|.  ...            ...   ..++.+++..|..||+..                                  
T Consensus        99 G~~l~--~~~------------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           99 GQDLL--SSH------------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             SEETT--TSC------------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             CcccC--cCc------------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            98884  211            111   256667777788887642                                  


Q ss_pred             ---------------------CCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          192 ---------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       192 ---------------------~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                                           ...++|+|++|.|||+++++.+.|+||+.+.
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                 1129999999999999877667799999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.31  E-value=6.6e-12  Score=115.60  Aligned_cols=140  Identities=17%  Similarity=0.233  Sum_probs=105.2

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcC--CCC--CChHHHHHHHHHHhcCC--CCCcceeeeEEEeC---CeeEEEEE
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLD--ASK--QPDEEFLAQVSMVSRLK--HENFVQLLGYCVDG---TSRVLAYE  142 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~---~~~~lv~e  142 (361)
                      .+.|+.|.++.||++... +..+++|+..  ...  .....+.+|+.+++.+.  +..+.+++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            456899999999999876 5688899876  332  22356788999999886  45678888887765   34799999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-------------------------------  191 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------  191 (361)
                      |++|..+.+...           ..++......++.+++..|..||+..                               
T Consensus       122 ~v~G~~l~~~~~-----------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          122 FVSGRVLWDQSL-----------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             CCCCBCCCCTTC-----------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             ecCCeecCCCcc-----------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            999977744211           12778888899999999999999831                               


Q ss_pred             ------------------------CCCeEeccCCCCceEeccCCc--eEEeccccCCC
Q 018071          192 ------------------------DPHIIHRDIKSSNVLIFDDDV--AKIADFDLSNQ  223 (361)
Q Consensus       192 ------------------------~~~ivHrDikp~Nill~~~~~--~kl~Dfg~a~~  223 (361)
                                              ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    235999999999999987753  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.13  E-value=2.8e-11  Score=108.82  Aligned_cols=183  Identities=17%  Similarity=0.166  Sum_probs=119.6

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCC--cceeeeEEEeCC---eeEEEEEeCC
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HEN--FVQLLGYCVDGT---SRVLAYEFAS  145 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpn--iv~~~~~~~~~~---~~~lv~e~~~  145 (361)
                      .+.++.|....||++.    ..+++|..... .....+.+|+.+++.+. +..  +.+.+.......   ..|+||++++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4568999999999863    56889986432 23457889999998873 332  334444432222   3478999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA----------------------------------  191 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------------------------------  191 (361)
                      |.+|.+....           .++..+...++.+++..|..||+..                                  
T Consensus       100 G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (304)
T 3sg8_A          100 GVPLTPLLLN-----------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP  168 (304)
T ss_dssp             CEECCHHHHH-----------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred             CeECCccccc-----------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence            9888654322           1677778888888888888888621                                  


Q ss_pred             ---------------------CCCeEeccCCCCceEecc--CCceEEeccccCCCCccccccccccccccCCCC---CCc
Q 018071          192 ---------------------DPHIIHRDIKSSNVLIFD--DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY---HAP  245 (361)
Q Consensus       192 ---------------------~~~ivHrDikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~aP  245 (361)
                                           ...++|+|++|.||+++.  ++.+.|+||+.+.......      .......+   ..|
T Consensus       169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~  242 (304)
T 3sg8_A          169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGM  242 (304)
T ss_dssp             HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCH
T ss_pred             cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCH
Confidence                                 134899999999999998  5568899999875321100      00001111   233


Q ss_pred             hhhcc-----CCC---------CCccceecHHHHHHHHHhCCCCC
Q 018071          246 EYAMT-----GQL---------NAKSDVYSFGVVLLELLTGRKPV  276 (361)
Q Consensus       246 E~~~~-----~~~---------~~~~DvwslG~~l~ell~g~~pf  276 (361)
                      +....     +..         ....+.|+++.++|.+.+|..+|
T Consensus       243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            32210     111         11258899999999999998876

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.76  E-value=5.5e-08  Score=85.45  Aligned_cols=133  Identities=14%  Similarity=0.110  Sum_probs=96.8

Q ss_pred             cccCCce-EEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEEeCCCCcHHH
Q 018071           75 IGEGSYG-RVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHD  151 (361)
Q Consensus        75 lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~  151 (361)
                      +..|..| .||+.... .+..+++|+-...  ....+.+|...|+.+. +-.+.+++.++.+.+..++|||+++|.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            4445554 69988765 5678999976432  3457888999998874 4447788889999999999999999988877


Q ss_pred             hhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 018071          152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA----------------------------------------  191 (361)
Q Consensus       152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------------------------------------  191 (361)
                      ......             .....+..+++..|..||+..                                        
T Consensus       110 ~~~~~~-------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          110 VLEEYP-------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             HHHHCG-------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             cccCCH-------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            654321             122345666777777777521                                        


Q ss_pred             ---------------CCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          192 ---------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       192 ---------------~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                                     ...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                           0138999999999999987777899999764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.73  E-value=5.7e-08  Score=87.17  Aligned_cols=134  Identities=16%  Similarity=0.145  Sum_probs=91.9

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCC---CcceeeeEEE-eCCeeEEEEEeCCCCc
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE---NFVQLLGYCV-DGTSRVLAYEFASNGS  148 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp---niv~~~~~~~-~~~~~~lv~e~~~~g~  148 (361)
                      +.++.|....||+.    +..+++|+... ......+.+|+.+++.+.+.   .+.+.+.+.. ..+..+++||+++|.+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            45788888999988    67788897432 22245788999999998642   3556666654 3455789999999988


Q ss_pred             HHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------
Q 018071          149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-------------------------------------  191 (361)
Q Consensus       149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------------  191 (361)
                      |.+..-..           ++..+...++.++...|..||+..                                     
T Consensus       100 l~~~~~~~-----------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A          100 LGEDGMAV-----------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             CHHHHHTT-----------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             Cchhhhhh-----------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            86632111           444555555555555555555431                                     


Q ss_pred             --------------------CCCeEeccCCCCceEecc---CCc-eEEeccccCC
Q 018071          192 --------------------DPHIIHRDIKSSNVLIFD---DDV-AKIADFDLSN  222 (361)
Q Consensus       192 --------------------~~~ivHrDikp~Nill~~---~~~-~kl~Dfg~a~  222 (361)
                                          ...++|+|++|.||+++.   ++. +.|+||+.+.
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                                224799999999999987   355 4899999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.55  E-value=1.3e-07  Score=86.59  Aligned_cols=79  Identities=8%  Similarity=0.026  Sum_probs=55.1

Q ss_pred             Ccc-ccCCceEEEEEEEC-------CCCEEEEEEcCCCC---C-ChHHHHHHHHHHhcCC-C--CCcceeeeEEEeC---
Q 018071           73 ALI-GEGSYGRVYYGILK-------SGHAAAIKKLDASK---Q-PDEEFLAQVSMVSRLK-H--ENFVQLLGYCVDG---  134 (361)
Q Consensus        73 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~e~~~l~~l~-h--pniv~~~~~~~~~---  134 (361)
                      +.| +.|..+.+|+....       ++..+++|......   . ....+.+|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            356 78888999988754       26789999865432   1 2246788888888874 3  3567777776554   


Q ss_pred             CeeEEEEEeCCCCcHHH
Q 018071          135 TSRVLAYEFASNGSLHD  151 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~  151 (361)
                      ...++|||+++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            34689999999876543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.45  E-value=1.7e-06  Score=80.38  Aligned_cols=74  Identities=18%  Similarity=0.059  Sum_probs=49.7

Q ss_pred             CCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--------CChHHHHHHHHHHhcCCC--CC-cceeeeEEEeCCeeEE
Q 018071           72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--------QPDEEFLAQVSMVSRLKH--EN-FVQLLGYCVDGTSRVL  139 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~h--pn-iv~~~~~~~~~~~~~l  139 (361)
                      .+.||.|.++.||++... +++.+++|......        ....++..|.++++.+..  |. +.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            347899999999999754 57889999764321        123467789988887742  43 3455543  4556789


Q ss_pred             EEEeCCCC
Q 018071          140 AYEFASNG  147 (361)
Q Consensus       140 v~e~~~~g  147 (361)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.35  E-value=6.5e-06  Score=74.52  Aligned_cols=159  Identities=17%  Similarity=0.273  Sum_probs=85.9

Q ss_pred             HHHHH-HhhcCCCC----CccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-----CCCcceee-
Q 018071           60 DELKE-ITENFGTN----ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----HENFVQLL-  128 (361)
Q Consensus        60 ~~~~~-~~~~y~~~----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~~~-  128 (361)
                      +++.. +.+.|.+.    +.|+.|..+.||++...+| .+++|+....   ..++..|..+++.|.     .|.++... 
T Consensus        20 ~~l~~~l~~~~~~~~~~~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~   95 (346)
T 2q83_A           20 TELAENVLQGWDVQAEKIDVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKK   95 (346)
T ss_dssp             HHHHHHHGGGSCCCCCEEEECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTT
T ss_pred             HHHHHHHHHHcCCceEEeeeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCC
Confidence            34433 33566542    3455577899999987644 5899988652   344555666655553     24444311 


Q ss_pred             e--EEEeCCeeEEEEEeCCCCcHH--------------HhhhcCCC-C--C-CCC-CCCCCCHHHH--------------
Q 018071          129 G--YCVDGTSRVLAYEFASNGSLH--------------DILHGRKG-V--K-GAQ-PGPVLSWQQR--------------  173 (361)
Q Consensus       129 ~--~~~~~~~~~lv~e~~~~g~L~--------------~~l~~~~~-~--~-~~~-~~~~l~~~~~--------------  173 (361)
                      +  +....+..+++|+|++|.++.              ..++.... .  . ... ....-.|...              
T Consensus        96 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  175 (346)
T 2q83_A           96 GSLYSKHGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLM  175 (346)
T ss_dssp             SCSCEEETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEEEECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHH
Confidence            1  223467789999999986432              11111110 0  0 000 0011122211              


Q ss_pred             -----------------HHHHHHHHHHHHHhhh----------cCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          174 -----------------VKIAVGAAKGLEYLHE----------KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       174 -----------------~~i~~qi~~al~~LH~----------~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                                       ..+..++..++.+|++          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          176 AEAEKEDPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHCSSCHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHhccCCcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                             1111223445666653          012359999999999999888899999999764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=98.15  E-value=5.3e-05  Score=68.17  Aligned_cols=94  Identities=9%  Similarity=0.091  Sum_probs=62.9

Q ss_pred             cCccCHHHHHHHhhcCCCC-----CccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCC--Ccce
Q 018071           54 VPAISVDELKEITENFGTN-----ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQ  126 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--niv~  126 (361)
                      .+.++.+.+..+.+.|.+.     ..|+ |....||++...+|+.+++|...........+..|..+++.+...  .+.+
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecc
Confidence            4556777777777777542     2466 778899998876677899999865444556777888887777421  2333


Q ss_pred             eeeE-----EEeCCeeEEEEEeCCCCc
Q 018071          127 LLGY-----CVDGTSRVLAYEFASNGS  148 (361)
Q Consensus       127 ~~~~-----~~~~~~~~lv~e~~~~g~  148 (361)
                      ++..     ....+..+++|++++|..
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~  113 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQ  113 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCC
Confidence            3332     223556688999998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=98.06  E-value=7.2e-05  Score=67.08  Aligned_cols=166  Identities=16%  Similarity=0.228  Sum_probs=91.3

Q ss_pred             CccCHHHHHHHhhcCCCCC-----ccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-----CCCc
Q 018071           55 PAISVDELKEITENFGTNA-----LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----HENF  124 (361)
Q Consensus        55 ~~~~~~~~~~~~~~y~~~~-----~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----hpni  124 (361)
                      +.++.+++..+..+|.+..     .|+.|....+|+....+| .+++|..... .....+..|+.+++.+.     -|.+
T Consensus         5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            4567788888888887732     356688899999987655 6889987652 22345667777776663     2333


Q ss_pred             ceee-e--EEEeCCeeEEEEEeCCCCcHHH--------------hhhcCC-CCCCCCCC--CCCCHHHHHH---------
Q 018071          125 VQLL-G--YCVDGTSRVLAYEFASNGSLHD--------------ILHGRK-GVKGAQPG--PVLSWQQRVK---------  175 (361)
Q Consensus       125 v~~~-~--~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~-~~~~~~~~--~~l~~~~~~~---------  175 (361)
                      +... +  +....+..+++|++++|..+..              .++... ........  ....|...+.         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            3211 1  1223456789999998854311              111111 00000000  0011221100         


Q ss_pred             ---HHHHHHHHHHHhhhc----CCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          176 ---IAVGAAKGLEYLHEK----ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       176 ---i~~qi~~al~~LH~~----~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                         +...+...++.++..    ....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               001133444555432    12349999999999999887666899999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.04  E-value=3.1e-05  Score=69.32  Aligned_cols=143  Identities=17%  Similarity=0.173  Sum_probs=91.2

Q ss_pred             CccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC---CCCcceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      +.|+.|.+..+|+.... +..+++|+....  ....+..|+..|+.|.   ...+.+.+.+.......++|||+++|..+
T Consensus        42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            46889999999998864 778899986543  3456888998888873   35688888888878889999999998754


Q ss_pred             H--------H---hhhcCCC--CCCCC-----------CCCCCCHHHHH---HHH----------------HHHHHHH-H
Q 018071          150 H--------D---ILHGRKG--VKGAQ-----------PGPVLSWQQRV---KIA----------------VGAAKGL-E  185 (361)
Q Consensus       150 ~--------~---~l~~~~~--~~~~~-----------~~~~l~~~~~~---~i~----------------~qi~~al-~  185 (361)
                      .        .   .|+....  .-+..           ....-+|....   ++.                .+++..+ .
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            2        1   2232211  00000           01112444321   111                1111111 2


Q ss_pred             Hhhh-cCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          186 YLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       186 ~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      .|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3321 1235699999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.03  E-value=2.9e-05  Score=72.66  Aligned_cols=76  Identities=20%  Similarity=0.237  Sum_probs=44.4

Q ss_pred             CeEeccCCCCceEeccCCceEEeccccCCCCcccccccccccccc--CCCCCCchhhccCC---CCCccceecHHHHHHH
Q 018071          194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG--TFGYHAPEYAMTGQ---LNAKSDVYSFGVVLLE  268 (361)
Q Consensus       194 ~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwslG~~l~e  268 (361)
                      .++|+|++|.|||++.++ ++|+||+.+........   -.....  ...|.+|+......   -....++..+...+|+
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            499999999999998776 99999998764321100   000010  12345555432111   1112345577777887


Q ss_pred             HHhCC
Q 018071          269 LLTGR  273 (361)
Q Consensus       269 ll~g~  273 (361)
                      .+.+.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.00  E-value=2.4e-05  Score=69.65  Aligned_cols=71  Identities=7%  Similarity=0.031  Sum_probs=45.0

Q ss_pred             CCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCeeEEEEEeC-CCCcH
Q 018071           72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFA-SNGSL  149 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~-~~g~L  149 (361)
                      .+.|+.|....+|++     ..+++|+........-...+|+.+++.+...++ .+++.+  +....++++||+ +|.+|
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence            667889999999998     568899876532222233567777777642223 344443  444457899999 66544

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.98  E-value=5.2e-05  Score=67.01  Aligned_cols=77  Identities=23%  Similarity=0.258  Sum_probs=55.2

Q ss_pred             cCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCC---CCcceeeeEEEeCCeeEEEEEe
Q 018071           68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKH---ENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h---pniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ...-...+|.|..+.||+....+|+.|++|+..... .....+..|+..|+.|..   -.+.+.+++  +  ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence            344455689999999999999999999999876433 233467889999888742   234445543  2  34789999


Q ss_pred             CCCCc
Q 018071          144 ASNGS  148 (361)
Q Consensus       144 ~~~g~  148 (361)
                      ++++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            98764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.75  E-value=5.9e-05  Score=70.72  Aligned_cols=72  Identities=13%  Similarity=0.179  Sum_probs=49.0

Q ss_pred             CccccCCceEEEEEEECC--------CCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCeeEEEEEe
Q 018071           73 ALIGEGSYGRVYYGILKS--------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~  143 (361)
                      +.|+.|....||++...+        +..+++|+.... .....+.+|..+++.|...++ .++++.+.  +  .+|+||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence            457788889999998652        578999987432 222567789988888853333 55665543  2  389999


Q ss_pred             CCCCcH
Q 018071          144 ASNGSL  149 (361)
Q Consensus       144 ~~~g~L  149 (361)
                      ++|.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            987443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.74  E-value=7.5e-05  Score=68.64  Aligned_cols=143  Identities=15%  Similarity=0.165  Sum_probs=82.3

Q ss_pred             CccccCCceEEEEEEEC--------CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEEe
Q 018071           73 ALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +.|..|-...+|++...        ++..+++|+..........+.+|..+++.|. +.-..++++++.  +  .+||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEE
Confidence            45777888899999864        2578999987443334566778999988874 322355665543  2  299999


Q ss_pred             CCCCcHHH--------------h---hhcCCCCCCCCCCCCC-CHHHHHHHHHHHHH-------------------HHHH
Q 018071          144 ASNGSLHD--------------I---LHGRKGVKGAQPGPVL-SWQQRVKIAVGAAK-------------------GLEY  186 (361)
Q Consensus       144 ~~~g~L~~--------------~---l~~~~~~~~~~~~~~l-~~~~~~~i~~qi~~-------------------al~~  186 (361)
                      ++|.+|..              .   ++....   ....... -+.++..+..++..                   .+..
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~---~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEM---PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC---SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCC---CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99865431              1   111110   0011111 24455555544322                   1222


Q ss_pred             h----hhc-CCCCeEeccCCCCceEeccC----CceEEeccccCC
Q 018071          187 L----HEK-ADPHIIHRDIKSSNVLIFDD----DVAKIADFDLSN  222 (361)
Q Consensus       187 L----H~~-~~~~ivHrDikp~Nill~~~----~~~kl~Dfg~a~  222 (361)
                      |    ... ....++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2    221 12359999999999999876    789999999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.74  E-value=0.00033  Score=63.08  Aligned_cols=146  Identities=11%  Similarity=0.089  Sum_probs=72.4

Q ss_pred             ccccCCceE-EEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-C-CCcceeeeEEEeCCeeEEEEEeCCCCcHH
Q 018071           74 LIGEGSYGR-VYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H-ENFVQLLGYCVDGTSRVLAYEFASNGSLH  150 (361)
Q Consensus        74 ~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h-pniv~~~~~~~~~~~~~lv~e~~~~g~L~  150 (361)
                      .|+.|.... +|+....++..+++|.......  ..+..|+.+++.+. + -.+.+++.+..  ...+++||++.+..+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l~  100 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALFT  100 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBHH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcchH
Confidence            455554444 6677654467788886544321  23455666666663 2 23455665532  2337899999877776


Q ss_pred             HhhhcCCCC-----------------CCCCCCCCCCHHHHH-------H-H------------HHHHHHHHHHhh---hc
Q 018071          151 DILHGRKGV-----------------KGAQPGPVLSWQQRV-------K-I------------AVGAAKGLEYLH---EK  190 (361)
Q Consensus       151 ~~l~~~~~~-----------------~~~~~~~~l~~~~~~-------~-i------------~~qi~~al~~LH---~~  190 (361)
                      +++......                 ......+.+......       . +            ...+...+..+.   ..
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~  180 (333)
T 3csv_A          101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE  180 (333)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence            554321100                 000001112211100       0 0            001111222221   11


Q ss_pred             CCCCeEeccCCCCceEeccC----CceEEeccccCCC
Q 018071          191 ADPHIIHRDIKSSNVLIFDD----DVAKIADFDLSNQ  223 (361)
Q Consensus       191 ~~~~ivHrDikp~Nill~~~----~~~kl~Dfg~a~~  223 (361)
                      ....++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            12359999999999999874    6789999998754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.66  E-value=6.6e-05  Score=68.83  Aligned_cols=73  Identities=12%  Similarity=0.032  Sum_probs=43.9

Q ss_pred             CccccCCceEEEEEEECC---------CCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCC-cceeeeEEEeCCeeEEEEE
Q 018071           73 ALIGEGSYGRVYYGILKS---------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~e  142 (361)
                      +.|+.|....+|++...+         +..+++|+.............|..+++.+...+ +.++++..  .  .++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            457788889999998763         268999987543221112457788887774333 34565443  2  378999


Q ss_pred             eCCCCcH
Q 018071          143 FASNGSL  149 (361)
Q Consensus       143 ~~~~g~L  149 (361)
                      |++|.++
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.66  E-value=0.0001  Score=61.34  Aligned_cols=103  Identities=16%  Similarity=0.143  Sum_probs=67.0

Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      .+|.+.|....        .++++.++|.++.|.+.+|.-+-....  -..+=+.|..|++..+|.|.+.+ ..+.    
T Consensus        33 vSL~eIL~~~~--------~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----   97 (229)
T 2yle_A           33 LSLEEILRLYN--------QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----   97 (229)
T ss_dssp             EEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred             ccHHHHHHHcC--------CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----
Confidence            38999998765        349999999999999999877632211  12334457899999999988764 1110    


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCC
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP  275 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p  275 (361)
                                .....+.|||... ...+.+.-|||||+++|..+--..|
T Consensus        98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                      1123466888653 3445677899999999998874433

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.58  E-value=0.0003  Score=66.29  Aligned_cols=72  Identities=13%  Similarity=0.002  Sum_probs=46.2

Q ss_pred             ccccCCceEEEEEEECC-CCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCeeEEEEEeCCCCcH
Q 018071           74 LIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus        74 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~L  149 (361)
                      .|+.|-...+|++...+ +..+++|+........-...+|..+++.|...++ .++++++  .+  .+||||++|.+|
T Consensus       115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL  188 (458)
T ss_dssp             EECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred             EcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence            46778889999998774 4789999875432221123578888888864444 4566655  22  359999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.42  E-value=0.0015  Score=58.96  Aligned_cols=89  Identities=17%  Similarity=0.197  Sum_probs=51.7

Q ss_pred             CccCHHHHHHH-hhcCCCC----Ccc--ccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC---CCCc
Q 018071           55 PAISVDELKEI-TENFGTN----ALI--GEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENF  124 (361)
Q Consensus        55 ~~~~~~~~~~~-~~~y~~~----~~l--g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpni  124 (361)
                      |.++.+++... .+.|.+.    +.+  |.|....||+....+| .+++|+......     ..|+.+++.|.   -|++
T Consensus         4 p~l~~~~l~~~l~~~ygl~~~~~~~l~~G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~v   77 (339)
T 3i1a_A            4 QPIQAQQLIELLKVHYGIDIHTAQFIQGGADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEI   77 (339)
T ss_dssp             CSSCTTHHHHHHHHHHCCCCSEEEEETTTSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSS
T ss_pred             CCCCHHHHHHHHHHHcCCCcceeEEeeccCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCccc
Confidence            34455555543 3555432    233  3333689999987766 899998765432     24555555442   2224


Q ss_pred             ceeeeE------EEeCCeeEEEEEeCCCCcH
Q 018071          125 VQLLGY------CVDGTSRVLAYEFASNGSL  149 (361)
Q Consensus       125 v~~~~~------~~~~~~~~lv~e~~~~g~L  149 (361)
                      .+.+..      .......+++|+|++|..+
T Consensus        78 p~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           78 IFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             CCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             ccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            444321      2345677899999998755

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.04  E-value=0.0013  Score=61.25  Aligned_cols=73  Identities=8%  Similarity=-0.023  Sum_probs=47.5

Q ss_pred             CccccCCceEEEEEEECC--------CCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCeeEEEEEe
Q 018071           73 ALIGEGSYGRVYYGILKS--------GHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +.|..|-...+|+....+        +..+++|+........-...+|..+++.+. +.-..++++.+  .  -++||||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence            456677888999998763        588999987543322223457888887774 32234555432  2  3789999


Q ss_pred             CCCCcH
Q 018071          144 ASNGSL  149 (361)
Q Consensus       144 ~~~g~L  149 (361)
                      ++|.+|
T Consensus       152 I~G~~l  157 (424)
T 3mes_A          152 IDGEPL  157 (424)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.60  E-value=0.029  Score=51.75  Aligned_cols=29  Identities=24%  Similarity=0.465  Sum_probs=24.5

Q ss_pred             eEeccCCCCceEe------ccCCceEEeccccCCC
Q 018071          195 IIHRDIKSSNVLI------FDDDVAKIADFDLSNQ  223 (361)
Q Consensus       195 ivHrDikp~Nill------~~~~~~kl~Dfg~a~~  223 (361)
                      ++|+|+.+.|||+      +++..+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4566799999998753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.44  E-value=0.59  Score=38.82  Aligned_cols=115  Identities=10%  Similarity=0.020  Sum_probs=77.5

Q ss_pred             CCCCcceeeeEEEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCCeEec
Q 018071          120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE-YLHEKADPHIIHR  198 (361)
Q Consensus       120 ~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~~ivHr  198 (361)
                      .||++  --.+-.+++.+.+.++.-+++.=...+..            ++....++++.+|+.... +++.     -+|-
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------------~~~~eKlrll~nl~~L~~~~~~~-----r~tf  108 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------------TTLLSRIRAAIHLVSKVKHHSAR-----RLIF  108 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------------SCHHHHHHHHHHHHHHHSSCCSS-----SEEC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------------cCHHHHHHHHHHHHHHHHHhhhC-----ceeE
Confidence            57888  33444677777777777644322333332            788999999999988766 5543     5788


Q ss_pred             cCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCC
Q 018071          199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD  277 (361)
Q Consensus       199 Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~  277 (361)
                      -+.|+||+++.++.++|.-.|+-..++.              .=+.+|-+          +-++=|++..++.++..|+
T Consensus       109 ~l~P~NL~f~~~~~p~i~hRGi~~~lpP--------------~e~~ee~f----------l~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          109 IVCPENLMFNRALEPFFLHVGVKESLPP--------------DEWDDERL----------LREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CCCGGGEEECTTCCEEESCCEETTTBSS--------------CSCCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred             EEeCceEEEeCCCcEEEEEcCCcccCCC--------------CCCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence            9999999999999999997776433211              11222222          2356778888888888874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.11  E-value=0.45  Score=39.38  Aligned_cols=115  Identities=8%  Similarity=0.093  Sum_probs=78.4

Q ss_pred             CCCCcceeeeEEEeCCeeEEEEEeCCCC-cHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEec
Q 018071          120 KHENFVQLLGYCVDGTSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR  198 (361)
Q Consensus       120 ~hpniv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHr  198 (361)
                      .||+++.. .+-.+.+.+.+.++.-+.+ ++.. +..            ++....++++.+|+....+++.     -+|-
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~------------~~~~eKlr~l~ni~~l~~~~~~-----r~tf  103 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS------------FTKNEKLRYLLNIKNLEEVNRT-----RYTF  103 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG------------SCHHHHHHHHHHGGGGGGGGGS-----SEEC
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh------------cCHHHHHHHHHHHHHHHHHhcC-----ceEE
Confidence            58888877 4656666666666654422 3333 322            7889999999999988755543     4788


Q ss_pred             cCCCCceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCC
Q 018071          199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD  277 (361)
Q Consensus       199 Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~  277 (361)
                      -+.|+||+++.++.+++.=.|+-..++.              .=+.+|          .=.-.+=|++..+++++..|+
T Consensus       104 ~L~P~NL~f~~~~~p~i~~RGik~~l~P--------------~~~~ee----------~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          104 VLAPDELFFTRDGLPIAKTRGLQNVVDP--------------LPVSEA----------EFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CCSGGGEEECTTSCEEESCCEETTTBSC--------------CCCCHH----------HHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEecceEEEcCCCCEEEEEccCccCCCC--------------CCCCHH----------HHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999999999987776432211              001122          123356788889999998884

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.04  E-value=0.068  Score=50.26  Aligned_cols=60  Identities=5%  Similarity=0.062  Sum_probs=18.4

Q ss_pred             CCCccccCCceEEEEEEEC-CCCEEEE------EEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 018071           71 TNALIGEGSYGRVYYGILK-SGHAAAI------KKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVD  133 (361)
Q Consensus        71 ~~~~lg~G~~g~Vy~~~~~-~~~~vav------K~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~  133 (361)
                      +.+.||   ||.||++.++ ....||+      |......   .....+.+|..+++.++|||+++.+.+...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            345665   9999999976 3467888      6654322   222467788889999999999999988653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	361
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-70
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-69
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-65
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-64
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-64
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-62
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-61
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-57
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-55
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-53
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 4e-70
 Identities = 71/284 (25%), Positives = 123/284 (43%), Gaps = 27/284 (9%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
            IG GS+G VY G      A  +  + A + Q  + F  +V ++ + +H N +  +GY  
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 73

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
                 +  ++    SL+  LH  +              + + IA   A+G++YLH K  
Sbjct: 74  TAPQLAIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTAQGMDYLHAK-- 123

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-- 250
             IIHRD+KS+N+ + +D   KI DF L+      +      ++ G+  + APE      
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 251 -GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG 309
               + +SDVY+FG+VL EL+TG+ P  +   R Q               V +   +   
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----------IFMVGRGYLSPDL 231

Query: 310 GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 353
                     M  + A C++ + D RP    ++ +++ L  + P
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 3e-69
 Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 27/285 (9%)

Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E       +G G +G V+ G        A+K L       + FLA+ +++ +L+H+  V+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L           +  E+  NGSL D L    G+K       L+  + + +A   A+G+ +
Sbjct: 73  LYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAF 124

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           + E+   + IHRD++++N+L+ D    KIADF L+    D               + APE
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPE 180

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA 306
               G    KSDV+SFG++L E++T  +                  P ++  +V Q ++ 
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPY---------------PGMTNPEVIQNLER 225

Query: 307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
                 P     ++  +  LC +   + RP    +   L+    A
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 5e-65
 Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 29/273 (10%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           +G G +G V YG  +  +  AIK +      ++EF+ +  ++  L HE  VQL G C   
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               +  E+ +NG L + L   +             QQ +++     + +EYL  K    
Sbjct: 72  RPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---Q 120

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
            +HRD+ + N L+ D  V K++DF LS    D      S        +  PE  M  + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFS 179

Query: 255 AKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP 313
           +KSD+++FGV++ E+ + G+ P +                  +  +  + +   L    P
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYER----------------FTNSETAEHIAQGLRLYRP 223

Query: 314 PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
             A  K+  +   C   +AD RP   I++  + 
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 1e-64
 Identities = 66/326 (20%), Positives = 121/326 (37%), Gaps = 37/326 (11%)

Query: 43  GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK------SGHAAAI 96
           G   V + P ++P     E             +G G++G+V            +    A+
Sbjct: 1   GNNYVYIDPTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAV 58

Query: 97  KKLDASKQPD--EEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
           K L  S      E  ++++ ++S L  H N V LLG C  G   ++  E+   G L + L
Sbjct: 59  KMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118

Query: 154 HGRKG---------VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
             ++                   L  +  +  +   AKG+ +L  K   + IHRD+ + N
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175

Query: 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264
           +L+    + KI DF L+    + +  +          + APE         +SDV+S+G+
Sbjct: 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235

Query: 265 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVA 324
            L EL +        +P               + K  + +        P  A A+M  + 
Sbjct: 236 FLWELFSLGSSPYPGMP--------------VDSKFYKMIKEGFRMLSPEHAPAEMYDIM 281

Query: 325 ALCVQYEADFRPNMSIVVKALQPLLN 350
             C   +   RP    +V+ ++  ++
Sbjct: 282 KTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 2e-64
 Identities = 64/277 (23%), Positives = 121/277 (43%), Gaps = 27/277 (9%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           IG G +G V+ G   +    AIK +      +E+F+ +  ++ +L H   VQL G C++ 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72

Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
               L +EF  +G L D L  ++G+         + +  + + +   +G+ YL E     
Sbjct: 73  APICLVFEFMEHGCLSDYLRTQRGLF--------AAETLLGMCLDVCEGMAYLEEA---C 121

Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
           +IHRD+ + N L+ ++ V K++DF ++    D      ST       + +PE     + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYS 180

Query: 255 AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP 314
           +KSDV+SFGV++ E+ +  K                     S  +V + +        P 
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYEN---------------RSNSEVVEDISTGFRLYKPR 225

Query: 315 KAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
            A   +  +   C +   + RP  S +++ L  +  +
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 1e-63
 Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 27/289 (9%)

Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
           E+      +G+G +G V+ G        AIK L       E FL +  ++ +L+HE  VQ
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L     +     +  E+ S GSL D L G         G  L   Q V +A   A G+ Y
Sbjct: 77  LYAVVSEE-PIYIVTEYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAY 128

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           +      + +HRD++++N+L+ ++ V K+ADF L+    D               + APE
Sbjct: 129 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPE 184

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA 306
            A+ G+   KSDV+SFG++L EL T  +                  P +   +V   V+ 
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPY---------------PGMVNREVLDQVER 229

Query: 307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP 355
                 PP+    +  +   C + E + RP    +   L+    +    
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  201 bits (513), Expect = 2e-63
 Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 27/285 (9%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
            +      +G G YG VY G+ K      A+K L       EEFL + +++  +KH N V
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76

Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
           QLLG C       +  EF + G+L D L      +       +S    + +A   +  +E
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAME 129

Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           YL +K   + IHRD+ + N L+ ++ + K+ADF LS          H         + AP
Sbjct: 130 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAP 185

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD 305
           E     + + KSDV++FGV+L E+ T                     P +   +V + ++
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------------PGIDLSQVYELLE 230

Query: 306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 350
                + P     K+  +   C Q+    RP+ + + +A + +  
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-63
 Identities = 63/298 (21%), Positives = 115/298 (38%), Gaps = 33/298 (11%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
           IG+G +G V+ G  + G   A+K   + ++      A++     L+HEN +  +      
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69

Query: 135 TSRV----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
                   L  ++  +GSL D L+             ++ +  +K+A+  A GL +LH +
Sbjct: 70  NGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHME 119

Query: 191 A-----DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH--STRVLGTFGYH 243
                  P I HRD+KS N+L+  +    IAD  L+ +       +       +GT  Y 
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 244 APEYAMT------GQLNAKSDVYSFGVVLLELLTGRKP----VDHTLPRGQQSLVTWATP 293
           APE           +   ++D+Y+ G+V  E+           D+ LP         +  
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 294 KLSEDKVRQCVDARLGGDY-PPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 350
           ++ +    Q +   +   +   +A+  MA +   C       R     + K L  L  
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 8e-63
 Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 20/230 (8%)

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVS 117
           ELK+  ++F   + +G G+ G V+    K SG   A K +    +P    + + ++ ++ 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59

Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
                  V   G         +  E    GSL  +L              +  Q   K++
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVS 110

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
           +   KGL YL EK    I+HRD+K SN+L+      K+ DF +S Q  D      +   +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287
           GT  Y +PE       + +SD++S G+ L+E+  GR P+     +  + +
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (504), Expect = 5e-62
 Identities = 71/310 (22%), Positives = 125/310 (40%), Gaps = 44/310 (14%)

Query: 58  SVDELKEITENFGTNA---------LIGEGSYGRVYYGILKS----GHAAAIKKL--DAS 102
           + ++  E    F             +IG G +G V  G LK         AIK L    +
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 103 KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA 162
           ++   +FL++ S++ +  H N + L G     T  ++  EF  NGSL   L    G    
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-- 125

Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
                 +  Q V +  G A G++YL    D + +HRD+ + N+L+  + V K++DF LS 
Sbjct: 126 ------TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176

Query: 223 QAPDMAARLHSTRVLG---TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279
              D  +    T  LG      + APE     +  + SDV+S+G+V+ E+++  +     
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER---- 232

Query: 280 LPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 339
                          ++   V   ++       P    + +  +   C Q + + RP   
Sbjct: 233 -----------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281

Query: 340 IVVKALQPLL 349
            +V  L  ++
Sbjct: 282 QIVNTLDKMI 291

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 9e-62
 Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 35/297 (11%)

Query: 64  EI-TENFGTNALIGEGSYGRVYYGILKSGHAA-----AIKKLDASKQPDE--EFLAQVSM 115
           EI         +IG G +G VY G+LK+         AIK L A     +  +FL +  +
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           + +  H N ++L G        ++  E+  NG+L   L  + G          S  Q V 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVG 114

Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST- 234
           +  G A G++YL      + +HRD+ + N+L+  + V K++DF LS    D     ++T 
Sbjct: 115 MLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171

Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
                  + APE     +  + SDV+SFG+V+ E++T  +                   +
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW---------------E 216

Query: 295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 351
           LS  +V + ++       P    + +  +   C Q E   RP  + +V  L  L+ A
Sbjct: 217 LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 1e-61
 Identities = 69/323 (21%), Positives = 123/323 (38%), Gaps = 41/323 (12%)

Query: 51  PIEVPAISVDELKEIT-ENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLDASK 103
            ++      D   E   EN     ++G G++G+V                 A+K L    
Sbjct: 20  YVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA 79

Query: 104 QPDE--EFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG-- 158
              E    ++++ M+++L  HEN V LLG C       L +E+   G L + L  ++   
Sbjct: 80  DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139

Query: 159 ------------VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL 206
                       ++  +   VL+++  +  A   AKG+E+L  K     +HRD+ + NVL
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVL 196

Query: 207 IFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL 266
           +    V KI DF L+      +  +          + APE    G    KSDV+S+G++L
Sbjct: 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256

Query: 267 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAAL 326
            E+ +        +P                    + +      D P  A  ++  +   
Sbjct: 257 WEIFSLGVNPYPGIPVDAN--------------FYKLIQNGFKMDQPFYATEEIYIIMQS 302

Query: 327 CVQYEADFRPNMSIVVKALQPLL 349
           C  +++  RP+   +   L   L
Sbjct: 303 CWAFDSRKRPSFPNLTSFLGCQL 325

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-61
 Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 33/278 (11%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
            IG+G +G V  G  + G+  A+K +       + FLA+ S++++L+H N VQLLG  V+
Sbjct: 14  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVIVE 71

Query: 134 GTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
               + +  E+ + GSL D L  R          VL     +K ++   + +EYL     
Sbjct: 72  EKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN-- 122

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
            + +HRD+ + NVL+ +D+VAK++DF L+ +A                 + APE     +
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKK 176

Query: 253 LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY 312
            + KSDV+SFG++L E+ +  +                  P++    V   V+     D 
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPY---------------PRIPLKDVVPRVEKGYKMDA 221

Query: 313 PPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 350
           P      +  V   C   +A  RP+   + + L+ +  
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (501), Expect = 1e-61
 Identities = 67/306 (21%), Positives = 115/306 (37%), Gaps = 41/306 (13%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQPD--EEFLAQVSMVSR 118
            N      IGEG++GRV+                A+K L      D   +F  + ++++ 
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---------------GAQ 163
             + N V+LLG C  G    L +E+ + G L++ L                       + 
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
             P LS  +++ IA   A G+ YL E      +HRD+ + N L+ ++ V KIADF LS  
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283
                             +  PE     +   +SDV+++GVVL E+ +      +     
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY----- 244

Query: 284 QQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 343
                      ++ ++V   V        P     ++  +  LC       RP+   + +
Sbjct: 245 ----------GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

Query: 344 ALQPLL 349
            LQ + 
Sbjct: 295 ILQRMC 300

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-61
 Identities = 76/316 (24%), Positives = 137/316 (43%), Gaps = 41/316 (12%)

Query: 51  PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGH---AAAIKKLD--ASKQP 105
           P   P +  +++K          +IGEG++G+V    +K       AAIK++   ASK  
Sbjct: 1   PTIYPVLDWNDIKFQD-------VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 53

Query: 106 DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---- 160
             +F  ++ ++ +L  H N + LLG C       LA E+A +G+L D L   + ++    
Sbjct: 54  HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113

Query: 161 ---GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217
                     LS QQ +  A   A+G++YL +K     IHRD+ + N+L+ ++ VAKIAD
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170

Query: 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           F LS         +  T       + A E          SDV+S+GV+L E+++      
Sbjct: 171 FGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 227

Query: 278 HTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN 337
                            ++  ++ + +      + P     ++  +   C + +   RP+
Sbjct: 228 ---------------CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS 272

Query: 338 MSIVVKALQPLLNARP 353
            + ++ +L  +L  R 
Sbjct: 273 FAQILVSLNRMLEERK 288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 1e-60
 Identities = 68/322 (21%), Positives = 126/322 (39%), Gaps = 47/322 (14%)

Query: 52  IEVPAISVDELKEITE----------NFGTNALIGEGSYGRVYYGILK----SGHAAAIK 97
           I++ A++ + ++ +            +F    +IG G +G VY+G L          A+K
Sbjct: 4   IDLSALNPELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVK 61

Query: 98  KLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILH 154
            L+      E  +FL +  ++    H N + LLG C+       +   +  +G L + + 
Sbjct: 62  SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121

Query: 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214
                         + +  +   +  AKG+++L        +HRD+ + N ++ +    K
Sbjct: 122 NETHN--------PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVK 170

Query: 215 IADFDLSNQAPD--MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
           +ADF L+    D    +  + T       + A E   T +   KSDV+SFGV+L EL+T 
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 230

Query: 273 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEA 332
             P     P    +        L   ++ Q          P      +  V   C   +A
Sbjct: 231 GAP-----PYPDVNTFDITVYLLQGRRLLQ----------PEYCPDPLYEVMLKCWHPKA 275

Query: 333 DFRPNMSIVVKALQPLLNARPG 354
           + RP+ S +V  +  + +   G
Sbjct: 276 EMRPSFSELVSRISAIFSTFIG 297

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-59
 Identities = 64/278 (23%), Positives = 124/278 (44%), Gaps = 33/278 (11%)

Query: 75  IGEGSYGRVYYGILK---SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLG 129
           +G G++G V  G+ +        AIK L    +    EE + +  ++ +L +   V+L+G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
            C    + +L  E A  G LH  L G++          +      ++    + G++YL E
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 127

Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAPEYA 248
           K   + +HRD+ + NVL+ +   AKI+DF LS     D +     +       ++APE  
Sbjct: 128 K---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL 308
              + +++SDV+S+GV + E L+  +                   K+   +V   ++   
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQK---------------PYKKMKGPEVMAFIEQGK 229

Query: 309 GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
             + PP+   ++ A+ + C  Y+ + RP+   V + ++
Sbjct: 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 3e-57
 Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 37/281 (13%)

Query: 75  IGEGSYGRVYYGIL---KSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLL 128
           +G G++G V  G     K     A+K L          +E LA+ +++ +L +   V+++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           G C    S +L  E A  G L+  L   +          +  +  +++    + G++YL 
Sbjct: 75  GICEAE-SWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 124

Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEY 247
           E    + +HRD+ + NVL+     AKI+DF LS     D       T       ++APE 
Sbjct: 125 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181

Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA 306
               + ++KSDV+SFGV++ E  + G+KP                   +   +V   ++ 
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG----------------MKGSEVTAMLEK 225

Query: 307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 347
                 P     +M  +  LC  Y+ + RP  + V   L+ 
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 6e-57
 Identities = 59/284 (20%), Positives = 110/284 (38%), Gaps = 34/284 (11%)

Query: 74  LIGEGSYGRVYYGILKSGH-----AAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
           ++G G++G VY G+            AIK+L  +  P   +E L +  +++ + + +  +
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           LLG C+  T +++  +    G L D +   K             Q  +   V  AKG+ Y
Sbjct: 76  LLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--------GSQYLLNWCVQIAKGMNY 126

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           L ++    ++HRD+ + NVL+      KI DF L+          H+        + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA 306
             +      +SDV+S+GV + EL+T                       +   ++   ++ 
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEK 228

Query: 307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 350
                 PP     +  +   C   +AD RP    ++     +  
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-56
 Identities = 73/294 (24%), Positives = 124/294 (42%), Gaps = 36/294 (12%)

Query: 74  LIGEGSYGRVYYGILKS--------GHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHE 122
            +GEG++G+V                   A+K L  DA+++   + ++++ M+  + KH+
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGPVLSWQQRVK 175
           N + LLG C       +  E+AS G+L + L  R+             P   LS +  V 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
            A   A+G+EYL  K     IHRD+ + NVL+ +D+V KIADF L+     +     +T 
Sbjct: 140 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 295
                 + APE         +SDV+SFGV+L E+ T                     P +
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY---------------PGV 241

Query: 296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
             +++ + +      D P     ++  +   C       RP    +V+ L  ++
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-56
 Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 31/285 (10%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHE 122
           E++     IG GSYGR      K  G     K+LD     + E    +++V+++  LKH 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 123 NFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           N V+     +D T+  L    E+   G L  ++      KG +    L  +  +++    
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRVMTQL 118

Query: 181 AKGLEYLHEKAD--PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
              L+  H ++D    ++HRD+K +NV +      K+ DF L+       +   +   +G
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVG 176

Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           T  Y +PE       N KSD++S G +L EL     P      +                
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------------G 224

Query: 299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 343
           K+R+    R+   Y  +       +    +  +   RP++  +++
Sbjct: 225 KIREGKFRRIPYRYSDEL----NEIITRMLNLKDYHRPSVEEILE 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 4e-56
 Identities = 68/282 (24%), Positives = 108/282 (38%), Gaps = 38/282 (13%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKH 121
           E+F     +G+G +G VY    K S    A+K L  ++        +   +V + S L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N ++L GY  D T   L  E+A  G+++  L                 Q+        A
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELA 116

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             L Y H K    +IHRDIK  N+L+      KIADF  S  AP        T + GT  
Sbjct: 117 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 169

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR 301
           Y  PE       + K D++S GV+  E L G+ P +    +     ++       +    
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 229

Query: 302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 343
              D                 + +  +++    RP +  V++
Sbjct: 230 GARD-----------------LISRLLKHNPSQRPMLREVLE 254

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 5e-56
 Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 27/292 (9%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQPDE--EFLAQVSMVSR 118
           E    +  +G+GS+G VY G+ K           AIK ++ +    E  EFL + S++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-GPVLSWQQRVKIA 177
               + V+LLG    G   ++  E  + G L   L   +      P     S  + +++A
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
              A G+ YL+       +HRD+ + N ++ +D   KI DF ++    +        + L
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 297
               + +PE    G     SDV+SFGVVL E+ T  +                    LS 
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---------------QGLSN 241

Query: 298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
           ++V + V      D P      +  +  +C QY    RP+   ++ +++  +
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 1e-55
 Identities = 63/278 (22%), Positives = 105/278 (37%), Gaps = 38/278 (13%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
           IG GS+  VY G+   +    A  +L     +K   + F  +  M+  L+H N V+    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 131 CVDGTSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
                      VL  E  ++G+L   L   K         V+  +          KGL++
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQF 127

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
           LH +  P IIHRD+K  N+ I       KI D  L+           +  V+GT  + AP
Sbjct: 128 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD 305
           E     + +   DVY+FG+ +LE+ T   P        Q                R+   
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--------------YRRVTS 227

Query: 306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 343
                 +   A+ ++  +   C++   D R ++  ++ 
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 6e-55
 Identities = 63/272 (23%), Positives = 112/272 (41%), Gaps = 34/272 (12%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV 132
           +G+G++G+VY    K +   AA K +D   + + E+++ ++ +++   H N V+LL    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
              +  +  EF + G++  ++   +          L+  Q   +       L YLH+   
Sbjct: 80  YENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDALNYLHDN-- 129

Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
             IIHRD+K+ N+L   D   K+ADF +S +      R  S   +GT  + APE  M   
Sbjct: 130 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCET 186

Query: 253 L-----NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR 307
                 + K+DV+S G+ L+E+     P     P                 K+ +     
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------------LKIAKSEPPT 234

Query: 308 LGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 339
           L    P +  +        C++   D R   S
Sbjct: 235 L--AQPSRWSSNFKDFLKKCLEKNVDARWTTS 264

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 8e-54
 Identities = 66/282 (23%), Positives = 105/282 (37%), Gaps = 34/282 (12%)

Query: 74  LIGEGSYGRVYYGILKS----GHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQL 127
            IGEG +G V+ GI  S      A AIK           E+FL +   + +  H + V+L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
           +G   +     +  E  + G L   L  RK          L     +  A   +  L YL
Sbjct: 74  IGVITENP-VWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYL 124

Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
             K     +HRDI + NVL+  +D  K+ DF LS    D      +++      + APE 
Sbjct: 125 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPES 180

Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR 307
               +  + SDV+ FGV + E+L                        +  + V   ++  
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQ---------------GVKNNDVIGRIENG 225

Query: 308 LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
                PP     + ++   C  Y+   RP  + +   L  +L
Sbjct: 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-53
 Identities = 67/281 (23%), Positives = 110/281 (39%), Gaps = 30/281 (10%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHEN 123
           E++     +GEG+YG V   + + +  A A+K +D  +  D  E    ++ +   L HEN
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
            V+  G+  +G  + L  E+ S G L D +    G         +      +       G
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAG 115

Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
           + YLH      I HRDIK  N+L+ + D  KI+DF L+             ++ GT  Y 
Sbjct: 116 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172

Query: 244 APEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ 302
           APE     + +A   DV+S G+VL  +L G  P D      Q+                 
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------------YSD 218

Query: 303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 343
             + +   +   K  +   A+    +      R  +  + K
Sbjct: 219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (446), Expect = 4e-53
 Identities = 64/300 (21%), Positives = 119/300 (39%), Gaps = 45/300 (15%)

Query: 53  EVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE--- 108
           +V  +   +  +  + F     IG GS+G VY+   +++    AIKK+  S +   E   
Sbjct: 3   DVAELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60

Query: 109 -FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
             + +V  + +L+H N +Q  G  +   +  L  E+    +   +   +K          
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--------- 111

Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
           L   +   +  GA +GL YLH     ++IHRD+K+ N+L+ +  + K+ DF  ++     
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168

Query: 228 AARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
                    +GT  + APE  +    GQ + K DV+S G+  +EL   + P+ +      
Sbjct: 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222

Query: 285 -QSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 343
              +    +P L                +              C+Q     RP   +++K
Sbjct: 223 LYHIAQNESPALQSG------------HWSEYF----RNFVDSCLQKIPQDRPTSEVLLK 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 5e-53
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 33/285 (11%)

Query: 58  SVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-FLAQVSM 115
           S+  + +  + +     IG+G+ G VY  + + +G   AI++++  +QP +E  + ++ +
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
           +   K+ N V  L   + G    +  E+ + GSL D++                  Q   
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQIAA 120

Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
           +     + LE+LH      +IHRDIKS N+L+  D   K+ DF    Q      +   + 
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRST 175

Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSLVTWATPK 294
           ++GT  + APE         K D++S G++ +E++ G  P ++    R    + T  TP+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235

Query: 295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 339
           L                 P K  A        C+  + + R +  
Sbjct: 236 L---------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAK 265

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-52
 Identities = 62/302 (20%), Positives = 109/302 (36%), Gaps = 34/302 (11%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKL--DASKQPDEEFLAQVSMVSR 118
           +       +G G++G+V            +    A+K L   A+       ++++ ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 119 LKHENFVQLLGYCV--DGTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGPVLS 169
           + H   V  L       G   ++  EF   G+L   L  ++                 L+
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
            +  +  +   AKG+E+L  +     IHRD+ + N+L+ + +V KI DF L+        
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 289
            +          + APE         +SDV+SFGV+L E+ +         P     +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244

Query: 290 WATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
               +L E    +          P     +M      C   E   RP  S +V+ L  LL
Sbjct: 245 EFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

Query: 350 NA 351
            A
Sbjct: 296 QA 297

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-51
 Identities = 65/281 (23%), Positives = 107/281 (38%), Gaps = 35/281 (12%)

Query: 75  IGEGSYGRVYYGILKS----GHAAAIKKLD----ASKQPDEEFLAQVSMVSRLKHENFVQ 126
           +G+GS+G V  G   +      + A+K L     +  +  ++F+ +V+ +  L H N ++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L G  +    + +  E A  GSL D L   +G                + AV  A+G+ Y
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGY 126

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
           L  K     IHRD+ + N+L+   D+ KI DF L    P +    +        F + AP
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD 305
           E   T   +  SD + FGV L E+ T  +     L   Q               + +   
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKIDK 229

Query: 306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 346
                  P      +  V   C  ++ + RP    +   L 
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 3e-49
 Identities = 57/248 (22%), Positives = 90/248 (36%), Gaps = 17/248 (6%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVS 117
           K+  E+F    ++GEGS+  V     L +    AIK L+      E  +  V     ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           RL H  FV+L     D         +A NG L   +                        
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYT 114

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
                 LEYLH      IIHRD+K  N+L+ +D   +I DF  +      + +  +   +
Sbjct: 115 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 297
           GT  Y +PE          SD+++ G ++ +L+ G  P            +        E
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231

Query: 298 DKVRQCVD 305
               +  D
Sbjct: 232 KFFPKARD 239

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  164 bits (416), Expect = 3e-48
 Identities = 57/294 (19%), Positives = 106/294 (36%), Gaps = 37/294 (12%)

Query: 50  QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD-E 107
           QP+E+          + +++  +  +G G++G V+      +G+  A K +    + D E
Sbjct: 15  QPVEIKH------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 68

Query: 108 EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
               ++  +S L+H   V L     D    V+ YEF S G L + +              
Sbjct: 69  TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--------K 120

Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAP 225
           +S  + V+      KGL ++HE    + +H D+K  N++         K+ DF L+    
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177

Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
              +   +T   GT  + APE A    +   +D++S GV+   LL+G  P          
Sbjct: 178 PKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234

Query: 286 SLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 339
             V      + +                              +  + + R  + 
Sbjct: 235 RNVKSCDWNMDD-------------SAFSGISEDGKDFIRKLLLADPNTRMTIH 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 5e-48
 Identities = 44/244 (18%), Positives = 92/244 (37%), Gaps = 17/244 (6%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
           KE+ E +     +G G +G V+  +   S      K +            ++S+++  +H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
            N + L          V+ +EF S   + + ++             L+ ++ V       
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIVSYVHQVC 112

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAPDMAARLHSTRVLGT 239
           + L++LH     +I H DI+  N++         KI +F  + Q        +   +   
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTA 166

Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 299
             Y+APE      ++  +D++S G ++  LL+G  P      +     +  A     E+ 
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226

Query: 300 VRQC 303
            ++ 
Sbjct: 227 FKEI 230

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  163 bits (413), Expect = 7e-48
 Identities = 60/258 (23%), Positives = 102/258 (39%), Gaps = 24/258 (9%)

Query: 50  QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE 108
           QP+EV   SV +  +I E       +G G++G V+  +   +G     K ++     D+ 
Sbjct: 18  QPVEVKQGSVYDYYDILE------ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71

Query: 109 -FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
               ++S++++L H   + L     D    VL  EF S G L D +              
Sbjct: 72  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--------K 123

Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI--FDDDVAKIADFDLSNQAP 225
           +S  + +     A +GL+++HE     I+H DIK  N++         KI DF L+ +  
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180

Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
                  +T    T  + APE      +   +D+++ GV+   LL+G  P          
Sbjct: 181 PDEIVKVTT---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237

Query: 286 SLVTWATPKLSEDKVRQC 303
             V     +  ED     
Sbjct: 238 QNVKRCDWEFDEDAFSSV 255

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  156 bits (396), Expect = 3e-46
 Identities = 64/299 (21%), Positives = 111/299 (37%), Gaps = 36/299 (12%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE----FLAQVSMVS 117
             +++ +    ++G G    V+    L+     A+K L A    D      F  +    +
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 118 RLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
            L H   V +          G    +  E+    +L DI+H             ++ ++ 
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRA 113

Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
           +++   A + L + H+     IIHRD+K +N++I   +  K+ DF ++    D    +  
Sbjct: 114 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170

Query: 234 T-RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 292
           T  V+GT  Y +PE A    ++A+SDVYS G VL E+LTG  P     P           
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 230

Query: 293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-NMSIVVKALQPLLN 350
           P                        A + AV    +    + R    + +   L  + N
Sbjct: 231 PIPPS-------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (391), Expect = 2e-45
 Identities = 61/291 (20%), Positives = 102/291 (35%), Gaps = 46/291 (15%)

Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD----------EEFLAQVSM 115
           EN+    ++G G    V   I   +    A+K +D +              E  L +V +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 116 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
           + ++  H N +QL       T   L ++    G L D L  +           LS ++  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETR 113

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
           KI     + +  LH+    +I+HRD+K  N+L+ DD   K+ DF  S Q           
Sbjct: 114 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLR 167

Query: 235 RVLGTFGYHAPEYAMTGQLNA------KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
            V GT  Y APE       +       + D++S GV++  LL G  P  H        ++
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227

Query: 289 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 339
                +    +           DY       ++      +  +   R    
Sbjct: 228 MSGNYQFGSPEWD---------DYSDTVKDLVSR----FLVVQPQKRYTAE 265

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-44
 Identities = 54/245 (22%), Positives = 94/245 (38%), Gaps = 20/245 (8%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQV-----SMVSRLK 120
           E+F  + ++G+GS+G+V+    K +    AIK L       ++ +         +    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
           H     +        +     E+ + G L   +                  +    A   
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEI 112

Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
             GL++LH K    I++RD+K  N+L+  D   KIADF +  +     A+  +    GT 
Sbjct: 113 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTP 167

Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
            Y APE  +  + N   D +SFGV+L E+L G+ P            +    P       
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 227

Query: 301 RQCVD 305
           ++  D
Sbjct: 228 KEAKD 232

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  151 bits (383), Expect = 7e-44
 Identities = 47/282 (16%), Positives = 92/282 (32%), Gaps = 28/282 (9%)

Query: 61  ELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE--FLAQVSMVS 117
           + ++I + +    ++G G++  V      ++    AIK +       +E     +++++ 
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62

Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
           ++KH N V L      G    L  +  S G L D +  +            + +   ++ 
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---------FYTERDASRLI 113

Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
                 ++YLH+    H   +        + +D    I+DF LS      +     +   
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STAC 170

Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 297
           GT GY APE       +   D +S GV+   LL G  P            +  A  +   
Sbjct: 171 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 230

Query: 298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 339
                         Y               ++ + + R    
Sbjct: 231 -------------PYWDDISDSAKDFIRHLMEKDPEKRFTCE 259

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  151 bits (382), Expect = 3e-43
 Identities = 49/231 (21%), Positives = 87/231 (37%), Gaps = 25/231 (10%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQ-------VSMVSR 118
            +F  + +IG G +G VY      +G   A+K LD  +   ++           +S+VS 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
                 V +              +  + G LH  L                       A 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADMRFYAA 114

Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
               GLE++H +    +++RD+K +N+L+ +    +I+D  L+               +G
Sbjct: 115 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVG 167

Query: 239 TFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
           T GY APE    G   ++ +D +S G +L +LL G  P      + +  + 
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (373), Expect = 1e-42
 Identities = 53/286 (18%), Positives = 99/286 (34%), Gaps = 32/286 (11%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC- 131
            IG GS+G +Y G  + +G   AIK      +   +   +  +   ++    +  + +C 
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCG 72

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
            +G   V+  E              +           S +  + +A      +EY+H K 
Sbjct: 73  AEGDYNVMVMELLGPSLEDLFNFCSRK---------FSLKTVLLLADQMISRIEYIHSK- 122

Query: 192 DPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPD-----MAARLHSTRVLGTFGYH 243
             + IHRD+K  N L+       +  I DF L+ +  D           +  + GT  Y 
Sbjct: 123 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 303
           +    +  + + + D+ S G VL+    G  P        ++      + K     +   
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV- 239

Query: 304 VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 349
               L   YP     + A     C     D +P+ S + +  + L 
Sbjct: 240 ----LCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-42
 Identities = 61/299 (20%), Positives = 113/299 (37%), Gaps = 36/299 (12%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLK 120
           ++   +   + IGEG+YG V       +    AIKK+   +     +  L ++ ++ R +
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 121 HENFVQLLGYCVDGTSRVLAYEF----ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
           HEN + +       T   +   +         L+ +L  +           LS       
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYF 114

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTR 235
                +GL+Y+H     +++HRD+K SN+L+      KI DF L+  A PD       T 
Sbjct: 115 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171

Query: 236 VLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
            + T  Y APE  +  +   KS D++S G +L E+L+ R          Q + +      
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231

Query: 295 LSEDKVRQCVDARLGG--------------DYPPKAVAKMAAVAALCVQYEADFRPNMS 339
            S++ +   ++ +                    P A +K   +    + +    R  + 
Sbjct: 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  146 bits (370), Expect = 6e-42
 Identities = 58/244 (23%), Positives = 94/244 (38%), Gaps = 22/244 (9%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKH 121
           ++F     +G GS+GRV+    + +G   A+K L           E    +  M+S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
              +++ G   D     +  ++   G L  +L   +                   A    
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPVAKFYAAEVC 114

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH K    II+RD+K  N+L+  +   KI DF  +   PD+     +  + GT  
Sbjct: 115 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPD 166

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR 301
           Y APE   T   N   D +SFG+++ E+L G  P   +        +  A  +       
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226

Query: 302 QCVD 305
              D
Sbjct: 227 DVKD 230

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 7e-42
 Identities = 49/283 (17%), Positives = 92/283 (32%), Gaps = 27/283 (9%)

Query: 75  IGEGSYGRVYYGILK--SGHAAAIKKLDASKQPDEEFLAQV------SMVSRLKHENFVQ 126
           IGEG+YG+V+        G   A+K++      +   L+ +        +   +H N V+
Sbjct: 15  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           L   C    +            +              P P +  +    +     +GL++
Sbjct: 75  LFDVCTVSRTDRETKLTLVFEHVD---QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           LH      ++HRD+K  N+L+      K+ADF L+            T V+ T  Y APE
Sbjct: 132 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPE 185

Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV----------TWATPKLS 296
             +        D++S G +  E+   +     +    Q   +           W      
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 339
             +      A+    +          +   C+ +    R +  
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 7e-41
 Identities = 64/303 (21%), Positives = 112/303 (36%), Gaps = 37/303 (12%)

Query: 74  LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD------EEFLAQVSMVSRLKHENFVQ 126
            +GEG +  VY    K +    AIKK+    + +         L ++ ++  L H N + 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
           LL      ++  L ++F        I               L+        +   +GLEY
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSHIKAYMLMTLQGLEY 115

Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
           LH+     I+HRD+K +N+L+ ++ V K+ADF L+            T  + T  Y APE
Sbjct: 116 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPE 170

Query: 247 YAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED------K 299
                ++     D+++ G +L ELL     +       Q + +       +E+       
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230

Query: 300 VRQCVDARLGGDYPPKAVAKMAAVAAL-----CVQYEADFRPNMSIVVKALQ-PLLNARP 353
           +   V  +     P   +   A    L        +    R   +   +AL+    + RP
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT---QALKMKYFSNRP 287

Query: 354 GPA 356
           GP 
Sbjct: 288 GPT 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  141 bits (356), Expect = 4e-40
 Identities = 48/298 (16%), Positives = 94/298 (31%), Gaps = 34/298 (11%)

Query: 65  ITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN 123
           +  ++     IGEGS+G ++ G  L +    AIK     +    +   +      L    
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCT 61

Query: 124 FV-QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
            +  +  +  +G   VL  +         +            G   S +     A     
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---------LCGRKFSVKTVAMAAKQMLA 112

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLI-----FDDDVAKIADFDLSNQAPDMAARLH----- 232
            ++ +HEK    +++RDIK  N LI      + ++  + DF +     D   + H     
Sbjct: 113 RVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169

Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 292
              + GT  Y +    +  + + + D+ + G V +  L G  P         +       
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229

Query: 293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 350
            K     +R+     L   +P     +             D  P+   +      +L 
Sbjct: 230 EKKQSTPLRE-----LCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  140 bits (352), Expect = 1e-39
 Identities = 49/280 (17%), Positives = 94/280 (33%), Gaps = 28/280 (10%)

Query: 75  IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYC 131
           IGEG+YG VY      G   A+KK+   K+ +      + ++S++  LKH N V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
                 VL +E         +     G         L         +    G+ Y H++ 
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNGIAYCHDR- 119

Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
              ++HRD+K  N+LI  +   KIADF L+        +     ++  +         + 
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSK 176

Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE------------DK 299
           + +   D++S G +  E++ G           Q   +       +             D 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 339
                +      +          + +  ++ + + R    
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 1e-39
 Identities = 56/270 (20%), Positives = 95/270 (35%), Gaps = 24/270 (8%)

Query: 52  IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFL 110
           +  P    D  +E+  ++    +IG GS+G VY   L  SG   AIKK+   K       
Sbjct: 7   VATPGQGPDRPQEV--SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKN 61

Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQP 164
            ++ ++ +L H N V+L  +      +       L  ++          H  +       
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------ 115

Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQ 223
              L             + L Y+H      I HRDIK  N+L+  D  V K+ DF  + Q
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172

Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283
                   + + +   +              +  DV+S G VL ELL G+          
Sbjct: 173 LVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230

Query: 284 QQSLVTWATPKLSEDKVRQCVDARLGGDYP 313
           Q   +       + +++R+         +P
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFP 260

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 5e-39
 Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 16/213 (7%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
           ENF     IGEG+YG VY    K +G   A+KK+    + +      + ++S++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           N V+LL          L +EF        +               +             +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--------IPLPLIKSYLFQLLQ 113

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           GL + H      ++HRD+K  N+LI  +   K+ADF L+ +A  +  R ++  V+  +  
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTLWYR 169

Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
                      +   D++S G +  E++T R  
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 4e-38
 Identities = 56/289 (19%), Positives = 107/289 (37%), Gaps = 40/289 (13%)

Query: 63  KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-------EEFLAQVS 114
           + + + + T   +G G +  V     K +G   A K +   +          E+   +VS
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 115 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
           ++  ++H N + L     + T  +L  E  + G L D L  ++          L+ ++  
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEAT 116

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLSNQAPDMAAR 230
           +       G+ YLH      I H D+K  N+++ D +V     KI DF L+++       
Sbjct: 117 EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-- 171

Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
                + GT  + APE      L  ++D++S GV+   LL+G  P      +   + V+ 
Sbjct: 172 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230

Query: 291 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 339
              +  +             +Y     A         +  +   R  + 
Sbjct: 231 VNYEFED-------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-37
 Identities = 48/217 (22%), Positives = 83/217 (38%), Gaps = 27/217 (12%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD-------EEFLAQVSMVSRLK--HEN 123
           L+G G +G VY GI +      AIK ++  +  D            +V ++ ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
            ++LL +     S VL  E              +G         L  +          + 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQEELARSFFWQVLEA 122

Query: 184 LEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
           + + H      ++HRDIK  N+LI  +    K+ DF       D       T   GT  Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 175

Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
             PE+    + + +S  V+S G++L +++ G  P +H
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 4e-37
 Identities = 40/210 (19%), Positives = 79/210 (37%), Gaps = 24/210 (11%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
           ++G G  G+V      ++    A+K L    +   E           +  + V+++    
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL---HWRASQCPHIVRIVDVYE 75

Query: 133 DGTSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
           +  +     ++  E    G L   +  R            + ++  +I     + ++YLH
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-------FTEREASEIMKSIGEAIQYLH 128

Query: 189 EKADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
                +I HRD+K  N+L      + + K+ DF  + +     +         T  Y AP
Sbjct: 129 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAP 182

Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
           E     + +   D++S GV++  LL G  P
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-36
 Identities = 50/244 (20%), Positives = 88/244 (36%), Gaps = 19/244 (7%)

Query: 67  ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE----FLAQVSMVSRLKH 121
            +F    L+G+G++G+V     K +G   A+K L       ++     + +  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
                L              E+A+ G L   L   +           + ++         
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIV 115

Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
             LEYLH +    +++RDIK  N+++  D   KI DF L  +     A +      GT  
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPE 170

Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR 301
           Y APE           D +  GVV+ E++ GR P  +        L+     +       
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230

Query: 302 QCVD 305
           +   
Sbjct: 231 EAKS 234

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-35
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 27/239 (11%)

Query: 75  IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
           IG+G++G V+     K+G   A+KK+    + +      L ++ ++  LKHEN V L+  
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 131 CVDGTSRV--------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           C    S          L ++F  +     + +              +  +  ++      
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---------FTLSEIKRVMQMLLN 128

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVLGTF 240
           GL Y+H      I+HRD+K++NVLI  D V K+ADF L+        +     T  + T 
Sbjct: 129 GLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 241 GYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
            Y  PE  +  +      D++  G ++ E+ T    +     + Q +L++     ++ +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (326), Expect = 2e-35
 Identities = 59/276 (21%), Positives = 100/276 (36%), Gaps = 32/276 (11%)

Query: 37  SEAAPKGAQAVKVQPIEVPAISVDELKEIT---------ENFGTNALIGEGSYGRVYYGI 87
           + AA KG++   V+     A   D LK+           + F     +G GS+GRV    
Sbjct: 3   AAAAKKGSEQESVKEFLAKA-KEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61

Query: 88  -LKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142
             +SG+  A+K LD  K       E  L +  ++  +     V+L     D ++  +  E
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202
           + + G +   L               S       A       EYLH      +I+RD+K 
Sbjct: 122 YVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKP 169

Query: 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSF 262
            N+LI      ++ DF  + +         +  + GT    APE  ++   N   D ++ 
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWAL 224

Query: 263 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 298
           GV++ E+  G  P     P      +     +    
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 3e-35
 Identities = 51/244 (20%), Positives = 94/244 (38%), Gaps = 16/244 (6%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRL 119
           E+   +     +G G+YG V   +  ++G   AIKKL    Q +   +    ++ ++  +
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74

Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
           +HEN + LL       +     +F           G+           L   +   +   
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQ 129

Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
             KGL Y+H      IIHRD+K  N+ + +D   KI DF L+ QA        +  V+  
Sbjct: 130 MLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTR 182

Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 299
           +           +     D++S G ++ E++TG+     +    Q   +   T     + 
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242

Query: 300 VRQC 303
           V++ 
Sbjct: 243 VQRL 246

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 2e-34
 Identities = 44/205 (21%), Positives = 82/205 (40%), Gaps = 17/205 (8%)

Query: 75  IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
           IGEG+YG V+    + +    A+K++      +      L ++ ++  LKH+N V+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
                   L +EF               +           +          KGL + H +
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVKSFLFQLLKGLGFCHSR 120

Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
              +++HRD+K  N+LI  +   K+A+F L+ +A  +  R +S  V+  +          
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 251 GQLNAKSDVYSFGVVLLELLTGRKP 275
              +   D++S G +  EL    +P
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRP 201

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 8e-32
 Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 26/221 (11%)

Query: 64  EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRL 119
           E+ E +   + +G G+YG V      K+G   A+KKL    Q     +    ++ ++  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 120 KHENFVQLLGYCVDGTS-----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
           KHEN + LL       S      V          L++I+  +K          L+     
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQ 124

Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
            +     +GL+Y+H      IIHRD+K SN+ + +D   KI DF L+    D      + 
Sbjct: 125 FLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTG 177

Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
            V   +             N   D++S G ++ ELLTGR  
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 8e-31
 Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 25/234 (10%)

Query: 67  ENFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDASKQPD-----EEFLAQVSMVS 117
           ENF    ++G G+YG+V+     SGH      A+K L  +         E    +  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 118 RLKHENF-VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
            ++   F V L       T   L  ++ + G L   L  R+           +  +    
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIY 134

Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
                  LE+LH+     II+RDIK  N+L+  +    + DF LS +         +   
Sbjct: 135 VGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDF 190

Query: 237 LGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
            GT  Y AP+    G    +   D +S GV++ ELLTG  P      +  Q+ +
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  117 bits (293), Expect = 1e-30
 Identities = 40/215 (18%), Positives = 83/215 (38%), Gaps = 26/215 (12%)

Query: 67  ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENF 124
           +++     +G G Y  V+  I + +     +K L   K+  ++   ++ ++  L+   N 
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92

Query: 125 VQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
           + L     D  SR   L +E  +N     +               L+            K
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYEILK 140

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
            L+Y H      I+HRD+K  NV+I  +    ++ D+ L+               + +  
Sbjct: 141 ALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRY 194

Query: 242 YHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKP 275
           +  PE  +  Q+ +   D++S G +L  ++  ++P
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (290), Expect = 4e-30
 Identities = 39/213 (18%), Positives = 80/213 (37%), Gaps = 11/213 (5%)

Query: 74  LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
            +G G +  V+    + +    A+K +   K   E    ++ ++ R+   +  +      
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 133 DGTSRVLAY--EFASNGSLHDILHGRKGVKG-----AQPGPVLSWQQRVKIAVGAAKGLE 185
           +   ++L +      NG    ++    G              +      +I+     GL+
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 186 YLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
           Y+H +    IIH DIK  NVL+   D    +    +++         H T  + T  Y +
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
           PE  +       +D++S   ++ EL+TG    +
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 7e-29
 Identities = 48/239 (20%), Positives = 82/239 (34%), Gaps = 28/239 (11%)

Query: 60  DELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSM 115
           D    + + +     IG G+ G V            AIKKL    Q     +    ++ +
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 116 VSRLKHENFVQLLGYCV------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
           +  + H+N + LL          +     L  E         I                 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------------D 117

Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
            ++   +      G+++LH      IIHRD+K SN+++  D   KI DF L+        
Sbjct: 118 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGT 171

Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
               T  + T  Y APE  +        D++S G ++ E++  +          Q + V
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.7 bits (188), Expect = 3e-17
 Identities = 26/173 (15%), Positives = 54/173 (31%), Gaps = 32/173 (18%)

Query: 74  LIGEGSYGRVYYGILKSGHAAAIKKLDASK-----------QPDEEFLAQVSMVSRLKHE 122
           L+GEG    V+    +      +K                   D  F       +R +  
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
              +L G  V        Y +  N  L +++         +    +  +   ++     +
Sbjct: 67  ALQKLQGLAV-----PKVYAWEGNAVLMELIDA-------KELYRVRVENPDEVLDMILE 114

Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-----NQAPDMAAR 230
            +   + +    I+H D+   NVL+ ++ +  I DF  S         ++  R
Sbjct: 115 EVAKFYHR---GIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILER 163

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	361
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.91
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.46
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.16
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.67
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.65
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.53

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-60  Score=426.17  Aligned_cols=260  Identities=27%  Similarity=0.411  Sum_probs=223.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      .++|++.+.||+|+||+||+|.++ +++.||||++..+....+++.+|+.++++++|||||++++++.++...++|||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            468889999999999999999987 7899999999887777889999999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++|+|.+++.....       ..+++..++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++..
T Consensus        96 ~~g~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          96 TYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             TTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             cCcchHHHhhhccc-------cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence            99999999976532       23999999999999999999999998   999999999999999999999999999876


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..... .......||+.|+|||++.+..|+.++|||||||++|||++|..||....               ....+.+.+
T Consensus       166 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---------------~~~~~~~~i  229 (287)
T d1opja_         166 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---------------DLSQVYELL  229 (287)
T ss_dssp             CSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC---------------CHHHHHHHH
T ss_pred             CCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc---------------hHHHHHHHH
Confidence            44222 22344568999999999999999999999999999999999777764221               122333444


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      ......+.+..++..+.+|+.+||+.||++|||+++|++.|+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            44455566667778899999999999999999999999999988764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-60  Score=421.06  Aligned_cols=252  Identities=25%  Similarity=0.336  Sum_probs=208.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|++.+.||+|+||+||+|.++ +|+.||||++....  ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            468999999999999999999987 89999999986543  234568999999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      ||++|+|.+++....         .+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+
T Consensus        84 y~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~  151 (271)
T d1nvra_          84 YCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT  151 (271)
T ss_dssp             CCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence            999999999997543         3999999999999999999999998   9999999999999999999999999998


Q ss_pred             CCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ..............+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..........              .
T Consensus       152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--------------~  217 (271)
T d1nvra_         152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------S  217 (271)
T ss_dssp             ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--------------H
T ss_pred             eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH--------------H
Confidence            7654444444567789999999999998876 578999999999999999999997543321111              1


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ...............+..+.+|+.+||+.||++|||++|+++
T Consensus       218 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111111122344677899999999999999999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-60  Score=417.32  Aligned_cols=257  Identities=24%  Similarity=0.437  Sum_probs=209.6

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++|++.+.||+|+||+||+|.+++++.||||++.......+++.+|++++++++||||+++++++.++...++||||+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            47888999999999999999998888999999988777788999999999999999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|.+++....        ..+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        85 g~L~~~l~~~~--------~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          85 GCLSDYLRTQR--------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             CBHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             CcHHHHhhccc--------cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccC
Confidence            99999987653        23899999999999999999999998   99999999999999999999999999987643


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhC-CCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ... .......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||.....                ..+...+.
T Consensus       154 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----------------~~~~~~i~  216 (263)
T d1sm2a_         154 DQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------------SEVVEDIS  216 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH----------------HHHHHHHH
T ss_pred             CCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH----------------HHHHHHHH
Confidence            322 223446789999999999999999999999999999999995 555542211                11222222


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      .......|..++.++.+|+.+||+.||++|||+++|++.|+++.++
T Consensus       217 ~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         217 TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            2333344555677899999999999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-59  Score=414.45  Aligned_cols=263  Identities=27%  Similarity=0.446  Sum_probs=206.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|++.+.||+|+||+||+|+++  ..||||++....   ...+.+.+|+.++++++|||||++++++.+ ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            368999999999999999999865  359999986533   334678899999999999999999998754 56899999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      ||++|+|.+++.....        .+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++
T Consensus        84 y~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             CCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             cCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence            9999999999975532        3899999999999999999999998   9999999999999999999999999998


Q ss_pred             CCccccccccccccccCCCCCCchhhccC---CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...............||+.|+|||++.+.   .|+.++|||||||++|||+||+.||.........  ............
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~p~  230 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVGRGYLSPD  230 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHHTSCCCC
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHhcCCCCCc
Confidence            76544444445667899999999999743   5899999999999999999999999754332111  000000000000


Q ss_pred             hhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          300 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                      .         ...+..++..+.+|+.+||+.||.+|||+++|++.|+.+.++-|
T Consensus       231 ~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         231 L---------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             G---------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             c---------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            0         11233456779999999999999999999999999999987655

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-59  Score=415.72  Aligned_cols=259  Identities=25%  Similarity=0.428  Sum_probs=217.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS  145 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  145 (361)
                      .++|++.+.||+|+||.||+|.+++++.||||++.......+.+.+|+.++++++|||||++++++.+ ...++||||++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            36888999999999999999999988999999998877778899999999999999999999998754 56799999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +|+|.+++......       .+++..++.++.||+.||.|||+.+   |+||||||+||||++++.+||+|||+++...
T Consensus        91 ~g~L~~~~~~~~~~-------~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          91 NGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             TCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence            99999987654322       2899999999999999999999998   9999999999999999999999999998764


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .... .......||+.|+|||++.+..++.++|||||||++|||+||..|+.....               ...+...+.
T Consensus       161 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---------------~~~~~~~i~  224 (272)
T d1qpca_         161 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------------NPEVIQNLE  224 (272)
T ss_dssp             SSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---------------HHHHHHHHH
T ss_pred             CCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC---------------HHHHHHHHH
Confidence            3322 223456789999999999999999999999999999999996555432211               112222223


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      .......+..++..+.+|+.+||+.||++|||+++|++.|++++.+
T Consensus       225 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            3333445556677899999999999999999999999999998865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-59  Score=415.12  Aligned_cols=247  Identities=23%  Similarity=0.382  Sum_probs=210.2

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC-CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++... ....+.+.+|+.+++.++||||+++++++.+++..++|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999976 8999999998653 344567999999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      +||+|.+++....          +++..++.++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||+++..
T Consensus       100 ~gg~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~  166 (293)
T d1yhwa1         100 AGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (293)
T ss_dssp             TTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheee
Confidence            9999999887643          999999999999999999999998   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ....  ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........               +..+.
T Consensus       167 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---------------~~~~~  229 (293)
T d1yhwa1         167 TPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---------------LYLIA  229 (293)
T ss_dssp             CSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---------------HHHHH
T ss_pred             cccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH---------------HHHHH
Confidence            4322  234567899999999999999999999999999999999999999965432111               11111


Q ss_pred             -ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          305 -DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       305 -~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ........+...+..+.+||.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             111112334456778999999999999999999999986

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-59  Score=410.92  Aligned_cols=244  Identities=28%  Similarity=0.414  Sum_probs=209.9

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC----CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||+||+|.++ +++.||+|++.+    .....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999987 899999999864    2344567899999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |||++|+|.+++....         .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        86 Ey~~~g~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a  153 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS  153 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred             eecCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeeccccee
Confidence            9999999999997654         2999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....    .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........               +.
T Consensus       154 ~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---------------~~  214 (263)
T d2j4za1         154 VHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---------------YK  214 (263)
T ss_dssp             SCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---------------HH
T ss_pred             eecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH---------------HH
Confidence            876432    23456899999999999999999999999999999999999999975432211               11


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+....  ...+...+.++.+|+.+||+.||.+|||++|+++
T Consensus       215 ~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         215 RISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            111111  1234456678999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=406.40  Aligned_cols=254  Identities=26%  Similarity=0.445  Sum_probs=219.9

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++|++.++||+|+||+||+|++++++.||||++.+.....+++.+|+.++++++||||+++++++.++...++||||+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            58999999999999999999999888999999988777888999999999999999999999999999999999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|.+++.....        .+++..++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        84 g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          84 GCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             CcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccC
Confidence            999999765542        3899999999999999999999998   99999999999999999999999999986644


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhcc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD  305 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....                ..+...+.
T Consensus       153 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----------------~~~~~~i~  215 (258)
T d1k2pa_         153 DEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----------------SETAEHIA  215 (258)
T ss_dssp             SSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----------------HHHHHHHH
T ss_pred             CCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----------------HHHHHHHH
Confidence            322 23345678999999999999999999999999999999998 8999975432                22222222


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          306 ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                      ...+...|...+..+.+|+.+||+.||++|||+++|++.|.++
T Consensus       216 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         216 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             hCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            3334445556677899999999999999999999999998653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-59  Score=416.81  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=207.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC----CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.++||+|+||+||+|..+ +++.||||++.+    .....+.+.+|++++++++||||+++++++.+....++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999986 899999999864    2344567899999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |||+||+|.+++....         .+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        88 Ey~~gg~L~~~~~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a  155 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA  155 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EccCCCCHHHhhhccC---------CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccc
Confidence            9999999999987654         3999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +..............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......               ...
T Consensus       156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---------------~~~  220 (288)
T d1uu3a_         156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---------------IFQ  220 (288)
T ss_dssp             EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------HHH
T ss_pred             eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---------------HHH
Confidence            87654433334456789999999999999999999999999999999999999997543211               111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+....  ..++...+..+.+||.+||+.||.+|||++|+++
T Consensus       221 ~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         221 KIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            122211  1334456677999999999999999999998643

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-58  Score=415.08  Aligned_cols=258  Identities=26%  Similarity=0.445  Sum_probs=204.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCC---EEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGH---AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|++.++||+|+||+||+|.++ +++   .||||.+......  .+++.+|+++|++++|||||++++++.+....++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            46777889999999999999976 333   5899988654332  35789999999999999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      ||||++|+|.+++.....        .+++.+++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+
T Consensus       106 ~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl  174 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL  174 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EEecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCccc
Confidence            999999999998876532        3899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCcccccccc---ccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCC
Q 018071          221 SNQAPDMAARLH---STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       221 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ++..........   .....||+.|+|||++.++.++.++|||||||++|||+| |+.||.....               
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---------------  239 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---------------  239 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------------
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---------------
Confidence            987643322211   223457999999999999999999999999999999998 8999964322               


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                       ..+...+......+.+..++..+.+|+.+||+.||.+|||+.+|++.|+.+++.
T Consensus       240 -~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         240 -QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence             122223333344455666778899999999999999999999999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-59  Score=412.10  Aligned_cols=255  Identities=22%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEe--CCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~l  139 (361)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++......   .+.+.+|++++++++|||||++++++.+  ....++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            368999999999999999999987 8999999999765433   3468899999999999999999999864  456899


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeEeccCCCCceEeccCCceEEec
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--DPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      |||||++|+|.+++......     ...+++..++.++.||+.||+|||+.+  ..+|+||||||+|||+++++.+||+|
T Consensus        83 vmEy~~~g~L~~~i~~~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             EEecCCCCcHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            99999999999998653211     124999999999999999999999875  23599999999999999999999999


Q ss_pred             cccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       218 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ||+++......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......              
T Consensus       158 FG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--------------  221 (269)
T d2java1         158 FGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------------  221 (269)
T ss_dssp             HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------------
T ss_pred             ccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--------------
Confidence            99997654322  22356789999999999999999999999999999999999999997543211              


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       ....+.+.. ....+..++.++.+|+.+||+.||.+|||++|+++
T Consensus       222 -~~~~i~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         222 -LAGKIREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -HHHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             011111111 12334456678999999999999999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-58  Score=409.78  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=208.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC-CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      +.|++.+.||+|+||+||+|.++ +++.||||++... ....+.+.+|++++++++|||||++++++.+....++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999987 8999999999654 334467899999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++|+|.+++.....        .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          92 AGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             TTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhcc
Confidence            99999999765432        3999999999999999999999998   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCCCCchhhc-----cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK  299 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ....  ......+||+.|+|||++.     +..|+.++|||||||++|||++|+.||....+...               
T Consensus       161 ~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---------------  223 (288)
T d2jfla1         161 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---------------  223 (288)
T ss_dssp             HHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---------------
T ss_pred             CCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---------------
Confidence            3321  2234678999999999984     45689999999999999999999999975433211               


Q ss_pred             hhhhcccc-cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 VRQCVDAR-LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +..+.... .....+...+.++.+||.+||+.||.+|||++|+++
T Consensus       224 ~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         224 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111 112233456778999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-58  Score=415.96  Aligned_cols=263  Identities=25%  Similarity=0.420  Sum_probs=216.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CC-----CEEEEEEcCCC--CCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCee
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SG-----HAAAIKKLDAS--KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~  137 (361)
                      ++|++.++||+|+||+||+|.++ ++     ..||+|.+...  ......+.+|+.+++++ +|||||++++++.+....
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            68999999999999999999965 22     26999998653  33456789999999998 899999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCC--------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCC
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKG--------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS  203 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~  203 (361)
                      ++|||||++|+|.+++........              ......+++..++.++.||+.||+|||+++   ||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence            999999999999999976542210              112235899999999999999999999998   999999999


Q ss_pred             ceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCc
Q 018071          204 NVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR  282 (361)
Q Consensus       204 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~  282 (361)
                      |||++.++.+||+|||+|+...............||+.|+|||++.++.|+.++|||||||++|||++ |+.||.+....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987655444434456778999999999999999999999999999999998 89999754321


Q ss_pred             ccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018071          283 GQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP  347 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  347 (361)
                                     ..+.+++......+.+..++..+.+||.+||+.||++|||++||++.|..
T Consensus       274 ---------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         274 ---------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             ---------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence                           22334444444555666777889999999999999999999999999863

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-58  Score=416.31  Aligned_cols=266  Identities=21%  Similarity=0.311  Sum_probs=208.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      .++|++.+.||+|+||+||+|..+ +|+.||+|++....  ...+.+.+|+.+++.++|||||+++++|.+....++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            478999999999999999999987 89999999987543  334678999999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |++||+|.+++....         .+++..++.++.||+.||.|||++ +   |+||||||+||||+++|.+||+|||+|
T Consensus        85 y~~gg~L~~~l~~~~---------~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla  152 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS  152 (322)
T ss_dssp             CCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             cCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCc
Confidence            999999999997654         299999999999999999999974 7   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh-hcc-------
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-ATP-------  293 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~-~~~-------  293 (361)
                      +....    ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+............ ...       
T Consensus       153 ~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  228 (322)
T d1s9ja_         153 GQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  228 (322)
T ss_dssp             HHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred             cccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence            75432    123567899999999999999999999999999999999999999976443211000000 000       


Q ss_pred             ------------------cCCc-hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHH
Q 018071          294 ------------------KLSE-DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQP  347 (361)
Q Consensus       294 ------------------~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~  347 (361)
                                        .... +....+.............+.++.+|+.+||+.||.+|||++|+++  .|+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                              0000 0000000100000011123567999999999999999999999998  4544

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=406.08  Aligned_cols=263  Identities=27%  Similarity=0.442  Sum_probs=215.4

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      ++|++.+.||+|+||.||+|.++++..||||++.......+.+.+|+.++++++|||||++++++. .+..++||||+++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~   95 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK   95 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence            689999999999999999999998888999999887777889999999999999999999999985 4568999999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|..++.....       ..+++.+++.++.||+.||+|||+.+   |+||||||+||||++++.+||+|||+++....
T Consensus        96 g~l~~~~~~~~~-------~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          96 GSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             CBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             Cchhhhhhhccc-------ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence            999988865432       13999999999999999999999998   99999999999999999999999999987643


Q ss_pred             ccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhhccc
Q 018071          227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA  306 (361)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      .. ........||+.|+|||++.++.++.++|||||||++|||++|..||.....               ...+...+..
T Consensus       166 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---------------~~~~~~~i~~  229 (285)
T d1fmka3         166 NE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------------NREVLDQVER  229 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---------------HHHHHHHHHT
T ss_pred             CC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC---------------HHHHHHHHHh
Confidence            22 2223456789999999999999999999999999999999997666542211               1222222333


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCC
Q 018071          307 RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPA  356 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~  356 (361)
                      ....+.+..++.++.+++.+||+.||++|||+++|+++|++.+....++.
T Consensus       230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~  279 (285)
T d1fmka3         230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  279 (285)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred             cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCC
Confidence            34445666677889999999999999999999999999999887665443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-57  Score=404.62  Aligned_cols=256  Identities=26%  Similarity=0.452  Sum_probs=211.7

Q ss_pred             hcCCCCCc-cccCCceEEEEEEEC---CCCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNAL-IGEGSYGRVYYGILK---SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|.+..+ ||+|+||+||+|.++   ++..||||++.....  ..+++.+|++++++++|||||++++++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666664 999999999999865   355799999976432  24678999999999999999999999865 468999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      ||||++|+|.+++...+.        .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        87 mE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl  155 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL  155 (285)
T ss_dssp             EECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchh
Confidence            999999999999865432        3999999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccc-cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          221 SNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       221 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ++....... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||.....                .
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----------------~  219 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----------------P  219 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----------------H
T ss_pred             hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH----------------H
Confidence            986643222 222345678999999999999999999999999999999998 9999964322                1


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      .+...+....+.+.+..++.++.+|+.+||+.||++|||+.+|++.|+....
T Consensus       220 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            2222333334445666777889999999999999999999999999987664

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=403.68  Aligned_cols=248  Identities=26%  Similarity=0.423  Sum_probs=203.5

Q ss_pred             CccccCCceEEEEEEEC---CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeCCC
Q 018071           73 ALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN  146 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  146 (361)
                      +.||+|+||+||+|.++   +++.||||++......   .+++.+|++++++++|||||++++++.+ ...+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999864   4568999999653322   3578999999999999999999999865 457899999999


Q ss_pred             CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCcc
Q 018071          147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD  226 (361)
Q Consensus       147 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~~  226 (361)
                      |+|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        92 g~L~~~l~~~~---------~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~  159 (277)
T d1xbba_          92 GPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  159 (277)
T ss_dssp             EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccc
Confidence            99999997654         3999999999999999999999998   99999999999999999999999999976533


Q ss_pred             cc-ccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          227 MA-ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       227 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .. .........||+.|+|||++.+..++.++|||||||++|||++ |+.||.....                ..+...+
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----------------~~~~~~i  223 (277)
T d1xbba_         160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------SEVTAML  223 (277)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHHH
T ss_pred             cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----------------HHHHHHH
Confidence            22 2222345678999999999999999999999999999999998 8999964322                2222333


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      ....+.+.+..++..+.+|+.+||+.||++|||+++|++.|+...
T Consensus       224 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            333444556667788999999999999999999999999888765

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-57  Score=409.84  Aligned_cols=249  Identities=22%  Similarity=0.327  Sum_probs=194.4

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.+.|++.++||+|+||+||+|..+ +++.||||++.+..  .....+.+|+.+++.++||||+++++++.++...++||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4577999999999999999999987 89999999986543  23356789999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec---cCCceEEecc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADF  218 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~---~~~~~kl~Df  218 (361)
                      |||+||+|.+++....         .+++..+..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+||
T Consensus        87 E~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DF  154 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDF  154 (307)
T ss_dssp             CCCCSCBHHHHHHTCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             eccCCCcHHHhhhccc---------CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecc
Confidence            9999999999997653         3999999999999999999999998   99999999999995   5789999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      |+++......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......               
T Consensus       155 G~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---------------  216 (307)
T d1a06a_         155 GLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---------------  216 (307)
T ss_dssp             ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------------
T ss_pred             ceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---------------
Confidence            9998654322   2345789999999999999999999999999999999999999997543211               


Q ss_pred             hhhhhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 KVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      ....+.....  ..+.....+..+.+|+.+||+.||.+|||++|+++
T Consensus       217 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         217 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111111111  12233456678999999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-57  Score=402.22  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=208.6

Q ss_pred             hcCCCCCccccCCceEEEEEEECC-C----CEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKS-G----HAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      +.|++.++||+|+||.||+|.++. +    ..||||++......  ..++.+|+.++++++|||||++++++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            467888999999999999999763 2    36999998654332  3468899999999999999999999999999999


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+.+++|.+++.....        .+++..++.++.||+.||+|||+.+   |+||||||+||||++++.+||+|||
T Consensus        87 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence            9999999999998866532        3999999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||....               ...
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~---------------~~~  220 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---------------SNH  220 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---------------CHH
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC---------------CHH
Confidence            99876443222 12334568999999999999999999999999999999999766653221               122


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      .+...+....+.+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+++.
T Consensus       221 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            33344444455566666778899999999999999999999999999998863

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-57  Score=406.45  Aligned_cols=244  Identities=25%  Similarity=0.396  Sum_probs=203.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      +.|+..+.||+|+||+||+|.++ +++.||||++.......    +.+.+|++++++++|||||++++++.++...++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45999999999999999999976 89999999997654332    46889999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |||.+|+|..++....         .+++..++.++.||+.||.|||+++   |+||||||+|||+++++.+||+|||++
T Consensus        95 E~~~~g~l~~~~~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a  162 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA  162 (309)
T ss_dssp             ECCSEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             EecCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccc
Confidence            9999999977765443         3999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhcc---CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +....      ....+||+.|+|||++.+   ..|+.++|||||||++|||++|..||......               .
T Consensus       163 ~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---------------~  221 (309)
T d1u5ra_         163 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---------------S  221 (309)
T ss_dssp             BSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------H
T ss_pred             cccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---------------H
Confidence            76532      245679999999999864   46899999999999999999999999644321               1


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+..+.........+...+..+.+|+.+||+.||.+|||++++++
T Consensus       222 ~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            111122221111223345677999999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=395.56  Aligned_cols=245  Identities=25%  Similarity=0.395  Sum_probs=196.3

Q ss_pred             CCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEe----CCeeEEEE
Q 018071           70 GTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLAY  141 (361)
Q Consensus        70 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~  141 (361)
                      ++.+.||+|+||+||+|.++ ++..||+|++......   .+.+.+|++++++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56668999999999999987 7899999998654322   3568899999999999999999999875    35678999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec-cCCceEEecccc
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDL  220 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~-~~~~~kl~Dfg~  220 (361)
                      ||+++|+|.+++....         .+++..++.++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||+
T Consensus        92 E~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             ECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             eCCCCCcHHHHHhccc---------cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            9999999999997653         3899999999999999999999874 3499999999999997 478999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ++.....    .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.......  .+..           
T Consensus       162 a~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~-----------  223 (270)
T d1t4ha_         162 ATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR-----------  223 (270)
T ss_dssp             GGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH-----------
T ss_pred             ceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHH-----------
Confidence            9754321    2346789999999998865 69999999999999999999999996432211  1111           


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                       .+.........+...+.++.+|+.+||+.||++|||++|+++
T Consensus       224 -~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         224 -RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence             111110001112223456899999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3e-56  Score=408.16  Aligned_cols=249  Identities=21%  Similarity=0.294  Sum_probs=208.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|++.+.||+|+||.||+|..+ +|+.||||++..... ..+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            578999999999999999999987 899999999976432 345688999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc--CCceEEeccccC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDLS  221 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~--~~~~kl~Dfg~a  221 (361)
                      |+||+|.+++.....        .+++..++.++.||+.||+|||+++   ||||||||+|||++.  ++.+||+|||++
T Consensus       105 ~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a  173 (350)
T d1koaa2         105 MSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT  173 (350)
T ss_dssp             CCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred             CCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchh
Confidence            999999999865432        3999999999999999999999998   999999999999964  578999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....   .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+......               +.
T Consensus       174 ~~~~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---------------~~  235 (350)
T d1koaa2         174 AHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---------------LR  235 (350)
T ss_dssp             EECCTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------------HH
T ss_pred             eecccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---------------HH
Confidence            765432   223567899999999999999999999999999999999999999975432211               11


Q ss_pred             hhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+.....  ........+..+.+||.+||+.||.+|||++|+++
T Consensus       236 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         236 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111111  11112334667999999999999999999999987

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-56  Score=403.99  Aligned_cols=246  Identities=22%  Similarity=0.300  Sum_probs=211.0

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++++.||+|+||.||+|+.+ +|+.||||++.+.    ....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            68999999999999999999987 8999999998642    344577899999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |||+||+|.+++....         .+++..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||++
T Consensus        85 ey~~gg~L~~~~~~~~---------~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a  152 (337)
T d1o6la_          85 EYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eccCCCchhhhhhccc---------CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccc
Confidence            9999999999998764         2899999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........               ..
T Consensus       153 ~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---------------~~  215 (337)
T d1o6la_         153 KEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---------------FE  215 (337)
T ss_dssp             BCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------------HH
T ss_pred             cccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH---------------HH
Confidence            8654322  234567899999999999999999999999999999999999999975432211               11


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~  343 (361)
                      .+....  ..+|...+.++.+||.+||+.||.+||+     ++++++
T Consensus       216 ~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         216 LILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            111111  2344556778999999999999999995     888876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=402.79  Aligned_cols=256  Identities=25%  Similarity=0.433  Sum_probs=208.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCC----EEEEEEcCCC--CCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .+|+++++||+|+||+||+|.+. +|+    .||+|++...  ....+++.+|++++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999976 554    5899988643  34457899999999999999999999999865 5678


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ++|++.+|+|.+++.....        .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        88 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             EEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccc
Confidence            8899999999998876542        3899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++...............||+.|+|||++.++.|+.++|||||||++|||+| |..||.....                .
T Consensus       157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~----------------~  220 (317)
T d1xkka_         157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----------------S  220 (317)
T ss_dssp             HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG----------------G
T ss_pred             cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH----------------H
Confidence            9986644333333445678999999999999999999999999999999998 8889864322                2


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                      .+...+..+.+.+.+..++..+.+|+.+||+.||.+|||+.+|++.|..+..
T Consensus       221 ~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         221 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             GHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            2333333444445566677889999999999999999999999999988753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=395.96  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=207.5

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-------CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-------QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS  136 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  136 (361)
                      +.++|++.+.||+|+||+||+|.++ +|+.||||++.+..       ...+.+.+|+.++++++|||||++++++.+...
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3468999999999999999999986 89999999986432       124678999999999999999999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC----c
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V  212 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~----~  212 (361)
                      .++|||||++|+|.+++....         .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++    .
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~---------~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~  155 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR  155 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCC
T ss_pred             EEEEEEcCCCccccchhcccc---------ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccc
Confidence            999999999999999997654         3999999999999999999999998   99999999999998777    5


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      +||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+......        
T Consensus       156 vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--------  224 (293)
T d1jksa_         156 IKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--------  224 (293)
T ss_dssp             EEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------
T ss_pred             eEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--------
Confidence            9999999987654322   23456799999999999999999999999999999999999999975432211        


Q ss_pred             ccCCchhhhhhcccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          293 PKLSEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                             +..+.......  ..+...+..+.+||.+||+.||.+|||++++++
T Consensus       225 -------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         225 -------LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -------HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   11111111100  011234567899999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.2e-56  Score=407.49  Aligned_cols=249  Identities=21%  Similarity=0.267  Sum_probs=209.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|++.+.||+|+||.||+|..+ +|+.||||++.... .....+.+|+.++++++|||||++++++.++...++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999986 89999999987643 2345678999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec--cCCceEEeccccC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF--DDDVAKIADFDLS  221 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~--~~~~~kl~Dfg~a  221 (361)
                      |+||+|.+++....        ..+++.+++.++.||+.||+|||+.|   |+||||||+||||+  .++.+||+|||++
T Consensus       108 ~~gg~L~~~~~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla  176 (352)
T d1koba_         108 LSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA  176 (352)
T ss_dssp             CCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             CCCChHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence            99999999876543        23999999999999999999999998   99999999999998  6789999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....   .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+......               +.
T Consensus       177 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---------------~~  238 (352)
T d1koba_         177 TKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---------------LQ  238 (352)
T ss_dssp             EECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---------------HH
T ss_pred             eecCCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---------------HH
Confidence            876432   223557899999999999999999999999999999999999999975432211               11


Q ss_pred             hhccc--ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+...  ..........+.++.+||.+||+.||.+|||+.|+++
T Consensus       239 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         239 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111  1112233456678999999999999999999999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.9e-56  Score=399.66  Aligned_cols=243  Identities=25%  Similarity=0.365  Sum_probs=209.4

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC----CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+    .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999986 899999999864    2344578899999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      |||+||+|..++....         .+++..++.++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||++
T Consensus        84 E~~~gg~l~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a  151 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFA  151 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eecCCccccccccccc---------cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccc
Confidence            9999999999987765         2889999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....     ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||......               +...
T Consensus       152 ~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---------------~~~~  211 (316)
T d1fota_         152 KYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---------------KTYE  211 (316)
T ss_dssp             EECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---------------HHHH
T ss_pred             eEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---------------HHHH
Confidence            875432     34578999999999999999999999999999999999999999754321               1112


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      .+....  ..+++..+.++.+++.+||+.||.+||     |++++++
T Consensus       212 ~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         212 KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            222221  134455667799999999999999996     8999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-56  Score=392.62  Aligned_cols=257  Identities=27%  Similarity=0.413  Sum_probs=202.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l  139 (361)
                      .++|++.+.||+|+||.||+|.+.    .+..||||.+......  .+.+.+|+.++++++||||+++++++. ....++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            368999999999999999999865    2457899998654333  357899999999999999999999985 467899


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccc
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD  219 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg  219 (361)
                      ||||+++|+|.+++.....        .+++..++.++.||+.||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        85 v~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccch
Confidence            9999999999998765542        3899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++...... ....+...||+.|+|||++.+..|+.++|||||||++|||++ |..||.......               
T Consensus       154 ~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---------------  217 (273)
T d1mp8a_         154 LSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------------  217 (273)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------------
T ss_pred             hheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---------------
Confidence            998764322 223345678999999999999999999999999999999998 899997543321               


Q ss_pred             hhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          299 KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                       +...+......+.+..++..+.+||.+||+.||++|||+++|++.|+.+++.
T Consensus       218 -~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         218 -VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence             1111222222345566778899999999999999999999999999998764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-56  Score=391.65  Aligned_cols=252  Identities=29%  Similarity=0.480  Sum_probs=205.9

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEe-CCeeEEEEEeCC
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLAYEFAS  145 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~  145 (361)
                      ++|++.+.||+|+||.||+|.++ |+.||||+++.+ ...+.+.+|++++++++||||+++++++.+ ....++||||++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            57888999999999999999986 889999999654 445789999999999999999999999865 456899999999


Q ss_pred             CCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCCc
Q 018071          146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP  225 (361)
Q Consensus       146 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~~  225 (361)
                      +|+|.+++......       .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~g~L~~~l~~~~~~-------~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          85 KGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             TEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecC
Confidence            99999999754321       2899999999999999999999998   9999999999999999999999999998653


Q ss_pred             cccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCCchhhhhhc
Q 018071          226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV  304 (361)
Q Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..     .....+|..|+|||++.+..++.++|||||||++|||+| |+.||.....                ..+...+
T Consensus       155 ~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----------------~~~~~~i  213 (262)
T d1byga_         155 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----------------KDVVPRV  213 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----------------GGHHHHH
T ss_pred             CC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----------------HHHHHHH
Confidence            32     234568999999999999999999999999999999998 7888764322                2222333


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          305 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                      ......+.+...+.++.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         214 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            33444556666778899999999999999999999999999998754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-56  Score=400.09  Aligned_cols=265  Identities=25%  Similarity=0.381  Sum_probs=214.5

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      .++|++.+.||+|+||+||+|+++      +++.||||++......  .+++.+|+.++++++||||+++++++.+....
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            478999999999999999999864      4578999999764433  35789999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCC---------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 018071          138 VLAYEFASNGSLHDILHGRKGVK---------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS  202 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~---------------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp  202 (361)
                      +++|||+++|+|.+++.......               .......+++..++.++.||+.||+|||+.+   ||||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence            99999999999999997543211               0112234899999999999999999999998   99999999


Q ss_pred             CceEeccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCC-CCCCCCCC
Q 018071          203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR-KPVDHTLP  281 (361)
Q Consensus       203 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~pf~~~~~  281 (361)
                      +||||+.++.+||+|||+++...........+...||+.|+|||++.+..|+.++|||||||++|||++|. .||.....
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999987654444344445678899999999999999999999999999999999986 56754322


Q ss_pred             cccchhhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 018071          282 RGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL  349 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~  349 (361)
                      .                .+...+......+.+..++.++.+|+.+||+.+|++|||+.+|+++|+++.
T Consensus       249 ~----------------e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         249 E----------------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             H----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             H----------------HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            1                111122222233445566678999999999999999999999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=398.05  Aligned_cols=248  Identities=18%  Similarity=0.228  Sum_probs=209.9

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      +.++|++.+.||+|+||+||+|.++ +++.||||++.........+.+|+++|+.++||||+++++++.+....|+||||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            4578999999999999999999987 899999999987665566788999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC--CceEEeccccC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD--DVAKIADFDLS  221 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~--~~~kl~Dfg~a  221 (361)
                      |+||+|.+++.....        .+++.+++.++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||++
T Consensus        83 ~~gg~L~~~i~~~~~--------~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~  151 (321)
T d1tkia_          83 ISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             CCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             CCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchh
Confidence            999999999976531        3899999999999999999999998   9999999999999854  48999999998


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....   .......||+.|+|||.+.+..|+.++|||||||++|+|++|..||.......               .+.
T Consensus       152 ~~~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---------------~~~  213 (321)
T d1tkia_         152 RQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---------------IIE  213 (321)
T ss_dssp             EECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------------HHH
T ss_pred             hccccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---------------HHH
Confidence            765332   22345678999999999999999999999999999999999999997543221               111


Q ss_pred             hhcccccCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          302 QCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .+.....  .++.    ..+.++.+|+.+||..||.+|||++|+++
T Consensus       214 ~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         214 NIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHhCCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2222211  1121    24567899999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-55  Score=392.43  Aligned_cols=258  Identities=24%  Similarity=0.342  Sum_probs=203.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCcceeeeEEEeCC----e
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGT----S  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~  136 (361)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.+....    .+.+.+|+++++.++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            578999999999999999999976 8999999999764432    246889999999999999999999987643    3


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .|+||||++|++|.+++....         .+++.+++.++.||+.||+|||+++   |+||||||+|||++.++..+|+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~  153 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM  153 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEEC
T ss_pred             EEEEEECCCCCEehhhhcccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceee
Confidence            789999999999999987654         3999999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccc-cccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          217 DFDLSNQAPDM-AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       217 Dfg~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |||.+...... .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||....+....          
T Consensus       154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~----------  223 (277)
T d1o6ya_         154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----------  223 (277)
T ss_dssp             CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----------
T ss_pred             hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH----------
Confidence            99987654322 1222345678999999999999999999999999999999999999999754332110          


Q ss_pred             Cchhhhhhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHh
Q 018071          296 SEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRP-NMSIVVKALQPLLN  350 (361)
Q Consensus       296 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~l~~  350 (361)
                           ...+....  ........+..+.++|.+||+.||.+|| |++++++.|.++.+
T Consensus       224 -----~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         224 -----YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             -----HHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             -----HHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence                 01111000  0011223456799999999999999999 89999999888754

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=397.21  Aligned_cols=269  Identities=23%  Similarity=0.352  Sum_probs=207.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEeC-C
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG-T  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~~-~  135 (361)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++......  .+.+.+|+.++.++ +|+||+.+++++.+. .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            478999999999999999999854      3468999998754322  34677788887776 689999999987654 5


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF  208 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~  208 (361)
                      ..++|||||++|+|.+++........       ......+++..++.++.||+.||+|||+++   |+||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            68999999999999999976542110       111235899999999999999999999998   99999999999999


Q ss_pred             cCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhC-CCCCCCCCCcccchh
Q 018071          209 DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSL  287 (361)
Q Consensus       209 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~pf~~~~~~~~~~~  287 (361)
                      +++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++| ..||......     
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-----  243 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----  243 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-----
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-----
Confidence            9999999999999876544444445567899999999999999999999999999999999986 4577543221     


Q ss_pred             hhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          288 VTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                                ..+...+........+...+.++.+|+.+||+.||++|||+++|++.|+.+++++
T Consensus       244 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         244 ----------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             ----------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence                      1222233333334455556778999999999999999999999999999998764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-55  Score=392.99  Aligned_cols=267  Identities=27%  Similarity=0.422  Sum_probs=217.2

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-C-------CCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-S-------GHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG  134 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~~  134 (361)
                      .++|++.+.||+|+||.||+|+.. +       +..||||++.+....  ..++.+|+..+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            368999999999999999999854 2       247999999765442  35788898888888 799999999999999


Q ss_pred             CeeEEEEEeCCCCcHHHhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEe
Q 018071          135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI  207 (361)
Q Consensus       135 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill  207 (361)
                      ...++||||+++|+|.+++.......       .......+++..++.++.||+.||+|||+.+   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999997664221       1122345999999999999999999999998   9999999999999


Q ss_pred             ccCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccch
Q 018071          208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS  286 (361)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~  286 (361)
                      +.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |..||.....     
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-----  243 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  243 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence            9999999999999988765554444566789999999999999999999999999999999998 7888864322     


Q ss_pred             hhhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          287 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                                 ..+...+......+.+..++..+.+|+.+||+.||.+|||+.||++.|+.+++.
T Consensus       244 -----------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         244 -----------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             -----------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence                       222333334444455666778899999999999999999999999999999874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=392.10  Aligned_cols=269  Identities=28%  Similarity=0.415  Sum_probs=214.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCC--EEEEEEcCC--CCCChHHHHHHHHHHhcC-CCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGH--AAAIKKLDA--SKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~--~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|++.++||+|+||.||+|.++ ++.  .||||++..  .....+++.+|+++++++ +|||||++++++.+....++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            68888999999999999999977 554  578888754  233456899999999998 799999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          141 YEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      |||+++|+|.+++.......       .......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            99999999999997542100       0011234999999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCC-CCCCCCCCcccchhhhhhc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR-KPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~pf~~~~~~~~~~~~~~~~  292 (361)
                      ||+|||+++......   ......||..|+|||.+.+..|+.++|||||||++|||++|. .||.....           
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-----------  232 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------  232 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-----------
Confidence            999999987654322   223556899999999999999999999999999999999976 46653321           


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCC
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAG  357 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~  357 (361)
                           ..+...+......+.+..++.++.+||.+||+.||++|||+++|++.|+.+++..+....
T Consensus       233 -----~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~  292 (309)
T d1fvra_         233 -----AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN  292 (309)
T ss_dssp             -----HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBC
T ss_pred             -----HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCCC
Confidence                 122222223333455566778899999999999999999999999999999987665443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.7e-55  Score=398.69  Aligned_cols=243  Identities=22%  Similarity=0.306  Sum_probs=208.4

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCC----CCCChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY  141 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~  141 (361)
                      ++|++++.||+|+||.||+|.++ +|+.||||++.+    .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            68999999999999999999987 899999999864    2344567899999999999999999999999999999999


Q ss_pred             EeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccC
Q 018071          142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS  221 (361)
Q Consensus       142 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a  221 (361)
                      ||+.+|+|.+++....         .+++..++.++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||++
T Consensus       121 e~~~~g~l~~~l~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a  188 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccccccchhhhHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceee
Confidence            9999999999987654         2999999999999999999999998   999999999999999999999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhh
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR  301 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      +.....     ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+..+..               .+.
T Consensus       189 ~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---------------~~~  248 (350)
T d1rdqe_         189 KRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---------------IYE  248 (350)
T ss_dssp             EECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------HHH
T ss_pred             eecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---------------HHH
Confidence            865432     345789999999999999999999999999999999999999997543211               111


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018071          302 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~  343 (361)
                      .+.....  ..+...+..+.+||.+||+.||.+|+     |++++++
T Consensus       249 ~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         249 KIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHhcCCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            1111111  23344567799999999999999994     8999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-54  Score=385.47  Aligned_cols=248  Identities=25%  Similarity=0.312  Sum_probs=207.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC----------hHHHHHHHHHHhcCC-CCCcceeeeEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----------DEEFLAQVSMVSRLK-HENFVQLLGYCVD  133 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~-hpniv~~~~~~~~  133 (361)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++.+....          .+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999986 8999999999764322          135788999999997 9999999999999


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      +...+||||||++|+|.+++..+.         .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~  149 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI  149 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCe
Confidence            999999999999999999997654         3999999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhcc------CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchh
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT------GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL  287 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~  287 (361)
                      ||+|||+++......   ......||+.|+|||++.+      ..++.++||||+||++|+|++|+.||....+...   
T Consensus       150 kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~---  223 (277)
T d1phka_         150 KLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---  223 (277)
T ss_dssp             EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---
T ss_pred             EEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH---
Confidence            999999998764322   2355789999999999863      3578899999999999999999999975533211   


Q ss_pred             hhhhcccCCchhhhhhccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          288 VTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                  ...+.....  ........+.++.+|+.+||+.||.+|||++|+++
T Consensus       224 ------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         224 ------------LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ------------HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ------------HHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                        111111111  12223356678999999999999999999999876

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-54  Score=399.41  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=202.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC----CChHHHHHH---HHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQ---VSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e---~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      ++|++.++||+|+||.||+|+.+ +|+.||||++.+..    .....+.+|   +.+++.++|||||++++++.+....+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            68999999999999999999987 89999999985421    222334444   66777788999999999999999999


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +|||||+||+|.+++....         .+++..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+||
T Consensus        84 ivmE~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DF  151 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL  151 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEEecCCCcHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeee
Confidence            9999999999999997654         3899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCc
Q 018071          219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE  297 (361)
Q Consensus       219 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      |+++.....    .....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||..........+..        
T Consensus       152 Gla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~--------  219 (364)
T d1omwa3         152 GLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--------  219 (364)
T ss_dssp             TTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH--------
T ss_pred             ceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------
Confidence            999865432    2345689999999999974 578999999999999999999999997544322211111        


Q ss_pred             hhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018071          298 DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK  343 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~  343 (361)
                          ....  .....+...+..+.+||.+||+.||.+|||     ++++++
T Consensus       220 ----~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         220 ----MTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ----HSSS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ----hccc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                0011  111233445677999999999999999999     688876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-55  Score=387.06  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=200.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC--CC--CEEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK--SG--HAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV  138 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  138 (361)
                      ++|++.+.||+|+||.||+|.++  ++  ..||||++.+..    ...+++.+|+.++++++||||+++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            57999999999999999999864  23  378999986532    223578999999999999999999999965 4678


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecc
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF  218 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df  218 (361)
                      +||||+++|+|.+++.....        .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        87 lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~Df  155 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDF  155 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCC
T ss_pred             eeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccc
Confidence            99999999999988876542        3999999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCcccccc-ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccCC
Q 018071          219 DLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS  296 (361)
Q Consensus       219 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (361)
                      |+++........ .......||..|+|||.+.+..++.++|||||||++|||++ |..||......              
T Consensus       156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--------------  221 (273)
T d1u46a_         156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------------  221 (273)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------------
T ss_pred             hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--------------
Confidence            999876443222 22345568889999999999999999999999999999998 89999644221              


Q ss_pred             chhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018071          297 EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL  348 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l  348 (361)
                       +.+..+.......+.+..++..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus       222 -~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         222 -QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence             112223333334445556677899999999999999999999999998864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=391.06  Aligned_cols=267  Identities=23%  Similarity=0.389  Sum_probs=221.4

Q ss_pred             hcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCcceeeeEEEeCCee
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~  137 (361)
                      ++|++.++||+|+||.||+|+++      +++.||||++......  ..++.+|+.+++.+ +|||||++++++.+....
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            68899999999999999999852      5678999999765433  34688999999999 699999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKG---------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF  208 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~  208 (361)
                      ++|||||++|+|.+++........         ......+++..++.++.||+.||+|||+++   ++||||||+|||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence            999999999999999976542110         112235899999999999999999999998   99999999999999


Q ss_pred             cCCceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHh-CCCCCCCCCCcccchh
Q 018071          209 DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL  287 (361)
Q Consensus       209 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~  287 (361)
                      .++.+||+|||+++...........+...||+.|+|||.+.++.++.++|||||||++|||++ |.+||.....      
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~------  253 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------  253 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS------
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH------
Confidence            999999999999998765544445566789999999999999999999999999999999999 5555543222      


Q ss_pred             hhhhcccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          288 VTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                               .+.+.++++.......+...+..+.+||.+||+.||.+|||+.+|+++|+.+++.
T Consensus       254 ---------~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         254 ---------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             ---------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence                     1233444444455555556678899999999999999999999999999988765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=389.40  Aligned_cols=271  Identities=23%  Similarity=0.302  Sum_probs=203.4

Q ss_pred             CCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC------hHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEeC
Q 018071           72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA  144 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  144 (361)
                      +++||+|+||+||+|..+ +|+.||||++......      .+.+.+|+.++++++|||||++++++.++...++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999976 8999999999653321      246889999999999999999999999999999999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      .++++..++....         .+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++..
T Consensus        83 ~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~  150 (299)
T d1ua2a_          83 ETDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF  150 (299)
T ss_dssp             SEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             cchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcccccc
Confidence            8877776665432         3889999999999999999999998   999999999999999999999999999876


Q ss_pred             ccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhhh
Q 018071          225 PDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC  303 (361)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      .....  .....+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.........+...............
T Consensus       151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         151 GSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             TSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             CCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence            44322  23456799999999998754 6899999999999999999999999765433221111100000000000000


Q ss_pred             ------cccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCCC
Q 018071          304 ------VDARLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAGE  358 (361)
Q Consensus       304 ------~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~~  358 (361)
                            .........+     ...+..+.+|+.+||+.||++|||++|+++  ...++..|.|.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~--Hp~f~~~p~p~~~  292 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSNRPGPTPG  292 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTSSSCCCCS
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC--CHhhCCCCCCCCC
Confidence                  0000000111     123567999999999999999999999986  2455666555543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=393.09  Aligned_cols=246  Identities=23%  Similarity=0.324  Sum_probs=206.6

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCC----CCChHHHHHHHHHHh-cCCCCCcceeeeEEEeCCeeEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVS-RLKHENFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~-~l~hpniv~~~~~~~~~~~~~lv  140 (361)
                      ++|++.++||+|+||+||+|.++ +++.||||++.+.    ....+.+..|+.++. .++||||+++++++.++...++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999987 8999999999642    334456777777665 68999999999999999999999


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEecccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL  220 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~  220 (361)
                      |||+++|+|.+++....         .+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        82 mEy~~~g~L~~~i~~~~---------~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~  149 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM  149 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EeecCCCcHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccch
Confidence            99999999999997654         2899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhh
Q 018071          221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV  300 (361)
Q Consensus       221 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ++......  ...+...||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+..+...               +
T Consensus       150 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~---------------~  212 (320)
T d1xjda_         150 CKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---------------F  212 (320)
T ss_dssp             CBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------------H
T ss_pred             hhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH---------------H
Confidence            98654322  234557899999999999999999999999999999999999999975433211               1


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 018071          301 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS-IVVK  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~  343 (361)
                      ..+....  ..++...+..+.+||.+||+.||.+|||+. ++++
T Consensus       213 ~~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         213 HSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHcCC--CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1111111  133445567799999999999999999996 6764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=389.26  Aligned_cols=274  Identities=23%  Similarity=0.342  Sum_probs=205.9

Q ss_pred             hhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHH--HHHHHhcCCCCCcceeeeEEEeCC----eeEE
Q 018071           66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYCVDGT----SRVL  139 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--e~~~l~~l~hpniv~~~~~~~~~~----~~~l  139 (361)
                      .++|.+.+.||+|+||.||+|+++ |+.||||++....  .+++.+  |+..+..++||||+++++++.+..    ..++
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            467888899999999999999975 8999999986543  334444  445556789999999999998653    5789


Q ss_pred             EEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeEeccCCCCceEeccCCceE
Q 018071          140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-----DPHIIHRDIKSSNVLIFDDDVAK  214 (361)
Q Consensus       140 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~ivHrDikp~Nill~~~~~~k  214 (361)
                      ||||+++|+|.++++...          +++..++.++.|++.||.|||+.+     .++|+||||||+||||+.++.+|
T Consensus        79 v~Ey~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             EEecccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence            999999999999998653          899999999999999999999741     22499999999999999999999


Q ss_pred             EeccccCCCCccccc--cccccccccCCCCCCchhhccCC------CCCccceecHHHHHHHHHhCCCCCCCCCCcccch
Q 018071          215 IADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQ------LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS  286 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~  286 (361)
                      |+|||+++.......  ........||+.|+|||++.+..      ++.++|||||||+||||+||..||..........
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            999999876533221  11234578999999999987643      6778999999999999999998886433222111


Q ss_pred             hhhhhcccCCchhhh-hhcccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          287 LVTWATPKLSEDKVR-QCVDARLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                      . ...........+. ...+...+.+.+     ...+..+.+|+.+||+.||.+|||+.||++.|+++.++.+
T Consensus       229 ~-~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         229 Y-DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             T-TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             h-hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            1 1111111111222 222233322222     2456779999999999999999999999999999887643

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-54  Score=390.73  Aligned_cols=250  Identities=18%  Similarity=0.243  Sum_probs=200.7

Q ss_pred             hhcCCCCC-ccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhc-CCCCCcceeeeEEEe----CCeeE
Q 018071           66 TENFGTNA-LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSR-LKHENFVQLLGYCVD----GTSRV  138 (361)
Q Consensus        66 ~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~----~~~~~  138 (361)
                      .++|.+.+ +||+|+||+||+|.++ +++.||||++..    ...+.+|+.++.+ .+|||||+++++|.+    ....+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            47898875 6999999999999986 899999999864    3567889988655 489999999999875    46689


Q ss_pred             EEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc---CCceEE
Q 018071          139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKI  215 (361)
Q Consensus       139 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~---~~~~kl  215 (361)
                      +|||||+||+|.+++.....       ..+++.+++.++.||+.||+|||+.+   |+||||||+|||+++   .+.+||
T Consensus        86 ivmEy~~gg~L~~~i~~~~~-------~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSC-------CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEECCCCCcHHHHHHhcCC-------CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccc
Confidence            99999999999999976532       23999999999999999999999998   999999999999985   557999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      +|||+++......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||............       
T Consensus       156 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-------  225 (335)
T d2ozaa1         156 TDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------  225 (335)
T ss_dssp             CCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------
T ss_pred             cccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-------
Confidence            9999997654322   235678999999999999999999999999999999999999999654332111000       


Q ss_pred             CchhhhhhcccccCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          296 SEDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                          ...+.......+  .....+.++.+||.+||+.||++|||+.|+++
T Consensus       226 ----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         226 ----KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                001111111111  12345778999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-53  Score=382.28  Aligned_cols=256  Identities=25%  Similarity=0.380  Sum_probs=207.1

Q ss_pred             CCccccCCceEEEEEEECC----CCEEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCcceeeeEEEe-CCeeEEEEEeC
Q 018071           72 NALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLAYEFA  144 (361)
Q Consensus        72 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~  144 (361)
                      .++||+|+||+||+|.+..    ...||||++.....  ..+++.+|++++++++||||+++++++.+ +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4579999999999999752    23689999975332  23679999999999999999999999875 46889999999


Q ss_pred             CCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCCC
Q 018071          145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA  224 (361)
Q Consensus       145 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~~  224 (361)
                      ++|+|.+++.....        .+++..++.++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++..
T Consensus       112 ~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~  180 (311)
T d1r0pa_         112 KHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  180 (311)
T ss_dssp             TTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred             ecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhc
Confidence            99999999876542        3788999999999999999999998   999999999999999999999999999876


Q ss_pred             cccccc--ccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchhhhh
Q 018071          225 PDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ  302 (361)
Q Consensus       225 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      ......  .......||+.|+|||.+.+..++.++||||||+++|||++|..||.......               .+..
T Consensus       181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---------------~~~~  245 (311)
T d1r0pa_         181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---------------DITV  245 (311)
T ss_dssp             TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------------------CHH
T ss_pred             cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---------------HHHH
Confidence            443222  12334578999999999999999999999999999999999888875432111               1111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCC
Q 018071          303 CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP  353 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~  353 (361)
                      .+....+...+..++..+.+|+.+||+.||++|||+.||++.|+.+++...
T Consensus       246 ~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence            111122233444566789999999999999999999999999999998643

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-54  Score=386.72  Aligned_cols=266  Identities=24%  Similarity=0.394  Sum_probs=216.8

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC------CCCEEEEEEcCCCCCCh--HHHHHHHHHHhcCCCCCcceeeeEEEeCCee
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYCVDGTSR  137 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  137 (361)
                      .++|++.+.||+|+||+||+|.++      +++.||||++.......  ..+.+|+.++++++||||+++++++......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            368899999999999999999864      35789999997543332  4588999999999999999999999999999


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          138 VLAYEFASNGSLHDILHGRKGVK-GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      ++||||+++|+|.+++....... .......+++..++.++.|++.||.|||+++   |+||||||+|||+++++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            99999999999999886432110 0111123789999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCC-CCCCCCCCcccchhhhhhcccC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR-KPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. .||.....              
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------------  241 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------------  241 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------------
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--------------
Confidence            999998765544444455667899999999999999999999999999999999985 67753322              


Q ss_pred             CchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 018071          296 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN  350 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~  350 (361)
                        ..+...+......+.+..++..+.+|+.+||+.+|.+|||+++|++.|+..++
T Consensus       242 --~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         242 --EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             --HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             --HHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              12222222222334455667789999999999999999999999999987755

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=380.64  Aligned_cols=276  Identities=23%  Similarity=0.321  Sum_probs=206.4

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++....   ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999986 89999999996533   235688999999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      |+.+ ++.+++.....       ..+++..++.++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+++
T Consensus        82 ~~~~-~~~~~~~~~~~-------~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~  150 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR  150 (298)
T ss_dssp             CCSE-EHHHHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred             ecCC-chhhhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcce
Confidence            9966 55555433322       23999999999999999999999998   9999999999999999999999999986


Q ss_pred             CCccccccccccccccCCCCCCchhhccCC-CCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch---
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED---  298 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  298 (361)
                      .....  ........||+.|+|||++.... ++.++|||||||++|+|++|+.||...........+..........   
T Consensus       151 ~~~~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (298)
T d1gz8a_         151 AFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  228 (298)
T ss_dssp             HHCCC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             eccCC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence            54322  22234567999999999887665 5789999999999999999999997654322111110000000000   


Q ss_pred             hhhhhccccc------CCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCCCCC
Q 018071          299 KVRQCVDARL------GGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGPAG  357 (361)
Q Consensus       299 ~~~~~~~~~~------~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~  357 (361)
                      .+....+...      ...   .....+..+.+|+.+||+.||++|||++|+++.  ..++.-+.|.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H--~ff~~~~~p~p  294 (298)
T d1gz8a_         229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVTKPVP  294 (298)
T ss_dssp             TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGTTCCCCCC
T ss_pred             ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC--HhhccCCCCCC
Confidence            0000000000      000   011334678999999999999999999999873  44454455554

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=381.29  Aligned_cols=239  Identities=21%  Similarity=0.356  Sum_probs=198.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC-------ChHHHHHHHHHHhcCC--CCCcceeeeEEEeCC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLK--HENFVQLLGYCVDGT  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~  135 (361)
                      .++|++.++||+|+||+||+|..+ +|+.||||++.+...       ...++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            468999999999999999999986 899999999864321       1234678999999986  899999999999999


Q ss_pred             eeEEEEEeCCC-CcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-CCce
Q 018071          136 SRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVA  213 (361)
Q Consensus       136 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-~~~~  213 (361)
                      ..++||||+.+ +++.+++....         .+++..++.++.||+.||+|||+++   |+||||||+|||++. ++.+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---------~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~v  150 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL  150 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred             eEEEEEEeccCcchHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeE
Confidence            99999999976 57888886553         3999999999999999999999998   999999999999985 5799


Q ss_pred             EEeccccCCCCccccccccccccccCCCCCCchhhccCCC-CCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      ||+|||+++.....    ..+...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....     ..     
T Consensus       151 kl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-----  216 (273)
T d1xwsa_         151 KLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-----  216 (273)
T ss_dssp             EECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-----
T ss_pred             EECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH-----
Confidence            99999999754322    2356789999999999987766 567899999999999999999996321     00     


Q ss_pred             ccCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          293 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                 ....  ..++...+.++.+||.+||+.||++|||++|+++
T Consensus       217 -----------~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         217 -----------IRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -----------HHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----------hhcc--cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                       0000  1122234567999999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-52  Score=374.55  Aligned_cols=263  Identities=21%  Similarity=0.266  Sum_probs=200.6

Q ss_pred             hcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEEe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  143 (361)
                      ++|++.++||+|+||+||+|++++|+.||||++....   ...+.+.+|+.++++++||||+++++++.+.+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999999999999999996543   2346899999999999999999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCCC
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ  223 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~~  223 (361)
                      +.++.+..+.....         .+++..++.++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||++..
T Consensus        82 ~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~  149 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA  149 (286)
T ss_dssp             CSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             ehhhhHHHHHhhcC---------CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence            98766666655433         3999999999999999999999998   99999999999999999999999999865


Q ss_pred             CccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCchh---
Q 018071          224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK---  299 (361)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  299 (361)
                      .....  .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+...........   
T Consensus       150 ~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (286)
T d1ob3a_         150 FGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (286)
T ss_dssp             HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence            43221  123445689999999998754 568999999999999999999999975543221111100000000000   


Q ss_pred             ---hhhh---c---ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 ---VRQC---V---DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 ---~~~~---~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                         ....   .   ............+..+.+|+.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0000   0   000001122334567899999999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=376.02  Aligned_cols=264  Identities=20%  Similarity=0.305  Sum_probs=199.6

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-C-CCEEEEEEcCCC---CCChHHHHHHHHHHhcC---CCCCcceeeeEEEe----
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-S-GHAAAIKKLDAS---KQPDEEFLAQVSMVSRL---KHENFVQLLGYCVD----  133 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~---~~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~----  133 (361)
                      .++|++++.||+|+||+||+|.+. + ++.||||++...   ......+.+|+.+++.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999974 4 667999998542   22334567788777666   79999999999863    


Q ss_pred             -CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCc
Q 018071          134 -GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV  212 (361)
Q Consensus       134 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~  212 (361)
                       ....+++|||+.++.+........        ..+++..++.++.|++.||+|||+++   |+||||||+|||+++++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~  154 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ  154 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence             346789999998877655444332        23899999999999999999999998   999999999999999999


Q ss_pred             eEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 018071          213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT  292 (361)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~  292 (361)
                      +||+|||+++.....   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..+......+....
T Consensus       155 ~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  231 (305)
T d1blxa_         155 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  231 (305)
T ss_dssp             EEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence            999999998865432   23456789999999999999999999999999999999999999997654332211111100


Q ss_pred             ccCCchhhh-------hhcc---cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          293 PKLSEDKVR-------QCVD---ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       293 ~~~~~~~~~-------~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      .......+.       ....   ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000000       0000   00001122334567899999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-50  Score=362.61  Aligned_cols=267  Identities=18%  Similarity=0.203  Sum_probs=212.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCC-CCcceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|++.++||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.++| +|++.+++++.+....++||||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            468999999999999999999977 89999999885533 33467889999999975 8999999999999999999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc-----CCceEEecc
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-----DDVAKIADF  218 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~-----~~~~kl~Df  218 (361)
                      + +++|.+++.....        .+++..+..++.|++.||+|||++|   |+||||||+|||++.     ++.+||+||
T Consensus        83 ~-~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          83 L-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             c-CCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccc
Confidence            9 6799999876542        3899999999999999999999998   999999999999974     578999999


Q ss_pred             ccCCCCccccc-----cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          219 DLSNQAPDMAA-----RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       219 g~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+++.......     .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+...............
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~  230 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  230 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence            99976543211     1123456899999999999999999999999999999999999999976544322111110000


Q ss_pred             cCCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcCCC
Q 018071          294 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG  354 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~  354 (361)
                      .......     ..+    ...++.++.+++..|++.+|++||+++.+.+.|+++++....
T Consensus       231 ~~~~~~~-----~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~  282 (293)
T d1csna_         231 KKQSTPL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  282 (293)
T ss_dssp             HHHHSCH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ccCCCCh-----HHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence            0000000     001    112345699999999999999999999999999999876543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-51  Score=368.53  Aligned_cols=273  Identities=20%  Similarity=0.285  Sum_probs=200.4

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCcceeeeEEEe--------
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVD--------  133 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--------  133 (361)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++....   ....++.+|+++|+.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            379999999999999999999986 89999999986532   334678999999999999999999998754        


Q ss_pred             CCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCce
Q 018071          134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA  213 (361)
Q Consensus       134 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~  213 (361)
                      ....++||||+.++.+..+.....         .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~  156 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL  156 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred             CceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence            346789999998766655543332         3899999999999999999999998   9999999999999999999


Q ss_pred             EEeccccCCCCcccc--ccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 018071          214 KIADFDLSNQAPDMA--ARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW  290 (361)
Q Consensus       214 kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~  290 (361)
                      ||+|||+++......  ........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........+..
T Consensus       157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~  236 (318)
T d3blha1         157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  236 (318)
T ss_dssp             EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence            999999997554222  11223446799999999999865 689999999999999999999999976543322222211


Q ss_pred             hcccCCchh--------hhhhcccccCCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhcC
Q 018071          291 ATPKLSEDK--------VRQCVDARLGGDYPP-------KAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR  352 (361)
Q Consensus       291 ~~~~~~~~~--------~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~  352 (361)
                      .........        ....+........+.       ..+..+.+|+.+||+.||++|||++|+++  ...+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~--Hpff~~~  311 (318)
T d3blha1         237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWSD  311 (318)
T ss_dssp             HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGSSS
T ss_pred             hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc--ChhhccC
Confidence            111111110        000111111111111       11446788999999999999999999985  3344433

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=375.73  Aligned_cols=267  Identities=22%  Similarity=0.299  Sum_probs=199.6

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcceeeeEEEeCC----ee
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGT----SR  137 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~  137 (361)
                      ++.+|++++.||+|+||+||+|..+ +|+.||||++.+....  .+.+.+|+.+|+.++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            3468999999999999999999976 8999999999764432  357889999999999999999999987543    23


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEec
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD  217 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D  217 (361)
                      +++++++.+|+|.+++....          +++..++.++.||+.||+|||+++   ||||||||+|||+++++.+||+|
T Consensus        86 ~~l~~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~D  152 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD  152 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcc
Confidence            45556667999999997653          999999999999999999999998   99999999999999999999999


Q ss_pred             cccCCCCccccc-cccccccccCCCCCCchhhc-cCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          218 FDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       218 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      ||+++....... .......+||+.|+|||++. +..++.++||||+||++|+|++|+.||...................
T Consensus       153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~  232 (345)
T d1pmea_         153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  232 (345)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence            999976533222 22235577999999999985 4577899999999999999999999997654322211111111111


Q ss_pred             Cchh--------hhhhc-ccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018071          296 SEDK--------VRQCV-DARLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVKA  344 (361)
Q Consensus       296 ~~~~--------~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  344 (361)
                      ....        ..... ........+     +..+..+.+|+.+||+.||.+|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1000        00000 000000111     1234578999999999999999999999973

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-50  Score=361.74  Aligned_cols=263  Identities=20%  Similarity=0.257  Sum_probs=202.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCeeEEEEEe
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~  143 (361)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... ..+++..|+++++.++|+|+ +.+..++.+....++||||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            468999999999999999999976 89999999876543 33468899999999987665 4555666788899999999


Q ss_pred             CCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEecc---CCceEEecccc
Q 018071          144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDL  220 (361)
Q Consensus       144 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~---~~~~kl~Dfg~  220 (361)
                      + +++|.+.+.....        .+++..++.++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+
T Consensus        85 ~-~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~  152 (299)
T d1ckia_          85 L-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  152 (299)
T ss_dssp             C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred             c-CCchhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCc
Confidence            9 5577666654332        3999999999999999999999998   999999999999863   45799999999


Q ss_pred             CCCCccccc-----cccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhh-hhccc
Q 018071          221 SNQAPDMAA-----RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-WATPK  294 (361)
Q Consensus       221 a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~-~~~~~  294 (361)
                      ++.......     ........||+.|+|||++.+..++.++|||||||++|||++|+.||............. .....
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ckia_         153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  232 (299)
T ss_dssp             CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred             ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc
Confidence            986543221     122345689999999999999999999999999999999999999997654322211110 00000


Q ss_pred             CCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhc
Q 018071          295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA  351 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~  351 (361)
                           .. .....    ....++.++.+++.+||+.+|++||++.++.+.|+.++..
T Consensus       233 -----~~-~~~~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         233 -----MS-TPIEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             -----HH-SCHHH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -----CC-CChhH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence                 00 00000    1112456799999999999999999999999999988654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-51  Score=372.75  Aligned_cols=266  Identities=23%  Similarity=0.305  Sum_probs=200.0

Q ss_pred             HhhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCcceeeeEEEeCC-----
Q 018071           65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----  135 (361)
Q Consensus        65 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----  135 (361)
                      +.++|++++.||+|+||+||+|..+ +|+.||||++.+....   .+.+.+|+++|+.++|||||+++++|....     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3578999999999999999999986 8999999999764433   346789999999999999999999997654     


Q ss_pred             -eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceE
Q 018071          136 -SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK  214 (361)
Q Consensus       136 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~k  214 (361)
                       ..++||||+ +.+|..++....          +++..++.++.||+.||+|||+++   |+||||||+|||++.++.+|
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~k  161 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK  161 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred             ceEEEEEecc-cccHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccc
Confidence             469999999 668888876543          999999999999999999999998   99999999999999999999


Q ss_pred             EeccccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 018071          215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP  293 (361)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~  293 (361)
                      |+|||+++....     ..+...||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+...............
T Consensus       162 l~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~  236 (346)
T d1cm8a_         162 ILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  236 (346)
T ss_dssp             ECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence            999999976533     23567799999999998864 568999999999999999999999976543221111111101


Q ss_pred             cCCch--------h---hhhhcccccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhH
Q 018071          294 KLSED--------K---VRQCVDARLG---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA--LQPLL  349 (361)
Q Consensus       294 ~~~~~--------~---~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~  349 (361)
                      .....        .   ..........   .......+..+.+||.+||..||.+|||++|+++.  |+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            10000        0   0000000000   01122345678899999999999999999999983  55544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-51  Score=373.08  Aligned_cols=267  Identities=23%  Similarity=0.272  Sum_probs=197.8

Q ss_pred             cCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcceeeeEEEeC------CeeEEE
Q 018071           68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------TSRVLA  140 (361)
Q Consensus        68 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~~~~lv  140 (361)
                      +|...++||+|+||+||+|+++ +|+.||||++.+....   ..+|+.++++++||||+++++++...      ...++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            6888999999999999999987 8999999999765432   34799999999999999999998643      347899


Q ss_pred             EEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-ceEEeccc
Q 018071          141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFD  219 (361)
Q Consensus       141 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~Dfg  219 (361)
                      ||||+++.+..+.....      ....+++..++.++.||+.||+|||++|   |+||||||+|||++.++ .+||+|||
T Consensus        98 ~Ey~~~~~~~~l~~~~~------~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSR------AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             EECCSEEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             EeccCCccHHHHHhhhh------ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEeccc
Confidence            99997654433332111      1124999999999999999999999998   99999999999999775 89999999


Q ss_pred             cCCCCccccccccccccccCCCCCCchhhcc-CCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccCCch
Q 018071          220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED  298 (361)
Q Consensus       220 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +++......   .....+||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||...........+.........+
T Consensus       169 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         169 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             TCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             chhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence            987653322   2345689999999998875 478999999999999999999999997554322111111110111111


Q ss_pred             hhhhhcccc------------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhH
Q 018071          299 KVRQCVDAR------------LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLL  349 (361)
Q Consensus       299 ~~~~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~  349 (361)
                      .+.......            .........+..+.+|+.+||+.||++|||+.|+++  .|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            111111000            000112234567999999999999999999999997  455553

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=365.38  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=205.5

Q ss_pred             hcCCCCCccccCCceEEEEEEEC----CCCEEEEEEcCCC-----CCChHHHHHHHHHHhcCCC-CCcceeeeEEEeCCe
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTS  136 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~  136 (361)
                      ++|++.+.||+|+||+||+|...    +|+.||||++.+.     ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999852    6899999998643     2334678899999999976 899999999999999


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .+++|||+.+|+|.+++.....         +++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~  171 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLT  171 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEES
T ss_pred             eeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEe
Confidence            9999999999999999977652         789999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccC--CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK  294 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~  294 (361)
                      |||+++....... .......|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||...........+.     
T Consensus       172 DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~-----  245 (322)
T d1vzoa_         172 DFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-----  245 (322)
T ss_dssp             CSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH-----
T ss_pred             eccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence            9999976543222 223557799999999999765  46889999999999999999999997654432211111     


Q ss_pred             CCchhhhhhcccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018071          295 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK  343 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~  343 (361)
                            ......  ....+...+.++.+|+.+||+.||.+|||     ++|+++
T Consensus       246 ------~~~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         246 ------RRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------HhcccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                  111111  12344556788999999999999999994     788886

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-49  Score=363.02  Aligned_cols=257  Identities=16%  Similarity=0.250  Sum_probs=199.1

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCcceeeeEEEe--CCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVD--GTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~e  142 (361)
                      ++|+++++||+|+||+||+|+.+ +|+.||||+++..  ..+++.+|+.+|+.++ ||||+++++++..  ....++|||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            68999999999999999999986 8999999998653  3568899999999995 9999999999984  456899999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCC-ceEEeccccC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLS  221 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~Dfg~a  221 (361)
                      ||.+++|.++..            .+++..++.++.||+.||+|||++|   |+||||||+|||++.++ .+||+|||++
T Consensus       113 ~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a  177 (328)
T d3bqca1         113 HVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA  177 (328)
T ss_dssp             CCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred             ecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccc
Confidence            999999977642            2899999999999999999999998   99999999999998655 6999999999


Q ss_pred             CCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhh--h---------
Q 018071          222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV--T---------  289 (361)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~--~---------  289 (361)
                      +......   .....+||+.|+|||.+.+. .++.++||||+||++|+|++|+.||............  .         
T Consensus       178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~  254 (328)
T d3bqca1         178 EFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  254 (328)
T ss_dssp             EECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             eeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence            7654322   23566789999999998865 5799999999999999999999999754432110000  0         


Q ss_pred             hh-cc-cCCchhhhhhcc--------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          290 WA-TP-KLSEDKVRQCVD--------ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       290 ~~-~~-~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                      +. .. ............        ...........+.++.+||.+||+.||.+|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00 00 000000000000        00111112234567899999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=355.52  Aligned_cols=263  Identities=19%  Similarity=0.250  Sum_probs=204.3

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCcceeeeEEEeCCeeEEEEE
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE  142 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  142 (361)
                      ++|++++.||+|+||+||+|+++ +++.||||+++....   ...++.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999986 899999999865432   24678899999999999999999999999999999999


Q ss_pred             eCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       143 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                      ++.+++|..++....         .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++
T Consensus        82 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~  149 (292)
T d1unla_          82 FCDQDLKKYFDSCNG---------DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             CCSEEHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ecccccccccccccc---------ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhh
Confidence            999999888876554         3899999999999999999999998   9999999999999999999999999997


Q ss_pred             CCccccccccccccccCCCCCCchhhccCC-CCCccceecHHHHHHHHHhCCCCCCCCCCccc-chhhhhhcccCCchh-
Q 018071          223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSLVTWATPKLSEDK-  299 (361)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~-  299 (361)
                      .......  ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||........ ...+........... 
T Consensus       150 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (292)
T d1unla_         150 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             ECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred             cccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence            6543221  234456788999999988664 68999999999999999999999743322111 000000000000000 


Q ss_pred             --hhhhcc---------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          300 --VRQCVD---------ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       300 --~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                        .....+         ...........+..+.+|+.+||+.||.+|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000000         00111223345667899999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=363.51  Aligned_cols=260  Identities=20%  Similarity=0.208  Sum_probs=192.3

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCcceeeeEEEe------CC
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVD------GT  135 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hpniv~~~~~~~~------~~  135 (361)
                      .++|++.++||+|+||+||+|.++ +|+.||||++.+.....   .++.+|+.++++++||||++++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999987 89999999997654332   467899999999999999999999863      36


Q ss_pred             eeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEE
Q 018071          136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI  215 (361)
Q Consensus       136 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl  215 (361)
                      ..|+|||||.++ +.+.+..           .+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+|+
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~~-----------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl  160 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred             eeEEEEeccchH-HHHhhhc-----------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence            889999999765 4444432           2899999999999999999999998   999999999999999999999


Q ss_pred             eccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc--
Q 018071          216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP--  293 (361)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~--  293 (361)
                      +|||+++.....   ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+.....  
T Consensus       161 ~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~  237 (355)
T d2b1pa1         161 LDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_dssp             CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             echhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence            999998765432   234566799999999999999999999999999999999999999975542211111000000  


Q ss_pred             --------------------cCCchhhhhhcccccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018071          294 --------------------KLSEDKVRQCVDARLGG---DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK  343 (361)
Q Consensus       294 --------------------~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  343 (361)
                                          .................   ......+..+.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                00000111111111111   112345778999999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=365.66  Aligned_cols=265  Identities=25%  Similarity=0.326  Sum_probs=200.0

Q ss_pred             hhcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCcceeeeEEEeC-----Ce
Q 018071           66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS  136 (361)
Q Consensus        66 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~  136 (361)
                      .++|++.+.||+|+||+||+|.++ +|+.||||++.+.....   +++.+|+.+++.++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999976 89999999998654433   4678999999999999999999998633     33


Q ss_pred             eEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccCCceEEe
Q 018071          137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA  216 (361)
Q Consensus       137 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~  216 (361)
                      .+++|+++.+|+|.+++...+          +++..++.++.||+.||+|||++|   |+||||||+|||++.++.+|++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~----------l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEeecCCchhhhccccc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccccc
Confidence            466777888999999996543          999999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCCCCCCchhhccC-CCCCccceecHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccC
Q 018071          217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL  295 (361)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~  295 (361)
                      |||++.....     ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.........+.......
T Consensus       164 dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~  238 (348)
T d2gfsa1         164 DFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  238 (348)
T ss_dssp             CC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999876533     23456789999999987765 46889999999999999999999997654322111111110000


Q ss_pred             C--------chhhhhhcccccC-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHh
Q 018071          296 S--------EDKVRQCVDARLG-GDY-----PPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPL  348 (361)
Q Consensus       296 ~--------~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l  348 (361)
                      .        ............. ...     ....+..+.+||.+||+.||.+|||++|+++  .|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            0        0001111110000 000     0123567899999999999999999999997  34443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.2e-44  Score=328.38  Aligned_cols=272  Identities=18%  Similarity=0.225  Sum_probs=196.8

Q ss_pred             hcCCCCCccccCCceEEEEEEEC-CCCEEEEEEcCCCCCChHHHHHHHHHHhcCC-----------CCCcceeeeEEEe-
Q 018071           67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----------HENFVQLLGYCVD-  133 (361)
Q Consensus        67 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~~~~~~~~-  133 (361)
                      ++|+++++||+|+||+||+|+.+ +|+.||||++.+.....+.+.+|+++++.++           |+||+++++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            46999999999999999999986 8999999999876544567788999888775           4789999988753 


Q ss_pred             -CCeeEEEEEeCCCCcHH-HhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCceEeccC
Q 018071          134 -GTSRVLAYEFASNGSLH-DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDD  210 (361)
Q Consensus       134 -~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivHrDikp~Nill~~~  210 (361)
                       ....+++|+++..+... .......       ...+++..+..++.||+.||+|||+ .+   |+||||||+|||++.+
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYE-------HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV  162 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTT-------TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred             cccceeeeeeeccccccccccccccc-------ccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeecc
Confidence             45667777776555432 2222222       1248999999999999999999998 66   9999999999999866


Q ss_pred             C------ceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHHHHHHhCCCCCCCCCCccc
Q 018071          211 D------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ  284 (361)
Q Consensus       211 ~------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~  284 (361)
                      +      .++++|||.+.....     .....+||+.|+|||++.+..++.++||||+||++++|++|+.||........
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~  237 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  237 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence            5      499999999865432     23557799999999999999999999999999999999999999975432211


Q ss_pred             ch----hhhh--hcccCCchhh------hhhcc---------c----------ccCCCCCHHHHHHHHHHHHHccccCCC
Q 018071          285 QS----LVTW--ATPKLSEDKV------RQCVD---------A----------RLGGDYPPKAVAKMAAVAALCVQYEAD  333 (361)
Q Consensus       285 ~~----~~~~--~~~~~~~~~~------~~~~~---------~----------~~~~~~~~~~~~~l~~li~~cl~~~p~  333 (361)
                      ..    +...  ..........      ....+         .          ..........+..+.+|+.+||..||.
T Consensus       238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~  317 (362)
T d1q8ya_         238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  317 (362)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence            00    0000  0000000000      00000         0          001234567788999999999999999


Q ss_pred             CCCCHHHHHH--HHHHhHhcCC
Q 018071          334 FRPNMSIVVK--ALQPLLNARP  353 (361)
Q Consensus       334 ~RPs~~evl~--~L~~l~~~~~  353 (361)
                      +|||++|+++  .|++......
T Consensus       318 ~Rpta~e~L~Hp~f~~~~~~~~  339 (362)
T d1q8ya_         318 KRADAGGLVNHPWLKDTLGMEE  339 (362)
T ss_dssp             TCBCHHHHHTCGGGTTCTTCTT
T ss_pred             HCcCHHHHhcCcccCCCCCccc
Confidence            9999999997  3555544433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=2.2e-27  Score=197.92  Aligned_cols=168  Identities=14%  Similarity=0.122  Sum_probs=118.7

Q ss_pred             CCCCccccCCceEEEEEEECCCCEEEEEEcCCCCCC-------------------hHHHHHHHHHHhcCCCCCcceeeeE
Q 018071           70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-------------------DEEFLAQVSMVSRLKHENFVQLLGY  130 (361)
Q Consensus        70 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~e~~~l~~l~hpniv~~~~~  130 (361)
                      .+.+.||+|+||+||+|...+|+.||||+++.....                   .....+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            456789999999999999888999999987532110                   1233467888999999999988765


Q ss_pred             EEeCCeeEEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCceEeccC
Q 018071          131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD  210 (361)
Q Consensus       131 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivHrDikp~Nill~~~  210 (361)
                      .    ..+++|||+++..+.+                +++..+..++.|++.+|+|||+.|   |+||||||+|||++++
T Consensus        83 ~----~~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~  139 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE  139 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred             c----CCEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence            3    2379999998865533                333445688999999999999998   9999999999999865


Q ss_pred             CceEEeccccCCCCccccccccccccccCCCCCCchhhccCCCCCccceecHHHHH
Q 018071          211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL  266 (361)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l  266 (361)
                       .++|+|||++...............+   .. -.+ +....|+.++|+||+.--+
T Consensus       140 -~~~liDFG~a~~~~~~~~~~~l~rd~---~~-~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWREILERDV---RN-IIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHHHHHHHHH---HH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcHHHHHHHH---HH-HHH-HHcCCCCCcccHHHHHHHH
Confidence             48999999986543221110000000   00 001 1235788999999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.91  E-value=3.9e-09  Score=90.33  Aligned_cols=148  Identities=19%  Similarity=0.143  Sum_probs=104.0

Q ss_pred             HHHHHHhhcCCCCCccccCCceEEEEEEECCCCEEEEEEcCCC-CCChHHHHHHHHHHhcCC-CCCcceeeeEEEeCCee
Q 018071           60 DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSR  137 (361)
Q Consensus        60 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~  137 (361)
                      .+++.....|++.+..+.++.+.||+.... +..+++|+.... ......+.+|...++.+. +-.+.+++.+..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            467777888888777666666889988754 667788877543 233446778888887764 43467778888888899


Q ss_pred             EEEEEeCCCCcHHHhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------
Q 018071          138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--------------------------  191 (361)
Q Consensus       138 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------------------------  191 (361)
                      ++||++++|.++.+.....           ..   ...++.+++..++.||+..                          
T Consensus        86 ~lv~~~l~G~~~~~~~~~~-----------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE-----------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC-----------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             EEEEEeccccccccccccc-----------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence            9999999998886554221           11   2234455556666666421                          


Q ss_pred             ------------------------------CCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          192 ------------------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       192 ------------------------------~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                                                    ...++|+|+.|.|||+++++..-|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                          1137999999999999877666799999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.46  E-value=1.3e-07  Score=80.04  Aligned_cols=74  Identities=12%  Similarity=0.004  Sum_probs=54.1

Q ss_pred             cccCC-ceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCC--CCCcceeeeEEEeCCeeEEEEEeCCCCcHH
Q 018071           75 IGEGS-YGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASNGSLH  150 (361)
Q Consensus        75 lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  150 (361)
                      +..|. .+.||+....++..+++|......  ...+..|...++.+.  .-.+.+++.+..+++..++||++++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            44444 367999998888889999865443  335777888887764  233667788888888899999999886553

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.16  E-value=6.6e-06  Score=74.04  Aligned_cols=74  Identities=19%  Similarity=0.067  Sum_probs=48.7

Q ss_pred             CccccCCceEEEEEEEC-CCCEEEEEEcCC--------CCCChHHHHHHHHHHhcCC-C-C-CcceeeeEEEeCCeeEEE
Q 018071           73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDA--------SKQPDEEFLAQVSMVSRLK-H-E-NFVQLLGYCVDGTSRVLA  140 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--------~~~~~~~~~~e~~~l~~l~-h-p-niv~~~~~~~~~~~~~lv  140 (361)
                      +.||.|....||++... +++.+++|.-..        ......+...|.+.++.+. + | .+.+++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            46899999999999865 577899996432        1123345667888887663 2 3 34555544  55667899


Q ss_pred             EEeCCCCc
Q 018071          141 YEFASNGS  148 (361)
Q Consensus       141 ~e~~~~g~  148 (361)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.67  E-value=0.00056  Score=59.29  Aligned_cols=68  Identities=10%  Similarity=0.041  Sum_probs=49.5

Q ss_pred             ceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCC-----cceee--eEEEeCCeeEEEEEeCCCC
Q 018071           80 YGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-----FVQLL--GYCVDGTSRVLAYEFASNG  147 (361)
Q Consensus        80 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn-----iv~~~--~~~~~~~~~~lv~e~~~~g  147 (361)
                      -..||++..++|..|++|+........+++..|...+..|...+     .+..-  ..+......+.+++++.|.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            46899999999999999999877777788899998887774211     11111  1334567778899999763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.65  E-value=0.00022  Score=61.56  Aligned_cols=165  Identities=14%  Similarity=0.100  Sum_probs=87.4

Q ss_pred             ccCHHHHHHHhhcCCCCCccc-----cCCceEEEEEEECCCCEEEEEEcCCCCCChHHHHHHHHHHhcCCC-----CCcc
Q 018071           56 AISVDELKEITENFGTNALIG-----EGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-----ENFV  125 (361)
Q Consensus        56 ~~~~~~~~~~~~~y~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-----pniv  125 (361)
                      .++.++++.+..+|.++++..     .|--.+.|+....+| .+++|+.... ....++..|++++..|..     |..+
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccc
Confidence            467889999999999876543     555688899988755 5899988653 233455666777666632     2222


Q ss_pred             eee---eEEEeCCeeEEEEEeCCCCcHH--------------HhhhcCCCCCCCCCCCCCCHH-----------------
Q 018071          126 QLL---GYCVDGTSRVLAYEFASNGSLH--------------DILHGRKGVKGAQPGPVLSWQ-----------------  171 (361)
Q Consensus       126 ~~~---~~~~~~~~~~lv~e~~~~g~L~--------------~~l~~~~~~~~~~~~~~l~~~-----------------  171 (361)
                      ...   .+..-......++.+..+....              ..++.................                 
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            211   1222345566677776653221              011100000000000001110                 


Q ss_pred             -HHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCceEeccCCceEEeccccCC
Q 018071          172 -QRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN  222 (361)
Q Consensus       172 -~~~~i~~qi~~al~~LH~~-~~~~ivHrDikp~Nill~~~~~~kl~Dfg~a~  222 (361)
                       .....+..+...+...+.. -...+||+|+.++||+++.+...-|+||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             1112222222223332221 12249999999999999988777899999764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.53  E-value=0.00013  Score=65.44  Aligned_cols=72  Identities=13%  Similarity=0.180  Sum_probs=49.3

Q ss_pred             CccccCCceEEEEEEECC--------CCEEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCeeEEEEEe
Q 018071           73 ALIGEGSYGRVYYGILKS--------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEF  143 (361)
Q Consensus        73 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~  143 (361)
                      +.|+.|-.-.+|++...+        ...|.+++... ........+|..+++.+.-.++ .++++++.+    .+|+||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            468888889999998653        35677777653 3344566788888888853344 466666532    689999


Q ss_pred             CCCCcH
Q 018071          144 ASNGSL  149 (361)
Q Consensus       144 ~~~g~L  149 (361)
                      ++|..|
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            987544